protein,imputed,n,average_expression,proportional_expression,foldchange,log2_foldchange,p_value,adj_p_value,normalization,abundance_control_1,abundance_control_2,abundance_control_3,abundance_knockdown_1,abundance_knockdown_2,abundance_knockdown_3,description,biological_process,cellular_component,molecular_function,gene_id_entrez,gene_name,wiki_pathway,reactome_pathway,gene_id_ensemble
Q5SVJ8,0.3333333333333333,6,755886.14111328125,2.9259944407410473e-6,52.112573032503505,5.703559583769082,1,1,raw,32688.91796875,1257341.5,30010.521484375,NA,1703503.625,NA,BK channel OS=Homo sapiens OX=9606 GN=KCNMA1 PE=1 SV=2,conjugation,cytoplasm;cytoskeleton,catalytic activity,NA,KCNMA1,Splicing factor NOVA regulated synaptic proteins,NA,ENSG00000156113
Q15011,0,6,4919331.8125,1.9042467843551092e-5,48.62284101543182,5.6035622868786215,1,1,raw,142625.28125,NA,NA,6934846.375,4679589.53125,7920266.0625,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein OS=Homo sapiens OX=9606 GN=HERPUD1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,9709,HERPUD1,VEGFA-VEGFR2 signaling pathway; Exercise-induced circadian regulation,ATF4 activates genes in response to endoplasmic reticulum  stress,ENSG00000051108
F6SA91,0.16666666666666666,6,879217.87109375,3.4034049086169838e-6,39.64303290359079,5.308995435504322,1,1,raw,NA,43265.3671875,NA,NA,1715170.375,NA,TNF receptor-associated factor OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,development;metabolic process,cytosol;membrane,antioxidant activity;structural molecule activity,NA,TRAF4,Small cell lung cancer; p53 transcriptional gene network,NA,ENSG00000076604
Q9NXV2,0,6,3103100.40625,1.2011934131212043e-5,19.63113476730982,4.295071664321758,0.004166260710061297,0.6429522395902524,raw,250906.71875,223317.671875,1541568.640625,5743636.53125,4383979.3125,6475193.5625,BTB/POZ domain-containing protein KCTD5 OS=Homo sapiens OX=9606 GN=KCTD5 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,54442,KCTD5,NA,NA,ENSG00000167977
Q13751,0,6,1072517.087890625,4.151655740302085e-6,11.925955200028053,3.576032917273675,1,1,raw,NA,109616.0703125,NA,1307276.34375,1267339.625,1605836.3125,Laminin subunit beta-3 OS=Homo sapiens OX=9606 GN=LAMB3 PE=1 SV=1,cell communication;cell growth;defense response;metabolic process,cell surface;chromosome,enzyme regulator activity;structural molecule activity,3914,LAMB3,Alpha 6 beta 4 signaling pathway; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Small cell lung cancer; Malignant pleural mesothelioma,Degradation of the extracellular matrix; Non-integrin membrane-ECM interactions; Laminin interactions; MET activates PTK2 signaling; Anchoring fibril formation; Type I hemidesmosome assembly,ENSG00000196878
O00308,0,6,733271.7421875,2.8384553234871175e-6,10.137466396525822,3.341625227120697,1,1,raw,175167.4296875,NA,187676.171875,NA,NA,1836971.625,NEDD4-like E3 ubiquitin-protein ligase WWP2 OS=Homo sapiens OX=9606 GN=WWP2 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,11060,WWP2,NA,RHOQ GTPase cycle; Regulation of PTEN stability and activity; RHOJ GTPase cycle; NOTCH3 Activation and Transmission of Signal to the Nucleus; RHOU GTPase cycle,ENSG00000198373
Q9BY50,0,6,2049680.1171875,7.934201068106747e-6,9.754702958926417,3.2860979419057035,1,1,raw,NA,NA,297960.6875,2906518,1700474.5625,3293767.21875,Signal peptidase complex catalytic subunit SEC11C OS=Homo sapiens OX=9606 GN=SEC11C PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,90701,SEC11C,NA,"SRP-dependent cotranslational protein targeting to membrane; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP); Synthesis, secretion, and deacylation of Ghrelin",ENSG00000166562
Q8TBM8,0.3333333333333333,6,3374207.1145833335,1.3061373561683168e-5,8.717821154586485,3.1239676072204983,0.004373588384430993,0.6429522395902524,raw,465368.15625,1666471.25,658408.34375,5739886.1875,4817677.9375,6897430.8125,DnaJ homolog subfamily B member 14 OS=Homo sapiens OX=9606 GN=DNAJB14 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;extracellular;membrane,structural molecule activity,79982,DNAJB14,NA,NA,ENSG00000164031
Q5JUW8,0,6,1745372.6223958333,6.756243185819272e-6,7.982569822410107,2.996853266900193,0.023211883046773425,0.6429522395902524,raw,668091.46875,169792.015625,415131.3125,3313814.6875,2151800.3125,3753605.9375,"Discs, large homolog 3 (Neuroendocrine-dlg, Drosophila), isoform CRA_b OS=Homo sapiens OX=9606 GN=DLG3 PE=1 SV=1",NA,NA,NA,NA,DLG3,NA,NA,ENSG00000082458
Q5T9L3,0.16666666666666666,6,961925.59375,3.723562037496361e-6,7.9707989332363445,2.994724336417917,1,1,raw,NA,214457.0625,NA,NA,NA,1709394.125,Protein wntless homolog OS=Homo sapiens OX=9606 GN=WLS PE=1 SV=2,cell death;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,79971,WLS,NA,WNT ligand biogenesis and trafficking,ENSG00000116729
Q03938,0.5,6,160268.03662109375,6.203889166311947e-7,7.464763829187416,2.90009661697737,0.22373656193170513,0.7125799511687476,raw,NA,138453.203125,18309.974609375,243098.6875,NA,241210.28125,Zinc finger protein 90 OS=Homo sapiens OX=9606 GN=ZNF90 PE=2 SV=3,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,7643,ZNF90,NA,NA,ENSG00000213988
O95833,0.16666666666666666,6,3424853.2447916665,1.32574219972536e-5,7.12737601668001,2.833371038172116,0.02983218414527696,0.6429522395902524,raw,549399.65625,768449.828125,1193801.390625,7902578.5625,4657859.15625,5477030.875,Chloride intracellular channel protein 3 OS=Homo sapiens OX=9606 GN=CLIC3 PE=1 SV=2,conjugation;development;metabolic process,cytoskeleton;membrane;nucleus,catalytic activity,9022,CLIC3,NA,NA,ENSG00000169583
Q9Y385,0,6,1415381.1979166667,5.4788641984281575e-6,7.104180101255999,2.8286681565606697,0.012625102155397057,0.6429522395902524,raw,362818.828125,485948.71875,270601.25,2746177.5625,1922400.015625,2704340.8125,Ubiquitin-conjugating enzyme E2 J1 OS=Homo sapiens OX=9606 GN=UBE2J1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;extracellular;membrane,structural molecule activity,51465,UBE2J1,Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000198833
Q14534,0.3333333333333333,6,4560341.53125,1.7652835847294996e-5,7.020782208563216,2.8116317749099564,0.015423862857352595,0.6429522395902524,raw,1259314.421875,1210312.59375,1157762.671875,8497341.125,6246440.25,8990878.125,Squalene monooxygenase OS=Homo sapiens OX=9606 GN=SQLE PE=1 SV=3,cell growth;cellular homeostasis;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,6713,SQLE,Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Statin inhibition of cholesterol production; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,ENSG00000104549
Q9Y536,0.3333333333333333,6,303009.033203125,1.1729316075842592e-6,6.748215190314311,2.7545059797086586,0.2917035392225426,0.7730231021500684,raw,307525.09375,NA,33704.9140625,403701.0625,467105.0625,NA,Peptidyl-prolyl cis-trans isomerase A-like 4A OS=Homo sapiens OX=9606 GN=PPIAL4A PE=2 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,nucleus,structural molecule activity,653505,PPIAL4A,NA,NA,ENSG00000263353
O00214,0.3333333333333333,6,1332337.0078125,5.157404622224314e-6,6.487782666558195,2.697725491699087,0.00817691816810148,0.6429522395902524,raw,354546.21875,250573.671875,494382.40625,2683800.1875,2300218.8125,1910500.75,Galectin-8 OS=Homo sapiens OX=9606 GN=LGALS8 PE=1 SV=4,cellular homeostasis;coagulation;defense response;metabolic process,cell surface;cytosol;nucleus,antioxidant activity;structural molecule activity,3964,LGALS8,NA,NA,ENSG00000116977
Q9Y4C2,0,6,7289388.690104167,2.8216830053574193e-5,5.7805178322401325,2.5311987384943864,0.015167739346754106,0.6429522395902524,raw,1534409.859375,2301051.6875,2689719.625,13301270.3125,9592103.875,14317776.78125,TRPM8 channel-associated factor 1 OS=Homo sapiens OX=9606 GN=TCAF1 PE=1 SV=3,metabolic process,cytoplasm;cytoskeleton,structural molecule activity,9747,TCAF1,NA,NA,ENSG00000198420
Q8WU67,0.16666666666666666,6,960149.6,3.7166872615788697e-6,5.772392708958239,2.5291694529812196,0.07629772308603569,0.6429522395902524,raw,276079.84375,NA,258474.15625,784629.5,1541154.25,1940410.25,Phospholipase ABHD3 OS=Homo sapiens OX=9606 GN=ABHD3 PE=2 SV=2,cellular homeostasis,cytoplasm;cytoskeleton,structural molecule activity,171586,ABHD3,NA,Synthesis of PC,ENSG00000158201
Q9H6H4,0,6,2328479.203125,9.013417276959762e-6,5.7226254094454,2.5166771743126284,0.25517348193606865,0.735366952583477,raw,426298.25,3598575.8125,518765.75,2968702.0625,2756853.71875,3701679.625,Receptor expression-enhancing protein 4 OS=Homo sapiens OX=9606 GN=REEP4 PE=1 SV=1,cell differentiation;cell growth;metabolic process,cytoskeleton;endoplasmic reticulum;extracellular,motor activity,80346,REEP4,NA,NA,ENSG00000168476
Q96BQ5,0.3333333333333333,6,746880.83125,2.891135372471449e-6,5.566204425474218,2.4766938943328527,0.171553428094692,0.6688917965646828,raw,280538.03125,294437.5625,225828.21875,1800666.5625,1132933.78125,NA,Coiled-coil domain-containing protein 127 OS=Homo sapiens OX=9606 GN=CCDC127 PE=1 SV=1,NA,NA,NA,133957,CCDC127,NA,NA,ENSG00000164366
P84022,0.16666666666666666,6,802127.3046875,3.104991488302056e-6,5.487636303879525,2.456184869270111,0.08612228105002519,0.6429522395902524,raw,363594.75,182647.71875,191040.296875,756055,1324150.3125,1995275.75,Mothers against decapentaplegic homolog 3 OS=Homo sapiens OX=9606 GN=SMAD3 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,4088,SMAD3,Androgen receptor signaling pathway; Cell cycle; AGE/RAGE pathway; Adipogenesis; Endoderm differentiation; Mesodermal commitment pathway; Extracellular vesicle-mediated signaling in recipient cells; Mesodermal commitment pathway; Ovarian infertility; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Canonical and non-canonical TGF-B signaling; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; Pancreatic adenocarcinoma pathway; Neovascularisation processes; Vitamin D in inflammatory diseases; Envelope proteins and their potential roles in EDMD physiopathology; Hippo signaling regulation pathways; Hepatitis B infection; TGF-beta receptor signaling in skeletal dysplasias; Overlap between signal transduction pathways contributing to LMNA laminopathies; Angiotensin II receptor type 1 pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Progeria-associated lipodystrophy; GDNF signaling; TGF-beta receptor signaling; DNA damage response (only ATM dependent),"Ub-specific processing proteases; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Signaling by NODAL; FOXO-mediated transcription of cell cycle genes; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity; Germ layer formation at gastrulation; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; RUNX3 regulates BCL2L11 (BIM) transcription; Signaling by Activin; SMAD2/3 Phosphorylation Motif Mutants in Cancer; TGFBR1 KD Mutants in Cancer; Interleukin-37 signaling; RUNX3 regulates CDKN1A transcription; NOTCH4 Intracellular Domain Regulates Transcription; SMAD4 MH2 Domain Mutants in Cancer; SMAD2/3 MH2 Domain Mutants in Cancer",ENSG00000166949
Q5BJH2,0.16666666666666666,6,700618.3645833334,2.7120558617897622e-06,4.9424179786050395,2.3052170240543046,0.011997471306617156,0.6429522395902524,raw,509242.5625,238918.703125,159274.703125,1180836.09375,828623.6875,1286814.4375,Transmembrane protein 128 OS=Homo sapiens OX=9606 GN=TMEM128 PE=1 SV=2,NA,cytoskeleton,NA,85013,TMEM128,NA,NA,ENSG00000132406
Q5VZF2,0.16666666666666666,6,1336552.1354166667,5.173721153598525e-6,4.821231842573981,2.269401807475183,0.015737242375902395,0.6429522395902524,raw,400858.5,529877.46875,457067.46875,2315794.0625,1761053.1875,2554662.125,Muscleblind-like protein 2 OS=Homo sapiens OX=9606 GN=MBNL2 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,10150,MBNL2,NA,NA,ENSG00000139793
C9JYS5,0,6,2007122.9166666667,7.769464442622304e-6,4.778278913760793,2.2564910680586627,0.05379010219839893,0.6429522395902524,raw,836280.25,677282.375,770707.3125,4021260.75,2054552.3125,3682654.5,Golgi apparatus membrane protein TVP23 homolog OS=Homo sapiens OX=9606 GN=TVP23C PE=1 SV=1,NA,cytoskeleton,NA,NA,TVP23C,NA,NA,ENSG00000175106
Q99988,0,6,4036224.5885416665,1.562400745998772e-5,4.692952369543431,2.230495818011137,0.0017806865401509815,0.6429522395902524,raw,1318580.328125,1207802.890625,2017077.1875,6936046.8125,5668161.4375,7069678.875,Growth/differentiation factor 15 OS=Homo sapiens OX=9606 GN=GDF15 PE=1 SV=3,cell death;development;metabolic process,cell surface;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,9518,GDF15,Epithelial to mesenchymal transition in colorectal cancer,NA,ENSG00000130513
Q8TEY7,0.16666666666666666,6,667239.609375,2.582848502550981e-6,4.6657231236138665,2.222100696511753,1,1,raw,NA,160631.25,NA,1242607.8125,516258.4375,749460.9375,Ubiquitin carboxyl-terminal hydrolase 33 OS=Homo sapiens OX=9606 GN=USP33 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,23032,USP33,NA,Ub-specific processing proteases; Regulation of expression of SLITs and ROBOs,ENSG00000077254
Q8IZ52,0,6,2414902.72265625,9.347958054920415e-6,4.497503966067735,2.1691245536999326,0.0066627198520635,0.6429522395902524,raw,365390.90625,1323326.84375,829689.6796875,3731532.625,3383537.65625,4855938.625,Chondroitin sulfate synthase 2 OS=Homo sapiens OX=9606 GN=CHPF PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytoskeleton;cytosol;endosome;extracellular,structural molecule activity,79586,CHPF,NA,Chondroitin sulfate biosynthesis,ENSG00000123989
O14763,0,6,957522.378125,3.7065174275486794e-6,4.4699047523379365,2.1602440898439954,0.10253744810224477,0.6429522395902524,raw,NA,190450.328125,580956.703125,1445076.96875,1228861.78125,1342266.109375,Tumor necrosis factor receptor superfamily member 10B OS=Homo sapiens OX=9606 GN=TNFRSF10B PE=1 SV=2,coagulation;development;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,8795,TNFRSF10B,miRNA regulation of DNA damage response; Apoptosis modulation and signaling; Apoptosis; Apoptosis-related network due to altered Notch3 in ovarian cancer; miRNA regulation of p53 pathway in prostate cancer; Unfolded protein response; p53 transcriptional gene network; DNA damage response,Cell surface interactions at the vascular wall; Regulation by c-FLIP; RIPK1-mediated regulated necrosis; CASP8 activity is inhibited; TP53 Regulates Transcription of Death Receptors and Ligands; Dimerization of procaspase-8; TRAIL  signaling,ENSG00000120889
O00399,0,6,2941508.8125,1.1386421796395831e-5,4.465713573337601,2.158890721026685,0.031031203131896855,0.6429522395902524,raw,859690.5,2165612.6875,682072.9375,5541171.25,3045942.375,5354563.125,Dynactin subunit 6 OS=Homo sapiens OX=9606 GN=DCTN6 PE=1 SV=1,cell differentiation;cell growth,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,10671,DCTN6,NA,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic,ENSG00000104671
Q86UL3,0,6,980705.578125,3.7962583430504253e-6,4.451259680133549,2.1542136680138886,0.137100391220898,0.654928512316515,raw,644900.125,344028.5625,122034.328125,2186866.1875,543206.484375,2043197.78125,Glycerol-3-phosphate acyltransferase 4 OS=Homo sapiens OX=9606 GN=GPAT4 PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cytoskeleton;extracellular,structural molecule activity,137964,GPAT4,Glycerolipids and glycerophospholipids; IL-18 signaling pathway,Synthesis of PA,ENSG00000158669
Q9H7M9,0.5,6,1521109.375,5.8881322634834155e-6,4.381546757088253,2.1314402544969258,0.0032502622202340748,0.6429522395902524,raw,548394.125,305064.46875,1024113.84375,2402814.5,2108224.8125,2738044.5,V-type immunoglobulin domain-containing suppressor of T-cell activation OS=Homo sapiens OX=9606 GN=VSIR PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton,DNA binding;structural molecule activity,64115,VSIR,NA,NA,ENSG00000107738
Q14451,0,6,1507116.1875,5.833965390185614e-6,4.293815849420251,2.1022603190902323,0.030790721153689297,0.6429522395902524,raw,524041.25,798860.4375,319722.28125,3248631.3125,1901305.21875,2250136.625,Growth factor receptor-bound protein 7 OS=Homo sapiens OX=9606 GN=GRB7 PE=1 SV=2,cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,RNA binding;structural molecule activity,2886,GRB7,Kit receptor signaling pathway; RAC1/PAK1/p38/MMP2 pathway,RET signaling; Signaling by SCF-KIT; Downstream signal transduction; Tie2 Signaling; RND1 GTPase cycle; GRB7 events in ERBB2 signaling,ENSG00000141738
Q9NPA0,0,6,4178640.1979166665,1.6175290594630546e-5,4.2525929724053375,2.0883427771848133,0.007493341819982616,0.6429522395902524,raw,1394049.375,2229526.90625,1389268.90625,6196503.5625,5907995.1875,7954497.25,ER membrane protein complex subunit 7 OS=Homo sapiens OX=9606 GN=EMC7 PE=1 SV=1,cell growth,cytoskeleton;extracellular,structural molecule activity,56851,EMC7,NA,NA,ENSG00000134153
Q8WWA1,0,6,606918.928125,2.3493504022428263e-6,4.1659549903143835,2.05864725234039,0.11611392921058548,0.6429522395902524,raw,185556.765625,NA,239498.40625,439604.4375,871121.40625,1298813.625,Transmembrane protein 40 OS=Homo sapiens OX=9606 GN=TMEM40 PE=1 SV=2,NA,cytoskeleton,NA,55287,TMEM40,NA,NA,ENSG00000088726
P07910,0,6,552574.75625,2.138987047043944e-6,4.1498350713396865,2.0530539999562896,0.2862697284595483,0.7655844406429082,raw,325892.34375,150438.671875,314719.6875,1343349.953125,NA,628473.125,Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens OX=9606 GN=HNRNPC PE=1 SV=4,cellular component movement;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,3183,HNRNPC,mRNA processing,SUMOylation of RNA binding proteins; mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,ENSG00000092199
Q13438,0,6,15797879.296875,6.115273780529186e-5,4.127544676794125,2.045283831041742,0.009937751232861803,0.6429522395902524,raw,5123626.953125,6895819.109375,5845080.1875,28209084.46875,21147999.15625,27565665.90625,Protein OS-9 OS=Homo sapiens OX=9606 GN=OS9 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;extracellular,structural molecule activity,10956,OS9,NA,ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis; ER Quality Control Compartment (ERQC),ENSG00000135506
Q9NXF1,0,6,1740468.41796875,6.737259275267918e-6,4.052421066228601,2.018784084948342,0.09142537755603768,0.6429522395902524,raw,1413113.375,332527.3359375,674271.828125,3139765.9375,1347540.78125,3535591.25,Testis-expressed protein 10 OS=Homo sapiens OX=9606 GN=TEX10 PE=1 SV=2,NA,endosome;membrane,NA,54881,TEX10,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000136891
P48651,0,6,2095845.6041666667,8.112905175654212e-6,4.0270054183776836,2.0097074134461588,0.10124025915731287,0.6429522395902524,raw,2138165.15625,405125.875,502162.53125,3540252.9375,1631444.09375,4357923.03125,Phosphatidylserine synthase 1 OS=Homo sapiens OX=9606 GN=PTDSS1 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,9791,PTDSS1,Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids,Synthesis of PS,ENSG00000156471
A0A087X117,0,6,1731470.828125,6.702430090777108e-6,3.99189204701334,1.9970727063103508,0.006880361542044716,0.6429522395902524,raw,544473.125,1079433.84375,577295.75,2915297.4375,2173477.9375,3098846.875,Nodal modulator 1 OS=Homo sapiens OX=9606 GN=NOMO1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
O95674,0,6,2810950.0885416665,1.0881036025028607e-5,3.9591558126695774,1.9851928457823411,0.044572776057125015,0.6429522395902524,raw,898531.3125,2843655.03125,999649.84375,4456541.875,3557425.46875,4109897,Phosphatidate cytidylyltransferase 2 OS=Homo sapiens OX=9606 GN=CDS2 PE=1 SV=1,cell growth;cellular homeostasis,cytoskeleton;endosome;extracellular,structural molecule activity,8760,CDS2,NA,Synthesis of PG,ENSG00000101290
Q9H8Y5,0,6,1169152.671875,4.5257268683950005e-6,3.9505265595132615,1.9820449606742971,0.0019059310148898225,0.6429522395902524,raw,726925.078125,239281.265625,476569.46875,1882700.34375,1644069.53125,2045370.34375,Ankyrin repeat and zinc finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKZF1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation,nucleus,structural molecule activity,55139,ANKZF1,NA,NA,ENSG00000163516
Q15036,0,6,3146970.15625,1.2181751564863684e-5,3.9258881937141337,1.9730190865404513,0.017143001740830117,0.6429522395902524,raw,1283560.65625,1764247.09375,969490.4375,5873608.4375,3806111.0625,5184803.25,Sorting nexin-17 OS=Homo sapiens OX=9606 GN=SNX17 PE=1 SV=1,cellular homeostasis;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,9784,SNX17,NA,NA,ENSG00000115234
Q9UIC8,0,6,1414421.5052083333,5.4751492797695515e-6,3.8628572137581814,1.9496683509298862,0.3052851104537144,0.7849075999456834,raw,2222486.625,401746.8125,367715.75,2045974.3125,2028172.09375,1420433.4375,Leucine carboxyl methyltransferase 1 OS=Homo sapiens OX=9606 GN=LCMT1 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,51451,LCMT1,NA,Cyclin A/B1/B2 associated events during G2/M transition,ENSG00000205629
Q86VQ0,0.6666666666666666,6,3229790.3,1.250234386972717e-5,3.7681553068112432,1.9138584277290775,0.1266923075335848,0.6467541459113174,raw,1188481.125,4222394.5,1257929.375,4843637.5,4636509,NA,Lebercilin OS=Homo sapiens OX=9606 GN=LCA5 PE=1 SV=2,cell growth;conjugation;metabolic process,endoplasmic reticulum;nucleus,structural molecule activity,167691,LCA5,Ciliary landscape; Ciliopathies; Bardet-Biedl syndrome,NA,ENSG00000135338
Q5JPE7,0,6,104982596.51822917,4.0638196294283364e-4,3.7544943246228364,1.9086186109391237,0.024330344824571793,0.6429522395902524,raw,49386856.765625,45207671.1875,44406549.1875,179462682.84375,126009145.6875,185422673.4375,Nodal modulator 2 OS=Homo sapiens OX=9606 GN=NOMO2 PE=1 SV=1,NA,cytoskeleton;extracellular;nucleus,protein binding;structural molecule activity,283820,NOMO2,NA,NA,ENSG00000185164
Q93063,0.3333333333333333,6,2755424.2682291665,1.0666098572527262e-5,3.752628667517531,1.9079015388165401,0.03203216608573067,0.6429522395902524,raw,808123.90625,1587737.109375,1114698.21875,5286207.09375,3032588.9375,4703190.34375,Exostosin-2 OS=Homo sapiens OX=9606 GN=EXT2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoskeleton;extracellular,structural molecule activity,2132,EXT2,Mesodermal commitment pathway; Mesodermal commitment pathway; Proteoglycan biosynthesis,"HS-GAG biosynthesis; Defective EXT2 causes exostoses 2; Defective EXT1 causes exostoses 1, TRPS2 and CHDS",ENSG00000151348
Q8NHH9,0,6,2241289.578125,8.675910946092844e-6,3.7419387899342897,1.9037859593856161,0.005841426204820088,0.6429522395902524,raw,1232420.65625,713807.375,969626.0625,3628281.375,2925563.375,3978038.625,Atlastin-2 OS=Homo sapiens OX=9606 GN=ATL2 PE=1 SV=2,cell growth,cytoskeleton;extracellular,structural molecule activity,64225,ATL2,NA,NA,ENSG00000119787
P30414,0,6,114836.0517578125,4.445241561713648e-7,3.691572846455237,1.8842356277527101,1,1,raw,NA,37373.74609375,NA,97693.1953125,137967.90625,186309.359375,NK-tumor recognition protein OS=Homo sapiens OX=9606 GN=NKTR PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,4820,NKTR,NA,NA,ENSG00000114857
O60337,0.16666666666666666,6,1218344.03125,4.716143964615017e-6,3.6406005828934513,1.8641764686902191,1,1,raw,NA,441364.96875,NA,2254707.75,958959.375,NA,E3 ubiquitin-protein ligase MARCHF6 OS=Homo sapiens OX=9606 GN=MARCHF6 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation,cytoskeleton;extracellular,structural molecule activity,10299,MARCHF6,NA,ER Quality Control Compartment (ERQC),ENSG00000145495
Q6UWE0,0,6,564705.1666666667,2.1859432108264928e-6,3.6282654528851332,1.859280010869523,0.267513207860323,0.7473260925206285,raw,338582.09375,187018.828125,157094.71875,268378.09375,678553.953125,1758603.3125,E3 ubiquitin-protein ligase LRSAM1 OS=Homo sapiens OX=9606 GN=LRSAM1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;nucleus,structural molecule activity,90678,LRSAM1,Intracellular trafficking proteins involved in CMT neuropathy,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000148356
Q8WVX9,0,6,12278639.40625,4.7529950198104246e-5,3.6045979979992073,1.8498383721895164,0.11393424603607058,0.6429522395902524,raw,4313978.0625,6197311.65625,4234812.71875,12840798.6875,30534778.625,15550156.6875,Fatty acyl-CoA reductase 1 OS=Homo sapiens OX=9606 GN=FAR1 PE=1 SV=1,cellular homeostasis,mitochondrion;nucleus,structural molecule activity,84188,FAR1,NA,Wax biosynthesis,ENSG00000197601
Q9NWU2,0,6,4916818.502604167,1.9032738956641964e-5,3.603960789277121,1.849583314863111,0.03439904449486527,0.6429522395902524,raw,2368319,2267879.078125,2272800.46875,8520508.4375,5536075.21875,8535328.8125,Glucose-induced degradation protein 8 homolog OS=Homo sapiens OX=9606 GN=GID8 PE=1 SV=1,cell death;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,54994,GID8,Ciliary landscape,NA,ENSG00000101193
Q9BWE0,0,6,412664.28125,1.5974011523105097e-6,3.5918836499886204,1.8447406183688548,1,1,raw,NA,297428.125,168336.3125,NA,NA,772228.40625,Replication initiator 1 OS=Homo sapiens OX=9606 GN=REPIN1 PE=1 SV=1,cell proliferation;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,29803,REPIN1,NA,NA,ENSG00000214022
Q99666,0,6,724899.8375,2.8060481324544035e-6,3.567739532767757,1.8350102933689552,0.04633765001755938,0.6429522395902524,raw,272827.5625,327796.03125,NA,1217816.28125,1121165.4375,684893.875,RANBP2-like and GRIP domain-containing protein 5/6 OS=Homo sapiens OX=9606 GN=RGPD5 PE=1 SV=3,conjugation;metabolic process,membrane;nucleus,NA,729540; 84220,RGPD5; RGPD6,NA,NA,ENSG00000015568; ENSG00000183054
Q9UPN4,0,6,793377.725,3.0711223377356233e-6,3.5369860092239964,1.8225205123769492,0.1330048252928013,0.6514609890946903,raw,160829.625,950100.3125,353724.125,NA,995733.9375,1506500.625,Centrosomal protein of 131 kDa OS=Homo sapiens OX=9606 GN=CEP131 PE=1 SV=3,cell differentiation;cell growth;conjugation;metabolic process,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,22994,CEP131,NA,Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,ENSG00000141577
Q9HBI6,0,6,1960782.84375,7.590084522336953e-6,3.525530832790219,1.8178404978451308,0.043066958896549754,0.6429522395902524,raw,716823.5625,833925.5,1000818.625,3987223.4375,2285875.875,2940030.0625,Cytochrome P450 4F11 OS=Homo sapiens OX=9606 GN=CYP4F11 PE=1 SV=3,cellular homeostasis;coagulation,cytoskeleton;extracellular;nucleus,structural molecule activity,57834,CYP4F11,Oxidation by cytochrome P450; Metapathway biotransformation Phase I and II,Synthesis of Leukotrienes (LT) and Eoxins (EX); Fatty acids; Miscellaneous substrates; Eicosanoids,ENSG00000171903
P78382,0,6,1170912.1614583333,4.532537757574411e-6,3.5243689920952317,1.8173649785141412,0.018990845939573668,0.6429522395902524,raw,476309.90625,408950.15625,1067716.03125,1685593.9375,1441291.25,1945611.6875,CMP-sialic acid transporter OS=Homo sapiens OX=9606 GN=SLC35A1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation,cytoplasm;cytoskeleton;extracellular,catalytic activity,10559,SLC35A1,NA,Sialic acid metabolism; Transport of nucleotide sugars; Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F); Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),ENSG00000164414
F8VZX2,0.16666666666666666,6,3659493.3802083335,1.416570129285323e-5,3.5112832335299324,1.8119983742101786,0.37005742827236376,0.8545843392672754,raw,5783105.5,498677.15625,1570942.625,5516024.5,2215859,6372351.5,Poly(rC)-binding protein 2 OS=Homo sapiens OX=9606 GN=PCBP2 PE=1 SV=1,NA,NA,RNA binding,NA,PCBP2,Ferroptosis; Modulators of TCR signaling and T cell activation,NA,ENSG00000197111
Q8ND04,0,6,360572.228125,1.3957556271973637e-6,3.5073210359097864,1.8103694909606312,0.15029678748280928,0.6638855679885327,raw,140142.0625,175417.5,NA,546469.078125,215387.140625,725445.359375,Protein SMG8 OS=Homo sapiens OX=9606 GN=SMG8 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol,NA,55181,SMG8,NA,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSG00000167447
Q9UBV2,0,6,10649296.1328125,4.122285035749152e-5,3.495704995789528,1.8055834402534643,0.007957089311532802,0.6429522395902524,raw,5380891.84375,3472885.703125,5286892.625,17238700,13706396.125,18810010.5,Protein sel-1 homolog 1 OS=Homo sapiens OX=9606 GN=SEL1L PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;extracellular,NA,6400,SEL1L,Familial  hyperlipidemia type 1; Familial hyperlipidemia type 4; Familial hyperlipidemia type 5,ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis; ER Quality Control Compartment (ERQC); Pre-NOTCH Processing in Golgi,ENSG00000071537
P63172,0,6,4281046.78125,1.6571700949617744e-5,3.4905420419205115,1.803451088145397,0.11105312296387473,0.6429522395902524,raw,1426749.125,2061729.375,2581673.09375,9080669.25,3338906.78125,7196553.0625,Dynein light chain Tctex-type 1 OS=Homo sapiens OX=9606 GN=DYNLT1 PE=1 SV=1,cell differentiation;cell growth;conjugation;defense response;metabolic process,cell surface;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,6993,DYNLT1,Ciliary landscape; Intraflagellar transport proteins binding to dynein; Genes related to primary cilium development (based on CRISPR); 3q29 copy number variation syndrome,Neutrophil degranulation,ENSG00000146425
O75886,0.16666666666666666,6,3188558.3072916665,1.2342737052134813e-5,3.478058195111583,1.7982820721202009,0.3028159371757116,0.7825518083423609,raw,1381170.5625,4597341.5,445151,6059676.125,4803791.59375,1844219.0625,Signal transducing adapter molecule 2 OS=Homo sapiens OX=9606 GN=STAM2 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;development,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,10254,STAM2,EGF/EGFR signaling pathway,Ub-specific processing proteases; Endosomal Sorting Complex Required For Transport (ESCRT); RHOU GTPase cycle; Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell,ENSG00000115145
P55268,0.3333333333333333,6,5170268.206380208,2.0013829075801884e-5,3.465129089389722,1.7929090993042855,0.022336869929015055,0.6429522395902524,raw,848712.5,3759663.80078125,2466783.875,9709000.9375,5689723.5625,8547724.5625,Laminin subunit beta-2 OS=Homo sapiens OX=9606 GN=LAMB2 PE=1 SV=2,cell communication;cell growth;coagulation;defense response;metabolic process,cell surface;chromosome;extracellular;nucleus,antioxidant activity;enzyme regulator activity;structural molecule activity,3913,LAMB2,Alpha 6 beta 4 signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); miRNA targets in ECM and membrane receptors; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Inflammatory response pathway; Small cell lung cancer; Nephrotic syndrome; Genes controlling nephrogenesis; Malignant pleural mesothelioma,ECM proteoglycans; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Non-integrin membrane-ECM interactions; Laminin interactions; MET activates PTK2 signaling,ENSG00000172037
Q8NFJ5,0,6,16557983.494791668,6.409506011617915e-5,3.446218434105742,1.7850141478233745,0.036826938275479726,0.6429522395902524,raw,7356588.0625,7035099.875,6542583.28125,24244490.875,20698776.125,33470362.75,Retinoic acid-induced protein 3 OS=Homo sapiens OX=9606 GN=GPRC5A PE=1 SV=2,development;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,DNA binding;structural molecule activity,9052,GPRC5A,"GPCRs, class C metabotropic glutamate, pheromone",NA,ENSG00000013588
F8WAL6,0,6,1382048.8875,5.349836624470289e-6,3.4133267205947044,1.7711785145311305,0.34520552678828054,0.8277692477090556,raw,1443297.4375,NA,212170.46875,1968614.28125,1131699.6875,2154462.5625,Abl interactor 2 OS=Homo sapiens OX=9606 GN=ABI2 PE=1 SV=2,cell growth,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,100478728; 101098245; 101127082; 10152; 105712797; 109265196; 459892,ABI2,Regulation of actin cytoskeleton,NA,ENSAMEG00000012960; ENSANAG00000037183; ENSCAFG00030021014; ENSFCAG00000012982; ENSG00000138443; ENSGGOG00000016384; ENSLAFG00000015117; ENSLCNG00005015506; ENSPLOG00000010377; ENSPPAG00000030582; ENSPPRG00000024330; ENSPPYG00000013094; ENSPTRG00000012830
Q6P9B9,0.16666666666666666,6,535592.03125,2.0732478354935804e-6,3.3867939412987558,1.759920213312803,0.14859043750737824,0.6638855679885327,raw,242761.875,269700.875,322249.34375,1091392.125,350788,936659.96875,Integrator complex subunit 5 OS=Homo sapiens OX=9606 GN=INTS5 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;cytosol;membrane;nucleus,NA,80789,INTS5,NA,RNA polymerase II transcribes snRNA genes,ENSG00000185085
A0A669KB77,0.16666666666666666,6,739120.0859375,2.861093946381882e-6,3.380923016155422,1.7574171663421267,1,1,raw,NA,NA,275323.59375,951560.875,798748,930847.875,Microtubule-associated protein OS=Homo sapiens OX=9606 GN=MAP2 PE=1 SV=1,cell growth;defense response,endoplasmic reticulum;nucleus,motor activity,NA,MAP2,Melatonin metabolism and effects; Neurogenesis regulation in the olfactory epithelium; Sudden infant death syndrome (SIDS) susceptibility pathways,NA,ENSG00000078018
P02792,0.5,6,978631.765625,3.7882307268313974e-6,3.3740154352379386,1.7544665735929632,0.05278113946079636,0.6429522395902524,raw,983206.6875,126989.4375,408671.21875,1080076.75,1893983.5,1378863,Ferritin light chain OS=Homo sapiens OX=9606 GN=FTL PE=1 SV=2,conjugation;metabolic process,cell surface;cytosol;mitochondrion;nucleus,structural molecule activity,2512,FTL,Nuclear receptors meta-pathway; NRF2 pathway; Ferroptosis; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway,Scavenging by Class A Receptors; Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Iron uptake and transport,ENSG00000087086
Q9H000,0,6,973063.2125,3.7666751583396617e-6,3.3007744799954706,1.7228045721543204,0.120445307635552,0.6445597830897484,raw,344257.375,NA,479614.5625,1991904.25,1323005.8125,726534.0625,Probable E3 ubiquitin-protein ligase makorin-2 OS=Homo sapiens OX=9606 GN=MKRN2 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;development;metabolic process,membrane;nucleus,structural molecule activity,23609,MKRN2,NA,NA,ENSG00000075975
O43929,0,6,1296062.84375,5.016989291638835e-6,3.281945317307901,1.7145512013422006,0.04904085827586945,0.6429522395902524,raw,853385.34375,274727.21875,641745.5625,2106173.84375,1294099.71875,2606245.375,Origin recognition complex subunit 4 OS=Homo sapiens OX=9606 GN=ORC4 PE=1 SV=2,cell proliferation;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5000,ORC4,Cell cycle; G1 to S cell cycle control; DNA replication,Orc1 removal from chromatin; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; E2F-enabled inhibition of pre-replication complex formation; Assembly of the ORC complex at the origin of replication; CDC6 association with the ORC:origin complex,ENSG00000115947
Q86W10,0.6666666666666666,6,181735.7640625,7.034893304797468e-7,3.27540283288922,1.711672350702658,0.2677874361292911,0.7473260925206285,raw,114660.921875,88252.359375,73711.1484375,NA,214325.171875,417729.21875,Cytochrome P450 4Z1 OS=Homo sapiens OX=9606 GN=CYP4Z1 PE=2 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,199974,CYP4Z1,Oxidation by cytochrome P450; Metapathway biotransformation Phase I and II,NA,ENSG00000186160
Q9NP58,0,6,3275099.7991536465,1.2677734494618205e-5,3.246121844640524,1.698717153108165,0.08700696706878759,0.6429522395902524,raw,1846816.578125,1679576.14453125,1339066.84375,6452225.99609375,2880804.41992188,5452108.8125,"ATP-binding cassette sub-family B member 6, mitochondrial OS=Homo sapiens OX=9606 GN=ABCB6 PE=1 SV=1",cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endosome;extracellular;membrane;mitochondrion,catalytic activity;structural molecule activity,10058,ABCB6,NA,Mitochondrial ABC transporters; Defective ABCB6 causes MCOPCB7,ENSG00000115657
A1XBS5,0,6,667301.340625,2.5830874608867615e-6,3.2454301405976507,1.698409701824262,0.0032773595100595,0.6429522395902524,raw,NA,235734.359375,322982.09375,994369.3125,979060.6875,804360.25,Protein FAM92A OS=Homo sapiens OX=9606 GN=FAM92A PE=1 SV=2,cell growth;defense response;metabolic process,cytoskeleton;endoplasmic reticulum;endosome;membrane;nucleus,structural molecule activity,137392,CIBAR1,Genes related to primary cilium development (based on CRISPR),NA,ENSG00000188343
Q8TCD1,0.5,6,2000761.2604166667,7.744838814754605e-6,3.218541850051667,1.6864072280427347,0.0012657289747385668,0.6429522395902524,raw,923087.1875,1363625.375,816531.25,3160410.5,2628040,3112873.25,UPF0729 protein C18orf32 OS=Homo sapiens OX=9606 GN=C18orf32 PE=1 SV=1,NA,extracellular;nucleus,NA,497661,C18orf32,NA,NA,ENSG00000177576
Q9P0K7,0,6,4626961.5546875,1.7910718361099348e-5,3.197259396037365,1.676835795790491,0.008186578794827683,0.6429522395902524,raw,2600961.8125,1285317.09375,2449362.484375,8315949.59375,5786499.65625,7323678.6875,Ankycorbin OS=Homo sapiens OX=9606 GN=RAI14 PE=1 SV=2,metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity,26064,RAI14,NA,NA,ENSG00000039560
Q9NRY6,0,6,548263.734375,2.1222993141248233e-6,3.191067994992155,1.6740393497619663,0.10328945333446048,0.6429522395902524,raw,616481.953125,149066.125,240073.4375,880635.125,475680.140625,927645.625,Phospholipid scramblase 3 OS=Homo sapiens OX=9606 GN=PLSCR3 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;membrane,catalytic activity;structural molecule activity,57048,PLSCR3,Complement system in neuronal development and plasticity,NA,ENSG00000187838; ENSG00000284009
Q9GZP9,0,6,690173.484375,2.6716242944391847e-6,3.183109259574057,1.6704366780358357,1,1,raw,NA,329981.09375,NA,NA,1050365.875,NA,Derlin-2 OS=Homo sapiens OX=9606 GN=DERL2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;extracellular;mitochondrion,structural molecule activity,51009,DERL2,NA,ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis; ER Quality Control Compartment (ERQC),ENSG00000072849
O15460,0,6,5430477.552083333,2.102108540389761e-5,3.1798182296626516,1.668944298006669,0.012952110359178882,0.6429522395902524,raw,1981800.25,3698061.8125,2527494.40625,8868179.59375,6301764.5625,9205564.6875,Prolyl 4-hydroxylase subunit alpha-2 OS=Homo sapiens OX=9606 GN=P4HA2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;membrane;nucleus,structural molecule activity,8974,P4HA2,VEGFA-VEGFR2 signaling pathway; Amino acid metabolism; Type I collagen synthesis in the context of osteogenesis imperfecta,Collagen biosynthesis and modifying enzymes,ENSG00000072682
P29372,0.16666666666666666,6,880297.9088541666,3.4075856764745806e-6,3.1752294309443396,1.6668608397358045,0.008773219672340462,0.6429522395902524,raw,531024.8125,274121.375,414684.28125,1316717.734375,1133856.59375,1611382.65625,DNA-3-methyladenine glycosylase OS=Homo sapiens OX=9606 GN=MPG PE=1 SV=3,cell proliferation;cellular homeostasis;coagulation,cytosol;endosome;membrane,RNA binding;structural molecule activity,4350,MPG,"Base excision repair; DNA repair pathways, full network",Recognition and association of DNA glycosylase with site containing an affected purine; Cleavage of the damaged purine; Displacement of DNA glycosylase by APEX1,ENSG00000103152
A0A087WU02,0,6,875486.2734375,3.388960095564599e-6,3.1596720089499013,1.6597748066237454,0.20892976508832373,0.6992407460617286,raw,620781.9921875,279953.0546875,469055.9609375,1961467.484375,402090.5234375,1519568.625,Endoplasmic reticulum-Golgi intermediate compartment protein 2 OS=Homo sapiens OX=9606 GN=ERGIC2 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q9BW04,0,6,389217.1354166667,1.5066385167387905e-6,3.154863814020006,1.6575777297471177,0.07170993723365346,0.6429522395902524,raw,184600.5,233723.421875,147537.328125,582389.4375,388084,798968.125,Specifically androgen-regulated gene protein OS=Homo sapiens OX=9606 GN=SARG PE=1 SV=2,NA,cytoplasm;cytoskeleton;cytosol;nucleus,NA,79098,SARG,NA,NA,ENSG00000182795
X6REH9,0.16666666666666666,6,700772.390625,2.71265208828094e-6,3.0889923898040994,1.627136316674385,1,1,raw,NA,288765.5625,NA,930278.5625,692050.8125,891994.625,Ubiquitin-conjugating enzyme E2 W OS=Homo sapiens OX=9606 GN=UBE2W PE=1 SV=1,NA,NA,NA,55284,UBE2W,NA,NA,ENSG00000104343
E7ESC7,0,6,849319.8828125,3.2876714102207378e-6,3.084476433337133,1.6250256235297327,0.38749611640399223,0.87285603487553165,raw,1320913.90625,235780.625,222754.171875,716794.6875,727259.78125,1872416.125,E3 ubiquitin-protein transferase MAEA OS=Homo sapiens OX=9606 GN=MAEA PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,motor activity;structural molecule activity,NA,MAEA,Ciliary landscape,NA,ENSG00000090316
A0A087X256,0,6,555143.9296875,2.1489321787067003e-6,3.0824164804375975,1.6240618046391795,0.018360005644887906,0.6429522395902524,raw,450191.484375,230027.125,201155.15625,620043.96875,973201.96875,856243.875,WASH complex subunit 4 OS=Homo sapiens OX=9606 GN=WASHC4 PE=1 SV=1,NA,membrane;nucleus,NA,23325,WASHC4,NA,NA,ENSG00000136051
Q5TEJ8,0,6,711475.625,2.7540837306617268e-06,3.0781931072352062,1.6220837404743527,1,1,raw,NA,296163.8125,NA,911649.40625,678493.25,959596.03125,Protein THEMIS2 OS=Homo sapiens OX=9606 GN=THEMIS2 PE=1 SV=1,cell communication;coagulation;development;metabolic process,membrane;nucleus,NA,9473,THEMIS2,NA,NA,ENSG00000130775
Q9H4Y5,0.16666666666666666,6,563130.8958333334,2.1798492934280738e-6,3.065052475424364,1.615911773879003,1,1,raw,NA,299559.875,372281.5625,1017551.25,NA,NA,Glutathione S-transferase omega-2 OS=Homo sapiens OX=9606 GN=GSTO2 PE=1 SV=1,cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,119391,GSTO2,Metapathway biotransformation Phase I and II,Glutathione conjugation; Vitamin C (ascorbate) metabolism,ENSG00000065621
P45983,0,6,1166341.734375,4.514845881099537e-6,3.057589332022529,1.6123946498510047,0.032435276138088755,0.6429522395902524,raw,535040.5,703721.0625,494210.65625,1409719.15625,1635934.125,2219424.90625,Mitogen-activated protein kinase 8 OS=Homo sapiens OX=9606 GN=MAPK8 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytosol;endosome;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,5599,MAPK8,"Osteoclast signaling; Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Type II diabetes mellitus; IL-1 signaling pathway; RANKL/RANK signaling pathway; Leptin signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; Thymic stromal lymphopoietin (TSLP) signaling pathway; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Nanoparticle triggered regulated necrosis; Ebstein-Barr virus LMP1 signaling; Cardiac hypertrophic response; IL-3 signaling pathway; Nod-like receptor (NLR) signaling pathway; Transcriptional activation by NRF2 in response to phytochemicals; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; Fas ligand pathway and stress induction of heat shock proteins; RAC1/PAK1/p38/MMP2 pathway; Transcription factor regulation in adipogenesis; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Wnt signaling pathway; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; Novel intracellular components of RIG-I-like receptor pathway; Canonical and non-canonical TGF-B signaling; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Wnt signaling in kidney disease; Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Pancreatic adenocarcinoma pathway; Ethanol metabolism production of ROS by CYP2E1; Wnt signaling; miRNAs involvement in the immune response in sepsis; Neovascularisation processes; Non-genomic actions of 1,25 dihydroxyvitamin D3; NRF2-ARE regulation; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Signal transduction through IL1R; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Regulatory circuits of the STAT3 signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Measles virus infection; Gastrin signaling pathway; Hepatitis B infection; Osteoblast differentiation and related diseases; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; Host-pathogen interaction of human coronaviruses - interferon induction; Neuroinflammation; Malignant pleural mesothelioma; CCL18 signaling pathway; Alzheimer's disease; Th17 cell differentiation pathway; GDNF signaling; Roles of ceramides in the development of insulin resistance; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response (only ATM dependent); Toll-like receptor signaling pathway",FCERI mediated MAPK activation; NRAGE signals death through JNK; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Oxidative Stress Induced Senescence; WNT5:FZD7-mediated leishmania damping; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; DSCAM interactions; Activation of BIM and translocation to mitochondria ; Activation of the AP-1 family of transcription factors; NRIF signals cell death from the nucleus; Activation of BMF and translocation to mitochondria; Interleukin-38 signaling,ENSG00000107643
Q9HBU6,0,6,424528.6510416667,1.6433274871976448e-6,3.0562091285406225,1.6117432666673963,1,1,raw,NA,NA,179065.109375,288532.125,805988.71875,NA,Ethanolamine kinase 1 OS=Homo sapiens OX=9606 GN=ETNK1 PE=1 SV=1,cellular homeostasis,cytosol;nucleus,signal transducer activity;structural molecule activity,55500,ETNK1,"Trans-sulfuration, one-carbon metabolism and related pathways; Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids",Synthesis of PE,ENSG00000139163
P78348,0,6,259949.875,1.0062519310131665e-6,3.047722586816901,1.6077315902204297,1,1,raw,NA,109908.484375,NA,NA,171435.953125,498505.1875,Acid-sensing ion channel 1 OS=Homo sapiens OX=9606 GN=ASIC1 PE=1 SV=3,cell death;cell growth;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,catalytic activity,41,ASIC1,NA,Stimuli-sensing channels,ENSG00000110881
Q96RT1,0,6,3269494.53515625,1.2656036820321503e-5,3.0258687288480335,1.5973494005262565,0.019975857394582068,0.6429522395902524,raw,1725220.0625,2352583.3125,799965.4375,5891909.50390625,3626999.45703125,5220289.4375,Erbin OS=Homo sapiens OX=9606 GN=ERBIN PE=1 SV=2,cell communication;cell growth;conjugation;development;metabolic process,chromosome;cytoplasm;cytoskeleton;membrane;nucleus,antioxidant activity;motor activity,55914,ERBIN,Nucleotide-binding oligomerization domain (NOD) pathway; Nod-like receptor (NLR) signaling pathway; Pathways affected in adenoid cystic carcinoma,RHOA GTPase cycle; RAC1 GTPase cycle; RHOC GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Signaling by ERBB2 ECD mutants; Constitutive Signaling by Overexpressed ERBB2; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants,ENSG00000112851
R4GMX8,0,6,729055.9609375,2.822136261885177e-6,3.0219054586879914,1.5954585260171226,0.4214748482478992,0.9084952809009865,raw,370646.625,NA,344701.78125,NA,521376.125,1679499.3125,Ran-binding protein 10 OS=Homo sapiens OX=9606 GN=RANBP10 PE=1 SV=1,NA,NA,NA,57610,RANBP10,Ciliary landscape,NA,ENSG00000141084
P78381,0.16666666666666666,6,940747.459375,3.641582622772272e-6,3.0138555487798495,1.591610271596299,0.42962579762746106,0.9143318257199812,raw,NA,213594.578125,1057941.75,1015056.65625,1415427.5625,1001716.75,UDP-galactose translocator OS=Homo sapiens OX=9606 GN=SLC35A2 PE=1 SV=1,cellular homeostasis;conjugation,cytoskeleton;extracellular;membrane,catalytic activity,7355,SLC35A2,NA,Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M); Transport of nucleotide sugars,ENSG00000102100
Q8IZH2,0,6,950923.0885416666,3.680971933877854e-6,3.0133368260328988,1.5913619441197788,0.0168085864035506,0.6429522395902524,raw,797832.203125,403984.328125,379124.125,1142428.6875,1685310.3125,1296858.875,5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,54464,XRN1,miRNA degrading enzymes,"mRNA decay by 5' to 3' exoribonuclease; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA",ENSG00000114127
Q9ULT8,0,6,34873812.447916664,1.3499464509266314e-4,2.995560943981953,1.5828261850924716,0.01136172850902673,0.6429522395902524,raw,14768928.296875,25579065.8515625,13510334.7578125,59154815,40471031.140625,55758699.640625,E3 ubiquitin-protein ligase HECTD1 OS=Homo sapiens OX=9606 GN=HECTD1 PE=1 SV=3,NA,NA,NA,NA,NA,NA,NA,NA
Q8WUX2,0.3333333333333333,6,993371.8020833334,3.8452886121233306e-06,2.9803573987175294,1.5754853462714113,1,1,raw,NA,428133.53125,NA,NA,940345.75,1611636.125,Glutathione-specific gamma-glutamylcyclotransferase 2 OS=Homo sapiens OX=9606 GN=CHAC2 PE=1 SV=1,cellular homeostasis,cytosol;nucleus,structural molecule activity,494143,CHAC2,NA,Glutathione synthesis and recycling,ENSG00000143942
Q9NV35,0,6,1650936.4479166667,6.390685853171362e-6,2.970972102744311,1.5709350584141903,0.28161281515364484,0.764145542657294,raw,1231159.40625,729875.6875,869961.75,2960440.25,456441.34375,3657740.25,Nucleotide triphosphate diphosphatase NUDT15 OS=Homo sapiens OX=9606 GN=NUDT15 PE=1 SV=1,cell differentiation;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol,structural molecule activity,55270,NUDT15,NA,Azathioprine ADME; Phosphate bond hydrolysis by NUDT proteins,ENSG00000136159
P25098,0,6,1723833.0875,6.672864809191633e-6,2.9676242095382577,1.5693084149504843,0.6233285133097257,1,raw,NA,2299662.8125,371349.4375,1926352,1853993.71875,2167807.46875,Beta-adrenergic receptor kinase 1 OS=Homo sapiens OX=9606 GN=GRK2 PE=1 SV=2,cell death;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,156,GRK2,Chemokine signaling pathway; Hedgehog signaling pathway; Hedgehog signaling pathway,G alpha (q) signalling events; Activation of SMO; G alpha (s) signalling events; Cargo recognition for clathrin-mediated endocytosis; Calmodulin induced events,ENSG00000173020
Q9HAU5,0,6,2403120.8723958335,9.302351148683387e-6,2.940502182226871,1.5560625611635812,0.3042439882879132,0.7842313983818882,raw,3419700.53125,586801.5,904068.609375,4997256.75,1852482.125,2658415.71875,Regulator of nonsense transcripts 2 OS=Homo sapiens OX=9606 GN=UPF2 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,26019,UPF2,NA,Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSG00000151461
Q5VZE5,0,6,791291.0052083334,3.0630447580874393e-6,2.934592903614622,1.553160381811762,0.8212968507026278,1,raw,212394.96875,1793989.3125,151099.8125,1131260.25,443416.4375,1015585.25,"N-alpha-acetyltransferase 35, NatC auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA35 PE=1 SV=1",cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,NA,60560,NAA35,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000135040
Q8N766,0,6,26468987.248697918,1.0246002053651752e-4,2.9182555625046396,1.5451062309643193,0.018974758388520186,0.6429522395902524,raw,12337764.015625,15576992.625,12853651.3828125,45457645.375,31679854,40908016.09375,ER membrane protein complex subunit 1 OS=Homo sapiens OX=9606 GN=EMC1 PE=1 SV=1,cell growth,cytoskeleton;extracellular;nucleus,NA,23065,EMC1,NA,NA,ENSG00000127463
Q8N4W9,0.6666666666666666,6,424732.41875,1.6441162609948567e-6,2.9136042321673337,1.54280492302129,0.20714078379593048,0.6988382857167694,raw,NA,208248.171875,235442.03125,643940.75,207492.703125,828538.4375,Zinc finger protein 808 OS=Homo sapiens OX=9606 GN=ZNF808 PE=1 SV=2,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,388558,ZNF808,NA,NA,ENSG00000198482
Q96D05,0.16666666666666666,6,1981477.875,7.670193870947681e-6,2.9100864110860805,1.5410619926505593,0.01810908895564884,0.6429522395902524,raw,892326.1875,1158213.25,1140568.8125,2596746.3125,2615052.4375,3485960.25,Protein FAM241B OS=Homo sapiens OX=9606 GN=FAM241B PE=1 SV=1,NA,cytoskeleton;nucleus,NA,219738,FAM241B,NA,NA,ENSG00000171224
Q96S59,0,6,6192932.911458333,2.397250893384711e-5,2.9065661929222792,1.5393157642771138,0.016246900077168204,0.6429522395902524,raw,2201006.609375,5355368.34375,3167340.734375,10174223.03125,7053573.25,9206085.5,Ran-binding protein 9 OS=Homo sapiens OX=9606 GN=RANBP9 PE=1 SV=1,cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,10048,RANBP9,Brain-derived neurotrophic factor (BDNF) signaling pathway; Ciliary landscape,RAF/MAP kinase cascade; L1CAM interactions; MET activates RAS signaling,ENSG00000010017
E7EQR8,0,6,3407720.4791666665,1.3191101986544796e-5,2.9023611984447495,1.5372270737734754,0.06291589910965832,0.6429522395902524,raw,1288610.71875,3525397.5,1457953.03125,6169402.625,3740013.75,4264945.25,Protein YIPF3 OS=Homo sapiens OX=9606 GN=YIPF3 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,NA,NA,YIPF3,NA,NA,ENSG00000137207
A0A0A6YYL2,0,6,4381493.713541667,1.696052560122736e-5,2.899859437241142,1.5359829712368014,0.05058181523046904,0.6429522395902524,raw,2859020.96875,1699131.875,2164225.25,8290758.9375,4485539.5625,6790285.6875,Sulfotransferase OS=Homo sapiens OX=9606 GN=SULT1A4 PE=1 SV=1,NA,NA,structural molecule activity,NA,SULT1A4,Sulfation biotransformation reaction; Metapathway biotransformation Phase I and II,NA,ENSG00000213648
O94804,0,6,1424563.3307291667,5.514407738787227e-6,2.894873025933358,1.5335000705379638,1.7352596174766824e-4,0.40807522004326646,raw,774067.53125,783244.953125,616498,2267394.6875,2077890.3125,2028284.5,Serine/threonine-protein kinase 10 OS=Homo sapiens OX=9606 GN=STK10 PE=1 SV=1,cell communication;cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,signal transducer activity;structural molecule activity,6793,STK10,NA,RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; Neutrophil degranulation,ENSG00000072786
A0A087WZ62,0.16666666666666666,6,454732.453125,1.7602447743103763e-6,2.885447440846649,1.5287950521942002,0.22287690458291046,0.7114915236088185,raw,260684.640625,247039.890625,NA,731977.1875,208856.765625,825103.78125,Mannosyltransferase OS=Homo sapiens OX=9606 PE=3 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,NA,NA,NA,NA,NA
G5E9Z2,0,6,4859062.890625,1.880917010098899e-5,2.880045043371419,1.526091375327449,0.04824551018155895,0.6429522395902524,raw,2549320.71875,1632551.6875,4137481.15625,8731859.375,4761005.90625,7342158.5,Cleft lip and palate transmembrane protein 1-like protein OS=Homo sapiens OX=9606 GN=CLPTM1L PE=1 SV=1,NA,cytoskeleton,NA,NA,CLPTM1L,NA,NA,ENSG00000049656; ENSG00000274811
A0A0D9SG04,0.3333333333333333,6,227720.7890625,8.814948794492885e-7,2.8768519227686458,1.5244909646346436,1,1,raw,180014.34375,110092.3671875,NA,393055.65625,NA,NA,Cordon-bleu protein-like 1 OS=Homo sapiens OX=9606 GN=COBLL1 PE=1 SV=2,NA,NA,motor activity,22837,COBLL1,NA,NA,ENSG00000082438
Q9UFN0,0,6,291053.3697916667,1.1266518800240001e-6,2.872457874717782,1.5222857355584618,1,1,raw,NA,151480.046875,213058.65625,508621.40625,NA,NA,Protein NipSnap homolog 3A OS=Homo sapiens OX=9606 GN=NIPSNAP3A PE=1 SV=2,NA,cytosol;endosome,NA,25934,NIPSNAP3A,NA,NA,ENSG00000136783
Q6UW56,0.6666666666666666,6,579738.2239583334,2.2441353639435933e-6,2.8703297665975804,1.5212164948468818,0.0401498715186553,0.6429522395902524,raw,231883.640625,500692.78125,230440.921875,751018.4375,661441.4375,1102952.125,All-trans retinoic acid-induced differentiation factor OS=Homo sapiens OX=9606 GN=ATRAID PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton;membrane;mitochondrion;nucleus,NA,51374,ATRAID,NA,NA,ENSG00000138085
P07205,0.5,6,1269158.7864583333,4.912845138456116e-6,2.86294354580158,1.5174992222076435,0.19634745981982116,0.6867780510802372,raw,557495.4375,749885.75,877737.53125,2239152.875,677768.125,2512913,Phosphoglycerate kinase 2 OS=Homo sapiens OX=9606 GN=PGK2 PE=1 SV=3,cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum,signal transducer activity;structural molecule activity,5232,PGK2,Cori cycle; Clear cell renal cell carcinoma pathways; Glycolysis and gluconeogenesis,Glycolysis; Gluconeogenesis,ENSG00000170950
P63146,0.5,6,441527.9739583333,1.7091309483872767e-6,2.8617252748665667,1.5168851802366599,0.0031450543068378797,0.6429522395902524,raw,304891.625,193223.015625,220554.703125,710203.5625,552951.1875,667343.75,Ubiquitin-conjugating enzyme E2 B OS=Homo sapiens OX=9606 GN=UBE2B PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,7320,UBE2B,Proteasome degradation; Male infertility,E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; Recognition of DNA damage by PCNA-containing replication complex,ENSG00000119048
Q86XX4,0,6,695708.7239583334,2.693050908009781e-6,2.8570624125445874,1.5145325522998612,0.12259462864839323,0.6445597830897484,raw,372511.25,305525.1875,453742.09375,1421518.46875,556667.453125,1064287.890625,Extracellular matrix protein FRAS1 OS=Homo sapiens OX=9606 GN=FRAS1 PE=1 SV=2,conjugation;defense response;metabolic process,chromosome;cytoplasm;cytoskeleton,enzyme regulator activity;structural molecule activity,80144,FRAS1,Development of ureteric collection system,NA,ENSG00000138759
Q5R372,0,6,630205.0286458334,2.439489640104954e-6,2.856814959702275,1.514407593724301,0.5895776569475104,1,raw,226660.59375,206716.53125,1154097.3125,909042.34375,647527.375,637186.015625,Rab GTPase-activating protein 1-like OS=Homo sapiens OX=9606 GN=RABGAP1L PE=1 SV=1,conjugation;metabolic process,extracellular;membrane;mitochondrion,DNA binding;structural molecule activity,9910,RABGAP1L,NA,NA,ENSG00000152061
O60563,0,6,1807693.4635416667,6.9974837970923485e-6,2.855986207761136,1.5139890122652417,0.15782422138672614,0.6638855679885327,raw,824648.25,2246865.8125,766264.28125,2388674.15625,2188440.21875,2431268.0625,Cyclin-T1 OS=Homo sapiens OX=9606 GN=CCNT1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane,DNA binding;RNA binding;structural molecule activity,904,CCNT1,Initiation of transcription and translation elongation at the HIV-1 LTR; Male infertility,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; Estrogen-dependent gene expression; Interactions of Tat with host cellular proteins,ENSG00000129315
Q9NRX5,0,6,598939.7786458334,2.318463545416086e-6,2.8515671100263273,1.5117549861226216,0.2586020092245904,0.7381027251958325,raw,182425.171875,859674.71875,254492.640625,620881.5,725702.84375,950461.796875,Serine incorporator 1 OS=Homo sapiens OX=9606 GN=SERINC1 PE=1 SV=1,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;extracellular,structural molecule activity,57515,SERINC1,Sphingolipid pathway,Serine biosynthesis,ENSG00000111897
Q6P1N0,0,6,6997372.905598958,2.708645271815639e-5,2.8509085907706297,1.5114217826094123,0.004046564755501639,0.6429522395902524,raw,3033932.5625,4919863.71875,3652913.68359375,10418690.5,8649464.40625,11309372.5625,Coiled-coil and C2 domain-containing protein 1A OS=Homo sapiens OX=9606 GN=CC2D1A PE=1 SV=1,cellular component movement;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane,RNA binding;structural molecule activity,54862,CC2D1A,Sudden infant death syndrome (SIDS) susceptibility pathways,NA,ENSG00000132024; ENSG00000288293
Q14146,0,6,667074.41875,2.5822090585605135e-6,2.8507620031295406,1.5113476003993325,0.009571890726537536,0.6429522395902524,raw,338604.28125,NA,292957.09375,882149.40625,910702.625,910958.6875,Unhealthy ribosome biogenesis protein 2 homolog OS=Homo sapiens OX=9606 GN=URB2 PE=1 SV=2,metabolic process,membrane;nucleus,NA,9816,URB2,NA,NA,ENSG00000135763
Q13433,0,6,744651.5364583334,2.8825058926961185e-6,2.846732593323986,1.5093069804689534,0.04888354012700617,0.6429522395902524,raw,348575.46875,502212.125,320824.28125,807140.75,1059492.96875,1429663.625,Zinc transporter ZIP6 OS=Homo sapiens OX=9606 GN=SLC39A6 PE=1 SV=3,conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular,catalytic activity,25800,SLC39A6,Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis,Zinc influx into cells by the SLC39 gene family,ENSG00000141424
Q7Z6M1,0,6,520718.28125,2.0156723523012643e-6,2.8417771391061355,1.506793418439468,0.4648508000922303,0.9467443402571262,raw,286977.09375,327934.40625,244103.40625,1397319.3125,NA,347257.1875,Rab9 effector protein with kelch motifs OS=Homo sapiens OX=9606 GN=RABEPK PE=1 SV=1,conjugation,cytoskeleton;cytosol;extracellular;mitochondrion,NA,10244,RABEPK,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000136933
Q5BJD5,0,6,1600110.1979166667,6.1939401836123445e-6,2.835082628689313,1.5033907832320992,5.8131750677459e-4,0.5858850014706761,raw,795754.9375,1019780.125,722221.375,2577091.5,2256031,2229782.25,Transmembrane protein 41B OS=Homo sapiens OX=9606 GN=TMEM41B PE=1 SV=1,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;extracellular;nucleus,catalytic activity,440026,TMEM41B,NA,NA,ENSG00000166471
Q8N488,0,6,517464.0729166667,2.0030754875428728e-6,2.8301083070921615,1.5008572654652232,1,1,raw,233084.34375,NA,NA,574793.375,NA,744514.5,RING1 and YY1-binding protein OS=Homo sapiens OX=9606 GN=RYBP PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,23429,RYBP,NA,Transcriptional Regulation by E2F6; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,ENSG00000163602
O60333,0,6,1142066.916015625,4.420879369866882e-6,2.8285878517765335,1.5000819796626448,0.019438661265388388,0.6429522395902524,raw,466530.59375,930731.98828125,466293.6171875,1622624.703125,1318952.4609375,2047268.1328125,Kinesin-like protein KIF1B OS=Homo sapiens OX=9606 GN=KIF1B PE=1 SV=5,cell death;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;endosome;extracellular;nucleus,motor activity;structural molecule activity,23095,KIF1B,Intracellular trafficking proteins involved in CMT neuropathy,COPI-dependent Golgi-to-ER retrograde traffic; Kinesins,ENSG00000054523
Q9UBT7,0.3333333333333333,6,413682.61328125,1.6013430606220944e-6,2.825877068168984,1.4986987066483055,0.082219960525173455,0.6429522395902524,raw,281121.25,189430.5625,213062.90625,620336.25,383730.6171875,794414.09375,Alpha-catulin OS=Homo sapiens OX=9606 GN=CTNNAL1 PE=1 SV=2,cell communication;development,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum,motor activity;structural molecule activity,8727,CTNNAL1,NA,NA,ENSG00000119326
Q9UQ13,0,6,3099692.08203125,1.1998740692182169e-5,2.813532634150972,1.4923826973050927,0.011555060870514626,0.6429522395902524,raw,1280537.8125,1716292.21875,1873370.4921875,4678092.875,3779070.078125,5270789.015625,Leucine-rich repeat protein SHOC-2 OS=Homo sapiens OX=9606 GN=SHOC2 PE=1 SV=2,development;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,8036,SHOC2,Ras signaling; 22q11.2 copy number variation syndrome,RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling,ENSG00000108061
Q9NVU0,0,6,615919.93125,2.3841927993610666e-6,2.807354962049203,1.4892114897897422,0.01906372825839762,0.6429522395902524,raw,NA,272209.78125,276116.1875,758221.84375,1003418.09375,769633.75,DNA-directed RNA polymerase III subunit RPC5 OS=Homo sapiens OX=9606 GN=POLR3E PE=1 SV=1,cellular component movement;cellular homeostasis;coagulation,cytosol;membrane,NA,55718,POLR3E,Pyrimidine metabolism; Eukaryotic transcription initiation; Cytosolic DNA-sensing pathway,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation,ENSG00000058600
P38936,0,6,3910980.9114583335,1.5139195948105696e-5,2.80607681034949,1.4885545001886167,8.884160879003745e-5,0.31338877500685713,raw,2041897.6875,2277154.8125,1730560.59375,5662079.25,5729721.75,6024471.375,Cyclin-dependent kinase inhibitor 1 OS=Homo sapiens OX=9606 GN=CDKN1A PE=1 SV=3,cell differentiation;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,1026,CDKN1A,Androgen receptor signaling pathway; Androgen receptor signaling pathway; AMP-activated protein kinase signaling; miRNA regulation of DNA damage response; miRNAs involved in DNA damage response; TP53 network; Cell cycle; Integrated cancer pathway; Glioblastoma signaling pathways; Adipogenesis; Retinoblastoma gene in cancer; ATM signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); Aryl hydrocarbon receptor pathway; Bladder cancer; Apoptosis-related network due to altered Notch3 in ovarian cancer; Vitamin D receptor pathway; miR-517 relationship with ARCN1 and USP1; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; lncRNA-mediated mechanisms of therapeutic resistance; Physico-chemical features and toxicity-associated pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Oxidative damage response; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Type 2 papillary renal cell carcinoma; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; G1 to S cell cycle control; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; Head and neck squamous cell carcinoma; Melanoma; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; FGF23 signaling in hypophosphatemic rickets and related disorders; Overlap between signal transduction pathways contributing to LMNA laminopathies; p53 transcriptional gene network; Galanin receptor pathway; Malignant pleural mesothelioma; Lipid metabolism in senescent cells; Notch signaling pathway; ErbB signaling pathway; DNA damage response; DNA damage response (only ATM dependent); Androgen receptor signaling pathway,"Senescence-Associated Secretory Phenotype (SASP); TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest; The role of GTSE1 in G2/M progression after G2 checkpoint; Constitutive Signaling by AKT1 E17K in Cancer; SCF(Skp2)-mediated degradation of p27/p21; Interleukin-4 and Interleukin-13 signaling; Cyclin D associated events in G1; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3); FOXO-mediated transcription of cell cycle genes; AKT phosphorylates targets in the cytosol; Transcriptional regulation by RUNX2; DNA Damage/Telomere Stress Induced Senescence; Transcriptional regulation of granulopoiesis; p53-Dependent G1 DNA Damage Response; TFAP2 (AP-2) family regulates transcription of cell cycle factors; Signaling by FLT3 fusion proteins; RUNX3 regulates CDKN1A transcription; Transcriptional  activation of  cell cycle inhibitor p21 ; STAT5 activation downstream of FLT3 ITD mutants",ENSG00000124762
Q8N2K1,0.5,6,569625.75,2.204990523239618e-6,2.7837249949410094,1.4770166939339004,0.050356947854192216,0.6429522395902524,raw,362804.9375,250675.53125,262218.8125,729945.0625,686287.4375,1125822.71875,Ubiquitin-conjugating enzyme E2 J2 OS=Homo sapiens OX=9606 GN=UBE2J2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,118424,UBE2J2,Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway,E3 ubiquitin ligases ubiquitinate target proteins; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000160087
Q15646,0,6,2009028.4713541667,7.776840741933654e-6,2.777087408657177,1.4735725866100036,0.011788876635829587,0.6429522395902524,raw,1069197.046875,449205.53125,1574627.78125,2969253.65625,3518936.03125,2472950.78125,2'-5'-oligoadenylate synthase-like protein OS=Homo sapiens OX=9606 GN=OASL PE=1 SV=2,coagulation;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,8638,OASL,NA,OAS antiviral response; Interferon gamma signaling; Interferon alpha/beta signaling,ENSG00000135114
B0QYD3,0.16666666666666666,6,603665.54375,2.3367567269826562e-6,2.772398163511613,1.4711344678910145,0.05907035850309327,0.6429522395902524,raw,NA,399739.90625,221211.125,691958,633240.4375,1072178.25,DNA dC->dU-editing enzyme APOBEC-3B OS=Homo sapiens OX=9606 GN=APOBEC3B PE=1 SV=1,NA,membrane,structural molecule activity,NA,APOBEC3B,NA,NA,ENSG00000179750
Q9UKV5,0.16666666666666666,6,1887967.46875,7.308220137131159e-6,2.767791625393125,1.4687353330295854,0.03484007916870213,0.6429522395902524,raw,709001.9375,1458882.25,989439.0625,1962369.625,2858151.625,3349960.3125,E3 ubiquitin-protein ligase AMFR OS=Homo sapiens OX=9606 GN=AMFR PE=1 SV=2,cell death;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,267,AMFR,Sterol regulatory element-binding proteins (SREBP) signaling,ER Quality Control Compartment (ERQC); N-glycan trimming in the ER and Calnexin/Calreticulin cycle,ENSG00000159461
Q8NHQ9,0,6,2084800.3567708335,8.070149619335612e-6,2.762737496707332,1.4660984900585583,0.29941306004826707,0.7805333494403178,raw,1855306.96875,940736.75,531721.1875,1835113,5876918.171875,1469006.0625,ATP-dependent RNA helicase DDX55 OS=Homo sapiens OX=9606 GN=DDX55 PE=1 SV=3,NA,cytosol;membrane,structural molecule activity,57696,DDX55,NA,NA,ENSG00000111364
Q14790,0,6,2727560.4270833335,1.055823914786534e-5,2.7578144032079663,1.4635253688964258,0.05090795473962419,0.6429522395902524,raw,318132.65625,1999989.78125,1870240.9375,2999450.5625,3661948,5515600.625,Caspase-8 OS=Homo sapiens OX=9606 GN=CASP8 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,antioxidant activity;structural molecule activity,841,CASP8,Nucleotide-binding oligomerization domain (NOD) pathway; miRNA regulation of DNA damage response; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; AGE/RAGE pathway; Allograft rejection; Parkin-ubiquitin proteasomal system pathway; Nanomaterial induced apoptosis; Nanoparticle triggered regulated necrosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Apoptosis modulation by HSP70; Novel intracellular components of RIG-I-like receptor pathway; miRNA regulation of p53 pathway in prostate cancer; Non-small cell lung cancer; Acute viral myocarditis; Nonalcoholic fatty liver disease; Measles virus infection; Cytosolic DNA-sensing pathway; Small cell lung cancer; Hepatitis B infection; Head and neck squamous cell carcinoma; IL-18 signaling pathway; Regucalcin in proximal tubule epithelial kidney cells; Host-pathogen interaction of human coronaviruses - apoptosis; 16p11.2 proximal deletion syndrome; Complement system in neuronal development and plasticity; CCL18 signaling pathway; Alzheimer's disease; DNA damage response; Toll-like receptor signaling pathway,"TRIF-mediated programmed cell death; Regulation by c-FLIP; CASP8 activity is inhibited; Dimerization of procaspase-8; TRAIL  signaling; NOD1/2 Signaling Pathway; Regulation of TNFR1 signaling; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Regulation of NF-kappa B signaling; TLR3-mediated TICAM1-dependent programmed cell death; Caspase-mediated cleavage of cytoskeletal proteins; TNFR1-induced proapoptotic signaling; CLEC7A/inflammasome pathway; Microbial modulation of RIPK1-mediated regulated necrosis; Activation, myristolyation of BID and translocation to mitochondria; FasL/ CD95L signaling; Defective RIPK1-mediated regulated necrosis",ENSG00000064012
Q969G6,0,6,1674704.703125,6.482691485796495e-6,2.7208625528371173,1.4440640792084252,0.0660967899966918,0.6429522395902524,raw,1156975.5,707124.6875,722226.8125,2757485.5,1556444.40625,3147971.3125,Riboflavin kinase OS=Homo sapiens OX=9606 GN=RFK PE=1 SV=2,cellular homeostasis;metabolic process,cytosol;endosome;nucleus,signal transducer activity;structural molecule activity,55312,RFK,Selenium micronutrient network; Folate metabolism; TNF-alpha signaling pathway,Vitamin B2 (riboflavin) metabolism,ENSG00000135002
Q08357,0.16666666666666666,6,581422.853125,2.250656472491922e-6,2.710932730456907,1.4387893143411306,0.010896895653750545,0.6429522395902524,raw,NA,263155.1875,310359.78125,895209.875,770649.109375,667740.3125,Sodium-dependent phosphate transporter 2 OS=Homo sapiens OX=9606 GN=SLC20A2 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton,catalytic activity;structural molecule activity,6575,SLC20A2,Proximal tubule transport,Sodium-coupled phosphate cotransporters; Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1),ENSG00000168575
Q5J8M3,0.3333333333333333,6,1275049.2083333333,4.93564664350089e-6,2.7097094065493543,1.4381381430148623,0.013462610773874025,0.6429522395902524,raw,602181.5,748134,768373.625,1734226,1631736.875,2165643.25,ER membrane protein complex subunit 4 OS=Homo sapiens OX=9606 GN=EMC4 PE=1 SV=2,cell growth;metabolic process,cytoskeleton;extracellular,NA,51234,EMC4,NA,NA,ENSG00000128463
Q53FV1,0,6,2897288.0625,1.1215245660695244e-5,2.709674921587652,1.438119782522149,0.011456632426113018,0.6429522395902524,raw,1308171.1875,2465625.875,1370578.9375,3686421.25,3713823.375,4839107.75,ORM1-like protein 2 OS=Homo sapiens OX=9606 GN=ORMDL2 PE=1 SV=2,cellular homeostasis;metabolic process,cytoskeleton;extracellular,NA,29095,ORMDL2,NA,Sphingolipid de novo biosynthesis,ENSG00000123353
P16333,0,6,2361546.7447916665,9.14141994538167e-6,2.6964344267400864,1.431052950085382,0.050747890530104284,0.6429522395902524,raw,1003362.5,1163729.34375,1676941.25,2705501.1875,3049900.53125,4569845.65625,Cytoplasmic protein NCK1 OS=Homo sapiens OX=9606 GN=NCK1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;Golgi;membrane;nucleus,antioxidant activity;DNA binding;structural molecule activity,4690,NCK1,Pathogenic Escherichia coli infection; B cell receptor signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); RAC1/PAK1/p38/MMP2 pathway; Physico-chemical features and toxicity-associated pathways; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling pathway; EGF/EGFR signaling pathway; Genes controlling nephrogenesis; GDNF signaling; ErbB signaling pathway; T-cell receptor signaling pathway,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Generation of second messenger molecules; RHO GTPases Activate WASPs and WAVEs; RHOV GTPase cycle; RHOU GTPase cycle; Nephrin family interactions; DCC mediated attractive signaling; Downstream signal transduction; VEGFA-VEGFR2 Pathway; Activation of RAC1,ENSG00000158092
Q5HYI7,0.16666666666666666,6,1557208.6041666667,6.027870430532141e-6,2.694183872762159,1.4298483152656052,0.05361278689660695,0.6429522395902524,raw,956427.34375,851556.6875,835944.5625,2576791.125,1569534.21875,2552997.6875,Metaxin-3 OS=Homo sapiens OX=9606 GN=MTX3 PE=1 SV=2,cell growth;conjugation,nucleus,NA,345778,MTX3,NA,NA,ENSG00000177034
Q9UQN3,0,6,2555006.4791666665,9.890292131945093e-6,2.6895431017378075,1.4273611092714211,0.02358318710717584,0.6429522395902524,raw,644606.75,2007167.875,1400478.625,3651229.5,3859908.5,3766647.625,Charged multivesicular body protein 2b OS=Homo sapiens OX=9606 GN=CHMP2B PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,25978,CHMP2B,NA,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Sealing of the nuclear envelope (NE) by ESCRT-III; Late endosomal microautophagy; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex,ENSG00000083937
Q86Y07,0,6,1131385.1640625,4.379530884781302e-6,2.6795225485167347,1.421975956559151,0.12351863169845943,0.6445597830897484,raw,697688.5625,682015.5625,713272.734375,1911230.375,891012.1875,1893091.5625,Serine/threonine-protein kinase VRK2 OS=Homo sapiens OX=9606 GN=VRK2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoskeleton;endosome;extracellular;membrane;nucleus,signal transducer activity;structural molecule activity,7444,VRK2,NA,RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle,ENSG00000028116
Q96JJ7,0,6,2372964.0234375,9.185615614582456e-6,2.674871662613042,1.4194696742601993,0.017709237029785933,0.6429522395902524,raw,1376432.96875,792323.1875,1619300.515625,4331421.0625,3130490.09375,2987816.3125,Protein disulfide-isomerase TMX3 OS=Homo sapiens OX=9606 GN=TMX3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,54495,TMX3,NA,Platelet degranulation,ENSG00000166479
P51965,0,6,1538000.1458333333,5.953515525419365e-6,2.6710051571070683,1.4173827614936556,0.05617505419408854,0.6429522395902524,raw,888278.875,885527.0625,949696.6875,2536644.75,1543880.75,2423972.75,Ubiquitin-conjugating enzyme E2 E1 OS=Homo sapiens OX=9606 GN=UBE2E1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,7324,UBE2E1,Photodynamic therapy-induced unfolded protein response; 7q11.23 copy number variation syndrome,E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; ISG15 antiviral mechanism; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,ENSG00000170142
Q9NUY8,0,6,2426474.91015625,9.3927533679319e-6,2.670807110571273,1.4172757862796757,0.0033050667786359332,0.6429522395902524,raw,1289342.734375,1711722.609375,1117284.0859375,3717704.625,2984050.28125,3738745.125,TBC1 domain family member 23 OS=Homo sapiens OX=9606 GN=TBC1D23 PE=1 SV=3,cell growth;conjugation;defense response,cytosol;extracellular;nucleus,NA,55773,TBC1D23,NA,NA,ENSG00000036054
Q5W0V3,0,6,330801.296875,1.2805139597090729e-6,2.6597820986525567,1.4113080584820608,1,1,raw,NA,NA,161497.96875,429549.40625,284220.53125,447937.28125,Protein FAM160B1 OS=Homo sapiens OX=9606 GN=FAM160B1 PE=1 SV=1,NA,NA,NA,57700,FHIP2A,NA,NA,ENSG00000151553
Q9UJY5,0,6,1484898.59375,5.747962284342984e-6,2.6552583203461437,1.4088522223678626,0.29912755592048723,0.7805333494403178,raw,2102008.03125,294400.6875,586958.25,2707283.34375,781709.875,2437031.375,ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens OX=9606 GN=GGA1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,26088,GGA1,NA,TBC/RABGAPs; Amyloid fiber formation,ENSG00000100083
Q9BXB5,0,6,1411732.5677083333,5.464740547887112e-6,2.6515470963170595,1.406834373603925,0.025827873707384843,0.6429522395902524,raw,116745.484375,930395.09375,1025895.140625,1944651.28125,1732499.125,2720209.28125,Oxysterol-binding protein-related protein 10 OS=Homo sapiens OX=9606 GN=OSBPL10 PE=1 SV=2,cellular homeostasis;conjugation,cytoskeleton;cytosol;endoplasmic reticulum;nucleus,catalytic activity;structural molecule activity,114884,OSBPL10,NA,Acyl chain remodelling of PS,ENSG00000144645
P15104,0,6,24994651.916666668,9.675294806796033e-5,2.6498315257066754,1.4059006371271483,0.0030217713743778004,0.6429522395902524,raw,14562641.625,7635769.0625,15921216.0625,37176870.5,32482874,42188540.25,Glutamine synthetase OS=Homo sapiens OX=9606 GN=GLUL PE=1 SV=4,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;nucleus,structural molecule activity,2752,GLUL,TNF-alpha signaling pathway; Amino acid metabolism,Glutamate and glutamine metabolism; Astrocytic Glutamate-Glutamine Uptake And Metabolism,ENSG00000135821
Q5MNZ6,0.16666666666666666,6,2564261.1458333335,9.926116446937423e-6,2.649168683681218,1.4055397090764894,0.06527940553588427,0.6429522395902524,raw,1586012.5625,1477918.875,1529321.625,4201614.8125,2483583.3125,4107115.6875,WD repeat domain phosphoinositide-interacting protein 3 OS=Homo sapiens OX=9606 GN=WDR45B PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation,cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,56270,WDR45B,NA,Macroautophagy,ENSG00000141580
Q9UID3,0,6,309992.83984375,1.1999655460231658e-6,2.6460770567530902,1.4038550751376953,0.07232251780791708,0.6429522395902524,raw,NA,134232.546875,211276.75,NA,389655.71875,504806.34375,Vacuolar protein sorting-associated protein 51 homolog OS=Homo sapiens OX=9606 GN=VPS51 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;defense response,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,NA,738,VPS51,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000149823
Q14315,0,6,80158919.9453125,3.102908511992958e-4,2.6445032044112344,1.4029967235302796,0.013761418088499846,0.6429522395902524,raw,36542535.875,54200733.65625,37603274.515625,139238388.5625,96636853.21875,116731733.84375,Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,cell growth,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,2318,FLNC,Focal adhesion; MAPK signaling pathway; Ebola virus infection in host,Cell-extracellular matrix interactions,ENSG00000128591
Q9NS23,0.8333333333333334,6,550383.2369791666,2.130503794270198e-6,2.640944694243698,1.401054089397545,0.013774797926538549,0.6429522395902524,raw,294521.21875,413056.84375,203967.859375,960167.5,777814.25,652771.75,Ras association domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RASSF1 PE=1 SV=1,cell differentiation;coagulation;development;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,11186,RASSF1,Bladder cancer; Ras signaling; Non-small cell lung cancer; Hippo-Yap signaling pathway; Malignant pleural mesothelioma,NA,ENSG00000068028
Q92667,0,6,719018.2890625,2.783280976007101e-6,2.626895188658235,1.3933586390632626,0.04979407831217731,0.6429522395902524,raw,200243.671875,636574.40625,418570.21875,1261453.0625,697728.28125,1099540.09375,"A-kinase anchor protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=AKAP1 PE=1 SV=1",coagulation;metabolic process,cytoskeleton;cytosol;endosome,structural molecule activity,8165,AKAP1,G protein signaling pathways,Factors involved in megakaryocyte development and platelet production; Mitochondrial calcium ion transport,ENSG00000121057
O75794,0,6,2157259.5625,8.35063529252416e-6,2.625269078737545,1.3924653003655212,0.022256896071393324,0.6429522395902524,raw,1212542.96875,1938531.40625,856607.5,3183251.5625,2346693.5625,3405930.375,Cell division cycle protein 123 homolog OS=Homo sapiens OX=9606 GN=CDC123 PE=1 SV=1,cell differentiation;cell growth;metabolic process,nucleus,NA,8872,CDC123,NA,NA,ENSG00000151465
Q9UDY4,0,6,6407033.375,2.4801280268588535e-5,2.600261411943793,1.3786566689294686,0.06419810194536603,0.6429522395902524,raw,2996932.375,6740215.15625,3208226.59375,9205282.5,7949315.8125,8342227.8125,DnaJ homolog subfamily B member 4 OS=Homo sapiens OX=9606 GN=DNAJB4 PE=1 SV=1,coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane,structural molecule activity,11080,DNAJB4,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000162616
P43121,0,6,2076354.7760416667,8.037457232323493e-6,2.598874267126374,1.377886838280645,0.039425649127776574,0.6429522395902524,raw,1783489.84375,1109438.375,586381.875,3858767.15625,2236760.5625,2883290.84375,Cell surface glycoprotein MUC18 OS=Homo sapiens OX=9606 GN=MCAM PE=1 SV=2,cell communication;coagulation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;membrane,NA,4162,MCAM,NA,RHOC GTPase cycle; RHOA GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle,ENSG00000076706
P32929,0,6,5048621.91015625,1.9542942830998123e-5,2.594329364114585,1.3753616491388254,0.04042564349773723,0.6429522395902524,raw,3334323.6875,2118648.34375,3493290.1640625,6683429.8125,5599294.203125,9062745.25,Cystathionine gamma-lyase OS=Homo sapiens OX=9606 GN=CTH PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;nucleus,structural molecule activity,1491,CTH,"Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; Trans-sulfuration pathway; Trans-sulfuration, one-carbon metabolism and related pathways; Amino acid metabolism; Methionine metabolism leading to sulfur amino acids and related disorders; Ferroptosis","Degradation of cysteine and homocysteine; Metabolism of ingested SeMet, Sec, MeSec into H2Se; Cysteine formation from homocysteine",ENSG00000116761
Q13425,0,6,5485240.921875,2.123307145159874e-5,2.5878129065941167,1.3717333172972317,0.022974777405789355,0.6429522395902524,raw,5025386.15625,3159847.46875,1886035.625,8274720.125,6388362.09375,8177094.0625,Beta-2-syntrophin OS=Homo sapiens OX=9606 GN=SNTB2 PE=1 SV=1,NA,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity;structural molecule activity,6645,SNTB2,NA,NA,ENSG00000168807
P21397,0,6,446648.140625,1.7289508371079102e-6,2.5842373587472953,1.3697385857288176,1,1,raw,347719.1875,246572.859375,NA,NA,NA,745652.375,Amine oxidase [flavin-containing] A OS=Homo sapiens OX=9606 GN=MAOA PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;cytosol;endosome,structural molecule activity,4128,MAOA,Biogenic amine synthesis; Serotonin transporter activity; Dopamine metabolism; Melatonin metabolism and effects; Amino acid metabolism; Oxidative stress response; Neurotransmitter disorders; Tryptophan metabolism; Overlap between signal transduction pathways contributing to LMNA laminopathies; Biogenic amine synthesis; Sudden infant death syndrome (SIDS) susceptibility pathways,Interleukin-4 and Interleukin-13 signaling; Norepinephrine Neurotransmitter Release Cycle; Metabolism of serotonin; Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB; Enzymatic degradation of dopamine by COMT; Enzymatic degradation of Dopamine by monoamine oxidase; Defective MAOA causes BRUNS,ENSG00000189221
Q9NRW3,0,6,6161948.294921875,2.385256915614376e-5,2.5739176940131214,1.3639659213373272,0.0168000178101494,0.6429522395902524,raw,3890798.375,3340463.80859375,3207952.640625,9217876.828125,7300003.3359375,10014594.78125,DNA dC->dU-editing enzyme APOBEC-3C OS=Homo sapiens OX=9606 GN=APOBEC3C PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,27350,APOBEC3C,NA,Formation of the Editosome,ENSG00000244509
Q9GZX9,0.16666666666666666,6,413901.90625,1.6021919318641455e-6,2.5703070792829443,1.3619407311286087,1,1,raw,231857.875,NA,NA,595945.9375,NA,NA,Twisted gastrulation protein homolog 1 OS=Homo sapiens OX=9606 GN=TWSG1 PE=1 SV=1,defense response;development;metabolic process,cell surface,structural molecule activity,57045,TWSG1,Mesodermal commitment pathway; Mesodermal commitment pathway,NA,ENSG00000128791
Q96AQ6,0,6,3283695.25,1.2711007020762224e-5,2.5699477960708035,1.3617390539270522,0.020877590709948882,0.6429522395902524,raw,1649178.1875,3074995.6875,1499917.03125,5050043.15625,3854708.46875,4573328.96875,Pre-B-cell leukemia transcription factor-interacting protein 1 OS=Homo sapiens OX=9606 GN=PBXIP1 PE=1 SV=1,cell communication;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,57326,PBXIP1,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000163346
Q9Y320,0,6,6179110.466145833,2.3919002994338477e-5,2.5669194893098854,1.3600380469086992,0.033010404832391795,0.6429522395902524,raw,4641989.15625,3430245.5625,2551230.328125,8805164.1875,6682971.75,10963061.8125,Thioredoxin-related transmembrane protein 2 OS=Homo sapiens OX=9606 GN=TMX2 PE=1 SV=1,defense response,cytoskeleton;endosome;extracellular;nucleus,structural molecule activity,51075,TMX2,NA,NA,ENSG00000213593
E9PHI4,0,6,27470360.53125,1.0633628244752258e-4,2.5657965991614824,1.359406806821975,0.05204540411269315,0.6429522395902524,raw,16443006.359375,16057256.0625,17208112.90625,42189409.796875,28069548.5,44854829.5625,SUN domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SUN1 PE=1 SV=1,NA,cytoskeleton;membrane;nucleus,NA,NA,SUN1,NA,NA,ENSG00000164828
Q8N108,0,6,666063.49375,2.5782958224669805e-6,2.5621106530144306,1.357332784464835,0.24468648511727728,0.7301988479077035,raw,355268.8125,365063.125,466802.25,NA,792552.65625,1350630.625,Mesoderm induction early response protein 1 OS=Homo sapiens OX=9606 GN=MIER1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,57708,MIER1,NA,NA,ENSG00000198160
Q8TDX7,0,6,2543094.75,9.844182471474341e-6,2.5575854913877745,1.3547824651669962,0.015900920645106835,0.6429522395902524,raw,2138109.6875,1482336.8125,736271.75,4150860.25,2959786.875,3791203.125,Serine/threonine-protein kinase Nek7 OS=Homo sapiens OX=9606 GN=NEK7 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,signal transducer activity;structural molecule activity,140609,NEK7,Ciliary landscape,"EML4 and NUDC in mitotic spindle formation; Nuclear Pore Complex (NPC) Disassembly; Activation of NIMA Kinases NEK9, NEK6, NEK7",ENSG00000151414
Q9UBU6,0,6,913091.5520833334,3.5345280988331444e-6,2.5467963844470747,1.3486836212175435,1,1,raw,449533.59375,NA,NA,1685374,604367.0625,NA,Protein FAM8A1 OS=Homo sapiens OX=9606 GN=FAM8A1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation,cytoskeleton;extracellular,NA,51439,FAM8A1,NA,NA,ENSG00000137414
P11047,0,6,11397312.708333334,4.411838213471471e-5,2.544770049362101,1.3475352973095212,0.024518694997364223,0.6429522395902524,raw,6568418.53125,9934361.9375,4589361.03125,16715114.75,12143642.59375,18432977.40625,Laminin subunit gamma-1 OS=Homo sapiens OX=9606 GN=LAMC1 PE=1 SV=3,cell communication;cell growth;metabolic process,cell surface;chromosome;extracellular;nucleus,enzyme regulator activity,3915,LAMC1,Alpha 6 beta 4 signaling pathway; Complement system; Endoderm differentiation; miRNA targets in ECM and membrane receptors; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Inflammatory response pathway; Small cell lung cancer; Malignant pleural mesothelioma,Degradation of the extracellular matrix; ECM proteoglycans; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Non-integrin membrane-ECM interactions; L1CAM interactions; Laminin interactions; MET activates PTK2 signaling; EGR2 and SOX10-mediated initiation of Schwann cell myelination,ENSG00000135862
Q14669,0,6,21665027.760416668,8.386415273087987e-5,2.544088618608194,1.3471489251033388,0.07318556081325218,0.6429522395902524,raw,11557401.75,14405682.125,10975483.5625,36494643.6875,19907623.5,36649331.9375,E3 ubiquitin-protein ligase TRIP12 OS=Homo sapiens OX=9606 GN=TRIP12 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane,structural molecule activity,9320,TRIP12,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000153827
A0A087WYV9,0,6,1429299.1125,5.532739694329648e-6,2.5309932928667407,1.3397036843112153,0.09560443977045453,0.6429522395902524,raw,820238.3125,698738.375,NA,1909961.125,1200911.75,2516646,"Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=SYNJ2BP-COX16 PE=3 SV=1",NA,cytoskeleton;endosome,NA,100529257,SYNJ2BP-COX16,NA,NA,ENSG00000258644
Q7Z569,0,6,1971748.890625,7.63253349771557e-6,2.5292000418665075,1.3386811485058536,0.10640235488068381,0.6429522395902524,raw,1020298.03125,1286951.265625,1129333.515625,2856310.375,1740057.5,3797542.65625,BRCA1-associated protein OS=Homo sapiens OX=9606 GN=BRAP PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,8315,BRAP,Ras signaling,RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Negative regulation of MAPK pathway,ENSG00000089234
P49662,0,6,343943.8328125,1.3313880067364828e-6,2.5164395437404545,1.3313839381910488,0.3367540417430736,0.8206562226243124,raw,NA,344700.71875,106659.2890625,472267.8125,405419.875,390671.46875,Caspase-4 OS=Homo sapiens OX=9606 GN=CASP4 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endosome;extracellular;nucleus,structural molecule activity,837,CASP4,Apoptosis modulation and signaling; Apoptosis,NOD1/2 Signaling Pathway; Pyroptosis,ENSG00000196954
Q8TB36,0,6,2408891.765625,9.324689964793684e-6,2.4941232687848593,1.3185327702476968,0.12216165007166134,0.6445597830897484,raw,1196775,746214.5625,2898954.84375,3735314.625,2891187.1875,2984904.375,Ganglioside-induced differentiation-associated protein 1 OS=Homo sapiens OX=9606 GN=GDAP1 PE=1 SV=3,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;endosome;mitochondrion,NA,54332,GDAP1,Intracellular trafficking proteins involved in CMT neuropathy,Class I peroxisomal membrane protein import,ENSG00000104381
Q7L523,0,6,440854.6640625,1.70652460213359e-6,2.47681392121014,1.3084854854468624,0.006048518584420037,0.6429522395902524,raw,276938.375,225971.734375,274457.78125,608117.125,699953.03125,559689.9375,Ras-related GTP-binding protein A OS=Homo sapiens OX=9606 GN=RRAGA PE=1 SV=1,coagulation;development;metabolic process,cytosol;membrane;mitochondrion;nucleus,structural molecule activity,10670,RRAGA,Target of rapamycin signaling; 2q37 copy number variation syndrome,E3 ubiquitin ligases ubiquitinate target proteins; Amino acids regulate mTORC1; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK,ENSG00000155876
P02686,0,6,1183654.6145833333,4.581863105635748e-6,2.4740548471606285,1.306877483681118,0.08729734602002133,0.6429522395902524,raw,416468.6875,560839.0625,1164970.0625,1030366.375,1778525.5,2150758,Myelin basic protein OS=Homo sapiens OX=9606 GN=MBP PE=1 SV=3,cell death;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,4155,MBP,Neural crest differentiation; Glial cell differentiation; Spinal cord injury; Interleukin-1 (IL-1) structural pathway; MECP2 and associated Rett syndrome; MAPK cascade; Complement system in neuronal development and plasticity,EGR2 and SOX10-mediated initiation of Schwann cell myelination,ENSG00000197971
U3KQB3,0,6,770433.6223958334,2.982306955343895e-6,2.469818548263006,1.3044050543050754,0.015480123381505407,0.6429522395902524,raw,450932.8125,558499.0625,258689.828125,988483.59375,986605.09375,1379391.34375,Non-specific serine/threonine protein kinase OS=Homo sapiens OX=9606 GN=CSNK1G1 PE=1 SV=1,cell death;cell organization and biogenesis;cellular homeostasis;development,NA,signal transducer activity;structural molecule activity,53944,CSNK1G1,Wnt signaling pathway; Hedgehog signaling pathway,NA,ENSG00000169118
Q712K3,0,6,1188090,4.599032243110073e-6,2.4627794807068155,1.3002874535235875,0.0363271147162185,0.6429522395902524,raw,649107.5625,800412.5625,582330,1434150.375,1518641.5,2143898,Ubiquitin-conjugating enzyme E2 R2 OS=Homo sapiens OX=9606 GN=UBE2R2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol,structural molecule activity,54926,UBE2R2,NA,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000107341
Q13439,0,6,1049348.2317708333,4.061970349186176e-6,2.4585802194031983,1.2978254286777806,0.020468172976804856,0.6429522395902524,raw,936718.515625,609898.8125,338152.75,1499485.15625,1648767.78125,1263066.375,Golgin subfamily A member 4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=1,cell growth;conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,2803,GOLGA4,NA,Retrograde transport at the Trans-Golgi-Network; Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,ENSG00000144674
A2A2Q9,0,6,2785692.2916666665,1.0783264457034559e-5,2.4518559375023625,1.2938742137934884,0.11467326029455968,0.6429522395902524,raw,2223908.0625,2167710.78125,856433.53125,3318310.875,2695088.3125,5452702.1875,AAR2 splicing factor homolog OS=Homo sapiens OX=9606 GN=AAR2 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,NA,NA,AAR2,Ciliary landscape,NA,ENSG00000131043
P42566,0,6,2474511.84375,9.578701744282003e-6,2.446934649262623,1.2909755716078568,0.11459441379471591,0.6429522395902524,raw,1667921.03125,1413981.75,1406494.78125,2178646.25,3459920.9375,4720106.3125,Epidermal growth factor receptor substrate 15 OS=Homo sapiens OX=9606 GN=EPS15 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,2060,EPS15,VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host; EGF/EGFR signaling pathway,Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell,ENSG00000085832
P51688,0,6,937807.1125,3.6302006987732036e-6,2.446831284737422,1.290914627341235,0.021419869795726507,0.6429522395902524,raw,598101.5,NA,396915.0625,1436947.25,988774.375,1268297.375,N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,mitochondrion,structural molecule activity,6448,SGSH,Glycosaminoglycan degradation,HS-GAG degradation; MPS IIIA - Sanfilippo syndrome A,ENSG00000181523
Q9Y2L5,0,6,977636.04296875,3.7843763381897215e-6,2.4451209460409506,1.2899058287513165,0.2585582148334592,0.7381027251958325,raw,NA,328168.3125,981222.75,1496999.75,1104153.359375,NA,Trafficking protein particle complex subunit 8 OS=Homo sapiens OX=9606 GN=TRAPPC8 PE=1 SV=2,cell growth;cellular homeostasis;conjugation,cytosol;extracellular;nucleus,NA,22878,TRAPPC8,NA,RAB GEFs exchange GTP for GDP on RABs,ENSG00000153339
P35227,0.16666666666666666,6,674830.4895833334,2.6122323899936084e-6,2.4444608369696104,1.2895162919231309,1,1,raw,NA,NA,343779.65625,779139.125,NA,901572.6875,Polycomb group RING finger protein 2 OS=Homo sapiens OX=9606 GN=PCGF2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,7703,PCGF2,NA,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; Transcriptional Regulation by E2F6; Activation of anterior HOX genes in hindbrain development during early embryogenesis,ENSG00000277258; ENSG00000278644
Q9UH62,0,6,5272527.591145833,2.040966963308097e-5,2.4251197650368113,1.2780559968495022,0.007703556929061579,0.6429522395902524,raw,3166404.8125,3133427,2909966.734375,7598935.75,6676501.5,8149929.75,Armadillo repeat-containing X-linked protein 3 OS=Homo sapiens OX=9606 GN=ARMCX3 PE=1 SV=1,cell growth;conjugation;metabolic process,cytosol;endosome;membrane;nucleus,NA,51566,ARMCX3,NA,RAC2 GTPase cycle,ENSG00000102401
P35240,0.16666666666666666,6,1480338,5.730308472170525e-6,2.4184209373906693,1.2740653742117893,0.06675479403531225,0.6429522395902524,raw,1054510,630125.875,NA,2147604.375,1764511.25,1804938.5,Merlin OS=Homo sapiens OX=9606 GN=NF2 PE=1 SV=1,cell differentiation;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,antioxidant activity;motor activity,4771,NF2,Ectoderm differentiation; Ectoderm differentiation; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Yap signaling pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; 3q29 copy number variation syndrome; Malignant pleural mesothelioma,Regulation of actin dynamics for phagocytic cup formation; RHO GTPases activate PAKs,ENSG00000186575
P49757,0,6,900015.6510416666,3.48391199188978e-6,2.410954906962867,1.269604667900445,0.03112222371572536,0.6429522395902524,raw,842643.28125,487505.28125,431518.96875,1175353.25,1172431.6875,1290641.4375,Protein numb homolog OS=Homo sapiens OX=9606 GN=NUMB PE=1 SV=2,cell differentiation;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;membrane;mitochondrion;nucleus,structural molecule activity,8650,NUMB,Notch signaling; VEGFA-VEGFR2 signaling pathway; Head and neck squamous cell carcinoma; Neurogenesis regulation in the olfactory epithelium; Notch signaling pathway,Recycling pathway of L1; Degradation of GLI1 by the proteasome; Hedgehog 'on' state; Activated NOTCH1 Transmits Signal to the Nucleus,ENSG00000133961
Q9NPA3,0,6,1374383.2291666667,5.320163274943179e-6,2.404297820440143,1.2656156137944063,0.40911212271973507,0.8935675900241862,raw,2099238.3125,691280.625,568246.9375,1662044.5,1447160.4375,1778328.5625,Mid1-interacting protein 1 OS=Homo sapiens OX=9606 GN=MID1IP1 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane,structural molecule activity,58526,MID1IP1,NA,Carnitine metabolism,ENSG00000165175
H7C4G8,0.6666666666666666,6,377802.6432291667,1.4624536337677693e-6,2.402726050494829,1.2646721673513612,0.7768177598993735,1,raw,799490,95670.6875,116451.9375,373216.65625,229870.453125,652116.125,5'-nucleotidase domain-containing protein 2 (Fragment) OS=Homo sapiens OX=9606 GN=NT5DC2 PE=1 SV=1,NA,NA,structural molecule activity,NA,NT5DC2,NA,NA,ENSG00000168268
I3NI02,0,6,2160086.5625,8.361578456889883e-6,2.402505114111973,1.2645395020067798,0.023254979332482474,0.6429522395902524,raw,778409.90625,1985017.03125,1239065.3125,2624599.125,2976860.75,3356567.25,Golgi SNAP receptor complex member 2 OS=Homo sapiens OX=9606 GN=GOSR2 PE=1 SV=2,conjugation,cytoskeleton;nucleus,NA,9570,GOSR2,NA,NA,ENSG00000108433
P61764,0,6,6916190.4609375,2.677219985804264e-5,2.399486144719365,1.2627254825676,0.03208944034568071,0.6429522395902524,raw,6003477.65625,2994191.765625,3576513.5625,11650704.9375,7184521.65625,10087733.1875,Syntaxin-binding protein 1 OS=Homo sapiens OX=9606 GN=STXBP1 PE=1 SV=1,cell communication;cell death;cell growth;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,structural molecule activity,6812,STXBP1,Synaptic vesicle pathway; Rett syndrome causing genes; EGF/EGFR signaling pathway; Insulin signaling; Dravet syndrome,Regulation of insulin secretion; Neurexins and neuroligins,ENSG00000136854
Q9Y530,0,6,1138087.625,4.4054757491937186e-6,2.390362546661758,1.257229448584225,0.0010982080560854232,0.6429522395902524,raw,NA,651083.25,585356.5,1496389.875,1380785.875,1576822.625,ADP-ribose glycohydrolase OARD1 OS=Homo sapiens OX=9606 GN=OARD1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation,membrane;nucleus,structural molecule activity,221443,OARD1,NA,NA,ENSG00000124596
Q9NZ45,0,6,15831752.25,6.128385817798353e-5,2.3869261220393945,1.2551539141294443,0.017510196790348778,0.6429522395902524,raw,8449947,7556424.75,12801132.875,21698934.75,18036627.625,26447446.5,CDGSH iron-sulfur domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CISD1 PE=1 SV=1,metabolic process,cytoskeleton;endosome,structural molecule activity,55847,CISD1,Adipogenesis; Ferroptosis,NA,ENSG00000122873
Q9BXI6,0,6,2391588.1432291665,9.257708576749816e-6,2.3859142586022917,1.2545421985604273,0.013869534608190593,0.6429522395902524,raw,2139778.59375,1206009.46875,1402000.140625,3378835.34375,2877435.1875,3345470.125,TBC1 domain family member 10A OS=Homo sapiens OX=9606 GN=TBC1D10A PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,DNA binding;structural molecule activity,83874,TBC1D10A,Deregulation of Rab and Rab effector genes in bladder cancer,TBC/RABGAPs,ENSG00000099992
P46821,0,6,355494.7174479167,1.3761008575093417e-6,2.3798042302803206,1.2508428980624504,0.08776185230919609,0.6429522395902524,raw,211862.4375,345219.6875,112969.6171875,504191.125,638493.21875,320232.21875,Microtubule-associated protein 1B OS=Homo sapiens OX=9606 GN=MAP1B PE=1 SV=2,cell growth;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,4131,MAP1B,Microtubule cytoskeleton regulation; Fragile X syndrome; Neurogenesis regulation in the olfactory epithelium,NA,ENSG00000131711
J3KPS0,0,6,1298488.03125,5.026377061511561e-6,2.3761557910131783,1.2486294285435124,0.010074833301745344,0.6429522395902524,raw,944773.6875,808724.0625,274271.53125,1707863.75,2244929.46875,1810365.6875,"DnaJ (Hsp40) homolog, subfamily B, member 12, isoform CRA_c OS=Homo sapiens OX=9606 GN=DNAJB12 PE=1 SV=1",NA,cytoskeleton;extracellular;membrane,NA,54788,DNAJB12,NA,NA,ENSG00000148719
A0A3B3ITT1,0,6,932447.0260416666,3.6094520934926836e-6,2.3696550410016908,1.2446770562297609,0.24719060878946186,0.7316541032247736,raw,432947.71875,381794.46875,1280950.90625,1366226.4375,904721.1875,1228041.4375,Ras-related protein Rab-12 OS=Homo sapiens OX=9606 GN=RAB12 PE=1 SV=1,development,NA,structural molecule activity,NA,RAB12,NA,NA,ENSG00000206418
Q15633,0,6,568246.3515625,2.1996509463639955e-6,2.3572516540116393,1.2371057851533138,1,1,raw,393780.53125,551898.4375,395355.0625,NA,NA,931951.375,RISC-loading complex subunit TARBP2 OS=Homo sapiens OX=9606 GN=TARBP2 PE=1 SV=3,cell differentiation;cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,6895,TARBP2,Fragile X syndrome; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies,MicroRNA (miRNA) biogenesis; Small interfering RNA (siRNA) biogenesis,ENSG00000139546
P41743,0.16666666666666666,6,1321696.3255208333,5.1162151155808225e-6,2.3514801415473867,1.233569148563286,0.10928755308221258,0.6429522395902524,raw,811879.171875,814839.46875,589161.8125,1909117.75,1157698.125,2647481.625,Protein kinase C iota type OS=Homo sapiens OX=9606 GN=PRKCI PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,signal transducer activity;structural molecule activity,5584,PRKCI,Glioblastoma signaling pathways; Corticotropin-releasing hormone signaling pathway; G protein signaling pathways; VEGFA-VEGFR2 signaling pathway; Wnt signaling pathway and pluripotency; EGF/EGFR signaling pathway; Hippo signaling regulation pathways; Osteoblast differentiation and related diseases; Insulin signaling; Complement system in neuronal development and plasticity; Chronic hyperglycemia impairment of neuron function,Tight junction interactions; Pre-NOTCH Transcription and Translation; p75NTR recruits signalling complexes,ENSG00000163558
Q9HB21,0,6,1046661.4270833334,4.05156987330577e-6,2.3480660834782476,1.231473011925286,0.0011347449784578276,0.6429522395902524,raw,619528.90625,744796.8125,510811.3125,1545481.3125,1404655.40625,1454694.8125,Pleckstrin homology domain-containing family A member 1 OS=Homo sapiens OX=9606 GN=PLEKHA1 PE=1 SV=2,cell growth;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,59338,PLEKHA1,NA,Synthesis of PIPs at the plasma membrane,ENSG00000107679
Q8NDX5,0.5,6,1114092.5846354167,4.312592243473238e-6,2.325189288389666,1.2173481675347055,0.2273883427312876,0.7148463313429879,raw,777602.53125,685514.6328125,532060.1875,1593951.28125,639658.8125,2455768.0625,Polyhomeotic-like protein 3 OS=Homo sapiens OX=9606 GN=PHC3 PE=1 SV=1,metabolic process,membrane,RNA binding;structural molecule activity,80012,PHC3,NA,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6,ENSG00000173889
C9JA93,0,6,573072.715625,2.218333541066775e-6,2.3246810383943486,1.217032782502795,0.2482012465632374,0.7316541032247736,raw,705052,201297.296875,346767.34375,609874.0625,NA,1002372.875,TBC1 domain family member 15 (Fragment) OS=Homo sapiens OX=9606 GN=TBC1D15 PE=1 SV=1,NA,nucleus,NA,NA,TBC1D15,NA,NA,ENSG00000121749
A0A0U1RQC9,0.8333333333333334,6,1254574.7083333333,4.856390959452075e-6,2.314564981078886,1.2107410666541156,0.030637090029678127,0.6429522395902524,raw,700790.875,944827.4375,631464.6875,1567360.875,1496139.875,2186864.5,Cellular tumor antigen p53 OS=Homo sapiens OX=9606 GN=TP53 PE=1 SV=1,cell differentiation;cell growth;cellular component movement;metabolic process,cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,NA,TP53,AMP-activated protein kinase signaling; miRNA regulation of DNA damage response; Cell cycle; Metastatic brain tumor; Glioblastoma signaling pathways; Spinal cord injury; ATM signaling pathway; Copper homeostasis; RAC1/PAK1/p38/MMP2 pathway; Hepatitis C and hepatocellular carcinoma; Pathways affected in adenoid cystic carcinoma; lncRNA-mediated mechanisms of therapeutic resistance; miRNA regulation of p53 pathway in prostate cancer; Endometrial cancer; PI3K-Akt signaling pathway; Caloric restriction and aging; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer; Ferroptosis; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome; MicroRNA network associated with chronic lymphocytic leukemia; Measles virus infection; 22q11.2 copy number variation syndrome; Small cell lung cancer; Head and neck squamous cell carcinoma; Melanoma; Thyroid hormones production and peripheral downstream signaling effects; Unfolded protein response; 16p11.2 proximal deletion syndrome; Pentose phosphate pathway in senescent cells; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis in senescence; TCA cycle in senescence; Malignant pleural mesothelioma; Lipid metabolism in senescent cells; DYRK1A; 2q37 copy number variation syndrome; DNA damage response; DNA damage response (only ATM dependent),NA,ENSG00000141510
Q9P265,0,6,3587851.1536458335,1.3888378101908828e-5,2.31358958601105,1.2101329635202593,0.19183827081221913,0.6828551970636761,raw,2016595.1875,4577425.71875,1327511.703125,4164924.21875,4775076.46875,4665573.625,Disco-interacting protein 2 homolog B OS=Homo sapiens OX=9606 GN=DIP2B PE=1 SV=3,cell growth;defense response;metabolic process,membrane;nucleus,motor activity,57609,DIP2B,NA,NA,ENSG00000066084
O14933,0,6,2197599.921875,8.506790645623902e-6,2.309540614154157,1.2076059167535622,0.13698055964449998,0.654928512316515,raw,1421675,1432848.390625,1424679.96875,3290356.25,1737884.109375,3878155.8125,Ubiquitin/ISG15-conjugating enzyme E2 L6 OS=Homo sapiens OX=9606 GN=UBE2L6 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,9246,UBE2L6,Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway; 7q11.23 copy number variation syndrome,Antigen processing: Ubiquitination & Proteasome degradation; Amyloid fiber formation; ISG15 antiviral mechanism; Termination of translesion DNA synthesis; Negative regulators of DDX58/IFIH1 signaling,ENSG00000156587
O00754,0,6,585802.3984375,2.267609455937914e-6,2.3084570914339237,1.2069289164675012,0.2930210346115498,0.774322745775844,raw,182632.546875,446852.0625,489369.96875,1166343,198078,1031538.8125,Lysosomal alpha-mannosidase OS=Homo sapiens OX=9606 GN=MAN2B1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;membrane;mitochondrion;nucleus,structural molecule activity,4125,MAN2B1,NA,Neutrophil degranulation; Lysosomal oligosaccharide catabolism,ENSG00000104774
C9JEJ2,0,6,6497845.578125,2.5152809403788506e-5,2.308011553216562,1.206650445701993,0.041676690388434696,0.6429522395902524,raw,3292971.21875,4871100.15625,3710713.84375,8941308.8125,6928424,11242555.4375,Choline-phosphate cytidylyltransferase A OS=Homo sapiens OX=9606 GN=PCYT1A PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,NA,PCYT1A,"Trans-sulfuration, one-carbon metabolism and related pathways; Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids; 3q29 copy number variation syndrome",NA,ENSG00000161217
P23497,0,6,13814891.037760416,5.34766973189847e-5,2.2951419603056245,1.1985833907174848,0.0036739062485618566,0.6429522395902524,raw,7495987.6328125,7824600.3125,10006027.96875,18839841.4375,17204355.75,21518533.125,Nuclear autoantigen Sp-100 OS=Homo sapiens OX=9606 GN=SP100 PE=1 SV=3,cell growth;cell proliferation;cellular component movement;coagulation;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6672,SP100,NA,SUMOylation of DNA damage response and repair proteins; Interferon gamma signaling,ENSG00000067066
Q9BZL6,0,6,3040760.9557291665,1.1770621484053091e-5,2.294269147977251,1.1980346484046944,0.08048013854719442,0.6429522395902524,raw,1366968.28125,3313947.25,1793318.09375,4114354.375,3448945.453125,4207032.28125,Serine/threonine-protein kinase D2 OS=Homo sapiens OX=9606 GN=PRKD2 PE=1 SV=3,cell communication;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,signal transducer activity;structural molecule activity,25865,PRKD2,VEGFA-VEGFR2 signaling pathway; Gastrin signaling pathway,Sphingolipid de novo biosynthesis,ENSG00000105287
A0A669KAX3,0,6,4167987.06998698,1.613405291159424e-5,2.2938684327346777,1.1977826464171475,0.021900048714696772,0.6429522395902524,raw,2942049.6953125,2240403.0546875,2633562.51367188,6872981.78125,5179735.53125,5139189.84375,Wolframin OS=Homo sapiens OX=9606 GN=WFS1 PE=1 SV=1,metabolic process,cytoskeleton;extracellular,NA,NA,WFS1,NA,NA,ENSG00000109501
A0A0D9SEY1,0,6,2802695.4557291665,1.0849082787092322e-5,2.2928801469862914,1.1971609445970188,0.028321805555447426,0.6429522395902524,raw,915404.828125,2595139.0625,1734141.3125,3976178.1875,3210220.28125,4385089.0625,Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP4K4 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,MAP4K4,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Yap signaling pathway; Malignant pleural mesothelioma,NA,ENSG00000071054
Q9NQS1,0,6,185681.294921875,7.187622674108306e-7,2.2874474433794467,1.193738596272356,0.1789814685724702,0.6741527184744509,raw,74650.6953125,170374.671875,NA,277978.84375,NA,219720.96875,Cell death regulator Aven OS=Homo sapiens OX=9606 GN=AVEN PE=1 SV=1,metabolic process,cytoskeleton;cytosol;nucleus,NA,57099,AVEN,NA,Regulation of the apoptosome activity,ENSG00000169857
A6NHB5,0,6,1915740.515625,7.415728102072816e-6,2.286918857384541,1.1934051781126425,0.1717309101163965,0.6688917965646828,raw,1397043.71875,1121435.34375,1350786.34375,3095546.03125,1334706.03125,3194925.625,Zinc finger MYM-type protein 3 OS=Homo sapiens OX=9606 GN=ZMYM3 PE=1 SV=1,NA,membrane,structural molecule activity,NA,ZMYM3,NA,NA,ENSG00000147130
P78540,0,6,3699964.9713541665,1.4322364637052453e-5,2.286299666534788,1.1930145107657448,0.045652593811700386,0.6429522395902524,raw,2689312.671875,2553174.9375,1643237.375,6301317.96875,3756933.0625,5255813.8125,"Arginase-2, mitochondrial OS=Homo sapiens OX=9606 GN=ARG2 PE=1 SV=1",cellular homeostasis;coagulation;defense response;metabolic process,endosome;nucleus,structural molecule activity,384,ARG2,Amino acid metabolism,Urea cycle,ENSG00000081181
Q9NX76,0.16666666666666666,6,356130.130859375,1.3785605085181048e-6,2.2812751410166814,1.189840458329979,0.3827926448027312,0.867802734281256,raw,NA,119255.8359375,400560.96875,513461.90625,391241.8125,NA,CKLF-like MARVEL transmembrane domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CMTM6 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;mitochondrion,NA,54918,CMTM6,NA,Neutrophil degranulation,ENSG00000091317
Q8N4C8,0,6,1309557.578125,5.069226679802047e-6,2.279661949815697,1.188819903563988,0.08144136689955161,0.6429522395902524,raw,717747.65625,730446.28125,942955.03125,2448338.78125,1665170.59375,1352687.125,Misshapen-like kinase 1 OS=Homo sapiens OX=9606 GN=MINK1 PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;extracellular;nucleus,signal transducer activity;structural molecule activity,50488,MINK1,Angiopoietin-like protein 8 regulatory pathway; Hippo-Yap signaling pathway; Insulin signaling; Malignant pleural mesothelioma,Oxidative Stress Induced Senescence,ENSG00000141503
P49903,0,6,9473211.661458334,3.6670290867571666e-5,2.2771076427104937,1.187202491709062,0.07104664425291976,0.6429522395902524,raw,6611260.5,5560183.40625,6182221.8125,15054551.8125,8962239.5625,14468812.875,"Selenide, water dikinase 1 OS=Homo sapiens OX=9606 GN=SEPHS1 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;membrane;nucleus,signal transducer activity;structural molecule activity,22929,SEPHS1,NA,NA,ENSG00000086475
Q9H1C4,0,6,1158516.4479166667,4.48455461971913e-6,2.2669928294197605,1.1807798277893682,0.0459219562111841,0.6429522395902524,raw,574962.1875,617600.8125,1189646.34375,1605826.125,1303435.15625,1659628.0625,Protein unc-93 homolog B1 OS=Homo sapiens OX=9606 GN=UNC93B1 PE=1 SV=2,coagulation;conjugation;development;metabolic process,cytoskeleton;extracellular;mitochondrion;nucleus,antioxidant activity,81622,UNC93B1,NA,Trafficking and processing of endosomal TLR; UNC93B1 deficiency - HSE,ENSG00000110057
Q9UBS9,0.16666666666666666,6,106724.5556640625,4.1312499274517854e-7,2.262710354493695,1.1780519196115111,0.0823007178822073,0.6429522395902524,raw,69933.1875,NA,60750.13671875,134043.8203125,NA,162171.078125,SUN domain-containing ossification factor OS=Homo sapiens OX=9606 GN=SUCO PE=1 SV=1,metabolic process,cytoskeleton;extracellular;nucleus,NA,51430,SUCO,NA,NA,ENSG00000094975
Q86Y82,0,6,5457283.640625,2.1124850325338567e-5,2.259370068681119,1.1759205932296493,0.048473243194854895,0.6429522395902524,raw,3305578.03125,2531041.4375,4164390.5,7826272,5507520.625,9408899.25,Syntaxin-12 OS=Homo sapiens OX=9606 GN=STX12 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,23673,STX12,NA,NA,ENSG00000117758
Q9HA64,0,6,1424240.5052083333,5.51315809862595e-6,2.256021686854793,1.1737809362506606,0.08068104390421886,0.6429522395902524,raw,848670.78125,340900.125,1525970.75,2168363.4375,1746918.25,1914619.6875,Ketosamine-3-kinase OS=Homo sapiens OX=9606 GN=FN3KRP PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol,signal transducer activity;structural molecule activity,79672,FN3KRP,NA,"Gamma carboxylation, hypusine formation and arylsulfatase activation",ENSG00000141560
Q9H2W6,0,6,5733158.229166667,2.2192745962670632e-5,2.2545215017617135,1.1728212692733135,0.09231344829298163,0.6429522395902524,raw,3404994.25,2225265.25,5934567.5625,9812034.5,5345455.0625,7676632.75,"39S ribosomal protein L46, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL46 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane;nucleus,structural molecule activity,26589,MRPL46,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000259494
P39656,0,6,99949169.09505208,3.868978371505571e-4,2.254339938460286,1.1727050800853371,0.03923183074844119,0.6429522395902524,raw,72413939.03125,52951688.9375,61226522.0546875,145626074.6875,104231155,163245634.859375,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens OX=9606 GN=DDOST PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,DNA binding,1650,DDOST,AGE/RAGE pathway,Neutrophil degranulation; SRP-dependent cotranslational protein targeting to membrane; Advanced glycosylation endproduct receptor signaling; Asparagine N-linked glycosylation; Maturation of spike protein,ENSG00000244038
Q9HCM4,0,6,1409541.60625,5.456259454375437e-6,2.252831687109382,1.1717395313970025,0.02971651655816067,0.6429522395902524,raw,875399.375,NA,713482.5625,2244113.84375,1645907.1875,1568805.0625,Band 4.1-like protein 5 OS=Homo sapiens OX=9606 GN=EPB41L5 PE=1 SV=3,cell communication;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,57669,EPB41L5,Endoderm differentiation; Mesodermal commitment pathway; Mesodermal commitment pathway,Neurexins and neuroligins,ENSG00000115109
Q9UIL1,0,6,783499.5390625,3.032884413310707e-6,2.25186630748904,1.1711211776632633,0.5450543250964057,1,raw,1300796.75,177378.578125,414338.625,933680.0625,399432.84375,1475370.375,Short coiled-coil protein OS=Homo sapiens OX=9606 GN=SCOC PE=1 SV=2,metabolic process,cytoskeleton;cytosol;extracellular;membrane,NA,60592,SCOC,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000153130
Q8N9N8,0,6,2840299.0859375,1.0994644409348308e-5,2.2478339026565863,1.1685354356181183,0.11390955360850996,0.6429522395902524,raw,1369043.90625,2324543.5,1477156.859375,4374307,2271555.5625,5225187.6875,Probable RNA-binding protein EIF1AD OS=Homo sapiens OX=9606 GN=EIF1AD PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,84285,EIF1AD,NA,NA,ENSG00000175376
Q15796,0,6,4991187.192708333,1.9320616140750004e-5,2.246403045808065,1.1676167968489555,0.01311290912171711,0.6429522395902524,raw,2786146.734375,3157454.375,3202901.140625,7741215,5966490.78125,7092915.125,Mothers against decapentaplegic homolog 2 OS=Homo sapiens OX=9606 GN=SMAD2 PE=1 SV=1,cell death;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytosol;membrane;nucleus,antioxidant activity;motor activity;RNA binding;structural molecule activity,4087,SMAD2,Cell cycle; AGE/RAGE pathway; Endoderm differentiation; Mesodermal commitment pathway; Extracellular vesicle-mediated signaling in recipient cells; Mesodermal commitment pathway; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; Tgif disruption of Shh signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Canonical and non-canonical TGF-B signaling; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; Pancreatic adenocarcinoma pathway; Neovascularisation processes; Envelope proteins and their potential roles in EDMD physiopathology; Hippo signaling regulation pathways; Hepatitis B infection; TGF-beta receptor signaling in skeletal dysplasias; Regucalcin in proximal tubule epithelial kidney cells; Overlap between signal transduction pathways contributing to LMNA laminopathies; LDLRAD4 and what we know about it; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Progeria-associated lipodystrophy; Th17 cell differentiation pathway; GDNF signaling; Inflammatory bowel disease signaling; TGF-beta receptor signaling,"Ub-specific processing proteases; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Signaling by NODAL; FOXO-mediated transcription of cell cycle genes; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity; Germ layer formation at gastrulation; Transcriptional regulation of pluripotent stem cells; Signaling by Activin; SMAD2/3 Phosphorylation Motif Mutants in Cancer; TGFBR1 KD Mutants in Cancer; SMAD4 MH2 Domain Mutants in Cancer; SMAD2/3 MH2 Domain Mutants in Cancer",ENSG00000175387
P48507,0,6,13966110.9296875,5.4062061356029264e-5,2.2411639688962164,1.1642482037165256,0.028061275787124147,0.6429522395902524,raw,8978824.515625,9651972.90625,7196231.8125,21631653.90625,15012322.9375,21325659.5,Glutamate--cysteine ligase regulatory subunit OS=Homo sapiens OX=9606 GN=GCLM PE=1 SV=1,cell growth;cellular homeostasis;coagulation;metabolic process,cytosol;nucleus,DNA binding;structural molecule activity,2730,GCLM,"Glutathione metabolism; Trans-sulfuration pathway; Trans-sulfuration, one-carbon metabolism and related pathways; Nuclear receptors meta-pathway; NRF2 pathway; Transcriptional activation by NRF2 in response to phytochemicals; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Amino acid metabolism; Ferroptosis; NRF2-ARE regulation; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway",Glutathione synthesis and recycling; Nuclear events mediated by NFE2L2; Defective GCLC causes HAGGSD,ENSG00000023909
P62699,0,6,956388.8619791666,3.702129647748518e-6,2.2402705007484256,1.1636729405538841,0.024803808938166628,0.6429522395902524,raw,454328.6875,856000.0625,561763.796875,1344485.90625,1017819.15625,1503935.5625,Protein yippee-like 5 OS=Homo sapiens OX=9606 GN=YPEL5 PE=1 SV=1,cell differentiation,cell surface;endoplasmic reticulum;membrane;nucleus,structural molecule activity,51646,YPEL5,Ciliary landscape,Neutrophil degranulation,ENSG00000119801
Q01968,0,6,1377927.6875,5.3338836817805056e-6,2.237934183342123,1.1621676079129746,0.05113056618566954,0.6429522395902524,raw,1112642.90625,675869.3125,701894.375,1840834.4375,1446303.5,2490021.59375,Inositol polyphosphate 5-phosphatase OCRL OS=Homo sapiens OX=9606 GN=OCRL PE=1 SV=3,cell growth;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,DNA binding;structural molecule activity,4952,OCRL,VEGFA-VEGFR2 signaling pathway; Ciliopathies; Bardet-Biedl syndrome,"RAC3 GTPase cycle; RHOJ GTPase cycle; Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis; Synthesis of PIPs at the plasma membrane; Synthesis of PIPs at the Golgi membrane; Synthesis of IP2, IP, and Ins in the cytosol; Synthesis of IP3 and IP4 in the cytosol",ENSG00000122126
P06756,0,6,10918980.859375,4.226678537330283e-5,2.2352808468966026,1.1604561070104569,0.014504358788361087,0.6429522395902524,raw,7391357.9375,7186442.515625,5627971.640625,16806534.5,12437861.25,16063717.3125,Integrin alpha-V OS=Homo sapiens OX=9606 GN=ITGAV PE=1 SV=2,cell communication;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,antioxidant activity;catalytic activity;structural molecule activity,3685,ITGAV,Osteopontin signaling; Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; Osteoblast signaling; MFAP5-mediated ovarian cancer cell motility and invasiveness; VEGFA-VEGFR2 signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Small cell lung cancer; Thyroid hormones production and peripheral downstream signaling effects; Genes associated with the development of rheumatoid arthritis; Malignant pleural mesothelioma; Complement system in neuronal development and plasticity,Neutrophil degranulation; Integrin cell surface interactions; ECM proteoglycans; VEGFA-VEGFR2 Pathway; Signal transduction by L1; Syndecan interactions; Laminin interactions; Molecules associated with elastic fibres; TGF-beta receptor signaling activates SMADs; Cross-presentation of particulate exogenous antigens (phagosomes); PECAM1 interactions,ENSG00000138448
E9PIM0,0.6666666666666666,6,1307010.25,5.059366110164514e-6,2.2344457567310316,1.1599170223811621,0.11166504015888105,0.6429522395902524,raw,776776.6875,NA,759993.6875,2207715,1073855.625,1716710.25,CREB/ATF bZIP transcription factor OS=Homo sapiens OX=9606 GN=CREBZF PE=1 SV=1,cellular component movement,membrane,structural molecule activity,58487,CREBZF,NA,NA,ENSG00000137504
Q14571,0.16666666666666666,6,15087866.5,5.840431660332157e-5,2.2288856614190333,1.1563226103461337,0.07371734060779757,0.6429522395902524,raw,14035275,5867953,10091152,22492024,13624459,24416336,"Inositol 1,4,5-trisphosphate receptor type 2 OS=Homo sapiens OX=9606 GN=ITPR2 PE=1 SV=2",coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,3709,ITPR2,Alzheimer's disease and miRNA effects; Myometrial relaxation and contraction pathways; Vitamin D-sensitive calcium signaling in depression; Thyroid hormones production and peripheral downstream signaling effects; Alzheimer's disease; GDNF signaling; Calcium regulation in cardiac cells,Role of phospholipids in phagocytosis; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Ion homeostasis; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Ca2+ pathway; VEGFR2 mediated cell proliferation; Elevation of cytosolic Ca2+ levels; PLC beta mediated events; DAG and IP3 signaling; CLEC7A (Dectin-1) induces NFAT activation; Effects of PIP2 hydrolysis,ENSG00000123104
Q4G0F5,0,6,816069.3984375,3.1589605804522414e-6,2.2288290150181918,1.1562859442571107,0.27407426494687537,0.7551026273759062,raw,312135.65625,660170.1875,649050.203125,1471406.46875,1456843.28125,346810.59375,Vacuolar protein sorting-associated protein 26B OS=Homo sapiens OX=9606 GN=VPS26B PE=1 SV=2,coagulation;conjugation;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,NA,112936,VPS26B,NA,NA,ENSG00000151502
Q9NX08,0.16666666666666666,6,712150.6796875,2.756696830909751e-6,2.217169998569407,1.1487193911752058,1,1,raw,1400908.5625,330303.65625,347320.9375,770069.5625,NA,NA,COMM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=COMMD8 PE=1 SV=1,NA,cytosol;membrane,NA,54951,COMMD8,NA,Neddylation,ENSG00000169019
Q96BX8,0.3333333333333333,6,658708.3515625,2.549824464175124e-6,2.2158233834918106,1.1478428931582887,0.2292886371642625,0.7154495069411199,raw,247296.390625,859781.0625,362812.78125,996231.5,547965.125,938163.25,MOB kinase activator 3A OS=Homo sapiens OX=9606 GN=MOB3A PE=1 SV=1,development;metabolic process,membrane;nucleus,DNA binding;structural molecule activity,126308,MOB3A,NA,NA,ENSG00000172081
Q8IXQ4,0,6,795029.3958333334,3.077515866355092e-6,2.2153654170786474,1.1475446861058465,0.20410462785361422,0.6957374751850184,raw,429994.96875,1011455.78125,396268.9375,1020151.96875,1034424.21875,877880.5,GPALPP motifs-containing protein 1 OS=Homo sapiens OX=9606 GN=GPALPP1 PE=1 SV=1,NA,NA,NA,55425,GPALPP1,NA,NA,ENSG00000133114
O15270,0,6,20181719.822916668,7.812234779099855e-5,2.2151944168894535,1.1474333226961155,0.024722152577194154,0.6429522395902524,raw,11554673.84375,14665812.0625,10600672.53125,32487625,22043944.5625,29737590.9375,Serine palmitoyltransferase 2 OS=Homo sapiens OX=9606 GN=SPTLC2 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,9517,SPTLC2,Sphingolipid pathway; Sphingolipid metabolism overview; Sphingolipid metabolism: integrated pathway; Biosynthesis and turnover of 1-deoxy-sphingoid bases,Sphingolipid de novo biosynthesis,ENSG00000100596
Q96RU3,0,6,891790.9036458334,3.4520744387878492e-6,2.2141369438705825,1.1467444552418988,0.0448991084612633,0.6429522395902524,raw,832408.828125,555295.9375,332289.78125,1229501.25,1164871.9375,1236377.6875,Formin-binding protein 1 OS=Homo sapiens OX=9606 GN=FNBP1 PE=1 SV=2,conjugation;development,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,structural molecule activity,23048,FNBP1,NA,RND2 GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle; RHOJ GTPase cycle; Clathrin-mediated endocytosis,ENSG00000187239
S4R341,0.16666666666666666,6,1784601.8375,6.908097359439085e-6,2.2119246557540952,1.145302244242966,0.1492086613104874,0.6638855679885327,raw,NA,1306742.125,643735.5625,2529014.75,1191701.25,3251815.5,Nucleolar and coiled-body phosphoprotein 1 OS=Homo sapiens OX=9606 GN=NOLC1 PE=1 SV=1,NA,NA,NA,NA,NOLC1,NA,NA,ENSG00000166197
A0A087X020,0,6,27099435.821614582,1.0490045292334552e-4,2.2081209991611503,1.1428192301354705,0.021843384037151286,0.6429522395902524,raw,18194743.90625,19113109.75,13362794.6796875,40176196.09375,29450788.0625,42298982.4375,Ribosome maturation protein SBDS OS=Homo sapiens OX=9606 GN=SBDS PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P11021,0,6,1995729128.9908881,0.007725359705698286,2.2077365053358466,1.142567995879902,0.012830474296097518,0.6429522395902524,raw,1159865248.04688,1415901005.33594,1151952814.8125,2774909198.28125,2345810170.04688,3125936337.42188,Endoplasmic reticulum chaperone BiP OS=Homo sapiens OX=9606 GN=HSPA5 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,protein binding;structural molecule activity,3309,HSPA5,Parkin-ubiquitin proteasomal system pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Photodynamic therapy-induced unfolded protein response; Prion disease pathway; Unfolded protein response,"Regulation of HSF1-mediated heat shock response; Platelet degranulation ; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; IRE1alpha activates chaperones; PERK regulates gene expression; ATF6 (ATF6-alpha) activates chaperone genes",ENSG00000044574
J3KQL8,0,6,188158.02734375,7.283495648931419e-7,2.2053069540440315,1.1409794767607617,1,1,raw,97680.796875,NA,NA,306165.125,133370.046875,215416.140625,Apolipoprotein L2 OS=Homo sapiens OX=9606 GN=APOL2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;conjugation,cell surface;cytoskeleton,structural molecule activity,23780,APOL2,NA,NA,ENSG00000128335
Q8IUF1,0,6,2711981.9622395835,1.0497935751561555e-5,2.202708988934478,1.1392789058633706,0.15674606641817346,0.6638855679885327,raw,3100193.53125,1084966.09375,921364.8515625,4014350.59375,2029498.640625,5121518.0625,COBW domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CBWD2 PE=2 SV=1,NA,membrane;nucleus,structural molecule activity,150472,ZNG1B,NA,NA,ENSG00000136682
Q658Y4,0,6,5366357.78125,2.0772881232931327e-5,2.2005114179301675,1.1378388575531786,0.049941060619497005,0.6429522395902524,raw,3491744.265625,3966448.25,2498985.171875,9163628.4375,5393717.4375,7683623.125,Protein FAM91A1 OS=Homo sapiens OX=9606 GN=FAM91A1 PE=1 SV=3,cell growth;conjugation,extracellular;nucleus,NA,157769,FAM91A1,Gastric cancer network 2,RHOH GTPase cycle,ENSG00000176853
P62745,0.16666666666666666,6,148953.76171875,5.765919693601209e-7,2.1998518186104143,1.1374063474972784,0.4317894919154635,0.9162373203757352,raw,NA,110167.9296875,68424.3984375,306606.3125,110616.40625,NA,Rho-related GTP-binding protein RhoB OS=Homo sapiens OX=9606 GN=RHOB PE=1 SV=1,cell communication;cell differentiation;cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,388,RHOB,Androgen receptor signaling pathway; Neural crest differentiation; Spinal cord injury; Ebola virus infection in host; Gastrin signaling pathway,G alpha (12/13) signalling events; RHO GTPases Activate Formins; RHOB GTPase cycle; GPVI-mediated activation cascade; RHO GTPases activate CIT; RHO GTPases Activate Rhotekin and Rhophilins; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs,ENSG00000143878
O75582,0,6,3125432.8489583335,1.2098381811171502e-5,2.199745240696556,1.1373364504472765,0.03177168160189311,0.6429522395902524,raw,2293537.4375,1833093.21875,1783805.21875,5045198.0625,3369794.78125,4427168.375,Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens OX=9606 GN=RPS6KA5 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,membrane;nucleus,signal transducer activity;structural molecule activity,9252,RPS6KA5,Brain-derived neurotrophic factor (BDNF) signaling pathway; Interleukin-1 (IL-1) structural pathway; Bladder cancer; MAPK signaling pathway; ERK pathway in Huntington's disease; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; p38 MAPK signaling pathway; EGF/EGFR signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Insulin signaling; Malignant pleural mesothelioma; Hippocampal synaptogenesis and neurogenesis; Interferon type I signaling pathways; Serotonin HTR1 group and FOS pathway; Serotonin receptor 4/6/7 and NR3C signaling,Recycling pathway of L1; NCAM signaling for neurite out-growth; ERK/MAPK targets; CREB phosphorylation; CD209 (DC-SIGN) signaling,ENSG00000100784
Q9H361,0.8333333333333334,6,4219363.0625,1.6332926604739676e-5,2.1968873173328904,1.135460872995534,0.08173571569580508,0.6429522395902524,raw,4455847,1811757.125,2641820,6290661,3980226.25,6135867,Polyadenylate-binding protein 3 OS=Homo sapiens OX=9606 GN=PABPC3 PE=1 SV=2,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,5042,PABPC3,NA,NA,ENSG00000151846
Q9HAD4,0.5,6,259545.109375,1.0046851051327387e-6,2.196603864664572,1.1352747177296931,0.09868270588505308,0.6429522395902524,raw,185754.796875,141733.0625,155886.75,484083,247391.609375,342421.4375,WD repeat-containing protein 41 OS=Homo sapiens OX=9606 GN=WDR41 PE=1 SV=3,cellular homeostasis;metabolic process,nucleus,NA,55255,WDR41,NA,NA,ENSG00000164253
Q9P2I0,0,6,15133579.434895834,5.858126890618847e-5,2.1933208153888772,1.1331168493664467,0.001534595558864362,0.6429522395902524,raw,9407728.8125,11308945.5625,8434566.703125,21919027.875,18499710.71875,21231496.9375,Cleavage and polyadenylation specificity factor subunit 2 OS=Homo sapiens OX=9606 GN=CPSF2 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,RNA binding,53981,CPSF2,mRNA processing,mRNA Splicing - Major Pathway; Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,ENSG00000165934
Q86XL3,0,6,1185351.296875,4.588430871180184e-6,2.1931705634136636,1.1330180151224507,0.22608965621115978,0.7148463313429879,raw,705793.03125,1555606.9375,434965.96875,1547924.5,1258285.0625,1609532.28125,Ankyrin repeat and LEM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ANKLE2 PE=1 SV=4,cell differentiation;cell growth;defense response;metabolic process,cytoskeleton;extracellular,DNA binding;structural molecule activity,23141,ANKLE2,NA,RHOG GTPase cycle; RAC2 GTPase cycle; Initiation of Nuclear Envelope (NE) Reformation,ENSG00000176915
Q9H974,0,6,1058901.6041666667,4.098950937928507e-6,2.192046120096231,1.1322781525567196,0.1376920519057743,0.6554773456108216,raw,762337,382840.625,722765.1875,1584334.625,799374.625,2101757.5625,Queuine tRNA-ribosyltransferase accessory subunit 2 OS=Homo sapiens OX=9606 GN=QTRT2 PE=1 SV=1,cellular component movement;cellular homeostasis,cytoskeleton;endosome;nucleus,structural molecule activity,79691,QTRT2,NA,tRNA modification in the nucleus and cytosol,ENSG00000151576
Q14141,0,6,1005721.765625,3.893094654198728e-6,2.189807188909185,1.1308038470636972,0.3684517915087135,0.852141615295751,raw,529627.0625,1042206.96875,478018.53125,1350125.6875,352120.03125,2282232.3125,Septin-6 OS=Homo sapiens OX=9606 GN=SEPTIN6 PE=1 SV=4,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,23157,SEPTIN6,2q37 copy number variation syndrome,NA,ENSG00000125354
Q14789,0,6,12966528.333333334,5.0192731094614315e-5,2.189568970390324,1.1306468947199633,0.02746333583633008,0.6429522395902524,raw,10436462.4375,8460168.859375,5590871.671875,21118683.90625,13668859.90625,18524123.21875,Golgin subfamily B member 1 OS=Homo sapiens OX=9606 GN=GOLGB1 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytoskeleton;cytosol;extracellular,RNA binding,2804,GOLGB1,NA,COPI-mediated anterograde transport; Golgi Associated Vesicle Biogenesis; Signaling by FLT3 fusion proteins,ENSG00000173230
Q15434,0.5,6,879178.2395833334,3.40325149717993e-6,2.1892200492512845,1.1304169741662389,0.09851099466995179,0.6429522395902524,raw,355877.6875,390791.6875,771819.96875,1689683.75,1332533.65625,734362.6875,"RNA-binding motif, single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1",cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,5939,RBMS2,NA,NA,ENSG00000076067
Q96LR5,0,6,8084656.9140625,3.1295270410706445e-5,2.187031648137792,1.1289740975149891,0.016010216972613102,0.6429522395902524,raw,4220625.046875,6129945.1875,4136144.328125,11934777.4375,9045878.546875,13040570.9375,Ubiquitin-conjugating enzyme E2 E2 OS=Homo sapiens OX=9606 GN=UBE2E2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,membrane,structural molecule activity,7325,UBE2E2,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000182247
Q9UIF9,0,6,1298443.3072916667,5.026203937483571e-6,2.185377622835874,1.1278825920924531,0.21931945086171659,0.7087130179153194,raw,1168523.8125,318996.375,1192203.125,2605414.03125,1360968.1875,1144554.3125,Bromodomain adjacent to zinc finger domain protein 2A OS=Homo sapiens OX=9606 GN=BAZ2A PE=1 SV=4,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,11176,BAZ2A,NA,NoRC negatively regulates rRNA expression,ENSG00000076108
Q8IVT2,0,6,10257889.847981775,3.9707737761566605e-5,2.184273228626284,1.127153332873605,0.013130611217584364,0.6429522395902524,raw,6887667.390625,6684784.265625,6147293.30859375,15178071.625,12048127.1875,14601395.3105469,Mitotic interactor and substrate of PLK1 OS=Homo sapiens OX=9606 GN=MISP PE=1 SV=1,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,motor activity,126353,MISP,NA,NA,ENSG00000099812
Q96SB8,0,6,769879.0286458334,2.9801601528810538e-6,2.1816559147564294,1.1254235813962798,0.18088243528297468,0.674297118008435,raw,493995.15625,277582.90625,673395.359375,1220162.28125,485021.5,1469116.96875,Structural maintenance of chromosomes protein 6 OS=Homo sapiens OX=9606 GN=SMC6 PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,79677,SMC6,NA,SUMOylation of DNA damage response and repair proteins,ENSG00000163029
Q96K76,0,6,377243.2942708333,1.4602884241502107e-6,2.181071781999224,1.1250372517898257,0.17890027604918154,0.6741527184744509,raw,166952.140625,333709.875,222123.0625,766658.8125,289549.53125,484466.34375,Ubiquitin carboxyl-terminal hydrolase 47 OS=Homo sapiens OX=9606 GN=USP47 PE=1 SV=3,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,55031,USP47,NA,Ub-specific processing proteases,ENSG00000170242
Q9Y5B6,0,6,489014.20625,1.892947589730264e-6,2.169885431802963,1.1176188715484914,0.1358716241174089,0.6543169338896382,raw,NA,350375.375,211646.75,879513.6875,641035.15625,362500.0625,PAX3- and PAX7-binding protein 1 OS=Homo sapiens OX=9606 GN=PAXBP1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,94104,PAXBP1,NA,NA,ENSG00000159086; ENSG00000263141
Q9P2E3,0,6,1698264.3001302083,6.573889413783122e-6,2.1689736453058592,1.1170125232648955,0.05917188112651397,0.6429522395902524,raw,991956.7109375,1369470.21875,780603.31640625,2427740.203125,1649470.5390625,2970344.8125,NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=2 SV=2,cell growth;coagulation;metabolic process,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,57169,ZNFX1,NA,NA,ENSG00000124201
Q14192,0,6,15165802.145833334,5.870600128047154e-5,2.1682362942061,1.1165219900418788,0.04038667986724655,0.6429522395902524,raw,11884095.875,6769284.109375,9869418.921875,25767528,15744107.96875,20960378,Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,cellular component movement;defense response;metabolic process,endoplasmic reticulum;membrane,structural molecule activity,2274,FHL2,Androgen receptor signaling pathway; RANKL/RANK signaling pathway; Ectoderm differentiation; VEGFA-VEGFR2 signaling pathway,PPARA activates gene expression,ENSG00000115641
Q86SK9,0,6,974345.4947916666,3.77163880385822e-6,2.166634911344703,1.115456072690129,0.021574834797412575,0.6429522395902524,raw,367556.3125,802632.375,625551.3125,1291693.75,1355341.3125,1403297.90625,Stearoyl-CoA desaturase 5 OS=Homo sapiens OX=9606 GN=SCD5 PE=1 SV=2,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,79966,SCD5,NA,Fatty acyl-CoA biosynthesis; EGR2 and SOX10-mediated initiation of Schwann cell myelination,ENSG00000145284
P32121,0,6,1753028.7135416667,6.7858795012801195e-6,2.1655505176522087,1.11473382778125,0.15139984793945974,0.6638855679885327,raw,811252.9375,1535932.9375,978184.75,1850425.78125,1756809.21875,3585566.65625,Beta-arrestin-2 OS=Homo sapiens OX=9606 GN=ARRB2 PE=1 SV=2,cell death;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,antioxidant activity;structural molecule activity,409,ARRB2,Corticotropin-releasing hormone signaling pathway; Complement system; Myometrial relaxation and contraction pathways; Wnt signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Hedgehog signaling pathway; Gastrin signaling pathway; Kisspeptin/kisspeptin receptor system in the ovary; GPR143 in melanocytes and retinal pigment epithelium cells; Calcium regulation in cardiac cells,Ub-specific processing proteases; Activation of SMO; Activated NOTCH1 Transmits Signal to the Nucleus; G alpha (s) signalling events; Signaling by BRAF and RAF1 fusions; Thrombin signalling through proteinase activated receptors (PARs); Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants,ENSG00000141480
P35658,0,6,2725289.0625,1.0549446818197883e-5,2.1645098471251227,1.1140403638980458,0.3470493285342476,0.8299731034180416,raw,1611940.171875,1664839.59375,1317164.890625,7506942.25,761787.09375,3489060.375,Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214 PE=1 SV=2,cell differentiation;cellular homeostasis;conjugation;metabolic process,cytosol;membrane,structural molecule activity,8021,NUP214,TGF-beta signaling pathway,Rev-mediated nuclear export of HIV RNA; Nuclear import of Rev protein; SUMOylation of DNA damage response and repair proteins; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; HuR (ELAVL1) binds and stabilizes mRNA,ENSG00000126883
Q13325,0,6,5399731.776041667,2.0902070164854217e-5,2.1618271298524507,1.1122511628154437,0.06648661587190342,0.6429522395902524,raw,4553171.1875,2543364.9375,2562399,7767335,5128951.53125,9843169,Interferon-induced protein with tetratricopeptide repeats 5 OS=Homo sapiens OX=9606 GN=IFIT5 PE=1 SV=1,coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,RNA binding,24138,IFIT5,NA,Interferon alpha/beta signaling,ENSG00000152778
Q07617,0,6,726206.7864583334,2.811107261307836e-6,2.1615456193411813,1.112063284581157,0.45892712276076286,0.9414745132530334,raw,337075.5625,1146424.59375,310715.25,1065867.25,671625.1875,825532.875,Sperm-associated antigen 1 OS=Homo sapiens OX=9606 GN=SPAG1 PE=1 SV=3,cell growth;metabolic process,cytosol;nucleus,structural molecule activity,6674,SPAG1,Ciliopathies,NA,ENSG00000104450
P82664,0,6,2634999.5520833335,1.0199940998250849e-5,2.157145518533344,1.1091235023143788,0.2840006812413094,0.7650076250313386,raw,1258049.6875,2295054.3125,1821329.875,4319263.5625,1165533.75,4950766.125,"28S ribosomal protein S10, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS10 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,NA,55173,MRPS10,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000048544
Q96AD5,0,6,3197230.6953125,1.2376307397927283e-5,2.155367270058949,1.107933722468315,0.060501778535349056,0.6429522395902524,raw,1882006.5,2018107.703125,1900154.46875,3554144.3125,4095530.75,5733440.4375,Patatin-like phospholipase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PNPLA2 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,57104,PNPLA2,Fatty acid beta-oxidation; Triacylglyceride synthesis; Lipid metabolism pathway; Thermogenesis; Glycerolipids and glycerophospholipids; Familial partial lipodystrophy,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Acyl chain remodeling of DAG and TAG,ENSG00000177666
O95140,0,6,5674333.3359375,2.196503797703112e-5,2.153591095169024,1.1067443497088758,0.04004391737955109,0.6429522395902524,raw,3867335.15625,3027594.703125,4061244.96875,8546654.875,5796909.3125,8746261,Mitofusin-2 OS=Homo sapiens OX=9606 GN=MFN2 PE=1 SV=3,cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;endosome,structural molecule activity,9927,MFN2,Intracellular trafficking proteins involved in CMT neuropathy,Factors involved in megakaryocyte development and platelet production; PINK1-PRKN Mediated Mitophagy; RHOT2 GTPase cycle,ENSG00000116688
Q9BXV9,0,6,1389118.6625,5.377203341786767e-6,2.1511651198800883,1.1051182678987357,0.6316135047865881,1,raw,1859539.375,311757.4375,NA,1670497.25,986273.875,2117525.375,EKC/KEOPS complex subunit GON7 OS=Homo sapiens OX=9606 GN=GON7 PE=1 SV=2,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,NA,84520,GON7,NA,NA,ENSG00000170270; ENSG00000275619
P62993,0,6,56850067.622395836,2.2006354233971033e-4,2.150278411734855,1.104523467826359,0.004471422990671235,0.6429522395902524,raw,36247750.921875,45760317.03125,30290950.0625,77942756.28125,67008107.0625,83850524.375,Growth factor receptor-bound protein 2 OS=Homo sapiens OX=9606 GN=GRB2 PE=1 SV=1,cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;structural molecule activity,2885,GRB2,IL-5 signaling pathway; Integrin-mediated cell adhesion; Leptin signaling pathway; Prolactin signaling pathway; IL-9 signaling pathway; Pilocytic astrocytoma; Glioblastoma signaling pathways; B cell receptor signaling pathway; TNF-alpha signaling pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; BDNF-TrkB signaling; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; p38 MAPK signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Breast cancer pathway; Thermogenesis; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; Fragile X syndrome; Gastrin signaling pathway; Hepatitis B infection; Melanoma; Thyroid hormones production and peripheral downstream signaling effects; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; IL-2 signaling pathway; 7q11.23 copy number variation syndrome; 16p11.2 distal deletion syndrome; Modulators of TCR signaling and T cell activation; Kallmann syndrome; Malignant pleural mesothelioma; Congenital generalized lipodystrophy; GDNF signaling; 2q13 copy number variation syndrome; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response (only ATM dependent),Signaling by ALK fusions and activated point mutants; Signaling by CSF3 (G-CSF); STAT5 activation downstream of FLT3 ITD mutants; Interleukin-15 signaling,ENSG00000177885
Q8NF37,0,6,4481357.25,1.7347091959064622e-5,2.1459074556310553,1.1015878597938553,0.02634681965197806,0.6429522395902524,raw,4154708.75,1838598.125,2767895.3125,7131111.25,5939647.1875,5056182.875,Lysophosphatidylcholine acyltransferase 1 OS=Homo sapiens OX=9606 GN=LPCAT1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,79888,LPCAT1,NA,Neutrophil degranulation; Synthesis of PA; Acyl chain remodelling of PC; Acyl chain remodelling of PG; Synthesis of PC,ENSG00000153395
Q96AB3,0,6,2085118.3020833333,8.071380368473919e-6,2.1452927197780314,1.10117451325376,0.51106212811307306,0.9944212432021446,raw,3463861.4375,270494.9375,1322101.6875,2836295.125,1427985.25,3189971.375,Isochorismatase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ISOC2 PE=1 SV=1,metabolic process,membrane;nucleus,NA,79763,ISOC2,NA,NA,ENSG00000063241
P17050,0,6,714688.6875,2.766521322120815e-6,2.1418245164222185,1.0988402823017778,0.28456211179786206,0.7650076250313386,raw,380460.4375,557005.46875,576305.78125,1193007.96875,341917.71875,1239434.75,Alpha-N-acetylgalactosaminidase OS=Homo sapiens OX=9606 GN=NAGA PE=1 SV=2,cellular homeostasis,mitochondrion;nucleus,structural molecule activity,4668,NAGA,NA,NA,ENSG00000198951
Q9BSD7,0,6,5749334.768229167,2.225536447198421e-5,2.1394585745694474,1.0972457449385855,0.09225731508671105,0.6429522395902524,raw,3755003.96875,3801835.296875,3960512.9375,8133869.125,5294269.65625,9550517.625,Cancer-related nucleoside-triphosphatase OS=Homo sapiens OX=9606 GN=NTPCR PE=1 SV=1,NA,NA,structural molecule activity,84284,NTPCR,NA,NA,ENSG00000135778
P16083,0,6,5271050.802083333,2.040395306235425e-5,2.138738162881799,1.0967598699577115,0.05060234836600309,0.6429522395902524,raw,2076221.125,3587094.3125,4895589.5,7671855.5,5143398.5,8252145.875,Ribosyldihydronicotinamide dehydrogenase [quinone] OS=Homo sapiens OX=9606 GN=NQO2 PE=1 SV=5,cellular homeostasis,cytosol;membrane,structural molecule activity,4835,NQO2,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,Phase I - Functionalization of compounds,ENSG00000124588
Q99653,0,6,7757467.229166667,3.0028736805971986e-5,2.1367540151895312,1.0954208333638877,0.01235506438673242,0.6429522395902524,raw,3533063.875,6818579.4375,4710168.375,10064471.1875,9507934,11910586.5,Calcineurin B homologous protein 1 OS=Homo sapiens OX=9606 GN=CHP1 PE=1 SV=3,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;membrane;nucleus,catalytic activity;DNA binding;motor activity;structural molecule activity,11261,CHP1,T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection,Hyaluronan uptake and degradation,ENSG00000187446
Q15811,0,6,1046090.8541666666,4.049361216351503e-6,2.1296744442599334,1.0906329076582157,0.07879184755016301,0.6429522395902524,raw,501825.625,726637.8125,685746.625,1460417.0625,1002830.1875,1899087.8125,Intersectin-1 OS=Homo sapiens OX=9606 GN=ITSN1 PE=1 SV=3,conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,DNA binding;structural molecule activity,6453,ITSN1,NA,G alpha (12/13) signalling events; CDC42 GTPase cycle; NRAGE signals death through JNK; RHOQ GTPase cycle; RHOG GTPase cycle; EPHB-mediated forward signaling; Cargo recognition for clathrin-mediated endocytosis,ENSG00000205726
P56134,0.16666666666666666,6,2100583.03125,8.131243500112486e-6,2.1211163194538556,1.0848237386892166,0.2684331602895392,0.7482401998588301,raw,2121489.5,1005542.1875,1046237.875,2689034.75,1241267.875,4499926,"ATP synthase subunit f, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5MF PE=1 SV=3",cellular homeostasis;conjugation,cytoskeleton;endosome;membrane,NA,9551,ATP5MF,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000241468
O76062,0,6,893221.3958333334,3.457611796811088e-6,2.114790554578626,1.0805147882467532,0.06948595437830359,0.6429522395902524,raw,690869.125,487685,513844.75,1380169,825717,1461043.5,Delta(14)-sterol reductase TM7SF2 OS=Homo sapiens OX=9606 GN=TM7SF2 PE=1 SV=3,cellular homeostasis,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,7108,TM7SF2,Cholesterol metabolism with Bloch and Kandutsch-Russell pathways,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,ENSG00000149809
I3L448,0.16666666666666666,6,1033515.6927083333,4.000683445299487e-6,2.111070335135896,1.077974646170313,0.9123894385436442,1,raw,330358.96875,532806.25,2129834.03125,1124791.46875,834352.375,1248951.0625,ATP synthase mitochondrial F1 complex assembly factor 1 OS=Homo sapiens OX=9606 GN=ATPAF1 PE=1 SV=1,cell growth,endosome,NA,64756,ATPAF1,7q11.23 copy number variation syndrome,NA,ENSG00000123472
Q9UK61,0,6,164163.0390625,6.35466260784432e-7,2.110801188868326,1.0777907012142358,0.10489788464737565,0.6429522395902524,raw,84593.484375,149354.21875,78744.40625,165536.296875,315257.0625,191492.765625,Protein TASOR OS=Homo sapiens OX=9606 GN=TASOR PE=1 SV=3,cell differentiation;cell growth;defense response;metabolic process,membrane;nucleus,structural molecule activity,23272,TASOR,NA,NA,ENSG00000163946
Q4J6C6,0,6,853015.39375,3.3019765335332214e-6,2.1033842757414916,1.0727124459143818,0.03760050753869725,0.6429522395902524,raw,NA,608146,429668.59375,1183939,971037.25,1072286.125,Prolyl endopeptidase-like OS=Homo sapiens OX=9606 GN=PREPL PE=1 SV=1,cell organization and biogenesis;conjugation;metabolic process,cytosol;endoplasmic reticulum;extracellular;membrane,structural molecule activity,9581,PREPL,NA,NA,ENSG00000138078
Q9P2M7,0,6,16154828.796875,6.253447004751427e-5,2.1033035263034967,1.0726570594349252,0.006469994249659313,0.6429522395902524,raw,9852046.109375,13209035.25,9120267.078125,21037265.375,19182689.90625,24527669.0625,Cingulin OS=Homo sapiens OX=9606 GN=CGN PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
O94855,0,6,3374729.09375,1.306339411485484e-5,2.102200020407646,1.0718999455709655,5.413263080694134e-4,0.5858850014706761,raw,2558292.78125,2141660.53125,2008927.09375,4773706.65625,4263588.6875,4502198.8125,Protein transport protein Sec24D OS=Homo sapiens OX=9606 GN=SEC24D PE=1 SV=2,cell growth;conjugation;defense response,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,9871,SEC24D,Sterol regulatory element-binding proteins (SREBP) signaling,"MHC class II antigen presentation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; COPII-mediated vesicle transport; Cargo concentration in the ER; Regulation of cholesterol biosynthesis by SREBP (SREBF); Antigen Presentation: Folding, assembly and peptide loading of class I MHC",ENSG00000150961
Q8N5A5,0,6,908038.0846354167,3.5149663991870943e-6,2.1017944238437822,1.0716215664432749,0.4139488415611919,0.8999719806515282,raw,966177.984375,849452.015625,125487.0703125,343372.84375,1133031.09375,2030707.5,Zinc finger CCCH-type with G patch domain-containing protein OS=Homo sapiens OX=9606 GN=ZGPAT PE=1 SV=3,cellular component movement;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,84619,ZGPAT,NA,NA,ENSG00000197114
A0A0R4J2F2,0,6,1206840.5,4.671614416240421e-6,2.1014554108789674,1.0713888454091096,0.16383917142878174,0.6638855679885327,raw,639097.875,1135722.5,535301.3125,1108316.875,1343035.6875,2479568.75,Claudin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CLDND1 PE=1 SV=1,NA,cytoskeleton,NA,56650,CLDND1,NA,NA,ENSG00000080822
Q96GC9,0,6,5129182.71875,1.9854789371456905e-5,2.1011719241265574,1.0711942124331741,0.11340741754656122,0.6429522395902524,raw,4910990.3125,1891936.6875,2813498.0625,8612853.375,3975284.25,8570533.625,Vacuole membrane protein 1 OS=Homo sapiens OX=9606 GN=VMP1 PE=1 SV=1,cell communication;cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,catalytic activity,81671,VMP1,Nanoparticle triggered autophagic cell death,NA,ENSG00000062716
Q6VY07,0,6,516656.46875,1.999949295417554e-6,2.101139982586702,1.0711722807431086,1,1,raw,297940.40625,NA,NA,580398.0625,671630.9375,NA,Phosphofurin acidic cluster sorting protein 1 OS=Homo sapiens OX=9606 GN=PACS1 PE=1 SV=2,metabolic process,cytosol;extracellular,structural molecule activity,55690,PACS1,NA,Nef mediated downregulation of MHC class I complex cell surface expression,ENSG00000175115
O60231,0,6,7520390.934895833,2.9111027270980013e-5,2.1010707033096825,1.0711247110818647,0.08896072017033828,0.6429522395902524,raw,5309072.90625,5194660.90625,4697500.734375,10914349.84375,6872132.5,12134628.71875,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 OS=Homo sapiens OX=9606 GN=DHX16 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,structural molecule activity,8449,DHX16,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000204560; ENSG00000206486; ENSG00000226171; ENSG00000231377; ENSG00000233049; ENSG00000233418; ENSG00000233561
G3V1L9,0,6,52124934.955729164,2.0177280890455585e-4,2.097340261826649,1.0685609359350674,0.004336332988150578,0.6429522395902524,raw,32367863.625,39653188.984375,29989210.09375,78452265.1875,62897577.75,69389504.09375,"Tight junction protein 1 (Zona occludens 1), isoform CRA_a OS=Homo sapiens OX=9606 GN=TJP1 PE=1 SV=1",defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,7082,TJP1,Epithelial to mesenchymal transition in colorectal cancer; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; Disruption of postsynaptic signaling by CNV; 1q21.1 copy number variation syndrome,NA,ENSG00000104067
Q9UHW5,0,6,1416159.09375,5.4818753911991436e-6,2.096026019023195,1.0676566258843068,0.20284254937494273,0.6930044483487753,raw,393402.78125,1477603.15625,1026326,2151206,929713.3125,2518703.3125,GPN-loop GTPase 3 OS=Homo sapiens OX=9606 GN=GPN3 PE=1 SV=2,NA,nucleus,structural molecule activity,51184,GPN3,NA,NA,ENSG00000111231
Q96DA6,0,6,1009910.6125,3.909309454289273e-6,2.095774000473864,1.0674831510476832,0.020732553120913058,0.6429522395902524,raw,857742.25,675909.5,619503.0625,1354872.25,NA,1541526,Mitochondrial import inner membrane translocase subunit TIM14 OS=Homo sapiens OX=9606 GN=DNAJC19 PE=1 SV=3,cell growth;conjugation;defense response;metabolic process,cytoskeleton;endosome;nucleus,structural molecule activity,131118,DNAJC19,NA,Mitochondrial protein import,ENSG00000205981
A0A2R8Y549,0.5,6,321219.09375,1.243421768770756e-6,2.0949456786345806,1.066912835723891,0.05728099362869676,0.6429522395902524,raw,194641.46875,234628.5,244737.25,430188.9375,NA,501899.3125,InaD-like protein OS=Homo sapiens OX=9606 GN=PATJ PE=1 SV=1,NA,cytosol;endoplasmic reticulum;nucleus,NA,NA,PATJ,NA,NA,ENSG00000132849
Q13740,0,6,19444171.578125,7.526733835682595e-5,2.092584590376246,1.0652859432772475,0.07995803841421437,0.6429522395902524,raw,12541705.203125,16492248.0625,9995440.046875,34511424.15625,21014153.3125,22110058.6875,CD166 antigen OS=Homo sapiens OX=9606 GN=ALCAM PE=1 SV=2,cell communication;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;structural molecule activity,214,ALCAM,NA,L1CAM interactions,ENSG00000170017
Q9NXG6,0,6,2442057.6927083335,9.453073477851523e-6,2.0906768533422904,1.0639700881790004,0.05036246076834052,0.6429522395902524,raw,2046983.96875,1244044.96875,1435772.625,4255399.0625,2668408.9375,3001736.59375,Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,54681,P4HTM,NA,NA,ENSG00000178467
Q9Y223,0,6,1104141.0729166667,4.27407047890808e-6,2.0905519826785026,1.0638839172017505,0.04263270774581489,0.6429522395902524,raw,948737.09375,568597.78125,523237.09375,1641795.96875,1093854.34375,1848624.15625,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens OX=9606 GN=GNE PE=1 SV=1,cell communication;cellular homeostasis,cytosol;nucleus,signal transducer activity;structural molecule activity,10020,GNE,NA,"Sialic acid metabolism; Defective GNE causes sialuria, NK and IBM2",ENSG00000159921
Q9HCN8,0,6,10383516.932291666,4.019403342212186e-5,2.090446496485888,1.0638111190853399,0.06150992487091841,0.6429522395902524,raw,6020613.59375,11008930.0625,5477294.125,12585770.59375,12039383.375,15169109.84375,Stromal cell-derived factor 2-like protein 1 OS=Homo sapiens OX=9606 GN=SDF2L1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,23753,SDF2L1,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000128228
P22676,0,6,1360732.2447916667,5.267321051466155e-6,2.089694788205472,1.0632922438865455,0.12983573811177945,0.6498046150645307,raw,1399291.1875,465305.875,934063.46875,2297547.625,1116277.75,1951907.5625,Calretinin OS=Homo sapiens OX=9606 GN=CALB2 PE=2 SV=2,metabolic process,cytosol;membrane;nucleus,structural molecule activity,794,CALB2,NA,NA,ENSG00000172137; ENSG00000282830
Q6JQN1,0.3333333333333333,6,265634.52734375,1.0282569133123e-6,2.0874140693499683,1.0617168087127542,0.27715211026341624,0.7569911490160285,raw,371134.5,76441.3203125,89400.15625,486276.34375,159564.6875,410990.15625,Acyl-CoA dehydrogenase family member 10 OS=Homo sapiens OX=9606 GN=ACAD10 PE=1 SV=1,cellular homeostasis,endosome;nucleus,structural molecule activity,80724,ACAD10,NA,Mitochondrial Fatty Acid Beta-Oxidation,ENSG00000111271
Q9BSJ5,0.16666666666666666,6,318902.325,1.234453682025577e-6,2.084716720539358,1.0598513579439373,0.0392981041404658,0.6429522395902524,raw,184973.34375,207479.15625,NA,407730.84375,318967.78125,475360.5,Uncharacterized protein C17orf80 OS=Homo sapiens OX=9606 GN=C17orf80 PE=2 SV=2,NA,cytoskeleton,NA,55028,C17orf80,NA,NA,ENSG00000141219
Q96DZ1,0,6,1806214.9114583333,6.991760401807169e-6,2.08147495851074,1.0576062020286054,0.07791027156851514,0.6429522395902524,raw,1509125.5,883418.609375,881024.140625,3141206.9375,1586770.03125,2835744.25,Endoplasmic reticulum lectin 1 OS=Homo sapiens OX=9606 GN=ERLEC1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,extracellular,structural molecule activity,27248,ERLEC1,NA,ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis,ENSG00000068912
Q9HBH0,0,6,1334936.9635416667,5.167468910476127e-6,2.0812042087766986,1.0574185299628627,0.09390669232489117,0.6429522395902524,raw,639872.3125,1132428.21875,639727.8125,2356814.375,1107278.625,2133500.4375,Rho-related GTP-binding protein RhoF OS=Homo sapiens OX=9606 GN=RHOF PE=1 SV=1,cell growth;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,54509,RHOF,NA,Neutrophil degranulation; RHOF GTPase cycle,ENSG00000139725
Q9Y4L1,0,6,234527873.61458334,9.078447362249602e-4,2.0806361866071423,1.0570247220825169,0.04113279772954863,0.6429522395902524,raw,167566679.8125,154389968.671875,144443275.828125,348298440.8125,243823578.875,348645297.6875,Hypoxia up-regulated protein 1 OS=Homo sapiens OX=9606 GN=HYOU1 PE=1 SV=1,coagulation;conjugation;metabolic process,cell surface;extracellular;nucleus,structural molecule activity,10525,HYOU1,VEGFA-VEGFR2 signaling pathway,XBP1(S) activates chaperone genes; Scavenging by Class F Receptors,ENSG00000149428; ENSG00000280682
A0A2R8Y6W8,0,6,463443.875,1.7939662180448235e-6,2.0784316952761044,1.055495336605224,1,1,raw,NA,NA,269608,601379.9375,519343.6875,NA,DNA excision repair protein ERCC-3 OS=Homo sapiens OX=9606 GN=ERCC3 PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation,membrane,RNA binding;structural molecule activity,NA,ERCC3,"Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",NA,ENSG00000163161
Q9UPY8,0.16666666666666666,6,944857.0078125,3.6574904628927046e-6,2.0765118591424283,1.0541621111448964,0.08675890435705366,0.6429522395902524,raw,766327.28125,616402.140625,428888.1875,1591287.6875,819049.75,1447187,Microtubule-associated protein RP/EB family member 3 OS=Homo sapiens OX=9606 GN=MAPRE3 PE=1 SV=1,cell differentiation;cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,22924,MAPRE3,NA,NA,ENSG00000084764
Q6P1M3,0,6,14785192.2265625,5.723268083271583e-5,2.0753092317399253,1.0533263214515671,0.04926982923283487,0.6429522395902524,raw,10544350.3125,7465691.234375,10131029.6875,24588486.125,14956576.5625,21025019.4375,LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,DNA binding;motor activity;structural molecule activity,3993,LLGL2,Complement system in neuronal development and plasticity,NA,ENSG00000073350
O14579,0,6,31233695.690104168,1.2090394965892919e-4,2.0742835168540323,1.0526130978178099,0.09853987455995603,0.6429522395902524,raw,24705302.4375,20908918.671875,19119333.8125,43446643.625,27976173.96875,51245801.625,Coatomer subunit epsilon OS=Homo sapiens OX=9606 GN=COPE PE=1 SV=3,conjugation;metabolic process,cytoskeleton;cytosol;extracellular;membrane,structural molecule activity,11316,COPE,NA,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000105669
P60059,0,6,9581803.5,3.709064401151844e-5,2.070236128323324,1.0497953289481075,0.04031776265094951,0.6429522395902524,raw,6806761.5,7281233,5080775.5,11990844,10518405,15812802,Protein transport protein Sec61 subunit gamma OS=Homo sapiens OX=9606 GN=SEC61G PE=1 SV=1,conjugation,cytoskeleton;cytosol;extracellular,catalytic activity;protein binding,23480,SEC61G,NA,SRP-dependent cotranslational protein targeting to membrane; ER-Phagosome pathway; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,ENSG00000132432
Q9Y4P8,0,6,996430.3932291667,3.857128253310597e-6,2.0688353256780507,1.0488188147085171,0.39121965602506104,0.8763288281216618,raw,1133144.5625,247056.109375,725721.375,742520.125,785850.6875,2344289.5,WD repeat domain phosphoinositide-interacting protein 2 OS=Homo sapiens OX=9606 GN=WIPI2 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation,cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,26100,WIPI2,Alzheimer's disease and miRNA effects; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Autophagy; Alzheimer's disease,Macroautophagy,ENSG00000157954
Q9NQE9,0,6,541513.328125,2.0961688559963637e-6,2.067553803164914,1.047924872588443,0.07811838591701764,0.6429522395902524,raw,462384.21875,312464.84375,302086.03125,668977.375,547163.25,956004.25,Histidine triad nucleotide-binding protein 3 OS=Homo sapiens OX=9606 GN=HINT3 PE=1 SV=1,NA,membrane;nucleus,structural molecule activity,135114,HINT3,NA,NA,ENSG00000111911
O43772,0,6,1858047.765625,7.192402581747176e-6,2.0664243447373853,1.0471365451931194,0.1308319843934774,0.6498046150645307,raw,2097425.3125,1053569.21875,878763.84375,3117780.625,1815899,2184848.59375,Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens OX=9606 GN=SLC25A20 PE=1 SV=1,conjugation;defense response,cytoskeleton;cytosol;endosome,catalytic activity,788,SLC25A20,Fatty acid beta-oxidation; Mitochondrial long chain fatty acid beta-oxidation; Thermogenesis,Carnitine metabolism,ENSG00000178537
Q9BXK5,0,6,6052047.458333333,2.3427148951432437e-5,2.062703775392755,1.0445366508622669,0.08226422368980338,0.6429522395902524,raw,4676736.9375,3498059.8125,3737072.4375,9312369.75,5441322.875,9646722.9375,Bcl-2-like protein 13 OS=Homo sapiens OX=9606 GN=BCL2L13 PE=1 SV=1,metabolic process,cytoskeleton;endosome;membrane,DNA binding,23786,BCL2L13,Regulation of apoptosis by parathyroid hormone-related protein,NA,ENSG00000099968
Q6P2H3,0.3333333333333333,6,532348.7620442709,2.0606933155075235e-6,2.062102825159887,1.044116273370242,0.16711442799778314,0.6670444762382309,raw,359521.6875,451956.8125,300188.1875,741370.6875,402624.978515625,938430.21875,Centrosomal protein of 85 kDa OS=Homo sapiens OX=9606 GN=CEP85 PE=1 SV=1,metabolic process,cytosol;endoplasmic reticulum;extracellular;membrane,NA,64793,CEP85,NA,NA,ENSG00000130695
Q96A57,0,6,1676261.53125,6.488717883412715e-6,2.055585768250386,1.0395495688602654,0.04059765540174593,0.6429522395902524,raw,1093175.5,1025545.8125,1135081.75,2247116,1842130.125,2714520,Transmembrane protein 230 OS=Homo sapiens OX=9606 GN=TMEM230 PE=1 SV=1,conjugation,cytoskeleton;extracellular;mitochondrion;nucleus,NA,29058,TMEM230,NA,NA,ENSG00000089063
Q92506,0,6,638879.4583333334,2.4730678890788566e-6,2.0547120029862453,1.0389361939163444,1,1,raw,614843,NA,363319.6875,NA,NA,938475.6875,Estradiol 17-beta-dehydrogenase 8 OS=Homo sapiens OX=9606 GN=HSD17B8 PE=1 SV=2,cell growth;cellular homeostasis,cytoplasm;cytoskeleton;endosome;nucleus,structural molecule activity,7923,HSD17B8,NA,Fatty acyl-CoA biosynthesis,ENSG00000112474; ENSG00000204228; ENSG00000225312; ENSG00000228357; ENSG00000228712; ENSG00000232357
F2Z2U4,0,6,2019839.703125,7.818690436402758e-6,2.0545943497757055,1.0388535825513763,0.043116639366166255,0.6429522395902524,raw,618141.40625,1478349,1663598.78125,3418020.65625,2898239.0625,2042689.3125,Transformation/transcription domain-associated protein OS=Homo sapiens OX=9606 GN=TRRAP PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,extracellular;membrane;nucleus,signal transducer activity,NA,TRRAP,Rett syndrome causing genes,NA,ENSG00000196367
A0A3B3IRL2,0.16666666666666666,6,950596.734375,3.679708634519074e-6,2.053598463912406,1.038154121893332,0.23531145736770173,0.7192904383575112,raw,1172407.375,284737.46875,593097.6875,1703312.875,732040.5,1217984.5,"Cellular repressor of E1A-stimulated genes 1, isoform CRA_a OS=Homo sapiens OX=9606 GN=CREG1 PE=1 SV=1",NA,cell surface,NA,NA,CREG1,NA,NA,ENSG00000143162
Q8NCF5,0,6,714390.8567708334,2.765368435448571e-6,2.05327712740915,1.0379283587454882,0.7599543851057322,1,raw,255185.140625,1368299.34375,313904.6875,523965.8125,1165007.34375,659982.8125,NFATC2-interacting protein OS=Homo sapiens OX=9606 GN=NFATC2IP PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,NA,84901,NFATC2IP,16p11.2 distal deletion syndrome,NA,ENSG00000176953
F2Z2W7,0,6,1083974.7421875,4.196007701468105e-6,2.051243438384309,1.0364987187844195,0.08772542521297881,0.6429522395902524,raw,711903.53125,1174038.78125,520638.609375,1466996.71875,1067956.53125,1562314.28125,tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens OX=9606 GN=TRMT2A PE=1 SV=1,cellular component movement;cellular homeostasis,NA,RNA binding;structural molecule activity,27037,TRMT2A,22q11.2 copy number variation syndrome,NA,ENSG00000099899
Q12768,0,6,1070117.8932291667,4.142368587303959e-6,2.050194917764006,1.0357610773031731,0.04558968490400249,0.6429522395902524,raw,890271.28125,313225.3125,800896.53125,1825229.65625,1093740.234375,1497344.34375,WASH complex subunit 5 OS=Homo sapiens OX=9606 GN=WASHC5 PE=1 SV=1,cell differentiation;cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,NA,9897,WASHC5,NA,NA,ENSG00000164961
Q8TED1,0,6,5683187.385416667,2.1999311524520604e-5,2.0481170315320245,1.0342981547846501,0.02442664571475558,0.6429522395902524,raw,3798617.28125,3894438.6875,3159473.53125,7780012.75,6414242.9375,9052339.125,Probable glutathione peroxidase 8 OS=Homo sapiens OX=9606 GN=GPX8 PE=1 SV=2,coagulation;metabolic process,cytoskeleton;extracellular,structural molecule activity,493869,GPX8,NA,Detoxification of Reactive Oxygen Species,ENSG00000164294
Q96GD0,0,6,2141415.6302083335,8.289304286062506e-6,2.047116879654774,1.033593475045507,0.09143304724036322,0.6429522395902524,raw,2303972.75,980466.03125,1341804.375,3023078.3125,2007128.5625,3192043.75,Pyridoxal phosphate phosphatase OS=Homo sapiens OX=9606 GN=PDXP PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,57026,PDXP,NA,NA,ENSG00000241360
Q9H488,0,6,1701306.7135416667,6.5856664318340846e-6,2.0462538621941624,1.0329851397113319,0.18267144597302756,0.6753459175264409,raw,878672.34375,1335800.53125,1172706.125,3211179.5,1209827.34375,2399654.4375,GDP-fucose protein O-fucosyltransferase 1 OS=Homo sapiens OX=9606 GN=POFUT1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoskeleton;extracellular,structural molecule activity,23509,POFUT1,NA,Pre-NOTCH Processing in the Endoplasmic Reticulum,ENSG00000101346
P45877,0,6,3270255.4166666665,1.2658982151567108e-5,2.0424770138161747,1.0303198422681352,0.1198599848887957,0.6445597830897484,raw,2682453.75,2091679.625,2128795.875,4402269.75,2837483.375,5478850.125,Peptidyl-prolyl cis-trans isomerase C OS=Homo sapiens OX=9606 GN=PPIC PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,nucleus,structural molecule activity,5480,PPIC,NA,NA,ENSG00000168938
Q9BZ67,0,6,739917.74375,2.8641816367072415e-6,2.038019905946388,1.0271681428039663,0.027847419931987794,0.6429522395902524,raw,459846.25,NA,416524.40625,875263.25,822506.8125,1125448,FERM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=FRMD8 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane,NA,83786,FRMD8,NA,NA,ENSG00000126391
Q9NP84,0,6,121435.830078125,4.700715417166485e-7,2.0363941413990325,1.0260168201610798,0.30278805111670387,0.7825518083423609,raw,84799.4296875,NA,73655.578125,207776.109375,119512.203125,NA,Tumor necrosis factor receptor superfamily member 12A OS=Homo sapiens OX=9606 GN=TNFRSF12A PE=1 SV=1,cell communication;defense response;metabolic process,cytoplasm;cytoskeleton,NA,51330,TNFRSF12A,TNF-related weak inducer of apoptosis (TWEAK) signaling pathway,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,ENSG00000006327
Q9BTT6,0,6,1772094.9765625,6.85968397601556e-6,2.036133562522048,1.025832199757522,0.1215288577894361,0.6445597830897484,raw,1548741.90625,813485.71875,1168208.578125,2484239.25,1464449.03125,3153445.375,Leucine-rich repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=LRRC1 PE=1 SV=1,NA,cytoskeleton;cytosol,NA,55227,LRRC1,NA,RND2 GTPase cycle,ENSG00000137269
Q9HCG8,0,6,5510946.981770833,2.133257822154399e-5,2.035698312908063,1.025523772257936,0.020193378240745723,0.6429522395902524,raw,3430373.5625,5152556.15625,2960842.828125,7810767.96875,6027382.75,7683758.625,Pre-mRNA-splicing factor CWC22 homolog OS=Homo sapiens OX=9606 GN=CWC22 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane,RNA binding,57703,CWC22,NA,mRNA Splicing - Major Pathway,ENSG00000163510
Q9HBR0,0,6,2423832.8359375,9.382526041280955e-6,2.0339169466278846,1.0242607690998193,0.08597552431027321,0.6429522395902524,raw,1400885.515625,1438625.7734375,1967794.875,3571934.484375,2161425.0234375,4002331.34375,Putative sodium-coupled neutral amino acid transporter 10 OS=Homo sapiens OX=9606 GN=SLC38A10 PE=1 SV=2,conjugation;defense response,cytoskeleton;extracellular,catalytic activity,124565,SLC38A10,NA,NA,ENSG00000157637
Q04721,0,6,286172.84765625,1.1077596423450418e-6,2.0327714534827033,1.023448020661268,1,1,raw,NA,NA,155928.390625,306298.625,316966.78125,365497.59375,Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3,cell differentiation;cell growth;coagulation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,4853,NOTCH2,Neural crest differentiation; Notch signaling; Canonical and non-canonical Notch signaling; OSX and miRNAs in tooth development; Epithelial to mesenchymal transition in colorectal cancer; Breast cancer pathway; Head and neck squamous cell carcinoma; Osteoblast differentiation and related diseases; Genes controlling nephrogenesis; Notch signaling pathway,NOTCH2 Activation and Transmission of Signal to the Nucleus; Pre-NOTCH Processing in Golgi; Pre-NOTCH Transcription and Translation; Notch-HLH transcription pathway; NOTCH2 intracellular domain regulates transcription; NOTCH4 Intracellular Domain Regulates Transcription; Pre-NOTCH Processing in the Endoplasmic Reticulum; Defective LFNG causes SCDO3,ENSG00000134250
P35080,0.3333333333333333,6,1816368.40625,7.031064031942198e-6,2.031682822282436,1.0226751922493926,0.06066321784716899,0.6429522395902524,raw,1838084.75,561821.1875,1223194.375,2725474.5,2064492.625,2485143,Profilin-2 OS=Homo sapiens OX=9606 GN=PFN2 PE=1 SV=3,cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,5217,PFN2,Physico-chemical features and toxicity-associated pathways,RHO GTPases Activate Formins; Signaling by ROBO receptors,ENSG00000070087
Q8WXC6,0.16666666666666666,6,440500.6796875,1.7051543477301508e-06,2.028470805553365,1.0203925389324167,0.38519121006100565,0.8701645811656724,raw,492841.71875,NA,168685.25,467799.8125,NA,632675.9375,COP9 signalosome complex subunit 9 OS=Homo sapiens OX=9606 GN=COPS9 PE=1 SV=3,metabolic process,membrane;nucleus,NA,150678,COPS9,2q37 copy number variation syndrome,NA,ENSG00000172428
O14908,0,6,14426897.140625,5.584573989997971e-5,2.028448985712287,1.020377020076666,0.039890904452368314,0.6429522395902524,raw,9693773.03125,11044021.8125,8560097.03125,22402234.84375,14967243.8125,19894012.3125,PDZ domain-containing protein GIPC1 OS=Homo sapiens OX=9606 GN=GIPC1 PE=1 SV=2,cell death;conjugation;development;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,antioxidant activity;motor activity;structural molecule activity,10755,GIPC1,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000123159
Q96FS4,0,6,484675.1666666667,1.8761514017749063e-6,2.0252366673402213,1.0180905098971067,0.10700334197430962,0.6429522395902524,raw,236231.171875,330899.34375,365836.5,478424.03125,584434.015625,912225.9375,Signal-induced proliferation-associated protein 1 OS=Homo sapiens OX=9606 GN=SIPA1 PE=1 SV=1,cell growth;coagulation;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,DNA binding;structural molecule activity,6494,SIPA1,MAPK cascade,Rap1 signalling,ENSG00000213445
Q9P2K3,0.3333333333333333,6,1900670.3541666667,7.357392320729862e-6,2.024178876039822,1.0173367861650053,0.2303801262969642,0.7173388538497806,raw,1056821.25,926531.625,1088603.125,4791387.75,1401483.125,2139195.25,REST corepressor 3 OS=Homo sapiens OX=9606 GN=RCOR3 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,55758,RCOR3,NA,NA,ENSG00000117625
P50225,0,6,22135950.776041668,8.568707029847324e-5,2.024137735015467,1.017307463383455,0.048876126351585156,0.6429522395902524,raw,17064890.8125,11252247.90625,15129666.875,33198341.375,21628868.25,34541689.4375,Sulfotransferase 1A1 OS=Homo sapiens OX=9606 GN=SULT1A1 PE=1 SV=3,cellular homeostasis,cytosol;nucleus,structural molecule activity,6817,SULT1A1,Constitutive androstane receptor pathway; Nuclear receptors meta-pathway; Melatonin metabolism and effects; Tamoxifen metabolism; Sulfation biotransformation reaction; Arylamine metabolism; Estrogen metabolism; Metapathway biotransformation Phase I and II; Vitamin A and carotenoid metabolism,Paracetamol ADME; Cytosolic sulfonation of small molecules,ENSG00000196502
O15013,0,6,1041566.6354166666,4.0318482098401e-6,2.023532288739851,1.016875869730443,0.1536213766079934,0.6638855679885327,raw,706153.859375,643675.4375,512055.6875,1302498.03125,900934.921875,2184081.875,Rho guanine nucleotide exchange factor 10 OS=Homo sapiens OX=9606 GN=ARHGEF10 PE=1 SV=4,cell differentiation;cell growth;defense response;metabolic process,cytosol;endoplasmic reticulum,DNA binding;motor activity,9639,ARHGEF10,NA,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle,ENSG00000104728; ENSG00000274726
P11277,0.6666666666666666,6,1569349.6875,6.0748679085988575e-6,2.0234361359915516,1.0168073151589183,0.021816283546698848,0.6429522395902524,raw,842945.875,1161987.625,1107119.125,2268154.75,1684683,2351207.75,"Spectrin beta chain, erythrocytic OS=Homo sapiens OX=9606 GN=SPTB PE=1 SV=5",cell growth,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity,6710,SPTB,NA,COPI-mediated anterograde transport; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins,ENSG00000070182
O60437,0,6,65053585.4350586,2.518189168714073e-4,2.021413002409038,1.0153641142235663,0.03102274267549537,0.6429522395902524,raw,51181452.0869141,33141867.59375,42073755.265625,97741860.21875,66993402.078125,99189175.3671875,Periplakin OS=Homo sapiens OX=9606 GN=PPL PE=1 SV=4,cell growth;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,5493,PPL,NA,Formation of the cornified envelope; Butyrophilin (BTN) family interactions,ENSG00000118898
P42574,0,6,1775771.5416666667,6.873915761030127e-6,2.0170251104124386,1.0122290445071471,0.10328063293632106,0.6429522395902524,raw,992177.5,1017267.4375,1561135.25,2322830.6875,1612369.375,3148849,Caspase-3 OS=Homo sapiens OX=9606 GN=CASP3 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;DNA binding;structural molecule activity,836,CASP3,miRNA regulation of DNA damage response; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; AGE/RAGE pathway; Allograft rejection; Corticotropin-releasing hormone signaling pathway; Parkinson's disease pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Amyotrophic lateral sclerosis (ALS); Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Copper homeostasis; Hepatitis C and hepatocellular carcinoma; MAPK signaling pathway; Apoptosis modulation by HSP70; ERK pathway in Huntington's disease; Oxidative damage response; miRNA regulation of p53 pathway in prostate cancer; Prion disease pathway; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; MTHFR deficiency; Acute viral myocarditis; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; Host-pathogen interaction of human coronaviruses - apoptosis; Peroxiredoxin 2 induced ovarian failure; Complement system in neuronal development and plasticity; Network map of SARS-CoV-2 signaling pathway; Alzheimer's disease; DYRK1A; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response,Degradation of the extracellular matrix; Apoptosis induced DNA fragmentation; Signaling by Hippo; Activation of caspases through apoptosome-mediated cleavage; SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Caspase activation via Dependence Receptors in the absence of ligand; Pyroptosis; Caspase-mediated cleavage of cytoskeletal proteins; NADE modulates death signalling; Other interleukin signaling; Apoptotic cleavage of cell adhesion  proteins; Stimulation of the cell death response by PAK-2p34,ENSG00000164305
Q96DE0,0.3333333333333333,6,344635.24609375,1.3340644302176864e-6,2.0164416814985184,1.0118116814544094,1,1,raw,NA,186895.421875,NA,376863.71875,340156.53125,474625.3125,U8 snoRNA-decapping enzyme OS=Homo sapiens OX=9606 GN=NUDT16 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,131870,NUDT16,NA,Phosphate bond hydrolysis by NUDT proteins,ENSG00000198585
Q15334,0,6,4033558.9583333335,1.5613688949372925e-5,2.012290165977629,1.008838352277429,0.0628803488852831,0.6429522395902524,raw,2862725.78125,1690759.03125,3443292.78125,5760634.9375,3789543.09375,6654398.125,Lethal(2) giant larvae protein homolog 1 OS=Homo sapiens OX=9606 GN=LLGL1 PE=1 SV=3,cell differentiation;cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;mitochondrion;nucleus,DNA binding;motor activity;structural molecule activity,3996,LLGL1,NA,NA,ENSG00000131899; ENSG00000284137
Q99828,0,6,3723486.3151041665,1.4413414488753525e-5,2.0115939775343605,1.0083391392838,0.014113816722267412,0.6429522395902524,raw,2735469.96875,1695939.234375,2792581.3125,5416736.40625,4082651.21875,5617539.75,Calcium and integrin-binding protein 1 OS=Homo sapiens OX=9606 GN=CIB1 PE=1 SV=4,cell communication;cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;membrane;nucleus,DNA binding;structural molecule activity,10519,CIB1,NA,NA,ENSG00000185043
Q9BRJ6,0,6,562200.5234375,2.1762478721161045e-6,2.0087452659095435,1.0062946238471655,1,1,raw,417121.75,507330.8125,440166.71875,NA,NA,884182.8125,Uncharacterized protein C7orf50 OS=Homo sapiens OX=9606 GN=C7orf50 PE=1 SV=1,NA,NA,NA,84310,C7orf50,NA,NA,ENSG00000146540
Q9NR09,0,6,3540148.7513020835,1.3703724677965596e-5,2.008413069604961,1.0060560183841551,0.007199711203541864,0.6429522395902524,raw,2066539.125,2778025.59375,2127574.9140625,4740032.71875,4150464.1875,5378255.96875,Baculoviral IAP repeat-containing protein 6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
Q6NW34,0,6,562603.4010416666,2.1778073895698238e-6,1.9982419234288415,0.9987312581065607,0.25526770614839617,0.735366952583477,raw,551988.1875,345226.125,271476.5625,767382.375,336541.21875,1103005.9375,Nucleolus and neural progenitor protein OS=Homo sapiens OX=9606 GN=NEPRO PE=1 SV=3,metabolic process,membrane,NA,25871,NEPRO,NA,NA,ENSG00000163608
Q9BXS5,0,6,4944064.78125,1.913820783020958e-5,1.9972513987069833,0.9980159396123655,0.07041809957832969,0.6429522395902524,raw,3325532.34375,3738242.34375,3200512.84375,6641924.125,4855602.8125,7902574.21875,AP-1 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP1M1 PE=1 SV=3,cell growth;conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,8907,AP1M1,NA,MHC class II antigen presentation; Neutrophil degranulation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Nef mediated downregulation of MHC class I complex cell surface expression,ENSG00000072958
P63261,0,6,247230294.46614584,9.570151215172272e-4,1.997021666292732,0.9978499851021235,0.11750626105632148,0.6429522395902524,raw,163126742.25,209276119.625,146311212.984375,325767638.625,217181137.9375,421718915.375,"Actin, cytoplasmic 2 OS=Homo sapiens OX=9606 GN=ACTG1 PE=1 SV=1",cell growth;coagulation;conjugation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,71,ACTG1,Arrhythmogenic right ventricular cardiomyopathy; Pathogenic Escherichia coli infection; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; Focal adhesion; Fas ligand pathway and stress induction of heat shock proteins; Striated muscle contraction pathway; VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host; Thermogenesis; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Malignant pleural mesothelioma; Regulation of actin cytoskeleton; Network map of SARS-CoV-2 signaling pathway,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; RHO GTPases Activate WASPs and WAVEs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; Signaling by BRAF and RAF1 fusions; Clathrin-mediated endocytosis; EPHB-mediated forward signaling; VEGFA-VEGFR2 Pathway; EPH-ephrin mediated repulsion of cells; Interaction between L1 and Ankyrins; RHOBTB2 GTPase cycle; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Adherens junctions interactions; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Formation of annular gap junctions; Cell-extracellular matrix interactions,ENSG00000184009
Q03169,0.3333333333333333,6,613923.8880208334,2.3764662237905464e-6,1.9958491901991724,0.9970027122725469,0.1216288699563461,0.6445597830897484,raw,465545.875,434644.34375,310180.4375,694321.4375,619073.375,1159777.859375,Tumor necrosis factor alpha-induced protein 2 OS=Homo sapiens OX=9606 GN=TNFAIP2 PE=1 SV=2,conjugation;defense response;metabolic process,cell surface;nucleus,structural molecule activity,7127,TNFAIP2,IL-18 signaling pathway,NA,ENSG00000185215
Q8TE68,0,6,1200940.4,4.648775447696309e-6,1.9957237079334122,0.996912004851081,0.07779954397864774,0.6429522395902524,raw,NA,727126.75,841591,1810374.1875,1068580.6875,1557029.375,Epidermal growth factor receptor kinase substrate 8-like protein 1 OS=Homo sapiens OX=9606 GN=EPS8L1 PE=1 SV=3,development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,antioxidant activity;motor activity,54869,EPS8L1,Fragile X syndrome,NA,ENSG00000131037
P36952,0,6,41575757.244791664,1.6093751155258783e-4,1.9937788196687256,0.9955053728926284,0.04452041762868506,0.6429522395902524,raw,31097230.3125,27355470.09375,25582826.6875,54540756.875,44327582.125,66550677.375,Serpin B5 OS=Homo sapiens OX=9606 GN=SERPINB5 PE=1 SV=2,cell growth;defense response;metabolic process,cell surface;cytoplasm;cytosol;nucleus,DNA binding,5268,SERPINB5,p53 transcriptional gene network,NA,ENSG00000206075
E9PLP0,0.5,6,1205733.5546875,4.667329490701492e-6,1.9914059258930603,0.9937873283321653,0.01226919096118365,0.6429522395902524,raw,1056309.71875,790257.46875,711507.484375,1620443.21875,1482160.03125,1573723.40625,"Cysteine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=CARS1 PE=1 SV=1",NA,NA,NA,NA,CARS1,NA,NA,ENSG00000110619; ENSG00000278191
Q58WW2,0,6,361898.9427083333,1.4008912677179928e-6,1.9870046497610694,0.9905952486214972,1,1,raw,NA,218273.984375,NA,382788.84375,NA,484634,DDB1- and CUL4-associated factor 6 OS=Homo sapiens OX=9606 GN=DCAF6 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,55827,DCAF6,NA,Neddylation,ENSG00000143164
Q96FX7,0,6,543829.75,2.105135600007146e-6,1.984767398084712,0.988969942737276,1,1,raw,NA,NA,364403.4375,723256.0625,NA,NA,tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A OS=Homo sapiens OX=9606 GN=TRMT61A PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,structural molecule activity,115708,TRMT61A,NA,tRNA modification in the nucleus and cytosol,ENSG00000166166
A0A1B0GUA8,0.16666666666666666,6,596562.9375,2.3092629216700413e-6,1.9828258318370429,0.9875579591702426,0.1147204521306915,0.6429522395902524,raw,432066.3125,560520.1875,298292.875,724353.125,NA,967582.1875,Kinesin-like protein KIF13A OS=Homo sapiens OX=9606 GN=KIF13A PE=1 SV=1,conjugation,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,NA,KIF13A,NA,NA,ENSG00000137177
G3V5T9,0,6,11414189.697916666,4.418371205017597e-5,1.9821706063444586,0.9870811413005883,0.1240586285882223,0.6445597830897484,raw,8450458.6875,8363818.5,7724298.75,16578515.1875,9626519.1875,17741527.875,Cyclin-dependent kinase 2 OS=Homo sapiens OX=9606 GN=CDK2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,endoplasmic reticulum;membrane,signal transducer activity;structural molecule activity,1017,CDK2,miRNA regulation of DNA damage response; Cell cycle; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; Oncostatin M signaling pathway; Spinal cord injury; Retinoblastoma gene in cancer; Aryl hydrocarbon receptor pathway; Vitamin D receptor pathway; PI3K-Akt signaling pathway; G1 to S cell cycle control; Measles virus infection; Small cell lung cancer; DNA replication; p53 transcriptional gene network; Malignant pleural mesothelioma; Sphingolipid metabolism in senescence; ID signaling pathway; DNA damage response,NA,ENSG00000123374
Q8IW45,0,6,546174.8671875,2.11421342202331e-6,1.9795812109332456,0.985195254136067,0.12373205533865979,0.6445597830897484,raw,280481.9375,467885.59375,NA,622770.1875,NA,813561.75,ATP-dependent (S)-NAD(P)H-hydrate dehydratase OS=Homo sapiens OX=9606 GN=NAXD PE=1 SV=1,cellular homeostasis,endosome,structural molecule activity,55739,NAXD,NA,Nicotinamide salvaging,ENSG00000213995
J3KMZ9,0,6,4563536.651041667,1.7665203983498883e-5,1.9793964446317753,0.9850605923873837,0.011842877754691328,0.6429522395902524,raw,3696874.9375,2576102.71875,2960106,6208742,5099128.5625,6840265.6875,Low-density lipoprotein receptor (Fragment) OS=Homo sapiens OX=9606 GN=LDLR PE=1 SV=1,conjugation,cytoskeleton,structural molecule activity,NA,LDLR,"Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; PCSK9-mediated LDL receptor degradation; Evolocumab mechanism to reduce LDL cholesterol; Lipid particles composition; Bile acids synthesis and enterohepatic circulation ; Metabolic pathway of LDL, HDL and TG, including diseases; Familial  hyperlipidemia type 1; Familial hyperlipidemia type 2; Familial hyperlipidemia type 3; Familial hyperlipidemia type 4; Familial hyperlipidemia type 5",NA,ENSG00000130164
Q9NVE7,0,6,5248230.234375,2.0315615876874447e-5,1.9745670611317179,0.9815363660860482,0.13933516870868132,0.6572502130392559,raw,4176776.3125,3818885,2549078.90625,9283318.5625,4120678.09375,7540644.53125,4'-phosphopantetheine phosphatase OS=Homo sapiens OX=9606 GN=PANK4 PE=1 SV=1,cellular homeostasis,cytosol;membrane,structural molecule activity,55229,PANK4,NA,Coenzyme A biosynthesis,ENSG00000157881; ENSG00000273494
Q5SWX3,0,6,4081045.458333333,1.5797506627000417e-5,1.9743375849088076,0.981368692141579,0.20094192523035515,0.691648270213144,raw,4424518.71875,1460085.0625,2032364.25,4012573.125,3927668.875,8629062.71875,Calcium/calmodulin-dependent protein kinase OS=Homo sapiens OX=9606 GN=CAMK2G PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,nucleus,signal transducer activity;structural molecule activity,818,CAMK2G,"Energy metabolism; Myometrial relaxation and contraction pathways; NO/cGMP/PKG mediated neuroprotection; Splicing factor NOVA regulated synaptic proteins; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; Disruption of postsynaptic signaling by CNV; Neuroinflammation and glutamatergic signaling; Calcium regulation in cardiac cells; ErbB signaling pathway",NA,ENSG00000148660
Q9UBN4,0,6,505779.2578125,1.957844199156604e-6,1.9739175787760948,0.9810617511046031,1,1,raw,294369.71875,NA,NA,581061.5625,453120.21875,694565.53125,Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,catalytic activity;structural molecule activity,7223,TRPC4,NA,TRP channels; Role of second messengers in netrin-1 signaling,ENSG00000133107
Q96QD8,0,6,25411691.203125,9.836728462921873e-5,1.9726681677276492,0.9801482936000048,0.03662325446146206,0.6429522395902524,raw,19988195.25,14489596.375,15093635.03125,37491294.1875,25977349.875,39430076.5,Sodium-coupled neutral amino acid transporter 2 OS=Homo sapiens OX=9606 GN=SLC38A2 PE=1 SV=2,coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity,54407,SLC38A2,Endochondral ossification; Endochondral ossification with skeletal dysplasias; Neuroinflammation and glutamatergic signaling,Glutamate Neurotransmitter Release Cycle; Amino acid transport across the plasma membrane,ENSG00000134294
Q96HY7,0,6,269975.921875,1.0450622171438957e-6,1.971895771105743,0.9795832969070648,1,1,raw,295816.09375,170192,206567,NA,NA,407328.59375,"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial OS=Homo sapiens OX=9606 GN=DHTKD1 PE=1 SV=2",cellular homeostasis;metabolic process,endosome,structural molecule activity,55526,DHTKD1,NA,Glyoxylate metabolism and glycine degradation,ENSG00000181192
H7C1M2,0,6,579247.578125,2.2422361004135177e-6,1.9706656786545034,0.9786830454540754,0.18024249367048964,0.6742444420587625,raw,534237.6875,270388.75,388353.5625,814189.6875,415511.90625,1052803.875,Protein SON (Fragment) OS=Homo sapiens OX=9606 GN=SON PE=1 SV=1,metabolic process,membrane,RNA binding,NA,SON,NA,NA,ENSG00000159140
Q9NXS2,0,6,967473.8020833334,3.745038852398003e-6,1.9681755461565325,0.9768589037435835,0.039146921898113377,0.6429522395902524,raw,729742.71875,805343.75,382151.0625,1296224.28125,1006323.125,1585057.875,Glutaminyl-peptide cyclotransferase-like protein OS=Homo sapiens OX=9606 GN=QPCTL PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,54814,QPCTL,NA,NA,ENSG00000011478
Q9UP95,0,6,680773.6953125,2.6352382184879767e-6,1.9673879808924086,0.9762814939224559,0.04436290597259542,0.6429522395902524,raw,486677.484375,367069.421875,523482.765625,872522.71875,722167.96875,1112721.8125,Solute carrier family 12 member 4 OS=Homo sapiens OX=9606 GN=SLC12A4 PE=1 SV=2,cell death;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity;structural molecule activity,6560,SLC12A4,Proximal tubule transport,Cation-coupled Chloride cotransporters,ENSG00000124067
Q75N03,0,6,370419.1979166667,1.4338727156071693e-6,1.9671031185601222,0.9760725878838066,0.08594309881125746,0.6429522395902524,raw,215408.90625,402569.65625,218886.28125,423731.53125,491853,470065.8125,E3 ubiquitin-protein ligase Hakai OS=Homo sapiens OX=9606 GN=CBLL1 PE=1 SV=1,cell communication;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,79872,CBLL1,NA,InlA-mediated entry of Listeria monocytogenes into host cells,ENSG00000105879
O95376,0,6,917492.2760416666,3.5515630636736885e-6,1.9617081711787177,0.9721104384441468,0.14483941579107404,0.6572502130392559,raw,831029.125,495478.96875,538064.5,1294396.375,715748.0625,1630236.625,E3 ubiquitin-protein ligase ARIH2 OS=Homo sapiens OX=9606 GN=ARIH2 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,10425,ARIH2,Modulators of TCR signaling and T cell activation,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000177479
P84243,0,6,33928481.439453125,1.3133531979884233e-4,1.96124295123744,0.9717682621159662,0.7817311399607606,1,raw,70056518.625,1579315.12109375,18528836.796875,66100340.625,10966326.90625,36339550.5625,Histone H3.3 OS=Homo sapiens OX=9606 GN=H3-3A PE=1 SV=2,cell differentiation;cell growth;defense response;metabolic process,cell surface;membrane;nucleus,RNA binding;structural molecule activity,3020; 3021,H3-3A; H3-3B,Gastric cancer network 1; Histone modifications; Tumor suppressor activity of SMARCB1; Ciliary landscape; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; DYRK1A,RUNX1 regulates transcription of genes involved in differentiation of HSCs; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; RNA Polymerase I Promoter Escape; Inhibition of DNA recombination at telomere; Amyloid fiber formation; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); Factors involved in megakaryocyte development and platelet production; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Meiotic recombination; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Condensation of Prophase Chromosomes; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis,ENSG00000132475; ENSG00000163041
A0A669KAY5,0,6,3500523.2682291665,1.3550336572433895e-5,1.9609520004509324,0.9715542221394848,0.02938822943926919,0.6429522395902524,raw,2847433,2028003.921875,2174386.71875,4562314.8125,3807321.71875,5583679.4375,Uncharacterized protein OS=Homo sapiens OX=9606 GN=DUS4L-BCAP29 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation,cytoskeleton;extracellular,structural molecule activity,NA,DUS4L-BCAP29,NA,NA,ENSG00000288558
F8VVM2,0,6,7245180.25,2.8045701568815744e-5,1.9607430317504024,0.9714004732601021,0.2129161276829592,0.7022549232366887,raw,8549592,2323332.75,3687670.25,11670220,4555458.5,12684808,"Phosphate carrier protein, mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A3 PE=1 SV=1",conjugation,cytoskeleton;endosome,catalytic activity,NA,SLC25A3,NA,NA,ENSG00000075415
Q86T03,0,6,1017570.1875,3.9389592555615e-6,1.960361269748269,0.9711195492618258,1,1,raw,NA,NA,612727.75,1444585.125,811800.125,1201167.75,"Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase OS=Homo sapiens OX=9606 GN=PIP4P1 PE=1 SV=1",cell growth;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;membrane;mitochondrion,structural molecule activity,90809,PIP4P1,NA,PI5P Regulates TP53 Acetylation; Synthesis of PIPs in the nucleus,ENSG00000165782
E7EQR4,0,6,1532499368.0781267,0.005932222311724799,1.9579317658100932,0.9693304876981345,0.0437737394626853,0.6429522395902524,raw,1163614135.73438,934779555.21875,1015645104.60938,2247478623.375,1555201710.03125,2278277079.5,Ezrin OS=Homo sapiens OX=9606 GN=EZR PE=1 SV=3,NA,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,motor activity,NA,NA,NA,NA,NA
P50416,0,6,35499027.760416664,1.374148198109704e-4,1.955694223858881,0.9676808200819416,0.023711085736334934,0.6429522395902524,raw,30832113.21875,18250992.90625,25623816.15625,51130901.34375,37043993.6875,50112349.25,"Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2",cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;endosome,structural molecule activity,1374,CPT1A,AMP-activated protein kinase signaling; Fatty acid beta-oxidation; PPAR-alpha pathway; Nuclear receptors meta-pathway; Mitochondrial long chain fatty acid beta-oxidation; Leptin and adiponectin; PPAR signaling pathway; Thermogenesis; Fragile X syndrome; IL-18 signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,PPARA activates gene expression; Signaling by Retinoic Acid; Carnitine metabolism; RORA activates gene expression,ENSG00000110090
Q15121,0,6,5531291.325520833,2.1411330077776403e-5,1.9539184778350256,0.9663702758648364,0.2093951662501985,0.6994710690791431,raw,4740826.46875,3641894.078125,3074247.3125,9036410.875,3431180.78125,9263188.4375,Astrocytic phosphoprotein PEA-15 OS=Homo sapiens OX=9606 GN=PEA15 PE=1 SV=2,conjugation;development;metabolic process,cytosol;endoplasmic reticulum;membrane,NA,8682,PEA15,Apoptosis modulation and signaling,RAF/MAP kinase cascade; RAF-independent MAPK1/3 activation,ENSG00000162734
O94966,0,6,4187091.2760416665,1.6208004261765123e-5,1.9518541940787464,0.9648452858228476,0.0154550729025344,0.6429522395902524,raw,3884106.640625,2487320.109375,2678689.34375,5827179.25,4854886.1875,5390366.125,Ubiquitin carboxyl-terminal hydrolase 19 OS=Homo sapiens OX=9606 GN=USP19 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;extracellular,structural molecule activity,10869,USP19,NA,Ub-specific processing proteases,ENSG00000172046
Q9NXJ5,0.16666666666666666,6,929135.9125,3.5966349517452376e-6,1.9490035916939388,0.9627367492485783,0.12414692943046791,0.6445597830897484,raw,697442.5,NA,491611.8125,1188798.5,737989.375,1529837.375,Pyroglutamyl-peptidase 1 OS=Homo sapiens OX=9606 GN=PGPEP1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol,structural molecule activity,54858,PGPEP1,NA,NA,ENSG00000130517
Q4KWH8,0,6,1971430.4583333333,7.6313008635072e-6,1.9481340637616809,0.9620929620552553,0.028176319250108155,0.6429522395902524,raw,1414935.5,1593174.75,1108488,2348786,2259480.5,3103718,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 OS=Homo sapiens OX=9606 GN=PLCH1 PE=1 SV=1",cellular homeostasis;development,cytoplasm;cytoskeleton;nucleus,structural molecule activity,23007,PLCH1,Mesodermal commitment pathway; GPR40 pathway,Synthesis of IP3 and IP4 in the cytosol,ENSG00000114805
Q9BTV5,0,6,338989.74375,1.3122109954547816e-6,1.9480823560304326,0.96205466927096694,0.05160341605330327,0.6429522395902524,raw,185331.59375,NA,250401.4375,449433.40625,389439.71875,420342.5625,Fibronectin type III and SPRY domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FSD1 PE=1 SV=1,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,79187,FSD1,NA,NA,ENSG00000105255
Q96JC1,0.16666666666666666,6,564730.3489583334,2.186040690117902e-6,1.9447281719435052,0.9595685138769665,0.026048009630709225,0.6429522395902524,raw,383391.34375,469120.65625,280862.875,912312.15625,632042.6875,710652.375,Vam6/Vps39-like protein OS=Homo sapiens OX=9606 GN=VPS39 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;mitochondrion;nucleus,NA,23339,VPS39,VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host,SARS-CoV-2 modulates autophagy,ENSG00000166887
O75410,0,6,3429599.8424479165,1.3275795820504503e-5,1.9439727888459988,0.9590080246681333,0.016089791373221106,0.6429522395902524,raw,1462593.125,3011646.890625,2258713.0078125,4390876.625,4280575.4375,5173193.96875,Transforming acidic coiled-coil-containing protein 1 OS=Homo sapiens OX=9606 GN=TACC1 PE=1 SV=2,cell differentiation;cell growth;cellular component movement;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;structural molecule activity,6867,TACC1,NA,NA,ENSG00000147526
O75787,0,6,5699999.984375,2.2064392187349054e-5,1.9419324555542077,0.9574930216985819,0.10929933553178167,0.6429522395902524,raw,3175751.8125,5970173.09375,3089254.75,9777845.75,6187850.4375,5999124.0625,Renin receptor OS=Homo sapiens OX=9606 GN=ATP6AP2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,10159,ATP6AP2,ACE inhibitor pathway; Oxidative phosphorylation,Neutrophil degranulation; Metabolism of Angiotensinogen to Angiotensins,ENSG00000182220
Q7Z460,0,6,5327921.798177083,2.062409761767661e-5,1.9411873729701554,0.9569393808068635,0.03132549256345306,0.6429522395902524,raw,4067492.90625,3969477.4140625,3001401.59375,8371790.9375,5826282.875,6731085.0625,CLIP-associating protein 1 OS=Homo sapiens OX=9606 GN=CLASP1 PE=1 SV=1,cell differentiation;cell growth;conjugation;metabolic process,cytosol;endoplasmic reticulum;extracellular;nucleus,motor activity;structural molecule activity,23332,CLASP1,Microtubule cytoskeleton regulation; Splicing factor NOVA regulated synaptic proteins; 7q11.23 copy number variation syndrome,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Role of ABL in ROBO-SLIT signaling,ENSG00000074054
Q96JY6,0,6,918825.0208333333,3.556722046805195e-6,1.9408204237143614,0.9566666374735704,0.8909845889514496,1,raw,177943.96875,2107055.09375,302721.625,587528.3125,1861648.78125,476052.34375,PDZ and LIM domain protein 2 OS=Homo sapiens OX=9606 GN=PDLIM2 PE=1 SV=1,cell growth;defense response;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,64236,PDLIM2,NA,NA,ENSG00000120913
Q7Z4S6,0,6,2358853.7395833335,9.130995467619896e-6,1.9405090191716872,0.956435138551873,0.0041385859240664616,0.6429522395902524,raw,1316372.5625,1831481.21875,1671436.921875,3243438.421875,2734489.71875,3355903.59375,Kinesin-like protein KIF21A OS=Homo sapiens OX=9606 GN=KIF21A PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,55605,KIF21A,NA,COPI-dependent Golgi-to-ER retrograde traffic; Kinesins,ENSG00000139116
P48444,0,6,106729525.85416667,4.1314423208272327e-4,1.9387195053495643,0.9551040888941419,0.04116209299846313,0.6429522395902524,raw,75475427.625,78971789.3125,71148354.1875,153104148.3125,110810762.3125,150866673.375,Coatomer subunit delta OS=Homo sapiens OX=9606 GN=ARCN1 PE=1 SV=1,conjugation;defense response;metabolic process,cytoskeleton;cytosol;extracellular,NA,372,ARCN1,miR-517 relationship with ARCN1 and USP1,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000095139
Q52LW3,0,6,22623705.260416668,8.757514157283978e-5,1.937117747395137,0.9539116505958223,0.00463803711979686,0.6429522395902524,raw,14945088.375,19104729.3125,13672180.375,29228262.25,26484623.25,32307348,Rho GTPase-activating protein 29 OS=Homo sapiens OX=9606 GN=ARHGAP29 PE=1 SV=2,development;metabolic process,cytosol;nucleus,DNA binding;structural molecule activity,9411,ARHGAP29,Hypothetical craniofacial development pathway,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle,ENSG00000137962
E9PKE1,0.6666666666666666,6,556277.478125,2.1533200835061597e-6,1.9359144670865227,0.9530152126145424,0.2510732890855015,0.7326612824296702,raw,521988.21875,NA,204560.609375,691677.125,423964.0625,939197.375,FPGT-TNNI3K readthrough (Fragment) OS=Homo sapiens OX=9606 GN=FPGT-TNNI3K PE=4 SV=1,NA,NA,NA,NA,FPGT-TNNI3K,NA,NA,ENSG00000259030
Q13485,0,6,5296013.546875,2.0500582499664054e-5,1.9328990546236662,0.95076629497459475,0.06657889351718345,0.6429522395902524,raw,4104502.59375,3277039.40625,3574274.34375,8603878.1875,5307675.25,6908711.5,Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1,cell differentiation;cell growth;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,4089,SMAD4,Androgen receptor signaling pathway; Bone morphogenic protein signaling and regulation; Heart development; Cell cycle; Endoderm differentiation; Mesodermal commitment pathway; Ectoderm differentiation; Extracellular vesicle-mediated signaling in recipient cells; Mesodermal commitment pathway; Hepatitis C and hepatocellular carcinoma; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Canonical and non-canonical TGF-B signaling; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; Pancreatic adenocarcinoma pathway; Vitamin D in inflammatory diseases; Envelope proteins and their potential roles in EDMD physiopathology; Hepatitis B infection; Head and neck squamous cell carcinoma; Osteoblast differentiation and related diseases; TGF-beta receptor signaling in skeletal dysplasias; Regucalcin in proximal tubule epithelial kidney cells; Angiotensin II receptor type 1 pathway; Neuroinflammation and glutamatergic signaling; Progeria-associated lipodystrophy; Clock-controlled autophagy in bone metabolism; TGF-beta receptor signaling; DNA damage response (only ATM dependent),"Ub-specific processing proteases; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Signaling by BMP; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Signaling by NODAL; FOXO-mediated transcription of cell cycle genes; Downregulation of SMAD2/3:SMAD4 transcriptional activity; Germ layer formation at gastrulation; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; Transcriptional regulation of pluripotent stem cells; RUNX3 regulates BCL2L11 (BIM) transcription; RUNX2 regulates bone development; Signaling by Activin; TGF-beta receptor signaling activates SMADs; RUNX3 regulates CDKN1A transcription; SMAD4 MH2 Domain Mutants in Cancer; SMAD2/3 MH2 Domain Mutants in Cancer",ENSG00000141646
O00625,0,6,13585100.526041666,5.258719065488072e-5,1.931823402334649,0.9499632162125671,0.0606283869677058,0.6429522395902524,raw,10901454.28125,8972806.0625,7949024.375,19616588.4375,13011045.5,21059684.5,Pirin OS=Homo sapiens OX=9606 GN=PIR PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,8544,PIR,NA,Digestion,ENSG00000087842
P36405,0,6,25795795.536458332,9.985413176514134e-5,1.9301226493906762,0.9486925262734505,0.06890584157181334,0.6429522395902524,raw,21350401.625,17940339.125,13403525.375,36902915,23968698.34375,41208893.75,ADP-ribosylation factor-like protein 3 OS=Homo sapiens OX=9606 GN=ARL3 PE=1 SV=2,cell differentiation;cell growth;conjugation;defense response;development;metabolic process,cytoskeleton;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity;structural molecule activity,403,ARL3,Genes related to primary cilium development (based on CRISPR); Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome,Trafficking of myristoylated proteins to the cilium,ENSG00000138175
P17275,0,6,1276892.703125,4.942782712306183e-6,1.9255436404568185,0.945265820697697,0.028430242500275104,0.6429522395902524,raw,1012097.96875,988216.6875,733814.5,1412991.84375,1552680.03125,1961555.1875,Transcription factor jun-B OS=Homo sapiens OX=9606 GN=JUNB PE=1 SV=1,cell differentiation;cellular component movement;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,3726,JUNB,Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Aryl hydrocarbon receptor pathway; Vitamin D receptor pathway; Nuclear receptors meta-pathway; Kit receptor signaling pathway; IL6 signaling pathway; TGF-beta signaling pathway; Oxidative stress response; Host-pathogen interaction of human coronaviruses - MAPK signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies,NGF-stimulated transcription; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Interleukin-4 and Interleukin-13 signaling; Nuclear events stimulated by ALK signaling in cancer,ENSG00000171223
Q9BW61,0,6,2788284.3567708335,1.0793298201103025e-5,1.9253038240463203,0.9450861293701199,0.053097760885377696,0.6429522395902524,raw,2697043.375,2028960.125,1145982.375,3906364.6875,2806190.265625,4145165.3125,DET1- and DDB1-associated protein 1 OS=Homo sapiens OX=9606 GN=DDA1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,NA,79016,DDA1,NA,Neddylation,ENSG00000130311
A7E2V4,0,6,47981.13203125,1.8573237151448147e-7,1.9243451820974533,0.9443676077532145,0.34073352358522213,0.8242917664336578,raw,27550.30859375,41468.91796875,35352.48046875,87895.9140625,47638.0390625,NA,Zinc finger SWIM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=ZSWIM8 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,23053,ZSWIM8,NA,Regulation of expression of SLITs and ROBOs,ENSG00000214655
Q5JRX3,0,6,9139951.296875,3.5380257989532654e-5,1.922365409523343,0.9428825943845643,0.1205845718929971,0.6445597830897484,raw,7654382.8125,5676198.0625,6063174.8125,13092657.71875,7638773.625,14714520.75,"Presequence protease, mitochondrial OS=Homo sapiens OX=9606 GN=PITRM1 PE=1 SV=3",cell growth;cell organization and biogenesis;cellular homeostasis;conjugation,endosome,DNA binding;structural molecule activity,10531,PITRM1,NA,Mitochondrial protein import,ENSG00000107959
Q9NWU1,0,6,4990433.013020833,1.9317696751899067e-5,1.9222676369672984,0.9428092162597523,0.0974090881327625,0.6429522395902524,raw,3574125.125,4499808.125,2397652.578125,5920787.34375,4900389.375,8649835.53125,"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial OS=Homo sapiens OX=9606 GN=OXSM PE=1 SV=1",cellular homeostasis,cytosol;endosome,structural molecule activity,54995,OXSM,Mitochondrial fatty acid synthesis pathway,NA,ENSG00000151093
Q9BTU6,0,6,2520332.6809895835,9.756071731295733e-6,1.9216531944754498,0.9423479928463041,0.0321591122074568,0.6429522395902524,raw,1694560.1875,1516874.625,1782520.0546875,3170867.3125,2914906.96875,4042266.9375,Phosphatidylinositol 4-kinase type 2-alpha OS=Homo sapiens OX=9606 GN=PI4K2A PE=1 SV=1,cell growth;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,signal transducer activity;structural molecule activity,55361,PI4K2A,Thymic stromal lymphopoietin (TSLP) signaling pathway; Wnt signaling pathway,Synthesis of PIPs at the plasma membrane; Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the early endosome membrane,ENSG00000155252
Q13907,0,6,11624687.28125,4.4998536830156234e-5,1.9203632740556373,0.9413792505840202,0.04750706826747389,0.6429522395902524,raw,9286706.5625,7255256.9375,8040183.3125,15440072.75,11849564.9375,17876339.1875,Isopentenyl-diphosphate Delta-isomerase 1 OS=Homo sapiens OX=9606 GN=IDI1 PE=1 SV=2,cellular homeostasis,cytosol;mitochondrion;nucleus,structural molecule activity,3422,IDI1,Target of rapamycin signaling; Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Exercise-induced circadian regulation; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,ENSG00000067064
Q9UMR2,0,6,1538482.3854166667,5.955382248809559e-6,1.9192305295996193,0.9405280121769017,0.09276396880765884,0.6429522395902524,raw,763823.375,981838.5625,1311109.5625,2341194.875,1316606.4375,2516321.5,ATP-dependent RNA helicase DDX19B OS=Homo sapiens OX=9606 GN=DDX19B PE=1 SV=1,cellular homeostasis;conjugation,membrane;nucleus,RNA binding;structural molecule activity,11269,DDX19B,NA,NA,ENSG00000157349
Q68CR1,0.3333333333333333,6,213353.671875,8.258805445202398e-7,1.9189098795136328,0.9402869577908292,1,1,raw,132303.609375,NA,NA,293913.71875,213843.6875,NA,Protein sel-1 homolog 3 OS=Homo sapiens OX=9606 GN=SEL1L3 PE=1 SV=2,NA,cytoskeleton;membrane,NA,23231,SEL1L3,NA,NA,ENSG00000091490
P30154,0,6,4619919.049479167,1.7883457203674075e-5,1.9160961577526086,0.9381699633871614,0.0687249872889331,0.6429522395902524,raw,2885644.78125,4313982.625,2198423.234375,7208507.25,4212390.3125,6900566.09375,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens OX=9606 GN=PPP2R1B PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;nucleus,DNA binding,5519,PPP2R1B,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Netrin-UNC5B signaling pathway; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome,"Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Regulation of TP53 Degradation; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Cyclin D associated events in G1; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Cyclin A/B1/B2 associated events during G2/M transition; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; MASTL Facilitates Mitotic Progression; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling; Inhibition of replication initiation of damaged DNA by RB1/E2F1; DARPP-32 events; PP2A-mediated dephosphorylation of key metabolic factors; ERKs are inactivated",ENSG00000137713
Q86SQ0,0,6,807479.9166666666,3.1257111602772807e-6,1.9158225821563275,0.9379639641562159,0.1505245081811705,0.6638855679885327,raw,335539.8125,720178.890625,615521.515625,642834.75,1443965.78125,1086838.75,Pleckstrin homology-like domain family B member 2 OS=Homo sapiens OX=9606 GN=PHLDB2 PE=1 SV=2,cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,NA,90102,PHLDB2,Microtubule cytoskeleton regulation,NA,ENSG00000144824
P23743,0,6,5412994.5390625,2.0953409604429954e-5,1.915398962494064,0.9376449254468441,0.028303204766274064,0.6429522395902524,raw,4607074.8125,2371123.390625,4055175.59375,8062609.875,5614704.4375,7767279.125,Diacylglycerol kinase alpha OS=Homo sapiens OX=9606 GN=DGKA PE=1 SV=3,cellular homeostasis;coagulation;development,cytoplasm;cytoskeleton;cytosol,signal transducer activity;structural molecule activity,1606,DGKA,Modulators of TCR signaling and T cell activation,Effects of PIP2 hydrolysis,ENSG00000065357
Q6NUQ4,0,6,9588833.5703125,3.711785703413333e-5,1.9144008404805422,0.9368929353764524,0.19813280315680293,0.6875760999904456,raw,7885981.9375,6794267.9375,6513195.9375,16247914.03125,7084689.328125,13006952.25,Transmembrane protein 214 OS=Homo sapiens OX=9606 GN=TMEM214 PE=1 SV=2,metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular,NA,54867,TMEM214,NA,NA,ENSG00000119777
P40855,0,6,4328403.083333333,1.6755014638139413e-5,1.9105770385532166,0.9340084314184747,0.16513072578499885,0.6645734571666667,raw,2263732.15625,2931944.375,2872717.5,5488548.09375,3568323.375,8845153,Peroxisomal biogenesis factor 19 OS=Homo sapiens OX=9606 GN=PEX19 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,5824,PEX19,NA,Class I peroxisomal membrane protein import; ABC transporters in lipid homeostasis,ENSG00000162735
Q6ZXV5,0,6,3566341.6666666665,1.380511603914427e-5,1.9105170842366737,0.9339631586288579,0.05046100741475693,0.6429522395902524,raw,2307636.28125,3040806.5,1807347.265625,5655294.90625,3452967.828125,5133997.21875,Protein O-mannosyl-transferase TMTC3 OS=Homo sapiens OX=9606 GN=TMTC3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;extracellular,structural molecule activity,160418,TMTC3,NA,NA,ENSG00000139324
Q9H3Q1,0,6,3365984.1666666665,1.3029542974267934e-5,1.9101512166461985,0.9336868533762445,0.11413490585261124,0.6429522395902524,raw,2440410.0625,2143592.84375,2473089.59375,2943318.1875,4661552.25,5533942.0625,Cdc42 effector protein 4 OS=Homo sapiens OX=9606 GN=CDC42EP4 PE=1 SV=1,cell growth;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,23580,CDC42EP4,NA,CDC42 GTPase cycle; RHOQ GTPase cycle; RAC1 GTPase cycle; RAC2 GTPase cycle,ENSG00000179604
Q9H2G2,0,6,10944897.846354166,4.236710863059937e-5,1.9094426613892233,0.9331515979539138,0.0771613268232689,0.6429522395902524,raw,6111545,11790354.65625,7131378.109375,14368681.0625,11669644.75,14597783.5,STE20-like serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=SLK PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,signal transducer activity;structural molecule activity,9748,SLK,NA,RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle,ENSG00000065613
Q9Y376,0,6,19851934.734375,7.684576751888108e-5,1.9069345171121097,0.9312553032942693,0.006194248128263054,0.6429522395902524,raw,16904039.09375,13730479.3125,11532776.25,26183124.9375,22737702.3125,28023486.5,Calcium-binding protein 39 OS=Homo sapiens OX=9606 GN=CAB39 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cell surface;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,51719,CAB39,AMP-activated protein kinase signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Endochondral ossification; Endochondral ossification with skeletal dysplasias,Neutrophil degranulation; Energy dependent regulation of mTOR by LKB1-AMPK,ENSG00000135932
Q8N442,0,6,238517.98828125,9.232902546669186e-7,1.9055954777273525,0.9302418945803742,0.3876988483658229,0.872979446768193,raw,172641.875,151873.421875,NA,207786.625,NA,421770.03125,"Translation factor GUF1, mitochondrial OS=Homo sapiens OX=9606 GN=GUF1 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome,protein binding;structural molecule activity,60558,GUF1,NA,NA,ENSG00000151806
Q9BRS8,0.5,6,180677.89375,6.993943716161788e-7,1.9051458325711412,0.9299014354480353,0.03422484214691682,0.6429522395902524,raw,136713.65625,NA,101715.8125,192808.203125,210381.53125,261770.265625,La-related protein 6 OS=Homo sapiens OX=9606 GN=LARP6 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,motor activity;RNA binding,55323,LARP6,NA,NA,ENSG00000166173
Q969S9,0,6,1258237.6171875,4.8705698818602135e-6,1.9045845787410725,0.9294763564866612,0.399007976028716,0.8828783020957324,raw,2014573.9375,284681.28125,334868.71875,1904961.0625,542199.578125,2468141.125,"Ribosome-releasing factor 2, mitochondrial OS=Homo sapiens OX=9606 GN=GFM2 PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis,endosome,structural molecule activity,84340,GFM2,NA,Mitochondrial translation termination,ENSG00000164347
Q15436,0,6,23136226.682291668,8.955908432506204e-5,1.9042830140914164,0.9292479075763898,0.08715100206641603,0.6429522395902524,raw,20106283.25,15703945.96875,12933716,38434869.4375,21733787.875,29904757.5625,Protein transport protein Sec23A OS=Homo sapiens OX=9606 GN=SEC23A PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,DNA binding;structural molecule activity,10484,SEC23A,Sterol regulatory element-binding proteins (SREBP) signaling,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC; MHC class II antigen presentation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; COPII-mediated vesicle transport; Cargo concentration in the ER; Regulation of cholesterol biosynthesis by SREBP (SREBF)",ENSG00000100934
A0A0G2JH50,0,6,5099493.973958333,1.9739865843311442e-05,1.9032244018481412,0.9284456742483299,0.010132397271184096,0.6429522395902524,raw,4481672,2746345.28125,3496567.125,7301836.75,5915790.8125,6654751.875,"HLA class I histocompatibility antigen, C alpha chain OS=Homo sapiens OX=9606 GN=HLA-C PE=1 SV=1",metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,NA,NA,HLA-C,NA,NA,ENSG00000206435; ENSG00000206452
Q8IXB1,0,6,658916.484375,2.550630135054886e-6,1.9024844619707364,0.9278846709538907,0.06725204542284001,0.6429522395902524,raw,550775.6875,370659.75,355362.15625,1025977.375,1047842.1875,602881.75,DnaJ homolog subfamily C member 10 OS=Homo sapiens OX=9606 GN=DNAJC10 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,extracellular,structural molecule activity,54431,DNAJC10,NA,NA,ENSG00000077232
Q8NI22,0,6,13376437.895833334,5.177946887937527e-5,1.901764987917419,0.9273389750552291,0.5412068096483793,1,raw,22211295.875,5418918.125,3772476.25,13000137.375,7174363.25,28681436.5,Multiple coagulation factor deficiency protein 2 OS=Homo sapiens OX=9606 GN=MCFD2 PE=1 SV=1,conjugation,cytoskeleton;extracellular,structural molecule activity,90411,MCFD2,NA,COPII-mediated vesicle transport; Cargo concentration in the ER; Transport to the Golgi and subsequent modification,ENSG00000180398
O75962,0.3333333333333333,6,159974.708984375,6.192534611866873e-7,1.900945100484703,0.9267168673877514,1,1,raw,NA,105975.0078125,NA,201452.671875,96984.453125,235486.703125,Triple functional domain protein OS=Homo sapiens OX=9606 GN=TRIO PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoskeleton;cytosol;nucleus,DNA binding;signal transducer activity;structural molecule activity,7204,TRIO,Microtubule cytoskeleton regulation; Neural crest cell migration during development; Neural crest cell migration in cancer,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOG GTPase cycle; G alpha (q) signalling events; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; DCC mediated attractive signaling,ENSG00000038382
Q01459,0.16666666666666666,6,782620.0296223959,3.029479879754193e-6,1.9007321683864487,0.9265552565718967,0.13310455500405058,0.6514609890946903,raw,896191.8828125,502584.609375,383599.138671875,955278.734375,766111.6875,1191954.125,Di-N-acetylchitobiase OS=Homo sapiens OX=9606 GN=CTBS PE=1 SV=1,cellular homeostasis,mitochondrion,structural molecule activity,1486,CTBS,NA,NA,ENSG00000117151
Q8WUW1,0,6,3156857.1770833335,1.2220023688693361e-5,1.9005634746442284,0.9264272088490441,0.0753769771188791,0.6429522395902524,raw,1682300.375,1634902.6875,2873432.3125,4345828.5625,2943538.625,5461140.5,Protein BRICK1 OS=Homo sapiens OX=9606 GN=BRK1 PE=1 SV=1,cell differentiation;cell growth;defense response;development;metabolic process,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,55845,BRK1,Regulation of actin cytoskeleton,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RAC2 GTPase cycle; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway,ENSG00000254999
P00395,0,6,15677753.380208334,6.0687736867666646e-5,1.9001013679976466,0.9260763865596432,0.14438720628991242,0.6572502130392559,raw,17622911.625,6036422,11401774,21664526.375,14101661.78125,23239224.5,Cytochrome c oxidase subunit 1 OS=Homo sapiens OX=9606 GN=MT-CO1 PE=1 SV=1,cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,4512,MT-CO1,Electron transport chain: OXPHOS system in mitochondria; Effects of nitric oxide; Quercetin and Nf-kB / AP-1 induced apoptosis; Nonalcoholic fatty liver disease; Neuroinflammation; Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000198804
O95486,0,6,3805867.5364583335,1.473230774872087e-5,1.8991572443986675,0.9253593611600945,0.05369544930795887,0.6429522395902524,raw,2462301.9375,2897618.625,2253653.625,6377290.5625,4168041.90625,4676298.5625,Protein transport protein Sec24A OS=Homo sapiens OX=9606 GN=SEC24A PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular,structural molecule activity,10802,SEC24A,Sterol regulatory element-binding proteins (SREBP) signaling,"MHC class II antigen presentation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; COPII-mediated vesicle transport; Cargo concentration in the ER; Regulation of cholesterol biosynthesis by SREBP (SREBF); Antigen Presentation: Folding, assembly and peptide loading of class I MHC",ENSG00000113615
A0A0J9YWL0,0,6,476774.8932291667,1.845569869846813e-6,1.8990875652079178,0.925306428382984,0.1317295839867216,0.6514609890946903,raw,525158.65625,250266.171875,256199.3125,819656.40625,534091.4375,475277.375,Beta/gamma crystallin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CRYBG1 PE=1 SV=1,NA,NA,structural molecule activity,NA,CRYBG1,NA,NA,ENSG00000112297
Q6ZRP7,0,6,2618421.22265625,1.0135767180129278e-5,1.898910401846205,0.9251718349967987,0.05904777311791896,0.6429522395902524,raw,2443369.1875,1581459.5234375,1375768.09375,3381218.3125,2612460.34375,4316251.875,Sulfhydryl oxidase 2 OS=Homo sapiens OX=9606 GN=QSOX2 PE=1 SV=3,metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;membrane,structural molecule activity,169714,QSOX2,NA,NA,ENSG00000165661
A0A0A0MTI1,0,6,15131232.888020834,5.857218554992918e-5,1.8983020283668826,0.9247095498730308,0.03173730117563141,0.6429522395902524,raw,11127113.9375,11277061.515625,8489642.34375,20206745.4375,16115905.28125,23570928.8125,Delta(24)-sterol reductase OS=Homo sapiens OX=9606 GN=DHCR24 PE=1 SV=1,NA,cytoskeleton,structural molecule activity,NA,DHCR24,Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders,NA,ENSG00000116133
Q01831,0,6,5161084.854166667,1.9978280815207223e-5,1.8972800408106287,0.9239326379854643,0.055697793892187604,0.6429522395902524,raw,4429973.40625,3287744.96875,3134141.1875,6301625.75,5408123.6875,8404900.125,DNA repair protein complementing XP-C cells OS=Homo sapiens OX=9606 GN=XPC PE=1 SV=4,cell differentiation;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,7508,XPC,"Male infertility; Nucleotide excision repair; DNA repair pathways, full network; p53 transcriptional gene network; Nucleotide excision repair in xeroderma pigmentosum",SUMOylation of DNA damage response and repair proteins; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER,ENSG00000154767
P05161,0,6,74485612.17057292,2.883297831142901e-4,1.8952933851207225,0.9224211900834479,0.06794811268510642,0.6429522395902524,raw,58114252.65625,52756218.1875,51098305.4765625,110143558.640625,72043343.5625,102757994.5,Ubiquitin-like protein ISG15 OS=Homo sapiens OX=9606 GN=ISG15 PE=1 SV=5,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cell surface;cytosol;Golgi;membrane;nucleus,antioxidant activity;structural molecule activity,9636,ISG15,"Novel intracellular components of RIG-I-like receptor pathway; Non-genomic actions of 1,25 dihydroxyvitamin D3; Cytosolic DNA-sensing pathway; p53 transcriptional gene network; Extrafollicular B cell activation by SARS-CoV-2; Type II interferon signaling",SARS-CoV-2 activates/modulates innate and adaptive immune responses; Interferon alpha/beta signaling; ISG15 antiviral mechanism; NS1 Mediated Effects on Host Pathways; Termination of translesion DNA synthesis; Negative regulators of DDX58/IFIH1 signaling,ENSG00000187608
P13674,0,6,27763748.772135418,1.0747197248748705e-4,1.8923221527664704,0.9201577169198077,0.12939630193835078,0.6498046150645307,raw,18491274.15625,24004143.75,18257410.1328125,34991447.71875,24556034.5625,46282182.3125,Prolyl 4-hydroxylase subunit alpha-1 OS=Homo sapiens OX=9606 GN=P4HA1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis,endosome;extracellular;nucleus,structural molecule activity,5033,P4HA1,Type I collagen synthesis in the context of osteogenesis imperfecta,Collagen biosynthesis and modifying enzymes,ENSG00000122884
Q9NX47,0,6,5966709.067708333,2.3096808648880022e-5,1.8873746859339555,0.9163808584862644,0.07719214674518766,0.6429522395902524,raw,4445582.5625,4302041,3344064.28125,9902255.03125,5686748.25,8119563.28125,E3 ubiquitin-protein ligase MARCHF5 OS=Homo sapiens OX=9606 GN=MARCHF5 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome;extracellular,structural molecule activity,54708,MARCHF5,NA,NA,ENSG00000198060
O95396,0,6,354625.7078125,1.3727369681298716e-6,1.8862501346199418,0.9155210037157839,0.5107206058461831,0.9944212432021446,raw,423780.65625,211469.171875,122846.5390625,238268.515625,NA,776763.65625,Adenylyltransferase and sulfurtransferase MOCS3 OS=Homo sapiens OX=9606 GN=MOCS3 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;nucleus,structural molecule activity,27304,MOCS3,NA,Molybdenum cofactor biosynthesis,ENSG00000124217
O15116,0,6,1303229.7239583333,5.044731897973903e-6,1.88403797186047,0.9138280420540611,0.3569448339681715,0.8406066251623018,raw,1845437.125,475427.71875,731678,1854166.25,895723.875,2016945.375,U6 snRNA-associated Sm-like protein LSm1 OS=Homo sapiens OX=9606 GN=LSM1 PE=1 SV=1,cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding,27257,LSM1,NA,mRNA decay by 5' to 3' exoribonuclease,ENSG00000175324
O15121,0,6,430560.7578125,1.6666774468243945e-6,1.883331537911038,0.9132869914537083,0.4341055217972583,0.9176747809749992,raw,321949.5,263568.09375,NA,NA,342882.4375,793843,Sphingolipid delta(4)-desaturase DES1 OS=Homo sapiens OX=9606 GN=DEGS1 PE=1 SV=1,cell growth;cellular homeostasis;defense response,cytoplasm;cytoskeleton;endosome;extracellular,structural molecule activity,8560,DEGS1,Sphingolipid metabolism overview; Sphingolipid metabolism: integrated pathway; Sphingolipid metabolism in senescence,Neutrophil degranulation; Sphingolipid de novo biosynthesis,ENSG00000143753
Q96CT7,0,6,21100636.458333332,8.16794244729094e-5,1.8825248284064657,0.9126688925639597,0.060241033519103,0.6429522395902524,raw,12132655.1875,21812560.4375,14320542.5,23781470.1875,26958776.8125,27597813.625,Coiled-coil domain-containing protein 124 OS=Homo sapiens OX=9606 GN=CCDC124 PE=1 SV=1,cell differentiation;cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,115098,CCDC124,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000007080
F5H0E2,0.5,6,1185314.859375,4.588289823585004e-6,1.8806872781572865,0.9112599765807516,1,1,raw,1419938.5,715542.6875,904568.25,1701210,NA,NA,4F2 cell-surface antigen heavy chain (Fragment) OS=Homo sapiens OX=9606 GN=SLC3A2 PE=1 SV=1,cellular homeostasis;conjugation,cytoskeleton,NA,NA,SLC3A2,"mRNA, protein, and metabolite inducation pathway by cyclosporin A; Ferroptosis; Proximal tubule transport; Malignant pleural mesothelioma",NA,ENSG00000168003
D4PHA4,0,6,380521.125,1.4729767299274622e-6,1.8794156737596954,0.9102841855177013,1,1,raw,NA,264304.40625,NA,NA,NA,496737.84375,"GC-rich promoter binding protein 1, isoform CRA_c OS=Homo sapiens OX=9606 GN=GPBP1 PE=1 SV=1",cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding,65056,GPBP1,NA,NA,ENSG00000062194
Q92597,0,6,40409289.25,1.564221769242324e-4,1.8784710805700866,0.9095589055781517,0.058143912613376404,0.6429522395902524,raw,34050552.1875,26899483.1875,24033661,50529901.25,41454860.5,65487277.375,Protein NDRG1 OS=Homo sapiens OX=9606 GN=NDRG1 PE=1 SV=1,cell growth;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,motor activity;structural molecule activity,10397,NDRG1,VEGFA-VEGFR2 signaling pathway; Hippo-Yap signaling pathway; Leukocyte-intrinsic Hippo pathway functions; Intracellular trafficking proteins involved in CMT neuropathy; Malignant pleural mesothelioma,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,ENSG00000104419
Q6ZRS2,0,6,402874.7083333333,1.5595062441048795e-6,1.8774023329479075,0.9087378571740463,0.9566229820577855,1,raw,167644.65625,815711.625,205481.875,394552.875,314736.46875,519120.75,Helicase SRCAP OS=Homo sapiens OX=9606 GN=SRCAP PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,extracellular;membrane;nucleus,RNA binding;structural molecule activity,10847,SRCAP,Pathways affected in adenoid cystic carcinoma,NA,ENSG00000080603
Q9BUL8,0,6,10429404.5078125,4.0371661749419005e-5,1.8764722902924746,0.9080229862265965,0.09691732008425877,0.6429522395902524,raw,6928455.046875,6534048.125,6130698.75,19567214.75,11155050.125,12260960.25,Programmed cell death protein 10 OS=Homo sapiens OX=9606 GN=PDCD10 PE=1 SV=1,cell growth;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,11235,PDCD10,NA,NA,ENSG00000114209
P30043,0,6,66425489.93554688,2.57129485121467e-4,1.8745878662848923,0.9065734496764497,0.03759116564096967,0.6429522395902524,raw,50460012.015625,49793390.84375,41494148.3125,95321761.84375,68141540.3007813,93342086.296875,Flavin reductase (NADPH) OS=Homo sapiens OX=9606 GN=BLVRB PE=1 SV=3,cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,645,BLVRB,Nuclear receptors meta-pathway; NRF2 pathway; IL-10 anti-inflammatory signaling pathway,Cytoprotection by HMOX1; Heme degradation,ENSG00000090013
Q9Y421,0,6,374394.35546875,1.4492603358661342e-6,1.8726824975095961,0.9051063197107867,1,1,raw,212989.421875,NA,NA,506452.875,398861.5625,379273.5625,Protein FAM32A OS=Homo sapiens OX=9606 GN=FAM32A PE=1 SV=2,cell differentiation;metabolic process,membrane,NA,26017,FAM32A,NA,NA,ENSG00000105058
Q96S44,0,6,1732762.9010416667,6.70743163527643e-6,1.871368596488452,0.904093748825589,0.05216490512468337,0.6429522395902524,raw,1758353.625,1155830.09375,948015,2259437.4375,1774085.5,2500855.75,EKC/KEOPS complex subunit TP53RK OS=Homo sapiens OX=9606 GN=TP53RK PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,signal transducer activity;structural molecule activity,112858,TP53RK,NA,Regulation of TP53 Activity through Phosphorylation; tRNA modification in the nucleus and cytosol,ENSG00000172315
P46734,0,6,6549483.966145833,2.5352698815777533e-5,1.871144027460891,0.9039206113346343,0.08404760664337843,0.6429522395902524,raw,5206922.875,4232091.375,4215373.234375,11052949.625,6670714.1875,7918852.5,Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens OX=9606 GN=MAP2K3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane,signal transducer activity;structural molecule activity,5606,MAP2K3,"Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Endoderm differentiation; TGF-beta signaling pathway; MAPK signaling pathway; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; MAPK cascade; Epithelial to mesenchymal transition in colorectal cancer; Thermogenesis; Vitamin D in inflammatory diseases; Signal transduction through IL1R; Translation inhibitors in chronically activated PDGFRA cells; Hepatitis B infection; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; 16p11.2 proximal deletion syndrome; Malignant pleural mesothelioma; Interferon type I signaling pathways; Serotonin HTR1 group and FOS pathway; Toll-like receptor signaling pathway",Oxidative Stress Induced Senescence; activated TAK1 mediates p38 MAPK activation,ENSG00000034152
Q9Y5B8,0,6,2015143.8515625,7.800513048540898e-6,1.8704611298602183,0.9033939854874695,0.09750765857661195,0.6429522395902524,raw,1357318.125,1910845.609375,847281.5625,2434735,1966520.375,3574162.4375,Nucleoside diphosphate kinase 7 OS=Homo sapiens OX=9606 GN=NME7 PE=1 SV=1,cellular homeostasis,cytosol;endoplasmic reticulum,signal transducer activity;structural molecule activity,29922,NME7,Pyrimidine metabolism; Ciliopathies,Recruitment of NuMA to mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes,ENSG00000143156
H0YJ75,0,6,538148.1692708334,2.0831425077622235e-6,1.870394247494906,0.9033423978974475,0.10359551535352088,0.6429522395902524,raw,370401.0625,290478.4375,446561.96875,832479.34375,453721.265625,835246.9375,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (Fragment) OS=Homo sapiens OX=9606 GN=PPP2R5C PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
O75554,0,6,586551.55625,2.2705094053818664e-6,1.86753944495349,0.9011387150026287,0.060902152438695595,0.6429522395902524,raw,367063.1875,NA,406722.46875,875995.5,562337.0625,720639.5625,WW domain-binding protein 4 OS=Homo sapiens OX=9606 GN=WBP4 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,11193,WBP4,NA,mRNA Splicing - Major Pathway,ENSG00000120688
Q96PU5,0,6,614490.4947916666,2.3786595280084313e-6,1.867319384506194,0.900968705837156,0.023181521771400797,0.6429522395902524,raw,374945.59375,508284.96875,373238.65625,815533,665810.375,949130.375,E3 ubiquitin-protein ligase NEDD4-like OS=Homo sapiens OX=9606 GN=NEDD4L PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,23327,NEDD4L,TGF-beta signaling pathway,Budding and maturation of HIV virion; Antigen processing: Ubiquitination & Proteasome degradation; Stimuli-sensing channels; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity,ENSG00000049759
Q9BQI0,0,6,683804.9140625,2.6469719026088513e-6,1.8672325548362034,0.9009016194844398,1,1,raw,NA,NA,397546.15625,742311.125,732189.9375,863172.4375,Allograft inflammatory factor 1-like OS=Homo sapiens OX=9606 GN=AIF1L PE=1 SV=1,cell growth,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,83543,AIF1L,NA,NA,ENSG00000126878
Q9NRP0,0,6,8308994.046875,3.2163667339501025e-5,1.8669626505542651,0.9006930660755644,0.11569776800637241,0.6429522395902524,raw,7263514.75,5464277.375,5555031.34375,10517707.5,7492722.5625,13560710.75,Oligosaccharyltransferase complex subunit OSTC OS=Homo sapiens OX=9606 GN=OSTC PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,NA,58505,OSTC,NA,NA,ENSG00000198856
Q9H0J9,0,6,278990.4625,1.0799570171937241e-6,1.8668843755227589,0.9006325777914932,0.0899834513372851,0.6429522395902524,raw,225812.421875,148300.609375,NA,318963.125,431617.5625,270258.59375,Protein mono-ADP-ribosyltransferase PARP12 OS=Homo sapiens OX=9606 GN=PARP12 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,membrane,structural molecule activity,64761,PARP12,NA,NA,ENSG00000059378
Q8N0X4,0,6,4000950.6223958335,1.5487463841535367e-5,1.866486139546764,0.9003247952836861,0.15102831066159994,0.6638855679885327,raw,4287235.4375,1759569.421875,2885920.875,6146158.25,3284211.9375,5642607.8125,"Citramalyl-CoA lyase, mitochondrial OS=Homo sapiens OX=9606 GN=CLYBL PE=1 SV=2",cell growth;metabolic process,endosome,structural molecule activity,171425,CLYBL,NA,NA,ENSG00000125246
Q9HAN9,0,6,1145941.515625,4.435877735758907e-6,1.8658990965122,0.8998709707033318,0.19033540926081605,0.6816045476187055,raw,811102.5,NA,786226.21875,1708518.125,1277919.21875,NA,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 OS=Homo sapiens OX=9606 GN=NMNAT1 PE=1 SV=1,cellular homeostasis;coagulation;metabolic process,membrane,structural molecule activity,64802,NMNAT1,NAD biosynthesis II (from tryptophan); NAD+ metabolism; NAD+ biosynthetic pathways,Nicotinate metabolism,ENSG00000173614
P51649,0,6,9790165.09375,3.7897200491147135e-5,1.8654517309137517,0.8995250304992136,0.21096964942194216,0.7016553543929079,raw,10925544.5625,3857438.21875,7167203.40625,13370072,7342406.1875,16078326.1875,"Succinate-semialdehyde dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH5A1 PE=1 SV=2",cellular homeostasis;defense response,endosome,structural molecule activity,7915,ALDH5A1,Fragile X syndrome,Degradation of GABA,ENSG00000112294
Q9Y6W3,0.16666666666666666,6,265204.4635416667,1.026592159554272e-6,1.865153073533264,0.899294037646708,1,1,raw,NA,267750.1875,157677.984375,370185.21875,NA,NA,Calpain-7 OS=Homo sapiens OX=9606 GN=CAPN7 PE=1 SV=1,cell organization and biogenesis;metabolic process,cytosol;endoplasmic reticulum;membrane,structural molecule activity,23473,CAPN7,Integrin-mediated cell adhesion,Degradation of the extracellular matrix,ENSG00000131375
Q8WUH6,0,6,9238066.03125,3.576005482892597e-5,1.8641452169986286,0.8985142503802741,0.00915178181894346,0.6429522395902524,raw,6667275.84375,6925103.53125,5909207.125,12496131.6875,10521279.375,12909398.625,Transmembrane protein 263 OS=Homo sapiens OX=9606 GN=TMEM263 PE=1 SV=1,NA,cytoskeleton,NA,90488,TMEM263,NA,NA,ENSG00000151135
Q9H8M7,0,6,960445.4270833334,3.717832392246273e-6,1.8637462724481304,0.8982054670755991,0.013791830760409279,0.6429522395902524,raw,676361.3125,562082.1875,869401.6875,1119598.125,1260565.875,1274663.375,Ubiquitin carboxyl-terminal hydrolase MINDY-3 OS=Homo sapiens OX=9606 GN=MINDY3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;membrane,structural molecule activity,80013,MINDY3,NA,NA,ENSG00000148481
P13797,0,6,73608648.36979167,2.849351035901519e-4,1.8622260893821827,0.8970282384334088,0.04870070503828725,0.6429522395902524,raw,49565470.40625,63046743.5,38254027.75,112814317.125,71237648.5,106733682.9375,Plastin-3 OS=Homo sapiens OX=9606 GN=PLS3 PE=1 SV=4,cell growth;defense response,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,5358,PLS3,NA,NA,ENSG00000102024
Q9BYG5,0,6,1142435.3880208333,4.4223057051046465e-6,1.8617328524831702,0.8966460696482753,0.3329701056788297,0.8158667519449163,raw,914633.890625,681974.359375,736824.296875,2566434.65625,1371770,582975.125,Partitioning defective 6 homolog beta OS=Homo sapiens OX=9606 GN=PARD6B PE=1 SV=1,cell differentiation;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,84612,PARD6B,Complement system in neuronal development and plasticity,RHOV GTPase cycle; Tight junction interactions,ENSG00000124171
P36941,0,6,256901.6375,9.944523682299118e-7,1.8615636402333542,0.896514937639684,0.05399469879490277,0.6429522395902524,raw,186618.015625,161884.140625,NA,365584.78125,241203.40625,329217.84375,Tumor necrosis factor receptor superfamily member 3 OS=Homo sapiens OX=9606 GN=LTBR PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton;extracellular,structural molecule activity,4055,LTBR,NA,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,ENSG00000111321
P10589,0,6,475911.21875,1.8422266325691328e-6,1.858210359644617,0.8939138319882556,1,1,raw,302715.5,NA,NA,464046.15625,NA,660972,COUP transcription factor 1 OS=Homo sapiens OX=9606 GN=NR2F1 PE=1 SV=1,cellular component movement;defense response;development;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,7025,NR2F1,Nuclear receptors; Adipogenesis,Nuclear Receptor transcription pathway,ENSG00000175745
Q8NEN9,0,6,438047.39453125,1.6956578133471182e-6,1.858122233376035,0.8938454100548056,0.38452357157970185,0.8695425300008842,raw,341247.96875,260665.859375,NA,768942.625,381333.125,NA,PDZ domain-containing protein 8 OS=Homo sapiens OX=9606 GN=PDZD8 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endosome;extracellular;nucleus,structural molecule activity,118987,PDZD8,NA,NA,ENSG00000165650
O00151,0,6,23180473.21875,8.973036027875058e-5,1.8574967915197016,0.8933597187786155,0.03864411161411387,0.6429522395902524,raw,16425197.28125,16484997.65625,15785687.625,30509751.25,25026659.75,34850545.75,PDZ and LIM domain protein 1 OS=Homo sapiens OX=9606 GN=PDLIM1 PE=1 SV=4,cell growth;cellular component movement;coagulation;defense response;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,9124,PDLIM1,NA,NA,ENSG00000107438
B5ME97,0,6,14848521.15625,5.747782370030538e-5,1.8548048151964447,0.8912673771620475,0.02009776652892007,0.6429522395902524,raw,9510205.6875,12039737.25,9353822.5625,19612792.875,16243205.9375,22331362.625,"Septin 10, isoform CRA_c OS=Homo sapiens OX=9606 GN=SEPTIN10 PE=1 SV=2",NA,nucleus,structural molecule activity,151011,SEPTIN10,NA,NA,ENSG00000186522
P78560,0,6,145596.4453125,5.635959788184397e-7,1.8538163356553639,0.8904983179846873,1,1,raw,131433.546875,66449.0625,140849.515625,243653.65625,NA,NA,Death domain-containing protein CRADD OS=Homo sapiens OX=9606 GN=CRADD PE=1 SV=1,cell differentiation;coagulation;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,8738,CRADD,Apoptosis,TP53 Regulates Transcription of Caspase Activators and Caspases,ENSG00000169372
Q9H173,0,6,714229.65625,2.7647444369359005e-6,1.8531551564367743,0.8899836768594733,0.19667940472117626,0.6869174258949993,raw,573895.5,NA,424420.875,1096410.125,762192.125,NA,Nucleotide exchange factor SIL1 OS=Homo sapiens OX=9606 GN=SIL1 PE=1 SV=1,conjugation;metabolic process,extracellular,structural molecule activity,64374,SIL1,NA,NA,ENSG00000120725
Q8NFW8,0,6,11720037.203125,4.5367631229638723e-5,1.8529193718745633,0.889800105149579,0.045698937229940784,0.6429522395902524,raw,8356116.578125,8629198.125,7849972.359375,15483210.28125,12295687.6875,17706038.1875,N-acylneuraminate cytidylyltransferase OS=Homo sapiens OX=9606 GN=CMAS PE=1 SV=2,cellular homeostasis,membrane,structural molecule activity,55907,CMAS,NA,Sialic acid metabolism,ENSG00000111726
E7EQB3,0,6,490876.625,1.9001569121565302e-6,1.8518811294650501,0.8889914963113348,1,1,raw,359146.1875,463421.0625,400065.5,NA,NA,740873.75,tRNA-splicing endonuclease subunit Sen34 OS=Homo sapiens OX=9606 GN=TSEN34 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,79042,TSEN34,NA,NA,ENSG00000170892; ENSG00000273896; ENSG00000274078; ENSG00000274129; ENSG00000274672; ENSG00000274796; ENSG00000275165; ENSG00000278605; ENSG00000278622; ENSG00000278712
Q5SWX8,0,6,1196461.3385416667,4.631437242622833e-6,1.8513756184489198,0.8885976277301048,0.03007569745981767,0.6429522395902524,raw,365805.625,984021.3125,953197.40625,1775496.5625,1335520.6875,1764726.4375,Protein odr-4 homolog OS=Homo sapiens OX=9606 GN=ODR4 PE=1 SV=1,metabolic process,cytoskeleton,NA,54953,ODR4,NA,NA,ENSG00000157181
P32780,0.16666666666666666,6,277886.3880208333,1.0756832044956267e-6,1.8509755325760138,0.8882858248332572,0.1348433956031144,0.653345503642978,raw,225961.40625,123723.171875,218842,405071.1875,217879.4375,475841.125,General transcription factor IIH subunit 1 OS=Homo sapiens OX=9606 GN=GTF2H1 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane,structural molecule activity,2965,GTF2H1,"Eukaryotic transcription initiation; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Dual Incision in GG-NER,ENSG00000110768; ENSG00000288114
P61254,0.5,6,1349348.8645833333,5.223256601286701e-6,1.8464615261446284,0.8847632020947742,0.1896278462426245,0.6806579357154494,raw,787510.3125,1641731.75,752561.375,1468985.125,1389575.625,2055729,60S ribosomal protein L26 OS=Homo sapiens OX=9606 GN=RPL26 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6154,RPL26,VEGFA-VEGFR2 signaling pathway; Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000161970
O94888,0,6,5792854.046875,2.242382524994638e-5,1.8458641444768271,0.8842963745968467,0.012283318069042,0.6429522395902524,raw,3436907.5625,5189713.03125,4112643.1875,7823322.25,6344064.4375,7850473.8125,UBX domain-containing protein 7 OS=Homo sapiens OX=9606 GN=UBXN7 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytoskeleton;cytosol;extracellular;membrane,structural molecule activity,26043,UBXN7,3q29 copy number variation syndrome,Neddylation; KEAP1-NFE2L2 pathway,ENSG00000163960
O14681,0,6,1603616.28125,6.207512042896599e-6,1.8453905640163957,0.8839261849245366,0.0639391962944747,0.6429522395902524,raw,1562091.53125,338386.8125,1171229.25,2161375.40625,1831197.3125,2557417.375,Etoposide-induced protein 2.4 homolog OS=Homo sapiens OX=9606 GN=EI24 PE=1 SV=4,cellular homeostasis;metabolic process,cytoskeleton;cytosol;extracellular;membrane,structural molecule activity,9538,EI24,miRNA regulation of p53 pathway in prostate cancer,NA,ENSG00000149547
P49366,0,6,13739189.778645834,5.3183661832184884e-5,1.8447468883899716,0.8834228824564967,0.0552242704658461,0.6429522395902524,raw,11550928.3125,7668058.640625,8222284.625,21308539.0625,13081426.875,20603901.15625,Deoxyhypusine synthase OS=Homo sapiens OX=9606 GN=DHPS PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,1725,DHPS,NA,Hypusine synthesis from eIF5A-lysine,ENSG00000095059
Q9Y3I1,0,6,751639.5625,2.909556164208645e-6,1.8436992391135614,0.8826033295043506,1,1,raw,NA,NA,528635.0625,974644.0625,NA,NA,F-box only protein 7 OS=Homo sapiens OX=9606 GN=FBXO7 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,25793,FBXO7,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation,ENSG00000100225
O95071,0,6,3210751.6432291665,1.2428646257294974e-5,1.8434185352852728,0.8823836619772514,0.03352861614162397,0.6429522395902524,raw,1214394.796875,2750191.40625,2482936.5625,4577091.28125,3349107.09375,4890788.71875,E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,51366,UBR5,Mesodermal commitment pathway,NA,ENSG00000104517
Q9Y3B8,0,6,14838856.520833334,5.744041241841667e-5,1.8430456578194747,0.8820918113342386,0.03289769962895091,0.6429522395902524,raw,9734064.5,12283107.53125,9537236.40625,19066135.6875,15774267,22638328,"Oligoribonuclease, mitochondrial OS=Homo sapiens OX=9606 GN=REXO2 PE=1 SV=3",cell proliferation;cellular component movement;cellular homeostasis,endosome;membrane;nucleus,RNA binding;structural molecule activity,25996,REXO2,NA,NA,ENSG00000076043
O95801,0,6,2741854.8854166665,1.0613572224292877e-5,1.8427188540546866,0.8818359739520508,0.14197640841980022,0.6572502130392559,raw,1763561.46875,2269798.59375,1742428.84375,2509881.75,3249747.96875,4915710.6875,Tetratricopeptide repeat protein 4 OS=Homo sapiens OX=9606 GN=TTC4 PE=1 SV=3,coagulation;metabolic process,membrane;nucleus,structural molecule activity,7268,TTC4,NA,NA,ENSG00000243725
O15231,0,6,3715473.0104166665,1.438239541895942e-5,1.8426589559022126,0.8817890779365016,0.11852372307610261,0.6429522395902524,raw,3404164.203125,2163208.109375,2181760.34375,6272713.65625,3117782.4375,5153209.3125,Zinc finger protein 185 OS=Homo sapiens OX=9606 GN=ZNF185 PE=1 SV=3,NA,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,7739,ZNF185,NA,NA,ENSG00000147394
Q16644,0,6,4337225.205729167,1.6789164597613108e-5,1.841434966760962,0.8808304470404252,0.03660227721228931,0.6429522395902524,raw,3675944.03125,2444428.4375,3222949.015625,5123127.75,4787890.125,6769011.875,MAP kinase-activated protein kinase 3 OS=Homo sapiens OX=9606 GN=MAPKAPK3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,7867,MAPKAPK3,Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; Serotonin HTR1 group and FOS pathway,Oxidative Stress Induced Senescence; VEGFA-VEGFR2 Pathway; p38MAPK events; activated TAK1 mediates p38 MAPK activation,ENSG00000114738
P55957,0,6,13533894.526041666,5.238897499357502e-5,1.8398383752981178,0.8795790350880022,0.17645685746505196,0.6714687860927409,raw,10394017.625,8158371.34375,10818371.6875,22587376.3125,10121917.6875,19123312.5,BH3-interacting domain death agonist OS=Homo sapiens OX=9606 GN=BID PE=1 SV=1,cell growth;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;cytosol;endosome,antioxidant activity;structural molecule activity,637,BID,miRNA regulation of DNA damage response; TP53 network; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Amyotrophic lateral sclerosis (ALS); Nanomaterial induced apoptosis; Apoptosis; Photodynamic therapy-induced HIF-1 survival signaling; Apoptosis modulation by HSP70; Regulation of apoptosis by parathyroid hormone-related protein; miRNA regulation of p53 pathway in prostate cancer; Non-small cell lung cancer; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Hepatitis B infection; IL-18 signaling pathway; Host-pathogen interaction of human coronaviruses - apoptosis; Unfolded protein response; Complement system in neuronal development and plasticity; Network map of SARS-CoV-2 signaling pathway; Alzheimer's disease; DNA damage response,"TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members; Activation, myristolyation of BID and translocation to mitochondria; Activation of BAD and translocation to mitochondria ; Activation and oligomerization of BAK protein; Activation, translocation and oligomerization of BAX",ENSG00000015475
H7BYT1,0,6,2674045.20703125,1.0351084620416525e-5,1.8391772164362483,0.8790604993015976,0.06390926812919481,0.6429522395902524,raw,2131729.375,1739658.3046875,1853476.5,3408871.75,2699882.375,4210652.9375,Casein kinase I isoform delta OS=Homo sapiens OX=9606 GN=CSNK1D PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,CSNK1D,Melatonin metabolism and effects; Hedgehog signaling pathway,NA,ENSG00000141551
P56937,0,6,994501.09375,3.849660039192724e-6,1.8358402689197506,0.8764405395457535,0.13195987968683415,0.6514609890946903,raw,855611.1875,NA,516602.53125,1136727.875,1033128.5,1430435.375,3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 OS=Homo sapiens OX=9606 GN=HSD17B7 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,51478,HSD17B7,Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Steroid biosynthesis,Cholesterol biosynthesis,ENSG00000132196
Q6XQN6,0,6,14162874.986979166,5.482372439819739e-5,1.8357716688996795,0.876386629214025,0.10626595198750387,0.6429522395902524,raw,12662755.40625,9071003.328125,9182796.75,17803864,13010902.8125,23245927.625,Nicotinate phosphoribosyltransferase OS=Homo sapiens OX=9606 GN=NAPRT PE=1 SV=2,cellular homeostasis;coagulation,cell surface;cytosol;mitochondrion,structural molecule activity,93100,NAPRT,NAD+ biosynthetic pathways,Neutrophil degranulation; Nicotinamide salvaging,ENSG00000147813; ENSG00000278488
C9JLB7,0.16666666666666666,6,299677.71875,1.1600362691992375e-6,1.833663527092975,0.8747289321014196,0.16903202402597015,0.668039680404208,raw,216256.796875,NA,206092.421875,NA,339069.65625,437292,Oxidoreductase NAD-binding domain-containing protein 1 OS=Homo sapiens OX=9606 GN=OXNAD1 PE=1 SV=2,NA,NA,structural molecule activity,92106,OXNAD1,NA,NA,ENSG00000154814
A0A499FIZ0,0,6,8171954.248697917,3.163319367975665e-5,1.8313024343641235,0.872870067774674,0.005509848250660328,0.6429522395902524,raw,6313538.15625,6039879.0390625,4321646.109375,11111645.375,10184171.625,11060845.1875,WD repeat-containing protein 26 OS=Homo sapiens OX=9606 GN=WDR26 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
O60725,0.3333333333333333,6,778950.890625,3.015276840797989e-6,1.831057098622738,0.8726767800022468,0.161446572198391,0.6638855679885327,raw,588440.75,508864.75,NA,NA,872487.6875,1146010.375,Protein-S-isoprenylcysteine O-methyltransferase OS=Homo sapiens OX=9606 GN=ICMT PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;extracellular,structural molecule activity,23463,ICMT,Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome,"RAS processing; Gamma carboxylation, hypusine formation and arylsulfatase activation",ENSG00000116237
Q9BXB4,0,6,607739.3046875,2.352526035622814e-6,1.8306323342478834,0.8723420681316023,0.0977822203056777,0.6429522395902524,raw,172118.703125,611940.59375,469225.484375,858979.34375,567034.296875,967137.40625,Oxysterol-binding protein-related protein 11 OS=Homo sapiens OX=9606 GN=OSBPL11 PE=1 SV=2,conjugation;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,catalytic activity;structural molecule activity,114885,OSBPL11,NA,RHOH GTPase cycle,ENSG00000144909
Q9H7D0,0,6,2926425.2369791665,1.1328034089941186e-5,1.8284543578292698,0.8706246143439178,0.08341345978153447,0.6429522395902524,raw,2366964,1863186.84375,2017542.421875,4327885.640625,2666799.296875,4316173.21875,Dedicator of cytokinesis protein 5 OS=Homo sapiens OX=9606 GN=DOCK5 PE=1 SV=3,development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,DNA binding;structural molecule activity,80005,DOCK5,Ciliary landscape,RAC1 GTPase cycle; RHOG GTPase cycle; Factors involved in megakaryocyte development and platelet production,ENSG00000147459
Q13107,0,6,621053.6140625,2.404065008352462e-6,1.8272032722584668,0.8696371394751903,0.6611232025302902,1,raw,179789.640625,829568.109375,NA,656907.96875,440656.0390625,998346.3125,Ubiquitin carboxyl-terminal hydrolase 4 OS=Homo sapiens OX=9606 GN=USP4 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,antioxidant activity;structural molecule activity,7375,USP4,NA,Ub-specific processing proteases; Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway; TNFR1-induced proapoptotic signaling,ENSG00000114316
Q15800,0.16666666666666666,6,2103793.0729166665,8.143669398088841e-6,1.8266087854035646,0.8691676773181477,0.21243837579863936,0.7022549232366887,raw,944275.0625,2195313.09375,1339243.28125,4030292.5,2388813.375,1724821.125,Methylsterol monooxygenase 1 OS=Homo sapiens OX=9606 GN=MSMO1 PE=1 SV=1,cellular homeostasis,cytoplasm;cytoskeleton;extracellular,structural molecule activity,6307,MSMO1,Cholesterol biosynthesis pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,Cholesterol biosynthesis,ENSG00000052802
Q13049,0,6,3330870.2760416665,1.2893618999513988e-5,1.8265107890005217,0.8690902755677536,0.07586085209278272,0.6429522395902524,raw,1992029.9375,2874398.84375,2320465,4403172.5625,3145034.8125,5250120.5,E3 ubiquitin-protein ligase TRIM32 OS=Homo sapiens OX=9606 GN=TRIM32 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,22954,TRIM32,Ciliopathies; Bardet-Biedl syndrome,Antigen processing: Ubiquitination & Proteasome degradation; Regulation of innate immune responses to cytosolic DNA,ENSG00000119401
O43633,0,6,14495700.5390625,5.6112074140525134e-5,1.826292213915212,0.8689176206549304,0.024996193690338432,0.6429522395902524,raw,7825447.671875,13502288.03125,10135127.15625,18509703.8125,15742601.59375,21259034.96875,Charged multivesicular body protein 2a OS=Homo sapiens OX=9606 GN=CHMP2A PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,27243,CHMP2A,NA,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Lysosome Vesicle Biogenesis; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex,ENSG00000130724
A0A669KB53,0,6,103108831.39908855,3.991287193342327e-4,1.8261052860298757,0.8687699478271956,0.04507818738758744,0.6429522395902524,raw,82129907.90625,66248647.7851563,75022344.109375,141417430.8125,103856798.8125,149977858.96875,Signal transducer and activator of transcription OS=Homo sapiens OX=9606 GN=STAT1 PE=1 SV=1,cellular component movement;development,cytosol;membrane,RNA binding;structural molecule activity,NA,STAT1,"Allograft rejection; Endoderm differentiation; Chemokine signaling pathway; Immune response to tuberculosis; Ebola virus infection in host; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Non-genomic actions of 1,25 dihydroxyvitamin D3; Measles virus infection; Tryptophan metabolism; Hepatitis B infection; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Malignant pleural mesothelioma; Th17 cell differentiation pathway; Inflammatory bowel disease signaling; 2q13 copy number variation syndrome",NA,ENSG00000115415
B5MDU6,0,6,543468.6875,2.103737946563991e-6,1.8256034388182416,0.8683734142903667,1,1,raw,NA,NA,329851.6875,602178.375,480483.1875,761361.5,Lipid droplet-associated hydrolase OS=Homo sapiens OX=9606 GN=LDAH PE=1 SV=1,metabolic process,nucleus,structural molecule activity,NA,LDAH,NA,NA,ENSG00000118961
Q6GMV2,0,6,436598.6458333333,1.6900497853577551e-6,1.825370610355094,0.8681894083428623,0.08238402119717946,0.6429522395902524,raw,279169.96875,382341.375,276491.1875,509588.65625,447162.5,724838.1875,SET and MYND domain-containing protein 5 OS=Homo sapiens OX=9606 GN=SMYD5 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,NA,structural molecule activity,10322,SMYD5,Histone modifications,NA,ENSG00000135632
Q9Y375,0,6,1130914.75,4.377709937343776e-6,1.8248539823665042,0.8677810298318053,1,1,raw,NA,NA,503626.03125,2674795.375,426193.625,919043.96875,"Complex I intermediate-associated protein 30, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFAF1 PE=1 SV=2",cell growth;cellular homeostasis,cytoskeleton;cytosol;endosome,structural molecule activity,51103,NDUFAF1,Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,Complex I biogenesis,ENSG00000137806
Q13217,0,6,18743486.088541668,7.255502265778538e-5,1.8229886500436343,0.8663055791627099,0.08592480323750515,0.6429522395902524,raw,16324458.671875,15105739.515625,8824022.3125,27537591.6875,16576224.46875,28092879.875,DnaJ homolog subfamily C member 3 OS=Homo sapiens OX=9606 GN=DNAJC3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cell surface;cytosol;extracellular;mitochondrion;nucleus,DNA binding;structural molecule activity,5611,DNAJC3,Photodynamic therapy-induced unfolded protein response,Neutrophil degranulation; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; XBP1(S) activates chaperone genes; Viral mRNA Translation,ENSG00000102580
O75190,0,6,6824745.8125,2.641822256118472e-5,1.8228824194638866,0.8662215068915219,0.007994676072314468,0.6429522395902524,raw,4216152.3125,5613674.4375,4724724.375,8612617,7861446,9919860.75,DnaJ homolog subfamily B member 6 OS=Homo sapiens OX=9606 GN=DNAJB6 PE=1 SV=2,cell communication;cell growth;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,10049,DNAJB6,NA,Regulation of HSF1-mediated heat shock response,ENSG00000105993
Q8WWQ0,0,6,2347027.9609375,9.085218516974684e-6,1.8224967105218712,0.8659162105916822,0.18065166944483005,0.6742444420587625,raw,1716782.984375,1619035.3125,1453323.8125,1885069.75,2950686.53125,4457269.375,PH-interacting protein OS=Homo sapiens OX=9606 GN=PHIP PE=1 SV=2,cell growth;development;metabolic process,membrane,antioxidant activity;structural molecule activity,55023,PHIP,NA,RHOBTB2 GTPase cycle,ENSG00000146247
O14802,0,6,2569051.8125,9.944660858948289e-6,1.821937191876277,0.8654732255886645,0.17951454274034517,0.6742444420587625,raw,1472025.5625,2336318,1835925.5,4256624.65625,1907446.21875,3605970.9375,DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens OX=9606 GN=POLR3A PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,11128,POLR3A,Pyrimidine metabolism; Cytosolic DNA-sensing pathway,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation,ENSG00000148606
O60645,0,6,1005853.0989583334,3.893603038441163e-6,1.819938605678983,0.863889782964394,0.49599155167550174,0.9797947585234871,raw,956723.8125,758661.375,715381.84375,1915675.5,307958.9375,1380717.125,Exocyst complex component 3 OS=Homo sapiens OX=9606 GN=EXOC3 PE=1 SV=3,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,11336,EXOC3,Ciliary landscape,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing; VxPx cargo-targeting to cilium,ENSG00000180104
P49770,0,6,6274190.8359375,2.4287053972259933e-5,1.8197226250702963,0.863718561450252,0.02653899704095146,0.6429522395902524,raw,4383932,4725953.203125,4596277.65625,8599923.96875,6786799.6875,8552258.5,Translation initiation factor eIF-2B subunit beta OS=Homo sapiens OX=9606 GN=EIF2B2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,8892,EIF2B2,Translation factors; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; Rett syndrome causing genes,Recycling of eIF2:GDP,ENSG00000119718
Q147X3,0,6,1299086.2916666667,5.028692895283436e-6,1.8195193471566753,0.863557391602,0.0742304360353229,0.6429522395902524,raw,637871.5,1002614.21875,1253211.5625,1824275.96875,1863451.46875,1213093.03125,N-alpha-acetyltransferase 30 OS=Homo sapiens OX=9606 GN=NAA30 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,122830,NAA30,Metapathway biotransformation Phase I and II,Retrograde transport at the Trans-Golgi-Network,ENSG00000139977
Q96S99,0.8333333333333334,6,299915.3802083333,1.1609562438727213e-6,1.8193300647617372,0.8634073019764955,0.30099141950522607,0.7806964943416801,raw,161333.796875,408983.75,154192.609375,280527.25,380459.6875,413995.1875,Pleckstrin homology domain-containing family F member 1 OS=Homo sapiens OX=9606 GN=PLEKHF1 PE=1 SV=3,cell growth;conjugation;metabolic process,cytoskeleton;membrane;mitochondrion;nucleus,structural molecule activity,79156,PLEKHF1,NA,NA,ENSG00000166289
Q6NYC1,0,6,14095543.744791666,5.456308879501163e-5,1.8188777854565263,0.8630486082784175,0.042863158932553325,0.6429522395902524,raw,8150587.28125,11965247.15625,8550363.15625,21763322.25,13974752.625,20168990,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 OS=Homo sapiens OX=9606 GN=JMJD6 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,23210,JMJD6,NA,HDMs demethylate histones,ENSG00000070495
O75909,0,6,2037747.5416666667,7.888010712524546e-6,1.8171338458751995,0.8616646890649371,0.06856183698830148,0.6429522395902524,raw,1523607.53125,1841662.5625,966634.84375,2490294.78125,2057738.15625,3346547.375,Cyclin-K OS=Homo sapiens OX=9606 GN=CCNK PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,8812,CCNK,Male infertility,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes,ENSG00000090061
P49459,0,6,2220616.7864583335,8.59588768570845e-6,1.8153179764612675,0.8602222770827608,0.14048625517049426,0.6572502130392559,raw,1665835.9375,1277190.15625,1462274.875,2318506.25,2340630.25,4259263.25,Ubiquitin-conjugating enzyme E2 A OS=Homo sapiens OX=9606 GN=UBE2A PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7319,UBE2A,NA,E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000077721
Q15208,0,6,1178228.2125,4.560857796151341e-6,1.81407436401525,0.8592335972098989,0.07792361921692939,0.6429522395902524,raw,391148.25,1281049.375,911583.375,1513834.875,NA,1793525.1875,Serine/threonine-protein kinase 38 OS=Homo sapiens OX=9606 GN=STK38 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,11329,STK38,Interactome of polycomb repressive complex 2 (PRC2),RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,ENSG00000112079
Q8TAD4,0,6,499028.1276041667,1.931710938624524e-6,1.8123458222351032,0.8578582690819005,0.19761255462248084,0.6875760999904456,raw,242189.859375,615729.5625,308161.9375,558496,506410.15625,763181.25,Zinc transporter 5 OS=Homo sapiens OX=9606 GN=SLC30A5 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,catalytic activity,64924,SLC30A5,Zinc homeostasis,Insulin processing; Zinc efflux and compartmentalization by the SLC30 family,ENSG00000145740
Q53LP3,0,6,392528.021875,1.5194547794589138e-6,1.8123066203813358,0.8578270626029779,0.07933279990426102,0.6429522395902524,raw,NA,246346.015625,254685.9375,453885.96875,623777.6875,383944.5,Ankyrin repeat domain-containing protein SOWAHC OS=Homo sapiens OX=9606 GN=SOWAHC PE=1 SV=1,NA,NA,NA,65124,SOWAHC,NA,RHOA GTPase cycle; RHOB GTPase cycle; RHOF GTPase cycle,ENSG00000198142
Q96AC1,0,6,10299604.10546875,3.986921140007883e-5,1.8103813197888405,0.8562936035116092,0.09905651019221429,0.6429522395902524,raw,6388792.703125,9240316.1171875,6241512.140625,14109907.1875,9088600.796875,16728495.6875,Fermitin family homolog 2 OS=Homo sapiens OX=9606 GN=FERMT2 PE=1 SV=1,cell communication;cell death;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,10979,FERMT2,NA,RAC1 GTPase cycle; RAC3 GTPase cycle; Cell-extracellular matrix interactions,ENSG00000073712
A0A0A0MRF6,0,6,419964.71923828137,1.6256607536007585e-6,1.8098689053744714,0.8558852020512413,0.004536776328688174,0.6429522395902524,raw,300839.46875,364472.7578125,267540.280273438,557776.734375,484679.07421875,544480,A-kinase anchor protein 9 OS=Homo sapiens OX=9606 GN=AKAP9 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
O75792,0.16666666666666666,6,1806398.9947916667,6.992472978451549e-6,1.8092034883836958,0.855354682791561,0.16113821985668844,0.6638855679885327,raw,893196.875,2120995.1875,1268356.03125,2365932.90625,1895198.8125,2294714.15625,Ribonuclease H2 subunit A OS=Homo sapiens OX=9606 GN=RNASEH2A PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis;coagulation,cytosol;membrane;nucleus,RNA binding;structural molecule activity,10535,RNASEH2A,NA,NA,ENSG00000104889
Q9BYK8,0,6,1872288.0833333333,7.247526082738478e-6,1.8091518647714346,0.8553135165034892,0.04135613252361875,0.6429522395902524,raw,1285113.09375,1872941.953125,1059504.875,2324964.75,2022793.359375,2668410.46875,Helicase with zinc finger domain 2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=6,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,85441,HELZ2,NA,"Heme signaling; Cytoprotection by HMOX1; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Transcriptional activation of mitochondrial biogenesis; Activation of gene expression by SREBF (SREBP); RORA activates gene expression",ENSG00000130589
Q9H799,0.8333333333333334,6,452137.4296875,1.7501995786933028e-6,1.809057968746689,0.8552386378560236,0.10005379349698035,0.6429522395902524,raw,414394.09375,341112.9375,243733.390625,501498.1875,462423.03125,749662.9375,Ciliogenesis and planar polarity effector 1 OS=Homo sapiens OX=9606 GN=CPLANE1 PE=1 SV=4,cell growth,cytoskeleton;nucleus,NA,65250,CPLANE1,Genes related to primary cilium development (based on CRISPR); Joubert syndrome; Ciliopathies,NA,ENSG00000197603
P31937,0,6,17985325.9921875,6.962022585908136e-5,1.8090475627994442,0.8552303392542527,0.05593821669029305,0.6429522395902524,raw,15126717.4375,9857991.8125,13391798.078125,23370649.3125,17833576.0625,28331223.25,"3-hydroxyisobutyrate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=HIBADH PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,11112,HIBADH,Amino acid metabolism,Branched-chain amino acid catabolism,ENSG00000106049
O75351,0,6,18481710.940104168,7.15417051918451e-5,1.8079431326870685,0.8543492997217815,0.01766279413541835,0.6429522395902524,raw,13160857.90625,14557570.25,12411797.625,23794082.671875,20513173.75,26452783.4375,Vacuolar protein sorting-associated protein 4B OS=Homo sapiens OX=9606 GN=VPS4B PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,9525,VPS4B,NA,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT),ENSG00000119541
Q7Z7C8,0,6,408362.06875,1.580747520006382e-6,1.8071907150739497,0.8537487636307206,0.02943621655123487,0.6429522395902524,raw,391635.40625,306827.96875,234353.65625,545718.4375,NA,563274.875,Transcription initiation factor TFIID subunit 8 OS=Homo sapiens OX=9606 GN=TAF8 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,structural molecule activity,129685,TAF8,NA,RNA polymerase II transcribes snRNA genes,ENSG00000137413
Q9BX95,0.3333333333333333,6,1596179.1041666667,6.178723131952168e-6,1.8065327802084985,0.853223433245404,0.08901557781865556,0.6429522395902524,raw,1044887.5625,950471.09375,1269290.65625,1804812.125,1717057.1875,2790556,Sphingosine-1-phosphate phosphatase 1 OS=Homo sapiens OX=9606 GN=SGPP1 PE=1 SV=2,cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;extracellular,structural molecule activity,81537,SGPP1,Sphingolipid metabolism overview; Sphingolipid metabolism: integrated pathway; Sphingolipid metabolism in senescence; Biosynthesis and turnover of 1-deoxy-sphingoid bases,Sphingolipid de novo biosynthesis,ENSG00000126821; ENSG00000285281
P68402,0,6,27318644.6875,1.0574899860774874e-4,1.8063975036364082,0.8531153974824848,0.17203480797306342,0.6689341104244626,raw,31630305,12764603,19604596.125,35413693.5,24574364.25,39924306.25,Platelet-activating factor acetylhydrolase IB subunit beta OS=Homo sapiens OX=9606 GN=PAFAH1B2 PE=1 SV=1,cellular homeostasis;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,5049,PAFAH1B2,NA,COPI-independent Golgi-to-ER retrograde traffic; Neutrophil degranulation,ENSG00000168092
Q86VR2,0,6,422689.828125,1.6362095029682347e-6,1.8051264651617274,0.8520999142705484,0.21447882461540232,0.7040869719539218,raw,528248,153625.71875,299151.0625,540005.5,435842.1875,579266.5,Reticulophagy regulator 3 OS=Homo sapiens OX=9606 GN=RETREG3 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,162427,RETREG3,NA,NA,ENSG00000141699
P48426,0,6,5883622.171875,2.2775183761104326e-5,1.8034376497810116,0.8507495457167361,0.21975290889672072,0.7087130179153194,raw,4610362.46875,4242274.96875,4387068.84375,7911805.125,4224765.875,9925455.75,Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Homo sapiens OX=9606 GN=PIP4K2A PE=1 SV=2,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,signal transducer activity;structural molecule activity,5305,PIP4K2A,Regulation of actin cytoskeleton; G13 signaling pathway,"Synthesis of PIPs at the plasma membrane; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; PI5P Regulates TP53 Acetylation; Synthesis of PIPs in the nucleus",ENSG00000150867
A0A0G2JQM1,0.3333333333333333,6,357995.3984375,1.3857808586042303e-6,1.803353048693289,0.8506818658428885,0.4158033781730067,0.9013279742103876,raw,NA,150512.4375,385292.6875,NA,316346.96875,579829.5,AP-2 complex subunit alpha-2 (Fragment) OS=Homo sapiens OX=9606 GN=AP2A2 PE=1 SV=1,conjugation,cytoskeleton;extracellular,NA,NA,AP2A2,NA,NA,ENSG00000280759; ENSG00000281385
A0A0C4DG49,0,6,2706564.8072916665,1.0476966237239077e-5,1.8019679636339396,0.8495733623627214,0.14357121832825503,0.6572502130392559,raw,2483652.125,1527330.6875,1760527.0625,4896449.875,2752200.96875,2819228.125,Poliovirus receptor OS=Homo sapiens OX=9606 GN=PVR PE=1 SV=1,NA,cytoskeleton,NA,5817,PVR,Interactions of natural killer cells in pancreatic cancer,NA,ENSG00000073008
P18085,0,6,44577068.072916664,1.7255542372266103e-4,1.8011610950909924,0.8489272210527405,0.06937071942590584,0.6429522395902524,raw,32813475.125,31385058.625,30723354.75,56529546.5625,45471893.25,70539080.125,ADP-ribosylation factor 4 OS=Homo sapiens OX=9606 GN=ARF4 PE=1 SV=3,cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,antioxidant activity;DNA binding;structural molecule activity,378,ARF4,VEGFA-VEGFR2 signaling pathway,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; VxPx cargo-targeting to cilium,ENSG00000168374
H0YIV9,0,6,5837479.786458333,2.259656907845801e-5,1.801108996993102,0.8488854908850684,0.09197045091166041,0.6429522395902524,raw,4829437.125,3749316.8125,4346262.3125,8698342.65625,5271523.875,8129995.9375,Uncharacterized protein (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;endosome;nucleus,structural molecule activity,NA,NA,NA,NA,NA
Q66K74,0,6,4780106.130208333,1.8503532744418556e-5,1.800374836664532,0.8482973058319978,0.009031762443473807,0.6429522395902524,raw,3572139.21875,3865029.4375,2398174.5,5805867,6608237.0625,6431189.5625,Microtubule-associated protein 1S OS=Homo sapiens OX=9606 GN=MAP1S PE=1 SV=2,cell differentiation;cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,55201,MAP1S,NA,NA,ENSG00000130479
P30419,0,6,31705932.204427082,1.2273195170906429e-4,1.7988444345207806,0.8470704265839931,0.10022325960569037,0.6429522395902524,raw,26490271.90625,22361759.8125,22864782.6328125,42000022.625,28866878.0625,47651878.1875,Glycylpeptide N-tetradecanoyltransferase 1 OS=Homo sapiens OX=9606 GN=NMT1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;nucleus,structural molecule activity,4836,NMT1,NA,"Inactivation, recovery and regulation of the phototransduction cascade; Late Phase of HIV Life Cycle; Activation, myristolyation of BID and translocation to mitochondria",ENSG00000136448
Q9H993,0,6,9300582.7265625,3.600205358110373e-5,1.7985354451090307,0.8468225920443944,0.08619151131302565,0.6429522395902524,raw,9003871.34375,6682691.65625,3726205.125,15521143.6875,8850526.734375,12019057.8125,Damage-control phosphatase ARMT1 OS=Homo sapiens OX=9606 GN=ARMT1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,NA,structural molecule activity,79624,ARMT1,NA,NA,ENSG00000146476
Q86TN4,0,6,1727933.86875,6.688738712002608e-6,1.7975938189374148,0.8460670689030043,0.4585062618101952,0.9412524313762942,raw,1844303.375,NA,353164.59375,3921009.5,518861.125,2002330.75,tRNA 2'-phosphotransferase 1 OS=Homo sapiens OX=9606 GN=TRPT1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,NA,structural molecule activity,83707,TRPT1,NA,NA,ENSG00000149743
P10398,0,6,2026293.9921875,7.843674640886247e-6,1.7965447132589734,0.8452248422670063,0.08008931130743872,0.6429522395902524,raw,1215722.46875,1767742.21875,1336096.828125,2808007.25,1854367.25,3175827.9375,Serine/threonine-protein kinase A-Raf OS=Homo sapiens OX=9606 GN=ARAF PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;endosome,signal transducer activity;structural molecule activity,369,ARAF,Integrin-mediated cell adhesion; Alzheimer's disease and miRNA effects; Glioblastoma signaling pathways; Common pathways underlying drug addiction; Bladder cancer; MAPK signaling pathway; Embryonic stem cell pluripotency pathways; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Fragile X syndrome; Hepatitis B infection; Melanoma; EGFR tyrosine kinase inhibitor resistance; Alzheimer's disease; ErbB signaling pathway,Signaling by BRAF and RAF1 fusions; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants,ENSG00000078061
P83111,0.5,6,603287.175,2.335292081980144e-6,1.796289877238434,0.8450201845493028,0.037849901156597324,0.6429522395902524,raw,523188.1875,421793.53125,432007.90625,766727.6875,NA,872718.5625,"Serine beta-lactamase-like protein LACTB, mitochondrial OS=Homo sapiens OX=9606 GN=LACTB PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endosome,structural molecule activity,114294,LACTB,NA,NA,ENSG00000103642
Q8N4J0,0,6,385408.4869791667,1.4918954442722826e-6,1.7961496302394826,0.8449075403978463,0.007232801655221914,0.6429522395902524,raw,251009.171875,342408.4375,263264.6875,505186.78125,499731.8125,450850.03125,Carnosine N-methyltransferase OS=Homo sapiens OX=9606 GN=CARNMT1 PE=1 SV=1,cellular homeostasis,cytosol;membrane,structural molecule activity,138199,CARNMT1,NA,Histidine catabolism,ENSG00000156017
O15173,0,6,15041175.895833334,5.822357979549322e-5,1.7944897410007392,0.8435736753692787,0.03409422769649065,0.6429522395902524,raw,11749479.4375,10984447.375,10771987.25,19711478.125,15912214.8125,21117448.375,Membrane-associated progesterone receptor component 2 OS=Homo sapiens OX=9606 GN=PGRMC2 PE=1 SV=1,conjugation;development;metabolic process,cytoskeleton;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,10424,PGRMC2,Ciliary landscape,RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle,ENSG00000164040
Q99442,0,6,9207428.895833334,3.564146013187627e-5,1.793699323317645,0.8429380724678512,0.08215752333028971,0.6429522395902524,raw,6581518.5,9796716.625,5124136.125,12374766.875,9191159.5,12176275.75,Translocation protein SEC62 OS=Homo sapiens OX=9606 GN=SEC62 PE=1 SV=1,conjugation,cytoskeleton;extracellular,structural molecule activity,7095,SEC62,NA,NA,ENSG00000008952
Q5VV89,0,6,7463526.322916667,2.8890907428220516e-5,1.7926984569950373,0.8421328383548752,0.0960217437571742,0.6429522395902524,raw,7570977.875,3705671.1875,5547916.375,9945741.125,6847753.875,11163097.5,Microsomal glutathione S-transferase 3 OS=Homo sapiens OX=9606 GN=MGST3 PE=1 SV=1,NA,cytoskeleton,NA,NA,MGST3,Nuclear receptors meta-pathway; NRF2 pathway; Metapathway biotransformation Phase I and II,NA,ENSG00000143198
O75663,0,6,11872999.8671875,4.595974144352442e-5,1.7922467312450214,0.8417692609674291,0.058870736778036795,0.6429522395902524,raw,10072886.1875,7900292.46875,6699042.859375,17266860.78125,11245819.5625,18053097.34375,TIP41-like protein OS=Homo sapiens OX=9606 GN=TIPRL PE=1 SV=2,coagulation;development;metabolic process,cytosol,NA,261726,TIPRL,Ciliary landscape,NA,ENSG00000143155
P85298,0,6,568988.21875,2.2025226741922053e-6,1.7916840369768456,0.8413162409235698,0.05495400629928094,0.6429522395902524,raw,NA,447690.90625,322154.9375,689138.8125,560170.5,825785.9375,Rho GTPase-activating protein 8 OS=Homo sapiens OX=9606 GN=ARHGAP8 PE=1 SV=1,development;metabolic process,cytosol;nucleus,DNA binding,23779,ARHGAP8,NA,RHOA GTPase cycle,ENSG00000241484
Q5VW32,0,6,3842090.4244791665,1.4872524592517532e-5,1.79135305314041,0.8410497023816634,0.08740689340034859,0.6429522395902524,raw,4183181.5,2100531.875,2323973.609375,5120736.625,3762794.1875,5561324.75,BRO1 domain-containing protein BROX OS=Homo sapiens OX=9606 GN=BROX PE=1 SV=1,NA,cytoskeleton,NA,148362,BROX,NA,NA,ENSG00000162819
X6RLX0,0,6,3513456.21875,1.3600399325629243e-5,1.789678351361874,0.8397003234714641,0.1671934791450299,0.6670444762382309,raw,2353165.0625,3512104.875,1838866.375,3787546.8125,3303516.125,6285538.0625,ELKS/Rab6-interacting/CAST family member 1 OS=Homo sapiens OX=9606 GN=ERC1 PE=1 SV=1,NA,cytoskeleton;nucleus,NA,23085,ERC1,NA,NA,ENSG00000082805
Q9NP77,0,6,5244305.083333333,2.030042182911737e-5,1.7891804143897483,0.8392988708006457,0.008856102033466326,0.6429522395902524,raw,4605054.9375,2991520.6875,3726831.15625,7353571.3125,6120879.09375,6667973.3125,RNA polymerase II subunit A C-terminal domain phosphatase SSU72 OS=Homo sapiens OX=9606 GN=SSU72 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;membrane,structural molecule activity,29101,SSU72,NA,RNA polymerase II transcribes snRNA genes,ENSG00000160075
A0A087WT44,0,6,25166383.84375,9.741771308561697e-5,1.7885130762547101,0.8387606662665239,0.09414095797175177,0.6429522395902524,raw,21774407.84375,17235718.40625,17717066.84375,38943813.15625,23604557.875,31722738.9375,Heme oxygenase (biliverdin-producing) OS=Homo sapiens OX=9606 GN=HMOX2 PE=1 SV=1,cellular homeostasis,cytoskeleton,structural molecule activity,3163,HMOX2,NA,NA,ENSG00000103415; ENSG00000277424
Q9Y2G8,0,6,780701.7447916666,3.022054302745723e-6,1.7874837444197937,0.8379301219181113,0.2646889239425829,0.7454335379461359,raw,405653.96875,653876.1875,746999.5,1427398.5,725099.875,725182.4375,DnaJ homolog subfamily C member 16 OS=Homo sapiens OX=9606 GN=DNAJC16 PE=2 SV=3,NA,cytoskeleton,NA,23341,DNAJC16,NA,NA,ENSG00000116138
Q92979,0,6,22113527.864583332,8.560027241886708e-5,1.7867937843652177,0.8373731411277303,0.10321824909672798,0.6429522395902524,raw,17486999.125,16740941.71875,16065454.6875,31245661.34375,19925855.8125,31216254.5,Ribosomal RNA small subunit methyltransferase NEP1 OS=Homo sapiens OX=9606 GN=EMG1 PE=1 SV=4,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,10436,EMG1,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000126749
Q9BQ67,0,6,16543876.078125,6.40404510679446e-5,1.7863434965233904,0.8370095233942105,0.04304927806340269,0.6429522395902524,raw,14286408.96875,10694224.6875,10801551.5,20743122.4375,17217515.125,25520433.75,Glutamate-rich WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=GRWD1 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,83743,GRWD1,NA,NA,ENSG00000105447
Q9NR45,0,6,17362634.817708332,6.72098219427705e-5,1.7861400123014979,0.8368451751600391,0.020042013728860133,0.6429522395902524,raw,13588690.8125,12532396.1875,11683016.25,23215937.75,18884463.53125,24271304.375,Sialic acid synthase OS=Homo sapiens OX=9606 GN=NANS PE=1 SV=2,cellular homeostasis,cytosol;nucleus,structural molecule activity,54187,NANS,NA,Sialic acid metabolism,ENSG00000095380
Q9Y3B3,0,6,33309569.046875,1.289395433432479e-4,1.7858540972269668,0.8366142183060387,0.18662198593593346,0.6790811483756987,raw,21100494.625,25021953.3125,26836397.25,56918365.625,25294645.625,44685557.84375,Transmembrane emp24 domain-containing protein 7 OS=Homo sapiens OX=9606 GN=TMED7 PE=1 SV=2,cell growth;conjugation,cytoskeleton;extracellular;nucleus,NA,100302736; 51014,TMED7,NA,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000134970
Q12965,0,6,25149833.864583332,9.735364900982279e-5,1.785777650812681,0.8365524600562633,0.057264354800132734,0.6429522395902524,raw,17968143.46875,20892881.0625,14536964.21875,37310040.0625,24037182.3125,36153792.0625,Unconventional myosin-Ie OS=Homo sapiens OX=9606 GN=MYO1E PE=1 SV=2,cell growth;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,4643,MYO1E,Primary focal segmental glomerulosclerosis (FSGS); Nephrotic syndrome,NA,ENSG00000157483
A0A2U3TZE7,0.5,6,1393351.65625,5.393589032046876e-6,1.7850818653945264,0.8359902390109142,1,1,raw,1266361.375,1093023.875,1154013.25,2060008.125,NA,NA,Cochlin OS=Homo sapiens OX=9606 GN=COCH PE=1 SV=1,coagulation;metabolic process,chromosome,NA,1690,COCH,NA,NA,ENSG00000100473
O14493,0,6,742204.71875,2.873034393454783e-6,1.7826316031194744,0.8340085878384854,1,1,raw,NA,533455.25,NA,950954.1875,NA,NA,Claudin-4 OS=Homo sapiens OX=9606 GN=CLDN4 PE=1 SV=1,cell communication;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity;structural molecule activity,1364,CLDN4,Mammary gland development pathway - Embryonic development (Stage 1 of 4); Epithelial to mesenchymal transition in colorectal cancer; IL-18 signaling pathway; 7q11.23 copy number variation syndrome,Tight junction interactions,ENSG00000189143
P35611,0,6,7231637.591145833,2.79932786675812e-5,1.7822057794622947,0.8336639248900828,0.06671696989149334,0.6429522395902524,raw,6069675.8125,4767011.40625,4876353.71875,9982540.5625,6876832.734375,10817411.3125,Alpha-adducin OS=Homo sapiens OX=9606 GN=ADD1 PE=1 SV=2,cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,118,ADD1,NA,XBP1(S) activates chaperone genes; Caspase-mediated cleavage of cytoskeletal proteins; Miscellaneous transport and binding events,ENSG00000087274
Q4V328,0,6,2767013.8229166665,1.0710961112983878e-5,1.7815492737315444,0.8331323857923358,0.08217359833397486,0.6429522395902524,raw,2437243.6875,1883912.96875,1724418.625,3356283.78125,2726903.90625,4473319.96875,GRIP1-associated protein 1 OS=Homo sapiens OX=9606 GN=GRIPAP1 PE=1 SV=2,conjugation;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,56850,GRIPAP1,NA,NA,ENSG00000068400
O60271,0.6666666666666666,6,762653.18125,2.9521892877469053e-6,1.7794575859316466,0.8314375460562838,0.4637437068036667,0.9453082494943278,raw,466999.09375,880289.125,330288.1875,1536857.125,598832.375,NA,C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4,conjugation;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,9043,SPAG9,NA,Myogenesis,ENSG00000008294
Q15843,0,6,760117.2875,2.942372979957637e-6,1.779265623915239,0.8312819044775217,0.9723712252063738,1,raw,1270758.375,NA,221860.71875,1060886.03125,642802.28125,604279.03125,NEDD8 OS=Homo sapiens OX=9606 GN=NEDD8 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,4738,NEDD8,EGF/EGFR signaling pathway; 2q37 copy number variation syndrome,UCH proteinases; Neddylation; Cargo recognition for clathrin-mediated endocytosis; Iron uptake and transport; TGF-beta receptor signaling activates SMADs,ENSG00000129559; ENSG00000285246
Q7LG56,0,6,10565858.15625,4.089986645516863e-5,1.7786530287015427,0.8307851038635138,0.1416727794200108,0.6572502130392559,raw,8335577.671875,8044992.078125,8050516.75,15681672.0625,8963314.375,14319076,Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens OX=9606 GN=RRM2B PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;endosome;membrane,structural molecule activity,50484,RRM2B,miRNA regulation of DNA damage response; Pyrimidine metabolism; p53 transcriptional gene network; DNA damage response,TP53 Regulates Metabolic Genes; Interconversion of nucleotide di- and triphosphates,ENSG00000048392
P60604,0,6,4338652.375,1.6794689092805338e-5,1.7769580983475095,0.8294096622225365,0.09257318168862616,0.6429522395902524,raw,3211415.625,3666821.375,2758562.0625,6515787.9375,3912996.25,5966331,Ubiquitin-conjugating enzyme E2 G2 OS=Homo sapiens OX=9606 GN=UBE2G2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,extracellular;nucleus,structural molecule activity,7327,UBE2G2,Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway,Antigen processing: Ubiquitination & Proteasome degradation; Synthesis of active ubiquitin: roles of E1 and E2 enzymes,ENSG00000184787
Q6PL24,0.16666666666666666,6,1391378.28125,5.385950203967566e-6,1.7761721087901912,0.8287713837531734,0.032415034065474795,0.6429522395902524,raw,515446.65625,1099350.53125,1076749.1875,1912491.875,1922001.125,1822230.3125,Protein TMED8 OS=Homo sapiens OX=9606 GN=TMED8 PE=1 SV=1,NA,NA,NA,283578,TMED8,NA,NA,ENSG00000100580
Q9P0S9,0.3333333333333333,6,519834.1041666667,2.012249750549824e-6,1.7743211552775147,0.8272671636367213,0.05449225524640486,0.6429522395902524,raw,427914.5,388897.46875,318903.46875,759257.75,504842.3125,719189.125,Transmembrane protein 14C OS=Homo sapiens OX=9606 GN=TMEM14C PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,NA,51522,TMEM14C,NA,NA,ENSG00000111843; ENSG00000284936
O43617,0,6,9931496.361979166,3.844428619975976e-5,1.7741108802651222,0.827096179542948,0.04987955348911691,0.6429522395902524,raw,7349612.09375,7599129.125,7070254.734375,13039026.78125,10184752.875,14346202.5625,Trafficking protein particle complex subunit 3 OS=Homo sapiens OX=9606 GN=TRAPPC3 PE=1 SV=1,cell growth;conjugation,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,NA,27095,TRAPPC3,NA,RAB GEFs exchange GTP for GDP on RABs; COPII-mediated vesicle transport,ENSG00000054116
Q8N0Z8,0,6,235265.875,9.107014997420263e-7,1.7728407852779544,0.8260629769563091,1,1,raw,184889.125,NA,189281.625,NA,331626.875,NA,tRNA pseudouridine synthase-like 1 OS=Homo sapiens OX=9606 GN=PUSL1 PE=1 SV=1,cellular component movement;cellular homeostasis,endosome;nucleus,RNA binding;structural molecule activity,126789,PUSL1,NA,NA,ENSG00000169972
P29350,0,6,229973111.93229166,8.902134996717178e-4,1.771038794720084,0.8245958147647406,0.125121514466634,0.6449267539975253,raw,178394281.96875,149768858.125,166158140.8125,294272513.4375,205757451.8125,385487425.4375,Tyrosine-protein phosphatase non-receptor type 6 OS=Homo sapiens OX=9606 GN=PTPN6 PE=1 SV=1,cell communication;cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,5777,PTPN6,Prolactin signaling pathway; B cell receptor signaling pathway; T cell receptor and co-stimulatory signaling; IL-3 signaling pathway; Kit receptor signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling pathway; Microglia pathogen phagocytosis pathway; IL-4 signaling pathway; Cancer immunotherapy by CTLA4 blockade; Modulators of TCR signaling and T cell activation; Interferon type I signaling pathways,CD22 mediated BCR regulation; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; PD-1 signaling; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Neutrophil degranulation; Signal regulatory protein family interactions; Interleukin receptor SHC signaling; GPVI-mediated activation cascade; Signaling by ALK; Regulation of KIT signaling; Growth hormone receptor signaling; Regulation of IFNG signaling; Regulation of IFNA/IFNB signaling; Interleukin-37 signaling; Platelet sensitization by LDL; PECAM1 interactions,ENSG00000111679
Q969T4,0,6,279535.33203125,1.0820661777308105e-6,1.7703823283103726,0.8240609555589322,1,1,raw,NA,202494.078125,NA,371158.4375,185996.875,358491.9375,Ubiquitin-conjugating enzyme E2 E3 OS=Homo sapiens OX=9606 GN=UBE2E3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,10477,UBE2E3,7q11.23 copy number variation syndrome,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000170035
Q9NVH0,0,6,2257775.5729166665,8.739727341826012e-6,1.7701463295455286,0.8238686259488075,0.1349907773108291,0.653345503642978,raw,2207688.125,1638441.65625,1108881.78125,2454263.59375,2229447.25,3907931.03125,Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis;coagulation,cytoskeleton;endoplasmic reticulum;endosome;membrane;nucleus,RNA binding;structural molecule activity,55218,EXD2,NA,NA,ENSG00000081177
O75298,0,6,1016475.2473958334,3.9347208015358485e-6,1.7683172554410513,0.8223771332081892,0.02928626755843933,0.6429522395902524,raw,599058.125,850038.21875,838400.609375,1503137.25,1117635.4375,1190581.84375,Reticulon-2 OS=Homo sapiens OX=9606 GN=RTN2 PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,NA,6253,RTN2,NA,NA,ENSG00000125744
P32320,0,6,3951656.7083333335,1.5296649761657128e-5,1.7677108106490154,0.8218822757657318,0.04856819947378214,0.6429522395902524,raw,3566492,2029615.125,2993227.4375,5291160.5,3894423.6875,5935021.5,Cytidine deaminase OS=Homo sapiens OX=9606 GN=CDA PE=1 SV=2,cellular homeostasis;development;metabolic process,cell surface;cytosol;nucleus,structural molecule activity,978,CDA,Fluoropyrimidine activity; Pyrimidine metabolism,Neutrophil degranulation; Pyrimidine salvage,ENSG00000158825
A0A087WWF6,0,6,970246.2291666666,3.755770767949789e-6,1.7652163000670118,0.8198449743828421,0.35539847315592216,0.839697330246159,raw,391209.28125,1354942.6875,397675.96875,1053850.75,690569,1933229.6875,DNA polymerase delta subunit 2 OS=Homo sapiens OX=9606 GN=POLD2 PE=1 SV=1,cell proliferation;cellular homeostasis;coagulation,membrane,RNA binding,5425,POLD2,"Homologous recombination; Pyrimidine metabolism; DNA replication; Base excision repair; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",NA,ENSG00000106628
Q9Y263,0,6,10446873.859375,4.0439284666119057e-5,1.7651733117478392,0.8198098399972875,0.022074640451089936,0.6429522395902524,raw,7154718.6875,9709568.8125,6396888.5625,13079313.875,11291616.96875,15049136.25,Phospholipase A-2-activating protein OS=Homo sapiens OX=9606 GN=PLAA PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cell surface;membrane;nucleus,DNA binding;structural molecule activity,9373,PLAA,NA,NA,ENSG00000137055
Q13153,0,6,2592670.7552083335,1.0036088510947546e-5,1.7613194098503477,0.8166565611970903,0.12382986692363843,0.6445597830897484,raw,685989.8125,2295495.453125,2499316.265625,3070776.3125,2602352.4375,4402094.25,Serine/threonine-protein kinase PAK 1 OS=Homo sapiens OX=9606 GN=PAK1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;signal transducer activity;structural molecule activity,5058,PAK1,Integrin-mediated cell adhesion; Prolactin signaling pathway; Microtubule cytoskeleton regulation; Focal adhesion; Hepatocyte growth factor receptor signaling; Fas ligand pathway and stress induction of heat shock proteins; RAC1/PAK1/p38/MMP2 pathway; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Ebola virus infection in host; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Merlin signaling dysregulation; Neural crest cell migration during development; Neural crest cell migration in cancer; Gastrin signaling pathway; Melanoma; Malignant pleural mesothelioma; Regulation of actin cytoskeleton; ErbB signaling pathway; T-cell receptor signaling pathway,Regulation of actin dynamics for phagocytic cup formation; FCERI mediated MAPK activation; Generation of second messenger molecules; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; MAPK6/MAPK4 signaling; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; EPHB-mediated forward signaling; Ephrin signaling; G beta:gamma signalling through CDC42; Sema3A PAK dependent Axon repulsion; Signal transduction by L1; Smooth Muscle Contraction; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs; DSCAM interactions; VEGFR2 mediated vascular permeability; Activation of RAC1; RHOH GTPase cycle; CD209 (DC-SIGN) signaling; CD28 dependent Vav1 pathway,ENSG00000149269
O00257,0,6,530746.578125,2.0544913480605124e-6,1.7609628643711328,0.8163644855731482,1,1,raw,NA,384464.84375,NA,NA,NA,677028.3125,E3 SUMO-protein ligase CBX4 OS=Homo sapiens OX=9606 GN=CBX4 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,8535,CBX4,NA,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription,ENSG00000141582
Q92504,0.16666666666666666,6,1295485.328125,5.014753759835457e-6,1.7593509487340557,0.8150432949169009,0.07356663745892655,0.6429522395902524,raw,1137652.0625,711988.25,981696.015625,2054407.9375,1252637.203125,1634530.5,Zinc transporter SLC39A7 OS=Homo sapiens OX=9606 GN=SLC39A7 PE=1 SV=2,conjugation;metabolic process,cytoskeleton;extracellular;membrane,catalytic activity,7922,SLC39A7,Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis,Zinc influx into cells by the SLC39 gene family,ENSG00000112473; ENSG00000206288; ENSG00000224399; ENSG00000226614; ENSG00000227402; ENSG00000229802
P41214,0,6,1765510.15,6.8341944679174985e-6,1.7583955014191999,0.8142596004941213,0.09446280420861555,0.6429522395902524,raw,1447366.25,NA,919660.3125,2567102.125,1603109.6875,2290312.375,Eukaryotic translation initiation factor 2D OS=Homo sapiens OX=9606 GN=EIF2D PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,1939,EIF2D,NA,NA,ENSG00000143486
P53618,0,6,95984855.59895833,3.715521936468397e-4,1.7572061903287048,0.8132834869134425,0.019070298148458495,0.6429522395902524,raw,66421323,80589409.3125,58127440.34375,138172098.9375,102141898,130456964,Coatomer subunit beta OS=Homo sapiens OX=9606 GN=COPB1 PE=1 SV=3,conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,1315,COPB1,NA,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Neutrophil degranulation,ENSG00000129083
Q9UNY4,0,6,269202.521875,1.0420684275010055e-6,1.7568101375154153,0.8129582844221764,0.37604985320455614,0.8615698665976935,raw,241547.828125,243920.96875,153519.21875,254764.0625,NA,452260.53125,Transcription termination factor 2 OS=Homo sapiens OX=9606 GN=TTF2 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation,cytosol;membrane,RNA binding;structural molecule activity,8458,TTF2,Thyroid stimulating hormone (TSH) signaling pathway; Thyroid hormones production and peripheral downstream signaling effects,NA,ENSG00000116830
Q8NEY8,0,6,1765388.5872395833,6.833723905035294e-6,1.7560668674738809,0.8123477808278623,0.011719913940899097,0.6429522395902524,raw,1140890.078125,1223761,1623501.7578125,2432223.84375,2003479.265625,2168475.578125,Periphilin-1 OS=Homo sapiens OX=9606 GN=PPHLN1 PE=1 SV=2,cell growth;metabolic process,cytosol;extracellular;membrane;nucleus,NA,51535,PPHLN1,NA,NA,ENSG00000134283
Q13643,0,6,3948390.4505208335,1.5284006254015455e-5,1.7556264654101963,0.8119859235605114,0.01537095374536067,0.6429522395902524,raw,2573493.171875,2778723.8125,3295645.59375,5785922.625,4611642.6875,4644914.8125,Four and a half LIM domains protein 3 OS=Homo sapiens OX=9606 GN=FHL3 PE=1 SV=4,cell growth;cellular component movement;metabolic process,endoplasmic reticulum;membrane,motor activity;structural molecule activity,2275,FHL3,NA,NA,ENSG00000183386
Q96M27,0,6,7291210.130208333,2.822388074987494e-5,1.7545590120861367,0.8111084715430346,0.03597250951533821,0.6429522395902524,raw,6486948.90625,4203149.84375,4547757.21875,10042062.875,7374674.4375,11092667.5,Protein PRRC1 OS=Homo sapiens OX=9606 GN=PRRC1 PE=1 SV=1,metabolic process,extracellular;nucleus,structural molecule activity,133619,PRRC1,NA,NA,ENSG00000164244
Q8TAF3,0,6,2660073.1145833335,1.0296999404926383e-5,1.7534019881728333,0.8101567889431884,0.05073814896726618,0.6429522395902524,raw,2031379.921875,2154725.640625,1777691.5625,3790235.6875,2644580.28125,3561825.59375,WD repeat-containing protein 48 OS=Homo sapiens OX=9606 GN=WDR48 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;membrane;mitochondrion;nucleus,DNA binding;RNA binding;structural molecule activity,57599,WDR48,"DNA repair pathways, full network",Ub-specific processing proteases; Fanconi Anemia Pathway; Signaling by cytosolic PDGFRA and PDGFRB fusion proteins; Recognition of DNA damage by PCNA-containing replication complex,ENSG00000114742
Q9GZR2,0,6,426577.5390625,1.651258622103531e-6,1.7527441843922023,0.8096154479855552,0.10623371753901464,0.6429522395902524,raw,NA,328161.8125,290879.09375,594978.5,492290.75,NA,RNA exonuclease 4 OS=Homo sapiens OX=9606 GN=REXO4 PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane,RNA binding;structural molecule activity,57109,REXO4,NA,NA,ENSG00000148300; ENSG00000280706
Q15477,0.6666666666666666,6,432863.84375,1.675592568141143e-6,1.7513667975408411,0.8084812662815882,9.915244436558915e-4,0.6429522395902524,raw,304501.59375,NA,291700.34375,546368.6875,500429.0625,521319.53125,Helicase SKI2W OS=Homo sapiens OX=9606 GN=SKIV2L PE=1 SV=3,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,6499,SKIV2L,NA,Association of TriC/CCT with target proteins during biosynthesis; mRNA decay by 3' to 5' exoribonuclease,ENSG00000204351; ENSG00000206353; ENSG00000223493; ENSG00000225737; ENSG00000228896; ENSG00000232616
Q99720,0,6,4992280.458333333,1.932484811295721e-5,1.7510535894946364,0.8082232368925958,0.24400554716376846,0.7301988479077035,raw,3563528.1875,3850147.75,4315633.625,7253944.6875,3413522.75,7556905.75,Sigma non-opioid intracellular receptor 1 OS=Homo sapiens OX=9606 GN=SIGMAR1 PE=1 SV=1,cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,10280,SIGMAR1,NA,Potential therapeutics for SARS,ENSG00000147955
A0A5F9ZHS3,0,6,553302.4270833334,2.1418038215516588e-6,1.7497557556430559,0.8071535536492331,1,1,raw,NA,365571.0625,534577.46875,NA,759758.75,NA,Menin OS=Homo sapiens OX=9606 GN=MEN1 PE=1 SV=1,NA,membrane,RNA binding,4221,MEN1,NA,NA,ENSG00000133895
Q8IV38,0,6,1357109.640625,5.253298146327213e-6,1.749491631534127,0.8069357636500173,0.45451327911941525,0.9378739936202032,raw,1650224.0625,1094643,407753.53125,2887053.1875,1271703,831281.0625,Ankyrin repeat and MYND domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ANKMY2 PE=1 SV=1,NA,nucleus,structural molecule activity,57037,ANKMY2,NA,NA,ENSG00000106524
P55145,0,6,40758101.348958336,1.5777240972637388e-4,1.7494088850847633,0.8068675262756746,0.05714763295644519,0.6429522395902524,raw,30253265.125,33231959.15625,27350715.3125,52925330.8125,40587683.0625,60199654.625,Mesencephalic astrocyte-derived neurotrophic factor OS=Homo sapiens OX=9606 GN=MANF PE=1 SV=3,cell growth;coagulation;defense response;development;metabolic process,cell surface;cytosol;extracellular;nucleus,antioxidant activity;structural molecule activity,7873,MANF,NA,Platelet degranulation,ENSG00000145050
Q92572,0,6,20290131.221354168,7.854200246104436e-5,1.7493607667809206,0.8068278437328142,0.02273229883325089,0.6429522395902524,raw,14677071,16386942.6875,13771650.765625,26433657.25,21804791,28666674.625,AP-3 complex subunit sigma-1 OS=Homo sapiens OX=9606 GN=AP3S1 PE=1 SV=1,cell growth;conjugation;development,cytoskeleton;extracellular;mitochondrion;nucleus,NA,1176,AP3S1,NA,Golgi Associated Vesicle Biogenesis,ENSG00000177879
Q8N4F7,0.5,6,5923315.853515625,2.2928835859609474e-5,1.7493285002500767,0.8068012333307558,0.013107193218941372,0.6429522395902524,raw,4662297.26171875,3959813.4140625,4423317.5,7800823.5625,6537753.90625,8155889.4765625,RING finger protein 175 OS=Homo sapiens OX=9606 GN=RNF175 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation,cytoskeleton;extracellular,structural molecule activity,285533,RNF175,NA,NA,ENSG00000145428
Q9HBH5,0,6,2260642.9921875,8.75082696700683e-6,1.7491514869627212,0.8066552406750936,0.06739452697517966,0.6429522395902524,raw,1220345.78125,1715234.03125,2192291.171875,3276588.0625,3000204.15625,2159194.75,Retinol dehydrogenase 14 OS=Homo sapiens OX=9606 GN=RDH14 PE=1 SV=1,cellular homeostasis,cytoskeleton;cytosol;extracellular;membrane,structural molecule activity,57665,RDH14,NA,RA biosynthesis pathway,ENSG00000240857
O00560,0,6,1110743.6041666667,4.299628520895549e-6,1.7483361854893178,0.8059826256302551,0.18027576807786777,0.6742444420587625,raw,525391.6875,863520.0625,839761.296875,1468185.0625,837399.328125,2130204.1875,Syntenin-1 OS=Homo sapiens OX=9606 GN=SDCBP PE=1 SV=1,cell death;cell growth;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;structural molecule activity,6386,SDCBP,Ectoderm differentiation; Ectoderm differentiation; VEGFA-VEGFR2 signaling pathway,Neutrophil degranulation; Ephrin signaling; Neurofascin interactions; Regulation of necroptotic cell death,ENSG00000137575
A3KMH1,0,6,1037155.8072916666,4.014774132315929e-6,1.7483086653869828,0.8059599163664566,0.053440315233860426,0.6429522395902524,raw,375806,954483.84375,816857.125,1266884.21875,1140171.28125,1668732.375,von Willebrand factor A domain-containing protein 8 OS=Homo sapiens OX=9606 GN=VWA8 PE=1 SV=2,NA,endosome;mitochondrion;nucleus,structural molecule activity,23078,VWA8,NA,NA,ENSG00000102763
P49902,0,6,22072074.411458332,8.54398083399588e-5,1.747943628390527,0.8056586583208751,0.03500962358999208,0.6429522395902524,raw,19021629.59375,13382450.25,13440727.25,33248736.25,22336345.78125,31002557.34375,Cytosolic purine 5'-nucleotidase OS=Homo sapiens OX=9606 GN=NT5C2 PE=1 SV=1,cellular homeostasis,cytosol,signal transducer activity;structural molecule activity,22978,NT5C2,NA,Purine catabolism; Ribavirin ADME; Abacavir metabolism,ENSG00000076685
Q9ULX6,0,6,20723840.03125,8.022086584751493e-5,1.7478339218008436,0.8055681072771268,0.06631150291409679,0.6429522395902524,raw,16762076.625,15286603.375,14445015.0625,29297326.125,19992804.5,28559214.5,A-kinase anchor protein 8-like OS=Homo sapiens OX=9606 GN=AKAP8L PE=1 SV=4,cell differentiation;cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,26993,AKAP8L,NA,NA,ENSG00000011243
P14209,0,6,2958573.1822916665,1.14524770505266e-5,1.7469999211574136,0.8048795431454504,0.059832148511667224,0.6429522395902524,raw,2803663.75,622297.9375,2216441.75,3872123.5625,3504879.28125,4732032.8125,CD99 antigen OS=Homo sapiens OX=9606 GN=CD99 PE=1 SV=1,cell communication;metabolic process,cytoplasm;cytoskeleton;nucleus,NA,4267,CD99,NA,Cell surface interactions at the vascular wall; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,ENSG00000002586
O60488,0,6,20933986.265625,8.103433057464738e-5,1.7462874611342012,0.8042910644753116,0.09937162933153215,0.6429522395902524,raw,15169612.1875,18282597.953125,14320807.296875,31926671.5625,19321921.15625,26582307.4375,Long-chain-fatty-acid--CoA ligase 4 OS=Homo sapiens OX=9606 GN=ACSL4 PE=1 SV=2,cellular homeostasis;defense response;metabolic process,cytoplasm;cytoskeleton;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,2182,ACSL4,Fatty acid beta-oxidation; Fatty acid biosynthesis; Mitochondrial long chain fatty acid beta-oxidation; PPAR signaling pathway; Ferroptosis; Thermogenesis; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-3 / omega-6 fatty acid synthesis; Omega-9 fatty acid synthesis; Fatty acid transporters,Synthesis of very long-chain fatty acyl-CoAs; Intracellular metabolism of fatty acids regulates insulin secretion,ENSG00000068366
Q9H4A5,0,6,1178440.0208333333,4.5616776947738015e-6,1.745632601093999,0.8037499505169647,0.03782908719572509,0.6429522395902524,raw,1020659,551088.5,923501.5,1595012.75,1198682.75,1781695.625,Golgi phosphoprotein 3-like OS=Homo sapiens OX=9606 GN=GOLPH3L PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular,structural molecule activity,55204,GOLPH3L,NA,NA,ENSG00000143457
O14957,0,6,1244217.0833333333,4.816297152301907e-6,1.7443418136318711,0.8026827720600059,0.1818083408209031,0.6743269455727479,raw,1364788.625,561045.5,841335.625,1668107.5,978655.125,2051370.125,Cytochrome b-c1 complex subunit 10 OS=Homo sapiens OX=9606 GN=UQCR11 PE=1 SV=1,cellular homeostasis,cytoskeleton;endosome,structural molecule activity,10975,UQCR11,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,Respiratory electron transport,ENSG00000127540
Q96GZ6,0.5,6,201849.2328125,7.813474820524701e-7,1.744229096848981,0.8025895442323768,0.2553812873272836,0.7353938702424432,raw,141567.125,202952.328125,116440.3671875,333333,NA,214953.34375,Solute carrier family 41 member 3 OS=Homo sapiens OX=9606 GN=SLC41A3 PE=1 SV=2,conjugation,cytoplasm;cytoskeleton;endosome,catalytic activity,54946,SLC41A3,NA,NA,ENSG00000114544
Q8WVM8,0,6,11444038.1484375,4.429925379057627e-5,1.744009415051533,0.8024078285388602,0.02949282431842273,0.6429522395902524,raw,9146008.65625,8442837.484375,7673101.265625,14724388.0625,12192275.953125,16485617.46875,Sec1 family domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SCFD1 PE=1 SV=4,coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular,structural molecule activity,23256,SCFD1,NA,RHOA GTPase cycle; COPII-mediated vesicle transport,ENSG00000092108
Q8TBE9,0,6,357390.040625,1.3834375511962848e-6,1.7440076970922764,0.802406407392564,0.145355901082612,0.6572502130392559,raw,290596.75,NA,200270.296875,447139.875,282477.21875,566466.0625,N-acylneuraminate-9-phosphatase OS=Homo sapiens OX=9606 GN=NANP PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,140838,NANP,NA,Sialic acid metabolism,ENSG00000170191
Q9H6Y2,0,6,7137698.158854167,2.7629644197121193e-5,1.7437849174805242,0.8022221056997509,0.2029702972598458,0.6931052503234328,raw,5554682.53125,4735319.21875,6247917.09375,10146606.421875,5246640.09375,10895023.59375,WD repeat-containing protein 55 OS=Homo sapiens OX=9606 GN=WDR55 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,NA,54853,WDR55,NA,NA,ENSG00000120314
Q5T4S7,0,6,56878754.053385414,2.2017458596524444e-4,1.7417192935459493,0.800512128849799,0.08296584462207326,0.6429522395902524,raw,41803443.328125,45801827.9375,40665989.5859375,85483459.03125,54707940.65625,72809863.78125,E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens OX=9606 GN=UBR4 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane,structural molecule activity,23352,UBR4,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neutrophil degranulation,ENSG00000127481
Q96AG4,0,6,160241532.8125,6.202863218191116e-4,1.7416722429525144,0.8004731555347914,0.09308295480582861,0.6429522395902524,raw,117859027.125,126454638.1875,109451652.0625,205271796.125,151899987.375,250512096,Leucine-rich repeat-containing protein 59 OS=Homo sapiens OX=9606 GN=LRRC59 PE=1 SV=1,development;metabolic process,cytoskeleton;endosome;extracellular;membrane,NA,55379,LRRC59,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000108829
Q99755,0,6,2399984.6744791665,9.290211095876338e-6,1.7413397185337294,0.8001976862933888,0.0070018501324807065,0.6429522395902524,raw,1771335.6875,1332425.7109375,1988133.9609375,3452578.375,2770937.125,3084497.1875,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Homo sapiens OX=9606 GN=PIP5K1A PE=1 SV=1,cell communication;cell growth;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,8394,PIP5K1A,B cell receptor signaling pathway; Regulation of actin cytoskeleton,"Synthesis of PIPs at the plasma membrane; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",ENSG00000143398
O15551,0,6,13574877.291666666,5.2547617066583964e-5,1.7410633149032024,0.7999686684892728,0.07561789462813913,0.6429522395902524,raw,10586434,8697750.375,10544101.25,18357947.875,12843221.375,20419808.875,Claudin-3 OS=Homo sapiens OX=9606 GN=CLDN3 PE=1 SV=1,cell communication;cell growth;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,1365,CLDN3,Epithelial to mesenchymal transition in colorectal cancer; 22q11.2 copy number variation syndrome; IL-18 signaling pathway; 7q11.23 copy number variation syndrome,Tight junction interactions,ENSG00000165215
O15344,0,6,754250.109375,2.9196614502141455e-6,1.7409069237524426,0.7998390724718876,0.17918936678204564,0.6741527184744509,raw,735321.5625,580844.875,422893.875,736218.875,766345.75,1283875.71875,E3 ubiquitin-protein ligase Midline-1 OS=Homo sapiens OX=9606 GN=MID1 PE=1 SV=1,cell growth;defense response;metabolic process,cytosol;endoplasmic reticulum;extracellular;nucleus,motor activity;structural molecule activity,4281,MID1,NA,Interferon gamma signaling,ENSG00000101871
Q6XZF7,0,6,8810757.38671875,3.410596613702647e-5,1.740609931106184,0.7995929327363415,0.04351295550892336,0.6429522395902524,raw,7401676.8828125,5526188.90625,6567483.7421875,12883432.2890625,8842464.953125,11643297.546875,Dynamin-binding protein OS=Homo sapiens OX=9606 GN=DNMBP PE=1 SV=1,development;metabolic process,cytosol;endoplasmic reticulum;extracellular;nucleus,DNA binding,23268,DNMBP,NA,CDC42 GTPase cycle,ENSG00000107554
Q16222,0,6,7165038.317708333,2.7735476475906522e-5,1.7405415324982678,0.7995362398095965,0.004960340337010484,0.6429522395902524,raw,5850429.125,5154174.53125,4531296.75,10182914.875,8835856.8125,8435557.8125,UDP-N-acetylhexosamine pyrophosphorylase OS=Homo sapiens OX=9606 GN=UAP1 PE=1 SV=3,cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane,structural molecule activity,6675,UAP1,NA,Synthesis of UDP-N-acetyl-glucosamine,ENSG00000117143
P62979,0,6,2078435225.9570317,0.008045510541619035,1.7400774891427142,0.7991515536100333,0.015487808252287686,0.6429522395902524,raw,1587543132.75,1522568109.125,1353437127.55469,2649386492.375,2352464834.34375,3005211659.59375,Ubiquitin-40S ribosomal protein S27a OS=Homo sapiens OX=9606 GN=RPS27A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;Golgi;membrane;mitochondrion,structural molecule activity,6233,RPS27A,Cytoplasmic ribosomal proteins,"Oxidative Stress Induced Senescence; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); ER-Phagosome pathway; SARS-CoV-2 modulates host translation machinery; SARS-CoV-1 modulates host translation machinery; FCERI mediated NF-kB activation; Downstream TCR signaling; E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; Stimuli-sensing channels; Amyloid fiber formation; Fanconi Anemia Pathway; Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Aggrephagy; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Regulation of PLK1 Activity at G2/M Transition; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; NOTCH3 Activation and Transmission of Signal to the Nucleus; Peroxisomal protein import; Regulation of TP53 Degradation; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon; IKK complex recruitment mediated by RIP1; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; ER Quality Control Compartment (ERQC); SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Deactivation of the beta-catenin transactivating complex; Regulation of TP53 Activity through Phosphorylation; Circadian Clock; Regulation of signaling by CBL; Metalloprotease DUBs; Regulation of necroptotic cell death; Oncogene Induced Senescence; Cyclin D associated events in G1; APC/C:Cdc20 mediated degradation of Cyclin B; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Negative regulation of FLT3; Downregulation of ERBB2:ERBB3 signaling; Cargo recognition for clathrin-mediated endocytosis; Inactivation of CSF3 (G-CSF) signaling; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; Regulation of TP53 Activity through Methylation; Processing of DNA double-strand break ends; Regulation of BACH1 activity; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; p75NTR recruits signalling complexes; NF-kB is activated and signals survival; TAK1-dependent IKK and NF-kappa-B activation  ; Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway; MAP3K8 (TPL2)-dependent MAPK1/3 activation; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; Regulation of NF-kappa B signaling; Termination of translesion DNA synthesis; Negative regulators of DDX58/IFIH1 signaling; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Prevention of phagosomal-lysosomal fusion; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity; HDR through Homologous Recombination (HRR); NOTCH1 Intracellular Domain Regulates Transcription; TICAM1-dependent activation of IRF3/IRF7; TICAM1,TRAF6-dependent induction of TAK1 complex; Glycogen synthesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Modulation by Mtb of host immune system; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; SARS-CoV-1 activates/modulates innate immune responses; Alpha-protein kinase 1 signaling pathway; Ovarian tumor domain proteases; Spry regulation of FGF signaling; RAS processing; PINK1-PRKN Mediated Mitophagy; Josephin domain DUBs; Regulation of FZD by ubiquitination; Chaperone Mediated Autophagy; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; InlA-mediated entry of Listeria monocytogenes into host cells; Formation of Incision Complex in GG-NER; Iron uptake and transport; Recognition of DNA damage by PCNA-containing replication complex; VLDLR internalisation and degradation; Myoclonic epilepsy of Lafora; DNA Damage Recognition in GG-NER; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Negative regulation of MAPK pathway; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); NRIF signals cell death from the nucleus; Assembly Of The HIV Virion; Dual Incision in GG-NER; Translesion Synthesis by POLH; Downregulation of ERBB4 signaling; Regulation of innate immune responses to cytosolic DNA; N-glycan trimming in the ER and Calnexin/Calreticulin cycle; Gap-filling DNA repair synthesis and ligation in GG-NER; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1; Regulation of PTEN localization; Pexophagy; Maturation of protein E; Maturation of protein E; FLT3 signaling by CBL mutants; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling",ENSG00000143947
Q5T0D9,0,6,480865.09375,1.8614028152264543e-6,1.739296784653761,0.7985041277081998,0.22775956479976053,0.7148463313429879,raw,257616.5625,330017.5625,NA,961040.71875,352373.125,503277.5,Tumor protein p63-regulated gene 1-like protein OS=Homo sapiens OX=9606 GN=TPRG1L PE=1 SV=1,metabolic process,cytoskeleton;extracellular;nucleus,NA,127262,TPRG1L,NA,NA,ENSG00000158109
P62191,0,6,118777860.20833333,4.5978268385875304e-4,1.7392583956413246,0.7984722848107907,0.04824363339679358,0.6429522395902524,raw,92378813.34375,95114821.4375,80410880.21875,160670626.6875,118607259.1875,165484760.375,26S proteasome regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMC1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5700,PSMC1,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; N-glycan trimming in the ER and Calnexin/Calreticulin cycle,ENSG00000100764
Q71DI3,0,6,46352951.4921875,1.7942977255585644e-4,1.738888052694539,0.798165056841692,0.9552471294592569,1,raw,121161870.375,1544825.1875,20291376.90625,87889884.375,11945319.234375,35284432.875,Histone H3.2 OS=Homo sapiens OX=9606 GN=H3C15 PE=1 SV=3,cell growth,cell surface;membrane;nucleus,RNA binding;structural molecule activity,126961; 333932; 653604,H3C13; H3C14; H3C15,Histone modifications; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,Amyloid fiber formation; HCMV Late Events; RUNX1 regulates transcription of genes involved in differentiation of HSCs; HCMV Early Events; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Interleukin-7 signaling; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); Factors involved in megakaryocyte development and platelet production; RMTs methylate histone arginines; HDMs demethylate histones; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; HATs acetylate histones; RNA Polymerase I Promoter Escape; Meiotic recombination; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Condensation of Prophase Chromosomes; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis,ENSG00000183598; ENSG00000203811; ENSG00000203852
P84157,0,6,8360244.505208333,3.236205509661469e-5,1.7385010813157105,0.7978439643956117,0.03923249184593315,0.6429522395902524,raw,5670364.0625,5464118.28125,7168148.1875,10826472.4375,8570530.6875,12461833.375,Matrix-remodeling-associated protein 7 OS=Homo sapiens OX=9606 GN=MXRA7 PE=1 SV=1,NA,cytoskeleton;extracellular,NA,439921,MXRA7,NA,NA,ENSG00000182534
O95757,0,6,28891751.129231784,1.1183840870914564e-4,1.7379905236624484,0.7974202159253494,0.10107644255127558,0.6429522395902524,raw,21483049.609375,24940898.703125,19160030.0625,38430964.3964844,25988518.40625,43347045.5976563,Heat shock 70 kDa protein 4L OS=Homo sapiens OX=9606 GN=HSPA4L PE=1 SV=3,coagulation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,22824,HSPA4L,NA,Regulation of HSF1-mediated heat shock response,ENSG00000164070
P29084,0,6,3994230.1536458335,1.5461449269853033e-5,1.7369345609938716,0.7965434015393705,0.08167860583788111,0.6429522395902524,raw,2707412.375,4111751.0625,2054805,4702598.125,4093602.671875,6295211.6875,Transcription initiation factor IIE subunit beta OS=Homo sapiens OX=9606 GN=GTF2E2 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane,RNA binding;structural molecule activity,2961,GTF2E2,Eukaryotic transcription initiation,RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,ENSG00000197265
P01111,0,6,3325268.0104166665,1.2871932931754943e-5,1.7358643068864235,0.7956541762194306,0.0539782687628277,0.6429522395902524,raw,2395099.4375,2799283.375,2179666.75,4157567.625,3382255.25,5037735.625,GTPase NRas OS=Homo sapiens OX=9606 GN=NRAS PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular,structural molecule activity,4893,NRAS,"Alzheimer's disease and miRNA effects; Glioblastoma signaling pathways; RalA downstream regulated genes; TNF-alpha signaling pathway; Aryl hydrocarbon receptor pathway; Bladder cancer; Extracellular vesicle-mediated signaling in recipient cells; RAC1/PAK1/p38/MMP2 pathway; G protein signaling pathways; BDNF-TrkB signaling; MAPK signaling pathway; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; MAPK cascade; Ras signaling; Non-small cell lung cancer; Breast cancer pathway; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Thermogenesis; Non-genomic actions of 1,25 dihydroxyvitamin D3; Relationship between inflammation, COX-2 and EGFR; Envelope proteins and their potential roles in EDMD physiopathology; Synaptic signaling pathways associated with autism spectrum disorder; Hippo-Merlin signaling dysregulation; Hepatitis B infection; Head and neck squamous cell carcinoma; Melanoma; EGFR tyrosine kinase inhibitor resistance; Kisspeptin/kisspeptin receptor system in the ovary; CCL18 signaling pathway; Regulation of actin cytoskeleton; Alzheimer's disease; GDNF signaling; ErbB signaling pathway; DNA damage response (only ATM dependent); Serotonin receptor 2 and ELK-SRF/GATA4 signaling","FCERI mediated MAPK activation; Regulation of RAS by GAPs; Neutrophil degranulation; Signaling by BRAF and RAF1 fusions; Signaling by SCF-KIT; Downstream signal transduction; Tie2 Signaling; DAP12 signaling; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants; Signaling by PDGFRA extracellular domain mutants; SHC1 events in ERBB2 signaling; SHC1 events in ERBB4 signaling; GRB2 events in ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; RAF activation; Ras activation upon Ca2+ influx through NMDA receptor; GRB2 events in EGFR signaling; SHC1 events in EGFR signaling; NCAM signaling for neurite out-growth; Signaling by FGFR1 in disease; p38MAPK events; SHC-mediated cascade:FGFR1; FRS-mediated FGFR1 signaling; SHC-mediated cascade:FGFR2; FRS-mediated FGFR2 signaling; Signaling by FGFR2 in disease; VEGFR2 mediated cell proliferation; Estrogen-stimulated signaling through PRKCZ; SHC-mediated cascade:FGFR3; FRS-mediated FGFR3 signaling; FRS-mediated FGFR4 signaling; SHC-mediated cascade:FGFR4; Signaling by FGFR3 in disease; FLT3 Signaling; Activated NTRK2 signals through FRS2 and FRS3; RAS processing; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Erythropoietin activates RAS; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; CD209 (DC-SIGN) signaling; Activation of RAS in B cells; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; EGFR Transactivation by Gastrin; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; SOS-mediated signalling; SHC-related events triggered by IGF1R; Signaling by FGFR4 in disease; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants; RAS signaling downstream of NF1 loss-of-function variants; Insulin receptor signalling cascade; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases; MET activates RAS signaling; Activated NTRK2 signals through RAS; Activated NTRK3 signals through RAS; Constitutive Signaling by Overexpressed ERBB2; Signaling by FLT3 fusion proteins; Signaling by FLT3 ITD and TKD mutants; Signaling by RAS GAP mutants; Signaling by RAS GTPase mutants",ENSG00000213281
P62714,0,6,79319693.65104167,3.070422515253508e-4,1.7351933201704028,0.7950964043102479,0.0512246592299828,0.6429522395902524,raw,60396267.46875,60402805.875,50754137.5,119294388.15625,80271363.03125,104799199.875,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform OS=Homo sapiens OX=9606 GN=PPP2CB PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,5516,PPP2CB,Serotonin transporter activity; Dopamine metabolism; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Wnt signaling pathway and pluripotency; Exercise-induced circadian regulation; PI3K-Akt signaling pathway; 16p11.2 proximal deletion syndrome; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome; Monoamine transport,"Regulation of TP53 Degradation; Cyclin D associated events in G1; Cyclin A/B1/B2 associated events during G2/M transition; RAF activation; Negative regulation of MAPK pathway; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Spry regulation of FGF signaling; MASTL Facilitates Mitotic Progression; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; Platelet sensitization by LDL; CTLA4 inhibitory signaling; Inhibition of replication initiation of damaged DNA by RB1/E2F1; DARPP-32 events; PP2A-mediated dephosphorylation of key metabolic factors; ERKs are inactivated",ENSG00000104695
Q5FWF5,0.6666666666666666,6,1142164.8854166667,4.4212586041287885e-6,1.7342507893098733,0.7943125411962079,0.008210628487954254,0.6429522395902524,raw,724921.25,990950.1875,818030,1529770.625,1257195.25,1532122,N-acetyltransferase ESCO1 OS=Homo sapiens OX=9606 GN=ESCO1 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,114799,ESCO1,Cohesin complex - Cornelia de Lange syndrome,Establishment of Sister Chromatid Cohesion,ENSG00000141446
Q9H2P9,0.16666666666666666,6,219182.03255208334,8.484418140186626e-7,1.7335698602891718,0.7937459761784337,0.22881270909571585,0.7149130481267827,raw,280349.375,106732.671875,104965.1328125,282138.375,181964.390625,358942.25,Diphthine methyl ester synthase OS=Homo sapiens OX=9606 GN=DPH5 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol,structural molecule activity,51611,DPH5,NA,Synthesis of diphthamide-EEF2,ENSG00000117543
Q8N357,0,6,2812192.265625,1.0885844425451053e-5,1.7333915319082478,0.7935975617936558,0.07055401037420819,0.6429522395902524,raw,887897.375,2370380.625,2605447.53125,4516260.6875,3100737.6875,3392429.6875,Solute carrier family 35 member F6 OS=Homo sapiens OX=9606 GN=SLC35F6 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;endosome;membrane;mitochondrion;nucleus,catalytic activity,54978,SLC35F6,NA,NA,ENSG00000213699
P43686,0,6,95200170.453125,3.685147198137319e-4,1.7332552592844312,0.7934841381595031,0.05120021368770687,0.6429522395902524,raw,77794895.8125,72151053.5,59730270.875,134838412.3125,93151884.40625,133534505.8125,26S proteasome regulatory subunit 6B OS=Homo sapiens OX=9606 GN=PSMC4 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5704,PSMC4,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000013275; ENSG00000281221
Q9H2U1,0,6,1496151.0833333333,5.791520063980056e-6,1.7330153179448602,0.7932844063881116,0.17892561265521173,0.6741527184744509,raw,1194469.765625,927523.25,826342.546875,1392313.65625,1607412,3028845.28125,ATP-dependent DNA/RNA helicase DHX36 OS=Homo sapiens OX=9606 GN=DHX36 PE=1 SV=2,cell growth;cellular component movement;coagulation;metabolic process,cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,170506,DHX36,VEGFA-VEGFR2 signaling pathway,DEx/H-box helicases activate type I IFN and inflammatory cytokines production,ENSG00000174953
Q9H1I8,0,6,2432657.7083333335,9.416686645856172e-6,1.7326635270974065,0.7929915189421091,0.03787052805697256,0.6429522395902524,raw,1198226.0625,1932167.75,2136724.90625,3077972.125,2548630.09375,3702225.3125,Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens OX=9606 GN=ASCC2 PE=1 SV=3,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,84164,ASCC2,NA,ALKBH3 mediated reversal of alkylation damage,ENSG00000100325
Q8TBQ9,0,6,3898445.53125,1.5090672168124576e-5,1.7317009877474443,0.7921898418803375,0.03731543865666559,0.6429522395902524,raw,3387252.5,2647529.5,2399165.6875,5865708.5,3992470.125,5098546.875,Protein kish-A OS=Homo sapiens OX=9606 GN=TMEM167A PE=1 SV=1,conjugation,cytoskeleton;extracellular,NA,153339,TMEM167A,NA,NA,ENSG00000174695
P29353,0,6,2254509.34375,8.727083945070812e-6,1.7303050470833092,0.7910264026705817,0.07670201360565902,0.6429522395902524,raw,2369527.5,1482166.6875,1546890.125,2837725.125,2726146.125,2564600.5,SHC-transforming protein 1 OS=Homo sapiens OX=9606 GN=SHC1 PE=1 SV=4,cell communication;cell growth;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome,antioxidant activity;structural molecule activity,6464,SHC1,IL-5 signaling pathway; Integrin-mediated cell adhesion; Leptin signaling pathway; Prolactin signaling pathway; B cell receptor signaling pathway; AGE/RAGE pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; IL6 signaling pathway; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; BDNF-TrkB signaling; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; IL-4 signaling pathway; p38 MAPK signaling pathway; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Breast cancer pathway; EGF/EGFR signaling pathway; Fragile X syndrome; Gastrin signaling pathway; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; mBDNF and proBDNF regulation of GABA neurotransmission; IL-2 signaling pathway; MAPK pathway in congenital thyroid cancer; Malignant pleural mesothelioma; GDNF signaling; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response (only ATM dependent),Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; Constitutive Signaling by Overexpressed ERBB2; RET signaling; Interleukin receptor SHC signaling; RAF/MAP kinase cascade; Tie2 Signaling; SHC1 events in ERBB2 signaling; SHC1 events in ERBB4 signaling; Signaling by CSF3 (G-CSF); XBP1(S) activates chaperone genes; SHC1 events in EGFR signaling; Integrin signaling; Erythropoietin activates RAS; Signalling to RAS; Signal attenuation; Interleukin-2 signaling; Interleukin-15 signaling,ENSG00000160691
P51452,0,6,2556189.453125,9.894871360267134e-6,1.730136920586307,0.7908862152228949,0.25112713016719224,0.7326612824296702,raw,1884606.125,2276718.90625,1863261.75,3640197.625,1733316.875,3939035.4375,Dual specificity protein phosphatase 3 OS=Homo sapiens OX=9606 GN=DUSP3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytosol;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,1845,DUSP3,MAPK signaling pathway; Fragile X syndrome,ERKs are inactivated,ENSG00000108861
A0A140T9T7,0,6,4072279.1145833335,1.5763572583653164e-5,1.7288707947593729,0.7898300547956515,0.07059314867760276,0.6429522395902524,raw,2137551.234375,4189213.90625,2919558.796875,5365879.5625,5047539.9375,4773931.25,Antigen peptide transporter 1 OS=Homo sapiens OX=9606 GN=TAP1 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;extracellular,antioxidant activity;catalytic activity;structural molecule activity,NA,TAP1,NA,NA,ENSG00000224748
Q9Y6D9,0,6,3655408.5729166665,1.4149889224372504e-5,1.7282906077645546,0.7893458234794858,0.1611072602813067,0.6638855679885327,raw,2016452.3125,4335896.84375,2335462.375,3984059.46875,4036357.6875,5224222.75,Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens OX=9606 GN=MAD1L1 PE=1 SV=2,cell differentiation;cell growth;defense response;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,8379,MAD1L1,Cell cycle; Regulation of sister chromatid separation at the metaphase-anaphase transition; Malignant pleural mesothelioma; CCL18 signaling pathway,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000002822
J3KPT4,0,6,2965838.8072916665,1.1480601892618821e-5,1.7275423512369497,0.7887210791637943,0.2830992081332379,0.7643417997205958,raw,2410715.84375,2670121.3125,1278611.5625,6090680.25,2208855.625,3136048.25,TraB domain-containing protein OS=Homo sapiens OX=9606 GN=TRABD PE=1 SV=1,NA,NA,NA,80305,TRABD,NA,NA,ENSG00000170638
P23381,0,6,74046092.2890625,2.8662842538334853e-4,1.7267991890715568,0.7881003204029022,0.09703588933712304,0.6429522395902524,raw,63564193.53125,54708240.71875,51360299.453125,97201695.375,67679526.8125,109762597.84375,"Tryptophan--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=WARS1 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,7453,WARS1,Photodynamic therapy-induced unfolded protein response; Amino acid metabolism,Cytosolic tRNA aminoacylation,ENSG00000140105
Q5T3F8,0,6,419196.871875,1.6226884579148105e-6,1.7260501018963272,0.7874743420998936,0.16365102134459547,0.6638855679885327,raw,232842.359375,NA,306631.78125,439444.59375,364350.5625,752715.0625,CSC1-like protein 2 OS=Homo sapiens OX=9606 GN=TMEM63B PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;endoplasmic reticulum,catalytic activity,55362,TMEM63B,NA,NA,ENSG00000137216
Q8TBB5,0,6,3143911.2734375,1.21699107946505e-5,1.7258281957472539,0.7872888529988031,0.045499705728250836,0.6429522395902524,raw,2052006.9375,2816677.765625,2060498.96875,4861101.90625,3368454.9375,3704727.125,Kelch domain-containing protein 4 OS=Homo sapiens OX=9606 GN=KLHDC4 PE=1 SV=1,NA,NA,NA,54758,KLHDC4,NA,NA,ENSG00000104731
Q9NPL8,0,6,2161592.2552083335,8.367406912069072e-6,1.724718366852317,0.7863608001995572,0.08512722512470179,0.6429522395902524,raw,1343088.5625,2009368.1875,1320687,2829036.125,2001779.4375,3465594.21875,"Complex I assembly factor TIMMDC1, mitochondrial OS=Homo sapiens OX=9606 GN=TIMMDC1 PE=1 SV=2",NA,cytoskeleton;endosome;membrane,NA,51300,TIMMDC1,NA,Complex I biogenesis,ENSG00000113845
Q9P2R3,0,6,10929625.921875,4.230799183549628e-5,1.7231764496371476,0.7850704380589008,0.0860239068950365,0.6429522395902524,raw,8781747.78125,8339627.34375,7307724.21875,14370649.4375,10265741.75,16512265,Rabankyrin-5 OS=Homo sapiens OX=9606 GN=ANKFY1 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,51479,ANKFY1,NA,RHOD GTPase cycle,ENSG00000185722
Q9H2K0,0.3333333333333333,6,171318.775390625,6.631657297608909e-7,1.7213914810404476,0.7835752342336724,0.503278585588301,0.9876579753339259,raw,139793.71875,104635.078125,NA,NA,120332.3984375,320513.90625,"Translation initiation factor IF-3, mitochondrial OS=Homo sapiens OX=9606 GN=MTIF3 PE=1 SV=4",cell growth;cell organization and biogenesis;cellular homeostasis,endosome,protein binding;RNA binding,219402,MTIF3,NA,Mitochondrial translation initiation,ENSG00000122033
Q15057,0,6,7255340.963541667,2.8085033142342274e-5,1.7204499141398342,0.7827858928456766,0.06566286161043128,0.6429522395902524,raw,5102937.53125,5373923.34375,4940751.09375,8779348.4375,7729805.0625,11605280.3125,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ACAP2 PE=1 SV=3",conjugation;metabolic process,cytoskeleton;mitochondrion;nucleus,DNA binding;structural molecule activity,23527,ACAP2,NA,NA,ENSG00000114331
Q9HB90,0,6,4093624.0768229165,1.5846197780033752e-5,1.719338171621831,0.7818533322150057,0.6306455008010974,1,raw,7141631.46875,1754075.6328125,1788816.65625,5950044.72265625,3015849.19140625,4911326.7890625,Ras-related GTP-binding protein C OS=Homo sapiens OX=9606 GN=RRAGC PE=1 SV=1,cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;mitochondrion;nucleus,structural molecule activity,64121,RRAGC,Target of rapamycin signaling; 2q37 copy number variation syndrome,Amino acids regulate mTORC1; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK,ENSG00000116954
Q92544,0,6,10507859.130208334,4.067535535682204e-5,1.7188782662348525,0.7814673744156516,0.07626870559294381,0.6429522395902524,raw,6401165.28125,7774311.3125,8221915.6875,13363094.75,10338418.3125,16948249.4375,Transmembrane 9 superfamily member 4 OS=Homo sapiens OX=9606 GN=TM9SF4 PE=1 SV=2,cell communication;cell growth;coagulation;conjugation;metabolic process,cytoskeleton;extracellular;mitochondrion,NA,9777,TM9SF4,NA,NA,ENSG00000101337
Q9BZJ0,0,6,1945386.6458333333,7.530486671467023e-6,1.7173556881178271,0.7801888723859675,0.09252371354538554,0.6429522395902524,raw,1346247.9375,1987598.375,588657.625,3413413.375,2161897.9375,2174504.625,Crooked neck-like protein 1 OS=Homo sapiens OX=9606 GN=CRNKL1 PE=1 SV=4,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,51340,CRNKL1,NA,mRNA Splicing - Major Pathway,ENSG00000101343
O00267,0,6,12420394.2890625,4.807867569589732e-5,1.7161775966231336,0.7791988561648587,0.024412394257325724,0.6429522395902524,raw,8715635.953125,9432752.40625,8742039.8125,18218329.8125,14410714.875,15002892.875,Transcription elongation factor SPT5 OS=Homo sapiens OX=9606 GN=SUPT5H PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,6829,SUPT5H,Initiation of transcription and translation elongation at the HIV-1 LTR; mRNA processing,Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE,ENSG00000196235
P51553,0,6,9413145.067708334,3.643777632625742e-5,1.7161119677019292,0.7791436845265703,0.11766809831683647,0.6429522395902524,raw,10402444.1875,4501902.65625,6505419.53125,11164028.3125,9441028.34375,14464047.375,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial OS=Homo sapiens OX=9606 GN=IDH3G PE=1 SV=1",cellular homeostasis,endosome;membrane,structural molecule activity,3421,IDH3G,TCA cycle (aka Krebs or citric acid cycle),Citric acid cycle (TCA cycle); Mitochondrial protein import,ENSG00000067829
Q8IUR0,0,6,1971623.546875,7.63204829882683e-6,1.7151105220384097,0.7783015469281935,0.3213037169530832,0.8027885809803746,raw,535653.5,2551226.21875,1432335.9375,3432245.6875,1421665.5,2456614.4375,Trafficking protein particle complex subunit 5 OS=Homo sapiens OX=9606 GN=TRAPPC5 PE=1 SV=1,cell growth;conjugation,cytosol;extracellular;mitochondrion;nucleus,NA,126003,TRAPPC5,NA,RAB GEFs exchange GTP for GDP on RABs; COPII-mediated vesicle transport,ENSG00000181029
A0A0G2JH68,0,6,46946594.665364586,1.8172773322747525e-4,1.7150667217340783,0.7782647030700712,0.036783559516859354,0.6429522395902524,raw,35053307.859375,39352694.8203125,30696613.328125,60993898.25,48090556.4375,67492497.296875,Protein diaphanous homolog 1 OS=Homo sapiens OX=9606 GN=DIAPH1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
O43759,0.16666666666666666,6,398905.7604166667,1.5441426610093443e-6,1.715017008321369,0.7782228840944246,1,1,raw,322582.375,NA,321677.59375,NA,NA,552457.3125,Synaptogyrin-1 OS=Homo sapiens OX=9606 GN=SYNGR1 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,NA,9145,SYNGR1,NA,Neutrophil degranulation,ENSG00000100321
A0A024RCG2,0,6,1600806.125,6.196634079777706e-6,1.713769188104788,0.7771728191357328,0.15576757547977133,0.6638855679885327,raw,1377301,NA,987683.5,1730173.5,NA,2308066.5,"Solute carrier family 22 (Organic cation transporter), member 18, isoform CRA_a OS=Homo sapiens OX=9606 GN=SLC22A18 PE=1 SV=1",conjugation,cytoskeleton,catalytic activity,NA,SLC22A18,NA,NA,ENSG00000276130
Q16795,0,6,21929453.9609375,8.488773227630016e-5,1.713546390450548,0.7769852501395434,0.13720543461428905,0.654928512316515,raw,17187048.1875,16741779.71875,18000992.078125,29933507.0625,18867861.71875,30845535,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFA9 PE=1 SV=2",cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,4704,NDUFA9,Electron transport chain: OXPHOS system in mitochondria; Ciliary landscape; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000139180
Q9BPY3,0.16666666666666666,6,639938.859375,2.477168773312382e-6,1.7126893908614496,0.7762635315177461,0.2515717102350299,0.7326612824296702,raw,553988.4375,459571.65625,342042.6875,1259503.3125,437423.5625,787103.5,Protein FAM118B OS=Homo sapiens OX=9606 GN=FAM118B PE=1 SV=1,cell growth,membrane,structural molecule activity,79607,FAM118B,NA,NA,ENSG00000197798
A0A5F9ZI21,0,6,12514175.950520834,4.84416994439798e-5,1.7113954830613707,0.7751731879520177,0.008331184181394738,0.6429522395902524,raw,10542482.78125,8278411.125,8809232.203125,17676247.5,14167635.40625,15611046.6875,Guanine nucleotide exchange factor H1 OS=Homo sapiens OX=9606 GN=ARHGEF2 PE=1 SV=1,cell differentiation;coagulation;defense response;metabolic process,endoplasmic reticulum;extracellular;nucleus,DNA binding,9181,ARHGEF2,Pathogenic Escherichia coli infection,NA,ENSG00000116584
Q96E39,0,6,948196.734375,3.6704183640989336e-6,1.7104416794563169,0.7743689136974132,0.35834195123413576,0.8420882601494262,raw,676587.46875,NA,766761.140625,1229563.8125,492710.09375,1575361.15625,"RNA binding motif protein, X-linked-like-1 OS=Homo sapiens OX=9606 GN=RBMXL1 PE=1 SV=1",cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,494115,RBMXL1,NA,NA,ENSG00000213516
Q9NYP7,0,6,2155063.7083333335,8.342135259602693e-6,1.7104181876835831,0.7743490991096537,0.17541339813137416,0.6697819849820321,raw,1130232.125,2575764.3125,1442976.5,2245155.1875,2468093.25,3068160.875,Elongation of very long chain fatty acids protein 5 OS=Homo sapiens OX=9606 GN=ELOVL5 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,60481,ELOVL5,Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-3 / omega-6 fatty acid synthesis; Omega-9 fatty acid synthesis; Linoleic acid metabolism affected by SARS-CoV-2,Synthesis of very long-chain fatty acyl-CoAs; alpha-linolenic acid (ALA) metabolism; Linoleic acid (LA) metabolism,ENSG00000012660
Q8TEB1,0,6,842759.9401041666,3.2622782261786364e-6,1.709791808780468,0.773820667376936,0.26407822956165256,0.7449307915063809,raw,935141.640625,558911.90625,269920.125,461507.21875,1296273.84375,1534804.90625,DDB1- and CUL4-associated factor 11 OS=Homo sapiens OX=9606 GN=DCAF11 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,membrane;nucleus,NA,80344,DCAF11,Ciliary landscape,Neddylation,ENSG00000100897; ENSG00000284796
Q9BRX2,0,6,11117171.856770834,4.30339720235714e-5,1.708637369011643,0.7728462405240266,0.058203354837675976,0.6429522395902524,raw,9470706.03125,8098414.78125,7565343.140625,16557780.1875,13837254.125,11173532.875,Protein pelota homolog OS=Homo sapiens OX=9606 GN=PELO PE=1 SV=2,cell differentiation;cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,structural molecule activity,53918,PELO,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,NA,ENSG00000152684
Q96HW7,0,6,683734.9557291666,2.6467010976776806e-6,1.7086137957034948,0.7728263361663286,0.1645872872536572,0.6638855679885327,raw,578370.3125,530412.875,382784.9375,1227205.171875,729604.8125,654031.625,Integrator complex subunit 4 OS=Homo sapiens OX=9606 GN=INTS4 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,NA,92105,INTS4,NA,RNA polymerase II transcribes snRNA genes,ENSG00000149262
P42765,0,6,1567725.203125,6.068579617291757e-6,1.7083787688098337,0.7726278738471438,0.3906417284635634,0.8757475037529201,raw,1421802.03125,1132608.6875,1309492.0625,2237108.4375,827732.96875,2477607.03125,"3-ketoacyl-CoA thiolase, mitochondrial OS=Homo sapiens OX=9606 GN=ACAA2 PE=1 SV=2",cell growth;cellular homeostasis;coagulation;conjugation,endosome,structural molecule activity,10449,ACAA2,Fatty acid biosynthesis,Mitochondrial Fatty Acid Beta-Oxidation,ENSG00000167315
Q08378,0,6,5988029.979166667,2.3179340745984935e-5,1.7081451165244919,0.7724305452141859,0.003739227294705097,0.6429522395902524,raw,4865372,4595055.296875,3523885.9375,7343155.40625,7289949.8125,8310761.421875,Golgin subfamily A member 3 OS=Homo sapiens OX=9606 GN=GOLGA3 PE=1 SV=2,metabolic process,cytoskeleton;cytosol;extracellular;membrane,NA,2802,GOLGA3,NA,RND2 GTPase cycle,ENSG00000090615
P51116,0,6,7696699.651041667,2.979350879198939e-5,1.7073373382874015,0.77174813639263,0.0185120968472471,0.6429522395902524,raw,6292050.9375,5123493.65625,5633938.5625,10110426.5625,8277634.6875,10742653.5,Fragile X mental retardation syndrome-related protein 2 OS=Homo sapiens OX=9606 GN=FXR2 PE=1 SV=2,metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,9513,FXR2,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000129245
P07339,0,6,53798649.6015625,2.082516679320311e-4,1.7064270195810707,0.7709787146184797,0.04396296553084761,0.6429522395902524,raw,40263011.375,44268232.171875,33985492.5625,68705890.5,55170806.125,80398464.875,Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;mitochondrion;nucleus,structural molecule activity,1509,CTSD,Prolactin signaling pathway,Neutrophil degranulation; MHC class II antigen presentation; Collagen degradation; Estrogen-dependent gene expression; Metabolism of Angiotensinogen to Angiotensins,ENSG00000117984
O15258,0,6,2963613.4583333335,1.1471987686951285e-5,1.7064172608021593,0.7709704640563186,0.10355006451686877,0.6429522395902524,raw,1560850.125,2483404.6875,2426854.1875,4141225.875,2564543.75,4604802.125,Protein RER1 OS=Homo sapiens OX=9606 GN=RER1 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,antioxidant activity,11079,RER1,NA,NA,ENSG00000157916
O95758,0,6,6966753.15625,2.6967925321636087e-5,1.7062984662123697,0.7708700253562615,0.03470085953534853,0.6429522395902524,raw,5073311.5,4694047.8125,5870149.375,8928840.15625,7217943.21875,10016226.875,Polypyrimidine tract-binding protein 3 OS=Homo sapiens OX=9606 GN=PTBP3 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,9991,PTBP3,NA,NA,ENSG00000119314
P49768,0,6,498689.3411458333,1.930399514535941e-6,1.7061907410367354,0.7707789396019751,0.2476436089838246,0.7316541032247736,raw,478282.921875,277629.875,312231.90625,991155.625,400108.53125,532727.1875,Presenilin-1 OS=Homo sapiens OX=9606 GN=PSEN1 PE=1 SV=1,cell communication;cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;endosome;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;catalytic activity;structural molecule activity,5663,PSEN1,Alzheimer's disease and miRNA effects; Notch signaling; Canonical and non-canonical Notch signaling; Inclusion body myositis; Alzheimer's disease; DYRK1A; Neurogenesis regulation in the olfactory epithelium; Notch signaling pathway,Degradation of the extracellular matrix; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; Neutrophil degranulation; Nuclear signaling by ERBB4; EPH-ephrin mediated repulsion of cells; NOTCH4 Activation and Transmission of Signal to the Nucleus; NRIF signals cell death from the nucleus; Regulated proteolysis of p75NTR; Noncanonical activation of NOTCH3,ENSG00000080815
P08240,0,6,40106073.614583336,1.552484455706343e-4,1.706052066151849,0.7706616762182499,0.045946425980629084,0.6429522395902524,raw,26376153.8125,34832323.84375,28335376.25,59425758.0625,40577367.78125,51089461.9375,Signal recognition particle receptor subunit alpha OS=Homo sapiens OX=9606 GN=SRPRA PE=1 SV=2,cell growth;conjugation,cytoskeleton;extracellular,structural molecule activity,6734,SRPRA,NA,XBP1(S) activates chaperone genes; SRP-dependent cotranslational protein targeting to membrane,ENSG00000182934
Q9Y4E8,0,6,9965712.3828125,3.85767345690276e-5,1.705413103733189,0.7701212468850518,0.1148992740228113,0.6429522395902524,raw,6428514.078125,11168121,6274901.6875,12945499.90625,10701299.5625,12275938.0625,Ubiquitin carboxyl-terminal hydrolase 15 OS=Homo sapiens OX=9606 GN=USP15 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;endosome;membrane;nucleus,antioxidant activity;structural molecule activity,9958,USP15,NA,UCH proteinases; Ub-specific processing proteases; Downregulation of TGF-beta receptor signaling,ENSG00000135655
P29590,0,6,7313177.713541667,2.830891607889312e-5,1.7052515530034709,0.7699845764936486,0.0052359930397730264,0.6429522395902524,raw,4635920.65625,5851725.71875,5937803.65625,10125448.90625,8497554.96875,8830612.375,Protein PML OS=Homo sapiens OX=9606 GN=PML PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,5371,PML,miRNA regulation of DNA damage response; Wnt/beta-catenin signaling pathway in leukemia; TGF-beta signaling pathway; p53 transcriptional gene network; DNA damage response,HCMV Early Events; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Interferon gamma signaling; Regulation of TP53 Activity through Acetylation; Regulation of PTEN localization; Regulation of RUNX1 Expression and Activity,ENSG00000140464
Q9UK58,0,6,745351.1875,2.8852142041031248e-6,1.7044807601117484,0.7693323146740886,0.13905393298370297,0.6572502130392559,raw,439961.625,861617.625,478852,975559.75,749906.125,966210,Cyclin-L1 OS=Homo sapiens OX=9606 GN=CCNL1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,DNA binding,57018,CCNL1,NA,NA,ENSG00000163660
O95365,0.16666666666666666,6,281581.046875,1.0899850294395323e-6,1.7039691108044592,0.7688991829269308,0.2573046535653468,0.7380182509946936,raw,235790.375,NA,189079.96875,400569.8125,179475.859375,402989.21875,Zinc finger and BTB domain-containing protein 7A OS=Homo sapiens OX=9606 GN=ZBTB7A PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,51341,ZBTB7A,IL-18 signaling pathway,NA,ENSG00000178951
P11233,0,6,7644691.208333333,2.9592186918284897e-5,1.703855978996054,0.768803394736685,0.06804296652294564,0.6429522395902524,raw,5290571.75,5927158.25,5426028,9245170.25,7979081,12000138,Ras-related protein Ral-A OS=Homo sapiens OX=9606 GN=RALA PE=1 SV=1,cell differentiation;cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endosome;nucleus,antioxidant activity;motor activity;structural molecule activity,5898,RALA,RalA downstream regulated genes; Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; p38MAPK events,ENSG00000006451
P07602,0,6,141804555.96354166,5.489177798788265e-4,1.7037702503787224,0.7687308044683943,0.05148829878817312,0.6429522395902524,raw,132102572.0625,80740357.25,109691868.96875,194967356.625,137563018.6875,195762162.1875,Prosaposin OS=Homo sapiens OX=9606 GN=PSAP PE=1 SV=2,cellular homeostasis;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;mitochondrion;nucleus,DNA binding;structural molecule activity,5660,PSAP,"Degradation pathway of sphingolipids, including diseases",Glycosphingolipid metabolism; G alpha (i) signalling events; Neutrophil degranulation; Platelet degranulation ; Peptide ligand-binding receptors,ENSG00000197746
Q9UHR4,0,6,15506702.71875,6.002560899246175e-5,1.7033808549168716,0.7684010398722015,0.00669370545223165,0.6429522395902524,raw,9961335.9375,13444142.46875,11221670.71875,19114779.0625,17711492.8125,21586795.3125,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 OS=Homo sapiens OX=9606 GN=BAIAP2L1 PE=1 SV=2,cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane,motor activity;structural molecule activity,55971,BAIAP2L1,NA,RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOF GTPase cycle,ENSG00000006453
P30622,0,6,15297315.03515625,5.921508057444814e-5,1.7023611148637836,0.7675371024543913,0.04516136062149754,0.6429522395902524,raw,9726556.4296875,15318007.625,11250084.03125,19151705.59375,17040059.25,19297477.28125,CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,6249,CLIP1,Microtubule cytoskeleton regulation,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000130779
P62195,0,6,117806031.609375,4.560207878227744e-4,1.701848992522152,0.7671030303231965,0.09557285313735095,0.6429522395902524,raw,92544645.671875,96486099.9375,76744899.6875,157497012,107177047.359375,176386485,26S proteasome regulatory subunit 8 OS=Homo sapiens OX=9606 GN=PSMC5 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,5705,PSMC5,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Pregnane X receptor pathway; Nuclear receptors meta-pathway; Alzheimer's disease,Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000087191
P61586,0,6,121824578.9921875,4.715763677738053e-4,1.701617978881431,0.7669071816564351,0.13746750068581984,0.6552927144178777,raw,109994171.90625,71306711.125,89907541.3125,201150609.25,105600151.625,152988288.734375,Transforming protein RhoA OS=Homo sapiens OX=9606 GN=RHOA PE=1 SV=1,cell communication;cell death;cell differentiation;cell growth;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,motor activity;structural molecule activity,387,RHOA,"Androgen receptor signaling pathway; Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Leptin signaling pathway; Pathogenic Escherichia coli infection; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Spinal cord injury; Alpha 6 beta 4 signaling pathway; Focal adhesion; G protein signaling pathways; Wnt signaling pathway; Hypothetical craniofacial development pathway; TGF-beta signaling pathway; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling pathway; Wnt signaling pathway and pluripotency; Fibrin complement receptor 3 signaling pathway; Wnt signaling in kidney disease; Chromosomal and microsatellite instability in colorectal cancer ; Ebola virus infection in host; Ras signaling; Pancreatic adenocarcinoma pathway; Wnt signaling; Envelope proteins and their potential roles in EDMD physiopathology; Hippo signaling regulation pathways; Leukocyte-intrinsic Hippo pathway functions; Neural crest cell migration during development; Neural crest cell migration in cancer; Joubert syndrome; Gastrin signaling pathway; Netrin-UNC5B signaling pathway; mBDNF and proBDNF regulation of GABA neurotransmission; MAP3K1 role in promoting and blocking gonadal determination; Airway smooth muscle cell contraction; RAS and bradykinin pathways in COVID-19; Regulation of actin cytoskeleton; GDNF signaling; PtdIns(4,5)P2 in cytokinesis pathway; 2q11.2 copy number variation syndrome; 2q21.1 copy number variation syndrome; G13 signaling pathway; DNA damage response (only ATM dependent); Serotonin HTR1 group and FOS pathway","Neutrophil degranulation; RHOC GTPase cycle; RHOA GTPase cycle; G alpha (12/13) signalling events; RHO GTPases Activate Formins; EPHB-mediated forward signaling; GPVI-mediated activation cascade; PI3K/AKT activation; VEGFA-VEGFR2 Pathway; ERBB2 Regulates Cell Motility; RHO GTPases activate CIT; G beta:gamma signalling through PI3Kgamma; PCP/CE pathway; RHO GTPases Activate Rhotekin and Rhophilins; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; Sema4D mediated inhibition of cell attachment and migration; Ovarian tumor domain proteases; SLIT2:ROBO1 increases RHOA activity; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); Axonal growth stimulation; Axonal growth inhibition (RHOA activation); RHO GTPases activate KTN1",ENSG00000067560
Q9NWV8,0,6,1746865.2291666667,6.762020986040929e-6,1.7015694167287236,0.7668660082688157,0.5374071508583508,1,raw,1076778.4375,897739.96875,2632801.875,1527566.875,2355898.09375,1990406.125,BRISC and BRCA1-A complex member 1 OS=Homo sapiens OX=9606 GN=BABAM1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,NA,29086,BABAM1,NA,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Metalloprotease DUBs; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ),ENSG00000105393
P18031,0,6,38286001.294270836,1.4820304388733644e-4,1.7014392220816323,0.7667556170287475,0.055857833775670086,0.6429522395902524,raw,30053712.6875,29789089.65625,25845286.390625,50684325.53125,38017441.53125,55326151.96875,Tyrosine-protein phosphatase non-receptor type 1 OS=Homo sapiens OX=9606 GN=PTPN1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,5770,PTPN1,Leptin signaling pathway; Prolactin signaling pathway; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Insulin signaling,Growth hormone receptor signaling; Regulation of IFNG signaling; Regulation of IFNA/IFNB signaling; Negative regulation of MET activity; Integrin signaling; MECP2 regulates neuronal receptors and channels; PTK6 Down-Regulation,ENSG00000196396
P31751,0.16666666666666666,6,390297.9375,1.510822243249131e-6,1.700787501317649,0.7662028999982939,1,1,raw,NA,307199.0625,325833.9375,537860.8125,NA,NA,RAC-beta serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=AKT2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,signal transducer activity;structural molecule activity,208,AKT2,"AMP-activated protein kinase signaling; MicroRNAs in cardiomyocyte hypertrophy; Transcription factors regulate miRNAs related to cardiac hypertrophy; Integrin-mediated cell adhesion; RANKL/RANK signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Alzheimer's disease and miRNA effects; Glioblastoma signaling pathways; S1P receptor signal transduction; Cardiac hypertrophic response; Focal adhesion; MAPK signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Lipid metabolism pathway; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Nonalcoholic fatty liver disease; Resistin as a regulator of inflammation; Relationship between inflammation, COX-2 and EGFR; Synaptic signaling pathways associated with autism spectrum disorder; Neural crest cell migration during development; Neural crest cell migration in cancer; Translation inhibitors in chronically activated PDGFRA cells; Small cell lung cancer; Hepatitis B infection; Head and neck squamous cell carcinoma; Melanoma; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Malignant pleural mesothelioma; Congenital generalized lipodystrophy; Familial partial lipodystrophy; Alzheimer's disease; ErbB signaling pathway; Toll-like receptor signaling pathway",RAB GEFs exchange GTP for GDP on RABs; Regulation of PTEN stability and activity; KEAP1-NFE2L2 pathway; Translocation of SLC2A4 (GLUT4) to the plasma membrane; AKT phosphorylates targets in the nucleus; Constitutive Signaling by AKT1 E17K in Cancer; Regulation of localization of FOXO transcription factors; Regulation of TP53 Degradation; Deactivation of the beta-catenin transactivating complex; CD28 dependent PI3K/Akt signaling; TP53 Regulates Metabolic Genes; Downregulation of ERBB2:ERBB3 signaling; G beta:gamma signalling through PI3Kgamma; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; AKT phosphorylates targets in the cytosol; Regulation of TP53 Activity through Association with Co-factors; Activation of AKT2; VEGFR2 mediated vascular permeability; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; FLT3 Signaling; Negative regulation of the PI3K/AKT network; Regulation of TP53 Activity through Acetylation; RUNX2 regulates genes involved in cell migration; Cyclin E associated events during G1/S transition ; Cyclin A:Cdk2-associated events at S phase entry; CTLA4 inhibitory signaling; Activation of BAD and translocation to mitochondria ; AKT-mediated inactivation of FOXO1A; PDE3B signalling; Inhibition of TSC complex formation by PKB,ENSG00000105221
C9JEH3,0,6,9065755.276041666,3.509304919884932e-5,1.700731378373021,0.7661552928576217,0.10713088518847183,0.6429522395902524,raw,6797133,7850647.4375,5926138.03125,12510662.4375,7958108.3125,13351842.4375,Angio-associated migratory cell protein OS=Homo sapiens OX=9606 GN=AAMP PE=1 SV=1,NA,cytosol;endoplasmic reticulum;nucleus,NA,14,AAMP,Nucleotide-binding oligomerization domain (NOD) pathway,NA,ENSG00000127837
Q9Y3D3,0,6,2602989.0572916665,1.0076030101210403e-5,1.7007045821601874,0.7661325620087573,0.1526950531407505,0.6638855679885327,raw,3026971.5,1709701.25,1574080.34375,2907696.75,2775028.875,3624455.625,"28S ribosomal protein S16, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS16 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;cytosol;endosome;Golgi,structural molecule activity,51021,MRPS16,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000182180
P62736,0,6,813613832.5416666,0.0031494552174494224,1.7006263016250598,0.7660661556850533,0.02896191333861039,0.6429522395902524,raw,777517133.625,495737576.875,545828340,1110567593.9375,843064361.9375,1108967988.875,"Actin, aortic smooth muscle OS=Homo sapiens OX=9606 GN=ACTA2 PE=1 SV=1",defense response;metabolic process,chromosome;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,59,ACTA2,Myometrial relaxation and contraction pathways; Striated muscle contraction pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; 22q11.2 copy number variation syndrome; IL-18 signaling pathway; Regucalcin in proximal tubule epithelial kidney cells; Angiotensin II receptor type 1 pathway; Malignant pleural mesothelioma; CCL18 signaling pathway,Smooth Muscle Contraction; NOTCH4 Intracellular Domain Regulates Transcription,ENSG00000107796
Q8IXQ3,0.3333333333333333,6,775600.203125,3.002306510394496e-6,1.7005146943436884,0.7659714725939317,1,1,raw,502227.6875,NA,NA,854045.5625,787380.5,958747.0625,Uncharacterized protein C9orf40 OS=Homo sapiens OX=9606 GN=C9orf40 PE=1 SV=1,NA,NA,NA,55071,C9orf40,NA,NA,ENSG00000135045
Q14344,0,6,3233832.3606770835,1.2517990468370806e-5,1.6997759310452207,0.7653445790243631,0.08144955469597404,0.6429522395902524,raw,2679990.71875,2077049.6484375,2210526.578125,5336692.25,3568215.96875,3530519,Guanine nucleotide-binding protein subunit alpha-13 OS=Homo sapiens OX=9606 GN=GNA13 PE=1 SV=2,coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;DNA binding;structural molecule activity,10672,GNA13,Thyroid stimulating hormone (TSH) signaling pathway; G protein signaling pathways; Modulators of TCR signaling and T cell activation; Regulation of actin cytoskeleton; G13 signaling pathway,CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; Thrombin signalling through proteinase activated receptors (PARs); Thromboxane signalling through TP receptor,ENSG00000120063
Q53G59,0,6,575973.18125,2.229561086900346e-6,1.6992736533374542,0.764918204800964,0.09977961366723602,0.6429522395902524,raw,485609.15625,329898.8125,NA,693456.0625,592091.5625,778810.3125,Kelch-like protein 12 OS=Homo sapiens OX=9606 GN=KLHL12 PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,59349,KLHL12,NA,Degradation of DVL,ENSG00000117153
Q8TE02,0.16666666666666666,6,411512.4166666667,1.592942346699448e-6,1.699169817667137,0.7648300449077902,0.10483309239809248,0.6429522395902524,raw,272580.96875,386492.65625,277473.09375,397864.53125,656716.65625,477946.59375,Elongator complex protein 5 OS=Homo sapiens OX=9606 GN=ELP5 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,NA,23587,ELP5,NA,HATs acetylate histones,ENSG00000170291; ENSG00000288485
Q8NFQ8,0,6,12609827.787760416,4.881196254153769e-5,1.6982915784472286,0.7640841754200915,0.10134233227763272,0.6429522395902524,raw,6411915.65625,12563457.3125,6570375.421875,21336413.75,10859559.0703125,17917245.515625,Torsin-1A-interacting protein 2 OS=Homo sapiens OX=9606 GN=TOR1AIP2 PE=1 SV=1,cell growth;metabolic process,cytoskeleton;extracellular;membrane,structural molecule activity,163590,TOR1AIP2,NA,NA,ENSG00000169905
O60783,0,6,5116839.208333333,1.9807008309079968e-5,1.697904444854045,0.7637552687765206,0.053054658586078295,0.6429522395902524,raw,4537279.1875,4376862.875,2232817.4375,6613010,5237199.25,7703866.5,"28S ribosomal protein S14, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS14 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,structural molecule activity,63931,MRPS14,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000120333
Q13492,0,6,19882724.28125,7.696495219245705e-5,1.6977051200512014,0.7635858942360015,0.07521569840767381,0.6429522395902524,raw,20522691,11313690.265625,13285914.8125,29177523.03125,19207309.890625,25789216.6875,Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens OX=9606 GN=PICALM PE=1 SV=2,cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;motor activity;structural molecule activity,8301,PICALM,NA,Cargo recognition for clathrin-mediated endocytosis; Golgi Associated Vesicle Biogenesis; RND3 GTPase cycle,ENSG00000073921
Q8ND82,0,6,1458264.9270833333,5.644864798670816e-6,1.697165345108468,0.7631271252504797,0.20924648708823027,0.6993492614438964,raw,736184.65625,1303668.21875,1179321.25,2001503.15625,1028660.90625,2500251.375,Zinc finger protein 280C OS=Homo sapiens OX=9606 GN=ZNF280C PE=1 SV=1,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,55609,ZNF280C,NA,NA,ENSG00000056277
O00400,0,6,2126373.6979166665,8.23107777829958e-6,1.6971438809964137,0.7631088793182704,0.07031166048901337,0.6429522395902524,raw,1348827.5,1996658.3125,1353397.40625,2493030.5,2177712.03125,3388616.4375,Acetyl-coenzyme A transporter 1 OS=Homo sapiens OX=9606 GN=SLC33A1 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;extracellular,catalytic activity,9197,SLC33A1,Ganglio sphingolipid metabolism,"Transport of vitamins, nucleosides, and related molecules; Defective SLC33A1 causes spastic paraplegia 42 (SPG42)",ENSG00000169359
Q13867,0,6,23231076.71875,8.992624369508624e-5,1.6954200793510397,0.7616427785588761,0.03579926241986902,0.6429522395902524,raw,19011770.4375,17350222.28125,16410784.25,30353047.4375,24027698.5625,32232937.34375,Bleomycin hydrolase OS=Homo sapiens OX=9606 GN=BLMH PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,642,BLMH,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000108578
P52789,0,6,40545236.10742188,1.5694841986932303e-4,1.6941082904683011,0.7605260972959859,0.07504056758197028,0.6429522395902524,raw,34632477.609375,31414763.8710938,26911996.15625,53389888.15625,38251123.4140625,58671167.4375,Hexokinase-2 OS=Homo sapiens OX=9606 GN=HK2 PE=1 SV=2,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;nucleus,signal transducer activity;structural molecule activity,3099,HK2,Clear cell renal cell carcinoma pathways; Glycolysis and gluconeogenesis,Glycolysis,ENSG00000159399
P80303,0,6,23985470.088541668,9.284645969863845e-5,1.6939882214811246,0.7604238434600484,0.07229815329292817,0.6429522395902524,raw,19826707.625,16002718.09375,18556858.8125,33321545.625,22618781.1875,33586209.1875,Nucleobindin-2 OS=Homo sapiens OX=9606 GN=NUCB2 PE=1 SV=3,development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane,DNA binding;RNA binding;structural molecule activity,4925,NUCB2,NA,NA,ENSG00000070081
Q5T1C6,0.16666666666666666,6,1252970.0872395833,4.850179557834242e-6,1.6933676904706798,0.7598952677539396,0.25724712875366945,0.7380182509946936,raw,1343291.96875,719050.8359375,734508.15625,1588568.5,857713.84375,2274687.21875,Acyl-coenzyme A thioesterase THEM4 OS=Homo sapiens OX=9606 GN=THEM4 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;development,cytoplasm;cytoskeleton;cytosol;endosome,structural molecule activity,117145,THEM4,PI3K-Akt signaling pathway,Mitochondrial Fatty Acid Beta-Oxidation; CD28 dependent PI3K/Akt signaling; Activation of AKT2; VEGFR2 mediated vascular permeability; Negative regulation of the PI3K/AKT network,ENSG00000159445
Q96S19,0.16666666666666666,6,243524.015625,9.426683162311073e-7,1.692179440813124,0.758882561746781,0.1331360727891534,0.6514609890946903,raw,162228.78125,199175.28125,NA,343140,269552,NA,Methyltransferase-like 26 OS=Homo sapiens OX=9606 GN=METTL26 PE=1 SV=2,NA,NA,NA,84326,METTL26,NA,NA,ENSG00000130731
A0A0A0MTH3,0,6,20886411.322916668,8.085017054007109e-5,1.6911102703294476,0.75797073501144,0.02366048417949421,0.6429522395902524,raw,10932242.875,19122461.3125,15555630.5,26306286.5,24572227.4375,28829619.3125,Integrin-linked protein kinase OS=Homo sapiens OX=9606 GN=ILK PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,signal transducer activity;structural molecule activity,NA,ILK,Primary focal segmental glomerulosclerosis (FSGS); Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; PPAR signaling pathway; Endometrial cancer; Acute viral myocarditis; Genes controlling nephrogenesis; Development of ureteric collection system; 2q37 copy number variation syndrome,NA,ENSG00000166333
O95983,0,6,1713710.9895833333,6.633682714664562e-6,1.688428558828006,0.7556811369971308,0.1374427610932695,0.6552927144178777,raw,925781.8125,1572350.0625,1286316.1875,2654800.75,1375848.8125,2467168.3125,Methyl-CpG-binding domain protein 3 OS=Homo sapiens OX=9606 GN=MBD3 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,53615,MBD3,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,ENSG00000071655
P55735,0,6,34468800.604166664,1.3342686611274773e-4,1.6880924470510534,0.7553939142642936,0.038190374456519176,0.6429522395902524,raw,28859633.375,26707816.75,21607602.125,48717729.125,34632130.5,46287891.75,Protein SEC13 homolog OS=Homo sapiens OX=9606 GN=SEC13 PE=1 SV=3,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,6396,SEC13,Sterol regulatory element-binding proteins (SREBP) signaling,"Separation of Sister Chromatids; HCMV Late Events; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; Amino acids regulate mTORC1; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; COPII-mediated vesicle transport; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Postmitotic nuclear pore complex (NPC) reformation",ENSG00000157020
F8W9S7,0,6,914397.625,3.5395838365765836e-6,1.6880209243075983,0.7553327874619864,1,1,raw,659798.5625,NA,837475.0625,1245919.25,NA,NA,GTPase-activating protein and VPS9 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GAPVD1 PE=1 SV=1,conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol,DNA binding,26130,GAPVD1,NA,NA,ENSG00000165219
Q9H269,0,6,1485759.4153645833,5.751294478335892e-6,1.6876691231743397,0.7550320834607127,0.1239779106556319,0.6445597830897484,raw,1325054.625,917567.1484375,941020.875,2611929.40625,1530852.5625,1588131.875,Vacuolar protein sorting-associated protein 16 homolog OS=Homo sapiens OX=9606 GN=VPS16 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;mitochondrion;nucleus,motor activity,64601,VPS16,Ebola virus infection in host; Network map of SARS-CoV-2 signaling pathway,SARS-CoV-2 modulates autophagy,ENSG00000215305
L7N2F9,0,6,614596.59375,2.379070231347686e-6,1.6871395561234213,0.7545793148228129,0.11650265157000833,0.6429522395902524,raw,480260.125,NA,401818.09375,738210,528520.125,924174.625,Synaptobrevin-2 (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1,cell growth;conjugation,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,NA,NA,NA,NA,NA
O14562,0,6,8884976.791666666,3.439326544635481e-5,1.6867889495209467,0.7542794753877642,0.026569001053422397,0.6429522395902524,raw,6420020.25,7383584.875,6462735,11088772.75,9500198.5,12454549.375,Ubiquitin domain-containing protein UBFD1 OS=Homo sapiens OX=9606 GN=UBFD1 PE=1 SV=2,NA,NA,NA,56061,UBFD1,NA,NA,ENSG00000103353
P62166,0,6,1903765.4791666667,7.369373382494086e-6,1.6862289255896301,0.7538004125509643,0.15853638042122545,0.6638855679885327,raw,2191965.96875,1013234.53125,1202124.6875,2892492.53125,1708545.375,2414229.78125,Neuronal calcium sensor 1 OS=Homo sapiens OX=9606 GN=NCS1 PE=1 SV=2,conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,catalytic activity;DNA binding;structural molecule activity,23413,NCS1,GDNF signaling,NA,ENSG00000107130
Q8TAE8,0,6,6103229.760416667,2.3625272879382215e-5,1.6858683189524026,0.7534918535910679,0.07695082754593462,0.6429522395902524,raw,4446796.25,5033604.375,4676309.8125,7883642.5625,5862105.3125,8716920.25,Growth arrest and DNA damage-inducible proteins-interacting protein 1 OS=Homo sapiens OX=9606 GN=GADD45GIP1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,NA,90480,GADD45GIP1,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000179271
A0A494C108,0,6,8246033.192708333,3.191994927237963e-5,1.6849002909176432,0.7526632180807612,0.12072665929334661,0.6445597830897484,raw,7699709.1875,4639125.5625,6239493.375,10770728.625,7153900.15625,12973242.25,Protein KRI1 homolog OS=Homo sapiens OX=9606 GN=KRI1 PE=1 SV=1,NA,membrane,NA,65095,KRI1,NA,NA,ENSG00000129347
P04350,0,6,8944403.104166666,3.462330149352012e-5,1.6845040324079912,0.752323882023368,0.2575955000320621,0.7380182509946936,raw,10481333.25,3721742.375,6878365.25,11586634,6832526.5,14165817.25,Tubulin beta-4A chain OS=Homo sapiens OX=9606 GN=TUBB4A PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,10382,TUBB4A,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,ENSG00000104833
Q9P031,0,6,3623033.234375,1.402456603687431e-5,1.6844230671823646,0.7522545376142635,0.07287335587599945,0.6429522395902524,raw,3748637.75,2604181.84375,2131032.4375,4386543.96875,4232842.34375,4634961.0625,Thyroid transcription factor 1-associated protein 26 OS=Homo sapiens OX=9606 GN=CCDC59 PE=1 SV=2,NA,membrane,NA,29080,CCDC59,NA,Surfactant metabolism,ENSG00000133773
O15031,0,6,15156067.639322916,5.866831953135138e-5,1.6840776344224722,0.7519586468453129,0.026210547678628758,0.6429522395902524,raw,11201155.75,12973402.109375,9737092.625,18454410.1875,16398019.9140625,22172325.25,Plexin-B2 OS=Homo sapiens OX=9606 GN=PLXNB2 PE=1 SV=3,cell communication;cell differentiation;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,23654,PLXNB2,2q11.2 copy number variation syndrome,NA,ENSG00000196576
Q8TCJ2,0,6,26616622.28125,1.0303150777647378e-4,1.6839631749539015,0.7518605897746897,0.15692210210410568,0.6638855679885327,raw,22462176.375,20452740.9375,21069165.75,35479699.25,22386649.125,37849302.25,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B OS=Homo sapiens OX=9606 GN=STT3B PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation,cytoskeleton;extracellular;nucleus,structural molecule activity,201595,STT3B,NA,NA,ENSG00000163527
P11182,0,6,4536045.072916667,1.7558785568891526e-5,1.6837692838432308,0.751694468654578,0.1425164548190824,0.6572502130392559,raw,3541725.84375,2983707.65625,3812349.9375,5963449.1875,3830749.3125,7084288.5,"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial OS=Homo sapiens OX=9606 GN=DBT PE=1 SV=3",cellular homeostasis,cytosol;endoplasmic reticulum;endosome;nucleus,structural molecule activity,1629,DBT,NA,Glyoxylate metabolism and glycine degradation; Branched-chain amino acid catabolism; RHOH GTPase cycle,ENSG00000137992
Q8N4V1,0.16666666666666666,6,3166749.359375,1.225831579224957e-5,1.6830222528030523,0.751054252007357,0.20036806162536563,0.6907968838306926,raw,1789973.9375,2725897.6875,2538151,5753639.625,3012565.96875,3180267.9375,Membrane magnesium transporter 1 OS=Homo sapiens OX=9606 GN=MMGT1 PE=1 SV=1,cell growth;conjugation,cytoplasm;cytoskeleton;extracellular;mitochondrion,catalytic activity,93380,MMGT1,NA,Miscellaneous transport and binding events,ENSG00000169446
D6RBR1,0.6666666666666666,6,2617150.6041666665,1.0130848684558836e-5,1.6825872896405598,0.7506813512337661,0.2566521214476924,0.737462267065437,raw,2164084.5,2073853.625,1839487.75,3489439.75,1782979.5,4353058.5,Calpastatin (Fragment) OS=Homo sapiens OX=9606 GN=CAST PE=1 SV=1,NA,NA,NA,NA,CAST,NA,NA,ENSG00000153113
Q8IY17,0,6,5532372.458333333,2.141551508452149e-5,1.682500437462909,0.7506068799473232,0.17824124524431662,0.6741527184744509,raw,4167579.15625,5039177.21875,3943593.3125,7045434.8125,4520032.375,8478417.875,Patatin-like phospholipase domain-containing protein 6 OS=Homo sapiens OX=9606 GN=PNPLA6 PE=1 SV=3,cellular homeostasis,cytoskeleton;cytosol;extracellular,structural molecule activity,10908,PNPLA6,NA,Glycerophospholipid catabolism,ENSG00000032444
Q53GS7,0,6,222614.9921875,8.617306154163485e-7,1.6824839022230003,0.7505927013918186,0.12368367087801858,0.6445597830897484,raw,NA,137122.65625,199608.359375,NA,258829.953125,294899,Nucleoporin GLE1 OS=Homo sapiens OX=9606 GN=GLE1 PE=1 SV=2,cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,2733,GLE1,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript,ENSG00000119392
Q9Y678,0,6,107336565.1015625,4.154940482343672e-4,1.6819646562118398,0.7501473899904169,0.05562527385207714,0.6429522395902524,raw,82119631.9375,91510023.625,68339681.234375,158142551.4375,105785183.875,138122318.5,Coatomer subunit gamma-1 OS=Homo sapiens OX=9606 GN=COPG1 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;cytosol;extracellular,structural molecule activity,22820,COPG1,VEGFA-VEGFR2 signaling pathway,COPI-mediated anterograde transport; COPI-dependent Golgi-to-ER retrograde traffic,ENSG00000181789
Q8N573,0,6,597071.3229166666,2.3112308541694116e-6,1.6816824014720304,0.7499052673732916,0.05301597763582871,0.6429522395902524,raw,435979.46875,602609.8125,341110.03125,733179,678192.5625,791357.0625,Oxidation resistance protein 1 OS=Homo sapiens OX=9606 GN=OXR1 PE=1 SV=2,coagulation;metabolic process,endosome;membrane,structural molecule activity,55074,OXR1,NA,NA,ENSG00000164830
O43427,0.3333333333333333,6,404731.7473958333,1.5666947420512914e-6,1.6815039121926258,0.7497521354475079,0.1526324578495227,0.6638855679885327,raw,361530,277343.1875,287955.75,326125.5625,607914.109375,567521.875,Acidic fibroblast growth factor intracellular-binding protein OS=Homo sapiens OX=9606 GN=FIBP PE=1 SV=3,development,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,9158,FIBP,Modulators of TCR signaling and T cell activation,NA,ENSG00000172500
Q96CS3,0,6,21975076.3671875,8.506433414766682e-5,1.6803322284076245,0.748746504962345,0.06176360991964354,0.6429522395902524,raw,19452806.71875,15884671.46875,14755304.703125,27347061.53125,21723435.71875,32687178.0625,FAS-associated factor 2 OS=Homo sapiens OX=9606 GN=FAF2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation,cell surface;cytoskeleton;extracellular;mitochondrion;nucleus,DNA binding;structural molecule activity,23197,FAF2,NA,RHOA GTPase cycle; Neutrophil degranulation,ENSG00000113194
Q5T6W2,0,6,7265707.375,2.8125160961398252e-5,1.6803304205194178,0.7487449527498068,0.03171840647692424,0.6429522395902524,raw,5986177,5793270.375,4858203.125,8163386.5,8252833.5,10540373.75,Heterogeneous nuclear ribonucleoprotein K (Fragment) OS=Homo sapiens OX=9606 GN=HNRNPK PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding,NA,HNRNPK,lncRNA in canonical Wnt signaling and colorectal cancer,NA,ENSG00000165119
Q9BZF1,0,6,15348223.473958334,5.941214439242252e-5,1.6800973873543144,0.748544861683182,0.0403143523590793,0.6429522395902524,raw,14773811.65625,9238006.375,11849287.625,20288473.71875,15520750.375,20419011.09375,Oxysterol-binding protein-related protein 8 OS=Homo sapiens OX=9606 GN=OSBPL8 PE=1 SV=3,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,114882,OSBPL8,NA,Acyl chain remodelling of PS,ENSG00000091039
O43301,0,6,1976164.7981770833,7.649627237427734e-6,1.6798905681614809,0.748367255674953,0.0358123779504128,0.6429522395902524,raw,1431644.59375,1249914.875,1956281.6171875,2206958.5625,2607182.890625,2405006.25,Heat shock 70 kDa protein 12A OS=Homo sapiens OX=9606 GN=HSPA12A PE=1 SV=2,NA,membrane;nucleus,structural molecule activity,259217,HSPA12A,NA,Regulation of HSF1-mediated heat shock response,ENSG00000165868
Q6IAA8,0,6,8616734.28125,3.335491317137645e-5,1.679631212919539,0.7481445034223981,0.058502061474725496,0.6429522395902524,raw,7382494.625,6567285.375,5581858.75,11030617.5,8464492.3125,12673657.125,Ragulator complex protein LAMTOR1 OS=Homo sapiens OX=9606 GN=LAMTOR1 PE=1 SV=2,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;mitochondrion,structural molecule activity,55004,LAMTOR1,NA,Regulation of PTEN gene transcription; Neutrophil degranulation; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; Amino acids regulate mTORC1; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; mTORC1-mediated signalling; RHOH GTPase cycle,ENSG00000149357
Q5BJF2,0.3333333333333333,6,995049.6041666666,3.851783293400681e-6,1.6795275327902492,0.7480554461198199,0.05071111653281422,0.6429522395902524,raw,678380.6875,997865.5,710133.9375,1192689.5,1243262.875,1147965.125,Sigma intracellular receptor 2 OS=Homo sapiens OX=9606 GN=TMEM97 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion,NA,27346,TMEM97,NA,NA,ENSG00000109084
Q14116,0,6,41737580.7890625,1.615639217553468e-4,1.679461414701944,0.7479986503163121,0.05291827859536029,0.6429522395902524,raw,36530151.4375,26530838.53125,28217949.984375,57351876.625,40443688.34375,61350979.8125,Interleukin-18 OS=Homo sapiens OX=9606 GN=IL18 PE=1 SV=1,cell death;cell differentiation;coagulation;defense response;development;metabolic process,cell surface;cytosol,antioxidant activity,3606,IL18,Nucleotide-binding oligomerization domain (NOD) pathway; Corticotropin-releasing hormone signaling pathway; IL1 and megakaryocytes in obesity; Development and heterogeneity of the ILC family; TYROBP causal network in microglia; Cytosolic DNA-sensing pathway; IL-18 signaling pathway; Overview of proinflammatory and profibrotic mediators; Hypertrophy model; Inflammatory bowel disease signaling,Interleukin-10 signaling; Interleukin-4 and Interleukin-13 signaling; Purinergic signaling in leishmaniasis infection; Pyroptosis; Interleukin-18 signaling; Interleukin-1 processing,ENSG00000150782
A0A0A0MTH9,0,6,5591586.251302083,2.1644728480055604e-5,1.678984439363105,0.7475888596032875,0.10436126614267707,0.6429522395902524,raw,4260112.4765625,4811682.46875,3981758.9765625,7363751.15625,5053472.4375,8078739.9921875,TATA-binding protein-associated factor 172 OS=Homo sapiens OX=9606 GN=BTAF1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q9NZ42,0,6,571030,2.2104262991719018e-6,1.6783773389973058,0.7470671042760826,0.03915348611094317,0.6429522395902524,raw,366657.3125,508521.1875,417982.25,624640.6875,654888.125,853490.4375,Gamma-secretase subunit PEN-2 OS=Homo sapiens OX=9606 GN=PSENEN PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;endosome;extracellular;mitochondrion,DNA binding;structural molecule activity,55851,PSENEN,Alzheimer's disease and miRNA effects; Inclusion body myositis; Alzheimer's disease; DYRK1A; Notch signaling pathway,Amyloid fiber formation; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; Nuclear signaling by ERBB4; EPH-ephrin mediated repulsion of cells; NOTCH4 Activation and Transmission of Signal to the Nucleus; NRIF signals cell death from the nucleus; Regulated proteolysis of p75NTR; Noncanonical activation of NOTCH3,ENSG00000205155
Q8IY21,0,6,889176.828125,3.441955493584845e-6,1.6783703258694367,0.7470610759380554,0.09203732589119339,0.6429522395902524,raw,767248.5,NA,567713.875,1215374.875,NA,1006370.0625,Probable ATP-dependent RNA helicase DDX60 OS=Homo sapiens OX=9606 GN=DDX60 PE=1 SV=3,coagulation;metabolic process,cytosol;endoplasmic reticulum;nucleus,RNA binding;structural molecule activity,55601,DDX60,NA,NA,ENSG00000137628
Q07812,0,6,5989527.786458333,2.318513867714195e-5,1.6780862130013336,0.7468168372761826,0.07747452234668176,0.6429522395902524,raw,4220652.5625,5307648.5625,4069278.59375,7082618.875,5998318,9258650.125,Apoptosis regulator BAX OS=Homo sapiens OX=9606 GN=BAX PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,581,BAX,miRNA regulation of DNA damage response; TP53 network; Leptin signaling pathway; TNF-alpha signaling pathway; Amyotrophic lateral sclerosis (ALS); Nanomaterial induced apoptosis; Apoptosis; Mammary gland development pathway - Involution (Stage 4 of 4); Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Overview of nanoparticle effects; RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced HIF-1 survival signaling; Regulation of apoptosis by parathyroid hormone-related protein; miRNA regulation of p53 pathway in prostate cancer; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Hepatitis B infection; Melanoma; IL-18 signaling pathway; EGFR tyrosine kinase inhibitor resistance; Regucalcin in proximal tubule epithelial kidney cells; Host-pathogen interaction of human coronaviruses - apoptosis; Peroxiredoxin 2 induced ovarian failure; p53 transcriptional gene network; Malignant pleural mesothelioma; Complement system in neuronal development and plasticity; DNA damage response; DNA damage response (only ATM dependent),"TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest; Transcriptional regulation by RUNX2; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; Release of apoptotic factors from the mitochondria; Pyroptosis; Activation, translocation and oligomerization of BAX; NTRK3 as a dependence receptor",ENSG00000087088
Q9P287,0,6,30432373.598958332,1.1780207510877214e-4,1.6769922388260388,0.745876012078708,0.09246666998620347,0.6429522395902524,raw,26133681.109375,24390213.1875,18664563.328125,40902198.21875,27474529.859375,45029055.890625,BRCA2 and CDKN1A-interacting protein OS=Homo sapiens OX=9606 GN=BCCIP PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endoplasmic reticulum;membrane,DNA binding;motor activity,56647,BCCIP,NA,NA,ENSG00000107949
Q9Y276,0,6,2067851.2278645833,8.004540456450247e-6,1.676000308048651,0.7450224142044604,0.04673226607319966,0.6429522395902524,raw,2007574.875,1290633.5546875,1512748.0625,2488866.3125,2535366.21875,2571918.34375,Mitochondrial chaperone BCS1 OS=Homo sapiens OX=9606 GN=BCS1L PE=1 SV=1,cell growth;conjugation,cytoskeleton;endosome,structural molecule activity,617,BCS1L,Mitochondrial complex III assembly; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,Mitochondrial protein import,ENSG00000074582
Q05513,0,6,239607.484375,9.275076352221784e-7,1.675265090594245,0.7443894028094852,1,1,raw,NA,179128.03125,NA,NA,NA,300086.9375,Protein kinase C zeta type OS=Homo sapiens OX=9606 GN=PRKCZ PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,signal transducer activity;structural molecule activity,5590,PRKCZ,"Type II diabetes mellitus; IL-1 signaling pathway; Glioblastoma signaling pathways; TNF-alpha signaling pathway; AGE/RAGE pathway; Allograft rejection; Myometrial relaxation and contraction pathways; G protein signaling pathways; Interleukin-1 induced activation of NF-kB; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Wnt signaling pathway and pluripotency; Prader-Willi and Angelman syndrome; Splicing factor NOVA regulated synaptic proteins; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Hippo signaling regulation pathways; Osteoblast differentiation and related diseases; Insulin signaling; Complement system in neuronal development and plasticity; CCL18 signaling pathway; Chronic hyperglycemia impairment of neuron function; Calcium regulation in cardiac cells",GPVI-mediated activation cascade; VEGFR2 mediated cell proliferation; Estrogen-stimulated signaling through PRKCZ; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); RHO GTPases Activate NADPH Oxidases,ENSG00000067606
Q15904,0,6,29521516.666666668,1.1427619710250184e-4,1.6742303248634482,0.7434980139579556,0.08251684021804752,0.6429522395902524,raw,29995201.75,11094812.75,23374524.875,42944733,30585489.25,39134338.375,V-type proton ATPase subunit S1 OS=Homo sapiens OX=9606 GN=ATP6AP1 PE=1 SV=2,cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,537,ATP6AP1,Hepatitis B infection; Oxidative phosphorylation,RHOA GTPase cycle; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000071553
O95167,0,6,3702307.9583333335,1.4331434213147174e-5,1.6742110479492753,0.743481402821379,0.05474956072993789,0.6429522395902524,raw,3396214,3054048.125,1257286,4450191.875,4370128.75,5685979,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 OS=Homo sapiens OX=9606 GN=NDUFA3 PE=1 SV=1,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,4696,NDUFA3,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000170906; ENSG00000273642; ENSG00000274359; ENSG00000275605; ENSG00000275724; ENSG00000276061; ENSG00000276220; ENSG00000276766; ENSG00000277722; ENSG00000278365
Q9HC21,0,6,478154.8125,1.8509114628401478e-6,1.6737027238774989,0.7430433051443581,0.012071782402237517,0.6429522395902524,raw,409567.625,327327.75,317658.375,599469.1875,531665.6875,683240.25,Mitochondrial thiamine pyrophosphate carrier OS=Homo sapiens OX=9606 GN=SLC25A19 PE=1 SV=1,cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,60386,SLC25A19,Thiamine metabolic pathways,Vitamin B1 (thiamin) metabolism,ENSG00000125454
E5RK69,0,6,5850341.083333333,2.264635446425903e-5,1.6733037852923447,0.7426993878441855,0.07551504252967217,0.6429522395902524,raw,5480792,3526275.5,4120469,6991292.5,5812187.5,9171030,Annexin OS=Homo sapiens OX=9606 GN=ANXA6 PE=1 SV=1,NA,NA,structural molecule activity,NA,ANXA6,NA,NA,ENSG00000197043
Q9UHA4,0,6,2611849.609375,1.011032881992953e-5,1.6731920014167978,0.7426030064032746,0.3041093285605794,0.7841708015332192,raw,3369983.375,1383401.25,1567505.375,2802704.25,2314695.90625,4232807.5,Ragulator complex protein LAMTOR3 OS=Homo sapiens OX=9606 GN=LAMTOR3 PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton;mitochondrion,DNA binding,8649,LAMTOR3,MAPK signaling pathway; MAPK cascade; Gastrin signaling pathway; Melanoma,Regulation of PTEN gene transcription; TP53 Regulates Metabolic Genes; Amino acids regulate mTORC1; Neutrophil degranulation; mTORC1-mediated signalling; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; MAP2K and MAPK activation,ENSG00000109270
P03886,0,6,2788185.2708333335,1.0792914644788772e-5,1.6728958551706101,0.7423476343149253,0.25852798500174545,0.7381027251958325,raw,3054076.25,1212372.875,2063830.5,2994235.75,2295444.75,5109151.5,NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens OX=9606 GN=MT-ND1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,4535,MT-ND1,Electron transport chain: OXPHOS system in mitochondria; Arsenic metabolism and reactive oxygen species generation; Oxidative phosphorylation,Complex I biogenesis,ENSG00000198888
Q86V48,0,6,4306570.526041667,1.6670501987638257e-5,1.672874933557307,0.7423295915321609,0.019123311222061474,0.6429522395902524,raw,3593204.5625,3079725.640625,2833865.59375,5735917.671875,4585727.84375,6010981.84375,Leucine zipper protein 1 OS=Homo sapiens OX=9606 GN=LUZP1 PE=1 SV=2,defense response,membrane,NA,7798,LUZP1,NA,NA,ENSG00000169641
A0A087WU53,0,6,9390491.161458334,3.63500842782845e-5,1.6724501718712361,0.7419632285856402,0.008375642675097092,0.6429522395902524,raw,8255811.15625,6994298.625,6373590.4375,11152157,11697615.9375,11869473.8125,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1 OS=Homo sapiens OX=9606 GN=MAGT1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation,cytoplasm;cytoskeleton;extracellular,catalytic activity,84061,MAGT1,NA,NA,ENSG00000102158
Q96HA1,0,6,1211333.1875,4.689005366985497e-6,1.6720770839114232,0.7416413581923047,0.21476898138126715,0.7040869719539218,raw,1015377.25,561251.9375,1021096.5625,2157607.03125,1697789.03125,814877.3125,Nuclear envelope pore membrane protein POM 121 OS=Homo sapiens OX=9606 GN=POM121 PE=1 SV=2,conjugation,cytoskeleton;extracellular;membrane,structural molecule activity,9883,POM121,Ciliary landscape,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000196313
Q96JH7,0,6,7317905.0234375,2.8327215240264826e-5,1.6717730532743607,0.7413790118097923,0.14887340860113554,0.6638855679885327,raw,6776632.25,5645045.015625,4518261.96875,9540189.84375,6098309.875,11328991.1875,Deubiquitinating protein VCIP135 OS=Homo sapiens OX=9606 GN=VCPIP1 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,extracellular;membrane;nucleus,structural molecule activity,80124,VCPIP1,Alstrom syndrome,Ovarian tumor domain proteases,ENSG00000175073
Q92925,0,6,8778365.083333334,3.398057727953408e-5,1.6711372855947442,0.7408302571040893,0.1909534942154168,0.6823711621042031,raw,5863597.875,7845159.875,7072780.9375,13248228.875,6820835,11819587.9375,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 OS=Homo sapiens OX=9606 GN=SMARCD2 PE=1 SV=3,cell growth;cellular component movement;metabolic process,membrane;nucleus,structural molecule activity,6603,SMARCD2,Tumor suppressor activity of SMARCB1; Thermogenesis,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,ENSG00000108604
Q9NYK5,0,6,7492689.114583333,2.9003795020216157e-5,1.6710170606675,0.7407264630309072,0.15689660635142014,0.6638855679885327,raw,8084015.34375,3840046.1875,5709834.84375,11258428.6875,6522578.1875,9541231.4375,"39S ribosomal protein L39, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL39 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,54148,MRPL39,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000154719
Q14527,0,6,8397396.973958334,3.25058702972244e-5,1.6699967628229233,0.739845306134153,0.05380627579247758,0.6429522395902524,raw,7237052.4375,5364434.6875,6076946.21875,12973264.875,9774095.0625,8958588.5625,Helicase-like transcription factor OS=Homo sapiens OX=9606 GN=HLTF PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6596,HLTF,Retinoblastoma gene in cancer,E3 ubiquitin ligases ubiquitinate target proteins,ENSG00000071794
Q9H3H3,0,6,2105638.7083333335,8.150813753137933e-6,1.6690421682774332,0.7390204047881213,0.29749800021982287,0.7790952437047332,raw,2658595.5,1357169.5,1414898.6875,2465518.625,2265173.125,2472476.8125,UPF0696 protein C11orf68 OS=Homo sapiens OX=9606 GN=C11orf68 PE=1 SV=3,NA,NA,NA,83638,C11orf68,NA,NA,ENSG00000175573
B3KY94,0,6,14884006.557291666,5.761518577182379e-5,1.6685399028622119,0.7385861887516164,0.09077960520018433,0.6429522395902524,raw,10700666,12153269.96875,11330503,18905396.375,14110530,22103674,CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Homo sapiens OX=9606 GN=CDIPT PE=1 SV=1,NA,cytoskeleton,structural molecule activity,10423,CDIPT,Glycerolipids and glycerophospholipids; 16p11.2 proximal deletion syndrome,NA,ENSG00000103502
P55010,0,6,39628981.489583336,1.5340164771373045e-4,1.6679630797909042,0.7380873552141891,0.05519587746148175,0.6429522395902524,raw,27927749.75,36179897.34375,23852088.5,50085564.5625,39381855.78125,60346733,Eukaryotic translation initiation factor 5 OS=Homo sapiens OX=9606 GN=EIF5 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,DNA binding;RNA binding;structural molecule activity,1983,EIF5,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit,ENSG00000100664
O96013,0,6,4522424.837890625,1.7506062374484112e-5,1.6678556244031117,0.737994409302624,0.002301062927812226,0.6429522395902524,raw,3006852.83203125,3483437.15625,3642189.0546875,5223921.015625,5703503.46875,6074645.5,Serine/threonine-protein kinase PAK 4 OS=Homo sapiens OX=9606 GN=PAK4 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytosol;extracellular;nucleus,signal transducer activity;structural molecule activity,10298,PAK4,Integrin-mediated cell adhesion; Focal adhesion; Ras signaling; Pancreatic adenocarcinoma pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Merlin signaling dysregulation; Neural crest cell migration during development; Neural crest cell migration in cancer; 22q11.2 copy number variation syndrome; Malignant pleural mesothelioma; Regulation of actin cytoskeleton; ErbB signaling pathway,RHOG GTPase cycle; RAC2 GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; Activation of RAC1; RHOH GTPase cycle,ENSG00000130669
Q8TDU6,0.16666666666666666,6,1514716.5625,5.863386031454144e-6,1.6676289465924183,0.7377983196809156,1,1,raw,NA,1135627.625,NA,1893805.5,NA,NA,G-protein coupled bile acid receptor 1 OS=Homo sapiens OX=9606 GN=GPBAR1 PE=2 SV=1,development;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,151306,GPBAR1,NA,G alpha (s) signalling events; Class A/1 (Rhodopsin-like receptors),ENSG00000179921
G3V1A6,0,6,9746406.817708334,3.772781456716955e-5,1.6675896217141037,0.7377642986380551,0.05471791731690776,0.6429522395902524,raw,9219454.5625,6990679.9375,5886913.65625,11657585.3125,9997303.1875,14726504.25,"Gasdermin domain containing 1, isoform CRA_d OS=Homo sapiens OX=9606 GN=GSDMD PE=1 SV=1",metabolic process,cytoplasm;cytoskeleton;membrane,NA,NA,GSDMD,STING pathway in Kawasaki-like disease and COVID-19,NA,ENSG00000104518; ENSG00000278718
Q92575,0,6,25374849.026041668,9.822467055089754e-5,1.6668430532908496,0.7371182693521832,0.006368464076414806,0.6429522395902524,raw,16941890.75,18819036.96875,21552831.34375,34370209.875,28239472.90625,32325652.3125,UBX domain-containing protein 4 OS=Homo sapiens OX=9606 GN=UBXN4 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation,cytoskeleton;cytosol;extracellular;membrane,NA,23190,UBXN4,NA,NA,ENSG00000144224
P51571,0,6,31806130.229166668,1.231198128529787e-4,1.6665581861969512,0.7368716885686809,0.0848765064732036,0.6429522395902524,raw,19314637.65625,30223182.1875,19344126.53125,50368691.6875,29105842.3125,42480301,Translocon-associated protein subunit delta OS=Homo sapiens OX=9606 GN=SSR4 PE=1 SV=1,NA,cytoskeleton;extracellular;nucleus,NA,6748,SSR4,VEGFA-VEGFR2 signaling pathway,SRP-dependent cotranslational protein targeting to membrane,ENSG00000180879
P00156,0.3333333333333333,6,1285302.5833333333,4.975336904529683e-6,1.6665326659561381,0.7368495962066679,0.24413923517123767,0.7301988479077035,raw,1144454.125,885256.5,848030.25,1475308.875,990542.25,2368223.5,Cytochrome b OS=Homo sapiens OX=9606 GN=MT-CYB PE=1 SV=2,cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity;structural molecule activity,4519,MT-CYB,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,Respiratory electron transport,ENSG00000198727
Q9BRQ8,0,6,4780959.651041667,1.8506836677481426e-5,1.6664274798716083,0.7367585351462697,0.07480549645708891,0.6429522395902524,raw,3051104.3125,5058492.3125,2804337.15625,6589622.75,4673224.5,6508976.875,Ferroptosis suppressor protein 1 OS=Homo sapiens OX=9606 GN=AIFM2 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,84883,AIFM2,Apoptosis modulation and signaling; Ferroptosis,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,ENSG00000042286
O14787,0,6,2958906.6490885415,1.1453767882492896e-5,1.6658121830880495,0.7362257489614875,0.2909486724776378,0.7730231021500684,raw,3022317.6875,1831719.9296875,1570342.734375,4821426.28125,1473019.63671875,5034613.625,Transportin-2 OS=Homo sapiens OX=9606 GN=TNPO2 PE=1 SV=3,conjugation,membrane;nucleus,structural molecule activity,30000,TNPO2,NA,NA,ENSG00000105576
P23511,0,6,1830368.3645833333,7.085257114770264e-6,1.6654517124076165,0.7359135255643682,0.13567029671911732,0.653793677153943,raw,1006265.625,1807081.0625,1376643.375,1986025.1875,1796588.6875,3009606.25,Nuclear transcription factor Y subunit alpha OS=Homo sapiens OX=9606 GN=NFYA PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4800,NFYA,Sterol regulatory element-binding proteins (SREBP) signaling; Wnt signaling pathway and pluripotency; Sudden infant death syndrome (SIDS) susceptibility pathways,PPARA activates gene expression; Activation of gene expression by SREBF (SREBP); FOXO-mediated transcription of cell death genes; ATF4 activates genes in response to endoplasmic reticulum  stress; ATF6 (ATF6-alpha) activates chaperone genes,ENSG00000001167
P27797,0,6,750289709.263672,0.002904330955211566,1.6653160359404782,0.7357959912412314,0.06238810536791962,0.6429522395902524,raw,596592708.195313,607083707.34375,481444573.46875,993515403.882813,726093437.378906,1097008425.3125,Calreticulin OS=Homo sapiens OX=9606 GN=CALR PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cell surface;chromosome;cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;RNA binding;structural molecule activity,811,CALR,Androgen receptor signaling pathway; Complement system; Photodynamic therapy-induced unfolded protein response; VEGFA-VEGFR2 signaling pathway; GDNF signaling; Calcium regulation in cardiac cells,"ER-Phagosome pathway; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Scavenging by Class A Receptors; Assembly of Viral Components at the Budding Site; Scavenging by Class F Receptors; ATF6 (ATF6-alpha) activates chaperone genes; Calnexin/calreticulin cycle",ENSG00000179218
Q9BYT8,0,6,19491003.85546875,7.544862357387364e-5,1.6646306206248407,0.735202080651802,0.09949828908482129,0.6429522395902524,raw,15217138.96875,14780149.3671875,16071184.640625,26219998,17904966.09375,26752586.0625,"Neurolysin, mitochondrial OS=Homo sapiens OX=9606 GN=NLN PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;development;metabolic process,cell surface;cytoplasm;cytoskeleton;endosome,structural molecule activity,57486,NLN,NA,Peptide ligand-binding receptors,ENSG00000123213
Q9H8T0,0,6,424008.1979166667,1.641312841250871e-6,1.6638538995998529,0.7345287582527129,1,1,raw,459074.84375,260247.25,NA,NA,NA,552702.5,AKT-interacting protein OS=Homo sapiens OX=9606 GN=AKTIP PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,64400,AKTIP,NA,NA,ENSG00000166971
P49755,0,6,40131126.141927086,1.553454225513557e-4,1.663152391427782,0.7339203660301208,0.08094296481306439,0.6429522395902524,raw,36697538.25,24550255.953125,27582698.2890625,54107326.21875,36815339.640625,61033598.5,Transmembrane emp24 domain-containing protein 10 OS=Homo sapiens OX=9606 GN=TMED10 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,catalytic activity;structural molecule activity,10972,TMED10,mRNA processing,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; COPII-mediated vesicle transport; Cargo concentration in the ER,ENSG00000170348
P28482,0,6,22224814.015625,8.60310551010311e-5,1.6631183305722064,0.7338908197715411,0.08499664162704332,0.6429522395902524,raw,19317602.375,20018264.71875,13113516.96875,25477810.3125,22128946.71875,33292743,Mitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3,cell death;cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;mitochondrion;nucleus,RNA binding;signal transducer activity;structural molecule activity,5594,MAPK1,"IL-5 signaling pathway; Osteopontin signaling; Physiological and pathological hypertrophy of the heart; Angiogenesis; MicroRNAs in cardiomyocyte hypertrophy; Type II diabetes mellitus; Heart development; Integrin-mediated cell adhesion; IL-1 signaling pathway; Thyroxine (thyroid hormone) production; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; IL-17 signaling pathway; Endothelin pathways; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Alpha 6 beta 4 signaling pathway; PDGF pathway; Aryl hydrocarbon receptor pathway; S1P receptor signal transduction; Ebstein-Barr virus LMP1 signaling; Common pathways underlying drug addiction; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Bladder cancer; IL-3 signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; TCA cycle nutrient use and invasiveness of ovarian cancer; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; MFAP5-mediated ovarian cancer cell motility and invasiveness; RAC1/PAK1/p38/MMP2 pathway; Wnt signaling pathway; IL6 signaling pathway; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; BDNF-TrkB signaling; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; ERK pathway in Huntington's disease; Toll-like receptor signaling related to MyD88; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; Prion disease pathway; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Ebola virus infection in host; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Neovascularisation processes; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Bile acids synthesis and enterohepatic circulation ; Resistin as a regulator of inflammation; Relationship between inflammation, COX-2 and EGFR; Envelope proteins and their potential roles in EDMD physiopathology; Regulatory circuits of the STAT3 signaling pathway; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Hepatitis B infection; Melanoma; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Regucalcin in proximal tubule epithelial kidney cells; Kisspeptin/kisspeptin receptor system in the ovary; MAP3K1 role in promoting and blocking gonadal determination; CAMKK2 pathway; Disruption of postsynaptic signaling by CNV; Host-pathogen interaction of human coronaviruses - MAPK signaling; IL-2 signaling pathway; RAS and bradykinin pathways in COVID-19; Angiotensin II receptor type 1 pathway; Kallmann syndrome; Neuroinflammation and glutamatergic signaling; Malignant pleural mesothelioma; CCL18 signaling pathway; Regulation of actin cytoskeleton; Sphingolipid metabolism in senescence; Alzheimer's disease; Th17 cell differentiation pathway; GDNF signaling; 2q11.2 copy number variation syndrome; 2q13 copy number variation syndrome; Hippocampal synaptogenesis and neurogenesis; Genetic causes of porto-sinusoidal vascular disease; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response (only ATM dependent); Estrogen signaling pathway; Vitamin A and carotenoid metabolism; Toll-like receptor signaling pathway","Regulation of actin dynamics for phagocytic cup formation; FCERI mediated MAPK activation; FCGR3A-mediated phagocytosis; Recycling pathway of L1; NPAS4 regulates expression of target genes; RHO GTPases Activate WASPs and WAVEs; Regulation of HSF1-mediated heat shock response; Neutrophil degranulation; Signaling by BRAF and RAF1 fusions; Thrombin signalling through proteinase activated receptors (PARs); SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Signaling by NODAL; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Oncogene Induced Senescence; Senescence-Associated Secretory Phenotype (SASP); Growth hormone receptor signaling; Regulation of the apoptosome activity; Signal transduction by L1; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; NCAM signaling for neurite out-growth; Downregulation of SMAD2/3:SMAD4 transcriptional activity; RUNX2 regulates osteoblast differentiation; RSK activation; Estrogen-stimulated signaling through PRKCZ; Spry regulation of FGF signaling; Suppression of apoptosis; MAPK1 (ERK2) activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Golgi Cisternae Pericentriolar Stack Reorganization; Signaling by Activin; Activation of the AP-1 family of transcription factors; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; Signal attenuation; Gastrin-CREB signalling pathway via PKC and MAPK; Nuclear events stimulated by ALK signaling in cancer; ESR-mediated signaling; Negative feedback regulation of MAPK pathway; Advanced glycosylation endproduct receptor signaling; RHO GTPases Activate NADPH Oxidases; ERKs are inactivated; Signaling by MAP2K mutants; phospho-PLA2 pathway; Signaling by MAPK mutants",ENSG00000100030
Q9H1E3,0,6,16312357.333333334,6.314425450692544e-5,1.6623071255564872,0.73318695706767,0.12532878522049712,0.6449267539975253,raw,12450516.25,13907116.4375,12684912.625,21258761.125,14454938.8125,23117898.75,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 OS=Homo sapiens OX=9606 GN=NUCKS1 PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,64710,NUCKS1,NA,NA,ENSG00000069275
Q8IY57,0.16666666666666666,6,254196.4171875,9.839806064594196e-7,1.662220602560375,0.7331118629143643,0.31764569079659205,0.7987484302904563,raw,NA,252951.234375,116098.2578125,290660.03125,194821.0625,416451.5,YY1-associated factor 2 OS=Homo sapiens OX=9606 GN=YAF2 PE=1 SV=3,cellular component movement;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,10138,YAF2,NA,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Transcriptional Regulation by E2F6,ENSG00000015153
O00401,0,6,3578837.078125,1.3853485102252118e-5,1.6619159216673036,0.7328473962707623,0.0522601643640325,0.6429522395902524,raw,2614929.1875,2705317.75,2416899.4375,4016683.65625,4155443.8125,5563748.625,Neural Wiskott-Aldrich syndrome protein OS=Homo sapiens OX=9606 GN=WASL PE=1 SV=2,cell differentiation;cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;motor activity,8976,WASL,Pathogenic Escherichia coli infection; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; Chemokine signaling pathway; G13 signaling pathway,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RHOJ GTPase cycle; RHOV GTPase cycle; Clathrin-mediated endocytosis; NOSTRIN mediated eNOS trafficking; Nephrin family interactions; EPHB-mediated forward signaling; DCC mediated attractive signaling,ENSG00000106299
Q13190,0,6,3985508.6653645835,1.5427688859603494e-5,1.659470091042224,0.7307226276723712,0.15428293922013636,0.6638855679885327,raw,3618406.0546875,3021245.765625,2750244.265625,6004636.625,3325175.15625,5193344.125,Syntaxin-5 OS=Homo sapiens OX=9606 GN=STX5 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,6811,STX5,Alstrom syndrome,COPI-mediated anterograde transport; RHOC GTPase cycle; RHOA GTPase cycle; RHOG GTPase cycle; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; Intra-Golgi traffic; COPII-mediated vesicle transport; Cargo concentration in the ER,ENSG00000162236
Q9UQB8,0,6,15224005.713541666,5.8931304148566266e-5,1.6585750245852615,0.7299442729936079,0.02274337160480285,0.6429522395902524,raw,11009263.625,12559142.0625,10617328.28125,18259689.6875,16994672.5,21903938.125,Brain-specific angiogenesis inhibitor 1-associated protein 2 OS=Homo sapiens OX=9606 GN=BAIAP2 PE=1 SV=1,cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,structural molecule activity,10458,BAIAP2,Regulation of actin cytoskeleton,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; CDC42 GTPase cycle; RAC1 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway,ENSG00000175866
P49720,0,6,56063429.256510414,2.1701850769723842e-4,1.6578726364671965,0.7293331782480083,0.06303240600983903,0.6429522395902524,raw,44009825.4375,45529190.125,41566205.1484375,74838767,54954989.359375,75481598.46875,Proteasome subunit beta type-3 OS=Homo sapiens OX=9606 GN=PSMB3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,NA,5691,PSMB3,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000275903; ENSG00000277791
A0A590UJA9,0,6,693183.1979166666,2.6832747330597018e-6,1.6578535818448215,0.7293165966562863,0.1669001989812648,0.6670444762382309,raw,395747.96875,778696.4375,411104.96875,656092.1875,770510.625,1146947,Transmembrane and ubiquitin-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TMUB1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation,NA,NA,NA,TMUB1,NA,NA,ENSG00000164897
Q14651,0,6,23106421.569010418,8.944371034077633e-5,1.6577128609306744,0.7291941335003731,0.08885439586400043,0.6429522395902524,raw,19859757.59375,17653535.625,14650939.6328125,32706349.78125,20846171.203125,32921775.578125,Plastin-1 OS=Homo sapiens OX=9606 GN=PLS1 PE=1 SV=2,cell growth;conjugation;defense response;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,5357,PLS1,NA,Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea,ENSG00000120756
Q9NQ48,0,6,5970832.098958333,2.3112768680239684e-5,1.6575771976606573,0.7290760619449226,0.1881503010285526,0.6796724904026823,raw,5496506.21875,4064936.15625,4143390.90625,8548706.9375,4460569,9110883.375,Leucine zipper transcription factor-like protein 1 OS=Homo sapiens OX=9606 GN=LZTFL1 PE=1 SV=1,metabolic process,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,54585,LZTFL1,Ciliary landscape; Genes related to primary cilium development (based on CRISPR); Ciliopathies; Bardet-Biedl syndrome,BBSome-mediated cargo-targeting to cilium,ENSG00000163818
Q9H553,0,6,1414198.0625,5.474284345109624e-6,1.6573464395771225,0.7288752045015965,0.3796332389426434,0.8634147326693583,raw,1661822.4375,402051.9375,1202490.0625,1526620.75,937987.6875,2754215.5,"Alpha-1,3/1,6-mannosyltransferase ALG2 OS=Homo sapiens OX=9606 GN=ALG2 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,85365,ALG2,NA,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein; Defective ALG2 causes CDG-1i",ENSG00000119523
E9PC69,0,6,6557435.494791667,2.5383478753849736e-5,1.6572644010404665,0.7288037894271212,0.10764776740167152,0.6429522395902524,raw,3691374,6204548.4375,5362180.09375,10282577.25,6599230.125,7204703.0625,Non-specific serine/threonine protein kinase OS=Homo sapiens OX=9606 GN=MARK2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;membrane;nucleus,signal transducer activity;structural molecule activity,NA,MARK2,Microtubule cytoskeleton regulation; Neurogenesis regulation in the olfactory epithelium,NA,ENSG00000072518
P07948,0,6,6514123.859375,2.5215821751616672e-5,1.6559488423368054,0.7276581039682649,0.01519069736420848,0.6429522395902524,raw,5077303.6875,4519550.78125,5216510.75,8638274.9375,7056037.3125,8577065.6875,Tyrosine-protein kinase Lyn OS=Homo sapiens OX=9606 GN=LYN PE=1 SV=3,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;motor activity;signal transducer activity;structural molecule activity,4067,LYN,IL-5 signaling pathway; RANKL/RANK signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Chemokine signaling pathway; Microglia pathogen phagocytosis pathway; GDNF signaling,"FCGR activation; Role of LAT2/NTAL/LAB on calcium mobilization; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; FCERI mediated NF-kB activation; CD22 mediated BCR regulation; FCGR3A-mediated IL10 synthesis; FCGR3A-mediated phagocytosis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Erythropoietin activates Phosphoinositide-3-kinase (PI3K); Regulation of signaling by CBL; EPHB-mediated forward signaling; GPVI-mediated activation cascade; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Cyclin D associated events in G1; Regulation of KIT signaling; Growth hormone receptor signaling; Inactivation of CSF3 (G-CSF) signaling; EPH-ephrin mediated repulsion of cells; EPHA-mediated growth cone collapse; Erythropoietin activates Phospholipase C gamma (PLCG); Erythropoietin activates STAT5; Erythropoietin activates RAS; Platelet Adhesion to exposed collagen; CD209 (DC-SIGN) signaling; CD28 co-stimulation; Dectin-2 family; PECAM1 interactions; CTLA4 inhibitory signaling",ENSG00000254087
P13473,0,6,10178759.71875,3.940142930367335e-5,1.6558404722295628,0.7275636867203634,0.07594899748045078,0.6429522395902524,raw,9193706.5,5875452.625,7943023.9375,13319997.75,9517066.1875,15223311.3125,Lysosome-associated membrane glycoprotein 2 OS=Homo sapiens OX=9606 GN=LAMP2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,3920,LAMP2,Clock-controlled autophagy in bone metabolism,Neutrophil degranulation; Platelet degranulation ; Chaperone Mediated Autophagy,ENSG00000005893
P51665,0,6,42536267.565104164,1.6465559514302052e-4,1.6552347132088125,0.7270358065025999,0.055547203348078125,0.6429522395902524,raw,33176474.875,34069011.25,30479547.546875,54914852.875,42601904.6875,59975814.15625,26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMD7 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cell surface;cytosol;membrane;nucleus,structural molecule activity,5713,PSMD7,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000103035
Q13200,0,6,208254251.484375,8.061409635140388e-4,1.654264431920391,0.7261898657835999,0.06369556469699908,0.6429522395902524,raw,160229827.34375,178215815.675781,139080339.441406,277546182.71875,199637258.648438,294816085.078125,26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiens OX=9606 GN=PSMD2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytosol;membrane;nucleus,DNA binding,5708,PSMD2,Proteasome degradation; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000175166
Q9BTT0,0,6,36614558.041666664,1.4173297730041512e-4,1.6534520558517845,0.7254812131808673,0.1646279989143583,0.6638855679885327,raw,34927970.875,26799462.6875,24002829.75,45465044.5,30740315.1875,57751725.25,Acidic leucine-rich nuclear phosphoprotein 32 family member E OS=Homo sapiens OX=9606 GN=ANP32E PE=1 SV=1,metabolic process,membrane;nucleus,DNA binding;structural molecule activity,81611,ANP32E,NA,NA,ENSG00000143401
Q14258,0,6,83475702.52604167,3.2312993749087244e-4,1.6532192495435865,0.7252780671915264,0.05392451680971662,0.6429522395902524,raw,70594293.90625,59012511.875,63421510.5,116707845.59375,82535804.84375,108582248.4375,E3 ubiquitin/ISG15 ligase TRIM25 OS=Homo sapiens OX=9606 GN=TRIM25 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,7706,TRIM25,Novel intracellular components of RIG-I-like receptor pathway; Cytosolic DNA-sensing pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response,Interferon gamma signaling; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Termination of translesion DNA synthesis; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses; Ovarian tumor domain proteases; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation,ENSG00000121060
P36959,0,6,2693982.9375,1.0428262498590922e-5,1.6530503457283423,0.7251306643921901,0.37140512748565213,0.8568551911089849,raw,1037294.1875,3391332.28125,1611278.71875,5606043,2148224.375,2369725.0625,GMP reductase 1 OS=Homo sapiens OX=9606 GN=GMPR PE=1 SV=1,cellular homeostasis;coagulation,cytosol;nucleus,structural molecule activity,2766,GMPR,NA,Purine salvage,ENSG00000137198
Q9UHB6,0,6,65828373.477864586,2.5481807955305677e-4,1.652879154942067,0.7249812503780219,0.035542906719166906,0.6429522395902524,raw,44520517.03125,61413477.078125,40451521.7734375,95357086.40625,66861477.125,86366161.453125,LIM domain and actin-binding protein 1 OS=Homo sapiens OX=9606 GN=LIMA1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,51474,LIMA1,NA,NA,ENSG00000050405
Q9UDY8,0,6,3908001.2604166665,1.5127661879799555e-5,1.6525422535045808,0.7246871601699953,0.05862161677658054,0.6429522395902524,raw,2912814.96875,3882286.03125,2036486.34375,4632871.0625,4813549.8125,5169999.34375,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 OS=Homo sapiens OX=9606 GN=MALT1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,10892,MALT1,B cell receptor signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; 22q11.2 copy number variation syndrome; Modulators of TCR signaling and T cell activation; T-cell receptor signaling pathway,FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; CLEC7A/inflammasome pathway,ENSG00000172175
P98171,0,6,992546.5703125,3.842094184494025e-6,1.6508477264764023,0.7232070527836756,0.1110818712120705,0.6429522395902524,raw,714753.6875,717728.84375,704021.921875,974670.9375,1179949.5,1664154.53125,Rho GTPase-activating protein 4 OS=Homo sapiens OX=9606 GN=ARHGAP4 PE=1 SV=2,cell growth;defense response;development;metabolic process,cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,DNA binding;structural molecule activity,393,ARHGAP4,Clock-controlled autophagy in bone metabolism,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle,ENSG00000089820
O00487,0,6,59622639.268229164,2.3079601748512881e-4,1.6505417814922598,0.7229396591231545,0.11414811440544015,0.6429522395902524,raw,47924515.6875,50396156.203125,42202098.6875,85068406.21875,53043243.3125,79101415.5,26S proteasome non-ATPase regulatory subunit 14 OS=Homo sapiens OX=9606 GN=PSMD14 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cell surface;cytosol;membrane;nucleus,DNA binding;structural molecule activity,10213,PSMD14,Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Metalloprotease DUBs,ENSG00000115233
Q9UPZ3,0.3333333333333333,6,194043.6953125,7.511326678234935e-7,1.6495108614869984,0.7220382776068989,0.143050619884022,0.6572502130392559,raw,173238.25,157257.609375,123878.09375,285758.375,161599.96875,262529.875,Hermansky-Pudlak syndrome 5 protein OS=Homo sapiens OX=9606 GN=HPS5 PE=1 SV=2,cell growth;coagulation;conjugation;metabolic process,cytosol;mitochondrion;nucleus,NA,11234,HPS5,NA,NA,ENSG00000110756; ENSG00000288445
Q96RF0,0,6,434845.28125,1.6832626057226455e-6,1.6493439769136908,0.7218923096523744,0.04491884951099061,0.6429522395902524,raw,382217.875,361145.40625,271212.59375,630408.75,451649.75,512437.3125,Sorting nexin-18 OS=Homo sapiens OX=9606 GN=SNX18 PE=1 SV=2,cell differentiation;cell growth;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;mitochondrion;nucleus,structural molecule activity,112574,SNX18,NA,Clathrin-mediated endocytosis,ENSG00000178996
Q96T60,0,6,3128010.1666666665,1.2108358468866932e-5,1.6493241759281756,0.7218749894599306,0.21234483669553492,0.7022549232366887,raw,2725794.90625,1201144.15625,3233505.03125,4790276.0625,2321621.40625,4495719.4375,Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens OX=9606 GN=PNKP PE=1 SV=1,cell proliferation;cellular homeostasis;coagulation;metabolic process,endosome;membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,11284,PNKP,"Base excision repair; DNA repair pathways, full network",APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,ENSG00000039650
Q07817,0,6,5517440.375,2.1357713796145352e-5,1.649061976708533,0.7216456206127458,0.05744953509205442,0.6429522395902524,raw,5006881.9375,3210477.4375,4408985.625,8256658.625,5578450.25,6643188.375,Bcl-2-like protein 1 OS=Homo sapiens OX=9606 GN=BCL2L1 PE=1 SV=1,cell differentiation;cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;nucleus,structural molecule activity,598,BCL2L1,Leptin signaling pathway; IL-7 signaling pathway; TNF-alpha signaling pathway; Amyotrophic lateral sclerosis (ALS); Apoptosis; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); IL-3 signaling pathway; Photodynamic therapy-induced HIF-1 survival signaling; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; lncRNA-mediated mechanisms of therapeutic resistance; Regulation of apoptosis by parathyroid hormone-related protein; VEGFA-VEGFR2 signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Measles virus infection; Small cell lung cancer; Gastrin signaling pathway; IL-18 signaling pathway; EGFR tyrosine kinase inhibitor resistance; Host-pathogen interaction of human coronaviruses - apoptosis,Interleukin-4 and Interleukin-13 signaling; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members; RAS processing; The NLRP1 inflammasome; STAT5 activation downstream of FLT3 ITD mutants; SARS-CoV-1-mediated effects on programmed cell death,ENSG00000171552
Q8NEZ5,0,6,12489122.651041666,4.834471947436387e-5,1.648911853358292,0.7215142780222805,0.08231727836529555,0.6429522395902524,raw,7879027.5,11938448.65625,8049598.140625,19685449.5,12036296.890625,15345915.21875,F-box only protein 22 OS=Homo sapiens OX=9606 GN=FBXO22 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane,structural molecule activity,26263,FBXO22,NA,Neddylation; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000167196
Q9H0V9,0.16666666666666666,6,703218.3645833334,2.7221203214115806e-6,1.6488051862681925,0.7214209479517395,0.13715939549927375,0.654928512316515,raw,795626.4375,325645.6875,524645.0625,734392.875,865037.5,973962.625,VIP36-like protein OS=Homo sapiens OX=9606 GN=LMAN2L PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,81562,LMAN2L,2q11.2 copy number variation syndrome,COPII-mediated vesicle transport; Cargo concentration in the ER,ENSG00000114988
B1ALM5,0.16666666666666666,6,1557672.3854166667,6.029665702710595e-6,1.648382407549016,0.7210509715718479,0.024420248033627606,0.6429522395902524,raw,1035962.8125,1281040.75,1296120.25,1818790.875,2206456.75,1707662.875,Transmembrane protein 9 OS=Homo sapiens OX=9606 GN=TMEM9 PE=1 SV=1,NA,cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,NA,252839,TMEM9,NA,NA,ENSG00000116857
Q9NRW1,0,6,1535565.7395833333,5.944092070263125e-6,1.648234956801193,0.7209219141537186,0.1382350017314801,0.6567326176535974,raw,1114649,791132.4375,1561197.625,1572824.0625,1600370.8125,2573220.5,Ras-related protein Rab-6B OS=Homo sapiens OX=9606 GN=RAB6B PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,motor activity;structural molecule activity,51560,RAB6B,NA,TBC/RABGAPs; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; COPI-independent Golgi-to-ER retrograde traffic; Retrograde transport at the Trans-Golgi-Network,ENSG00000154917
Q8N1S5,0.16666666666666666,6,1437399.25,5.564094889252696e-6,1.6482183373164028,0.7209073670959266,0.20641232471043852,0.6986564272044358,raw,867906.5625,1471750.25,801575.875,2069861.1875,987535.875,2425765.75,Zinc transporter ZIP11 OS=Homo sapiens OX=9606 GN=SLC39A11 PE=2 SV=3,conjugation,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,catalytic activity,201266,SLC39A11,Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis,NA,ENSG00000133195
P82932,0,6,7116014.916666667,2.7545709537326498e-5,1.6478732284341073,0.7206052596666019,0.01802239113415195,0.6429522395902524,raw,5411143.75,6106479.75,4780903.625,7885534.375,8449323.5,10062704.5,"28S ribosomal protein S6, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS6 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,RNA binding;structural molecule activity,64968,MRPS6,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000243927
Q9NRA2,0.16666666666666666,6,466388.6302083333,1.8053652064642119e-6,1.6470865862494477,0.7199163985792729,0.017890544121185247,0.6429522395902524,raw,331757.8125,380323.8125,342278.90625,626426.25,503222.5625,614322.4375,Sialin OS=Homo sapiens OX=9606 GN=SLC17A5 PE=1 SV=2,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,catalytic activity,26503,SLC17A5,NA,Sialic acid metabolism; Organic anion transporters; Defective SLC17A5 causes Salla disease (SD) and ISSD,ENSG00000119899
Q05655,0,6,14502509.325520834,5.613843058528801e-5,1.6460045134289922,0.7189682917089293,0.053632240552799706,0.6429522395902524,raw,12603084.0625,9370369.46875,9699006.234375,20615939.1875,13981923.75,20744733.25,Protein kinase C delta type OS=Homo sapiens OX=9606 GN=PRKCD PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endosome;extracellular;membrane;mitochondrion;nucleus,DNA binding;signal transducer activity;structural molecule activity,5580,PRKCD,"Type II diabetes mellitus; Glioblastoma signaling pathways; B cell receptor signaling pathway; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; IL6 signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Wnt signaling pathway and pluripotency; Pancreatic adenocarcinoma pathway; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Hippo signaling regulation pathways; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; IL-18 signaling pathway; Osteoblast differentiation and related diseases; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Galanin receptor pathway; CCL18 signaling pathway; Chronic hyperglycemia impairment of neuron function; Calcium regulation in cardiac cells; Type II interferon signaling; T-cell receptor signaling pathway",CLEC7A (Dectin-1) signaling; KEAP1-NFE2L2 pathway; Role of phospholipids in phagocytosis; G alpha (z) signalling events; Neutrophil degranulation; Interferon gamma signaling; SHC1 events in ERBB2 signaling; HuR (ELAVL1) binds and stabilizes mRNA; VEGFR2 mediated cell proliferation; DAG and IP3 signaling; Effects of PIP2 hydrolysis; RHO GTPases Activate NADPH Oxidases; Calmodulin induced events; Apoptotic cleavage of cellular proteins,ENSG00000163932
Q8N3E9,0,6,885403.1119791666,3.427347642133328e-6,1.6454619445802054,0.7184926609196981,0.049719949534943186,0.6429522395902524,raw,724777.921875,786141.71875,489330.19921875,1142685.40234375,875917.1484375,1293566.28125,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 OS=Homo sapiens OX=9606 GN=PLCD3 PE=1 SV=3",cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol,structural molecule activity,113026,PLCD3,GPR40 pathway; Resistin as a regulator of inflammation,Synthesis of IP3 and IP4 in the cytosol,ENSG00000161714
D6REX3,0,6,23624691.846354168,9.144990660212817e-5,1.645398138560827,0.7184367165006574,0.06900861531037562,0.6429522395902524,raw,20467162.546875,16721991.1875,16502603.875,33676631.15625,22375496.21875,32004266.09375,Protein transport protein Sec31A OS=Homo sapiens OX=9606 GN=SEC31A PE=1 SV=1,conjugation,cytoskeleton;cytosol;extracellular;nucleus,NA,NA,SEC31A,Sterol regulatory element-binding proteins (SREBP) signaling,NA,ENSG00000138674
Q9BUT1,0.16666666666666666,6,518757.875,2.0080837255530007e-6,1.645352076361287,0.7183963283201437,1,1,raw,309816.0625,NA,581372,NA,NA,665085.5625,3-hydroxybutyrate dehydrogenase type 2 OS=Homo sapiens OX=9606 GN=BDH2 PE=1 SV=2,cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,56898,BDH2,NA,Synthesis of Ketone Bodies,ENSG00000164039
Q96S52,0,6,1776732.6302083333,6.877636082884201e-6,1.645321226744251,0.7183692781784778,0.1800279544132031,0.6742444420587625,raw,1234429.5625,1669325.125,1202994.25,2746576.0625,1371890.90625,2435179.875,GPI transamidase component PIG-S OS=Homo sapiens OX=9606 GN=PIGS PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,NA,94005,PIGS,NA,Attachment of GPI anchor to uPAR,ENSG00000087111
P49354,0,6,6840318.575520833,2.6478503886039843e-5,1.6452987293067494,0.7183495512322182,0.3041063613885907,0.7841708015332192,raw,6247537.46875,5003782.359375,5512446.15625,9069620.65625,4541768.1875,10666756.625,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha OS=Homo sapiens OX=9606 GN=FNTA PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,antioxidant activity;motor activity;structural molecule activity,2339,FNTA,Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome,"Potential therapeutics for SARS; Inactivation, recovery and regulation of the phototransduction cascade; RAS processing; Apoptotic cleavage of cellular proteins",ENSG00000168522
Q9Y5L0,0,6,8786211.739583334,3.401095126222424e-5,1.6449977707296055,0.7180856288483453,0.083181669174414,0.6429522395902524,raw,7167251.0625,6856643.5625,5571617.21875,13509526.5625,8333068.65625,11279163.375,Transportin-3 OS=Homo sapiens OX=9606 GN=TNPO3 PE=1 SV=3,conjugation,cytoskeleton;membrane;nucleus,structural molecule activity,23534,TNPO3,NA,NA,ENSG00000064419
P55196,0,6,6862592.828125,2.656472631524785e-5,1.6449855714246209,0.7180749297809195,0.05352583017255969,0.6429522395902524,raw,5775025.546875,5505697.75,4513146.234375,9056793.359375,6701565.546875,9623328.53125,Afadin OS=Homo sapiens OX=9606 GN=AFDN PE=1 SV=3,cell communication;cell death;cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,motor activity;structural molecule activity,4301,AFDN,VEGFA-VEGFR2 signaling pathway; Ras signaling; 1q21.1 copy number variation syndrome,NA,ENSG00000130396
O60701,0,6,75970238.54329422,2.9407669164572864e-4,1.644896536841607,0.7179968420275071,0.06513254871696521,0.6429522395902524,raw,64630706.3125,45908019.640625,60839187.6835938,111906782.427734,72462566.0703125,100074169.125,UDP-glucose 6-dehydrogenase OS=Homo sapiens OX=9606 GN=UGDH PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;defense response,cytosol;membrane,structural molecule activity,7358,UGDH,Glucuronidation,"Formation of the active cofactor, UDP-glucuronate",ENSG00000109814
Q9NWA0,0,6,421510.859375,1.6316457785914037e-6,1.643909564862861,0.7171309353258375,1,1,raw,NA,NA,318854.21875,524167.5,NA,NA,Mediator of RNA polymerase II transcription subunit 9 OS=Homo sapiens OX=9606 GN=MED9 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,55090,MED9,Vitamin D receptor pathway,Transcriptional regulation of white adipocyte differentiation; PPARA activates gene expression,ENSG00000141026
Q9Y5X1,0,6,16365586.5703125,6.335030200933968e-5,1.6433132462531532,0.7166075111712332,0.041776800434225214,0.6429522395902524,raw,14691149.1875,11264227.171875,11460829.0625,19372247.96875,17262905.96875,24142160.0625,Sorting nexin-9 OS=Homo sapiens OX=9606 GN=SNX9 PE=1 SV=1,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,51429,SNX9,NA,Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis,ENSG00000130340
Q7Z2K6,0,6,6881852.442708333,2.6639279243442365e-5,1.643003762390384,0.7163357839859386,0.08029657862254368,0.6429522395902524,raw,6083221.46875,3929524.78125,5634842.09375,8802846.25,6456224,10384456.0625,Endoplasmic reticulum metallopeptidase 1 OS=Homo sapiens OX=9606 GN=ERMP1 PE=1 SV=2,cell organization and biogenesis;coagulation;development,cytoskeleton;extracellular,structural molecule activity,79956,ERMP1,NA,NA,ENSG00000099219
E7ERK9,0,6,7316069.536458333,2.8320110169269364e-5,1.6416513745990127,0.7151477851313568,0.15708878553808378,0.6638855679885327,raw,5991040.90625,5826641.71875,5934823.9375,9742911.875,6201395.34375,10199603.4375,Translation initiation factor eIF-2B subunit delta OS=Homo sapiens OX=9606 GN=EIF2B4 PE=1 SV=1,NA,NA,NA,8890,EIF2B4,Translation factors,NA,ENSG00000115211
Q9UGP8,0,6,9553897.552083334,3.698262159382004e-5,1.6415478034931898,0.715056763226992,0.10939920738182154,0.6429522395902524,raw,8771560.34375,8352166.65625,5801330.75,9523161.75,10460862.75,14414303.0625,Translocation protein SEC63 homolog OS=Homo sapiens OX=9606 GN=SEC63 PE=1 SV=2,cellular homeostasis;conjugation;defense response,cytoskeleton;extracellular,catalytic activity;structural molecule activity,11231,SEC63,NA,NA,ENSG00000025796
Q16531,0,6,188317185.765625,7.289656585510009e-4,1.6414539740742178,0.7149742976990094,0.05389054364053165,0.6429522395902524,raw,159519325.59375,142569183.28125,135466429.90625,261843630.9375,186511544.625,243993000.25,DNA damage-binding protein 1 OS=Homo sapiens OX=9606 GN=DDB1 PE=1 SV=1,cell death;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,1642,DDB1,"Hippo-Merlin signaling dysregulation; Hepatitis B infection; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Neddylation; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; DNA Damage Recognition in GG-NER; Dual Incision in GG-NER,ENSG00000167986
Q9Y3E0,0,6,2595629.7291666665,1.0047542539380489e-5,1.6414374484352174,0.7149597730289152,0.21282821550307934,0.7022549232366887,raw,2590339.875,1601372.5625,1555019,3820322,1754844.0625,4251880.875,Vesicle transport protein GOT1B OS=Homo sapiens OX=9606 GN=GOLT1B PE=1 SV=1,conjugation,cytoskeleton;cytosol;extracellular;nucleus,NA,51026,GOLT1B,NA,NA,ENSG00000111711
E7EVC7,0,6,2496474.1614583335,9.663716690350106e-6,1.6395000890297862,0.713255980073656,0.09690886296994927,0.6429522395902524,raw,874501.3125,2208449.03125,2347177.9375,3848198.4375,2389553.6875,3310964.5625,Autophagy-related protein 16-1 OS=Homo sapiens OX=9606 GN=ATG16L1 PE=1 SV=1,cell growth;cellular homeostasis,NA,NA,NA,ATG16L1,Nanoparticle triggered autophagic cell death; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; LDLRAD4 and what we know about it; Autophagy; Clock-controlled autophagy in bone metabolism,NA,ENSG00000085978; ENSG00000281089
O15264,0.16666666666666666,6,483596.4609375,1.8719757901383593e-6,1.639091947798088,0.7128967872693177,1,1,raw,NA,NA,304902.625,444875.71875,499763.4375,684844.0625,Mitogen-activated protein kinase 13 OS=Homo sapiens OX=9606 GN=MAPK13 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,5603,MAPK13,"Parkinson's disease pathway; Retinoblastoma gene in cancer; RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; MAPK signaling pathway; Novel intracellular components of RIG-I-like receptor pathway; Angiopoietin-like protein 8 regulatory pathway; Oxidative damage response; Epithelial to mesenchymal transition in colorectal cancer; Thermogenesis; Non-genomic actions of 1,25 dihydroxyvitamin D3; Regulatory circuits of the STAT3 signaling pathway; Hepatitis B infection; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; Insulin signaling; Host-pathogen interaction of human coronaviruses - apoptosis; Host-pathogen interaction of human coronaviruses - MAPK signaling; Toll-like receptor signaling pathway",VEGFA-VEGFR2 Pathway; NOD1/2 Signaling Pathway; p38MAPK events; DSCAM interactions,ENSG00000156711
Q02338,0,6,5791199.438802083,2.241742035143107e-5,1.6387612449753581,0.7126056800745042,0.12631774046724825,0.646524034332063,raw,4771697.96875,3944051.6015625,3972857.75,6510565.3125,5710645.0625,9837378.9375,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=BDH1 PE=1 SV=3",cellular homeostasis,cytoskeleton;endosome;nucleus,structural molecule activity,622,BDH1,NA,Utilization of Ketone Bodies; Synthesis of Ketone Bodies,ENSG00000161267; ENSG00000275544
P11166,0,6,24464705.145833332,9.470155273074297e-5,1.637972542185047,0.7119111728607966,0.5261679599220584,1,raw,14327224.125,36695165.125,13509696.625,29300693.625,22128512.125,30826939.25,"Solute carrier family 2, facilitated glucose transporter member 1 OS=Homo sapiens OX=9606 GN=SLC2A1 PE=1 SV=2",cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,6513,SLC2A1,Cori cycle; HIF1A and PPARG regulation of glycolysis; Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced HIF-1 survival signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; Type 2 papillary renal cell carcinoma; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Insulin signaling; Proximal tubule transport; p53 transcriptional gene network; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Neuroinflammation and glutamatergic signaling; Malignant pleural mesothelioma; CCL18 signaling pathway; Glucose metabolism in triple-negative breast cancer cells; Amino acid metabolism in triple-negative breast cancer cells; Chronic hyperglycemia impairment of neuron function; Glycolysis and gluconeogenesis,Cellular hexose transport; Regulation of insulin secretion; Vitamin C (ascorbate) metabolism; Lactose synthesis; Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),ENSG00000117394
O15305,0,6,56558761.541666664,2.1893591222929153e-4,1.637817752396573,0.7117748305187684,0.2794316119514826,0.760567138239857,raw,42033706.375,54649695.125,40745079.625,92038197.875,41042339.75,68843550.5,Phosphomannomutase 2 OS=Homo sapiens OX=9606 GN=PMM2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,5373,PMM2,Nephrotic syndrome,Defective PMM2 causes PMM2-CDG; Synthesis of GDP-mannose,ENSG00000140650
Q9Y2S7,0,6,4553988.286458333,1.7628242779728356e-5,1.637776856192032,0.7117388060660901,0.19645558199694907,0.6868157239784319,raw,4144426.5625,3204399.3125,3406989.78125,6312308.5625,3468159.59375,6787645.90625,Polymerase delta-interacting protein 2 OS=Homo sapiens OX=9606 GN=POLDIP2 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;endosome;membrane;nucleus,RNA binding,26073,POLDIP2,NA,NA,ENSG00000004142
Q9H871,0,6,1408743.3645833333,5.453169503982121e-6,1.637753584934689,0.7117183065908642,0.4962876213958505,0.9797947585234871,raw,658188.875,1506732.90625,1474888.625,2467657.21875,1118777.75,1226214.8125,E3 ubiquitin-protein transferase RMND5A OS=Homo sapiens OX=9606 GN=RMND5A PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,membrane;nucleus,structural molecule activity,64795,RMND5A,Ciliary landscape,NA,ENSG00000153561
O75915,0,6,12306334.5859375,4.763715674336726e-5,1.6374545530383124,0.711454865724211,0.10373516973050231,0.6429522395902524,raw,10552776.375,9533670.703125,9220471.6875,15610952.5,11347712.5,17572423.75,PRA1 family protein 3 OS=Homo sapiens OX=9606 GN=ARL6IP5 PE=1 SV=1,cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular,NA,10550,ARL6IP5,NA,Glutamate Neurotransmitter Release Cycle,ENSG00000144746
Q8WTS6,0,6,5895552.421875,2.2821365114720942e-5,1.6374041060151519,0.7114104182058755,0.0931770084354886,0.6429522395902524,raw,4926169,3729904.34375,4855639.625,9268417,6107360.6875,6485823.875,Histone-lysine N-methyltransferase SETD7 OS=Homo sapiens OX=9606 GN=SETD7 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,80854,SETD7,Histone modifications,PKMTs methylate histone lysines,ENSG00000145391
E9PI68,0,6,18914098.802083332,7.321545526025037e-5,1.6363837568195712,0.7105111218349558,0.1194321664355231,0.6445597830897484,raw,14070398.25,14396903.75,16211452.625,25615776.5,16661903.9375,26528157.75,Microsomal signal peptidase 25 kDa subunit OS=Homo sapiens OX=9606 GN=SPCS2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,NA,SPCS2,NA,NA,ENSG00000118363
Q8WUX9,0,6,2490133.7526041665,9.639173310004498e-6,1.6363057169004263,0.7104423173820633,0.12602933198169977,0.6461789084539729,raw,2587864.375,1326440.203125,1445471.28125,4182648.0625,2170461.6875,3227916.90625,Charged multivesicular body protein 7 OS=Homo sapiens OX=9606 GN=CHMP7 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,NA,91782,CHMP7,NA,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex,ENSG00000147457
Q99496,0,6,4297728.322916667,1.663627429674615e-5,1.6362241408530813,0.7103703917684862,0.09367302920151578,0.6429522395902524,raw,3550673.71875,2753972.3125,3315681.8125,5425198.625,4042626.71875,6698216.75,E3 ubiquitin-protein ligase RING2 OS=Homo sapiens OX=9606 GN=RNF2 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,membrane;nucleus,structural molecule activity,6045,RNF2,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; Malignant pleural mesothelioma,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6,ENSG00000121481
Q8TDQ7,0,6,2804210.4895833335,1.0854947401342688e-5,1.6354073379198018,0.7096500187231995,0.06386113788674705,0.6429522395902524,raw,2522165.75,1246919.875,2466477.6875,3668765.125,2796166.125,4124768.375,Glucosamine-6-phosphate isomerase 2 OS=Homo sapiens OX=9606 GN=GNPDA2 PE=1 SV=1,cellular homeostasis,cytosol;nucleus,structural molecule activity,132789,GNPDA2,NA,Glycolysis,ENSG00000163281
Q15652,0.16666666666666666,6,161181.95703125,6.239266531948767e-7,1.6352469742923028,0.7095085450067916,0.5430762474993023,1,raw,169416.71875,70962.859375,NA,296428.3125,NA,107919.9375,Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens OX=9606 GN=JMJD1C PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,221037,JMJD1C,Pathways affected in adenoid cystic carcinoma,Factors involved in megakaryocyte development and platelet production,ENSG00000171988
P08243,0,6,172972902.21614584,6.695687653935144e-4,1.6349261440293938,0.7092254650510806,0.053809037340677074,0.6429522395902524,raw,160039881.125,100122290.859375,137006143.65625,247655590.90625,169018580.59375,223994926.15625,Asparagine synthetase [glutamine-hydrolyzing] OS=Homo sapiens OX=9606 GN=ASNS PE=1 SV=4,cellular homeostasis;coagulation;metabolic process,cytosol,structural molecule activity,440,ASNS,Photodynamic therapy-induced unfolded protein response; Amino acid metabolism,Aspartate and asparagine metabolism; Response of EIF2AK1 (HRI) to heme deficiency; ATF4 activates genes in response to endoplasmic reticulum  stress; Response of EIF2AK4 (GCN2) to amino acid deficiency,ENSG00000070669
O00483,0,6,39130128.166666664,1.5147061343461323e-4,1.634618899031229,0.7089543197812297,0.04942181419337419,0.6429522395902524,raw,32087402.5,25052258.5,30292812,49517203,39693329.5,58137763.5,Cytochrome c oxidase subunit NDUFA4 OS=Homo sapiens OX=9606 GN=NDUFA4 PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,4697,NDUFA4,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly; Oxidative phosphorylation,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000189043
O95159,0,6,798038.3177083334,3.0891632404766856e-6,1.6344407862498742,0.7087971110108969,0.1816596286773721,0.6743269455727479,raw,858384.875,376483.1875,363965.21875,1253308,533109.375,1402979.25,Zinc finger protein-like 1 OS=Homo sapiens OX=9606 GN=ZFPL1 PE=1 SV=2,conjugation;metabolic process,cytoskeleton;extracellular;membrane,RNA binding;structural molecule activity,7542,ZFPL1,NA,NA,ENSG00000162300
Q01449,0.6666666666666666,6,271879.6901041667,1.0524316011714914e-6,1.634073507042033,0.7084728830305623,0.11450473131854984,0.6429522395902524,raw,182521.203125,196964.125,297043.9375,298253.0625,329671.75,326824.0625,"Myosin regulatory light chain 2, atrial isoform OS=Homo sapiens OX=9606 GN=MYL7 PE=1 SV=1",defense response;metabolic process,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,58498,MYL7,Focal adhesion,Smooth Muscle Contraction,ENSG00000106631
P49588,0,6,256014083.86328134,9.91016696022622e-4,1.633942406599763,0.7083571320899178,0.05928274356784928,0.6429522395902524,raw,219739301.90625,166792206.195313,189084995.15625,359041363.78125,245488988.296875,355937647.84375,"Alanine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=AARS1 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;endosome;nucleus,RNA binding;structural molecule activity,16,AARS1,IL-18 signaling pathway,Cytosolic tRNA aminoacylation,ENSG00000090861
Q53EL6,0,6,28678673.270833332,1.110135958237015e-4,1.633905100634421,0.7083241922840806,0.0337052416360114,0.6429522395902524,raw,25785382.46875,16274884.71875,22558833.4375,34939622.0625,30382449,42130867.9375,Programmed cell death protein 4 OS=Homo sapiens OX=9606 GN=PDCD4 PE=1 SV=2,defense response;development;metabolic process,cytosol;membrane;nucleus,RNA binding,27250,PDCD4,Translation inhibitors in chronically activated PDGFRA cells; Interferon type I signaling pathways,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,ENSG00000150593
Q9H5X1,0,6,637345.2265625,2.4671289607296012e-6,1.6335619982247642,0.7080212101075066,1,1,raw,NA,451771,NA,737995.9375,497127.90625,862486.0625,Cytosolic iron-sulfur assembly component 2A OS=Homo sapiens OX=9606 GN=CIAO2A PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,84191,CIAO2A,2q11.2 copy number variation syndrome,NA,ENSG00000166797
B1ANH2,0,6,1278834.4635416667,4.950299162040332e-6,1.633467218851973,0.7079375024195386,0.387864405728243,0.872979446768193,raw,1099047.53125,1337881.1875,577204.5,2185385.0625,590775.625,1882712.875,Guanylate kinase (Fragment) OS=Homo sapiens OX=9606 GN=GUK1 PE=1 SV=1,cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,GUK1,NA,NA,ENSG00000143774
Q9ULH1,0.16666666666666666,6,365599.14453125,1.4152145491946558e-6,1.6333034026363187,0.70779281099824,0.2193136890695317,0.7087130179153194,raw,345774.34375,223839.546875,NA,458217.0625,434565.625,NA,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ASAP1 PE=1 SV=4",cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,50807,ASAP1,EGF/EGFR signaling pathway; CCL18 signaling pathway,VxPx cargo-targeting to cilium,ENSG00000153317
Q9Y4X5,0,6,7231127.640625,2.79913046766481e-5,1.633257575336149,0.707752331228144,0.12784005470401694,0.6488572560696687,raw,6506503.65625,5451920.296875,4628314.390625,8904390.125,6467254.25,11428383.125,E3 ubiquitin-protein ligase ARIH1 OS=Homo sapiens OX=9606 GN=ARIH1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,25820,ARIH1,NA,ISG15 antiviral mechanism,ENSG00000166233
Q9Y5Z9,0.3333333333333333,6,353075.0572916667,1.3667344836858415e-6,1.6330216814250902,0.7075439455087983,1,1,raw,NA,NA,248292.171875,337152.84375,NA,473780.15625,UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBIAD1 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;endosome;extracellular;membrane;nucleus,structural molecule activity,29914,UBIAD1,7q11.23 copy number variation syndrome,Metabolism of vitamin K,ENSG00000120942
Q9UNZ2,0,6,64791126.213541664,2.5080295139551077e-4,1.632931991502207,0.7074647066585558,0.05014098014417806,0.6429522395902524,raw,47410902.25,55114250.375,46439003.65625,89997822.625,64244097.375,85540681,NSFL1 cofactor p47 OS=Homo sapiens OX=9606 GN=NSFL1C PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,structural molecule activity,55968,NSFL1C,Alstrom syndrome,RHOH GTPase cycle,ENSG00000088833
A0A0G2JMZ8,0,6,7185279.513020833,2.781382905010652e-5,1.6328006390039795,0.7073486520886666,0.03224698037088276,0.6429522395902524,raw,4875321.75,6981295.640625,4965806.375,10153285,7960428.46875,8175539.84375,Occludin OS=Homo sapiens OX=9606 GN=OCLN PE=1 SV=1,cell growth,cytoplasm;cytoskeleton;nucleus,NA,NA,OCLN,NA,NA,ENSG00000273814
O95817,0,6,23245215.78678385,8.998097526405425e-5,1.6319576130651516,0.7066035865895298,0.04727187534882268,0.6429522395902524,raw,16647563.71875,21267429.7832031,14053154.046875,30526797.21875,22934151.734375,34042198.21875,BAG family molecular chaperone regulator 3 OS=Homo sapiens OX=9606 GN=BAG3 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,9531,BAG3,NA,Regulation of HSF1-mediated heat shock response,ENSG00000151929
Q86TU7,0,6,5859292.299479167,2.2681004138669e-5,1.631371290634977,0.7060851684365096,0.06366968332477571,0.6429522395902524,raw,4308480.875,4978955.578125,4513984.375,7506488.5,5725319.28125,8122525.1875,Actin-histidine N-methyltransferase OS=Homo sapiens OX=9606 GN=SETD3 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,motor activity;structural molecule activity,84193,SETD3,Histone modifications,PKMTs methylate histone lysines,ENSG00000183576
O60678,0,6,2560673.2552083335,9.912227916044032e-6,1.6313609863755134,0.706076055887415,0.30026294218813776,0.7806964943416801,raw,2081945.4375,1121230.0625,3008666.65625,3902550.375,1853242.4375,3396404.5625,Protein arginine N-methyltransferase 3 OS=Homo sapiens OX=9606 GN=PRMT3 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytosol;nucleus,protein binding;structural molecule activity,10196,PRMT3,Nitric oxide metabolism in cystic fibrosis,RMTs methylate histone arginines; Protein methylation,ENSG00000185238
A0A087WXL6,0,6,694399.7473958334,2.687983930410093e-6,1.6312375987807657,0.7059669338691903,0.11244090039826923,0.6429522395902524,raw,507644.453125,764631.609375,367463.96875,714042.390625,828088.71875,984527.34375,Vacuolar protein sorting-associated protein 11 homolog OS=Homo sapiens OX=9606 GN=VPS11 PE=1 SV=1,cellular homeostasis;conjugation,cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,structural molecule activity,55823,VPS11,Ebola virus infection in host; Network map of SARS-CoV-2 signaling pathway,NA,ENSG00000160695; ENSG00000280616
O14874,0,6,678027.53125,2.6246079656718536e-6,1.6310125495894638,0.7057678827002145,0.35927647070272667,0.8420915285075536,raw,NA,365398.1875,627007.5625,352417.5,847694.90625,1197619.5,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial OS=Homo sapiens OX=9606 GN=BCKDK PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,endosome,signal transducer activity;structural molecule activity,10295,BCKDK,Thiamine metabolic pathways,Branched-chain amino acid catabolism,ENSG00000103507
O75368,0,6,18499227.416666668,7.160951052687579e-5,1.6308885202440808,0.7056581696722812,0.140934981704065,0.6572502130392559,raw,17008186.125,10524527.71875,15068834.90625,21089901.9375,17164331.4375,30139582.375,SH3 domain-binding glutamic acid-rich-like protein OS=Homo sapiens OX=9606 GN=SH3BGRL PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,6451,SH3BGRL,NA,NA,ENSG00000131171
Q9NY12,0,6,16507873.921875,6.390108866491517e-5,1.6308666003180532,0.7056387790268108,0.05242646017660113,0.6429522395902524,raw,16302053.125,10004854.25,12997508.5,21197202.5,16541524.75,22004100.40625,H/ACA ribonucleoprotein complex subunit 1 OS=Homo sapiens OX=9606 GN=GAR1 PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis,membrane,RNA binding,54433,GAR1,NA,rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase,ENSG00000109534
O15541,0.5,6,506077.8802083333,1.9590001503277714e-6,1.6306370278180267,0.7054356806123233,0.06199098949877164,0.6429522395902524,raw,343091.375,388178.46875,404950,559457.5,564932.4375,775857.5,E3 ubiquitin-protein ligase RNF113A OS=Homo sapiens OX=9606 GN=RNF113A PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane,structural molecule activity,7737,RNF113A,NA,NA,ENSG00000125352
Q8IV36,0,6,2622916.2994791665,1.015316737981436e-5,1.6301390216339442,0.7049950057258559,0.17926442237534654,0.6741527184744509,raw,2075723.140625,2374784.390625,1872111.234375,3871228.703125,2131872.5625,3411777.765625,Protein HID1 OS=Homo sapiens OX=9606 GN=HID1 PE=1 SV=1,NA,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,NA,283987,HID1,NA,NA,ENSG00000167861
O95302,0,6,10226782.059895834,3.9587321193445436e-5,1.6300916034073891,0.704953039344841,0.07463859335204202,0.6429522395902524,raw,8846351.46875,7070710.875,7707019.265625,14420363.25,9622516.6875,13693730.8125,Peptidyl-prolyl cis-trans isomerase FKBP9 OS=Homo sapiens OX=9606 GN=FKBP9 PE=1 SV=2,metabolic process,extracellular,structural molecule activity,11328,FKBP9,NA,Association of TriC/CCT with target proteins during biosynthesis,ENSG00000122642
Q96SZ5,0,6,2098812.5625,8.124390111171691e-6,1.6297943249438451,0.7046899122442409,0.12017725471204573,0.6445597830897484,raw,1245883.375,1651014.5,1832366.5,1849221.3125,2690814.0625,3323575.625,2-aminoethanethiol dioxygenase OS=Homo sapiens OX=9606 GN=ADO PE=1 SV=2,coagulation,cytosol,structural molecule activity,84890,ADO,NA,Degradation of cysteine and homocysteine,ENSG00000181915
P11498,0,6,4512625.25,1.7468128698855016e-5,1.629417474291676,0.7043562852184733,0.21548494026165932,0.7049259030937425,raw,5402310.3125,1639652.125,3634915.21875,6037494.5,4438584.96875,5922794.375,"Pyruvate carboxylase, mitochondrial OS=Homo sapiens OX=9606 GN=PC PE=1 SV=2",cellular homeostasis;metabolic process,cytosol;endosome;nucleus,structural molecule activity,5091,PC,Alanine and aspartate metabolism; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Fatty acid biosynthesis; Amino acid metabolism; Glycolysis and gluconeogenesis,Gluconeogenesis; Biotin transport and metabolism; Defective HLCS causes multiple carboxylase deficiency,ENSG00000173599
Q7Z3E5,0.3333333333333333,6,632609.8216145834,2.448798463848345e-6,1.6289285193344623,0.7039232968871755,0.31130317559939447,0.7920100626951777,raw,509251.78125,792894.3984375,281867.0625,544210.25,837900.6875,829534.75,LisH domain-containing protein ARMC9 OS=Homo sapiens OX=9606 GN=ARMC9 PE=1 SV=3,cell growth;metabolic process,endoplasmic reticulum;nucleus,NA,80210,ARMC9,Genes related to primary cilium development (based on CRISPR); Joubert syndrome,NA,ENSG00000135931
O95754,0.6666666666666666,6,183202862.66666666,7.091683899654627e-4,1.6287500606163787,0.7037652324854726,0.1831885417675628,0.6755855526242318,raw,118639288,183448768,125151920,153065568,220119440,298792192,Semaphorin-4F OS=Homo sapiens OX=9606 GN=SEMA4F PE=2 SV=2,cell death;cell growth;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;nucleus,antioxidant activity,10505,SEMA4F,NA,RND3 GTPase cycle,ENSG00000135622
Q9BRG1,0,6,3527365.4583333335,1.365424124107411e-5,1.6287260967880632,0.7037440059317841,0.4421477231072687,0.9249261346766603,raw,2190183.5625,5005052.6875,1739142.6875,3075503.71875,3567209.125,5587100.96875,Vacuolar protein-sorting-associated protein 25 OS=Homo sapiens OX=9606 GN=VPS25 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,84313,VPS25,NA,Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events,ENSG00000131475
Q9H6T0,0,6,4128899.9427083335,1.5982748752275466e-5,1.6282665674882726,0.703336906061022,0.07069436888475085,0.6429522395902524,raw,1903564.75,4285095.03125,3016450,4911584.6875,4629713.5625,6026991.625,Epithelial splicing regulatory protein 2 OS=Homo sapiens OX=9606 GN=ESRP2 PE=1 SV=1,cell differentiation;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding,80004,ESRP2,NA,FGFR2 alternative splicing,ENSG00000103067
Q06210,0,6,117564700.2265625,4.550866070697767e-4,1.627793872130208,0.7029180224030751,0.026698285395161208,0.6429522395902524,raw,93559960.59375,94078101.046875,84057104.375,152296330.53125,123913037.4375,157483667.375,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens OX=9606 GN=GFPT1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol,structural molecule activity,2673,GFPT1,NA,XBP1(S) activates chaperone genes; Synthesis of UDP-N-acetyl-glucosamine; Defective GFPT1 causes CMSTA1,ENSG00000198380
Q5JSH3,0,6,8975210.359375,3.4742554715098325e-5,1.6277774291382816,0.7029034490942978,0.17593728759716287,0.6702146673855206,raw,6768219.625,8789125,5214336.671875,11568281.21875,7204560.34375,14306739.296875,WD repeat-containing protein 44 OS=Homo sapiens OX=9606 GN=WDR44 PE=1 SV=1,NA,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,NA,54521,WDR44,Ectoderm differentiation,NA,ENSG00000131725
Q92542,0,6,8406324.337239584,3.254042763848342e-5,1.6275593104007433,0.7027101180526145,0.054488132864708584,0.6429522395902524,raw,7759319.015625,6119926.875,5491894.0390625,9111271.125,9326783.0625,12628751.90625,Nicastrin OS=Homo sapiens OX=9606 GN=NCSTN PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;endosome;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,23385,NCSTN,Alzheimer's disease and miRNA effects; Notch signaling; Inclusion body myositis; Alzheimer's disease; DYRK1A; Notch signaling pathway,Neutrophil degranulation; Amyloid fiber formation; Degradation of the extracellular matrix; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; Nuclear signaling by ERBB4; EPH-ephrin mediated repulsion of cells; NOTCH4 Activation and Transmission of Signal to the Nucleus; NRIF signals cell death from the nucleus; Regulated proteolysis of p75NTR; Noncanonical activation of NOTCH3,ENSG00000162736
Q92769,0,6,17862463.447916668,6.914463158375533e-5,1.6274887195486993,0.7026475438163791,0.06602415867209918,0.6429522395902524,raw,12897650.6875,15725462.375,12935711.0625,22721602.75,17301341.1875,25593012.625,Histone deacetylase 2 OS=Homo sapiens OX=9606 GN=HDAC2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,3066,HDAC2,Cell cycle; Neural crest differentiation; Notch signaling; Initiation of transcription and translation elongation at the HIV-1 LTR; Ethanol effects on histone modifications; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome; Ciliary landscape; 7q11.23 copy number variation syndrome; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Notch signaling pathway,"Potential therapeutics for SARS; SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Regulation of PTEN gene transcription; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Factors involved in megakaryocyte development and platelet production; RNA Polymerase I Transcription Initiation; p75NTR negatively regulates cell cycle via SC1; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation; EGR2 and SOX10-mediated initiation of Schwann cell myelination; MECP2 regulates neuronal receptors and channels",ENSG00000196591
P35998,0,6,171649405.55729166,6.644455812848031e-4,1.6274458684287634,0.7026095577392025,0.0471596943852949,0.6429522395902524,raw,126946097.4375,149941189.625,115766061.375,222741438.9375,170480476.40625,244021169.5625,26S proteasome regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMC2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytosol;membrane;nucleus,structural molecule activity,5701,PSMC2,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000161057
Q96CB9,0,6,2988941.7135416665,1.1570031995349506e-5,1.6272243276356613,0.7024131533204426,0.2623199110827306,0.7434453518424705,raw,3090503.78125,1226029.03125,2184259.0625,4709328.9375,1694586.53125,5028942.9375,5-methylcytosine rRNA methyltransferase NSUN4 OS=Homo sapiens OX=9606 GN=NSUN4 PE=1 SV=2,cellular component movement;cellular homeostasis,endosome;Golgi,RNA binding;structural molecule activity,387338,NSUN4,NA,rRNA modification in the mitochondrion,ENSG00000117481
Q9UNF0,0,6,22144705.244791668,8.572095837433664e-5,1.6272016808339014,0.7023930745547823,0.09631274946738232,0.6429522395902524,raw,18487272.8125,13791517.65625,19269006.875,30151892.8125,19813980.9375,31354560.375,Protein kinase C and casein kinase substrate in neurons protein 2 OS=Homo sapiens OX=9606 GN=PACSIN2 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,motor activity;structural molecule activity,11252,PACSIN2,NA,Clathrin-mediated endocytosis,ENSG00000100266
P53990,0,6,19310160.196614582,7.474858753448914e-5,1.6269427131570933,0.7021634526704184,0.024343230949170423,0.6429522395902524,raw,16295309.65625,16431834.3671875,11733549.0625,24538135.4375,20128479.46875,26733653.1875,IST1 homolog OS=Homo sapiens OX=9606 GN=IST1 PE=1 SV=1,cell differentiation;cell growth;conjugation;defense response;metabolic process,cell surface;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,9798,IST1,NA,Neutrophil degranulation; Sealing of the nuclear envelope (NE) by ESCRT-III,ENSG00000182149
E5RFJ3,0.3333333333333333,6,930658.15625,3.6025274751130993e-6,1.6266146814207458,0.7018725404758618,0.07955300229125532,0.6429522395902524,raw,654589.25,993969.5,607351.8125,1124562.375,987927.375,1215548.625,Cell cycle and apoptosis regulator protein 2 (Fragment) OS=Homo sapiens OX=9606 GN=CCAR2 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,nucleus,NA,NA,CCAR2,NA,NA,ENSG00000158941
P31947,0,6,207662000.29166666,8.038483911236593e-4,1.625865360559668,0.7012077914256081,0.22673868628681693,0.7148463313429879,raw,196272612.875,167380041.375,133353685,319112842.5,153528480.625,276324339.375,14-3-3 protein sigma OS=Homo sapiens OX=9606 GN=SFN PE=1 SV=1,cell differentiation;cell growth;coagulation;development;metabolic process,cell surface;cytosol;membrane;nucleus,DNA binding;structural molecule activity,2810,SFN,miRNA regulation of DNA damage response; Cell cycle; Myometrial relaxation and contraction pathways; p53 transcriptional gene network; Calcium regulation in cardiac cells; DNA damage response,TP53 Regulates Metabolic Genes; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Activation of BAD and translocation to mitochondria ; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,ENSG00000175793
Q9UBD5,0,6,7077835.072916667,2.7397917423561418e-5,1.625742842106726,0.7010990718299227,0.0807017148963643,0.6429522395902524,raw,5303059.5625,5519891.25,5269028.015625,8621411.125,7075290.828125,10678329.65625,Origin recognition complex subunit 3 OS=Homo sapiens OX=9606 GN=ORC3 PE=1 SV=1,cell differentiation;cell proliferation;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding,23595,ORC3,Cell cycle; G1 to S cell cycle control; DNA replication,Assembly of the ORC complex at the origin of replication; Orc1 removal from chromatin; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; E2F-enabled inhibition of pre-replication complex formation; CDC6 association with the ORC:origin complex,ENSG00000135336
Q7Z2Z2,0,6,1676176.3776041667,6.488388258247277e-6,1.625669991326658,0.7010344221133036,0.29081717391615386,0.7730231021500684,raw,1612249.765625,963681.53125,1408014.53125,2401565.90625,1050560.46875,2620986.0625,Elongation factor-like GTPase 1 OS=Homo sapiens OX=9606 GN=EFL1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis,nucleus,protein binding;RNA binding;structural molecule activity,79631,EFL1,Genetic causes of porto-sinusoidal vascular disease,NA,ENSG00000140598
O95999,0,6,3657177.8229166665,1.415673789559785e-5,1.62555666403911,0.7009338467101466,0.13939148019331024,0.6572502130392559,raw,2949349.625,3132401.84375,2754306.96875,4794334.9375,3172627.3125,5140046.25,B-cell lymphoma/leukemia 10 OS=Homo sapiens OX=9606 GN=BCL10 PE=1 SV=1,cell growth;cellular component movement;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,8915,BCL10,B cell receptor signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Modulators of TCR signaling and T cell activation; T-cell receptor signaling pathway,FCERI mediated NF-kB activation; Downstream TCR signaling; E3 ubiquitin ligases ubiquitinate target proteins; Activation of NF-kappaB in B cells; CLEC7A (Dectin-1) signaling,ENSG00000142867
Q9NZN4,0,6,15329103.0234375,5.933813016080025e-5,1.6250764718516406,0.7005076091966445,0.09226112642594904,0.6429522395902524,raw,13773756.8125,10856943.984375,10128460.859375,22383408.125,13759968.921875,21072079.4375,EH domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EHD2 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,30846,EHD2,Insulin signaling,Factors involved in megakaryocyte development and platelet production,ENSG00000024422
Q9BXW9,0,6,780651.1302083334,3.0218583764264028e-6,1.624944618106526,0.7003905485751662,0.07514928295332814,0.6429522395902524,raw,373574,697776.5625,713370.5625,958175.125,1159187.65625,781822.875,Fanconi anemia group D2 protein OS=Homo sapiens OX=9606 GN=FANCD2 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,2177,FANCD2,"miRNA regulation of DNA damage response; 15q13.3 copy number variation syndrome; DNA repair pathways, full network; DNA damage response",Fanconi Anemia Pathway; TP53 Regulates Transcription of DNA Repair Genes,ENSG00000144554
Q9NVA1,0,6,2854882.0052083335,1.1051094102490438e-5,1.624391952402461,0.699899784961788,0.19587272040947754,0.6857975396967068,raw,2514221.875,1870755.75,2186699.1875,3552056.5625,2276091.53125,4729467.125,Ubiquinol-cytochrome-c reductase complex assembly factor 1 OS=Homo sapiens OX=9606 GN=UQCC1 PE=1 SV=3,cell growth,cytoskeleton;endosome;nucleus,NA,55245,UQCC1,Ciliary landscape; Mitochondrial complex III assembly,NA,ENSG00000101019
Q8IY81,0,6,46971379.401041664,1.8182367360111348e-4,1.6236328914964977,0.6992254715083307,0.06697956554800896,0.6429522395902524,raw,38707430.8125,36275297.40625,36570391.5625,62846657.8125,45872457,61556041.8125,pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 OS=Homo sapiens OX=9606 GN=FTSJ3 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,structural molecule activity,117246,FTSJ3,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000108592
P29317,0,6,37226339.315104164,1.4410114957883678e-4,1.6216642653201094,0.6974751679563501,0.15783562701612408,0.6638855679885327,raw,33923298.78125,28623252.546875,27081091.25,55476343.1875,31836744.3125,46417305.8125,Ephrin type-A receptor 2 OS=Homo sapiens OX=9606 GN=EPHA2 PE=1 SV=2,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,signal transducer activity;structural molecule activity,1969,EPHA2,Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Malignant pleural mesothelioma,RND2 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; EPH-ephrin mediated repulsion of cells; EPHA-mediated growth cone collapse,ENSG00000142627
Q8WZ74,0.8333333333333334,6,4181489.9166666665,1.6186321702050897e-5,1.6209033003512476,0.6967980253002376,0.020641084476015748,0.6429522395902524,raw,3532235,3250492.25,2811905.25,5038090,4557826.5,5898390.5,Cortactin-binding protein 2 OS=Homo sapiens OX=9606 GN=CTTNBP2 PE=1 SV=1,defense response;metabolic process,endoplasmic reticulum;extracellular;nucleus,structural molecule activity,83992,CTTNBP2,NA,NA,ENSG00000077063
Q96CN4,0.8333333333333334,6,456035.2942708333,1.765288002043408e-6,1.6208488213097565,0.6967495350764022,0.6934260230707066,1,raw,328598.3125,712781,220415.015625,568631.8125,373177.4375,532608.1875,EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1,metabolic process,NA,DNA binding;structural molecule activity,115704,EVI5L,NA,NA,ENSG00000142459
Q9BXY0,0,6,10406581.729166666,4.028331600551951e-5,1.6195360576674658,0.6955805889351622,0.11269485534534347,0.6429522395902524,raw,9809586.625,8462702.625,6617990.625,10829524.25,10832707,15886979.25,Protein MAK16 homolog OS=Homo sapiens OX=9606 GN=MAK16 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,NA,84549,MAK16,NA,NA,ENSG00000198042
Q6YP21,0,6,7107216.640625,2.751165188580228e-5,1.6187958774885585,0.6949210800809418,0.10413067488232403,0.6429522395902524,raw,5937190.125,4812923.4375,5642443.40625,9133964.125,6486937,10629841.75,Kynurenine--oxoglutarate transaminase 3 OS=Homo sapiens OX=9606 GN=KYAT3 PE=1 SV=1,cellular homeostasis,endosome;nucleus,structural molecule activity,56267,KYAT3,Tryptophan metabolism,Tryptophan catabolism,ENSG00000137944
Q5HYI8,0,6,793413.3020833334,3.071260054704343e-6,1.6185642555064985,0.6947146403450328,0.29918375904754474,0.7805333494403178,raw,859648.0625,634267.625,317949.65625,1417048.625,1026602.90625,504962.9375,Rab-like protein 3 OS=Homo sapiens OX=9606 GN=RABL3 PE=1 SV=1,conjugation;metabolic process,NA,structural molecule activity,285282,RABL3,NA,NA,ENSG00000144840
Q9Y608,0,6,2375235.5755208335,9.194408670052289e-6,1.6185109007871032,0.694667082234473,0.07400943541671591,0.6429522395902524,raw,1742143.40625,2476043.8125,1568853.296875,2819678.09375,2674406.875,2970287.96875,Leucine-rich repeat flightless-interacting protein 2 OS=Homo sapiens OX=9606 GN=LRRFIP2 PE=1 SV=1,cell death;development;metabolic process,NA,structural molecule activity,9209,LRRFIP2,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000093167
P22033,0,6,4497323.033854167,1.7408894646345755e-5,1.61837706296255,0.6945477780336241,0.32252845223823345,0.8037523716522456,raw,3207901.71875,3730783.46875,3427623.34375,8308380.9375,2762061.734375,5547187,"Methylmalonyl-CoA mutase, mitochondrial OS=Homo sapiens OX=9606 GN=MMUT PE=1 SV=4",cellular homeostasis;defense response;metabolic process,endosome;nucleus,structural molecule activity,4594,MMUT,Vitamin B12 metabolism; Amino acid metabolism,"Propionyl-CoA catabolism; Defective MMAA causes MMA, cblA type; Defective MUT causes MMAM; Cobalamin (Cbl) metabolism",ENSG00000146085
Q6ZMU5,0,6,31784248.559895832,1.2303511009265783e-4,1.6176963090746366,0.6939407953359311,0.11330003583889893,0.6429522395902524,raw,27494242.46875,23586237.734375,23360051.28125,43714818.625,28072806.6875,44477334.5625,Tripartite motif-containing protein 72 OS=Homo sapiens OX=9606 GN=TRIM72 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,493829,TRIM72,NA,Smooth Muscle Contraction,ENSG00000177238
Q9NPF4,0,6,2979505.8229166665,1.1533506172199042e-5,1.6168649129263717,0.6931991484514188,0.21898497809997544,0.7087130179153194,raw,2371398.25,3505716.25,1478826.125,3958924.125,2727939.5625,3834230.625,Probable tRNA N6-adenosine threonylcarbamoyltransferase OS=Homo sapiens OX=9606 GN=OSGEP PE=1 SV=1,cellular component movement;cellular homeostasis,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,55644,OSGEP,NA,tRNA modification in the nucleus and cytosol,ENSG00000092094
Q8IYB8,0,6,7725878.270833333,2.9906457653802318e-5,1.6167616447849964,0.6931070014871138,0.02420143745230529,0.6429522395902524,raw,6426087.703125,6215845.09375,5142962.453125,10049539.9375,8030301.34375,10490533.09375,"ATP-dependent RNA helicase SUPV3L1, mitochondrial OS=Homo sapiens OX=9606 GN=SUPV3L1 PE=1 SV=1",cell growth;cell proliferation;cellular component movement;cellular homeostasis;metabolic process,endosome;membrane;mitochondrion,RNA binding;structural molecule activity,6832,SUPV3L1,NA,NA,ENSG00000156502
Q15738,0,6,11949245.770833334,4.6254885219898476e-5,1.615972307803552,0.692402475480302,0.045848775387704925,0.6429522395902524,raw,9290017.875,11514493.5625,6974956.5625,15012411.625,12142100.125,16761494.875,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating OS=Homo sapiens OX=9606 GN=NSDHL PE=1 SV=2",cellular homeostasis;defense response;development;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,50814,NSDHL,Cholesterol biosynthesis pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias,Cholesterol biosynthesis,ENSG00000147383
A0AV96,0,6,971378.5625,3.7601539691466246e-6,1.615739645818877,0.6921947463900299,1,1,raw,NA,688680.125,NA,1402770.25,NA,822685.3125,RNA-binding protein 47 OS=Homo sapiens OX=9606 GN=RBM47 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,54502,RBM47,TYROBP causal network in microglia,NA,ENSG00000163694
P00403,0,6,51674158.041666664,2.000278758083905e-4,1.6150109461559408,0.6915439431924977,0.10131188981680621,0.6429522395902524,raw,48171409,32734408.75,38701314.625,62503046.75,48477321.875,79457447.25,Cytochrome c oxidase subunit 2 OS=Homo sapiens OX=9606 GN=MT-CO2 PE=1 SV=1,cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,4513,MT-CO2,Electron transport chain: OXPHOS system in mitochondria; Endothelin pathways; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Neuroinflammation; Mitochondrial complex IV assembly; CCL18 signaling pathway,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000198712
Q6ZSJ8,0,6,796897.015625,3.084745321732837e-6,1.61465099906435,0.6912223653338992,0.02259146714798531,0.6429522395902524,raw,433207.46875,717749.6875,619339.1875,908994.5625,943175.9375,1158915.25,Uncharacterized protein C1orf122 OS=Homo sapiens OX=9606 GN=C1orf122 PE=4 SV=2,NA,NA,NA,127687,C1orf122,NA,NA,ENSG00000197982
P25787,0,6,61273791.278645836,2.3718753776909914e-4,1.6146268480258277,0.6912007861541822,0.04630989630946347,0.6429522395902524,raw,53510164.484375,44629011.84375,43144375.4375,78776916.5625,61183331.125,86398948.21875,Proteasome subunit alpha type-2 OS=Homo sapiens OX=9606 GN=PSMA2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytosol;membrane;nucleus,NA,5683,PSMA2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000106588
Q14318,0,6,13009992.072916666,5.0360976883864185e-5,1.6138604235764482,0.6905158110063271,0.1610566056966035,0.6638855679885327,raw,9740034.25,14663816.28125,7348438.84375,16903475.1875,11859354.625,17544833.25,Peptidyl-prolyl cis-trans isomerase FKBP8 OS=Homo sapiens OX=9606 GN=FKBP8 PE=1 SV=2,defense response;development;metabolic process,cytoskeleton;cytosol;endosome;extracellular;nucleus,structural molecule activity,23770,FKBP8,NA,Ub-specific processing proteases,ENSG00000105701
Q8WZA1,0.5,6,538486.0208333334,2.0844503129195117e-6,1.6129156479500248,0.6896709905913186,0.19119514521953426,0.6823711621042031,raw,614299,412245.09375,298822.59375,664916.5625,482730.1875,757902.6875,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=POMGNT1 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,55624,POMGNT1,Ciliopathies,"O-linked glycosylation; Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",ENSG00000085998
Q8N6S5,0,6,595109.25,2.3036357758444674e-6,1.612492812119833,0.6892927295639947,0.19442518427287359,0.6851169040350013,raw,NA,548887,330079.5625,571182.1875,705059.6875,820337.8125,ADP-ribosylation factor-like protein 6-interacting protein 6 OS=Homo sapiens OX=9606 GN=ARL6IP6 PE=1 SV=1,NA,cytoskeleton;membrane,NA,151188,ARL6IP6,NA,NA,ENSG00000177917
Q9H4E7,0,6,2278366.7109375,8.819434525355999e-6,1.6124665953680288,0.6892692732825115,0.2745479180128749,0.7551026273759062,raw,1058634.0625,2704979.4375,1686365.265625,2941615.625,1707012.0625,3571593.8125,Differentially expressed in FDCP 6 homolog OS=Homo sapiens OX=9606 GN=DEF6 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding,50619,DEF6,NA,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RAC2 GTPase cycle,ENSG00000023892
P26038,0,6,875581397.4791666,0.0033893283155939902,1.6123838472233216,0.6891952355308928,0.0633136020426149,0.6429522395902524,raw,687194659.390625,670683785.71875,614848373.203125,1081399702.6875,892797270.875,1306564593,Moesin OS=Homo sapiens OX=9606 GN=MSN PE=1 SV=3,cell communication;cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,antioxidant activity;motor activity;RNA binding;structural molecule activity,4478,MSN,Glial cell differentiation; AGE/RAGE pathway; Measles virus infection; 16p11.2 proximal deletion syndrome; Regulation of actin cytoskeleton,Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Signaling by ALK fusions and activated point mutants,ENSG00000147065
Q96D71,0,6,3879326.578125,1.501666373284073e-5,1.6119437721850784,0.688801420662073,0.24469239854620603,0.7301988479077035,raw,3472813.015625,3204912.84375,2905837.046875,5597979.3125,2885355.4375,5209061.8125,RalBP1-associated Eps domain-containing protein 1 OS=Homo sapiens OX=9606 GN=REPS1 PE=1 SV=3,conjugation,cytoplasm;cytoskeleton;cytosol,structural molecule activity,85021,REPS1,NA,Cargo recognition for clathrin-mediated endocytosis,ENSG00000135597
Q05519,0,6,20443780.151041668,7.913676917211184e-5,1.6111734117925205,0.688111780741608,0.053937435751007366,0.6429522395902524,raw,18881632.03125,14999296.75,12810302.0625,24948346.375,20601520.1875,30421583.5,Serine/arginine-rich splicing factor 11 OS=Homo sapiens OX=9606 GN=SRSF11 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,structural molecule activity,9295,SRSF11,NA,mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000116754
Q9Y5K8,0,6,5688946.645833333,2.2021605310641784e-5,1.6110518378743774,0.6880029155473402,0.09342498597476624,0.6429522395902524,raw,5200960.75,3750887.625,4132233.78125,7515589.25,5154991.09375,8379017.375,V-type proton ATPase subunit D OS=Homo sapiens OX=9606 GN=ATP6V1D PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,catalytic activity,51382,ATP6V1D,Proximal tubule transport,Amino acids regulate mTORC1; Neutrophil degranulation; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000100554
Q9Y6M9,0,6,16319275.479166666,6.317103427592445e-5,1.6100499318553714,0.6871054307765979,0.04281627173123179,0.6429522395902524,raw,14248224.4375,12243398.9375,11389669.59375,19712483.625,16895612.53125,23426263.75,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 OS=Homo sapiens OX=9606 GN=NDUFB9 PE=1 SV=3,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity,4715,NDUFB9,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial immune response to SARS-CoV-2; Oxidative phosphorylation,Complex I biogenesis,ENSG00000147684
P04844,0,6,143637985.51822916,5.560148866952114e-4,1.6095117865871638,0.686623141828693,0.11750342323024417,0.6429522395902524,raw,133350027.1875,100456856.03125,94721787.921875,214628440.5,123568932.3125,195101869.15625,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 OS=Homo sapiens OX=9606 GN=RPN2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;extracellular;membrane;mitochondrion,protein binding,6185,RPN2,Proteasome degradation,SRP-dependent cotranslational protein targeting to membrane; Asparagine N-linked glycosylation; Maturation of spike protein,ENSG00000118705
Q86SZ2,0,6,961736.7552083334,3.7228310536972657e-6,1.6092922803187457,0.6864263727189247,0.10702160039160225,0.6429522395902524,raw,659741.53125,1054398.75,573827.125,1281141,923455.5625,1277856.5625,Trafficking protein particle complex subunit 6B OS=Homo sapiens OX=9606 GN=TRAPPC6B PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,cytosol;extracellular;mitochondrion;nucleus,NA,122553,TRAPPC6B,NA,RAB GEFs exchange GTP for GDP on RABs; COPII-mediated vesicle transport,ENSG00000182400
P63151,0,6,27856006.075520832,1.078290955277718e-4,1.6085665268302722,0.6857756039691238,0.12762545628814487,0.64823440900854,raw,22997380.515625,24376760.75,18625713.59375,39211641.375,23932780.53125,37991759.6875,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform OS=Homo sapiens OX=9606 GN=PPP2R2A PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,DNA binding,5520,PPP2R2A,Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Glycogen synthesis and degradation,Cyclin D associated events in G1; Cyclin A/B1/B2 associated events during G2/M transition; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Initiation of Nuclear Envelope (NE) Reformation,ENSG00000221914
Q6PD74,0,6,2568780.53125,9.94361074387645e-6,1.6085376113840346,0.6857496699806043,0.031316536710484934,0.6429522395902524,raw,2080176.375,2254045.875,1487871.625,3618167.6875,2626379.6875,3346041.9375,Alpha- and gamma-adaptin-binding protein p34 OS=Homo sapiens OX=9606 GN=AAGAB PE=1 SV=1,conjugation,cytosol;membrane;nucleus,NA,79719,AAGAB,NA,NA,ENSG00000103591
Q96J02,0,6,3285204.2643229165,1.2716848333732124e-5,1.608312240253977,0.6855475207804729,0.10077033865568479,0.6429522395902524,raw,2936233.0625,3044090.609375,1500689.6484375,4895848.1875,3027458.359375,4306905.71875,E3 ubiquitin-protein ligase Itchy homolog OS=Homo sapiens OX=9606 GN=ITCH PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,antioxidant activity;structural molecule activity,83737,ITCH,TGF-beta signaling pathway; VEGFA-VEGFR2 signaling pathway; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Notch signaling pathway,Antigen processing: Ubiquitination & Proteasome degradation; Degradation of GLI1 by the proteasome; Hedgehog 'on' state; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Activated NOTCH1 Transmits Signal to the Nucleus; NOD1/2 Signaling Pathway; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses; Downregulation of ERBB4 signaling,ENSG00000078747
H0UI06,0,6,26164172.833333332,1.0128010039206174e-4,1.6080803580621068,0.685339501840847,0.0067288109888412025,0.6429522395902524,raw,23561141,18697315,18900102,30671532,30066785,35088162,"Cytochrome c oxidase subunit 7A2, mitochondrial OS=Homo sapiens OX=9606 GN=COX7A2 PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome,NA,1347,COX7A2,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly,NA,ENSG00000112695
P56537,0,6,102277625.69791667,3.95911166943129e-4,1.607813989153342,0.6851005082278053,0.07321110975462992,0.6429522395902524,raw,82200389.25,84024769.625,72813422.5625,144154147.25,98310089.75,132162935.75,Eukaryotic translation initiation factor 6 OS=Homo sapiens OX=9606 GN=EIF6 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,protein binding;RNA binding,3692,EIF6,Translation factors; Genetic causes of porto-sinusoidal vascular disease,NA,ENSG00000242372
Q9UDW1,0,6,9355649.677083334,3.621521477341665e-5,1.6073195857157128,0.6846568107100016,0.11707609903633195,0.6429522395902524,raw,6784432.9375,8706008.4375,6723271.875,11387901.875,8538945.0625,13993337.875,Cytochrome b-c1 complex subunit 9 OS=Homo sapiens OX=9606 GN=UQCR10 PE=1 SV=3,cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,29796,UQCR10,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,Respiratory electron transport,ENSG00000184076
P02794,0,6,874454.6328125,3.3849666704051606e-6,1.6072307729697204,0.684577092121741,0.5425001938631216,1,raw,1450230.53125,217351.46875,458401.890625,736757.625,694849.125,1689137.15625,Ferritin heavy chain OS=Homo sapiens OX=9606 GN=FTH1 PE=1 SV=2,conjugation;metabolic process,cell surface;cytosol;mitochondrion;nucleus,structural molecule activity,2495,FTH1,Iron metabolism in placenta; Nuclear receptors meta-pathway; NRF2 pathway; Ferroptosis,Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Iron uptake and transport; Scavenging by Class A Receptors,ENSG00000167996
Q13188,0,6,17161183.934895832,6.643001645206047e-5,1.6069504176794809,0.6843254154651057,0.029440725456922435,0.6429522395902524,raw,12963005.125,16675814.3125,10835280.640625,22690291.875,18971805.15625,20830906.5,Serine/threonine-protein kinase 3 OS=Homo sapiens OX=9606 GN=STK3 PE=1 SV=2,cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,6788,STK3,MAPK signaling pathway; Transcription co-factors SKI and SKIL protein partners; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Yap signaling pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Leukocyte-intrinsic Hippo pathway functions; Malignant pleural mesothelioma,Signaling by Hippo,ENSG00000104375
Q01959,0.16666666666666666,6,1096293.3375,4.243692318822019e-6,1.606913885189881,0.6842926167924721,0.014801850620896123,0.6429522395902524,raw,873563.5625,NA,756126.625,1214265.25,1232885.875,1404625.375,Sodium-dependent dopamine transporter OS=Homo sapiens OX=9606 GN=SLC6A3 PE=1 SV=1,cell death;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;catalytic activity;structural molecule activity,6531,SLC6A3,Parkinson's disease pathway; Dopaminergic neurogenesis; Nuclear receptors meta-pathway; NRF2 pathway; GDNF signaling; Monoamine transport,Na+/Cl- dependent neurotransmitter transporters; Dopamine clearance from the synaptic cleft; Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS); Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),ENSG00000142319; ENSG00000276996
O43237,0,6,12854600.46875,4.975946437397765e-5,1.6067326472643946,0.6841298913315623,0.08332503111742824,0.6429522395902524,raw,11453392.25,9241054.8125,9593481.4375,16350361,12086774.0625,18402539.25,Cytoplasmic dynein 1 light intermediate chain 2 OS=Homo sapiens OX=9606 GN=DYNC1LI2 PE=1 SV=1,cell growth;metabolic process,cytosol;endoplasmic reticulum;mitochondrion;nucleus,structural molecule activity,1783,DYNC1LI2,Intraflagellar transport proteins binding to dynein,HCMV Early Events; Separation of Sister Chromatids; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000135720
Q6IA69,0.16666666666666666,6,8325477,3.2227471961106754e-5,1.6067028782706232,0.6841031613229182,0.043568195813084784,0.6429522395902524,raw,6378066,8266626.5,5104862.5,10247657,9176799,10778851,Glutamine-dependent NAD(+) synthetase OS=Homo sapiens OX=9606 GN=NADSYN1 PE=1 SV=3,cellular homeostasis,cytosol;nucleus,structural molecule activity,55191,NADSYN1,NAD biosynthesis II (from tryptophan); NAD+ biosynthetic pathways,Nicotinate metabolism,ENSG00000172890
P24385,0,6,2520807.875,9.757911181653566e-6,1.6053328431408456,0.682872450845907,0.07307142116370088,0.6429522395902524,raw,2082504.0625,1612631.8125,2267725.53125,2588810.8125,2832436.78125,3740738.25,G1/S-specific cyclin-D1 OS=Homo sapiens OX=9606 GN=CCND1 PE=1 SV=1,cell death;cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,595,CCND1,Androgen receptor signaling pathway; miRNA regulation of DNA damage response; miRNAs involved in DNA damage response; Cell cycle; Leptin signaling pathway; IL-7 signaling pathway; Glioblastoma signaling pathways; Spinal cord injury; Retinoblastoma gene in cancer; Mammary gland development pathway - Embryonic development (Stage 1 of 4); Mammary gland development pathway - Puberty (Stage 2 of 4); Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Bladder cancer; Mesodermal commitment pathway; Vitamin D receptor pathway; PPAR-alpha pathway; Nuclear receptors meta-pathway; Focal adhesion; Copper homeostasis; Photodynamic therapy-induced NF-kB survival signaling; Wnt signaling pathway; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; VEGFA-VEGFR2 signaling pathway; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; Wnt signaling pathway and pluripotency; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Hedgehog signaling pathway; Non-small cell lung cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Wnt signaling; Acute viral myocarditis; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; G1 to S cell cycle control; Hippo-Merlin signaling dysregulation; Measles virus infection; Small cell lung cancer; Gastrin signaling pathway; Head and neck squamous cell carcinoma; Melanoma; FGF23 signaling in hypophosphatemic rickets and related disorders; EGFR tyrosine kinase inhibitor resistance; Influence of laminopathies on Wnt signaling; Development of ureteric collection system; Malignant pleural mesothelioma; DYRK1A; Notch signaling pathway; ErbB signaling pathway; DNA damage response; DNA damage response (only ATM dependent),"Estrogen-dependent nuclear events downstream of ESR-membrane signaling; Ubiquitin-dependent degradation of Cyclin D; SCF(Skp2)-mediated degradation of p27/p21; Estrogen-dependent gene expression; Interleukin-4 and Interleukin-13 signaling; Pre-NOTCH Transcription and Translation; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3); Transcriptional Regulation by VENTX; RMTs methylate histone arginines; Transcriptional regulation by RUNX2; RUNX3 regulates WNT signaling; RUNX3 regulates p14-ARF; PTK6 Regulates Cell Cycle; Drug-mediated inhibition of CDK4/CDK6 activity; Regulation of RUNX1 Expression and Activity",ENSG00000110092
Q8WWC4,0,6,8891058.104166666,3.4416805878702465e-5,1.6052981049199875,0.6828412316495721,0.05166793476431052,0.6429522395902524,raw,7934197,7312148.5625,5572343.875,10768609.625,8945273.0625,12813776.5,"m-AAA protease-interacting protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=MAIP1 PE=1 SV=1",cell growth;conjugation;metabolic process,cytoskeleton;endosome,protein binding,79568,MAIP1,NA,Processing of SMDT1,ENSG00000162972
Q9Y3A6,0,6,11550119.635416666,4.4709889499162527e-5,1.6051321426014085,0.6826920721938347,0.029649308467536606,0.6429522395902524,raw,9254682.4375,9557012.1875,8218985.875,14854988.25,11969936.75,15445112.3125,Transmembrane emp24 domain-containing protein 5 OS=Homo sapiens OX=9606 GN=TMED5 PE=1 SV=1,cell growth;conjugation,cytoskeleton;extracellular;nucleus,NA,50999,TMED5,NA,WNT ligand biogenesis and trafficking,ENSG00000117500
Q15654,0,6,10860586.729166666,4.2040744848059374e-5,1.6048199795134594,0.6824114722825465,0.05813971575543286,0.6429522395902524,raw,7632428.0625,11071548,6730211.4375,14173919.90625,10800777.78125,14754635.1875,Thyroid receptor-interacting protein 6 OS=Homo sapiens OX=9606 GN=TRIP6 PE=1 SV=3,cell communication;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;structural molecule activity,7205,TRIP6,NA,NA,ENSG00000087077
Q4KMQ2,0,6,431027.6953125,1.6684849366761879e-6,1.6047612074652724,0.6823586366398054,0.1780712558708222,0.6741527184744509,raw,405477.5,197639.234375,397415.5625,593804.375,341134.9375,650694.5625,Anoctamin-6 OS=Homo sapiens OX=9606 GN=ANO6 PE=1 SV=2,cell growth;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol,catalytic activity;structural molecule activity,196527,ANO6,Endothelial cell senescence,Neutrophil degranulation; Stimuli-sensing channels; Induction of Cell-Cell Fusion,ENSG00000177119
H3BNQ7,0,6,504399.6197916667,1.952503694866834e-6,1.6039446307752685,0.681624339869708,0.1770123868134322,0.6724728279208513,raw,281002.21875,378603.21875,356378.5,568931.25,450712,990770.53125,(S)-3-amino-2-methylpropionate transaminase OS=Homo sapiens OX=9606 GN=ABAT PE=1 SV=1,cellular homeostasis,endosome,structural molecule activity,NA,ABAT,Valproic acid pathway; Fragile X syndrome,NA,ENSG00000183044
Q9UKL0,0,6,2737779.9166666665,1.0597798240275744e-5,1.603837881118312,0.6815283188955967,0.3154423972794117,0.7958588159583763,raw,2418436.25,2071663.5,995393,3091462.9375,1596449,6253274.8125,REST corepressor 1 OS=Homo sapiens OX=9606 GN=RCOR1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,23186,RCOR1,NA,Regulation of PTEN gene transcription; Potential therapeutics for SARS; HDACs deacetylate histones; Factors involved in megakaryocyte development and platelet production,ENSG00000089902
P14625,0,6,1754797128.889975,0.006792724941613832,1.6025992162670142,0.6804136762733283,0.038094674688913754,0.6429522395902524,raw,1274376318.875,1570443301.23438,1151880072.04297,2234805375.625,1780486501.8125,2516791203.75,Endoplasmin OS=Homo sapiens OX=9606 GN=HSP90B1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,antioxidant activity;RNA binding;structural molecule activity,7184,HSP90B1,Photodynamic therapy-induced unfolded protein response; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; PI3K-Akt signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Interleukin-4 and Interleukin-13 signaling; Trafficking and processing of endosomal TLR; Scavenging by Class A Receptors; ATF6 (ATF6-alpha) activates chaperone genes,ENSG00000166598
Q8IY37,0,6,2853729.9635416665,1.1046634611399354e-5,1.6022366274380058,0.6800872289086362,0.5632009389092142,1,raw,2274189.5625,2450472.375,2619240.53125,3926236.59375,964687.5,4887553.21875,Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens OX=9606 GN=DHX37 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,57647,DHX37,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000150990
Q9BTD8,0,6,5375840.010416667,2.0809586430074694e-5,1.6021346244582864,0.6799953798802443,0.02726583303434005,0.6429522395902524,raw,3779884.875,4373952.5625,4101178.0625,6570639.375,5832162.125,7597223.0625,RNA-binding protein 42 OS=Homo sapiens OX=9606 GN=RBM42 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,79171,RBM42,NA,mRNA Splicing - Major Pathway,ENSG00000126254
O60522,0.8333333333333334,6,1500344.75,5.807753521223916e-6,1.6018486095594426,0.6797378053256105,0.36953603739508384,0.8536597065560958,raw,1889095.5,605098.375,744864.9375,2107383,629581.6875,3026045,Tudor domain-containing protein 6 OS=Homo sapiens OX=9606 GN=TDRD6 PE=2 SV=2,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,nucleus,NA,221400,TDRD6,NA,PIWI-interacting RNA (piRNA) biogenesis,ENSG00000180113
O15260,0,6,25154758.135416668,9.737271059634933e-5,1.6015247630054956,0.6794461054426174,0.12022597098479934,0.6445597830897484,raw,24257089.375,18078635.5625,13800936,34672171.5625,21271387,38848329.3125,Surfeit locus protein 4 OS=Homo sapiens OX=9606 GN=SURF4 PE=1 SV=3,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion,structural molecule activity,6836,SURF4,NA,COPI-dependent Golgi-to-ER retrograde traffic; Neutrophil degranulation,ENSG00000148248; ENSG00000280951
Q9C0D9,0,6,5224669.166666667,2.0224412255875428e-5,1.6011844891282796,0.6791395453409013,0.08377029776643292,0.6429522395902524,raw,5340686.5,3075886.5,2981876.25,7278792.5,4774534,7896239.25,Ethanolaminephosphotransferase 1 OS=Homo sapiens OX=9606 GN=SELENOI PE=1 SV=3,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,85465,SELENOI,Selenium micronutrient network,Synthesis of PE,ENSG00000138018
Q9Y4B6,0,6,13104690.71940105,5.072755023147301e-5,1.601116242867586,0.6790780529639405,0.12363124033867967,0.6445597830897484,raw,10092423.109375,9965103.8125,10777272.1328125,19650428.96875,11983773.7226563,16159142.5703125,DDB1- and CUL4-associated factor 1 OS=Homo sapiens OX=9606 GN=DCAF1 PE=1 SV=3,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;defense response;metabolic process,membrane;nucleus,signal transducer activity;structural molecule activity,9730,DCAF1,Hippo-Merlin signaling dysregulation,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000145041
P62834,0,6,5603702.171875,2.1691628554435327e-5,1.6008235442751355,0.6788142910964154,0.16867265629113484,0.668039680404208,raw,3863000.1875,5035620.6875,4047900.15625,6479973.875,4955020.25,9240697.875,Ras-related protein Rap-1A OS=Homo sapiens OX=9606 GN=RAP1A PE=1 SV=1,cell death;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,DNA binding;structural molecule activity,5906,RAP1A,"Integrin-mediated cell adhesion; Thyroid stimulating hormone (TSH) signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Common pathways underlying drug addiction; Focal adhesion; Hepatocyte growth factor receptor signaling; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Ras signaling; EGF/EGFR signaling pathway; Leukocyte-intrinsic Hippo pathway functions; DNA repair pathways, full network; GDNF signaling; Interferon type I signaling pathways; Serotonin HTR1 group and FOS pathway; Serotonin receptor 4/6/7 and NR3C signaling",Neutrophil degranulation; Signaling by BRAF and RAF1 fusions; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Rap1 signalling; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; ARMS-mediated activation; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins; MET activates RAP1 and RAC1,ENSG00000116473
Q6QNY1,0,6,1556066.84375,6.023450737604705e-6,1.5989876995429466,0.677158840709022,0.22131998703351136,0.7102829728901873,raw,975897.78125,1280951.03125,915921.25,1497098.6875,1464546.8125,3201985.5,Biogenesis of lysosome-related organelles complex 1 subunit 2 OS=Homo sapiens OX=9606 GN=BLOC1S2 PE=1 SV=1,cell growth;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;mitochondrion;nucleus,motor activity;structural molecule activity,282991,BLOC1S2,NA,NA,ENSG00000196072
Q2TAA2,0,6,252160.18489583334,9.760984611978344e-7,1.5989489853114547,0.677123910167681,0.23892746766899514,0.7253155268523066,raw,232689.328125,201430.34375,174463.703125,322076.84375,188371.890625,393929,Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Homo sapiens OX=9606 GN=IAH1 PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,285148,IAH1,NA,NA,ENSG00000134330
Q6PI48,0,6,6728541.734375,2.604582176897575e-5,1.5987724753282324,0.676964640462139,0.28124360247493674,0.7637311837800919,raw,6253153,4842264.15625,5537424.34375,8853081.625,4737569.09375,10147758.1875,"Aspartate--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=DARS2 PE=1 SV=1",cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome;membrane,RNA binding;structural molecule activity,55157,DARS2,NA,Mitochondrial tRNA aminoacylation,ENSG00000117593
Q9BVK6,0,6,33381396,1.2921758160074203e-4,1.5986651747695468,0.6768678116880401,0.02026670922196992,0.6429522395902524,raw,28367796.125,25995570.25,23187534.375,42051159.5,35335708,45350607.75,Transmembrane emp24 domain-containing protein 9 OS=Homo sapiens OX=9606 GN=TMED9 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,54732,TMED9,NA,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000184840
Q53ET0,0.5,6,591874.34375,2.2911136284085086e-6,1.5976570454796761,0.6759577512654171,0.3766748993402766,0.8615698665976935,raw,597532.0625,417704.4375,367280.5,667348.4375,352541.875,1148838.75,CREB-regulated transcription coactivator 2 OS=Homo sapiens OX=9606 GN=CRTC2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,membrane;nucleus,structural molecule activity,200186,CRTC2,AMP-activated protein kinase signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway,Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis,ENSG00000160741
Q92733,0,6,1580565.8802083333,6.118285184992532e-6,1.5972598693003932,0.6755990539205743,0.25059478372036303,0.7326612824296702,raw,1810508.984375,782043.9765625,933295.8984375,1199001.71875,1866691.359375,2891853.34375,Proline-rich protein PRCC OS=Homo sapiens OX=9606 GN=PRCC PE=1 SV=1,cell differentiation;metabolic process,membrane,NA,5546,PRCC,Type 2 papillary renal cell carcinoma; IL-18 signaling pathway,mRNA Splicing - Major Pathway,ENSG00000143294
P67812,0,6,11357807.59375,4.3965459969107294e-5,1.597101409007712,0.6754559205310177,0.08148502720612291,0.6429522395902524,raw,10689344.4375,7250599,7924407.875,14609364.6875,10601162.5,17071967.0625,Signal peptidase complex catalytic subunit SEC11A OS=Homo sapiens OX=9606 GN=SEC11A PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,23478,SEC11A,NA,"SRP-dependent cotranslational protein targeting to membrane; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP); Synthesis, secretion, and deacylation of Ghrelin",ENSG00000140612
Q9BTV4,0,6,20108987.4375,7.78408046539891e-5,1.5965998064488693,0.675002741300232,0.08554239934669423,0.6429522395902524,raw,16802996.78125,14236761.3125,16522636.625,26380038.4375,18767788.84375,27943702.625,Transmembrane protein 43 OS=Homo sapiens OX=9606 GN=TMEM43 PE=1 SV=1,cell growth;coagulation,cytoskeleton;extracellular,structural molecule activity,79188,TMEM43,Envelope proteins and their potential roles in EDMD physiopathology,NA,ENSG00000170876
Q9HAU4,0,6,641658.703125,2.4838261956115016e-6,1.5962449475408294,0.6746820534945923,0.15017542275454349,0.6638855679885327,raw,NA,378915.625,553354.453125,885691.59375,880886.90625,509444.9375,E3 ubiquitin-protein ligase SMURF2 OS=Homo sapiens OX=9606 GN=SMURF2 PE=1 SV=1,cell death;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,64750,SMURF2,TGF-beta signaling pathway; Hedgehog signaling pathway,Antigen processing: Ubiquitination & Proteasome degradation; Asymmetric localization of PCP proteins; Degradation of AXIN; Hedgehog 'on' state; Ub-specific processing proteases; Regulation of RUNX3 expression and activity; Signaling by BMP; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity,ENSG00000108854
Q6UXN9,0,6,13629214.885416666,5.275795495821613e-5,1.5953377287955257,0.6738618710629688,0.019435370885898577,0.6429522395902524,raw,9103327.125,11846535.75,9258749.8125,18319146.75,14348304.4375,18899225.4375,WD repeat-containing protein 82 OS=Homo sapiens OX=9606 GN=WDR82 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,80335,WDR82,NA,NA,ENSG00000164091
Q86WR7,0.16666666666666666,6,728665.1223958334,2.820623346992387e-6,1.5946353015601002,0.6732265125217716,0.7303011810164528,1,raw,265093.375,505051.6875,1229779.109375,1049381.59375,805373.25,517311.71875,Proline and serine-rich protein 2 OS=Homo sapiens OX=9606 GN=PROSER2 PE=1 SV=2,NA,NA,NA,254427,PROSER2,NA,NA,ENSG00000148426
P09110,0,6,10383502.666666666,4.019397820065771e-5,1.5945634614848434,0.6731615160583786,0.09781419136669624,0.6429522395902524,raw,9045091.71875,6086995,8940767.15625,14256620.625,9226280.59375,14745260.90625,"3-ketoacyl-CoA thiolase, peroxisomal OS=Homo sapiens OX=9606 GN=ACAA1 PE=1 SV=2",cellular homeostasis,cell surface;cytosol;mitochondrion;nucleus,structural molecule activity,30,ACAA1,PPAR-alpha pathway; Nuclear receptors meta-pathway; Amino acid metabolism; PPAR signaling pathway; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX),Neutrophil degranulation; TYSND1 cleaves peroxisomal proteins; alpha-linolenic acid (ALA) metabolism; Beta-oxidation of very long chain fatty acids,ENSG00000060971
B4DR61,0,6,47204295.967447914,1.8272528105413204e-4,1.5943401316907895,0.6729594423502987,0.026669403806495018,0.6429522395902524,raw,30544476.6875,42692668.4765625,36729262.84375,59833108.5625,48698284.984375,64727974.25,Protein transport protein Sec61 subunit alpha isoform 1 OS=Homo sapiens OX=9606 GN=SEC61A1 PE=1 SV=1,conjugation,cytoskeleton;extracellular,NA,NA,SEC61A1,NA,NA,ENSG00000058262
Q08AF3,0,6,11323221.348958334,4.383157848288573e-5,1.593787407747364,0.6724592038308006,0.160170477278015,0.6638855679885327,raw,10264861.65625,8974525.28125,7195935.34375,16360007.25,9050070.4375,16093928.125,Schlafen family member 5 OS=Homo sapiens OX=9606 GN=SLFN5 PE=1 SV=1,metabolic process,membrane,structural molecule activity,162394,SLFN5,NA,NA,ENSG00000166750
A0A2R8YEA7,0,6,1086135.3020833333,4.204371112172772e-6,1.5935575855550528,0.6722511539721221,0.17372516784374026,0.669032211414766,raw,924090.4375,831924.125,792222.5,1721474.625,921381.125,1325719,"Actin, cytoplasmic 1 (Fragment) OS=Homo sapiens OX=9606 GN=ACTB PE=1 SV=1",NA,NA,NA,NA,ACTB,Common pathways underlying drug addiction; Ebola virus infection in host; Acute viral myocarditis; Thermogenesis; Malignant pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway,NA,ENSG00000075624
Q15417,0,6,25716418.864583332,9.954686895398739e-5,1.593372091987208,0.6720832113578659,0.028162268379140713,0.6429522395902524,raw,20268334.25,20854147.25,17262886.6875,31720066.625,27506201.875,36686876.5,Calponin-3 OS=Homo sapiens OX=9606 GN=CNN3 PE=1 SV=1,cell growth;metabolic process,cytosol;endoplasmic reticulum,motor activity;structural molecule activity,1266,CNN3,NA,NA,ENSG00000117519
P35606,0,6,89071711.234375,3.447917850633204e-4,1.5925493658038616,0.6713380937981059,0.0834940840545178,0.6429522395902524,raw,72195725,73603952.546875,62730670.828125,126912548.625,84012114.34375,114975256.0625,Coatomer subunit beta' OS=Homo sapiens OX=9606 GN=COPB2 PE=1 SV=2,conjugation,cytoskeleton;cytosol;extracellular,structural molecule activity,9276,COPB2,NA,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000184432
P23258,0,6,11957585.143229166,4.6287166480186617e-5,1.5922935958264093,0.6711063724333055,0.12173589241109434,0.6445597830897484,raw,10210460.4375,9620112.484375,8594952.34375,15318043.5,10662858.0625,17339084.03125,Tubulin gamma-1 chain OS=Homo sapiens OX=9606 GN=TUBG1 PE=1 SV=2,cell differentiation;cell growth,cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,motor activity;structural molecule activity,7283,TUBG1,Alstrom syndrome,Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,ENSG00000131462
Q9UI12,0,6,4570523.139322917,1.7692248302423862e-5,1.5922516020901696,0.6710683235746713,0.31145043830788616,0.7920633653972666,raw,4880860.1875,2291446.0078125,3511151.3046875,6205856.40625,2762267.4765625,7771557.453125,V-type proton ATPase subunit H OS=Homo sapiens OX=9606 GN=ATP6V1H PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion,catalytic activity;DNA binding,51606,ATP6V1H,Proximal tubule transport,Nef Mediated CD4 Down-regulation; Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport; Nef Mediated CD8 Down-regulation; Blockage of phagosome acidification,ENSG00000047249
O60669,0,6,685079.0416666666,2.6519039817723817e-6,1.591640348810492,0.6705143775867097,0.06384557022833232,0.6429522395902524,raw,416844.125,642763.0625,538539.3125,716068.6875,773211.4375,1023047.625,Monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC16A7 PE=1 SV=2,conjugation,cytoplasm;cytoskeleton;membrane,catalytic activity;structural molecule activity,9194,SLC16A7,Male infertility,Proton-coupled monocarboxylate transport,ENSG00000118596
Q3KQU3,0,6,966847.0364583334,3.742612676503712e-6,1.5916107669197792,0.6704875637127921,0.1933092191438192,0.6839501208924997,raw,793002.21875,913480.40625,508876.96875,1130582.84375,1645205.71875,809934.0625,MAP7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MAP7D1 PE=1 SV=1,cell growth,endoplasmic reticulum;nucleus,NA,55700,MAP7D1,NA,NA,ENSG00000116871
A0A0C4DFL7,0,6,10858315.020833334,4.203195118775423e-5,1.5915171845950362,0.6704027347282732,0.0592644778063057,0.6429522395902524,raw,8004215.71875,9716598.625,6593145.125,15063881.5,10307915.46875,15464133.6875,Lanosterol 14-alpha demethylase OS=Homo sapiens OX=9606 GN=CYP51A1 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,1595,CYP51A1,Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Oxidation by cytochrome P450; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders; Metapathway biotransformation Phase I and II,Endogenous sterols; Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis; EGR2 and SOX10-mediated initiation of Schwann cell myelination,ENSG00000001630
H0Y5K5,0,6,4357757.416666667,1.686864367758508e-5,1.591413521574787,0.6703087621356559,0.4232389172656188,0.9086347256931654,raw,3756930.1875,3493394.4375,3942433.6875,6483490.375,2491466.3125,5978829.5,Endoplasmic reticulum-Golgi intermediate compartment protein 3 (Fragment) OS=Homo sapiens OX=9606 GN=ERGIC3 PE=1 SV=1,conjugation,cytoskeleton;extracellular,NA,NA,ERGIC3,NA,NA,ENSG00000125991
P68400,0,6,65775633.114583336,2.546139244543321e-4,1.5913899585553808,0.6702874009354067,0.04626541325245981,0.6429522395902524,raw,60812058.71875,50081217.625,40556327.71875,91628935.75,64540932.6875,87034326.1875,Casein kinase II subunit alpha OS=Homo sapiens OX=9606 GN=CSNK2A1 PE=1 SV=1,cell death;cell differentiation;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,1457,CSNK2A1,Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Translation inhibitors in chronically activated PDGFRA cells; Measles virus infection; Malignant pleural mesothelioma; Alzheimer's disease,Signal transduction by L1; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN stability and activity; KEAP1-NFE2L2 pathway; Regulation of TP53 Activity through Phosphorylation; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; WNT mediated activation of DVL; Receptor Mediated Mitophagy; Condensation of Prometaphase Chromosomes; Synthesis of PC,ENSG00000101266
A0A2R8Y7Q1,0,6,3285697.9140625,1.271875922522111e-5,1.591292171817763,0.670198748386587,0.0626273785713897,0.6429522395902524,raw,2817149.0625,2794530.125,2041516.328125,4482907.25,3114718.1875,4463366.53125,Nucleosome-remodeling factor subunit BPTF OS=Homo sapiens OX=9606 GN=BPTF PE=1 SV=1,metabolic process,membrane,structural molecule activity,NA,BPTF,Endoderm differentiation; 16p11.2 proximal deletion syndrome,NA,ENSG00000171634
Q14568,0.16666666666666666,6,518074.3203125,2.0054377222639055e-6,1.591147747677326,0.6700678048359736,1,1,raw,400578.84375,NA,NA,691604,342734.3125,637380.125,Heat shock protein HSP 90-alpha A2 OS=Homo sapiens OX=9606 GN=HSP90AA2P PE=1 SV=2,metabolic process,nucleus,structural molecule activity,NA,HSP90AA2P,NA,NA,NA
Q4LE39,0,6,108973.3515625,4.2182996025192277e-7,1.5910091617692568,0.6699421434005859,1,1,raw,NA,84116.53125,NA,NA,NA,133830.171875,AT-rich interactive domain-containing protein 4B OS=Homo sapiens OX=9606 GN=ARID4B PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;endosome;membrane,RNA binding,51742,ARID4B,Pathways affected in adenoid cystic carcinoma,Potential therapeutics for SARS; HDACs deacetylate histones; NoRC negatively regulates rRNA expression,ENSG00000054267
Q9H008,0,6,4860027.9921875,1.8812905957030043e-5,1.590986583627452,0.6699216698513916,0.03818887965784772,0.6429522395902524,raw,3995429.5,3377771.890625,3988717.875,6345996.625,4914530.9375,6537721.125,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase OS=Homo sapiens OX=9606 GN=LHPP PE=1 SV=2,cellular homeostasis,cytosol;membrane,structural molecule activity,64077,LHPP,NA,Pyrophosphate hydrolysis,ENSG00000107902
O43181,0,6,4724956.109375,1.8290049991411045e-5,1.590850860677603,0.6697985920196494,0.11290941427768098,0.6429522395902524,raw,4167961.09375,2899997.375,3928737.71875,6250035.78125,4145704.6875,6957300,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS4 PE=1 SV=1",cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;endosome,catalytic activity,4724,NDUFS4,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000164258
Q15629,0,6,4753799.036458333,1.8401699404874608e-5,1.5905577023461432,0.6695327110026024,0.1042128081981059,0.6429522395902524,raw,4653213.3125,3477310,2601355.71875,6824917.125,4137606.375,6828391.6875,Translocating chain-associated membrane protein 1 OS=Homo sapiens OX=9606 GN=TRAM1 PE=1 SV=3,cell growth;coagulation;conjugation,cytoskeleton;extracellular,structural molecule activity,23471,TRAM1,TLR4 signaling and tolerance,SRP-dependent cotranslational protein targeting to membrane,ENSG00000067167
P45985,0,6,3805428.4010416665,1.4730607879232578e-5,1.5902068001064062,0.6692143944955055,0.25321715944838297,0.7343965948630279,raw,3032717.25,3553305.09375,2377707.6875,4822647.59375,2725868.90625,6320323.875,Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP2K4 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,6416,MAP2K4,MicroRNAs in cardiomyocyte hypertrophy; IL-1 signaling pathway; Glioblastoma signaling pathways; TNF-alpha signaling pathway; PDGF pathway; Apoptosis; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Fas ligand pathway and stress induction of heat shock proteins; IL6 signaling pathway; TGF-beta signaling pathway; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Oxidative damage response; Wnt signaling pathway and pluripotency; p38 MAPK signaling pathway; MAPK cascade; Epithelial to mesenchymal transition in colorectal cancer; Translation inhibitors in chronically activated PDGFRA cells; Hepatitis B infection; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; Malignant pleural mesothelioma; ErbB signaling pathway; Toll-like receptor signaling pathway,FCERI mediated MAPK activation; Oxidative Stress Induced Senescence; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; Uptake and function of anthrax toxins; MAP3K8 (TPL2)-dependent MAPK1/3 activation,ENSG00000065559
Q9BV86,0,6,6926861.5703125,2.6813507146282908e-5,1.5897958376931645,0.6688415058495473,0.1433120941338894,0.6572502130392559,raw,6747979.8125,6020892.0625,3328833.375,10727910.21875,6105197.671875,8630356.28125,N-terminal Xaa-Pro-Lys N-methyltransferase 1 OS=Homo sapiens OX=9606 GN=NTMT1 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,28989,NTMT1,NA,NA,ENSG00000148335
P49748,0,6,101692968.7109375,3.9364799131310366e-4,1.5895311394408125,0.6686012796258031,0.04170156200884938,0.6429522395902524,raw,90078771.609375,63286016.71875,77109954.1875,136701468.71875,100595094.265625,142386506.765625,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADVL PE=1 SV=1",cellular homeostasis;coagulation;metabolic process,cytoskeleton;endosome;membrane,structural molecule activity,37,ACADVL,Fatty acid beta-oxidation; Mitochondrial long chain fatty acid beta-oxidation,XBP1(S) activates chaperone genes; Beta oxidation of palmitoyl-CoA to myristoyl-CoA,ENSG00000072778
P62330,0,6,20667897.911458332,8.00043169222064e-5,1.5885884095157219,0.66774538241566606,0.04007767545222274,0.6429522395902524,raw,17380151.375,14614526.84375,15407186.25,24475677.5,22156070,29973775.5,ADP-ribosylation factor 6 OS=Homo sapiens OX=9606 GN=ARF6 PE=1 SV=2,cell communication;cell differentiation;cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,382,ARF6,VEGFA-VEGFR2 signaling pathway; Ras signaling; EGF/EGFR signaling pathway; IL-18 signaling pathway; Insulin signaling; CCL18 signaling pathway; 2q13 copy number variation syndrome,Clathrin-mediated endocytosis; TBC/RABGAPs; MET receptor recycling,ENSG00000165527
Q5H8A4,0.16666666666666666,6,19365053.755208332,7.496107753601404e-5,1.5882114456433605,0.667402997665856,0.007016884982946361,0.6429522395902524,raw,14487628,15585554,14834698.53125,23560638,22187092,25534712,GPI ethanolamine phosphate transferase 2 OS=Homo sapiens OX=9606 GN=PIGG PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,54872,PIGG,NA,Synthesis of glycosylphosphatidylinositol (GPI),ENSG00000174227
Q5UIP0,0,6,964118.640625,3.732051203543358e-6,1.5881736360035483,0.667368651842881,0.02383636135391482,0.6429522395902524,raw,708190.0625,789263.875,773498.59375,1253488.078125,1017952.453125,1242318.78125,Telomere-associated protein RIF1 OS=Homo sapiens OX=9606 GN=RIF1 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,NA,55183,RIF1,ATM signaling in development and disease,Nonhomologous End-Joining (NHEJ),ENSG00000080345
Q9NZT2,0,6,19437662.1171875,7.524214058499316e-5,1.5880066343715717,0.6672169397824906,0.11331888910267683,0.6429522395902524,raw,16479179.5,15508886.953125,15703790.6875,25015647.03125,17749422.15625,26169046.375,Opioid growth factor receptor OS=Homo sapiens OX=9606 GN=OGFR PE=1 SV=3,metabolic process,cytoskeleton;membrane;nucleus,structural molecule activity,11054,OGFR,NA,NA,ENSG00000060491
Q9H446,0,6,1691497.6393229167,6.547696035140997e-6,1.5874592335862734,0.6667195435332535,0.42616725767086305,0.911043979658989,raw,1916301.921875,1335313.375,769458.9921875,2119755.546875,820527.125,3187628.875,RWD domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RWDD1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,nucleus,NA,51389,RWDD1,NA,NA,ENSG00000111832
Q9H223,0,6,58898698.161458336,2.2799368054756363e-4,1.5871262544187164,0.666416897787955,0.10195131873807567,0.6429522395902524,raw,45974840.125,50222819.9375,46018592.3125,79709956.09375,54157216.75,77308763.75,EH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=EHD4 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,30844,EHD4,NA,NA,ENSG00000103966
Q9Y3Q8,0.16666666666666666,6,443260.859375,1.7158388542739227e-6,1.5869407557843858,0.6662482699932142,1,1,raw,NA,342691.15625,NA,NA,NA,543830.5625,TSC22 domain family protein 4 OS=Homo sapiens OX=9606 GN=TSC22D4 PE=1 SV=2,coagulation;metabolic process,membrane,NA,81628,TSC22D4,NA,NA,ENSG00000166925
Q8N8S7,0,6,15514769.455078132,6.005683489325188e-5,1.5867756111254154,0.6660981284221368,0.03545381726292315,0.6429522395902524,raw,11855403.2890625,12497298.3085938,10760237.3046875,18321040.734375,17074082.125,22580554.96875,Protein enabled homolog OS=Homo sapiens OX=9606 GN=ENAH PE=1 SV=2,cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,55740,ENAH,Regulation of actin cytoskeleton,Generation of second messenger molecules; Signaling by ROBO receptors,ENSG00000154380
A0A669KBL1,0,6,73354130.29947917,2.839498778818122e-4,1.5867246877606105,0.6660518281990667,0.09118584818633124,0.6429522395902524,raw,63231299.46875,60863609.109375,50101722.453125,100330663.90625,67080494.109375,98516992.75,Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,NA,USP7,Nucleotide excision repair in xeroderma pigmentosum,NA,ENSG00000187555
Q9BW72,0,6,672368.48125,2.6027020886630646e-6,1.5867134596354342,0.6660416192334224,0.11396501318408174,0.6429522395902524,raw,742478.3125,543920.75,349350.59375,775505.0625,NA,950587.6875,"HIG1 domain family member 2A, mitochondrial OS=Homo sapiens OX=9606 GN=HIGD2A PE=1 SV=1",cell growth;metabolic process,cytoskeleton;endosome,NA,192286,HIGD2A,NA,NA,ENSG00000146066
Q13609,0.8333333333333334,6,330640.421875,1.279891221269973e-6,1.5865686285268186,0.6659099277439764,0.12813146709315718,0.649639734499993,raw,231502.25,232419.0625,321796.53125,375333.34375,312239.0625,510552.28125,Deoxyribonuclease gamma OS=Homo sapiens OX=9606 GN=DNASE1L3 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;metabolic process,cell surface;extracellular;membrane,RNA binding;structural molecule activity,1776,DNASE1L3,NA,NA,ENSG00000163687
Q13610,0,6,4008656.4739583335,1.5517292776882484e-5,1.5861282828111003,0.6655094579845409,0.046284288040157176,0.6429522395902524,raw,2700512.8125,3633271.8125,3021438.90625,4555506.5625,4283359.75,5857849,Periodic tryptophan protein 1 homolog OS=Homo sapiens OX=9606 GN=PWP1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,extracellular;membrane;nucleus,structural molecule activity,11137,PWP1,NA,NA,ENSG00000136045
Q9UKN8,0,6,8165106.010416667,3.160668451911733e-5,1.586073229843288,0.6654593825758128,0.012627592768602217,0.6429522395902524,raw,6440362.25,7151754.6875,4686617.296875,9754371.59375,9614323.578125,11343206.65625,General transcription factor 3C polypeptide 4 OS=Homo sapiens OX=9606 GN=GTF3C4 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,9329,GTF3C4,NA,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter,ENSG00000125484
P99999,0,6,45434750.822916664,1.7587546734023992e-4,1.5856701289560153,0.6650926746878218,0.10973662585573477,0.6429522395902524,raw,42311190.25,29941554.6875,31176336.75,62725945,39361887.75,67091590.5,Cytochrome c OS=Homo sapiens OX=9606 GN=CYCS PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoskeleton;cytosol;endosome;membrane,structural molecule activity,54205,CYCS,miRNA regulation of DNA damage response; Apoptosis modulation and signaling; Alzheimer's disease and miRNA effects; AGE/RAGE pathway; Parkinson's disease pathway; Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Apoptosis modulation by HSP70; VEGFA-VEGFR2 signaling pathway; Oxidative damage response; NO/cGMP/PKG mediated neuroprotection; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; Acute viral myocarditis; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Hepatitis B infection; IL-18 signaling pathway; Malignant pleural mesothelioma; Complement system in neuronal development and plasticity; Alzheimer's disease; DNA damage response,Respiratory electron transport; Detoxification of Reactive Oxygen Species; Transcriptional activation of mitochondrial biogenesis; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1; Activation of caspases through apoptosome-mediated cleavage; SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Regulation of the apoptosome activity; Release of apoptotic factors from the mitochondria; Pyroptosis,ENSG00000172115
O75925,0,6,678052.48125,2.6247045457747627e-6,1.5854037801017848,0.6648503213507073,0.15421433908462956,0.6638855679885327,raw,511661.15625,791385.625,464836.5625,840001.625,NA,782377.4375,E3 SUMO-protein ligase PIAS1 OS=Homo sapiens OX=9606 GN=PIAS1 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;development;metabolic process,membrane,RNA binding;structural molecule activity,8554,PIAS1,Androgen receptor signaling pathway; Interleukin-11 signaling pathway; Mesodermal commitment pathway; TGF-beta signaling pathway; Immune response to tuberculosis; Interferon type I signaling pathways,SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of transcription cofactors; SUMOylation of intracellular receptors; Regulation of IFNG signaling; SUMOylation of transcription factors; Formation of Incision Complex in GG-NER,ENSG00000033800
O00442,0,6,7931443.083333333,3.070218794421498e-5,1.5849860872727453,0.6644701766986202,0.03546934459547976,0.6429522395902524,raw,7171631.09375,5669929.75,5042696.15625,10465804.5625,7992603.25,11245993.6875,RNA 3'-terminal phosphate cyclase OS=Homo sapiens OX=9606 GN=RTCA PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,structural molecule activity,8634,RTCA,NA,NA,ENSG00000137996
A0A590UJK3,0,6,614974.6796875,2.380533781598281e-6,1.5843800861458506,0.6639184734347114,1,1,raw,NA,NA,431107.53125,683038.1875,636851.25,708901.75,Sarcolemmal membrane-associated protein OS=Homo sapiens OX=9606 GN=SLMAP PE=1 SV=1,metabolic process,cytoskeleton,NA,NA,SLMAP,NA,NA,ENSG00000163681
O15239,0,6,351588.671875,1.3609807659902639e-6,1.5838893815749195,0.6634715814869797,1,1,raw,NA,NA,227952.53125,460668.1875,361051.59375,356682.375,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 OS=Homo sapiens OX=9606 GN=NDUFA1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,4694,NDUFA1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease,Complex I biogenesis,ENSG00000125356
P20337,0,6,2573267.7526041665,9.960980535466132e-6,1.5837405893392584,0.6633360468300659,0.10849492869924905,0.6429522395902524,raw,1622495,2795869.5,1794209.328125,2992519.625,2569611.1875,3664901.875,Ras-related protein Rab-3B OS=Homo sapiens OX=9606 GN=RAB3B PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,5865,RAB3B,Intracellular trafficking proteins involved in CMT neuropathy,RAB geranylgeranylation,ENSG00000169213
P61225,0,6,4347647.125651042,1.682950728693447e-5,1.5836222954531858,0.6632282839944885,0.36340431950732544,0.8458062414401234,raw,3885438.75,3297956.0625,3219922,7842049.18359375,2617800.0078125,5222716.75,Ras-related protein Rap-2b OS=Homo sapiens OX=9606 GN=RAP2B PE=1 SV=1,cell communication;coagulation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,5912,RAP2B,NA,Neutrophil degranulation,ENSG00000181467
Q9P0J7,0,6,2226778.53125,8.619739467114479e-6,1.5826895659687095,0.662378308186948,0.22783681717866522,0.7148463313429879,raw,2778475.375,920412.9375,1605005.25,2517189,2999363.5625,2540225.0625,E3 ubiquitin-protein ligase KCMF1 OS=Homo sapiens OX=9606 GN=KCMF1 PE=1 SV=2,cell death;cell organization and biogenesis;cellular homeostasis,cell surface;cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,56888,KCMF1,NA,Neutrophil degranulation,ENSG00000176407
A0A0A0MQU4,0,6,2940117,1.1381034165354526e-5,1.582671970888999,0.6623622693655071,1,1,raw,2276802.5,NA,NA,NA,3603431.5,NA,Selenocysteine lyase OS=Homo sapiens OX=9606 GN=SCLY PE=1 SV=1,NA,extracellular,structural molecule activity,51540,SCLY,2q37 copy number variation syndrome,NA,ENSG00000132330
Q3B726,0,6,412191.1953125,1.5955698621891179e-6,1.5821943554998035,0.6619268302109811,0.1797849111611685,0.6742444420587625,raw,NA,259584.75,384156.71875,566176.625,NA,438846.6875,DNA-directed RNA polymerase I subunit RPA43 OS=Homo sapiens OX=9606 GN=POLR1F PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,NA,221830,POLR1F,Pyrimidine metabolism; 2q13 copy number variation syndrome,B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination,ENSG00000105849
P41594,0.8333333333333334,6,8907564.166666666,3.4480699955451105e-5,1.581956727497237,0.6617101371817729,0.05356861449283966,0.6429522395902524,raw,5879346.5,9096284,6806747.5,10767980,9448238,11446789,Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;DNA binding;structural molecule activity,2915,GRM5,"Common pathways underlying drug addiction; Fragile X syndrome; Vitamin D-sensitive calcium signaling in depression; GPCRs, class C metabotropic glutamate, pheromone; Neuroinflammation and glutamatergic signaling",G alpha (q) signalling events; Class C/3 (Metabotropic glutamate/pheromone receptors); Neurexins and neuroligins,ENSG00000168959
Q53EU6,0,6,3139770.0546875,1.215388036046031e-5,1.5815398273562207,0.661329887190004,0.09814139565305108,0.6429522395902524,raw,2557469.296875,2474285.5,2032316.1875,3913181.0625,2956427.46875,4904940.8125,Glycerol-3-phosphate acyltransferase 3 OS=Homo sapiens OX=9606 GN=GPAT3 PE=1 SV=2,cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,84803,GPAT3,HIF1A and PPARG regulation of glycolysis; Congenital generalized lipodystrophy,Synthesis of PA,ENSG00000138678
Q86UE8,0.3333333333333333,6,317874.815625,1.2304762487118354e-6,1.581038813863223,0.6608727857106022,0.017843932274379654,0.6429522395902524,raw,249475.734375,NA,223475.375,369429.28125,359858.71875,387134.96875,Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens OX=9606 GN=TLK2 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,endoplasmic reticulum;membrane;nucleus,signal transducer activity;structural molecule activity,11011,TLK2,miRNA regulation of DNA damage response; DNA damage response,NA,ENSG00000146872
Q8IWE2,0,6,6332916.4609375,2.451437769594399e-5,1.580973116080985,0.660812835358266,0.10971582112004599,0.6429522395902524,raw,6615829,3810720.21875,4635304.859375,7553395.03125,6024646.21875,9357603.4375,Protein NOXP20 OS=Homo sapiens OX=9606 GN=FAM114A1 PE=1 SV=2,NA,cytosol;extracellular;membrane,NA,92689,FAM114A1,NA,NA,ENSG00000197712
Q9H7B2,0,6,17138597.013020832,6.634258369698659e-5,1.5809557531122191,0.6607969909354656,0.10155715881461337,0.6429522395902524,raw,16352267.59375,7526400.875,14795078.359375,23390364.25,15600072,25167399,Ribosome production factor 2 homolog OS=Homo sapiens OX=9606 GN=RPF2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding,84154,RPF2,NA,NA,ENSG00000197498
A0A0A0MQX8,0,6,13289185.90625,5.144172113857343e-5,1.580364599033018,0.6602574346909826,0.05064246289519691,0.6429522395902524,raw,12893422,8246624.3125,9938696.5,17566486.875,13032673.125,18057212.625,Muscleblind-like protein 1 OS=Homo sapiens OX=9606 GN=MBNL1 PE=1 SV=1,NA,cytosol;membrane,structural molecule activity,NA,MBNL1,NA,NA,ENSG00000152601
Q7Z406,0,6,44096727.697916664,1.7069605206538542e-4,1.5800307980276664,0.6599526797496845,0.03302622235094901,0.6429522395902524,raw,37629621.53125,32720329.03125,30399437.6875,59455960.9375,44968216.5625,59406800.4375,Myosin-14 OS=Homo sapiens OX=9606 GN=MYH14 PE=1 SV=2,cell growth;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,79784,MYH14,NA,RHO GTPases activate CIT; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs,ENSG00000105357
A0A0U1RRE5,0.16666666666666666,6,442340.015625,1.7122743178355078e-6,1.5787194336846442,0.6587548015989059,0.5486515785049219,1,raw,397137.1875,NA,352361.6875,693486.6875,179201.765625,589512.75,Negative regulator of P-body association OS=Homo sapiens OX=9606 GN=NBDY PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,nucleus,NA,550643,NBDY,NA,NA,ENSG00000204272
Q96EQ0,0,6,2354943.1145833335,9.11585764938583e-6,1.5781790181610424,0.6582608643909608,0.019680877086015694,0.6429522395902524,raw,1645280,1922379.625,1817594.875,2596546.375,2857707.5625,3290150.25,Small glutamine-rich tetratricopeptide repeat-containing protein beta OS=Homo sapiens OX=9606 GN=SGTB PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation,cytoskeleton;cytosol,structural molecule activity,54557,SGTB,NA,NA,ENSG00000197860
P13747,0.16666666666666666,6,19319311.53125,7.478401185676757e-5,1.5775686297681983,0.6577027688671112,0.6452652446844627,1,raw,30058610.1875,11859021.375,10848032.6875,20802861.125,17113516.0625,25233827.75,"HLA class I histocompatibility antigen, alpha chain E OS=Homo sapiens OX=9606 GN=HLA-E PE=1 SV=4",coagulation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,3133,HLA-E,Proteasome degradation; Allograft rejection; Ebola virus infection in host,"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; ER-Phagosome pathway; SARS-CoV-2 activates/modulates innate and adaptive immune responses; DAP12 signaling; Interferon gamma signaling; Interferon alpha/beta signaling; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Endosomal/Vacuolar pathway",ENSG00000204592; ENSG00000206493; ENSG00000225201; ENSG00000229252; ENSG00000230254; ENSG00000233904; ENSG00000236632
P49790,0,6,19525405.817708332,7.558179171228578e-5,1.5773672927418685,0.6575186333176344,0.007600889120969342,0.6429522395902524,raw,14640288.390625,15960300.203125,15073272.4375,22062754.40625,23776086.9375,25639732.53125,Nuclear pore complex protein Nup153 OS=Homo sapiens OX=9606 GN=NUP153 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,9972,NUP153,TGF-beta signaling pathway,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses,ENSG00000124789
O96005,0,6,27085211.971354168,1.04845393166956e-4,1.5771639784183573,0.657332665551609,0.040073072411430405,0.6429522395902524,raw,17770667.0625,24226891.84375,17299569.046875,38185466.75,26818896,38209781.125,Cleft lip and palate transmembrane protein 1 OS=Homo sapiens OX=9606 GN=CLPTM1 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton,antioxidant activity,1209,CLPTM1,NA,NA,ENSG00000104853
K7EMV4,0,6,1727254.9583333333,6.686110686435157e-6,1.5762477389740368,0.6564943011017687,0.1439285271232343,0.6572502130392559,raw,1513209.625,1439125.25,1262015.125,2385193.25,1484502,2279484.5,Transcription elongation factor 1 homolog OS=Homo sapiens OX=9606 GN=ELOF1 PE=1 SV=1,NA,membrane,structural molecule activity,NA,ELOF1,NA,NA,ENSG00000130165
Q01415,0,6,433974.697265625,1.6798926221233595e-6,1.5756330301011567,0.6559315656947444,1,1,raw,NA,NA,298904.625,470964,284243.6875,681786.4765625,N-acetylgalactosamine kinase OS=Homo sapiens OX=9606 GN=GALK2 PE=1 SV=1,cellular homeostasis,cytosol,signal transducer activity;structural molecule activity,2585,GALK2,NA,NA,ENSG00000156958
Q96ER3,0,6,3839009.6510416665,1.486059908487688e-5,1.575632608158903,0.655931179352197,0.019699709848868468,0.6429522395902524,raw,3579762.28125,2827350.78125,2609433.96875,4660492.625,4111509.25,5245509,Protein SAAL1 OS=Homo sapiens OX=9606 GN=SAAL1 PE=1 SV=2,metabolic process,membrane,NA,113174,SAAL1,NA,NA,ENSG00000166788
O43913,0,6,3257237.3880208335,1.2608590065543392e-5,1.575622904918683,0.6559222947558907,0.10741377861957016,0.6429522395902524,raw,3078185.6875,2471048.109375,2156492.59375,3419416.5,3397819.125,5020462.3125,Origin recognition complex subunit 5 OS=Homo sapiens OX=9606 GN=ORC5 PE=1 SV=1,cell proliferation;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5001,ORC5,Cell cycle; G1 to S cell cycle control; DNA replication,Orc1 removal from chromatin; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; E2F-enabled inhibition of pre-replication complex formation; Assembly of the ORC complex at the origin of replication; CDC6 association with the ORC:origin complex,ENSG00000164815
Q96GX9,0,6,3582170.34375,1.386638799351812e-5,1.575546005984725,0.6558518817035729,0.06613026159294552,0.6429522395902524,raw,3599606.5625,2211588.625,2329153.75,4588091,3484459.625,5280122.5,Methylthioribulose-1-phosphate dehydratase OS=Homo sapiens OX=9606 GN=APIP PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,51074,APIP,Methionine de novo and salvage pathway,Regulation of the apoptosome activity; Methionine salvage pathway,ENSG00000149089
P84085,0,6,160687212.6158855,6.220115242750474e-4,1.575348315063518,0.6556708488392694,0.03801679580092461,0.6429522395902524,raw,145038948.015625,107292686.125,120400702.554688,198567824.625,164336252,228486862.375,ADP-ribosylation factor 5 OS=Homo sapiens OX=9606 GN=ARF5 PE=1 SV=2,conjugation,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,381,ARF5,2q37 copy number variation syndrome,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000004059
K7EMM8,0,6,2792191.0989583335,1.0808420989179544e-5,1.5744726485260345,0.6548686954354734,0.15990765762104625,0.6638855679885327,raw,988380.8125,3238149.75,2092699.71875,3294898.46875,3898007.78125,3241010.0625,Glyoxylate reductase 1 homolog (Fragment) OS=Homo sapiens OX=9606 GN=GLYR1 PE=1 SV=2,NA,cytosol;membrane,structural molecule activity,NA,GLYR1,NA,NA,ENSG00000140632
Q6IN85,0,6,20618732.638020832,7.981400080324203e-5,1.574462244894534,0.6548591625184198,0.0912274453155835,0.6429522395902524,raw,16515176.1875,18223009.3125,14671233.921875,29080694.21875,19219760.8125,26002521.375,Serine/threonine-protein phosphatase 4 regulatory subunit 3A OS=Homo sapiens OX=9606 GN=PPP4R3A PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation,cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding,55671,PPP4R3A,16p11.2 proximal deletion syndrome,NA,ENSG00000100796
P28070,0,6,58209041.278645836,2.2532405598988073e-4,1.5740170638070907,0.6544511810845529,0.1065717179602466,0.6429522395902524,raw,51159152.328125,47710956.84375,41129865.59375,80525378.734375,52434930.90625,76293963.265625,Proteasome subunit beta type-4 OS=Homo sapiens OX=9606 GN=PSMB4 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;endosome;membrane;nucleus,structural molecule activity,5692,PSMB4,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,Regulation of PTEN stability and activity; KEAP1-NFE2L2 pathway; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000159377
Q9BYM8,0,6,1440734.0234375,5.577003617179478e-6,1.5736371096153716,0.654102884861004,0.0894292995110556,0.6429522395902524,raw,1451865.1875,1027525.828125,915152.640625,1644054.578125,1440118.15625,2165687.75,RanBP-type and C3HC4-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=RBCK1 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytosol;nucleus,structural molecule activity,10616,RBCK1,NA,Antigen processing: Ubiquitination & Proteasome degradation; Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway,ENSG00000125826
Q96I59,0,6,4002182.9166666665,1.549223398612421e-5,1.5722840049082212,0.6528618381213533,0.018740503220896577,0.6429522395902524,raw,3366280.375,2697515,3389111.375,4901681.75,4241259.6875,5417249.3125,"Probable asparagine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=NARS2 PE=1 SV=3",cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;endosome;membrane,RNA binding;structural molecule activity,79731,NARS2,Ectoderm differentiation,Mitochondrial tRNA aminoacylation,ENSG00000137513
Q96L92,0,6,6153880.135416667,2.382133774631201e-5,1.5722329492280662,0.6528149897324595,0.0493327501030458,0.6429522395902524,raw,5786684.703125,4696757.5625,3813753.515625,8361074.25,5996108.9375,8268901.84375,Sorting nexin-27 OS=Homo sapiens OX=9606 GN=SNX27 PE=1 SV=2,conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion,structural molecule activity,81609,SNX27,NA,NA,ENSG00000143376
O75150,0,6,67912726.51171875,2.6288649760953365e-4,1.5720739625667606,0.6526690947708906,0.04344272042821485,0.6429522395902524,raw,44073695.21875,66562199.09375,51268648.4765625,83264172.25,69287108.6875,93020535.34375,E3 ubiquitin-protein ligase BRE1B OS=Homo sapiens OX=9606 GN=RNF40 PE=1 SV=5,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,9810,RNF40,ATM signaling in development and disease,E3 ubiquitin ligases ubiquitinate target proteins,ENSG00000103549
Q01628,0,6,67136425.15104167,2.5988147695611165e-4,1.5715818665738526,0.6522174267175195,0.1699619612309946,0.668039680404208,raw,58933969.3125,40958823,51428918.75,113599132.875,57072950.84375,80824756.125,Interferon-induced transmembrane protein 3 OS=Homo sapiens OX=9606 GN=IFITM3 PE=1 SV=2,coagulation;development;metabolic process,cytoplasm;cytoskeleton;mitochondrion;nucleus,NA,10410,IFITM3,Host-pathogen interaction of human coronaviruses - MAPK signaling; Network map of SARS-CoV-2 signaling pathway,Interferon alpha/beta signaling,ENSG00000142089
P46109,0,6,14180259.979166666,5.4891020764311515e-5,1.5712751569028354,0.651935843101422,0.08872616350819286,0.6429522395902524,raw,12948454.21875,10554417.09375,10021898.25,16583893.375,13854852.9375,21118044,Crk-like protein OS=Homo sapiens OX=9606 GN=CRKL PE=1 SV=1,cell death;cell growth;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,1399,CRKL,B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; MAPK signaling pathway; Chemokine signaling pathway; EGF/EGFR signaling pathway; 22q11.2 copy number variation syndrome; IL-2 signaling pathway; Interferon type I signaling pathways; ErbB signaling pathway; T-cell receptor signaling pathway,Regulation of signaling by CBL; Downstream signal transduction; Erythropoietin activates RAS; Frs2-mediated activation; MET activates RAP1 and RAC1; MET receptor recycling,ENSG00000099942
Q70Z53,0,6,552402.41875,2.1383199378862223e-6,1.5711603249050623,0.6518304041482563,0.36676349785755863,0.8508768422838132,raw,387819.25,515196.40625,415297.875,NA,533465.0625,910233.5,Protein FRA10AC1 OS=Homo sapiens OX=9606 GN=FRA10AC1 PE=1 SV=3,cellular homeostasis,membrane,structural molecule activity,118924,FRA10AC1,NA,NA,ENSG00000148690
O00178,0,6,5346068.127604167,2.069434107913934e-5,1.570541743042483,0.6512622885359174,0.15112520348593733,0.6638855679885327,raw,4264258.15625,4624125.28125,3925980.234375,6697195.4375,4625991.34375,7938858.3125,GTP-binding protein 1 OS=Homo sapiens OX=9606 GN=GTPBP1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;mitochondrion,RNA binding;structural molecule activity,9567,GTPBP1,NA,NA,ENSG00000100226
P00846,0,6,7827458.583333333,3.0299669559005373e-5,1.570365878369981,0.6511007307177747,0.22352376411792518,0.7125799511687476,raw,6311683,6074997,5830942.5,9539968,6110187,13096974,ATP synthase subunit a OS=Homo sapiens OX=9606 GN=MT-ATP6 PE=1 SV=1,cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity,4508,MT-ATP6,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000198899
Q9BYG3,0,6,30850352.0859375,1.1942004726453775e-4,1.5698698917772003,0.6506449958901513,0.06659508003021627,0.6429522395902524,raw,22329448.625,26922949.953125,24688807.5625,38758215.65625,29900900.34375,42501790.375,MKI67 FHA domain-interacting nucleolar phosphoprotein OS=Homo sapiens OX=9606 GN=NIFK PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,84365,NIFK,NA,NA,ENSG00000155438
Q92973,0,6,63363388.98828125,2.4527625768235674e-4,1.5694281875626748,0.6502390169305651,0.016071021506417232,0.6429522395902524,raw,53707837.34375,49268745.625,44830419.046875,80495919.375,67586818.71875,84290593.8203125,Transportin-1 OS=Homo sapiens OX=9606 GN=TNPO1 PE=1 SV=2,conjugation,cytosol;membrane;nucleus,structural molecule activity,3842,TNPO1,22q11.2 copy number variation syndrome,"Postmitotic nuclear pore complex (NPC) reformation; Intraflagellar transport; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",ENSG00000083312
P42785,0,6,7995576.380208333,3.0950444473758255e-5,1.5691793913590673,0.6500102931791162,0.06460702232111168,0.6429522395902524,raw,7623334.0625,4780109,5462268.53125,11138015.71875,7500848.53125,11468882.4375,Lysosomal Pro-X carboxypeptidase OS=Homo sapiens OX=9606 GN=PRCP PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;mitochondrion;nucleus,structural molecule activity,5547,PRCP,NA,Neutrophil degranulation; Intrinsic Pathway of Fibrin Clot Formation,ENSG00000137509
Q9Y2L1,0,6,34304000.819010414,1.3278893504221334e-4,1.5681285437124046,0.6490438258914655,0.05431950064683402,0.6429522395902524,raw,29377564.25,27045840.5546875,26029093.59375,42411354.5625,34347410.734375,46612741.21875,Exosome complex exonuclease RRP44 OS=Homo sapiens OX=9606 GN=DIS3 PE=1 SV=2,cellular component movement;cellular homeostasis,cytosol;membrane;mitochondrion;nucleus,DNA binding;RNA binding;structural molecule activity,22894,DIS3,NA,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000083520
Q8WUY1,0,6,601618.1822916666,2.328831501317786e-6,1.568118616890711,0.6490346930803726,0.8132681043886685,1,raw,1125434.34375,159460.625,383840.78125,601907.875,315322.9375,1023742.53125,Protein THEM6 OS=Homo sapiens OX=9606 GN=THEM6 PE=1 SV=2,NA,cell surface,NA,51337,THEM6,NA,NA,ENSG00000130193
P53365,0,6,2639565.9791666665,1.0217617390941689e-5,1.5679279475438608,0.6488592634648759,0.2466093945581283,0.7316541032247736,raw,2623005.65625,1584218.8125,1928931.21875,3831257.9375,1757298.375,4112683.875,Arfaptin-2 OS=Homo sapiens OX=9606 GN=ARFIP2 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,23647,ARFIP2,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000132254
Q9NRG9,0,6,6650564.518229167,2.574397617539054e-5,1.5678770593305473,0.6488124390144827,0.06347250777919997,0.6429522395902524,raw,5322681.28125,5656209.59375,4908330.296875,9142529.84375,6528326.21875,8345309.875,Aladin OS=Homo sapiens OX=9606 GN=AAAS PE=1 SV=1,cell differentiation;cell growth;conjugation;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane,NA,8086,AAAS,NA,RHOA GTPase cycle; tRNA processing in the nucleus; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); SARS-CoV-2 activates/modulates innate and adaptive immune responses,ENSG00000094914
O75044,0,6,2082083.2135416667,8.05963170459844e-6,1.5675529877578362,0.6485142110550088,0.013177987214784723,0.6429522395902524,raw,1719539.75,1789949.859375,1439357.78125,2458873.84375,2278936.796875,2805841.25,SLIT-ROBO Rho GTPase-activating protein 2 OS=Homo sapiens OX=9606 GN=SRGAP2 PE=1 SV=3,cell communication;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,DNA binding;structural molecule activity,23380,SRGAP2,NA,CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHO GTPases Activate Formins; RAC3 GTPase cycle; RHOF GTPase cycle; RHOU GTPase cycle; Inactivation of CDC42 and RAC1,ENSG00000266028
Q9NW13,0,6,18769854.143229168,7.265709197382701e-5,1.5673972777736624,0.6483708964865839,0.16965069082847037,0.668039680404208,raw,14097545,15500519.296875,15990167.75,27067545.6875,15667875.375,24295471.75,RNA-binding protein 28 OS=Homo sapiens OX=9606 GN=RBM28 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane,NA,55131,RBM28,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000106344
P55209,0,6,85755654.15625,3.3195550715315345e-4,1.5659250929035886,0.6470152019768243,0.09834449040573572,0.6429522395902524,raw,77596958.8125,68199781.25,56688269.5625,113248509.3125,77289381.0625,121511024.9375,Nucleosome assembly protein 1-like 1 OS=Homo sapiens OX=9606 GN=NAP1L1 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;defense response;metabolic process,membrane;nucleus,structural molecule activity,4673,NAP1L1,VEGFA-VEGFR2 signaling pathway; Overlap between signal transduction pathways contributing to LMNA laminopathies,NA,ENSG00000187109
Q9NXA8,0,6,1614100.4921875,6.248095857376252e-6,1.5657630497298338,0.6468659030219175,0.548268874737738,1,raw,359938,2012384.8125,1648021.390625,3150917.78125,906080.1875,1607260.78125,"NAD-dependent protein deacylase sirtuin-5, mitochondrial OS=Homo sapiens OX=9606 GN=SIRT5 PE=1 SV=2",cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endosome;membrane,structural molecule activity,23408,SIRT5,NAD+ metabolism; NAD+ biosynthetic pathways; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence,Transcriptional activation of mitochondrial biogenesis,ENSG00000124523
Q9UNM6,0,6,111919992.16666667,4.332362469367866e-4,1.5657146291419797,0.6468212875725078,0.06221711442391901,0.6429522395902524,raw,93288628.5,92751329,68966482.375,144794194.75,107981830.375,163737488,26S proteasome non-ATPase regulatory subunit 13 OS=Homo sapiens OX=9606 GN=PSMD13 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis,cell surface;cytosol;membrane;nucleus,structural molecule activity,5719,PSMD13,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,Downstream TCR signaling; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Neddylation; Neutrophil degranulation; FCERI mediated NF-kB activation; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000185627
Q96CW5,0,6,698086.5052083334,2.702255170848297e-6,1.5656270504920906,0.6467405877978794,0.4512491570664239,0.9333224283505189,raw,568077.8125,825650,341429.09375,1299594.9375,534550.625,619216.5625,Gamma-tubulin complex component 3 OS=Homo sapiens OX=9606 GN=TUBGCP3 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,10426,TUBGCP3,15q11.2 copy number variation syndrome,Recruitment of NuMA to mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes,ENSG00000126216
Q9NPJ3,0,6,16005861.486979166,6.195782563389215e-5,1.5645776560189735,0.6457732668709945,0.1881129998188179,0.6796724904026823,raw,11460909.75,11977178,11280549.90625,29199963.25,14185084.703125,17931483.3125,Acyl-coenzyme A thioesterase 13 OS=Homo sapiens OX=9606 GN=ACOT13 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;endosome,structural molecule activity,55856,ACOT13,NA,Mitochondrial Fatty Acid Beta-Oxidation,ENSG00000112304
Q8TF01,0,6,1612567.9427083333,6.242163441087209e-6,1.5645265448359558,0.6457261365451586,0.03294884439689959,0.6429522395902524,raw,1118729.875,1415536.625,1080444.59375,2214644.625,1631564.28125,2214487.65625,Arginine/serine-rich protein PNISR OS=Homo sapiens OX=9606 GN=PNISR PE=1 SV=2,NA,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,NA,25957,PNISR,NA,NA,ENSG00000132424
Q7Z7F7,0,6,5580401.395833333,2.160143250842441e-5,1.5645058588746967,0.6457070612976864,0.10697557451582486,0.6429522395902524,raw,5084807.5,4056673.25,4076149.6875,7955211.125,4994060.9375,7315505.875,"39S ribosomal protein L55, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL55 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,128308,MRPL55,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000162910
O60299,0.3333333333333333,6,825766.7875,3.196498649935547e-6,1.5644599186315147,0.645664697292623,0.1393311652860683,0.6572502130392559,raw,540834,NA,555458.6875,1395679.625,857400.375,779461.25,Leucine zipper putative tumor suppressor 3 OS=Homo sapiens OX=9606 GN=LZTS3 PE=2 SV=1,metabolic process,endoplasmic reticulum;nucleus,NA,9762,LZTS3,NA,NA,ENSG00000088899
Q8WYH8,0.16666666666666666,6,1434891.7916666667,5.554388653426072e-6,1.5644349708977892,0.6456416911048163,0.06490306744649571,0.6429522395902524,raw,1017639.25,1421937.5,965906,1595993.375,1511097.125,2096777.5,Inhibitor of growth protein 5 OS=Homo sapiens OX=9606 GN=ING5 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;development;metabolic process,membrane;nucleus,structural molecule activity,84289,ING5,2q37 copy number variation syndrome,HATs acetylate histones; Regulation of TP53 Activity through Acetylation,ENSG00000168395
Q96EL2,0,6,4866326.341796875,1.8837286528309908e-5,1.563335619353126,0.6446275316316536,0.10977662016366595,0.6429522395902524,raw,4461557.15625,3257455.421875,3593576.48828125,5617966.125,4680466.359375,7586936.5,"28S ribosomal protein S24, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS24 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,64951,MRPS24,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000062582
O43159,0,6,330663.6328125,1.2799810695558396e-6,1.5629444083996398,0.6442664647403504,0.24984904173368078,0.7326612824296702,raw,259779.640625,163974.09375,360710.40625,294581.03125,341166.3125,563770.3125,Ribosomal RNA-processing protein 8 OS=Homo sapiens OX=9606 GN=RRP8 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,23378,RRP8,NA,SIRT1 negatively regulates rRNA expression,ENSG00000132275
C9J6U3,0,6,3531731.625,1.3671142436504418e-5,1.5629435160753118,0.6442656410691798,0.04086226227421973,0.6429522395902524,raw,2932060.25,2798704.5,2812503.75,4611000,3640336.75,4395784.5,Protein diaphanous homolog 2 OS=Homo sapiens OX=9606 GN=DIAPH2 PE=1 SV=3,NA,NA,NA,NA,NA,NA,NA,NA
Q9UET6,0,6,523189.5375,2.025238451817915e-6,1.5622852345901113,0.6436578779106906,0.33457257849179683,0.8181662188074962,raw,329414.78125,510346.03125,465219.71875,516421.84375,NA,794545.3125,Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase OS=Homo sapiens OX=9606 GN=FTSJ1 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;nucleus,structural molecule activity,24140,FTSJ1,NA,tRNA modification in the nucleus and cytosol,ENSG00000068438
P01116,0,6,12912996.625,4.998551274191901e-5,1.5615843442837407,0.6430104942983825,0.11777894608654177,0.6429522395902524,raw,11624771.9375,9025115.3125,9785441.78125,19704552.0625,12057305.96875,15280792.6875,GTPase KRas OS=Homo sapiens OX=9606 GN=KRAS PE=1 SV=1,cell death;cell differentiation;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;nucleus,structural molecule activity,3845,KRAS,"IL-5 signaling pathway; Alzheimer's disease and miRNA effects; Glioblastoma signaling pathways; RalA downstream regulated genes; TNF-alpha signaling pathway; Oncostatin M signaling pathway; Aryl hydrocarbon receptor pathway; Bladder cancer; Extracellular vesicle-mediated signaling in recipient cells; RAC1/PAK1/p38/MMP2 pathway; G protein signaling pathways; BDNF-TrkB signaling; MAPK signaling pathway; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Thermogenesis; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Relationship between inflammation, COX-2 and EGFR; Envelope proteins and their potential roles in EDMD physiopathology; Synaptic signaling pathways associated with autism spectrum disorder; Hippo-Merlin signaling dysregulation; Fragile X syndrome; Gastrin signaling pathway; Hepatitis B infection; Head and neck squamous cell carcinoma; Melanoma; EGFR tyrosine kinase inhibitor resistance; Kisspeptin/kisspeptin receptor system in the ovary; MAPK pathway in congenital thyroid cancer; Regulation of actin cytoskeleton; Alzheimer's disease; ErbB signaling pathway; DNA damage response (only ATM dependent); Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Signaling by CSF3 (G-CSF); RAS processing; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAS GAP mutants; Signaling by RAS GTPase mutants; RUNX3 regulates p14-ARF,ENSG00000133703
Q9P1F3,0,6,7719007.854166667,2.98798626418305e-5,1.561534526779357,0.64296446885426906,0.511513325363372,0.9944212432021446,raw,11661557.25,3416297.5,4514991.625,9039795.75,5334666.5,12346738.5,Costars family protein ABRACL OS=Homo sapiens OX=9606 GN=ABRACL PE=1 SV=1,metabolic process,NA,NA,58527,ABRACL,NA,NA,ENSG00000146386
P78318,0,6,7637256.317708333,2.9563406858097222e-5,1.5614026400078036,0.6428426140866383,0.21175322210369824,0.7020295967770634,raw,5497594.84375,7178982.09375,5497619,10774878.5,5665181.875,11209281.59375,Immunoglobulin-binding protein 1 OS=Homo sapiens OX=9606 GN=IGBP1 PE=1 SV=1,development;metabolic process,cytosol;nucleus,DNA binding;structural molecule activity,3476,IGBP1,16p11.2 proximal deletion syndrome,NA,ENSG00000089289
Q9UGI8,0,6,80300022.4296875,0.00031083705129796133,1.5611850305347237,0.6426415346350458,0.0190457082440393,0.6429522395902524,raw,59247489.71875,61460402.59375,62816041.828125,95951060.5,91697678.4375,110627461.5,Testin OS=Homo sapiens OX=9606 GN=TES PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,26136,TES,NA,NA,ENSG00000135269
O60664,0,6,229038512.0625,8.865957140363044e-4,1.5606887414386312,0.6421828397126315,0.10579780389042981,0.6429522395902524,raw,204417374,176687648.96875,164007697.90625,319031894.15625,205454173.625,304632283.71875,Perilipin-3 OS=Homo sapiens OX=9606 GN=PLIN3 PE=1 SV=3,cell growth;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,NA,10226,PLIN3,NA,Late endosomal microautophagy; Triglyceride catabolism; Retrograde transport at the Trans-Golgi-Network; RHOBTB3 ATPase cycle; Lipophagy; Chaperone Mediated Autophagy,ENSG00000105355
Q9UII4,0,6,1592192.0572916667,6.163289488766117e-6,1.5602277018232489,0.6417565933944771,0.09607035499529654,0.6429522395902524,raw,1193874.9375,1293703.03125,1090231.15625,1862716.75,1590048.84375,2522577.625,E3 ISG15--protein ligase HERC5 OS=Homo sapiens OX=9606 GN=HERC5 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;nucleus,structural molecule activity,51191,HERC5,NA,Antigen processing: Ubiquitination & Proteasome degradation; ISG15 antiviral mechanism; Negative regulators of DDX58/IFIH1 signaling,ENSG00000138646
Q9Y5X2,0.16666666666666666,6,424390.6692708333,1.6427933672126065e-6,1.5601780198930135,0.6417106532951627,0.04901433799766341,0.6429522395902524,raw,411040.125,325946.71875,246271.234375,508534.90625,441254.03125,613297,Sorting nexin-8 OS=Homo sapiens OX=9606 GN=SNX8 PE=1 SV=1,conjugation,cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,29886,SNX8,NA,NA,ENSG00000106266
Q8WUA2,0,6,15667745.880208334,6.064899837548766e-5,1.5597087309877256,0.6412766370403623,0.04011455847573401,0.6429522395902524,raw,10515066.34375,13821200.78125,11001129.21875,21557047.53125,15583349.40625,21528682,Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,85313,PPIL4,NA,mRNA Splicing - Major Pathway,ENSG00000131013
Q9H2C0,0,6,1950790.4479166667,7.551404497571641e-6,1.5589799368677801,0.6406023615394759,0.028911739497346624,0.6429522395902524,raw,1550035.5,1803614.09375,1286615.21875,2427099.625,2005807.3125,2631570.9375,Gigaxonin OS=Homo sapiens OX=9606 GN=GAN PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis,cytosol;endoplasmic reticulum;nucleus,NA,8139,GAN,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation,ENSG00000261609
A0A1C7CYX1,0,6,595531.6549479166,2.30527088259153e-6,1.5575563858076222,0.639284391854456,0.46335559424182904,0.945063231389449,raw,583084.8828125,501755.25,373419.75,1080041.453125,253376.5,781512.09375,Mitotic deacetylase-associated SANT domain protein OS=Homo sapiens OX=9606 GN=MIDEAS PE=1 SV=1,NA,membrane,NA,91748,MIDEAS,NA,NA,ENSG00000156030
Q9NXE4,0,6,3828954.9296875,1.482167780138548e-5,1.5572249646008463,0.6389773785013659,0.12876470622103556,0.6498046150645307,raw,2861982.5,2671795.421875,2565047.53125,3949520.90625,4160586.53125,6764796.6875,Sphingomyelin phosphodiesterase 4 OS=Homo sapiens OX=9606 GN=SMPD4 PE=1 SV=3,cell growth;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane,structural molecule activity,55627,SMPD4,NA,Glycosphingolipid metabolism,ENSG00000136699
O75436,0,6,29488540.895833332,1.141485496740209e-4,1.556713581369528,0.6385035283931783,0.03030460794926019,0.6429522395902524,raw,25425518.0625,23150618.25,21982247.34375,36058965.1875,30733647.25,39580249.28125,Vacuolar protein sorting-associated protein 26A OS=Homo sapiens OX=9606 GN=VPS26A PE=1 SV=2,conjugation;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,NA,9559,VPS26A,NA,WNT ligand biogenesis and trafficking,ENSG00000122958
P51636,0,6,5624442.135416667,2.1771911833521133e-5,1.556689143542148,0.6384808802904512,0.07038756029591758,0.6429522395902524,raw,5553720.375,3911860.25,3494239.375,7050980.5,5439444.5,8296407.8125,Caveolin-2 OS=Homo sapiens OX=9606 GN=CAV2 PE=1 SV=2,cell differentiation;cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,858,CAV2,Integrin-mediated cell adhesion; Focal adhesion; Splicing factor NOVA regulated synaptic proteins; Ebola virus infection in host; EGF/EGFR signaling pathway,Extra-nuclear estrogen signaling,ENSG00000105971
Q14728,0,6,2233405.7057291665,8.645392901711524e-6,1.5564582267152847,0.6382668572957372,0.3370278209115473,0.8207563950745482,raw,2390982.375,1227449.125,1681786.6875,3103625.0625,1275126.796875,3721464.1875,Major facilitator superfamily domain-containing protein 10 OS=Homo sapiens OX=9606 GN=MFSD10 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;membrane,catalytic activity,10227,MFSD10,NA,NA,ENSG00000109736
Q96HA7,0.16666666666666666,6,1204441.15625,4.662326686128599e-6,1.5563347357028383,0.6381523878315003,1,1,raw,NA,942318.8125,NA,NA,NA,1466563.5,Tonsoku-like protein OS=Homo sapiens OX=9606 GN=TONSL PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;coagulation,membrane;nucleus,structural molecule activity,4796,TONSL,NA,NA,ENSG00000160949
Q07021,0,6,200737333.375,7.770433793631465e-4,1.5559735689795342,0.637817553752113,0.10554922904521105,0.6429522395902524,raw,183012884.65625,154760596.75,150174376.78125,240803398.0625,187915608.25,287757135.75,"Complement component 1 Q subcomponent-binding protein, mitochondrial OS=Homo sapiens OX=9606 GN=C1QBP PE=1 SV=1",cell growth;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endosome;membrane;nucleus,antioxidant activity;protein binding;RNA binding;structural molecule activity,708,C1QBP,Complement system; Mesodermal commitment pathway; Ebola virus infection in host,RHOC GTPase cycle; RHOA GTPase cycle; Intrinsic Pathway of Fibrin Clot Formation; Apoptotic factor-mediated response; Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,ENSG00000108561
A2RRP1,0,6,401254.70625,1.5532353035068142e-6,1.555895217137723,0.6377449042791314,0.06925285468706492,0.6429522395902524,raw,334776.65625,NA,264689.4375,478761.875,429431.125,498614.4375,Neuroblastoma-amplified sequence OS=Homo sapiens OX=9606 GN=NBAS PE=1 SV=2,cellular component movement;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;extracellular,structural molecule activity,51594,NBAS,NA,COPI-dependent Golgi-to-ER retrograde traffic,ENSG00000151779
O14640,0,6,456051.90625,1.765352306117855e-6,1.5558048323382767,0.6376610930506094,1,1,raw,NA,332754.28125,NA,344228.4375,NA,691173,Segment polarity protein dishevelled homolog DVL-1 OS=Homo sapiens OX=9606 GN=DVL1 PE=1 SV=2,cell death;cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,antioxidant activity;structural molecule activity,1855,DVL1,MicroRNAs in cardiomyocyte hypertrophy; Microtubule cytoskeleton regulation; Alzheimer's disease and miRNA effects; Neural crest differentiation; Adipogenesis; Notch signaling; Wnt signaling pathway; Physico-chemical features and toxicity-associated pathways; Embryonic stem cell pluripotency pathways; Wnt signaling pathway and pluripotency; Wnt signaling in kidney disease; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Joubert syndrome; Malignant pleural mesothelioma; Alzheimer's disease; DNA damage response (only ATM dependent),Degradation of DVL; RHO GTPases Activate Formins; WNT mediated activation of DVL; PCP/CE pathway; Disassembly of the destruction complex and recruitment of AXIN to the membrane; Negative regulation of TCF-dependent signaling by DVL-interacting proteins; WNT5:FZD7-mediated leishmania damping,ENSG00000107404
Q8IWB7,0,6,2037562.2864583333,7.887293599615314e-6,1.5554488627261898,0.6373309652972085,0.13416798610405725,0.6527000726250668,raw,1626371.71875,1927001.3125,1135726.375,2997352,1691631.1875,2847291.125,WD repeat and FYVE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=WDFY1 PE=1 SV=1,metabolic process,cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,57590,WDFY1,NA,NA,ENSG00000085449
Q16539,0,6,7649848.794270833,2.96121516549826e-5,1.555168453260023,0.6370708591470408,0.08989461350770085,0.6429522395902524,raw,6410611.6875,6549626.765625,4917943.84375,9969581.0625,7017634.15625,11033695.25,Mitogen-activated protein kinase 14 OS=Homo sapiens OX=9606 GN=MAPK14 PE=1 SV=3,cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cell surface;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,signal transducer activity;structural molecule activity,1432,MAPK14,"Physiological and pathological hypertrophy of the heart; Angiogenesis; Energy metabolism; MicroRNAs in cardiomyocyte hypertrophy; IL-1 signaling pathway; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; B cell receptor signaling pathway; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Parkinson's disease pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Cardiac progenitor differentiation; Alpha 6 beta 4 signaling pathway; Amyotrophic lateral sclerosis (ALS); Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Kit receptor signaling pathway; RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; MAPK signaling pathway; Novel intracellular components of RIG-I-like receptor pathway; Canonical and non-canonical TGF-B signaling; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; IL-4 signaling pathway; p38 MAPK signaling pathway; Oxidative stress response; MAPK cascade; Epithelial to mesenchymal transition in colorectal cancer; Thermogenesis; miRNAs involvement in the immune response in sepsis; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Resistin as a regulator of inflammation; Vitamin D in inflammatory diseases; Signal transduction through IL1R; Regulatory circuits of the STAT3 signaling pathway; Leukocyte-intrinsic Hippo pathway functions; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; Insulin signaling; Host-pathogen interaction of human coronaviruses - apoptosis; Host-pathogen interaction of human coronaviruses - MAPK signaling; Host-pathogen interaction of human coronaviruses - interferon induction; Neuroinflammation; Malignant pleural mesothelioma; Th17 cell differentiation pathway; GDNF signaling; Hippocampal synaptogenesis and neurogenesis; Interferon type I signaling pathways; T-cell receptor signaling pathway; Estrogen signaling pathway; Serotonin HTR1 group and FOS pathway; Monoamine transport; Toll-like receptor signaling pathway",Neutrophil degranulation; Oxidative Stress Induced Senescence; Regulation of TP53 Activity through Phosphorylation; VEGFA-VEGFR2 Pathway; Myogenesis; ADP signalling through P2Y purinoceptor 1; NOD1/2 Signaling Pathway; p38MAPK events; DSCAM interactions; activated TAK1 mediates p38 MAPK activation; Activation of PPARGC1A (PGC-1alpha) by phosphorylation; ERK/MAPK targets; KSRP (KHSRP) binds and destabilizes mRNA; Activation of the AP-1 family of transcription factors; Platelet sensitization by LDL; RHO GTPases Activate NADPH Oxidases; CD163 mediating an anti-inflammatory response,ENSG00000112062
Q12802,0,6,2740016.1458333335,1.0606454562642303e-5,1.5549343473099322,0.6368536679379178,0.08933134234981584,0.6429522395902524,raw,2261321.09375,2725473.8125,834161.375,3457520.8125,2923686.9375,4237932.84375,A-kinase anchor protein 13 OS=Homo sapiens OX=9606 GN=AKAP13 PE=1 SV=2,conjugation;defense response;development;metabolic process,cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,11214,AKAP13,Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; G protein signaling pathways,RHOC GTPase cycle; RHOA GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle,ENSG00000170776
P56545,0,6,21043699.40625,8.145902421841783e-5,1.5548577819449534,0.6367826275160567,0.11082200652229128,0.6429522395902524,raw,20083479.8125,14515977.40625,14144059.9375,31226954.875,18505782.65625,27785941.75,C-terminal-binding protein 2 OS=Homo sapiens OX=9606 GN=CTBP2 PE=1 SV=1,cell death;cell growth;cellular component movement;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,1488,CTBP2,Neural crest differentiation; Notch signaling; Mesodermal commitment pathway; Wnt signaling pathway and pluripotency; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Ciliary landscape; Malignant pleural mesothelioma,Repression of WNT target genes; Signaling by TCF7L2 mutants,ENSG00000175029
P62256,0,6,7584981.729166667,2.9361054748241543e-5,1.554834292802876,0.636760832645069,0.1286714994701748,0.6498046150645307,raw,4958275.75,7760559.875,4581074.75,12066384.625,6771839.25,9371756.125,Ubiquitin-conjugating enzyme E2 H OS=Homo sapiens OX=9606 GN=UBE2H PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,7328,UBE2H,Ciliary landscape,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000186591
O43464,0,6,2846453.6302083335,1.101846831792696e-5,1.554492249380926,0.6364434234930151,0.2479810509027019,0.7316541032247736,raw,3343232.875,1301878.8125,2158982.78125,3356122,2390055.75,4528449.5625,"Serine protease HTRA2, mitochondrial OS=Homo sapiens OX=9606 GN=HTRA2 PE=1 SV=2",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;nucleus,structural molecule activity,27429,HTRA2,Apoptosis modulation and signaling; Parkinson's disease pathway; Nanomaterial induced apoptosis; Ciliary landscape; Complement system in neuronal development and plasticity,NA,ENSG00000115317
Q9BYX4,0.16666666666666666,6,246286.5989583333,9.533621271581233e-7,1.5538410193239522,0.635838902480497,0.24878539715909823,0.7316541032247736,raw,202435.296875,160313.984375,131790.78125,204781.921875,248222.46875,530175.140625,Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IFIH1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,64135,IFIH1,Novel intracellular components of RIG-I-like receptor pathway; Measles virus infection; Hepatitis B infection; Pathways of nucleic acid metabolism and innate immune sensing; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity,Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses; Ovarian tumor domain proteases; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation,ENSG00000115267
P61009,0,6,16649517.708333334,6.444938411471954e-5,1.5538192695022381,0.6358187082784212,0.02638851623615496,0.6429522395902524,raw,15079726,11553925.125,12460712.375,19361695,18021741.25,23419306.5,Signal peptidase complex subunit 3 OS=Homo sapiens OX=9606 GN=SPCS3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;extracellular,NA,60559,SPCS3,NA,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP); Synthesis, secretion, and deacylation of Ghrelin; SRP-dependent cotranslational protein targeting to membrane",ENSG00000129128
Q6P1Q9,0.16666666666666666,6,414855.5572916667,1.6058834635572837e-6,1.5532479017308545,0.6352881053566546,0.20517836697276076,0.697389706288305,raw,251248.75,405693.96875,377910.96875,430010.5625,390251.59375,634017.5,tRNA N(3)-methylcytidine methyltransferase METTL2B OS=Homo sapiens OX=9606 GN=METTL2B PE=1 SV=3,cellular component movement;cellular homeostasis,nucleus,structural molecule activity,55798,METTL2B,NA,NA,ENSG00000165055
Q9H0U9,0,6,2750752.3125,1.0648013684146063e-5,1.553197951217334,0.635241709339107,0.2747481849006309,0.7551026273759062,raw,2290456.34375,2744059.359375,1528060.953125,3859533.8125,1820336.03125,4262067.375,Testis-specific Y-encoded-like protein 1 OS=Homo sapiens OX=9606 GN=TSPYL1 PE=1 SV=3,cell growth,membrane;nucleus,structural molecule activity,7259,TSPYL1,Sudden infant death syndrome (SIDS) susceptibility pathways,NA,ENSG00000189241
Q96L91,0.16666666666666666,6,120048.2125,4.6470014899143135e-7,1.5530345137090957,0.6350898916721999,0.5533789494830033,1,raw,133836.53125,96837.640625,59690.625,NA,85197.0625,224679.203125,E1A-binding protein p400 OS=Homo sapiens OX=9606 GN=EP400 PE=1 SV=4,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,57634,EP400,NA,HATs acetylate histones; Formation of Senescence-Associated Heterochromatin Foci (SAHF),ENSG00000183495
Q5T5C7,0,6,93155398.66145833,3.605995186087079e-4,1.5529661704326116,0.6350264026288258,0.019806959145724525,0.6429522395902524,raw,84295356.625,63183495.3125,68330523.46875,117337486.875,98121830.75,127663698.9375,Seryl-tRNA synthetase OS=Homo sapiens OX=9606 GN=SARS1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol,structural molecule activity,6301,SARS1,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000031698
P41240,0,6,9895371.8359375,3.830445010987373e-5,1.5529403294858892,0.6350023963648316,0.008617274706685928,0.6429522395902524,raw,8333194.5,7363122.71875,7750116.359375,12060193.0625,10924650.5625,12940953.8125,Tyrosine-protein kinase CSK OS=Homo sapiens OX=9606 GN=CSK PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,signal transducer activity;structural molecule activity,1445,CSK,Integrin-mediated cell adhesion; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; EGF/EGFR signaling pathway; Regulation of actin cytoskeleton,Phosphorylation of CD3 and TCR zeta chains; PD-1 signaling; Signaling by BRAF and RAF1 fusions; Negative regulation of FLT3; GAB1 signalosome; Integrin signaling; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; RHOH GTPase cycle; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants,ENSG00000103653
Q9H3P7,0,6,9886234.731770834,3.8269080872971516e-5,1.5524059263271173,0.634505845751087,0.032283136874747057,0.6429522395902524,raw,7457349.671875,8804468.71875,6448386.875,12978674,10010514,13618015.125,Golgi resident protein GCP60 OS=Homo sapiens OX=9606 GN=ACBD3 PE=1 SV=4,cellular homeostasis,cytoskeleton;endosome;extracellular,structural molecule activity,64746,ACBD3,NA,Golgi Associated Vesicle Biogenesis,ENSG00000182827
Q9UMX0,0,6,49537106.96875,1.9175546648795457e-4,1.551188481245698,0.6333739954891318,0.06557988833777903,0.6429522395902524,raw,40701086.375,40192648.9375,31467148.3125,61753894.0625,48811478,74296386.125,Ubiquilin-1 OS=Homo sapiens OX=9606 GN=UBQLN1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,29979,UBQLN1,NA,Cargo recognition for clathrin-mediated endocytosis,ENSG00000135018
O43707,0,6,1038126496.2942709,0.00401853161703595,1.5509690436559354,0.6331698913967239,0.10767524014075322,0.6429522395902524,raw,898987724.296875,866817658.8125,743195479.8125,1344407355.3125,939046223.71875,1436304535.8125,Alpha-actinin-4 OS=Homo sapiens OX=9606 GN=ACTN4 PE=1 SV=2,cell growth;cellular component movement;coagulation;conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;motor activity;RNA binding;structural molecule activity,81,ACTN4,Arrhythmogenic right ventricular cardiomyopathy; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; Striated muscle contraction pathway; Ebola virus infection in host; Nephrotic syndrome; Alstrom syndrome,Platelet degranulation ; Nephrin family interactions,ENSG00000130402; ENSG00000282844
Q96IF1,0,6,907686.0286458334,3.513603609459486e-6,1.5503287254148321,0.6325741511402609,0.19387240709403497,0.6848190557739395,raw,778141.4375,691679.578125,687521.8125,1449423.375,767019.25,1072330.71875,LIM domain-containing protein ajuba OS=Homo sapiens OX=9606 GN=AJUBA PE=1 SV=1,cell communication;cell differentiation;cell growth;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity;structural molecule activity,84962,AJUBA,Interleukin-1 induced activation of NF-kB; Hippo-Merlin signaling dysregulation; Head and neck squamous cell carcinoma; Malignant pleural mesothelioma,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Regulation of PLK1 Activity at G2/M Transition; Activation of anterior HOX genes in hindbrain development during early embryogenesis,ENSG00000129474
F5GWE5,0,6,6611131.369791667,2.5591332586848083e-5,1.5499592532585973,0.6322302891159994,0.03241597793995455,0.6429522395902524,raw,5004353.375,4391992.3125,6133081.09375,8141916.5625,6807409.125,9188035.75,Phosphatidylinositol transfer protein alpha isoform OS=Homo sapiens OX=9606 GN=PITPNA PE=1 SV=1,cell growth;conjugation,NA,catalytic activity,NA,NA,NA,NA,NA
Q9H267,0,6,4981247.9375,1.9282141820474922e-5,1.5499322846595307,0.6322051866479562,0.103600768749882,0.6429522395902524,raw,3552763.09375,5353460.09375,2791757.8125,7439416.375,5243548.03125,5506542.21875,Vacuolar protein sorting-associated protein 33B OS=Homo sapiens OX=9606 GN=VPS33B PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,26276,VPS33B,NA,Prevention of phagosomal-lysosomal fusion; SARS-CoV-2 modulates autophagy,ENSG00000184056
P49916,0,6,5756033.083333333,2.228129328809963e-5,1.548571412414344,0.6309379144691237,0.12894841910329205,0.6498046150645307,raw,5169095.5625,5680833.875,2504602.78125,6849101.625,5535387.71875,8797176.9375,DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,endosome;membrane;nucleus,RNA binding;structural molecule activity,3980,LIG3,"Base excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Gap-filling DNA repair synthesis and ligation in TC-NER; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway; HDR through MMEJ (alt-NHEJ); Resolution of AP sites via the single-nucleotide replacement pathway; Gap-filling DNA repair synthesis and ligation in GG-NER,ENSG00000005156
P12532,0,6,15137025.856770834,5.859460981918873e-5,1.548460575799119,0.6308346520967552,0.0411578628539801,0.6429522395902524,raw,14104072.625,9739777.515625,12189197.875,19340146.25,15081661.5,20367299.375,"Creatine kinase U-type, mitochondrial OS=Homo sapiens OX=9606 GN=CKMT1A PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome,signal transducer activity;structural molecule activity,1159; 548596,CKMT1A; CKMT1B,NA,Creatine metabolism,ENSG00000223572; ENSG00000237289
Q16595,0,6,2081224.5208333333,8.05630775148668e-6,1.5481649067471202,0.6305591520217454,0.16942883593548963,0.668039680404208,raw,754520.9375,1823000,2191408,3102444.4375,1793669.125,2822304.625,"Frataxin, mitochondrial OS=Homo sapiens OX=9606 GN=FXN PE=1 SV=2",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytosol;endosome,structural molecule activity,2395,FXN,NA,Mitochondrial protein import; Mitochondrial iron-sulfur cluster biogenesis,ENSG00000165060
P62070,0,6,8808173.270833334,3.4095963163954596e-5,1.5479663366666125,0.6303740978051843,0.1609821527369799,0.6638855679885327,raw,7685112.375,6838195,7404228.71875,11498826.8125,7526381.46875,11896295.25,Ras-related protein R-Ras2 OS=Homo sapiens OX=9606 GN=RRAS2 PE=1 SV=1,defense response;development;metabolic process,cytoplasm;cytoskeleton;extracellular,structural molecule activity,22800,RRAS2,MAPK signaling pathway; Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; EGFR tyrosine kinase inhibitor resistance; Regulation of actin cytoskeleton,RND1 GTPase cycle,ENSG00000133818
Q6NTF9,0,6,816352.828125,3.160057721469729e-6,1.5473190475715946,0.6297707022115037,0.3940965415147628,0.877277789871942,raw,723799.8125,543220.625,NA,NA,726506.25,1271884.625,Rhomboid domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RHBDD2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;development,cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,57414,RHBDD2,Ciliary landscape,NA,ENSG00000005486
H8Y6P7,0.6666666666666666,6,388850.9479166667,1.5052210246973426e-6,1.547278071421563,0.6297324962117076,0.19660120283972327,0.6869174258949993,raw,286702.6875,395568.5625,251210.96875,464304.6875,323264.21875,612054.5625,GRINL1A combined protein 15 OS=Homo sapiens OX=9606 GN=GCOM1 PE=2 SV=1,development,membrane,NA,145781,GCOM1,NA,NA,ENSG00000137878
Q8TCA0,0,6,705043.3177083334,2.7291846164263013e-6,1.547257419317499,0.6297132398882906,0.33246417222629787,0.8158667519449163,raw,616666.3125,389910.5,757542.09375,685064.625,608963.75,1172112.625,Leucine-rich repeat-containing protein 20 OS=Homo sapiens OX=9606 GN=LRRC20 PE=1 SV=1,NA,NA,NA,55222,LRRC20,NA,NA,ENSG00000172731
Q7L9L4,0,6,15886242.760416666,6.149478800177614e-5,1.5471496131619864,0.6296127156816391,0.06012042720920397,0.6429522395902524,raw,12967490.1875,13688088.25,10039328.125,23107293.75,15532342.625,19982913.625,MOB kinase activator 1B OS=Homo sapiens OX=9606 GN=MOB1B PE=1 SV=3,development;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,92597,MOB1B,Malignant pleural mesothelioma,Signaling by Hippo,ENSG00000173542
Q7KZ85,0,6,19129243.697916668,7.404826953600226e-5,1.546773068640961,0.629261550528719,0.010571032409834615,0.6429522395902524,raw,15191169.40625,17002949.46875,11968864.75,23497291.71875,21765417.8125,25349769.03125,Transcription elongation factor SPT6 OS=Homo sapiens OX=9606 GN=SUPT6H PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,membrane,RNA binding;structural molecule activity,6830,SUPT6H,NA,Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,ENSG00000109111
P20618,0,6,108534658.609375,4.20131803516114e-4,1.545589258817883,0.6281569732097066,0.05993205005514435,0.6429522395902524,raw,74072905.5,99441820.125,80772589.875,153696209.0625,105087500.84375,138136926.25,Proteasome subunit beta type-1 OS=Homo sapiens OX=9606 GN=PSMB1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cell surface;cytosol;membrane;nucleus,NA,5689,PSMB1,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000008018
P68036,0,6,60707622.911458336,2.3499593058805705e-4,1.544639511676942,0.6272701809135776,0.2424964231432645,0.7289874209382666,raw,61747852.1875,43285884.71875,44386349,70605764.5625,48841714.75,95378172.25,Ubiquitin-conjugating enzyme E2 L3 OS=Homo sapiens OX=9606 GN=UBE2L3 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,7332,UBE2L3,Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway,E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; Regulation of TNFR1 signaling,ENSG00000185651
Q96ME1,0,6,425303.7291666667,1.6463277727718052e-6,1.5445843062620976,0.6272186180725997,0.21874486695372614,0.7087130179153194,raw,357362.90625,319488,354278.25,547212.625,330074.46875,643406.125,F-box/LRR-repeat protein 18 OS=Homo sapiens OX=9606 GN=FBXL18 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,NA,NA,FBXL18,NA,Neddylation; Antigen processing: Ubiquitination & Proteasome degradation; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,ENSG00000155034
P82673,0,6,7589229.713541667,2.937749846640166e-5,1.5439607153641497,0.6266360450474772,0.19996434959474316,0.6905278934855178,raw,8805253.625,6141192.21875,3826735.5,9917349.34375,7363088.0625,9481759.53125,"28S ribosomal protein S35, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS35 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,60488,MRPS35,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000061794
Q9BX68,0,6,4879820.625,1.888952217001115e-5,1.543791738546271,0.6264781424817365,0.2046911198112434,0.6969949879362929,raw,3632049.9375,3622180.125,4663087.625,5607128.6875,4148543.375,7605934,"Histidine triad nucleotide-binding protein 2, mitochondrial OS=Homo sapiens OX=9606 GN=HINT2 PE=1 SV=1",cellular homeostasis;metabolic process,cytoskeleton;endosome;nucleus,structural molecule activity,84681,HINT2,NA,RHOD GTPase cycle,ENSG00000137133
O75396,0,6,24743325.916666668,9.578007869145528e-5,1.5427933758181547,0.6255448566958443,0.08867053138067248,0.6429522395902524,raw,22291044.75,16388388,19244716.25,29690620.75,23778956.25,37066229.5,Vesicle-trafficking protein SEC22b OS=Homo sapiens OX=9606 GN=SEC22B PE=1 SV=4,NA,NA,NA,NA,NA,NA,NA,NA
O60763,0,6,76928974.86458333,2.9778790818172285e-4,1.5419312934447937,0.6247384819748472,0.03630796306760444,0.6429522395902524,raw,64622133.28125,59684093.015625,62125460.859375,95793192.21875,79440374.96875,99908594.84375,General vesicular transport factor p115 OS=Homo sapiens OX=9606 GN=USO1 PE=1 SV=2,cell growth;conjugation;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,NA,8615,USO1,NA,COPI-mediated anterograde transport; COPII-mediated vesicle transport; Golgi Cisternae Pericentriolar Stack Reorganization,ENSG00000138768
P47755,0,6,46569920.864583336,1.8026964928187535e-4,1.5417861913252946,0.6246027120092701,0.12504886638637172,0.6449267539975253,raw,41602708.0625,38317965.1875,34255022.8125,59747647.375,41353700.9375,64142480.8125,F-actin-capping protein subunit alpha-2 OS=Homo sapiens OX=9606 GN=CAPZA2 PE=1 SV=3,cell growth,cell surface;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity,830,CAPZA2,NA,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Sensory processing of sound by inner hair cells of the cochlea; Factors involved in megakaryocyte development and platelet production; Advanced glycosylation endproduct receptor signaling,ENSG00000198898
Q96ST2,0,6,7920117.6875,3.065834794842048e-5,1.5415978215674058,0.624426438074683,0.07115338812113407,0.6429522395902524,raw,6248667.0625,6624422.125,6040094.34375,9632931.53125,7857121.375,11117469.6875,Protein IWS1 homolog OS=Homo sapiens OX=9606 GN=IWS1 PE=1 SV=2,cellular component movement;cellular homeostasis;conjugation;metabolic process,membrane,NA,55677,IWS1,NA,Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,ENSG00000163166
O15151,0.3333333333333333,6,1944702.35,7.527837799242423e-6,1.5407935521726017,0.6236735709964529,0.22236022514387035,0.7106930585959085,raw,NA,1567799,1157428.625,3431567,1571866.875,1994850.25,Protein Mdm4 OS=Homo sapiens OX=9606 GN=MDM4 PE=1 SV=2,cell growth;coagulation;defense response;development;metabolic process,membrane;nucleus,structural molecule activity,4194,MDM4,Glioblastoma signaling pathways; Malignant pleural mesothelioma,Ub-specific processing proteases; Regulation of TP53 Degradation; Oxidative Stress Induced Senescence; Regulation of TP53 Activity through Phosphorylation; Oncogene Induced Senescence; Regulation of TP53 Activity through Methylation; Stabilization of p53,ENSG00000198625
Q02218,0,6,61171969.1953125,2.3679338998205382e-4,1.5401985904452884,0.6231163814260481,0.1046617397282299,0.6429522395902524,raw,56812791.1875,44048514.84375,47767443.96875,74101297.40625,56798786.859375,87502980.90625,"2-oxoglutarate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=OGDH PE=1 SV=3",cell organization and biogenesis;cellular homeostasis;defense response,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,4967,OGDH,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Thiamine metabolic pathways; 7q11.23 copy number variation syndrome; TCA cycle (aka Krebs or citric acid cycle),Lysine catabolism; Glyoxylate metabolism and glycine degradation; Citric acid cycle (TCA cycle),ENSG00000105953
H0Y8X4,0,6,9264014.494791666,3.586049993029648e-5,1.5401301770052567,0.6230522975323267,0.3637258099872386,0.8458062414401234,raw,11832008.40625,4984083.96875,7110203.90625,12042206.9375,7676138.125,11939445.625,2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (Fragment) OS=Homo sapiens OX=9606 GN=DNPH1 PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,NA,DNPH1,NA,NA,ENSG00000112667
Q99460,0,6,152007310.86979166,5.884120932577734e-4,1.5400959881721816,0.6230202712736768,0.019800579594647007,0.6429522395902524,raw,127661581.59375,130773450.875,102176556.5,196611089.65625,157854172.03125,196967014.5625,26S proteasome non-ATPase regulatory subunit 1 OS=Homo sapiens OX=9606 GN=PSMD1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytosol;membrane;mitochondrion;nucleus,DNA binding;structural molecule activity,5707,PSMD1,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,Neutrophil degranulation; Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000173692
Q9BUN8,0,6,7297377.276041667,2.8247753438421654e-5,1.5393733409002102,0.6223431678228452,0.005462718265109212,0.6429522395902524,raw,5197542.8125,6347126.96875,5758780.28125,9380143.09375,8000958.84375,9099711.65625,Derlin-1 OS=Homo sapiens OX=9606 GN=DERL1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;extracellular;mitochondrion,antioxidant activity;structural molecule activity,79139,DERL1,Amyotrophic lateral sclerosis (ALS),ABC-family proteins mediated transport; Defective CFTR causes cystic fibrosis; E3 ubiquitin ligases ubiquitinate target proteins; N-glycan trimming in the ER and Calnexin/Calreticulin cycle,ENSG00000136986
Q5H9R7,0,6,20525008.002604168,7.945119779988793e-5,1.5390906016659232,0.6220781613131522,0.027941666142194108,0.6429522395902524,raw,15262868.234375,18200697.375,13629710.75,27891445.84375,20977359.71875,27187966.09375,Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Homo sapiens OX=9606 GN=PPP6R3 PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton;cytosol;membrane,DNA binding;structural molecule activity,55291,PPP6R3,NA,Telomere Extension By Telomerase; COPII-mediated vesicle transport,ENSG00000110075
P19784,0,6,17172268.411458332,6.647292386236519e-5,1.5386182766793701,0.6216353508017799,0.10391836298984737,0.6429522395902524,raw,17217463.90625,9700489.90625,11499067.65625,24624401.75,14925351.0625,25066836.1875,Casein kinase II subunit alpha' OS=Homo sapiens OX=9606 GN=CSNK2A2 PE=1 SV=1,cell death;cell differentiation;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,1459,CSNK2A2,Alzheimer's disease and miRNA effects; Allograft rejection; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Measles virus infection; Malignant pleural mesothelioma; Alzheimer's disease,Regulation of PTEN stability and activity; KEAP1-NFE2L2 pathway; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of TP53 Activity through Phosphorylation; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; WNT mediated activation of DVL; Signal transduction by L1; Receptor Mediated Mitophagy; Condensation of Prometaphase Chromosomes; Synthesis of PC,ENSG00000070770
F5GYQ1,0,6,12394932.658854166,4.798011510007523e-5,1.5381128745590837,0.6211613794969705,0.2076388906886467,0.6988382857167694,raw,10576654.40625,11523798.890625,7628488.90625,17582502.125,9333248.1875,17724903.4375,V-type proton ATPase subunit OS=Homo sapiens OX=9606 GN=ATP6V0D1 PE=1 SV=1,conjugation,cytoskeleton;mitochondrion,catalytic activity,NA,ATP6V0D1,NA,NA,ENSG00000159720
Q9BS26,0,6,38066819.473958336,1.4735460289488575e-4,1.5380411208558948,0.6210940755115854,0.1082815515017325,0.6429522395902524,raw,31465054.875,34230136.25,26895712.25,52647357.125,34376787.25,48785869.09375,Endoplasmic reticulum resident protein 44 OS=Homo sapiens OX=9606 GN=ERP44 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cell surface;cytoskeleton;extracellular;nucleus,structural molecule activity,23071,ERP44,NA,Neutrophil degranulation,ENSG00000023318
Q9Y679,0,6,3000309.9322916665,1.1614037756342343e-5,1.5379218979713396,0.6209822391446709,0.014517950391977587,0.6429522395902524,raw,2123867.6875,2828829.65625,2204217.5625,3652922.6875,3266342.625,3925679.375,Lipid droplet-regulating VLDL assembly factor AUP1 OS=Homo sapiens OX=9606 GN=AUP1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;extracellular;mitochondrion;nucleus,DNA binding;structural molecule activity,550,AUP1,NA,NA,ENSG00000115307
Q9NQ88,0,6,5402321.361979167,2.0912094312202368e-5,1.5372769478215105,0.6203770968803296,0.20509403268402512,0.697389706288305,raw,4266379.25,4983306.203125,3796382.90625,7573682.875,4133455.1875,7660721.75,"Fructose-2,6-bisphosphatase TIGAR OS=Homo sapiens OX=9606 GN=TIGAR PE=1 SV=1",cell growth;cellular homeostasis;coagulation;defense response;metabolic process,cytoskeleton;cytosol;endosome;membrane;nucleus,structural molecule activity,57103,TIGAR,Metabolic reprogramming in colon cancer; p53 transcriptional gene network,TP53 Regulates Metabolic Genes,ENSG00000078237
P78347,0,6,89100191.41536458,3.449020303062403e-4,1.5372051618189828,0.6203097259826126,0.11190681272454239,0.6429522395902524,raw,75751898.46875,73344165.03125,72035402.9921875,116446209.34375,81814029.9375,115209442.71875,General transcription factor II-I OS=Homo sapiens OX=9606 GN=GTF2I PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,2969,GTF2I,B cell receptor signaling pathway; 7q11.23 copy number variation syndrome; Genetic causes of porto-sinusoidal vascular disease,NA,ENSG00000263001
Q96Q15,0,6,247453.73046875,9.578800302196388e-7,1.536665415723876,0.61980307548897,0.37329157029227256,0.8594431551104292,raw,NA,151035.296875,237534.984375,NA,224858.234375,376386.40625,Serine/threonine-protein kinase SMG1 OS=Homo sapiens OX=9606 GN=SMG1 PE=1 SV=3,cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytosol;membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,23049,SMG1,NA,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSG00000157106
Q9NUQ9,0,6,52509343.74772137,2.0326083458350872e-4,1.5365098662078729,0.619657030766522,0.10513486990292474,0.6429522395902524,raw,45604302.375,41973606.5332031,39832773.4375,64492860.5585938,48967552.6445313,74184966.9375,CYFIP-related Rac1 interactor B OS=Homo sapiens OX=9606 GN=CYRIB PE=1 SV=1,cell growth;metabolic process,cell surface;cytoskeleton;endosome;nucleus,antioxidant activity;structural molecule activity,51571,CYRIB,NA,Platelet degranulation,ENSG00000153310
A0A494BZV2,0,6,9010222.447916666,3.487808461948414e-5,1.536227008403219,0.6193914189879312,0.10966673705739526,0.6429522395902524,raw,7935389.0625,4169877.171875,8546949.859375,13128878.9375,12190559,8089680.65625,Myosin phosphatase Rho-interacting protein OS=Homo sapiens OX=9606 GN=MPRIP PE=1 SV=1,NA,cytosol;endoplasmic reticulum,NA,NA,MPRIP,NA,NA,ENSG00000133030
P49257,0,6,50875709.479166664,1.9693712453247505e-4,1.535464962791756,0.6186755923637426,0.0451345761591103,0.6429522395902524,raw,46042102.53125,33183839.71875,39059201.6875,70696035.25,50184124.0625,66088953.625,Protein ERGIC-53 OS=Homo sapiens OX=9606 GN=LMAN1 PE=1 SV=2,cell growth;coagulation;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,3998,LMAN1,VEGFA-VEGFR2 signaling pathway; Complement and coagulation cascades,RHOC GTPase cycle; RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; COPII-mediated vesicle transport; Cargo concentration in the ER; Transport to the Golgi and subsequent modification,ENSG00000074695
O75306,0,6,30209257.4889323,1.16938404693259e-4,1.5350823294016918,0.6183160321650867,0.14388381197659236,0.6572502130392559,raw,28264587.3125,21391516.1328125,23982025.3476563,38063199.25,26165748.359375,43388468.53125,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS2 PE=1 SV=2",cell differentiation;cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;endosome;membrane,catalytic activity;structural molecule activity,4720,NDUFS2,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000158864
Q27J81,0,6,4393227.65625,1.700594705991688e-5,1.5350657029373602,0.6183004062621099,0.09464184612706343,0.6429522395902524,raw,4296249.15625,2945290.21875,3204371.0625,6636103.28125,4521214,4756138.21875,Inverted formin-2 OS=Homo sapiens OX=9606 GN=INF2 PE=1 SV=2,cell growth;metabolic process,nucleus,motor activity;structural molecule activity,64423,INF2,Primary focal segmental glomerulosclerosis (FSGS); Nephrotic syndrome,NA,ENSG00000203485
Q9H9P8,0,6,4486731.950520833,1.7367897134592043e-5,1.5349834762787986,0.6182231254202477,0.27984375305137477,0.761101649104645,raw,5306793,1981067.640625,3118762.15625,7360551.9375,3040906.09375,6112310.875,"L-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=L2HGDH PE=1 SV=3",cellular homeostasis,cytoskeleton;endosome,structural molecule activity,79944,L2HGDH,"Cerebral organic acidurias, including diseases",Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,ENSG00000087299
Q9H0S4,0,6,39263523.891927086,1.519869810848466e-4,1.5340173850760073,0.6173148330499837,0.11062827886787067,0.6429522395902524,raw,33270517.109375,32964077.5078125,31383153.015625,51037551.65625,36108229.25,50817614.8125,Probable ATP-dependent RNA helicase DDX47 OS=Homo sapiens OX=9606 GN=DDX47 PE=1 SV=1,cellular component movement;cellular homeostasis;development,membrane,structural molecule activity,51202,DDX47,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000213782
Q96EU6,0,6,2445764.5286458335,9.467422439627552e-6,1.5339610900817031,0.6172618884092202,0.3501713475486732,0.8340509307751145,raw,1719435.828125,3168533.5625,1437107.875,2903881.65625,2204467.5625,3241160.6875,Ribosomal RNA processing protein 36 homolog OS=Homo sapiens OX=9606 GN=RRP36 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,88745,RRP36,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000124541
P49840,0,6,4885248.3046875,1.891053242503231e-5,1.533521795110251,0.6168486709896914,0.03471819653267136,0.6429522395902524,raw,3204037.1875,4512685.09375,3510015.28125,6738121.15625,4913460.859375,6433170.25,Glycogen synthase kinase-3 alpha OS=Homo sapiens OX=9606 GN=GSK3A PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytosol;endoplasmic reticulum;endosome;membrane;nucleus,antioxidant activity;motor activity;signal transducer activity;structural molecule activity,2931,GSK3A,IL-5 signaling pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Leptin signaling pathway; B cell receptor signaling pathway; T cell receptor and co-stimulatory signaling; Wnt signaling pathway; Regulation of apoptosis by parathyroid hormone-related protein; Angiopoietin-like protein 8 regulatory pathway; Nonalcoholic fatty liver disease; Insulin signaling; Glycogen synthesis and degradation,Constitutive Signaling by AKT1 E17K in Cancer; XBP1(S) activates chaperone genes; AKT phosphorylates targets in the cytosol; Suppression of apoptosis; Maturation of nucleoprotein; Maturation of nucleoprotein,ENSG00000105723
P24666,0,6,28389347.098958332,1.0989362983355872e-4,1.5334139186863809,0.6167471802534426,0.04320864960033783,0.6429522395902524,raw,21965530.125,25159114.65625,21751009.625,33682249.625,29147052.8125,38631125.75,Low molecular weight phosphotyrosine protein phosphatase OS=Homo sapiens OX=9606 GN=ACP1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,52,ACP1,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000143727
Q9Y696,0,6,80312640.22916667,3.108858941184899e-4,1.5332262727176613,0.6165706248755985,0.11642881040941687,0.6429522395902524,raw,71998536.71875,55655165.21875,62888477.9375,120629789.25,74281605.625,96422266.625,Chloride intracellular channel protein 4 OS=Homo sapiens OX=9606 GN=CLIC4 PE=1 SV=4,conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,catalytic activity,25932,CLIC4,NA,NA,ENSG00000169504
Q04912,0,6,925757.828125,3.583558569517821e-6,1.5330573888893322,0.6164117042480559,0.05949628370398208,0.6429522395902524,raw,783143.75,581739.46875,808689.21875,1291084,889286.21875,1200604.3125,Macrophage-stimulating protein receptor OS=Homo sapiens OX=9606 GN=MST1R PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,signal transducer activity;structural molecule activity,4486,MST1R,NA,Signaling by MST1,ENSG00000164078
P62487,0,6,2383272.2552083335,9.225518223209339e-6,1.532717713945034,0.616092015201586,0.0997744360150149,0.6429522395902524,raw,1786418.6875,1854274.09375,1974786.6875,2842078.75,2305099.4375,3536975.875,DNA-directed RNA polymerase II subunit RPB7 OS=Homo sapiens OX=9606 GN=POLR2G PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,5436,POLR2G,Pyrimidine metabolism; Eukaryotic transcription initiation,Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; mRNA Splicing - Major Pathway; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,ENSG00000168002
Q14241,0,6,600953.55,2.326258745601311e-6,1.5325478750008807,0.6159321427235767,0.051333418081967286,0.6429522395902524,raw,NA,440227.59375,463510.71875,598687.8125,692051.46875,810290.15625,Elongin-A OS=Homo sapiens OX=9606 GN=ELOA PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,6924,ELOA,VEGFA-VEGFR2 signaling pathway,Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation,ENSG00000011007
P30533,0,6,34247887.5,1.3257172341397236e-4,1.5323587752490273,0.6157541188515895,0.025651532084713206,0.6429522395902524,raw,25049884.1875,30559241.90625,23242419.875,44518830.0625,35289226.46875,46827722.5,Alpha-2-macroglobulin receptor-associated protein OS=Homo sapiens OX=9606 GN=LRPAP1 PE=1 SV=1,conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,4043,LRPAP1,NA,NA,ENSG00000163956
A0A3B3IRT8,0,6,27282662.778645832,1.0560971458129539e-4,1.53144420691593,0.6148928080913448,0.039360581723686526,0.6429522395902524,raw,21899157.046875,20622158.59375,20467100.3125,31581685.3125,30246154.90625,38879720.5,Signal sequence receptor subunit alpha OS=Homo sapiens OX=9606 GN=SSR1 PE=1 SV=1,NA,cytoskeleton;extracellular,NA,NA,SSR1,NA,NA,ENSG00000124783
A0A2U3TZS7,0.8333333333333334,6,1614277.3958333333,6.24878064183796e-6,1.5312735126626071,0.6147319968278988,0.09737879745485493,0.6429522395902524,raw,1070400.625,1757300.125,1106096.5,2165088.5,1639076.125,1947702.5,Amino acid transporter OS=Homo sapiens OX=9606 GN=SLC1A2 PE=1 SV=1,conjugation,cytoskeleton,catalytic activity,6506,SLC1A2,Neuroinflammation and glutamatergic signaling,NA,ENSG00000110436
Q9BTY7,0,6,907096.2734375,3.51132069888986e-6,1.5305736732859176,0.6140724898346139,0.7899317261821835,1,raw,1248021.875,NA,425268.5,990958.1875,NA,964136.53125,Protein HGH1 homolog OS=Homo sapiens OX=9606 GN=HGH1 PE=1 SV=1,NA,NA,NA,51236,HGH1,NA,NA,ENSG00000235173
R4GN18,0,6,1312226.1875,5.079556722610159e-6,1.530537015161098,0.6140379360400793,0.031360955359084355,0.6429522395902524,raw,910840.9375,NA,1068631.375,1564292.875,1310498.875,1706866.875,Membrane cofactor protein (Fragment) OS=Homo sapiens OX=9606 GN=CD46 PE=1 SV=1,NA,cytoskeleton,NA,NA,CD46,Complement system; Measles virus infection,NA,ENSG00000117335
O15254,0,6,371245.875,1.4370727379631271e-6,1.5305262408785945,0.614027780089263,0.008157121791161993,0.6429522395902524,raw,351213.1875,293238.5625,293691.53125,449155.6875,NA,468930.40625,Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens OX=9606 GN=ACOX3 PE=1 SV=2,cellular homeostasis;metabolic process,cytosol;mitochondrion,structural molecule activity,8310,ACOX3,PPAR signaling pathway; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX); Omega-3 / omega-6 fatty acid synthesis,Peroxisomal protein import; Beta-oxidation of pristanoyl-CoA,ENSG00000087008
Q13501,0,6,2433204.3723958335,9.418802752926839e-6,1.5302530507852836,0.6137702443728136,0.16114285189248664,0.6638855679885327,raw,1968720.65625,2190916.4375,1831914.53125,3352656.5625,2052276.078125,3202741.96875,Sequestosome-1 OS=Homo sapiens OX=9606 GN=SQSTM1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytosol;endoplasmic reticulum;endosome;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,8878,SQSTM1,IL-1 signaling pathway; RANKL/RANK signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Nuclear receptors meta-pathway; NRF2 pathway; Interleukin-1 induced activation of NF-kB; Clear cell renal cell carcinoma pathways; CAMKK2 pathway; 7q11.23 copy number variation syndrome; Clock-controlled autophagy in bone metabolism,Neddylation; Interleukin-1 signaling; Signaling by ALK fusions and activated point mutants; Nuclear events mediated by NFE2L2; p75NTR recruits signalling complexes; NF-kB is activated and signals survival; PINK1-PRKN Mediated Mitophagy; NRIF signals cell death from the nucleus; Pexophagy,ENSG00000161011
O75795,0.6666666666666666,6,1601201.4166666667,6.19816423247694e-6,1.530213628141516,0.6137330769348819,0.022741786384165602,0.6429522395902524,raw,1539873.5,1101107.25,1236962.5,2102944.25,1733504.125,1892816.875,UDP-glucuronosyltransferase 2B17 OS=Homo sapiens OX=9606 GN=UGT2B17 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,7367,UGT2B17,Glucuronidation; Metapathway biotransformation Phase I and II,Aspirin ADME; Glucuronidation; Prednisone ADME,ENSG00000197888
Q8N5I2,0,6,5171645.25,2.00191595373053e-5,1.5301604267010138,0.6136829174099265,0.10885995792054572,0.6429522395902524,raw,3997356.25,4639689,3736166.25,6939566.5,4617625,7099468.5,Arrestin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ARRDC1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;nucleus,structural molecule activity,92714,ARRDC1,NA,NA,ENSG00000197070
Q15833,0,6,23491692.876302082,9.093507476988485e-5,1.5298018138975762,0.6133447636192535,0.08501610885038081,0.6429522395902524,raw,21967100.84375,16216769.28125,18175787.6640625,27805352.9375,22696457.625,34088688.90625,Syntaxin-binding protein 2 OS=Homo sapiens OX=9606 GN=STXBP2 PE=1 SV=2,cell death;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,6813,STXBP2,Splicing factor NOVA regulated synaptic proteins; Insulin signaling,Platelet degranulation ; Other interleukin signaling,ENSG00000076944
Q5T4U5,0,6,30645722.692708332,1.186279379316177e-4,1.5297098459753533,0.6132580297348287,0.07865509304358043,0.6429522395902524,raw,26564183.890625,24669989.421875,24526628.8125,37737925.71875,29601489.625,40774118.6875,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADM PE=1 SV=1",cellular homeostasis,endosome,structural molecule activity,34,ACADM,Fatty acid beta-oxidation; PPAR-alpha pathway; Nuclear receptors meta-pathway; Mitochondrial long chain fatty acid beta-oxidation; Amino acid metabolism; PPAR signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,NA,ENSG00000117054
P03905,0,6,6692952.354166667,2.5908057199717168e-5,1.5294880469203298,0.613048832155254,0.08450741306044715,0.6429522395902524,raw,6686303.875,3384628.5,5587514,9389860.6875,6563371.1875,8546035.875,NADH-ubiquinone oxidoreductase chain 4 OS=Homo sapiens OX=9606 GN=MT-ND4 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,4538,MT-ND4,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,Complex I biogenesis,ENSG00000198886
Q7L2H7,0,6,58511680.635416664,2.26495556599955e-4,1.5284481014275482,0.6120675662358321,0.16900171383424106,0.668039680404208,raw,57479453.125,41904529.75,42698294.8125,71291238.375,49842206.75,87854361,Eukaryotic translation initiation factor 3 subunit M OS=Homo sapiens OX=9606 GN=EIF3M PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,10480,EIF3M,NA,"L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Translation initiation complex formation; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition",ENSG00000149100
Q15437,0,6,31186090.856770832,1.2071967391935737e-4,1.5280672762506662,0.6117080623373806,0.1167236891517833,0.6429522395902524,raw,25666178.375,28734265.5625,21141515.375,39219647.28125,27938621.84375,44416316.703125,Protein transport protein Sec23B OS=Homo sapiens OX=9606 GN=SEC23B PE=1 SV=2,cell growth;conjugation,cytoskeleton;cytosol;extracellular;nucleus,DNA binding;structural molecule activity,10483,SEC23B,Sterol regulatory element-binding proteins (SREBP) signaling,NA,ENSG00000101310
Q9UHQ9,0,6,4218842.171875,1.6330910265254023e-5,1.5277416736625995,0.6114006182212192,0.11593875416279585,0.6429522395902524,raw,3459636.59375,3321017.40625,3661937.59375,5725955.375,3859075.0625,5285431,NADH-cytochrome b5 reductase 1 OS=Homo sapiens OX=9606 GN=CYB5R1 PE=1 SV=1,cellular homeostasis;conjugation,cytoplasm;cytoskeleton;extracellular,structural molecule activity,51706,CYB5R1,Oxidation by cytochrome P450,Platelet degranulation ; Erythrocytes take up carbon dioxide and release oxygen,ENSG00000159348
J3KQ48,0,6,18090164.885416668,7.002605155435101e-5,1.5275394837159555,0.6112096711896753,0.020792267105841897,0.6429522395902524,raw,12833388.53125,16065693.5625,13338170.09375,22793029.6875,18969726.1875,24540981.25,Aminoacyl-tRNA hydrolase OS=Homo sapiens OX=9606 GN=PTRH2 PE=1 SV=1,NA,cytoskeleton;endosome,structural molecule activity,51651,PTRH2,Apoptosis modulation and signaling,NA,ENSG00000141378
P49407,0,6,9529647.8125,3.6888752161175395e-5,1.5262001113364119,0.6099441369464096,0.06006072191563695,0.6429522395902524,raw,8667425,6501164.5,7688254.25,11813220.125,9279598,13228225,Beta-arrestin-1 OS=Homo sapiens OX=9606 GN=ARRB1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;DNA binding;structural molecule activity,408,ARRB1,Corticotropin-releasing hormone signaling pathway; Myometrial relaxation and contraction pathways; MAPK signaling pathway; Chemokine signaling pathway; Hedgehog signaling pathway; Gastrin signaling pathway; Kisspeptin/kisspeptin receptor system in the ovary; GPR143 in melanocytes and retinal pigment epithelium cells; Calcium regulation in cardiac cells,Cargo recognition for clathrin-mediated endocytosis; Ub-specific processing proteases; Activation of SMO; Activated NOTCH1 Transmits Signal to the Nucleus; G alpha (s) signalling events; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Signaling by BRAF and RAF1 fusions; Thrombin signalling through proteinase activated receptors (PARs); Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants,ENSG00000137486
Q9Y305,0,6,32368645.291666668,1.252972782888233e-4,1.5260056292407738,0.6097602841008636,0.06656170129986487,0.6429522395902524,raw,27325320.1875,25998976.75,25594401.625,39674584.875,32050377.0625,43568211.25,"Acyl-coenzyme A thioesterase 9, mitochondrial OS=Homo sapiens OX=9606 GN=ACOT9 PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,23597,ACOT9,VEGFA-VEGFR2 signaling pathway,Mitochondrial Fatty Acid Beta-Oxidation,ENSG00000123130
P17980,0,6,78437522.76302083,3.0362741564764716e-4,1.525510501039295,0.609292110919632,0.12437291089195597,0.6445597830897484,raw,70603327.125,63475206.359375,55472875.90625,104774940.6875,68592669.5625,107706116.9375,26S proteasome regulatory subunit 6A OS=Homo sapiens OX=9606 GN=PSMC3 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytosol;membrane;nucleus,structural molecule activity,5702,PSMC3,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,Neutrophil degranulation; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000165916
Q15269,0,6,19603001.3076172,7.588215966421771e-5,1.5252831321994194,0.6090770692368549,0.1053670244032654,0.6429522395902524,raw,17953793.0839844,14994345.7460938,15271927.375,23800495.625,18212828.265625,27384617.75,Periodic tryptophan protein 2 homolog OS=Homo sapiens OX=9606 GN=PWP2 PE=2 SV=2,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,NA,5822,PWP2,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000241945
Q9NX55,0,6,16778311.53125,6.494793804944431e-5,1.524609865596282,0.6084401167890005,0.11257629097938981,0.6429522395902524,raw,15397763.625,13004592.8125,12970476.75,19826930.5,15693380.75,23776724.75,Huntingtin-interacting protein K OS=Homo sapiens OX=9606 GN=HYPK PE=1 SV=2,metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,100137436; 100989225; 101127706; 102116290; 104002286; 104679625; 105491324; 105549422; 105588143; 108521295; 25764; 713266,HYPK; LOC113219833,NA,NA,ENSCATG00000038565; ENSGGOG00000014809; ENSMFAG00000057677; ENSMLEG00000000898; ENSMMUG00000022768; ENSMNEG00000018318; ENSPANG00000018102; ENSPPAG00000034659; ENSPTEG00000009792; ENSPTEG00000019135; ENSPTRG00000038721; ENSRBIG00000028237; ENSRROG00000039445; ENSTGEG00000007663
Q9UJM3,0,6,31672423.9296875,1.22602242986713e-4,1.524204409397314,0.6080563940704372,0.18116006393781947,0.674297118008435,raw,28424937.65625,25962740.8125,24508538.203125,43325415.3125,26263881.84375,41549029.75,ERBB receptor feedback inhibitor 1 OS=Homo sapiens OX=9606 GN=ERRFI1 PE=1 SV=1,coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,DNA binding;structural molecule activity,54206,ERRFI1,Glioblastoma signaling pathways; EGF/EGFR signaling pathway,NA,ENSG00000116285
P08134,0,6,811834.609375,3.1425679406343764e-6,1.5240440798154111,0.6079046303977899,0.7138167037884153,1,raw,1136176.75,NA,204827.890625,964153.875,375887.15625,1378127.375,Rho-related GTP-binding protein RhoC OS=Homo sapiens OX=9606 GN=RHOC PE=1 SV=1,cell differentiation;cell growth;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,structural molecule activity,389,RHOC,Spinal cord injury; VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host,RHOC GTPase cycle; G alpha (12/13) signalling events; RHO GTPases Activate Formins; RHO GTPases activate CIT; RHO GTPases Activate Rhotekin and Rhophilins; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs,ENSG00000155366
G3V325,0,6,15974106.333333334,6.183490314864095e-5,1.5239820235975319,0.6078458853642728,0.13049821864365468,0.6498046150645307,raw,16395841.5,8848044,11432324.5,22271205,13484260,23412963,ATP5MF-PTCD1 readthrough OS=Homo sapiens OX=9606 GN=ATP5MF-PTCD1 PE=4 SV=1,NA,NA,NA,100526740,ATP5MF-PTCD1,NA,NA,ENSG00000248919
P54577,0,6,169546807.0234375,6.563065358829301e-4,1.5236928189462398,0.607572080487421,0.060396171330853676,0.6429522395902524,raw,150198489.46875,134222063.40625,131035497.015625,204513194.15625,168161182.46875,229150415.625,"Tyrosine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=YARS1 PE=1 SV=4",cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cell surface;cytosol;membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,8565,YARS1,Nephrotic syndrome,Cytosolic tRNA aminoacylation,ENSG00000134684
Q9Y5M8,0,6,39927208.630208336,1.5455606887332686e-4,1.523236157556277,0.6071396298903255,0.20905126919181127,0.6993156491930909,raw,29248230.6875,34417342.0625,30265070.78125,66098469,33433289.125,46100850.125,Signal recognition particle receptor subunit beta OS=Homo sapiens OX=9606 GN=SRPRB PE=1 SV=3,cell growth;conjugation,cytoskeleton;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,58477,SRPRB,NA,XBP1(S) activates chaperone genes; SRP-dependent cotranslational protein targeting to membrane,ENSG00000144867
O95470,0,6,14595846.921875,5.6499735381328046e-5,1.5231867109761688,0.6070927970381604,0.16593744693238602,0.6665497934577248,raw,13810562.9375,10279166.625,11337983.84375,19032014.25,12079287.9375,21036065.9375,Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3,cellular homeostasis;defense response;development;metabolic process,cytoskeleton;extracellular,structural molecule activity,8879,SGPL1,Sphingolipid pathway; Kennedy pathway from sphingolipids; Sphingolipid metabolism overview; Sphingolipid metabolism: integrated pathway,Sphingolipid de novo biosynthesis,ENSG00000166224
Q96IJ6,0,6,9326198.087239584,3.61012092592702e-5,1.5229177559265428,0.6068380322252384,0.19471244680033992,0.6851169040350013,raw,8735952.609375,7512276.1171875,6569675.859375,13304137.34375,7401010.53125,12434136.0625,Mannose-1-phosphate guanyltransferase alpha OS=Homo sapiens OX=9606 GN=GMPPA PE=1 SV=1,cellular homeostasis,nucleus,structural molecule activity,29926,GMPPA,NA,Synthesis of GDP-mannose,ENSG00000144591
Q15363,0,6,41963067.13964844,1.6243676724409425e-4,1.522744900272626,0.6066742727921604,0.14561050077680468,0.6572502130392559,raw,33040038.25,36219304.4003906,31958998.5625,50311549.75,37668264.5,62580247.375,Transmembrane emp24 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=TMED2 PE=1 SV=1,cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;extracellular;nucleus,NA,10959,TMED2,NA,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Pre-NOTCH Processing in Golgi; COPII-mediated vesicle transport; Cargo concentration in the ER,ENSG00000086598
Q9BQ39,0,6,1923562.1223958333,7.446005119581582e-6,1.5223356273877886,0.606286463038351,0.18657310406456692,0.6790811483756987,raw,1483958.34375,1652295.4375,1397543.015625,3101870.53125,1646622.75,2259082.65625,ATP-dependent RNA helicase DDX50 OS=Homo sapiens OX=9606 GN=DDX50 PE=1 SV=1,NA,cytoplasm;cytoskeleton;membrane,structural molecule activity,79009,DDX50,NA,NA,ENSG00000107625
O75369,0,6,380801130.0885417,0.001474060614507282,1.5221417358518008,0.6061027031843966,0.05587489617708968,0.6429522395902524,raw,325748424.1875,312254470.4375,288535444.53125,486719483.84375,375713685.6875,495835271.84375,Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2,cell growth;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,2317,FLNB,Focal adhesion; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host,ISG15 antiviral mechanism,ENSG00000136068
Q9Y295,0,6,25882002.044270832,1.0018783250245552e-4,1.5217310517990048,0.6057134018625149,0.06404920100793793,0.6429522395902524,raw,20552768.0625,22909576.578125,19352794.5625,34862214.0625,25140110.875,32474548.125,Developmentally-regulated GTP-binding protein 1 OS=Homo sapiens OX=9606 GN=DRG1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,motor activity;structural molecule activity,4733,DRG1,NA,NA,ENSG00000185721
Q96JB5,0,6,24925072.369791668,9.648360939871884e-5,1.5215987271540274,0.6055879444700648,0.025283678932279896,0.6429522395902524,raw,19593771.65625,21672653.71875,18069317.8125,31395434.4375,25842174.28125,32977082.3125,CDK5 regulatory subunit-associated protein 3 OS=Homo sapiens OX=9606 GN=CDK5RAP3 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,80279,CDK5RAP3,NA,NA,ENSG00000108465
Q5VYS8,0,6,791334.5260416666,3.063213224883513e-6,1.5206269607435974,0.6046662754206651,0.051312634286853114,0.6429522395902524,raw,580314.9375,810814.875,555313.875,927003.4375,844425.25,1030134.78125,Terminal uridylyltransferase 7 OS=Homo sapiens OX=9606 GN=TUT7 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,79670,TUT7,NA,Deadenylation of mRNA,ENSG00000083223
Q9H814,0,6,660186.13125,2.5555448695577343e-6,1.5198706361925272,0.6039485338886628,0.34165005068526816,0.8247147020235626,raw,383869.84375,664028.625,627506.1875,644827.9375,NA,980698.0625,Phosphorylated adapter RNA export protein OS=Homo sapiens OX=9606 GN=PHAX PE=1 SV=1,conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,51808,PHAX,NA,snRNP Assembly; RNA polymerase II transcribes snRNA genes,ENSG00000164902
P13667,0,6,506770513.8671875,0.0019616812978247907,1.5197796554915333,0.6038621703970869,0.05588630333392342,0.6429522395902524,raw,386174295.34375,454780649.84375,357739166.671875,691166379.34375,491625329.875,659137262.125,Protein disulfide-isomerase A4 OS=Homo sapiens OX=9606 GN=PDIA4 PE=1 SV=2,coagulation;conjugation;metabolic process,cell surface;extracellular;nucleus,structural molecule activity,9601,PDIA4,NA,NA,ENSG00000155660
Q7L5D6,0,6,6026478.104166667,2.3328171361983828e-5,1.5197399392908741,0.6038244681458262,0.10140709012240358,0.6429522395902524,raw,4068174.78125,5772762.65625,4275476.03125,8773097.96875,5409821.1875,7859536,Golgi to ER traffic protein 4 homolog OS=Homo sapiens OX=9606 GN=GET4 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,51608,GET4,NA,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,ENSG00000239857
Q9Y330,0.6666666666666666,6,1731670.4583333333,6.70320284853521e-6,1.51968256498241,0.6037700014632974,0.030321440189181287,0.6429522395902524,raw,1406933.625,1448714.5,1294252.375,1807648.5,2138092.5,2294381.25,Zinc finger and BTB domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ZBTB12 PE=1 SV=1,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,221527,ZBTB12,NA,NA,ENSG00000204366; ENSG00000206366; ENSG00000234196; ENSG00000234852; ENSG00000237900
Q9Y5N5,0,6,386470.75,1.4960074070726395e-6,1.5195463872612764,0.6036407167491957,0.32764688979153783,0.809933008927575,raw,387107.5625,191735.75,NA,467053.8125,284602,601854.625,Methyltransferase N6AMT1 OS=Homo sapiens OX=9606 GN=N6AMT1 PE=1 SV=4,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,29104,N6AMT1,NA,Eukaryotic Translation Termination; Methylation,ENSG00000156239
Q9P2B4,0,6,2022829.1692708333,7.830262498447193e-6,1.5192238123534376,0.6033344236167559,0.22501075774645451,0.7134610768095445,raw,1894644.5,1330123.765625,1516899.625,3434058.28125,1656738.8125,2304510.03125,CTTNBP2 N-terminal-like protein OS=Homo sapiens OX=9606 GN=CTTNBP2NL PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,endoplasmic reticulum;nucleus,structural molecule activity,55917,CTTNBP2NL,NA,NA,ENSG00000143079
O14617,0,6,44418909.9296875,1.7194320208943346e-4,1.518859536967482,0.6029884566139269,0.06611591597495306,0.6429522395902524,raw,37694556.96875,37710320.390625,32117895.75,59010196.4375,42727752.6875,57252737.34375,AP-3 complex subunit delta-1 OS=Homo sapiens OX=9606 GN=AP3D1 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;extracellular;mitochondrion;nucleus,NA,8943,AP3D1,NA,NA,ENSG00000065000
O00159,0,6,88365426.48958333,3.4205779494968116e-4,1.5186979128952787,0.6028349291488337,0.10326904976595336,0.6429522395902524,raw,78271464.8125,66937898.015625,71723352.171875,118870710.25,81068408,113320725.6875,Unconventional myosin-Ic OS=Homo sapiens OX=9606 GN=MYO1C PE=1 SV=4,cell growth;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,4641,MYO1C,VEGFA-VEGFR2 signaling pathway; Insulin signaling,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Translocation of SLC2A4 (GLUT4) to the plasma membrane,ENSG00000197879
Q6IPR3,0.6666666666666666,6,401980.5104166667,1.5560448522486466e-6,1.5186389880808644,0.6027789521266443,0.2825184168169791,0.7642736213388397,raw,253646.75,491932.9375,296456.34375,385197.84375,452312.8125,532336.375,tRNA wybutosine-synthesizing protein 3 homolog OS=Homo sapiens OX=9606 GN=TYW3 PE=1 SV=2,cellular component movement;cellular homeostasis,nucleus,structural molecule activity,127253,TYW3,NA,Synthesis of wybutosine at G37 of tRNA(Phe),ENSG00000162623
Q86WA6,0.5,6,679962.0416666666,2.6320963510474416e-6,1.5181230396272878,0.6022887218908208,0.09014506908591156,0.6429522395902524,raw,525454.5,565146.5625,582299.1875,883972.125,638898.0625,884001.8125,Valacyclovir hydrolase OS=Homo sapiens OX=9606 GN=BPHL PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;endosome,structural molecule activity,670,BPHL,NA,Phase I - Functionalization of compounds,ENSG00000137274
H3BLV9,0,6,8395133.447916666,3.2497108310128516e-5,1.5170885197272654,0.6013052670257664,0.06408454243599507,0.6429522395902524,raw,7246938.875,7827416.9375,4639830.1875,11874884.375,8279428.6875,10502301.625,SRSF protein kinase 1 (Fragment) OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane,signal transducer activity;structural molecule activity,NA,SRPK1,NA,NA,ENSG00000096063
P21333,0,6,793466461.4674481,0.00307146583181009,1.5168417630178397,0.601070591440896,0.04263550989447101,0.6429522395902524,raw,604798068.857422,710979768.84375,566979682.537109,1078443806.04297,791503409.367188,1008094033.15625,Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,2316,FLNA,Androgen receptor signaling pathway; Prolactin signaling pathway; Focal adhesion; Hypothesized pathways in pathogenesis of cardiovascular disease; MAPK signaling pathway; IL-4 signaling pathway; Ebola virus infection in host; Joubert syndrome,OAS antiviral response; Platelet degranulation ; RHO GTPases activate PAKs; GP1b-IX-V activation signalling; Cell-extracellular matrix interactions,ENSG00000196924
Q14331,0,6,6360895.671875,2.4622683710840455e-5,1.5166380963992956,0.6008768675102112,0.24473460023636173,0.7301988479077035,raw,4628318.3125,6515201.96875,3883802.0625,7019483.875,5222489.4375,10896078.375,Protein FRG1 OS=Homo sapiens OX=9606 GN=FRG1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane,motor activity,2483,FRG1,NA,NA,ENSG00000109536; ENSG00000275145; ENSG00000283153; ENSG00000283630
Q15084,0,6,154351958.61458334,5.974880980865595e-4,1.5160293418772284,0.6002976763131704,0.07411800179331313,0.6429522395902524,raw,134945052.40625,128733391.71875,106699670.375,195163599.125,146691628.90625,213878409.15625,Protein disulfide-isomerase A6 OS=Homo sapiens OX=9606 GN=PDIA6 PE=1 SV=1,coagulation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,10130,PDIA6,Photodynamic therapy-induced unfolded protein response; VEGFA-VEGFR2 signaling pathway,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; XBP1(S) activates chaperone genes,ENSG00000143870
Q9UBB4,0,6,29365804.5390625,1.1367344386369431e-4,1.515766918181752,0.6000479251211073,0.08529694117855964,0.6429522395902524,raw,21073665,27011774.4375,21369430.78125,40943554.09375,27037059.265625,38759343.65625,Ataxin-10 OS=Homo sapiens OX=9606 GN=ATXN10 PE=1 SV=1,cell growth;defense response,cytoplasm;cytoskeleton;cytosol;nucleus,NA,25814,ATXN10,Ciliopathies,NA,ENSG00000130638
Q9NRR4,0.8333333333333334,6,1462737.8125,5.662179096620455e-6,1.5154578665604659,0.5997537422250072,0.10902050084839957,0.6429522395902524,raw,1109154.75,1323593.875,1056290.25,2005850.75,1301284.125,1980253.125,Ribonuclease 3 OS=Homo sapiens OX=9606 GN=DROSHA PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,29102,DROSHA,miRNA biogenesis; exRNA mechanism of action and biogenesis; DDX1 as a regulatory component of the Drosha microprocessor; 22q11.2 copy number variation syndrome,MicroRNA (miRNA) biogenesis,ENSG00000113360
Q9Y4W6,0,6,34958862.786458336,1.353238703611534e-4,1.5151881819681123,0.5994969833565749,0.16171714062487325,0.6638855679885327,raw,29715928.6875,24545744,28893321.9375,53135514.4375,29683847.71875,43778819.9375,AFG3-like protein 2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;endosome,structural molecule activity,10939,AFG3L2,Ciliary landscape,Processing of SMDT1,ENSG00000141385
O00232,0,6,94863025.91927083,3.67209651526158e-4,1.5146393874951782,0.5989743509261305,0.06598916763953339,0.6429522395902524,raw,77914408.25,85447994.671875,66042965.53125,119293465.5,91056423.25,129422898.3125,26S proteasome non-ATPase regulatory subunit 12 OS=Homo sapiens OX=9606 GN=PSMD12 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cell surface;cytosol;membrane;nucleus,NA,5718,PSMD12,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000197170
P06280,0,6,2974713.1171875,1.151495386708733e-5,1.5145486305062985,0.5988879022428241,0.08312582672414652,0.6429522395902524,raw,2371406.46875,2266511.65625,2190512.109375,3432742.125,3067458.90625,4519647.4375,Alpha-galactosidase A OS=Homo sapiens OX=9606 GN=GLA PE=1 SV=1,cellular homeostasis;metabolic process,cell surface;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,2717,GLA,"Degradation pathway of sphingolipids, including diseases; Ciliary landscape",Glycosphingolipid metabolism; Neutrophil degranulation,ENSG00000102393
H0Y5C6,0,6,575667.2604166666,2.2283768838716704e-6,1.514113769194988,0.598473612250202,1,1,raw,NA,644509.75,370307.40625,NA,NA,712184.625,Filamin-A (Fragment) OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=1,cell growth,NA,motor activity,NA,FLNA,Hypothesized pathways in pathogenesis of cardiovascular disease; Ebola virus infection in host; Joubert syndrome,NA,ENSG00000196924
Q96TA1,0,6,40213447.236979164,1.5566408306565398e-4,1.5140991609049894,0.5984596929466237,0.05688013059409117,0.6429522395902524,raw,36520588.6875,28882363.53125,29329578.171875,52367437.5625,38884922.78125,55295792.6875,Protein Niban 2 OS=Homo sapiens OX=9606 GN=NIBAN2 PE=1 SV=3,cell death;cell growth;cellular component movement;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,64855,NIBAN2,NA,NA,ENSG00000136830
F2Z2X4,0,6,1841292.2311197917,7.127542812335771e-6,1.5139540942425618,0.5983214609295434,0.06928035779054717,0.6429522395902524,raw,1344914.6796875,1554867.23046875,1501719.3125,2273534.1015625,1802694.75,2570023.3125,Exportin-4 OS=Homo sapiens OX=9606 GN=XPO4 PE=1 SV=1,conjugation,membrane,structural molecule activity,NA,NA,NA,NA,NA
O76070,0,6,17766230.182291668,6.877211780830975e-5,1.513946711868605,0.5983144260132899,0.08320417328444081,0.6429522395902524,raw,15248849.65625,11667993.78125,14659778.796875,22194123.90625,16818876.390625,26007758.5625,Gamma-synuclein OS=Homo sapiens OX=9606 GN=SNCG PE=1 SV=2,cell death;cell growth;conjugation;metabolic process,endoplasmic reticulum;nucleus,structural molecule activity,6623,SNCG,NA,NA,ENSG00000173267
Q9NZ63,0,6,2048613.3333333333,7.930071605404644e-6,1.5134649458169436,0.597855260509515,0.06419812654419546,0.6429522395902524,raw,1437244.9375,1869679.75,1598493.25,2419263.5,2043216.0625,2923782.5,Telomere length and silencing protein 1 homolog OS=Homo sapiens OX=9606 GN=C9orf78 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane,NA,51759,C9orf78,NA,NA,ENSG00000136819
O60870,0,6,575131.7291666666,2.226303871317114e-6,1.5133057717611862,0.5977035214829958,0.10363261269913597,0.6429522395902524,raw,386815.78125,447036.96875,514999.3125,676503.625,549792.4375,875642.25,DNA/RNA-binding protein KIN17 OS=Homo sapiens OX=9606 GN=KIN PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis;coagulation,membrane;nucleus,RNA binding;structural molecule activity,22944,KIN,NA,Protein methylation,ENSG00000151657
P52294,0,6,7071662.0625,2.737402203352926e-5,1.5132117904956535,0.5976139225938599,0.05210318667818742,0.6429522395902524,raw,5344686.25,7190105.75,4910835.125,8087642.25,7473259.875,9423443.125,Importin subunit alpha-5 OS=Homo sapiens OX=9606 GN=KPNA1 PE=1 SV=3,cell death;cell differentiation;conjugation;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,3836,KPNA1,Ebola virus infection in host,ISG15 antiviral mechanism; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Vpr-mediated nuclear import of PICs; Apoptosis induced DNA fragmentation; Interferon alpha/beta signaling; Assembly of the ORC complex at the origin of replication; Integration of provirus; Inhibition of nitric oxide production,ENSG00000114030
O95721,0,6,1819963.0182291667,7.04497858083467e-6,1.5131676136035968,0.5975718037616935,0.042277434268052805,0.6429522395902524,raw,1350813,1625636.25,1400444.703125,2251118.5,1831905.53125,2459860.125,Synaptosomal-associated protein 29 OS=Homo sapiens OX=9606 GN=SNAP29 PE=1 SV=1,cell death;cell growth;cellular homeostasis;conjugation,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,9342,SNAP29,Ciliary landscape; 22q11.2 copy number variation syndrome,Neutrophil degranulation; Intra-Golgi traffic,ENSG00000099940
A6NCE7,0.16666666666666666,6,1062596.3541666667,4.113253115693012e-6,1.5125524389504559,0.596985160306132,0.03217243598155555,0.6429522395902524,raw,818541.125,1028502.5,645546,1238086.375,1219396.5,1425505.625,Microtubule-associated proteins 1A/1B light chain 3 beta 2 OS=Homo sapiens OX=9606 GN=MAP1LC3B2 PE=2 SV=1,cell growth;cellular homeostasis;coagulation,cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,643246,MAP1LC3B2,NA,NA,ENSG00000258102
Q15050,0,6,28765396.770833332,1.1134929780986025e-4,1.5124849717499222,0.596920807650324,0.19860545097025814,0.6885314283022954,raw,23560128.03125,25969840,22727800,37561995.25,23493624.625,39278992.71875,Ribosome biogenesis regulatory protein homolog OS=Homo sapiens OX=9606 GN=RRS1 PE=1 SV=2,cell differentiation;cell growth;cellular component movement;cellular homeostasis;conjugation;metabolic process,extracellular;membrane;nucleus,RNA binding,23212,RRS1,NA,NA,ENSG00000179041
O95777,0,6,12866938.890625,4.9807225738884534e-5,1.5122706477426242,0.5967163586158319,0.27643652375077665,0.756515890988102,raw,12596841.625,10383168.0625,9487778.625,16058262.25,9625748.9375,19049833.84375,U6 snRNA-associated Sm-like protein LSm8 OS=Homo sapiens OX=9606 GN=LSM8 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,51691,LSM8,NA,mRNA Splicing - Major Pathway,ENSG00000128534
P11171,0,6,3247630.90625,1.2571403893277896e-5,1.5121400968334706,0.5965918086355264,0.08939126636228925,0.6429522395902524,raw,2984619.625,1144954,3014227.65625,4477173.34375,4557934.5,3306876.3125,Protein 4.1 OS=Homo sapiens OX=9606 GN=EPB41 PE=1 SV=4,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,2035,EPB41,VEGFA-VEGFR2 signaling pathway; Splicing factor NOVA regulated synaptic proteins; IL-18 signaling pathway,Neurexins and neuroligins,ENSG00000159023
O43148,0,6,24577428.192708332,9.51378975590975e-5,1.5116644273631326,0.5961379128984652,0.051316576644880416,0.6429522395902524,raw,21450586.875,20151030.625,17230118.5625,32426089.125,24040487.96875,32166256,mRNA cap guanine-N7 methyltransferase OS=Homo sapiens OX=9606 GN=RNMT PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8731,RNMT,mRNA processing,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE,ENSG00000101654
Q13951,0,6,12714070.104166666,4.9215478920135966e-5,1.5113179452781456,0.5958072010871888,0.07476068268788415,0.6429522395902524,raw,8357104.375,13346072.5,8872719.4375,17242676.75,12630241.8125,15835605.75,Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,865,CBFB,Dual hijack model of Vif in HIV infection; Hijack of ubiquitination by SARS-CoV-2,RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of RUNX3 expression and activity; RUNX2 regulates osteoblast differentiation; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Estrogen-dependent gene expression; RUNX1 regulates expression of components of tight junctions; RUNX1 regulates transcription of genes involved in differentiation of keratinocytes; RUNX1 regulates estrogen receptor mediated transcription; RUNX1 regulates transcription of genes involved in WNT signaling; Transcriptional regulation of granulopoiesis; RUNX2 regulates genes involved in cell migration; RUNX3 regulates p14-ARF; RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs); RUNX1 regulates transcription of genes involved in differentiation of myeloid cells; RUNX1 regulates transcription of genes involved in interleukin signaling; RUNX2 regulates chondrocyte maturation; RUNX3 Regulates Immune Response and Cell Migration; Regulation of RUNX1 Expression and Activity; RUNX2 regulates genes involved in differentiation of myeloid cells; RUNX1 regulates transcription of genes involved in BCR signaling; RUNX3 regulates RUNX1-mediated transcription,ENSG00000067955
A0A087WY85,0,6,33904889.854166664,1.3124399804594606e-4,1.5109669152892002,0.5954720710449221,0.011284852737968702,0.6429522395902524,raw,28046997.25,27875557.25,24410763,42119044.75,36672199.375,44304777.5,Ubiquitin-conjugating enzyme E2 D3 OS=Homo sapiens OX=9606 GN=UBE2D3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,NA,UBE2D3,NA,NA,ENSG00000109332
Q9NR12,0,6,21602665.28515625,8.362275095619714e-5,1.5105045649609337,0.5950305441032911,0.03744470540343121,0.6429522395902524,raw,18546293.3125,17072559.3359375,16256462,25788178.8125,22558331.0625,29394167.1875,PDZ and LIM domain protein 7 OS=Homo sapiens OX=9606 GN=PDLIM7 PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,9260,PDLIM7,Ebstein-Barr virus LMP1 signaling; GDNF signaling,RET signaling,ENSG00000196923
P17706,0,6,531017.8359375,2.0555413724070546e-6,1.5103913784390661,0.5949224346967246,0.21976242619157813,0.7087130179153194,raw,413428.4375,NA,431558.03125,560026.4375,NA,719058.4375,Tyrosine-protein phosphatase non-receptor type 2 OS=Homo sapiens OX=9606 GN=PTPN2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,5771,PTPN2,Immune response to tuberculosis,Negative regulation of MET activity; Interleukin-37 signaling,ENSG00000175354
O43795,0,6,44867535.260416664,1.736798065226829e-4,1.5103528118913465,0.5948855962465702,0.07162772511838077,0.6429522395902524,raw,40437981.1875,34729444.28125,32955718.9375,61075618.59375,42726933.6875,57279514.875,Unconventional myosin-Ib OS=Homo sapiens OX=9606 GN=MYO1B PE=1 SV=3,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,4430,MYO1B,NA,NA,ENSG00000128641
Q93074,0,6,2592427.84375,1.0035148213807516e-5,1.5099648625955224,0.5945149779284988,0.12966112106914124,0.6498046150645307,raw,1398138.65625,2865676.84375,1929936.765625,2914136.703125,2662503.15625,3784174.9375,Mediator of RNA polymerase II transcription subunit 12 OS=Homo sapiens OX=9606 GN=MED12 PE=1 SV=4,cell death;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,9968,MED12,NA,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Generic Transcription Pathway,ENSG00000184634
P53621,0,6,202755372.00260416,7.848550979334511e-4,1.5099641593001676,0.5945143059652087,0.055111458855006956,0.6429522395902524,raw,155276605.484375,187764164.59375,138821282.875,252236234.9375,198916785.1875,283517158.9375,Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=2,conjugation;development,cell surface;cytoskeleton;cytosol;extracellular;nucleus,antioxidant activity;structural molecule activity,1314,COPA,NA,COPI-mediated anterograde transport; COPI-dependent Golgi-to-ER retrograde traffic,ENSG00000122218
Q9H788,0,6,1887812.7473958333,7.307621219122834e-6,1.5099312595690204,0.5944828715793171,0.02195891409959715,0.6429522395902524,raw,1544723.34375,1530390.28125,1386785.15625,2528520.4375,2025673.140625,2310784.125,SH2 domain-containing protein 4A OS=Homo sapiens OX=9606 GN=SH2D4A PE=1 SV=1,NA,cytosol;nucleus,structural molecule activity,63898,SH2D4A,NA,NA,ENSG00000104611
Q5VZ89,0,6,1251148.203125,4.843127142793144e-6,1.5097802967404528,0.594338623812434,0.25215961265094833,0.7333001101617644,raw,944075.234375,1516306.6875,636890.703125,1425346.1875,1156500.78125,1827769.625,DENN domain-containing protein 4C OS=Homo sapiens OX=9606 GN=DENND4C PE=1 SV=3,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,DNA binding,55667,DENND4C,NA,RAB GEFs exchange GTP for GDP on RABs,ENSG00000137145
Q9UN86,0,6,22962958.299479168,8.888837177023352e-5,1.5094229357949582,0.5939971013466891,0.07316661226392117,0.6429522395902524,raw,20429025.796875,17399291.7109375,16942000.8515625,30836040.09375,21717518.28125,30453873.0625,Ras GTPase-activating protein-binding protein 2 OS=Homo sapiens OX=9606 GN=G3BP2 PE=1 SV=2,cell growth;coagulation;conjugation;development;metabolic process,cytosol;nucleus,RNA binding;structural molecule activity,9908,G3BP2,NA,SARS-CoV-2 activates/modulates innate and adaptive immune responses,ENSG00000138757
Q9UBP6,0,6,555883.8098958334,2.1517962150458366e-6,1.5092535896515324,0.5938352325015109,0.1936186818029377,0.6847016541953511,raw,495514.578125,276652.40625,573691.21875,602086.375,521512.75,865845.53125,tRNA (guanine-N(7)-)-methyltransferase OS=Homo sapiens OX=9606 GN=METTL1 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,4234,METTL1,NA,tRNA modification in the nucleus and cytosol,ENSG00000037897
J3KNF5,0,6,343075.090625,1.3280251526334583e-6,1.508715652263653,0.5933209266568767,0.2304829436246926,0.7173388538497806,raw,320616.75,215347.453125,NA,422111.59375,391021.625,366278.03125,Centrosomal protein of 290 kDa OS=Homo sapiens OX=9606 GN=CEP290 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q9P1Y5,0,6,244006.1203125,9.445345174468123e-7,1.5082048535962307,0.5928323975690251,0.5397310725671778,1,raw,242184.15625,287979.984375,96557.3203125,396814.9375,196494.203125,NA,Calmodulin-regulated spectrin-associated protein 3 OS=Homo sapiens OX=9606 GN=CAMSAP3 PE=1 SV=2,cell communication;cell growth;conjugation;defense response;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,57662,CAMSAP3,NA,NA,ENSG00000076826
Q01658,0,6,8433414.973958334,3.264529403055465e-5,1.5079443559639838,0.5925831932909681,0.07831639576956247,0.6429522395902524,raw,8118003.875,6364476.8125,5635312.03125,10042350.5,8198848.5,12241498.125,Protein Dr1 OS=Homo sapiens OX=9606 GN=DR1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,1810,DR1,NA,HATs acetylate histones,ENSG00000117505
Q9Y221,0,6,9874377.484375,3.82231821084941e-5,1.5078634096377954,0.5925057474638632,0.05919541412694866,0.6429522395902524,raw,8103963.0625,8287658.09375,6975126.25,13868060.625,9791787.5,12219669.375,60S ribosome subunit biogenesis protein NIP7 homolog OS=Homo sapiens OX=9606 GN=NIP7 PE=1 SV=1,cell growth;metabolic process,cytosol;membrane;nucleus,NA,51388,NIP7,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000132603
O95340,0,6,7496581.838541667,2.901886354448444e-5,1.5069449038908598,0.5916266708597652,0.09070252383620277,0.6429522395902524,raw,4875942.65625,7936649.75,5576148.59375,9171754.5625,7347776.9375,10071218.53125,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 OS=Homo sapiens OX=9606 GN=PAPSS2 PE=1 SV=2,cellular homeostasis;coagulation;defense response,cytosol,signal transducer activity;structural molecule activity,9060,PAPSS2,RANKL/RANK signaling pathway; Proteoglycan biosynthesis; Sulfation biotransformation reaction,Transport and synthesis of PAPS; Metabolism of ingested H2SeO4 and H2SeO3 into H2Se; Defective PAPSS2 causes SEMD-PA,ENSG00000198682
O94973,0,6,17245231.43359375,6.675535978166049e-5,1.5069173443784172,0.5916002861290401,0.2085795961411194,0.6988382857167694,raw,16040314.4375,14411653.046875,12967679.8203125,24308645.5625,14025925.796875,21717169.9375,AP-2 complex subunit alpha-2 OS=Homo sapiens OX=9606 GN=AP2A2 PE=1 SV=2,conjugation,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,161,AP2A2,Synaptic vesicle pathway; GABA receptor signaling; mBDNF and proBDNF regulation of GABA neurotransmission,"Potential therapeutics for SARS; Recycling pathway of L1; MHC class II antigen presentation; Neutrophil degranulation; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Nef Mediated CD4 Down-regulation; Retrograde neurotrophin signalling; Nef Mediated CD8 Down-regulation; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation",ENSG00000183020
P41223,0,6,8799511.640625,3.406243446107348e-5,1.5067598206658779,0.591449467931427,0.12858619698026746,0.6498046150645307,raw,7742525.875,5580979.875,7024966.78125,13870655.125,7993004.5,10584937.6875,Protein BUD31 homolog OS=Homo sapiens OX=9606 GN=BUD31 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,8896,BUD31,NA,mRNA Splicing - Major Pathway,ENSG00000106245
O43402,0,6,4795600.822916667,1.8563511863309135e-5,1.5064831238820275,0.59118451147995,0.4563542269319206,0.9399855109820654,raw,5012282.75,3643044.625,3764564.6875,7550919.375,2757252.125,6045541.375,ER membrane protein complex subunit 8 OS=Homo sapiens OX=9606 GN=EMC8 PE=1 SV=1,cell growth,cytoskeleton;extracellular;nucleus,NA,10328,EMC8,NA,NA,ENSG00000131148
Q92878,0,6,511193.890625,1.9788039504290575e-6,1.5060794817273435,0.5907979087004713,0.08018939725919616,0.6429522395902524,raw,324173.9375,420996.34375,483210.90625,622451.03125,488577.09375,727754.03125,DNA repair protein RAD50 OS=Homo sapiens OX=9606 GN=RAD50 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,10111,RAD50,"miRNA regulation of DNA damage response; Homologous recombination; DDX1 as a regulatory component of the Drosha microprocessor; ATM signaling in development and disease ; Breast cancer pathway; Joubert syndrome; DNA repair pathways, full network; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; DNA damage response",Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Resolution of D-loop Structures through Holliday Junction Intermediates; Regulation of TP53 Activity through Phosphorylation; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA); Defective HDR through Homologous Recombination (HRR) due to BRCA1 loss-of-function; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function; Impaired BRCA2 binding to PALB2; Meiotic recombination; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; DNA Damage/Telomere Stress Induced Senescence; Nonhomologous End-Joining (NHEJ); HDR through MMEJ (alt-NHEJ); Sensing of DNA Double Strand Breaks,ENSG00000113522
Q9P2W9,0,6,1688313.8802083333,6.535371875504719e-6,1.506030584633978,0.5907510687161652,0.3271962951642409,0.8096702428564433,raw,1809548.140625,1632440.453125,595228.09375,2458505.25,1076409.3125,2557752.03125,Syntaxin-18 OS=Homo sapiens OX=9606 GN=STX18 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;extracellular,structural molecule activity,53407,STX18,NA,COPI-dependent Golgi-to-ER retrograde traffic,ENSG00000168818
P14373,0,6,1036838.6640625,4.013546487998898e-6,1.5059437030148037,0.5906678384696946,0.38234600177615236,0.8670688018420941,raw,739444.015625,1080090.03125,820058.375,1284827.0625,670057.71875,1626554.78125,Zinc finger protein RFP OS=Homo sapiens OX=9606 GN=TRIM27 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,5987,TRIM27,NA,Regulation of PTEN stability and activity; SUMOylation of ubiquitinylation proteins; Suppression of apoptosis,ENSG00000204713; ENSG00000215641; ENSG00000229006; ENSG00000234495; ENSG00000237071
O60287,0,6,2161561.9635416665,8.3672896546629e-6,1.505808921706585,0.5905387121108394,0.17976187763336487,0.6742444420587625,raw,1295221.53125,1614645.890625,1850320.15625,3860269.875,1917566.140625,2431348.1875,Nucleolar pre-ribosomal-associated protein 1 OS=Homo sapiens OX=9606 GN=URB1 PE=1 SV=4,cellular component movement;cellular homeostasis,membrane,NA,9875,URB1,NA,NA,ENSG00000142207
A0A087X0M4,0,6,3601138.2760416665,1.3939811835309991e-5,1.50560699592912,0.590345236798109,0.3602105586085279,0.8422895555819307,raw,1993695.15625,3594568.21875,3564632.53125,5902947.6875,3549264.6875,3001721.375,Kanadaptin OS=Homo sapiens OX=9606 GN=SLC4A1AP PE=1 SV=1,NA,cytoplasm;cytoskeleton;membrane;nucleus,NA,NA,SLC4A1AP,NA,NA,ENSG00000163798
P62136,0,6,136495433.2408854,5.283664524674986e-4,1.5055859080899552,0.5903250299751278,0.1369660389185821,0.654928512316515,raw,130184282.625,103107688.6875,94735617.7578125,177880996.5625,117060392.4375,196003621.375,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit OS=Homo sapiens OX=9606 GN=PPP1CA PE=1 SV=1,cell communication;cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,5499,PPP1CA,Sphingolipid pathway; Nicotine effect on dopaminergic neurons; Common pathways underlying drug addiction; Focal adhesion; VEGFA-VEGFR2 signaling pathway; Hippo-Merlin signaling dysregulation; Fragile X syndrome; Netrin-UNC5B signaling pathway; Neuroinflammation and glutamatergic signaling,Triglyceride catabolism; Circadian Clock; Downregulation of TGF-beta receptor signaling; DARPP-32 events,ENSG00000172531
P06748,0,6,1135226331.4973958,0.004394399836530976,1.5054900613445925,0.5902331839867367,0.07091776832778797,0.6429522395902524,raw,949584949.5625,968624325.734375,852708984.34375,1429590703.96875,1096028063.25,1514820962.125,Nucleophosmin OS=Homo sapiens OX=9606 GN=NPM1 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytosol;endoplasmic reticulum;Golgi;membrane;nucleus,DNA binding;protein binding;RNA binding;structural molecule activity,4869,NPM1,NA,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain; Nuclear import of Rev protein; Deposition of new CENPA-containing nucleosomes at the centromere; SUMOylation of transcription cofactors; ALK mutants bind TKIs; Nuclear events stimulated by ALK signaling in cancer; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation; SARS-CoV-1-host interactions,ENSG00000181163
Q15345,0,6,1381906.0078125,5.349283544914281e-6,1.5054223008816288,0.5901682483976913,0.09835248245505898,0.6429522395902524,raw,705729.375,1452421.5,1080608.203125,1411688.84375,1626771.6875,2014216.4375,Leucine-rich repeat-containing protein 41 OS=Homo sapiens OX=9606 GN=LRRC41 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,10489,LRRC41,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation; RHOBTB3 ATPase cycle,ENSG00000132128
H7BXI1,0,6,32022970.091145832,1.2395918825116716e-4,1.5052820450026037,0.5900338303758433,0.31977319418291417,0.802275970216152,raw,26304396.828125,30251927.46875,25676166.75,47089530.5625,23220262.6875,39595536.25,Extended synaptotagmin-2 OS=Homo sapiens OX=9606 GN=ESYT2 PE=1 SV=2,cell growth;conjugation,cytoplasm;cytoskeleton;cytosol;extracellular,structural molecule activity,NA,ESYT2,NA,NA,ENSG00000117868
P30101,0,6,623531683.9941406,0.002413657483262862,1.5047615550944662,0.5895348952662239,0.05115934405825516,0.6429522395902524,raw,508712107.390625,550911581.738281,461398891.3125,765490421.8125,619698756.429688,834978345.28125,Protein disulfide-isomerase A3 OS=Homo sapiens OX=9606 GN=PDIA3 PE=1 SV=4,cell growth;coagulation;development;metabolic process,cell surface;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,2923,PDIA3,Prion disease pathway,"ER-Phagosome pathway; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Calnexin/calreticulin cycle",ENSG00000167004
Q7Z7H5,0,6,16413354.447916666,6.353520888448087e-5,1.5046954191598796,0.5894714858301134,0.12234746862842322,0.6445597830897484,raw,15168241.125,11548006.4375,13119102.9375,22823582.9375,14443137,21378056.25,Transmembrane emp24 domain-containing protein 4 OS=Homo sapiens OX=9606 GN=TMED4 PE=1 SV=1,cell growth;conjugation,cytoskeleton;extracellular;nucleus,NA,222068,TMED4,NA,NA,ENSG00000158604
P14854,0,6,35734515.052083336,1.3832637840267446e-4,1.5045270491362215,0.5893100443940092,0.05911299873873653,0.6429522395902524,raw,31989947.125,24430092.0625,29426141.75,46011836,34419332.625,48129740.75,Cytochrome c oxidase subunit 6B1 OS=Homo sapiens OX=9606 GN=COX6B1 PE=1 SV=2,cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,1340,COX6B1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000126267
Q5VT52,0,6,13914443.2734375,5.3862058648305376e-5,1.5042620115822585,0.5890558767817078,0.08735641993728238,0.6429522395902524,raw,13261354.59375,9145894.328125,11091818.8125,16839412.125,13199627.84375,19948551.9375,Regulation of nuclear pre-mRNA domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RPRD2 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,structural molecule activity,23248,RPRD2,NA,RNA polymerase II transcribes snRNA genes,ENSG00000163125
Q93050,0,6,3869493.1432291665,1.4978599037281923e-5,1.504152195529294,0.5889505514746289,0.2103743592468858,0.7008646353372271,raw,3102504.53125,3897512.4375,2336079.625,6285362.625,3513819.296875,4081680.34375,V-type proton ATPase 116 kDa subunit a1 OS=Homo sapiens OX=9606 GN=ATP6V0A1 PE=1 SV=3,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,catalytic activity;structural molecule activity,535,ATP6V0A1,NA,Neutrophil degranulation; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000033627
Q9Y617,0,6,148933762.99739584,5.765145553895221e-4,1.5038644443063043,0.5886745308847255,0.09866764944588592,0.6429522395902524,raw,131455425.25,97698163.34375,120797508.046875,222424647.5,139563756.53125,181663077.3125,Phosphoserine aminotransferase OS=Homo sapiens OX=9606 GN=PSAT1 PE=1 SV=2,cellular homeostasis,cytosol;nucleus,structural molecule activity,29968,PSAT1,"Trans-sulfuration, one-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Male infertility; Neuroinflammation and glutamatergic signaling; Amino acid metabolism in triple-negative breast cancer cells",Serine biosynthesis,ENSG00000135069
Q9UBN6,0.16666666666666666,6,1182935.1875,4.579078242239191e-6,1.5038382897765596,0.5886494399673734,1,1,raw,832095.3125,1705588.75,876277.3125,NA,1317779.375,NA,Tumor necrosis factor receptor superfamily member 10D OS=Homo sapiens OX=9606 GN=TNFRSF10D PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
O60637,0.5,6,1804546,6.9853001356591755e-6,1.502381493042758,0.5872511964989706,0.10660084655901586,0.6429522395902524,raw,1358849,1443315.625,1673380.125,NA,2077711.75,2469473.5,Tetraspanin-3 OS=Homo sapiens OX=9606 GN=TSPAN3 PE=2 SV=1,NA,cytoplasm;cytoskeleton,NA,10099,TSPAN3,NA,NA,ENSG00000140391
Q01650,0,6,22625306.6484375,8.758134045940691e-5,1.5019471998248188,0.5868340965473814,0.08239324089139549,0.6429522395902524,raw,20803029.9375,17465589.578125,17290026.5,27297214.0625,21650927.25,31245052.5625,Large neutral amino acids transporter small subunit 1 OS=Homo sapiens OX=9606 GN=SLC7A5 PE=1 SV=2,coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,catalytic activity;structural molecule activity,8140,SLC7A5,"Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; mRNA, protein, and metabolite inducation pathway by cyclosporin A; Malignant pleural mesothelioma",Tryptophan catabolism; Basigin interactions; Amino acid transport across the plasma membrane,ENSG00000103257
Q5T200,0,6,1379189.2786458333,5.338767232990691e-6,1.501921467543144,0.5868093791983393,0.17482009975579033,0.6697819849820321,raw,798543.953125,1271584.578125,1344805.4375,1619783.125,1220626.421875,2019792.15625,Zinc finger CCCH domain-containing protein 13 OS=Homo sapiens OX=9606 GN=ZC3H13 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,23091,ZC3H13,NA,NA,ENSG00000123200
P00441,0,6,259153734.30078134,0.001003170113351408,1.5010563503885987,0.5859781374517464,0.10632070274430673,0.6429522395902524,raw,249920803.125,182403462.5,181048810.242188,334217254.4375,232186866.875,375145208.625,Superoxide dismutase [Cu-Zn] OS=Homo sapiens OX=9606 GN=SOD1 PE=1 SV=2,cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cell surface;cytosol;endosome;membrane;mitochondrion;nucleus,structural molecule activity,6647,SOD1,"Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; AGE/RAGE pathway; Dopamine metabolism; Amyotrophic lateral sclerosis (ALS); Trans-sulfuration, one-carbon metabolism and related pathways; Copper homeostasis; Physico-chemical features and toxicity-associated pathways; Oxidative stress response; Extracellular vesicles in the crosstalk of cardiac cells; Arsenic metabolism and reactive oxygen species generation",Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Platelet degranulation ; Detoxification of Reactive Oxygen Species,ENSG00000142168
E9PES4,0,6,596467.2875,2.3088926656843383e-06,1.4996897912353635,0.5846641121015833,0.07028889467698386,0.6429522395902524,raw,486200.6875,NA,473127.9375,739544.71875,719214.09375,564249,Kinesin-like protein OS=Homo sapiens OX=9606 GN=KIF3A PE=1 SV=1,metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,11127,KIF3A,Hedgehog signaling pathway; Endochondral ossification; Endochondral ossification with skeletal dysplasias; Insulin signaling,NA,ENSG00000131437
Q9UPN7,0,6,2085949.1510416667,8.074596539932756e-6,1.4993701294725277,0.5843565661012069,0.022665882640399575,0.6429522395902524,raw,1794479.28125,1496388.875,1783011.0625,2397968.4375,2800206.46875,2243640.78125,Serine/threonine-protein phosphatase 6 regulatory subunit 1 OS=Homo sapiens OX=9606 GN=PPP6R1 PE=1 SV=5,metabolic process,cytosol;membrane,DNA binding;structural molecule activity,22870,PPP6R1,NA,COPII-mediated vesicle transport,ENSG00000105063
Q38SD2,0.6666666666666666,6,948044.775,3.66983013756284e-6,1.4990757297404589,0.5840732666488893,0.37413146025479777,0.8600513040396214,raw,974615.0625,564628.0625,NA,1017172.3125,1016686.5625,1167121.875,Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=LRRK1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytosol;endosome;nucleus,signal transducer activity;structural molecule activity,79705,LRRK1,NA,NA,ENSG00000154237
P86790,0,6,1425002.5598958333,5.516107971176704e-6,1.498645091133858,0.5836587649500613,0.09646309951972493,0.6429522395902524,raw,1130968.59375,992647.9375,1252005.265625,1366146.71875,1694920.53125,2113326.3125,Vacuolar fusion protein CCZ1 homolog B OS=Homo sapiens OX=9606 GN=CCZ1B PE=1 SV=1,conjugation,cytoskeleton;mitochondrion;nucleus,NA,221960; 51622,CCZ1B,NA,RAB GEFs exchange GTP for GDP on RABs,ENSG00000146574
Q8TBC4,0,6,17007990.5546875,6.5837013148431e-5,1.4984965712435392,0.5835157827800148,0.14261193502334366,0.6572502130392559,raw,16252337.5,13963207.375,11378138.765625,24615447.5,14914993.8125,20923818.375,NEDD8-activating enzyme E1 catalytic subunit OS=Homo sapiens OX=9606 GN=UBA3 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9039,UBA3,Hijack of ubiquitination by SARS-CoV-2,Antigen processing: Ubiquitination & Proteasome degradation; Dectin-1 mediated noncanonical NF-kB signaling; NIK-->noncanonical NF-kB signaling; Neddylation,ENSG00000144744
P54886,0,6,97099506.1171875,3.7586694562113064e-4,1.4984090116328876,0.5834314812812778,0.11012583881225059,0.6429522395902524,raw,87003513.65625,74985504.09375,79279888.734375,122073924.5625,88887356.75,130366848.90625,Delta-1-pyrroline-5-carboxylate synthase OS=Homo sapiens OX=9606 GN=ALDH18A1 PE=1 SV=2,cellular homeostasis,cytoskeleton;endosome,signal transducer activity;structural molecule activity,5832,ALDH18A1,Amino acid metabolism,NA,ENSG00000059573
P61019,0,6,36320796.0703125,1.4059584056998444e-4,1.4981713478135097,0.5832026361490233,0.15709508523050267,0.6638855679885327,raw,33432469.3125,29698790.296875,27490584,44493876.6875,31670842.5625,51138213.5625,Ras-related protein Rab-2A OS=Homo sapiens OX=9606 GN=RAB2A PE=1 SV=1,cell growth;conjugation,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,5862,RAB2A,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Ciliary landscape,RAB geranylgeranylation; Golgi Cisternae Pericentriolar Stack Reorganization,ENSG00000104388
Q92615,0,6,15415296.760416666,5.9671781462908115e-5,1.4981031122168074,0.5831369257754879,0.10971228287660126,0.6429522395902524,raw,14006207.09375,11367026.59375,12681822.28125,19435878.75,14018103.40625,20982742.4375,La-related protein 4B OS=Homo sapiens OX=9606 GN=LARP4B PE=1 SV=3,metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding,23185,LARP4B,NA,NA,ENSG00000107929
P05026,0,6,19667816.6875,7.613305650025743e-5,1.497853590647545,0.5828966128690578,0.065008006942928,0.6429522395902524,raw,17464720.375,17942567.0625,12819050.9375,26875338.5,19217925.75,23687297.5,Sodium/potassium-transporting ATPase subunit beta-1 OS=Homo sapiens OX=9606 GN=ATP1B1 PE=1 SV=1,cell communication;cell growth;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,catalytic activity;structural molecule activity,481,ATP1B1,Proximal tubule transport; Calcium regulation in cardiac cells,Potential therapeutics for SARS; Ion homeostasis; Ion transport by P-type ATPases; Basigin interactions,ENSG00000143153
Q8N6L1,0.16666666666666666,6,2603055.3958333335,1.0076286894123472e-5,1.497752301174761,0.582799050088497,0.02284965810057134,0.6429522395902524,raw,1949498.125,2339837.5,1912552.75,3504497,2723781.5,3188165.5,CRAP Keratinocyte-associated protein 2 OS=Homo sapiens OX=9606 GN=KRTCAP2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,DNA binding,200185,KRTCAP2,NA,NA,ENSG00000163463
A0A0G2JIS2,0,6,674116.875,2.6094700264707242e-6,1.4976892670986341,0.5827383318625019,0.9329854397322266,1,raw,457234.53125,1207733.625,315668.21875,899655.65625,479613.96875,684795.25,Histone-lysine N-methyltransferase EHMT2 OS=Homo sapiens OX=9606 GN=EHMT2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,membrane;nucleus,structural molecule activity,NA,EHMT2,NA,NA,ENSG00000232045; ENSG00000238134
P09543,0,6,37416487.760416664,1.4483720394422109e-4,1.4964510384909704,0.5815450769103095,0.11185444381215312,0.6429522395902524,raw,32232105,31037527,30937395.6875,48233767,34580505.0625,47477626.8125,"2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Homo sapiens OX=9606 GN=CNP PE=1 SV=2",cell death;cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;endoplasmic reticulum;endosome;nucleus,RNA binding;structural molecule activity,1267,CNP,Glial cell differentiation; MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation,NA,ENSG00000173786
H7BYH4,0.8333333333333334,6,445943.5208333333,1.7262232919379242e-6,1.4957486274393534,0.5808677391169892,0.0879525920513107,0.6429522395902524,raw,351481.59375,433194.65625,301725.4375,459297.21875,482011.90625,647950.3125,Superoxide dismutase [Cu-Zn] OS=Homo sapiens OX=9606 GN=SOD1 PE=1 SV=1,cellular homeostasis;coagulation,cytosol;membrane,structural molecule activity,NA,SOD1,"Trans-sulfuration, one-carbon metabolism and related pathways; Copper homeostasis; Physico-chemical features and toxicity-associated pathways; Extracellular vesicles in the crosstalk of cardiac cells; Arsenic metabolism and reactive oxygen species generation",NA,ENSG00000142168
F5GXJ1,0,6,6649019.1640625,2.573799419284753e-5,1.4956437356355698,0.580766564234631,0.19490143535056662,0.6851169040350013,raw,6007433.5625,4870099.015625,5812567.375,8798917.9375,5420116.71875,8984980.375,Complex I-20kD OS=Homo sapiens OX=9606 GN=NDUFS7 PE=1 SV=1,cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity;structural molecule activity,NA,NDUFS7,NA,NA,ENSG00000115286
P50750,0,6,11737170.5703125,4.5433953568963486e-5,1.495489652682834,0.5806179284614073,0.05930673484729206,0.6429522395902524,raw,8417498.9375,10830364.375,9318105.796875,12588282.5625,12657502.9375,16611268.8125,Cyclin-dependent kinase 9 OS=Homo sapiens OX=9606 GN=CDK9 PE=1 SV=3,cell differentiation;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,1025,CDK9,MicroRNAs in cardiomyocyte hypertrophy; IL-9 signaling pathway; Cardiac hypertrophic response; Initiation of transcription and translation elongation at the HIV-1 LTR; Male infertility,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; Estrogen-dependent gene expression; Interactions of Tat with host cellular proteins,ENSG00000136807
Q96BP3,0,6,8704349.223958334,3.3694065884128746e-5,1.495287370189338,0.580422773858815,0.07596638193778067,0.6429522395902524,raw,7346341.75,7184944.65625,6561671.625,10743557,8441743.4375,11947836.875,Peptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,membrane,structural molecule activity,23398,PPWD1,NA,mRNA Splicing - Major Pathway,ENSG00000113593
P46060,0,6,60953282.776041664,2.3594686666028792e-4,1.4950552545145983,0.5801988047853278,0.15737665244709434,0.6638855679885327,raw,52417447.625,53060984,48377103.03125,80540590.5,52956591,78366980.5,Ran GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RANGAP1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,5905,RANGAP1,22q11.2 copy number variation syndrome; IL-18 signaling pathway,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Rev-mediated nuclear export of HIV RNA; SUMOylation of DNA replication proteins; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation; SUMOylation of nuclear envelope proteins,ENSG00000100401
O75781,0,6,688292.9125,2.66434470224616e-6,1.4949033862612005,0.5800522478575857,0.1567571916725283,0.6638855679885327,raw,NA,491833.0625,474142.9375,721778.25,624665.6875,1129044.625,Paralemmin-1 OS=Homo sapiens OX=9606 GN=PALM PE=1 SV=2,cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,antioxidant activity,5064,PALM,NA,NA,ENSG00000099864
Q5TAQ9,0,6,1827383.7083333333,7.073703671572905e-6,1.494610832921351,0.5797698840867527,0.3533222434088004,0.8383308462007302,raw,1615173.03125,1967494.4375,880094.09375,2435546.96875,1125355.21875,2940638.5,DDB1- and CUL4-associated factor 8 OS=Homo sapiens OX=9606 GN=DCAF8 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;endosome;membrane;nucleus,NA,50717,DCAF8,NA,Neddylation,ENSG00000132716
Q9BUP3,0,6,9212893.09375,3.566261174699085e-5,1.4943464904027184,0.5795147010242542,0.001195431467714511,0.6429522395902524,raw,7721569.75,7161021.9375,7296921.125,10701048,10788635.25,11608162.5,Oxidoreductase HTATIP2 OS=Homo sapiens OX=9606 GN=HTATIP2 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,10553,HTATIP2,NA,NA,ENSG00000109854
P35813,0,6,4633706.307291667,1.7936826934270038e-5,1.4942322025123105,0.5794043592265318,0.14769233084005295,0.6638855679885327,raw,4276447.96875,4058649.5625,2799752.625,6692892.375,3909930.4375,6064564.875,Protein phosphatase 1A OS=Homo sapiens OX=9606 GN=PPM1A PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane,structural molecule activity,5494,PPM1A,TGF-beta signaling pathway; MAPK signaling pathway,Downregulation of SMAD2/3:SMAD4 transcriptional activity; Energy dependent regulation of mTOR by LKB1-AMPK,ENSG00000100614
O43791,0.16666666666666666,6,101798.48828125,3.940564518726121e-7,1.4941924141485747,0.5793659426810851,0.23299525542960933,0.718951462768674,raw,78499.671875,NA,84412.578125,138398.203125,105883.5,NA,Speckle-type POZ protein OS=Homo sapiens OX=9606 GN=SPOP PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,8405,SPOP,mRNA processing; Hedgehog signaling pathway,Hedgehog 'on' state,ENSG00000121067
O43813,0,6,16332571.783854166,6.32225035534809e-5,1.493768042253603,0.5789561385746264,0.12218154363149741,0.6445597830897484,raw,14950949.8125,13966333.65625,10601087.953125,21896604.5,14247203.75,22333251.03125,Glutathione S-transferase LANCL1 OS=Homo sapiens OX=9606 GN=LANCL1 PE=1 SV=1,cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;structural molecule activity,10314,LANCL1,NA,NA,ENSG00000115365
P53004,0,6,21729173.388020832,8.411245699200999e-5,1.4931884332549241,0.5783962381908072,0.17291304971246482,0.6689341104244626,raw,23491690.3125,11834070.46875,18015196.140625,30814767.0625,19319233.84375,26900082.5,Biliverdin reductase A OS=Homo sapiens OX=9606 GN=BLVRA PE=1 SV=2,cellular homeostasis,cytosol,structural molecule activity,644,BLVRA,IL-10 anti-inflammatory signaling pathway,Cytoprotection by HMOX1; Heme degradation,ENSG00000106605
P61962,0,6,15333864.956868483,5.935656334800714e-5,1.4930316952672662,0.5782447924781747,0.056578157967850644,0.6429522395902524,raw,12331563.4287109,13531716.625,11067826.9375,20203281.8125,14910991.625,19957809.3125,DDB1- and CUL4-associated factor 7 OS=Homo sapiens OX=9606 GN=DCAF7 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,10238,DCAF7,Ciliary landscape; DYRK1A,Neddylation; Association of TriC/CCT with target proteins during biosynthesis,ENSG00000136485
Q9NNW7,0,6,1594006.5625,6.17031334045952e-6,1.4927276831690326,0.5779510000505764,0.26324740438698835,0.7438355132238149,raw,1485099.53125,1272741.75,953270.34375,1899856.84375,1166834.46875,2786236.4375,"Thioredoxin reductase 2, mitochondrial OS=Homo sapiens OX=9606 GN=TXNRD2 PE=1 SV=3",coagulation;metabolic process,cytosol;endosome;nucleus,structural molecule activity,10587,TXNRD2,Selenium micronutrient network; Selenium micronutrient network ; Selenium micronutrient network; Oxidative stress response; 22q11.2 copy number variation syndrome,Detoxification of Reactive Oxygen Species,ENSG00000184470
Q9NUQ7,0,6,2714166.8255208335,1.0506393239358993e-5,1.4920559835950018,0.5773016681264099,0.11796014594357093,0.6429522395902524,raw,1984171.40625,2794261.921875,1691542.40625,3244221.25,2523875.96875,4046928,Ufm1-specific protease 2 OS=Homo sapiens OX=9606 GN=UFSP2 PE=1 SV=3,cell organization and biogenesis;metabolic process,extracellular;membrane;nucleus,structural molecule activity,55325,UFSP2,NA,NA,ENSG00000109775
Q99956,0.3333333333333333,6,276062.9635416667,1.0686248267863929e-6,1.491368491184438,0.5766367664891742,0.2357426984565335,0.7196640448521243,raw,172419.703125,335360.6875,187571.390625,335925.59375,257141.3125,367959.09375,Dual specificity protein phosphatase 9 OS=Homo sapiens OX=9606 GN=DUSP9 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,1852,DUSP9,MAPK signaling pathway,Negative regulation of MAPK pathway; RAF-independent MAPK1/3 activation; Signaling by MAPK mutants,ENSG00000130829
Q9Y2H0,0,6,1061773.9114583333,4.110069484374058e-6,1.4909609587947426,0.5762424807664623,0.05331732250003347,0.6429522395902524,raw,736722.59375,1022239,689678.375,1414449.625,1028283.53125,1479270.34375,Disks large-associated protein 4 OS=Homo sapiens OX=9606 GN=DLGAP4 PE=1 SV=3,metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,22839,DLGAP4,NA,Neurexins and neuroligins,ENSG00000080845
P14678,0,6,49800406.84375,1.9277468608809584e-4,1.4907454995069875,0.5760339813377992,0.10184022253243823,0.6429522395902524,raw,42489971.78125,40800432.75,37387184.96875,60823061.5,46831283.9375,70470506.125,Small nuclear ribonucleoprotein-associated proteins B and B' OS=Homo sapiens OX=9606 GN=SNRPB PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response,cytosol;membrane;nucleus,RNA binding;structural molecule activity,6628,SNRPB,mRNA processing,snRNP Assembly; RNA Polymerase II Transcription Termination; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway; SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,ENSG00000125835
Q01105,0,6,283294799.8984375,0.0010966188748649768,1.4906516106505876,0.5759431158927993,0.16220065633208008,0.6638855679885327,raw,260347612.0625,236723711.0625,209468602.703125,388087587.25,240869753.8125,364271532.5,Protein SET OS=Homo sapiens OX=9606 GN=SET PE=1 SV=3,cell growth;cell proliferation;cellular homeostasis;metabolic process,cytosol;extracellular;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,6418,SET,Histone modifications; VEGFA-VEGFR2 signaling pathway,HuR (ELAVL1) binds and stabilizes mRNA; Condensation of Prophase Chromosomes,ENSG00000119335
Q8NFH3,0,6,9170201.276041666,3.549735402564179e-5,1.4896136468211083,0.5749381950548275,0.11559796463014879,0.6429522395902524,raw,6125595.0625,8715734.9375,7158495.65625,9957941.875,9124770,13938670.125,Nucleoporin Nup43 OS=Homo sapiens OX=9606 GN=NUP43 PE=1 SV=1,cell differentiation;conjugation;metabolic process,cytosol;membrane;nucleus,NA,348995,NUP43,NA,Regulation of HSF1-mediated heat shock response; SUMOylation of chromatin organization proteins; SUMOylation of DNA damage response and repair proteins; SUMOylation of SUMOylation proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000120253
Q5C9Z4,0,6,26414866.192708332,1.022505208508647e-4,1.4895510381907109,0.5748775571444367,2.4634785620940134e-4,0.4344960313893316,raw,21844072.78125,21499238.1875,19910361.875,32024212.5625,30917973.1875,32293338.5625,Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NOM1 PE=1 SV=1,metabolic process,membrane,NA,64434,NOM1,NA,NA,ENSG00000146909
Q9Y237,0,6,7942065.036458333,3.074330495126552e-5,1.488714342494193,0.5740669532461514,0.0329227286304796,0.6429522395902524,raw,6054156.84375,7309323,5730059,9012910.125,8525047.8125,11020893.4375,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 OS=Homo sapiens OX=9606 GN=PIN4 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;endosome;membrane;nucleus,RNA binding;structural molecule activity,5303,PIN4,NA,NA,ENSG00000102309
Q9BTC0,0,6,15787885.7154948,6.111405319133865e-5,1.4880108024472012,0.5733849999543025,0.3797596531222795,0.8634238971246155,raw,10140494.890625,20459104.28125,10995535.1054688,16361475.015625,15521560.125,21249144.875,Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,cellular component movement;cellular homeostasis;development,endoplasmic reticulum;membrane;nucleus,structural molecule activity,11083,DIDO1,NA,NA,ENSG00000101191
P02647,0.16666666666666666,6,426248.90625,1.6499865022297575e-6,1.4876131955817031,0.5729994502632989,1,1,raw,342697.09375,NA,NA,NA,NA,509800.71875,Apolipoprotein A-I OS=Homo sapiens OX=9606 GN=APOA1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,antioxidant activity;catalytic activity;DNA binding;structural molecule activity,335,APOA1,Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; Complement system; PPAR-alpha pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Statin inhibition of cholesterol production; Familial  hyperlipidemia type 1; Familial hyperlipidemia type 2; Familial hyperlipidemia type 3; Familial hyperlipidemia type 4; Familial hyperlipidemia type 5,Scavenging of heme from plasma; PPARA activates gene expression; Amyloid fiber formation; Scavenging by Class B Receptors; Platelet degranulation ; Heme signaling; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Retinoid metabolism and transport; HDL clearance; Defective ABCA1 causes TGD; HDL assembly; Scavenging by Class A Receptors; ABC transporters in lipid homeostasis; Chylomicron assembly; Chylomicron remodeling; HDL remodeling,ENSG00000118137
O95049,0,6,3841364.6770833335,1.486971526353253e-5,1.4875044650919456,0.5728939990130778,0.5243870142265971,1,raw,5692256.6875,2345188.96875,1772734.875,3163484.78125,3488479.0625,6586043.6875,Tight junction protein ZO-3 OS=Homo sapiens OX=9606 GN=TJP3 PE=1 SV=3,cell communication;cell growth;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,27134,TJP3,1q21.1 copy number variation syndrome,NA,ENSG00000105289
O43615,0,6,42377748.520833336,1.640419764813463e-4,1.487392325271676,0.5727852331808044,0.16459175189370384,0.6638855679885327,raw,38570564,36036525.8125,31199143.75,57369560.875,35857992.1875,55232704.5,Mitochondrial import inner membrane translocase subunit TIM44 OS=Homo sapiens OX=9606 GN=TIMM44 PE=1 SV=2,cell growth;conjugation,cytoskeleton;endosome;membrane,structural molecule activity,10469,TIMM44,NA,Mitochondrial protein import,ENSG00000104980
O60684,0,6,29016200.252604168,1.123201445465118e-4,1.4871378641076616,0.5725383976559012,0.17521789227064605,0.6697819849820321,raw,24437288.609375,27066626.859375,21342423.5,40251805.65625,24506855.515625,36492201.375,Importin subunit alpha-7 OS=Homo sapiens OX=9606 GN=KPNA6 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,23633,KPNA6,NA,Assembly of the ORC complex at the origin of replication,ENSG00000025800
Q9NWS8,0.16666666666666666,6,744225.09375,2.8808551559964875e-6,1.4865569233605358,0.5719747081009925,0.09695280485457777,0.6429522395902524,raw,683311.0625,494308.8125,692853.125,828128,734818.1875,1031931.375,Required for meiotic nuclear division protein 1 homolog OS=Homo sapiens OX=9606 GN=RMND1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,endosome,NA,55005,RMND1,NA,NA,ENSG00000155906
Q16718,0,6,17695402.276041668,6.849794680732858e-5,1.4864991666591527,0.5719186544618071,0.15459228837557673,0.6638855679885327,raw,17495392.25,12459451.875,13670108.1875,20782313.75,15758261.59375,26006886,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 OS=Homo sapiens OX=9606 GN=NDUFA5 PE=1 SV=3,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,4698,NDUFA5,Electron transport chain: OXPHOS system in mitochondria; Ciliary landscape; Nonalcoholic fatty liver disease; Oxidative phosphorylation,RHOG GTPase cycle; Complex I biogenesis,ENSG00000128609
P53611,0,6,7070673.4609375,2.737019521025701e-5,1.4862688420960564,0.57169509977832,0.14419589635425836,0.6572502130392559,raw,5558732.09375,7827002.125,4793137.015625,8261770.3125,7373682.15625,8609717.0625,Geranylgeranyl transferase type-2 subunit beta OS=Homo sapiens OX=9606 GN=RABGGTB PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,5876,RABGGTB,NA,RAB geranylgeranylation; TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,ENSG00000137955
Q9NVZ3,0,6,2749386.53125,1.0642726818668038e-5,1.4859664203250658,0.5714015144109118,0.06736937834225866,0.6429522395902524,raw,2139149.28125,2025496.5625,2469486.84375,2776002.25,3178704,3907480.25,Adaptin ear-binding coat-associated protein 2 OS=Homo sapiens OX=9606 GN=NECAP2 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton,NA,55707,NECAP2,NA,Cargo recognition for clathrin-mediated endocytosis,ENSG00000157191
O75947,0,6,65402100.315104164,2.531679991551848e-4,1.4859265167406739,0.5713627722997131,0.08311462694014708,0.6429522395902524,raw,62873784.6875,42798503.234375,52029520.84375,78616163.375,62668805.875,93425823.875,"ATP synthase subunit d, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PD PE=1 SV=3",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,10476,ATP5PD,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000167863
A0A140T9H5,0,6,79343284.546875,3.071335706094112e-4,1.48538035159947,0.5708323997838404,0.06770062148359894,0.6429522395902524,raw,69852590.71875,72248789.9375,49642879.1875,101265956.3125,75732558.125,107316933,"HLA class I histocompatibility antigen, C alpha chain OS=Homo sapiens OX=9606 GN=HLA-C PE=1 SV=1",metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,NA,NA,HLA-C,NA,NA,ENSG00000233841
Q14847,0,6,106836211.35579424,4.1355720589940175e-4,1.4852199433737505,0.5706765927892881,0.05774139767035859,0.6429522395902524,raw,87698911.6914063,93880420.640625,80133346.4863281,130252172.65625,105665056.410156,143387360.25,LIM and SH3 domain protein 1 OS=Homo sapiens OX=9606 GN=LASP1 PE=1 SV=2,conjugation,endoplasmic reticulum;nucleus,catalytic activity;motor activity;structural molecule activity,3927,LASP1,NA,NA,ENSG00000002834
Q9H7Z3,0.3333333333333333,6,204488.6640625,7.915645779140819e-7,1.4850084924967184,0.570471181563325,0.12004127012400648,0.6445597830897484,raw,179380.515625,206524.21875,85839.671875,246588.296875,201909.0625,306690.21875,Nuclear exosome regulator NRDE2 OS=Homo sapiens OX=9606 GN=NRDE2 PE=1 SV=3,cell differentiation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane,NA,55051,NRDE2,NA,NA,ENSG00000119720
P53801,0,6,1130626.8958333333,4.376595669406319e-6,1.4840616972721785,0.5695510707311946,0.04691837177186366,0.6429522395902524,raw,941905.5,1015060.0625,773456.8125,1534047,1121446.125,1397845.875,Pituitary tumor-transforming gene 1 protein-interacting protein OS=Homo sapiens OX=9606 GN=PTTG1IP PE=1 SV=1,conjugation;metabolic process,cytoskeleton;membrane;nucleus,structural molecule activity,754,PTTG1IP,NA,NA,ENSG00000183255
O75352,0,6,1240273.1458333333,4.801030383178935e-6,1.4838236976609098,0.5693196865542764,0.09616465948377793,0.6429522395902524,raw,1019365.375,959922.875,1112525,1670908.125,1166359,1512558.5,Mannose-P-dolichol utilization defect 1 protein OS=Homo sapiens OX=9606 GN=MPDU1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;extracellular,NA,9526,MPDU1,NA,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein; Defective MPDU1 causes CDG-1f",ENSG00000129255
Q562R1,0,6,912443138.7604166,0.003532018125869012,1.4835949496062322,0.5690972617979624,0.06139109903164459,0.6429522395902524,raw,719922743.375,808317422,732547222.0625,1086803359,907860168.125,1219207918,Beta-actin-like protein 2 OS=Homo sapiens OX=9606 GN=ACTBL2 PE=1 SV=2,cell growth;defense response;metabolic process,cytoskeleton;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,345651,ACTBL2,NA,NA,ENSG00000169067
I3L0E3,0,6,2629298.5416666665,1.0177872694734653e-5,1.483496109485073,0.5690011433102921,0.06538016945828008,0.6429522395902524,raw,2706165.875,1880707.5625,1744740.125,3391411.75,2588315.1875,3464450.75,"HCG1984214, isoform CRA_a OS=Homo sapiens OX=9606 GN=hCG_1984214 PE=3 SV=1",cell organization and biogenesis;cellular homeostasis;metabolic process,endosome;Golgi,structural molecule activity,NA,NA,NA,NA,ENSG00000249773
Q9C0C9,0,6,43473967.901041664,1.6828538251548533e-4,1.483415414250892,0.5689226653285433,0.04607572956052757,0.6429522395902524,raw,32753834.4453125,40002592.28125,30470149.109375,59340462,42907129.8125,55369639.7578125,(E3-independent) E2 ubiquitin-conjugating enzyme OS=Homo sapiens OX=9606 GN=UBE2O PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,63893,UBE2O,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000175931
P25789,0,6,92516005.6484375,3.581244627771614e-4,1.4833597799134102,0.5688685571622384,0.06815017169473103,0.6429522395902524,raw,79642950.5625,78305611.5,68085594.8125,123640351,89266131.375,116155394.640625,Proteasome subunit alpha type-4 OS=Homo sapiens OX=9606 GN=PSMA4 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,NA,5685,PSMA4,Proteasome degradation; Alzheimer's disease and miRNA effects; Exercise-induced circadian regulation; Alzheimer's disease,MAPK6/MAPK4 signaling; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000041357
G5E9A6,0,6,14935295.40625,5.7813722136974056e-5,1.483325335742988,0.5688350568533613,0.1455221083232205,0.6572502130392559,raw,13312798.96875,13322936.53125,10247141.71875,19747212,12791458.21875,20190225,Ubiquitin carboxyl-terminal hydrolase OS=Homo sapiens OX=9606 GN=USP11 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,NA,USP11,NA,NA,ENSG00000102226
P78383,0.16666666666666666,6,499160.9479166667,1.932225078883029e-6,1.4832739899028606,0.5687851165811519,0.11223376256749511,0.6429522395902524,raw,518219.6875,326316.40625,295622.09375,677440.125,438488.5625,738878.8125,Solute carrier family 35 member B1 OS=Homo sapiens OX=9606 GN=SLC35B1 PE=1 SV=1,conjugation,cytoskeleton;extracellular;nucleus,catalytic activity,10237,SLC35B1,NA,NA,ENSG00000121073
A0A1B0GTU4,0,6,21229431.619791668,8.21779835890567e-5,1.4827691733044814,0.5682940270251355,0.22488052183353432,0.713368741697655,raw,18718334.8125,14581112,16538483.453125,35764132.125,17251773.890625,24522753.4375,Paxillin OS=Homo sapiens OX=9606 GN=PXN PE=1 SV=1,cell communication,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,NA,PXN,RAC1/PAK1/p38/MMP2 pathway; Chemokine signaling pathway; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; 3q29 copy number variation syndrome,NA,ENSG00000089159
P55212,0,6,583923.890625,2.2603378536193846e-6,1.482754338825148,0.5682795933983704,0.36726464832215727,0.8513844201444349,raw,482187.21875,NA,455592.34375,849483,548433,NA,Caspase-6 OS=Homo sapiens OX=9606 GN=CASP6 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,839,CASP6,Parkinson's disease pathway; Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Apoptosis modulation by HSP70; Acute viral myocarditis,TP53 Regulates Transcription of Caspase Activators and Caspases; Caspase-mediated cleavage of cytoskeletal proteins; Breakdown of the nuclear lamina,ENSG00000138794
P31930,0,6,94705715.08333333,3.66600709773709e-4,1.4824255321889688,0.5679596345924924,0.03699549088609862,0.6429522395902524,raw,85888432.9375,66524751.96875,73805258.75,119547662.875,95144978.0625,127323205.90625,"Cytochrome b-c1 complex subunit 1, mitochondrial OS=Homo sapiens OX=9606 GN=UQCRC1 PE=1 SV=3",cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,7384,UQCRC1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,Respiratory electron transport,ENSG00000010256
Q7Z4H3,0,6,6185613.369791667,2.394417538324927e-5,1.4823687891351491,0.5679044112525314,0.5303249654231894,1,raw,6217304,5041818.875,5249377.125,7781512.8125,3388382.78125,9435284.625,5'-deoxynucleotidase HDDC2 OS=Homo sapiens OX=9606 GN=HDDC2 PE=1 SV=1,NA,NA,structural molecule activity,51020,HDDC2,NA,NA,ENSG00000111906
Q9UK22,0,6,64585238.384114586,2.5000597072401357e-4,1.4823482895668907,0.5678844601916496,0.054788413230440106,0.6429522395902524,raw,62449348.578125,42174976.71875,46772277.5625,85111408.46875,62518004.6015625,88485414.375,F-box only protein 2 OS=Homo sapiens OX=9606 GN=FBXO2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,26232,FBXO2,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation,ENSG00000116661
Q92917,0,6,8592732.778645834,3.3262004650675455e-5,1.481852285946388,0.5674016440312641,0.04216494161959266,0.6429522395902524,raw,5756234.625,7950313.4375,6798199.25,10919680.5,8529889.4375,11602079.421875,G-patch domain and KOW motifs-containing protein OS=Homo sapiens OX=9606 GN=GPKOW PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,RNA binding,27238,GPKOW,NA,mRNA Splicing - Major Pathway,ENSG00000068394
P47756,0,6,9518947,3.684732989374197e-5,1.481769935193437,0.56732146713012,0.15807764958331524,0.6638855679885327,raw,8950791,7358767.5,6661083.5,13022834,7857193,13263013,F-actin-capping protein subunit beta OS=Homo sapiens OX=9606 GN=CAPZB PE=1 SV=4,cell growth,endoplasmic reticulum;nucleus,motor activity,100612860; 101140941; 102838979,CAPZB,NA,NA,ENSGGOG00000003982; ENSPPYG00000001789; ENSPTRG00000000268
Q5T160,0.16666666666666666,6,5196902.296875,2.0116928202089844e-5,1.481119801244125,0.5666883385812546,0.11542300287636681,0.6429522395902524,raw,4613558.75,4248528.5,3994432.03125,6292579.6875,4802477.1875,7229837.625,"Probable arginine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=RARS2 PE=1 SV=1",cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome,structural molecule activity,57038,RARS2,NA,Mitochondrial tRNA aminoacylation,ENSG00000146282
Q9UHD1,0,6,91027590.35221355,3.523628875274142e-4,1.4809751530384383,0.5665474361102641,0.1304804565134626,0.6498046150645307,raw,71829096.09375,85428255.8710938,65985940.625,116537765.9375,79867359.2734375,126517124.3125,Cysteine and histidine-rich domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CHORDC1 PE=1 SV=2,cell differentiation;cell growth;metabolic process,NA,structural molecule activity,26973,CHORDC1,NA,NA,ENSG00000110172; ENSG00000285023
Q8WTT2,0,6,20698225.677083332,8.012171406549593e-5,1.480892026577318,0.5664664560217025,0.2582058469187372,0.7381027251958325,raw,20209215.6875,13178431.3125,17531629.75,28488760.625,14853650.3125,29927666.375,Nucleolar complex protein 3 homolog OS=Homo sapiens OX=9606 GN=NOC3L PE=1 SV=1,cell proliferation;cellular homeostasis;metabolic process,endosome;membrane,structural molecule activity,64318,NOC3L,NA,NA,ENSG00000173145
Q9NR31,0,6,31277412.296875,1.2107317428340918e-4,1.4806759302898524,0.5662559181935151,0.15878445261936364,0.6638855679885327,raw,29751758.875,23502759.71875,21973462.09375,44052713.25,25713555.46875,42670224.375,GTP-binding protein SAR1a OS=Homo sapiens OX=9606 GN=SAR1A PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;extracellular,structural molecule activity,56681,SAR1A,Sterol regulatory element-binding proteins (SREBP) signaling,NA,ENSG00000079332
O14976,0,6,5425135.989583333,2.1000408503859658e-5,1.4805040276947006,0.56608841535657906,0.40282330080531703,0.888947988048845,raw,4724606.65625,5228103.09375,4109602.4375,7372762.59375,3375513.46875,7740227.6875,Cyclin-G-associated kinase OS=Homo sapiens OX=9606 GN=GAK PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;extracellular;nucleus,signal transducer activity;structural molecule activity,2580,GAK,NA,Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis,ENSG00000178950
Q9H8Y8,0,6,20428155.4375,7.907628674959545e-5,1.4804395695876014,0.5660256020077823,0.2542728343392543,0.7352028058456717,raw,17263141.375,16014446.625,16925499.875,25057179.75,15599695.25,31708969.75,Golgi reassembly-stacking protein 2 OS=Homo sapiens OX=9606 GN=GORASP2 PE=1 SV=3,cell growth;coagulation;metabolic process,cytoskeleton;extracellular,NA,26003,GORASP2,NA,Golgi Cisternae Pericentriolar Stack Reorganization,ENSG00000115806
Q9BYN0,0,6,6479610.450520833,2.5082222209376643e-5,1.4803868452867552,0.5659742210237496,0.032145542590167435,0.6429522395902524,raw,3947534.84375,6051892.15625,5357246.671875,7930797.5,6811478.375,8778713.15625,Sulfiredoxin-1 OS=Homo sapiens OX=9606 GN=SRXN1 PE=1 SV=2,coagulation;metabolic process,cytosol;nucleus,structural molecule activity,140809,SRXN1,Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,Nuclear events mediated by NFE2L2,ENSG00000271303
Q15058,0.5,6,1123078.5833333333,4.347376559264351e-6,1.480068023824315,0.5656634835425814,0.03289194875075749,0.6429522395902524,raw,978002.9375,907686.3125,848026,1447510.875,1146742.125,1410503.25,Kinesin-like protein KIF14 OS=Homo sapiens OX=9606 GN=KIF14 PE=1 SV=1,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,9928,KIF14,NA,RND2 GTPase cycle; RND1 GTPase cycle; RHO GTPases activate CIT,ENSG00000118193
A0A1W2PNP0,0.5,6,1986946.59375,7.691362985964011e-6,1.479737395016331,0.5653411673926069,0.07270801851414686,0.6429522395902524,raw,1433285.359375,1586489.3125,1743745.015625,2347587.5625,1971963.5,2838608.8125,GPI transamidase component PIG-T (Fragment) OS=Homo sapiens OX=9606 GN=PIGT PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,NA,NA,PIGT,NA,NA,ENSG00000124155
Q14289,0.8333333333333334,6,53295653.333333336,2.063045965352935e-4,1.4793455399037885,0.5649590710179191,0.03962173125064589,0.6429522395902524,raw,42185368,39418336,45164988,62406736,56555772,74042720,Protein-tyrosine kinase 2-beta OS=Homo sapiens OX=9606 GN=PTK2B PE=1 SV=2,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;catalytic activity;signal transducer activity;structural molecule activity,2185,PTK2B,IL-7 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Hepatocyte growth factor receptor signaling; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; EGF/EGFR signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-2 signaling pathway; CCL18 signaling pathway; T-cell receptor signaling pathway,Signal regulatory protein family interactions; RHOU GTPase cycle; VEGFA-VEGFR2 Pathway; Interleukin-2 signaling,ENSG00000120899
Q6P1X5,0,6,1432605.6625,5.545539170853696e-6,1.4790283434742573,0.5646496999000917,0.37161458105486783,0.8570581462380165,raw,NA,1263448.75,789953.25,2816333,855516.3125,1437777,Transcription initiation factor TFIID subunit 2 OS=Homo sapiens OX=9606 GN=TAF2 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,6873,TAF2,NA,RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,ENSG00000064313
Q9P0L0,0,6,81177380.73958333,3.1423325794558186e-4,1.4788281129284702,0.5644543749273349,0.09460302223530302,0.6429522395902524,raw,65763593.5,68649489.875,60605186.4375,97253050.875,78157870.5,116635093.25,Vesicle-associated membrane protein-associated protein A OS=Homo sapiens OX=9606 GN=VAPA PE=1 SV=3,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,motor activity;structural molecule activity,9218,VAPA,Exercise-induced circadian regulation,Neutrophil degranulation; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; Sphingolipid de novo biosynthesis,ENSG00000101558
Q99700,0,6,9785671.963541666,3.7879807826702004e-5,1.4786071999169423,0.5642388435137431,0.018497141541756752,0.6429522395902524,raw,6563265.125,9078684.53125,8024554.375,12257643.8125,10924720.0625,11865163.875,Ataxin-2 OS=Homo sapiens OX=9606 GN=ATXN2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;extracellular;nucleus,antioxidant activity;structural molecule activity,6311,ATXN2,Parkinson's disease pathway; EGF/EGFR signaling pathway,NA,ENSG00000204842
O14974,0,6,34426780.848958336,1.3326420990905044e-4,1.4779229778086664,0.5635710851613771,0.05704908422315547,0.6429522395902524,raw,29558398.625,27025193.65625,29039914.8125,43957245.1875,34061175.4375,42918757.375,Protein phosphatase 1 regulatory subunit 12A OS=Homo sapiens OX=9606 GN=PPP1R12A PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,4659,PPP1R12A,Focal adhesion; Hippo-Merlin signaling dysregulation; Regulation of actin cytoskeleton,Regulation of PLK1 Activity at G2/M Transition; RHO GTPases activate CIT; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs,ENSG00000058272
O00231,0,6,197515718.5859375,7.645726824548494e-4,1.4777131635748102,0.5633662575434152,0.04915013427432192,0.6429522395902524,raw,164698068.34375,179440483.46875,136952148.625,244027672.8125,194814373.765625,265161564.5,26S proteasome non-ATPase regulatory subunit 11 OS=Homo sapiens OX=9606 GN=PSMD11 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytosol;membrane;nucleus,structural molecule activity,5717,PSMD11,Proteasome degradation; Parkin-ubiquitin proteasomal system pathway; VEGFA-VEGFR2 signaling pathway,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000108671
O43681,0,6,17319345.278645832,6.704225047433139e-5,1.4776536788689876,0.5633081813080876,0.12217695981241658,0.6445597830897484,raw,18011330.734375,10045437.0625,11507563.46875,24098990.75,14843677.03125,25409072.625,ATPase GET3 OS=Homo sapiens OX=9606 GN=GET3 PE=1 SV=2,cell growth;conjugation,cytoskeleton;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,439,GET3,NA,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,ENSG00000198356
O00303,0,6,93648653.58333333,3.625088817796595e-4,1.4776054722573801,0.5632611144107674,0.020054717243437672,0.6429522395902524,raw,76126797.59375,81807724.65625,69507802.8125,115677950.3125,97892104.5,120879541.625,Eukaryotic translation initiation factor 3 subunit F OS=Homo sapiens OX=9606 GN=EIF3F PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,8665,EIF3F,Translation factors; VEGFA-VEGFR2 signaling pathway; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000175390
C9IY94,0.16666666666666666,6,1931904.1875,7.4782968031983e-6,1.4769277687426787,0.5625992707710126,0.25473421756318004,0.735366952583477,raw,1707126,NA,1401685.5,1944837,NA,2673968.25,Septin-2 (Fragment) OS=Homo sapiens OX=9606 GN=SEPTIN2 PE=1 SV=1,NA,NA,structural molecule activity,NA,SEPTIN2,2q37 copy number variation syndrome,NA,ENSG00000168385
Q9P015,0,6,4840326.651041667,1.8736643129161615e-5,1.4767941422119073,0.5624687355756094,0.018845454076182485,0.6429522395902524,raw,4250990.3125,3263410.375,4313949.15625,6370814.84375,5300828.21875,5541967,"39S ribosomal protein L15, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL15 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome;Golgi,structural molecule activity,29088,MRPL15,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000137547
Q9UHW9,0.6666666666666666,6,7917176.583333333,3.064696309298626e-5,1.47653240877333,0.5622130228880078,0.10192131699641893,0.6429522395902524,raw,6433042,6587229.5,6220941.5,9498595,7564090.5,11199161,Solute carrier family 12 member 6 OS=Homo sapiens OX=9606 GN=SLC12A6 PE=1 SV=2,cell death;cell growth;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity;structural molecule activity,9990,SLC12A6,NA,"Cation-coupled Chloride cotransporters; Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",ENSG00000140199
A0A286YFF8,0,6,2638227.8072916665,1.0212437399863614e-5,1.4754082325985438,0.56111419085316006,0.022625202320800765,0.6429522395902524,raw,1986031.78125,2204365.375,2169351.5,3200679.0625,2804446.8125,3464492.3125,Protein MON2 homolog OS=Homo sapiens OX=9606 GN=MON2 PE=1 SV=1,conjugation,NA,NA,23041,MON2,NA,NA,ENSG00000061987
Q6ZYL4,0.3333333333333333,6,374268.41875,1.448772841627379e-6,1.475039366464408,0.5607534582338711,0.4090852224781244,0.8935675900241862,raw,389110,NA,225854.5,576469.625,348224.6875,331683.28125,General transcription factor IIH subunit 5 OS=Homo sapiens OX=9606 GN=GTF2H5 PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,NA,404672,GTF2H5,"Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Dual Incision in GG-NER,ENSG00000272047
P0CG08,0.16666666666666666,6,593088.359375,2.2958130173462275e-6,1.4747405945062764,0.5604612080799409,0.030105164367036415,0.6429522395902524,raw,580453.875,445344.59375,423185.1875,779669.375,624088.375,705788.75,Golgi pH regulator B OS=Homo sapiens OX=9606 GN=GPR89B PE=1 SV=1,conjugation;metabolic process,cytoskeleton;extracellular,catalytic activity,51463; 653519,GPR89B,NA,NA,ENSG00000188092
A0A3B3ISG5,0,6,74293190.17252605,2.875849279490238e-4,1.4746274955185914,0.5603505624475463,0.20249148238963313,0.6923632419251884,raw,67853415.5390625,61027384.484375,61662354.3164063,100058512.21875,62105574.5703125,93051899.90625,Insulin-degrading enzyme OS=Homo sapiens OX=9606 GN=IDE PE=1 SV=1,cell organization and biogenesis,endosome,structural molecule activity,3416,IDE,Alzheimer's disease and miRNA effects; Alzheimer's disease,NA,ENSG00000119912
Q08752,0,6,44753960.380208336,1.7324016429348692e-4,1.4742805455368597,0.5600110855880297,0.23128411773146595,0.7181819764944949,raw,39200011.09375,38508213.75,36311341.4375,61885732.5,35846553.125,56771910.375,Peptidyl-prolyl cis-trans isomerase D OS=Homo sapiens OX=9606 GN=PPID PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5481,PPID,Alzheimer's disease and miRNA effects; NO/cGMP/PKG mediated neuroprotection; Alzheimer's disease,ESR-mediated signaling,ENSG00000171497
Q68E01,0,6,2621326.1783854165,1.014701210691365e-5,1.4741748951717457,0.5599076950088275,0.34331491967565986,0.8250635218999488,raw,3411160.28125,1676877.0078125,1159463.46875,3670678.6875,1709251.9375,4100525.6875,Integrator complex subunit 3 OS=Homo sapiens OX=9606 GN=INTS3 PE=1 SV=1,cell differentiation;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,NA,65123,INTS3,NA,RNA polymerase II transcribes snRNA genes,ENSG00000143624; ENSG00000262826
P48163,0,6,46874820.604166664,1.814498997117751e-4,1.4734114600579657,0.5591603689293964,0.09150135825203572,0.6429522395902524,raw,45281104.40625,32866674.875,30100075.71875,64191220.6875,42092149.78125,66717698.15625,NADP-dependent malic enzyme OS=Homo sapiens OX=9606 GN=ME1 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytosol;endosome;nucleus,structural molecule activity,4199,ME1,Nuclear receptors meta-pathway; NRF2 pathway; PPAR signaling pathway; Clear cell renal cell carcinoma pathways; TCA cycle in senescence,Pyruvate metabolism; PPARA activates gene expression; Nuclear events mediated by NFE2L2,ENSG00000065833
D6RCM8,0,6,461872.1796875,1.7878822703484936e-6,1.4730153333747673,0.5587724482071634,1,1,raw,NA,NA,328334.03125,440092.625,483641.0625,595421,Tumor necrosis factor alpha-induced protein 8 OS=Homo sapiens OX=9606 GN=TNFAIP8 PE=1 SV=1,metabolic process,membrane,NA,NA,TNFAIP8,NA,NA,ENSG00000145779
Q9BV44,0,6,3128059.0625,1.21085477419978e-5,1.4725676958912062,0.558333958185864,0.10096840421613287,0.6429522395902524,raw,1725972.875,3379798.875,2361401.625,3439386.375,3477323.75,4384470.875,THUMP domain-containing protein 3 OS=Homo sapiens OX=9606 GN=THUMPD3 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,25917,THUMPD3,NA,NA,ENSG00000134077
O14561,0,6,16796491.291666668,6.501831092046272e-5,1.4725352773410831,0.5583021969320658,0.34003784026164813,0.8240393274854595,raw,17828529.75,10855175,13379045,21189926.5,11273132.5,26253139,"Acyl carrier protein, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFAB1 PE=1 SV=3",cell growth;cell organization and biogenesis;cellular homeostasis,cytoskeleton;cytosol;endosome;membrane,structural molecule activity,4706,NDUFAB1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Glyoxylate metabolism and glycine degradation; Mitochondrial Fatty Acid Beta-Oxidation; Complex I biogenesis,ENSG00000004779
Q8IYD1,0,6,2670856.3333333335,1.033874066250431e-5,1.4722348891851182,0.5580078659792589,0.17375363040882644,0.669032211414766,raw,2380455.5,1848103.75,2214312.25,3259987.75,2263044.5,4059234.25,Eukaryotic peptide chain release factor GTP-binding subunit ERF3B OS=Homo sapiens OX=9606 GN=GSPT2 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;nucleus,RNA binding;structural molecule activity,23708,GSPT2,Translation factors,Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000189369
O60573,0,6,801805.4375,3.103745557797371e-6,1.4716953409546045,0.5574790466769339,1,1,raw,609986.8125,NA,NA,1064718.375,NA,730711.125,Eukaryotic translation initiation factor 4E type 2 OS=Homo sapiens OX=9606 GN=EIF4E2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,9470,EIF4E2,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; EGFR tyrosine kinase inhibitor resistance,ISG15 antiviral mechanism,ENSG00000135930
Q96CV9,0,6,675363.4674479166,2.6142955185310784e-6,1.4715743612560854,0.5573604460532338,0.08501150610793473,0.6429522395902524,raw,525245.44140625,481107.8125,537707.11328125,1039284.703125,707985.921875,760849.8125,Optineurin OS=Homo sapiens OX=9606 GN=OPTN PE=1 SV=3,cell growth;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,10133,OPTN,NA,Regulation of PLK1 Activity at G2/M Transition; Regulation of TNFR1 signaling; TBC/RABGAPs,ENSG00000123240
Q9GZV5,0.3333333333333333,6,799435.96875,3.0945734721975496e-6,1.4714974130152458,0.5572850059321601,0.5876422889787951,1,raw,584296.9375,686190.125,NA,1398560.75,528696.0625,NA,WW domain-containing transcription regulator protein 1 OS=Homo sapiens OX=9606 GN=WWTR1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,25937,WWTR1,Adipogenesis; Malignant pleural mesothelioma,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Signaling by Hippo; Downregulation of SMAD2/3:SMAD4 transcriptional activity; RUNX2 regulates osteoblast differentiation; YAP1- and WWTR1 (TAZ)-stimulated gene expression; Physiological factors; EGR2 and SOX10-mediated initiation of Schwann cell myelination; RUNX3 regulates YAP1-mediated transcription,ENSG00000018408
P27824,0,6,510730858.1175132,0.001977011576592446,1.4711229407147717,0.5569178166458657,0.0657420408758775,0.6429522395902524,raw,401668766.835938,452771150.15625,402552492.882813,646276107.265625,495034605.675781,666082025.888672,Calnexin OS=Homo sapiens OX=9606 GN=CANX PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;extracellular;Golgi;nucleus,antioxidant activity;structural molecule activity,821,CANX,NA,"MHC class II antigen presentation; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Interleukin-35 Signalling; Interleukin-27 signaling; Assembly of Viral Components at the Budding Site; Maturation of spike protein; Calnexin/calreticulin cycle; Maturation of spike protein",ENSG00000127022; ENSG00000283777
Q9H1D9,0,6,688108.7682291666,2.6636318897160094e-6,1.4707411728713762,0.5565433774765066,0.3782159174760008,0.8617583924772685,raw,297624.59375,825956.9375,541154.546875,783366.0625,465781.59375,1214768.875,DNA-directed RNA polymerase III subunit RPC6 OS=Homo sapiens OX=9606 GN=POLR3F PE=1 SV=1,cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,10621,POLR3F,Pyrimidine metabolism; Cytosolic DNA-sensing pathway,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation,ENSG00000132664
Q09666,0,6,798409821.1621094,0.0030906013102881837,1.4700891971638106,0.5559036927499891,0.09387286280881806,0.6429522395902524,raw,659299359.21875,717783134.671875,612673576.050781,1000041656.96875,745455967.875,1055205232.1875,Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2,metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,79026,AHNAK,NA,NA,ENSG00000124942
Q8IWW6,0,6,8894922.744791666,3.443176569390368e-5,1.4700666781475151,0.5558815931916571,0.03685666392762319,0.6429522395902524,raw,5146007.5,8507737.203125,7068058.328125,9869068.09375,10271724.375,12506940.96875,Rho GTPase-activating protein 12 OS=Homo sapiens OX=9606 GN=ARHGAP12 PE=1 SV=1,cell growth;conjugation;development;metabolic process,cytoplasm;nucleus,DNA binding,94134,ARHGAP12,NA,RAC1 GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle; RHOV GTPase cycle,ENSG00000165322
Q9P0J1,0,6,47875553.901041664,1.8532368427277802e-4,1.4698982017286977,0.5557162442136033,0.11771498801881684,0.6429522395902524,raw,45634542.125,35507141.78125,34247924.71875,62610792.0625,42174791.3125,67078131.40625,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PDP1 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis;metabolic process,endosome;nucleus,structural molecule activity,54704,PDP1,Glucose metabolism in triple-negative breast cancer cells,Regulation of pyruvate dehydrogenase (PDH) complex,ENSG00000164951
Q9Y547,0,6,451480.1927083333,1.74765544983223e-6,1.4698129459968523,0.5556325638685665,0.04424715391828261,0.6429522395902524,raw,451293.6875,316426,339332.9375,598555.8125,465087.03125,538185.6875,Intraflagellar transport protein 25 homolog OS=Homo sapiens OX=9606 GN=HSPB11 PE=1 SV=1,cell growth;conjugation;defense response;development;metabolic process,endoplasmic reticulum;nucleus,structural molecule activity,51668,HSPB11,Ciliary landscape; Intraflagellar transport proteins binding to dynein; Genes related to primary cilium development (based on CRISPR); GDNF/RET signaling axis; Alstrom syndrome,Intraflagellar transport,ENSG00000081870
Q9NPJ8,0,6,1253519.1067708333,4.852304782797263e-6,1.4698098740269467,0.5556295485730542,0.6597523172513771,1,raw,720436.8125,401816.8125,2100230.3125,1058905.140625,729597.875,2510127.6875,NTF2-related export protein 2 OS=Homo sapiens OX=9606 GN=NXT2 PE=1 SV=1,conjugation,cytosol;membrane;nucleus,NA,55916,NXT2,NA,NA,ENSG00000101888
P09972,0,6,147533270.61458334,5.710933249904912e-4,1.469347839651364,0.5551759664432065,0.14430423084374747,0.6572502130392559,raw,122768747.8125,138340571.3125,105572192.15625,180389994.375,130065682.96875,208062435.0625,Fructose-bisphosphate aldolase C OS=Homo sapiens OX=9606 GN=ALDOC PE=1 SV=2,cellular homeostasis;metabolic process,cell surface;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,230,ALDOC,Clear cell renal cell carcinoma pathways; Glycolysis and gluconeogenesis,Neutrophil degranulation; Glycolysis; Gluconeogenesis,ENSG00000109107
O94826,0,6,53473687.8515625,2.069937585429886e-4,1.4693095415570536,0.555138362555735,0.0560757490778221,0.6429522395902524,raw,47513528.90625,44345245,38820839.765625,68323177.3125,52027254.75,69812081.375,Mitochondrial import receptor subunit TOM70 OS=Homo sapiens OX=9606 GN=TOMM70 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,9868,TOMM70,Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Mitochondrial protein import; DDX58/IFIH1-mediated induction of interferon-alpha/beta; SARS-CoV-1 activates/modulates innate immune responses; PINK1-PRKN Mediated Mitophagy,ENSG00000154174
Q86VU5,0,6,638787.6614583334,2.4727125483319923e-6,1.469249974896148,0.5550798736765264,0.1083641667586125,0.6429522395902524,raw,576978.1875,480815.625,507084.90625,842602.5,577519.5625,847725.1875,Catechol O-methyltransferase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=COMTD1 PE=1 SV=1,cellular homeostasis,cytoskeleton,structural molecule activity,118881,COMTD1,NA,NA,ENSG00000165644
Q5SNT2,0,6,1956773.4296875,7.574564296975729e-6,1.4687442133511137,0.5545831676700818,0.09299804045673295,0.6429522395902524,raw,917657.578125,1837716.78125,1846417.59375,2375962.5,2050970.96875,2711915.15625,Transmembrane protein 201 OS=Homo sapiens OX=9606 GN=TMEM201 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,199953,TMEM201,NA,NA,ENSG00000188807
Q8NG11,0,6,599939.640625,2.3223339571532838e-6,1.4687148602717903,0.5545543348993676,1,1,raw,NA,NA,486033.96875,NA,NA,713845.3125,Tetraspanin-14 OS=Homo sapiens OX=9606 GN=TSPAN14 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,81619,TSPAN14,NA,Neutrophil degranulation; Amyloid fiber formation,ENSG00000108219
Q9Y2Z4,0,6,8152398.263671875,3.155749351757992e-5,1.468706270463171,0.5545458972435152,0.26646719027115634,0.7468192644661517,raw,9357853.5078125,4319680.5,5324081.125,10318923.4375,5849912.88671875,13743938.125,"Tyrosine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=YARS2 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;endosome;membrane,RNA binding;structural molecule activity,51067,YARS2,NA,Mitochondrial tRNA aminoacylation,ENSG00000139131
Q9NXK8,0.16666666666666666,6,503962.53125,1.9508117487211557e-6,1.4686824809758319,0.5545225288858925,1,1,raw,NA,376189.40625,503328.25,NA,NA,632369.9375,F-box/LRR-repeat protein 12 OS=Homo sapiens OX=9606 GN=FBXL12 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,NA,54850,FBXL12,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation,ENSG00000127452
O14646,0,6,3666267.171875,1.419192227466699e-5,1.4683417956516867,0.5541878329599761,0.07701360192016546,0.6429522395902524,raw,3147817.0625,2669142.71875,2739664.875,4014169.75,3919213.8125,5507594.8125,Chromodomain-helicase-DNA-binding protein 1 OS=Homo sapiens OX=9606 GN=CHD1 PE=1 SV=2,cell growth;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,1105,CHD1,NA,Estrogen-dependent gene expression,ENSG00000153922
Q7Z739,0,6,11337680.55859375,4.3887549302708444e-5,1.4681127508563885,0.5539627712157845,0.06330072251686271,0.6429522395902524,raw,10455678.28125,10033651.0625,6429272.46875,15336106.546875,11040843.9296875,14730531.0625,YTH domain-containing family protein 3 OS=Homo sapiens OX=9606 GN=YTHDF3 PE=1 SV=1,cell growth;metabolic process,cytosol;nucleus,protein binding;RNA binding,253943,YTHDF3,NA,NA,ENSG00000185728
P82909,0,6,4599629,1.7804915517632622e-5,1.4673803100170155,0.5532428316576089,0.01386310934018114,0.6429522395902524,raw,3246606.8125,4123685,3862106.5625,5847592.375,4850604.125,5667179.125,"28S ribosomal protein S36, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS36 PE=1 SV=2",cellular homeostasis,cytoskeleton;endosome,NA,92259,MRPS36,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000134056; ENSG00000278461
Q9BRD0,0,6,567557.15625,2.1969831085200715e-6,1.467239708777936,0.5531045890849972,0.12033864713993592,0.6445597830897484,raw,397721.71875,606067.4375,370842.4375,827106.34375,544114.75,659490.25,BUD13 homolog OS=Homo sapiens OX=9606 GN=BUD13 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane,NA,84811,BUD13,NA,NA,ENSG00000137656
Q9Y4C8,0,6,1392609.5208333333,5.390716265918044e-6,1.4667667879422615,0.5526395045318223,0.31026822371857493,0.791258249420452,raw,727097.375,1671165.40625,977402.65625,1066482.28125,1605717.1875,2307792.21875,Probable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,9904,RBM19,NA,NA,ENSG00000122965
Q15642,0,6,31671848.802083332,1.2260001669880933e-4,1.4666472792531553,0.5525219523627372,0.11271546285700094,0.6429522395902524,raw,29861512.96875,23584988.3125,23948670.84375,43796306.75,28421954.3125,40417659.625,Cdc42-interacting protein 4 OS=Homo sapiens OX=9606 GN=TRIP10 PE=1 SV=3,cell growth;conjugation;development;metabolic process,cytoplasm;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,9322,TRIP10,Angiopoietin-like protein 8 regulatory pathway,RHOQ GTPase cycle; Clathrin-mediated endocytosis,ENSG00000125733
Q00653,0,6,45707186.1640625,1.7693004983659324e-4,1.4664826386432537,0.5523599914552204,0.10037046268145132,0.6429522395902524,raw,41798856.0625,38904729.203125,31590931.59375,62929806.9375,41965683.25,57053109.9375,Nuclear factor NF-kappa-B p100 subunit OS=Homo sapiens OX=9606 GN=NFKB2 PE=1 SV=4,cell growth;cellular component movement;defense response;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,4791,NFKB2,"Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; RANKL/RANK signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Neural crest differentiation; Thymic stromal lymphopoietin (TSLP) signaling pathway; TNF-alpha signaling pathway; Ebstein-Barr virus LMP1 signaling; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; Photodynamic therapy-induced NF-kB survival signaling; MAPK signaling pathway; Toll-like receptor signaling related to MyD88; ApoE and miR-146 in inflammation and atherosclerosis; Ebola virus infection in host; Breast cancer pathway; Acute viral myocarditis; miRNAs involvement in the immune response in sepsis; Non-genomic actions of 1,25 dihydroxyvitamin D3; Interactions between immune cells and microRNAs in tumor microenvironment; Measles virus infection; Head and neck squamous cell carcinoma; IL-18 signaling pathway; FGF23 signaling in hypophosphatemic rickets and related disorders; Mitochondrial immune response to SARS-CoV-2; Neuroinflammation and glutamatergic signaling; Network map of SARS-CoV-2 signaling pathway; Inclusion body myositis; GDNF signaling; Sudden infant death syndrome (SIDS) susceptibility pathways",Dectin-1 mediated noncanonical NF-kB signaling; NIK-->noncanonical NF-kB signaling; PKMTs methylate histone lysines; RIP-mediated NFkB activation via ZBP1; TAK1-dependent IKK and NF-kappa-B activation  ; IkBA variant leads to EDA-ID; TRAF6 mediated NF-kB activation; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; Interleukin-1 processing; DEx/H-box helicases activate type I IFN and inflammatory cytokines production ; SUMOylation of immune response proteins,ENSG00000077150
A0A087X2D8,0,6,35955625.0703125,1.3918228334515404e-4,1.4658799340542759,0.5517669413720012,0.02782097025894346,0.6429522395902524,raw,25291044.59375,34659225.90625,26002441.828125,46724686.4375,37073634.78125,45982716.875,C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P11234,0,6,15061875.044270834,5.830370508151447e-5,1.4654771418229022,0.5513704653758487,0.05996297821883225,0.6429522395902524,raw,9758119.28125,12364833.875,15236865.125,18120381.40625,15885999.734375,19005050.84375,Ras-related protein Ral-B OS=Homo sapiens OX=9606 GN=RALB PE=1 SV=1,cell differentiation;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,5899,RALB,Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Pancreatic adenocarcinoma pathway; Ciliary landscape; EGF/EGFR signaling pathway,p38MAPK events,ENSG00000144118
Q15008,0,6,103853816.921875,4.020125180699725e-4,1.4653310571175835,0.5512266445143104,0.10656649588470841,0.6429522395902524,raw,88537081.78125,91261361.84375,77979854.625,140081110.90625,95527356.734375,129736135.640625,26S proteasome non-ATPase regulatory subunit 6 OS=Homo sapiens OX=9606 GN=PSMD6 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cell surface;cytosol;membrane;nucleus,DNA binding,9861,PSMD6,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,Neutrophil degranulation; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000163636
O75431,0,6,7963102.71875,3.082474068355826e-5,1.46519829447868,0.5510959268330232,0.23481508464291,0.7192904383575112,raw,7046035.375,4933273.90625,6463742.125,9470663.9375,6145443.84375,13719457.125,Metaxin-2 OS=Homo sapiens OX=9606 GN=MTX2 PE=1 SV=1,cell growth;conjugation,cytoskeleton;endosome;membrane;nucleus,NA,10651,MTX2,NA,Mitochondrial protein import; Cristae formation,ENSG00000128654
Q69YN2,0,6,13990520.9609375,5.415655126906117e-5,1.4646381470453524,0.5505442769711938,0.10799242764297604,0.6429522395902524,raw,12945300.8125,11985657.625,9396328.4375,17554651.375,12689352.640625,19371834.875,CWF19-like protein 1 OS=Homo sapiens OX=9606 GN=CWF19L1 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,DNA binding,55280,CWF19L1,NA,NA,ENSG00000095485
Q15024,0,6,10496948.231770834,4.063311985806743e-5,1.464545737982429,0.5504532495027316,0.1998453212528174,0.6904548195096115,raw,7537049.15625,12090316.296875,7213755.75,11038353.21875,10607289.96875,14494925,Exosome complex component RRP42 OS=Homo sapiens OX=9606 GN=EXOSC7 PE=1 SV=3,cellular component movement;cellular homeostasis,cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,23016,EXOSC7,Ciliary landscape,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000075914
Q01082,0,6,176690525.38802084,6.839594839713884e-4,1.4644562845899656,0.5503651280437888,0.1564141443428837,0.6638855679885327,raw,153095446.15625,153754991.5625,140555111.140625,234271113.46875,154264901.734375,224201588.265625,"Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTBN1 PE=1 SV=2",cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,6711,SPTBN1,TGF-beta signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; COPI-mediated anterograde transport; RHOV GTPase cycle; RHOU GTPase cycle; Nephrin family interactions; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins; Signaling by FLT3 fusion proteins,ENSG00000115306
P13804,0,6,84407590.17252605,3.267372242563006e-4,1.464185970576826,0.5500988062104146,0.07774258026834346,0.6429522395902524,raw,85022406.375,54643198.5625,64974942,109820170.75,80007804.7226563,111977018.625,"Electron transfer flavoprotein subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=ETFA PE=1 SV=1",cellular homeostasis,endosome;nucleus,structural molecule activity,2108,ETFA,NA,Respiratory electron transport,ENSG00000140374
P26368,0,6,102648981.078125,3.973486635698412e-4,1.4638477210507346,0.5497654829174201,0.08625744654503233,0.6429522395902524,raw,83678373.21875,87052247.3125,81161104.4375,122492395.9375,100046082,141463683.5625,Splicing factor U2AF 65 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF2 PE=1 SV=4,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,11338,U2AF2,mRNA processing,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,ENSG00000063244
A0A3B3ITH3,0,6,855695.4583333334,3.3123509188343074e-6,1.4637114792982753,0.5496312036169342,0.11586313517440486,0.6429522395902524,raw,697652,587878.75,676237.4375,828602.5,1353985.5625,989816.5,Protein IMPACT OS=Homo sapiens OX=9606 GN=IMPACT PE=1 SV=1,defense response;metabolic process,nucleus,motor activity,NA,IMPACT,NA,NA,ENSG00000154059
Q9NWT8,0.6666666666666666,6,1074116,4.157845042749639e-6,1.4635440860838231,0.5494662044528791,0.20767737371582623,0.6988382857167694,raw,1084284.75,855260.625,707438.375,1071302.125,1035367.25,1691042.875,Aurora kinase A-interacting protein OS=Homo sapiens OX=9606 GN=AURKAIP1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;endosome;Golgi;membrane;nucleus,NA,54998,AURKAIP1,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000175756
P62820,0,6,156922213.57291666,6.074374162580687e-4,1.4634373454214908,0.5493609805367868,0.09160532209047814,0.6429522395902524,raw,115860577.205078,155291708.203125,104421013.279297,190381022.71875,148319274.8125,227259685.21875,Ras-related protein Rab-1A OS=Homo sapiens OX=9606 GN=RAB1A PE=1 SV=3,cell communication;cell death;cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,5861,RAB1A,NA,COPI-dependent Golgi-to-ER retrograde traffic; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; COPI-mediated anterograde transport; COPII-mediated vesicle transport; Golgi Cisternae Pericentriolar Stack Reorganization,ENSG00000138069
O43920,0,6,11994970.088541666,4.6431881585017975e-5,1.4629652392059396,0.5488954907197429,0.0921861500438337,0.6429522395902524,raw,11055762.84375,9802590.90625,8810040.03125,14340849.75,11368146.5625,16592430.4375,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 OS=Homo sapiens OX=9606 GN=NDUFS5 PE=1 SV=3,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,4725,NDUFS5,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000168653
Q96AT9,0,6,5540735.236979167,2.1447886949139645e-5,1.4626174859002343,0.5485525149647583,0.21569951949633345,0.7049259030937425,raw,4265232.046875,5402948.875,3857829,7597463.25,4218490.75,7902447.5,Ribulose-phosphate 3-epimerase OS=Homo sapiens OX=9606 GN=RPE PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,6120,RPE,Pentose phosphate metabolism; Pentose phosphate pathway in senescent cells,Pentose phosphate pathway,ENSG00000197713
P55265,0,6,65361569.575520836,2.530111068505776e-4,1.4617727593901568,0.5477190538472801,0.13079072883674878,0.6498046150645307,raw,60918281.234375,47155953.5,54626155.4375,79851025.96875,58571574.875,91046426.4375,Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens OX=9606 GN=ADAR PE=1 SV=4,cell growth;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,103,ADAR,Measles virus infection; Cytosolic DNA-sensing pathway,Interferon alpha/beta signaling; C6 deamination of adenosine; Formation of editosomes by ADAR proteins,ENSG00000160710
P61769,0,6,12323124.5,4.770214959418874e-5,1.4617424109547679,0.5476891011809283,0.19300234691972568,0.6839501208924997,raw,13611972.5,7388748.75,7562679.75,15451401,10026747.5,19897197.5,Beta-2-microglobulin OS=Homo sapiens OX=9606 GN=B2M PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,567,B2M,IL-18 signaling pathway,"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Amyloid fiber formation; ER-Phagosome pathway; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Neutrophil degranulation; DAP12 signaling; Interferon gamma signaling; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Modulation by Mtb of host immune system; Nef mediated downregulation of MHC class I complex cell surface expression; Endosomal/Vacuolar pathway",ENSG00000166710; ENSG00000273686
Q9H5K3,0,6,1100723.2682291667,4.260840341495539e-6,1.4613280206166606,0.5472800526110906,0.26230005896712566,0.7434453518424705,raw,1062568,622297.6875,957890.34375,1399792,791093.390625,1770698.1875,Protein O-mannose kinase OS=Homo sapiens OX=9606 GN=POMK PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytoskeleton;extracellular,signal transducer activity;structural molecule activity,84197,POMK,NA,O-linked glycosylation,ENSG00000185900
Q03135,0,6,49882333.541666664,1.9309181991237706e-4,1.4612303813267244,0.5471836550716296,0.22067489005030058,0.7095995211052282,raw,39672878.5,50513880.25,34427059.6875,60257280.875,40610485.4375,73812416.5,Caveolin-1 OS=Homo sapiens OX=9606 GN=CAV1 PE=1 SV=4,cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,antioxidant activity;DNA binding;structural molecule activity,857,CAV1,Androgen receptor signaling pathway; Integrin-mediated cell adhesion; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Focal adhesion; TGF-beta signaling pathway; VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host; Acute viral myocarditis; EGF/EGFR signaling pathway; Congenital generalized lipodystrophy,RHOC GTPase cycle; RND2 GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle; RND1 GTPase cycle; RHOH GTPase cycle; Triglyceride catabolism; RHOD GTPase cycle; RHOF GTPase cycle; Extra-nuclear estrogen signaling; NOSTRIN mediated eNOS trafficking; RND3 GTPase cycle; Disassembly of the destruction complex and recruitment of AXIN to the membrane; FOXO-mediated transcription of cell cycle genes; Basigin interactions; VEGFR2 mediated vascular permeability; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; eNOS activation,ENSG00000105974
Q13724,0,6,17623041.40625,6.821784178724477e-5,1.460957023284591,0.5469137392597271,0.1717283654341145,0.6688917965646828,raw,18826973.5,10763627.21875,15075676.1875,22961336.5625,15725196.78125,22385438.1875,Mannosyl-oligosaccharide glucosidase OS=Homo sapiens OX=9606 GN=MOGS PE=1 SV=5,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,7841,MOGS,NA,Maturation of spike protein; N-glycan trimming in the ER and Calnexin/Calreticulin cycle; Maturation of spike protein; Defective MOGS causes CDG-2b,ENSG00000115275
O75131,0,6,129572686.15625,5.01568872273124e-4,1.460599450127252,0.5465605925530872,0.0818395197231723,0.6429522395902524,raw,107740757.21875,108284562.921875,107717866,170436161.4375,125890678.609375,157366090.75,Copine-3 OS=Homo sapiens OX=9606 GN=CPNE3 PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;membrane;mitochondrion;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,8895,CPNE3,NA,Neutrophil degranulation; Glycerophospholipid biosynthesis,ENSG00000085719
Q15428,0,6,22337223.7421875,8.64661870833726e-5,1.460521469542346,0.5464835658183167,0.08683425375615968,0.6429522395902524,raw,22122820,19293746.078125,14071836.4375,29050768.0625,21305241.5,28178930.375,Splicing factor 3A subunit 2 OS=Homo sapiens OX=9606 GN=SF3A2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,8175,SF3A2,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000104897
Q9H0A8,0,6,559244.203125,2.1648041158029057e-6,1.4605203136036724,0.5464824239880275,0.33551890416354113,0.8190608542815858,raw,575281.625,NA,360784.5,638336.9375,NA,662573.75,COMM domain-containing protein 4 OS=Homo sapiens OX=9606 GN=COMMD4 PE=1 SV=1,NA,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,NA,54939,COMMD4,NA,Neddylation,ENSG00000140365
Q86U44,0,6,5402845.174479167,2.0914121962108388e-5,1.460445293854828,0.5464083179325683,0.4444315849556751,0.9271939562980955,raw,4465872.25,5150043,4770287.921875,7521356.0625,3457575.4375,7051936.375,N6-adenosine-methyltransferase catalytic subunit OS=Homo sapiens OX=9606 GN=METTL3 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,56339,METTL3,mRNA processing,Processing of Capped Intron-Containing Pre-mRNA,ENSG00000165819
Q9H0H0,0,6,890525.2369791666,3.447175111456561e-6,1.4604299785914137,0.5463931887315466,0.41130807161385663,0.8972722465169322,raw,648171.921875,1166298.375,342444.375,1256400.78125,500116.03125,1429719.9375,Integrator complex subunit 2 OS=Homo sapiens OX=9606 GN=INTS2 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;membrane;nucleus,NA,57508,INTS2,NA,RNA polymerase II transcribes snRNA genes,ENSG00000108506
Q9UDT6,0,6,4641499.354166667,1.7966993397964027e-5,1.4604102237179564,0.5463736736221968,0.4055351960481319,0.8914071190930648,raw,4694528.03125,1549882.46875,5304511.0625,5075553.4375,3477758.9375,7746762.1875,CAP-Gly domain-containing linker protein 2 OS=Homo sapiens OX=9606 GN=CLIP2 PE=1 SV=1,cell growth,endoplasmic reticulum;membrane;nucleus,motor activity,7461,CLIP2,7q11.23 copy number variation syndrome,NA,ENSG00000106665
Q6P1A2,0,6,3569909.484375,1.3818926868861012e-5,1.460269786929688,0.5462349337003903,0.15999814495506315,0.6638855679885327,raw,3516561.5,2559151.8125,2713799,3962878.6875,3294654.34375,5372411.5625,Lysophospholipid acyltransferase 5 OS=Homo sapiens OX=9606 GN=LPCAT3 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,10162,LPCAT3,Ferroptosis,Acyl chain remodelling of PC; Acyl chain remodelling of PS; Acyl chain remodelling of PE,ENSG00000111684
P23786,0,6,11442522.84375,4.42933881279447e-5,1.4599475574698642,0.5459165472306337,0.17482450760827564,0.6697819849820321,raw,11414971.75,8855209.625,7364512.53125,15056692.0625,9298490.96875,16665260.125,"Carnitine O-palmitoyltransferase 2, mitochondrial OS=Homo sapiens OX=9606 GN=CPT2 PE=1 SV=2",cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;endosome;membrane,structural molecule activity,1376,CPT2,Fatty acid beta-oxidation; PPAR-alpha pathway; Nuclear receptors meta-pathway; Mitochondrial long chain fatty acid beta-oxidation; PPAR signaling pathway; Thermogenesis,PPARA activates gene expression; Carnitine metabolism,ENSG00000157184
P61803,0,6,37929539.25,1.4682319855992312e-4,1.4594125806544744,0.5453877954695108,0.15299576143499988,0.6638855679885327,raw,31398676.5,33486848.5,30942424.25,52119949.5,33805713.25,45823623.5,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 OS=Homo sapiens OX=9606 GN=DAD1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytoskeleton;extracellular,DNA binding,1603,DAD1,NA,Asparagine N-linked glycosylation; Maturation of spike protein,ENSG00000129562
B3KW44,0.16666666666666666,6,359516.98125,1.3916708235187146e-6,1.4592974823125624,0.5452740110897026,0.33551640789934367,0.8190608542815858,raw,384610.0625,324152.5625,222319.53125,NA,353117.8125,513384.9375,Methyltransferase-like protein OS=Homo sapiens OX=9606 GN=METTL8 PE=1 SV=1,cellular component movement;cellular homeostasis,NA,structural molecule activity,79828,METTL8,NA,NA,ENSG00000123600
P51151,0,6,2955843.7864583335,1.144191170662024e-5,1.4590088408911774,0.5449886253196935,0.019144571546050287,0.6429522395902524,raw,2192899.6875,2830796.40625,2230938.15625,3425274.8125,3199460.03125,3855693.625,Ras-related protein Rab-9A OS=Homo sapiens OX=9606 GN=RAB9A PE=1 SV=1,conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,9367,RAB9A,Ebola virus infection in host; Measles virus infection,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Retrograde transport at the Trans-Golgi-Network; RHOBTB3 ATPase cycle,ENSG00000123595
O75489,0,6,21667898.760416668,8.387526621686997e-5,1.4588439774778892,0.5448255961034625,0.11200749528642737,0.6429522395902524,raw,21229643.15625,13892482.6875,17220387.96875,27091783.71875,19602357.96875,30970737.0625,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS3 PE=1 SV=1",cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome;membrane,catalytic activity;structural molecule activity,4722,NDUFS3,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,RHOG GTPase cycle; Complex I biogenesis,ENSG00000213619; ENSG00000285387
Q9NRD1,0,6,432737.453125,1.6751033168558012e-6,1.458750688983932,0.5447333373334577,0.40776633529035794,0.8921091312456526,raw,223948.4375,582931.5,286116.90625,511534.5625,326684.9375,665208.375,F-box only protein 6 OS=Homo sapiens OX=9606 GN=FBXO6 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development,cytosol;extracellular;nucleus,structural molecule activity,26270,FBXO6,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation; Association of TriC/CCT with target proteins during biosynthesis,ENSG00000116663
Q9H1K0,0.3333333333333333,6,1021405.30078125,3.9538047720092844e-6,1.4585676021489933,0.5445522542682553,0.07843022084655484,0.6429522395902524,raw,1065758.625,821798.2578125,714090.1875,1215214.59375,1041548.8125,1270021.328125,Rabenosyn-5 OS=Homo sapiens OX=9606 GN=RBSN PE=1 SV=2,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,64145,RBSN,NA,Factors involved in megakaryocyte development and platelet production; Toll Like Receptor 9 (TLR9) Cascade,ENSG00000131381
Q9UHF1,0,6,821573.2447916666,3.180265672527704e-6,1.4585391302098114,0.5445240918942099,0.1535065888327216,0.6638855679885327,raw,692483.125,792372.125,478535.53125,1131119.25,679223.6875,1155705.75,Epidermal growth factor-like protein 7 OS=Homo sapiens OX=9606 GN=EGFL7 PE=1 SV=3,cell communication;defense response;metabolic process,cell surface;nucleus,antioxidant activity;structural molecule activity,51162,EGFL7,NA,NA,ENSG00000172889
Q5JTH9,0,6,53607372.17578125,2.0751124334420773e-4,1.4584058961501165,0.544392299134596,0.22789999383041984,0.7148463313429879,raw,46081230.0625,46622811.65625,42021614.453125,76973235.1875,42740204.0703125,67205137.625,RRP12-like protein OS=Homo sapiens OX=9606 GN=RRP12 PE=1 SV=2,cellular component movement;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,NA,23223,RRP12,NA,NA,ENSG00000052749
O15355,0,6,71863770.69791667,2.7818077633107565e-4,1.4583865451454483,0.5443731564639855,0.018525144492830534,0.6429522395902524,raw,51487921.875,67068999.8125,53427607.125,92599358.0625,75089292.5,91509444.8125,Protein phosphatase 1G OS=Homo sapiens OX=9606 GN=PPM1G PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;membrane;nucleus,structural molecule activity,5496,PPM1G,VEGFA-VEGFR2 signaling pathway; mRNA processing,NA,ENSG00000115241
Q53T59,0,6,507529.875,1.964620743770779e-6,1.4582975456339755,0.544285111855871,0.18967732127804018,0.6806579357154494,raw,515663.96875,271294.5,460308.34375,601411.8125,444509.125,751991.5,HCLS1-binding protein 3 OS=Homo sapiens OX=9606 GN=HS1BP3 PE=1 SV=1,metabolic process,endosome;extracellular,structural molecule activity,64342,HS1BP3,NA,NA,ENSG00000118960
C9JVC9,0.16666666666666666,6,12592931.666666666,4.8746558569032536e-5,1.4582713833948147,0.5442592292975531,0.12312554248623774,0.6445597830897484,raw,8845501,12645291,8648104,15766501,11211927,18440266,Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=1,conjugation;metabolic process,cytoskeleton,catalytic activity,NA,CACNA2D2,MAPK signaling pathway,NA,ENSG00000007402
Q9UKF6,0,6,12149227.1171875,4.702900221432093e-5,1.457908885768378,0.5439005590629191,0.09063851478127302,0.6429522395902524,raw,10693082.890625,10272428.34375,9551305.15625,15589540.5625,11447426.46875,15341579.28125,Cleavage and polyadenylation specificity factor subunit 3 OS=Homo sapiens OX=9606 GN=CPSF3 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,51692,CPSF3,mRNA processing,Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs,ENSG00000119203
Q15054,0.5,6,3170244,1.2271843357427678e-5,1.457600638474925,0.5435954961985441,0.07185987698961441,0.6429522395902524,raw,2554838,2876440.5,2437682.25,3723933.5,3117163.25,4311406.5,DNA polymerase delta subunit 3 OS=Homo sapiens OX=9606 GN=POLD3 PE=1 SV=2,cell proliferation;cellular homeostasis;coagulation,membrane;nucleus,structural molecule activity,10714,POLD3,"Homologous recombination; Retinoblastoma gene in cancer; Pyrimidine metabolism; DNA replication; Base excision repair; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Removal of the Flap Intermediate; Gap-filling DNA repair synthesis and ligation in GG-NER; Removal of the Flap Intermediate from the C-strand; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),ENSG00000077514
Q15022,0,6,1415712.5442708333,5.480146822275214e-6,1.4575511221871047,0.5435464854376963,0.044619388539959136,0.6429522395902524,raw,1072878.40625,1129237.25,1184990.328125,1972253.4375,1571140.71875,1563775.125,Polycomb protein SUZ12 OS=Homo sapiens OX=9606 GN=SUZ12 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,23512,SUZ12,Interactome of polycomb repressive complex 2 (PRC2) ; Tumor suppressor activity of SMARCB1; Epithelial to mesenchymal transition in colorectal cancer; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; Malignant pleural mesothelioma,HCMV Early Events; SUMOylation of chromatin organization proteins; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6; Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; PRC2 methylates histones and DNA; Defective pyroptosis,ENSG00000178691
P21980,0,6,5310397.041666667,2.0556260231414577e-5,1.4571519795420529,0.5431513569473321,0.2116027081853201,0.7020295967770634,raw,5923149.8125,1126577.625,4963645.65625,7232786.09375,5107237.5625,7508985.5,Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens OX=9606 GN=TGM2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,chromosome;cytoplasm;cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,structural molecule activity,7052,TGM2,IL-18 signaling pathway,NA,ENSG00000198959
Q8TEA8,0,6,6587345.989583333,2.5499260664272554e-5,1.4569386422212678,0.5429401207606573,0.20136719305709394,0.691648270213144,raw,6986127.25,4766495.625,4519719.625,6994483.625,6078891.0625,10178358.75,D-aminoacyl-tRNA deacylase 1 OS=Homo sapiens OX=9606 GN=DTD1 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,92675,DTD1,NA,NA,ENSG00000125821
A0A0B4J1W0,0,6,565355.91015625,2.188462203739982e-6,1.4568408039648209,0.5428432357561158,1,1,raw,NA,NA,408498.90625,595117.875,199780.765625,1058026.09375,Mediator complex subunit 24 OS=Homo sapiens OX=9606 GN=MED24 PE=1 SV=1,NA,membrane,NA,NA,MED24,NA,NA,ENSG00000008838
Q9NZJ7,0,6,8600208.541666666,3.329094292570063e-5,1.4563251244756321,0.5423324730547893,0.1849069651355289,0.6773201656444218,raw,8388231.90625,6778414,6712226.5,12215992.875,7512183.96875,9994202,Mitochondrial carrier homolog 1 OS=Homo sapiens OX=9606 GN=MTCH1 PE=1 SV=1,cell growth;defense response;metabolic process,cytoskeleton;endosome,NA,23787,MTCH1,IL-18 signaling pathway,NA,ENSG00000137409
Q9Y450,0,6,13276955.268229166,5.13943769991466e-5,1.456146970995575,0.5421559761586193,0.2216672669263341,0.7104176293723399,raw,12074601.90625,11294568.65625,10372483.03125,18670419.5,10803106.578125,16446551.9375,HBS1-like protein OS=Homo sapiens OX=9606 GN=HBS1L PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development,cytosol,RNA binding;structural molecule activity,10767,HBS1L,NA,mRNA decay by 3' to 5' exoribonuclease,ENSG00000112339
Q7L5N1,0,6,18507960.375,7.164331533707766e-5,1.456052961236159,0.5420628318574671,0.04062669026011046,0.6429522395902524,raw,16169033.46875,15330927.46875,14200285.1875,23542969.0625,18639490.1875,23165056.875,COP9 signalosome complex subunit 6 OS=Homo sapiens OX=9606 GN=COPS6 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,NA,10980,COPS6,Nucleotide-binding oligomerization domain (NOD) pathway; Ciliary landscape,Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; DNA Damage Recognition in GG-NER,ENSG00000168090
Q9ULC3,0,6,4392529.098958333,1.700324298235707e-5,1.455771982862423,0.5417844043314815,0.09532124642164558,0.6429522395902524,raw,3415708.875,4297694.03125,3050628.15625,4785141.78125,4441019,6364982.75,Ras-related protein Rab-23 OS=Homo sapiens OX=9606 GN=RAB23 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,structural molecule activity,51715,RAB23,Genes related to primary cilium development (based on CRISPR); Ciliopathies; Bardet-Biedl syndrome,RAB geranylgeranylation,ENSG00000112210
P15153,0,6,10469521.854166666,4.052695383115593e-5,1.455593422544841,0.5416074371362819,0.1251302336586737,0.6449267539975253,raw,8806263,8941353.75,8686511.5,13955134.75,9609529.625,12818338.5,Ras-related C3 botulinum toxin substrate 2 OS=Homo sapiens OX=9606 GN=RAC2 PE=1 SV=1,cell communication;cell differentiation;cell growth;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;nucleus,DNA binding;structural molecule activity,5880,RAC2,Integrin-mediated cell adhesion; RalA downstream regulated genes; B cell receptor signaling pathway; Focal adhesion; MAPK signaling pathway; Chemokine signaling pathway; Microglia pathogen phagocytosis pathway; Macrophage markers; Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Insulin signaling; Regulation of actin cytoskeleton; DNA damage response (only ATM dependent),"RAC2 GTPase cycle; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; GPVI-mediated activation cascade; PCP/CE pathway; ROS and RNS production in phagocytes; RHO GTPases Activate NADPH Oxidases",ENSG00000128340
Q53GQ0,0,6,32235235.005208332,1.24780854272979e-4,1.455568193861561,0.5415824317940487,0.16486570022904454,0.6638855679885327,raw,29522185.6875,25949925.125,25459367.75,42047756.625,27460620.34375,42971554.5,Very-long-chain 3-oxoacyl-CoA reductase OS=Homo sapiens OX=9606 GN=HSD17B12 PE=1 SV=2,cell growth;cellular homeostasis;metabolic process,chromosome;cytoskeleton;extracellular,structural molecule activity,51144,HSD17B12,Mitochondrial fatty acid synthesis pathway,Synthesis of very long-chain fatty acyl-CoAs; Androgen biosynthesis,ENSG00000149084
P80217,0,6,343977.1432291667,1.3315169495609165e-6,1.4555596456710762,0.5415739591795152,0.3528106594561321,0.8381547534932687,raw,457129.78125,172332.8125,200210.109375,417818.84375,250840.6875,565530.625,Interferon-induced 35 kDa protein OS=Homo sapiens OX=9606 GN=IFI35 PE=1 SV=5,coagulation;metabolic process,cell surface;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,3430,IFI35,Immune response to tuberculosis,Interferon alpha/beta signaling,ENSG00000068079
Q5T5Y3,0,6,502977.8619791667,1.9470001471376373e-6,1.4554291044922678,0.541444565954334,0.23245451696947542,0.7186532064941494,raw,377919.859375,349305.5625,462012.5625,854208.5625,550035.5625,424385.0625,Calmodulin-regulated spectrin-associated protein 1 OS=Homo sapiens OX=9606 GN=CAMSAP1 PE=1 SV=2,cell growth;defense response;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,157922,CAMSAP1,NA,NA,ENSG00000130559
Q5JRA6,0,6,17839719.223958332,6.905658992080986e-5,1.4551530318724026,0.5411708828338181,0.04934017589134374,0.6429522395902524,raw,16332801.75,10666060.8125,15901922.765625,23139731.125,17847628.84375,23150170.046875,Transport and Golgi organization protein 1 homolog OS=Homo sapiens OX=9606 GN=MIA3 PE=1 SV=1,cell growth;coagulation;conjugation;defense response;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,375056,MIA3,Type I collagen synthesis in the context of osteogenesis imperfecta,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Cargo concentration in the ER,ENSG00000154305
A9Z1X7,0,6,22439894.598958332,8.686362042656781e-5,1.4551051230637577,0.5411233834045761,0.02093250179426004,0.6429522395902524,raw,20527857.625,18567012.625,15926955.0625,27910649.5,23175393.90625,28531498.875,Serine/arginine repetitive matrix protein 1 OS=Homo sapiens OX=9606 GN=SRRM1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,NA,NA,SRRM1,NA,NA,ENSG00000133226
O00299,0,6,368068701.0364583,0.0014247740690909894,1.4548682311096857,0.5408884926983563,0.053724490550003806,0.6429522395902524,raw,312711939.96875,336345870.859375,249955229.96875,445279447.4375,363651923.28125,500467794.703125,Chloride intracellular channel protein 1 OS=Homo sapiens OX=9606 GN=CLIC1 PE=1 SV=4,conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;endosome;membrane;nucleus,catalytic activity,1192,CLIC1,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000206394; ENSG00000213719; ENSG00000223639; ENSG00000226248; ENSG00000226417; ENSG00000226651; ENSG00000230685
Q6NZY4,0,6,2136892.765625,8.271796521457155e-6,1.454443456341858,0.5404672106074497,0.042389076388723,0.6429522395902524,raw,1500236.203125,1577972.6875,2017791.21875,2934763.234375,2140208.5625,2650384.6875,Zinc finger CCHC domain-containing protein 8 OS=Homo sapiens OX=9606 GN=ZCCHC8 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,55596,ZCCHC8,NA,NA,ENSG00000033030
J3QL71,0,6,8717943.067708334,3.374668691933151e-5,1.4540925515953118,0.540119098334649,0.29443584506341436,0.775959987643776,raw,8848599.5,5919627.1875,7188982.96875,11222233.6875,6261532.4375,12866682.625,Secernin-2 OS=Homo sapiens OX=9606 GN=SCRN2 PE=1 SV=1,cell organization and biogenesis,NA,structural molecule activity,NA,SCRN2,NA,NA,ENSG00000141295
A0A0D9SFG6,0.16666666666666666,6,760014.1458333334,2.9419737241347552e-6,1.4537996911805504,0.5398285041625114,0.0803323178392257,0.6429522395902524,raw,652100.28125,751267.9375,377948.8125,773628.65625,948023.1875,1057116,Cytohesin-2 OS=Homo sapiens OX=9606 GN=CYTH2 PE=1 SV=1,metabolic process,NA,DNA binding,NA,CYTH2,2q37 copy number variation syndrome,NA,ENSG00000105443
Q07960,0,6,16592562.875325516,6.42289150312293e-5,1.4535680343215487,0.5395985984650342,0.21692369947280546,0.7052519353827845,raw,14154927.5957031,14524493.03125,12640002.375,20575150.28125,13387501.8125,24273302.15625,Rho GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=ARHGAP1 PE=1 SV=1,conjugation;development;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,DNA binding;structural molecule activity,392,ARHGAP1,NA,RHOC GTPase cycle; RND2 GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle,ENSG00000175220
P17568,0,6,6919754.890625,2.678599757291366e-5,1.4526267452683834,0.5386640478244038,0.08884407888428514,0.6429522395902524,raw,5438812.5,5407961.125,6250679.96875,7900564.5,6820448.625,9700062.625,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 OS=Homo sapiens OX=9606 GN=NDUFB7 PE=1 SV=4,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,4713,NDUFB7,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000099795
O95373,0,6,57172844.9609375,2.2131299598993748e-4,1.4525697275993092,0.5386074188774839,0.2769142735747933,0.7566344694307385,raw,53495690.8125,49656864.921875,44467808.625,77706221.03125,43561558.9375,74148925.4375,Importin-7 OS=Homo sapiens OX=9606 GN=IPO7 PE=1 SV=1,coagulation;conjugation;metabolic process,cytosol;membrane,DNA binding;structural molecule activity,10527,IPO7,NA,NA,ENSG00000205339
D5H3J5,0,6,9687434.041666666,3.749953413514727e-5,1.4516978213839498,0.5377411799448822,0.05082677357717063,0.6429522395902524,raw,9243463.5,6073542.75,8021290.625,11644490.125,9801893.625,13339923.625,HLA class I histocompatibility antigen B alpha chain OS=Homo sapiens OX=9606 GN=HLA-B PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,NA,NA,HLA-B,NA,NA,ENSG00000228964
Q9UG63,0,6,30928696.213541668,1.1972331315256804e-4,1.4511643373283438,0.537210906877819,0.1304488651493005,0.6498046150645307,raw,20220531.625,31165270.25,22883280.34375,45225928.75,27281192.4375,38795973.875,ATP-binding cassette sub-family F member 2 OS=Homo sapiens OX=9606 GN=ABCF2 PE=1 SV=2,NA,NA,structural molecule activity,10061; 114483834,ABCF2,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000033050
Q93008,0,6,18087047.221354168,7.001398324509278e-5,1.4511351978754665,0.5371819371979829,0.24783789687872063,0.7316541032247736,raw,14057941.890625,16961703.9375,15463618.78125,22439801.5,14384086.375,25215130.84375,Probable ubiquitin carboxyl-terminal hydrolase FAF-X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,8239,USP9X,Ciliopathies; Bardet-Biedl syndrome,Ub-specific processing proteases; Amyloid fiber formation; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Peroxisomal protein import; RHOV GTPase cycle; RHOU GTPase cycle; Downregulation of SMAD2/3:SMAD4 transcriptional activity,ENSG00000124486
Q9Y2G5,0.16666666666666666,6,992420.8294270834,3.8416074483155305e-6,1.4508581492575539,0.5369064736661613,0.41765810985073154,0.9038582714714452,raw,1218203,625701.5390625,543217.625,1290405.71875,509557.34375,1767439.75,GDP-fucose protein O-fucosyltransferase 2 OS=Homo sapiens OX=9606 GN=POFUT2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytoskeleton;extracellular,structural molecule activity,23275,POFUT2,NA,O-glycosylation of TSR domain-containing proteins,ENSG00000186866
Q96QU8,0,6,9952786.5,3.852669917454961e-5,1.450724349205114,0.5367734202910706,0.13251462623957697,0.6514609890946903,raw,7530829,10923439,6970162,10925157,10168484,13198648,Exportin-6 OS=Homo sapiens OX=9606 GN=XPO6 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,23214,XPO6,NA,NA,ENSG00000169180
Q9H5V9,0,6,574577.8203125,2.2241597200490646e-6,1.4506841079156505,0.5367334011695922,0.2347921645560407,0.7192904383575112,raw,NA,562126.6875,383202.53125,NA,595296.0625,757686,UPF0428 protein CXorf56 OS=Homo sapiens OX=9606 GN=CXorf56 PE=1 SV=1,cell growth;conjugation,membrane;nucleus,NA,63932,STEEP1,NA,NA,ENSG00000018610
Q96GQ7,0,6,24491683.583333332,9.480598480569624e-5,1.449740237451247,0.5357944231966063,0.10476432918777223,0.6429522395902524,raw,20018161.875,21562005,19272434.625,29021134.75,23237637.375,33838727.875,Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,structural molecule activity,55661,DDX27,NA,NA,NA
E7ESA6,0,6,12082614.429036466,4.6771148095014445e-5,1.4496220966557656,0.5356768517307312,0.06577196911023797,0.6429522395902524,raw,11437812.25,9211235.90625,7912036.9375,15911372.625,11442723.4804688,16580505.375,Non-specific protein-tyrosine kinase OS=Homo sapiens OX=9606 GN=PTK2 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,signal transducer activity;structural molecule activity,NA,PTK2,Primary focal segmental glomerulosclerosis (FSGS); Overview of nanoparticle effects; MFAP5-mediated ovarian cancer cell motility and invasiveness; RAC1/PAK1/p38/MMP2 pathway; Physico-chemical features and toxicity-associated pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; PI3K-Akt signaling pathway; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Malignant pleural mesothelioma; 2q13 copy number variation syndrome,NA,ENSG00000169398
Q99943,0,6,1380883.9895833333,5.345327367529585e-6,1.449275848669102,0.5353322171385004,0.26538609233661886,0.7454335379461359,raw,828784.8125,1288508.53125,1189617.8125,1391717.90625,1201137.8125,2385537.0625,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Homo sapiens OX=9606 GN=AGPAT1 PE=1 SV=2,cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,10554,AGPAT1,Triacylglyceride synthesis,ChREBP activates metabolic gene expression; Synthesis of PA,ENSG00000204310; ENSG00000206324; ENSG00000226467; ENSG00000227642; ENSG00000228892; ENSG00000235758; ENSG00000236873
O00499,0,6,2846070.9479166665,1.101698697543755e-5,1.449218553536292,0.5352751810414703,0.20987252936854423,0.6997404039201699,raw,2937063.40625,1987684.75,2194830.03125,4256446.78125,2437562.90625,3262837.8125,Myc box-dependent-interacting protein 1 OS=Homo sapiens OX=9606 GN=BIN1 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,DNA binding;motor activity;structural molecule activity,274,BIN1,VEGFA-VEGFR2 signaling pathway; IL-18 signaling pathway,Clathrin-mediated endocytosis,ENSG00000136717
Q562E7,0.5,6,120955.93671875,4.6821390043272213e-7,1.4485806007325177,0.5346399600946773,0.4235729807236733,0.9086347256931654,raw,130870.2890625,NA,54341.73046875,157427.046875,83088.1796875,179052.4375,WD repeat-containing protein 81 OS=Homo sapiens OX=9606 GN=WDR81 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;endosome;mitochondrion,DNA binding;structural molecule activity,124997,WDR81,NA,CDC42 GTPase cycle,ENSG00000167716; ENSG00000276021
O76094,0,6,54279380.119791664,2.1011254981268234e-4,1.448510660457148,0.5345703023039092,0.1932137858934404,0.6839501208924997,raw,49228063.0625,46572879.625,44649463.0625,71467345.71875,46297216.625,67461312.625,Signal recognition particle subunit SRP72 OS=Homo sapiens OX=9606 GN=SRP72 PE=1 SV=3,conjugation,cytosol;extracellular;Golgi;nucleus,RNA binding;structural molecule activity,6731,SRP72,NA,SRP-dependent cotranslational protein targeting to membrane,ENSG00000174780
Q8WZA6,0.5,6,791766.75,3.0648863404897545e-6,1.4481489920052486,0.5342100409357716,0.1343251590109336,0.6527000726250668,raw,621868.9375,666020.875,615139.0625,900558.875,752416.875,1194595.875,Olfactory receptor 1E3 OS=Homo sapiens OX=9606 GN=OR1E3 PE=3 SV=2,development;metabolic process,cytoplasm;cytoskeleton,structural molecule activity,NA,OR1E3,NA,Expression and translocation of olfactory receptors,NA
Q9P212,0.3333333333333333,6,1717857.2083333333,6.649732503584794e-6,1.4479358677440421,0.5339977037079755,1,1,raw,1322828.875,NA,NA,NA,1647244.75,2183498,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 OS=Homo sapiens OX=9606 GN=PLCE1 PE=1 SV=3",cell growth;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,DNA binding;structural molecule activity,51196,PLCE1,"Primary focal segmental glomerulosclerosis (FSGS); GPR40 pathway; Ras signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Resistin as a regulator of inflammation; Nephrotic syndrome",Synthesis of IP3 and IP4 in the cytosol,ENSG00000138193
Q96IZ0,0,6,5340622.653645833,2.0673261943456526e-5,1.4473675281439704,0.533431310055234,0.010592829819673176,0.6429522395902524,raw,4453032.53125,4763275.5625,3587443.171875,6445174.6875,6018194.21875,6776615.75,PRKC apoptosis WT1 regulator protein OS=Homo sapiens OX=9606 GN=PAWR PE=1 SV=1,cell growth;cellular component movement;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,5074,PAWR,NA,NA,ENSG00000177425
F8W8A6,0.8333333333333334,6,1628265.53125,6.302927958793948e-6,1.4470677677770476,0.533132486449144,0.24129458519936595,0.727008366442287,raw,1805465.375,846723.6875,1108611.125,2612630.75,1136046,2260116.25,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=HIBCH PE=1 SV=1",cellular homeostasis,NA,structural molecule activity,NA,HIBCH,Amino acid metabolism,NA,ENSG00000198130
P61981,0,6,326212070.4384767,0.0012627493119530073,1.4470351541008886,0.53309997095807,0.09839466210574113,0.6429522395902524,raw,271533475.375,292837543.236328,256176091.5,392918484.382813,307699015,436107813.136719,14-3-3 protein gamma OS=Homo sapiens OX=9606 GN=YWHAG PE=1 SV=2,conjugation;development;metabolic process,cytosol;nucleus,antioxidant activity;DNA binding;structural molecule activity,7532,YWHAG,Cell cycle; Prolactin signaling pathway; Myometrial relaxation and contraction pathways; Disruption of postsynaptic signaling by CNV; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,TP53 Regulates Metabolic Genes; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Regulation of localization of FOXO transcription factors; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Activation of BAD and translocation to mitochondria,ENSG00000170027
E9PFW3,0,6,36366487.502604164,1.4077270963743155e-4,1.4468530184150274,0.5329183701252505,0.12127750579793849,0.6445597830897484,raw,29754843.53125,33726803.796875,29090651.5625,48797727.875,33540275,43288623.25,AP-2 complex subunit mu OS=Homo sapiens OX=9606 GN=AP2M1 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton,structural molecule activity,1173,AP2M1,Synaptic vesicle pathway; GABA receptor signaling; EGF/EGFR signaling pathway; Fragile X syndrome; GDNF signaling,NA,ENSG00000161203
A0A2R8Y5S7,0,6,50233005.54101563,1.944492522885117e-4,1.4466544556086616,0.5327203643629911,0.07836949079646359,0.6429522395902524,raw,41615382.6621094,48622365.2148438,33430724.7753906,60203078.75,48400335.5,69126146.34375,Radixin OS=Homo sapiens OX=9606 GN=RDX PE=1 SV=1,NA,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,motor activity,NA,RDX,NA,NA,ENSG00000137710
O95372,0,6,22450703.114583332,8.690545960698304e-5,1.4462790364141902,0.5323459240831491,0.11399895912473229,0.6429522395902524,raw,21672950.4375,16991977,15633079.875,29133051,19928026.5,31345133.875,Acyl-protein thioesterase 2 OS=Homo sapiens OX=9606 GN=LYPLA2 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;defense response,cytosol;extracellular;nucleus,structural molecule activity,11313,LYPLA2,NA,L1CAM interactions,ENSG00000011009
Q9BUR4,0,6,305377.71875,1.1821006614470702e-6,1.4462491849410977,0.5323161462770918,0.5630158529653004,1,raw,206078.4375,422749.71875,230715.6875,NA,325648.46875,341696.28125,Telomerase Cajal body protein 1 OS=Homo sapiens OX=9606 GN=WRAP53 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,55135,WRAP53,NA,Association of TriC/CCT with target proteins during biosynthesis; Telomere Extension By Telomerase,ENSG00000141499
Q14966,0,6,7445793.080729167,2.882226300515897e-5,1.4461991047957745,0.5322661883382976,0.03373485434759668,0.6429522395902524,raw,5376671.46875,7330756.6875,5325778.453125,9165283.75,7702136.03125,9774132.09375,Zinc finger protein 638 OS=Homo sapiens OX=9606 GN=ZNF638 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,27332,ZNF638,NA,Transcriptional regulation of white adipocyte differentiation,ENSG00000075292
Q92734,0,6,41468898.140625,1.6052386572985356e-4,1.4459950576763294,0.5320626212530449,0.08014911685815136,0.6429522395902524,raw,39341312.5,27795377.46875,31275490.875,55200871.25,38312993.3125,56887343.4375,Protein TFG OS=Homo sapiens OX=9606 GN=TFG PE=1 SV=2,cell growth;conjugation,cytosol;extracellular;nucleus,structural molecule activity,10342,TFG,NA,Signaling by ALK fusions and activated point mutants; COPII-mediated vesicle transport,ENSG00000114354
P28290,0,6,54962259.53125,2.1275593914467985e-4,1.445584611435435,0.531653053592439,0.0883455896022426,0.6429522395902524,raw,48393612.84375,46672415.21875,40902774.84375,67468925.21875,51941160.375,74394668.6875,Protein ITPRID2 OS=Homo sapiens OX=9606 GN=ITPRID2 PE=1 SV=3,NA,cytoplasm;cytoskeleton;cytosol;membrane,antioxidant activity;motor activity,6744,ITPRID2,NA,NA,ENSG00000138434
A0A087WVQ6,0,6,855655001.5787768,0.003312194312921744,1.445511996755336,0.531580582241188,0.09016042634284194,0.6429522395902524,raw,768952447.046875,729264918.4375,620272004.941406,1110868211.59375,793042440.3125,1111529987.14063,Clathrin heavy chain OS=Homo sapiens OX=9606 GN=CLTC PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;mitochondrion,structural molecule activity,1213,CLTC,Synaptic vesicle pathway; VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host; Fragile X syndrome; 7q11.23 copy number variation syndrome; Complement and coagulation cascades,NA,ENSG00000141367
Q96N66,0,6,14704201.489583334,5.691917006268963e-5,1.4454056817457752,0.5314744705118397,0.13457629945497096,0.6527000726250668,raw,14285653.25,11653978.125,10684169.625,17782057,13170786.5625,20648564.375,Lysophospholipid acyltransferase 7 OS=Homo sapiens OX=9606 GN=MBOAT7 PE=1 SV=2,cellular homeostasis;defense response;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,79143,MBOAT7,NA,Acyl chain remodelling of PI,ENSG00000125505; ENSG00000273592; ENSG00000274194; ENSG00000275118; ENSG00000276935; ENSG00000277025; ENSG00000277733; ENSG00000277923; ENSG00000278322; ENSG00000278519
Q9Y6G9,0,6,20728071.223958332,8.023724456603998e-5,1.4453210987375382,0.5313900436560153,0.03270552381503789,0.6429522395902524,raw,16708357.5625,20355731,14872164.125,25878608.8125,21495052.59375,25058513.25,Cytoplasmic dynein 1 light intermediate chain 1 OS=Homo sapiens OX=9606 GN=DYNC1LI1 PE=1 SV=3,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,51143,DYNC1LI1,Ciliary landscape; Intraflagellar transport proteins binding to dynein,MHC class II antigen presentation; RHO GTPases Activate Formins; HCMV Early Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Neutrophil degranulation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000144635
A0A2R8YDH4,0,6,4500285.809895833,1.7420363392438e-5,1.4452644428405286,0.5313334895907661,0.13376985430766242,0.6514609890946903,raw,2869084.875,3679514.734375,4097562.78125,6944160.84375,4093519.8125,5317871.8125,Uncharacterized protein OS=Homo sapiens OX=9606 PE=1 SV=1,NA,cytoplasm;cytoskeleton;nucleus,NA,NA,NA,NA,NA,NA
Q8WU90,0,6,28798613.165364582,1.1147787667968416e-4,1.445149907029805,0.5312191528720677,0.06185054118306713,0.6429522395902524,raw,23208656.109375,24531838.609375,22039508.609375,33539987.21875,29474559.828125,39997128.6171875,Zinc finger CCCH domain-containing protein 15 OS=Homo sapiens OX=9606 GN=ZC3H15 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;membrane,structural molecule activity,55854,ZC3H15,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000065548
O00233,0,6,14919779.489583334,5.775366086128669e-5,1.4449831488568068,0.5310526683643809,0.0580671409420136,0.6429522395902524,raw,12408319.875,11416650.8125,12654087.5,20127742.25,14982063.375,17929813.125,26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens OX=9606 GN=PSMD9 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5715,PSMD9,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000110801
Q9NYL2,0,6,475516.7708333333,1.8406997459805936e-6,1.444931758514528,0.5310013584854818,1,1,raw,NA,366735.3125,NA,490742.75,NA,569072.25,Mitogen-activated protein kinase kinase kinase 20 OS=Homo sapiens OX=9606 GN=MAP3K20 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,51776,MAP3K20,MAPK signaling pathway,NA,ENSG00000091436
P40616,0,6,12811914.481770834,4.959422922306639e-5,1.4448269525480446,0.530896710960698,0.13380113014857636,0.6514609890946903,raw,12830519.75,8200282.578125,8390344.5,18537880.75,10611754.6875,18300704.625,ADP-ribosylation factor-like protein 1 OS=Homo sapiens OX=9606 GN=ARL1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,DNA binding;structural molecule activity,400,ARL1,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000120805
Q9BQF6,0.8333333333333334,6,4228827.791666667,1.6369564060327894e-5,1.444362948813355,0.5304333174728345,0.02353963726976361,0.6429522395902524,raw,3261537.5,3782070.5,3387485.25,5462682.5,4399975,5079216,Sentrin-specific protease 7 OS=Homo sapiens OX=9606 GN=SENP7 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;coagulation,membrane;nucleus,structural molecule activity,57337,SENP7,NA,NA,ENSG00000138468
Q8NE71,0,6,64080937.484375,2.480538491691383e-4,1.4441629093801795,0.5302334952016458,0.04220160886781837,0.6429522395902524,raw,50962974.25,58958994.5,47834292.8125,77161629.53125,64421340.78125,85146393.03125,ATP-binding cassette sub-family F member 1 OS=Homo sapiens OX=9606 GN=ABCF1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;Golgi;membrane;nucleus,protein binding;RNA binding;structural molecule activity,23,ABCF1,IL-18 signaling pathway,ABC-family proteins mediated transport,ENSG00000204574; ENSG00000206490; ENSG00000225989; ENSG00000231129; ENSG00000232169; ENSG00000236149; ENSG00000236342
Q96QE5,0,6,546994.5872395834,2.1173865140869207e-6,1.4441095366889158,0.5301801757738899,0.18205642846929743,0.6743269455727479,raw,491926.5,104047.0859375,603667.390625,811753.09375,560177.703125,710395.75,"Transcription elongation factor, mitochondrial OS=Homo sapiens OX=9606 GN=TEFM PE=1 SV=1",cellular component movement;cellular homeostasis,endosome;nucleus,DNA binding,79736,TEFM,NA,NA,ENSG00000172171
P00367,0,6,98282139.48177083,3.8044485552315527e-4,1.4441092594870022,0.5301798988434671,0.06348534173491098,0.6429522395902524,raw,86470801.15625,78454657.375,80570900.234375,123181013.0625,96142180.4375,124873284.625,"Glutamate dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=GLUD1 PE=1 SV=2",cellular homeostasis;metabolic process,endosome;extracellular;nucleus,structural molecule activity,2746,GLUD1,VEGFA-VEGFR2 signaling pathway; Amino acid metabolism; Metabolic reprogramming in colon cancer; 22q11.2 copy number variation syndrome; Amino acid metabolism pathway excerpt: histidine catabolism extension,Transcriptional activation of mitochondrial biogenesis; Glutamate and glutamine metabolism,ENSG00000148672
P67936,0,6,150474388.294271,5.824782327328883e-4,1.4436892157857215,0.5297602054512468,0.09012425126071832,0.6429522395902524,raw,128567626.578125,126969121.882813,107454999.5625,183303952,142972318.367188,213578311.375,Tropomyosin alpha-4 chain OS=Homo sapiens OX=9606 GN=TPM4 PE=1 SV=3,cell growth;metabolic process,cytosol;endoplasmic reticulum,motor activity;structural molecule activity,7171,TPM4,Striated muscle contraction pathway,RHOV GTPase cycle; Signaling by ALK fusions and activated point mutants; Smooth Muscle Contraction; Striated Muscle Contraction,ENSG00000167460
O75394,0.16666666666666666,6,981123.4114583334,3.797875753324265e-6,1.4436191779445215,0.5296902141427928,0.4340962307601906,0.9176747809749992,raw,1082295.5625,936574.5625,331086.96875,450086.25,1352057,1734640.125,"39S ribosomal protein L33, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL33 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,9553,MRPL33,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000243147
Q9HC52,0,6,6337415.815104167,2.453179445299579e-5,1.443536218386884,0.529607305309702,0.15281847051073877,0.6638855679885327,raw,5462928.96875,3896951.0625,6518200.515625,7926779.375,5625390,8594244.96875,Chromobox protein homolog 8 OS=Homo sapiens OX=9606 GN=CBX8 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,57332,CBX8,NA,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription,ENSG00000141570
P26447,0,6,131328648.01041667,5.083661058033986e-4,1.4433304110648915,0.5294016032517744,0.03983216759445658,0.6429522395902524,raw,119323285.6875,92587157.5,119743519.5625,142339150.1875,141149311.8125,172829463.3125,Protein S100-A4 OS=Homo sapiens OX=9606 GN=S100A4 PE=1 SV=1,metabolic process,membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,6275,S100A4,Vitamin D receptor pathway,NA,ENSG00000196154
P10301,0,6,13656547.447916666,5.2863757831924627e-5,1.4427913234863503,0.528862652329573,0.06182379957577034,0.6429522395902524,raw,13629354.8125,10897749.8125,9200666.75,15723178.875,13906856.0625,18581478.375,Ras-related protein R-Ras OS=Homo sapiens OX=9606 GN=RRAS PE=1 SV=1,defense response;development;metabolic process,cytoplasm;cytoskeleton,structural molecule activity,6237,RRAS,G protein signaling pathways; MAPK signaling pathway; Canonical and non-canonical Notch signaling; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; MAPK cascade; Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; EGFR tyrosine kinase inhibitor resistance; Angiotensin II receptor type 1 pathway; Regulation of actin cytoskeleton,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion; Sema4D mediated inhibition of cell attachment and migration,ENSG00000126458
Q9NRP2,0,6,4774302.716308594,1.8481068042548312e-5,1.4427082082116152,0.5287795402074613,0.16822115013184366,0.668039680404208,raw,3892118.6328125,5309596.375,3273708.37597656,5672087.28125,4723005.9453125,5775299.6875,COX assembly mitochondrial protein 2 homolog OS=Homo sapiens OX=9606 GN=CMC2 PE=1 SV=1,NA,endosome,NA,56942,CMC2,NA,Mitochondrial protein import,ENSG00000103121
Q03252,0,6,282832693.0651042,0.0010948300842630347,1.4425085394120045,0.5285798594120995,0.0987539072297623,0.6429522395902524,raw,237870836.4375,240103786.4375,241945691.765625,346351762.28125,268088463.0625,362635618.40625,Lamin-B2 OS=Homo sapiens OX=9606 GN=LMNB2 PE=1 SV=4,cell growth;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;membrane,motor activity;structural molecule activity,84823,LMNB2,Gastric cancer network 2; Fas ligand pathway and stress induction of heat shock proteins; IL-18 signaling pathway; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome,NA,ENSG00000176619
Q9BVP2,0,6,40544558.658854164,1.5694579750249392e-4,1.4421678181192983,0.528239053816827,0.06346039490769548,0.6429522395902524,raw,35978855.5625,31465743.046875,33867403.125,51887547.625,39455649.71875,50612152.875,Guanine nucleotide-binding protein-like 3 OS=Homo sapiens OX=9606 GN=GNL3 PE=1 SV=2,cell differentiation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,26354,GNL3,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000163938
O75592,0,6,297701.359375,1.1523858887654338e-6,1.4421562686604208,0.5282275000894744,0.22824624929634624,0.7148463313429879,raw,215521.15625,271217.21875,NA,401433.21875,302633.84375,NA,E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,23077,MYCBP2,3q29 copy number variation syndrome,NA,ENSG00000005810
Q9BWH2,0,6,1748960.6354166667,6.770132190500325e-6,1.4418094444319904,0.5278805045655282,0.21916409066330753,0.7087130179153194,raw,1154981.65625,1611822.75,1396805.8125,2013927.8125,1441566.40625,2874659.375,FUN14 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=FUNDC2 PE=1 SV=2,cell growth;cellular homeostasis;metabolic process,endosome,structural molecule activity,65991,FUNDC2,NA,NA,ENSG00000165775
Q96FJ0,0.5,6,1762981.2083333333,6.82440507126746e-6,1.4415918782699555,0.5276627883418743,0.44004076460197655,0.9233600879723239,raw,1690119,1710005.125,1206936,2452869.25,1052828.375,2465129.5,AMSH-like protease OS=Homo sapiens OX=9606 GN=STAMBPL1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;mitochondrion,structural molecule activity,57559,STAMBPL1,TGF-beta signaling pathway,Metalloprotease DUBs,ENSG00000138134
O60888,0,6,15039397.197916666,5.821669455189256e-5,1.4413465193429835,0.5274172207582394,0.15675300943253076,0.6638855679885327,raw,16229287.625,8738270.3125,10655553.75,20720999.625,12594875.5,21297396.375,Protein CutA OS=Homo sapiens OX=9606 GN=CUTA PE=1 SV=2,metabolic process,cytoskeleton,structural molecule activity,51596,CUTA,NA,NA,ENSG00000112514; ENSG00000226492
Q9UI26,0,6,9486816.420572916,3.672295415556139e-5,1.441026321075766,0.5270966873091043,0.32935735436929453,0.8113184829173788,raw,9385620.375,8584040.734375,5905439.8984375,13524926,6287099.265625,13233772.25,Importin-11 OS=Homo sapiens OX=9606 GN=IPO11 PE=1 SV=1,conjugation,cytosol;membrane,structural molecule activity,51194,IPO11,NA,NA,ENSG00000086200
E7EWW0,0,6,347832.2109375,1.346439708518569e-6,1.4407049313323268,0.5267748895074619,1,1,raw,272108.09375,341901.6875,318481.375,NA,NA,458837.6875,VPS35 endosomal protein sorting factor-like OS=Homo sapiens OX=9606 GN=VPS35L PE=1 SV=2,conjugation,mitochondrion,NA,57020,VPS35L,NA,NA,ENSG00000103544
Q7KZF4,0,6,209226536.546875,8.099046264957421e-4,1.4404182767268776,0.5264878103725348,0.14467656077383145,0.6572502130392559,raw,183087863.1875,172319060.25,171908710.71875,289772739.8125,190059321.5,248211523.8125,Staphylococcal nuclease domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SND1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,27044,SND1,VEGFA-VEGFR2 signaling pathway,Signaling by BRAF and RAF1 fusions,ENSG00000197157
P13861,0,6,9812369.412760416,3.798315221118956e-5,1.4402684691838556,0.5263377582365938,0.0577005166433614,0.6429522395902524,raw,9075855.4296875,7536427.953125,7554704.859375,12050776.875,9584782.953125,13071668.40625,cAMP-dependent protein kinase type II-alpha regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR2A PE=1 SV=2,development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,5576,PRKAR2A,Myometrial relaxation and contraction pathways; G protein signaling pathways; TGF-beta signaling pathway; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; GDNF signaling; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,FCGR3A-mediated IL10 synthesis; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase; ROBO receptors bind AKAP5,ENSG00000114302
Q9H6S3,0,6,26400417.888020832,1.0219459224350659e-4,1.4402298729234868,0.5262990964310164,0.07251072785550165,0.6429522395902524,raw,19970133.5625,25206467.5,20240701.1875,30807444.3125,25874653.28125,36303107.484375,Epidermal growth factor receptor kinase substrate 8-like protein 2 OS=Homo sapiens OX=9606 GN=EPS8L2 PE=1 SV=2,development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,motor activity,64787,EPS8L2,NA,Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea,ENSG00000177106
P60953,0,6,105922074.125,4.1001863003473657e-4,1.4400102186284776,0.5260790493844777,0.4042679220305543,0.8902077371640484,raw,136481133.75,42224841.125,76284529.125,196534227.25,99458593,84549120.5,Cell division control protein 42 homolog OS=Homo sapiens OX=9606 GN=CDC42 PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,998,CDC42,Androgen receptor signaling pathway; Target of rapamycin signaling; Integrin-mediated cell adhesion; RANKL/RANK signaling pathway; Leptin signaling pathway; Microtubule cytoskeleton regulation; Metastatic brain tumor; Pathogenic Escherichia coli infection; RalA downstream regulated genes; B cell receptor signaling pathway; AGE/RAGE pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Focal adhesion; TGF-beta signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Oxidative damage response; p38 MAPK signaling pathway; Ebola virus infection in host; Ras signaling; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Hippo signaling regulation pathways; 22q11.2 copy number variation syndrome; Gastrin signaling pathway; Regulation of actin cytoskeleton; G13 signaling pathway; Genetic causes of porto-sinusoidal vascular disease; T-cell receptor signaling pathway; DNA damage response (only ATM dependent),Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; MAPK6/MAPK4 signaling; RHO GTPases Activate WASPs and WAVEs; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; RHOU GTPase cycle; EPHB-mediated forward signaling; DCC mediated attractive signaling; GPVI-mediated activation cascade; VEGFA-VEGFR2 Pathway; Myogenesis; Factors involved in megakaryocyte development and platelet production; G beta:gamma signalling through CDC42; EGFR downregulation; RHO GTPases activate PAKs; Inactivation of CDC42 and RAC1; CD28 dependent Vav1 pathway; RHO GTPases activate KTN1,ENSG00000070831
Q9NYT0,0,6,10200665.520833334,3.948622548080845e-5,1.439986760854334,0.5260555476831432,0.1613980224620467,0.6638855679885327,raw,11430874.65625,6541868.5,7513489,13798670.625,9420204.03125,12498886.3125,Pleckstrin-2 OS=Homo sapiens OX=9606 GN=PLEK2 PE=1 SV=1,cell growth;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,structural molecule activity,26499,PLEK2,NA,NA,ENSG00000100558
Q13084,0,6,3922553.4791666665,1.5183992732883112e-5,1.4398062705581403,0.5258747065930038,0.1758812274576364,0.6702146673855206,raw,4005560.5,3101079.40625,2656793.03125,4542933.3125,3461723.5,5767231.125,"39S ribosomal protein L28, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL28 PE=1 SV=4",cell organization and biogenesis;cellular homeostasis,cytoskeleton;cytosol;endosome;Golgi,structural molecule activity,10573,MRPL28,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000086504
Q13547,0,6,57150814.916666664,2.212277188780026e-4,1.4394725238526083,0.5255402515064904,0.05738613097331349,0.6429522395902524,raw,43770138.6875,52945749.5625,43270289.0625,71076426.375,55628334.0625,76213951.75,Histone deacetylase 1 OS=Homo sapiens OX=9606 GN=HDAC1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,3065,HDAC1,Androgen receptor signaling pathway; Energy metabolism; Cell cycle; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Neural crest differentiation; Retinoblastoma gene in cancer; Notch signaling; Apoptosis-related network due to altered Notch3 in ovarian cancer; Initiation of transcription and translation elongation at the HIV-1 LTR; MECP2 and associated Rett syndrome; IL6 signaling pathway; TGF-beta signaling pathway; Valproic acid pathway; VEGFA-VEGFR2 signaling pathway; Ethanol effects on histone modifications; Rett syndrome causing genes; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome; Ciliary landscape; Transcription co-factors SKI and SKIL protein partners; Overlap between signal transduction pathways contributing to LMNA laminopathies; Notch signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,"Potential therapeutics for SARS; SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Formation of the beta-catenin:TCF transactivating complex; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Deactivation of the beta-catenin transactivating complex; Regulation of PTEN gene transcription; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Estrogen-dependent gene expression; MECP2 regulates transcription of neuronal ligands; Factors involved in megakaryocyte development and platelet production; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Downregulation of SMAD2/3:SMAD4 transcriptional activity; RNA Polymerase I Transcription Initiation; p75NTR negatively regulates cell cycle via SC1; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; G1/S-Specific Transcription; Regulation of TP53 Activity through Acetylation; Transcription of E2F targets under negative control by DREAM complex; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1; MECP2 regulates neuronal receptors and channels; Repression of WNT target genes; Loss of MECP2 binding ability to 5mC-DNA",ENSG00000116478
Q14204,0,6,439757922.3932292,0.0017022791743466893,1.4394097405016661,0.525477326231504,0.0975270376447038,0.6429522395902524,raw,385570969,393983903.53125,324219822.265625,567104268.34375,405810026.609375,561858544.609375,Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens OX=9606 GN=DYNC1H1 PE=1 SV=5,cell differentiation;cell growth;conjugation;metabolic process,cell surface;cytosol;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,1778,DYNC1H1,Ciliary landscape; Intraflagellar transport proteins binding to dynein,Separation of Sister Chromatids; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; HCMV Early Events; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Neutrophil degranulation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000197102
P08238,0,6,2311389457.7187514,0.008947263795195014,1.4392740772723025,0.5253413469571075,0.11849726118995871,0.6429522395902524,raw,2005259632.26563,2121270881.34375,1705222295.15625,3053090190.39063,2088733716.25,2894760030.90625,Heat shock protein HSP 90-beta OS=Homo sapiens OX=9606 GN=HSP90AB1 PE=1 SV=4,cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,antioxidant activity;DNA binding;motor activity;RNA binding;structural molecule activity,3326,HSP90AB1,Nuclear receptors meta-pathway; NRF2 pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway,Regulation of actin dynamics for phagocytic cup formation; Potential therapeutics for SARS; The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Aryl hydrocarbon receptor signalling; Neutrophil degranulation; Estrogen-dependent gene expression; Sema3A PAK dependent Axon repulsion; DDX58/IFIH1-mediated induction of interferon-alpha/beta; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; RHOBTB2 GTPase cycle; Chaperone Mediated Autophagy; HSF1 activation; Attenuation phase; Uptake and function of diphtheria toxin,ENSG00000096384
P12270,0,6,116890782.33723967,4.5247790730611876e-4,1.439174763705434,0.5252417939003144,0.07965920972785163,0.6429522395902524,raw,97923975.484375,105061087.4375,92529762.0625,142588897.65625,112039705.695313,151201265.6875,Nucleoprotein TPR OS=Homo sapiens OX=9606 GN=TPR PE=1 SV=3,cell differentiation;cell growth;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,7175,TPR,NA,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Signaling by ALK fusions and activated point mutants,ENSG00000047410
P38432,0,6,6919211.109375,2.6783892625054534e-5,1.4390778107208435,0.5251446004911162,0.03761486390768915,0.6429522395902524,raw,5747616.15625,5864416.28125,5396052.1875,8271266.875,7175127.53125,9060787.625,Coilin OS=Homo sapiens OX=9606 GN=COIL PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,8161,COIL,NA,NA,ENSG00000121058
P03923,0,6,895983.9791666666,3.4683056077381037e-6,1.4390296807388212,0.5250963487238739,0.2196783998325267,0.7087130179153194,raw,750767.75,687348.4375,865277.0625,1084960.5,742390.75,1245159.375,NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens OX=9606 GN=MT-ND6 PE=1 SV=2,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity,4541,MT-ND6,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,Complex I biogenesis,ENSG00000198695
P25788,0,6,127632443.47460933,4.940582976093159e-4,1.4389731162014745,0.5250396389961297,0.13232469167400746,0.6514609890946903,raw,108484850.753906,111394823.6875,98609137.65625,175926821.75,115272243.25,156106783.75,Proteasome subunit alpha type-3 OS=Homo sapiens OX=9606 GN=PSMA3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5684,PSMA3,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000100567
Q9BVQ7,0,6,1558353.5286458333,6.03230237137468e-6,1.4388279177851906,0.5248940576770451,0.6311555658683409,1,raw,1185624.0625,1969927.9375,962410.890625,1724921.46875,672849.5,2834387.3125,Spermatogenesis-associated protein 5-like protein 1 OS=Homo sapiens OX=9606 GN=SPATA5L1 PE=1 SV=2,metabolic process,endoplasmic reticulum;nucleus,structural molecule activity,79029,SPATA5L1,NA,NA,ENSG00000171763
Q96EP5,0,6,18984959.341145832,7.348975258108683e-5,1.438751975203539,0.5248179089756773,0.022551875043642866,0.6429522395902524,raw,16085763.125,15677706.75,15868833.9375,23143423.46875,20138572.765625,22995456,DAZ-associated protein 1 OS=Homo sapiens OX=9606 GN=DAZAP1 PE=1 SV=1,cell differentiation;metabolic process,cytosol;membrane;nucleus,RNA binding,26528,DAZAP1,NA,NA,ENSG00000071626
O60256,0,6,7428415.119791667,2.875499385663397e-5,1.4385533502469874,0.5246187259152393,0.05910662357528263,0.6429522395902524,raw,6222586,7315276.25,5080847.71875,8951521.9375,7359596.9375,9640661.875,Phosphoribosyl pyrophosphate synthase-associated protein 2 OS=Homo sapiens OX=9606 GN=PRPSAP2 PE=1 SV=1,cellular homeostasis;defense response,nucleus,DNA binding;structural molecule activity,5636,PRPSAP2,NA,NA,ENSG00000141127
Q16881,0,6,64543807.596354164,2.4984559438150783e-4,1.4384013576296097,0.5244662876478268,0.05846442270286708,0.6429522395902524,raw,56305047.75,62762203.953125,41592542.4375,80989257.125,64594295.9375,81019498.375,"Thioredoxin reductase 1, cytoplasmic OS=Homo sapiens OX=9606 GN=TXNRD1 PE=1 SV=3",cell differentiation;defense response;development;metabolic process,cytosol;endosome;membrane,structural molecule activity,7296,TXNRD1,Selenium micronutrient network; Selenium micronutrient network ; Selenium micronutrient network; Nuclear receptors meta-pathway; NRF2 pathway; Oxidative stress response; Ferroptosis,PPARA activates gene expression; Detoxification of Reactive Oxygen Species; TP53 Regulates Metabolic Genes; Interconversion of nucleotide di- and triphosphates; Nuclear events mediated by NFE2L2; Metabolism of ingested H2SeO4 and H2SeO3 into H2Se; Uptake and function of diphtheria toxin; Metabolism of ingested MeSeO2H into MeSeH,ENSG00000198431
P10586,0,6,304695.7265625,1.1794607065111127e-6,1.438299893161585,0.5243645167149805,1,1,raw,249924.734375,NA,NA,NA,NA,359466.71875,Receptor-type tyrosine-protein phosphatase F OS=Homo sapiens OX=9606 GN=PTPRF PE=1 SV=2,cell communication;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,5792,PTPRF,Brain-derived neurotrophic factor (BDNF) signaling pathway; Insulin signaling,Synaptic adhesion-like molecules; Receptor-type tyrosine-protein phosphatases,ENSG00000142949
Q00403,0,6,13028356.411458334,5.043206424683881e-5,1.437996708534936,0.5240603735618008,0.057187428803794245,0.6429522395902524,raw,9895371.5625,12298227.90625,8968782.6875,16753229.4375,12569715.625,17684811.25,Transcription initiation factor IIB OS=Homo sapiens OX=9606 GN=GTF2B PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,2959,GTF2B,Eukaryotic transcription initiation,RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,ENSG00000137947
P12931,0,6,2774229.828125,1.073889387954161e-5,1.4378352063712294,0.5238983346264168,0.18068754972142012,0.6742444420587625,raw,2880291.875,2088221.375,1939888.21875,4141385.0625,2521800.9375,3073791.5,Proto-oncogene tyrosine-protein kinase Src OS=Homo sapiens OX=9606 GN=SRC PE=1 SV=3,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;mitochondrion;nucleus,antioxidant activity;DNA binding;signal transducer activity;structural molecule activity,6714,SRC,"Androgen receptor signaling pathway; Angiogenesis; Integrin-mediated cell adhesion; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Microtubule cytoskeleton regulation; Thymic stromal lymphopoietin (TSLP) signaling pathway; Glioblastoma signaling pathways; AGE/RAGE pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; Aryl hydrocarbon receptor pathway; Bladder cancer; IL-3 signaling pathway; Aryl hydrocarbon receptor pathway; Pregnane X receptor pathway; Nuclear receptors meta-pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; TGF-beta signaling pathway; Amplification and expansion of oncogenic pathways as metastatic traits; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling pathway; Robo4 and VEGF signaling pathways crosstalk; Fibrin complement receptor 3 signaling pathway; Acute viral myocarditis; NRF2-ARE regulation; EGF/EGFR signaling pathway; Relationship between inflammation, COX-2 and EGFR; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Fragile X syndrome; Gastrin signaling pathway; Hepatitis B infection; Thyroid hormones production and peripheral downstream signaling effects; Netrin-UNC5B signaling pathway; EGFR tyrosine kinase inhibitor resistance; Malignant pleural mesothelioma; CCL18 signaling pathway; GDNF signaling; EPO receptor signaling; Notch signaling pathway; ErbB signaling pathway","G alpha (i) signalling events; Extra-nuclear estrogen signaling; GPER1 signaling; Signaling by BRAF and RAF1 fusions; Regulation of RUNX3 expression and activity; RHOU GTPase cycle; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; DCC mediated attractive signaling; Downstream signal transduction; Signaling by ERBB2; Nuclear signaling by ERBB4; RAF activation; GAB1 signalosome; MET activates PTK2 signaling; RUNX2 regulates osteoblast differentiation; Long-term potentiation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; InlA-mediated entry of Listeria monocytogenes into host cells; Regulation of commissural axon pathfinding by SLIT and ROBO; Netrin mediated repulsion signals; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins; Activated NTRK2 signals through FYN; Downregulation of ERBB4 signaling; Regulation of RUNX1 Expression and Activity; Activated NTRK3 signals through PI3K",ENSG00000197122
Q6DKI1,0,6,15423213.041666666,5.9702424960214105e-5,1.437825793176807,0.5238888895847973,0.05252567656644742,0.6429522395902524,raw,14507811.9375,10392473.25,11842287.65625,20471174.75,14942566.09375,20382964.5625,60S ribosomal protein L7-like 1 OS=Homo sapiens OX=9606 GN=RPL7L1 PE=1 SV=2,cellular component movement;cellular homeostasis;defense response,cytosol;Golgi;membrane,structural molecule activity,285855,RPL7L1,NA,NA,ENSG00000146223
P46108,0,6,17759298.989583332,6.874528753556202e-5,1.4376912369455235,0.5237538713562828,0.2658238402941475,0.7459774038485325,raw,16931234.6875,15945063.0625,12509349.75,24719745.9375,13526323.0625,22924077.4375,Adapter molecule crk OS=Homo sapiens OX=9606 GN=CRK PE=1 SV=2,cell differentiation;cell growth;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,1398,CRK,Integrin-mediated cell adhesion; B cell receptor signaling pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Rett syndrome causing genes; EGF/EGFR signaling pathway; Gastrin signaling pathway; Insulin signaling; Regulation of actin cytoskeleton; GDNF signaling; Interferon type I signaling pathways; ErbB signaling pathway; T-cell receptor signaling pathway,"Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Regulation of signaling by CBL; Downstream signal transduction; VEGFA-VEGFR2 Pathway; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases; ARMS-mediated activation; p130Cas linkage to MAPK signaling for integrins; MET activates RAP1 and RAC1; MET receptor recycling",ENSG00000167193
Q9Y6W5,0,6,5737088.4375,2.2207959586930694e-5,1.4376048318194448,0.5236671628963834,0.04856214793162449,0.6429522395902524,raw,5277090.8125,4755805.6875,4093946.78125,7049368.9375,5659947.15625,7586371.25,Wiskott-Aldrich syndrome protein family member 2 OS=Homo sapiens OX=9606 GN=WASF2 PE=1 SV=3,cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,10163,WASF2,Regulation of actin cytoskeleton,RAC1 GTPase cycle; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; RAC2 GTPase cycle; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway,ENSG00000158195
P09601,0,6,3349758.9348958335,1.2966735978109397e-5,1.4375262780683595,0.523588328851722,0.10644167250777951,0.6429522395902524,raw,2485214.65625,3509209.96875,2115770.484375,3500287.78125,3572561.375,4915509.34375,Heme oxygenase 1 OS=Homo sapiens OX=9606 GN=HMOX1 PE=1 SV=1,cell differentiation;cellular homeostasis;coagulation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,structural molecule activity,3162,HMOX1,Nuclear receptors meta-pathway; NRF2 pathway; Transcriptional activation by NRF2 in response to phytochemicals; Overview of nanoparticle effects; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Lung fibrosis; Oxidative stress response; Ferroptosis; NRF2-ARE regulation; IL-10 anti-inflammatory signaling pathway ; IL-18 signaling pathway; CAMKK2 pathway; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway,Heme signaling; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; Interleukin-4 and Interleukin-13 signaling; Regulation of HMOX1 expression and activity; Nuclear events mediated by NFE2L2; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; Iron uptake and transport; Heme degradation,ENSG00000100292
P16278,0,6,8084924.244791667,3.129630523352543e-5,1.4372667439360813,0.5233278380242221,0.18006167977229529,0.6742444420587625,raw,8436175.375,5118492.28125,5417639.5625,11070191.75,6342012.1875,12125034.3125,Beta-galactosidase OS=Homo sapiens OX=9606 GN=GLB1 PE=1 SV=2,cellular homeostasis;metabolic process,cell surface;extracellular;mitochondrion;nucleus,structural molecule activity,2720,GLB1,"Ectoderm differentiation; Degradation pathway of sphingolipids, including diseases; Ciliary landscape; Glycosaminoglycan degradation; Sphingolipid metabolism in senescence",Glycosphingolipid metabolism; Neutrophil degranulation; HS-GAG degradation; Sialic acid metabolism; Keratan sulfate degradation; Defective NEU1 causes sialidosis; MPS IV - Morquio syndrome B,ENSG00000170266
P49427,0.16666666666666666,6,2228494.03125,8.626380074991875e-6,1.437053414838392,0.5231136873277945,1,1,raw,NA,NA,1735863.625,3438777.875,1244805.875,2494528.75,Ubiquitin-conjugating enzyme E2 R1 OS=Homo sapiens OX=9606 GN=CDC34 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cell proliferation;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,997,CDC34,Vitamin D receptor pathway,FCERI mediated NF-kB activation; Downstream TCR signaling; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; CLEC7A (Dectin-1) signaling,ENSG00000099804
Q96GQ5,0,6,812562.26875,3.1453846707875014e-6,1.4370141992549932,0.5230743172535338,0.6097985788583027,1,raw,881070.6875,859671.1875,436260.59375,1251820,NA,633988.875,RUS family member 1 OS=Homo sapiens OX=9606 GN=RUSF1 PE=1 SV=2,NA,cytoskeleton,NA,64755,RUSF1,NA,NA,ENSG00000140688
A0A075B762,0.5,6,3208086.8802083335,1.2418331103516172e-5,1.4368104741575318,0.5228697722852734,0.3540183373102082,0.8383308462007302,raw,1941383.375,4035086.3125,2197771.03125,2939804.8125,3157780.4375,4976695.3125,Neuroblastoma breakpoint family member 10 OS=Homo sapiens OX=9606 GN=NBPF10 PE=4 SV=3,NA,nucleus,NA,100132406,NBPF10,NA,NA,ENSG00000271425
O96019,0,6,19557446.067708332,7.570581779013115e-5,1.4367758889623923,0.5228350450258747,0.0388305350445198,0.6429522395902524,raw,19374100.578125,13406408.90625,15459969.25,25799307.875,21092378.734375,22212511.0625,Actin-like protein 6A OS=Homo sapiens OX=9606 GN=ACTL6A PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,86,ACTL6A,Gastric cancer network 1; Tumor suppressor activity of SMARCB1; Thermogenesis,UCH proteinases; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines; HATs acetylate histones; DNA Damage Recognition in GG-NER,ENSG00000136518
K7ELC2,0,6,32015181.213541668,1.2392903792649547e-4,1.436648012641626,0.5227066361727044,0.24385061434207825,0.7301988479077035,raw,37561009.09375,23086379.765625,24143417,35294381.40625,33167001.609375,38838898.40625,40S ribosomal protein S15 OS=Homo sapiens OX=9606 GN=RPS15 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi,RNA binding;structural molecule activity,6209,RPS15,Cytoplasmic ribosomal proteins,NA,ENSG00000115268
Q9BTZ2,0,6,831537.625,3.218837250321249e-6,1.4364000890646913,0.5224576475702244,0.16871525298297937,0.668039680404208,raw,828470.84375,190647.75,826004.1875,944193.40625,1009893.96875,1190015.59375,Dehydrogenase/reductase SDR family member 4 OS=Homo sapiens OX=9606 GN=DHRS4 PE=1 SV=3,cellular homeostasis;metabolic process,cytoskeleton;cytosol;endosome;extracellular;membrane;mitochondrion,structural molecule activity,10901,DHRS4,NA,Peroxisomal protein import; RA biosynthesis pathway,ENSG00000157326; ENSG00000284807
P21912,0,6,16238375.333333334,6.285787417933261e-5,1.43608473607065,0.522140877783676,0.12205846741742718,0.6445597830897484,raw,16097395,10547835.375,12334119.375,21079225,14254454,23117223.25,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial OS=Homo sapiens OX=9606 GN=SDHB PE=1 SV=3",cellular homeostasis,cytoplasm;cytoskeleton;endosome;membrane,structural molecule activity,6390,SDHB,Electron transport chain: OXPHOS system in mitochondria; Metabolic reprogramming in colon cancer; Nonalcoholic fatty liver disease; Mitochondrial complex II assembly; TCA cycle (aka Krebs or citric acid cycle),Respiratory electron transport; Citric acid cycle (TCA cycle),ENSG00000117118
P12814,0,6,167367444.87239584,6.478703426635156e-4,1.4360325259429898,0.5220884263790876,0.14538659675599594,0.6572502130392559,raw,157633948.203125,140978667.0625,124436244.8125,207497290.0625,147291042.28125,226367476.8125,Alpha-actinin-1 OS=Homo sapiens OX=9606 GN=ACTN1 PE=1 SV=2,cell communication;cell growth;cellular component movement;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;motor activity;RNA binding;structural molecule activity,87,ACTN1,Arrhythmogenic right ventricular cardiomyopathy; Focal adhesion; Ebola virus infection in host; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Regulation of actin cytoskeleton,RHOD GTPase cycle; RHOF GTPase cycle; Platelet degranulation ; Nephrin family interactions; Syndecan interactions; RHOBTB2 GTPase cycle; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,ENSG00000072110
Q969Z3,0,6,1778260.8017578134,6.8835515524438e-6,1.435700955544421,0.5217552791877271,0.15174358893614673,0.6638855679885327,raw,1511283.49609375,1313228.58203125,1335358.6796875,1917175.73242188,1728484.0546875,2864034.265625,Mitochondrial amidoxime reducing component 2 OS=Homo sapiens OX=9606 GN=MTARC2 PE=1 SV=1,cellular homeostasis;coagulation;metabolic process,cytoskeleton;endosome;mitochondrion,structural molecule activity,54996,MTARC2,NA,Phase I - Functionalization of compounds,ENSG00000117791
Q8N6R0,0,6,2071314.9739583333,8.01794843056593e-6,1.4356443967659505,0.521698443760973,0.058060894466937865,0.6429522395902524,raw,1782344.34375,1504638.3125,1764418.15625,2160125.5625,2321719.03125,2894644.4375,eEF1A lysine and N-terminal methyltransferase OS=Homo sapiens OX=9606 GN=EEF1AKNMT PE=1 SV=1,cellular homeostasis;metabolic process,endosome;membrane;nucleus,structural molecule activity,51603,METTL13,NA,NA,ENSG00000010165
Q9BTE3,0,6,23802851.9765625,9.213955484701266e-5,1.4354027115993357,0.5214555512001793,0.11630972265586996,0.6429522395902524,raw,19107323.3125,22636714.5,18539422.078125,27884575.5,22156275.09375,32492801.375,Mini-chromosome maintenance complex-binding protein OS=Homo sapiens OX=9606 GN=MCMBP PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,79892,MCMBP,NA,NA,ENSG00000197771
Q99798,0,6,55892375.43782553,2.1635636760058e-4,1.4346807034222273,0.5207296924093742,0.10083549898763876,0.6429522395902524,raw,54947387.8574219,38993653.4375,43146863.4609375,67208291.65625,52226099.1523438,78831957.0625,"Aconitate hydratase, mitochondrial OS=Homo sapiens OX=9606 GN=ACO2 PE=1 SV=2",cellular homeostasis;coagulation;defense response,cytosol;endosome,structural molecule activity,50,ACO2,Amino acid metabolism; Metabolic reprogramming in colon cancer; Fluoroacetic acid toxicity; TCA cycle (aka Krebs or citric acid cycle),Citric acid cycle (TCA cycle); Mitochondrial protein import,ENSG00000100412
P05455,0,6,91990973.83854167,3.560920929883665e-4,1.4343334330235056,0.5203804398363974,0.12157463022030672,0.6445597830897484,raw,82380445.8125,72526325.625,77795180.875,117664651.9375,83418211.125,118161027.65625,Lupus La protein OS=Homo sapiens OX=9606 GN=SSB PE=1 SV=2,cellular component movement;cellular homeostasis;conjugation;metabolic process,membrane;nucleus,RNA binding,6741,SSB,NA,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination,ENSG00000138385
P57721,0,6,3915268.125,1.5155791520251933e-5,1.4342826273872835,0.52032933711795,0.2519213206864138,0.7332115996050534,raw,4564488.5,2535138.25,3175436.75,4816363.5,3636104.75,4764077,Poly(rC)-binding protein 3 OS=Homo sapiens OX=9606 GN=PCBP3 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,nucleus,RNA binding;structural molecule activity,54039,PCBP3,NA,NA,ENSG00000183570
Q9NV96,0,6,2582693.5520833335,9.997467296335913e-6,1.433362458671351,0.519403474363683,0.23511141488946088,0.7192904383575112,raw,2141342,2188923.09375,2219810.59375,3137520.1875,2091052.0625,3717513.375,Cell cycle control protein 50A OS=Homo sapiens OX=9606 GN=TMEM30A PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,catalytic activity,55754,TMEM30A,NA,Neutrophil degranulation,ENSG00000112697
Q5R3I4,0,6,583624.5,2.259178928674591e-6,1.433228182856069,0.5192683179516344,0.49310586655586464,0.9774829695284138,raw,516072.71875,208173.25,741645.46875,564841,408067.375,1062947.1875,Tetratricopeptide repeat protein 38 OS=Homo sapiens OX=9606 GN=TTC38 PE=1 SV=1,NA,NA,NA,55020,TTC38,NA,NA,ENSG00000075234
P24311,0,6,2719860,1.0528431210384199e-5,1.433211834406002,0.5192518614217955,0.31234197277270415,0.7920821775382559,raw,2365380.25,2353767.75,2246818.25,3850476,2782857.75,NA,"Cytochrome c oxidase subunit 7B, mitochondrial OS=Homo sapiens OX=9606 GN=COX7B PE=1 SV=2",cellular homeostasis;conjugation;defense response,cytoskeleton;endosome,catalytic activity,1349,COX7B,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000131174
P78362,0,6,10197861.145833334,3.9475369896596165e-5,1.4331289514728063,0.5191684276603122,0.13852967785256598,0.65680569707651415,raw,7003889.59375,9540301.5625,8953654.28125,13672482.375,8905322.6875,13111516.375,SRSF protein kinase 2 OS=Homo sapiens OX=9606 GN=SRPK2 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,6733,SRPK2,mRNA processing,Maturation of nucleoprotein,ENSG00000135250
P15374,0,6,12569102.359375,4.865431660708912e-5,1.432664881659168,0.5187011845412337,0.02870260958443346,0.6429522395902524,raw,10522904.25,10197049.625,10207601.84375,14624072.6875,13543570.375,16319415.375,Ubiquitin carboxyl-terminal hydrolase isozyme L3 OS=Homo sapiens OX=9606 GN=UCHL3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,7347,UCHL3,Proteasome degradation,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; UCH proteinases; Neddylation,ENSG00000118939
Q15019,0,6,90019697.96875,3.484613905287576e-4,1.432198523163422,0.5182314845940044,0.1659997146853611,0.6665497934577248,raw,81723840.03125,79461492.4375,69809834.34375,114091631.5,77986626.5,117044763,Septin-2 OS=Homo sapiens OX=9606 GN=SEPTIN2 PE=1 SV=1,cell differentiation;cell growth;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;membrane;nucleus,structural molecule activity,4735,SEPTIN2,2q37 copy number variation syndrome,Anchoring of the basal body to the plasma membrane,ENSG00000168385
Q86TI2,0,6,6203209.903645833,2.4012290615733586e-5,1.4319060760146332,0.517936864032404,0.050758372047564775,0.6429522395902524,raw,5393816.8125,4548616.046875,5007610.65625,8658325.71875,6440462.0625,7170428.125,Dipeptidyl peptidase 9 OS=Homo sapiens OX=9606 GN=DPP9 PE=1 SV=3,cell organization and biogenesis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,91039,DPP9,Lung fibrosis,NA,ENSG00000142002
A0A087WVZ6,0,6,370367.3385416667,1.4336719707665152e-6,1.4317525289542228,0.517782151747619,0.30339184793118606,0.7831794684063365,raw,309624.65625,323226.5,231005.8125,693905.375,330743.15625,333698.53125,Protein kinase C-binding protein 1 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,metabolic process,extracellular;membrane,structural molecule activity,23613,ZMYND8,NA,NA,ENSG00000101040
Q9NX24,0,6,19324469.75,7.48039790430483e-5,1.4316730416944061,0.5177020547639528,0.04460696007400719,0.6429522395902524,raw,17343486.625,13943809.75,16170846.75,24574163.375,19084309.75,24830202.25,H/ACA ribonucleoprotein complex subunit 2 OS=Homo sapiens OX=9606 GN=NHP2 PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,55651,NHP2,NA,rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase,ENSG00000145912
O95782,0,6,74065940.29947917,2.867052559600455e-4,1.4315773741187017,0.5176056474526455,0.10339971400202333,0.6429522395902524,raw,68347884.09375,61930632.546875,56165444.1875,97845284.4375,68337305.34375,91769091.1875,AP-2 complex subunit alpha-1 OS=Homo sapiens OX=9606 GN=AP2A1 PE=1 SV=3,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,160,AP2A1,Synaptic vesicle pathway; VEGFA-VEGFR2 signaling pathway; GABA receptor signaling; EGF/EGFR signaling pathway; Fragile X syndrome; mBDNF and proBDNF regulation of GABA neurotransmission,"Potential therapeutics for SARS; Recycling pathway of L1; MHC class II antigen presentation; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Trafficking of GluR2-containing AMPA receptors; Nef Mediated CD4 Down-regulation; Retrograde neurotrophin signalling; Nef Mediated CD8 Down-regulation; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation",ENSG00000196961
Q9NP92,0,6,5380128.395833333,2.0826186538485783e-5,1.431574708985895,0.5176029616198488,0.10915331696386602,0.6429522395902524,raw,4550209,4866797.4375,3524698.6875,7861769.875,4963331.25,6513964.125,"39S ribosomal protein S30, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS30 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome;Golgi,structural molecule activity,10884,MRPS30,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000112996
P49841,0,6,1407266.5572916667,5.447452862691281e-6,1.4315164391375772,0.5175442379419329,0.39315638353861604,0.8769264261349782,raw,1227280,1604378.1875,772813.53125,1146996.0625,1395437.8125,2296693.75,Glycogen synthase kinase-3 beta OS=Homo sapiens OX=9606 GN=GSK3B PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,motor activity;signal transducer activity;structural molecule activity,2932,GSK3B,IL-5 signaling pathway; Androgen receptor signaling pathway; Energy metabolism; MicroRNAs in cardiomyocyte hypertrophy; Cell cycle; Leptin signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Microtubule cytoskeleton regulation; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; Neural crest differentiation; IL-17 signaling pathway; B cell receptor signaling pathway; Corticotropin-releasing hormone signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Cardiac progenitor differentiation; T cell receptor and co-stimulatory signaling; Cardiac hypertrophic response; Focal adhesion; Copper homeostasis; Melatonin metabolism and effects; Wnt signaling pathway; IL6 signaling pathway; Wnt/beta-catenin signaling pathway in leukemia; Regulation of Wnt / B-catenin signaling by small molecule compounds; Physico-chemical features and toxicity-associated pathways; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Regulation of apoptosis by parathyroid hormone-related protein; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Wnt signaling pathway and pluripotency; PI3K/AKT/mTOR - vitamin D3 signaling; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; Acute viral myocarditis; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; NRF2-ARE regulation; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Gastrin signaling pathway; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Influence of laminopathies on Wnt signaling; MAP3K1 role in promoting and blocking gonadal determination; Overlap between signal transduction pathways contributing to LMNA laminopathies; Glycogen synthesis and degradation; Malignant pleural mesothelioma; CCL18 signaling pathway; Alzheimer's disease; GDNF signaling; DYRK1A; Neurogenesis regulation in the olfactory epithelium; Notch signaling pathway; ErbB signaling pathway; DNA damage response (only ATM dependent),Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Ubiquitin-dependent degradation of Cyclin D; Regulation of RUNX2 expression and activity; Regulation of HSF1-mediated heat shock response; Constitutive Signaling by AKT1 E17K in Cancer; B-WICH complex positively regulates rRNA expression; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; CRMPs in Sema3A signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; AKT phosphorylates targets in the cytosol; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Maturation of nucleoprotein; Maturation of nucleoprotein,ENSG00000082701
P04179,0,6,38334461.580729164,1.4839063103976784e-4,1.431437183419954,0.5174643611113021,0.10036516633188187,0.6429522395902524,raw,36679877.125,28424394.15625,29453168.015625,47713612.5,35230777.6875,52504940,"Superoxide dismutase [Mn], mitochondrial OS=Homo sapiens OX=9606 GN=SOD2 PE=1 SV=3",cell growth;cellular homeostasis;coagulation;defense response;development;metabolic process,endosome,RNA binding;structural molecule activity,6648,SOD2,"Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; VEGFA-VEGFR2 signaling pathway; Oxidative stress response; Male infertility; Arsenic metabolism and reactive oxygen species generation; DNA damage response (only ATM dependent)","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Detoxification of Reactive Oxygen Species; Transcriptional activation of mitochondrial biogenesis; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models",ENSG00000112096
Q8TAT6,0,6,39132693.369791664,1.5148054319741067e-4,1.431399321660356,0.5174262010747667,0.10566570776220599,0.6429522395902524,raw,37107278.09375,32220621.625,28805620.59375,46120575.9375,36685330.03125,53856733.9375,Nuclear protein localization protein 4 homolog OS=Homo sapiens OX=9606 GN=NPLOC4 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,55666,NPLOC4,NA,Neddylation; KEAP1-NFE2L2 pathway; Translesion Synthesis by POLH,ENSG00000182446
P00966,0,6,40670092.75976563,1.5743173322933421e-4,1.43128485502257,0.5173108265237673,0.17046122634477698,0.668039680404208,raw,40001086.6875,24650235.28125,35630082.4804688,58237163.90625,34505190.765625,50996797.4375,Argininosuccinate synthase OS=Homo sapiens OX=9606 GN=ASS1 PE=1 SV=2,cellular homeostasis;coagulation;defense response;metabolic process,cytoskeleton;cytosol;endosome;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,445,ASS1,Alanine and aspartate metabolism; Amino acid metabolism,Urea cycle,ENSG00000130707
Q8IWZ8,0,6,2689541.375,1.0411069449960525e-5,1.4306975549050003,0.5167187229691922,0.30065816717189764,0.7806964943416801,raw,2498085.21875,2033467.625,2388557.5,3815465.25,1984369.28125,3417303.375,SURP and G-patch domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SUGP1 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,NA,57794,SUGP1,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000105705
Q13405,0,6,7278640.354166667,2.8175223825480076e-5,1.4303847137358507,0.5164032238938503,0.08686029526567489,0.6429522395902524,raw,4155851.0625,7128492.75,6331311.5,9056211.1875,7021553.5,9978422.125,"39S ribosomal protein L49, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL49 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,740,MRPL49,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000149792
A0A2R8YEM2,0,6,3142739.828125,1.2165376193094028e-5,1.429756779716496,0.5157697466254301,0.17239003276516696,0.6689341104244626,raw,2051698.6875,3519342.5625,2275538.78125,3253467,3203223.625,4553168.3125,Cyclin-H OS=Homo sapiens OX=9606 GN=CCNH PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,DNA binding,NA,CCNH,"Cell cycle; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",NA,ENSG00000134480
P50453,0,6,54396863.666666664,2.1056732227950982e-4,1.4296608088712548,0.5156729040634314,0.13092825698872515,0.6498046150645307,raw,50744929.75,43488769.59375,43819231.71875,66786225.375,48993988.25,72548037.3125,Serpin B9 OS=Homo sapiens OX=9606 GN=SERPINB9 PE=1 SV=1,metabolic process,cell surface;cytosol;extracellular;membrane;nucleus,DNA binding;structural molecule activity,5272,SERPINB9,Glucocorticoid receptor pathway; Nuclear receptors meta-pathway,NA,ENSG00000170542
P78316,0,6,12554538.072916666,4.8597939040558165e-5,1.4296254031777753,0.5156371751334702,0.19272188546564978,0.6839501208924997,raw,11415183.1875,8506714.46875,11306601.1875,16164204.28125,10215873.125,17718652.1875,Nucleolar protein 14 OS=Homo sapiens OX=9606 GN=NOP14 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8602,NOP14,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000087269
Q9Y5S2,0,6,3684567.6588541665,1.4262762471690618e-5,1.4294694424536687,0.5154797800307445,0.4328038083142156,0.9168514603569733,raw,3143643.734375,2619738.4375,3767534.6875,4493742.65625,2274424.65625,5808321.78125,Serine/threonine-protein kinase MRCK beta OS=Homo sapiens OX=9606 GN=CDC42BPB PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,signal transducer activity;structural molecule activity,9578,CDC42BPB,VEGFA-VEGFR2 signaling pathway,CDC42 GTPase cycle; RHOQ GTPase cycle; RHOJ GTPase cycle,ENSG00000198752
Q15397,0,6,13078032.75,5.0624358671228184e-5,1.429094715878726,0.5151015368677355,0.12316680121753439,0.6445597830897484,raw,11809064.34375,11524616.8125,9936315.421875,16516040.15625,11805888.3125,16876271.453125,Pumilio homolog 3 OS=Homo sapiens OX=9606 GN=PUM3 PE=1 SV=3,metabolic process,extracellular;membrane;nucleus,RNA binding,9933,PUM3,NA,NA,ENSG00000080608
P63104,0,6,992821180.6276041,0.003843157186197141,1.4290424151954122,0.5150487374861803,0.21040840505233835,0.7008646353372271,raw,969953749.8125,833185674.609375,710433548.609375,1190657668.75,826617565.421875,1426078876.5625,14-3-3 protein zeta/delta OS=Homo sapiens OX=9606 GN=YWHAZ PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7534,YWHAZ,Cell cycle; Prolactin signaling pathway; Pathogenic Escherichia coli infection; Myometrial relaxation and contraction pathways; Hepatitis B infection; GDNF signaling; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,"Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; Deactivation of the beta-catenin transactivating complex; TP53 Regulates Metabolic Genes; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Activation of BAD and translocation to mitochondria ; Negative regulation of NOTCH4 signaling; Interleukin-3, Interleukin-5 and GM-CSF signaling; NOTCH4 Activation and Transmission of Signal to the Nucleus; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; Rap1 signalling; KSRP (KHSRP) binds and destabilizes mRNA; GP1b-IX-V activation signalling",ENSG00000164924
Q86UU0,0,6,8523363.93359375,3.299348159681435e-5,1.4288631418328046,0.5148677400484584,0.011357395840854826,0.6429522395902524,raw,7036875.8359375,7875953.0625,6216113.84375,10054732.515625,10780117.90625,9176390.4375,B-cell CLL/lymphoma 9-like protein OS=Homo sapiens OX=9606 GN=BCL9L PE=1 SV=1,cell death;cellular component movement;cellular homeostasis;development;metabolic process,membrane,structural molecule activity,283149,BCL9L,NA,Formation of the beta-catenin:TCF transactivating complex; Deactivation of the beta-catenin transactivating complex,ENSG00000186174
P63010,0,6,150279039.22005218,5.817220470137979e-4,1.4281583679244114,0.5141559681281291,0.17012550134031068,0.668039680404208,raw,139501522.84375,129400937.070313,114023001.34375,199230267.1875,128643993.3125,190874513.5625,AP-2 complex subunit beta OS=Homo sapiens OX=9606 GN=AP2B1 PE=1 SV=1,conjugation;defense response,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,163,AP2B1,Synaptic vesicle pathway; GABA receptor signaling; EGF/EGFR signaling pathway; Fragile X syndrome; mBDNF and proBDNF regulation of GABA neurotransmission,"Potential therapeutics for SARS; Recycling pathway of L1; MHC class II antigen presentation; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Nef Mediated CD4 Down-regulation; Retrograde neurotrophin signalling; Nef Mediated CD8 Down-regulation; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation",ENSG00000006125
Q9BT78,0,6,30039837.046875,1.1628258730933734e-4,1.427943424664952,0.5139388207030027,0.14152807971438078,0.6572502130392559,raw,25749299.5625,25566764.375,25915707.625,36768543,27193348.59375,39045359.125,COP9 signalosome complex subunit 4 OS=Homo sapiens OX=9606 GN=COPS4 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;extracellular;membrane;nucleus,structural molecule activity,51138,COPS4,Ciliary landscape,Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; RHOBTB1 GTPase cycle; DNA Damage Recognition in GG-NER,ENSG00000138663
Q9UHL4,0,6,9897557.90625,3.831291227002397e-5,1.427513874355503,0.5135047675612227,0.20043390803705569,0.6907968838306926,raw,9333903.734375,5725699.765625,9934352.21875,14181425.625,8801478.5625,11408487.53125,Dipeptidyl peptidase 2 OS=Homo sapiens OX=9606 GN=DPP7 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cell surface;extracellular;mitochondrion;nucleus,structural molecule activity,29952,DPP7,NA,Neutrophil degranulation,ENSG00000176978
F5H189,0,6,1310974.5729166667,5.074711790134761e-6,1.4274740014633316,0.51346447007044,0.14995155774015356,0.6638855679885327,raw,1240313,1121926.125,964184.9375,1782704.875,1155198.125,1601520.375,LYR motif-containing protein 4 OS=Homo sapiens OX=9606 GN=LYRM4 PE=1 SV=3,cell growth;cellular homeostasis,NA,NA,57128,LYRM4,NA,NA,ENSG00000214113
Q6P587,0,6,6305658.296875,2.440886281457017e-5,1.4274464527859632,0.5134366273750931,0.1749082012680555,0.6697819849820321,raw,5265248.25,5309885.96875,5019265.1875,7515859.9375,5500309.4375,9223381,"Acylpyruvase FAHD1, mitochondrial OS=Homo sapiens OX=9606 GN=FAHD1 PE=1 SV=2",NA,cytosol;endosome;membrane,structural molecule activity,81889,FAHD1,NA,Citric acid cycle (TCA cycle),ENSG00000180185
P51809,0,6,4464814.25,1.72830548992478e-5,1.4271694567164463,0.5131566451499807,0.07844948718106039,0.6429522395902524,raw,3484130.875,3682020.625,3819855.5625,5254867.375,4415258.125,6132752.9375,Vesicle-associated membrane protein 7 OS=Homo sapiens OX=9606 GN=VAMP7 PE=1 SV=3,cell growth;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,6845,VAMP7,NA,Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Cargo recognition for clathrin-mediated endocytosis; Interleukin-12 signaling,ENSG00000124333
P42356,0,6,188224.4046875,7.286065080069787e-7,1.4269889947873902,0.512974208515933,0.35417494054652227,0.8383308462007302,raw,103512.2578125,NA,193640.96875,264038.15625,154278.09375,225652.546875,Phosphatidylinositol 4-kinase alpha OS=Homo sapiens OX=9606 GN=PI4KA PE=1 SV=4,cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,signal transducer activity;structural molecule activity,5297,PI4KA,Ectoderm differentiation; 22q11.2 copy number variation syndrome,Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the ER membrane,ENSG00000241973
Q96PC3,0,6,2799625.3125,1.0837198428414189e-5,1.426606580654313,0.5125875335565189,0.06347352948063278,0.6429522395902524,raw,2602227.9375,2475342.625,1825305.5625,3468213.8125,2714306.4375,3712355.5,AP-1 complex subunit sigma-3 OS=Homo sapiens OX=9606 GN=AP1S3 PE=1 SV=1,cell growth;conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,130340,AP1S3,NA,MHC class II antigen presentation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Nef mediated downregulation of MHC class I complex cell surface expression,ENSG00000152056
P04843,0,6,249714657.171875,9.666319554163667e-4,1.4264437706708177,0.5124228780985866,0.10234145245191482,0.6429522395902524,raw,231206157.25,199282974.1875,192689793.59375,315985008.9375,229321426.3125,329802582.75,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Homo sapiens OX=9606 GN=RPN1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;cytosol;extracellular;nucleus,NA,6184,RPN1,Proteasome degradation,SRP-dependent cotranslational protein targeting to membrane; Asparagine N-linked glycosylation; Maturation of spike protein,ENSG00000163902
Q99829,0,6,38686050.291666664,1.4975161195696692e-4,1.4261301622859601,0.5121056619463874,0.18687425472249064,0.6791107619890848,raw,35335446.5625,33632083.234375,31161255.96875,48476221.71875,33118348.125,50392946.140625,Copine-1 OS=Homo sapiens OX=9606 GN=CPNE1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,8904,CPNE1,NA,Neutrophil degranulation; Glycerophospholipid biosynthesis,ENSG00000214078
Q9Y3D5,0,6,2091033.5208333333,8.094277860882995e-6,1.4259999586982164,0.511973939996472,0.013576541565711317,0.6429522395902524,raw,1692989.5,1852220.25,1632567.875,2507871.25,2219286.25,2641266,"28S ribosomal protein S18c, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS18C PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,RNA binding;structural molecule activity,51023,MRPS18C,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000163319
O95478,0,6,10279868.489583334,3.979281589654403e-5,1.4258888922872246,0.5118615688846926,0.05091657386224315,0.6429522395902524,raw,6777053.9375,10215770.8125,8110587.9375,11564797.25,10938679,14072322,Ribosome biogenesis protein NSA2 homolog OS=Homo sapiens OX=9606 GN=NSA2 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,NA,10412,NSA2,NA,NA,ENSG00000164346
Q9NWT1,0,6,4549520.125,1.7610946767966376e-5,1.4258567306390066,0.5118290277982648,0.5291759515640607,1,raw,4857561.625,3514316.15625,3645833.59375,6926186.9375,2300246.28125,6052976.15625,p21-activated protein kinase-interacting protein 1 OS=Homo sapiens OX=9606 GN=PAK1IP1 PE=1 SV=2,cell differentiation;metabolic process,membrane,NA,55003,PAK1IP1,NA,NA,ENSG00000111845; ENSG00000285226
P62304,0,6,27386053.998697918,1.0600993641185876e-4,1.4258116834364591,0.5117834479016641,0.11755671403002829,0.6429522395902524,raw,28091420.375,18595338.2109375,17449754.75,40053075.375,24096735.03125,36030000.25,Small nuclear ribonucleoprotein E OS=Homo sapiens OX=9606 GN=SNRPE PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,6635,SNRPE,mRNA processing,snRNP Assembly; RNA Polymerase II Transcription Termination; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway; SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,ENSG00000182004
Q13636,0,6,1022719.453125,3.958891784778742e-6,1.4257682296408392,0.5117394788898428,0.5304113828336086,1,raw,1226767.75,705381.9375,704207.5625,629882.875,1005711.15625,1864365.4375,Ras-related protein Rab-31 OS=Homo sapiens OX=9606 GN=RAB31 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,11031,RAB31,NA,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Neutrophil degranulation,ENSG00000168461
Q8NCN5,0,6,9187352.190104166,3.5563744287972296e-5,1.4250572509516422,0.5110198799825574,0.04524829503666666,0.6429522395902524,raw,9283502.59375,6613016.984375,7093495.625,10108637.375,10089802.375,11935658.1875,"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,endosome;nucleus,structural molecule activity,55066,PDPR,NA,Regulation of pyruvate dehydrogenase (PDH) complex,ENSG00000090857
P45984,0,6,439192.803125,1.7000916281710722e-6,1.4248176298047999,0.5107772726713449,0.3584047472040035,0.8420882601494262,raw,533372.015625,165834.0625,407981.078125,658729.28125,430047.578125,NA,Mitogen-activated protein kinase 9 OS=Homo sapiens OX=9606 GN=MAPK9 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;membrane;nucleus,signal transducer activity;structural molecule activity,5601,MAPK9,"IL-1 signaling pathway; RANKL/RANK signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; Thymic stromal lymphopoietin (TSLP) signaling pathway; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; ATM signaling pathway; Interleukin-1 (IL-1) structural pathway; Focal adhesion; RAC1/PAK1/p38/MMP2 pathway; Wnt signaling pathway; TGF-beta signaling pathway; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; Canonical and non-canonical TGF-B signaling; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; BMP signaling in eyelid development; Wnt signaling pathway and pluripotency; Splicing factor NOVA regulated synaptic proteins; Wnt signaling in kidney disease; Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Pancreatic adenocarcinoma pathway; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Regulatory circuits of the STAT3 signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Measles virus infection; Gastrin signaling pathway; Hepatitis B infection; IL-18 signaling pathway; Osteoblast differentiation and related diseases; Insulin signaling; TGF-beta receptor signaling in skeletal dysplasias; Host-pathogen interaction of human coronaviruses - MAPK signaling; Malignant pleural mesothelioma; CCL18 signaling pathway; Familial partial lipodystrophy; Alzheimer's disease; GDNF signaling; TGF-beta receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response (only ATM dependent); Estrogen signaling pathway; Toll-like receptor signaling pathway",FCERI mediated MAPK activation; Oxidative Stress Induced Senescence; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; Activation of the AP-1 family of transcription factors,ENSG00000050748
P09132,0,6,8360226.786458333,3.23619865082901e-5,1.4246107952324878,0.5105678277106214,0.061741804757853784,0.6429522395902524,raw,7497013.3125,7409073.875,5748798.09375,10915466.8125,8035962,10555046.625,Signal recognition particle 19 kDa protein OS=Homo sapiens OX=9606 GN=SRP19 PE=1 SV=3,cell growth;conjugation,cytosol;Golgi;membrane;nucleus,RNA binding,6728,SRP19,NA,SRP-dependent cotranslational protein targeting to membrane,ENSG00000153037
Q9BT73,0,6,1131816.671875,4.381201228225689e-6,1.423866100693823,0.5098134827173918,0.0852603004229746,0.6429522395902524,raw,1103326.21875,648030,1000813.625,1517923.59375,1095782,1425024.59375,Proteasome assembly chaperone 3 OS=Homo sapiens OX=9606 GN=PSMG3 PE=1 SV=1,cell growth,nucleus,structural molecule activity,84262,PSMG3,NA,NA,ENSG00000157778
P53007,0,6,26700720.200520832,1.0335704628138925e-4,1.4234513405621614,0.5093931766562068,0.03905126737606545,0.6429522395902524,raw,23461446.09375,19677067.421875,22940655.71875,30212583.4375,28009348,35903220.53125,"Tricarboxylate transport protein, mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A1 PE=1 SV=2",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,6576,SLC25A1,22q11.2 copy number variation syndrome,Gluconeogenesis; Fatty acyl-CoA biosynthesis,ENSG00000100075
O43865,0,6,11429330.763020834,4.424232229570375e-5,1.4229195276795008,0.5088540734592315,0.09152541951854486,0.6429522395902524,raw,10651549.125,9662269.078125,8199725.3125,15156297.25,10611583.5625,14294560.25,S-adenosylhomocysteine hydrolase-like protein 1 OS=Homo sapiens OX=9606 GN=AHCYL1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,RNA binding;structural molecule activity,10768,AHCYL1,"Trans-sulfuration, one-carbon metabolism and related pathways",Role of phospholipids in phagocytosis; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Ion homeostasis; Regulation of insulin secretion; VEGFR2 mediated cell proliferation; PLC beta mediated events; DAG and IP3 signaling; CLEC7A (Dectin-1) induces NFAT activation,ENSG00000168710
O15126,0,6,7313522.557291667,2.8310250950430702e-5,1.4226934768784245,0.5086248628323013,0.27739731603261053,0.7570746865029274,raw,4395199.40625,6342141.875,8373822.0625,9388833.84375,6358214.28125,9022923.875,Secretory carrier-associated membrane protein 1 OS=Homo sapiens OX=9606 GN=SCAMP1 PE=1 SV=2,conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,9522,SCAMP1,NA,Neutrophil degranulation,ENSG00000085365
A0A669KAX4,0,6,42886072.96158855,1.660096729462556e-4,1.4226122054437467,0.5085424464532556,0.09141983470183505,0.6429522395902524,raw,35578372.0820313,39922536.625,33502575.375,50730422.125,40788243.6875,56794287.875,Cullin-4B OS=Homo sapiens OX=9606 GN=CUL4B PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,NA,CUL4B,"Mesodermal commitment pathway; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",NA,ENSG00000158290
E9PCH4,0,6,249491.3125,9.657674002502767e-7,1.422274391752167,0.50819982320749435,1,1,raw,NA,194684.46875,NA,327458.125,226331.34375,NA,Uncharacterized protein OS=Homo sapiens OX=9606 PE=4 SV=1,development,cytosol;endoplasmic reticulum,DNA binding,NA,NA,NA,NA,NA
E9PGM1,0,6,324853.609375,1.2574907825217867e-6,1.4222563769294014,0.5081815496168179,1,1,raw,NA,NA,268223.96875,NA,381483.25,NA,Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,RNA binding;structural molecule activity,NA,EIF4G1,Acute viral myocarditis; Fragile X syndrome; Malignant pleural mesothelioma,NA,ENSG00000114867
A0A3B3ITT5,0,6,67839325,2.6260236432073603e-4,1.4221073065532608,0.5080303290863019,0.04047776884790848,0.6429522395902524,raw,55591684,64487458,47791888,79057340,69503664,90603916,60S ribosomal protein L29 OS=Homo sapiens OX=9606 GN=RPL29 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,structural molecule activity,NA,RPL29,NA,NA,ENSG00000162244
Q8N567,0,6,9858362.802083334,3.816119013800152e-5,1.421912911368526,0.507833106177928,0.09763066844429494,0.6429522395902524,raw,7832209.5,10200252.75,6679230,11681563.1875,9497283.375,13259638,Zinc finger CCHC domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZCCHC9 PE=1 SV=2,NA,membrane,structural molecule activity,84240,ZCCHC9,NA,NA,ENSG00000131732
Q9UPN9,0,6,5581698.158854167,2.1606452208063736e-5,1.421868374710568,0.5077879178817017,0.0043067671259823135,0.6429522395902524,raw,4900176.546875,4448641.71875,4331245.5,6967406.0625,6106813,6735906.125,E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens OX=9606 GN=TRIM33 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,51592,TRIM33,Ectoderm differentiation,Downregulation of SMAD2/3:SMAD4 transcriptional activity; Germ layer formation at gastrulation,ENSG00000197323
Q08AG7,0.8333333333333334,6,529026.1354166666,2.047831607226023e-6,1.421867206199483,0.5077867322544873,0.6540502387644931,1,raw,916499.625,241845.40625,225163.9375,874198.625,320153.21875,596296,Mitotic-spindle organizing protein 1 OS=Homo sapiens OX=9606 GN=MZT1 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum,NA,440145,MZT1,NA,Recruitment of NuMA to mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes,ENSG00000204899
O43396,0,6,62478240.752604164,2.418498966526276e-4,1.4217117569916151,0.507628997368678,0.08945504087157591,0.6429522395902524,raw,46600073.109375,59802199.875,45112311.65625,80907035.71875,57426333.5,85021490.65625,Thioredoxin-like protein 1 OS=Homo sapiens OX=9606 GN=TXNL1 PE=1 SV=3,metabolic process,cytosol;membrane;nucleus,structural molecule activity,9352,TXNL1,NA,RND2 GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,ENSG00000091164
Q9H299,0,6,34464361.666666664,1.334096832253506e-4,1.4216884463196457,0.5076053424566388,0.06156836396435922,0.6429522395902524,raw,27084593.5,31195821.5,27542041.5,43114965.5,33498009,44350739,SH3 domain-binding glutamic acid-rich-like protein 3 OS=Homo sapiens OX=9606 GN=SH3BGRL3 PE=1 SV=1,NA,membrane;nucleus,NA,83442,SH3BGRL3,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000142669
P61956,0,6,20688880.833333332,8.008554067988283e-5,1.421631645084233,0.5075477007856183,0.07656405538882145,0.6429522395902524,raw,13794907,21495012,16492116,23445714,21605062,27300474,Small ubiquitin-related modifier 2 OS=Homo sapiens OX=9606 GN=SUMO2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane,structural molecule activity,6613,SUMO2,NA,"SUMOylation of chromatin organization proteins; SUMOylation of intracellular receptors; SUMOylation of DNA damage response and repair proteins; SUMOylation of SUMOylation proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; SUMOylation of transcription cofactors; Processing of DNA double-strand break ends; Vitamin D (calciferol) metabolism; SUMOylation of transcription factors; Formation of Incision Complex in GG-NER; SUMO is conjugated to E1 (UBA2:SAE1); SUMO is transferred from E1 to E2 (UBE2I, UBC9); SUMO is proteolytically processed",ENSG00000188612
Q01629,0,6,1086002.3854166667,4.203856598932491e-6,1.4215074988645786,0.507421709670526,0.05256508895096218,0.6429522395902524,raw,806002.3125,1045179.0625,789508.5625,1311432.375,1078162.125,1485729.875,Interferon-induced transmembrane protein 2 OS=Homo sapiens OX=9606 GN=IFITM2 PE=1 SV=2,coagulation;development;metabolic process,cytoplasm;cytoskeleton;membrane;mitochondrion;nucleus,NA,10581,IFITM2,Host-pathogen interaction of human coronaviruses - MAPK signaling,Interferon alpha/beta signaling,ENSG00000185201
O60828,0,6,4749991.96875,1.8386962451325356e-5,1.4209297495023527,0.5068352297742909,0.23680606069537674,0.7210473708268809,raw,2950571.625,5155651.375,3687868,5120339.125,4192555,7392966.6875,Polyglutamine-binding protein 1 OS=Homo sapiens OX=9606 GN=PQBP1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,10084,PQBP1,NA,mRNA Splicing - Major Pathway,ENSG00000102103
Q14692,0,6,28455672.748697918,1.1015037284267215e-4,1.4208080138603287,0.506711624134517,0.08803849481084491,0.6429522395902524,raw,24498742.421875,24700260.3515625,23760127.0703125,34808009.5625,27295638.28125,35671258.8046875,Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens OX=9606 GN=BMS1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,9790,BMS1,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000165733
P30044,0,6,130438430.91471367,5.049201234901849e-4,1.4208010667061166,0.5067045699446929,0.1080713998871282,0.6429522395902524,raw,120863543.140625,97574833.15625,110571059.046875,157099478.640625,120831218.386719,175690453.117188,"Peroxiredoxin-5, mitochondrial OS=Homo sapiens OX=9606 GN=PRDX5 PE=1 SV=4",cellular homeostasis;coagulation;metabolic process,cytosol;endosome;membrane;mitochondrion;nucleus,antioxidant activity;DNA binding;RNA binding;structural molecule activity,25824,PRDX5,Selenium micronutrient network,NA,ENSG00000126432
Q00613,0,6,4265917.473958333,1.6513136217947335e-5,1.4206712093712115,0.5065727055342615,0.3427499705376823,0.8248253176137212,raw,3587327,3352828.4375,4245319.59375,5096412.1875,3169823.625,6143794,Heat shock factor protein 1 OS=Homo sapiens OX=9606 GN=HSF1 PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,3297,HSF1,NA,Aggrephagy; Regulation of HSF1-mediated heat shock response; HSF1 activation; Attenuation phase,ENSG00000185122; ENSG00000284774
O43847,0,6,31274937.192708332,1.2106359328881486e-4,1.420580197284319,0.5064802795798683,0.04460332619084965,0.6429522395902524,raw,24246644.5,28764105.03125,22700625.84375,40246628.46875,30829901.3125,40861718,Nardilysin OS=Homo sapiens OX=9606 GN=NRDC PE=1 SV=3,cell organization and biogenesis;metabolic process,cytosol;endosome;nucleus,structural molecule activity,4898,NRDC,NA,NA,ENSG00000078618
Q9UM47,0.8333333333333334,6,2625815.5,1.0164390028498008e-5,1.4204011182999483,0.5062984013242078,0.06396325401254162,0.6429522395902524,raw,2444067,1758528,2332179.25,3471555.5,2553366,3195197.25,Neurogenic locus notch homolog protein 3 OS=Homo sapiens OX=9606 GN=NOTCH3 PE=1 SV=2,cell growth;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,structural molecule activity,4854,NOTCH3,Neural crest differentiation; Notch signaling; Canonical and non-canonical Notch signaling; OSX and miRNAs in tooth development; Epithelial to mesenchymal transition in colorectal cancer; Breast cancer pathway; Neovascularisation processes; Osteoblast differentiation and related diseases; Notch signaling pathway,Pre-NOTCH Processing in Golgi; Pre-NOTCH Transcription and Translation; Notch-HLH transcription pathway; NOTCH3 Intracellular Domain Regulates Transcription; Pre-NOTCH Processing in the Endoplasmic Reticulum; Defective LFNG causes SCDO3; Noncanonical activation of NOTCH3,ENSG00000074181
A0A499FI31,0,6,53325667.67773438,2.0642078044194723e-4,1.4194507683174762,0.5053328120521307,0.14238942295064155,0.6572502130392559,raw,48127128.1953125,45008181.328125,44616587.1953125,65848272.6875,48039747.5664063,68314089.09375,Squamous cell carcinoma antigen recognized by T-cells 3 OS=Homo sapiens OX=9606 GN=SART3 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding,9733,SART3,NA,NA,ENSG00000075856
P10599,0,6,274473302.2291667,0.0010624713336740764,1.4191059145060594,0.5049822684896075,0.04971309451899687,0.6429522395902524,raw,231460671.4375,273578869.78125,193167466.21875,338698947.75,281466650.375,328467207.8125,Thioredoxin OS=Homo sapiens OX=9606 GN=TXN PE=1 SV=3,metabolic process,cell surface;cytosol;membrane;nucleus,structural molecule activity,7295,TXN,Selenium micronutrient network; Folic acid network; Selenium micronutrient network ; Folic acid network; Selenium micronutrient network; TNF-alpha signaling pathway; Complement system; Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling pathway,TP53 Regulates Metabolic Genes; Detoxification of Reactive Oxygen Species; Oxidative Stress Induced Senescence; Interconversion of nucleotide di- and triphosphates; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; Regulation of FOXO transcriptional activity by acetylation; Protein repair,ENSG00000136810
Q9NQG5,0,6,4707651.223958333,1.8223063714281723e-5,1.4187272722201765,0.5045972808491,0.32055595679369603,0.8025274219941538,raw,4468712.25,2151973.40625,4168116.375,5913420.375,2853930.4375,8689754.5,Regulation of nuclear pre-mRNA domain-containing protein 1B OS=Homo sapiens OX=9606 GN=RPRD1B PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,58490,RPRD1B,Modulators of TCR signaling and T cell activation,RNA polymerase II transcribes snRNA genes,ENSG00000101413
P21964,0,6,45824788.447916664,1.7738528192785626e-4,1.4187120167882386,0.5045817676107454,0.08466973981055315,0.6429522395902524,raw,45288921.125,30030845.625,34325902,63824537.625,42605121.5625,58873402.75,Catechol O-methyltransferase OS=Homo sapiens OX=9606 GN=COMT PE=1 SV=2,cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,1312,COMT,Dopamine metabolism; Flavan-3-ol metabolic pathway; MTHFR deficiency; 22q11.2 copy number variation syndrome; Biogenic amine synthesis; Estrogen metabolism; Metapathway biotransformation Phase I and II; Methylation pathways,Potential therapeutics for SARS; Methylation; Enzymatic degradation of dopamine by COMT; Enzymatic degradation of Dopamine by monoamine oxidase,ENSG00000093010
Q8NC44,0.6666666666666666,6,395752.078125,1.5319349271306816e-6,1.4186184850401111,0.5044866515929596,0.05953640218515461,0.6429522395902524,raw,329911.375,324360.1875,339108.90625,514531.8125,398581.8125,468018.375,Reticulophagy regulator 2 OS=Homo sapiens OX=9606 GN=RETREG2 PE=1 SV=3,cell growth;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,79137,RETREG2,NA,NA,ENSG00000144567
Q8IZA0,0.3333333333333333,6,489046.3697916667,1.8930720930634945e-6,1.4184121125205926,0.5042767612863367,0.40790879785215534,0.8921091312456526,raw,443079.1875,437468.8125,416347.28125,620511.0625,330675.6875,686196.1875,Dyslexia-associated protein KIAA0319-like protein OS=Homo sapiens OX=9606 GN=KIAA0319L PE=1 SV=2,defense response,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,NA,79932,KIAA0319L,NA,NA,ENSG00000142687
Q13823,0,6,10973675.872395834,4.247850681563476e-5,1.4182581237567744,0.5041201277634899,0.19133092443870758,0.6824265277629332,raw,9032749.03125,9723549.328125,9707909.46875,13768321.46875,9388767.375,14220758.5625,Nucleolar GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=GNL2 PE=1 SV=1,metabolic process,membrane,structural molecule activity,29889,GNL2,NA,NA,ENSG00000134697
Q9Y3C6,0,6,12184309.239583334,4.716480321597499e-5,1.4182423127325265,0.5041040442219676,0.09853254617842781,0.6429522395902524,raw,9158217.4375,13025905.375,9310493,13182372.5,13204535.125,15224332,Peptidyl-prolyl cis-trans isomerase-like 1 OS=Homo sapiens OX=9606 GN=PPIL1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane,structural molecule activity,51645,PPIL1,NA,mRNA Splicing - Major Pathway,ENSG00000137168
P00387,0,6,85471043.44010417,3.3085379443754324e-4,1.4182046546010951,0.5040657362965285,0.24691049380246993,0.7316541032247736,raw,83045550.84375,68638524.390625,71159161.8125,100918254.5,70545060.21875,118519708.875,NADH-cytochrome b5 reductase 3 OS=Homo sapiens OX=9606 GN=CYB5R3 PE=1 SV=3,cellular homeostasis;metabolic process,cell surface;cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,1727,CYB5R3,Oxidation by cytochrome P450,Phase I - Functionalization of compounds; Neutrophil degranulation; Vitamin C (ascorbate) metabolism,ENSG00000100243
G3V4C1,0,6,492352722.7057292,0.0019058708066785187,1.418056301113543,0.5039148130603897,0.06083259609568185,0.6429522395902524,raw,434054156.5625,410577302.6875,413966404.296875,587027668.0625,489078682.625,619412122,Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens OX=9606 GN=HNRNPC PE=1 SV=1,NA,NA,RNA binding,NA,HNRNPC,NA,NA,ENSG00000092199
Q8N2H4,0,6,456710.6927083333,1.7679024329291227e-6,1.417861409215534,0.5037165212875462,0.3810320175344087,0.8654800011929341,raw,390009.90625,433494.28125,400233.8125,332320.53125,569570.8125,614634.8125,Protein SYS1 homolog OS=Homo sapiens OX=9606 GN=SYS1 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;cytosol;extracellular,NA,90196,SYS1,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000204070
M0QYZ2,0,6,4924703.1875,1.9063260146166917e-5,1.4174163693435906,0.5032636155254521,0.06504066586503615,0.6429522395902524,raw,4454521.375,4273937.625,3388885.125,5907629.25,4803461.25,6719784.5,AP complex subunit sigma OS=Homo sapiens OX=9606 GN=AP2S1 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton,structural molecule activity,1175,AP2S1,Synaptic vesicle pathway; VEGFA-VEGFR2 signaling pathway; GABA receptor signaling; EGF/EGFR signaling pathway; Fragile X syndrome,NA,ENSG00000042753
A0A0J9YXC7,0,6,5841871.854166667,2.261357053542217e-5,1.4173614034890656,0.5032076683069353,0.3423388924556919,0.8247147020235626,raw,4682967.25,5667502.875,4985461,8329427.375,4319672.625,7066200,LIM and senescent cell antigen-like-containing domain protein OS=Homo sapiens OX=9606 GN=LIMS4 PE=4 SV=1,NA,cytoplasm;cytoskeleton;nucleus,structural molecule activity,NA,LIMS4,NA,NA,ENSG00000256671; ENSG00000256977
Q13263,0,6,356193405.969401,0.0013788054430526905,1.4171092754563719,0.502951010959165,0.1859132370810699,0.6787948525161039,raw,298240330.8125,332437390.21875,299091195.65625,471100109.1875,311100329.3125,425191080.628906,Transcription intermediary factor 1-beta OS=Homo sapiens OX=9606 GN=TRIM28 PE=1 SV=5,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,10155,TRIM28,Corticotropin-releasing hormone signaling pathway; Mesodermal commitment pathway; ATM signaling in development and disease,Generic Transcription Pathway; HCMV Early Events; SUMOylation of transcription cofactors,ENSG00000130726
Q86WR0,0,6,5509114.359375,2.1325484239195952e-5,1.41691931856869,0.502757611456542,0.16457136474515932,0.6638855679885327,raw,4565137.3125,6112449.34375,3304415.1875,6468431.25,5927950.6875,6676302.375,Coiled-coil domain-containing protein 25 OS=Homo sapiens OX=9606 GN=CCDC25 PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton;nucleus,RNA binding,55246,CCDC25,NA,NA,ENSG00000147419
Q9H840,0,6,281296.73125,1.0888844590058152e-6,1.416603644290621,0.5024361588172939,0.6135726207593819,1,raw,118726.21875,NA,348337.3125,361778.875,366017.5625,211623.6875,Gem-associated protein 7 OS=Homo sapiens OX=9606 GN=GEMIN7 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,NA,79760,GEMIN7,NA,snRNP Assembly; SARS-CoV-2 modulates host translation machinery,ENSG00000142252
P49792,0,6,97087805.33723958,3.7582165253369616e-4,1.4164178037983366,0.502246883048005,0.11266238012136506,0.6429522395902524,raw,79056078.125,88549907.03125,77052002.7109375,125423664.84375,88629744.0625,123815435.25,E3 SUMO-protein ligase RanBP2 OS=Homo sapiens OX=9606 GN=RANBP2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,5903,RANBP2,NA,SARS-CoV-2 activates/modulates innate and adaptive immune responses; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Signaling by ALK fusions and activated point mutants,ENSG00000153201
P08133,0,6,153210983.375,5.930714445372205e-4,1.416052365188478,0.501874616833949,0.09023146114514408,0.6429522395902524,raw,154725956.9375,100949211.75,118856208.5,195272494.625,142949370.0625,206512658.375,Annexin A6 OS=Homo sapiens OX=9606 GN=ANXA6 PE=1 SV=3,cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;endosome;mitochondrion;nucleus,catalytic activity;motor activity;structural molecule activity,309,ANXA6,Calcium regulation in cardiac cells; Prostaglandin synthesis and regulation,Smooth Muscle Contraction,ENSG00000197043
Q12800,0,6,8009073.098958333,3.100268954332995e-5,1.415870158283008,0.5016889698064464,0.1227450393607329,0.6445597830897484,raw,8636218,6211978.96875,5371798.1875,9892312.4375,7605768.75,10336362.25,Alpha-globin transcription factor CP2 OS=Homo sapiens OX=9606 GN=TFCP2 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,7024,TFCP2,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000135457
Q9ULC4,0,6,23795667.8046875,9.211174530556953e-5,1.4158174254533884,0.501635236907217,0.2560692895412856,0.7369596008729927,raw,23873100.5,19147470.96875,16695107.546875,31456724.625,17801651.5,33799951.6875,Malignant T-cell-amplified sequence 1 OS=Homo sapiens OX=9606 GN=MCTS1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,nucleus,RNA binding,28985,MCTS1,NA,NA,ENSG00000232119; ENSG00000288295
O95104,0,6,1049905.275,4.06412663345062e-6,1.4151850733410223,0.5009907364010062,0.13763261061998755,0.6554773456108216,raw,NA,754579.625,932804.1875,1220500.75,921961.4375,1419680.375,SR-related and CTD-associated factor 4 OS=Homo sapiens OX=9606 GN=SCAF4 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,57466,SCAF4,NA,NA,ENSG00000156304
Q16186,0,6,22974827.161458332,8.893431549413592e-5,1.414407464177601,0.5001977933202028,0.023618195075512757,0.6429522395902524,raw,18374335.8125,21617131.21875,16724347.5,28152384.125,23655041.9375,29325722.375,Proteasomal ubiquitin receptor ADRM1 OS=Homo sapiens OX=9606 GN=ADRM1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,DNA binding;structural molecule activity,11047,ADRM1,Alzheimer's disease and miRNA effects; Alzheimer's disease,UCH proteinases; Ub-specific processing proteases,ENSG00000130706
F8WAN9,0,6,14193355.458333334,5.4941712657119706e-5,1.4141288824646836,0.49991361209871343,0.09203874781611326,0.6429522395902524,raw,9139122.6875,12742358.1875,13771590.78125,19474804.28125,14286371.21875,15745885.59375,GMP reductase OS=Homo sapiens OX=9606 GN=GMPR2 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q8WXH0,0,6,491449.7760416667,1.9023755488934756e-6,1.4137226088590713,0.4994990719986467,0.1853096079132942,0.6778506319470519,raw,411863.3125,260796.203125,522463.0625,738617.84375,580321.359375,434636.875,Nesprin-2 OS=Homo sapiens OX=9606 GN=SYNE2 PE=1 SV=3,cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;nucleus,motor activity;structural molecule activity,23224,SYNE2,Ovarian infertility; Rett syndrome causing genes; Envelope proteins and their potential roles in EDMD physiopathology,Meiotic synapsis,ENSG00000054654
P06576,0,6,825303312.5260416,0.0031947045633351134,1.4136237840391082,0.49939821836564735,0.14953530823712174,0.6638855679885327,raw,770165934.25,613776429.21875,699328006.234375,1063184347.1875,716640275.953125,1088724882.3125,"ATP synthase subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1B PE=1 SV=3",cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;endosome;nucleus,antioxidant activity;catalytic activity;structural molecule activity,506,ATP5F1B,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,Transcriptional activation of mitochondrial biogenesis; Mitochondrial protein import; Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000110955
Q12851,0.16666666666666666,6,428708.3645833333,1.6595069326479799e-6,1.413611255628118,0.49938543225048376,1,1,raw,321491.40625,439629.6875,NA,525004,NA,NA,Mitogen-activated protein kinase kinase kinase kinase 2 OS=Homo sapiens OX=9606 GN=MAP4K2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,signal transducer activity;structural molecule activity,5871,MAP4K2,TNF-alpha signaling pathway; MAPK signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Yap signaling pathway; Insulin signaling; Malignant pleural mesothelioma,NA,ENSG00000168067
Q6NZI2,0,6,46208921.875,1.788722416841143e-4,1.4135724792116793,0.49934585750122806,0.12524856781193397,0.6449267539975253,raw,41258967,37239686.34375,35631714.21875,66622942.875,43859225.0625,52640995.75,Caveolae-associated protein 1 OS=Homo sapiens OX=9606 GN=CAVIN1 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,RNA binding;structural molecule activity,284119,CAVIN1,Congenital generalized lipodystrophy,RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; RNA Polymerase I Transcription Termination,ENSG00000177469
Q9Y399,0,6,8785076.631510416,3.400655732016028e-5,1.413503373406481,0.49927532624725857,0.4359430466423912,0.919218088383844,raw,6902364.890625,8898451.4375,7238961.8984375,12577991.125,5371882.9375,11720807.5,"28S ribosomal protein S2, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS2 PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,51116,MRPS2,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000122140
Q96QK1,0,6,73256787.875,2.8357307061232736e-4,1.413426515555369,0.49919687899526755,0.07972157505894104,0.6429522395902524,raw,67361499.109375,59986995.671875,56405377.1875,91138138.78125,69438187.53125,95210528.96875,Vacuolar protein sorting-associated protein 35 OS=Homo sapiens OX=9606 GN=VPS35 PE=1 SV=2,cell death;cell growth;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,antioxidant activity,55737,VPS35,NA,WNT ligand biogenesis and trafficking,ENSG00000069329
Q9GZT9,0,6,2210944.7708333335,8.558447835431753e-6,1.412995801666287,0.49875717910127476,0.32918880039112247,0.8111865130141003,raw,1030112.8125,2630681.25,1966501.90625,2778658.9375,1800881.40625,3058832.3125,Egl nine homolog 1 OS=Homo sapiens OX=9606 GN=EGLN1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,54583,EGLN1,Photodynamic therapy-induced HIF-1 survival signaling; Type 2 papillary renal cell carcinoma,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,ENSG00000135766
Q6UW68,0,6,10208594.21875,3.951691704236071e-5,1.4129240110187367,0.49868387765035577,0.13305622394890065,0.6514609890946903,raw,9487201,5943230.375,9986376.3125,14109990.875,9508333.9375,12216432.8125,Transmembrane protein 205 OS=Homo sapiens OX=9606 GN=TMEM205 PE=1 SV=1,NA,cytoskeleton,NA,374882,TMEM205,NA,NA,ENSG00000105518
O75534,0,6,63552459.825520836,2.4600814068507257e-4,1.4129165238309942,0.49867623268349154,0.3214568024478467,0.8027885809803746,raw,47289274.8125,78293677.671875,43110893.34375,74744022.25,60912093.5625,76964797.3125,Cold shock domain-containing protein E1 OS=Homo sapiens OX=9606 GN=CSDE1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,RNA binding,7812,CSDE1,NA,NA,ENSG00000009307
O95251,0,6,1596650.9739583333,6.1805497144387005e-6,1.4128383564818674,0.49859641567759405,0.6325331411203966,1,raw,891634.0625,2236658.46875,984412.875,1700710.4375,606453.125,3160036.875,Histone acetyltransferase KAT7 OS=Homo sapiens OX=9606 GN=KAT7 PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,11143,KAT7,Androgen receptor signaling pathway,HATs acetylate histones,ENSG00000136504
Q16513,0,6,9706221.747395834,3.7572260329646436e-5,1.412774746947943,0.4985314604584594,0.04646371850061592,0.6429522395902524,raw,8512588.875,9092425.59375,6366385.375,12536901.9375,9702658.109375,12026370.59375,Serine/threonine-protein kinase N2 OS=Homo sapiens OX=9606 GN=PKN2 PE=1 SV=1,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,signal transducer activity;structural molecule activity,5586,PKN2,PI3K-Akt signaling pathway,RHOC GTPase cycle; RHOA GTPase cycle; RAC1 GTPase cycle; RHOB GTPase cycle; RHO GTPases activate PKNs,ENSG00000065243
O60502,0,6,29588882.109375,1.1453696509405719e-4,1.4123833631946525,0.49813173245630493,0.06187213027849609,0.6429522395902524,raw,28010604.140625,24270018.40625,21024626.109375,39561711.28125,28776670.15625,35889662.5625,Protein O-GlcNAcase OS=Homo sapiens OX=9606 GN=OGA PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,10724,OGA,NA,NA,ENSG00000198408
A0A0G2JJD3,0,6,311760.734375,1.2068089703021656e-6,1.4118389784661698,0.49757555729526376,1,1,raw,NA,244602.765625,NA,374849.71875,315829.71875,NA,Alpha/beta hydrolase domain-containing protein 16A OS=Homo sapiens OX=9606 GN=ABHD16A PE=1 SV=1,NA,cytoskeleton,structural molecule activity,NA,ABHD16A,NA,NA,ENSG00000224552; ENSG00000230475; ENSG00000231488; ENSG00000235676; ENSG00000236063
M0R2K9,0,6,1029081.71875,3.983519771504163e-6,1.411781234656599,0.4975165502748902,0.15633055582127864,0.6638855679885327,raw,715774.9375,773097.125,1065121.125,1533496,1010517.625,1076483.5,Peptidylprolyl isomerase (Fragment) OS=Homo sapiens OX=9606 GN=FKBP8 PE=1 SV=2,NA,NA,structural molecule activity,NA,FKBP8,NA,NA,ENSG00000105701
Q86X76,0,6,12043312.395833334,4.6619012046465105e-5,1.4117259220903473,0.4974600254207919,0.04179494422753617,0.6429522395902524,raw,10423465.6875,9725091.40625,9227626.65625,13426316.8125,13026879.75,16430494.0625,Deaminated glutathione amidase OS=Homo sapiens OX=9606 GN=NIT1 PE=1 SV=2,cellular homeostasis,endosome;nucleus,structural molecule activity,4817,NIT1,NA,NA,ENSG00000158793
P05423,0,6,395857.640625,1.5323435538686925e-6,1.4116767287385001,0.49740975203542054,0.24417102780814315,0.7301988479077035,raw,NA,301564.375,250639.546875,385587.46875,322056.5625,719440.25,DNA-directed RNA polymerase III subunit RPC4 OS=Homo sapiens OX=9606 GN=POLR3D PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,661,POLR3D,Pyrimidine metabolism; Eukaryotic transcription initiation; Cytosolic DNA-sensing pathway,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation,ENSG00000168495
Q14152,0,6,318220826.9583333,0.0012318156399014604,1.411672123114033,0.4974050452053917,0.047818290970077976,0.6429522395902524,raw,267268486.4375,286385517,234206964.953125,404282450.8125,313114201.84375,404067340.703125,Eukaryotic translation initiation factor 3 subunit A OS=Homo sapiens OX=9606 GN=EIF3A PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,8661,EIF3A,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000107581
Q9Y3T9,0,6,15508236.212239584,6.0031545062964146e-5,1.4115355698178091,0.49726548426276174,0.05937279420234781,0.6429522395902524,raw,11550837.0625,14925340.671875,11842188.71875,18316068.875,15347332.6953125,21067649.25,Nucleolar complex protein 2 homolog OS=Homo sapiens OX=9606 GN=NOC2L PE=1 SV=4,cell growth;cellular component movement;metabolic process,cytosol;membrane;nucleus,structural molecule activity,26155,NOC2L,NA,Regulation of TP53 Activity through Phosphorylation,ENSG00000188976
Q8N5G0,0,6,1704534.7291666667,6.598161906032704e-6,1.4113587007173714,0.4970846994724241,0.0759807425277856,0.6429522395902524,raw,1522700.0625,1309824,1317065.25,1858851.5,1784704.4375,2434063.125,Small integral membrane protein 20 OS=Homo sapiens OX=9606 GN=SMIM20 PE=1 SV=3,cell growth,cell surface;cytoskeleton;endosome,NA,389203,SMIM20,Mitochondrial complex IV assembly,NA,ENSG00000250317
Q8NFH5,0,6,8827400.796223959,3.417039187661669e-5,1.411017764670063,0.4967361515355089,0.13378709197828179,0.6514609890946903,raw,6753655.5703125,9297888.75,5834690.71484375,12543748.375,10301569.1171875,8232852.25,Nucleoporin NUP35 OS=Homo sapiens OX=9606 GN=NUP35 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane,RNA binding;structural molecule activity,129401,NUP35,NA,HCMV Early Events; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000163002
P36542,0,6,107622583.15625,4.166012086814878e-4,1.4107799339653777,0.49649296104797036,0.10198924438253779,0.6429522395902524,raw,99194687.5625,92731430.75,80344877.375,130823641.75,99946300,142694561.5,"ATP synthase subunit gamma, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1C PE=1 SV=1",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,509,ATP5F1C,Electron transport chain: OXPHOS system in mitochondria,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000165629
Q9BVL2,0,6,6384572.036458333,2.4714333639817533e-5,1.4106826377033574,0.49639346028820214,0.1931506070694349,0.6839501208924997,raw,5616255.125,5842304.9375,4472854.3125,7922753.59375,5284641,9168623.25,Nucleoporin p58/p45 OS=Homo sapiens OX=9606 GN=NUP58 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;membrane,structural molecule activity,9818,NUP58,NA,NA,ENSG00000139496
Q9BZF9,0,6,2214885.7864583335,8.573703294134356e-6,1.4106352914166262,0.4963450387669174,0.046956636349570924,0.6429522395902524,raw,2143753.84375,1760772.15625,1560674.5625,2483807.34375,2319702.75,3020604.0625,Uveal autoantigen with coiled-coil domains and ankyrin repeats OS=Homo sapiens OX=9606 GN=UACA PE=1 SV=2,development;metabolic process,cell surface;cytosol;endoplasmic reticulum;membrane,NA,55075,UACA,NA,Regulation of the apoptosome activity; RHOH GTPase cycle,ENSG00000137831
P10253,0,6,37010094.307291664,1.4326407682901037e-4,1.410426332385148,0.4961313148578255,0.19164785018310637,0.6828255842456847,raw,38910988.1875,21980779.4375,31495439.53125,48616043.5625,31002270.125,50055045,Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,cell growth;cellular homeostasis;defense response;metabolic process,cytoplasm;cytoskeleton;mitochondrion;nucleus,structural molecule activity,2548,GAA,NA,Neutrophil degranulation; Glycogen breakdown (glycogenolysis); Glycogen storage disease type II (GAA),ENSG00000171298
Q99426,0,6,20882398.96875,8.083463893372538e-5,1.41041604158647,0.49612078858074127,0.11553149952080785,0.6429522395902524,raw,15511587.125,20316559.75,16349889.625,28654801.78125,19047701,25413854.53125,Tubulin-folding cofactor B OS=Homo sapiens OX=9606 GN=TBCB PE=1 SV=2,defense response;metabolic process,cytosol;endoplasmic reticulum;nucleus,NA,1155,TBCB,NA,Post-chaperonin tubulin folding pathway,ENSG00000105254
I3L505,0.5,6,1451384,5.6182291014435525e-6,1.4094755398985979,0.4951584415314709,0.21679898653851115,0.7052519353827845,raw,1321931.125,1253400.875,1158954.375,1766637.875,1208505.375,1998874.375,"Acyl carrier protein, mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=NDUFAB1 PE=1 SV=1",cellular homeostasis,NA,NA,NA,NDUFAB1,NA,NA,ENSG00000004779
Q99638,0.16666666666666666,6,154042.9828125,5.962920694387953e-7,1.4090193661703454,0.4946914408071743,0.01053239615829648,0.6429522395902524,raw,141819.953125,134276.515625,115722.0234375,192004.765625,186391.65625,NA,Cell cycle checkpoint control protein RAD9A OS=Homo sapiens OX=9606 GN=RAD9A PE=1 SV=1,cell differentiation;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,structural molecule activity,5883,RAD9A,Androgen receptor signaling pathway; miRNA regulation of DNA damage response; ATM signaling pathway; ATR signaling; DNA IR-double strand breaks and cellular response via ATM; DNA damage response,Activation of ATR in response to replication stress; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Regulation of TP53 Activity through Phosphorylation; Presynaptic phase of homologous DNA pairing and strand exchange; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51,ENSG00000172613
F6PQP6,0,6,980279.7395833334,3.7946099450473415e-6,1.4089563127892266,0.494626879000665,0.02733432131556043,0.6429522395902524,raw,879618.9375,711893.125,841328.5625,1003026.3125,1182453.875,1263357.625,Epsin-2 (Fragment) OS=Homo sapiens OX=9606 GN=EPN2 PE=1 SV=8,conjugation,cytoskeleton,structural molecule activity,NA,EPN2,NA,NA,ENSG00000072134
O95394,0,6,34071554.986979164,1.3188914977654468e-4,1.4088953832086895,0.4945644890574164,0.15867098436715935,0.6638855679885327,raw,34812708.34375,21419578.09375,29765543.984375,49047464.0625,33956780.625,35427254.8125,Phosphoacetylglucosamine mutase OS=Homo sapiens OX=9606 GN=PGM3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol,structural molecule activity,5238,PGM3,Glucuronidation,Synthesis of UDP-N-acetyl-glucosamine,ENSG00000013375
J3KQJ1,0,6,13974627.786458334,5.409502964875037e-5,1.4086870186429246,0.4943511100087139,0.15573487651100812,0.6638855679885327,raw,11043800.5,12783826.5625,11641415.53125,19421738.0625,12557875.125,16399110.9375,Inactive C-alpha-formylglycine-generating enzyme 2 OS=Homo sapiens OX=9606 GN=SUMF2 PE=1 SV=1,NA,extracellular,NA,NA,SUMF2,NA,NA,ENSG00000129103
Q13510,0,6,4028719.4166666665,1.5594955344875898e-5,1.408241610758152,0.4938948771136503,0.42345153211789804,0.9086347256931654,raw,5410899.125,1813039.09375,2834810.5,5798996.5625,2553197.09375,5761374.125,Acid ceramidase OS=Homo sapiens OX=9606 GN=ASAH1 PE=1 SV=5,cellular component movement;cellular homeostasis;metabolic process,cell surface;membrane;mitochondrion;nucleus,structural molecule activity,427,ASAH1,Sphingolipid pathway; S1P receptor signal transduction; Sphingolipid metabolism overview; Sphingolipid metabolism: integrated pathway; Sphingolipid metabolism in senescence; Biosynthesis and turnover of 1-deoxy-sphingoid bases; Synthesis of ceramides and 1-deoxyceramides,Glycosphingolipid metabolism; Neutrophil degranulation,ENSG00000104763
P22314,0,6,392461566.4895833,0.001519197534249999,1.4081658563453847,0.4938172672387103,0.1823824343596005,0.675082935155814,raw,373913276.3125,323998558.46875,307976816,487974810.46875,334374028.75,526531908.9375,Ubiquitin-like modifier-activating enzyme 1 OS=Homo sapiens OX=9606 GN=UBA1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation,cytosol;endosome;membrane;nucleus,structural molecule activity,7317,UBA1,Proteasome degradation; Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000130985
Q8NE86,0,6,5428906.6875,2.101500467190903e-5,1.4080227564612153,0.4936706509982484,0.35694754343606566,0.8406066251623018,raw,4534851.75,5690142.1875,3726188.125,8011849.6875,3705833.25,6904575.125,"Calcium uniporter protein, mitochondrial OS=Homo sapiens OX=9606 GN=MCU PE=1 SV=1",cell growth;conjugation;development;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,90550,MCU,Alzheimer's disease and miRNA effects; Malignant pleural mesothelioma; Alzheimer's disease,Processing of SMDT1,ENSG00000156026
A0A1B0GUA3,0,6,12347911.901041666,4.779810028530938e-5,1.4079420111519017,0.4935879149791806,0.17006755771254922,0.668039680404208,raw,9801557,12179775.1875,8371346.21875,13800023.875,11207075.875,18727693.25,KIF-binding protein OS=Homo sapiens OX=9606 GN=KIFBP PE=1 SV=1,NA,endoplasmic reticulum;nucleus,NA,NA,KIFBP,NA,NA,ENSG00000198954
Q9H330,0,6,1225598.4479166667,4.744225419854061e-6,1.4077473054762206,0.493388389476472,0.293859291216803,0.7750607974821754,raw,980808.75,1455994.25,854242.4375,1279297.375,1402517,1380730.875,Transmembrane protein 245 OS=Homo sapiens OX=9606 GN=TMEM245 PE=1 SV=3,NA,cytoskeleton,NA,23731,TMEM245,NA,NA,ENSG00000106771
Q9UH99,0,6,6660095.875,2.5780871542837154e-5,1.4075549662663103,0.49319126192287105,0.5773786166066337,1,raw,6671490.328125,6062603.5625,5476656.75,9390489.34375,3722362.890625,8636972.375,SUN domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUN2 PE=1 SV=3,cell differentiation;cell growth;conjugation;metabolic process,cytoskeleton;membrane;mitochondrion,motor activity;structural molecule activity,25777,SUN2,NA,Meiotic synapsis,ENSG00000100242
Q9Y2T3,0,6,31685081.345052082,1.2265123915819508e-4,1.4075322274793463,0.4931679552663224,0.06807433381705937,0.6429522395902524,raw,31080916.5,21747672.1875,25532492.75,38875347.84375,30610549.4765625,42263509.3125,Guanine deaminase OS=Homo sapiens OX=9606 GN=GDA PE=1 SV=1,cellular homeostasis;defense response,cytosol,structural molecule activity,9615,GDA,NA,Purine catabolism,ENSG00000119125
Q86TS9,0,6,1277026.6041666667,4.943301036008943e-6,1.4074291339298663,0.493062282375257,0.23118185672364713,0.7181805368495511,raw,1349652.25,771670.25,1072251.5,1509118,1059724.75,1899742.875,"39S ribosomal protein L52, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL52 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,structural molecule activity,122704,MRPL52,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000172590
O43852,0,6,117915911.38020833,4.564461264830847e-4,1.4073852383964642,0.4930172862511899,0.15571373684552547,0.6638855679885327,raw,106510352.34375,100404585.796875,101478030.703125,149901097.625,105897564.375,143303837.4375,Calumenin OS=Homo sapiens OX=9606 GN=CALU PE=1 SV=2,NA,cell surface;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,813,CALU,NOTCH1 regulation of endothelial cell calcification; VEGFA-VEGFR2 signaling pathway,Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,ENSG00000128595
Q9HAV7,0,6,39556647.5,1.5312164674548178e-4,1.4067478318787372,0.4923637398730216,0.1292084876765826,0.6498046150645307,raw,35887869.5,33943154.5,28644082.25,47749459,35771937.25,55343382.5,"GrpE protein homolog 1, mitochondrial OS=Homo sapiens OX=9606 GN=GRPEL1 PE=1 SV=2",cell growth;conjugation;metabolic process,cytoskeleton;endosome;membrane,structural molecule activity,80273,GRPEL1,NA,Mitochondrial protein import,ENSG00000109519
O00422,0,6,27596197.28125,1.0682338971264406e-4,1.406604953138787,0.4922172026517747,0.16434478326755278,0.6638855679885327,raw,21782017,26936425.96875,21688321.46875,37888910.1875,24206112.375,33075396.6875,Histone deacetylase complex subunit SAP18 OS=Homo sapiens OX=9606 GN=SAP18 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,10284,SAP18,Hedgehog signaling pathway,Potential therapeutics for SARS; HDACs deacetylate histones; NoRC negatively regulates rRNA expression,ENSG00000150459
Q9Y291,0,6,4167565.0416666665,1.6132419262752294e-5,1.4056561427502483,0.4912437197157649,0.2662167476527257,0.7464861505127105,raw,3073742.3125,3375153.5,3869981.75,4744305.25,3311891.6875,6630315.75,"28S ribosomal protein S33, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS33 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,51650,MRPS33,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000090263
Q9GZR7,0,6,25882991.088541668,1.0019166103942783e-4,1.405278070285327,0.4908556328861277,0.045644533874005126,0.6429522395902524,raw,19439947.65625,25066682.15625,18283122.625,32277771.3125,25692871.28125,34537551.5,ATP-dependent RNA helicase DDX24 OS=Homo sapiens OX=9606 GN=DDX24 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,structural molecule activity,57062,DDX24,NA,NA,ENSG00000089737; ENSG00000273761
Q9UHY7,0,6,13270371.432291666,5.136889132570443e-5,1.404735282791477,0.4902982854738703,0.16289990229178244,0.6638855679885327,raw,13473643.5625,9037845.65625,10359315.625,16425165.9375,11399355.3125,18926902.5,Enolase-phosphatase E1 OS=Homo sapiens OX=9606 GN=ENOPH1 PE=1 SV=1,cellular homeostasis,cytosol;membrane,structural molecule activity,58478,ENOPH1,Methionine de novo and salvage pathway,Methionine salvage pathway,ENSG00000145293
Q9NZN5,0,6,1923513.5208333333,7.445816985557221e-6,1.4045449173640692,0.4901027626075623,0.17382509475879038,0.669032211414766,raw,1305435.796875,1903660.5,1493882.359375,2966996.28125,1772881.3125,2098224.875,Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1,development;metabolic process,cytoskeleton;cytosol;nucleus,antioxidant activity;DNA binding,23365,ARHGEF12,Netrin-UNC5B signaling pathway,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle; Sema4D induced cell migration and growth-cone collapse,ENSG00000196914
P16591,0,6,2085090.125,8.071271296505663e-6,1.4040254726652805,0.48956911011149984,0.18803452706887464,0.6796724904026823,raw,1880105.1875,1978106.125,1312612.9375,1842942,2358077.9375,3138696.5625,Tyrosine-protein kinase Fer OS=Homo sapiens OX=9606 GN=FER PE=1 SV=2,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;motor activity;signal transducer activity;structural molecule activity,2241,FER,NA,Signaling by SCF-KIT,ENSG00000151422
O43278,0,6,16110772.088541666,6.236392890824848e-5,1.4038993548236223,0.4894395129206711,0.1308851806997789,0.6498046150645307,raw,9966616.15625,16067767.0625,12061889.1875,22310699,13700133.3125,22557527.8125,Kunitz-type protease inhibitor 1 OS=Homo sapiens OX=9606 GN=SPINT1 PE=1 SV=2,cell growth;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton,DNA binding,6692,SPINT1,NA,MET Receptor Activation; Signaling by MST1,ENSG00000166145
P47985,0,6,45100950.734375,1.7458334521989877e-4,1.4037822180229202,0.4893191341118982,0.1406823109900575,0.6572502130392559,raw,40890857.3125,38361793.75,37997843.84375,55049654.125,40903697,57401858.375,"Cytochrome b-c1 complex subunit Rieske, mitochondrial OS=Homo sapiens OX=9606 GN=UQCRFS1 PE=1 SV=2",cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity;structural molecule activity,7386,UQCRFS1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly; Arsenic metabolism and reactive oxygen species generation,Respiratory electron transport,ENSG00000169021
Q9Y2R4,0,6,30825101.0625,1.1932230191615456e-4,1.4037819868702879,0.48931889655169863,0.21384556270527186,0.703661823235592,raw,29531513.875,23763172.65625,24943963.84375,35015887.125,26528945.4375,45167123.4375,Probable ATP-dependent RNA helicase DDX52 OS=Homo sapiens OX=9606 GN=DDX52 PE=1 SV=3,NA,NA,NA,NA,NA,NA,NA,NA
Q9BTX3,0,6,704033.8125,2.7252768762696525e-6,1.4035450525210331,0.48907537379378596,0.34566082040118185,0.8277692477090556,raw,929183.8125,426591,427125.9375,864872.3125,598739.6875,977690.125,Transmembrane protein 208 OS=Homo sapiens OX=9606 GN=TMEM208 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular;mitochondrion,NA,29100,TMEM208,NA,NA,ENSG00000168701
Q9NUM4,0,6,5174818.020833333,2.0031441161898132e-5,1.4034126560075537,0.4889392778398006,0.08319787033357134,0.6429522395902524,raw,4186087.796875,4384610.90625,4653404.3125,6153418.4375,4988009.578125,6683377.09375,Transmembrane protein 106B OS=Homo sapiens OX=9606 GN=TMEM106B PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;mitochondrion,structural molecule activity,54664,TMEM106B,NA,NA,ENSG00000106460
O95861,0,6,30328554.265625,1.174001960748116e-4,1.4032429876457984,0.4887648498119434,0.14831502757804588,0.6638855679885327,raw,26837631.8125,26509432.625,25794440.5625,38230226.125,27400419.03125,37199175.4375,"3'(2'),5'-bisphosphate nucleotidase 1 OS=Homo sapiens OX=9606 GN=BPNT1 PE=1 SV=1",cellular homeostasis;defense response,cytosol,structural molecule activity,10380,BPNT1,NA,Cytosolic sulfonation of small molecules,ENSG00000162813
Q7Z2W4,0,6,25864641.356770832,1.0012063021847446e-4,1.4029645441052199,0.4884785494496692,0.1837008371912508,0.6760612448535599,raw,18147431.296875,29708219.21875,16517067.46875,33610456.5625,23172860.03125,34031813.5625,Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens OX=9606 GN=ZC3HAV1 PE=1 SV=3,coagulation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,56829,ZC3HAV1,NA,Signaling by BRAF and RAF1 fusions,ENSG00000105939
P46977,0,6,62581766.119791664,2.4225063775950933e-4,1.402468059257732,0.48796791430985775,0.14798928518869178,0.6638855679885327,raw,52748133.3125,57422815,43903246.375,73977572.15625,55980821.46875,91458008.40625,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A OS=Homo sapiens OX=9606 GN=STT3A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,3703,STT3A,NA,Asparagine N-linked glycosylation; Maturation of spike protein,ENSG00000134910
Q96JB2,0,6,3232961.5416666665,1.25146195749984e-5,1.4023490565738777,0.48784549307890956,0.3051971235560475,0.7849075999456834,raw,2282895.640625,3471151.5,2315439.453125,4206886.46875,2253630.15625,4867766.03125,Conserved oligomeric Golgi complex subunit 3 OS=Homo sapiens OX=9606 GN=COG3 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular,NA,83548,COG3,NA,COPI-mediated anterograde transport; Intra-Golgi traffic; Retrograde transport at the Trans-Golgi-Network,ENSG00000136152
Q9H1K1,0,6,18935129.5390625,7.329686410761341e-5,1.4023186013332727,0.4878141612920808,0.06651304819238316,0.6429522395902524,raw,13973156.671875,19508094.8125,14892396.875,19858750.90625,20883885.15625,24494492.8125,"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial OS=Homo sapiens OX=9606 GN=ISCU PE=1 SV=2",cell growth;cellular homeostasis;metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,23479,ISCU,NA,Maturation of replicase proteins,ENSG00000136003
O14972,0,6,411587.1,1.5932314418505078e-6,1.4021373349164883,0.48762766368478483,0.5086919349152206,0.992236492858638,raw,383293.5,282665.8125,NA,456223.4375,188188.5625,747564.1875,Vacuolar protein sorting-associated protein 26C OS=Homo sapiens OX=9606 GN=VPS26C PE=1 SV=1,conjugation,mitochondrion,NA,10311,VPS26C,NA,NA,ENSG00000157538
P16157,0.6666666666666666,6,796920.6625,3.0848368575092293e-6,1.4021117680552875,0.4876013570461717,0.06142754027090067,0.6429522395902524,raw,645234.0625,714612.125,713789.1875,909579.125,NA,1001388.8125,Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,motor activity;structural molecule activity,286,ANK1,NA,COPI-mediated anterograde transport; CHL1 interactions; Neurofascin interactions; Interaction between L1 and Ankyrins; NrCAM interactions,ENSG00000029534
O14949,0,6,2130419.2604166665,8.246737932310654e-6,1.4020908582505398,0.48757984185940667,0.08197401295153547,0.6429522395902524,raw,1221999.375,1912067.6875,2091553.125,2730194.5,2680892.625,2145808.25,Cytochrome b-c1 complex subunit 8 OS=Homo sapiens OX=9606 GN=UQCRQ PE=1 SV=4,cellular homeostasis;defense response,cytoskeleton;endosome,NA,27089,UQCRQ,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,Respiratory electron transport,ENSG00000164405
Q99717,0.16666666666666666,6,113443.921875,4.39135296558329e-7,1.402062837098462,0.4875510089340139,1,1,raw,101714.546875,98382.09375,NA,NA,NA,140235.125,Mothers against decapentaplegic homolog 5 OS=Homo sapiens OX=9606 GN=SMAD5 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,4090,SMAD5,Differentiation of white and brown adipocyte; BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; Neovascularisation processes; Osteoblast differentiation and related diseases; TGF-beta receptor signaling in skeletal dysplasias; Network map of SARS-CoV-2 signaling pathway; Clock-controlled autophagy in bone metabolism; TGF-beta receptor signaling,Signaling by BMP,ENSG00000113658
O43291,0,6,3332899.8802083335,1.2901475487661562e-5,1.4019229383370702,0.48740704868198825,0.5172738572325214,1,raw,1998817.09375,4462127.9375,2673811.6875,3748477.9375,3330780.9375,3783383.6875,Kunitz-type protease inhibitor 2 OS=Homo sapiens OX=9606 GN=SPINT2 PE=1 SV=2,cell growth;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;nucleus,DNA binding,10653,SPINT2,NA,MET Receptor Activation; Signaling by MST1,ENSG00000167642
Q13868,0,6,10675187.106770834,4.1323072919788904e-5,1.4017898737308716,0.4872701076609262,0.14870598055732817,0.6638855679885327,raw,10453698.3125,8613705.234375,8188742.375,12530273.65625,9610814.625,14653888.4375,Exosome complex component RRP4 OS=Homo sapiens OX=9606 GN=EXOSC2 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,23404,EXOSC2,Ciliary landscape,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000130713
A0A669KB05,0,6,133342215.98828134,5.161605187299391e-4,1.4017005945500418,0.4871782203276618,0.1962602922817338,0.6867780510802372,raw,119848742.75,116397538.898438,114558663.8125,165945492.1875,115310804.3125,167992053.96875,Catenin delta-1 OS=Homo sapiens OX=9606 GN=CTNND1 PE=1 SV=1,cell communication,cytoplasm;cytoskeleton,structural molecule activity,NA,CTNND1,NA,NA,ENSG00000198561
Q96A65,0,6,2845354.65625,1.1014214249069623e-5,1.401570027566999,0.4870438284943585,0.06190616565282327,0.6429522395902524,raw,2006699.8125,2773912.28125,2331714.875,3887832.3125,2996602.21875,3075366.4375,Exocyst complex component 4 OS=Homo sapiens OX=9606 GN=EXOC4 PE=1 SV=1,cell death;cell differentiation;cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,60412,EXOC4,Ciliary landscape,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing; VxPx cargo-targeting to cilium,ENSG00000131558
Q96C23,0,6,3523781.0755208335,1.3640366288733517e-5,1.4015659813145207,0.4870396635103076,0.5479423862201278,1,raw,3194862.53125,3418978.375,2968657.640625,4791923.78125,2019507.4375,4748756.6875,Galactose mutarotase OS=Homo sapiens OX=9606 GN=GALM PE=1 SV=1,cellular homeostasis,nucleus,structural molecule activity,130589,GALM,NA,NA,ENSG00000143891
O95169,0,6,6123348.911458333,2.3703153026799182e-5,1.4014492377181056,0.4869194890591969,0.08428342117023059,0.6429522395902524,raw,5608206.5,4641550.84375,4918283.875,6892725.1875,6104145.1875,8575181.875,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFB8 PE=1 SV=1",cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome;extracellular,catalytic activity,4714,NDUFB8,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis; Mitochondrial protein import,ENSG00000166136
B4DR80,0,6,24651720.796875,9.542548021864949e-5,1.4012898028096878,0.4867553525137384,0.10869079188436682,0.6429522395902524,raw,21583857.625,21502647.375,19474446.21875,32307997.6875,22909935.375,30131440.5,Serine/threonine-protein kinase 24 OS=Homo sapiens OX=9606 GN=STK24 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,signal transducer activity;structural molecule activity,8428,STK24,NA,NA,ENSG00000102572
Q92600,0,6,4678477.6015625,1.8110134197118246e-5,1.4009661019112147,0.48642204841952713,0.07561011546242266,0.6429522395902524,raw,3560468.0625,4825854.9375,3513116.5625,4988095.0625,4964820.609375,6218510.375,CCR4-NOT transcription complex subunit 9 OS=Homo sapiens OX=9606 GN=CNOT9 PE=1 SV=1,cellular component movement;cellular homeostasis;development;metabolic process,cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,9125,CNOT9,NA,Activation of anterior HOX genes in hindbrain development during early embryogenesis; Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,ENSG00000144580
Q13542,0,6,33900144.10091147,1.3122562749132605e-4,1.4008901155115816,0.486343796579714,0.019067702354022154,0.6429522395902524,raw,25892187.25,32634404.625,26126560.0429688,39341039.5,36272109.1875,43134564,Eukaryotic translation initiation factor 4E-binding protein 2 OS=Homo sapiens OX=9606 GN=EIF4EBP2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development;metabolic process,nucleus,structural molecule activity,1979,EIF4EBP2,Translation factors; Fragile X syndrome,NA,ENSG00000148730
P22695,0,6,106622474.72916667,4.1272984295771066e-4,1.4005756192208763,0.48601987882818887,0.070904455484007,0.6429522395902524,raw,101832357.875,71990178.21875,82094192.5,140908598.875,100285603.21875,142623917.6875,"Cytochrome b-c1 complex subunit 2, mitochondrial OS=Homo sapiens OX=9606 GN=UQCRC2 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;membrane,structural molecule activity,7385,UQCRC2,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,Respiratory electron transport,ENSG00000140740
A0A5F9ZHN9,0,6,55816730,2.160635481949762e-4,1.4000316593636588,0.48545945166346666,0.1616267743064983,0.6638855679885327,raw,50953590.125,46627990.25,46250225.875,75591368,50196543.1875,65280662.5625,Aldehyde dehydrogenase OS=Homo sapiens OX=9606 GN=ALDH3A2 PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,NA,ALDH3A2,Fragile X syndrome; Fluoroacetic acid toxicity,NA,ENSG00000072210
P83436,0,6,1420032.2057291667,5.496867998554953e-6,1.3999864571400755,0.48541287123356014,0.037894634769385135,0.6429522395902524,raw,1003208.5625,1341112.59375,1217624.515625,1576094.28125,1504613.8125,1877539.46875,Conserved oligomeric Golgi complex subunit 7 OS=Homo sapiens OX=9606 GN=COG7 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;extracellular;membrane;nucleus,NA,91949,COG7,NA,COPI-mediated anterograde transport; Intra-Golgi traffic; Retrograde transport at the Trans-Golgi-Network,ENSG00000168434
H0YFD6,0,6,133438512.21875,5.165332762388949e-4,1.3997735910949232,0.4851934947277054,0.18751546510356273,0.6796724904026823,raw,126060523.0625,103636092.21875,111990375.34375,170106794.25,112381097.375,176456191.0625,Enoyl-CoA hydratase OS=Homo sapiens OX=9606 GN=HADHA PE=1 SV=2,cellular homeostasis,endosome,structural molecule activity,NA,HADHA,Valproic acid pathway,NA,ENSG00000084754
O15145,0,6,22243400.927083332,8.610300403174905e-5,1.3997729668744021,0.4851928513664814,0.11598321196939261,0.6429522395902524,raw,17803447.6875,19610567.875,19291072.5625,27003121.875,20588307.625,29163887.9375,Actin-related protein 2/3 complex subunit 3 OS=Homo sapiens OX=9606 GN=ARPC3 PE=1 SV=3,cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity,10094,ARPC3,Pathogenic Escherichia coli infection,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,ENSG00000111229
P60709,0,6,8867126331.523445,0.034324167278915456,1.3997466658564193,0.4851657436100137,0.09901176078177516,0.6429522395902524,raw,7661588230.99219,7812405219.08984,6996032938.16406,10724282581.4961,8355269370.04688,11653179649.3516,"Actin, cytoplasmic 1 OS=Homo sapiens OX=9606 GN=ACTB PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,60,ACTB,Arrhythmogenic right ventricular cardiomyopathy; Pathogenic Escherichia coli infection; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; Focal adhesion; Fas ligand pathway and stress induction of heat shock proteins; Ebola virus infection in host; Acute viral myocarditis; Thermogenesis; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Overlap between signal transduction pathways contributing to LMNA laminopathies; Malignant pleural mesothelioma; Regulation of actin cytoskeleton; Network map of SARS-CoV-2 signaling pathway,UCH proteinases; RHO GTPases Activate Formins; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; RHO GTPases Activate WASPs and WAVEs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; RHO GTPases activate IQGAPs; RHOF GTPase cycle; B-WICH complex positively regulates rRNA expression; Signaling by BRAF and RAF1 fusions; Clathrin-mediated endocytosis; EPHB-mediated forward signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; EPH-ephrin mediated repulsion of cells; HATs acetylate histones; Interaction between L1 and Ankyrins; Prefoldin mediated transfer of substrate  to CCT/TriC; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Adherens junctions interactions; DNA Damage Recognition in GG-NER; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Formation of annular gap junctions; Folding of actin by CCT/TriC; Cell-extracellular matrix interactions,ENSG00000075624
A0A3B3ITW3,0,6,15609748.924479166,6.0424495291208975e-5,1.3996308744679067,0.48504639446208797,0.28295998567498926,0.7642736213388397,raw,15682165,12619940.703125,12333341.34375,18812165.25,12261638.9375,21949242.3125,ATP-binding cassette sub-family D member 3 OS=Homo sapiens OX=9606 GN=ABCD3 PE=1 SV=2,conjugation,cytoskeleton;mitochondrion;nucleus,catalytic activity;structural molecule activity,NA,ABCD3,Fragile X syndrome,NA,ENSG00000117528
O75880,0,6,3997850.5416666665,1.5475463596411104e-5,1.3996081822508544,0.4850230038560372,0.30518705255511575,0.7849075999456834,raw,3602851.625,1614721.375,4597481.875,6434673.25,3581474.625,4155900.5,"Protein SCO1 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=SCO1 PE=1 SV=1",cell growth;metabolic process,endoplasmic reticulum;endosome,structural molecule activity,6341,SCO1,Electron transport chain: OXPHOS system in mitochondria; Copper homeostasis,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000133028
Q9C0E8,0,6,4374524.354166667,1.6933547587373657e-5,1.399536827288435,0.48494945036016845,0.03275136661373754,0.6429522395902524,raw,3826786.84375,3414236.65625,3534790.1875,4778349.9375,4854284.75,5838697.75,Endoplasmic reticulum junction formation protein lunapark OS=Homo sapiens OX=9606 GN=LNPK PE=1 SV=2,cell growth;coagulation;defense response;metabolic process,cytoskeleton;extracellular;membrane,structural molecule activity,80856,LNPK,NA,NA,ENSG00000144320
P32321,0,6,3368861.1875,1.3040679766578786e-5,1.3994814531827156,0.4848923675263171,0.4585557228179412,0.9412524313762942,raw,2177166,4274561.4375,1876872.125,6342930.4375,3046903.4375,2494733.6875,Deoxycytidylate deaminase OS=Homo sapiens OX=9606 GN=DCTD PE=1 SV=2,cellular homeostasis,cytosol,structural molecule activity,1635,DCTD,Pyrimidine metabolism,Interconversion of nucleotide di- and triphosphates,ENSG00000129187
Q8NB37,0,6,5903881.338541667,2.2853605901446003e-5,1.3991978492123585,0.48459997672422633,0.0800652589089998,0.6429522395902524,raw,4398518.625,5879404.25,4119600.96875,7132257.09375,5667057.3125,8226449.78125,Glutamine amidotransferase-like class 1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GATD1 PE=1 SV=1,cellular homeostasis,nucleus,structural molecule activity,347862,GATD1,NA,NA,ENSG00000177225
C9JCC6,0,6,6814959.114583333,2.6380338781948863e-5,1.3990176629623472,0.4844141770182666,0.24694064699241414,0.7316541032247736,raw,6610064,4803607.5,5501370.5,7696514.5,5598842.5625,10679355.625,Dr1-associated corepressor OS=Homo sapiens OX=9606 GN=DRAP1 PE=1 SV=1,NA,NA,RNA binding;structural molecule activity,NA,DRAP1,NA,NA,ENSG00000175550
M0QY43,0,6,663152.015625,2.567025647840492e-6,1.3986842973676272,0.48407036277400384,0.19806802921331693,0.6875760999904456,raw,436083.53125,566131,544825.25,609943.1875,698929.75,1122999.375,Myosin-14 (Fragment) OS=Homo sapiens OX=9606 GN=MYH14 PE=1 SV=8,NA,endoplasmic reticulum,motor activity;structural molecule activity,NA,MYH14,NA,NA,ENSG00000105357
P04083,0,6,651780365.654948,0.0025230066047800914,1.3985822811349335,0.4839651326796012,0.06185522017569938,0.6429522395902524,raw,612039274.0625,503558569.90625,496055765.984375,814741008.84375,628300291.070313,855987284.0625,Annexin A1 OS=Homo sapiens OX=9606 GN=ANXA1 PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,antioxidant activity;DNA binding;structural molecule activity,301,ANXA1,Spinal cord injury; VEGFA-VEGFR2 signaling pathway; Prostaglandin synthesis and regulation,G alpha (q) signalling events; G alpha (i) signalling events; Interleukin-4 and Interleukin-13 signaling; Smooth Muscle Contraction; Formyl peptide receptors bind formyl peptides and many other ligands,ENSG00000135046
Q99643,0,6,7820533.229166667,3.0272861886937218e-5,1.3983681990015198,0.4837442812665958,0.2692491966994558,0.7494598698888127,raw,7973567.25,6623209,5557135.375,9435650.125,6183654.75,11149982.875,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial OS=Homo sapiens OX=9606 GN=SDHC PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome,structural molecule activity,6391,SDHC,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex II assembly; TCA cycle (aka Krebs or citric acid cycle),Respiratory electron transport; Citric acid cycle (TCA cycle),ENSG00000143252
P22570,0,6,53768833.71875,2.0813625225947136e-4,1.3983411701466297,0.48371639535514416,0.21214173800303604,0.7022006061790371,raw,48231079.34375,46630846.71875,43345460.078125,74111022.875,45088760.53125,65205832.765625,"NADPH:adrenodoxin oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=FDXR PE=1 SV=3",cellular homeostasis,cytoskeleton;endosome,structural molecule activity,2232,FDXR,NA,Endogenous sterols; Pregnenolone biosynthesis; Defective CYP11A1 causes AICSR; Electron transport from NADPH to Ferredoxin,ENSG00000161513
M0QXB5,0,6,14187338.9375,5.491842302981551e-5,1.3981851855610268,0.48355545413041473,0.1870554157899709,0.6791950377757306,raw,13494409.9375,11886702.75,11386917.8125,17285216.4375,12203102.625,18867684.0625,"Persulfide dioxygenase ETHE1, mitochondrial OS=Homo sapiens OX=9606 GN=ETHE1 PE=1 SV=1",cellular homeostasis,endosome;membrane,structural molecule activity,NA,ETHE1,NA,NA,ENSG00000105755
Q96FQ6,0,6,39435523.231770836,1.5265278124286074e-4,1.3979849855499011,0.48334886615754064,0.2667093930905397,0.7468192644661517,raw,36972142.75,40061697.6875,25771514.9375,36028190.9375,40400939.984375,57378653.09375,Protein S100-A16 OS=Homo sapiens OX=9606 GN=S100A16 PE=1 SV=1,metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,140576,S100A16,NA,NA,ENSG00000188643
Q99519,0.16666666666666666,6,771223.5286458333,2.985364639789336e-6,1.3976741495871854,0.4830280534388857,0.722788560794559,1,raw,247455.1875,2110524.5,338654.5,1056699.90625,528145.359375,345861.71875,Sialidase-1 OS=Homo sapiens OX=9606 GN=NEU1 PE=1 SV=1,cellular homeostasis,cell surface;cytoplasm;cytoskeleton;mitochondrion;nucleus,structural molecule activity,4758,NEU1,NA,Glycosphingolipid metabolism; Neutrophil degranulation; Sialic acid metabolism; Defective NEU1 causes sialidosis,ENSG00000184494; ENSG00000204386; ENSG00000223957; ENSG00000227129; ENSG00000227315; ENSG00000228691; ENSG00000234343; ENSG00000234846
Q13526,0,6,8338644.416666667,3.227844232009342e-5,1.3976033213079526,0.4829549418366998,0.08974201953488344,0.6429522395902524,raw,6286603.75,7574280.125,7162870.875,10010852.125,7899503.875,11097755.75,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 OS=Homo sapiens OX=9606 GN=PIN1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,5300,PIN1,Novel intracellular components of RIG-I-like receptor pathway,ISG15 antiviral mechanism; Regulation of TP53 Activity through Phosphorylation; Negative regulators of DDX58/IFIH1 signaling; PI5P Regulates TP53 Acetylation; RHO GTPases Activate NADPH Oxidases,ENSG00000127445
Q9UHN1,0.16666666666666666,6,854059.1979166666,3.306017043105722e-6,1.3975823368486595,0.48293328018050885,0.16384298736796246,0.6638855679885327,raw,927889.75,468007.375,747607.25,1044842.6875,836029.25,1099978.875,"DNA polymerase subunit gamma-2, mitochondrial OS=Homo sapiens OX=9606 GN=POLG2 PE=1 SV=1",cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,endosome;nucleus,DNA binding;RNA binding;structural molecule activity,11232,POLG2,NA,Transcriptional activation of mitochondrial biogenesis,ENSG00000256525
A0A0D9SGF6,0,6,216491914.24023435,8.380285112773093e-4,1.397537018648714,0.48288649839124415,0.2080665428823897,0.6988382857167694,raw,196230865.519531,189895932.578125,181810046.125,280929361.78125,184698683.96875,265386595.46875,"Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=1 SV=1",cell growth,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,NA,SPTAN1,NA,NA,ENSG00000197694
Q9BVS4,0,6,1943937.84375,7.524878436825595e-6,1.3970702851298094,0.482404603036222,0.44926761007073496,0.9300419568805853,raw,1100285.75,2223296.5625,1786973.0625,3106101.5625,1638711.3125,1808258.8125,Serine/threonine-protein kinase RIO2 OS=Homo sapiens OX=9606 GN=RIOK2 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,55781,RIOK2,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000058729
Q6P2Q9,0,6,232823861.45052084,9.012485971402316e-4,1.3969919850767587,0.4823237436370085,0.1834968729758827,0.6760158949581475,raw,216918081.171875,208094070.25,178270327.765625,290705748.28125,199477388.921875,303477552.3125,Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,10594,PRPF8,mRNA processing,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000174231; ENSG00000274442
Q14562,0,6,885339.64375,3.427101960044976e-6,1.396934916568129,0.48226480690938406,0.7284014550902496,1,raw,1088962.96875,932021.5625,386717.375,563586.34375,NA,1455409.96875,ATP-dependent RNA helicase DHX8 OS=Homo sapiens OX=9606 GN=DHX8 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane,structural molecule activity,1659,DHX8,mRNA processing,NA,ENSG00000067596
Q9BST9,0,6,3952835.5364583335,1.530121294168218e-5,1.3968745422177034,0.48220245349748925,0.10556795966832169,0.6429522395902524,raw,3424460.125,3747619.78125,2558189.25,5179323.25,3573469.4375,5233951.375,Rhotekin OS=Homo sapiens OX=9606 GN=RTKN PE=1 SV=2,cell differentiation;cell growth;development;metabolic process,cytosol;endoplasmic reticulum,DNA binding;structural molecule activity,6242,RTKN,G13 signaling pathway,RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; RHO GTPases Activate Rhotekin and Rhophilins,ENSG00000114993
O96011,0,6,1566639.2083333333,6.064375790087821e-6,1.3968567682732822,0.48218409641255594,0.3635388208299471,0.8458062414401234,raw,1653206.875,1440717.515625,963462.015625,1345818.4375,1522498.71875,2474131.6875,Peroxisomal membrane protein 11B OS=Homo sapiens OX=9606 GN=PEX11B PE=1 SV=1,cell growth;development,cytoskeleton;cytosol;endosome;membrane;mitochondrion;nucleus,structural molecule activity,8799,PEX11B,NA,Class I peroxisomal membrane protein import,ENSG00000131779
Q8NBL1,0.16666666666666666,6,374765.890625,1.4506985283961972e-6,1.396854286722181,0.4821815334263365,0.3615441318098762,0.8443210360538487,raw,383053.625,245947.875,NA,NA,358911.21875,511150.84375,Protein O-glucosyltransferase 1 OS=Homo sapiens OX=9606 GN=POGLUT1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,extracellular;nucleus,structural molecule activity,56983,POGLUT1,NA,Pre-NOTCH Processing in the Endoplasmic Reticulum,ENSG00000163389
Q9NWS0,0,6,3896037.0104166665,1.5081348914018656e-5,1.396689175689716,0.48201099384374846,0.07081925622323472,0.6429522395902524,raw,2689356.6875,3768307.1875,3366870.125,4756038.84375,3756195.375,5039453.84375,PIH1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PIH1D1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,55011,PIH1D1,NA,NA,ENSG00000104872
P09104,0,6,35317281.75,1.3671129081740689e-4,1.3966210026725148,0.48194057354125575,0.07409994380485917,0.6429522395902524,raw,32546817.6875,24489457.8125,30750854.75,41857396,34202491.125,48056673.125,Gamma-enolase OS=Homo sapiens OX=9606 GN=ENO2 PE=1 SV=3,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,2026,ENO2,Clear cell renal cell carcinoma pathways; Glycolysis and gluconeogenesis,Glycolysis; Gluconeogenesis,ENSG00000111674
Q9BTX1,0,6,4397601.192708333,1.702287678341282e-5,1.3965948993974373,0.481913608876277,0.2143437694035017,0.7040015331199742,raw,2881924.40625,4522340.6875,3936534.125,6315877.9375,4108880.375,4620049.625,Nucleoporin NDC1 OS=Homo sapiens OX=9606 GN=NDC1 PE=1 SV=2,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,structural molecule activity,55706,NDC1,NA,Transcriptional regulation by small RNAs; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000058804
P29083,0,6,5753279.494791667,2.2270634295525512e-5,1.3965359117867244,0.48185267285915867,0.19406495553397407,0.6848190557739395,raw,5750418.875,4409064.25,4022378.9375,6157416.5625,5268953.1875,8911445.15625,General transcription factor IIE subunit 1 OS=Homo sapiens OX=9606 GN=GTF2E1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,2960,GTF2E1,Eukaryotic transcription initiation,RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,ENSG00000153767
Q9Y6B6,0,6,7174916.076822917,2.7773712748122973e-5,1.3963854123193333,0.48169719061653504,0.15867676224002347,0.6638855679885327,raw,4952449.375,8110112.5546875,5037759.90625,8443372.5,6915528.0625,9590274.0625,GTP-binding protein SAR1b OS=Homo sapiens OX=9606 GN=SAR1B PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular,structural molecule activity,51128,SAR1B,Sterol regulatory element-binding proteins (SREBP) signaling,"MHC class II antigen presentation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; COPII-mediated vesicle transport; Cargo concentration in the ER; Regulation of cholesterol biosynthesis by SREBP (SREBF); Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Chylomicron assembly",ENSG00000152700
Q92576,0,6,433578.115625,1.6783574760045805e-6,1.396270021806843,0.48157796837508265,0.44213194941090317,0.9249261346766603,raw,216081.640625,472387.09375,NA,618569.53125,320467.5,540384.8125,PHD finger protein 3 OS=Homo sapiens OX=9606 GN=PHF3 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane,structural molecule activity,23469,PHF3,NA,NA,ENSG00000118482
A0A0G2JK23,0,6,23741891.536458332,9.190358027472163e-5,1.3962240387894145,0.48153045567154557,0.2374728848979622,0.7224078784981852,raw,22627299.625,20815524.34375,18098846.1875,32492648.125,19353895.46875,29063135.46875,BCL2-associated athanogene 6 OS=Homo sapiens OX=9606 GN=BAG6 PE=1 SV=1,cell growth;metabolic process,cell surface;membrane,NA,NA,BAG6,NA,NA,ENSG00000227761; ENSG00000228760; ENSG00000234651
A0A0C4DFY5,0,6,564591.109375,2.1855017012085876e-6,1.395621195754122,0.480907413491265,0.8602639533306324,1,raw,1049086.75,357248.8125,193246.25,976563.15625,269698.5625,541703.125,G-protein-coupled receptor family C group 5 member C OS=Homo sapiens OX=9606 GN=GPRC5C PE=1 SV=1,development,cytoplasm;cytoskeleton,structural molecule activity,55890,GPRC5C,"GPCRs, class C metabotropic glutamate, pheromone",NA,ENSG00000170412
Q8N5K1,0,6,9691803.03125,3.7516446257935584e-5,1.39538973611929,0.480668126955845,0.04384062279676509,0.6429522395902524,raw,8815197.6875,7462171.4375,7697314.5625,12300636.375,9618387.125,12257111,CDGSH iron-sulfur domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CISD2 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytoskeleton;endosome;extracellular;nucleus,structural molecule activity,493856,CISD2,NA,NA,ENSG00000145354
Q08945,0,6,94393424.48958333,3.653918497463742e-4,1.39443548870522,0.4796811919654388,0.07519330521312012,0.6429522395902524,raw,82335919.8125,81317617.3125,70432090.25,113392171.4375,91435123.625,127447624.5,FACT complex subunit SSRP1 OS=Homo sapiens OX=9606 GN=SSRP1 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane,RNA binding;structural molecule activity,6749,SSRP1,NA,Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Regulation of TP53 Activity through Phosphorylation,ENSG00000149136
P00491,0,6,89015986.09375,3.44576076052651e-4,1.3941742730381304,0.4794109106562467,0.12369393719230025,0.6445597830897484,raw,82457976.921875,77213304.8125,68665906.328125,110011594.25,80786344.21875,114960790.03125,Purine nucleoside phosphorylase OS=Homo sapiens OX=9606 GN=PNP PE=1 SV=2,cellular homeostasis;metabolic process,cell surface;cytosol;membrane;nucleus,structural molecule activity,4860,PNP,VEGFA-VEGFR2 signaling pathway,Neutrophil degranulation; Purine catabolism; Ribavirin ADME; Purine salvage; Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine,ENSG00000198805
P08758,0,6,326468476.3541667,0.0012637418454088756,1.3940119815841496,0.47924296127645694,0.17280136559767878,0.6689341104244626,raw,314401935.75,268527411.84375,251014582.625,406637309,279949553.4375,438280065.46875,Annexin A5 OS=Homo sapiens OX=9606 GN=ANXA5 PE=1 SV=2,coagulation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;nucleus,DNA binding;structural molecule activity,308,ANXA5,Apoptosis-related network due to altered Notch3 in ovarian cancer; Interactions between LOXL4 and oxidative stress pathway; Prostaglandin synthesis and regulation,Platelet degranulation,ENSG00000164111
Q9Y6X4,0,6,4044343.109375,1.5655433815801558e-5,1.3938799603203427,0.47910632296572064,0.3412533161850561,0.8242917664336578,raw,3197544.21875,2830899.625,4388394.75,4725788.4375,3006536.125,6116895.5,Soluble lamin-associated protein of 75 kDa OS=Homo sapiens OX=9606 GN=FAM169A PE=1 SV=2,NA,cytoskeleton;membrane,NA,26049,FAM169A,NA,RHOF GTPase cycle,ENSG00000198780
Q16576,0,6,38618406.890625,1.4948976800371067e-4,1.3937607271892876,0.47898290889176304,0.3617413654551458,0.8445020957266889,raw,38307201.234375,33041723.671875,31317246.65625,54194951.84375,28797061.125,46052256.8125,Histone-binding protein RBBP7 OS=Homo sapiens OX=9606 GN=RBBP7 PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5931,RBBP7,Retinoblastoma gene in cancer; Interactome of polycomb repressive complex 2 (PRC2) ; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,Activation of anterior HOX genes in hindbrain development during early embryogenesis; HCMV Early Events; Neddylation; Potential therapeutics for SARS; Deposition of new CENPA-containing nucleosomes at the centromere; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6; HDACs deacetylate histones; RMTs methylate histone arginines; PKMTs methylate histone lysines; HATs acetylate histones; RNA Polymerase I Transcription Initiation; PRC2 methylates histones and DNA; Defective pyroptosis; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,ENSG00000102054
Q9BZE4,0,6,57328580.596354164,2.2191584022621797e-4,1.3937314185758993,0.4789525709471297,0.12234157020818887,0.6445597830897484,raw,49519902.5625,52571467.5625,44689361.640625,71865649.625,52054596.125,73270506.0625,Nucleolar GTP-binding protein 1 OS=Homo sapiens OX=9606 GN=GTPBP4 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,23560,GTPBP4,NA,NA,ENSG00000107937
Q92499,0,6,84150943.4375,3.2574375860178477e-4,1.3934097367908043,0.47861954962363623,0.20213027110353754,0.6923632419251884,raw,79579573.8125,71633955.9375,66004884.15625,110886953,70354708.71875,106445585,ATP-dependent RNA helicase DDX1 OS=Homo sapiens OX=9606 GN=DDX1 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,1653,DDX1,DDX1 as a regulatory component of the Drosha microprocessor; mRNA processing,tRNA processing in the nucleus,ENSG00000079785
Q92783,0,6,10707621.864583334,4.144862611607635e-5,1.3929834458035357,0.47817811307265123,0.25344141604271714,0.7343965948630279,raw,10438323.1875,8409234.5625,8949305.5625,12466234.5,8816274.3125,15166359.0625,Signal transducing adapter molecule 1 OS=Homo sapiens OX=9606 GN=STAM PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,8027,STAM,Vitamin D receptor pathway; VEGFA-VEGFR2 signaling pathway; EGF/EGFR signaling pathway,Endosomal Sorting Complex Required For Transport (ESCRT); RHOU GTPase cycle; Metalloprotease DUBs; Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell,ENSG00000136738
Q9UQ90,0,6,3898271.0416666665,1.5089996728368465e-5,1.3928583977888083,0.478048596638503,0.11979674545915502,0.6445597830897484,raw,3382191.84375,3600091.90625,2947063.6875,5182827.09375,3566537.40625,4710914.3125,Paraplegin OS=Homo sapiens OX=9606 GN=SPG7 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response,cytoskeleton;endosome;nucleus,structural molecule activity,6687,SPG7,NA,Processing of SMDT1,ENSG00000197912
Q70CQ2,0.16666666666666666,6,6091849.423502606,2.358122020963058e-5,1.3927255005564696,0.4779109377596574,0.14508732939822724,0.6572502130392559,raw,5689550.109375,5502997.45898438,4334981.10351563,8002065.91796875,5357337.06054688,7664164.890625,Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2,cell death;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;membrane,structural molecule activity,9736,USP34,NA,Ub-specific processing proteases; TCF dependent signaling in response to WNT,ENSG00000115464
P51790,0,6,15174594.036458334,5.87400342143926e-5,1.39255666093293,0.47773602974405144,0.22438887554068515,0.7130916742970872,raw,12312615.53125,12153215,11005937,16924040.5,12769394.90625,25882361.28125,H(+)/Cl(-) exchange transporter 3 OS=Homo sapiens OX=9606 GN=CLCN3 PE=1 SV=2,cell death;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,catalytic activity;structural molecule activity,1182,CLCN3,NA,Stimuli-sensing channels,ENSG00000109572
Q5T5U3,0.3333333333333333,6,39818097.015625,1.5413370370438633e-4,1.3925135953589625,0.4776914129234447,0.08946613382193312,0.6429522395902524,raw,30050769.6875,32912344,38336428,45895601.28125,38329441.9375,53383997.1875,Rho GTPase-activating protein 21 OS=Homo sapiens OX=9606 GN=ARHGAP21 PE=1 SV=2,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,DNA binding,57584,ARHGAP21,NA,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; RND3 GTPase cycle,ENSG00000107863
Q9UM00,0,6,11687652.927083334,4.5242273445560586e-5,1.3925036020531696,0.4776810594558087,0.26940187527115933,0.7494598698888127,raw,9484648.625,12208184.9375,8501548.25,16999941.5,9614968.375,13316625.875,Calcium load-activated calcium channel OS=Homo sapiens OX=9606 GN=TMCO1 PE=1 SV=2,coagulation;conjugation;development;metabolic process,cytoskeleton;extracellular;nucleus,catalytic activity;protein binding,54499,TMCO1,NA,NA,ENSG00000143183
Q9Y314,0,6,24695621.828125,9.559541874033095e-5,1.3923680543586285,0.4775406192409625,0.039001341628966256,0.6429522395902524,raw,22256429.8125,20433444.65625,19579902.75,30062689,24852122.875,30989141.875,Nitric oxide synthase-interacting protein OS=Homo sapiens OX=9606 GN=NOSIP PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,51070,NOSIP,NA,NOSIP mediated eNOS trafficking,ENSG00000142546
Q13085,0,6,33685721.516927086,1.303956092457427e-4,1.3923562030931522,0.4775283395605703,0.23614773406558012,0.7196640448521243,raw,31878980.4375,29987087.6484375,26179188.609375,41752707.5,27631969.9375,44684394.96875,Acetyl-CoA carboxylase 1 OS=Homo sapiens OX=9606 GN=ACACA PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;endosome;membrane,structural molecule activity,31,ACACA,AMP-activated protein kinase signaling; Sterol regulatory element-binding proteins (SREBP) signaling; Leptin signaling pathway; Corticotropin-releasing hormone signaling pathway; Mesodermal commitment pathway; Fatty acid biosynthesis; VEGFA-VEGFR2 signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin and adiponectin; Lipid metabolism pathway; Clear cell renal cell carcinoma pathways; Mitochondrial fatty acid synthesis pathway; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; 7q11.23 copy number variation syndrome,ChREBP activates metabolic gene expression; Biotin transport and metabolism; Carnitine metabolism; Activation of gene expression by SREBF (SREBP); Fatty acyl-CoA biosynthesis; Defective HLCS causes multiple carboxylase deficiency,ENSG00000275176; ENSG00000278540
Q9Y6Y8,0,6,34605243.291666664,1.3395502838930008e-4,1.3921929220186084,0.4773591453490831,0.12432290549603411,0.6445597830897484,raw,29308616.71875,31975709.65625,28177886.375,40803248.75,32043102.4375,45322895.8125,SEC23-interacting protein OS=Homo sapiens OX=9606 GN=SEC23IP PE=1 SV=1,cell growth;conjugation,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,11196,SEC23IP,NA,COPII-mediated vesicle transport,ENSG00000107651
Q4ZIN3,0.16666666666666666,6,457748.31640625,1.771919018240786e-6,1.3919240782090394,0.47708052226534575,0.007737538508258492,0.6429522395902524,raw,389927,361829.625,389926.75390625,565671.36328125,496386.71875,542748.4375,Membralin OS=Homo sapiens OX=9606 GN=TMEM259 PE=1 SV=1,coagulation;metabolic process,cytoskeleton;extracellular,NA,91304,TMEM259,NA,NA,ENSG00000182087
Q9H019,0,6,1141430.7981770833,4.418416992058912e-6,1.391544928196829,0.4766874890794234,0.39562986594611177,0.8782783839678473,raw,1273276.8125,833854.9765625,864430.140625,1270335.09375,834865.875,1771821.890625,Mitochondrial fission regulator 1-like OS=Homo sapiens OX=9606 GN=MTFR1L PE=1 SV=2,cell growth;cellular homeostasis,endosome,NA,56181,MTFR1L,NA,NA,ENSG00000117640
O00743,0,6,9466976.361979166,3.664615435994165e-5,1.39108705391552,0.47621270623698975,0.051243543448279714,0.6429522395902524,raw,7024955.78125,9171083.75,6984984.078125,12757775.875,9383101.96875,11479956.71875,Serine/threonine-protein phosphatase 6 catalytic subunit OS=Homo sapiens OX=9606 GN=PPP6C PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation,cytosol;endosome;membrane;nucleus,structural molecule activity,5537,PPP6C,NA,Telomere Extension By Telomerase; COPII-mediated vesicle transport,ENSG00000119414
P37235,0,6,25118160.385416668,9.723104268207072e-5,1.390933748356904,0.4760537044285207,0.04020547763038779,0.6429522395902524,raw,23798728.625,18188963.46875,20077478.4375,30299116.25,25242220.71875,33102454.8125,Hippocalcin-like protein 1 OS=Homo sapiens OX=9606 GN=HPCAL1 PE=1 SV=3,NA,cytoskeleton,structural molecule activity,3241,HPCAL1,NA,NA,ENSG00000115756
Q15418,0,6,25266932.338541668,9.780693088018056e-5,1.3909324458378898,0.4760523534377891,0.10888272421620626,0.6429522395902524,raw,23471529.734375,21497931.96875,18491206.125,29902171.09375,23566844.453125,34671910.65625,Ribosomal protein S6 kinase alpha-1 OS=Homo sapiens OX=9606 GN=RPS6KA1 PE=1 SV=2,cell death;cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,6195,RPS6KA1,IL-5 signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Kit receptor signaling pathway; BDNF-TrkB signaling; Angiopoietin-like protein 8 regulatory pathway; TYROBP causal network in microglia; Thermogenesis; EGF/EGFR signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Cytoplasmic ribosomal proteins; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; Malignant pleural mesothelioma; Hippocampal synaptogenesis and neurogenesis,Recycling pathway of L1; Senescence-Associated Secretory Phenotype (SASP); RSK activation; ERK/MAPK targets; CREB phosphorylation; Gastrin-CREB signalling pathway via PKC and MAPK,ENSG00000117676; ENSG00000281877
Q9HCE5,0,6,1748047.1302083333,6.766596061160482e-6,1.3907882859688248,0.4759028210091715,0.3444036771575214,0.8264516810701747,raw,1690547.5625,1464727.40625,1313461.59375,2720416.875,2037125.71875,1262003.625,N6-adenosine-methyltransferase non-catalytic subunit OS=Homo sapiens OX=9606 GN=METTL14 PE=1 SV=2,cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,57721,METTL14,NA,Processing of Capped Intron-Containing Pre-mRNA,ENSG00000145388
P31431,0.5,6,330237.184375,1.278330310678914e-6,1.3906377673649175,0.4757466763269354,0.3430320596219593,0.8250629268698745,raw,251353.984375,334990.28125,247700.53125,NA,325082.40625,492058.71875,Syndecan-4 OS=Homo sapiens OX=9606 GN=SDC4 PE=1 SV=2,cell growth;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;mitochondrion;nucleus,structural molecule activity,6385,SDC4,IL-18 signaling pathway,"Cell surface interactions at the vascular wall; A tetrasaccharide linker sequence is required for GAG synthesis; HS-GAG biosynthesis; HS-GAG degradation; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective EXT2 causes exostoses 2; Defective EXT1 causes exostoses 1, TRPS2 and CHDS; Defective B3GALT6 causes EDSP2 and SEMDJL1; Attachment and Entry; Retinoid metabolism and transport; Syndecan interactions",ENSG00000124145
Q9BRZ2,0,6,63253041.2265625,2.448491074545966e-4,1.390530437356535,0.4756353242191082,0.15800141093272674,0.6638855679885327,raw,45110672.328125,62265933.46875,48670903.203125,62727762.921875,64938317.21875,95804658.21875,E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,81844,TRIM56,NA,Regulation of innate immune responses to cytosolic DNA,ENSG00000169871
Q9UJZ1,0,6,76773478.77994792,2.971859912335829e-4,1.3900429235139804,0.47512943300967436,0.25139085929849736,0.7326612824296702,raw,72720645.0625,66388628.375,64190982.4609375,92722712.875,63533085.84375,101084818.0625,"Stomatin-like protein 2, mitochondrial OS=Homo sapiens OX=9606 GN=STOML2 PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;endosome,antioxidant activity;structural molecule activity,30968,STOML2,NA,Processing of SMDT1,ENSG00000165283
P63208,0,6,99133836.43229167,3.837417284341333e-4,1.3898148156866736,0.4748926654748892,0.21431065350302636,0.7040015331199742,raw,86154541.96875,92627498.40625,80612668.65625,128735069.625,83337671.828125,123335568.109375,S-phase kinase-associated protein 1 OS=Homo sapiens OX=9606 GN=SKP1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,6500,SKP1,Cell cycle; TNF-alpha signaling pathway; TGF-beta signaling pathway; Breast cancer pathway; Small cell lung cancer; Notch signaling pathway,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; SCF-beta-TrCP mediated degradation of Emi1; Vpu mediated degradation of CD4; Degradation of beta-catenin by the destruction complex; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; NIK-->noncanonical NF-kB signaling; Orc1 removal from chromatin; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Neddylation; Regulation of PLK1 Activity at G2/M Transition; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; SCF(Skp2)-mediated degradation of p27/p21; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Circadian Clock; Cyclin D associated events in G1; Regulation of BACH1 activity; MAP3K8 (TPL2)-dependent MAPK1/3 activation; NOTCH1 Intracellular Domain Regulates Transcription; Prolactin receptor signaling; Iron uptake and transport; Nuclear events stimulated by ALK signaling in cancer; Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,ENSG00000113558
Q9P2X0,0,6,6378881.244791667,2.4692304892530863e-5,1.38978998663915,0.4748668914916933,0.1326527631222582,0.6514609890946903,raw,4101301.5625,5706940.6875,5842350.25,7764318.625,5699947.84375,9158428.5,Dolichol-phosphate mannosyltransferase subunit 3 OS=Homo sapiens OX=9606 GN=DPM3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;extracellular;nucleus,DNA binding,54344,DPM3,NA,Synthesis of dolichyl-phosphate mannose; Defective DPM1 causes DPM1-CDG; Defective DPM3 causes DPM3-CDG; Defective DPM2 causes DPM2-CDG,ENSG00000179085
P78406,0,6,19976691.859375,7.732869561391826e-5,1.3897675840284327,0.47484363589466827,0.0374746483955431,0.6429522395902524,raw,14838864.25,18758927.5625,15017911.25,25226037.75,19947860.90625,26070549.4375,mRNA export factor OS=Homo sapiens OX=9606 GN=RAE1 PE=1 SV=1,cell differentiation;cell growth;cellular homeostasis;conjugation;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,8480,RAE1,IL-18 signaling pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response,SARS-CoV-2 activates/modulates innate and adaptive immune responses; ISG15 antiviral mechanism; Regulation of HSF1-mediated heat shock response; HCMV Late Events; HCMV Early Events; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus,ENSG00000101146
Q9H3S7,0,6,11344762.393229166,4.39149627022225e-5,1.3897262697207875,0.4748007475488772,0.12293978814230003,0.6445597830897484,raw,12082757.1875,7398849.21875,7771147.734375,16204592.84375,10282375.125,14328852.25,Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens OX=9606 GN=PTPN23 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,25930,PTPN23,NA,Interleukin-37 signaling,ENSG00000076201
Q03924,0.8333333333333334,6,6116466,2.3676509648163436e-5,1.3896874431145296,0.47476044052150107,0.19714297330642166,0.6875760999904456,raw,4946891.5,6927467.5,4128599.5,6644396,6874633,7176808.5,Zinc finger protein 117 OS=Homo sapiens OX=9606 GN=ZNF117 PE=2 SV=5,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,109504726; 51351,ZNF117,NA,NA,ENSG00000152926
Q96PC5,0,6,3739993.0104166665,1.4477311015085184e-5,1.3896547662734748,0.47472651687123263,0.28380062380975185,0.7647873953314741,raw,2934744.59375,2800087.875,3095036.03125,2904240.875,4078281.8125,6627566.875,Melanoma inhibitory activity protein 2 OS=Homo sapiens OX=9606 GN=MIA2 PE=1 SV=4,conjugation;metabolic process,cytoskeleton;extracellular,DNA binding;structural molecule activity,4253,MIA2,NA,Cargo concentration in the ER,ENSG00000150527
Q8N5F7,0.16666666666666666,6,1023220.7291666666,3.960832197271334e-6,1.3896434274503213,0.47471474522041074,0.38164582477055115,0.8665952023676339,raw,713754.8125,931820.75,914019.8125,1270161.625,630359.5,1679207.875,NF-kappa-B-activating protein OS=Homo sapiens OX=9606 GN=NKAP PE=1 SV=1,cell differentiation;development;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,79576,NKAP,NA,NA,ENSG00000101882
Q6YN16,0,6,6912460.934895833,2.6757763064098455e-5,1.3895089284553614,0.47457510477732934,0.08379882667611624,0.6429522395902524,raw,6310324.78125,5814237.046875,5315358.5625,8747843.78125,6518748.8125,8768252.625,Hydroxysteroid dehydrogenase-like protein 2 OS=Homo sapiens OX=9606 GN=HSDL2 PE=1 SV=1,NA,endosome;mitochondrion,structural molecule activity,84263,HSDL2,NA,NA,ENSG00000119471
P30837,0,6,34062288.244791664,1.318532787178632e-4,1.3893156202872332,0.4743743834067786,0.050862347464878686,0.6429522395902524,raw,33169329.40625,24465602.4375,28585832.375,39714743.4375,34226216.5,44212005.3125,"Aldehyde dehydrogenase X, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH1B1 PE=1 SV=3",NA,NA,NA,NA,NA,NA,NA,NA
P27701,0,6,1376957.9557291667,5.3301299024529876e-6,1.389255956319229,0.4743124257365158,0.17045539369096938,0.668039680404208,raw,1149090.578125,1002868.0625,1144662.71875,1590229.5,1226007.375,2148889.5,CD82 antigen OS=Homo sapiens OX=9606 GN=CD82 PE=1 SV=1,NA,cytoplasm;cytoskeleton,NA,3732,CD82,16p11.2 distal deletion syndrome; Extrafollicular B cell activation by SARS-CoV-2,NA,ENSG00000085117
Q13601,0,6,19520643.71875,7.556335788433146e-5,1.3892305254388515,0.47428601639081763,0.07128372306238802,0.6429522395902524,raw,16720630.375,16707580.4375,15245284.75,23210680.75,19222481.375,26017204.625,KRR1 small subunit processome component homolog OS=Homo sapiens OX=9606 GN=KRR1 PE=1 SV=4,cellular component movement;cellular homeostasis,membrane;nucleus,NA,11103,KRR1,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000111615
Q53S08,0,6,920387.8333333334,3.5627716096139352e-6,1.3892235931792898,0.4742788173253914,0.03642481649284283,0.6429522395902524,raw,705790.4375,843966.375,775438.125,1096375.375,928298.6875,1172458,Ras-related protein Rab-6D OS=Homo sapiens OX=9606 GN=RAB6D PE=2 SV=1,conjugation,cytosol;extracellular,structural molecule activity,150786,RAB6D,NA,NA,ENSG00000233087
P27449,0,6,5647170.6875,2.1859892831484633e-5,1.388978903642489,0.47402468726639363,0.07028548063038828,0.6429522395902524,raw,4343726.1875,5265900.875,4478779.6875,7787775.5,5785911.375,6220930.5,V-type proton ATPase 16 kDa proteolipid subunit OS=Homo sapiens OX=9606 GN=ATP6V0C PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion,catalytic activity;structural molecule activity,527,ATP6V0C,Proximal tubule transport,Neutrophil degranulation; Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000185883
F8W6G1,0,6,6095992.125,2.3597256383455876e-5,1.3889750831861771,0.47402071905568793,0.23225659626524867,0.718627966119277,raw,5581143.5625,5481257.34375,4240316.53125,7613329.875,4810061.9375,8849843.5,Nuclear receptor-binding protein OS=Homo sapiens OX=9606 GN=NRBP1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,29959,NRBP1,NA,NA,ENSG00000115216
Q9H7Z7,0,6,22316329.354166668,8.638530603546557e-5,1.3889363444432523,0.4739804814932116,0.05013736765327597,0.6429522395902524,raw,22142332.5,15948548.75,17104652.75,27607312.375,22151519,28943610.75,Prostaglandin E synthase 2 OS=Homo sapiens OX=9606 GN=PTGES2 PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cell surface;cytoskeleton;cytosol;endosome;extracellular;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,80142,PTGES2,"Eicosanoid synthesis; Relationship between inflammation, COX-2 and EGFR",Neutrophil degranulation; Synthesis of Prostaglandins (PG) and Thromboxanes (TX),ENSG00000148334
Q9NYV4,0,6,4275671.966145833,1.6550895330544424e-5,1.3886688850389763,0.47370264333731743,0.16217583026231042,0.6638855679885327,raw,3236752.859375,4096685.1640625,3136193.6484375,4494777.984375,4130544.140625,6559078,Cyclin-dependent kinase 12 OS=Homo sapiens OX=9606 GN=CDK12 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,signal transducer activity;structural molecule activity,51755,CDK12,NA,TP53 Regulates Transcription of DNA Repair Genes,ENSG00000167258
O43665,0,6,10707666.557291666,4.144879911913727e-5,1.3885319410466737,0.4735603645241477,0.17832329467495045,0.6741527184744509,raw,9918212.5,9889181.15625,7615069,13731443.90625,9091233.03125,14000859.75,Regulator of G-protein signaling 10 OS=Homo sapiens OX=9606 GN=RGS10 PE=1 SV=3,cell death;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,DNA binding;structural molecule activity,6001,RGS10,Mesodermal commitment pathway; Myometrial relaxation and contraction pathways; Calcium regulation in cardiac cells,G alpha (i) signalling events,ENSG00000148908
Q9H1Y0,0,6,2946649.4895833335,1.140632107983199e-5,1.3884785591653006,0.473504899285155,0.10977106802209542,0.6429522395902524,raw,2632532.9375,2573633.1875,2209113,3968093.75,2723089.5625,3573434.5,Autophagy protein 5 OS=Homo sapiens OX=9606 GN=ATG5 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,NA,9474,ATG5,Nanoparticle triggered autophagic cell death; Novel intracellular components of RIG-I-like receptor pathway; Ferroptosis; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Cytosolic DNA-sensing pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Autophagy; Clock-controlled autophagy in bone metabolism,Negative regulators of DDX58/IFIH1 signaling; Macroautophagy; PINK1-PRKN Mediated Mitophagy; Receptor Mediated Mitophagy,ENSG00000057663
Q9Y2Q5,0,6,4715674.265625,1.825412047539647e-5,1.388378176605707,0.4734005932767716,0.04547209792603082,0.6429522395902524,raw,4082080.0625,4193386.3125,3465985.8125,5440336.15625,4812099.0625,6300158.1875,Ragulator complex protein LAMTOR2 OS=Homo sapiens OX=9606 GN=LAMTOR2 PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton;mitochondrion,DNA binding;structural molecule activity,28956,LAMTOR2,NA,Neutrophil degranulation; Amino acids regulate mTORC1; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; MAP2K and MAPK activation,ENSG00000116586
Q9Y6N5,0,6,12906237.885416666,4.995935002590714e-5,1.3882353870786202,0.47325220983191985,0.05389373809432084,0.6429522395902524,raw,10773021.78125,12770095.75,9197746.78125,14955490.0625,13051328.5625,16689744.375,"Sulfide:quinone oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=SQOR PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome,structural molecule activity,58472,SQOR,NA,Sulfide oxidation to sulfate,ENSG00000137767
O00559,0,6,446111.203125,1.7268723810355294e-6,1.3879047612038116,0.47290857277704984,1,1,raw,NA,NA,373642.375,518580.03125,NA,NA,Receptor-binding cancer antigen expressed on SiSo cells OS=Homo sapiens OX=9606 GN=EBAG9 PE=1 SV=1,metabolic process,cytoskeleton;extracellular;nucleus,DNA binding,9166,EBAG9,NA,Estrogen-dependent gene expression,ENSG00000147654
Q8NCA5,0,6,17300896.760416668,6.697083725633148e-5,1.3876441608205174,0.4726376592444123,0.392510937422367,0.8766453461629867,raw,12693451.875,22340467.4375,10729628.5625,17613994.375,16919838.5625,23507999.75,Protein FAM98A OS=Homo sapiens OX=9606 GN=FAM98A PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,25940,FAM98A,NA,NA,ENSG00000119812
P85037,0,6,10232679.619791666,3.961015032938346e-5,1.3875602848351904,0.47255045307961446,0.480427518754559,0.962082357312919,raw,7909003.4375,7880429.3125,11305123.96875,16346949.25,6980352.6875,10974219.0625,Forkhead box protein K1 OS=Homo sapiens OX=9606 GN=FOXK1 PE=1 SV=1,cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,221937,FOXK1,NA,UCH proteinases,ENSG00000164916
Q8WVC0,0,6,5310840.8125,2.055797804435051e-5,1.3873161694013492,0.4722966153808743,0.2878162486033953,0.7680960150654869,raw,6193181.625,4370179.1875,2739461.25,8023761,4475641.5625,6062820.25,RNA polymerase-associated protein LEO1 OS=Homo sapiens OX=9606 GN=LEO1 PE=1 SV=1,cell death;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,endoplasmic reticulum;membrane,structural molecule activity,123169,LEO1,Endoderm differentiation,Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events; E3 ubiquitin ligases ubiquitinate target proteins; Formation of the beta-catenin:TCF transactivating complex,ENSG00000166477
P61970,0,6,47631426.223958336,1.8437867921563438e-4,1.3872075922940241,0.47218369967509843,0.4928141202646564,0.9773523321302688,raw,51073278.875,40364500.6875,36542990.625,70849240.21875,30838462.375,56120084.5625,Nuclear transport factor 2 OS=Homo sapiens OX=9606 GN=NUTF2 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;cytosol;membrane,structural molecule activity,10204,NUTF2,NA,NA,ENSG00000102898
P27361,0,6,25407467.208333332,9.835093377344045e-5,1.3869499202385216,0.4719156960047669,0.11359166153915484,0.6429522395902524,raw,25289581.0625,19463420.375,17018280,32933221.3125,22664918.0625,35075382.4375,Mitogen-activated protein kinase 3 OS=Homo sapiens OX=9606 GN=MAPK3 PE=1 SV=4,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;mitochondrion;nucleus,signal transducer activity;structural molecule activity,5595,MAPK3,"IL-5 signaling pathway; Osteopontin signaling; MicroRNAs in cardiomyocyte hypertrophy; IL-1 signaling pathway; Thyroxine (thyroid hormone) production; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; IL-17 signaling pathway; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Glioblastoma signaling pathways; TNF-alpha signaling pathway; AGE/RAGE pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Alpha 6 beta 4 signaling pathway; PDGF pathway; S1P receptor signal transduction; Common pathways underlying drug addiction; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; IL-3 signaling pathway; TCA cycle nutrient use and invasiveness of ovarian cancer; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; MFAP5-mediated ovarian cancer cell motility and invasiveness; RAC1/PAK1/p38/MMP2 pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; Hypothesized pathways in pathogenesis of cardiovascular disease; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; BMP signaling in eyelid development; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; Prion disease pathway; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Neovascularisation processes; Non-genomic actions of 1,25 dihydroxyvitamin D3; Bile acids synthesis and enterohepatic circulation ; Resistin as a regulator of inflammation; Relationship between inflammation, COX-2 and EGFR; Envelope proteins and their potential roles in EDMD physiopathology; Regulatory circuits of the STAT3 signaling pathway; Synaptic signaling pathways associated with autism spectrum disorder; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Hepatitis B infection; Melanoma; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; TGF-beta receptor signaling in skeletal dysplasias; Kisspeptin/kisspeptin receptor system in the ovary; CAMKK2 pathway; Disruption of postsynaptic signaling by CNV; Host-pathogen interaction of human coronaviruses - MAPK signaling; IL-2 signaling pathway; MAPK pathway in congenital thyroid cancer; 7q11.23 copy number variation syndrome; 16p11.2 proximal deletion syndrome; Neuroinflammation and glutamatergic signaling; Malignant pleural mesothelioma; CCL18 signaling pathway; Regulation of actin cytoskeleton; Alzheimer's disease; GDNF signaling; 2q11.2 copy number variation syndrome; Genetic causes of porto-sinusoidal vascular disease; TGF-beta receptor signaling; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling; Serotonin receptor 4/6/7 and NR3C signaling; Toll-like receptor signaling pathway","ISG15 antiviral mechanism; Regulation of actin dynamics for phagocytic cup formation; FCERI mediated MAPK activation; FCGR3A-mediated phagocytosis; NPAS4 regulates expression of target genes; RHO GTPases Activate WASPs and WAVEs; Regulation of HSF1-mediated heat shock response; Signaling by BRAF and RAF1 fusions; Thrombin signalling through proteinase activated receptors (PARs); SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Signaling by NODAL; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Oncogene Induced Senescence; Senescence-Associated Secretory Phenotype (SASP); Growth hormone receptor signaling; Regulation of the apoptosome activity; Signal transduction by L1; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; NCAM signaling for neurite out-growth; Downregulation of SMAD2/3:SMAD4 transcriptional activity; RUNX2 regulates osteoblast differentiation; RSK activation; Spry regulation of FGF signaling; Suppression of apoptosis; MAPK3 (ERK1) activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; RNA Polymerase I Promoter Opening; Signaling by Activin; Activation of the AP-1 family of transcription factors; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; Signal attenuation; Gastrin-CREB signalling pathway via PKC and MAPK; Nuclear events stimulated by ALK signaling in cancer; ESR-mediated signaling; Negative feedback regulation of MAPK pathway; Advanced glycosylation endproduct receptor signaling; RHO GTPases Activate NADPH Oxidases; ERKs are inactivated; Signaling by MAP2K mutants",ENSG00000102882
A0A590UJD9,0,6,13966217.416666666,5.4062473561376214e-5,1.3869026247514062,0.47186649875032194,0.09786945077184983,0.6429522395902524,raw,13736041.3125,9898021.9375,11261803.125,16754854,13096032.375,19050551.75,Disks large homolog 1 OS=Homo sapiens OX=9606 GN=DLG1 PE=1 SV=1,NA,cytoplasm;cytoskeleton,NA,NA,DLG1,T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Disruption of postsynaptic signaling by CNV; 3q29 copy number variation syndrome,NA,ENSG00000075711
Q96EY8,0,6,910946.0625,3.5262230244944943e-6,1.3866576727032978,0.4716116702497086,0.46679443462783904,0.9485672170384823,raw,873185.09375,956254.125,557827.859375,773516.28125,783183.515625,1521709.5,Corrinoid adenosyltransferase OS=Homo sapiens OX=9606 GN=MMAB PE=1 SV=1,cellular homeostasis,endosome,structural molecule activity,326625,MMAB,Vitamin B12 metabolism,"Cobalamin (Cbl) metabolism; Defective MMAB causes MMA, cblB type",ENSG00000139428
P50570,0,6,44861356.692708336,1.7365588962067478e-4,1.3865416624408182,0.4714909667515157,0.17253740956111924,0.6689341104244626,raw,40776137.6875,37967443.109375,37244010.09375,52643441.6875,39916542.078125,60620565.5,Dynamin-2 OS=Homo sapiens OX=9606 GN=DNM2 PE=1 SV=2,cell differentiation;cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;motor activity;structural molecule activity,1785,DNM2,Synaptic vesicle pathway; Fragile X syndrome; Intracellular trafficking proteins involved in CMT neuropathy,Clathrin-mediated endocytosis; Recycling pathway of L1; MHC class II antigen presentation; Lysosome Vesicle Biogenesis; NGF-stimulated transcription; Golgi Associated Vesicle Biogenesis; Toll Like Receptor 4 (TLR4) Cascade; NOSTRIN mediated eNOS trafficking; Retrograde neurotrophin signalling; Formation of annular gap junctions,ENSG00000079805
P41250,0,6,177307318.77083334,6.863470578545888e-4,1.3864649502299198,0.47141114557419767,0.07573608656351148,0.6429522395902524,raw,169647619.625,123605149.46875,144551971.53125,223427690.5625,167401002.9375,235210478.5,Glycine--tRNA ligase OS=Homo sapiens OX=9606 GN=GARS1 PE=1 SV=3,cell organization and biogenesis;cellular component movement;cellular homeostasis,cell surface;cytosol;endosome;nucleus,structural molecule activity,2617,GARS1,NA,Cytosolic tRNA aminoacylation; Mitochondrial tRNA aminoacylation,ENSG00000106105
P19525,0,6,39767951.15625,1.539395917902013e-4,1.3863977983018907,0.471341268510413,0.04739556444351113,0.6429522395902524,raw,33369266.0625,33610574.4375,30240387.375,46263077,41245616.5,53878785.5625,"Interferon-induced, double-stranded RNA-activated protein kinase OS=Homo sapiens OX=9606 GN=EIF2AK2 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;Golgi;membrane;nucleus,DNA binding;RNA binding;signal transducer activity;structural molecule activity,5610,EIF2AK2,Translation factors; Alzheimer's disease and miRNA effects; Ebola virus infection in host; Measles virus infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; Alzheimer's disease; Roles of ceramides in the development of insulin resistance; Type II interferon signaling,ISG15 antiviral mechanism; Inhibition of PKR,ENSG00000055332
Q96IX5,0,6,20815490.833333332,8.05756411540053e-5,1.3863946666034457,0.47133800963988925,0.0829013542140966,0.6429522395902524,raw,15722212,20668255,16054515,21196328,22597276.5,28654358.5,"ATP synthase membrane subunit DAPIT, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5MD PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome,NA,84833,ATP5MK,NA,NA,ENSG00000173915
P78346,0,6,9912736.044270834,3.8371666022810534e-5,1.386394295789089,0.47133762376700755,0.05745610274157204,0.6429522395902524,raw,9913207.75,7025509.421875,7477369.71875,12998228.5625,9740126.1875,12321974.625,Ribonuclease P protein subunit p30 OS=Homo sapiens OX=9606 GN=RPP30 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,10556,RPP30,NA,tRNA processing in the nucleus; Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000148688
Q16181,0,6,84422756.94010417,3.267959339947174e-4,1.386380104359009,0.471322855954813,0.10558561292006213,0.6429522395902524,raw,72917727.90625,75968117.875,69195018.859375,104165176.40625,78969813.40625,105320687.1875,Septin-7 OS=Homo sapiens OX=9606 GN=SEPTIN7 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,989,SEPTIN7,NA,MAPK6/MAPK4 signaling,ENSG00000122545
A0A3B3IRV1,0.16666666666666666,6,510945,1.9778405082576877e-6,1.3861252358006464,0.471057610221333,1,1,raw,NA,406344.96875,NA,746681.0625,379808.96875,NA,Histone deacetylase (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,membrane,structural molecule activity,NA,NA,NA,NA,NA
A0A0A0MR08,0,6,715784.7291666666,2.7707640402354292e-6,1.3860218377787468,0.4709499883603407,0.21535770128765708,0.7049259030937425,raw,518932.8125,647916.1875,540622.75,749314.9375,648224.5625,1189697.125,Ubiquitin carboxyl-terminal hydrolase 19 (Fragment) OS=Homo sapiens OX=9606 GN=USP19 PE=1 SV=6,NA,NA,NA,NA,NA,NA,NA,NA
Q6IBS0,0,6,43136265.520833336,1.6697815483479353e-4,1.386014414657383,0.47094226169344006,0.03297603135583656,0.6429522395902524,raw,41502366,33837133.1875,31899917.0625,51100477.3125,44213744.875,56263954.6875,Twinfilin-2 OS=Homo sapiens OX=9606 GN=TWF2 PE=1 SV=2,cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,11344,TWF2,NA,Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea,ENSG00000247596
Q9H9L3,0.16666666666666666,6,167041.26953125,6.466077355286713e-7,1.385901486089781,0.4708247101584167,0.5510600320969459,1,raw,NA,193755.140625,101126.40625,194492.109375,NA,178791.421875,Interferon-stimulated 20 kDa exonuclease-like 2 OS=Homo sapiens OX=9606 GN=ISG20L2 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,81875,ISG20L2,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000143319
A0A1W2PS05,0,6,275255.4296875,1.0654989068369654e-6,1.3857113198132311,0.47062673737955746,1,1,raw,386793.53125,183301.515625,222544.390625,NA,308382.28125,NA,Phosphatidylinositol 3-kinase catalytic subunit type 3 OS=Homo sapiens OX=9606 GN=PIK3C3 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q06787,0,6,8106002.875,3.1377899472992746e-5,1.3854356946027069,0.47033974926697447,0.4157508855600902,0.9013279742103876,raw,6757573.8125,8194125,6530741.515625,12080952.59375,5710440.359375,9362183.96875,Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,motor activity;protein binding;RNA binding;structural molecule activity,2332,FMR1,Ovarian infertility; Serotonin and anxiety; Fragile X syndrome; Disruption of postsynaptic signaling by CNV; 15q11.2 copy number variation syndrome,NA,ENSG00000102081
Q9BWD1,0,6,15993860.578125,6.191137076366604e-5,1.3853261176853975,0.47022563907924236,0.2666437224109958,0.7468192644661517,raw,16607379,11631058.375,13161971.53125,18459505,13096613.6875,23006635.875,"Acetyl-CoA acetyltransferase, cytosolic OS=Homo sapiens OX=9606 GN=ACAT2 PE=1 SV=2",cellular homeostasis,cytosol;endosome;nucleus,structural molecule activity,39,ACAT2,Cholesterol metabolism with Bloch and Kandutsch-Russell pathways,Cholesterol biosynthesis,ENSG00000120437
P28074,0,6,84215933.98958333,3.259953335199549e-4,1.3853195192635586,0.4702187673881551,0.0564913448036966,0.6429522395902524,raw,62040759.09375,85245081.09375,70511081.375,98444632.71875,85946274.5625,103107775.09375,Proteasome subunit beta type-5 OS=Homo sapiens OX=9606 GN=PSMB5 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,5693,PSMB5,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,Asymmetric localization of PCP proteins; Degradation of DVL; ER-Phagosome pathway; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Degradation of AXIN; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000100804
Q9BW85,0,6,1604758.4947916667,6.2119334898464455e-6,1.3849878637448725,0.4698733344031279,0.7694783171510884,1,raw,830327.625,2510359.46875,1217066.125,1569135.46875,1685621.8125,1816040.46875,Splicing factor YJU2 OS=Homo sapiens OX=9606 GN=YJU2 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,55702,YJU2,NA,NA,ENSG00000105248
P68104,0,6,731938411.0729166,0.0028332940707312564,1.384938347665316,0.46982175425479494,0.09617142076517904,0.6429522395902524,raw,784182686.5,537541185.375,523509741.8125,898865530.09375,725028716.8125,922502605.84375,Elongation factor 1-alpha 1 OS=Homo sapiens OX=9606 GN=EEF1A1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,1915,EEF1A1,Translation factors; Fragile X syndrome; 2q37 copy number variation syndrome,Neutrophil degranulation; Chaperone Mediated Autophagy; Protein methylation; HSF1 activation; Peptide chain elongation; SARS-CoV-1 modulates host translation machinery,ENSG00000156508
P01040,0,6,4444246.947916667,1.7203439983344935e-5,1.3847560752742492,0.46963186798222645,0.012878597198165458,0.6429522395902524,raw,3874426.5,3354507.4375,4004762.625,5194097.625,4692068.125,5545619.375,Cystatin-A OS=Homo sapiens OX=9606 GN=CSTA PE=1 SV=1,cell communication;cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytoplasm;cytosol;membrane;nucleus,DNA binding;structural molecule activity,1475,CSTA,NA,Formation of the cornified envelope,ENSG00000121552
P0DI82,0.16666666666666666,6,705809.9625,2.7321522570224576e-6,1.3847252721542402,0.4695997756855776,0.29967570013630285,0.7806964943416801,raw,NA,638295.75,552134.9375,987165.9375,531561.125,819892.0625,Trafficking protein particle complex subunit 2B OS=Homo sapiens OX=9606 GN=TRAPPC2B PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,6399,TRAPPC2B,NA,NA,ENSG00000256060
Q9C0C2,0,6,16327099.520833334,6.320132071878353e-5,1.3846557763304725,0.46952736869023975,0.08303840659523432,0.6429522395902524,raw,15096528.828125,14992236.1875,11125841.671875,20921365.09375,15405460.9375,20421164.40625,182 kDa tankyrase-1-binding protein OS=Homo sapiens OX=9606 GN=TNKS1BP1 PE=1 SV=4,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,85456,TNKS1BP1,Ciliary landscape,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,ENSG00000149115
P25325,0,6,16175598.546875,6.261486862837206e-5,1.3846487356105672,0.4695200328327001,0.3399973875655933,0.8240393274854595,raw,16714989.625,12216300.53125,13285222.5625,19861568,11831121.3125,23144389.25,3-mercaptopyruvate sulfurtransferase OS=Homo sapiens OX=9606 GN=MPST PE=1 SV=3,cellular homeostasis;defense response;metabolic process,cytosol;endosome;nucleus,structural molecule activity,4357,MPST,Trans-sulfuration pathway; Amino acid metabolism,Degradation of cysteine and homocysteine,ENSG00000128309
Q08257,0,6,22473879.989583332,8.699517603875129e-5,1.3846178157082167,0.4694878163674657,0.08415609098998957,0.6429522395902524,raw,18292659.6875,20288532.84375,16915360.65625,25328342.5,22452811.625,31565572.625,Quinone oxidoreductase OS=Homo sapiens OX=9606 GN=CRYZ PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytosol,RNA binding;structural molecule activity,1429,CRYZ,NA,NA,ENSG00000116791
A0A087X2I1,0,6,76304433.5,2.953703422794135e-4,1.3844970382500548,0.4693619674596078,0.05173542432748337,0.6429522395902524,raw,68598923.3125,66802366.8125,55418632.125,92487679,75073434,99445565.75,26S proteasome regulatory subunit 10B OS=Homo sapiens OX=9606 GN=PSMC6 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,5706,PSMC6,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,NA,ENSG00000100519
Q9NY61,0,6,7776223.100260417,3.0101339770316248e-5,1.3844754435717945,0.46933946486310973,0.19224560248647082,0.6839501208924997,raw,7795676.4375,6060736.8046875,6007545.15625,10792922.59375,6614909.359375,9385548.25,Protein AATF OS=Homo sapiens OX=9606 GN=AATF PE=1 SV=1,cell communication;coagulation;defense response;metabolic process,extracellular;membrane;nucleus,motor activity;structural molecule activity,26574,AATF,NA,NRAGE signals death through JNK,ENSG00000275700; ENSG00000276072
O94874,0,6,21031657.78125,8.141241173818954e-5,1.3839774252769115,0.4688204106721321,0.08127770712118415,0.6429522395902524,raw,18664658.625,20165905.171875,14351678.984375,25831466.1875,20011184.21875,27165053.5,E3 UFM1-protein ligase 1 OS=Homo sapiens OX=9606 GN=UFL1 PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,23376,UFL1,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000014123
Q96ES7,0.6666666666666666,6,431391.946875,1.6698949348080977e-6,1.3837407328558906,0.4685736550681687,0.6455984166173927,1,raw,230343.421875,490872,419333.6875,713974.5625,302436.0625,NA,SAGA-associated factor 29 OS=Homo sapiens OX=9606 GN=SGF29 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,endoplasmic reticulum;nucleus,structural molecule activity,112869,SGF29,NA,HATs acetylate histones,ENSG00000176476
A0A1W2PNX8,0,6,49385279.680989586,1.9116775125443345e-4,1.3835905294094866,0.46841704370008336,0.17592528986537664,0.6702146673855206,raw,42726400.03125,45712104.6875,40651030.15625,60759995.96875,43215312.1171875,63246835.125,Protein unc-45 homolog A OS=Homo sapiens OX=9606 GN=UNC45A PE=1 SV=1,metabolic process,cytosol;extracellular;membrane;nucleus,NA,NA,UNC45A,NA,NA,ENSG00000140553
Q5QP82,0,6,646732.98828125,2.5034684794825288e-6,1.3834407176200432,0.4682608237613748,1,1,raw,534684.0625,NA,NA,529558.9375,739703.703125,782985.25,DDB1- and CUL4-associated factor 10 OS=Homo sapiens OX=9606 GN=DCAF10 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,membrane;nucleus,NA,79269,DCAF10,NA,Neddylation,ENSG00000122741
Q8TDI0,0.3333333333333333,6,1270129.0833333333,4.916601105271352e-6,1.3833231903413383,0.46813825745076854,1,1,raw,1107206,NA,1145512.75,NA,1557668.5,NA,Chromodomain-helicase-DNA-binding protein 5 OS=Homo sapiens OX=9606 GN=CHD5 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,26038,CHD5,NA,NA,ENSG00000116254
Q9NQY0,0,6,1937851.0364583333,7.501316734436068e-6,1.3832458402803793,0.4680575852910271,0.12035984229026765,0.6445597830897484,raw,1920086.96875,938807.09375,1795695.90625,2655952.3125,2430076.3125,1886487.625,Bridging integrator 3 OS=Homo sapiens OX=9606 GN=BIN3 PE=1 SV=1,cell differentiation;cell growth;conjugation;metabolic process,endoplasmic reticulum;nucleus,structural molecule activity,55909,BIN3,NA,NA,ENSG00000147439
C9J406,0,6,3407746.6875,1.31912034375881e-5,1.3831080593083525,0.4679138756049555,0.23514141676736694,0.7192904383575112,raw,2942250,2979453.625,2872093,4069449.6875,2820932.9375,4762300.875,MICOS complex subunit MIC60 OS=Homo sapiens OX=9606 GN=IMMT PE=1 SV=1,NA,cytoskeleton;endosome,NA,NA,IMMT,NA,NA,ENSG00000132305
P82663,0,6,6008446.416666667,2.3258371673231136e-5,1.3829836332036942,0.46778408314380565,0.2635493481760158,0.7438355132238149,raw,6608039.5625,3367058.1875,5063788.6875,9138810.5625,5006357.6875,6866623.8125,"28S ribosomal protein S25, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS25 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,64432,MRPS25,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000131368
O95865,0,6,8282293.692708333,3.206031171011692e-5,1.3822970384054576,0.4670676662237865,0.1567692705038917,0.6638855679885327,raw,8315804.28125,5556235.25,6694626.3125,9253962.125,7655126.75,12218007.4375,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 OS=Homo sapiens OX=9606 GN=DDAH2 PE=1 SV=1",cellular homeostasis;development;metabolic process,cytosol;endosome,structural molecule activity,23564,DDAH2,Nitric oxide metabolism in cystic fibrosis,eNOS activation,ENSG00000206395; ENSG00000213722; ENSG00000225635; ENSG00000226634; ENSG00000227317; ENSG00000228128; ENSG00000233076
Q0VDF9,0,6,5637040.5625,2.1820679664551373e-5,1.3822131238776563,0.466980082481244,0.42914120321770094,0.9138518529130335,raw,4022901.8125,6594911.5625,4055179.4375,5694061.625,4339615.625,9115573.3125,Heat shock 70 kDa protein 14 OS=Homo sapiens OX=9606 GN=HSPA14 PE=1 SV=1,coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,51182,HSPA14,Parkin-ubiquitin proteasomal system pathway,Regulation of HSF1-mediated heat shock response,ENSG00000187522
Q15075,0,6,14779140.4375,5.7209254684000717e-5,1.382074740386043,0.4668356364705089,0.07618115356804218,0.6429522395902524,raw,11916093.5,14257780.25,11418119.5625,19705317.9375,14494957,16882574.375,Early endosome antigen 1 OS=Homo sapiens OX=9606 GN=EEA1 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,8411,EEA1,VEGFA-VEGFR2 signaling pathway,Toll Like Receptor 9 (TLR9) Cascade,ENSG00000102189
P02545,0,6,1248302935.8203135,0.00483211326667726,1.3819399930349625,0.4666949719993828,0.12729948555842488,0.64823440900854,raw,1114807204.5,1090681651.45313,1025308616.6875,1603751786.375,1148011762.09375,1507256593.8125,Prelamin-A/C OS=Homo sapiens OX=9606 GN=LMNA PE=1 SV=1,cell differentiation;cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,4000,LMNA,Arrhythmogenic right ventricular cardiomyopathy; Adipogenesis; Fas ligand pathway and stress induction of heat shock proteins; Lamin A-processing pathway; Nephrotic syndrome; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome,Signaling by BRAF and RAF1 fusions; XBP1(S) activates chaperone genes,ENSG00000160789
Q8TDZ2,0,6,685670.421875,2.6541931826292718e-6,1.3818537588213837,0.46660494381096107,0.5015522501968808,0.9859156102365544,raw,621826.609375,675228.078125,566377.5625,438962.15625,952354.6875,859273.4375,[F-actin]-monooxygenase MICAL1 OS=Homo sapiens OX=9606 GN=MICAL1 PE=1 SV=2,cell growth;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,64780,MICAL1,NA,Factors involved in megakaryocyte development and platelet production,ENSG00000135596
Q9UBU8,0,6,3543530.171875,1.371681397443502e-5,1.3818396255944099,0.46659018824033077,0.04060736012678049,0.6429522395902524,raw,2267604.53125,3476476.375,2875331,3973246.3125,3949489.4375,4719033.375,Mortality factor 4-like protein 1 OS=Homo sapiens OX=9606 GN=MORF4L1 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,10933,MORF4L1,Pathways affected in adenoid cystic carcinoma,HATs acetylate histones,ENSG00000185787
P53602,0,6,15225926.0703125,5.8938737745943014e-5,1.381746707468833,0.4664931747926775,0.15467090543535775,0.6638855679885327,raw,14588913.84375,10974448.03125,13333605.75,20602443.125,13432479.828125,18423665.84375,Diphosphomevalonate decarboxylase OS=Homo sapiens OX=9606 GN=MVD PE=1 SV=1,cellular homeostasis;metabolic process,cytosol,structural molecule activity,4597,MVD,Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Aspirin and miRNAs; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis; Synthesis of Dolichyl-phosphate,ENSG00000167508
Q6WKZ4,0,6,6526929.140625,2.526539030395769e-5,1.3814173640485032,0.46614926316874833,0.63095747356747,1,raw,5335383.40625,8939178.0625,4047010.5,7370391.28125,6040261.1875,7429350.40625,Rab11 family-interacting protein 1 OS=Homo sapiens OX=9606 GN=RAB11FIP1 PE=1 SV=3,conjugation;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,80223,RAB11FIP1,NA,NA,ENSG00000156675
P42126,0,6,37722271.895833336,1.4602087782264177e-4,1.3811928435537781,0.4659147642125513,0.06491053114261006,0.6429522395902524,raw,37304599.75,26345275.875,29395337.5,47314599,36387906.5,49585912.75,"Enoyl-CoA delta isomerase 1, mitochondrial OS=Homo sapiens OX=9606 GN=ECI1 PE=1 SV=1",cellular homeostasis,endosome,structural molecule activity,1632,ECI1,Fatty acid beta-oxidation; Mitochondrial long chain fatty acid beta-oxidation,mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,ENSG00000167969
H0Y368,0,6,11326639.799479166,4.3844811120284236e-5,1.3811025480768804,0.4658204449466421,0.1545041508369308,0.6638855679885327,raw,10490300.125,9508337.2109375,8651358,13131988.75,10233695.578125,15944159.1328125,Dolichol-phosphate mannosyltransferase subunit 1 (Fragment) OS=Homo sapiens OX=9606 GN=DPM1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
B7Z596,0,6,8177020.697916667,3.165280563113669e-5,1.381081949021668,0.46579892708291226,0.3098537126182829,0.7911755130372731,raw,6808173.96875,8356025.625,6199011.25,11540356.15625,6256108.5,9902448.6875,Tropomyosin alpha-1 chain OS=Homo sapiens OX=9606 GN=TPM1 PE=1 SV=1,NA,cytoskeleton;cytosol;endoplasmic reticulum,motor activity,7168,TPM1,Vitamin D receptor pathway; Striated muscle contraction pathway,NA,ENSG00000140416
P30520,0,6,35652295.614583336,1.3800811139927163e-4,1.3810502541255445,0.4657658178281064,0.06288224275279775,0.6429522395902524,raw,27887680,34123531.15625,26739492.34375,43532105.625,34504653.1875,47126311.375,Adenylosuccinate synthetase isozyme 2 OS=Homo sapiens OX=9606 GN=ADSS2 PE=1 SV=3,cellular homeostasis;metabolic process,cytosol;endosome;nucleus,structural molecule activity,159,ADSS2,NA,Purine ribonucleoside monophosphate biosynthesis,ENSG00000035687
A6NFX8,0,6,51841154,2.0067430814671845e-4,1.380438148052442,0.46512624794258434,0.15559753935076254,0.6638855679885327,raw,45724778.6875,44716993.8125,43471291.625,61729044.125,46691507.6875,68713308.0625,ADP-sugar pyrophosphatase OS=Homo sapiens OX=9606 GN=NUDT5 PE=1 SV=1,NA,NA,structural molecule activity,NA,NUDT5,NA,NA,ENSG00000165609
Q9H6R4,0,6,6407468.453125,2.4802964432519842e-5,1.3801859624231032,0.464862664822766,0.2111825711095163,0.7016553543929079,raw,6138091.34375,4523183.65625,5002929.40625,6904972.9375,5699574.5,10176058.875,Nucleolar protein 6 OS=Homo sapiens OX=9606 GN=NOL6 PE=1 SV=2,cellular component movement;cellular homeostasis;conjugation,endosome;membrane;nucleus,NA,65083,NOL6,NA,rRNA modification in the nucleus and cytosol; Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000165271
O43896,0,6,332404.2125,1.2867187595494553e-6,1.380005813991473,0.4646743451186595,0.3460213122011665,0.82808017556961655,raw,NA,236620.375,286738.40625,357807.46875,224594,556260.8125,Kinesin-like protein KIF1C OS=Homo sapiens OX=9606 GN=KIF1C PE=1 SV=3,conjugation;metabolic process,endoplasmic reticulum;extracellular;nucleus,motor activity;structural molecule activity,10749,KIF1C,NA,COPI-dependent Golgi-to-ER retrograde traffic; Kinesins,ENSG00000129250
O00273,0,6,18433763.177083332,7.135610198996828e-5,1.379875900319382,0.4645385234929455,0.21772951953425557,0.7068945054368031,raw,16406977.15625,15807068.34375,16518172.4375,23525155.9375,15705612.8125,22639592.375,DNA fragmentation factor subunit alpha OS=Homo sapiens OX=9606 GN=DFFA PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,DNA binding;structural molecule activity,1676,DFFA,Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Acute viral myocarditis,Apoptosis induced DNA fragmentation,ENSG00000160049
P23284,0,6,369086679.5520833,0.0014287146089626765,1.379826606099192,0.4644869842224229,0.158713215348117,0.6638855679885327,raw,304470916.9375,362507243.375,268558155.375,500197139.3125,319991105.3125,458795517,Peptidyl-prolyl cis-trans isomerase B OS=Homo sapiens OX=9606 GN=PPIB PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,extracellular;membrane;nucleus,structural molecule activity,5479,PPIB,Prolactin signaling pathway; Type I collagen synthesis in the context of osteogenesis imperfecta,Collagen biosynthesis and modifying enzymes; SARS-CoV-1 activates/modulates innate immune responses,ENSG00000166794
Q7LBR1,0,6,5076999.5625,1.9652791191065687e-5,1.3797172064293952,0.46437259548870774,0.19120570913419113,0.6823711621042031,raw,1434749.125,4530177.25,5659268,7523334.5,5064105,6250363.5,Charged multivesicular body protein 1b OS=Homo sapiens OX=9606 GN=CHMP1B PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,57132,CHMP1B,NA,NA,ENSG00000255112
P10515,0,6,56054125.846354164,2.1698249469882965e-4,1.3796769150331079,0.46433046435769876,0.1656213880553629,0.6657885428664303,raw,53676332.9375,47240336.03125,45419846.796875,65915571.78125,50016670.09375,74055997.4375,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial OS=Homo sapiens OX=9606 GN=DLAT PE=1 SV=3",cellular homeostasis,endosome;nucleus,structural molecule activity,1737,DLAT,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Neuroinflammation and glutamatergic signaling; Glycolysis and gluconeogenesis,Glyoxylate metabolism and glycine degradation; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid,ENSG00000150768
Q86Y37,0,6,781553.6458333334,3.025351965682508e-6,1.3794408795266082,0.4640836265777367,0.2721239637549188,0.7524601054912853,raw,706944.875,678740.125,657091.0625,936281.875,627204.0625,1083059.875,CDK2-associated and cullin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CACUL1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,NA,structural molecule activity,143384,CACUL1,NA,NA,ENSG00000151893
P35244,0,6,19617116.1953125,7.593679763240073e-5,1.3792790921118352,0.463914410489378,0.2283860568174479,0.7148463313429879,raw,19986349.3125,16009457.65625,14258006.1875,23798671.625,16083458.65625,27566753.734375,Replication protein A 14 kDa subunit OS=Homo sapiens OX=9606 GN=RPA3 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding,6119,RPA3,"Retinoblastoma gene in cancer; G1 to S cell cycle control; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Fanconi Anemia Pathway; Regulation of HSF1-mediated heat shock response; Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Meiotic recombination; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; HSF1 activation; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Removal of the Flap Intermediate; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER; Removal of the Flap Intermediate from the C-strand; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),ENSG00000106399
Q96MG2,0.6666666666666666,6,1352757.4342447917,5.236450990412049e-6,1.3790249445438518,0.46364855333066846,0.1295327440135764,0.6498046150645307,raw,1050100.75,1218192.25,1221738.48046875,1723186.875,1223408.75,1679917.5,Junctional sarcoplasmic reticulum protein 1 OS=Homo sapiens OX=9606 GN=JSRP1 PE=1 SV=1,metabolic process,cytoskeleton;cytosol;extracellular,NA,126306,JSRP1,NA,NA,ENSG00000167476
P33527,0,6,8389687.208333334,3.247602621075267e-5,1.3789341082110407,0.4635535199205127,0.15789962625425819,0.6638855679885327,raw,8370858.53125,6536500.15625,6202663.234375,10426080.0625,7259158.921875,11542862.34375,Multidrug resistance-associated protein 1 OS=Homo sapiens OX=9606 GN=ABCC1 PE=1 SV=3,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton,catalytic activity;structural molecule activity,4363,ABCC1,Irinotecan pathway; Leukotriene metabolic pathway,ABC-family proteins mediated transport; Paracetamol ADME; Cytoprotection by HMOX1; Transport of RCbl within the body; Heme degradation; Synthesis of Leukotrienes (LT) and Eoxins (EX),ENSG00000103222; ENSG00000278183
Q76FK4,0,6,653883.2734375,2.531146847266977e-6,1.3784381985682224,0.46303458645013745,0.2484903034708717,0.7316541032247736,raw,521392.90625,827134.3125,88158.2734375,684172.84375,718707.8984375,1083733.40625,Nucleolar protein 8 OS=Homo sapiens OX=9606 GN=NOL8 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,55035,NOL8,NA,NA,ENSG00000198000
Q96T23,0,6,18275571.303385418,7.074374978791735e-5,1.3779939304023425,0.46256953347201163,0.11302790666284354,0.6429522395902524,raw,13841621.7265625,18986673.9375,12234192.3125,22573716.671875,16858642.75,25158580.421875,Remodeling and spacing factor 1 OS=Homo sapiens OX=9606 GN=RSF1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,51773,RSF1,NA,Deposition of new CENPA-containing nucleosomes at the centromere,ENSG00000048649
P46976,0,6,8271997.958333333,3.2020457478234557e-5,1.3779174133763756,0.4624894215089156,0.22750662943311997,0.7148463313429879,raw,7923441.125,7043409.5,6869180.375,9880238.625,6997870.625,10917847.5,Glycogenin-1 OS=Homo sapiens OX=9606 GN=GYG1 PE=1 SV=4,cellular homeostasis,cell surface;cytosol;mitochondrion;nucleus,structural molecule activity,2992,GYG1,Insulin signaling; Glycogen synthesis and degradation; Disorders of galactose metabolism,Neutrophil degranulation; Glycogen synthesis; Glycogen breakdown (glycogenolysis); Myoclonic epilepsy of Lafora; Glycogen storage disease type II (GAA); Glycogen storage disease type XV (GYG1); Glycogen storage disease type 0 (muscle GYS1),ENSG00000163754
P05091,0,6,38363632.30078125,1.4850354932211535e-4,1.3778821124811587,0.4624524606008427,0.12308304237020884,0.6445597830897484,raw,38365923.25,21339962.7734375,34753754.34375,52863719.375,36446856.875,46411577.1875,"Aldehyde dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH2 PE=1 SV=2",cellular homeostasis;metabolic process,endosome,structural molecule activity,217,ALDH2,Fatty acid omega-oxidation; Ethanol effects on histone modifications; Tryptophan metabolism; Fluoroacetic acid toxicity,Smooth Muscle Contraction; Ethanol oxidation; Metabolism of serotonin,ENSG00000111275
P09012,0,6,56804235.239583336,2.198861276604072e-4,1.377694989519577,0.4622565224295396,0.07705829604247169,0.6429522395902524,raw,48665364.8125,47847901.75,46633161.96875,65919814.5,56480826.8125,75278341.59375,U1 small nuclear ribonucleoprotein A OS=Homo sapiens OX=9606 GN=SNRPA PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,6626,SNRPA,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000077312
A0A1C7CYZ0,0.16666666666666666,6,4373844.536458333,1.693091604972915e-5,1.3774121129304409,0.4619602692251532,0.13141849627128943,0.651093743815974,raw,4571442.90625,2762120.625,3108320.3125,5790706.28125,3804578.40625,6205898.6875,Active breakpoint cluster region-related protein OS=Homo sapiens OX=9606 GN=ABR PE=1 SV=1,development;metabolic process,nucleus,DNA binding,NA,ABR,NA,NA,ENSG00000159842
Q7Z6E9,0,6,2576709.3177083335,9.974302648168726e-6,1.3773716308413053,0.46191786785018,0.16156203313862263,0.6638855679885327,raw,2125872.65625,2795750.5,1626856.09375,2457414.3125,3526245.65625,2928116.6875,E3 ubiquitin-protein ligase RBBP6 OS=Homo sapiens OX=9606 GN=RBBP6 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,5930,RBBP6,NA,RHOBTB1 GTPase cycle; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000122257
Q16204,0,6,64395451.989583336,2.492713178376558e-4,1.3773049343304522,0.46184800649027463,0.039827090067252185,0.6429522395902524,raw,49546240.6875,60630153.4375,52821329.3125,72751077.5,66388312.8125,84235598.1875,Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2,cell growth,cytosol;endoplasmic reticulum,motor activity;structural molecule activity,8030,CCDC6,Retinoblastoma gene in cancer; Mesodermal commitment pathway; 16p11.2 proximal deletion syndrome,NA,ENSG00000108091
Q06136,0,6,2864150.6145833335,1.1086972388953937e-5,1.3773003555146117,0.4618432102786863,0.14551172519794622,0.6572502130392559,raw,2617483.375,2412242.625,2293059.8125,3918420.625,2621314.625,3322382.625,3-ketodihydrosphingosine reductase OS=Homo sapiens OX=9606 GN=KDSR PE=1 SV=1,cellular homeostasis,cell surface;cytoskeleton;extracellular,structural molecule activity,2531,KDSR,Sphingolipid pathway; Sphingolipid metabolism overview; Sphingolipid metabolism: integrated pathway; Biosynthesis and turnover of 1-deoxy-sphingoid bases; Synthesis of ceramides and 1-deoxyceramides,Sphingolipid de novo biosynthesis,ENSG00000119537
Q9BW83,0,6,3338190.6692708335,1.292195584646429e-5,1.377100611977468,0.46163396767792264,0.3678308725575363,0.8520069708429603,raw,2725855.40625,2967246.453125,2786514.96875,3837311.46875,2319742.21875,5392473.5,Intraflagellar transport protein 27 homolog OS=Homo sapiens OX=9606 GN=IFT27 PE=1 SV=1,cell growth;conjugation;defense response;development;metabolic process,cytoskeleton;endoplasmic reticulum;extracellular;membrane;nucleus,structural molecule activity,11020,IFT27,Ciliary landscape; Intraflagellar transport proteins binding to dynein; Genes related to primary cilium development (based on CRISPR); Ciliopathies; GDNF/RET signaling axis; Alstrom syndrome; Bardet-Biedl syndrome,Intraflagellar transport,ENSG00000100360
E7EX59,0,6,9424040.125,3.647995050479179e-5,1.37688059100952,0.4614034481960314,0.08357663917875434,0.6429522395902524,raw,9677565.375,6940886.5,7522748.875,10382189.28125,9556771.90625,12464078.8125,"Propionyl-CoA carboxylase beta chain, mitochondrial OS=Homo sapiens OX=9606 GN=PCCB PE=1 SV=1",NA,NA,structural molecule activity,NA,PCCB,NA,NA,ENSG00000114054
P57076,0,6,7590610.65625,2.93828440210663e-5,1.3768574153715665,0.46137916456565814,0.23332637864211642,0.718951462768674,raw,5791512.875,7206190.1875,6638639.4375,9140459.9375,6248251.4375,10518610.0625,Cilia- and flagella-associated protein 298 OS=Homo sapiens OX=9606 GN=CFAP298 PE=1 SV=1,cell growth;metabolic process,endoplasmic reticulum;nucleus,NA,56683,CFAP298,Ciliopathies,NA,ENSG00000159079
Q13148,0,6,53288294.375,2.0627611040490714e-4,1.376662127143002,0.4611745236651551,0.09414196872466002,0.6429522395902524,raw,50871825.15625,42800132.2578125,41239964.2421875,65008554.375,49775975.1875,70033315.03125,TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,endosome;membrane;nucleus,RNA binding;structural molecule activity,23435,TARDBP,MECP2 and associated Rett syndrome,NA,ENSG00000120948
Q13277,0,6,1896445.9596354167,7.341039917581249e-6,1.3765644134227206,0.46107211937865067,0.39945805576275323,0.8834409352370608,raw,1373190.9140625,1689521.1875,1572464.375,3432722.28125,1146178.5,2164598.5,Syntaxin-3 OS=Homo sapiens OX=9606 GN=STX3 PE=1 SV=3,cell death;cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,6809,STX3,Synaptic vesicle pathway,Other interleukin signaling,ENSG00000166900
Q49AR2,0,6,1483725.265625,5.743420394520981e-6,1.37638391752318,0.46088293999114527,0.11291589361979947,0.6429522395902524,raw,825677.0625,1403202.28125,1451122.875,1997302.1875,1721571.75,1503475.4375,UPF0489 protein C5orf22 OS=Homo sapiens OX=9606 GN=C5orf22 PE=1 SV=2,NA,NA,NA,55322,C5orf22,NA,NA,ENSG00000082213
Q5JTV8,0,6,23126937.546875,8.952312658339949e-5,1.3762867215037236,0.4607810576857694,0.09152821159400605,0.6429522395902524,raw,20087843.8125,18869425.3125,17382037.78125,25969739.5,23235961.9375,33216616.9375,Torsin-1A-interacting protein 1 OS=Homo sapiens OX=9606 GN=TOR1AIP1 PE=1 SV=2,cell growth;metabolic process,cytoskeleton;membrane,motor activity;structural molecule activity,26092,TOR1AIP1,Influence of laminopathies on Wnt signaling,RHOD GTPase cycle; RHOF GTPase cycle,ENSG00000143337
Q8NBF2,0,6,17117132.160644535,6.625949441235984e-5,1.3756716526447648,0.46013616653062966,0.22589919387817453,0.7148463313429879,raw,16623710.875,14032331.125,13579126.2060547,21654942.1875,13943914.7578125,22868767.8125,NHL repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=NHLRC2 PE=1 SV=1,NA,cell surface;cytosol;nucleus,NA,374354,NHLRC2,NA,Platelet degranulation,ENSG00000196865
O95834,0,6,158046991.30729166,6.117913701392754e-4,1.3755911946701536,0.46005178613700937,0.17677024351132012,0.6722986889338887,raw,151242856.125,128590118.96875,125410178.0625,176887435.375,143122339.25,223029020.0625,Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens OX=9606 GN=EML2 PE=1 SV=1,cell growth;metabolic process,endoplasmic reticulum;nucleus,antioxidant activity;motor activity;structural molecule activity,24139,EML2,NA,NA,ENSG00000125746
Q3SXM5,0,6,8470177.666666666,3.27876004291517e-5,1.375516073939105,0.459972998728452,0.050225783986972874,0.6429522395902524,raw,8085974.9375,6135891.625,6644613.375,10524112.375,8308085.1875,11122388.5,Inactive hydroxysteroid dehydrogenase-like protein 1 OS=Homo sapiens OX=9606 GN=HSDL1 PE=1 SV=3,NA,endoplasmic reticulum;endosome;nucleus,NA,83693,HSDL1,NA,NA,ENSG00000103160
O95816,0,6,32606968.958333332,1.2621981633501188e-4,1.375508579562499,0.45996513831182484,0.11423216412330299,0.6429522395902524,raw,25070266.25,32150958.3125,22965493.125,44223919,29135610.8125,42095566.25,BAG family molecular chaperone regulator 2 OS=Homo sapiens OX=9606 GN=BAG2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,9532,BAG2,Malignant pleural mesothelioma,Regulation of HSF1-mediated heat shock response,ENSG00000112208
Q92882,0,6,764487.7916666666,2.9592909656162545e-6,1.375379878510899,0.45983014456571997,0.14190299712316123,0.6572502130392559,raw,593978.5,599733.875,763648.75,1050307.125,703117.125,876141.375,Osteoclast-stimulating factor 1 OS=Homo sapiens OX=9606 GN=OSTF1 PE=1 SV=2,development;metabolic process,nucleus,structural molecule activity,26578,OSTF1,NA,Neutrophil degranulation,ENSG00000134996
A0A3B3ISP1,0,6,1054530.5651041667,4.082030881716999e-6,1.3753647386855274,0.4598142636650742,0.5939636142319813,1,raw,405591.890625,1486541.21875,952158.5625,1309565.3125,801661.15625,1371665.25,Ankyrin repeat and SAM domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ANKS1A PE=1 SV=1,metabolic process,cytosol;membrane,antioxidant activity,NA,ANKS1A,NA,NA,ENSG00000064999
P52907,0,6,80721624.75520833,3.124690511370648e-4,1.3753606624770036,0.4598099879014371,0.28137875316183775,0.7638041952892518,raw,75243739.59375,71922768.25,65537725.8125,98919746.1875,64097852,108607916.6875,F-actin-capping protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=CAPZA1 PE=1 SV=3,cell growth,cell surface;cytosol;endoplasmic reticulum;nucleus,motor activity,829,CAPZA1,NA,Sensory processing of sound by inner hair cells of the cochlea; MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Factors involved in megakaryocyte development and platelet production; Advanced glycosylation endproduct receptor signaling,ENSG00000116489
O15525,0,6,523298.6354166667,2.0256607639629596e-6,1.3752980188587285,0.4597442759044833,1,1,raw,NA,509684.9375,423764.09375,NA,NA,636446.875,Transcription factor MafG OS=Homo sapiens OX=9606 GN=MAFG PE=1 SV=1,cellular component movement;defense response;metabolic process,membrane,RNA binding;structural molecule activity,4097,MAFG,Quercetin and Nf-kB / AP-1 induced apoptosis; Nuclear receptors meta-pathway; NRF2 pathway; Ethanol metabolism production of ROS by CYP2E1,Factors involved in megakaryocyte development and platelet production; Nuclear events mediated by NFE2L2,ENSG00000197063
Q14137,0,6,41697675.234375,1.6140944950771658e-4,1.3752576312207345,0.4597019084322603,0.21562632192966866,0.7049259030937425,raw,39578389.90625,33007921.59375,34925657.09375,54035942.5625,34207657.5,54430482.75,Ribosome biogenesis protein BOP1 OS=Homo sapiens OX=9606 GN=BOP1 PE=1 SV=2,cell differentiation;cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,23246,BOP1,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000261236; ENSG00000285301
Q9Y605,0,6,948075.4791666666,3.6699489917342392e-6,1.3749704954417774,0.45940066115618716,0.7757177374556777,1,raw,354023.6875,1658459,605011.5,1473120.6875,486772.125,1111065.875,MORF4 family-associated protein 1 OS=Homo sapiens OX=9606 GN=MRFAP1 PE=1 SV=1,NA,membrane;nucleus,NA,93621,MRFAP1,NA,NA,ENSG00000179010
Q8IXI2,0,6,3038258.7916666665,1.1760935742063016e-5,1.3748700824397417,0.459295298437121,0.36352257696674656,0.8458062414401234,raw,2587909.15625,1432121.125,3856219.03125,3558038.875,2925868.1875,3869396.375,Mitochondrial Rho GTPase 1 OS=Homo sapiens OX=9606 GN=RHOT1 PE=1 SV=2,cell growth;conjugation;development;metabolic process,cytoskeleton;endosome,structural molecule activity,55288,RHOT1,NA,Ub-specific processing proteases; RHOT1 GTPase cycle,ENSG00000126858
A0A2R8YF49,0,6,793526.6640625,3.0716988728051013e-6,1.3747882024146503,0.45920937655596733,0.15833628466513508,0.6638855679885327,raw,784827,691043.421875,551330.53125,950038.34375,703214.109375,1080706.578125,Rho guanine nucleotide exchange factor 5 OS=Homo sapiens OX=9606 GN=ARHGEF5 PE=1 SV=1,development,cytosol,DNA binding,NA,NA,NA,NA,NA
Q6NXG1,0,6,31062332.625,1.2024061248607846e-4,1.3747379366827357,0.45915662701404686,0.12061283085129637,0.6445597830897484,raw,29734888.5,27354583.1875,21504844.84375,37605383.25,28325204.34375,41849091.625,Epithelial splicing regulatory protein 1 OS=Homo sapiens OX=9606 GN=ESRP1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding,54845,ESRP1,NA,Signaling by BRAF and RAF1 fusions; FGFR2 alternative splicing,ENSG00000104413
P38646,0,6,732552533.7880862,0.002835671306604205,1.374668601372475,0.4590838624323756,0.11935714147876368,0.6445597830897484,raw,656847558.542969,619854249.453125,633640489.732422,902947714.617188,680463383.59375,901561806.789063,"Stress-70 protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPA9 PE=1 SV=2",cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,3313,HSPA9,Parkin-ubiquitin proteasomal system pathway,Regulation of HSF1-mediated heat shock response; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Mitochondrial protein import; Cristae formation,ENSG00000113013
O76003,0,6,26258425.557291668,1.016449475976483e-4,1.3744611437666385,0.45886612221096024,0.18203114359099834,0.6743269455727479,raw,22138049.875,25033259.875,20735846.625,34407243,22513629.65625,32722524.3125,Glutaredoxin-3 OS=Homo sapiens OX=9606 GN=GLRX3 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,10539,GLRX3,NA,Iron uptake and transport,ENSG00000108010
P09661,0,6,44056916.192708336,1.7054194387821118e-4,1.374223200909822,0.4586163452723559,0.23562244168815633,0.7196640448521243,raw,40140727.5,38418853.53125,37634389.40625,58315036.4375,37036410.40625,52796079.875,U2 small nuclear ribonucleoprotein A' OS=Homo sapiens OX=9606 GN=SNRPA1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,6627,SNRPA1,mRNA processing,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; mRNA Splicing - Major Pathway,ENSG00000131876
Q5SW79,0,6,7605433.264322917,2.9440221536620113e-5,1.374090172901335,0.4584766822702236,0.13378961439594914,0.6514609890946903,raw,6268838.125,6501023.28125,7077758.1171875,9725477.875,6953678.15625,9105824.03125,Centrosomal protein of 170 kDa OS=Homo sapiens OX=9606 GN=CEP170 PE=1 SV=1,NA,cytosol;endoplasmic reticulum;nucleus,NA,9859,CEP170,Ciliary landscape,NA,ENSG00000143702; ENSG00000276725
E9PRG8,0,6,10569788.645833334,4.0915081168132264e-5,1.3737049901409568,0.4580722116100029,0.04508424222183109,0.6429522395902524,raw,7816808.25,10393379,7904182.875,12470449.25,10737988.5,14095924,Uncharacterized protein C11orf98 OS=Homo sapiens OX=9606 GN=C11orf98 PE=4 SV=2,NA,NA,NA,102288414,C11orf98,NA,NA,ENSG00000278615
Q9BRU9,0,6,654943.78125,2.535252015750642e-6,1.3733249465820008,0.4576730263270206,0.19298048642723992,0.6839501208924997,raw,552160.5625,740070.0625,380956.25,673524.25,758295.875,824655.6875,rRNA-processing protein UTP23 homolog OS=Homo sapiens OX=9606 GN=UTP23 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,84294,UTP23,NA,NA,ENSG00000147679
Q9HC35,0,6,28715613.4733073,1.1115658935301728e-4,1.372603165885415,0.45691458734908225,0.14819120386633203,0.6638855679885327,raw,24343693.8515625,26583140.1875,23203995.4492188,33414231.25,26167186.3515625,38581433.75,Echinoderm microtubule-associated protein-like 4 OS=Homo sapiens OX=9606 GN=EML4 PE=1 SV=3,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,27436,EML4,Non-small cell lung cancer,EML4 and NUDC in mitotic spindle formation; ALK mutants bind TKIs; Nuclear events stimulated by ALK signaling in cancer,ENSG00000143924
Q8TCS8,0,6,21583065.963541668,8.354688304042598e-5,1.3725801407977711,0.45689038628412626,0.10368097610165722,0.6429522395902524,raw,17511493.625,20648129.59375,17009160.625,25886102.1875,20102297.125,28341212.625,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PNPT1 PE=1 SV=2",cell growth;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endosome;extracellular;Golgi;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,87178,PNPT1,Pyrimidine metabolism; miRNA degrading enzymes,NA,ENSG00000138035
Q9NWH9,0,6,13489581.28125,5.2217440815529836e-5,1.372567277944113,0.45687686629969276,0.1981349697066727,0.6875760999904456,raw,10903326.03125,15155734.1875,9778974.6875,14965548.53125,14685629.28125,15448274.96875,SAFB-like transcription modulator OS=Homo sapiens OX=9606 GN=SLTM PE=1 SV=2,metabolic process,membrane,RNA binding,79811,SLTM,NA,NA,ENSG00000137776
Q9BQ75,0,6,2225406.3723958335,8.614427914275063e-6,1.3724632818857967,0.45676755269140573,0.08947714547825707,0.6429522395902524,raw,1951041.75,1884451.375,1946914.5625,2672068.75,2139563.046875,2758398.75,Protein CMSS1 OS=Homo sapiens OX=9606 GN=CMSS1 PE=1 SV=2,NA,NA,NA,84319,CMSS1,NA,NA,ENSG00000184220
A0A3B3ISV5,0,6,18534786.40625,7.174715745566583e-5,1.3722838381075748,0.4565789140751615,0.0669765139232548,0.6429522395902524,raw,15117434.6875,17588605.5,14905746.25,21140406.875,18319966.0625,24136559.0625,Uncharacterized protein OS=Homo sapiens OX=9606 PE=4 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q92621,0,6,31779792.625,1.2301786140925914e-4,1.3722715144593984,0.4565659580485372,0.18828606238764656,0.6797963848944265,raw,25500942.390625,30477755.515625,24852652.65625,41543486.71875,26480162.75,41823755.71875,Nuclear pore complex protein Nup205 OS=Homo sapiens OX=9606 GN=NUP205 PE=1 SV=3,cell growth;conjugation,cytoskeleton;cytosol;membrane,structural molecule activity,23165,NUP205,NA,SARS-CoV-2 activates/modulates innate and adaptive immune responses; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000155561
O75695,0,6,1805850.8958333333,6.990351316976583e-6,1.3721277478488731,0.4564148055693127,0.19886929243519164,0.688581468393609,raw,1301271.34375,1759110.78125,1571502,2156301.5,1537251.125,2509668.625,Protein XRP2 OS=Homo sapiens OX=9606 GN=RP2 PE=1 SV=4,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;membrane;nucleus,DNA binding;structural molecule activity,6102,RP2,Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome,Trafficking of myristoylated proteins to the cilium,ENSG00000102218
E9PQY2,0,6,5353589.416666667,2.0723455583013787e-5,1.371833523609221,0.45610541647005853,0.29171177102579926,0.7730231021500684,raw,6678460.5,2818713.75,2872098.5,6817299,3773228.75,9161736,Prefoldin subunit 4 OS=Homo sapiens OX=9606 GN=PFDN4 PE=1 SV=1,metabolic process,nucleus,structural molecule activity,NA,PFDN4,Cellular proteostasis,NA,ENSG00000101132
O76071,0,6,12394748.135416666,4.797940081981138e-5,1.3717523233927953,0.4560200193612211,0.06002886739397284,0.6429522395902524,raw,10130568.3125,11535561.5625,9407580.0625,15823933.375,11990192.625,15480652.875,Probable cytosolic iron-sulfur protein assembly protein CIAO1 OS=Homo sapiens OX=9606 GN=CIAO1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,endoplasmic reticulum;nucleus,NA,9391,CIAO1,2q11.2 copy number variation syndrome,Cytosolic iron-sulfur cluster assembly,ENSG00000144021
O95471,0,6,7508429.950520833,2.906472694625717e-5,1.3716554948546398,0.455918179561143,0.06967015800480408,0.6429522395902524,raw,7285304.46875,5466984.328125,5956246.46875,9992927.90625,7223963.84375,9125152.6875,Claudin-7 OS=Homo sapiens OX=9606 GN=CLDN7 PE=1 SV=4,cell communication;cell growth;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,1366,CLDN7,Epithelial to mesenchymal transition in colorectal cancer,Tight junction interactions,ENSG00000181885; ENSG00000288292
P49406,0,6,11663877.588541666,4.5150240393734554e-5,1.3716274111308682,0.45588864104805127,0.11852000032237761,0.6429522395902524,raw,10444684,10026475.0625,10119781.5625,14326214.875,10889618.21875,14176491.8125,"39S ribosomal protein L19, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL19 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,structural molecule activity,9801,MRPL19,Cytoplasmic ribosomal proteins,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000115364
P24534,0,6,197786878.82291666,7.656223290918184e-4,1.370960931697261,0.45518745919175024,0.14521871000154934,0.6572502130392559,raw,180273522.875,174908099.78125,146136743.15625,239792171.4375,175858274.8125,269752460.875,Elongation factor 1-beta OS=Homo sapiens OX=9606 GN=EEF1B2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,DNA binding;RNA binding,1933,EEF1B2,Translation factors,Eukaryotic Translation Elongation,ENSG00000114942; ENSG00000283391
Q6IAN0,0,6,276588.75390625,1.0706601328994276e-6,1.3708604490119223,0.4550817149788571,0.4639497709507217,0.9454551224891224,raw,304565.8125,NA,178834.046875,301650.09375,NA,321305.0625,Dehydrogenase/reductase SDR family member 7B OS=Homo sapiens OX=9606 GN=DHRS7B PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;metabolic process,cytoskeleton;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,25979,DHRS7B,NA,Plasmalogen biosynthesis,ENSG00000109016
Q01970,0,6,47782871.365885414,1.8496491518326733e-4,1.3707945126296628,0.45501232178894135,0.16259372317674048,0.6638855679885327,raw,44076513,42240500.5625,39290715.09375,58085597.171875,42584060.2109375,60419842.15625,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 OS=Homo sapiens OX=9606 GN=PLCB3 PE=1 SV=2",cellular homeostasis;development;metabolic process,cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,5331,PLCB3,"Alzheimer's disease and miRNA effects; S1P receptor signal transduction; Myometrial relaxation and contraction pathways; G protein signaling pathways; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; GPR40 pathway; MAPK cascade; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; Resistin as a regulator of inflammation; Hippo signaling regulation pathways; PKC-gamma calcium signaling pathway in ataxia; Kisspeptin/kisspeptin receptor system in the ovary; GPR143 in melanocytes and retinal pigment epithelium cells; Neuroinflammation and glutamatergic signaling; Alzheimer's disease; Calcium regulation in cardiac cells",G alpha (q) signalling events; Ca2+ pathway; G beta:gamma signalling through PLC beta; Presynaptic function of Kainate receptors; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion; Synthesis of IP3 and IP4 in the cytosol; PLC beta mediated events; Acetylcholine regulates insulin secretion,ENSG00000149782
Q8NFV4,0,6,21242276.986979168,8.222770731189749e-5,1.3707681097899336,0.45498453380727544,0.47052949736750554,0.9514432800022218,raw,26616574.5625,8319563.1875,20214039,27708760.03125,14659381.265625,29935343.875,Protein ABHD11 OS=Homo sapiens OX=9606 GN=ABHD11 PE=1 SV=1,cellular homeostasis,endosome,structural molecule activity,83451,ABHD11,7q11.23 copy number variation syndrome,NA,ENSG00000106077
Q16401,0,6,40891778.294270836,1.582898659642453e-4,1.3707548447542226,0.45497057266118623,0.1615875610533725,0.6638855679885327,raw,38919545.46875,34931654.625,30887582.484375,47882734.8125,36458479.171875,56270673.203125,26S proteasome non-ATPase regulatory subunit 5 OS=Homo sapiens OX=9606 GN=PSMD5 PE=1 SV=3,cell growth,cytosol;membrane;nucleus,NA,5711,PSMD5,Proteasome degradation; Parkin-ubiquitin proteasomal system pathway,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000095261
Q9BUE0,0.3333333333333333,6,2235598.25,8.653880122204929e-6,1.3707150713675438,0.4549287112733319,0.16155911943290377,0.6638855679885327,raw,2144576.8125,2027171.625,1585861.8125,2331722.5625,2173764.6875,3150492,Mediator of RNA polymerase II transcription subunit 18 OS=Homo sapiens OX=9606 GN=MED18 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,54797,MED18,NA,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation,ENSG00000130772; ENSG00000284944
Q92599,0,6,5054218.166666667,1.9564605637799058e-5,1.3706753450103393,0.4548868981713431,0.13362448551222414,0.6514609890946903,raw,4278254.9375,4434117.8125,4146388.5,6896466.25,4705982.9375,5864098.5625,Septin-8 OS=Homo sapiens OX=9606 GN=SEPTIN8 PE=1 SV=4,cell differentiation;metabolic process,cytoskeleton;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,23176,SEPTIN8,22q11.2 copy number variation syndrome,NA,ENSG00000164402
P23508,0.5,6,915149.4791666666,3.5424942234619344e-6,1.3705230274716507,0.4547265684701886,0.44054288534583164,0.9233600879723239,raw,488188.71875,1162799.15625,710409.625,973632.75,695630.125,1460236.5,Colorectal mutant cancer protein OS=Homo sapiens OX=9606 GN=MCC PE=1 SV=2,cell death;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,4163,MCC,NA,NA,ENSG00000171444
Q12788,0,6,33460203.885416668,1.295226426702255e-4,1.370514675290167,0.4547177764343876,0.2915563534290937,0.7730231021500684,raw,28856399.1875,30529461.15625,26069216.59375,39548118.5625,25727295.625,50030732.1875,Transducin beta-like protein 3 OS=Homo sapiens OX=9606 GN=TBL3 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,10607,TBL3,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000183751
P83916,0,6,34251518.580729164,1.3258577913142708e-4,1.370292996452977,0.4544844036493664,0.11803414447834092,0.6429522395902524,raw,30207516.9375,29815179.625,25164320.25,40855531.828125,31631993.125,47834569.71875,Chromobox protein homolog 1 OS=Homo sapiens OX=9606 GN=CBX1 PE=1 SV=1,cell growth;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,10951,CBX1,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,HCMV Early Events,ENSG00000108468
P27144,0,6,9769361.609375,3.781667132634509e-5,1.3700594792857461,0.4542385272061536,0.11156007303517122,0.6429522395902524,raw,8930209.65625,7391018.25,7876802.09375,10791687.375,9597290.21875,14029162.0625,"Adenylate kinase 4, mitochondrial OS=Homo sapiens OX=9606 GN=AK4 PE=1 SV=1",cellular homeostasis;coagulation;metabolic process,endosome;nucleus,signal transducer activity;structural molecule activity,205,AK4,CCL18 signaling pathway,Interconversion of nucleotide di- and triphosphates,ENSG00000162433
Q9BTE7,0,6,2855494.75,1.1053466004495902e-5,1.369949493822984,0.45412270606590227,0.07640769404730119,0.6429522395902524,raw,2101445.125,2966056,2311709.8125,3166925.6875,3112988.1875,3473843.6875,DCN1-like protein 5 OS=Homo sapiens OX=9606 GN=DCUN1D5 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,84259,DCUN1D5,NA,Neddylation,ENSG00000137692
P27635,0,6,164310120.37760416,6.360356046140435e-4,1.3697694303108539,0.4539330685566813,0.18389141153382962,0.676113606267618,raw,152937370.09375,141024052.1875,124755331.609375,193170435.625,142985747.375,230987785.375,60S ribosomal protein L10 OS=Homo sapiens OX=9606 GN=RPL10 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,100137264; 100146244; 100172946; 100415355; 100468790; 100724614; 100982236; 101083663; 101136536; 101344695; 101444008; 101539056; 101690567; 101867181; 101975002; 102028809; 102257301; 102442647; 102841972; 102878669; 102890423; 102923570; 102957760; 103127392; 103211225; 103250904; 103679662; 103731218; 104667036; 104872587; 105294701; 105302495; 105467951; 105521640; 105579731; 105727260; 105824536; 105867804; 106000161; 107160308; 108298087; 108513162; 108518769; 109261154; 109696857; 110954; 465944; 700795; 81764,LOC100768740; LOC101344695; LOC105294701; LOC112632580; Rpl10; RPL10,Cytoplasmic ribosomal proteins,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; SRP-dependent cotranslational protein targeting to membrane; Major pathway of rRNA processing in the nucleolus and cytosol; L13a-mediated translational silencing of Ceruloplasmin expression; SRP-dependent cotranslational protein targeting to membrane; Major pathway of rRNA processing in the nucleolus and cytosol; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSAMEG00000000227; ENSANAG00000036053; ENSCAFG00020009114; ENSCAFG00030015144; ENSCAFG00040021422; ENSCAFG00845028627; ENSCANG00000032226; ENSCATG00000030970; ENSCCAG00000024992; ENSCGRG00001008387; ENSCJAG00000011822; ENSCLAG00000003108; ENSCPOG00000002355; ENSECAG00000017154; ENSFCAG00000011395; ENSGGOG00000000131; ENSLCNG00005021252; ENSMFAG00000040824; ENSMLUG00000014337; ENSMMMG00000014279; ENSMMUG00000005494; ENSMNEG00000038094; ENSMPUG00000009320; ENSMUSG00000008682; ENSMUSG00000058443; ENSNGAG00000023746; ENSNLEG00000028143; ENSNVIG00000023818; ENSPANG00000008309; ENSPCOG00000027122; ENSPPAG00000034160; ENSPPRG00000021464; ENSPPYG00000020874; ENSPSMG00000015404; ENSPTIG00000005599; ENSPTRG00000043378; ENSRBIG00000042996; ENSRNOG00000056765; ENSRROG00000019247; ENSSSUG00005010590; ENSSTOG00000011857; ENSTGEG00000012563; ENSUAMG00000020454; ENSUMAG00000019583; ENSUPAG00010000252
Q70UQ0,0,6,5377486.145833333,2.081595853139511e-5,1.3697368852719707,0.45389879043442444,0.2163893383712698,0.7052519353827845,raw,4488412.75,5291841,4350321.125,7314827.125,4671570.375,6147944.5,Inhibitor of nuclear factor kappa-B kinase-interacting protein OS=Homo sapiens OX=9606 GN=IKBIP PE=1 SV=1,metabolic process,cytoskeleton;extracellular,NA,121457,IKBIP,NA,Regulation of NF-kappa B signaling,ENSG00000166130
Q99627,0,6,8920219.489583334,3.452968802718029e-5,1.3696798444906912,0.4538387101615707,0.34354703845225315,0.8250635218999488,raw,7318173.375,9103564.25,7377371.875,10104637.5625,7048042.125,12569527.75,COP9 signalosome complex subunit 8 OS=Homo sapiens OX=9606 GN=COPS8 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;membrane;nucleus,NA,10920,COPS8,Ciliary landscape; 2q37 copy number variation syndrome,Neddylation; DNA Damage Recognition in GG-NER; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex,ENSG00000198612
P47224,0,6,686722.75,2.6582666879842586e-6,1.3693377991089706,0.4534783859557842,0.10245667368012237,0.6429522395902524,raw,490023.125,629276.0625,654157.8125,760115.75,671007.1875,915756.5625,Guanine nucleotide exchange factor MSS4 OS=Homo sapiens OX=9606 GN=RABIF PE=1 SV=2,cell growth;conjugation;development,cytoskeleton;cytosol,DNA binding;structural molecule activity,5877,RABIF,Retinoblastoma gene in cancer,NA,ENSG00000183155
Q15459,0,6,88396066.24186198,3.4217639977646234e-4,1.3687556196819384,0.4528648879800178,0.11300464345553132,0.6429522395902524,raw,80868731.5957031,79797109.5,65661643.5429688,109222742.0625,80851395.125,113974775.625,Splicing factor 3A subunit 1 OS=Homo sapiens OX=9606 GN=SF3A1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane,RNA binding,10291,SF3A1,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000099995
P51858,0,6,134088565.1002605,5.190495958458215e-4,1.3686031036591275,0.45270412416918304,0.25299161575224083,0.7343965948630279,raw,122540237.984375,119672599.65625,114624317.320313,172579417.78125,111330526.546875,163784291.3125,Hepatoma-derived growth factor OS=Homo sapiens OX=9606 GN=HDGF PE=1 SV=1,cellular component movement;development;metabolic process,membrane;nucleus,antioxidant activity;motor activity;RNA binding;structural molecule activity,3068,HDGF,IL-18 signaling pathway,XBP1(S) activates chaperone genes,ENSG00000143321
O75964,0,6,28267582.3125,1.0942228491945517e-4,1.368468844969861,0.4525625901876204,0.03929016316762026,0.6429522395902524,raw,21816023.375,26133578.75,23521442.5,32188361.25,29065862.75,36880225.25,"ATP synthase subunit g, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5MG PE=1 SV=3",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,10632,ATP5MG,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000167283
Q53FA7,0,6,401980.76875,1.556045852243032e-6,1.3684428618046889,0.45253519742705106,0.10810855136479698,0.6429522395902524,raw,NA,364881.375,299736.5625,399702.6875,420642.03125,524941.1875,Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2,cellular homeostasis,cytosol,structural molecule activity,9540,TP53I3,p53 transcriptional gene network; SARS-CoV-2 innate immunity evasion and cell-specific immune response,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,ENSG00000115129
Q8N3C0,0,6,13551673.6640625,5.2457797076929405e-5,1.36840091730297,0.4524909763245615,0.3235800601293044,0.8037523716522456,raw,12211777.75,12728995.359375,11028579.734375,16710607.875,10374462.765625,18255618.5,Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens OX=9606 GN=ASCC3 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation,cytosol;membrane;nucleus,structural molecule activity,10973,ASCC3,Mesodermal commitment pathway; VEGFA-VEGFR2 signaling pathway,ALKBH3 mediated reversal of alkylation damage,ENSG00000112249
Q9NV70,0,6,2219153.453125,8.590223201382836e-6,1.3683485583396597,0.4524357735978264,0.3840187565290607,0.8695425300008842,raw,1236372.296875,2684087.2734375,1814462.9453125,3308241.078125,1691788.25,2579968.875,Exocyst complex component 1 OS=Homo sapiens OX=9606 GN=EXOC1 PE=1 SV=4,cell differentiation;cell growth;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,55763,EXOC1,Ciliary landscape,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing; VxPx cargo-targeting to cilium,ENSG00000090989
O43252,0,6,68361354.78255208,2.646231134237676e-4,1.3682645979011296,0.4523472486208416,0.0871467765551812,0.6429522395902524,raw,67481801.34375,48889561.71875,50220234.9921875,87969186.4375,63274384.421875,92332959.78125,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 OS=Homo sapiens OX=9606 GN=PAPSS1 PE=1 SV=2,cellular homeostasis;defense response,cytosol,signal transducer activity;structural molecule activity,9061,PAPSS1,Sulfation biotransformation reaction,Signaling by BRAF and RAF1 fusions; Transport and synthesis of PAPS; Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,ENSG00000138801
P26232,0.5,6,2992590.2708333335,1.1584155363634074e-5,1.368233073602371,0.4523140090899168,0.16840286813702218,0.668039680404208,raw,3124836,1783303.625,2253801.25,4157471.25,2439975,4196154.5,Catenin alpha-2 OS=Homo sapiens OX=9606 GN=CTNNA2 PE=1 SV=5,cell communication;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,1496,CTNNA2,Arrhythmogenic right ventricular cardiomyopathy; Ectoderm differentiation; Ectoderm differentiation; Endometrial cancer; Malignant pleural mesothelioma,Myogenesis,ENSG00000066032
J3QQJ0,0,6,5369123.895833333,2.0783588713136435e-5,1.3682128295479683,0.4522926631558634,0.08651229240015842,0.6429522395902524,raw,4826784.375,4632386.6875,3923708,7496170.875,5967225.8125,5368467.625,SAP30-binding protein (Fragment) OS=Homo sapiens OX=9606 GN=SAP30BP PE=1 SV=1,metabolic process,endoplasmic reticulum;membrane,NA,NA,SAP30BP,NA,NA,ENSG00000161526
Q00577,0,6,3029054.6354166665,1.1725306950166465e-5,1.367651015520541,0.45170014366764016,0.1420881782728536,0.6572502130392559,raw,3280804.8125,1991787.1875,2559881.75,3501024.875,3041453.75,3799375.4375,Transcriptional activator protein Pur-alpha OS=Homo sapiens OX=9606 GN=PURA PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,5813,PURA,Exercise-induced circadian regulation,NA,ENSG00000185129
P0DP25,0,6,413982689.4085287,0.0016025046391091975,1.36753795402219,0.45158087347103154,0.17726337284528987,0.6727235585925336,raw,365940209.875,365317640.613281,319457685.871094,499585738.8125,358269836.150391,575325025.128906,Calmodulin-3 OS=Homo sapiens OX=9606 GN=CALM3 PE=1 SV=1,cell differentiation;cell growth;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;endosome;extracellular;nucleus,antioxidant activity;DNA binding;motor activity;structural molecule activity,801; 805; 808,CALM3,Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Alzheimer's disease and miRNA effects; T cell receptor and co-stimulatory signaling; Cardiac hypertrophic response; Myometrial relaxation and contraction pathways; G protein signaling pathways; Ras signaling; Melanoma; Endochondral ossification; Endochondral ossification with skeletal dysplasias; CAMKK2 pathway; Glycogen synthesis and degradation; Neuroinflammation and glutamatergic signaling; Alzheimer's disease; G13 signaling pathway; Calcium regulation in cardiac cells,NA,ENSG00000160014
Q9NS91,0,6,559095.8033854166,2.1642296684233187e-6,1.3674694136497823,0.45150856444798265,0.32466695304570803,0.8055660735320965,raw,394957.4375,691644.375,368631.6796875,779138.40625,504092.546875,616110.375,E3 ubiquitin-protein ligase RAD18 OS=Homo sapiens OX=9606 GN=RAD18 PE=1 SV=2,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,56852,RAD18,SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome,Recognition of DNA damage by PCNA-containing replication complex; E3 ubiquitin ligases ubiquitinate target proteins,ENSG00000070950
Q7Z4H7,0.3333333333333333,6,369839.2682291667,1.4316278390981932e-6,1.3672075122401386,0.4512322291613733,0.3232389855121638,0.8037523716522456,raw,455677.84375,251634.328125,269191.75,482348.0625,344036.34375,416147.28125,HAUS augmin-like complex subunit 6 OS=Homo sapiens OX=9606 GN=HAUS6 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum,motor activity,54801,HAUS6,NA,Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,ENSG00000147874
Q9UJ70,0,6,3056479.2291666665,1.1831466071874791e-5,1.3667126979467772,0.4507100002153138,0.150804031037747,0.6638855679885327,raw,2284671.78125,3069368.890625,2134361.171875,4194945.4375,2585322.65625,4070205.4375,N-acetyl-D-glucosamine kinase OS=Homo sapiens OX=9606 GN=NAGK PE=1 SV=4,cellular homeostasis,cytosol,signal transducer activity;structural molecule activity,55577,NAGK,NA,Synthesis of UDP-N-acetyl-glucosamine,ENSG00000124357
Q9NWZ8,0,6,1073225.15625,4.154396634691476e-6,1.3666966409329617,0.4506930504128281,0.19806092945084153,0.6875760999904456,raw,875675.46875,972857.53125,917036.625,1488193.6875,1253310.875,932276.75,Gem-associated protein 8 OS=Homo sapiens OX=9606 GN=GEMIN8 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,NA,54960,GEMIN8,NA,snRNP Assembly; SARS-CoV-2 modulates host translation machinery,ENSG00000046647
Q02040,0,6,503176.39375,1.9477686529034835e-6,1.3660351802484092,0.4499946386180174,0.44513195322206234,0.9271939562980955,raw,311779.90625,539537.78125,NA,461438.53125,675531.875,527593.875,A-kinase anchor protein 17A OS=Homo sapiens OX=9606 GN=AKAP17A PE=1 SV=2,cellular component movement;cellular homeostasis;development;metabolic process,cytosol;membrane,structural molecule activity,8227,AKAP17A,NA,NA,ENSG00000197976
A0A1Y0BRN3,0,6,83426440.09635417,3.229392452853099e-4,1.3660342747877137,0.4499936823438987,0.09663445704616186,0.6429522395902524,raw,78572153.3125,67987097.3203125,62723127.9765625,107332254.46875,76899598.21875,107044409.28125,Unconventional myosin-6 OS=Homo sapiens OX=9606 GN=MYO6 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,NA,MYO6,Joubert syndrome,NA,ENSG00000196586
P03891,0,6,5433380.791666667,2.103232368757412e-5,1.365551500520257,0.4494837250472423,0.32309991034118096,0.8037523716522456,raw,6297695.25,3356727.625,4793183.375,4700557.5,6545338.75,6906782.25,NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens OX=9606 GN=MT-ND2 PE=1 SV=2,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome;nucleus,antioxidant activity;catalytic activity;structural molecule activity,4536,MT-ND2,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,Complex I biogenesis,ENSG00000198763
F8VXU5,0.16666666666666666,6,27270524.520833332,1.0556272804066727e-4,1.3650888724725667,0.44899487913170844,0.2576525800425132,0.7380182509946936,raw,26828188.0625,24048431.78125,20696192.40625,37002096.5,22219991.75,32828246.625,Vacuolar protein sorting-associated protein 29 OS=Homo sapiens OX=9606 GN=VPS29 PE=1 SV=1,conjugation,cytoskeleton;cytosol;mitochondrion;nucleus,NA,51699,VPS29,NA,NA,ENSG00000111237
P04181,0,6,111141298.96875,4.302219676105493e-4,1.3644072522775357,0.44827432848745885,0.22728742881848865,0.7148463313429879,raw,108925250.875,89880647.25,88799611.8125,148618402.25,90602959.875,140020921.75,"Ornithine aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=OAT PE=1 SV=1",cellular homeostasis;metabolic process,endosome;membrane;nucleus,structural molecule activity,4942,OAT,Amino acid metabolism; 22q11.2 copy number variation syndrome; Creatine pathway,Glutamate and glutamine metabolism,ENSG00000065154
B4E0T2,0.16666666666666666,6,399571.1822916667,1.5467184731602721e-6,1.364399226749343,0.44826584244067386,0.27341266989529267,0.7546660352548081,raw,325072.46875,463388.96875,294874.59375,408671.78125,443528.625,461890.65625,PTS1-BP OS=Homo sapiens OX=9606 GN=PEX5 PE=1 SV=1,NA,cytoskeleton;cytosol;extracellular,NA,5830,PEX5,NA,NA,ENSG00000139197
Q13371,0,6,1226346.4166666667,4.747120766501276e-6,1.364263666488314,0.4481224959562301,0.30886296102402366,0.7900754858681969,raw,708994.875,1448091.6875,677466.3125,1831393.625,716553.125,1975578.875,Phosducin-like protein OS=Homo sapiens OX=9606 GN=PDCL PE=1 SV=3,cell growth;development;metabolic process,cytosol;nucleus,NA,5082,PDCL,NA,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,ENSG00000136940
P51812,0,6,8951751.067708334,3.465174506366155e-5,1.3642476433105564,0.44810555150816594,0.10816011562490792,0.6429522395902524,raw,6512520.75,8224504.03125,8159466.3125,11131532.6875,8212883.375,11469599.25,Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens OX=9606 GN=RPS6KA3 PE=1 SV=1,cell death;cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,6197,RPS6KA3,Brain-derived neurotrophic factor (BDNF) signaling pathway; Kit receptor signaling pathway; MAPK signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Thermogenesis; EGF/EGFR signaling pathway; Cytoplasmic ribosomal proteins; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; Malignant pleural mesothelioma,Recycling pathway of L1; Senescence-Associated Secretory Phenotype (SASP); RSK activation; ERK/MAPK targets; CREB phosphorylation; Gastrin-CREB signalling pathway via PKC and MAPK,ENSG00000177189
Q13330,0,6,18443688.184895832,7.139452115934334e-5,1.3641812276183247,0.4480353150502105,0.11237178422751112,0.6429522395902524,raw,14055942.984375,15598964.515625,16680986.8125,21279814.5625,17488291.796875,25558128.4375,Metastasis-associated protein MTA1 OS=Homo sapiens OX=9606 GN=MTA1 PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,9112,MTA1,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; SUMOylation of transcription factors,ENSG00000182979
A0A1W2PS27,0,6,417074.5625,1.6144731129110818e-6,1.364171512764649,0.44802504103320856,0.22679161521875324,0.7148463313429879,raw,485346.1875,331251.0625,328873.40625,NA,489646.5,450255.65625,Mediator of RNA polymerase II transcription subunit 17 OS=Homo sapiens OX=9606 GN=MED17 PE=1 SV=1,cellular component movement;metabolic process,membrane,structural molecule activity,NA,MED17,NA,NA,ENSG00000042429
Q13242,0,6,36392578.697916664,1.4087370724578065e-4,1.363697793215133,0.447523966549742,0.052469533029453556,0.6429522395902524,raw,29795252.5,33299856.3125,30744184,41925775.875,36495008.875,46095394.625,Serine/arginine-rich splicing factor 9 OS=Homo sapiens OX=9606 GN=SRSF9 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,8683,SRSF9,mRNA processing,mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000111786
P40926,0,6,557420144.1959635,0.0021577432821724804,1.363346259326045,0.4471520208154381,0.16089624045926867,0.6638855679885327,raw,560559411.097656,411421509.578125,422088857.90625,710776269.1875,475438241.15625,764236576.25,"Malate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=MDH2 PE=1 SV=3",cellular homeostasis,cytoskeleton;endosome;nucleus,structural molecule activity,4191,MDH2,Amino acid metabolism; Metabolic reprogramming in colon cancer; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis and gluconeogenesis; TCA cycle (aka Krebs or citric acid cycle),Gluconeogenesis; Citric acid cycle (TCA cycle),ENSG00000146701
A8MWD9,0,6,49126287.333333336,1.901652058600695e-4,1.3621277632793372,0.44586202993203894,0.011654622381234932,0.6429522395902524,raw,38451534,42685861,43827319,59698408,51555066,58539536,Putative small nuclear ribonucleoprotein G-like protein 15 OS=Homo sapiens OX=9606 GN=SNRPGP15 PE=5 SV=2,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,NA,SNRPGP15,NA,NA,NA
Q96EY7,0,6,17738752.5,6.866575318372296e-5,1.362095277450165,0.4458276222172905,0.2085637558805094,0.6988382857167694,raw,17985132.46875,12176317.25,15465206.4375,21262214.875,15046179.96875,24497464,"Pentatricopeptide repeat domain-containing protein 3, mitochondrial OS=Homo sapiens OX=9606 GN=PTCD3 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;Golgi;membrane,protein binding;RNA binding,55037,PTCD3,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000132300
Q96TC7,0,6,14047034.307291666,5.437531138155169e-5,1.3619942519373311,0.4457206147163527,0.08310644519128,0.6429522395902524,raw,14328146.125,9332184.15625,12226880.4375,16652940.875,14580753.875,17161300.375,Regulator of microtubule dynamics protein 3 OS=Homo sapiens OX=9606 GN=RMDN3 PE=1 SV=2,metabolic process,cytoskeleton;endoplasmic reticulum;endosome;membrane;nucleus,motor activity,55177,RMDN3,NA,NA,ENSG00000137824
P56282,0.3333333333333333,6,264493.7447916667,1.0238410056458703e-6,1.361927608621731,0.4456500209285233,1,1,raw,NA,240370.9375,231732.546875,NA,321377.75,NA,DNA polymerase epsilon subunit 2 OS=Homo sapiens OX=9606 GN=POLE2 PE=1 SV=2,cell proliferation;cellular homeostasis;coagulation,membrane;nucleus,RNA binding;structural molecule activity,5427,POLE2,"Retinoblastoma gene in cancer; Pyrimidine metabolism; G1 to S cell cycle control; DNA replication; Base excision repair; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Activation of the pre-replicative complex; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; DNA replication initiation; Gap-filling DNA repair synthesis and ligation in GG-NER,ENSG00000100479
Q9NQC3,0,6,91061988.09912108,3.5249603934850356e-4,1.361062388767743,0.44473319902625236,0.079747300698371,0.6429522395902524,raw,68421172.6582031,89667180.125,69367119.4365234,122042626.375,86806107.625,110067722.375,Reticulon-4 OS=Homo sapiens OX=9606 GN=RTN4 PE=1 SV=2,cell communication;cell growth;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,57142,RTN4,Alzheimer's disease and miRNA effects; Spinal cord injury; 22q11.2 copy number variation syndrome; Alzheimer's disease; Neurogenesis regulation in the olfactory epithelium,Axonal growth inhibition (RHOA activation),ENSG00000115310
Q53GS9,0,6,27005377.654947918,1.0453635883853055e-4,1.361006200744294,0.4446736397755331,0.138127727566539,0.6566651738422726,raw,24817746.5,24153339.609375,21387795.0390625,33535142.75,24361135.15625,33777106.875,U4/U6.U5 tri-snRNP-associated protein 2 OS=Homo sapiens OX=9606 GN=USP39 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,10713,USP39,NA,mRNA Splicing - Major Pathway,ENSG00000168883
Q04837,0,6,49193890.598958336,1.9042689445129485e-4,1.360888217762072,0.44454856992542413,0.1424491440305546,0.6572502130392559,raw,45574833,42441515.03125,37045139,57758157.75,44613242.6875,67730456.125,"Single-stranded DNA-binding protein, mitochondrial OS=Homo sapiens OX=9606 GN=SSBP1 PE=1 SV=1",cell growth;cell proliferation;cellular homeostasis;metabolic process,endosome;nucleus,RNA binding;structural molecule activity,6742,SSBP1,NA,Transcriptional activation of mitochondrial biogenesis,ENSG00000106028; ENSG00000262771
Q9BTA9,0,6,819408.7447916666,3.17188700989254e-6,1.3607803119522832,0.44443417305817345,0.446776636814585,0.9279078826673519,raw,400054.03125,393483.65625,1184771.3125,923226.78125,535444.8125,1479471.875,WW domain-containing adapter protein with coiled-coil OS=Homo sapiens OX=9606 GN=WAC PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,membrane,structural molecule activity,51322,WAC,NA,E3 ubiquitin ligases ubiquitinate target proteins,ENSG00000095787
J3KPF3,0,6,149223920.72395834,5.776377402829633e-4,1.360757452567132,0.4444099374057962,0.09136217248822356,0.6429522395902524,raw,139977821.1875,115945703,125981167.875,182963487.25,139999481.65625,190475863.375,4F2 cell-surface antigen heavy chain OS=Homo sapiens OX=9606 GN=SLC3A2 PE=1 SV=1,cellular homeostasis;conjugation,cytoplasm;cytoskeleton;membrane,NA,6520,SLC3A2,"mRNA, protein, and metabolite inducation pathway by cyclosporin A; Ferroptosis; Proximal tubule transport; Malignant pleural mesothelioma",NA,ENSG00000168003
Q9P253,0,6,55998230.03515625,2.1676612503158726e-4,1.3605701782125934,0.44421137271997957,0.8852256739046251,1,raw,36488810.9375,102301311.140625,34741002.1328125,48027896,49645588,64784772,Vacuolar protein sorting-associated protein 18 homolog OS=Homo sapiens OX=9606 GN=VPS18 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,57617,VPS18,Ebola virus infection in host,SARS-CoV-2 modulates autophagy,ENSG00000104142
Q8WYA0,0.5,6,273293.4427083333,1.0579041611714435e-6,1.3598033380834667,0.4433980164112804,0.474890852609739,0.9561536977028555,raw,371436.9375,139374.71875,139331.890625,379940.28125,104595.640625,505081.1875,Intraflagellar transport protein 81 homolog OS=Homo sapiens OX=9606 GN=IFT81 PE=1 SV=1,cell growth;conjugation;metabolic process,endoplasmic reticulum;nucleus,motor activity,28981,IFT81,Ciliary landscape; Intraflagellar transport proteins binding to dynein; Genes related to primary cilium development (based on CRISPR); Ciliopathies; Alstrom syndrome; Bardet-Biedl syndrome,Intraflagellar transport,ENSG00000122970
Q15149,0,6,1175776591.4010434,0.004551367703244246,1.3597292469143112,0.443319406606838,0.13904896490173424,0.6572502130392559,raw,1011259992.05469,1093277593.1875,980809516.46875,1410445367.29688,1072305560.94531,1486561518.45313,Plectin OS=Homo sapiens OX=9606 GN=PLEC PE=1 SV=3,cell differentiation;cell growth;cellular homeostasis;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;nucleus,motor activity;structural molecule activity,5339,PLEC,Envelope proteins and their potential roles in EDMD physiopathology,Assembly of collagen fibrils and other multimeric structures; Caspase-mediated cleavage of cytoskeletal proteins; Type I hemidesmosome assembly,ENSG00000178209
O75600,0,6,3212689.0104166665,1.2436145701076217e-5,1.3596060772525425,0.44318871565543966,0.3388532070505725,0.8220802530061173,raw,3614661.78125,2336153.03125,2301156.875,3641879.21875,2467767.03125,4914516.125,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial OS=Homo sapiens OX=9606 GN=GCAT PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome;membrane,structural molecule activity,23464,GCAT,NA,Threonine catabolism,ENSG00000100116
P62140,0,6,24484610.385416668,9.477860483845416e-5,1.3591612185613071,0.44271659328258534,0.41209483372267075,0.8978780271505381,raw,24988805.0625,17812528.375,21629174.375,36413200,16666419.5,29397535,Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Homo sapiens OX=9606 GN=PPP1CB PE=1 SV=3,cell differentiation;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,5500,PPP1CB,Common pathways underlying drug addiction; Focal adhesion; Hippo-Merlin signaling dysregulation; 22q11.2 copy number variation syndrome; Airway smooth muscle cell contraction; Neuroinflammation and glutamatergic signaling; G13 signaling pathway,Triglyceride catabolism; Regulation of PLK1 Activity at G2/M Transition; Circadian Clock; RHO GTPases activate CIT; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs; Downregulation of TGF-beta receptor signaling,ENSG00000213639
O76095,0.3333333333333333,6,410785.3625,1.590127959275105e-6,1.358899604513272,0.44243887374982976,0.47253083195329815,0.9535792290076607,raw,NA,443167.375,262755.75,401879.28125,376216.84375,569907.5625,Protein JTB OS=Homo sapiens OX=9606 GN=JTB PE=1 SV=1,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;endosome;nucleus,structural molecule activity,10899,JTB,NA,NA,ENSG00000143543
P61165,0,6,6762314.416666667,2.6176553998685358e-5,1.3588824762283638,0.44242068914859084,0.23939943935226812,0.7258167404748,raw,6176565.25,5826126.625,5535351.5,7917021.375,5642351.375,9476470.375,Transmembrane protein 258 OS=Homo sapiens OX=9606 GN=TMEM258 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular;nucleus,NA,746,TMEM258,NA,NA,ENSG00000134825
O95671,0,6,18355496.716145832,7.105313674541133e-5,1.3587913005414416,0.4423238867195826,0.20842082644975965,0.6988382857167694,raw,20204955.875,6852011.046875,17122190.59375,24760305.9375,17928033.21875,23265483.625,Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein OS=Homo sapiens OX=9606 GN=ASMTL PE=1 SV=3,cellular homeostasis,cytosol,structural molecule activity,8623,ASMTL,NA,NA,ENSG00000169093
Q8NEJ9,0,6,7596255.78125,2.940469599515192e-5,1.3586583288590655,0.4421826972860636,0.28190729879962334,0.7642515538458274,raw,8459368.0625,6303843.875,4598202.25,11493390.875,6639865.5,8082864.125,Neuroguidin OS=Homo sapiens OX=9606 GN=NGDN PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,endosome;membrane;nucleus,NA,25983,NGDN,NA,NA,ENSG00000129460
P35613,0,6,152116419.82291666,5.888344481243525e-4,1.3582965359087893,0.4417984752991284,0.15970755234235431,0.6638855679885327,raw,128637457.875,143987035.75,123593100.875,195577091.875,134606835.3125,186296997.25,Basigin OS=Homo sapiens OX=9606 GN=BSG PE=1 SV=2,cell communication;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,682,BSG,Matrix metalloproteinases; VEGFA-VEGFR2 signaling pathway; IL-18 signaling pathway,Degradation of the extracellular matrix; Integrin cell surface interactions; Pyruvate metabolism; Aspirin ADME; Basigin interactions; Proton-coupled monocarboxylate transport; Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),ENSG00000172270
Q6UX04,0,6,8399795.822916666,3.2515156112024386e-5,1.3582859413265915,0.44178722237283213,0.2972891543279327,0.7790952437047332,raw,8463744.84375,7198278.96875,5827934,9777321.125,6507442.75,12624053.25,Spliceosome-associated protein CWC27 homolog OS=Homo sapiens OX=9606 GN=CWC27 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane,NA,10283,CWC27,NA,mRNA Splicing - Major Pathway,ENSG00000153015
A0A1B0GVH5,0,6,12510168.239583334,4.8426185811323495e-5,1.3582363970844653,0.4417345983016678,0.39014975213573483,0.874922600545966,raw,12590023.71875,10147114.09375,10129192.40625,19127577.5,9284922.03125,13782179.6875,Alpha-ketoglutarate-dependent dioxygenase FTO OS=Homo sapiens OX=9606 GN=FTO PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,NA,FTO,NA,NA,ENSG00000140718
P09874,0,6,341532211.5703125,0.0013220527511152845,1.3576655060214093,0.44112808028513156,0.19029547001118946,0.6816045476187055,raw,312750729.578125,296523807.46875,298411526.3125,416648764.28125,300247564.25,424610877.53125,Poly [ADP-ribose] polymerase 1 OS=Homo sapiens OX=9606 GN=PARP1 PE=1 SV=4,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,142,PARP1,"Corticotropin-releasing hormone signaling pathway; Nanoparticle triggered regulated necrosis; Fas ligand pathway and stress induction of heat shock proteins; NAD metabolism, sirtuins and aging; NAD+ metabolism; NAD+ biosynthetic pathways; Breast cancer pathway; Acute viral myocarditis; Joubert syndrome; Male infertility; Base excision repair; IL-18 signaling pathway; DNA repair pathways, full network; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Progeria-associated lipodystrophy",SUMOylation of DNA damage response and repair proteins; Downregulation of SMAD2/3:SMAD4 transcriptional activity; HDR through MMEJ (alt-NHEJ); Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER; vRNA Synthesis; POLB-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER,ENSG00000143799
Q9UI30,0,6,15745379.513020834,6.094951397654016e-5,1.357602640227938,0.4410612757092195,0.15227951103514678,0.6638855679885327,raw,13461593.40625,15420035.5625,11235419.109375,18275494.75,14226249.75,21853484.5,Multifunctional methyltransferase subunit TRM112-like protein OS=Homo sapiens OX=9606 GN=TRMT112 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,51504,TRMT112,NA,rRNA modification in the nucleus and cytosol; tRNA modification in the nucleus and cytosol; Methylation; Eukaryotic Translation Termination,ENSG00000173113
Q16775,0,6,8678253.645833334,3.3593051310149104e-5,1.357481780656292,0.4409328351322476,0.35409525139182413,0.8383308462007302,raw,10242314.25,4858135.875,7820585.625,11193047.625,7339136,10616302.5,"Hydroxyacylglutathione hydrolase, mitochondrial OS=Homo sapiens OX=9606 GN=HAGH PE=1 SV=2",cellular homeostasis,cytosol;endosome;nucleus,structural molecule activity,3029,HAGH,NA,NA,ENSG00000063854
Q02543,0,6,140552762.69270834,5.440721557137626e-4,1.3573023218484979,0.4407420985413072,0.07735691238482263,0.6429522395902524,raw,100078357.71875,142356724.4375,116819597.1875,158559510.5,141074508.25,184427878.0625,60S ribosomal protein L18a OS=Homo sapiens OX=9606 GN=RPL18A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,structural molecule activity,6142,RPL18A,VEGFA-VEGFR2 signaling pathway; Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000105640
Q14498,0,6,34884454.40625,1.3503583953879505e-4,1.3571507687390214,0.4405810016923999,0.18023086171012845,0.6742444420587625,raw,31005572.875,31301067.25,26936221.53125,42079237.0625,30166510.53125,47818117.1875,RNA-binding protein 39 OS=Homo sapiens OX=9606 GN=RBM39 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,9584,RBM39,VEGFA-VEGFR2 signaling pathway; mRNA processing,NA,ENSG00000131051
Q9BQC6,0,6,3166402.59375,1.225697348123763e-5,1.3570391626823168,0.44046235597585104,0.20167886267467003,0.6920162065862512,raw,3148673.5,2644205.4375,2488996.375,4272873.25,2748064.5,3695602.5,"Ribosomal protein 63, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL57 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,78988,MRPL57,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000173141
P30084,0,6,26942770.255208332,1.0429400897441282e-4,1.3566138276312636,0.44001010303408866,0.2833702396755176,0.7643821370278715,raw,31486819.25,16635858.71875,22845361.6875,30992333.5625,24851084.8125,34845163.5,"Enoyl-CoA hydratase, mitochondrial OS=Homo sapiens OX=9606 GN=ECHS1 PE=1 SV=4",cellular homeostasis,endosome,structural molecule activity,1892,ECHS1,Fatty acid beta-oxidation; Fatty acid biosynthesis; Ciliary landscape; Tryptophan metabolism,Branched-chain amino acid catabolism; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA; Beta oxidation of octanoyl-CoA to hexanoyl-CoA; Beta oxidation of hexanoyl-CoA to butanoyl-CoA; Beta oxidation of butanoyl-CoA to acetyl-CoA; Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,ENSG00000127884
A0A0A0MTJ9,0,6,3291757.5052083335,1.2742215575379558e-5,1.3565887511584895,0.43998343513748706,0.25162838941560467,0.7326612824296702,raw,3077758.09375,2625780.96875,2860169.53125,4602603.4375,2704159.1875,3880073.8125,Neutral cholesterol ester hydrolase 1 OS=Homo sapiens OX=9606 GN=NCEH1 PE=1 SV=1,NA,cytoskeleton,structural molecule activity,57552,NCEH1,NA,NA,ENSG00000144959
Q9NRL2,0,6,115124052.03385417,4.4563898969032404e-4,1.3563959047574554,0.4397783336848953,0.32346010382312035,0.8037523716522456,raw,71320086.671875,139602192.015625,95545355.859375,123465220.53125,129597329.40625,131214127.71875,Bromodomain adjacent to zinc finger domain protein 1A OS=Homo sapiens OX=9606 GN=BAZ1A PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,11177,BAZ1A,Ectoderm differentiation,NA,ENSG00000198604
Q9UI09,0,6,5496032.140625,2.127484367674473e-5,1.3563505321704559,0.43973007351183113,0.12978270447675808,0.6498046150645307,raw,5726706.75,2754772.65625,4843695.9375,6569749.5625,5471884.6875,7609383.25,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 OS=Homo sapiens OX=9606 GN=NDUFA12 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;endosome,catalytic activity,55967,NDUFA12,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease,Complex I biogenesis,ENSG00000184752
P16219,0,6,7089748.494791667,2.7444033636414736e-5,1.3562333601459262,0.43960543699879734,0.04106382091303252,0.6429522395902524,raw,6748927.6875,5518228.34375,5977538.625,7640180.1875,7500495.25,9153120.875,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADS PE=1 SV=1",cellular homeostasis,endoplasmic reticulum;endosome;membrane,structural molecule activity,35,ACADS,Fatty acid beta-oxidation; Mitochondrial long chain fatty acid beta-oxidation; IL-18 signaling pathway,Beta oxidation of hexanoyl-CoA to butanoyl-CoA; Beta oxidation of butanoyl-CoA to acetyl-CoA,ENSG00000122971
Q14746,0,6,1788428.5625,6.922910405303048e-6,1.3561139125542656,0.4394783688685614,0.09800629290961607,0.6429522395902524,raw,1257236.484375,1676690.9375,1550933.640625,2451115.3125,1691352.3125,2103242.6875,Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens OX=9606 GN=COG2 PE=1 SV=1,cell growth;cellular homeostasis;conjugation,cytoskeleton;cytosol;extracellular,structural molecule activity,22796,COG2,NA,COPI-mediated anterograde transport; Intra-Golgi traffic; Retrograde transport at the Trans-Golgi-Network,ENSG00000135775
Q9C040,0,6,392581.9921875,1.5196636956246575e-6,1.3560701462551763,0.4394318075576101,1,1,raw,309446.3125,NA,NA,488961.28125,352289.46875,419630.90625,Tripartite motif-containing protein 2 OS=Homo sapiens OX=9606 GN=TRIM2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,nucleus,structural molecule activity,23321,TRIM2,NA,Interferon gamma signaling,ENSG00000109654
P31689,0,6,65589614.869791664,2.538938578721677e-4,1.3560316132463432,0.43939081250234496,0.09404081148766352,0.6429522395902524,raw,55098038.84375,57994177.875,48218354.9375,93134652.5,64377782.5625,74714682.5,DnaJ homolog subfamily A member 1 OS=Homo sapiens OX=9606 GN=DNAJA1 PE=1 SV=2,coagulation;conjugation;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,3301,DNAJA1,VEGFA-VEGFR2 signaling pathway; Exercise-induced circadian regulation,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,ENSG00000086061
Q8TAQ2,0,6,16784986.520833332,6.497377657372796e-5,1.3560274134121681,0.43938634425156026,0.1775250959066611,0.6729927735741504,raw,16130246.4296875,13718387.578125,14404852.2734375,19675641.609375,14907734.890625,21873056.34375,SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1,cell growth;cellular component movement;defense response;metabolic process,membrane;nucleus,structural molecule activity,6601,SMARCC2,Tumor suppressor activity of SMARCB1; Thermogenesis,RMTs methylate histone arginines; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,ENSG00000139613
P19388,0,6,15335671.802083334,5.936355754827935e-5,1.3558492168155039,0.439196746137977,0.04870976848152904,0.6429522395902524,raw,13415177.9375,13643690.96875,12605802,18188958.5,15344332.28125,18816069.125,"DNA-directed RNA polymerases I, II, and III subunit RPABC1 OS=Homo sapiens OX=9606 GN=POLR2E PE=1 SV=4",cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5434,POLR2E,Pyrimidine metabolism; Eukaryotic transcription initiation; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,Activation of anterior HOX genes in hindbrain development during early embryogenesis; mRNA Splicing - Major Pathway; RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; Estrogen-dependent gene expression; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,ENSG00000099817
Q9Y3D6,0,6,5765239.770833333,2.2316931878328265e-5,1.3553174185576184,0.43863077375602577,0.15219118218918024,0.6638855679885327,raw,5459695.75,4595800.25,5010028.125,6969804.75,5156489,7399620.75,Mitochondrial fission 1 protein OS=Homo sapiens OX=9606 GN=FIS1 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;development;metabolic process,cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,51024,FIS1,CAMKK2 pathway,Class I peroxisomal membrane protein import,ENSG00000214253
O60884,0,6,53977654.895833336,2.0894458776136976e-4,1.355301035751922,0.4386133346417182,0.11403663370021455,0.6429522395902524,raw,51974366.5,49741768.125,37167771.25,64142410.875,50398699.875,70440912.75,DnaJ homolog subfamily A member 2 OS=Homo sapiens OX=9606 GN=DNAJA2 PE=1 SV=1,coagulation;metabolic process,cytoskeleton;cytosol;nucleus,structural molecule activity,10294,DNAJA2,NA,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,ENSG00000069345
Q9HD33,0,6,3645381.7734375,1.411107602495168e-5,1.355213401223551,0.43852004615167317,0.13972818947770257,0.6572502130392559,raw,3464315.125,2470026.328125,3102850.71875,4195298.90625,3347412.78125,5292386.78125,"39S ribosomal protein L47, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL47 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,57129,MRPL47,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000136522
Q14149,0,6,2807954.1927083335,1.086943907401101e-5,1.3550558949872344,0.4383523628394528,0.10873696218195418,0.6429522395902524,raw,2090041,2645373.625,2454849.96875,3497196.75,2575634.6875,3584629.125,MORC family CW-type zinc finger protein 3 OS=Homo sapiens OX=9606 GN=MORC3 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,23515,MORC3,Interactome of polycomb repressive complex 2 (PRC2),NA,ENSG00000159256
Q09028,0,6,209395531.41927084,8.105587965224814e-4,1.3549783522606718,0.438269802622944,0.22833662545511743,0.7148463313429879,raw,184378461.625,189913052.25,184013696.375,249828824.125,179423197.015625,268815957.125,Histone-binding protein RBBP4 OS=Homo sapiens OX=9606 GN=RBBP4 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5928,RBBP4,Retinoblastoma gene in cancer; Interactome of polycomb repressive complex 2 (PRC2) ; Tumor suppressor activity of SMARCB1; Epithelial to mesenchymal transition in colorectal cancer; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome; Malignant pleural mesothelioma; DYRK1A,HCMV Early Events; Potential therapeutics for SARS; Deposition of new CENPA-containing nucleosomes at the centromere; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6; HDACs deacetylate histones; Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; RNA Polymerase I Transcription Initiation; PRC2 methylates histones and DNA; Defective pyroptosis; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; G1/S-Specific Transcription; Regulation of TP53 Activity through Acetylation; Polo-like kinase mediated events; Cyclin E associated events during G1/S transition ; Transcription of E2F targets under negative control by DREAM complex; Cyclin A:Cdk2-associated events at S phase entry; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,ENSG00000162521
Q9UFC0,0,6,4001612.6822916665,1.5490026639646458e-5,1.3544511923523594,0.4377084069619374,0.2602360507461221,0.7409061089644438,raw,3385488.59375,4700862.125,2072262.8125,4585479.0625,3734103.0625,5531480.4375,Leucine-rich repeat and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=LRWD1 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,222229,LRWD1,Male infertility,NA,ENSG00000161036
Q9NVX2,0,6,7406683.497395833,2.867087191966494e-5,1.35442614144063,0.4376817237115207,0.2936765358555612,0.7750607974821754,raw,7800689.0625,5799781.8125,5376681.65625,10565457.1875,5530809.390625,9366681.875,Notchless protein homolog 1 OS=Homo sapiens OX=9606 GN=NLE1 PE=1 SV=4,cell differentiation;cell growth;defense response;development;metabolic process,membrane,NA,54475,NLE1,NA,NA,ENSG00000073536
H7BZJ3,0,6,58881703.333333336,2.2792789448546985e-4,1.3542867129127523,0.43753320088409586,0.04348744178406914,0.6429522395902524,raw,43332172,56189350.4375,49310158.65625,70569432,58684184.78125,75204922.125,Protein disulfide-isomerase A3 (Fragment) OS=Homo sapiens OX=9606 GN=PDIA3 PE=1 SV=1,NA,extracellular,structural molecule activity,NA,NA,NA,NA,NA
Q8TF74,0.5,6,464882.3854166667,1.7995346142002493e-6,1.3541137797236413,0.43734896679068697,0.9548401060205387,1,raw,352068.625,798296.46875,226320.53125,607367.53125,498777.40625,306463.75,WAS/WASL-interacting protein family member 2 OS=Homo sapiens OX=9606 GN=WIPF2 PE=1 SV=1,metabolic process,cytosol;endoplasmic reticulum,motor activity,147179,WIPF2,NA,CDC42 GTPase cycle; RAC1 GTPase cycle; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; RHOJ GTPase cycle,ENSG00000171475
P56385,0,6,20381320.958333332,7.889499300941014e-5,1.3536850889510188,0.4368921602944148,0.15154854388578923,0.6638855679885327,raw,16531764.75,18507969.4375,17508315.5,23700745.625,18557711.75,27481418.6875,"ATP synthase subunit e, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5ME PE=1 SV=2",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,521,ATP5ME,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000169020
Q9UBB6,0,6,896059.4583333334,3.468597783517029e-6,1.3534907057068617,0.4366849807359888,0.10106129592856877,0.6429522395902524,raw,715441.03125,929195.421875,625931.8125,1156018.65625,847192.890625,1102576.9375,Neurochondrin OS=Homo sapiens OX=9606 GN=NCDN PE=1 SV=1,cell growth;defense response;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,NA,23154,NCDN,Splicing factor NOVA regulated synaptic proteins,NA,ENSG00000020129
F5H5P2,0,6,3406017.6604817715,1.3184510467353488e-5,1.353275834731656,0.43645593010574046,0.13847938285474215,0.65680569707651415,raw,3418601.02539063,2509752,2787516.9375,4626310.15625,3109546.21875,3984379.625,2-oxoisovalerate dehydrogenase subunit alpha OS=Homo sapiens OX=9606 PE=3 SV=1,cellular homeostasis,endosome,structural molecule activity,NA,NA,NA,NA,NA
Q8TDN6,0,6,35703696.5234375,1.3820708154222835e-4,1.3532343787948695,0.43641173424486907,0.09434428151399225,0.6429522395902524,raw,31461448.59375,32095674.171875,29008314.09375,42574713.84375,33936213.875,45145814.5625,Ribosome biogenesis protein BRX1 homolog OS=Homo sapiens OX=9606 GN=BRIX1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,55299,BRIX1,Gastric cancer network 2,NA,ENSG00000113460
O95825,0,6,2301334.1875,8.90834038707844e-6,1.353162306209252,0.43633489498294176,0.16701163828129867,0.6670444762382309,raw,2201795,1908681.1875,1819167.875,2905363.625,1993611.4375,2979386,Quinone oxidoreductase-like protein 1 OS=Homo sapiens OX=9606 GN=CRYZL1 PE=1 SV=2,cellular homeostasis,NA,structural molecule activity,9946,CRYZL1,NA,NA,ENSG00000205758
Q06587,0,6,1446288.4166666667,5.5985043734789585e-6,1.3529136971617248,0.436069812228023,0.195841343565949,0.6857975396967068,raw,1349946.1875,952440.25,1371340.375,1826360.6875,1972989.625,1204653.375,E3 ubiquitin-protein ligase RING1 OS=Homo sapiens OX=9606 GN=RING1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,6015,RING1,Malignant pleural mesothelioma; Notch signaling pathway,Oxidative Stress Induced Senescence; SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6,ENSG00000204227; ENSG00000206287; ENSG00000226788; ENSG00000228520; ENSG00000231115; ENSG00000235107
Q15650,0,6,952262.6484375,3.6861572979096316e-6,1.3528560570938617,0.4360083457710605,0.2058717406485442,0.6982813126324419,raw,628069.84375,820193.25,927349.9375,806887.875,1421471.578125,1109603.40625,Activating signal cointegrator 1 OS=Homo sapiens OX=9606 GN=TRIP4 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,9325,TRIP4,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000103671
Q8WUK0,0,6,1565198.5078125,6.058798916157413e-6,1.3523521834717152,0.43547091137069793,0.2718655564689223,0.7524601054912853,raw,1918419.65625,656031.046875,1246023.125,1685062.09375,1506329.90625,2379325.21875,Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 OS=Homo sapiens OX=9606 GN=PTPMT1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome,structural molecule activity,114971,PTPMT1,NA,Synthesis of PG,ENSG00000110536; ENSG00000285206
Q02252,0,6,8482407.84375,3.283494278431435e-5,1.3523018784460965,0.4354172447580083,0.08974688186064128,0.6429522395902524,raw,8334333.84375,6651654,6742342.03125,9707394.3125,8188187.5625,11270535.3125,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial OS=Homo sapiens OX=9606 GN=ALDH6A1 PE=1 SV=2",cellular homeostasis;metabolic process,endosome;membrane,structural molecule activity,4329,ALDH6A1,NA,Branched-chain amino acid catabolism,ENSG00000119711
A0A0U1RRM4,0,6,306391523.983073,0.0011860250467673205,1.3522467298861587,0.4353584086522712,0.19465384747234105,0.6851169040350013,raw,309256855.75,250284790.3125,223126072.65625,418191571.882813,257352365.671875,380137487.625,Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,NA,PTBP1,mir-124 predicted interactions with cell cycle and differentiation,NA,ENSG00000011304
Q9Y2C4,0,6,5824001.223958333,2.2544394290749776e-5,1.3521532785764947,0.4352587031792283,0.03196758335980421,0.6429522395902524,raw,4398680.59375,5578644.90625,4375707.96875,7135558.5,5912232.375,7543183,"Nuclease EXOG, mitochondrial OS=Homo sapiens OX=9606 GN=EXOG PE=1 SV=2",cell growth;cell proliferation;cellular component movement;cellular homeostasis,cytoskeleton;endosome;membrane;nucleus,RNA binding;structural molecule activity,9941,EXOG,NA,NA,ENSG00000157036
P84103,0,6,109290616.68229167,4.2305807640098225e-4,1.351981094276417,0.4350749775192385,0.00823457353515311,0.6429522395902524,raw,93208946.34375,96869004.125,87905574.875,123828668.5,118846675.3125,135084830.9375,Serine/arginine-rich splicing factor 3 OS=Homo sapiens OX=9606 GN=SRSF3 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6428,SRSF3,mRNA processing,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,ENSG00000112081
P35914,0,6,19455438.37109375,7.531095150409571e-5,1.3518944059924307,0.43498246974109517,0.09553046666070873,0.6429522395902524,raw,17433242.0859375,16060661.03125,15759315.09375,21712317.8046875,19280051.5234375,26487042.6875,"Hydroxymethylglutaryl-CoA lyase, mitochondrial OS=Homo sapiens OX=9606 GN=HMGCL PE=1 SV=2",cell growth;cellular homeostasis,cytosol;endosome;mitochondrion;nucleus,structural molecule activity,3155,HMGCL,Amino acid metabolism,Peroxisomal protein import; Synthesis of Ketone Bodies,ENSG00000117305
P14550,0,6,83375372.796875,3.2274156652623167e-4,1.3518481414873373,0.43493309701355043,0.15693838811632677,0.6638855679885327,raw,79321409.375,69273115.875,71459555.96875,107230499.84375,75481546.5,97486109.21875,Aldo-keto reductase family 1 member A1 OS=Homo sapiens OX=9606 GN=AKR1A1 PE=1 SV=3,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,10327,AKR1A1,Benzo(a)pyrene metabolism; Metapathway biotransformation Phase I and II,Glutathione conjugation; Formation of xylulose-5-phosphate,ENSG00000117448
P48739,0,6,50847470.3125,1.9682781224298642e-4,1.3516002392434128,0.4346685109822529,0.25033379344495443,0.7326612824296702,raw,44484449.5625,42206179.875,42946219,75226608.25,42175245.3125,58046119.875,Phosphatidylinositol transfer protein beta isoform OS=Homo sapiens OX=9606 GN=PITPNB PE=1 SV=2,cell growth;cellular homeostasis;conjugation,cytoskeleton;extracellular;nucleus,catalytic activity;structural molecule activity,23760,PITPNB,NA,PI and PC transport between ER and Golgi membranes,ENSG00000180957
Q9BTC8,0,6,1603614.2747395833,6.2075042758031116e-06,1.3512458943856995,0.43429023449395737,0.41990648025226185,0.9064994547673523,raw,1309615.796875,1989540.03125,1040681.7109375,1769612.96875,1412223.640625,2100011.5,Metastasis-associated protein MTA3 OS=Homo sapiens OX=9606 GN=MTA3 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,57504,MTA3,Pre-implantation embryo; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,ENSG00000057935
Q15528,0,6,769523.625,2.978784404556847e-6,1.3512181369490905,0.4342605981948757,0.15530123846434846,0.6638855679885327,raw,634472.1875,787442.25,546304.625,881670.25,703246.1875,1064006.25,Mediator of RNA polymerase II transcription subunit 22 OS=Homo sapiens OX=9606 GN=MED22 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,6837,MED22,NA,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation,ENSG00000148297; ENSG00000281022
E7EQZ4,0,6,13415898.572916666,5.1932219029819425e-5,1.3510429037336171,0.4340734896309651,0.07823118752044352,0.6429522395902524,raw,13931493.4375,10589371.5625,9888035.125,16997780.875,13359159.6875,15729550.75,Survival motor neuron protein OS=Homo sapiens OX=9606 GN=SMN1 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane,RNA binding,6606; 6607,SMN1,NA,NA,ENSG00000172062; ENSG00000205571; ENSG00000273772; ENSG00000275349; ENSG00000277773
Q9UMS4,0,6,78974536.09375,3.0570616525668636e-4,1.3508551192033893,0.43387295222455546,0.0654492409717197,0.6429522395902524,raw,67746569.25,73604982.9375,62923551.4375,93239197.8125,76903247.125,99429668,Pre-mRNA-processing factor 19 OS=Homo sapiens OX=9606 GN=PRPF19 PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,27339,PRPF19,NA,Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; mRNA Splicing - Major Pathway; Formation of TC-NER Pre-Incision Complex,ENSG00000110107
Q9HCU5,0,6,6091007.869791667,2.3577962600652374e-5,1.3507842574074116,0.4337972707975271,0.18876273820101794,0.6797963848944265,raw,5453582.84375,4727490.625,4971651.71875,6715628.875,5512006.71875,9165686.4375,Prolactin regulatory element-binding protein OS=Homo sapiens OX=9606 GN=PREB PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;extracellular;membrane,DNA binding;RNA binding;structural molecule activity,10113,PREB,NA,COPII-mediated vesicle transport; XBP1(S) activates chaperone genes; Cargo concentration in the ER,ENSG00000138073
Q86YN1,0.16666666666666666,6,644048.7109375,2.4930777868133236e-6,1.3499429933013503,0.4328984850405955,1,1,raw,484729.21875,NA,NA,654356.8125,543616.75,893492.0625,Dolichyldiphosphatase 1 OS=Homo sapiens OX=9606 GN=DOLPP1 PE=2 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular;nucleus,structural molecule activity,57171,DOLPP1,NA,Synthesis of Dolichyl-phosphate,ENSG00000167130
Q92685,0,6,717156.475,2.7760739942934985e-6,1.349813246184112,0.4327598165785945,0.38572347524022227,0.8705215576950358,raw,407003.0625,NA,619395.5,496766.5,601989.75,1460627.5625,"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG3 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,10195,ALG3,NA,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein; Defective ALG3 causes CDG-1d",ENSG00000214160
Q9BZI7,0,6,3760847.4153645835,1.4558037290675707e-5,1.3495376637290797,0.43246524098921696,0.08736371936914573,0.6429522395902524,raw,2873910.265625,3660835.6640625,3136500.984375,4940435.609375,3621107.71875,4332294.25,Regulator of nonsense transcripts 3B OS=Homo sapiens OX=9606 GN=UPF3B PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding,65109,UPF3B,NA,Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,ENSG00000125351
Q16864,0,6,7714990.65625,2.9864312285590058e-5,1.3494553869526653,0.43237728203925213,0.04591705344770833,0.6429522395902524,raw,7683618,6637594.875,5833373.375,9174612.75,7871877.125,9088867.8125,V-type proton ATPase subunit F OS=Homo sapiens OX=9606 GN=ATP6V1F PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,catalytic activity,9296,ATP6V1F,Proximal tubule transport,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000128524
Q9NPI1,0,6,289517.9921875,1.120708516215777e-6,1.3493693013609946,0.4322852454895828,1,1,raw,255693.28125,271382.4375,268581.125,362415.125,NA,NA,Bromodomain-containing protein 7 OS=Homo sapiens OX=9606 GN=BRD7 PE=1 SV=1,cell death;cell differentiation;cell growth;cellular component movement;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,29117,BRD7,NA,Regulation of TP53 Activity through Acetylation,ENSG00000166164
P30825,0,6,2214731.3854166665,8.573105616038424e-6,1.3490529797674264,0.4319470066604353,0.16118678222935598,0.6638855679885327,raw,2210146,1483165.25,1952021.3125,2564780.125,2000868.5,3077407.125,High affinity cationic amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A1 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity;structural molecule activity,6541,SLC7A1,VEGFA-VEGFR2 signaling pathway,Amino acid transport across the plasma membrane,ENSG00000139514
P24928,0,6,16074642.35546875,6.222407266222562e-5,1.3486637660619625,0.4315307163382708,0.11702276873791677,0.6429522395902524,raw,13271047.3125,15531809.0859375,13305979.046875,17945291.8125,15337846.953125,21055879.921875,DNA-directed RNA polymerase II subunit RPB1 OS=Homo sapiens OX=9606 GN=POLR2A PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,5430,POLR2A,Pyrimidine metabolism; Eukaryotic transcription initiation; mRNA processing,Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Estrogen-dependent gene expression; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Activation of anterior HOX genes in hindbrain development during early embryogenesis; mRNA Splicing - Major Pathway; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,NA
Q9Y2U8,0,6,45762055.092447914,1.7714244449591147e-4,1.3485461141359507,0.4314048560175282,0.33273929341272335,0.8158667519449163,raw,28876747.828125,56095392.09375,35500297.875,47873788.75,43571265.4765625,62654838.53125,Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,cell growth;metabolic process,cytoskeleton;membrane,RNA binding,23592,LEMD3,Envelope proteins and their potential roles in EDMD physiopathology,RND2 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; Initiation of Nuclear Envelope (NE) Reformation; Depolymerisation of the Nuclear Lamina,ENSG00000174106
E9PF82,0,6,21624432.276041668,8.370700980267974e-5,1.3484034997941248,0.43125227696833796,0.19061714352711268,0.6819492634806186,raw,20959475.5,19024194.03125,16490837.9375,25652289.8125,18787266.9375,28832529.4375,Calcium/calmodulin-dependent protein kinase OS=Homo sapiens OX=9606 GN=CAMK2D PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,nucleus,signal transducer activity;structural molecule activity,817,CAMK2D,"Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; SRF and miRs in smooth muscle differentiation and proliferation; Cardiac hypertrophic response; Myometrial relaxation and contraction pathways; NO/cGMP/PKG mediated neuroprotection; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; Disruption of postsynaptic signaling by CNV; Neuroinflammation and glutamatergic signaling; Calcium regulation in cardiac cells; ErbB signaling pathway",NA,ENSG00000145349
P04066,0,6,8614534.432291666,3.3346397674832126e-5,1.348364439847539,0.4312104850214579,0.21943360327533895,0.7087130179153194,raw,9164860.875,6604087.78125,6356201.6875,9637437.5,7567046.25,12357572.5,Tissue alpha-L-fucosidase OS=Homo sapiens OX=9606 GN=FUCA1 PE=1 SV=4,cellular homeostasis,cell surface;mitochondrion;nucleus,structural molecule activity,2517,FUCA1,p53 transcriptional gene network,Neutrophil degranulation; Reactions specific to the complex N-glycan synthesis pathway,ENSG00000179163
Q5SSJ5,0,6,75035560.58333333,2.9045860372748636e-4,1.3480841577795053,0.43091056344949513,0.07728757375207224,0.6429522395902524,raw,68218592.3125,62392200.84375,63447433,91964403.5625,72352648.65625,91838085.125,Heterochromatin protein 1-binding protein 3 OS=Homo sapiens OX=9606 GN=HP1BP3 PE=1 SV=1,cell growth;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,50809,HP1BP3,NA,NA,ENSG00000127483
O75521,0,6,9719868.231770834,3.762508513386642e-5,1.3479947983541292,0.43081492945509686,0.3123154365737807,0.7920821775382559,raw,9851593.375,5451570.671875,9537443.28125,13279896.625,7156073.1875,13042632.25,Enoyl-CoA delta isomerase 2 OS=Homo sapiens OX=9606 GN=ECI2 PE=1 SV=4,cellular homeostasis,cytosol;endosome;mitochondrion;nucleus,structural molecule activity,10455,ECI2,NA,NA,ENSG00000198721
P30046,0,6,52002238.458333336,2.012978573877178e-4,1.3467171292878701,0.42944685226286744,0.12278200563509437,0.6445597830897484,raw,51432854.75,42664845.78125,38316804.34375,63011680.875,47321738.5,69265506.5,D-dopachrome decarboxylase OS=Homo sapiens OX=9606 GN=DDT PE=1 SV=3,cellular homeostasis;metabolic process,cell surface;nucleus,antioxidant activity;structural molecule activity,1652,DDT,NA,NA,ENSG00000099977; ENSG00000275003
Q96A35,0,6,8700012.635416666,3.3677279184023335e-5,1.3466630600453862,0.42938892844779253,0.24801170996986774,0.7316541032247736,raw,7177947.125,8204177.625,7268806.8125,9788633.625,7388652.875,12371857.75,"39S ribosomal protein L24, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL24 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,RNA binding;structural molecule activity,79590,MRPL24,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000143314
P20645,0,6,6474794.890625,2.50635814370197e-5,1.3465456926414978,0.42926318596942725,0.16042075132855704,0.6638855679885327,raw,5288545.75,7027848,5096506.78125,7121268.5,7204334.25,7110266.0625,Cation-dependent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=M6PR PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,4074,M6PR,NA,Lysosome Vesicle Biogenesis; Cargo recognition for clathrin-mediated endocytosis; Retrograde transport at the Trans-Golgi-Network,ENSG00000003056
E7EX90,0,6,36989646.861979164,1.4318492587219613e-4,1.3463938478545925,0.42910048961624814,0.18143716288634537,0.6743269455727479,raw,33136468.90625,35281549.171875,28918415.3125,44614737.875,32359730.5625,47626979.34375,Dynactin subunit 1 OS=Homo sapiens OX=9606 GN=DCTN1 PE=1 SV=1,conjugation,endoplasmic reticulum;nucleus,motor activity,NA,DCTN1,NA,NA,ENSG00000204843
P39687,0,6,166459524.171875,6.443558306518982e-4,1.3457097399019298,0.42836726435963307,0.06589448604319624,0.6429522395902524,raw,144218192.03125,152251604.3125,129090628.1875,194075825.6875,163382008.375,215738886.4375,Acidic leucine-rich nuclear phosphoprotein 32 family member A OS=Homo sapiens OX=9606 GN=ANP32A PE=1 SV=1,conjugation;development;metabolic process,extracellular;membrane;nucleus,structural molecule activity,8125,ANP32A,IL-18 signaling pathway,HuR (ELAVL1) binds and stabilizes mRNA,ENSG00000140350
Q99623,0,6,221657875.2578125,8.580256674578106e-4,1.3456827749720386,0.4283383557776122,0.18208261251822605,0.6743269455727479,raw,211675143.6875,179104847.5625,187667201,274998572.9375,191653891.609375,284847594.75,Prohibitin-2 OS=Homo sapiens OX=9606 GN=PHB2 PE=1 SV=2,cell differentiation;cell growth;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endosome;membrane;nucleus,structural molecule activity,11331,PHB2,NA,Processing of SMDT1,ENSG00000215021
K7ER90,0,6,727144.2239583334,2.8147360312565776e-6,1.3456116444713542,0.42826209535818294,0.2147111726890101,0.7040869719539218,raw,625756.1875,628948.125,501293.21875,842024.8125,605019.25,1159823.75,Eukaryotic translation initiation factor 3 subunit G (Fragment) OS=Homo sapiens OX=9606 GN=EIF3G PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,RNA binding,NA,EIF3G,NA,NA,ENSG00000130811
C9JA08,0,6,26160701.75,1.0126666401588778e-4,1.345378692095091,0.42801231427627345,0.24130109091290866,0.727008366442287,raw,25065378.71875,24027822.75,19688929.875,33722426.4375,21441682.5625,33017970.15625,60S ribosomal export protein NMD3 OS=Homo sapiens OX=9606 GN=NMD3 PE=1 SV=1,conjugation,membrane;nucleus,protein binding,51068,NMD3,NA,NA,ENSG00000169251
Q6DKJ4,0,6,23455400.635416668,9.079458946489386e-5,1.345193198587108,0.42781338960495363,0.10556985382305066,0.6429522395902524,raw,22119134.25,21133662.34375,16168954.78125,28368412.4375,21750368,31191872,Nucleoredoxin OS=Homo sapiens OX=9606 GN=NXN PE=1 SV=2,cell death;defense response;development;metabolic process,cytosol;membrane,structural molecule activity,64359,NXN,NA,NA,ENSG00000167693
Q9Y284,0.8333333333333334,6,985406.8333333334,3.8144566481335537e-6,1.3451780906491857,0.42779718652755244,0.3138995490140443,0.7940341765127582,raw,954718.8125,890643.6875,575807.375,1198074.375,687462,1605734.75,Protein Asterix OS=Homo sapiens OX=9606 GN=WDR83OS PE=1 SV=1,cell growth;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,51398,WDR83OS,NA,NA,ENSG00000105583
P10606,0,6,42548497.822916664,1.647029378106814e-4,1.3449916079174191,0.4275971711062908,0.08811603078255148,0.6429522395902524,raw,34153154.59375,32828846,39507531.6875,45935706.3125,43484331.21875,59381417.125,"Cytochrome c oxidase subunit 5B, mitochondrial OS=Homo sapiens OX=9606 GN=COX5B PE=1 SV=2",cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,1329,COX5B,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000135940
Q6AI08,0,6,1832168.6927083333,7.092226087739528e-6,1.3447498915060467,0.42733787253131483,0.2964080283902785,0.7788269335661613,raw,1283517.671875,2167007.421875,1288425.578125,2683766.765625,1844284.46875,1726010.25,HEAT repeat-containing protein 6 OS=Homo sapiens OX=9606 GN=HEATR6 PE=1 SV=1,NA,NA,NA,63897,HEATR6,NA,NA,ENSG00000068097
Q8NEL9,0,6,640946.4479166666,2.4810690941558475e-6,1.3445182497747692,0.4270893377179404,0.12184593087304313,0.6445597830897484,raw,591861.125,641703.125,375591.0625,743853.9375,629887.875,862781.5625,Phospholipase DDHD1 OS=Homo sapiens OX=9606 GN=DDHD1 PE=1 SV=2,cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,80821,DDHD1,NA,Synthesis of PA,ENSG00000100523
Q15172,0,6,2204909.125,8.535084176285146e-6,1.3444242509810929,0.42698847160161135,0.24004403882089773,0.7263138257852598,raw,2116214.1875,1525005.3125,2212067.5,2050254.125,2301268.4375,3024645.1875,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform OS=Homo sapiens OX=9606 GN=PPP2R5A PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,5525,PPP2R5A,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome,"Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling",ENSG00000066027
O75083,0,6,144731203.16666666,5.602466731877338e-4,1.3442885297107108,0.42684282242309307,0.16401086995871705,0.6638855679885327,raw,133591810.71875,128334244.625,120829359.65625,179585938.8125,129395963.8125,176649901.375,WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=WDR1 PE=1 SV=4,cell growth;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity,9948,WDR1,Hypertrophy model,Platelet degranulation,ENSG00000071127
O76021,0,6,117988431.03873691,4.567268461657958e-4,1.3441529703827055,0.4266973323535354,0.16318944998013352,0.6638855679885327,raw,105068818.333984,104632630.296875,90637342.5078125,140642260.8125,104270870.96875,162678663.3125,Ribosomal L1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RSL1D1 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding,26156,RSL1D1,NA,NA,ENSG00000171490
Q8IYI6,0,6,1673438.4192708333,6.477789769365717e-6,1.3438900747669593,0.42641513582918866,0.14221620598713713,0.6572502130392559,raw,1434473.875,1395570.8125,1569102.90625,1927775.203125,1544101.59375,2169606.125,Exocyst complex component 8 OS=Homo sapiens OX=9606 GN=EXOC8 PE=1 SV=2,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,149371,EXOC8,RalA downstream regulated genes; Ciliary landscape,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing; VxPx cargo-targeting to cilium,ENSG00000116903
Q96P47,0,6,1027457.1119791666,3.9772310064094e-6,1.3437948649241103,0.426312922384338,0.05284877122819528,0.6429522395902524,raw,759909.046875,1018079.90625,830499.625,1021161.875,1223049,1312043.21875,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=AGAP3 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,DNA binding;structural molecule activity,116988,AGAP3,NA,NA,ENSG00000133612
P18754,0,6,88524119.015625,3.4267208514992376e-4,1.3437924385778157,0.4263103174622489,0.274715285763744,0.7551026273759062,raw,87810062.71875,72578955.9375,72968280.6875,117998498.3125,70650630.375,109138286.0625,Regulator of chromosome condensation OS=Homo sapiens OX=9606 GN=RCC1 PE=1 SV=1,cell differentiation;cell growth;metabolic process,cytoskeleton;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,1104,RCC1,22q11.2 copy number variation syndrome,Rev-mediated nuclear export of HIV RNA; Nuclear import of Rev protein; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000180198
J3KPP4,0,6,21819988.60091147,8.446399777785025e-5,1.343778589958413,0.42629544951321713,0.3221703886629825,0.8037171471065563,raw,19595144.4609375,21486185.15625,16140098.5625,26331535.59375,16561370.1289063,30805597.703125,"Cisplatin resistance-associated overexpressed protein, isoform CRA_b OS=Homo sapiens OX=9606 GN=LUC7L3 PE=1 SV=1",cell growth;cellular component movement;cellular homeostasis,membrane,RNA binding,51747,LUC7L3,NA,NA,ENSG00000108848
Q9BQ69,0,6,17461884.838541668,6.759401341474809e-5,1.3434168605115815,0.4259070406372285,0.28560581206287694,0.7655844406429082,raw,18097747.125,10957448.34375,17012030.6875,18976908,15414356.25,24312818.625,ADP-ribose glycohydrolase MACROD1 OS=Homo sapiens OX=9606 GN=MACROD1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation,membrane,structural molecule activity,28992,MACROD1,NA,NA,ENSG00000133315
Q9BZ23,0,6,2707904.7083333335,1.0482152921827959e-5,1.34290045697382,0.42535236838957285,0.118502291952736,0.6429522395902524,raw,2275239.75,2407878,2229020.5,3055420.5,2601713,3678156.5,"Pantothenate kinase 2, mitochondrial OS=Homo sapiens OX=9606 GN=PANK2 PE=1 SV=3",cell growth;cellular homeostasis;defense response;metabolic process,cytosol;endosome;membrane,signal transducer activity;structural molecule activity,80025,PANK2,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway,Coenzyme A biosynthesis,ENSG00000125779
Q2M2I8,0,6,1186496.2135416667,4.592862781780959e-6,1.3428004614402202,0.42524493791619955,0.06967414369054475,0.6429522395902524,raw,1008432.359375,1068321.15625,914397.453125,1354123.4375,1183988.15625,1589714.71875,AP2-associated protein kinase 1 OS=Homo sapiens OX=9606 GN=AAK1 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,22848,AAK1,NA,Cargo recognition for clathrin-mediated endocytosis,ENSG00000115977
Q6P2E9,0,6,36890867.3671875,1.428025557811214e-4,1.3426619937125628,0.42509616152663704,0.12853369463289818,0.6498046150645307,raw,32066234.40625,34327318.28125,31179332.765625,43054114.21875,34315259.59375,46402944.9375,Enhancer of mRNA-decapping protein 4 OS=Homo sapiens OX=9606 GN=EDC4 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,NA,23644,EDC4,NA,mRNA decay by 5' to 3' exoribonuclease,ENSG00000038358
Q9H0W9,0,6,11086585.328125,4.291557322259925e-5,1.3426446056759092,0.4250774778990341,0.021626832369172736,0.6429522395902524,raw,10385741.625,8532647.5,8808877.40625,13944359.96875,11412236.375,13435649.09375,Ester hydrolase C11orf54 OS=Homo sapiens OX=9606 GN=C11orf54 PE=1 SV=1,NA,membrane,structural molecule activity,28970,C11orf54,NA,NA,ENSG00000182919
F8VQZ7,0,6,26217289.856770832,1.0148571352191478e-4,1.342616622642002,0.4250474093278109,0.13307054605669438,0.6514609890946903,raw,21620558.125,28123947.84375,18753561.78125,32298786.78125,25178843.78125,31328040.828125,Methionine aminopeptidase 2 OS=Homo sapiens OX=9606 GN=METAP2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol,structural molecule activity,10988,METAP2,NA,NA,ENSG00000111142
Q96HE7,0,6,56089778,2.1712050226067555e-4,1.3424121869550452,0.4248277183127505,0.38551549260042567,0.8705215576950358,raw,55274965.375,49343252.5,45382859.375,78922789.25,41375818,66238983.5,ERO1-like protein alpha OS=Homo sapiens OX=9606 GN=ERO1A PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cell surface;cytoskeleton;extracellular;nucleus,structural molecule activity,30001,ERO1A,NA,Detoxification of Reactive Oxygen Species; Insulin processing,ENSG00000197930
A0A5F9ZA98,0,6,823012.01875,3.1858350888386925e-6,1.3419267735185152,0.4243059484650466,0.46219083485707285,0.944583057253577,raw,NA,564033.8125,831336.03125,1108480.25,488506.09375,1122703.90625,"ATP-binding cassette sub-family B member 7, mitochondrial OS=Homo sapiens OX=9606 GN=ABCB7 PE=1 SV=1",conjugation,cytoskeleton,catalytic activity;structural molecule activity,NA,ABCB7,NA,NA,ENSG00000131269
Q15366,0.3333333333333333,6,115307322.78417973,4.4634842086975176e-4,1.341913923586192,0.42429213353656864,0.14939199514124116,0.6638855679885327,raw,99971878.84375,112335310.800781,83700462.8652344,134153656.1875,104407479.570313,157275148.4375,Poly(rC)-binding protein 2 OS=Homo sapiens OX=9606 GN=PCBP2 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5094,PCBP2,mRNA processing; Ferroptosis; Modulators of TCR signaling and T cell activation,Negative regulators of DDX58/IFIH1 signaling; mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA; SARS-CoV-1 activates/modulates innate immune responses,ENSG00000197111
Q9BZE1,0,6,12717579.03125,4.9229061787422935e-5,1.3416898229076901,0.42405118221228416,0.10317647229616138,0.6429522395902524,raw,10939232.71875,12279371.96875,9143165.9375,14333492.25,12267292.6875,17342918.625,"39S ribosomal protein L37, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL37 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,51253,MRPL37,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000116221
P19338,0,6,901225275.7880867,0.0034885943839735862,1.341623295457086,0.42397964466235577,0.1343339410598085,0.6527000726250668,raw,780260249.070313,839471233.951172,768323836.765625,1046815326.67188,836418254.6875,1136062753.58203,Nucleolin OS=Homo sapiens OX=9606 GN=NCL PE=1 SV=3,defense response;metabolic process,cytoplasm;membrane;nucleus,RNA binding;structural molecule activity,4691,NCL,Pathogenic Escherichia coli infection; VEGFA-VEGFR2 signaling pathway,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000115053
P55786,0,6,225552409.50520834,8.731011992573122e-4,1.3416221695840775,0.423978433970731,0.15790876677097324,0.6638855679885327,raw,193959606.09375,210127522.40625,188147283.28125,281911742.5,201405255.25,277763047.5,Puromycin-sensitive aminopeptidase OS=Homo sapiens OX=9606 GN=NPEPPS PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation,cytosol;membrane;nucleus,structural molecule activity,9520,NPEPPS,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000141279
A6NGQ3,0.5,6,1531679.4947916667,5.92904862649919e-6,1.341596685064171,0.4239510292807065,0.2200358941754227,0.7087130179153194,raw,824328.6875,1771567.15625,1246291.09375,1672020,1502738.15625,2173131.875,Obscurin OS=Homo sapiens OX=9606 GN=OBSCN PE=1 SV=5,cell communication;cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane,DNA binding;signal transducer activity;structural molecule activity,84033,OBSCN,NA,NA,ENSG00000154358
P33121,0,6,419162.275,1.6225545352796264e-6,1.341509134531135,0.42385687815259177,0.5310849345196683,1,raw,463218.03125,NA,267542.03125,377202.6875,398108.9375,589739.6875,Long-chain-fatty-acid--CoA ligase 1 OS=Homo sapiens OX=9606 GN=ACSL1 PE=1 SV=1,cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;endosome;extracellular;mitochondrion,structural molecule activity,2180,ACSL1,Fatty acid beta-oxidation; Fatty acid biosynthesis; Mitochondrial long chain fatty acid beta-oxidation; PPAR signaling pathway; Ferroptosis; Thermogenesis; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-3 / omega-6 fatty acid synthesis; Omega-9 fatty acid synthesis; Fatty acid transporters,PPARA activates gene expression; Synthesis of very long-chain fatty acyl-CoAs; alpha-linolenic acid (ALA) metabolism; Linoleic acid (LA) metabolism,ENSG00000151726
C9J2R5,0.8333333333333334,6,1088044.4583333333,4.2117613529381056e-6,1.3412725557870298,0.42360243256500124,0.09882588771659254,0.6429522395902524,raw,991508.6875,902525.5625,808045.125,1199102.25,1083808.75,1543276.375,Lipoma-preferred partner (Fragment) OS=Homo sapiens OX=9606 GN=LPP PE=1 SV=8,NA,NA,NA,NA,LPP,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement,NA,ENSG00000145012
Q9NRN7,0,6,4983619.708333333,1.9291322817315033e-5,1.3409890392693047,0.4232974452539878,0.37816298257171693,0.8617583924772685,raw,3538903.625,5606406.5625,3846230.625,7518129.75,3686628.4375,5705419.25,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase OS=Homo sapiens OX=9606 GN=AASDHPPT PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol,structural molecule activity,60496,AASDHPPT,NA,Vitamin B5 (pantothenate) metabolism,ENSG00000149313
Q96S97,0,6,3883570.109375,1.5033090213194403e-5,1.3407328453962033,0.4230217942750646,0.12120339310385832,0.6445597830897484,raw,3111521.96875,3789768.46875,3072504.59375,4703203.375,3543355.1875,5081067.0625,Myeloid-associated differentiation marker OS=Homo sapiens OX=9606 GN=MYADM PE=1 SV=2,cell growth;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,NA,91663,MYADM,NA,NA,ENSG00000179820
P49815,0,6,385818.3625,1.4934820502835899e-6,1.3406743664826033,0.422958866691155,0.4768806907076354,0.9582435981037789,raw,NA,352623,279191.21875,417807.5625,210044.71875,669425.3125,Tuberin OS=Homo sapiens OX=9606 GN=TSC2 PE=1 SV=2,conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,DNA binding;structural molecule activity,7249,TSC2,AMP-activated protein kinase signaling; Target of rapamycin signaling; Follicle stimulating hormone (FSH) signaling pathway; Glioblastoma signaling pathways; Brain-derived neurotrophic factor (BDNF) signaling pathway; Nanoparticle triggered autophagic cell death; Wnt signaling pathway; BDNF-TrkB signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; ATM signaling in development and disease ; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; PI3K/AKT/mTOR - vitamin D3 signaling; PI3K-Akt signaling pathway; Thermogenesis; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Insulin signaling; p53 transcriptional gene network; Malignant pleural mesothelioma; DYRK1A; Monoamine transport,Constitutive Signaling by AKT1 E17K in Cancer; TP53 Regulates Metabolic Genes; AKT phosphorylates targets in the cytosol; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; TBC/RABGAPs; Inhibition of TSC complex formation by PKB,ENSG00000103197
P52926,0,6,8436666.236979166,3.265787949416737e-5,1.3405921805223655,0.4228704239531994,0.2588277318780084,0.7382628436284326,raw,9458429.125,6185251.046875,5871878,8700307.375,7724235.75,12679896.125,High mobility group protein HMGI-C OS=Homo sapiens OX=9606 GN=HMGA2 PE=1 SV=1,cell death;cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8091,HMGA2,Mesodermal commitment pathway; Mesodermal commitment pathway; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies,Formation of Senescence-Associated Heterochromatin Foci (SAHF),ENSG00000149948
O15479,0,6,80043020.62239583,3.098422111778762e-4,1.340486827928086,0.42275704298612526,0.163300691104802,0.6638855679885327,raw,76772037.34375,66471231,66587162.296875,102911904.8125,71075258.71875,96440529.5625,Melanoma-associated antigen B2 OS=Homo sapiens OX=9606 GN=MAGEB2 PE=1 SV=3,metabolic process,membrane,NA,4113,MAGEB2,NA,NA,ENSG00000099399
P62316,0,6,87985106.73958333,3.4058559773150613e-4,1.3404712350010923,0.4227402610462972,0.03751006150189198,0.6429522395902524,raw,77766408.4375,76912694.125,67521395.75,101059606.75,90510488.75,114140046.625,Small nuclear ribonucleoprotein Sm D2 OS=Homo sapiens OX=9606 GN=SNRPD2 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,NA,6633,SNRPD2,mRNA processing,mRNA Splicing - Major Pathway; snRNP Assembly; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Minor Pathway,ENSG00000125743
P20042,0,6,135024463.33919266,5.226724073980767e-4,1.340223245110319,0.42247333485289157,0.014511276079525048,0.6429522395902524,raw,108884687.4375,125684650.875,111881326.191406,151054491.53125,144196133.34375,168445490.65625,Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;defense response,cytosol;nucleus,RNA binding;structural molecule activity,8894,EIF2S2,Translation factors; Brain-derived neurotrophic factor (BDNF) signaling pathway; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"ABC-family proteins mediated transport; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Response of EIF2AK1 (HRI) to heme deficiency; PERK regulates gene expression; Recycling of eIF2:GDP; Response of EIF2AK4 (GCN2) to amino acid deficiency",ENSG00000125977
Q8N5M4,0,6,1572158.5208333333,6.085740750778762e-6,1.3400142552902379,0.42224834838986847,0.2735905001288605,0.7548615480677008,raw,1905775.4375,885028,1263039.875,1682559.625,1692491.4375,2004056.75,Tetratricopeptide repeat protein 9C OS=Homo sapiens OX=9606 GN=TTC9C PE=1 SV=1,NA,NA,NA,283237,TTC9C,NA,NA,ENSG00000162222
P53396,0,6,270514170.8372397,0.0010471457498157984,1.3399784102665804,0.42220975616643525,0.10307013939960509,0.6429522395902524,raw,258206696.75,230283278.085938,211265284.9375,325184328.3125,252154037.90625,345991399.03125,ATP-citrate synthase OS=Homo sapiens OX=9606 GN=ACLY PE=1 SV=3,cellular homeostasis,cell surface;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,47,ACLY,Sterol regulatory element-binding proteins (SREBP) signaling; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Fatty acid biosynthesis; Amino acid metabolism; Lipid metabolism pathway; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer,Neutrophil degranulation; ChREBP activates metabolic gene expression; Fatty acyl-CoA biosynthesis,ENSG00000131473
Q9H4A6,0,6,3020979.75390625,1.1694049519815483e-5,1.3398584654280827,0.4220806111237905,0.52180458575729,1,raw,2981929.5625,2566812.265625,2695400.4140625,3611455.0625,1943665.875,4326615.34375,Golgi phosphoprotein 3 OS=Homo sapiens OX=9606 GN=GOLPH3 PE=1 SV=1,cell communication;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,64083,GOLPH3,NA,NA,ENSG00000113384
O95639,0,6,3337184.1302083335,1.2918059588098015e-5,1.339815680909341,0.42203454207983204,0.21472111328068486,0.7040869719539218,raw,3364188.09375,3016128.25,2175113.8125,4764171.9375,2914251.59375,3789251.09375,Cleavage and polyadenylation specificity factor subunit 4 OS=Homo sapiens OX=9606 GN=CPSF4 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,10898,CPSF4,mRNA processing,Transport of Mature mRNA Derived from an Intronless Transcript; tRNA processing in the nucleus; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs; Inhibition of Host mRNA Processing and RNA Silencing,ENSG00000160917
P78536,0,6,2011681.953125,7.7871122266028e-6,1.339350052529978,0.42153307272152907,0.06456522494440041,0.6429522395902524,raw,1908809.59375,1189529.90625,1788651.28125,2277150.875,2395630.1875,2510319.875,Disintegrin and metalloproteinase domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ADAM17 PE=1 SV=1,cell communication;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,antioxidant activity;structural molecule activity,6868,ADAM17,Alzheimer's disease and miRNA effects; Brain-derived neurotrophic factor (BDNF) signaling pathway; Notch signaling; Copper homeostasis; Ebola virus infection in host; Soluble ACE2-mediated cell entry of SARS-CoV-2; Interactions of natural killer cells in pancreatic cancer; Alzheimer's disease; Notch signaling pathway,Collagen degradation; Release of Hh-Np from the secreting cell; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant; Growth hormone receptor signaling; Nuclear signaling by ERBB4; Signaling by EGFR; TNF signaling; CD163 mediating an anti-inflammatory response; Regulated proteolysis of p75NTR,ENSG00000151694
Q96BJ8,0,6,5060685.1875,1.9589639126280032e-5,1.3392935032512023,0.42147215878328487,0.28254019411851744,0.7642736213388397,raw,5689496.28125,3052223.046875,3972445.890625,7619905.40625,3976922.875,6053117.625,Engulfment and cell motility protein 3 OS=Homo sapiens OX=9606 GN=ELMO3 PE=1 SV=3,cell growth;conjugation;metabolic process,nucleus,structural molecule activity,79767,ELMO3,NA,NA,ENSG00000102890
P03915,0,6,3795930.953125,1.469384377112965e-5,1.3389855945456042,0.42114043953495445,0.44255230636739046,0.9249261346766603,raw,4325245.375,2103303.75,3584204.28125,2870211,4101180.0625,5791441.25,NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens OX=9606 GN=MT-ND5 PE=1 SV=2,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endosome;nucleus,catalytic activity;structural molecule activity,4540,MT-ND5,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,Complex I biogenesis,ENSG00000198786
Q86XZ4,0,6,5653755.526041667,2.18853823859534e-5,1.3384550477659107,0.4205686866408319,0.12286659253820374,0.6445597830897484,raw,4730831.125,4436362.8125,5484255.71875,7340429.75,5188527,6742126.75,Spermatogenesis-associated serine-rich protein 2 OS=Homo sapiens OX=9606 GN=SPATS2 PE=1 SV=1,NA,cytosol;nucleus,NA,65244,SPATS2,NA,NA,ENSG00000123352
Q12986,0.16666666666666666,6,89623.52604166667,3.469278303889775e-7,1.3384100909946766,0.42052022778500026,1,1,raw,NA,73125.84375,NA,97657.7265625,98087.0078125,NA,Transcriptional repressor NF-X1 OS=Homo sapiens OX=9606 GN=NFX1 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,4799,NFX1,Fas ligand pathway and stress induction of heat shock proteins,NA,ENSG00000086102
O43592,0,6,9875543.8515625,3.822769705290287e-5,1.3381287210146495,0.4202169024048384,0.218691207022024,0.7087130179153194,raw,8870086.46875,8863916.640625,8794864.5,11861061.4375,8587049,12276285.0625,Exportin-T OS=Homo sapiens OX=9606 GN=XPOT PE=1 SV=2,conjugation,cytosol;membrane;nucleus,RNA binding;structural molecule activity,11260,XPOT,NA,tRNA processing in the nucleus,ENSG00000184575
Q8NB90,0,6,27341671.768229168,1.0583813519398223e-4,1.3379251220143307,0.41999737672569565,0.4839310494723523,0.9660819337938442,raw,22268836.5625,33927465.71875,20397252.328125,30103071.625,27559368.5,29794035.875,ATPase family protein 2 homolog OS=Homo sapiens OX=9606 GN=SPATA5 PE=1 SV=3,defense response;metabolic process,endoplasmic reticulum;endosome;nucleus,structural molecule activity,166378,SPATA5,NA,NA,ENSG00000145375
Q969Y2,0,6,274387.2916666667,1.0621383914304875e-6,1.33761095638266,0.41965856970711585,0.3551163287547255,0.8393117920819392,raw,313474.8125,197189,168837.875,377116.46875,170398.25,419307.34375,"tRNA modification GTPase GTPBP3, mitochondrial OS=Homo sapiens OX=9606 GN=GTPBP3 PE=1 SV=2",cellular component movement;cellular homeostasis,endosome;membrane;nucleus,structural molecule activity,84705,GTPBP3,NA,tRNA modification in the mitochondrion,ENSG00000130299
A0A0U1RQQ9,0,6,9325794.328125,3.6099646329537255e-5,1.337483641251857,0.41952124603404595,0.13264401249556323,0.6514609890946903,raw,8084741.5,9724428.3125,6228043.21875,12207660.1875,8896683.25,10813209.5,SCY1-like protein 2 OS=Homo sapiens OX=9606 GN=SCYL2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,55681,SCYL2,NA,NA,ENSG00000136021
O00139,0,6,8162151.088541667,3.1595246176080184e-5,1.3372149724856557,0.41923141367988603,0.07278642665490706,0.6429522395902524,raw,6224186.75,7955509.375,6024264.28125,10405610.1875,7725109.6875,10638226.25,Kinesin-like protein KIF2A OS=Homo sapiens OX=9606 GN=KIF2A PE=1 SV=3,cell differentiation;cell growth;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,3796,KIF2A,NA,COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Kinesins; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000068796
P49961,0.8333333333333334,6,8175368.166666667,3.1646408771890755e-5,1.3368360050562753,0.41882249519682224,0.17324270102333775,0.6689341104244626,raw,7934363.5,5922146,7480484.5,8476950,7916938,11321327,Ectonucleoside triphosphate diphosphohydrolase 1 OS=Homo sapiens OX=9606 GN=ENTPD1 PE=1 SV=1,cell communication;cellular homeostasis;coagulation,cytoplasm;cytoskeleton,structural molecule activity,953,ENTPD1,Pyrimidine metabolism,Purinergic signaling in leishmaniasis infection; Phosphate bond hydrolysis by NTPDase proteins,ENSG00000138185
Q9UKS6,0,6,2412694.7552083335,9.339411132141244e-6,1.3367443879316598,0.4187236198671395,0.37320004364202425,0.8594431551104292,raw,1931291.78125,2627846.875,1642272.875,3168250.9375,1593746.5,3512759.5625,Protein kinase C and casein kinase substrate in neurons protein 3 OS=Homo sapiens OX=9606 GN=PACSIN3 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,motor activity;structural molecule activity,29763,PACSIN3,NA,Clathrin-mediated endocytosis,ENSG00000165912
Q15067,0,6,13554200.713541666,5.2467579149023793e-05,1.3366650407402731,0.4186379810582628,0.42706404344107723,0.911332120317874,raw,16856150.84375,7499827,11078056.6875,16040579.5,10024756.5625,19825833.6875,Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens OX=9606 GN=ACOX1 PE=1 SV=3,cell growth;cellular homeostasis;metabolic process,cytoskeleton;cytosol;mitochondrion,structural molecule activity,51,ACOX1,Estrogen receptor pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX); Omega-3 / omega-6 fatty acid synthesis,TYSND1 cleaves peroxisomal proteins,ENSG00000161533
P16435,0,6,42739448.109375,1.6544209605984854e-4,1.3364986103361756,0.41845833749707767,0.03891569158817512,0.6429522395902524,raw,37248734.4375,39191995,34439616.8125,49782881.8125,43021234.53125,52752226.0625,NADPH--cytochrome P450 reductase OS=Homo sapiens OX=9606 GN=POR PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;endosome;extracellular;nucleus,structural molecule activity,5447,POR,Oxidation by cytochrome P450; Ferroptosis,Cytochrome P450 - arranged by substrate type,ENSG00000127948
Q9BQG0,0,6,58893020.893229164,2.2797170414877335e-4,1.3362892193815028,0.41823229090320097,0.15764647496029838,0.6638855679885327,raw,57937689.59375,45976878.453125,47078327.296875,77421510,51352963.015625,73590757,Myb-binding protein 1A OS=Homo sapiens OX=9606 GN=MYBBP1A PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,10514,MYBBP1A,Energy metabolism,B-WICH complex positively regulates rRNA expression,ENSG00000132382
Q9Y5B9,0,6,179106851.82389316,6.933129531432996e-4,1.336265596669905,0.4182067869407224,0.06942613623294637,0.6429522395902524,raw,149614678.583984,166826237,143458869.609375,222924161.125,172502062.4375,219315102.1875,FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane,structural molecule activity,11198,SUPT16H,NA,Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Regulation of TP53 Activity through Phosphorylation,ENSG00000092201
Q9ULV4,0,6,54579451.106770836,2.1127410840196352e-4,1.3360185492671817,0.41794003831346216,0.15162835574253386,0.6638855679885327,raw,45561405.28125,54109172.625,40532533.171875,66739333.9375,48243403.3125,72290858.3125,Coronin-1C OS=Homo sapiens OX=9606 GN=CORO1C PE=1 SV=1,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,23603,CORO1C,NA,NA,ENSG00000110880
P10620,0,6,11453436.979166666,4.433563615687088e-5,1.3359793514703686,0.41789771008628473,0.06708702394340535,0.6429522395902524,raw,8536947.375,10567720.875,9902835.875,13229984.25,11287513.25,15195620.25,Microsomal glutathione S-transferase 1 OS=Homo sapiens OX=9606 GN=MGST1 PE=1 SV=1,coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;endosome;extracellular;mitochondrion,structural molecule activity,4257,MGST1,Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Oxidative stress response; Metapathway biotransformation Phase I and II,Aflatoxin activation and detoxification; Neutrophil degranulation; Glutathione conjugation,ENSG00000008394
A6NHR9,0,6,23915023.471354168,9.257376464703179e-5,1.3359786144123822,0.4178969141531784,0.22149150111387836,0.7102829728901873,raw,22235192.5,21431174.03125,19919375.171875,28631590.1875,20484715.4375,30788093.5,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SMCHD1 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,23347,SMCHD1,NA,NA,ENSG00000101596
P46940,0,6,361455503.5403647,0.00139917473864078,1.3359746919381046,0.4178926783499742,0.17702356716613912,0.6724728279208513,raw,344483608.28125,323233100.460938,288451150,431831241.8125,319449013.34375,461284907.34375,Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;motor activity;structural molecule activity,8826,IQGAP1,VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host; Ciliary landscape; EGF/EGFR signaling pathway; Regulation of actin cytoskeleton; G13 signaling pathway,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHO GTPases activate IQGAPs; RAC2 GTPase cycle; RHOV GTPase cycle; Neutrophil degranulation; Signaling by BRAF and RAF1 fusions; RHOU GTPase cycle; Nephrin family interactions; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants,ENSG00000140575
Q8IZY2,0.5,6,487061.971875,1.8853905958689127e-6,1.3357919255360482,0.4176952986981927,0.6811272681866073,1,raw,395937.75,367675.78125,476283.1875,934681.3125,260731.828125,NA,Phospholipid-transporting ATPase ABCA7 OS=Homo sapiens OX=9606 GN=ABCA7 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,catalytic activity;structural molecule activity,10347,ABCA7,NA,ABC transporters in lipid homeostasis,ENSG00000064687
Q9Y512,0,6,29451110.802083332,1.1400365980202561e-4,1.335516240821847,0.4173975202715418,0.14220703368436197,0.6572502130392559,raw,26177377.6875,24828831.25,23262771.3125,33159307.375,27645519.375,41632857.8125,Sorting and assembly machinery component 50 homolog OS=Homo sapiens OX=9606 GN=SAMM50 PE=1 SV=3,cell growth;conjugation,cytoskeleton;endosome,NA,25813,SAMM50,NA,RAC2 GTPase cycle; Mitochondrial protein import; Cristae formation,ENSG00000100347
A0A0C4DFW2,0,6,255390.28125,9.886019897867164e-7,1.3352989637061978,0.4171627869830643,0.20553075344833716,0.6977957004706539,raw,194753.96875,245460.625,NA,296435.8125,NA,284910.71875,Inhibitor of growth protein OS=Homo sapiens OX=9606 GN=ING1 PE=1 SV=1,cell growth;metabolic process,membrane,structural molecule activity,3621,ING1,NA,NA,ENSG00000153487
P14866,0,6,267420442.67708334,0.0010351700951431923,1.3351317390677713,0.41698210140553765,0.16472413129330601,0.6638855679885327,raw,228787383.0625,243832834.09375,227249817.1875,355207370.8125,243983954.28125,305461296.625,Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding,3191,HNRNPL,mRNA processing; Hippocampal synaptogenesis and neurogenesis,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000104824; ENSG00000282947
Q96GG9,0,6,9410568.083333334,3.642780095887733e-5,1.3350538040117292,0.4168978851463443,0.01050382778231976,0.6429522395902524,raw,7973569,7569558.625,8965395.75,10111374.25,10645143.625,11198367.25,DCN1-like protein 1 OS=Homo sapiens OX=9606 GN=DCUN1D1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,54165,DCUN1D1,NA,Neddylation,ENSG00000043093
Q6PK18,0,6,1406511.4166666667,5.444529754103163e-6,1.3345917047056974,0.41639844176954277,0.2528351712866278,0.7343565802499625,raw,964268.3125,1148502.09375,1138674.1875,2516580.5,1151378.28125,1519665.125,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 OS=Homo sapiens OX=9606 GN=OGFOD3 PE=1 SV=2,NA,cytoskeleton,structural molecule activity,79701,OGFOD3,NA,NA,ENSG00000181396
O75683,0,6,3639364.6302083335,1.4087783988386816e-5,1.3345644572750635,0.41636898696759905,0.4065080504442652,0.8914071190930648,raw,2921498.0625,3838578.65625,3024709,4036669.125,2775389.4375,5239343.5,Surfeit locus protein 6 OS=Homo sapiens OX=9606 GN=SURF6 PE=1 SV=3,metabolic process,membrane;nucleus,RNA binding,6838,SURF6,NA,NA,ENSG00000148296; ENSG00000281309
K7ERD8,0.5,6,396275.34375,1.533960460113104e-6,1.334427059130636,0.416220448749662,1,1,raw,347407.6875,NA,NA,463590.21875,307163.96875,466939.5,Microtubule-associated protein RP/EB family member 2 (Fragment) OS=Homo sapiens OX=9606 GN=MAPRE2 PE=1 SV=1,NA,NA,motor activity,NA,MAPRE2,Ciliary landscape,NA,ENSG00000166974
O15498,0,6,16948192.864583332,6.560553951861123e-5,1.3340277087633723,0.4157886326996681,0.27218684467948406,0.7524601054912853,raw,13810522.5,17238376.4375,13230935.5625,18423619.6875,14456674.1875,24529028.8125,Synaptobrevin homolog YKT6 OS=Homo sapiens OX=9606 GN=YKT6 PE=1 SV=1,cell growth;conjugation,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,10652,YKT6,NA,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; COPI-mediated anterograde transport; RAC3 GTPase cycle; Intra-Golgi traffic; COPII-mediated vesicle transport,ENSG00000106636
P06737,0,6,119466105.76041667,4.624468452313834e-4,1.3339087405834542,0.415659967863332,0.07286133068416543,0.6429522395902524,raw,117064326.03125,85317399.09375,95811088.6875,148881055.9375,113805624.375,155917140.4375,"Glycogen phosphorylase, liver form OS=Homo sapiens OX=9606 GN=PYGL PE=1 SV=4",cellular homeostasis;metabolic process,cell surface;cytosol;nucleus,structural molecule activity,5836,PYGL,TNF-alpha signaling pathway; Glycogen synthesis and degradation; Disorders of galactose metabolism,Neutrophil degranulation; Glycogen breakdown (glycogenolysis),ENSG00000100504
R4GND3,0,6,3098102.03125,1.1992585691457349e-5,1.333822633367844,0.4155668352082216,0.2643366070592095,0.7453246187943735,raw,3083110.625,2694192,2141664.8125,2856601,3063638.84375,4749404.90625,Pleckstrin homology-like domain family A member 1 OS=Homo sapiens OX=9606 GN=PHLDA1 PE=1 SV=1,metabolic process,membrane;nucleus,structural molecule activity,NA,PHLDA1,NA,NA,ENSG00000139289
P35269,0,6,35775204.2249349,1.3848388399390898e-4,1.3334515525112984,0.41516540927473833,0.1073129002777803,0.6429522395902524,raw,30477141.8808594,34911438.125,24469380.09375,45961892.875,32628732.875,46202639.5,General transcription factor IIF subunit 1 OS=Homo sapiens OX=9606 GN=GTF2F1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,2962,GTF2F1,NA,Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Viral Messenger RNA Synthesis; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA polymerase II transcribes snRNA genes; Estrogen-dependent gene expression; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM,ENSG00000125651
Q7RTP0,0.16666666666666666,6,445163.5375,1.7232040185671456e-6,1.333399004547287,0.41510855518001055,0.3153671925876048,0.7958588159583763,raw,370064.9375,NA,322621.3125,459647.125,326117.0625,747367.25,Magnesium transporter NIPA1 OS=Homo sapiens OX=9606 GN=NIPA1 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;mitochondrion,catalytic activity,123606,NIPA1,Prader-Willi and Angelman syndrome; 15q11.2 copy number variation syndrome,Miscellaneous transport and binding events,ENSG00000170113; ENSG00000288478
Q4G0N4,0,6,979660.9453125,3.7922146258346433e-6,1.3332467529166192,0.41494381438370825,0.7059646773009527,1,raw,698990.671875,1395976.8125,688425.5,1035468.84375,917841.0625,1141262.78125,"NAD kinase 2, mitochondrial OS=Homo sapiens OX=9606 GN=NADK2 PE=1 SV=2",cellular homeostasis,endosome,signal transducer activity;structural molecule activity,133686,NADK2,NA,Nicotinate metabolism,ENSG00000152620
Q9NU22,0,6,12895383.380208334,4.991733282229788e-5,1.3332313217596385,0.4149271163625523,0.15844621748626317,0.6638855679885327,raw,14177347.6875,9833953.609375,10233981.828125,13951606.46875,13110934.96875,16064475.71875,Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,23195,MDN1,NA,NA,ENSG00000112159; ENSG00000288121
Q8IYB7,0,6,10493793.786458334,4.0620909170576315e-5,1.333043857485405,0.41472424624522053,0.18853037316171006,0.6797963848944265,raw,8660192.84375,10509690.90625,8139547.71875,11544416.875,9543464.6875,14565449.6875,DIS3-like exonuclease 2 OS=Homo sapiens OX=9606 GN=DIS3L2 PE=1 SV=4,cell differentiation;cell growth;cellular component movement;cellular homeostasis;metabolic process,nucleus,RNA binding;structural molecule activity,129563,DIS3L2,NA,NA,ENSG00000144535
Q9Y5U9,0,6,4114099.75,1.5925458005387716e-5,1.3330297486848397,0.4147089768268806,0.049775028939057525,0.6429522395902524,raw,3032377.75,3994803.75,3248749.25,5265029,4042249.75,5101389,Immediate early response 3-interacting protein 1 OS=Homo sapiens OX=9606 GN=IER3IP1 PE=1 SV=1,conjugation;defense response;metabolic process,cytoskeleton;extracellular;nucleus,NA,51124,IER3IP1,NA,NA,ENSG00000134049
Q86UE4,0,6,64089597.49869794,2.4808737161701426e-4,1.3326985055139298,0.4143504384937201,0.1567118451950935,0.6638855679885327,raw,53365830.9179688,58833335.359375,55396227.65625,73826469.8085938,58521095.34375,84594625.90625,Protein LYRIC OS=Homo sapiens OX=9606 GN=MTDH PE=1 SV=2,cellular component movement;development;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,RNA binding;structural molecule activity,92140,MTDH,Gastric cancer network 2; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; CCL18 signaling pathway,NA,ENSG00000147649
P26440,0,6,10161018.520833334,3.933275408441374e-5,1.3324959692796605,0.41413116892513396,0.16173867739593464,0.6638855679885327,raw,8632211.953125,9382928.546875,8982025.5,12502714.46875,9149754.53125,12316476.125,"Isovaleryl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=IVD PE=1 SV=2",cellular homeostasis,endosome;membrane,structural molecule activity,3712,IVD,Valproic acid pathway,Branched-chain amino acid catabolism,ENSG00000128928
A0A2R8Y4H2,0,6,342743.25,1.3267406154906923e-6,1.3324036400474277,0.4140312004872548,0.12654793765141217,0.6465628140449752,raw,318563.84375,298694,292948.28125,424455.625,402558.21875,319239.53125,Neuronal-specific septin-3 OS=Homo sapiens OX=9606 GN=SEPTIN3 PE=1 SV=1,NA,nucleus,structural molecule activity,NA,SEPTIN3,NA,NA,ENSG00000100167
A0A087WYR3,0,6,84489446.27083333,3.270540847933057e-4,1.3321983945787543,0.4138089484461937,0.24896781521244693,0.7316541032247736,raw,67167586.5,88343386.75,67101350.75,92898716.375,73734719.25,117690918,Tumor protein D54 OS=Homo sapiens OX=9606 GN=TPD52L2 PE=1 SV=1,NA,nucleus,NA,7165,TPD52L2,NA,NA,ENSG00000101150
O00116,0,6,37263868.072916664,1.4424642137409098e-4,1.3313771994516033,0.4129193666541578,0.24164508957030978,0.7273063596068837,raw,34857865.6875,33458492.9375,31007695.75,44545874.625,31445952.4375,48267327,"Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Homo sapiens OX=9606 GN=AGPS PE=1 SV=1",cellular homeostasis,cytosol;membrane;mitochondrion,structural molecule activity,8540,AGPS,Triacylglyceride synthesis,Plasmalogen biosynthesis; TYSND1 cleaves peroxisomal proteins,ENSG00000018510
M0R346,0.16666666666666666,6,4566764.234375,1.76776977843198e-5,1.331364838934225,0.4129059725988062,0.3944330474094685,0.877277789871942,raw,5111522,3180066.5,3609632.65625,4805738,3527466,7166160.25,Serine/threonine-protein kinase D2 (Fragment) OS=Homo sapiens OX=9606 GN=PRKD2 PE=1 SV=8,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,PRKD2,NA,NA,ENSG00000105287
K7ELG9,0,6,7089907.520833333,2.7444649217635953e-5,1.3313618741390598,0.4129027598806094,0.37337453065890747,0.8594431551104292,raw,8793268.625,5523848.375,4854761,7288133.5625,7354241.125,8725192.4375,Protein LSM12 homolog OS=Homo sapiens OX=9606 GN=LSM12 PE=1 SV=1,NA,NA,NA,NA,LSM12,NA,NA,ENSG00000161654
Q13415,0.16666666666666666,6,1023838.1041666666,3.963222022563265e-6,1.331165361053739,0.41268979796200106,0.1434130195133777,0.6572502130392559,raw,887330.6875,1099670.75,685145.5625,1181183.875,1030475.25,1259222.5,Origin recognition complex subunit 1 OS=Homo sapiens OX=9606 GN=ORC1 PE=1 SV=2,cell differentiation;cell proliferation;cellular homeostasis;development,cytosol;membrane;nucleus,RNA binding;structural molecule activity,4998,ORC1,Cell cycle; Retinoblastoma gene in cancer; G1 to S cell cycle control; DNA replication,Orc1 removal from chromatin; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; E2F-enabled inhibition of pre-replication complex formation; Assembly of the ORC complex at the origin of replication; CDC6 association with the ORC:origin complex; G1/S-Specific Transcription,ENSG00000085840
Q7Z3K3,0,6,7256902.951171875,2.8091079512124582e-5,1.3311320950122962,0.4126537443250097,0.2263877222707123,0.7148463313429879,raw,6010423.390625,6840034.80078125,6504056.84375,8657758.8125,6209179.640625,9319964.21875,Pogo transposable element with ZNF domain OS=Homo sapiens OX=9606 GN=POGZ PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,23126,POGZ,NA,NA,ENSG00000143442
F8W914,0,6,2450469.0625,9.485633436171681e-6,1.3307642220576847,0.4122549846233109,0.1828419938356399,0.6753666316808584,raw,2592790.25,584697.875,2334444,3450392.5,2703096.25,3037393.5,Reticulon OS=Homo sapiens OX=9606 GN=RTN4 PE=1 SV=1,NA,cytoskeleton;extracellular,NA,NA,NA,NA,NA,NA
A0AVT1,0,6,34835549.576822914,1.348465315845332e-4,1.3306436950174412,0.41212431411447553,0.16228739223396435,0.6638855679885327,raw,31386783.015625,31009445.4765625,29278852.265625,44697166.921875,31378526.671875,41262523.109375,Ubiquitin-like modifier-activating enzyme 6 OS=Homo sapiens OX=9606 GN=UBA6 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,55236,UBA6,NA,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000033178
Q14980,0,6,145293315.55729166,5.624225799024912e-4,1.3301743418566843,0.4116153477176091,0.14077099682510658,0.6572502130392559,raw,126235929.78125,140214422.84375,114679056.1875,172064203.375,132056653.53125,186509627.625,Nuclear mitotic apparatus protein 1 OS=Homo sapiens OX=9606 GN=NUMA1 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity;structural molecule activity,4926,NUMA1,Ectoderm differentiation; Ectoderm differentiation,Recruitment of NuMA to mitotic centrosomes; Mitotic Prophase,ENSG00000137497
P46776,0,6,186403510.17708334,7.215579236701789e-4,1.3300343914347674,0.4114635507722572,0.33248604906548607,0.8158667519449163,raw,156408130,220116435.375,131911076.3125,208028192,179826259.375,222130968,60S ribosomal protein L27a OS=Homo sapiens OX=9606 GN=RPL27A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;Golgi;nucleus,structural molecule activity,6157,RPL27A,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000166441
A0A3B3ISV4,0.3333333333333333,6,707051.48125,2.736958109072113e-6,1.3299679437734662,0.41139147285699446,0.5657094315808591,1,raw,866179.625,417465.40625,529089.1875,1181557.375,540965.8125,NA,Vitamin-K-epoxide reductase (warfarin-sensitive) OS=Homo sapiens OX=9606 GN=VKORC1L1 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,NA,VKORC1L1,NA,NA,ENSG00000196715
P10155,0,6,28017781.018229168,1.0845531759650642e-4,1.3293303602264623,0.4106996823665058,0.2307370724798292,0.7174306065866879,raw,29500144.84375,19305692.0625,22733314.921875,39215438.171875,22884685.6875,34467410.421875,60 kDa SS-A/Ro ribonucleoprotein OS=Homo sapiens OX=9606 GN=RO60 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,6738,RO60,NA,NA,ENSG00000116747
Q9NQ50,0,6,7753178.552083333,3.0012135568534975e-5,1.3291489400211058,0.4105027772930175,0.19808822192322123,0.6875760999904456,raw,7267242.28125,6657914.15625,6585938.15625,9639237.625,6709491.71875,9659247.375,"39S ribosomal protein L40, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL40 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome;Golgi;membrane,NA,64976,MRPL40,22q11.2 copy number variation syndrome,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000185608
O75821,0,6,70905478.33854167,2.744712783476807e-4,1.3290139848869171,0.41035628581863914,0.1178313391989891,0.6429522395902524,raw,64810919.625,68888273.78125,49253275.25,91553479.25,65707019.625,85219902.5,Eukaryotic translation initiation factor 3 subunit G OS=Homo sapiens OX=9606 GN=EIF3G PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,RNA binding,8666,EIF3G,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000130811
Q9UBS4,0,6,49573387.36523438,1.9189590594390865e-4,1.328874649239706,0.41020502376435025,0.10680346015817754,0.6429522395902524,raw,42919404.6875,47048824.125,39759510.4375,62521989.65625,46356770.09375,58833825.1914063,DnaJ homolog subfamily B member 11 OS=Homo sapiens OX=9606 GN=DNAJB11 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cell surface;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,51726,DNAJB11,Photodynamic therapy-induced unfolded protein response,XBP1(S) activates chaperone genes,ENSG00000090520
Q969X6,0,6,13611372.424479166,5.268888775527023e-5,1.3288716270798209,0.4102017427475594,0.035326991620793155,0.6429522395902524,raw,11849045.125,13072450.15625,10331650.953125,16126018.8125,13729437.8125,16559631.6875,U3 small nucleolar RNA-associated protein 4 homolog OS=Homo sapiens OX=9606 GN=UTP4 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,84916,UTP4,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000141076; ENSG00000262788
P20340,0,6,42776655.21875,1.6558612277136752e-4,1.3288301800148967,0.4101567448664046,0.12940094570015565,0.6498046150645307,raw,36987744.75,40111781.0625,34618359.625,52639908,39000392.625,53301745.25,Ras-related protein Rab-6A OS=Homo sapiens OX=9606 GN=RAB6A PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,motor activity;structural molecule activity,5870,RAB6A,NA,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; COPI-independent Golgi-to-ER retrograde traffic; Neutrophil degranulation; Pre-NOTCH Processing in Golgi; Retrograde transport at the Trans-Golgi-Network; TBC/RABGAPs,ENSG00000175582
A0A0A0MT16,0.8333333333333334,6,5390278,2.0865475108221497e-5,1.3286850455682346,0.40999916552713755,0.9955698636987979,1,raw,4102693.5,8324777,3757186.5,5546672.5,5159151,5451187.5,ATP-binding cassette sub-family A member 13 OS=Homo sapiens OX=9606 GN=ABCA13 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;nucleus,catalytic activity;structural molecule activity,154664,ABCA13,NA,NA,ENSG00000179869
Q16537,0,6,2735173.0833333335,1.0587707329189536e-5,1.3286660235955012,0.40997851119504775,0.5009356272997926,0.984977940523979,raw,2187095.9375,3433024.375,2045997.1875,3015886.6875,2905920.0625,2823114.25,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform OS=Homo sapiens OX=9606 GN=PPP2R5E PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development,cytosol;membrane;nucleus,DNA binding,5529,PPP2R5E,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome; DNA damage response (only ATM dependent),"Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling",ENSG00000154001
P00492,0,6,42527758.598958336,1.6462265739448277e-4,1.3283670151412486,0.409653804644797,0.23198576138781654,0.718558432162761,raw,41021452,37521165.25,32879321.46875,54267116.5,34985952.625,54491543.75,Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens OX=9606 GN=HPRT1 PE=1 SV=2,cell differentiation;cell growth;cellular homeostasis;defense response;metabolic process,cytosol;nucleus,structural molecule activity,3251,HPRT1,Mesodermal commitment pathway,Azathioprine ADME; Purine salvage; Defective HPRT1 disrupts guanine and hypoxanthine salvage,ENSG00000165704
Q8IXI1,0,6,3369422.484375,1.304285251647659e-5,1.3282963987280119,0.4095771084787158,0.22634593906002975,0.7148463313429879,raw,2843176.84375,2824043.03125,3195882.1875,4632361.625,2944489.65625,3776581.5625,Mitochondrial Rho GTPase 2 OS=Homo sapiens OX=9606 GN=RHOT2 PE=1 SV=2,cell growth;conjugation;development;metabolic process,cytoskeleton;endosome,structural molecule activity,89941,RHOT2,NA,RHOT2 GTPase cycle,ENSG00000140983
J9JIC5,0,6,708647.6328125,2.743136725591761e-6,1.3282327857335527,0.40950801520302615,0.5982069370814362,1,raw,637754.25,NA,567514.34375,NA,523967.9375,1105354,Protein Njmu-R1 OS=Homo sapiens OX=9606 GN=C17orf75 PE=1 SV=1,cell growth;conjugation,extracellular,NA,NA,C17orf75,NA,NA,ENSG00000108666
Q9BQ95,0.3333333333333333,6,826373.6614583334,3.1988478262621544e-6,1.3281562270243064,0.4094248565469207,0.3004312409605969,0.7806964943416801,raw,765797.40625,836627.59375,488597.28125,1017098.59375,615430.9375,1234690.15625,"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial OS=Homo sapiens OX=9606 GN=ECSIT PE=1 SV=1",cell growth;coagulation;metabolic process,cytoskeleton;cytosol;endosome;membrane;nucleus,NA,51295,ECSIT,IL-1 signaling pathway; Interactions between LOXL4 and oxidative stress pathway; MAPK signaling pathway; Signal transduction through IL1R; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,MyD88:MAL(TIRAP) cascade initiated on plasma membrane; Complex I biogenesis; TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation; MyD88 cascade initiated on plasma membrane,ENSG00000130159
Q9H0U4,0,6,22406256.859375,8.673341055279639e-5,1.3277755372811682,0.4090112772406408,0.12551674341576996,0.645423195917097,raw,19570711.34375,21319988.125,18238070.71875,26241277.65625,20759334.625,28308158.6875,Ras-related protein Rab-1B OS=Homo sapiens OX=9606 GN=RAB1B PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,81876,RAB1B,NA,COPI-mediated anterograde transport; COPI-dependent Golgi-to-ER retrograde traffic; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; COPII-mediated vesicle transport; Golgi Cisternae Pericentriolar Stack Reorganization,ENSG00000174903
Q9BPU6,0,6,1419716.1666666667,5.495644628407473e-6,1.327509146613235,0.4087218013142463,1,1,raw,1165287.875,NA,NA,1331631,NA,1762229.625,Dihydropyrimidinase-related protein 5 OS=Homo sapiens OX=9606 GN=DPYSL5 PE=1 SV=1,cell growth;defense response;development;metabolic process,cytosol;nucleus,motor activity;structural molecule activity,56896,DPYSL5,NA,CRMPs in Sema3A signaling,ENSG00000157851
Q16540,0,6,4401545.171875,1.703814371382521e-5,1.327493177998496,0.4087044470233815,0.3282768814443298,0.8106382214174823,raw,5220267.5,3417416.5,3044503.78125,4585317.625,4041558,6100207.625,"39S ribosomal protein L23, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL23 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,RNA binding;structural molecule activity,6150,MRPL23,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000214026; ENSG00000288141
P48509,0,6,9716752.625,3.7613024788273146e-5,1.3273001738620556,0.4084946784469994,0.03043549999853135,0.6429522395902524,raw,8105164,9149437.6875,7399867.9375,11716607.625,9821846,12107592.5,CD151 antigen OS=Homo sapiens OX=9606 GN=CD151 PE=1 SV=3,cell communication;cell differentiation;coagulation;metabolic process,chromosome;cytoplasm;cytoskeleton;cytosol;nucleus,antioxidant activity,977,CD151,Primary focal segmental glomerulosclerosis (FSGS); Nephrotic syndrome,Assembly of collagen fibrils and other multimeric structures; Type I hemidesmosome assembly,ENSG00000177697
P51572,0,6,66905202.53125,2.589864266789792e-4,1.327284813254874,0.408477982299079,0.28454391815339913,0.7650076250313386,raw,59717097.375,63541601.125,57360837,86111327.9375,55438755.3125,79261596.4375,B-cell receptor-associated protein 31 OS=Homo sapiens OX=9606 GN=BCAP31 PE=1 SV=3,cell growth;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;nucleus,antioxidant activity;structural molecule activity,10134,BCAP31,NA,"RHOA GTPase cycle; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Apoptotic cleavage of cellular proteins",ENSG00000185825
Q96EY1,0,6,15752759.104166666,6.097807997542968e-5,1.3271540257286967,0.40833581551579673,0.20798430198787546,0.6988382857167694,raw,14816486.0625,13663531.84375,13409285.125,19372694,13590798.46875,19663759.125,"DnaJ homolog subfamily A member 3, mitochondrial OS=Homo sapiens OX=9606 GN=DNAJA3 PE=1 SV=2",cell growth;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;membrane;nucleus,antioxidant activity;DNA binding;structural molecule activity,9093,DNAJA3,NA,NA,ENSG00000103423; ENSG00000276726
A0A0A0MRJ6,0,6,38955125.916666664,1.5079318917351616e-4,1.3269948016911506,0.40816271917149194,0.12512270977846313,0.6449267539975253,raw,37436141.375,29545128.75,32990084.375,48951838.25,35129997.75,49677565,Protein-L-isoaspartate O-methyltransferase OS=Homo sapiens OX=9606 GN=PCMT1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol,structural molecule activity,5110,PCMT1,NA,NA,ENSG00000120265
Q9Y5K5,0.16666666666666666,6,947969.375,3.669538268233807e-6,1.3268833591826508,0.4080415549395978,0.17876534229233124,0.6741527184744509,raw,1017466.25,670270.4375,754573.4375,1001230.9375,916375.1875,1327900,Ubiquitin carboxyl-terminal hydrolase isozyme L5 OS=Homo sapiens OX=9606 GN=UCHL5 PE=1 SV=3,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,51377,UCHL5,TGF-beta signaling pathway,UCH proteinases; Downregulation of TGF-beta receptor signaling,ENSG00000116750
P34932,0,6,410227606.654948,0.0015879689165130438,1.3264744257789063,0.4075968608982206,0.24726366254638418,0.7316541032247736,raw,382482246.476563,389792174.3125,313854239.4375,529520793.578125,338363267.859375,507352918.265625,Heat shock 70 kDa protein 4 OS=Homo sapiens OX=9606 GN=HSPA4 PE=1 SV=4,cell growth;coagulation;conjugation;metabolic process,cell surface;cytosol;endosome;membrane,structural molecule activity,3308,HSPA4,Parkin-ubiquitin proteasomal system pathway,Regulation of HSF1-mediated heat shock response,ENSG00000170606
P08047,0,6,2452496.1145833335,9.493480045342463e-6,1.3264474099229653,0.4075674777171044,0.7702568321975436,1,raw,1718599.1875,3438866.15625,1926234.9375,2710842.1875,2555049.34375,2365384.875,Transcription factor Sp1 OS=Homo sapiens OX=9606 GN=SP1 PE=1 SV=3,cellular component movement;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6667,SP1,"Androgen receptor signaling pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Leptin signaling pathway; IL-17 signaling pathway; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Constitutive androstane receptor pathway; Estrogen receptor pathway; Nuclear receptors meta-pathway; Myometrial relaxation and contraction pathways; Copper homeostasis; Initiation of transcription and translation elongation at the HIV-1 LTR; MECP2 and associated Rett syndrome; TGF-beta signaling pathway; Mitochondrial gene expression; Oxidative stress response; Breast cancer pathway; Ethanol metabolism production of ROS by CYP2E1; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Gastrin signaling pathway; IL-18 signaling pathway; Angiotensin II receptor type 1 pathway; Malignant pleural mesothelioma; CCL18 signaling pathway; GDNF signaling; Genetic causes of porto-sinusoidal vascular disease; Sudden infant death syndrome (SIDS) susceptibility pathways; Estrogen signaling pathway",PPARA activates gene expression; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; RNA polymerase II transcribes snRNA genes; Estrogen-dependent gene expression; Oncogene Induced Senescence; Activation of gene expression by SREBF (SREBP); SARS-CoV-1 targets host intracellular signalling and regulatory pathways,ENSG00000185591
P54819,0,6,99285463.859375,3.843286700177642e-4,1.326447216282315,0.40756726710609636,0.30815683127413346,0.789127566112164,raw,93090185.9375,87954689.28125,88786136.125,123479218,81037158.4375,121365395.375,"Adenylate kinase 2, mitochondrial OS=Homo sapiens OX=9606 GN=AK2 PE=1 SV=2",cellular homeostasis,endoplasmic reticulum;endosome;nucleus,signal transducer activity;structural molecule activity,204,AK2,NA,Interconversion of nucleotide di- and triphosphates,ENSG00000004455
Q6ZNB6,0,6,5785476.268229167,2.2395266267146496e-5,1.3263941633253287,0.407509563514357,0.23377550450633483,0.7192700323995604,raw,5930401.1875,4635953.09375,4411966.484375,8394403.90625,5191031.8125,6149101.125,NF-X1-type zinc finger protein NFXL1 OS=Homo sapiens OX=9606 GN=NFXL1 PE=1 SV=2,cellular component movement;metabolic process,cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,152518,NFXL1,NA,NA,ENSG00000170448
A0A1B0GTW6,0,6,842065.5442708334,3.2595902573993513e-6,1.326315620486345,0.40742413135361066,0.5217126092680857,1,raw,728020.90625,461126.625,798743.78125,965585.5,249650.515625,1849265.9375,Band 4.1-like protein 1 OS=Homo sapiens OX=9606 GN=EPB41L1 PE=1 SV=2,cell growth,cytoplasm;cytoskeleton;endoplasmic reticulum,motor activity;structural molecule activity,NA,EPB41L1,Splicing factor NOVA regulated synaptic proteins,NA,ENSG00000088367
Q969Z0,0,6,21004360.791666668,8.130674656532083e-5,1.3261885246374827,0.40728587667729,0.14472825130871766,0.6572502130392559,raw,22375005.4375,14209722.65625,15674511.640625,29099759.46875,18844771.125,25822394.421875,FAST kinase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=TBRG4 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,endosome;nucleus,NA,9238,TBRG4,NA,NA,ENSG00000136270
Q14376,0,6,31164725.260416668,1.2063696884943331e-4,1.326107686887762,0.4071979345988991,0.09778568926445111,0.6429522395902524,raw,32254556.0625,22808446.5625,26509613.625,37523520.375,30246456.3125,37645758.625,UDP-glucose 4-epimerase OS=Homo sapiens OX=9606 GN=GALE PE=1 SV=2,cellular homeostasis,cytosol,structural molecule activity,2582,GALE,Disorders of galactose metabolism,Galactose catabolism; Defective GALE causes EDG,ENSG00000117308
O75312,0,6,11183062.838541666,4.328903245644621e-5,1.3260261688877109,0.4071092470583379,0.22242526908288673,0.7106930585959085,raw,9518859.71875,11770083.75,8145213.625,10887528.25,11169252.625,15607439.0625,Zinc finger protein ZPR1 OS=Homo sapiens OX=9606 GN=ZPR1 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;defense response;development;metabolic process,membrane;nucleus,antioxidant activity;structural molecule activity,8882,ZPR1,NA,NA,ENSG00000109917
P48147,0,6,303273214.7062175,0.0011739542399191462,1.3257516851793898,0.4068105823073622,0.05973547474872715,0.6429522395902524,raw,244209308.34375,296741959.171875,231950814.046875,354271650.28125,299059403.958008,393406152.435547,Prolyl endopeptidase OS=Homo sapiens OX=9606 GN=PREP PE=1 SV=2,cell organization and biogenesis,cytosol;membrane;nucleus,structural molecule activity,5550,PREP,NA,NA,ENSG00000085377
Q9BUF5,0,6,19705468.083333332,7.627880302066884e-5,1.325649087688689,0.4066989304645853,0.2622879104887985,0.7434453518424705,raw,19255012.5,16527582,14044123.75,21909774,16279331.25,30216985,Tubulin beta-6 chain OS=Homo sapiens OX=9606 GN=TUBB6 PE=1 SV=1,cell differentiation;cell growth,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,84617,TUBB6,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,Separation of Sister Chromatids; Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,ENSG00000176014
Q96KC8,0,6,2408240.2421875,9.32216795274392e-6,1.3255703124977904,0.4066131974035795,0.7984223973525816,1,raw,1051815.34375,3945784.125,1823114.390625,1882838.6875,2416666.3125,3329222.59375,DnaJ homolog subfamily C member 1 OS=Homo sapiens OX=9606 GN=DNAJC1 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,RNA binding;structural molecule activity,64215,DNAJC1,NA,NA,ENSG00000136770
P35221,0,6,248218123.39257815,9.608389539569743e-4,1.3254992765813125,0.40653588282468317,0.40512542019005937,0.8912744470641923,raw,251526456.109375,208625693.140625,215540899.699219,338474041.5625,189442343.21875,285699306.625,Catenin alpha-1 OS=Homo sapiens OX=9606 GN=CTNNA1 PE=1 SV=1,cell communication;cell differentiation;cell growth;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,1495,CTNNA1,Arrhythmogenic right ventricular cardiomyopathy; Apoptosis-related network due to altered Notch3 in ovarian cancer; VEGFA-VEGFR2 signaling pathway; White fat cell differentiation; Endometrial cancer; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Merlin signaling dysregulation; Malignant pleural mesothelioma,RHO GTPases activate IQGAPs; Myogenesis; VEGFR2 mediated vascular permeability; Adherens junctions interactions,ENSG00000044115
P07919,0,6,53387271,2.0665924357637499e-4,1.3254486006773756,0.4064807252895702,0.17615339399053803,0.6706757661107641,raw,46480083,45850751.375,41376398.5,60772814.25,47906842.75,77936736.125,"Cytochrome b-c1 complex subunit 6, mitochondrial OS=Homo sapiens OX=9606 GN=UQCRH PE=1 SV=2",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,7388,UQCRH,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,Respiratory electron transport,ENSG00000173660
Q9HCE7,0.5,6,581841.0833333334,2.2522754190474587e-6,1.3254314891399945,0.406462099980778,0.033446849802031484,0.6429522395902524,raw,502593.75,557567.625,398555.375,633924.8125,659387.25,739017.6875,E3 ubiquitin-protein ligase SMURF1 OS=Homo sapiens OX=9606 GN=SMURF1 PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,57154,SMURF1,Bone morphogenic protein signaling and regulation; Ectoderm differentiation; Ectoderm differentiation; TGF-beta signaling pathway; Hedgehog signaling pathway,Antigen processing: Ubiquitination & Proteasome degradation; Asymmetric localization of PCP proteins; Hedgehog 'on' state; Regulation of RUNX2 expression and activity; Regulation of RUNX3 expression and activity; Signaling by BMP; Downregulation of TGF-beta receptor signaling; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),ENSG00000198742; ENSG00000284126
P62913,0,6,120016084.69791667,4.6457578400419853e-4,1.3251528046093526,0.40615872778261075,0.3908301808571477,0.8758916537316318,raw,91398313.0625,148176223.5,88536534.875,139372326.75,117324437.5,135288672.5,60S ribosomal protein L11 OS=Homo sapiens OX=9606 GN=RPL11 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;Golgi;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,6135,RPL11,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000142676
Q7Z309,0,6,3810105.0833333335,1.4748711063882022e-5,1.3250010434969404,0.40599349586245437,0.09038926980584665,0.6429522395902524,raw,2805575.28125,3291217.125,3624577.3125,4360866.125,3677676,5100718.65625,Protein FAM122B OS=Homo sapiens OX=9606 GN=FAM122B PE=1 SV=2,NA,NA,DNA binding,159090,PABIR2,NA,NA,ENSG00000156504
Q08AD1,0,6,75776.203125,2.93325591017796e-7,1.3249372185110895,0.405923999910862,1,1,raw,NA,72402.0390625,NA,95928.15625,28682.203125,106092.4140625,Calmodulin-regulated spectrin-associated protein 2 OS=Homo sapiens OX=9606 GN=CAMSAP2 PE=1 SV=3,cell growth;defense response;metabolic process,cytosol;endoplasmic reticulum;extracellular,motor activity;structural molecule activity,23271,CAMSAP2,NA,NA,ENSG00000118200
P09496,0,6,33099125.864583332,1.2812492914676273e-4,1.3245531000464557,0.40550568110890806,0.09072445405413694,0.6429522395902524,raw,25756799.5,34681349,26313314.6875,35851338.875,34116248.625,41875704.5,Clathrin light chain A OS=Homo sapiens OX=9606 GN=CLTA PE=1 SV=1,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,structural molecule activity,1211,CLTA,Synaptic vesicle pathway; Ebola virus infection in host; Fragile X syndrome,"Recycling pathway of L1; MHC class II antigen presentation; Lysosome Vesicle Biogenesis; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Retrograde neurotrophin signalling; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation; Entry of Influenza Virion into Host Cell via Endocytosis; Formation of annular gap junctions",ENSG00000122705
Q9NXH9,0,6,14404184.830729166,5.575782177464708e-5,1.3245152768278032,0.4054644837049752,0.1854363402285461,0.6778506319470519,raw,12931919.90625,13433566.4375,12021238.671875,17792963.96875,12709119.1875,17536300.8125,tRNA (guanine(26)-N(2))-dimethyltransferase OS=Homo sapiens OX=9606 GN=TRMT1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,55621,TRMT1,NA,tRNA modification in the nucleus and cytosol,ENSG00000104907
O00220,0,6,3062462.2135416665,1.1854625881359467e-5,1.3243988548242784,0.405337668384511,0.3291847630170952,0.8111865130141003,raw,2502710.890625,3087506.21875,2470740.984375,4510052.6875,2489175.0625,3314587.4375,Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens OX=9606 GN=TNFRSF10A PE=1 SV=3,development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,8797,TNFRSF10A,Apoptosis modulation and signaling,Cell surface interactions at the vascular wall; Regulation by c-FLIP; RIPK1-mediated regulated necrosis; CASP8 activity is inhibited; TP53 Regulates Transcription of Death Receptors and Ligands; Dimerization of procaspase-8; TRAIL  signaling,ENSG00000104689
Q9UJW0,0,6,8290212.78125,3.209096607429739e-5,1.3243239144985668,0.4052560320293984,0.05959080034431625,0.6429522395902524,raw,7540045.59375,7660795.3125,6135188.09375,8124976.3125,9742230,10538041.375,Dynactin subunit 4 OS=Homo sapiens OX=9606 GN=DCTN4 PE=1 SV=1,NA,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,51164,DCTN4,NA,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; MHC class II antigen presentation; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic,ENSG00000132912
Q5VSL9,0,6,1302750.609375,5.042877271289987e-6,1.324319917952869,0.4052516782566577,0.3121036687742003,0.7920821775382559,raw,990772,1599285.75,669830.625,1217068.875,1312099.09375,2027447.3125,Striatin-interacting protein 1 OS=Homo sapiens OX=9606 GN=STRIP1 PE=1 SV=1,cell growth;metabolic process,cytosol;membrane,structural molecule activity,85369,STRIP1,NA,NA,ENSG00000143093
Q8N1G4,0,6,40073408.244791664,1.551219996878266e-4,1.3242409372578445,0.40516563525949756,0.09751042923388094,0.6429522395902524,raw,36216829.4375,36091701.125,32746138.28125,47794108.125,37941626.8125,49650045.6875,Leucine-rich repeat-containing protein 47 OS=Homo sapiens OX=9606 GN=LRRC47 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,NA,structural molecule activity,57470,LRRC47,NA,NA,ENSG00000130764
Q99459,0,6,32943390.388020832,1.2752208552539813e-4,1.3240590976118198,0.40496751635113,0.14254767665198556,0.6572502130392559,raw,29212661,30979586.671875,23589192.9375,38679289.5625,29813105.4375,45386506.71875,Cell division cycle 5-like protein OS=Homo sapiens OX=9606 GN=CDC5L PE=1 SV=2,cell differentiation;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,988,CDC5L,NA,mRNA Splicing - Major Pathway,ENSG00000096401
Q8N6M0,0,6,4269059.0625,1.652529713757271e-5,1.323648845107546,0.4045204358792886,0.43949542380775286,0.9233592063620298,raw,4402510.8125,3966770.875,2958713.71875,6205179.8125,2830567.46875,5250611.6875,Deubiquitinase OTUD6B OS=Homo sapiens OX=9606 GN=OTUD6B PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,NA,structural molecule activity,51633,OTUD6B,NA,NA,ENSG00000155100
Q9NRY2,0,6,1412791.3958333333,5.468839214391153e-6,1.3236360897728892,0.4045065332896488,0.4323929078761917,0.9168514603569733,raw,1517921.875,1105900,1130291.125,2170021,1056520.25,1496094.125,SOSS complex subunit C OS=Homo sapiens OX=9606 GN=INIP PE=1 SV=1,cell differentiation;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,NA,58493,INIP,NA,NA,ENSG00000148153
Q9BVK8,0.3333333333333333,6,377820.4375,1.4625225144294238e-6,1.3236058001239956,0.4044735187574917,1,1,raw,NA,320777.625,NA,460245.625,305675.375,424583.125,Transmembrane protein 147 OS=Homo sapiens OX=9606 GN=TMEM147 PE=1 SV=1,NA,cytoplasm;cytoskeleton;extracellular;nucleus,protein binding,10430,TMEM147,NA,NA,ENSG00000105677
Q8WW12,0,6,8085921.296875,3.130016476830757e-5,1.3236024211225725,0.404469835731308,0.13092289005791208,0.6498046150645307,raw,5996448.78125,7615164.125,7620908.3125,8573858.5625,7936914.125,10772233.875,PEST proteolytic signal-containing nuclear protein OS=Homo sapiens OX=9606 GN=PCNP PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis,membrane,NA,57092,PCNP,NA,NA,ENSG00000081154
P35251,0,6,9458795.9140625,3.661448828773178e-5,1.3234074354524645,0.4042572903498699,0.1369876433597712,0.654928512316515,raw,7813899.0625,9248345.21875,7337761.6875,11637591.375,8475849.3125,12239328.828125,Replication factor C subunit 1 OS=Homo sapiens OX=9606 GN=RFC1 PE=1 SV=4,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,5981,RFC1,"miRNA regulation of DNA damage response; DNA replication; Male infertility; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair; DNA damage response",PCNA-Dependent Long Patch Base Excision Repair; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,ENSG00000035928
Q8WXI4,0,6,2300046.3645833335,8.903355294099653e-6,1.3232532696359607,0.4040892187426793,0.7347385923575959,1,raw,1537112.0625,3361066.25,1631205.625,3009890.125,2033988.5625,2227015.5625,Acyl-coenzyme A thioesterase 11 OS=Homo sapiens OX=9606 GN=ACOT11 PE=1 SV=1,cellular homeostasis;coagulation;development;metabolic process,cytosol;endosome;nucleus,structural molecule activity,26027,ACOT11,NA,Mitochondrial Fatty Acid Beta-Oxidation,ENSG00000162390
Q9H1C7,0.16666666666666666,6,1477507.5625,5.719352001427898e-6,1.3232231187515635,0.4040563459525868,0.4066831087613618,0.8914071190930648,raw,1642398.375,1221573.25,1061698.125,1105803,1660313.125,2173259.5,Cysteine-rich and transmembrane domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CYSTM1 PE=1 SV=1,NA,cytoplasm;cytoskeleton,NA,84418,CYSTM1,NA,Neutrophil degranulation,ENSG00000120306
Q9UNH7,0,6,20851537.041666668,8.071517408027088e-5,1.3231519899063025,0.40397879290123645,0.0446358283747946,0.6429522395902524,raw,19440366.90625,16554432.6875,17976712.46875,26331732.9375,21020054.375,23785922.875,Sorting nexin-6 OS=Homo sapiens OX=9606 GN=SNX6 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,antioxidant activity;motor activity;structural molecule activity,58533,SNX6,NA,NA,ENSG00000129515
Q9UEY8,0,6,2429168.0520833335,9.403178374924577e-6,1.322937653056892,0.40374507239125834,0.11464780288391532,0.6429522395902524,raw,1999001.375,2588384.03125,1867865.90625,2644554.1875,2976846.375,2498356.4375,Gamma-adducin OS=Homo sapiens OX=9606 GN=ADD3 PE=1 SV=1,cell growth,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,120,ADD3,NA,RHOD GTPase cycle; RHOF GTPase cycle; Miscellaneous transport and binding events,ENSG00000148700
Q15785,0,6,29174949.333333332,1.1293465366689622e-4,1.3227347986791982,0.40352383789558005,0.11534723861778484,0.6429522395902524,raw,25532635.375,26527662.4375,25344720.875,33772905.3125,27646127.09375,36225644.90625,Mitochondrial import receptor subunit TOM34 OS=Homo sapiens OX=9606 GN=TOMM34 PE=1 SV=2,cell growth;conjugation,cytoskeleton;cytosol;endosome;nucleus,structural molecule activity,10953,TOMM34,NA,NA,ENSG00000025772
Q7Z422,0,6,3496501.125,1.3534767073155773e-5,1.3226551257113581,0.40343693668334607,0.1983124360767399,0.6878536069426745,raw,3242311.5625,3359226.5625,2431572.25,4976806.5,3216131.5,3752958.375,SUZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SZRD1 PE=1 SV=1,NA,NA,NA,26099,SZRD1,NA,NA,ENSG00000055070
P12235,0,6,11183497.8125,4.329071621715398e-5,1.322545389937673,0.4033172366790114,0.1741961309943529,0.669219086937761,raw,10797068.875,9181554,9476060.875,12532520.625,10190868.625,14922913.875,ADP/ATP translocase 1 OS=Homo sapiens OX=9606 GN=SLC25A4 PE=1 SV=4,cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;endosome,catalytic activity,291,SLC25A4,Electron transport chain: OXPHOS system in mitochondria; Alzheimer's disease and miRNA effects; Synaptic vesicle pathway; Alzheimer's disease; Sudden infant death syndrome (SIDS) susceptibility pathways,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane; Mitochondrial protein import; Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,ENSG00000151729
A0A0A6YYH1,0.5,6,338254.6145833333,1.3093653501414208e-6,1.322409329979027,0.40316880840816266,0.19424887963104315,0.6848704876546774,raw,305114.875,266815.71875,291565.5,298156.3125,385568.9375,482306.34375,Arpin OS=Homo sapiens OX=9606 GN=C15orf38-AP3S2 PE=3 SV=1,conjugation;metabolic process,cytoskeleton;nucleus,NA,100526783,C15orf38-AP3S2,NA,NA,ENSG00000250021
Q8N163,0,6,57320755.328125,2.2188554903540168e-4,1.322271010745418,0.4030178998318057,0.28230081309855437,0.7642736213388397,raw,52951112.84375,51664815.90625,51631368.21875,70015721.5,48177893.625,69483619.875,Cell cycle and apoptosis regulator protein 2 OS=Homo sapiens OX=9606 GN=CCAR2 PE=1 SV=2,cell death;cell differentiation;cell growth;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,endoplasmic reticulum;endosome;membrane;nucleus,DNA binding;structural molecule activity,57805,CCAR2,NA,Regulation of HSF1-mediated heat shock response,ENSG00000158941
P14923,0,6,111513482.34895833,4.316626693805565e-4,1.3222667308713287,0.4030132301664595,0.20123642769536912,0.691648270213144,raw,104476252.78125,97077461.40625,97305308.46875,134199188.3125,97877209.90625,138145473.21875,Junction plakoglobin OS=Homo sapiens OX=9606 GN=JUP PE=1 SV=3,cell communication;cell death;cell growth;cellular component movement;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,3728,JUP,Arrhythmogenic right ventricular cardiomyopathy; Corticotropin-releasing hormone signaling pathway; Ectoderm differentiation; Ectoderm differentiation; Epithelial to mesenchymal transition in colorectal cancer,RHOC GTPase cycle; Formation of the cornified envelope; RHOA GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle; Neutrophil degranulation; VEGFR2 mediated vascular permeability; Adherens junctions interactions; RHOH GTPase cycle,ENSG00000173801
A0A669KBG8,0,6,17853121.049479168,6.910846766381489e-5,1.322189263792244,0.40292870512910967,0.17890205463764156,0.6741527184744509,raw,14593094.515625,19627645.65625,12868230.28125,20206782.375,17014235.921875,22808737.546875,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Homo sapiens OX=9606 GN=GBF1 PE=1 SV=1,metabolic process,extracellular,DNA binding,8729,GBF1,NA,NA,ENSG00000107862
Q9Y570,0,6,36709530.486979164,1.4210061050850474e-4,1.322133114722366,0.40286743727059593,0.25969774131727724,0.7399707451508042,raw,31802498.671875,35953031.65625,27178342.8125,53017506.625,30258666.53125,42047136.625,Protein phosphatase methylesterase 1 OS=Homo sapiens OX=9606 GN=PPME1 PE=1 SV=3,cell differentiation;cell organization and biogenesis;cellular homeostasis,membrane,DNA binding;RNA binding;structural molecule activity,51400,PPME1,NA,Cyclin A/B1/B2 associated events during G2/M transition,ENSG00000214517
P28072,0,6,48581559.248697914,1.8805659285519116e-4,1.3218561037192336,0.4025651346748321,0.17288038139074163,0.6689341104244626,raw,36419971.234375,53348955.90625,40161720.140625,53506211.4375,48141961.2734375,59910535.5,Proteasome subunit beta type-6 OS=Homo sapiens OX=9606 GN=PSMB6 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,5694,PSMB6,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000142507
Q92485,0,6,4339620.177083333,1.679843540241673e-5,1.3218131038895493,0.4025182032048347,0.32848482399877027,0.810793084229206,raw,4532855.28125,3156505.34375,3758567.71875,6197036.25,3424632.40625,4968124.0625,Acid sphingomyelinase-like phosphodiesterase 3b OS=Homo sapiens OX=9606 GN=SMPDL3B PE=1 SV=2,cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton,structural molecule activity,27293,SMPDL3B,NA,NA,ENSG00000130768
Q14019,0,6,109704828.171875,4.2466146671321485e-4,1.3208535919753375,0.4014705620904228,0.06390652118043808,0.6429522395902524,raw,92609551.5,97889144.5,92420475.21875,122323658.75,111841387.6875,141144751.375,Coactosin-like protein OS=Homo sapiens OX=9606 GN=COTL1 PE=1 SV=3,cell growth;coagulation,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,23406,COTL1,NA,Neutrophil degranulation,ENSG00000103187
Q52LJ0,0,6,21496303.99609375,8.321103214885325e-5,1.32080654247403,0.4014191716171863,0.4035882425362603,0.8896213849325956,raw,21087685.921875,19553824.8125,17418903.703125,27548190.5625,15516465.4453125,27852753.53125,Protein FAM98B OS=Homo sapiens OX=9606 GN=FAM98B PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,283742,FAM98B,NA,tRNA processing in the nucleus,ENSG00000171262
Q9NV56,0,6,879168.2291666666,3.4032127473974914e-6,1.3206654679668117,0.40126507004704,0.19311201616941906,0.6839501208924997,raw,386823.375,990847.84375,740257.15625,1308578.53125,956876.34375,891626.125,MRG/MORF4L-binding protein OS=Homo sapiens OX=9606 GN=MRGBP PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,NA,55257,MRGBP,NA,HATs acetylate histones,ENSG00000101189
Q9NP97,0,6,13236579.895833334,5.123808611253362e-5,1.3206638071953287,0.401263255819026,0.09140813638390304,0.6429522395902524,raw,11462117.5625,11405939.9375,10060450.375,15063412.0625,13034887.3125,18392672.125,Dynein light chain roadblock-type 1 OS=Homo sapiens OX=9606 GN=DYNLRB1 PE=1 SV=3,metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,83658,DYNLRB1,Ciliary landscape; Intraflagellar transport proteins binding to dynein; 3q29 copy number variation syndrome,Intraflagellar transport,ENSG00000125971
Q9UIS9,0,6,281813.30078125,1.090884071770864e-6,1.3204095826366116,0.40098551381255376,0.3966599386909882,0.8797346329660238,raw,NA,299827.96875,194625.609375,338662.875,NA,294136.75,Methyl-CpG-binding domain protein 1 OS=Homo sapiens OX=9606 GN=MBD1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4152,MBD1,Sudden infant death syndrome (SIDS) susceptibility pathways,SUMOylation of transcription cofactors,ENSG00000141644
Q16822,0,6,40099740.364583336,1.5522392990182667e-4,1.3202996125518525,0.40086535420065184,0.14891713765121553,0.6638855679885327,raw,41609381.25,23615758.625,36840082.90625,51422699.96875,38470572.25,48639947.1875,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homo sapiens OX=9606 GN=PCK2 PE=1 SV=4",cellular homeostasis;coagulation;defense response;metabolic process,cytosol;endosome,structural molecule activity,5106,PCK2,Adipogenesis; Transcription factor regulation in adipogenesis; PPAR signaling pathway; PI3K-Akt signaling pathway; Krebs cycle disorders; DNA damage response (only ATM dependent),Gluconeogenesis,ENSG00000100889; ENSG00000285241
Q9UJX5,0.16666666666666666,6,701493.55625,2.715443681478423e-6,1.3202732258096015,0.4008365210462401,0.5996443930478704,1,raw,310916.59375,1791787.375,363233.0625,599180,NA,442350.75,Anaphase-promoting complex subunit 4 OS=Homo sapiens OX=9606 GN=ANAPC4 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,29945,ANAPC4,Cell cycle,Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,ENSG00000053900
Q16698,0,6,28735092.854166668,1.112319929846008e-4,1.3201347636426113,0.4006852120950109,0.1462799165087129,0.6598496233816941,raw,27032217.875,19871698.6875,27422850.8125,38285195.125,26233320.25,33565274.375,"2,4-dienoyl-CoA reductase, mitochondrial OS=Homo sapiens OX=9606 GN=DECR1 PE=1 SV=1",cellular homeostasis;metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,1666,DECR1,Fatty acid beta-oxidation; Fatty acid biosynthesis; VEGFA-VEGFR2 signaling pathway,mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,ENSG00000104325
Q6NUK1,0,6,24434847.84375,9.458597672642214e-5,1.3200967205462106,0.40064363650828694,0.04538123916830112,0.6429522395902524,raw,23108766.3125,19239880.59375,21195471.75,28143963.625,24415198.15625,30505806.625,Calcium-binding mitochondrial carrier protein SCaMC-1 OS=Homo sapiens OX=9606 GN=SLC25A24 PE=1 SV=2,coagulation;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,29957,SLC25A24,NA,NA,ENSG00000085491; ENSG00000284468
Q9Y5Y2,0,6,8306836.65625,3.215531619687264e-5,1.3199533624603002,0.40048695614744917,0.3308640737657349,0.8133261464868501,raw,10517036.375,5185200.625,5564388.75,10539983.1875,6844223,11190188,Cytosolic Fe-S cluster assembly factor NUBP2 OS=Homo sapiens OX=9606 GN=NUBP2 PE=1 SV=1,cell growth;cellular homeostasis,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,10101,NUBP2,NA,Cytosolic iron-sulfur cluster assembly,ENSG00000095906
A0A2U3TZU2,0,6,373521055.7604167,0.0014458798398460317,1.3198720265710673,0.4003980541431217,0.25893976385402206,0.7382628436284326,raw,340851610.46875,350513582.1875,319010513.84375,452451458.75,315666097.25,462633072.0625,Glucose-6-phosphate isomerase OS=Homo sapiens OX=9606 GN=GPI PE=1 SV=1,cellular homeostasis;development,cell surface;cytoplasm;cytoskeleton;cytosol;membrane,antioxidant activity;structural molecule activity,2821,GPI,Cori cycle; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Disorders of fructose metabolism; Glycolysis and gluconeogenesis,NA,ENSG00000105220
A0A087WYT3,0,6,192423930.63020834,7.448626461920428e-4,1.3194465938455415,0.39993295706547766,0.38673779312385625,0.8719782263249817,raw,204452745.21875,156902426.34375,152444293.15625,269764478.28125,141798930.5,229180710.28125,Prostaglandin E synthase 3 OS=Homo sapiens OX=9606 GN=PTGES3 PE=1 SV=1,NA,NA,structural molecule activity,10728,PTGES3,Aryl hydrocarbon receptor pathway; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway,NA,ENSG00000110958
O75367,0,6,111071703.02083333,4.2995256545376106e-4,1.3193548036783573,0.39983258936127936,0.1674593012050152,0.6670444762382309,raw,108531911.375,94404176.96875,92638942,126741575.65625,100921513.5,143192098.625,Core histone macro-H2A.1 OS=Homo sapiens OX=9606 GN=MACROH2A1 PE=1 SV=4,cell growth;metabolic process,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,100394084; 100466888; 100974858; 100998964; 101050376; 101131222; 101381952; 101564704; 101692673; 101706296; 102008188; 102123677; 103079324; 104855290; 105467125; 105506940; 105531308; 105816031; 105869993; 108529540; 109250833; 462076; 481514; 711836,H2afy; H2AFY; LOC100466888; LOC101338325; LOC101381952; LOC101564704; LOC102987354; LOC103079324; LOC103663804; LOC105869993; LOC106989149; LOC109250833; LOC110591142; LOC111141291; LOC111182462; LOC112404331; LOC112625777; LOC112815157; LOC112861289; LOC112917035; LOC113261754; LOC113928700; LOC114891795; LOC115516119; LOC116529369; LOC116750637; MACROH2A1,NA,NA,ENSAMEG00000017887; ENSBMSG00010001156; ENSCAFG00000001076; ENSCAFG00020007175; ENSCAFG00030007355; ENSCAFG00040009734; ENSCANG00000022762; ENSCJAG00000005818; ENSCLAG00000016530; ENSCWAG00000001657; ENSFCAG00000013924; ENSGGOG00000001707; ENSLCNG00005003680; ENSMICG00000005677; ENSMLEG00000037795; ENSMMNG00015002866; ENSMNEG00000031666; ENSMPUG00000010011; ENSPANG00000002758; ENSPCOG00000013464; ENSPCTG00005011747; ENSPLOG00000000479; ENSPPAG00000029258; ENSPPRG00000014201; ENSPPYG00000015799; ENSPSMG00000021213; ENSPSNG00000019193; ENSPTRG00000017256; ENSRBIG00000034425; ENSRROG00000045755; ENSSBOG00000034640; ENSSSUG00005001976; ENSSVLG00005008251; ENSTGEG00000021330; ENSVVUG00000017487
O00161,0,6,25016194.286458332,9.683633741831667e-5,1.319310770143166,0.39978443853573353,0.27771983825594493,0.7573689442967497,raw,24622063,21757576.375,20273935.03125,33938755.0625,20799831.40625,28705004.84375,Synaptosomal-associated protein 23 OS=Homo sapiens OX=9606 GN=SNAP23 PE=1 SV=1,cell death;cell growth;coagulation;conjugation,cytoplasm;cytoskeleton;endosome;membrane;mitochondrion;nucleus,structural molecule activity,8773,SNAP23,Insulin signaling,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; ER-Phagosome pathway; Translocation of SLC2A4 (GLUT4) to the plasma membrane; RAC3 GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; Neutrophil degranulation; trans-Golgi Network Vesicle Budding,ENSG00000092531
O75116,0,6,11822969.041666666,4.576607481917801e-5,1.3192862402197523,0.39975761428123446,0.1312869342475881,0.6508990310026241,raw,9232648.125,11524479.5625,9526824.90625,14869636.65625,10580137.6875,15204087.3125,Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;signal transducer activity;structural molecule activity,9475,ROCK2,Androgen receptor signaling pathway; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; Leptin signaling pathway; Pathogenic Escherichia coli infection; Spinal cord injury; Focal adhesion; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Wnt signaling; Airway smooth muscle cell contraction; Regulation of actin cytoskeleton; GDNF signaling; G13 signaling pathway,Potential therapeutics for SARS; RHOC GTPase cycle; RHOA GTPase cycle; G alpha (12/13) signalling events; RHOB GTPase cycle; EPHB-mediated forward signaling; VEGFA-VEGFR2 Pathway; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases Activate ROCKs; RHOBTB1 GTPase cycle; RHOH GTPase cycle,ENSG00000134318
P07900,0,6,5417702505.014485,0.020971633886439436,1.3192291358863002,0.399695166937214,0.12851286107761783,0.6498046150645307,raw,4741609818.9082,5260799266.22754,4279236895.69043,6258269365.72656,5026100013.47754,6940199670.05664,Heat shock protein HSP 90-alpha OS=Homo sapiens OX=9606 GN=HSP90AA1 PE=1 SV=5,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cell surface;chromosome;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;mitochondrion;nucleus,antioxidant activity;DNA binding;motor activity;RNA binding;structural molecule activity,3320,HSP90AA1,Nucleotide-binding oligomerization domain (NOD) pathway; TNF-alpha signaling pathway; Corticotropin-releasing hormone signaling pathway; Aryl hydrocarbon receptor pathway; Ebstein-Barr virus LMP1 signaling; Aryl hydrocarbon receptor pathway; Constitutive androstane receptor pathway; Pregnane X receptor pathway; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Th17 cell differentiation pathway,"Regulation of actin dynamics for phagocytic cup formation; Potential therapeutics for SARS; The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Aggrephagy; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Extra-nuclear estrogen signaling; Neutrophil degranulation; vRNP Assembly; Estrogen-dependent gene expression; Regulation of necroptotic cell death; Interleukin-4 and Interleukin-13 signaling; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Sema3A PAK dependent Axon repulsion; DDX58/IFIH1-mediated induction of interferon-alpha/beta; PIWI-interacting RNA (piRNA) biogenesis; VEGFR2 mediated vascular permeability; RHOBTB2 GTPase cycle; Chaperone Mediated Autophagy; HSF1 activation; Attenuation phase; eNOS activation; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; Uptake and function of diphtheria toxin; Constitutive Signaling by Overexpressed ERBB2; Scavenging by Class F Receptors; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants",ENSG00000080824
Q8IWA0,0,6,14431901.205729166,5.586511036582041e-5,1.3190829523777123,0.39953529333920157,0.14381337852292092,0.6572502130392559,raw,15134721.0625,10978636.609375,9552464.65625,18932841.90625,12600493.28125,19392249.71875,WD repeat-containing protein 75 OS=Homo sapiens OX=9606 GN=WDR75 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,NA,84128,WDR75,NA,rRNA modification in the nucleus and cytosol; Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000115368
H0YL70,0,6,1305134.921875,5.05210681624462e-6,1.3190783656620195,0.39953027679079056,0.35721313426457557,0.8406066251623018,raw,1171088.09375,1660205.84375,465133,1678951.1875,1310674.4375,1544756.96875,Transducin-like enhancer protein 3 OS=Homo sapiens OX=9606 GN=TLE3 PE=1 SV=1,cell death;development;metabolic process,membrane,NA,7090,TLE3,White fat cell differentiation,NA,ENSG00000140332
F8WAJ0,0,6,2707043.609375,1.0478819654252367e-5,1.3190377726892288,0.3994858789876057,0.0408862045718981,0.6429522395902524,raw,2298764.34375,2076305.453125,2627492.6328125,3391261.453125,2738725.3203125,3109712.453125,RNA helicase OS=Homo sapiens OX=9606 GN=DDX31 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
J3KQN7,0.8333333333333334,6,2703720.2916666665,1.0465955270834676e-5,1.3189045032494997,0.39934010842869955,0.060526225246743726,0.6429522395902524,raw,2173857.75,2565653,2294237.75,3025880.5,2705970.25,3456722.5,"Interleukin 17 receptor E, isoform CRA_c OS=Homo sapiens OX=9606 GN=IL17RE PE=4 SV=1",coagulation;development,cytoskeleton,structural molecule activity,NA,IL17RE,NA,NA,ENSG00000163701
Q13505,0,6,27693284.666666668,1.071992097396879e-4,1.3187450754453203,0.399165706412141,0.09543983533042102,0.6429522395902524,raw,22268074.71875,29037626.5390625,21297257.203125,29365913.875,28899622.9375,35291212.7265625,Metaxin-1 OS=Homo sapiens OX=9606 GN=MTX1 PE=1 SV=3,cell growth;conjugation,cytoskeleton;endosome;nucleus,NA,4580,MTX1,NA,RAC2 GTPase cycle; Mitochondrial protein import; Cristae formation,ENSG00000173171
O15269,0,6,17728854.9544271,6.862744031919467e-5,1.3186888910365009,0.3991042398738152,0.10144814131109585,0.6429522395902524,raw,15486040.1835938,15974132.15625,14639264.5117188,20421269.15625,17004715.46875,22847708.25,Serine palmitoyltransferase 1 OS=Homo sapiens OX=9606 GN=SPTLC1 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,10558,SPTLC1,Sphingolipid pathway; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Sphingolipid metabolism overview; Sphingolipid metabolism: integrated pathway; Biosynthesis and turnover of 1-deoxy-sphingoid bases,Sphingolipid de novo biosynthesis,ENSG00000090054
Q8WVP5,0.8333333333333334,6,4436167.791666667,1.7172166005707825e-5,1.318579046009498,0.3989840602943428,0.16147353706431128,0.6638855679885327,raw,4780586.5,2321745.5,3943723.75,5200111.5,4490068.5,5880771,Tumor necrosis factor alpha-induced protein 8-like protein 1 OS=Homo sapiens OX=9606 GN=TNFAIP8L1 PE=1 SV=2,metabolic process,nucleus,structural molecule activity,126282,TNFAIP8L1,NA,PI Metabolism,ENSG00000185361
Q96BN2,0.16666666666666666,6,244792.5703125,9.47578822935112e-7,1.3185056079797555,0.39890370740829556,0.3328255880039511,0.8158667519449163,raw,NA,173946.171875,251382.5,NA,244975.765625,308865.84375,Transcriptional adapter 1 OS=Homo sapiens OX=9606 GN=TADA1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,117143,TADA1,NA,HATs acetylate histones,ENSG00000152382
Q8N6T3,0,6,10579168.854166666,4.095139144813805e-5,1.3184208192251976,0.3988109294570384,0.12249310061602164,0.6445597830897484,raw,7937005.875,11237827.625,9071173.3125,12452098.8125,10817283.75,11959623.75,ADP-ribosylation factor GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=ARFGAP1 PE=1 SV=2,conjugation;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,DNA binding;structural molecule activity,55738,ARFGAP1,IL-18 signaling pathway,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Clathrin-mediated endocytosis; XBP1(S) activates chaperone genes,ENSG00000101199
Q9BQS8,0,6,1535712.8072916667,5.944661361421661e-6,1.3183210435173427,0.39870174476890025,0.16313226085269453,0.6638855679885327,raw,1003340.46875,1345529.25,1602133.171875,1677322.40625,1473825.671875,2112125.875,FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FYCO1 PE=1 SV=3,conjugation;metabolic process,extracellular;mitochondrion;nucleus,structural molecule activity,79443,FYCO1,Clock-controlled autophagy in bone metabolism,NA,ENSG00000163820
A0A3B3IRW6,0.3333333333333333,6,373097.1375,1.4442388751479874e-6,1.3183127284925544,0.39869264525333287,0.5267796957397288,1,raw,333709.5,391667.34375,262965.9375,317797.46875,NA,559345.4375,Glutamine and serine-rich protein 1 OS=Homo sapiens OX=9606 GN=QSER1 PE=1 SV=1,NA,NA,NA,NA,QSER1,NA,NA,ENSG00000060749
P08579,0,6,11376328.325520834,4.4037152721828096e-5,1.318286154196669,0.398663563389465,0.1734589428553511,0.6689341104244626,raw,10795650.484375,9677427.375,10011360.46875,13197837.890625,10274921.5625,14300772.171875,U2 small nuclear ribonucleoprotein B'' OS=Homo sapiens OX=9606 GN=SNRPB2 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,6629,SNRPB2,mRNA processing; Ciliary landscape,mRNA Splicing - Major Pathway,ENSG00000125870
P12429,0,6,312961952.90625,0.001211458822380914,1.3181437647203094,0.39850772796206024,0.19121868001134082,0.6823711621042031,raw,294694998.25,267501348.59375,268527934.09375,385038133.8125,273558928.25,388450374.4375,Annexin A3 OS=Homo sapiens OX=9606 GN=ANXA3 PE=1 SV=3,coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;nucleus,DNA binding;structural molecule activity,306,ANXA3,Prostaglandin synthesis and regulation,NA,ENSG00000138772
P60983,0,6,23160812.25,8.965425373024666e-5,1.3181263594835209,0.3984886779803682,0.1615044371406225,0.6638855679885327,raw,20199307,21545486.125,19530752.375,26625239,21123639.5,29940449.5,Glia maturation factor beta OS=Homo sapiens OX=9606 GN=GMFB PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,NA,antioxidant activity;DNA binding;motor activity;structural molecule activity,2764,GMFB,NA,NA,ENSG00000197045
Q9NQW7,0,6,46383791.88476563,1.79549154050404e-4,1.3180792253691966,0.39843708856458804,0.10949042759934204,0.6429522395902524,raw,45416734.9375,40209872.96875,35566127.25,52999798.2148438,43931269.71875,60178948.21875,Xaa-Pro aminopeptidase 1 OS=Homo sapiens OX=9606 GN=XPNPEP1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,structural molecule activity,7511,XPNPEP1,NA,NA,ENSG00000108039
P05787,0,6,5671894993.20573,0.021955599283966485,1.3180635489414896,0.39841992993059255,0.24697504492530234,0.7316541032247736,raw,4985969573.48438,5380629664.875,4765258788.59375,7092011831.625,4732778790.6875,7074721309.96875,"CRAP Keratin, type II cytoskeletal 8 OS=Homo sapiens OX=9606 GN=KRT8 PE=1 SV=7",cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,metal ion binding;structural molecule activity,3856,KRT8,Primary focal segmental glomerulosclerosis (FSGS); Acute viral myocarditis,Formation of the cornified envelope,ENSG00000170421
P60510,0,6,9285390.40625,3.594324492943185e-5,1.3178694560322886,0.39820746862937306,0.17847810631965244,0.6741527184744509,raw,8786012.0625,9619432.6875,5362868.875,11578816.9375,8619118.625,11746093.25,Serine/threonine-protein phosphatase 4 catalytic subunit OS=Homo sapiens OX=9606 GN=PPP4C PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,5531,PPP4C,16p11.2 proximal deletion syndrome,Processing of DNA double-strand break ends,ENSG00000149923
O43747,0,6,27932301.119791668,1.0812442952485206e-4,1.3178377508276566,0.39817275996266227,0.06933672830901383,0.6429522395902524,raw,25021924.25,27415989.15625,20473446.96875,34323540.125,27384069.84375,32974836.375,AP-1 complex subunit gamma-1 OS=Homo sapiens OX=9606 GN=AP1G1 PE=1 SV=5,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,164,AP1G1,NA,MHC class II antigen presentation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Nef mediated downregulation of MHC class I complex cell surface expression,ENSG00000166747
Q14165,0,6,35384502.760416664,1.3697149971935932e-4,1.3177296539151306,0.3980544166568197,0.1411435310080226,0.6572502130392559,raw,35019838.625,29486405.375,27308490.5625,38855110.75,33511414.75,48125756.5,Malectin OS=Homo sapiens OX=9606 GN=MLEC PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;extracellular,structural molecule activity,9761,MLEC,NA,Neutrophil degranulation; N-glycan trimming in the ER and Calnexin/Calreticulin cycle,ENSG00000110917
Q9UL25,0,6,19117931.09375,7.400447905605878e-5,1.3172352363905189,0.397513010035516,0.21670352611402738,0.7052519353827845,raw,18524613.78125,17666469.6875,12383584.53125,23270896.375,15817383.25,27044638.9375,Ras-related protein Rab-21 OS=Homo sapiens OX=9606 GN=RAB21 PE=1 SV=3,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,23011,RAB21,Ciliary landscape,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation,ENSG00000080371
Q9NZD2,0.3333333333333333,6,820637.6354166666,3.1766439791521337e-6,1.3171422782487534,0.39741119452164547,0.16477616748542082,0.6638855679885327,raw,791498.5,827316.375,496784.3125,921133.8125,797399.4375,1089693.375,Glycolipid transfer protein OS=Homo sapiens OX=9606 GN=GLTP PE=1 SV=3,cell growth;cellular homeostasis;conjugation,cytosol,catalytic activity;structural molecule activity,51228,GLTP,NA,Glycosphingolipid metabolism,ENSG00000139433
A0A0G2JMX7,0,6,14346525.697916666,5.55346263846392e-5,1.3169534607458093,0.3972043637132095,0.2079740760097797,0.6988382857167694,raw,14258150.4375,12239209.09375,11719414.5,18777320.5625,12620049.5625,16465010.03125,Microtubule-associated protein OS=Homo sapiens OX=9606 GN=MAPT PE=1 SV=1,NA,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity,NA,MAPT,NA,NA,ENSG00000277956
F5GXE4,0.5,6,3079007.578125,1.1918672094350707e-5,1.3169098098704277,0.39715654429740926,0.12966843923897262,0.6498046150645307,raw,2781765.875,3158786.625,1846122.78125,3445566.125,3081966.96875,4159837.09375,Arginyl-tRNA--protein transferase 1 OS=Homo sapiens OX=9606 GN=ATE1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,11101,ATE1,NA,NA,ENSG00000107669
P23443,0,6,2944696.3776041665,1.1398760688812292e-5,1.3166264052157588,0.39684603670758245,0.6410168073174374,1,raw,2840742.03125,3185292.328125,2064557.46875,4370711.84375,1466678.625,3740195.96875,Ribosomal protein S6 kinase beta-1 OS=Homo sapiens OX=9606 GN=RPS6KB1 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;cytosol;endosome;membrane;nucleus,signal transducer activity;structural molecule activity,6198,RPS6KB1,IL-5 signaling pathway; AMP-activated protein kinase signaling; Target of rapamycin signaling; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Kit receptor signaling pathway; IL6 signaling pathway; BDNF-TrkB signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; PI3K-Akt signaling pathway; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Thermogenesis; EGF/EGFR signaling pathway; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; Cytoplasmic ribosomal proteins; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; IL-2 signaling pathway; Malignant pleural mesothelioma; GDNF signaling; G13 signaling pathway; Interferon type I signaling pathways; ErbB signaling pathway,mTORC1-mediated signalling,ENSG00000108443
Q01081,0,6,27203213.875,1.0530217216485646e-4,1.3163611257183494,0.3965553270766703,0.30970534923918436,0.7910829974230433,raw,24693226.5,29664231.75,16309442.5,31291266,22212275,39048841.5,Splicing factor U2AF 35 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF1 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,102724594; 7307,U2AF1,mRNA processing,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,ENSG00000160201
Q9UGT4,0,6,611660.984375,2.367706645955333e-6,1.3160929675621056,0.3962614032855489,1,1,raw,477904.59375,NA,NA,957187.5,382584.96875,628966.875,Sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUSD2 PE=1 SV=1,metabolic process,cell surface;cytoplasm;cytoskeleton,NA,56241,SUSD2,NA,NA,ENSG00000099994
Q14151,0.3333333333333333,6,3621299.6875,1.401785557051817e-5,1.3159896022725024,0.3961480902820008,0.11721812779363226,0.6429522395902524,raw,3478577.25,2015781.375,3536542,4654052.5,4278459.5,3764385.5,Scaffold attachment factor B2 OS=Homo sapiens OX=9606 GN=SAFB2 PE=1 SV=1,defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,9667,SAFB2,NA,NA,ENSG00000130254
Q14525,0.5,6,18670325,7.227182003412542e-5,1.3156357437973585,0.3957601096212234,0.2548768158000885,0.735366952583477,raw,12075863,21498260,14693164,24191356,15887437,23675870,"CRAP Keratin, type I cuticular Ha3-II OS=Homo sapiens OX=9606 GN=KRT33B PE=1 SV=3",cell growth;metabolic process,cytosol;endoplasmic reticulum,structural molecule activity,3884,KRT33B,NA,Formation of the cornified envelope,ENSG00000131738; ENSG00000263012
Q96P16,0,6,20606036.260416668,7.976485381103415e-5,1.3156331760949496,0.3957572939367422,0.02465613326651633,0.6429522395902524,raw,16870205.625,19706210.8125,16053994.625,24377060.5625,21121167.9375,25507578,Regulation of nuclear pre-mRNA domain-containing protein 1A OS=Homo sapiens OX=9606 GN=RPRD1A PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,membrane,structural molecule activity,55197,RPRD1A,NA,RNA polymerase II transcribes snRNA genes,ENSG00000141425
O75400,0,6,33773274.052083336,1.3073452038223033e-4,1.315334871358217,0.3954301422888013,0.18454033235832487,0.6768541777950948,raw,29347906.375,31859675.515625,29708536.734375,39076674.34375,30399135.5625,42247715.78125,Pre-mRNA-processing factor 40 homolog A OS=Homo sapiens OX=9606 GN=PRPF40A PE=1 SV=2,cell differentiation;cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,NA,55660,PRPF40A,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000196504
Q13619,0,6,7947631.411458333,3.076485208835298e-5,1.3152088179743813,0.39529187688562734,0.29313810000105456,0.774322745775844,raw,7649304.75,6434500.3125,7069208.5625,9297485.4375,6442296.4375,10792992.96875,Cullin-4A OS=Homo sapiens OX=9606 GN=CUL4A PE=1 SV=3,cell differentiation;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,membrane;nucleus,structural molecule activity,8451,CUL4A,"Hippo-Merlin signaling dysregulation; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Neddylation; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; DNA Damage Recognition in GG-NER; Dual Incision in GG-NER,ENSG00000139842
Q9H061,0,6,2072688.33203125,8.023264625516379e-6,1.3147939457420381,0.39483671833946454,0.42278259539672275,0.9086347256931654,raw,2343471.6875,1745422.40625,1318982.2734375,1486034.4375,2294870.8125,3247348.375,Transmembrane protein 126A OS=Homo sapiens OX=9606 GN=TMEM126A PE=1 SV=1,cell growth;defense response,cytoskeleton;endosome,NA,84233,TMEM126A,NA,NA,ENSG00000171202
P48506,0,6,18062161.6953125,6.991765271739505e-5,1.3147859099184034,0.39482790077655056,0.0907885209745582,0.6429522395902524,raw,14399432.640625,15030224.9375,17490258.453125,21339920.671875,17117188.09375,22995945.375,Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens OX=9606 GN=GCLC PE=1 SV=2,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;endosome;nucleus,structural molecule activity,2729,GCLC,"Glutathione metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Aryl hydrocarbon receptor pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Nuclear receptors meta-pathway; NRF2 pathway; Transcriptional activation by NRF2 in response to phytochemicals; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Oxidative stress response; Ferroptosis; NRF2-ARE regulation; Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases; Vitamin D-sensitive calcium signaling in depression; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway",Glutathione synthesis and recycling; Nuclear events mediated by NFE2L2; Defective GCLC causes HAGGSD,ENSG00000001084
Q8NBS9,0,6,76957412.5625,2.978979889749612e-4,1.3146933278381798,0.3947263082587995,0.2655243771592685,0.7454335379461359,raw,74224280.0625,69648492.96875,61963160.3125,91566409,63880227.96875,100461905.0625,Thioredoxin domain-containing protein 5 OS=Homo sapiens OX=9606 GN=TXNDC5 PE=1 SV=2,metabolic process,cell surface;extracellular;mitochondrion,structural molecule activity,81567,TXNDC5,VEGFA-VEGFR2 signaling pathway,Neutrophil degranulation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis,ENSG00000239264
P15586,0,6,16587610.854166666,6.420974602469099e-5,1.3145365588776077,0.39455426563643814,0.08157728265512995,0.6429522395902524,raw,14108646.1875,14078494.8125,13944832.625,22075116.375,16811879,18506696.125,N-acetylglucosamine-6-sulfatase OS=Homo sapiens OX=9606 GN=GNS PE=1 SV=3,cellular homeostasis,cell surface;mitochondrion;nucleus,structural molecule activity,2799,GNS,Glycosaminoglycan degradation,Neutrophil degranulation; Lysosome Vesicle Biogenesis; Keratan sulfate degradation; MPS IIID - Sanfilippo syndrome D,ENSG00000135677
A0A5F9YFS9,0,6,17631411.524739582,6.825024206400178e-5,1.3144641350559656,0.3944747787891407,0.30482677559930227,0.7849075999456834,raw,13277258.4375,16709546.3203125,14263979.328125,28562080.4375,14226115.375,18749489.25,Microsomal signal peptidase 12 kDa subunit OS=Homo sapiens OX=9606 GN=SPCS1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,protein binding,NA,SPCS1,NA,NA,ENSG00000114902
Q13432,0.16666666666666666,6,817999.8541666666,3.1664332703514357e-6,1.3142945524438416,0.39428864074989434,0.546857597749251,1,raw,582342.6875,859280.25,790201.8125,1038557.9375,498455.6875,1139160.75,Protein unc-119 homolog A OS=Homo sapiens OX=9606 GN=UNC119 PE=1 SV=1,cell death;cell differentiation;conjugation;defense response;development;metabolic process,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,9094,UNC119,Joubert syndrome; Ciliopathies,NA,ENSG00000109103
O43295,0.5,6,7148421.25,2.7671152703989776e-5,1.3142241133372266,0.39421131799685816,1,1,raw,NA,5634653.5,NA,7405197.5,6838263,8715571,SLIT-ROBO Rho GTPase-activating protein 3 OS=Homo sapiens OX=9606 GN=SRGAP3 PE=1 SV=3,development;metabolic process,cytosol;nucleus,DNA binding,9901,SRGAP3,NA,CDC42 GTPase cycle; RAC1 GTPase cycle; Inactivation of CDC42 and RAC1,ENSG00000196220
B4DZS0,0,6,541793.5208333334,2.0972534668422673e-6,1.3141503944085908,0.39413039046352766,1,1,raw,447972.9375,NA,NA,453186.6875,NA,724220.9375,DNA fragmentation factor subunit beta OS=Homo sapiens OX=9606 GN=DFFB PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis,membrane;nucleus,structural molecule activity,1677,DFFB,Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Acute viral myocarditis,NA,ENSG00000169598
Q5T9B7,0,6,139635974.52604166,5.405233182194635e-4,1.313698398498484,0.39363409686687634,0.3765239188252639,0.8615698665976935,raw,116381096.65625,120998011.375,142090054.375,163179520.375,108503687.5,186663476.875,Adenylate kinase isoenzyme 1 OS=Homo sapiens OX=9606 GN=AK1 PE=1 SV=1,cellular homeostasis,cytosol,signal transducer activity;structural molecule activity,203,AK1,NA,NA,ENSG00000106992
A0A087WYL5,0.16666666666666666,6,325362.84375,1.2594620012930288e-6,1.3134899973193144,0.39340521389159167,0.3218810654439864,0.8032794187150067,raw,196876.453125,326997.375,NA,261686.203125,416880.25,424373.9375,Seizure 6-like protein 2 OS=Homo sapiens OX=9606 GN=SEZ6L2 PE=1 SV=1,cell growth;defense response;metabolic process,cytoskeleton;extracellular;nucleus,NA,26470,SEZ6L2,16p11.2 proximal deletion syndrome,NA,ENSG00000174938
P30876,0,6,20807309.817708332,8.054397288422711e-5,1.3134636483330935,0.39337627272483944,0.24067370040573155,0.7263138257852598,raw,18765197.984375,19711393.8125,17056148.890625,24647405.40625,17634931.0625,27028781.75,DNA-directed RNA polymerase II subunit RPB2 OS=Homo sapiens OX=9606 GN=POLR2B PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,5431,POLR2B,Pyrimidine metabolism; Eukaryotic transcription initiation,Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; mRNA Splicing - Major Pathway; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,ENSG00000047315
Q12846,0,6,376660.6458333333,1.4580330235067744e-6,1.3133738527816974,0.3932776388377501,1,1,raw,315240.375,368475.96875,NA,NA,NA,446265.59375,Syntaxin-4 OS=Homo sapiens OX=9606 GN=STX4 PE=1 SV=2,cell death;cell growth;coagulation;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,DNA binding;structural molecule activity,6810,STX4,Insulin signaling,ER-Phagosome pathway; Translocation of SLC2A4 (GLUT4) to the plasma membrane; trans-Golgi Network Vesicle Budding; Disinhibition of SNARE formation; Other interleukin signaling,ENSG00000103496
Q15014,0,6,4028731.6822916665,1.559500282444803e-5,1.3131639062687201,0.3930470015337741,0.11110686124996909,0.6429522395902524,raw,2935914.25,3805254,3699981.25,4526616.1875,3855336.625,5349287.78125,Mortality factor 4-like protein 2 OS=Homo sapiens OX=9606 GN=MORF4L2 PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,NA,9643,MORF4L2,NA,HATs acetylate histones,ENSG00000123562
Q15042,0,6,22725165.841145832,8.796789000282245e-5,1.3130328913338165,0.39290305604027775,0.17163617863558767,0.6688917965646828,raw,22076909.5,18706096.84375,18492079.25,28279226.484375,19808974.65625,28987708.3125,Rab3 GTPase-activating protein catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP1 PE=1 SV=3,cell death;cell growth;defense response;development;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,DNA binding;structural molecule activity,22930,RAB3GAP1,NA,RAB GEFs exchange GTP for GDP on RABs; COPI-independent Golgi-to-ER retrograde traffic,ENSG00000115839
A8K070,0,6,23406504.010416668,9.060531326952629e-5,1.3129693922253016,0.39283328470036183,0.09895119302710124,0.6429522395902524,raw,23572487.125,17460715.34375,16790785,30949954.09375,21452442.5625,30212639.9375,COP9 signalosome complex subunit 1 OS=Homo sapiens OX=9606 GN=GPS1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,NA,NA,GPS1,NA,NA,ENSG00000169727
O15213,0,6,9955651.889322916,3.8537790941911644e-5,1.312887319202522,0.3927430997771114,0.17022379799323226,0.668039680404208,raw,8186529.375,7917537.0234375,9683091.46875,12609841.71875,8624103.75,12712808,WD repeat-containing protein 46 OS=Homo sapiens OX=9606 GN=WDR46 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane;nucleus,NA,9277,WDR46,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000204221; ENSG00000206284; ENSG00000226916; ENSG00000227057; ENSG00000236222
P10768,0,6,86132009.76953125,3.334123594121203e-4,1.3128275006859715,0.3926773653900088,0.2060133777261839,0.6984259393840593,raw,89948141.75,63986394.859375,67388301.3828125,104651671.125,72731155.375,118086394.125,S-formylglutathione hydrolase OS=Homo sapiens OX=9606 GN=ESD PE=1 SV=2,cellular homeostasis,cytosol;extracellular;nucleus,structural molecule activity,2098,ESD,"Phase I biotransformations, non P450",Glutathione conjugation,ENSG00000139684
Q9BY43,0,6,816250.4635416666,3.159661473694474e-6,1.3125573924031426,0.3923805069121978,0.8770021417591775,1,raw,427950.15625,1486310.5,621135.125,815275.5,654188,892643.5,Charged multivesicular body protein 4a OS=Homo sapiens OX=9606 GN=CHMP4A PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,29082,CHMP4A,NA,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex,ENSG00000254505; ENSG00000285302
O60244,0.16666666666666666,6,1467380.8600260417,5.680152082908159e-6,1.3124439518044513,0.39225581349851213,0.05388864502510023,0.6429522395902524,raw,1401068.1875,1324152.359375,1052222.15625,1838823.46875,1461900.28125,1726118.70703125,Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,9282,MED14,Vitamin D in inflammatory diseases,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Generic Transcription Pathway,ENSG00000180182
Q9HB07,0,6,22116459.567708332,8.561162088337658e-5,1.3123832471546453,0.39218908278398407,0.15895917628804418,0.6638855679885327,raw,18546920.40625,19229824.4375,19341743.375,25236899.4375,20304333.125,30039036.625,MYG1 exonuclease OS=Homo sapiens OX=9606 GN=MYG1 PE=1 SV=3,cellular homeostasis;metabolic process,endosome;membrane;nucleus,structural molecule activity,60314,MYG1,NA,NA,ENSG00000139637
Q02978,0,6,20062933.217447918,7.76625312547089e-5,1.3122560373995316,0.3920492350844705,0.16264722785594196,0.6638855679885327,raw,17307596.5,18527739.125,16833429.515625,26584740.59375,18412095.5703125,22711998,Mitochondrial 2-oxoglutarate/malate carrier protein OS=Homo sapiens OX=9606 GN=SLC25A11 PE=1 SV=3,conjugation,cytoplasm;cytoskeleton;endosome,catalytic activity,8402,SLC25A11,VEGFA-VEGFR2 signaling pathway,Gluconeogenesis,ENSG00000108528
Q6P1L8,0,6,4648542.21875,1.7994255946510524e-5,1.3120096859861594,0.3917783707735397,0.21690838016180605,0.7052519353827845,raw,4627200.5,4040284.0625,3650402.125,6070931.875,3990430.625,5512004.125,"39S ribosomal protein L14, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL14 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,64928,MRPL14,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000180992
P25705,0,6,696741209.3593751,0.0026970476032516662,1.3116411277431759,0.3913730446149319,0.1471267969903002,0.6632457206176153,raw,691142116.125,587909035.898438,545105048.617188,817944158.328125,631816472.5625,906530424.625,"ATP synthase subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1A PE=1 SV=1",cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;endosome;membrane;nucleus,antioxidant activity;catalytic activity;structural molecule activity,498,ATP5F1A,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,Mitochondrial protein import; Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000152234
Q15029,0,6,148872021.18945333,5.762755561845162e-4,1.3114232817853304,0.3911334124635884,0.06485597781957804,0.6429522395902524,raw,128844716.96875,136648735.132813,128536001.132813,173422685.796875,146575655.425781,179204332.679688,116 kDa U5 small nuclear ribonucleoprotein component OS=Homo sapiens OX=9606 GN=EFTUD2 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,9343,EFTUD2,mRNA processing; Ciliary landscape,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000108883
O43390,0,6,114187818.67447917,4.420148809049283e-4,1.3110918134188179,0.3907687184551534,0.08353476384303947,0.6429522395902524,raw,109148197.6875,93574846.796875,95814076.15625,134277724,109208758.96875,143103308.4375,Heterogeneous nuclear ribonucleoprotein R OS=Homo sapiens OX=9606 GN=HNRNPR PE=1 SV=1,cellular component movement;cellular homeostasis,extracellular;membrane;nucleus,RNA binding,10236,HNRNPR,mRNA processing,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000125944; ENSG00000282958
Q13435,0,6,139314509.41666666,5.392789441374911e-4,1.3110746516668381,0.3907498339374813,0.2200978344794422,0.7087130179153194,raw,125007962.25,128275109.71875,121724247.75,175304999.375,121679966.84375,163894770.5625,Splicing factor 3B subunit 2 OS=Homo sapiens OX=9606 GN=SF3B2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,membrane,NA,10992,SF3B2,mRNA processing,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000087365
Q9BRS2,0,6,2962240.7447916665,1.1466673986946503e-5,1.311047305565851,0.3907197422141162,0.45553384871924263,0.9388814790284128,raw,1639399.75,2926115.8125,2736602.53125,3587815.375,1482824.09375,5400686.90625,Serine/threonine-protein kinase RIO1 OS=Homo sapiens OX=9606 GN=RIOK1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,83732,RIOK1,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000124784
Q13838,0,6,208334176.86197916,8.064503503354448e-4,1.3110427956497277,0.3907147794299443,0.11675575910385771,0.6429522395902524,raw,205043246.0625,164192813.09375,176740633.28125,239913166.4375,195294731.75,268820470.546875,Spliceosome RNA helicase DDX39B OS=Homo sapiens OX=9606 GN=DDX39B PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;conjugation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,7919,DDX39B,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; RHOBTB2 GTPase cycle,ENSG00000198563; ENSG00000215425; ENSG00000225073; ENSG00000225859; ENSG00000229496; ENSG00000230624; ENSG00000235439
P28066,0,6,122806917.671875,4.7537894776483036e-4,1.3107260123496667,0.39036614327494534,0.1881368865501426,0.6796724904026823,raw,118678809.375,112286798.15625,91556711.8125,155555402.5625,106117861.375,152645922.75,Proteasome subunit alpha type-5 OS=Homo sapiens OX=9606 GN=PSMA5 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cell surface;cytosol;membrane;nucleus,NA,5686,PSMA5,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,Downstream TCR signaling; Neutrophil degranulation; FCERI mediated NF-kB activation; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000143106
Q9P0M6,0,6,14829590.307291666,5.7404543406094646e-5,1.3107176099315712,0.3903568948388433,0.30924511629658874,0.7907663267388306,raw,14490723.1875,12995118.25,12865268.125,18993246.0625,12210663.53125,17422522.6875,Core histone macro-H2A.2 OS=Homo sapiens OX=9606 GN=MACROH2A2 PE=1 SV=3,cell growth;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,55506,MACROH2A2,Pre-implantation embryo; lncRNA in canonical Wnt signaling and colorectal cancer; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,NA,ENSG00000099284
K7EKE6,0,6,78819798.7109375,3.0510718520233935e-4,1.3105630626281874,0.39018677598757573,0.13307638088015408,0.6514609890946903,raw,81378345.3125,52667921.1875,59418634.546875,105270226.96875,69024632.09375,105159032.15625,"Lon protease homolog, mitochondrial OS=Homo sapiens OX=9606 GN=LONP1 PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation,cytosol;endosome;membrane,RNA binding;structural molecule activity,NA,LONP1,NA,NA,ENSG00000196365
Q93052,0,6,7450823.583333333,2.884173580913477e-5,1.310533236430725,0.3901539423162719,0.06836168300608186,0.6429522395902524,raw,6884302.375,6606751.75,5614829.9375,8487685.3125,7358421.25,9752950.875,Lipoma-preferred partner OS=Homo sapiens OX=9606 GN=LPP PE=1 SV=1,cell communication,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,4026,LPP,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement,NA,ENSG00000145012
Q86WB0,0,6,1972273.7135416667,7.634565058889954e-6,1.3105320393219815,0.3901526244835085,0.10858078036138791,0.6429522395902524,raw,1966546.375,1571094.328125,1627835.21875,2577222.03125,1903429.34375,2187514.984375,Nuclear-interacting partner of ALK OS=Homo sapiens OX=9606 GN=ZC3HC1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;membrane,structural molecule activity,51530,ZC3HC1,NA,Nuclear events stimulated by ALK signaling in cancer,ENSG00000091732
F8VVA7,0,6,24918326.177083332,9.645749525098267e-5,1.3104312785696628,0.3900416980643819,0.16678132796317346,0.6670444762382309,raw,19133678.6875,26001329.625,16956202.5,32167123.625,21178667,34072955.625,Coatomer subunit zeta OS=Homo sapiens OX=9606 GN=COPZ1 PE=1 SV=1,conjugation,cytoskeleton;extracellular,NA,NA,COPZ1,NA,NA,ENSG00000111481
P49327,0,6,1511419749.99935,0.0058506242482643375,1.3103977401509588,0.390004774091089,0.2550577968755692,0.735366952583477,raw,1441909419.84375,1381311327.76953,1222973735.72656,1875647624.57813,1257201546.8125,1889474845.26563,Fatty acid synthase OS=Homo sapiens OX=9606 GN=FASN PE=1 SV=3,cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,2194,FASN,AMP-activated protein kinase signaling; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Liver X receptor pathway; Nuclear receptors meta-pathway; Fatty acid biosynthesis; Angiopoietin-like protein 8 regulatory pathway; Lipid metabolism pathway; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-9 fatty acid synthesis; FOXA2 pathway,ChREBP activates metabolic gene expression; Activation of gene expression by SREBF (SREBP); Fatty acyl-CoA biosynthesis; NR1H2 & NR1H3 regulate gene expression linked to lipogenesis; Vitamin B5 (pantothenate) metabolism,ENSG00000169710
O94760,0,6,15340584.854166666,5.938257570763034e-5,1.310209239837232,0.38979722792307125,0.1662133822230322,0.6670281067027827,raw,14848174.84375,12018103.1875,13441303.9375,19454215.875,13545318.375,18736392.90625,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 OS=Homo sapiens OX=9606 GN=DDAH1 PE=1 SV=3",cellular homeostasis;development;metabolic process,cytosol,structural molecule activity,23576,DDAH1,Mesodermal commitment pathway; Nitric oxide metabolism in cystic fibrosis,eNOS activation,ENSG00000153904
Q9NUQ8,0,6,7096878.794270833,2.747163464072225e-5,1.3101659543050315,0.389749564655007,0.16126962865374267,0.6638855679885327,raw,4867109.625,7569151.6875,6328725.359375,8672364.15625,6852241.4375,8291680.5,ATP-binding cassette sub-family F member 3 OS=Homo sapiens OX=9606 GN=ABCF3 PE=1 SV=2,coagulation,NA,structural molecule activity,55324,ABCF3,NA,NA,ENSG00000161204
P14649,0,6,1392896.328125,5.391826481458898e-6,1.3101425260300377,0.38972376627561406,0.1752329883706978,0.6697819849820321,raw,1213534.90625,1233950.03125,950554,1589903.6875,1235994.34375,2133441,Myosin light chain 6B OS=Homo sapiens OX=9606 GN=MYL6B PE=1 SV=1,metabolic process,cytosol;endoplasmic reticulum,motor activity;structural molecule activity,140465,MYL6B,Ciliary landscape,Smooth Muscle Contraction,ENSG00000196465
Q9Y3A2,0,6,6223922.598958333,2.409246834097654e-5,1.31009797962666,0.3896747120951984,0.18050815603368622,0.6742444420587625,raw,6106779.75,4315095.34375,5627055.9375,8000479.8125,5333735,7960389.75,Probable U3 small nucleolar RNA-associated protein 11 OS=Homo sapiens OX=9606 GN=UTP11 PE=1 SV=2,cellular component movement;cellular homeostasis;defense response;metabolic process,cell surface;membrane;nucleus,NA,51118,UTP11,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000183520
Q9UNP9,0,6,1497505.35,5.796762357127688e-6,1.3098872711823444,0.3894426588588306,0.606784173081902,1,raw,704164.875,1814441.875,NA,2006082.4375,1896622.8125,1066214.75,Peptidyl-prolyl cis-trans isomerase E OS=Homo sapiens OX=9606 GN=PPIE PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cell surface;cytosol;membrane;nucleus,RNA binding;structural molecule activity,10450,PPIE,NA,mRNA Splicing - Major Pathway; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Neutrophil degranulation,ENSG00000084072
Q8NBQ5,0,6,12822774.541666666,4.963626792857106e-5,1.3095352348093092,0.3890548778639843,0.2680883967470204,0.7478701617438628,raw,12071125.25,12486793.3125,9459169.6875,16351895.8125,10402865.9375,16164797.25,Estradiol 17-beta-dehydrogenase 11 OS=Homo sapiens OX=9606 GN=HSD17B11 PE=1 SV=3,cellular homeostasis,cytosol;extracellular;nucleus,structural molecule activity,51170,HSD17B11,NA,Estrogen biosynthesis,ENSG00000198189
Q9H479,0.3333333333333333,6,741006.8723958334,2.8683975948914555e-6,1.3094584161084974,0.3889702453879173,0.23756006776977884,0.7224078784981852,raw,835203.59375,210389.234375,704459.59375,1093664.375,773397.09375,828927.34375,Fructosamine-3-kinase OS=Homo sapiens OX=9606 GN=FN3K PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol,signal transducer activity;structural molecule activity,64122,FN3K,NA,"Gamma carboxylation, hypusine formation and arylsulfatase activation",ENSG00000167363
Q9Y6C9,0,6,29313164.473958332,1.1346967701379785e-4,1.3093801833214365,0.3888840498858455,0.10523543781669012,0.6429522395902524,raw,27121651.1875,28832392.59375,21499873.9375,29740828.6875,30931676.9375,37752563.5,Mitochondrial carrier homolog 2 OS=Homo sapiens OX=9606 GN=MTCH2 PE=1 SV=1,metabolic process,cytoskeleton;endosome,NA,23788,MTCH2,NA,NA,ENSG00000109919; ENSG00000285121
O95747,0,6,34240148.440104164,1.3254176593095987e-4,1.3092385038145493,0.3887279367998241,0.30758994199720796,0.7885345351708948,raw,30895613.5625,29505647.859375,32925416.4375,43398056.8125,28266429.09375,40449726.875,Serine/threonine-protein kinase OSR1 OS=Homo sapiens OX=9606 GN=OXSR1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;nucleus,signal transducer activity;structural molecule activity,9943,OXSR1,NA,NA,ENSG00000172939
P45880,0,6,223799794.07552084,8.663169195555177e-4,1.3089887262855682,0.3884526720715858,0.1392272303918975,0.6572502130392559,raw,193016557.234375,195561335.9375,191500885.515625,252656497.40625,210903789.078125,299159699.28125,Voltage-dependent anion-selective channel protein 2 OS=Homo sapiens OX=9606 GN=VDAC2 PE=1 SV=2,cell growth;conjugation;development;metabolic process,cytoskeleton;endoplasmic reticulum;endosome;nucleus,catalytic activity;structural molecule activity,7417,VDAC2,Alzheimer's disease and miRNA effects; Ferroptosis; Alzheimer's disease,Ub-specific processing proteases; Mitochondrial calcium ion transport,ENSG00000165637
Q9Y3I0,0,6,65033911.403645836,2.517427597580411e-4,1.3088415342673643,0.38829043604112584,0.16238608853553702,0.6638855679885327,raw,64988749.5625,50382313.53125,52982845.5625,85059974.6875,57059872.078125,79729713,RNA-splicing ligase RtcB homolog OS=Homo sapiens OX=9606 GN=RTCB PE=1 SV=1,cellular component movement;cellular homeostasis;defense response;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,motor activity;structural molecule activity,51493,RTCB,Unfolded protein response,tRNA processing in the nucleus,ENSG00000100220
P20073,0,6,54609465.510416664,2.113902925379506e-4,1.3088244185627693,0.3882715698125193,0.07490963599629226,0.6429522395902524,raw,52434044.21875,46815992.8125,43612114.15625,63339507.375,52828177.0625,68626957.4375,Annexin A7 OS=Homo sapiens OX=9606 GN=ANXA7 PE=1 SV=3,cellular homeostasis;metabolic process,cytoskeleton;extracellular;membrane,antioxidant activity;structural molecule activity,310,ANXA7,NA,NA,ENSG00000138279
P08138,0,6,485586.5078125,1.879679154145653e-6,1.3086779770197083,0.38811014074293665,1,1,raw,577726.4375,448838.40625,328396.25,587384.9375,NA,NA,Tumor necrosis factor receptor superfamily member 16 OS=Homo sapiens OX=9606 GN=NGFR PE=1 SV=1,cell differentiation;cell growth;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,4804,NGFR,Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Neural crest cell migration during development; Neural crest cell migration in cancer; mBDNF and proBDNF regulation of GABA neurotransmission; Malignant pleural mesothelioma; Neurogenesis regulation in the olfactory epithelium,NRAGE signals death through JNK; p75NTR recruits signalling complexes; NF-kB is activated and signals survival; p75NTR negatively regulates cell cycle via SC1; Ceramide signalling; NFG and proNGF binds to p75NTR; NADE modulates death signalling; NRIF signals cell death from the nucleus; Axonal growth stimulation; Axonal growth inhibition (RHOA activation); Regulated proteolysis of p75NTR,ENSG00000064300
P35754,0,6,8531498.260416666,3.302496913676047e-5,1.3084895376738683,0.387902389035264,0.35594597918164317,0.8403332772639565,raw,7542033.9375,7353390.1875,7992071.5,11816019.3125,6616802.125,9868672.5,Glutaredoxin-1 OS=Homo sapiens OX=9606 GN=GLRX PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endosome;membrane,structural molecule activity,2745,GLRX,One-carbon metabolism,Interconversion of nucleotide di- and triphosphates,ENSG00000173221
Q2TAA5,0.3333333333333333,6,511365.4010416667,1.979467857991851e-6,1.3084705940155732,0.3878815022654976,0.2977372820943117,0.7794198609185043,raw,442062.96875,521090.875,361268.9375,472709.78125,490846.40625,780213.4375,"GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG11 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,440138,ALG11,NA,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein; Defective ALG11 causes CDG-1p",ENSG00000253710
Q14573,0,6,49310739.151041664,1.9087920888756816e-4,1.3083683415711245,0.38776875624005913,0.16944090965215067,0.668039680404208,raw,48537267.46875,37008049.234375,44485459.71875,58203367.15625,44012886.015625,63617405.3125,"Inositol 1,4,5-trisphosphate receptor type 3 OS=Homo sapiens OX=9606 GN=ITPR3 PE=1 SV=2",conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,3710,ITPR3,Alzheimer's disease and miRNA effects; Myometrial relaxation and contraction pathways; MFAP5-mediated ovarian cancer cell motility and invasiveness; GPR40 pathway; Vitamin D-sensitive calcium signaling in depression; Airway smooth muscle cell contraction; Malignant pleural mesothelioma; Alzheimer's disease; GDNF signaling; Calcium regulation in cardiac cells,"Effects of PIP2 hydrolysis; Role of phospholipids in phagocytosis; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Sensory perception of sweet, bitter, and umami (glutamate) taste; Ion homeostasis; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Ca2+ pathway; VEGFR2 mediated cell proliferation; Elevation of cytosolic Ca2+ levels; PLC beta mediated events; DAG and IP3 signaling; CLEC7A (Dectin-1) induces NFAT activation",ENSG00000096433
Q969S3,0,6,13886265.63671875,5.375298453792302e-5,1.308244122243198,0.3876317771413236,0.13690918355171017,0.654928512316515,raw,12042008.875,14015657.3984375,9611347.65625,18086768,12573989.078125,16987822.8125,Zinc finger protein 622 OS=Homo sapiens OX=9606 GN=ZNF622 PE=1 SV=1,coagulation;development;metabolic process,cytosol;extracellular;membrane;nucleus,structural molecule activity,90441,ZNF622,NA,NA,ENSG00000173545
P41252,0,6,180991174.33072916,7.00607063829659e-4,1.3080430336530042,0.38741000522170127,0.10267851505860222,0.6429522395902524,raw,175543077.28125,142269855.5625,150121400.875,220243538.421875,168151274.5,229617899.34375,"Isoleucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=IARS1 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,3376,IARS1,Amino acid metabolism,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,ENSG00000196305
Q9H6F5,0,6,8621627.995117197,3.337385647353689e-5,1.3078185090719008,0.38716234647125103,0.1013121309637592,0.6429522395902524,raw,7512241.875,8143742.13085938,6741067.1875,9824648.96875,8240840.1875,11267227.6210938,Coiled-coil domain-containing protein 86 OS=Homo sapiens OX=9606 GN=CCDC86 PE=1 SV=1,NA,membrane;nucleus,NA,79080,CCDC86,NA,NA,ENSG00000110104
A0A0A0MTI5,0,6,101756232.41145833,3.9389288168211085e-4,1.3078142050757735,0.3871575985922119,0.07800792443074994,0.6429522395902524,raw,98442286.90625,75998902.0625,91211135.0625,115930561.9375,99392443.6875,129562064.8125,Acyl-CoA-binding protein OS=Homo sapiens OX=9606 GN=DBI PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P11387,0,6,236266803.34635416,9.145760393290321e-4,1.3076594413134306,0.3869868632357228,0.1603992492979486,0.6638855679885327,raw,210497290.625,223693203.453125,199177083.796875,292514529.453125,214716642.8125,277002069.9375,DNA topoisomerase 1 OS=Homo sapiens OX=9606 GN=TOP1 PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,7150,TOP1,Ebola virus infection in host,SUMOylation of DNA replication proteins,ENSG00000198900
Q01813,0,6,261566932.9337565,0.0010125114749671793,1.3074917338484777,0.3868018255746979,0.1595843314418103,0.6638855679885327,raw,231453754.383789,245687365.90625,205108175.4375,302623870.625,236359487,348168944.25,"ATP-dependent 6-phosphofructokinase, platelet type OS=Homo sapiens OX=9606 GN=PFKP PE=1 SV=2",cellular homeostasis;metabolic process,cytosol;nucleus,signal transducer activity;structural molecule activity,5214,PFKP,Cori cycle; Clear cell renal cell carcinoma pathways; Glucose metabolism in triple-negative breast cancer cells; Glycolysis and gluconeogenesis,Glycolysis,ENSG00000067057
Q6ULP2,0,6,305543.0598958333,1.1827406880955565e-6,1.3073518466655496,0.38664746487274937,0.18360166657903415,0.6760489340892933,raw,197004.90625,332478.40625,258370.671875,291620.46875,337781.375,416002.53125,Aftiphilin OS=Homo sapiens OX=9606 GN=AFTPH PE=1 SV=3,conjugation,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,54812,AFTPH,NA,NA,ENSG00000119844
P08397,0,6,11467852.770833334,4.439143890808078e-5,1.307021257778633,0.3862826057411597,0.09042078444213794,0.6429522395902524,raw,11841102.625,8344247.03125,8704665.53125,14119985,10906108.25,14891008.1875,Porphobilinogen deaminase OS=Homo sapiens OX=9606 GN=HMBS PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,structural molecule activity,3145,HMBS,Hemesynthesis defects and porphyrias; Heme biosynthesis,Heme biosynthesis,ENSG00000256269
Q9UBT2,0,6,51674580.625,2.0002951160565788e-4,1.306993507404028,0.38625197444683007,0.2866526416163506,0.7657456973128942,raw,51251160.484375,44704451.015625,44225485.25,66984934,43501842.53125,59379610.46875,SUMO-activating enzyme subunit 2 OS=Homo sapiens OX=9606 GN=UBA2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,10054,UBA2,NA,"SUMO is conjugated to E1 (UBA2:SAE1); SUMO is transferred from E1 to E2 (UBE2I, UBC9)",ENSG00000126261
Q06265,0,6,10578831.302083334,4.0950084802248454e-5,1.3069920479116623,0.38625036341849533,0.08042275251621314,0.6429522395902524,raw,8512834.65625,9855786.90625,9408314.75,12296592.5625,10194760.75,13204698.1875,Exosome complex component RRP45 OS=Homo sapiens OX=9606 GN=EXOSC9 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,5393,EXOSC9,Ciliary landscape,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000123737
Q6ZMG9,0.3333333333333333,6,2425751.5729166665,9.389953368531614e-6,1.3066633762564392,0.385887520661806,0.00510387600466606,0.6429522395902524,raw,2234256.0625,2114731.25,1966877.5,2883082.875,2592319.875,2763241.875,Ceramide synthase 6 OS=Homo sapiens OX=9606 GN=CERS6 PE=1 SV=1,cellular homeostasis;coagulation,cytoskeleton;extracellular,RNA binding;structural molecule activity,253782,CERS6,Sphingolipid pathway; Sphingolipid metabolism overview; Sphingolipid metabolism: integrated pathway; Synthesis of ceramides and 1-deoxyceramides,Sphingolipid de novo biosynthesis,ENSG00000172292
Q9H2U2,0,6,53695553.807291664,2.0785258967871643e-4,1.306645350391253,0.38586761805631037,0.23201645761399994,0.718558432162761,raw,51980391.125,43649238.625,46729238.09375,67919936.375,44976819.3125,66917699.3125,"Inorganic pyrophosphatase 2, mitochondrial OS=Homo sapiens OX=9606 GN=PPA2 PE=1 SV=2",cellular homeostasis;metabolic process,cytosol;endosome,structural molecule activity,27068,PPA2,NA,Mitochondrial tRNA aminoacylation; Pyrophosphate hydrolysis,ENSG00000138777
O14745,0,6,52234155.463541664,2.0219559559330716e-4,1.3065459988903334,0.38575791777141544,0.1695808051731824,0.668039680404208,raw,46919793.90625,46825156.40625,40317991.40625,71801380.8125,46361389.5,61179220.75,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 OS=Homo sapiens OX=9606 GN=SLC9A3R1 PE=1 SV=4,cell death;cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,antioxidant activity;catalytic activity;motor activity;structural molecule activity,9368,SLC9A3R1,NA,NA,ENSG00000109062
Q9Y2K7,0,6,448273.3828125,1.7352420618662832e-6,1.3064517001715985,0.3856537888669094,0.6593236739362058,1,raw,NA,546959.96875,259664.125,NA,400107.375,586362.0625,Lysine-specific demethylase 2A OS=Homo sapiens OX=9606 GN=KDM2A PE=1 SV=3,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,22992,KDM2A,NA,HDMs demethylate histones,ENSG00000173120
O95168,0,6,7121017.125,2.756507281570756e-5,1.306335161156887,0.3855250908386129,0.174253077633546,0.669219086937761,raw,6810103,5876875.5,6122368,8896277,6276119.75,8744359.5,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 OS=Homo sapiens OX=9606 GN=NDUFB4 PE=1 SV=3,cell growth;cellular homeostasis;coagulation;conjugation,cytoskeleton;endosome;membrane,catalytic activity,4710,NDUFB4,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000065518
Q99816,0,6,13436037.703125,5.2010176515511855e-5,1.3056450259474226,0.3847627154788592,0.34751474188581827,0.8305176189776291,raw,12990078.6875,13060091.84375,10043490.8125,17272622.5625,10289510.6875,16960431.625,Tumor susceptibility gene 101 protein OS=Homo sapiens OX=9606 GN=TSG101 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,7251,TSG101,Ebola virus infection in host; 7q11.23 copy number variation syndrome,HCMV Late Events; Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy,ENSG00000074319
Q96SU4,0,6,2261868.609375,8.7555712649666e-6,1.3055972050997098,0.38470987403884743,0.6189972757427433,1,raw,920959.125,2724265.34375,2291459.40625,3556793.21875,790433.625,3287300.9375,Oxysterol-binding protein-related protein 9 OS=Homo sapiens OX=9606 GN=OSBPL9 PE=1 SV=2,cellular homeostasis;conjugation,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,catalytic activity;structural molecule activity,114883,OSBPL9,NA,Synthesis of bile acids and bile salts,ENSG00000117859
Q86UP2,0,6,43658701.580729164,1.6900047661548716e-4,1.3055163173704016,0.384620489701495,0.3008884652030377,0.7806964943416801,raw,40569050.1875,40954819.078125,35476072.59375,52963557,34979012.625,57009698,Kinectin OS=Homo sapiens OX=9606 GN=KTN1 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular,motor activity,3895,KTN1,Glucocorticoid receptor pathway; Nuclear receptors meta-pathway,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RND2 GTPase cycle; RHOG GTPase cycle; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; RND3 GTPase cycle; RHO GTPases activate KTN1,ENSG00000126777
A0A0G2JK44,0,6,5977071.859375,2.3136922455917902e-5,1.3053468455686492,0.38443319828632416,0.28550256484830727,0.7655844406429082,raw,3983044.625,6370923.4375,5556608.3125,8316264.8125,5863389.625,5772200.34375,Bromodomain-containing protein 2 OS=Homo sapiens OX=9606 GN=BRD2 PE=1 SV=1,cell growth,NA,NA,NA,BRD2,NA,NA,ENSG00000234704
P13498,0,6,1703819.2395833333,6.595392284486054e-6,1.3053281043772949,0.3844124850038619,0.3109284283190104,0.7919133797078044,raw,514605.1875,2103680.9375,1552492.8125,2026512.5,2328541.8125,1697082.1875,Cytochrome b-245 light chain OS=Homo sapiens OX=9606 GN=CYBA PE=1 SV=3,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,1535,CYBA,TNF-alpha signaling pathway; Microglia pathogen phagocytosis pathway; Genetic causes of porto-sinusoidal vascular disease,RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; Neutrophil degranulation; Detoxification of Reactive Oxygen Species; VEGFA-VEGFR2 Pathway; WNT5:FZD7-mediated leishmania damping; ROS and RNS production in phagocytes; Cross-presentation of particulate exogenous antigens (phagosomes); RHO GTPases Activate NADPH Oxidases,ENSG00000051523
Q14694,0,6,25746969.442708332,9.966512859243442e-5,1.3051735017461905,0.38424160255817386,0.05717877358318102,0.6429522395902524,raw,23019145.125,24124688.875,20275276.375,30043978.25,25253456.21875,31765271.8125,Ubiquitin carboxyl-terminal hydrolase 10 OS=Homo sapiens OX=9606 GN=USP10 PE=1 SV=2,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,9100,USP10,VEGFA-VEGFR2 signaling pathway,Ub-specific processing proteases; Termination of translesion DNA synthesis,ENSG00000103194
G8JLB6,0,6,299528005.2740885,0.0011594567364172554,1.304577731176545,0.38358290739181217,0.08139788129114021,0.6429522395902524,raw,267564290.675781,267351326.65625,246069973.203125,348780587.15625,290580300.546875,376821553.40625,Heterogeneous nuclear ribonucleoprotein H OS=Homo sapiens OX=9606 GN=HNRNPH1 PE=1 SV=1,NA,cytosol;membrane,RNA binding,NA,HNRNPH1,MECP2 and associated Rett syndrome; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells,NA,ENSG00000169045
Q9UL58,0.6666666666666666,6,914702.25,3.54076302350439e-6,1.3044919146237013,0.38348800220945517,0.20842510392017755,0.6988382857167694,raw,690925.625,856847.875,NA,1208908.25,790235.5,1026594,Zinc finger protein 215 OS=Homo sapiens OX=9606 GN=ZNF215 PE=2 SV=2,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,7762,ZNF215,NA,Generic Transcription Pathway,ENSG00000149054
Q5TFE4,0,6,31056806.3984375,1.2021922076142488e-4,1.3044859400485243,0.3834813946485946,0.11133430191325826,0.6429522395902524,raw,26940167.6875,31428037.875,21967931.140625,34931889.59375,30075378.5625,40997433.53125,5'-nucleotidase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NT5DC1 PE=1 SV=1,NA,NA,structural molecule activity,221294,NT5DC1,NA,NA,ENSG00000178425
Q8N4Q1,0,6,5563891.604166667,2.153752399627295e-5,1.304416140731061,0.3834041980915237,0.2406418195400998,0.7263138257852598,raw,4953860.1875,5185854.875,4514384,6461895.1875,4705070.75,7562284.625,Mitochondrial intermembrane space import and assembly protein 40 OS=Homo sapiens OX=9606 GN=CHCHD4 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,endosome,structural molecule activity,131474,CHCHD4,NA,Mitochondrial protein import,ENSG00000163528
O43809,0,6,25624281.213541668,9.919020908146508e-5,1.3043697216907815,0.38335285733551466,0.1867352838906953,0.6790811483756987,raw,28402027.75,20965491.03125,18600120.5,30901420.75,24261434,30615193.25,Cleavage and polyadenylation specificity factor subunit 5 OS=Homo sapiens OX=9606 GN=NUDT21 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,11051,NUDT21,mRNA processing,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs,ENSG00000167005
P36404,0,6,6752879.666666667,2.6140032590832682e-5,1.3042933028768633,0.3832683320113439,0.05130069291509071,0.6429522395902524,raw,5364573.75,6128827.0625,5897269.125,7691768.625,6807146.4375,8627693,ADP-ribosylation factor-like protein 2 OS=Homo sapiens OX=9606 GN=ARL2 PE=1 SV=4,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;nucleus,structural molecule activity,402,ARL2,Joubert syndrome,Post-chaperonin tubulin folding pathway; Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane; RAS processing,ENSG00000213465
E9PF18,0,6,20770500.850260418,8.040148735861159e-5,1.304202088936231,0.38316743560932076,0.5620919601899899,1,raw,27529807.0625,11641158.375,17304316.09375,24007634.3125,15182423.0703125,28957666.1875,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=HADH PE=1 SV=2",cellular homeostasis,endosome;membrane,structural molecule activity,NA,HADH,Amino acid metabolism,NA,ENSG00000138796
O00764,0,6,15360073.817708334,5.945801643325965e-5,1.3040827568911817,0.38303542567949495,0.26776834110468717,0.7473260925206285,raw,15812749.625,13707373.4375,10533969.96875,20621134.125,12252101.5,19233114.25,Pyridoxal kinase OS=Homo sapiens OX=9606 GN=PDXK PE=1 SV=1,cellular homeostasis,cell surface;membrane;nucleus,signal transducer activity;structural molecule activity,8566,PDXK,NA,Neutrophil degranulation; Vitamins B6 activation to pyridoxal phosphate,ENSG00000160209
Q9Y2S2,0,6,2047126.4557291667,7.924315982477828e-6,1.304025577584772,0.3829721673395544,0.1717015990005228,0.6688917965646828,raw,2151180.4375,1221687.65625,1847406.046875,2302259.5,1955030.78125,2805194.3125,Lambda-crystallin homolog OS=Homo sapiens OX=9606 GN=CRYL1 PE=1 SV=3,cellular homeostasis,cytosol,structural molecule activity,51084,CRYL1,NA,Formation of xylulose-5-phosphate,ENSG00000165475
P50213,0,6,61784730.986979164,2.3916535779360082e-4,1.3039239827565154,0.3828597645866725,0.11509595743089877,0.6429522395902524,raw,58913281.3125,52828659.03125,51659248.296875,76818440.40625,57673590.34375,72815166.53125,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=IDH3A PE=1 SV=1",cellular homeostasis,endosome,structural molecule activity,3419,IDH3A,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Metabolic reprogramming in colon cancer; TCA cycle (aka Krebs or citric acid cycle),Citric acid cycle (TCA cycle),ENSG00000166411
P53597,0,6,18424953.015625,7.132199833063787e-5,1.3038853993036994,0.38281707423021843,0.041757231038559973,0.6429522395902524,raw,17449771.8125,15256248.34375,14123209.4375,22702860.6875,18265125.125,22752502.6875,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=SUCLG1 PE=1 SV=4",cellular homeostasis,endosome;nucleus,structural molecule activity,8802,SUCLG1,Amino acid metabolism; TCA cycle (aka Krebs or citric acid cycle),Citric acid cycle (TCA cycle),ENSG00000163541
O00567,0,6,103161495.47591147,3.99332579132196e-4,1.3038560707337226,0.3827846230206565,0.26675897185750563,0.7468192644661517,raw,98922808.53125,89405107.5351563,92319132.6953125,128981104.4375,87736427.796875,121604391.859375,Nucleolar protein 56 OS=Homo sapiens OX=9606 GN=NOP56 PE=1 SV=4,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,10528,NOP56,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; Association of TriC/CCT with target proteins during biosynthesis,ENSG00000101361
B8ZZC8,0.3333333333333333,6,1496264.7875,5.791960206670153e-6,1.3033939326213644,0.38227318424874795,0.4241762697036638,0.9095937941517775,raw,NA,1075515.75,1159072.125,2964347,828151.0625,1454238,rRNA N6-adenosine-methyltransferase METTL5 OS=Homo sapiens OX=9606 GN=METTL5 PE=1 SV=1,cellular homeostasis,NA,RNA binding;structural molecule activity,NA,METTL5,NA,NA,ENSG00000138382
Q9Y3D0,0,6,5957867.625,2.3062583901519777e-5,1.303379632834923,0.38225735607613,0.2245914453364897,0.7132042007362297,raw,5867443.6875,4209236.6875,5547283.4375,7870928.5,5022097.1875,7230216.25,Cytosolic iron-sulfur assembly component 2B OS=Homo sapiens OX=9606 GN=CIAO2B PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,NA,51647,CIAO2B,2q11.2 copy number variation syndrome,Cytosolic iron-sulfur cluster assembly,ENSG00000166595
Q9H0C8,0,6,18841481.123046882,7.293435614544555e-5,1.3032872349934483,0.38215507840544993,0.14003573517083606,0.6572502130392559,raw,14123334.484375,18442345.484375,16018130.328125,23646869.4375,16782533.5507813,24035673.453125,Integrin-linked kinase-associated serine/threonine phosphatase 2C OS=Homo sapiens OX=9606 GN=ILKAP PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,80895,ILKAP,2q37 copy number variation syndrome,NA,ENSG00000132323
Q13283,0,6,94966345.9375,3.6760959773830923e-4,1.303263897857925,0.38212924475172666,0.16790042992196214,0.6677212700673297,raw,89437961.78125,88142319.59375,75769300.125,115051285.25,84835942.1875,116561266.6875,Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,10146,G3BP1,NA,SARS-CoV-2 activates/modulates innate and adaptive immune responses,ENSG00000145907
Q9Y487,0.3333333333333333,6,523100.86875,2.0248952198740334e-6,1.3032062511490512,0.38206542923397674,0.30265195756189867,0.7825518083423609,raw,430002.03125,454658.75,NA,575999.9375,407663.875,747179.75,V-type proton ATPase 116 kDa subunit a2 OS=Homo sapiens OX=9606 GN=ATP6V0A2 PE=1 SV=2,conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,catalytic activity;structural molecule activity,23545,ATP6V0A2,NA,ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000185344
Q2NL82,0,6,22069100.479166668,8.542829640862517e-5,1.3028939290051214,0.3817196362258677,0.07736389828875569,0.6429522395902524,raw,20191857.875,20109609.03125,16453670.09375,25436576.8125,21437386.875,28785502.1875,Pre-rRNA-processing protein TSR1 homolog OS=Homo sapiens OX=9606 GN=TSR1 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,55720,TSR1,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000167721
Q9NXG2,0,6,20146921.018229168,7.798764349689668e-5,1.3027500620716947,0.3815603235090697,0.23169459930883674,0.7184011161541765,raw,16145356.75,20475252.046875,17211338.71875,26674135.875,17614041.15625,22761401.5625,THUMP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=THUMPD1 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,NA,55623,THUMPD1,NA,rRNA modification in the nucleus and cytosol,ENSG00000066654
A0A3B3IRU2,0,6,818424.209375,3.168075926451274e-6,1.3027068359785048,0.38151245315639987,0.7037409491718707,1,raw,1108700.75,261111.703125,NA,1092195.875,387702.09375,1242410.625,"NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae), isoform CRA_b OS=Homo sapiens OX=9606 GN=SNU13 PE=1 SV=1",metabolic process,nucleus,NA,NA,SNU13,NA,NA,ENSG00000100138
O14818,0,6,150877129.20052084,5.840372210363522e-4,1.30265787114605,0.38145822556916364,0.26939887948382896,0.7494598698888127,raw,133528764.375,148030510.625,116256138,208724660.875,124780405.390625,173942295.9375,Proteasome subunit alpha type-7 OS=Homo sapiens OX=9606 GN=PSMA7 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,5688,PSMA7,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000101182
Q9Y520,0,6,20031097.526041668,7.753929701213548e-5,1.3024340173805065,0.3812102859708323,0.15441856379810498,0.6638855679885327,raw,17678310.40625,18750694.21875,17032652.34375,24111498.90625,18191887.28125,24421542,Protein PRRC2C OS=Homo sapiens OX=9606 GN=PRRC2C PE=1 SV=4,cell growth;metabolic process,cytosol;nucleus,structural molecule activity,23215,PRRC2C,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000117523
P53367,0,6,18478823.229166668,7.153052701871819e-5,1.3024304784728427,0.3812063659477026,0.34224406934695795,0.8247147020235626,raw,18114447.625,15388775.125,16459255,23592808.6875,14402523.4375,22915129.5,Arfaptin-1 OS=Homo sapiens OX=9606 GN=ARFIP1 PE=1 SV=2,conjugation;metabolic process,cytoskeleton;cytosol;extracellular,structural molecule activity,27236,ARFIP1,NA,NA,ENSG00000164144
P42345,0,6,9918960.546875,3.8395760736320354e-5,1.3016897249440795,0.38038560393380694,0.24904641576228226,0.7316541032247736,raw,10141841.09375,8244292.1953125,8195080.3359375,11110725.65625,8620293.65625,13201530.34375,Serine/threonine-protein kinase mTOR OS=Homo sapiens OX=9606 GN=MTOR PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoskeleton;cytosol;endosome;extracellular;membrane;mitochondrion;nucleus,protein binding;RNA binding;signal transducer activity;structural molecule activity,2475,MTOR,"AMP-activated protein kinase signaling; Target of rapamycin signaling; MicroRNAs in cardiomyocyte hypertrophy; Type II diabetes mellitus; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; Thymic stromal lymphopoietin (TSLP) signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; Cardiac hypertrophic response; Extracellular vesicle-mediated signaling in recipient cells; TSLP signaling pathway; Ovarian infertility; MECP2 and associated Rett syndrome; Wnt signaling pathway; BDNF-TrkB signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; ATM signaling in development and disease ; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; PI3K/AKT/mTOR - vitamin D3 signaling; PI3K-Akt signaling pathway; Somatroph axis (GH) and its relationship to dietary restriction and aging; Caloric restriction and aging; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Thermogenesis; EGF/EGFR signaling pathway; Synaptic signaling pathways associated with autism spectrum disorder; Hippo signaling regulation pathways; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Joubert syndrome; Gastrin signaling pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Regucalcin in proximal tubule epithelial kidney cells; CAMKK2 pathway; Neuroinflammation; Autophagy; p53 transcriptional gene network; Malignant pleural mesothelioma; CCL18 signaling pathway; Network map of SARS-CoV-2 signaling pathway; Sphingolipid metabolism in senescence; Alzheimer's disease; Th17 cell differentiation pathway; GDNF signaling; DYRK1A; Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; Dravet syndrome; Clock-controlled autophagy in bone metabolism; Interferon type I signaling pathways; ErbB signaling pathway",mTORC1-mediated signalling; Constitutive Signaling by AKT1 E17K in Cancer; Energy dependent regulation of mTOR by LKB1-AMPK; Amino acids regulate mTORC1; Regulation of TP53 Degradation; Regulation of PTEN gene transcription; PIP3 activates AKT signaling; CD28 dependent PI3K/Akt signaling; TP53 Regulates Metabolic Genes; VEGFR2 mediated vascular permeability; Macroautophagy; HSF1-dependent transactivation,ENSG00000198793
Q8N138,0,6,1748705.8229166667,6.769145825070562e-6,1.3016034935992242,0.38029002842755866,0.5520408475709508,1,raw,934672.4375,2396096.25,1192270.375,3118767.25,1152988.5,1697440.125,ORM1-like protein 3 OS=Homo sapiens OX=9606 GN=ORMDL3 PE=1 SV=1,cellular homeostasis;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular,NA,94103,ORMDL3,NA,Neutrophil degranulation; Sphingolipid de novo biosynthesis,ENSG00000172057
P50395,0,6,190089792.96875,7.358273253283839e-4,1.3015086426653006,0.38018489198710387,0.25022968827639636,0.7326612824296702,raw,187593175.8125,159625775.609375,166593088.515625,218984441.5,163588136.75,244154139.625,Rab GDP dissociation inhibitor beta OS=Homo sapiens OX=9606 GN=GDI2 PE=1 SV=2,conjugation;development;metabolic process,cell surface;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,DNA binding;structural molecule activity,2665,GDI2,NA,RAB GEFs exchange GTP for GDP on RABs; Neutrophil degranulation,ENSG00000057608
Q9Y3B9,0,6,6741011.28125,2.609409071167798e-5,1.3013350476238288,0.3799924526894541,0.1049982699213199,0.6429522395902524,raw,5516795.75,7115788.0625,5144207.875,8329082.8125,6694338,7645855.1875,RRP15-like protein OS=Homo sapiens OX=9606 GN=RRP15 PE=1 SV=2,cellular component movement;cellular homeostasis,nucleus,NA,51018,RRP15,NA,NA,ENSG00000067533
P25685,0,6,67695925.77083333,2.6204727364698686e-4,1.3013211914477791,0.37997709127816004,0.0898926945316377,0.6429522395902524,raw,49394245.5,68319200.75,49063515.625,88905223.71875,62833724.09375,87659644.9375,DnaJ homolog subfamily B member 1 OS=Homo sapiens OX=9606 GN=DNAJB1 PE=1 SV=4,cellular component movement;coagulation;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,3337,DNAJB1,Nuclear receptors meta-pathway; NRF2 pathway,MAPK6/MAPK4 signaling; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Regulation of HSF1-mediated heat shock response; Attenuation phase,ENSG00000132002
Q969V3,0,6,28529402.958333332,1.1043577850335824e-4,1.3013156999713482,0.37997100320199373,0.28016748212999404,0.7616884726116023,raw,28341955.90625,25859825.65625,21375627.4375,38707056.625,23240155,33651797.125,Nicalin OS=Homo sapiens OX=9606 GN=NCLN PE=1 SV=2,metabolic process,cytoskeleton;extracellular;nucleus,protein binding,56926,NCLN,NA,NA,ENSG00000125912
Q9BYD3,0,6,6591564.596354167,2.551559066331309e-5,1.3011878481195827,0.37982925412903334,0.212811263817854,0.7022549232366887,raw,7497133.25,4428457.890625,4025477.8125,9169051.3125,5237902.8125,9191364.5,"39S ribosomal protein L4, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL4 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,51073,MRPL4,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000105364
Q8NHP8,0,6,3541648.484375,1.3709530063717855e-5,1.3011050246309634,0.37973742047142195,0.28796796029032073,0.7680960150654869,raw,3217570.625,2162370.96875,3855779.4375,5016774,3044458.25,3952937.625,Putative phospholipase B-like 2 OS=Homo sapiens OX=9606 GN=PLBD2 PE=1 SV=2,cellular homeostasis,cell surface;mitochondrion,structural molecule activity,196463,PLBD2,NA,NA,ENSG00000151176
Q1KMD3,0,6,67255555.3688151,2.6034262359708054e-4,1.3010653493827204,0.3796934269770203,0.2239976935756958,0.7125799511687476,raw,65074884,53825818.3691406,60436336.625,84666676.6875,57257558.71875,82272057.8125,Heterogeneous nuclear ribonucleoprotein U-like protein 2 OS=Homo sapiens OX=9606 GN=HNRNPUL2 PE=1 SV=1,NA,membrane,NA,221092,HNRNPUL2,NA,NA,ENSG00000214753
M0R287,0,6,21609048.625,8.36474605200855e-5,1.3009450127195623,0.37955998468960456,0.41585011425298535,0.9013279742103876,raw,29454630,11225165.75,9682053,30816689,10156900,38318854,Zinc finger protein 83 OS=Homo sapiens OX=9606 GN=ZNF83 PE=1 SV=1,metabolic process,NA,NA,NA,ZNF83,NA,NA,ENSG00000167766
P55210,0,6,4513872.471354167,1.7472956625377506e-5,1.3008870549931144,0.37949571049944525,0.08600614667690068,0.6429522395902524,raw,4026260.59375,4516750.6875,2723445.046875,5126798.5625,4814197.4375,5875782.5,Caspase-7 OS=Homo sapiens OX=9606 GN=CASP7 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,840,CASP7,Nucleotide-binding oligomerization domain (NOD) pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Allograft rejection; Parkinson's disease pathway; Oncostatin M signaling pathway; Nanomaterial induced apoptosis; Apoptosis; Apoptosis-related network due to altered Notch3 in ovarian cancer; Fas ligand pathway and stress induction of heat shock proteins; RAC1/PAK1/p38/MMP2 pathway; Hepatitis C and hepatocellular carcinoma; Apoptosis modulation by HSP70; ERK pathway in Huntington's disease; Acute viral myocarditis; Nonalcoholic fatty liver disease; Host-pathogen interaction of human coronaviruses - apoptosis; 3q29 copy number variation syndrome; Complement system in neuronal development and plasticity; Alzheimer's disease,Activation of caspases through apoptosome-mediated cleavage; SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Caspase-mediated cleavage of cytoskeletal proteins,ENSG00000165806
Q9NPD3,0,6,9661128.677083334,3.7397707489114136e-5,1.3008861929415323,0.3794947544764379,0.12700847279316244,0.6478993315659878,raw,10393610.875,7140162.75,6913329.4375,12531878.875,8993454.8125,11994335.3125,Exosome complex component RRP41 OS=Homo sapiens OX=9606 GN=EXOSC4 PE=1 SV=3,cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,54512,EXOSC4,Ciliary landscape,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000178896
O60936,0,6,6693075.873697917,2.5908535337153618e-5,1.3008843470336697,0.37949270734577945,0.07686301741907883,0.6429522395902524,raw,6680216.546875,5130070.078125,5492408.6328125,7570189.203125,6595381.640625,8690189.140625,Nucleolar protein 3 OS=Homo sapiens OX=9606 GN=NOL3 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,antioxidant activity;DNA binding;RNA binding;structural molecule activity,8996,NOL3,NA,NA,ENSG00000140939
O43189,0.5,6,2727388.4166666665,1.0557573304829541e-5,1.3008473886064125,0.37945171946144357,0.13676253341451536,0.654928512316515,raw,2455662,2466245.75,2390857.25,3316871.75,2540252.25,3194441.5,PHD finger protein 1 OS=Homo sapiens OX=9606 GN=PHF1 PE=1 SV=3,cell growth;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,5252,PHF1,NA,PRC2 methylates histones and DNA,ENSG00000112511; ENSG00000225553
Q9UIA9,0,6,13137086.984375,5.085295442406072e-5,1.300791841157082,0.37939011366400754,0.08983813256858555,0.6429522395902524,raw,13400271.28125,10485677.71875,9648206.34375,15728403.15625,12550308.09375,17009655.3125,Exportin-7 OS=Homo sapiens OX=9606 GN=XPO7 PE=1 SV=3,conjugation,membrane;nucleus,structural molecule activity,23039,XPO7,NA,NA,ENSG00000130227
Q9Y265,0,6,175248181.80208334,6.783762498246743e-4,1.3007241461856454,0.37931503190392457,0.20255673016776596,0.6923632419251884,raw,156086482.9375,153095090.625,158286942,225837016.375,155158101.625,203025457.25,RuvB-like 1 OS=Homo sapiens OX=9606 GN=RUVBL1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,8607,RUVBL1,Gastric cancer network 1; lncRNA in canonical Wnt signaling and colorectal cancer,UCH proteinases; Ub-specific processing proteases; Deposition of new CENPA-containing nucleosomes at the centromere; Formation of the beta-catenin:TCF transactivating complex; Telomere Extension By Telomerase; HATs acetylate histones; DNA Damage Recognition in GG-NER,ENSG00000175792; ENSG00000284901
P09497,0,6,16193426.083333334,6.268387805946491e-5,1.3006788544571632,0.3792647958181932,0.2317620043043098,0.7184011161541765,raw,11878668.125,16326230.25,13316431.3125,23911372.5,14407453.6875,17320400.625,Clathrin light chain B OS=Homo sapiens OX=9606 GN=CLTB PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,1212,CLTB,Ebola virus infection in host; Fragile X syndrome,"Lysosome Vesicle Biogenesis; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; Formation of annular gap junctions",ENSG00000175416
Q9GZL7,0,6,46122319.432291664,1.785370083041955e-4,1.3004487437379835,0.37900953760286193,0.34127877687756913,0.8242917664336578,raw,42875403.3125,44421494.21875,37178432.6875,60458972.25,36042349.75,55757264.375,Ribosome biogenesis protein WDR12 OS=Homo sapiens OX=9606 GN=WDR12 PE=1 SV=2,cellular component movement;cellular homeostasis;development;metabolic process,membrane;nucleus,structural molecule activity,55759,WDR12,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000138442
Q9BSC4,0,6,14676089.903645834,5.68103516313153e-5,1.3002656767496457,0.3788064319988163,0.24694060338310517,0.7316541032247736,raw,14133687.375,12621529.28125,12436679.890625,16411341.3125,12737740.5,19715561.0625,Nucleolar protein 10 OS=Homo sapiens OX=9606 GN=NOL10 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,NA,79954,NOL10,NA,NA,ENSG00000115761
Q13151,0,6,57041557.708333336,2.2080479012351667e-4,1.3000652490072993,0.37858403252831185,0.11134237296472016,0.6429522395902524,raw,54243858.875,50001048.0625,44633112.25,65004625,54016520.8125,74350181.25,Heterogeneous nuclear ribonucleoprotein A0 OS=Homo sapiens OX=9606 GN=HNRNPA0 PE=1 SV=1,cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,10949,HNRNPA0,NA,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000177733
Q9Y639,0,6,4099084.8333333335,1.586733607365055e-5,1.3000215914702165,0.3785355845216744,0.2430325082677715,0.7293042730026066,raw,3531843.5,2634721,3902072.3125,3425194.1875,4535287.875,6565390.125,Neuroplastin OS=Homo sapiens OX=9606 GN=NPTN PE=1 SV=2,cell communication;cell death;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;structural molecule activity,27020,NPTN,NA,GABA receptor activation,ENSG00000156642
Q5W0U4,0.3333333333333333,6,130842.8828125,5.064857349495075e-7,1.2999666566183756,0.3784746194473955,1,1,raw,100837.3046875,NA,139512.859375,NA,152178.484375,NA,B box and SPRY domain-containing protein OS=Homo sapiens OX=9606 GN=BSPRY PE=2 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;nucleus,structural molecule activity,54836,BSPRY,NA,NA,ENSG00000119411
O43504,0,6,7358812.791666667,2.848556700240373e-5,1.299894318643058,0.37839433697131036,0.44458280286600355,0.9271939562980955,raw,8117325.75,5693634.25,5902810.75,8787937.125,5099503.25,10551665.625,Ragulator complex protein LAMTOR5 OS=Homo sapiens OX=9606 GN=LAMTOR5 PE=1 SV=1,cell growth;development;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,NA,10542,LAMTOR5,NA,Amino acids regulate mTORC1; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK,ENSG00000134248
O15084,0,6,1997489.7083333333,7.732174813276381e-6,1.2994982492284552,0.3779546901155181,0.23703115717653858,0.7214214037448144,raw,1385380.28125,2314633.375,1461964.75,2709450.4375,2313210.15625,1800299.25,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5,NA,cytosol;membrane,NA,23243,ANKRD28,NA,Telomere Extension By Telomerase; COPII-mediated vesicle transport,ENSG00000206560
J3KQ32,0,6,110714197.78125,4.2856868197361684e-4,1.299249035642579,0.3776779881771179,0.1894910293650471,0.6806579357154494,raw,107970033.5625,97304013.84375,85125554.578125,140279961.984375,95296996.21875,138308626.5,Obg-like ATPase 1 OS=Homo sapiens OX=9606 GN=OLA1 PE=1 SV=1,NA,cytosol;endoplasmic reticulum;membrane,protein binding;structural molecule activity,NA,OLA1,NA,NA,ENSG00000138430
P26196,0,6,37522875.067708336,1.4524902346672533e-4,1.2990813848578535,0.37749181558401584,0.07185515659690767,0.6429522395902524,raw,35543243.78125,33968593.875,28574110.890625,41960108.875,37120095.546875,47971097.4375,Probable ATP-dependent RNA helicase DDX6 OS=Homo sapiens OX=9606 GN=DDX6 PE=1 SV=2,cell growth;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,1656,DDX6,NA,mRNA decay by 5' to 3' exoribonuclease,ENSG00000110367
Q9UBF2,0,6,5489439.307291667,2.1249323174869077e-5,1.2988972464038993,0.37728730609990774,0.011773193261423887,0.6429522395902524,raw,4794873.53125,5139753.78125,4406322.0625,5723359.59375,6382463.125,6489863.75,Coatomer subunit gamma-2 OS=Homo sapiens OX=9606 GN=COPG2 PE=1 SV=1,conjugation,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,26958,COPG2,NA,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000158623
A0A5F9ZHN7,0,6,10329832.828125,3.9986225153383825e-5,1.298840851544638,0.37722466654138953,0.06164722731173322,0.6429522395902524,raw,8791058,9280476.5,9344486.34375,12310788.25,10198325.875,12053862,Phosphatidylinositol-3-phosphatase SAC1 OS=Homo sapiens OX=9606 GN=SACM1L PE=1 SV=1,cellular homeostasis,cytoskeleton,structural molecule activity,NA,SACM1L,NA,NA,ENSG00000211456
Q16891,0,6,159337793.5696615,6.16787996004419e-4,1.2988343708370511,0.37721746803973205,0.23039156323895635,0.7173388538497806,raw,153894067,130614725.84375,143969153.355469,190906293.25,136759618.28125,199882903.6875,MICOS complex subunit MIC60 OS=Homo sapiens OX=9606 GN=IMMT PE=1 SV=1,cell growth;metabolic process,cytoskeleton;endosome,NA,10989,IMMT,NA,Cristae formation,ENSG00000132305
P11177,0,6,39507465.65625,1.5293126648373238e-4,1.2987008247317455,0.37706912255871383,0.09904301637606414,0.6429522395902524,raw,38175776.75,32180454.8125,31991240,48278586.875,36839822.75,49578912.75,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=PDHB PE=1 SV=3",cellular homeostasis,endosome;membrane;nucleus,structural molecule activity,5162,PDHB,Metabolic reprogramming in colon cancer,Glyoxylate metabolism and glycine degradation; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid,ENSG00000168291
Q8WZA0,0,6,17072707.7109375,6.60875297660914e-5,1.2985864227616053,0.3769420306051725,0.34279062101253444,0.8248253176137212,raw,14740487.5625,16763407.921875,15066719.59375,19565437.5,13871304.375,22428889.3125,Protein LZIC OS=Homo sapiens OX=9606 GN=LZIC PE=1 SV=1,NA,NA,structural molecule activity,84328,LZIC,NA,NA,ENSG00000162441
Q8IWZ3,0,6,913207.0520833334,3.5349751930971137e-6,1.2985809625471454,0.3769359644391117,0.21220293300832135,0.7022006061790371,raw,672780.9375,1010497.90625,605250.421875,1105399.25,773100.453125,1312213.34375,Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKHD1 PE=1 SV=1,coagulation,nucleus,NA,404734; 54882,ANKHD1,NA,NA,ENSG00000131503
P62937,0,6,1605983310.34375,0.006216674684718798,1.2978654519709478,0.3761408287641814,0.13045345247141105,0.6498046150645307,raw,1479800013.40625,1437230429.8125,1248031830.09375,1865331721.375,1483931620.28125,2121574247.09375,Peptidyl-prolyl cis-trans isomerase A OS=Homo sapiens OX=9606 GN=PPIA PE=1 SV=2,cell communication;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cell surface;membrane;nucleus,antioxidant activity;structural molecule activity,5478,PPIA,Prolactin signaling pathway,Neutrophil degranulation; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Budding and maturation of HIV virion; Platelet degranulation ; Basigin interactions; SARS-CoV-1 activates/modulates innate immune responses; Integration of provirus; APOBEC3G mediated resistance to HIV-1 infection; Calcineurin activates NFAT; Binding and entry of HIV virion; Assembly Of The HIV Virion; Uncoating of the HIV Virion; Minus-strand DNA synthesis; Plus-strand DNA synthesis,ENSG00000196262
A0A087WUT6,0,6,119069762.90625,4.6091262344209234e-4,1.2976585010923725,0.3759107657693795,0.1308700396365675,0.6498046150645307,raw,101959940.3125,114745766.75,95610301.6875,148900819.6875,108474386.6875,144727362.3125,Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,RNA binding;structural molecule activity,NA,EIF5B,Ciliary landscape,NA,ENSG00000158417
A0A087WZN1,0,6,51757169.364583336,2.003492081574861e-4,1.297179730948666,0.37537838628509385,0.14454313092914434,0.6572502130392559,raw,48986283.75,43190731.25,44494662.375,63544014.375,46895445.3125,63431879.125,"Isocitrate dehydrogenase [NAD] subunit, mitochondrial OS=Homo sapiens OX=9606 GN=IDH3B PE=1 SV=1",cellular homeostasis,endosome,structural molecule activity,3420,IDH3B,TCA cycle (aka Krebs or citric acid cycle),NA,ENSG00000101365
P63279,0,6,53403851.90625,2.0672342736923892e-4,1.2969104684133659,0.37507888727317423,0.15340748929686926,0.6638855679885327,raw,54060259.625,43443942.0625,42096429.25,56342903.25,51746288.75,72733288.5,SUMO-conjugating enzyme UBC9 OS=Homo sapiens OX=9606 GN=UBE2I PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7329,UBE2I,Androgen receptor signaling pathway; TGF-beta signaling pathway,"Formation of Incision Complex in GG-NER; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; Meiotic synapsis; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; SUMOylation of intracellular receptors; Processing of DNA double-strand break ends; Vitamin D (calciferol) metabolism; SUMOylation of transcription factors; Postmitotic nuclear pore complex (NPC) reformation; Negative regulation of activity of TFAP2 (AP-2) family transcription factors; Maturation of nucleoprotein; SUMOylation of immune response proteins; SUMOylation of nuclear envelope proteins; Maturation of nucleoprotein; SUMO is transferred from E1 to E2 (UBE2I, UBC9)",ENSG00000103275
P43897,0,6,37994616.3343099,1.4707510843967029e-4,1.2965052725271007,0.3746280732434513,0.1474821623590178,0.6638855679885327,raw,33912046.3828125,35156800.5,30584148.8105469,43967146.9375,34779581.9375,49567973.4375,"Elongation factor Ts, mitochondrial OS=Homo sapiens OX=9606 GN=TSFM PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,endosome;membrane,RNA binding,10102,TSFM,NA,Mitochondrial translation elongation,ENSG00000123297
P63167,0,6,50092297.5,1.939045790587936e-4,1.2964797472680178,0.37459966955857366,0.2383111510398884,0.7237559925038366,raw,35569513.75,54881855,38109649.25,58417372.5,42422181,71153213.5,"Dynein light chain 1, cytoplasmic OS=Homo sapiens OX=9606 GN=DYNLL1 PE=1 SV=1",cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,structural molecule activity,8655,DYNLL1,Ciliary landscape; Intraflagellar transport proteins binding to dynein; Genes related to primary cilium development (based on CRISPR); 3q29 copy number variation syndrome,Intraflagellar transport; Separation of Sister Chromatids; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; HCMV Early Events; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Neutrophil degranulation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Macroautophagy; Activation of BIM and translocation to mitochondria,ENSG00000088986
P62253,0,6,5414622.171875,2.095971008316863e-5,1.2964219977578328,0.37453540570273625,0.08578261106200503,0.6429522395902524,raw,4728737.28125,4710621,4185673.75,6106952.6875,5375761.0625,7379987.25,Ubiquitin-conjugating enzyme E2 G1 OS=Homo sapiens OX=9606 GN=UBE2G1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol,structural molecule activity,7326,UBE2G1,Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000132388
Q01844,0,6,45127726.1328125,1.7468699134160352e-4,1.296159426516102,0.37424317940961116,0.13461071660800458,0.6527000726250668,raw,42968372.9375,37905106.125,39444510.609375,53124298.0625,41630207.4375,55693861.625,RNA-binding protein EWS OS=Homo sapiens OX=9606 GN=EWSR1 PE=1 SV=1,cellular component movement;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,2130,EWSR1,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000182944
Q9BQ70,0,6,42581261.141927086,1.6482976284962648e-4,1.2961274535985616,0.37420759139662196,0.1816010132021392,0.6743269455727479,raw,36423118.75,41386139.2265625,36695122.03125,48990255.59375,38351220,53641711.25,Transcription factor 25 OS=Homo sapiens OX=9606 GN=TCF25 PE=1 SV=1,cellular component movement;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,22980,TCF25,NA,NA,ENSG00000141002
P08559,0,6,47696604.223958336,1.8463097973456935e-4,1.2959583405929007,0.3740193426160378,0.149751358842064,0.6638855679885327,raw,44901468.90625,42018186.8125,39575587.5,54453819.65625,43971683.84375,61258878.625,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial OS=Homo sapiens OX=9606 GN=PDHA1 PE=1 SV=3",cellular homeostasis,endosome;membrane;nucleus,structural molecule activity,5160,PDHA1,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Lipid metabolism pathway; PI3K/AKT/mTOR - vitamin D3 signaling; Metabolic reprogramming in colon cancer; Thiamine metabolic pathways; TCA cycle in senescence; Neuroinflammation and glutamatergic signaling; Acetylcholine synthesis; Glycolysis and gluconeogenesis,Glyoxylate metabolism and glycine degradation; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid,ENSG00000131828
Q9NZI7,0,6,281492.3802083333,1.0896418055601213e-6,1.2957646125951088,0.373803663373106,0.2701374614555888,0.7506182711969984,raw,290204.6875,240875.25,204756.8125,312117.625,238080.75,402919.15625,Upstream-binding protein 1 OS=Homo sapiens OX=9606 GN=UBP1 PE=1 SV=1,cellular component movement;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,7342,UBP1,NA,NA,ENSG00000153560
B7ZKQ9,0,6,7781035.8125,3.01199695195496e-5,1.2957476150164353,0.3737847382665999,0.09423950855578547,0.6429522395902524,raw,6297704.5625,7701277.28125,6312802.28125,8179798.5,7930299.8125,10264332.4375,SCARB1 protein OS=Homo sapiens OX=9606 GN=SCARB1 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;mitochondrion;nucleus,NA,NA,SCARB1,Sterol regulatory element-binding proteins (SREBP) signaling; SARS-CoV-2 and COVID-19 pathway; Familial hyperlipidemia type 3,NA,ENSG00000073060
Q9UNQ2,0,6,6057003.94140625,2.3446335229799207e-5,1.2956853880301071,0.37371545261306627,0.5986364498068677,1,raw,5609980.0625,5707626.2734375,5828241.375,7449492.75,4195116,7551567.1875,Probable dimethyladenosine transferase OS=Homo sapiens OX=9606 GN=DIMT1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,27292,DIMT1,NA,rRNA modification in the nucleus and cytosol,ENSG00000086189
O95831,0,6,46185645.229166664,1.78782139044837e-4,1.2955080213657166,0.373517948245691,0.08687956035377034,0.6429522395902524,raw,46470687.4375,34157478.25,39454187.625,55395347,44251287.0625,57384884,"Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens OX=9606 GN=AIFM1 PE=1 SV=1",cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,9131,AIFM1,Apoptosis modulation and signaling; Nanomaterial induced apoptosis; Apoptosis modulation by HSP70,NA,ENSG00000156709
P51114,0,6,70978566.29166667,2.747541978680915e-4,1.2954976789304293,0.37350643072560363,0.16707593834316525,0.6670444762382309,raw,54887952.4375,73512001.0625,56068509.8125,95234626.75,63946699.40625,82221608.28125,Fragile X mental retardation syndrome-related protein 1 OS=Homo sapiens OX=9606 GN=FXR1 PE=1 SV=3,metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,8087,FXR1,Bile acids synthesis and enterohepatic circulation,Signaling by BRAF and RAF1 fusions,ENSG00000114416
Q15427,0,6,18059335.140625,6.990671127680997e-5,1.295427456713142,0.37342822758243166,0.13004171774830117,0.6498046150645307,raw,19225726.21875,12613372.9375,13257251.96875,23360801.53125,16339709.625,23559148.5625,Splicing factor 3B subunit 4 OS=Homo sapiens OX=9606 GN=SF3B4 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,10262,SF3B4,mRNA processing,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000143368
P84090,0,6,104340515.54427083,4.0389650215962535e-4,1.2952759965278706,0.37325953914519744,0.04372193712060764,0.6429522395902524,raw,82486067,101934871.296875,82068109.96875,123144466,104375787,132033792,Enhancer of rudimentary homolog OS=Homo sapiens OX=9606 GN=ERH PE=1 SV=1,cell differentiation;cellular homeostasis,membrane;nucleus,RNA binding,2079,ERH,NA,NA,ENSG00000100632
O95487,0,6,7057978.255208333,2.732105275431398e-5,1.2952527076720721,0.3732335994853011,0.24069623556132572,0.7263138257852598,raw,6855035.25,6726837.5625,5202905.0625,8757574.25,5926514.4375,8879002.96875,Protein transport protein Sec24B OS=Homo sapiens OX=9606 GN=SEC24B PE=1 SV=2,cell growth;conjugation;defense response;metabolic process,cytoskeleton;cytosol;extracellular,structural molecule activity,10427,SEC24B,Sterol regulatory element-binding proteins (SREBP) signaling,"MHC class II antigen presentation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; COPII-mediated vesicle transport; Cargo concentration in the ER; Regulation of cholesterol biosynthesis by SREBP (SREBF); Antigen Presentation: Folding, assembly and peptide loading of class I MHC",ENSG00000138802
P07737,0,6,866447642.313151,0.0033539720424924755,1.2950825663562777,0.37304407804739226,0.15453557040044508,0.6638855679885327,raw,772507357.546875,855256644.097656,659422059.765625,1020658129.59375,783213693.34375,1107627969.53125,Profilin-1 OS=Homo sapiens OX=9606 GN=PFN1 PE=1 SV=2,cell growth;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,5216,PFN1,Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling pathway; Burn wound healing; Regulation of actin cytoskeleton; G13 signaling pathway,RHO GTPases Activate Formins; Platelet degranulation ; PCP/CE pathway; Signaling by ROBO receptors,ENSG00000108518
Q4VC31,0,6,9957532.09375,3.854506911173363e-5,1.2947479907166384,0.3726713195922285,0.22468700897171867,0.7132042007362297,raw,8815263.4375,10052231.375,7652311,11601307.6875,8608972.6875,13015106.375,Coiled-coil domain-containing protein 58 OS=Homo sapiens OX=9606 GN=CCDC58 PE=1 SV=1,NA,endosome,NA,131076,MIX23,NA,NA,ENSG00000160124
Q13561,0,6,36986076.260416664,1.4317110426633023e-4,1.2944133625848075,0.3722984062947187,0.13663358568892284,0.654928512316515,raw,34401285.8125,34940575.25,28632654.625,45227547.5,33708241.5,45006152.875,Dynactin subunit 2 OS=Homo sapiens OX=9606 GN=DCTN2 PE=1 SV=4,cell differentiation;cell growth;conjugation;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,10540,DCTN2,NA,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,ENSG00000175203
H0UI80,0,6,3727581.8984375,1.4429268270709728e-5,1.2943104671741334,0.37218371912949744,0.3102363910701022,0.791258249420452,raw,3752435.453125,3299098.96875,2963809.0859375,4856816.484375,2980166.5859375,4513164.8125,Negative elongation factor C/D OS=Homo sapiens OX=9606 GN=NELFCD PE=1 SV=1,metabolic process,membrane,NA,51497,NELFCD,Initiation of transcription and translation elongation at the HIV-1 LTR,NA,ENSG00000101158
A0A2R8Y566,0,6,3666910.8229166665,1.4194413813097526e-5,1.2942528846113632,0.3721195336594322,0.11192130923491667,0.6429522395902524,raw,2046255.875,3407239.75,3604998.1875,4409829.875,4094334.25,4438807,RAB11-binding protein RELCH OS=Homo sapiens OX=9606 GN=RELCH PE=1 SV=1,conjugation,extracellular,NA,57614,RELCH,NA,NA,ENSG00000134444
Q96GA7,0,6,4827045.364583333,1.868523198635942e-5,1.294137844879887,0.37199129394019337,0.3232318910251972,0.8037523716522456,raw,5504509.875,4221309.09375,3085747.09375,5942192.6875,3993382.09375,6215131.34375,Serine dehydratase-like OS=Homo sapiens OX=9606 GN=SDSL PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,113675,SDSL,Clear cell renal cell carcinoma pathways,Threonine catabolism,ENSG00000139410
Q8NFC6,0,6,28123574.265625,1.0886483754522811e-4,1.293968857103269,0.37180289534947275,0.09475344414195648,0.6429522395902524,raw,23080528,27422254,22522413.875,29865484.4375,28433265.5,37417499.78125,Biorientation of chromosomes in cell division protein 1-like 1 OS=Homo sapiens OX=9606 GN=BOD1L1 PE=1 SV=2,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,259282,BOD1L1,NA,NA,ENSG00000038219
P51003,0,6,11195176.0625,4.333592209237648e-5,1.2938568599263522,0.37167802003753114,0.2240421677643233,0.7125799511687476,raw,10929793.65625,11249201.71875,7166685.0625,13522084.125,9748435,14554856.8125,Poly(A) polymerase alpha OS=Homo sapiens OX=9606 GN=PAPOLA PE=1 SV=4,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,10914,PAPOLA,mRNA processing,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs,ENSG00000090060
Q8NEW0,0,6,3029375.9895833335,1.1726550894795204e-5,1.2937126155571077,0.3715171736228764,0.7288684135225751,1,raw,3478540.40625,3538595.21875,1312879,5462151.375,1698488.125,2685601.8125,Zinc transporter 7 OS=Homo sapiens OX=9606 GN=SLC30A7 PE=2 SV=1,conjugation;metabolic process,cytoskeleton;extracellular;nucleus,catalytic activity,148867,SLC30A7,Zinc homeostasis,Insulin processing; Zinc efflux and compartmentalization by the SLC30 family,ENSG00000162695
Q7L1Q6,0,6,100531266.33072917,3.8915110412149714e-4,1.2935148791919164,0.3712966493167616,0.18598305455898353,0.6787948525161039,raw,90906313.59375,99326760.875,69963906.46875,128436091.953125,86073882,128480643.09375,Basic leucine zipper and W2 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=BZW1 PE=1 SV=1,metabolic process,nucleus,NA,9689,BZW1,NA,NA,ENSG00000082153
P23434,0,6,18530052.635416668,7.172883328435391e-5,1.29345970458933,0.3712351101535663,0.13272499013392844,0.6514609890946903,raw,18827857.5,15379675.15625,14034194.46875,21387170.75,17198342.9375,24353075,"Glycine cleavage system H protein, mitochondrial OS=Homo sapiens OX=9606 GN=GCSH PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,endosome;nucleus,structural molecule activity,2653,GCSH,NA,Glycine degradation,ENSG00000140905
P49721,0,6,42801131.0859375,1.6568086753175889e-4,1.2931471418111005,0.3708864427301112,0.27577895991117063,0.756515890988102,raw,39176736.0625,29359641,36876375.625,71119322.25,37966335.84375,42308375.734375,Proteasome subunit beta type-2 OS=Homo sapiens OX=9606 GN=PSMB2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,NA,5690,PSMB2,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,Ub-specific processing proteases; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000126067
P50454,0,6,110234868.234375,4.267132231774369e-4,1.2930595105850862,0.37078867394962406,0.28182274451572825,0.7642515538458274,raw,108558941.5,98010412.1875,87187939.53125,140373171.765625,88602289.375,138676455.046875,Serpin H1 OS=Homo sapiens OX=9606 GN=SERPINH1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cell surface;cytoskeleton;extracellular,DNA binding;structural molecule activity,871,SERPINH1,Endochondral ossification; Type I collagen synthesis in the context of osteogenesis imperfecta; Endochondral ossification with skeletal dysplasias; 15q13.3 copy number variation syndrome,Collagen biosynthesis and modifying enzymes,ENSG00000149257
Q9HB66,0,6,1415392.6666666667,5.478908593340192e-6,1.2929007086966529,0.37061148429642965,0.24690242498245268,0.7316541032247736,raw,1049087.125,1414833.125,1286818.875,1736860.5,1175517.625,1829238.75,Alternative protein MKKS OS=Homo sapiens OX=9606 GN=MKKS PE=1 SV=1,NA,cytoskeleton,NA,NA,MKKS,NA,NA,ENSG00000285723
A0A096LPI6,0,6,27345041.5078125,1.0585117927397164e-4,1.2925680880086856,0.3702402787183261,0.3216310259047773,0.80293945072831,raw,27210876.6875,19918621.015625,25951583.46875,33544188.625,21459268.375,35985710.875,Utp12 domain-containing protein (Fragment) OS=Homo sapiens OX=9606 PE=4 SV=2,NA,endosome,NA,NA,NA,NA,NA,NA
O60306,0,6,3687802.7447916665,1.4275285314687188e-5,1.292545703703917,0.3702152943438759,0.15020749526416616,0.6638855679885327,raw,3669762.0625,2723880.75,3204674.625,4490297.9375,3294865.90625,4743335.1875,RNA helicase aquarius OS=Homo sapiens OX=9606 GN=AQR PE=1 SV=4,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,9716,AQR,NA,mRNA Splicing - Major Pathway; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER,ENSG00000021776
A0PJW6,0,6,548052.425,2.1214813469431316e-6,1.292497520546048,0.3701615129585065,4.5235628337743235e-5,0.31338877500685713,raw,NA,464474.875,468475.125,605896.25,605109.625,596306.25,Transmembrane protein 223 OS=Homo sapiens OX=9606 GN=TMEM223 PE=1 SV=1,cell growth;defense response,endosome,protein binding,79064,TMEM223,NA,NA,ENSG00000168569
Q9UNF1,0,6,7199461.697916667,2.7868727522119322e-5,1.292427256318009,0.37008308138921986,0.3195794645380315,0.802275970216152,raw,7344521,5619253.5625,6299053.59375,9492259.125,5656726.84375,8784956.0625,Melanoma-associated antigen D2 OS=Homo sapiens OX=9606 GN=MAGED2 PE=1 SV=2,conjugation;metabolic process,cell surface;cytosol;membrane;nucleus,NA,10916,MAGED2,NA,Platelet degranulation,ENSG00000102316
Q9NP61,0,6,523244.9296875,2.0254528719850144e-6,1.2923577513830224,0.3700054931760819,0.5314471001158039,1,raw,528126.015625,600568.234375,222059.078125,847826.75,682527.75,258361.75,ADP-ribosylation factor GTPase-activating protein 3 OS=Homo sapiens OX=9606 GN=ARFGAP3 PE=1 SV=1,cell growth;conjugation,cytoskeleton;cytosol;extracellular,DNA binding;structural molecule activity,26286,ARFGAP3,Ciliary landscape,CDC42 GTPase cycle; RHOG GTPase cycle; COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000242247
P35579,0,6,1126475280.1901042,0.004360524989403785,1.29218096388695,0.3698081268586297,0.24731126293540534,0.7316541032247736,raw,1070673930.53125,1050602471.9375,926175705.390625,1383504471.5625,959784730.4375,1368110371.28125,Myosin-9 OS=Homo sapiens OX=9606 GN=MYH9 PE=1 SV=4,cell differentiation;cell growth;cell organization and biogenesis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,4627,MYH9,Primary focal segmental glomerulosclerosis (FSGS); VEGFA-VEGFR2 signaling pathway; Nephrotic syndrome,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Signaling by ALK fusions and activated point mutants; RHO GTPases activate CIT; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs; CD163 mediating an anti-inflammatory response,ENSG00000100345
Q14232,0,6,9011412.140625,3.4882689855724685e-5,1.2920809808242273,0.36969649338499516,0.05303899176693649,0.6429522395902524,raw,6842467.09375,8648010.640625,7873767.671875,8841021.59375,11013386.34375,10849819.5,Translation initiation factor eIF-2B subunit alpha OS=Homo sapiens OX=9606 GN=EIF2B1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;Golgi;nucleus,RNA binding;structural molecule activity,1967,EIF2B1,Translation factors,Recycling of eIF2:GDP,ENSG00000111361
Q99714,0,6,81275198.046875,3.146119034607942e-4,1.2919192776641357,0.3695159296666299,0.11106416144100538,0.6429522395902524,raw,80082651.453125,68438394.078125,63623199.1875,96438636.140625,75607986.203125,103460321.21875,3-hydroxyacyl-CoA dehydrogenase type-2 OS=Homo sapiens OX=9606 GN=HSD17B10 PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis,cytoplasm;cytoskeleton;endosome;nucleus,RNA binding;structural molecule activity,3028,HSD17B10,Alzheimer's disease and miRNA effects; Valproic acid pathway; Alzheimer's disease,Branched-chain amino acid catabolism; tRNA processing in the mitochondrion; tRNA modification in the mitochondrion; rRNA processing in the mitochondrion,ENSG00000072506
P50402,0,6,39103434.145833336,1.5136728232122054e-4,1.2918987582337844,0.3694930152972749,0.16217792731925143,0.6638855679885327,raw,32127565.5,38606260.5,31261850.5,48345010,34404538.375,49875380,Emerin OS=Homo sapiens OX=9606 GN=EMD PE=1 SV=1,cell growth;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity,2010,EMD,Arrhythmogenic right ventricular cardiomyopathy; Envelope proteins and their potential roles in EDMD physiopathology; Influence of laminopathies on Wnt signaling,RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; Initiation of Nuclear Envelope (NE) Reformation; Depolymerisation of the Nuclear Lamina,ENSG00000102119
Q9UBM7,0,6,15729144.53125,6.0886669238658034e-5,1.2918310988587156,0.369417456434466,0.05247545178460505,0.6429522395902524,raw,12047289.6875,15015022.875,14703774.875,16662915.25,16548991,19396873.5,7-dehydrocholesterol reductase OS=Homo sapiens OX=9606 GN=DHCR7 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular;membrane,structural molecule activity,1717,DHCR7,Vitamin D metabolism; Cholesterol biosynthesis pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis via desmosterol; Cholesterol biosynthesis via lathosterol,ENSG00000172893
Q96SB3,0,6,10313681.890625,3.9923705746336416e-5,1.2909551610417502,0.3684388921508214,0.16450920864896476,0.6638855679885327,raw,10778422.453125,8001591.40625,8304428.546875,10956905.125,9926283.71875,13914460.09375,Neurabin-2 OS=Homo sapiens OX=9606 GN=PPP1R9B PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,antioxidant activity;DNA binding;motor activity;signal transducer activity;structural molecule activity,84687,PPP1R9B,NA,NA,ENSG00000108819
O60869,0,6,13628172.666666666,5.275392058570595e-5,1.2908884071329603,0.3683642900065398,0.15749921738160913,0.6638855679885327,raw,10416466.375,14795111.875,11512976,14861967.25,14019986.25,16162528.25,Endothelial differentiation-related factor 1 OS=Homo sapiens OX=9606 GN=EDF1 PE=1 SV=1,cellular component movement;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,8721,EDF1,NA,NA,ENSG00000107223
O14656,0,6,763923.8385416666,2.957107933518116e-6,1.2907816197669812,0.36824493966214245,0.8342273294764245,1,raw,385100.53125,1001561.65625,790199.09375,1375263.53125,497080.6875,534337.53125,Torsin-1A OS=Homo sapiens OX=9606 GN=TOR1A PE=1 SV=1,cell communication;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity;structural molecule activity,1861,TOR1A,NA,Cargo recognition for clathrin-mediated endocytosis,ENSG00000136827
A0A494C0S1,0.8333333333333334,6,4127933.0416666665,1.5979005930547717e-5,1.290763102982738,0.3682242434700014,0.12518009703442326,0.6449267539975253,raw,3404586.75,4097225.5,3030497,5233492,3713249.5,5288547.5,GTP-binding protein Rit1 OS=Homo sapiens OX=9606 GN=RIT1 PE=1 SV=1,development,cytoskeleton,structural molecule activity,NA,RIT1,Ectoderm differentiation; Ectoderm differentiation,NA,ENSG00000143622
Q9UHD2,0,6,3250407.453125,1.2582151756320791e-5,1.290752929776307,0.36821287276047887,0.3417820004912835,0.8247147020235626,raw,3248412.484375,2878756.28125,2188468.328125,2824771.90625,3106014.25,5256021.46875,Serine/threonine-protein kinase TBK1 OS=Homo sapiens OX=9606 GN=TBK1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,29110,TBK1,TNF-alpha signaling pathway; TLR4 signaling and tolerance; Toll-like receptor signaling related to MyD88; Novel intracellular components of RIG-I-like receptor pathway; Chromosomal and microsatellite instability in colorectal cancer ; Ebola virus infection in host; Measles virus infection; Cytosolic DNA-sensing pathway; Hepatitis B infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; STING pathway in Kawasaki-like disease and COVID-19; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Network map of SARS-CoV-2 signaling pathway; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; Toll-like receptor signaling pathway,Potential therapeutics for SARS; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon; Negative regulators of DDX58/IFIH1 signaling; TICAM1-dependent activation of IRF3/IRF7; SARS-CoV-1 activates/modulates innate immune responses; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Interleukin-37 signaling; Regulation of innate immune responses to cytosolic DNA; IRF3-mediated induction of type I IFN; STAT6-mediated induction of chemokines; IRF3 mediated activation of type 1 IFN,ENSG00000183735
Q92890,0,6,25735642.833333332,9.962128389908565e-5,1.2905483597543437,0.3679842034780392,0.12817838560226652,0.649639734499993,raw,22592060.9375,25137802.8125,20153659.875,30398469.75,23690313.4375,32441550.1875,Ubiquitin recognition factor in ER-associated degradation protein 1 OS=Homo sapiens OX=9606 GN=UFD1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,7353,UFD1,22q11.2 copy number variation syndrome,Ub-specific processing proteases; Neddylation; KEAP1-NFE2L2 pathway; Translesion Synthesis by POLH,ENSG00000070010
Q92614,0,6,1597984.5,6.185711721746777e-6,1.2903968892441269,0.36781486570981925,0.23338455060217506,0.718951462768674,raw,1501142.484375,1481127.15625,1342135.296875,1972004.28125,1380255.90625,1911241.875,Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,cell growth;cell proliferation;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;extracellular;nucleus,motor activity;RNA binding;structural molecule activity,399687,MYO18A,NA,Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease; Signaling by FLT3 fusion proteins,ENSG00000196535
P62873,0,6,101207625.71223958,3.917692547695931e-4,1.2902977455562612,0.36770401640207023,0.11846793787583004,0.6429522395902524,raw,94579452.578125,92306961.75,83193940.8203125,122035654.4375,94318210,120811534.6875,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Homo sapiens OX=9606 GN=GNB1 PE=1 SV=3,cell death;cell differentiation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,2782,GNB1,Nicotine effect on dopaminergic neurons; Thyroid stimulating hormone (TSH) signaling pathway; Corticotropin-releasing hormone signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells; Estrogen signaling pathway,"G alpha (12/13) signalling events; Olfactory Signaling Pathway; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Sensory perception of sweet, bitter, and umami (glutamate) taste; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Inactivation, recovery and regulation of the phototransduction cascade; Glucagon signaling in metabolic regulation; Activation of the phototransduction cascade",ENSG00000078369
Q96HY6,0,6,6893014.2109375,2.668248584561565e-5,1.290153824570103,0.3675430879075157,0.5244431705292312,1,raw,5568056.75,6917881.75,6417534.796875,9651371.0625,4523633.84375,8279607.0625,DDRGK domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DDRGK1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,65992,DDRGK1,NA,RHOA GTPase cycle,ENSG00000198171
O95707,0,6,1272329.3125,4.925118073581607e-6,1.290137811974037,0.3675251819525382,0.5288525248134461,1,raw,1346878.15625,568511.75,1403626.84375,1917701.5625,1737658.4375,659599.125,Ribonuclease P protein subunit p29 OS=Homo sapiens OX=9606 GN=POP4 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,10775,POP4,NA,tRNA processing in the nucleus,ENSG00000105171
Q9UBL3,0,6,4482667.833333333,1.7352165156387453e-5,1.289948289534193,0.3673132331463087,0.2211733510756851,0.7102829728901873,raw,4191409.5625,4477593.34375,3167739.6875,5775863.875,3830803.90625,5452596.625,Set1/Ash2 histone methyltransferase complex subunit ASH2 OS=Homo sapiens OX=9606 GN=ASH2L PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,9070,ASH2L,NA,Activation of anterior HOX genes in hindbrain development during early embryogenesis; Formation of the beta-catenin:TCF transactivating complex; Deactivation of the beta-catenin transactivating complex; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,ENSG00000129691
P14174,0,6,231976705.64583334,8.979693027595906e-4,1.2899421440951448,0.36730635999051636,0.13894111880733565,0.6572502130392559,raw,239331316.90625,163103095.71875,195819443.75,289067745.9375,210393557,294145074.5625,Macrophage migration inhibitory factor OS=Homo sapiens OX=9606 GN=MIF PE=1 SV=4,cell growth;cellular homeostasis;coagulation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,4282,MIF,Adipogenesis; Spinal cord injury,Neutrophil degranulation; Cell surface interactions at the vascular wall; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,ENSG00000240972; ENSG00000276701
O75643,0,6,194937929.97916666,7.545942019369923e-4,1.2898477125401029,0.3672007421349589,0.2659436884213643,0.7460169868042644,raw,184498210.25,182956020.640625,157972357.578125,245508172.0625,162707414.625,235985404.71875,U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens OX=9606 GN=SNRNP200 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,membrane,structural molecule activity,23020,SNRNP200,2q11.2 copy number variation syndrome,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000144028
Q6P1J9,0,6,16918612.731770832,6.549103642157299e-5,1.2898354102239444,0.36718698192514343,0.12760051583823445,0.64823440900854,raw,13512607.4375,17235663.90625,12239192.453125,21024824.9375,15268218.03125,22231169.625,Parafibromin OS=Homo sapiens OX=9606 GN=CDC73 PE=1 SV=1,cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytosol;membrane,structural molecule activity,79577,CDC73,Endoderm differentiation,Hedgehog 'on' state; E3 ubiquitin ligases ubiquitinate target proteins; Formation of the beta-catenin:TCF transactivating complex; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,ENSG00000134371
Q9Y6E2,0,6,60484161.716145836,2.3413092436603167e-4,1.2896784876524343,0.36701145163148086,0.2612792413661089,0.7423781908328225,raw,54426933.875,58256625.828125,51543739.1875,72179456.75,51365897.5625,75132317.09375,Basic leucine zipper and W2 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=BZW2 PE=1 SV=1,metabolic process,nucleus,NA,28969,BZW2,NA,NA,ENSG00000136261
P04080,0,6,54535001.84375,2.1110204770469706e-4,1.2895996334181057,0.36692323887774553,0.18950849290168467,0.6806579357154494,raw,46610594.4375,49603178,45696313,60109005.5,49753675.75,75437244.375,Cystatin-B OS=Homo sapiens OX=9606 GN=CSTB PE=1 SV=2,metabolic process,cell surface;cytosol;membrane;nucleus,DNA binding;structural molecule activity,1476,CSTB,NA,Neutrophil degranulation,ENSG00000160213
Q8WWY3,0,6,15660445.58203125,6.0620739315399014e-5,1.2895975500275458,0.36692090815464434,0.08467309892781323,0.6429522395902524,raw,15822868.375,14171965.4609375,11732692.59375,18276131.9375,15557673.1875,18401341.9375,U4/U6 small nuclear ribonucleoprotein Prp31 OS=Homo sapiens OX=9606 GN=PRPF31 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,26121,PRPF31,NA,mRNA Splicing - Major Pathway,ENSG00000105618; ENSG00000275885
P08574,0,6,44458464.497395836,1.720963156854177e-4,1.2895347707852358,0.36685067422299344,0.23569929616929797,0.7196640448521243,raw,42598551.6875,40145878.03125,30311239.390625,51769505.625,36789583.1875,65136029.0625,"Cytochrome c1, heme protein, mitochondrial OS=Homo sapiens OX=9606 GN=CYC1 PE=1 SV=3",cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,1537,CYC1,Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,Respiratory electron transport; Mitochondrial protein import,ENSG00000179091
P61221,0,6,50424722.393229164,1.9519137787232907e-4,1.2894994656263463,0.3668111752687479,0.27538809566660677,0.7559778268201988,raw,39641141.171875,58999772.71875,35932751.34375,60825527.6875,46335263.65625,60813877.78125,ATP-binding cassette sub-family E member 1 OS=Homo sapiens OX=9606 GN=ABCE1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;endosome;nucleus,DNA binding;protein binding;structural molecule activity,6059,ABCE1,NA,OAS antiviral response; Interferon alpha/beta signaling,ENSG00000164163
P31153,0,6,67576225.55045573,2.615839205567126e-4,1.2894156080148973,0.36671735212469986,0.0606132945778438,0.6429522395902524,raw,59230913.0878906,66883372.71875,51218827.0039063,76373263.8125,67721448.625,84029528.0546875,S-adenosylmethionine synthase isoform type-2 OS=Homo sapiens OX=9606 GN=MAT2A PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,4144,MAT2A,"Trans-sulfuration, one-carbon metabolism and related pathways; Methionine de novo and salvage pathway; Methylation pathways",Methylation,ENSG00000168906
Q9NVH1,0,6,6729510.796875,2.6049572957592006e-5,1.2892573606901692,0.3665402822646001,0.19555625948210886,0.6857975396967068,raw,4930906.5,6673288.03125,6090064.65625,6357207.5,7045869.15625,9279728.9375,DnaJ homolog subfamily C member 11 OS=Homo sapiens OX=9606 GN=DNAJC11 PE=1 SV=2,cell growth,cytoskeleton;endosome;membrane,NA,55735,DNAJC11,NA,Cristae formation,ENSG00000007923
Q14554,0,6,15950085.984375,6.174192167472052e-5,1.28913811374741,0.3664068372793075,0.15540297627707755,0.6638855679885327,raw,16180003.5625,12295421.875,13297752.78125,21573308.125,15211389.625,17142639.9375,Protein disulfide-isomerase A5 OS=Homo sapiens OX=9606 GN=PDIA5 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,10954,PDIA5,NA,XBP1(S) activates chaperone genes,ENSG00000065485
Q96F86,0,6,6228867.666666667,2.4111610431083343e-5,1.2888722941464907,0.3661093236461568,0.2744790933157784,0.7551026273759062,raw,6585126.15625,4395096.984375,4939314.625,8259072.75,4707208.828125,8487386.65625,Enhancer of mRNA-decapping protein 3 OS=Homo sapiens OX=9606 GN=EDC3 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;nucleus,RNA binding;structural molecule activity,80153,EDC3,NA,mRNA decay by 5' to 3' exoribonuclease,ENSG00000179151
Q8WXA9,0,6,3369080.2135416665,1.3041527604560507e-5,1.288731433496499,0.3659516431158081,0.24158627923243453,0.7273063596068837,raw,3219968.40625,3110049.375,2794456.1875,4149674.5,2890910.8125,4049422,Splicing regulatory glutamine/lysine-rich protein 1 OS=Homo sapiens OX=9606 GN=SREK1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,NA,140890,SREK1,mRNA processing,NA,ENSG00000153914
Q9BV38,0,6,10208650.041666666,3.9517133129857156e-5,1.2885576434582164,0.36575707741574126,0.17553889301655243,0.6697819849820321,raw,10744471.0625,8438539.5625,7243034.8125,11737095.3125,9243889.1875,13844870.3125,WD repeat-containing protein 18 OS=Homo sapiens OX=9606 GN=WDR18 PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis,membrane;nucleus,NA,57418,WDR18,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000065268
Q8IWE4,0.16666666666666666,6,525078.71875,2.032551370436731e-6,1.2885120774063907,0.3657060598460756,0.23448068583218284,0.7192904383575112,raw,418957.65625,591815.125,397690.40625,523201.5625,539832,678975.5625,DCN1-like protein 3 OS=Homo sapiens OX=9606 GN=DCUN1D3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,123879,DCUN1D3,NA,Neddylation,ENSG00000188215
Q86W56,0,6,143590.4765625,5.558309820926687e-7,1.2879882236876912,0.3651194026877494,1,1,raw,NA,NA,125516.796875,NA,161664.15625,NA,Poly(ADP-ribose) glycohydrolase OS=Homo sapiens OX=9606 GN=PARG PE=1 SV=1,cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,670; 8505,PARG,NA,POLB-Dependent Long Patch Base Excision Repair,ENSG00000227345
Q9UIJ7,0,6,21972239.1875,8.50533515782804e-5,1.2879610858281856,0.3650890048416537,0.20035573313260466,0.6907968838306926,raw,22387473.75,13430581.25,20992012.25,26689248.875,19499924,28834195,"GTP:AMP phosphotransferase AK3, mitochondrial OS=Homo sapiens OX=9606 GN=AK3 PE=1 SV=4",cellular homeostasis;coagulation,endosome;nucleus,signal transducer activity;structural molecule activity,50808,AK3,NA,Factors involved in megakaryocyte development and platelet production,ENSG00000147853
Q9Y6V7,0,6,3882799.5774739585,1.5030107525807728e-5,1.2879061649205263,0.36502748449652717,0.22144658444064477,0.7102829728901873,raw,2975525.09375,3908799.375,3214514.03125,5034166.8125,3201639.01953125,4962153.1328125,Probable ATP-dependent RNA helicase DDX49 OS=Homo sapiens OX=9606 GN=DDX49 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,54555,DDX49,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000105671
P26006,0,6,56530877.213541664,2.1882797350063936e-4,1.2878810537088967,0.3649993549831668,0.1035535558041172,0.6429522395902524,raw,55035341.9375,43235793.25,49509154.6875,61276268.1875,55682558.96875,74446146.25,Integrin alpha-3 OS=Homo sapiens OX=9606 GN=ITGA3 PE=1 SV=5,cell communication;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;structural molecule activity,3675,ITGA3,Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Small cell lung cancer; Nephrotic syndrome; Genes controlling nephrogenesis; Malignant pleural mesothelioma; GDNF signaling,Integrin cell surface interactions; Laminin interactions; MET activates PTK2 signaling; Basigin interactions,ENSG00000005884
M0R0P8,0,6,6758378.5625,2.6161318519709285e-5,1.2875057235924705,0.36457884579497774,0.11832388084927084,0.6429522395902524,raw,5273246.78125,5631703.078125,6779948.828125,7805321.265625,6330828.5,8729222.921875,Unconventional myosin-IXb OS=Homo sapiens OX=9606 GN=MYO9B PE=1 SV=1,development;metabolic process,cytosol;endoplasmic reticulum,DNA binding;motor activity;structural molecule activity,NA,MYO9B,NA,NA,ENSG00000099331
O00566,0,6,18752289.171875,7.258909891807609e-5,1.2873968285978281,0.36445681999737367,0.5824289843860616,1,raw,14931636.28125,21860709,14676350.59375,20766011.9375,12135619.78125,28143407.4375,U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens OX=9606 GN=MPHOSPH10 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,NA,10199,MPHOSPH10,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000124383
O00330,0,6,9745839.411458334,3.772561816821097e-5,1.2872202710034872,0.3642589507559819,0.1293265487046042,0.6498046150645307,raw,8523723.6875,8429969.9375,8320628.15625,10851228.1875,9352479.25,12997007.25,"Pyruvate dehydrogenase protein X component, mitochondrial OS=Homo sapiens OX=9606 GN=PDHX PE=1 SV=3",cellular homeostasis,endosome;nucleus,structural molecule activity,8050,PDHX,Amino acid metabolism,Glyoxylate metabolism and glycine degradation; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid,ENSG00000110435
O00505,0,6,29091733.479166668,1.1261252958837486e-4,1.2871870286632199,0.3642216928135731,0.4066117077215151,0.8914071190930648,raw,26583135.25,29489126.625,23650413.8125,34217466.875,22349393.0625,38260865.25,Importin subunit alpha-4 OS=Homo sapiens OX=9606 GN=KPNA3 PE=1 SV=2,cell growth;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,3839,KPNA3,NA,ISG15 antiviral mechanism; NS1 Mediated Effects on Host Pathways,ENSG00000102753
Q6PCE3,0,6,591624.275,2.2901456257788727e-06,1.2871291578612853,0.3641568290494292,0.6274760732911997,1,raw,857267.15625,302942.65625,410277.4375,939938.78125,447695.34375,NA,"Glucose 1,6-bisphosphate synthase OS=Homo sapiens OX=9606 GN=PGM2L1 PE=1 SV=3",cellular homeostasis,cytosol,signal transducer activity;structural molecule activity,283209,PGM2L1,NA,Glycolysis,ENSG00000165434
Q9BZV1,0,6,8457420.5703125,3.273821839794087e-5,1.2869846927218498,0.36399489437787874,0.5508382908338153,1,raw,10914492.375,6282077,6505086.796875,8695365.375,8084936.9375,10262564.9375,UBX domain-containing protein 6 OS=Homo sapiens OX=9606 GN=UBXN6 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation,cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,NA,80700,UBXN6,NA,NA,ENSG00000167671
P51149,0,6,121082861.02083333,4.687052175532395e-4,1.2868598214453348,0.3638549083215903,0.15968977080069235,0.6638855679885327,raw,103997936.5,121744144.75,92444062,142805277.75,108838096.75,156667648.375,Ras-related protein Rab-7a OS=Homo sapiens OX=9606 GN=RAB7A PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,7879,RAB7A,Ebola virus infection in host; Autosomal recessive osteopetrosis pathways; Intracellular trafficking proteins involved in CMT neuropathy,Prevention of phagosomal-lysosomal fusion; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; MHC class II antigen presentation; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; Neutrophil degranulation; Suppression of autophagy; RHOH GTPase cycle; TBC/RABGAPs,ENSG00000075785
O95786,0,6,1910998.6901041667,7.397372751500456e-6,1.2867299791268858,0.36370933510783165,0.5436924981025251,1,raw,1375865.625,2258063.28125,1407586.140625,2574068.9375,944890.4375,2905517.71875,Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=DDX58 PE=1 SV=2,cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,RNA binding;structural molecule activity,23586,DDX58,Novel intracellular components of RIG-I-like receptor pathway; Ebola virus infection in host; Measles virus infection; Cytosolic DNA-sensing pathway; Hepatitis B infection; Pathways of nucleic acid metabolism and innate immune sensing; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation,Ub-specific processing proteases; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; OAS antiviral response; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses; Ovarian tumor domain proteases; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation,ENSG00000107201
Q14C86,0.16666666666666666,6,20178237.6796875,7.810886860256496e-5,1.2866912127017232,0.3636658691338069,0.05761211668954364,0.6429522395902524,raw,17055818.53125,19693977.515625,15560310,23560034.15625,19859218.0625,25340067.8125,GTPase-activating protein and VPS9 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GAPVD1 PE=1 SV=2,conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,DNA binding;structural molecule activity,26130,GAPVD1,NA,RAB GEFs exchange GTP for GDP on RABs; Clathrin-mediated endocytosis,ENSG00000165219
P18206,0,6,307281807.9404297,0.0011894712878983856,1.2866791805798428,0.36365237812402945,0.2510668447312955,0.7326612824296702,raw,285658813.222656,304414362.015625,232646943.9375,391683621.875,258490673.529297,370796433.0625,Vinculin OS=Homo sapiens OX=9606 GN=VCL PE=1 SV=4,cell communication;cell growth;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,7414,VCL,Integrin-mediated cell adhesion; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; VEGFA-VEGFR2 signaling pathway; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Melanoma; Regulation of actin cytoskeleton,Platelet degranulation ; Neutrophil degranulation; Signaling by BRAF and RAF1 fusions; Signaling by ALK fusions and activated point mutants; Smooth Muscle Contraction; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants,ENSG00000035403
P46459,0,6,76824047.16145833,2.973817387081414e-4,1.286670838287715,0.36364302425969375,0.15783439813856776,0.6638855679885327,raw,74305097.40625,66952607.6875,64869959.6875,89151212.65625,70059203.5625,95606201.96875,Vesicle-fusing ATPase OS=Homo sapiens OX=9606 GN=NSF PE=1 SV=3,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,antioxidant activity;structural molecule activity,4905,NSF,Synaptic vesicle pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Intra-Golgi traffic; COPII-mediated vesicle transport; Retrograde transport at the Trans-Golgi-Network; Trafficking of GluR2-containing AMPA receptors,ENSG00000073969; ENSG00000276262; ENSG00000278174
Q12888,0,6,34371353.162760414,1.3304965232840822e-4,1.2865968279573887,0.3635600369063249,0.14418235019074996,0.6572502130392559,raw,28816790.921875,34344269.875,25672692.046875,42576130.53125,30631006.921875,44187228.6796875,TP53-binding protein 1 OS=Homo sapiens OX=9606 GN=TP53BP1 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,7158,TP53BP1,ATM signaling pathway; ATM signaling in development and disease,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ); SUMOylation of transcription factors,ENSG00000067369
P18669,0,6,353376245.5494792,0.001367900367170195,1.286249205227133,0.3631701856788333,0.22126135820561527,0.7102829728901873,raw,316235592.875,340578332.984375,284008562.234375,406757780,307142290.953125,465534914.25,Phosphoglycerate mutase 1 OS=Homo sapiens OX=9606 GN=PGAM1 PE=1 SV=2,cellular homeostasis;metabolic process,cell surface;cytosol;nucleus,structural molecule activity,5223,PGAM1,Cori cycle; Metabolic reprogramming in colon cancer; Glycolysis and gluconeogenesis,Glycolysis; Neutrophil degranulation; Gluconeogenesis,ENSG00000171314
O75146,0,6,34642380.51953125,1.3409878459326525e-4,1.2862408652289363,0.3631608312605771,0.1845627023745243,0.6768541777950948,raw,25457314.328125,38261477.90625,26321440.75,38400338.9375,32744238.0078125,46669473.1875,Huntingtin-interacting protein 1-related protein OS=Homo sapiens OX=9606 GN=HIP1R PE=1 SV=2,cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;nucleus,motor activity;structural molecule activity,9026,HIP1R,NA,Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis,ENSG00000130787
Q02809,0,6,22159966.567708332,8.578003413136368e-5,1.2860700986643927,0.36296928048803306,0.29916466654632506,0.7805333494403178,raw,19472626.21875,22870237.8125,16127035.5,27765826.3125,17311344.5625,29412729,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens OX=9606 GN=PLOD1 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,5351,PLOD1,Type I collagen synthesis in the context of osteogenesis imperfecta,Collagen biosynthesis and modifying enzymes,ENSG00000083444
O43242,0,6,140830932.336914,5.451489353876563e-4,1.2858647570938202,0.36273891285992654,0.11634869945517151,0.6429522395902524,raw,119023259.390625,143214970.859375,101260233.458984,176938098.9375,130206965.5,174342065.875,26S proteasome non-ATPase regulatory subunit 3 OS=Homo sapiens OX=9606 GN=PSMD3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytosol;membrane;nucleus,DNA binding,5709,PSMD3,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000108344
P04156,0,6,1946189.65625,7.533595081434117e-6,1.2858011300358483,0.3626675237720356,0.45977750148712904,0.942396941601306,raw,1795962.5,937224.1875,2285082.375,1176732.5,2543974.875,2938161.5,Major prion protein OS=Homo sapiens OX=9606 GN=PRNP PE=1 SV=1,cell differentiation;cell growth;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,antioxidant activity;DNA binding;motor activity;structural molecule activity,5621,PRNP,Complement system; Copper homeostasis; Prion disease pathway; Ferroptosis,NCAM1 interactions; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,ENSG00000171867
Q99959,0,6,15100884.994791666,5.845471049377064e-5,1.2857463456894556,0.3626060533106755,0.10380805201538293,0.6429522395902524,raw,10417025.96875,14431398.46875,14459924.53125,18591795.125,14404328.5,18300837.375,Plakophilin-2 OS=Homo sapiens OX=9606 GN=PKP2 PE=1 SV=2,cell communication;cell death;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,structural molecule activity,5318,PKP2,Arrhythmogenic right ventricular cardiomyopathy; Epithelial to mesenchymal transition in colorectal cancer,Formation of the cornified envelope,ENSG00000057294
Q10471,0,6,6724322.951822917,2.602949108949549e-5,1.28563821232531,0.36248471520291325,0.18853660276014161,0.6797963848944265,raw,6794206.375,6118997.6640625,5132702.234375,6827737.3125,6598798.125,8873496,Polypeptide N-acetylgalactosaminyltransferase 2 OS=Homo sapiens OX=9606 GN=GALNT2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cell surface;cytoskeleton;extracellular;nucleus,structural molecule activity,2590,GALNT2,NA,COPI-independent Golgi-to-ER retrograde traffic; O-linked glycosylation of mucins,ENSG00000143641
Q5JP53,0.8333333333333334,6,63713622,2.466319907610764e-4,1.2855188255730672,0.3623507376410657,0.23812306822846205,0.7234962301256674,raw,67921368,39730424,54238516,84186512,51074208,85130704,Tubulin beta chain OS=Homo sapiens OX=9606 GN=TUBB PE=1 SV=1,cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,NA,TUBB,Alzheimer's disease and miRNA effects; Alzheimer's disease,NA,ENSG00000183311; ENSG00000196230; ENSG00000224156; ENSG00000227739; ENSG00000229684; ENSG00000232421; ENSG00000232575; ENSG00000235067
Q9NYH9,0,6,22169840.899739582,8.581825713752558e-5,1.2853974613560917,0.36221452818532246,0.1971138029333638,0.6875760999904456,raw,20500814.125,22235673.2421875,15328027.296875,25537728.84375,19702607.375,29714194.515625,U3 small nucleolar RNA-associated protein 6 homolog OS=Homo sapiens OX=9606 GN=UTP6 PE=2 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,55813,UTP6,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000108651
Q96MF7,0,6,321587.3125,1.2448471236712832e-6,1.285382781517006,0.3621980518403616,1,1,raw,NA,270183.5,NA,NA,278788.375,415790.0625,E3 SUMO-protein ligase NSE2 OS=Homo sapiens OX=9606 GN=NSMCE2 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,286053,NSMCE2,NA,SUMOylation of DNA damage response and repair proteins,ENSG00000156831
Q92990,0,6,690519.40625,2.6729633393404316e-6,1.285145453313236,0.3619316535032606,0.5671308581199528,1,raw,850277.125,689689,297013.03125,437209,776198.5,1092729.78125,Glomulin OS=Homo sapiens OX=9606 GN=GLMN PE=1 SV=2,cell growth;defense response;development;metabolic process,nucleus,antioxidant activity;DNA binding;structural molecule activity,11146,GLMN,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000174842
O15027,0,6,3667930.0833333335,1.4198359315138936e-5,1.284891254836855,0.3616462638967157,0.38009551756565835,0.8639091096732343,raw,4376445.96875,2824977.265625,2951180.828125,3670248.90625,3791946.4375,4392781.09375,Protein transport protein Sec16A OS=Homo sapiens OX=9606 GN=SEC16A PE=1 SV=4,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,NA,9919,SEC16A,NA,COPII-mediated vesicle transport,ENSG00000148396
P15954,0,6,12696752,4.91484414739391e-5,1.2847746347688054,0.3615153152044057,0.1645653109823916,0.6638855679885327,raw,10074115,10146929,11231404,13036517,12612875,19078672,"Cytochrome c oxidase subunit 7C, mitochondrial OS=Homo sapiens OX=9606 GN=COX7C PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome,NA,1350,COX7C,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000127184
A5YKK6,0,6,16642851.552083334,6.442357978379228e-5,1.284696842737621,0.36142795857980253,0.10460338651706061,0.6429522395902524,raw,15022985.25,12357883.6875,15147372.25,22445480.3125,15876134.15625,19007253.65625,CCR4-NOT transcription complex subunit 1 OS=Homo sapiens OX=9606 GN=CNOT1 PE=1 SV=2,cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,23019,CNOT1,Ciliary landscape,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,ENSG00000125107
O43752,0,6,5361077.583333333,2.075244187188229e-5,1.2846267145338948,0.3613492035226738,0.17241055728272445,0.6689341104244626,raw,4781333.1875,5812318.375,3268293.09375,6142228.34375,5474941.0625,6687351.4375,Syntaxin-6 OS=Homo sapiens OX=9606 GN=STX6 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,10228,STX6,NA,Intra-Golgi traffic; Retrograde transport at the Trans-Golgi-Network,ENSG00000135823
Q9H0W8,0,6,845634.3229166666,3.2734048068532728e-6,1.2845492996482544,0.36126226041638476,0.1441458720275005,0.6572502130392559,raw,790379.625,864275.046875,411053.1875,1015281.59375,914400.46875,1078416.015625,Protein SMG9 OS=Homo sapiens OX=9606 GN=SMG9 PE=1 SV=1,cellular component movement;cellular homeostasis;defense response,cytosol,structural molecule activity,56006,SMG9,NA,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSG00000105771
O14613,0,6,526932.6510416666,2.039727842240986e-6,1.2843273178760708,0.3610129280813793,0.17549009972453292,0.6697819849820321,raw,277039.25,588743.15625,446855.75,701167.75,573880.953125,573909.046875,Cdc42 effector protein 2 OS=Homo sapiens OX=9606 GN=CDC42EP2 PE=1 SV=1,cell growth;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,antioxidant activity;DNA binding;structural molecule activity,10435,CDC42EP2,NA,CDC42 GTPase cycle; RHOQ GTPase cycle; MAPK6/MAPK4 signaling,ENSG00000149798
P20339,0,6,4254006.661458333,1.646703010584376e-5,1.2840888386936928,0.36074501765426215,0.05885882933114506,0.6429522395902524,raw,3343945.5,3908579.9375,4081401.9375,5249529.25,4293923.09375,4646660.25,Ras-related protein Rab-5A OS=Homo sapiens OX=9606 GN=RAB5A PE=1 SV=2,cell death;cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,5868,RAB5A,Amyotrophic lateral sclerosis (ALS); VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host; Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; EGF/EGFR signaling pathway; 16p11.2 distal deletion syndrome,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Clathrin-mediated endocytosis; Synthesis of PIPs at the plasma membrane; Factors involved in megakaryocyte development and platelet production; Prevention of phagosomal-lysosomal fusion; TBC/RABGAPs,ENSG00000144566
Q53S33,0.16666666666666666,6,1884916.1614583333,7.296408691350105e-6,1.284053737713046,0.36070558058314484,0.37778012277348905,0.8617583924772685,raw,1839713.21875,1983175.125,1225531.3125,1988554,1573648.0625,2698875.25,BolA-like protein 3 OS=Homo sapiens OX=9606 GN=BOLA3 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endosome;membrane,NA,388962,BOLA3,NA,NA,ENSG00000163170
A0A087WUW9,0.16666666666666666,6,230587.11458333334,8.925902707829095e-7,1.2837348067544876,0.36034720207440374,1,1,raw,NA,NA,193908.125,236418.390625,NA,261434.828125,ADP-ribosylation factor-like protein 15 OS=Homo sapiens OX=9606 GN=ARL15 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q8N183,0,6,8358025.4375,3.235346520532676e-5,1.2836657966586402,0.36026964462353933,0.17351515550343963,0.6689341104244626,raw,4785086.0625,7481755.6875,9065255.5,9604073.875,8662858.25,10549123.25,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 OS=Homo sapiens OX=9606 GN=NDUFAF2 PE=1 SV=1,cell growth;metabolic process,cytoskeleton;endosome,structural molecule activity,91942,NDUFAF2,SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,Complex I biogenesis,ENSG00000164182
Q8N8A6,0,6,7379299.489583333,2.8564869903929377e-5,1.283494117745795,0.36007668405636434,0.32034958883622455,0.802295473638468,raw,6061908.625,5350579.1875,8625748,7047014.46875,7780424.0625,9410122.59375,ATP-dependent RNA helicase DDX51 OS=Homo sapiens OX=9606 GN=DDX51 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane,structural molecule activity,317781,DDX51,NA,NA,ENSG00000185163; ENSG00000288503
Q92797,0,6,20097307.040364582,7.779559046732131e-5,1.2832470181146083,0.3597989081570815,0.2440843431705394,0.7301988479077035,raw,19196925.03125,17776093.46875,16857043.078125,26567907.15625,17374754.5703125,22811118.9375,Symplekin OS=Homo sapiens OX=9606 GN=SYMPK PE=1 SV=2,cell communication;cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,NA,8189,SYMPK,NA,mRNA Splicing - Major Pathway; Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,ENSG00000125755
P31040,0,6,70519596.95703125,2.729775523542103e-4,1.2831242784098702,0.3596609110062245,0.24361984934060957,0.7301988479077035,raw,73366587.59375,50207994.4921875,61060961.625,85907347.859375,58436240.40625,94138449.765625,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial OS=Homo sapiens OX=9606 GN=SDHA PE=1 SV=2",cellular homeostasis;defense response,cytoskeleton;endosome;membrane,structural molecule activity,6389,SDHA,Electron transport chain: OXPHOS system in mitochondria; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Nonalcoholic fatty liver disease; Mitochondrial complex II assembly; Arsenic metabolism and reactive oxygen species generation; TCA cycle (aka Krebs or citric acid cycle),Respiratory electron transport; Citric acid cycle (TCA cycle),ENSG00000073578
E7EUC7,0,6,22214091.138020832,8.598954742077076e-5,1.282954512262551,0.35947001992361555,0.155009489189061,0.6638855679885327,raw,21589055.34375,20683319.53125,16505324.75,26785630.78125,20023440.453125,27697775.96875,UTP--glucose-1-phosphate uridylyltransferase OS=Homo sapiens OX=9606 GN=UGP2 PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,NA,UGP2,Glucuronidation,NA,ENSG00000169764
Q56VL3,0,6,14347531.875,5.553852124180367e-5,1.282826986710508,0.3593266090511432,0.35716301130888256,0.8406066251623018,raw,13801900.75,13626890.5,11902483,17705450.75,11421862,17626604.25,OCIA domain-containing protein 2 OS=Homo sapiens OX=9606 GN=OCIAD2 PE=1 SV=1,conjugation;metabolic process,extracellular;mitochondrion,NA,132299,OCIAD2,NA,NA,ENSG00000145247
Q9HCN4,0,6,2404967.40625,9.309498981535532e-6,1.282687918023038,0.3591702009121125,0.4646560992343625,0.9466210742415325,raw,2360272.875,2121009.9375,2194668.8125,2939490.6875,1786868.625,3027493.5,GPN-loop GTPase 1 OS=Homo sapiens OX=9606 GN=GPN1 PE=1 SV=1,NA,cytosol;endosome;membrane,structural molecule activity,11321,GPN1,NA,NA,ENSG00000198522
P36873,0.16666666666666666,6,6703366.791666667,2.5948370924987438e-5,1.2826702665619156,0.35915034740738244,0.09007728722701736,0.6429522395902524,raw,6405308.5,5931641,5083481.25,7527346.25,6520430.25,8751993.5,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit OS=Homo sapiens OX=9606 GN=PPP1CC PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,structural molecule activity,5501,PPP1CC,Common pathways underlying drug addiction; Focal adhesion; Hippo-Merlin signaling dysregulation; Neuroinflammation and glutamatergic signaling,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Triglyceride catabolism; Circadian Clock; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; Downregulation of TGF-beta receptor signaling,ENSG00000186298
P55795,0,6,18128889.59375,7.017595280950005e-5,1.2826517033198195,0.3591294680810212,0.045428041123261466,0.6429522395902524,raw,18064033.125,14176440.75,14591597.1875,22228279.625,18183435.875,21529551,Heterogeneous nuclear ribonucleoprotein H2 OS=Homo sapiens OX=9606 GN=HNRNPH2 PE=1 SV=1,metabolic process,cytosol;membrane;nucleus,NA,3188,HNRNPH2,mRNA processing,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000126945
Q5JWF2,0,6,13670160.40234375,5.2916452843526566e-5,1.2819910626456548,0.35838620429539264,0.2855612344695473,0.7655844406429082,raw,13910870.0625,12039993.75,9996071.7109375,17527355.1875,10713060.609375,17833611.09375,Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas OS=Homo sapiens OX=9606 GN=GNAS PE=1 SV=2,cell communication;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol,antioxidant activity;DNA binding;structural molecule activity,2778,GNAS,Thyroid stimulating hormone (TSH) signaling pathway; Endothelin pathways; Corticotropin-releasing hormone signaling pathway; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; G protein signaling pathways; Thermogenesis; Hippo signaling regulation pathways; Purinergic signaling; GPR143 in melanocytes and retinal pigment epithelium cells; Prostaglandin and leukotriene metabolism in senescence ; Calcium regulation in cardiac cells; Estrogen signaling pathway; Serotonin receptor 4/6/7 and NR3C signaling,G alpha (i) signalling events; G alpha (z) signalling events; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Prostacyclin signalling through prostacyclin receptor; Glucagon-type ligand receptors; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation in glucagon signalling; Hedgehog 'off' state,ENSG00000087460
P25445,0,6,423448.703125,1.6391470671203529e-6,1.2818033723727016,0.3581749706467055,1,1,raw,NA,NA,354292.46875,328621.875,454133.28125,556747.1875,Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens OX=9606 GN=FAS PE=1 SV=1,cell growth;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,355,FAS,miRNA regulation of DNA damage response; Alzheimer's disease and miRNA effects; Allograft rejection; Adipogenesis; Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; Apoptosis modulation by HSP70; VEGFA-VEGFR2 signaling pathway; Nonalcoholic fatty liver disease; Control of immune tolerance by vasoactive intestinal peptide; Measles virus infection; Hepatitis B infection; Male infertility; IL-18 signaling pathway; 7q11.23 copy number variation syndrome; p53 transcriptional gene network; Complement system in neuronal development and plasticity; Familial hyperlipidemia type 4; Alzheimer's disease; T-cell receptor signaling pathway; DNA damage response,Regulation by c-FLIP; RIPK1-mediated regulated necrosis; CASP8 activity is inhibited; TP53 Regulates Transcription of Death Receptors and Ligands; Dimerization of procaspase-8; FasL/ CD95L signaling,ENSG00000026103
P37108,0,6,52926716.979166664,2.0487646382778143e-4,1.281682831458922,0.358039293085108,0.11407655547707993,0.6429522395902524,raw,43841017.625,50991859.3125,44398680,63916495.6875,49056858.625,65355390.625,Signal recognition particle 14 kDa protein OS=Homo sapiens OX=9606 GN=SRP14 PE=1 SV=2,conjugation,cell surface;cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6727,SRP14,NA,Neutrophil degranulation; SRP-dependent cotranslational protein targeting to membrane,ENSG00000140319
O00629,0,6,4145792.78125,1.6048140018198736e-5,1.2816651443734222,0.35801938391102844,0.5287209786018618,1,raw,4621180.375,3714078.25,2795076.625,5421391.4375,2400224.1875,5922805.8125,Importin subunit alpha-3 OS=Homo sapiens OX=9606 GN=KPNA4 PE=1 SV=1,conjugation,cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,3840,KPNA4,Leptin signaling pathway,ISG15 antiviral mechanism; NS1 Mediated Effects on Host Pathways,ENSG00000186432
Q9UJS0,0,6,3297413.484375,1.2764109565358312e-5,1.2815703421433964,0.35791266667189436,0.3703340297648927,0.8549432526149602,raw,2074158.65625,3474067.78125,2818217.75,5508151.21875,2658180.21875,3251705.28125,Calcium-binding mitochondrial carrier protein Aralar2 OS=Homo sapiens OX=9606 GN=SLC25A13 PE=1 SV=2,cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;endosome,catalytic activity;structural molecule activity,10165,SLC25A13,NA,Gluconeogenesis; Mitochondrial protein import; Aspartate and asparagine metabolism,ENSG00000004864
O14896,0,6,308262.515625,1.193267554395372e-6,1.281542672164318,0.35788151756424547,0.33072908453563377,0.8133261464868501,raw,227187.03125,NA,317220.84375,NA,313960.3125,374681.875,Interferon regulatory factor 6 OS=Homo sapiens OX=9606 GN=IRF6 PE=1 SV=1,cell differentiation;cellular component movement;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,3664,IRF6,Apoptosis; Primary focal segmental glomerulosclerosis (FSGS); Hypothetical craniofacial development pathway; Head and neck squamous cell carcinoma; IL-18 signaling pathway,Interferon gamma signaling; Interferon alpha/beta signaling,ENSG00000117595
Q7Z333,0.16666666666666666,6,906689.0924479166,3.5097445232635393e-6,1.2811992051308587,0.35749480816269597,0.4726671245697788,0.9535792290076607,raw,603770.765625,1189429.125,655357.3515625,1011715.1875,773550.625,1206311.5,Probable helicase senataxin OS=Homo sapiens OX=9606 GN=SETX PE=1 SV=4,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,23064,SETX,Interactome of polycomb repressive complex 2 (PRC2),NA,ENSG00000107290
Q5VYK3,0,6,18970607.884114582,7.34341988657771e-5,1.2810133660116152,0.3572855287459718,0.16815517552333464,0.668039680404208,raw,19867629.65625,15043679.65625,14641750.265625,21384714.96875,17435173.6171875,25450699.140625,Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation,endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,NA,ECPAS,NA,NA,ENSG00000136813
Q7L576,0,6,49981094.453125,1.9347411806837182e-4,1.2809324921301917,0.35719444458247546,0.17767249953429343,0.6731898411463159,raw,49708167.5,42825185.65625,38158430.09375,63672806.875,43434039.53125,62087937.0625,Cytoplasmic FMR1-interacting protein 1 OS=Homo sapiens OX=9606 GN=CYFIP1 PE=1 SV=1,cell growth;defense response;development;metabolic process,cell surface;cytosol;nucleus,motor activity;RNA binding;structural molecule activity,23191,CYFIP1,Brain-derived neurotrophic factor (BDNF) signaling pathway; Prader-Willi and Angelman syndrome; Fragile X syndrome; Disruption of postsynaptic signaling by CNV; 15q11.2 copy number variation syndrome; G13 signaling pathway,Neutrophil degranulation; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; RHOG GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RAC2 GTPase cycle; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway,ENSG00000273749; ENSG00000288461
Q8WW59,0.5,6,702448.8020833334,2.719141386523998e-6,1.2808815110692873,0.35713702423606164,0.4629269801928587,0.9448882877131018,raw,498007.9375,810409.5625,572050.875,798022,498163.8125,1038038.625,SPRY domain-containing protein 4 OS=Homo sapiens OX=9606 GN=SPRYD4 PE=1 SV=2,NA,membrane,NA,283377,SPRYD4,NA,NA,ENSG00000176422
P50552,0,6,48325060.729166664,1.870637009348533e-4,1.280864011371544,0.35711731367001937,0.352844736764707,0.8381547534932687,raw,49154092.90625,43041296.9375,39400639.390625,64217870.90625,39006415.984375,55130048.25,Vasodilator-stimulated phosphoprotein OS=Homo sapiens OX=9606 GN=VASP PE=1 SV=3,cell growth;defense response,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,7408,VASP,Integrin-mediated cell adhesion; Focal adhesion,Generation of second messenger molecules; Signaling by ROBO receptors; Cell-extracellular matrix interactions,ENSG00000125753
Q15628,0.16666666666666666,6,399974.40625,1.5482793313322704e-6,1.2808394390117088,0.35708963644479425,0.2611077152392133,0.7423144016558971,raw,367130.65625,344091.40625,306374.5,606499.9375,335024.09375,440725.84375,Tumor necrosis factor receptor type 1-associated DEATH domain protein OS=Homo sapiens OX=9606 GN=TRADD PE=1 SV=2,development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;structural molecule activity,8717,TRADD,TNF-alpha signaling pathway; Nanoparticle triggered regulated necrosis; Apoptosis; Ebstein-Barr virus LMP1 signaling; Novel intracellular components of RIG-I-like receptor pathway; p38 MAPK signaling pathway; Measles virus infection; Cytosolic DNA-sensing pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response,Regulation by c-FLIP; CASP8 activity is inhibited; Dimerization of procaspase-8; Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway; TNFR1-induced proapoptotic signaling; Defective RIPK1-mediated regulated necrosis,ENSG00000102871
O43924,0,6,2805858.125,1.0861325309082118e-5,1.2808374185326628,0.35708736064244906,0.28648375950351207,0.7655844406429082,raw,1842092.5,2935954.25,2730989,3760480.0625,3049327.0625,2516305.875,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta OS=Homo sapiens OX=9606 GN=PDE6D PE=1 SV=1",metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,5147,PDE6D,Phosphodiesterases in neuronal function; Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome,ARL13B-mediated ciliary trafficking of INPP5E; RAS processing,ENSG00000156973
Q8N9F7,0,6,2266567.3854166665,8.773759973329415e-6,1.2807011379782725,0.3569338503392961,0.4786005448777092,0.960605076561092,raw,2571134.3125,1044754.75,2339175.8125,2995785.125,1470697.3125,3177857,Lysophospholipase D GDPD1 OS=Homo sapiens OX=9606 GN=GDPD1 PE=1 SV=2,cellular homeostasis,cytoskeleton;extracellular;nucleus,structural molecule activity,284161,GDPD1,NA,Glycerophospholipid catabolism,ENSG00000153982
Q58FG1,0.16666666666666666,6,1535136.4166666667,5.942430184432543e-6,1.2802894219954002,0.35646998247414646,0.4151275253924466,0.9013279742103876,raw,1184396.125,1910691.25,1101989.5,1410865.5,1796218,1806658.125,Putative heat shock protein HSP 90-alpha A4 OS=Homo sapiens OX=9606 GN=HSP90AA4P PE=5 SV=1,coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,NA,HSP90AA4P,NA,NA,NA
Q9NRF8,0,6,2547806.6484375,9.862421975922928e-6,1.2797139939631046,0.35582141522819083,0.700118743823479,1,raw,3129195.3125,2041317.1875,1870832.21875,4004475.03125,1117718.203125,3123301.9375,CTP synthase 2 OS=Homo sapiens OX=9606 GN=CTPS2 PE=1 SV=1,cellular homeostasis,cytosol;nucleus,structural molecule activity,56474,CTPS2,Pyrimidine metabolism,Interconversion of nucleotide di- and triphosphates,ENSG00000047230
P17900,0,6,3019096.0104166665,1.1686757650473646e-5,1.2796930214059892,0.3557977714669882,0.015034068611739379,0.6429522395902524,raw,2924685.25,2492447.1875,2584154.125,3558175.875,3248189.625,3306924,Ganglioside GM2 activator OS=Homo sapiens OX=9606 GN=GM2A PE=1 SV=4,cellular homeostasis;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,catalytic activity;DNA binding;structural molecule activity,2760,GM2A,"Degradation pathway of sphingolipids, including diseases",Glycosphingolipid metabolism; Neutrophil degranulation,ENSG00000196743
Q15006,0,6,4048989.4583333335,1.5673419581755415e-5,1.2796134532300207,0.35570806543603267,0.12447854307737378,0.6445597830897484,raw,3461146.5,4291243.4375,2860964.125,4428929.625,4107332.8125,5144320.25,ER membrane protein complex subunit 2 OS=Homo sapiens OX=9606 GN=EMC2 PE=1 SV=1,cell growth,cytoskeleton;extracellular;nucleus,NA,9694,EMC2,NA,NA,ENSG00000104412
O95881,0,6,17859674.802083332,6.913383688629796e-5,1.2795527755951015,0.3556396530585784,0.3562631938053145,0.8403332772639565,raw,21592309.3125,11539732.5,14237560.625,22401466.8125,14765696.75,22621282.8125,Thioredoxin domain-containing protein 12 OS=Homo sapiens OX=9606 GN=TXNDC12 PE=1 SV=1,metabolic process,extracellular,structural molecule activity,51060,TXNDC12,NA,NA,ENSG00000117862
A0A3B3IUB5,0,6,26257749.197916668,1.016423294470254e-4,1.2795521158880694,0.3556389092390759,0.1693625987553789,0.668039680404208,raw,27000639.625,25021424.0625,16296998.5,27871330.5,26807376.9375,34548725.5625,Minor histocompatibility antigen H13 OS=Homo sapiens OX=9606 GN=HM13 PE=1 SV=1,NA,extracellular,structural molecule activity,NA,HM13,NA,NA,ENSG00000101294
O96008,0,6,53567029.354166664,2.073550784599115e-4,1.279393419721139,0.3554599682103231,0.2599893309687731,0.7405025151331022,raw,43445781.125,54435658.4375,44873109.5,69644623.203125,44342574.375,64660429.484375,Mitochondrial import receptor subunit TOM40 homolog OS=Homo sapiens OX=9606 GN=TOMM40 PE=1 SV=1,cell growth;conjugation,cytoskeleton;cytosol;endosome;nucleus,catalytic activity,10452,TOMM40,IL-18 signaling pathway,Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy,ENSG00000130204
Q9H078,0,6,7138261.745605469,2.7631825811006526e-5,1.279258277767526,0.35530756870501645,0.18608228717412204,0.6788058614340388,raw,6215945.53613281,7708921,5144644.5,7951799.78125,6810971.15625,8997288.5,Caseinolytic peptidase B protein homolog OS=Homo sapiens OX=9606 GN=CLPB PE=1 SV=1,coagulation;development,endosome;nucleus,structural molecule activity,81570,CLPB,NA,NA,ENSG00000162129
O43143,0,6,179419744.3984375,6.945241434057874e-4,1.2792385871544363,0.3552853622679113,0.20783052401864813,0.6988382857167694,raw,175018266.40625,163493117.96875,144494341.140625,212370121.25,157252499.78125,223890119.84375,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 OS=Homo sapiens OX=9606 GN=DHX15 PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane,RNA binding;structural molecule activity,1665,DHX15,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000109606
P38571,0,6,2270384.1328125,8.788534396426356e-6,1.2792257490721706,0.3552708837095377,0.42484742827025573,0.9104795280822157,raw,1678288.359375,2501165.125,1906381.3125,1746020.125,2438692.0625,3351757.8125,Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens OX=9606 GN=LIPA PE=1 SV=2,cell differentiation;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;membrane;mitochondrion;nucleus,structural molecule activity,3988,LIPA,"Phase I biotransformations, non P450; Degradation pathway of sphingolipids, including diseases",LDL clearance,ENSG00000107798
J3QTA2,0.3333333333333333,6,277104.15234375,1.0726552124237995e-6,1.2791523842952168,0.3551881414451823,1,1,raw,243629.90625,284747.65625,254497.703125,NA,325541.34375,NA,BAG family molecular chaperone regulator 1 OS=Homo sapiens OX=9606 GN=BAG1 PE=1 SV=1,NA,cytosol;membrane,structural molecule activity,NA,BAG1,NA,NA,ENSG00000107262
P30085,0,6,19720969.890625,7.633880967972739e-5,1.2789439076411673,0.35495299139508263,0.15037324572769442,0.6638855679885327,raw,19368542.75,16866944.625,16349123.59375,22977751,17992177.625,24771279.75,UMP-CMP kinase OS=Homo sapiens OX=9606 GN=CMPK1 PE=1 SV=3,cellular homeostasis,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,51727,CMPK1,Pyrimidine metabolism,Interconversion of nucleotide di- and triphosphates,ENSG00000162368
Q99873,0,6,236846760.82291666,9.168210234079686e-4,1.2788317060462078,0.3548264183807294,0.2323444919515338,0.718627966119277,raw,224157868.53125,226627706.71875,178393586.15625,305186192.125,200055021.96875,286660189.4375,Protein arginine N-methyltransferase 1 OS=Homo sapiens OX=9606 GN=PRMT1 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,3276,PRMT1,Energy metabolism; mRNA processing; Nitric oxide metabolism in cystic fibrosis; 16p11.2 distal deletion syndrome; Interferon type I signaling pathways,Extra-nuclear estrogen signaling; Estrogen-dependent gene expression; RMTs methylate histone arginines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest; Maturation of nucleoprotein,ENSG00000126457
B3KS98,0,6,61080663.713541664,2.3643995139184873e-4,1.2785925208573714,0.3545565599167606,0.3454209255038129,0.8277692477090556,raw,52037588.0625,62570088.84375,48689573.5,80001647.625,46231330.5,76953753.75,Eukaryotic translation initiation factor 3 subunit H OS=Homo sapiens OX=9606 GN=EIF3H PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,RNA binding;structural molecule activity,NA,EIF3H,Measles virus infection,NA,ENSG00000147677
P84095,0,6,35100511.583333336,1.3587218520601016e-4,1.2785084690496054,0.3544617172595765,0.2222868947515483,0.7106930585959085,raw,27800168.75,35915238.625,28488453.625,45917936.75,29503733.5,42977538.25,Rho-related GTP-binding protein RhoG OS=Homo sapiens OX=9606 GN=RHOG PE=1 SV=1,cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,391,RHOG,Brain-derived neurotrophic factor (BDNF) signaling pathway,"RHOG GTPase cycle; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; GPVI-mediated activation cascade; Neutrophil degranulation; RHO GTPases activate KTN1",ENSG00000177105
A0MZ66,0,6,45966103.755208336,1.779323058525416e-4,1.278383304437667,0.3543204720438383,0.09840968905912531,0.6429522395902524,raw,34579518.40625,45254911.75,38795658.125,56453072.3125,42860338.3125,57853123.625,Shootin-1 OS=Homo sapiens OX=9606 GN=SHTN1 PE=1 SV=4,cell growth;defense response;development;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,57698,SHTN1,NA,Recycling pathway of L1,ENSG00000187164
Q86U42,0,6,24639015.395833332,9.537629829720222e-5,1.2783104615327192,0.35423826423376803,0.12738992289652493,0.64823440900854,raw,23418177.15625,21975061.34375,19122574.375,33024719.0625,24444586.875,25848973.5625,Polyadenylate-binding protein 2 OS=Homo sapiens OX=9606 GN=PABPN1 PE=1 SV=3,cellular component movement;cellular homeostasis;conjugation;development;metabolic process,membrane;nucleus,structural molecule activity,8106,PABPN1,mRNA processing,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs; Inhibition of Host mRNA Processing and RNA Silencing,ENSG00000100836
P60842,0,6,697825024,0.0027012429912086295,1.2782783696605307,0.35420204504646907,0.16078339543359843,0.6638855679885327,raw,497001198.375,763845674.390625,516958732.25,929028978.8125,635305881.578125,844809678.59375,Eukaryotic initiation factor 4A-I OS=Homo sapiens OX=9606 GN=EIF4A1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,1973,EIF4A1,Translation factors; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Interferon type I signaling pathways,Deadenylation of mRNA; ISG15 antiviral mechanism; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit,ENSG00000161960
Q15758,0,6,46762857.833333336,1.8101649787092934e-4,1.2782694398202925,0.3541919665834888,0.25464651468745136,0.735366952583477,raw,47668124.875,38150702.1875,40600871.75,52528122.5,40696618.40625,60932707.28125,Neutral amino acid transporter B(0) OS=Homo sapiens OX=9606 GN=SLC1A5 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity;structural molecule activity,6510,SLC1A5,"TYROBP causal network in microglia; mRNA, protein, and metabolite inducation pathway by cyclosporin A; Metabolic reprogramming in colon cancer; Ferroptosis; Amino acid metabolism in triple-negative breast cancer cells",RAC1 GTPase cycle; RHOQ GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOH GTPase cycle; Amino acid transport across the plasma membrane,ENSG00000105281
Q5T8P6,0,6,29228688.677083332,1.1314267576507886e-4,1.278089627573207,0.3539890105583372,0.14844674077403086,0.6638855679885327,raw,26393788.0625,28269279.71875,22421586.21875,35875375.5625,26281429.3125,36130673.1875,RNA-binding protein 26 OS=Homo sapiens OX=9606 GN=RBM26 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane,structural molecule activity,64062,RBM26,NA,NA,ENSG00000139746
P61978,0,6,755191400.6966146,0.0029233051380982834,1.2780642936990267,0.3539604136461221,0.2669018898968411,0.7469229802547457,raw,760693450.375,662136510.960938,629189567.4375,856214795.421875,650698942.609375,972215137.375,Heterogeneous nuclear ribonucleoprotein K OS=Homo sapiens OX=9606 GN=HNRNPK PE=1 SV=1,cellular component movement;cellular homeostasis;development;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,3190,HNRNPK,mRNA processing; lncRNA in canonical Wnt signaling and colorectal cancer,HCMV Late Events; SUMOylation of RNA binding proteins; mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000165119
Q14914,0,6,8940286.432291666,3.460736607895773e-5,1.27804565592591,0.3539393749401358,0.20521346991559478,0.697389706288305,raw,8357679.1875,7524710.75,7979899.21875,10198675.53125,7934084.375,11646669.53125,Prostaglandin reductase 1 OS=Homo sapiens OX=9606 GN=PTGR1 PE=1 SV=2,cellular homeostasis;metabolic process,nucleus,structural molecule activity,22949,PTGR1,Nuclear receptors meta-pathway; NRF2 pathway; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX); Leukotriene metabolic pathway,Synthesis of Leukotrienes (LT) and Eoxins (EX); Synthesis of Lipoxins (LX),ENSG00000106853
Q9UHD8,0,6,104313258.07291667,4.037909899596881e-4,1.2777782582208725,0.35363749706641,0.1845878721584355,0.6768541777950948,raw,94072083.625,100868981.3125,86687216.25,121880304.375,93482771.625,128888191.25,Septin-9 OS=Homo sapiens OX=9606 GN=SEPTIN9 PE=1 SV=2,cell differentiation;metabolic process,endoplasmic reticulum;nucleus,structural molecule activity,10801,SEPTIN9,NA,NA,ENSG00000184640
Q96C19,0,6,25367491.65625,9.819619056967023e-5,1.2777687482253826,0.35362675962092555,0.43786207276007294,0.9212994104748925,raw,21915826.625,25341580,22907996.90625,33279725.375,19488698.5,29271122.53125,EF-hand domain-containing protein D2 OS=Homo sapiens OX=9606 GN=EFHD2 PE=1 SV=1,NA,cytoskeleton,structural molecule activity,79180,EFHD2,NA,RHOD GTPase cycle,ENSG00000142634
P04792,0,6,556956004.078125,0.002155946620835999,1.2775400871593605,0.3533685613301305,0.16096762298337947,0.6638855679885327,raw,480055509.6875,549885560.875,436013925.34375,613290157.6875,518238683.875,744252187,Heat shock protein beta-1 OS=Homo sapiens OX=9606 GN=HSPB1 PE=1 SV=2,coagulation;conjugation;development;metabolic process,cytoplasm;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,3315,HSPB1,Apoptosis-related network due to altered Notch3 in ovarian cancer; Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling pathway; p38 MAPK signaling pathway; Extracellular vesicles in the crosstalk of cardiac cells; Ferroptosis; IL-18 signaling pathway; Intracellular trafficking proteins involved in CMT neuropathy; GDNF signaling,AUF1 (hnRNP D0) binds and destabilizes mRNA; MAPK6/MAPK4 signaling; Extra-nuclear estrogen signaling; VEGFA-VEGFR2 Pathway,ENSG00000106211
Q15370,0,6,30446762.53125,1.178577738887916e-4,1.2775374635622603,0.3533655985625036,0.174112108890156,0.669219086937761,raw,23875253.875,30674130.625,26109841.0625,33356300.125,28215560.25,40449489.25,Elongin-B OS=Homo sapiens OX=9606 GN=ELOB PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,6923,ELOB,Dual hijack model of Vif in HIV infection; Type 2 papillary renal cell carcinoma; Hijack of ubiquitination by SARS-CoV-2; Modulators of TCR signaling and T cell activation,Antigen processing: Ubiquitination & Proteasome degradation; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Vif-mediated degradation of APOBEC3G; Neddylation; Regulation of expression of SLITs and ROBOs; Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Inactivation of CSF3 (G-CSF) signaling,ENSG00000103363
E9PAV3,0,6,110862891.75,4.291442682984216e-4,1.27747768693029,0.3532980925436029,0.22184877019833854,0.7104598609846929,raw,103240842,102338731.5,93460087,130735446,96588969,138813275,"Nascent polypeptide-associated complex subunit alpha, muscle-specific form OS=Homo sapiens OX=9606 GN=NACA PE=1 SV=1",conjugation,Golgi;membrane;nucleus,RNA binding;structural molecule activity,NA,NACA,NA,NA,ENSG00000196531
F5H039,0,6,16917946.6953125,6.548845823040316e-5,1.2773488747854604,0.35315261367196904,0.05361692327793031,0.6429522395902524,raw,14019421.25,16730228.265625,13487697.78125,18708265.59375,17191729.03125,21370338.25,Molybdopterin molybdenumtransferase OS=Homo sapiens OX=9606 GN=GPHN PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,NA,GPHN,Splicing factor NOVA regulated synaptic proteins; GABA receptor signaling; Fragile X syndrome,NA,ENSG00000171723
Q99543,0,6,9279424.244791666,3.592015024054929e-5,1.2772147821606494,0.3530011555045546,0.04382750928815867,0.6429522395902524,raw,7866380.6875,9298190.28125,7509960.15625,11193122.21875,9591832.125,10217060,DnaJ homolog subfamily C member 2 OS=Homo sapiens OX=9606 GN=DNAJC2 PE=1 SV=4,cell growth;cell proliferation;cellular homeostasis;metabolic process,cytoskeleton;cytosol;membrane;nucleus,protein binding;structural molecule activity,27000,DNAJC2,NA,Regulation of HSF1-mediated heat shock response,ENSG00000105821
P28331,0,6,57586116.989583336,2.2291274969960402e-4,1.2771039541038505,0.3528759627588212,0.1154270727473088,0.6429522395902524,raw,56621503.8125,44154405.0625,49736015.125,69519672.75,53173558.78125,72311546.40625,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS1 PE=1 SV=3",cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,4719,NDUFS1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000023228; ENSG00000283447
P25786,0,6,158991908.701823,6.154490943558964e-4,1.2770494896824294,0.3528144350922731,0.2328210866544748,0.718951462768674,raw,142472068.710938,164212869.25,111754808.421875,209707960.875,134949083.5625,190854661.390625,Proteasome subunit alpha type-1 OS=Homo sapiens OX=9606 GN=PSMA1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,5682,PSMA1,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000129084
Q8N5L8,0,6,930165.7916666666,3.6006215583945716e-6,1.2770002333875066,0.3527587887109324,0.1419062473862244,0.6572502130392559,raw,706409.25,939424.75,746592.625,1160898.25,828024.25,1199645.625,Ribonuclease P protein subunit p25-like protein OS=Homo sapiens OX=9606 GN=RPP25L PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,NA,138716,RPP25L,NA,NA,ENSG00000164967
Q96A33,0,6,36053602.026041664,1.3956154685084823e-4,1.2769178587535748,0.35266572270676,0.1317775945835771,0.6514609890946903,raw,25680240.1875,38413662.6875,26778818.625,45975205.0625,32791557.3125,46682128.28125,Coiled-coil domain-containing protein 47 OS=Homo sapiens OX=9606 GN=CCDC47 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoskeleton;extracellular;nucleus,protein binding;structural molecule activity,57003,CCDC47,NA,NA,ENSG00000108588
Q96ME7,0,6,608476.2395833334,2.3553786708162847e-6,1.2766670146400267,0.3523822846557388,0.3636700034099343,0.8458062414401234,raw,458432.03125,618563.625,574157.9375,733008.5,475329.46875,791365.875,Zinc finger protein 512 OS=Homo sapiens OX=9606 GN=ZNF512 PE=1 SV=2,NA,membrane,RNA binding;structural molecule activity,84450,ZNF512,NA,NA,ENSG00000243943
Q14247,0,6,91123772.67447917,3.5273520410386615e-4,1.2766378229685753,0.3523492962878637,0.07582282218083979,0.6429522395902524,raw,74895506.3125,87387578.71875,76110651.640625,109471360.46875,87315250.65625,111562288.25,Src substrate cortactin OS=Homo sapiens OX=9606 GN=CTTN PE=1 SV=2,cell communication;cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,motor activity;structural molecule activity,2017,CTTN,Pathogenic Escherichia coli infection; Hepatitis C and hepatocellular carcinoma,Clathrin-mediated endocytosis; RHO GTPases activate PAKs,ENSG00000085733; ENSG00000288401
O60749,0,6,44662996.3671875,1.7288804751037663e-4,1.276617729636356,0.3523265891595319,0.29748700570878944,0.7790952437047332,raw,39194476.859375,45393969.078125,37010745.953125,58348766.5625,37993655.6875,50036364.0625,Sorting nexin-2 OS=Homo sapiens OX=9606 GN=SNX2 PE=1 SV=2,cell growth;conjugation,cytoskeleton;cytosol;mitochondrion;nucleus,antioxidant activity;structural molecule activity,6643,SNX2,NA,Golgi Associated Vesicle Biogenesis,ENSG00000205302
Q9BZX2,0,6,6405280.5,2.4794494984104076e-5,1.2765200798776997,0.35221623176158723,0.1873751445896113,0.6796563727916235,raw,4464293.5625,5130714.375,6980715.9375,8373790.875,5698760.375,7783407.875,Uridine-cytidine kinase 2 OS=Homo sapiens OX=9606 GN=UCK2 PE=1 SV=1,cellular homeostasis,cytosol;nucleus,signal transducer activity;structural molecule activity,7371,UCK2,Fluoropyrimidine activity; Pyrimidine metabolism,Pyrimidine salvage,ENSG00000143179
Q9BXR0,0,6,6627382.0390625,2.5654238050195708e-5,1.27649005438923,0.3521822972129255,0.28915541138161127,0.7705885302475419,raw,5416118.25,5560292,6653147.75,7097657.4375,5706738.9375,9330337.859375,Queuine tRNA-ribosyltransferase catalytic subunit 1 OS=Homo sapiens OX=9606 GN=QTRT1 PE=1 SV=3,cellular component movement;cellular homeostasis,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,81890,QTRT1,NA,tRNA modification in the nucleus and cytosol,ENSG00000213339
P32856,0.3333333333333333,6,9833669.166666666,3.8065602408552684e-5,1.2764132103583494,0.3520954451148946,0.2018222085512559,0.6920162065862512,raw,7493665,9824716,8545333,9565013,9887387,13685901,Syntaxin-2 OS=Homo sapiens OX=9606 GN=STX2 PE=1 SV=3,cell death;cell growth;coagulation;conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,2054,STX2,Synaptic vesicle pathway; Splicing factor NOVA regulated synaptic proteins,NA,ENSG00000111450
Q8N2F6,0,6,1326020.3125,5.132953035718165e-6,1.2763741541434155,0.3520513002649247,0.7971544805442903,1,raw,1713397.875,NA,706945.25,1057301.75,857938.875,2294517.8125,Armadillo repeat-containing protein 10 OS=Homo sapiens OX=9606 GN=ARMC10 PE=1 SV=1,metabolic process,cytoskeleton;endosome;extracellular,structural molecule activity,83787,ARMC10,NA,NA,ENSG00000170632
Q8TED0,0,6,15606661.453125,6.0412543856294537e-5,1.2763620790106114,0.35203765158944583,0.12656318160114965,0.6465628140449752,raw,15225791.09375,14034353.5,11736401.875,19433622.375,14309429.5625,18900370.3125,U3 small nucleolar RNA-associated protein 15 homolog OS=Homo sapiens OX=9606 GN=UTP15 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,extracellular;membrane;nucleus,NA,84135,UTP15,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000164338
Q3ZAQ7,0,6,826448.6979166666,3.1991382883410235e-6,1.2763276084171666,0.351998688330835,0.12005348315399245,0.6445597830897484,raw,609481.125,820284.9375,770512.375,903644.0625,807817.375,1046952.3125,Vacuolar ATPase assembly integral membrane protein VMA21 OS=Homo sapiens OX=9606 GN=VMA21 PE=1 SV=1,cell growth;metabolic process,cytoskeleton;extracellular;mitochondrion,NA,203547,VMA21,NA,NA,ENSG00000160131
Q9BSH5,0,6,2358241.6197916665,9.128625984955686e-6,1.276125725969633,0.3517704727528397,0.44261805507605506,0.9249261346766603,raw,2569075.78125,1202628.25,2316309.4375,3625839.5625,1479694.625,2955902.0625,Haloacid dehalogenase-like hydrolase domain-containing protein 3 OS=Homo sapiens OX=9606 GN=HDHD3 PE=1 SV=1,NA,membrane;nucleus,NA,81932,HDHD3,NA,NA,ENSG00000119431
A0A494C1N0,0,6,15218757.361979166,5.891098806303477e-5,1.2761165258959886,0.35176007178042956,0.2447571414812671,0.7301988479077035,raw,13195582.1875,12959553.265625,13015120.90625,16608810.875,13218742.1875,22314734.75,Peptidylprolyl isomerase OS=Homo sapiens OX=9606 GN=FKBP2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton,structural molecule activity,NA,FKBP2,Complement system,NA,ENSG00000173486
Q8NCE0,0,6,253939.234375,9.82985065677946e-7,1.2760096607911697,0.3516392519262542,1,1,raw,NA,223144.25,NA,284734.21875,NA,NA,tRNA-splicing endonuclease subunit Sen2 OS=Homo sapiens OX=9606 GN=TSEN2 PE=1 SV=2,cellular component movement;cellular homeostasis,cytosol;endoplasmic reticulum;membrane,RNA binding;structural molecule activity,80746,TSEN2,NA,tRNA processing in the nucleus,ENSG00000154743
Q9Y2P8,0,6,7055423.651041667,2.7311164019512006e-5,1.275941772513099,0.35156249334781736,0.2932465970638028,0.774322745775844,raw,6216966.0625,5183592.75,5766857.59375,7358174.5,5748652.25,12058298.75,RNA 3'-terminal phosphate cyclase-like protein OS=Homo sapiens OX=9606 GN=RCL1 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane,structural molecule activity,10171,RCL1,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000120158
Q9H8H0,0,6,11676058.671875,4.519739270964161e-5,1.2758016537802193,0.3514040537498691,0.2715804571178076,0.7524601054912853,raw,10886074.59375,11702034.84375,8625088.015625,14286261.9375,9627417.234375,14929475.40625,Nucleolar protein 11 OS=Homo sapiens OX=9606 GN=NOL11 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,NA,25926,NOL11,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000130935
Q99538,0,6,7076287.3828125,2.7391926398730466e-5,1.275740438544063,0.3513348290109066,0.5618719719475611,1,raw,7632767.4375,5896944.5,5757874.453125,11005350.46875,4641816.875,7522970.5625,Legumain OS=Homo sapiens OX=9606 GN=LGMN PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;mitochondrion;nucleus,motor activity;structural molecule activity,5641,LGMN,NA,MHC class II antigen presentation; Trafficking and processing of endosomal TLR; Vitamin D (calciferol) metabolism,ENSG00000100600
P27694,0,6,59232619.4609375,2.2928627186889945e-4,1.2756882848524127,0.3512758488233526,0.158802787167481,0.6638855679885327,raw,52922845.59375,55919636.1875,49769977.046875,67513054.125,54414912.0625,74855291.75,Replication protein A 70 kDa DNA-binding subunit OS=Homo sapiens OX=9606 GN=RPA1 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6117,RPA1,"Homologous recombination; Retinoblastoma gene in cancer; ATR signaling; G1 to S cell cycle control; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Fanconi Anemia Pathway; SUMOylation of DNA damage response and repair proteins; Regulation of HSF1-mediated heat shock response; Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Meiotic recombination; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; HSF1 activation; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Removal of the Flap Intermediate; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER; Removal of the Flap Intermediate from the C-strand; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),ENSG00000132383
O43823,0,6,7660100.380208333,2.965183499064705e-5,1.2755776706120745,0.3511507480938533,0.5407695666217298,1,raw,6611766.34375,9537371.1875,5400022.625,9055147.78125,6888148.28125,8468146.0625,A-kinase anchor protein 8 OS=Homo sapiens OX=9606 GN=AKAP8 PE=1 SV=1,cell differentiation;cell growth;coagulation;conjugation;development;metabolic process,endosome;extracellular;membrane;nucleus,RNA binding;structural molecule activity,10270,AKAP8,G protein signaling pathways,NA,ENSG00000105127
Q75V66,0.8333333333333334,6,1212009.9791666667,4.691625190986094e-6,1.275385194606925,0.3509330387869619,0.2120343845402895,0.7022006061790371,raw,1123190.375,1006284.625,1131533.875,1432500.375,1059909,1518641.625,Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;extracellular;nucleus,catalytic activity;structural molecule activity,203859,ANO5,NA,Stimuli-sensing channels; Induction of Cell-Cell Fusion,ENSG00000171714
P00558,0,6,802641187.6770834,0.0031069807016093644,1.2752253940771991,0.35075226369483975,0.1980605287438332,0.6875760999904456,raw,770138411.28125,722706001.71875,684867179.90625,921613045.84375,719761661.21875,996760826.09375,Phosphoglycerate kinase 1 OS=Homo sapiens OX=9606 GN=PGK1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cell surface;cytoskeleton;cytosol,signal transducer activity;structural molecule activity,5230,PGK1,Cori cycle; Photodynamic therapy-induced HIF-1 survival signaling; VEGFA-VEGFR2 signaling pathway; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Glycolysis in senescence; Glycolysis and gluconeogenesis,Glycolysis; Gluconeogenesis; Manipulation of host energy metabolism,ENSG00000102144
P08621,0,6,93011249.92708333,3.600415266407643e-4,1.2751659290731867,0.3506849878492611,0.21572431251302482,0.7049259030937425,raw,83987931.125,90695566.25,76562281.75,109815981.125,81353843.3125,115651896,U1 small nuclear ribonucleoprotein 70 kDa OS=Homo sapiens OX=9606 GN=SNRNP70 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,6625,SNRNP70,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000104852
A0A1W2PR17,0,6,418722.5625,1.6208524319329114e-6,1.2750212707406279,0.3505213152692678,1,1,raw,NA,NA,353845.8125,458291.59375,444030.28125,NA,6-phosphofructo-2-kinase OS=Homo sapiens OX=9606 GN=PFKFB3 PE=1 SV=1,cellular homeostasis,membrane,signal transducer activity;structural molecule activity,NA,PFKFB3,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,NA,ENSG00000170525
Q8IZL8,0,6,5613944.21875,2.173127496490387e-5,1.2750127066817254,0.35051162494716387,0.1954233926653567,0.6857975396967068,raw,5468596.4375,5224007.90625,4239464.90625,5405371.625,5754925.75,7591298.6875,"Proline-, glutamic acid- and leucine-rich protein 1 OS=Homo sapiens OX=9606 GN=PELP1 PE=1 SV=2",cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,27043,PELP1,NA,Major pathway of rRNA processing in the nucleolus and cytosol; PTK6 Expression,ENSG00000141456
Q9UJV9,0,6,5282196.15625,2.044709612657782e-5,1.2748049981109948,0.3502765805947439,0.5227810307221191,1,raw,3779158.8125,6509544.3125,3709435.3125,8298399.625,3241202.125,6155436.75,Probable ATP-dependent RNA helicase DDX41 OS=Homo sapiens OX=9606 GN=DDX41 PE=1 SV=2,cell differentiation;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,51428,DDX41,NA,Regulation of innate immune responses to cytosolic DNA; IRF3-mediated induction of type I IFN,ENSG00000183258
Q8NAF0,0.3333333333333333,6,6929662.903645833,2.6824350956367747e-5,1.2746068080838862,0.35005227178033854,0.31216185982716954,0.7920821775382559,raw,5102867.5,8076240,5649788.328125,7552696.21875,6504149.65625,8692235.71875,Zinc finger protein 579 OS=Homo sapiens OX=9606 GN=ZNF579 PE=1 SV=2,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,163033,ZNF579,NA,NA,ENSG00000218891
P53582,0,6,28626995.9609375,1.1081355574723581e-4,1.2745789539012293,0.3500207439946527,0.05160375583947444,0.6429522395902524,raw,25945862,25528031.625,24471055.6875,34523072.828125,28756461.78125,32537491.84375,Methionine aminopeptidase 1 OS=Homo sapiens OX=9606 GN=METAP1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,23173,METAP1,NA,"Inactivation, recovery and regulation of the phototransduction cascade",ENSG00000164024
P00813,0,6,2141751.3203125,8.290603724331285e-6,1.2744163246752869,0.34983665234092465,0.20963508238348916,0.6996099840186926,raw,2064601.34375,1550535.703125,1907086.171875,3033706.5625,1864156.390625,2430421.75,Adenosine deaminase OS=Homo sapiens OX=9606 GN=ADA PE=1 SV=3,cell communication;cell differentiation;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,100,ADA,NA,Ribavirin ADME; Purine salvage; Defective ADA disrupts (deoxy)adenosine deamination,ENSG00000196839
P39023,0,6,251907930.70605466,9.751219988488105e-4,1.274395950677247,0.34981358789932576,0.18808446829314732,0.6796724904026823,raw,236109435.046875,237901501.671875,205119169.760742,307453649.927734,223966919.888672,300896907.94043,60S ribosomal protein L3 OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6122,RPL3,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000100316
Q8WX93,0,6,18523657.513020832,7.170407811084257e-5,1.2743715887444436,0.3497860084209311,0.2140408607602524,0.703661823235592,raw,14701237.390625,20571548.1875,13764180.96875,24784318.40625,18585820.875,18734839.25,Palladin OS=Homo sapiens OX=9606 GN=PALLD PE=1 SV=3,cell communication;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,motor activity;structural molecule activity,23022,PALLD,NA,NA,ENSG00000129116
A0A1B0GW05,0,6,3572343.2239583335,1.3828347743386582e-5,1.2740794514537097,0.34945524670269634,0.8073646595043077,1,raw,4148464.84375,2970192.9375,3144237.90625,4172037.6875,1713652.15625,5285473.8125,Probable C-mannosyltransferase DPY19L1 OS=Homo sapiens OX=9606 GN=DPY19L1 PE=1 SV=1,NA,cytoskeleton,NA,NA,DPY19L1,NA,NA,ENSG00000173852
O75844,0,6,24295928.979166668,9.4048229302073e-5,1.2739225708917925,0.34927759314748646,0.18643193010941853,0.6790811483756987,raw,24769770.625,20467399.46875,18906914.75,28641760.6875,21434958.46875,31554769.875,CAAX prenyl protease 1 homolog OS=Homo sapiens OX=9606 GN=ZMPSTE24 PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,10269,ZMPSTE24,Adipogenesis; Lamin A-processing pathway; Nephrotic syndrome; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Familial partial lipodystrophy; Progeria-associated lipodystrophy,NA,ENSG00000084073
P45974,0,6,107377121.81770833,4.156510410928454e-4,1.2738687660994719,0.34921665887399117,0.44107960134290186,0.92421045069028,raw,99478534.125,103233188.09375,96704723.15625,130127339.25,83213412.34375,131505533.9375,Ubiquitin carboxyl-terminal hydrolase 5 OS=Homo sapiens OX=9606 GN=USP5 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;mitochondrion,structural molecule activity,8078,USP5,IL-18 signaling pathway,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Ub-specific processing proteases,ENSG00000111667
V9GZ54,0.16666666666666666,6,130089.50390625,5.035694458795525e-7,1.2737546120579974,0.34908737016432173,1,1,raw,NA,114427.0390625,NA,NA,145751.96875,NA,Moesin (Fragment) OS=Homo sapiens OX=9606 GN=MSN PE=1 SV=1,NA,endoplasmic reticulum,motor activity,NA,MSN,Glial cell differentiation; Measles virus infection; 16p11.2 proximal deletion syndrome,NA,ENSG00000147065
Q7Z5P9,0.3333333333333333,6,19676394.333333332,7.616626010415736e-5,1.273649102503501,0.34896786173285066,0.18812852756014956,0.6796724904026823,raw,15789377.6875,20342816.125,16430378.5,21261664.4375,18324519.75,25909609.5,Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3,NA,cell surface;cytoplasm;cytoskeleton;extracellular,NA,283463,MUC19,NA,Dectin-2 family; Termination of O-glycan biosynthesis; Defective GALNT3 causes HFTC; Defective C1GALT1C1 causes TNPS; Defective GALNT12 causes CRCS1,NA
Q9UQE7,0,6,32321258.119791668,1.251138451050048e-4,1.27336690286333,0.34864817153677546,0.1544903921785001,0.6638855679885327,raw,30208464.59375,29091202.125,28432423.5,37909909.09375,29819090.40625,38466459,Structural maintenance of chromosomes protein 3 OS=Homo sapiens OX=9606 GN=SMC3 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,9126,SMC3,Cell cycle; Retinoblastoma gene in cancer; MECP2 and associated Rett syndrome; Prion disease pathway; Regulation of sister chromatid separation at the metaphase-anaphase transition; Cohesin complex - Cornelia de Lange syndrome; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome,Meiotic synapsis; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,ENSG00000108055
A0A0G2JIW1,0,6,583907281.3880209,0.0022602735601597976,1.2732581405087318,0.34852494105954585,0.13240678983995957,0.6514609890946903,raw,510071893.6875,585539802.5,432745115.765625,693037144.125,536506412.125,745543320.125,Heat shock 70 kDa protein 1B OS=Homo sapiens OX=9606 GN=HSPA1B PE=1 SV=1,metabolic process,NA,structural molecule activity,NA,HSPA1B,NA,NA,ENSG00000212866; ENSG00000224501; ENSG00000232804
Q5RI15,0,6,5894302.927083333,2.2816528387844634e-5,1.2728883914973568,0.3481059274151003,0.19737086196155756,0.6875760999904456,raw,6086419.125,4058858.25,4858636.125,7747332.25,4898911.9375,7715659.875,"Cytochrome c oxidase assembly protein COX20, mitochondrial OS=Homo sapiens OX=9606 GN=COX20 PE=1 SV=2",cell growth,cytoskeleton;endosome,NA,116228,COX20,Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000203667
P55884,0,6,216772173.96875,8.3911338155472e-4,1.2728684139427056,0.34808328462458443,0.11986764057302418,0.6445597830897484,raw,185595203.625,214164779.4375,163401224.0625,272603583.125,198435076.5,266433177.0625,Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,8662,EIF3B,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000106263
H3BMF4,0,6,624239.15625,2.416396070167729e-6,1.2727741268316688,0.34797641373018673,0.555572870711994,1,raw,469643.90625,NA,616873.5,900563.1875,NA,509876.03125,Protein spinster homolog 1 OS=Homo sapiens OX=9606 GN=SPNS1 PE=1 SV=1,conjugation,cytoskeleton,catalytic activity,NA,SPNS1,16p11.2 distal deletion syndrome,NA,ENSG00000169682
Q15382,0,6,13586299.53125,5.2591831939305964e-5,1.2727572877260036,0.3479573264039824,0.19974354178341805,0.6904412970514524,raw,9655947.5625,14825921,10406456.125,18869799,12105847.875,15653825.625,GTP-binding protein Rheb OS=Homo sapiens OX=9606 GN=RHEB PE=1 SV=1,defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,6009,RHEB,Target of rapamycin signaling; Follicle stimulating hormone (FSH) signaling pathway; BDNF-TrkB signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; PI3K-Akt signaling pathway; Thermogenesis; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Joubert syndrome; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Insulin signaling; Malignant pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway,mTORC1-mediated signalling; Amino acids regulate mTORC1; Regulation of PTEN gene transcription; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK,ENSG00000106615
Q8TAA5,0,6,7824285.8125,3.028738793441254e-5,1.2727375176633615,0.3479349164809513,0.282324181166264,0.7642736213388397,raw,6407204,8655606.59375,5685231.625,7630645.125,7550712.28125,11016315.25,"GrpE protein homolog 2, mitochondrial OS=Homo sapiens OX=9606 GN=GRPEL2 PE=1 SV=1",cell growth;conjugation;metabolic process,cytoskeleton;endosome,structural molecule activity,134266,GRPEL2,NA,Mitochondrial protein import,ENSG00000164284
Q9H9T3,0,6,8599793.744791666,3.328933726939305e-5,1.2726085851128526,0.3477887592639154,0.124140342598115,0.6445597830897484,raw,6963434.625,7311444.25,8538792.09375,10866540.125,8030606.3125,9887945.0625,Elongator complex protein 3 OS=Homo sapiens OX=9606 GN=ELP3 PE=1 SV=2,cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,55140,ELP3,Ethanol effects on histone modifications,HATs acetylate histones,ENSG00000134014
P12268,0,6,305870480.6458333,0.0011840081161408336,1.2725010455095889,0.34766684164547307,0.2826915190233685,0.7642736213388397,raw,284045622.40625,284995291.46875,267927586.015625,377564108.90625,259241923.59375,361448351.484375,Inosine-5'-monophosphate dehydrogenase 2 OS=Homo sapiens OX=9606 GN=IMPDH2 PE=1 SV=2,cell differentiation;cellular homeostasis;defense response;metabolic process,cell surface;cytosol;membrane;nucleus,RNA binding;structural molecule activity,3615,IMPDH2,Rett syndrome causing genes,Potential therapeutics for SARS; Neutrophil degranulation; Purine ribonucleoside monophosphate biosynthesis; Azathioprine ADME,ENSG00000178035
Q13595,0,6,29547923.921875,1.1437841816164311e-4,1.2724118518334495,0.3475657149826062,0.12612166646932965,0.6461789084539729,raw,22342090.9375,31106947.59375,25097327.875,31934137.4375,29458274.9375,37348764.75,Transformer-2 protein homolog alpha OS=Homo sapiens OX=9606 GN=TRA2A PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,29896,TRA2A,NA,NA,ENSG00000164548
Q8IUC4,0,6,269201.171875,1.0420632017238942e-6,1.2723878101958355,0.3475384556648067,1,1,raw,NA,227829.234375,NA,251800.34375,NA,327973.9375,Rhophilin-2 OS=Homo sapiens OX=9606 GN=RHPN2 PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,NA,85415,RHPN2,G13 signaling pathway,RHOA GTPase cycle; RHOB GTPase cycle; RHO GTPases Activate Rhotekin and Rhophilins,ENSG00000131941
Q96G23,0,6,8178109.71875,3.165702117198453e-5,1.2723093512469312,0.34744949235848605,0.07877312857827945,0.6429522395902524,raw,7522930.9375,6808416.625,6715308.3125,8543949.5625,8627724,10850328.875,Ceramide synthase 2 OS=Homo sapiens OX=9606 GN=CERS2 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular,RNA binding;structural molecule activity,29956,CERS2,Sphingolipid pathway; Sphingolipid metabolism overview; Sphingolipid metabolism: integrated pathway; Sphingolipid metabolism in senescence; Synthesis of ceramides and 1-deoxyceramides,Sphingolipid de novo biosynthesis,ENSG00000143418
F8WCF6,0,6,21617471.075520832,8.368006337131e-5,1.272285547100576,0.347422500145366,0.20674583029626328,0.6986564272044358,raw,17536892.9375,21893874.03125,17792241.296875,26000314.09375,18626244.59375,27855259.5,Actin-related protein 2/3 complex subunit 4 OS=Homo sapiens OX=9606 GN=ARPC4-TTLL3 PE=3 SV=1,cell growth,endoplasmic reticulum;nucleus,motor activity,NA,ARPC4-TTLL3,NA,NA,ENSG00000250151
O43776,0,6,99311652.29166667,3.844300440252097e-4,1.272196129676305,0.34732110261847826,0.20651566362756593,0.6986564272044358,raw,97163086.375,85335785.0625,87853761.21875,111767215,89407750.34375,124342315.75,"Asparagine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=NARS1 PE=1 SV=1",cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;nucleus,antioxidant activity;RNA binding;structural molecule activity,4677,NARS1,Photodynamic therapy-induced unfolded protein response,Cytosolic tRNA aminoacylation,ENSG00000134440
Q9NR30,0,6,201920689.37239584,7.816240865377724e-4,1.271987992644609,0.3470850518849731,0.09673647905439747,0.6429522395902524,raw,153866375.21875,211255111.921875,154177656.46875,237256012.125,195716181.75,259252798.75,Nucleolar RNA helicase 2 OS=Homo sapiens OX=9606 GN=DDX21 PE=1 SV=5,cell growth;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,9188,DDX21,NA,Major pathway of rRNA processing in the nucleolus and cytosol; B-WICH complex positively regulates rRNA expression,ENSG00000165732
Q5QJE6,0,6,13395030.072916666,5.18514381930433e-5,1.2719349896345686,0.34702493435761,0.2064095552710685,0.6986564272044358,raw,11473479.5,13006664.3125,11823436.4375,15658042.75,11864926,16543631.4375,Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Homo sapiens OX=9606 GN=DNTTIP2 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,NA,30836,DNTTIP2,NA,NA,ENSG00000067334
Q9BRP8,0,6,7435000.177083333,2.8780484257872174e-5,1.2719090131080528,0.34699547012478377,0.16957338097996508,0.668039680404208,raw,6778722.5,6502381.6875,6010021.25,8270437.875,6844700.125,10203737.625,Partner of Y14 and mago OS=Homo sapiens OX=9606 GN=PYM1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,protein binding,84305,PYM1,NA,NA,ENSG00000170473
P07237,0,6,937156743.5113938,0.003627683155532777,1.2717862622514082,0.3468562301348377,0.15169282116694408,0.6638855679885327,raw,858750566.015625,852965896.0625,740161892.3125,1084790308.78125,853361115.398438,1232910682.49805,Protein disulfide-isomerase OS=Homo sapiens OX=9606 GN=P4HB PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,antioxidant activity;motor activity;structural molecule activity,5034,P4HB,VEGFA-VEGFR2 signaling pathway; Type I collagen synthesis in the context of osteogenesis imperfecta,Hedgehog ligand biogenesis; Collagen biosynthesis and modifying enzymes; Detoxification of Reactive Oxygen Species; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Interleukin-12 signaling; Interleukin-23 signaling; Chylomicron assembly; VLDL assembly; LDL remodeling,ENSG00000185624
E5RJD8,0,6,93617699.046875,3.623890584403145e-4,1.271752938330382,0.346818427489139,0.12325513449063105,0.6445597830897484,raw,81301078.71875,90364435.1875,75785097.8125,103394885.75,89411158,121449538.8125,Tubulin-specific chaperone A OS=Homo sapiens OX=9606 GN=TBCA PE=1 SV=1,cell growth;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity,NA,TBCA,NA,NA,ENSG00000171530
G3V1V4,0,6,20237634.989583332,7.833879238221543e-5,1.271704314683702,0.3467632670622352,0.22043739258491812,0.709482575130747,raw,16383424.375,22693710.5625,14830575.8125,23064806.75,18860107.25,25593185.1875,"Family with sequence similarity 112, member B, isoform CRA_b OS=Homo sapiens OX=9606 GN=GTSF1 PE=1 SV=1",metabolic process,NA,structural molecule activity,NA,GTSF1,NA,NA,ENSG00000170627
P35580,0,6,66174220.533854164,2.5615683483395365e-4,1.2715722152482876,0.34661339802652086,0.11544225832287563,0.6429522395902524,raw,66492807.15625,49449895.34375,52250841.828125,84179754.09375,60121618.6875,84550406.09375,Myosin-10 OS=Homo sapiens OX=9606 GN=MYH10 PE=1 SV=3,cell communication;cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;RNA binding;structural molecule activity,4628,MYH10,Regulation of actin cytoskeleton,EPHA-mediated growth cone collapse; RHO GTPases activate CIT; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs,ENSG00000133026
O95219,0,6,9433350.71875,3.6515991310504114e-5,1.2715302446947991,0.346565778467073,0.09018680995757884,0.6429522395902524,raw,8516451.375,7791102.75,8261056.25,12215297.0625,9312014,10504182.875,Sorting nexin-4 OS=Homo sapiens OX=9606 GN=SNX4 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,antioxidant activity;structural molecule activity,8723,SNX4,NA,NA,ENSG00000114520
P21399,0,6,42734192.373697914,1.6542175139080818e-4,1.2714325012297651,0.3464548731755352,0.13367284488614145,0.6514609890946903,raw,42144989.125,36971560.1640625,34510226.921875,53584508.9375,39443739.1875,49750129.90625,Cytoplasmic aconitate hydratase OS=Homo sapiens OX=9606 GN=ACO1 PE=1 SV=3,cellular homeostasis;conjugation;defense response;metabolic process,cytosol;endosome;extracellular;nucleus,RNA binding;structural molecule activity,48,ACO1,Iron metabolism in placenta; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc),Iron uptake and transport,ENSG00000122729
P01031,0,6,4749819.375,1.8386294350237723e-5,1.2711597275521787,0.3461453235521279,0.7378966105454845,1,raw,3198917.75,7158451.5,3069652,5047169,3902018,6122708,Complement C5 OS=Homo sapiens OX=9606 GN=C5 PE=1 SV=4,coagulation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton,antioxidant activity;DNA binding,727,C5,Allograft rejection; Spinal cord injury; Complement system; Oxidative damage response; Cells and molecules involved in local acute inflammatory response ; Complement system in neuronal development and plasticity; Acquired partial lipodystrophy / Barraquer-Simons syndrome; Complement activation,G alpha (i) signalling events; Regulation of Complement cascade; Peptide ligand-binding receptors; Activation of C3 and C5; Terminal pathway of complement,ENSG00000106804
Q9GZS3,0,6,12151905.484375,4.703937002909439e-5,1.2710722806323058,0.3460460727856478,0.18189887702763569,0.6743269455727479,raw,11720880,10754531.59375,8700256.0625,13669787,10906085.625,17159892.625,WD repeat-containing protein 61 OS=Homo sapiens OX=9606 GN=WDR61 PE=1 SV=1,cell death;cell organization and biogenesis;cellular component movement;cellular homeostasis;development;metabolic process,cytosol;membrane;nucleus,NA,80349,WDR61,NA,E3 ubiquitin ligases ubiquitinate target proteins; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events; mRNA decay by 3' to 5' exoribonuclease,ENSG00000140395
Q58EX7,0.8333333333333334,6,3935531.3333333335,1.523422930566706e-5,1.271019211465093,0.34598583685424145,0.5417854234175914,1,raw,4275113.5,3583329,2365075.25,6847987,1987203.25,4554480,Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1,metabolic process,cytosol,DNA binding,25894,PLEKHG4,NA,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle,ENSG00000196155
O15511,0,6,31447977.645833332,1.2173342354012937e-4,1.2710092315580137,0.345974508922415,0.17109478363325717,0.6688917965646828,raw,28070505.5,29261152.328125,24677968.828125,35677871.625,28468160.09375,42532207.5,Actin-related protein 2/3 complex subunit 5 OS=Homo sapiens OX=9606 GN=ARPC5 PE=1 SV=3,cell growth;defense response;metabolic process,cell surface;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,motor activity,10092,ARPC5,Pathogenic Escherichia coli infection; Regulation of actin cytoskeleton,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Neutrophil degranulation; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,ENSG00000162704
P46199,0,6,353364.86875,1.3678563281936631e-6,1.2707261358791602,0.3456531373595841,0.3068894298120203,0.7873108826632012,raw,NA,337905.9375,281518.25,392773.65625,288628.34375,465998.15625,"Translation initiation factor IF-2, mitochondrial OS=Homo sapiens OX=9606 GN=MTIF2 PE=1 SV=2",cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,endosome;membrane;nucleus,protein binding;RNA binding;structural molecule activity,4528,MTIF2,NA,Mitochondrial translation initiation,ENSG00000085760
P37268,0,6,10758336.302083334,4.164493896548481e-5,1.2705637411047295,0.3454687537218273,0.33503708148937555,0.818506769250165,raw,7387216.625,12417680.96875,8488722.34375,10716517.9375,9762424.75,15777455.1875,Squalene synthase OS=Homo sapiens OX=9606 GN=FDFT1 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,2222,FDFT1,Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Statin inhibition of cholesterol production; Ferroptosis; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,PPARA activates gene expression; Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,ENSG00000079459; ENSG00000284967
Q99447,0,6,21379387.766927082,8.275845573824434e-5,1.2698885763046615,0.3447019163164575,0.21950856500064997,0.7087130179153194,raw,14659982.0625,20624578.3046875,20191774.84375,24212937.609375,18616543.75,29970510.03125,Ethanolamine-phosphate cytidylyltransferase OS=Homo sapiens OX=9606 GN=PCYT2 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular;nucleus,structural molecule activity,5833,PCYT2,"Trans-sulfuration, one-carbon metabolism and related pathways; Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids",Synthesis of PE,ENSG00000185813
O60499,0,6,565779.25,2.1901009294183393e-6,1.2697454470477845,0.34453930086287454,1,1,raw,NA,479542.90625,NA,NA,509934.03125,707860.8125,Syntaxin-10 OS=Homo sapiens OX=9606 GN=STX10 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,8677,STX10,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000104915
O95619,0,6,242901.190625,9.402573942834306e-7,1.2696618396712624,0.3444443023581727,0.5021120526765182,0.9867410951623498,raw,261849.390625,NA,171203.734375,243989.109375,291748.59375,245715.125,YEATS domain-containing protein 4 OS=Homo sapiens OX=9606 GN=YEATS4 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;membrane;nucleus,motor activity;structural molecule activity,8089,YEATS4,NA,HATs acetylate histones; Activation of the TFAP2 (AP-2) family of transcription factors,ENSG00000127337
P22083,0.8333333333333334,6,2058796.2916666667,7.96948928731868e-6,1.26959118705247,0.34436401876161016,0.2157190781507447,0.7049259030937425,raw,1306475.25,2263694.5,1875014,2393044.25,2380501.25,2134048.5,"Alpha-(1,3)-fucosyltransferase 4 OS=Homo sapiens OX=9606 GN=FUT4 PE=2 SV=3",cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,2526,FUT4,NA,Lewis blood group biosynthesis,ENSG00000196371
E7ESZ7,0,6,21939116.3125,8.49251347175127e-5,1.2695622166269533,0.3443310979548824,0.24580789454442428,0.7315699559274061,raw,22875874.5,17096413.25,18472647.5625,29042345.9375,18787271.75,25360144.875,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFA10 PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome,NA,NA,NDUFA10,2q37 copy number variation syndrome,NA,ENSG00000130414
Q6ZS11,0,6,261719.07421875,1.0131004056670365e-6,1.2695298085301325,0.3442942698288379,0.4742780188239097,0.9554629990870026,raw,85801.7421875,299360.09375,299124.125,271706.46875,234275.453125,380046.5625,Ras and Rab interactor-like protein OS=Homo sapiens OX=9606 GN=RINL PE=2 SV=2,conjugation,cytosol;endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,126432,RINL,NA,RAB GEFs exchange GTP for GDP on RABs,ENSG00000187994; ENSG00000282895
A0A0B4J1V8,0,6,10722425.190104166,4.150592898991214e-5,1.2695291956184291,0.3442935733151503,0.2281740098614462,0.7148463313429879,raw,8260211.03125,10471038.28125,8771446.21875,11135607.0625,9809025.921875,15887222.625,HCG2039996 OS=Homo sapiens OX=9606 GN=PPAN-P2RY11 PE=3 SV=1,cellular component movement;cellular homeostasis;development,cytoplasm;cytoskeleton;membrane,RNA binding;structural molecule activity,692312,PPAN-P2RY11,NA,NA,ENSG00000243207
G4U4J3,0,6,1176504.1875,4.554184188459223e-6,1.2695226133443553,0.3442860931888051,0.21551067756856432,0.7049259030937425,raw,979258.625,994389.59375,895291.390625,1880719.40625,1066175.140625,1243190.96875,PAP associated domain containing 5 OS=Homo sapiens OX=9606 GN=TENT4B PE=1 SV=1,cellular component movement;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane,RNA binding;structural molecule activity,NA,PAPD5,NA,NA,NA
O95163,0,6,10980788.640625,4.2506039957420066e-5,1.2693880879426536,0.3441332094107407,0.12269615504232043,0.6445597830897484,raw,10121935.8125,10329727.25,8504790.84375,11668039.9375,10795880.1875,14464357.8125,Elongator complex protein 1 OS=Homo sapiens OX=9606 GN=ELP1 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,8518,ELP1,NA,HATs acetylate histones,ENSG00000070061
Q9UHB9,0,6,55082099.263020836,2.1321983227602488e-4,1.2691425910708178,0.34385416837051747,0.22511270728979374,0.7134636792136095,raw,49898677.40625,51225316.28125,49503476.8125,67582073.53125,48954514.8125,63328536.734375,Signal recognition particle subunit SRP68 OS=Homo sapiens OX=9606 GN=SRP68 PE=1 SV=2,conjugation;metabolic process,cytosol;extracellular;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6730,SRP68,NA,SRP-dependent cotranslational protein targeting to membrane,ENSG00000167881
E9PQA6,0,6,7782257.450520833,3.0124698414370043e-5,1.2690573231473667,0.3437572369903949,0.2652741013221832,0.7454335379461359,raw,8943640.90625,6013815.75,5640937.046875,7158672.46875,8494751.8125,10441726.71875,Multivesicular body subunit 12A OS=Homo sapiens OX=9606 GN=MVB12A PE=1 SV=1,NA,cytoskeleton;mitochondrion;nucleus,NA,NA,MVB12A,7q11.23 copy number variation syndrome,NA,ENSG00000141971
O95295,0,6,7198780.828125,2.7866091911917032e-5,1.2688576442192279,0.34353021929776567,0.2955867431544544,0.7775408176564786,raw,7141758.09375,6045665.25,6125367.03125,7772218.78125,6172662.1875,9935013.625,SNARE-associated protein Snapin OS=Homo sapiens OX=9606 GN=SNAPIN PE=1 SV=1,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,structural molecule activity,23557,SNAPIN,Alstrom syndrome,Golgi Associated Vesicle Biogenesis,ENSG00000143553
P16615,0,6,229399168.26269534,8.879917947148523e-4,1.2687615779280543,0.34342098749440503,0.14772438365174653,0.6638855679885327,raw,177257310.361328,237267581.84375,168579153.734375,289985485.25,202269486.855469,301035991.53125,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens OX=9606 GN=ATP2A2 PE=1 SV=1,cell communication;cell growth;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,catalytic activity;structural molecule activity,488,ATP2A2,Alzheimer's disease and miRNA effects; Arrhythmogenic right ventricular cardiomyopathy; Endothelin pathways; Myometrial relaxation and contraction pathways; Alzheimer's disease; Calcium regulation in cardiac cells,Ion homeostasis; Ion transport by P-type ATPases; Pre-NOTCH Processing in Golgi; Reduction of cytosolic Ca++ levels,ENSG00000174437
A0A2R8Y6M6,0.6666666666666666,6,19172800.9375,7.421687725870392e-5,1.2687193880684655,0.34337301306462537,0.17220589245916113,0.6689341104244626,raw,19026110.875,16171645.75,15938434,20517280.5,18080121.65625,25303212.84375,Breast cancer anti-estrogen resistance protein 1 OS=Homo sapiens OX=9606 GN=BCAR1 PE=1 SV=1,cell communication;development,nucleus,NA,NA,BCAR1,NA,NA,ENSG00000285460
Q9BPX5,0,6,6825015.635416667,2.6419267031126963e-5,1.2686276473542633,0.3432686884518411,0.29158368911531124,0.7730231021500684,raw,5186872.21875,6910291.4375,6650773.25,6697283.78125,6580209.5,8924663.625,Actin-related protein 2/3 complex subunit 5-like protein OS=Homo sapiens OX=9606 GN=ARPC5L PE=1 SV=1,cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity,81873,ARPC5L,Pathogenic Escherichia coli infection; VEGFA-VEGFR2 signaling pathway,NA,ENSG00000136950
Q96LW7,0.5,6,302223.2109375,1.1698897320218327e-6,1.2682653457210036,0.342856616855136,0.0708779769410049,0.6429522395902524,raw,287255.96875,209861.046875,287483.4375,303481.6875,360651.84375,364605.28125,Caspase recruitment domain-containing protein 19 OS=Homo sapiens OX=9606 GN=CARD19 PE=1 SV=1,metabolic process,cytoskeleton;cytosol;endosome;extracellular;membrane,structural molecule activity,84270,CARD19,NA,NA,ENSG00000165233
Q8WZ82,0,6,1183502.7708333333,4.581275326677787e-6,1.2681717034810867,0.3427500916841291,0.9452583664211351,1,raw,1899077.625,899568.25,708049.625,1140807,1063500.5,1390013.625,Esterase OVCA2 OS=Homo sapiens OX=9606 GN=OVCA2 PE=1 SV=1,metabolic process,membrane;nucleus,structural molecule activity,124641,OVCA2,NA,NA,ENSG00000262664
O00410,0,6,101627376.54427083,3.933940875773636e-4,1.2679863861082585,0.34253925588777795,0.3535075402046079,0.8383308462007302,raw,107872662.5625,89391228.8125,77385475.984375,117047094.5625,81286729.78125,136781067.5625,Importin-5 OS=Homo sapiens OX=9606 GN=IPO5 PE=1 SV=4,conjugation;metabolic process,membrane;nucleus,DNA binding;structural molecule activity,3843,IPO5,NA,vRNP Assembly,ENSG00000065150
Q92688,0,6,56807053.760416664,2.1989703800237654e-4,1.2679689585286658,0.3425194269245379,0.1272830838557531,0.64823440900854,raw,51045655.4375,53948472.625,48613772.8125,64724306.5625,53426628.25,69083486.875,Acidic leucine-rich nuclear phosphoprotein 32 family member B OS=Homo sapiens OX=9606 GN=ANP32B PE=1 SV=1,cell growth;defense response;metabolic process,membrane;nucleus,structural molecule activity,10541,ANP32B,NA,NA,ENSG00000136938
Q9Y394,0,6,14779614.6875,5.72110904801452e-5,1.2676472840495698,0.34215337927862916,0.416133536679995,0.9016652645200752,raw,14804267.25,12878967.875,12913497.375,20073542.75,11637653,16369759.875,Dehydrogenase/reductase SDR family member 7 OS=Homo sapiens OX=9606 GN=DHRS7 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,51635,DHRS7,NA,NA,ENSG00000100612
P05783,0,6,1880341005.0286467,0.007278698507830843,1.267172935390493,0.3416134274028769,0.2906108676883946,0.7730231021500684,raw,1706293317.09375,1821097542.17969,1589068043.88281,2297054445.59375,1560887163.26563,2307645518.15625,"CRAP Keratin, type I cytoskeletal 18 OS=Homo sapiens OX=9606 GN=KRT18 PE=1 SV=2",cell differentiation;cell growth;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,3875,KRT18,Pathogenic Escherichia coli infection,Formation of the cornified envelope,ENSG00000111057
P14868,0,6,172940400.65364584,6.694429535998885e-4,1.2671233742379988,0.34155700019769053,0.1345781499938915,0.6527000726250668,raw,151714638.875,166766421.84375,142182139.1875,206959026.875,158706545.984375,211313631.15625,"Aspartate--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=DARS1 PE=1 SV=2",cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;nucleus,structural molecule activity,1615,DARS1,Alanine and aspartate metabolism,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,ENSG00000115866
Q86UV5,0,6,2905476.9934895835,1.1246944570422367e-5,1.2670477944315803,0.34147094554337853,0.2715996541189793,0.7524601054912853,raw,3250053.8671875,2007703.8125,2414342.328125,3271055.140625,2543856.6875,3945850.125,Ubiquitin carboxyl-terminal hydrolase 48 OS=Homo sapiens OX=9606 GN=USP48 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;endosome;membrane,structural molecule activity,84196,USP48,NA,Ub-specific processing proteases,ENSG00000090686
A0A087WZM2,0,6,1361761.4479166667,5.271305041194698e-6,1.2666047506333482,0.34096639562127823,0.595692622405555,1,raw,1449476.46875,966292.6875,1354335.625,1835913.78125,829246.125,1735304,Ribonuclease T2 OS=Homo sapiens OX=9606 GN=RNASET2 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P17028,0.16666666666666666,6,474471.88125,1.8366550348187794e-6,1.2665493802415995,0.34090332595755185,0.2048009369230241,0.6969949879362929,raw,455825.3125,NA,365785.90625,560563.8125,513447.90625,476736.46875,Zinc finger protein 24 OS=Homo sapiens OX=9606 GN=ZNF24 PE=1 SV=4,cellular component movement;defense response;metabolic process,membrane,RNA binding;structural molecule activity,7572,ZNF24,NA,NA,ENSG00000172466
J3KQN4,0,6,51392827.083333336,1.9893885885819307e-4,1.2661282371238956,0.3404235324861286,0.2979482833785676,0.7796322644514885,raw,38665877,60828248.25,37148833,57044068.125,47035186.4375,67634749.6875,60S ribosomal protein L36a OS=Homo sapiens OX=9606 GN=RPL36A PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;extracellular;Golgi;nucleus,structural molecule activity,6173,RPL36A,Cytoplasmic ribosomal proteins,NA,ENSG00000241343
Q9NZD8,0,6,3120688.9947916665,1.208001860782065e-5,1.2658602290386944,0.3401181172426952,0.5437420768240153,1,raw,1398385.6875,3448921.875,3210661.09375,5169911.1875,1432005.9375,4064248.1875,Maspardin OS=Homo sapiens OX=9606 GN=SPG21 PE=1 SV=1,development,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,antioxidant activity,51324,SPG21,NA,NA,ENSG00000090487
Q8N3D4,0,6,6044473.936197917,2.3397832256152883e-5,1.26555471003604,0.33976987662408836,0.29074079590789587,0.7730231021500684,raw,5473965.90625,4966638.625,4198448.0859375,5826850.03125,5313365.75,10487575.21875,EH domain-binding protein 1-like protein 1 OS=Homo sapiens OX=9606 GN=EHBP1L1 PE=1 SV=2,cell growth,endoplasmic reticulum;mitochondrion,NA,254102,EHBP1L1,NA,NA,ENSG00000173442
Q7L5N7,0,6,1965589.5,7.608690829161601e-6,1.2651729468182087,0.33933461216262395,0.19748411259231932,0.6875760999904456,raw,1104774.21875,2190186.75,1724926.03125,2147800.75,2182329.75,2443519.5,Lysophosphatidylcholine acyltransferase 2 OS=Homo sapiens OX=9606 GN=LPCAT2 PE=1 SV=1,cell growth;cellular homeostasis,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,54947,LPCAT2,NA,Acyl chain remodelling of PC,ENSG00000087253
O14907,0,6,6481834.84375,2.5090832715468183e-5,1.2651375801679734,0.33929428249528354,0.21274598743544404,0.7022549232366887,raw,5599831.625,6757267.0625,4717516.125,7628088.125,5639433.625,8548872.5,Tax1-binding protein 3 OS=Homo sapiens OX=9606 GN=TAX1BP3 PE=1 SV=2,cell death;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,30851,TAX1BP3,NA,RHO GTPases Activate Rhotekin and Rhophilins,ENSG00000213977
P22059,0,6,34279945.567708336,1.326958184632047e-4,1.264980652236059,0.3391153191989911,0.09027332762602307,0.6429522395902524,raw,32222713.90625,31884320.8125,27053201.4375,40333048.9375,32609230.375,41577157.9375,Oxysterol-binding protein 1 OS=Homo sapiens OX=9606 GN=OSBP PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,5007,OSBP,NA,Sphingolipid de novo biosynthesis; Synthesis of bile acids and bile salts,ENSG00000110048
Q9GZT6,0.16666666666666666,6,442858.2265625,1.7142802843955283e-6,1.2647145695539364,0.33881182321728254,1,1,raw,472218.03125,418338.5625,351797.4375,NA,NA,529078.875,"Coiled-coil domain-containing protein 90B, mitochondrial OS=Homo sapiens OX=9606 GN=CCDC90B PE=1 SV=2",NA,cytoskeleton;endosome,NA,60492,CCDC90B,NA,NA,ENSG00000137500
A0A590UJ43,0,6,22529073.815104168,8.720882835733903e-5,1.264665776755651,0.33875616284320814,0.07061016989574531,0.6429522395902524,raw,18671594.125,21415179.53125,19459478.859375,26765705.875,21779439.84375,27083044.65625,Casein kinase I isoform alpha OS=Homo sapiens OX=9606 GN=CSNK1A1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,CSNK1A1,Alzheimer's disease and miRNA effects; Complement system; Wnt/beta-catenin signaling pathway in leukemia; Regulation of Wnt / B-catenin signaling by small molecule compounds; Chromosomal and microsatellite instability in colorectal cancer ; Hedgehog signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Malignant pleural mesothelioma; Alzheimer's disease; DYRK1A,NA,ENSG00000113712
O14841,0,6,689796.8515625,2.6701663691570087e-6,1.264249337119188,0.3382810220205771,0.7005050355224254,1,raw,NA,438426.78125,729681.4375,1208853.375,382225.8125,NA,5-oxoprolinase OS=Homo sapiens OX=9606 GN=OPLAH PE=1 SV=3,cellular homeostasis,cytosol,structural molecule activity,26873,OPLAH,Glutathione metabolism,Glutathione synthesis and recycling; Defective OPLAH causes OPLAHD,ENSG00000178814
P07355,0,6,1724293201.11198,0.006674645884141334,1.2642463241922428,0.338277583822261,0.26199670752632637,0.7434453518424705,raw,1609928867.04688,1657948314.90625,1376950276.0625,2213397859.9375,1452187236.34375,2035346652.375,Annexin A2 OS=Homo sapiens OX=9606 GN=ANXA2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,cell surface;chromosome;cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,catalytic activity;DNA binding;motor activity;structural molecule activity,302,ANXA2,Gastrin signaling pathway; CCL18 signaling pathway; Prostaglandin synthesis and regulation,Neutrophil degranulation; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Smooth Muscle Contraction; Dissolution of Fibrin Clot,ENSG00000182718
Q96NC0,0,6,2229929.4479166665,8.631936495408086e-6,1.264244273735353,0.3382752439409192,0.502296461799954,0.9868286098576095,raw,1599099.5625,2332378.625,2061580.625,1431152.625,2606341.5,3349023.75,Zinc finger matrin-type protein 2 OS=Homo sapiens OX=9606 GN=ZMAT2 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,153527,ZMAT2,NA,NA,ENSG00000146007
Q9Y3A4,0,6,3885205.7864583335,1.503942183087115e-5,1.264237651116217,0.3382676865052173,0.19270574337072516,0.6839501208924997,raw,3476804.625,3273549.90625,3775668,4879106.625,3510598.25,4395507.3125,Ribosomal RNA-processing protein 7 homolog A OS=Homo sapiens OX=9606 GN=RRP7A PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,endoplasmic reticulum;membrane;nucleus,NA,27341,RRP7A,NA,rRNA modification in the nucleus and cytosol; Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000189306
Q9NZ52,0,6,2096424.4869791667,8.115145999766584e-6,1.2639493887236155,0.33793869603138793,0.42717026012218945,0.911332120317874,raw,1736685.375,2500781.625,1299137.8125,3160861.40625,1637575.15625,2243505.546875,ADP-ribosylation factor-binding protein GGA3 OS=Homo sapiens OX=9606 GN=GGA3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,23163,GGA3,NA,Amyloid fiber formation; TBC/RABGAPs; MET receptor recycling,ENSG00000125447
Q9UG56,0,6,478170.40625,1.8509718254044662e-6,1.2637841820894056,0.33775011382083525,0.4626115918742113,0.9446381420181073,raw,518978.3125,341458.71875,449738.78125,NA,444476.21875,636200,"Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Homo sapiens OX=9606 GN=PISD PE=1 SV=4",cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,endosome;membrane;nucleus,structural molecule activity,23761,PISD,Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids,Synthesis of PE,ENSG00000241878
O95563,0.16666666666666666,6,1502418.0625,5.815779201969939e-6,1.263605988771867,0.33754667976548247,0.16689130344752298,0.6670444762382309,raw,1496976.375,1468497.375,1031197.3125,1694314.6875,1431934.3125,1891588.3125,Mitochondrial pyruvate carrier 2 OS=Homo sapiens OX=9606 GN=MPC2 PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,25874,MPC2,Glycolysis and gluconeogenesis,Pyruvate metabolism,ENSG00000143158
Q9BSJ8,0,6,48453332.643229164,1.875602345885823e-4,1.2635246779061766,0.3374538418412002,0.3210945457095069,0.8027885809803746,raw,38922250.28125,36834303.40625,53810446.234375,68286580.90625,43687191.28125,49179223.75,Extended synaptotagmin-1 OS=Homo sapiens OX=9606 GN=ESYT1 PE=1 SV=1,cell growth;conjugation,cytoplasm;cytoskeleton;extracellular,catalytic activity;structural molecule activity,23344,ESYT1,NA,RHOG GTPase cycle; Glycosphingolipid metabolism; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle,ENSG00000139641
Q13445,0,6,6243086.322916667,2.4166650081738974e-5,1.2634102576648112,0.33732319066171446,0.07589928979254836,0.6429522395902524,raw,5789072.875,5678022,4963963.625,6768918.5625,6271522.5625,7987018.3125,Transmembrane emp24 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TMED1 PE=1 SV=1,cell death;cell growth;coagulation;conjugation;development,cytoplasm;cytoskeleton;extracellular;nucleus,antioxidant activity,11018,TMED1,Ciliary landscape,NA,ENSG00000099203
Q8NE01,0.16666666666666666,6,264380.45703125,1.0234024748418856e-6,1.263285377499804,0.33718058227438,0.3345183444240332,0.8181662188074962,raw,240671.03125,NA,225796.28125,258328.546875,NA,332725.96875,Metal transporter CNNM3 OS=Homo sapiens OX=9606 GN=CNNM3 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity,26505,CNNM3,2q11.2 copy number variation syndrome,NA,ENSG00000168763
Q9NPE3,0,6,1796941.9166666667,6.955865139632532e-6,1.2632384575424078,0.3371269978284918,0.181052938195775,0.674297118008435,raw,1852428.5625,1428868.46875,1390980.59375,2210897.25,1558417.625,2340059,H/ACA ribonucleoprotein complex subunit 3 OS=Homo sapiens OX=9606 GN=NOP10 PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,55505,NOP10,NA,rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase,ENSG00000182117
Q8NI36,0,6,29238373.161458332,1.131801638812136e-4,1.2632013463838108,0.33708461400886525,0.2440200413768818,0.7301988479077035,raw,27943003.28125,26533425.84375,25364025.15625,33517059.25,25598268.6875,36474456.75,WD repeat-containing protein 36 OS=Homo sapiens OX=9606 GN=WDR36 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,134430,WDR36,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,NA
O60232,0,6,10291711.026041666,3.9838657715776645e-5,1.2630946133158023,0.336962709631498,0.4455324921928644,0.9273649839411913,raw,7112271.4375,13291578.3125,6965166.359375,10674122.5,8797664.109375,14909463.4375,Protein ZNRD2 OS=Homo sapiens OX=9606 GN=ZNRD2 PE=1 SV=1,cell differentiation;metabolic process,NA,NA,10534,ZNRD2,NA,NA,ENSG00000173465
Q13625,0,6,10560796.333984382,4.088027241447435e-5,1.2630637887270075,0.3369275016402985,0.06393745166125513,0.6429522395902524,raw,10014753.984375,9496580.9296875,8419828.8515625,11515406.1757813,10634780.9296875,13283427.1328125,Apoptosis-stimulating of p53 protein 2 OS=Homo sapiens OX=9606 GN=TP53BP2 PE=1 SV=2,cell differentiation;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7159,TP53BP2,NA,TP53 Regulates Transcription of Death Receptors and Ligands; Activation of PUMA and translocation to mitochondria; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain; Regulation of TP53 Activity through Association with Co-factors,ENSG00000143514
Q15424,0,6,79819721.91927083,3.0897783395433543e-4,1.2625273238190637,0.33631461124003004,0.1086661358853248,0.6429522395902524,raw,61783619.96875,83084802.96875,65481954.984375,89158778.84375,78003508.375,101405666.375,Scaffold attachment factor B1 OS=Homo sapiens OX=9606 GN=SAFB PE=1 SV=4,cell growth;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6294,SAFB,Interleukin-1 (IL-1) structural pathway,SUMOylation of transcription cofactors,ENSG00000160633
P21796,0,6,261094736.7721355,0.0010106836291201746,1.262391477503746,0.33615937075822244,0.2971746449392465,0.7790952437047332,raw,240207042.96875,235339396.625,247630987.476563,312607248.15625,223748800.234375,307034945.171875,Voltage-dependent anion-selective channel protein 1 OS=Homo sapiens OX=9606 GN=VDAC1 PE=1 SV=2,cell death;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;endosome;nucleus,catalytic activity;structural molecule activity,7416,VDAC1,Alzheimer's disease and miRNA effects; Alzheimer's disease; Arsenic metabolism and reactive oxygen species generation,Ub-specific processing proteases; Pyruvate metabolism; Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy; Mitochondrial calcium ion transport,ENSG00000213585
P30086,0,6,179699915.16145834,6.95608669302571e-4,1.2623862313850696,0.3361533753397968,0.09532075439951863,0.6429522395902524,raw,172969071.15625,142354076.375,160181104.71875,202210421.125,173138070.5,227346747.09375,Phosphatidylethanolamine-binding protein 1 OS=Homo sapiens OX=9606 GN=PEBP1 PE=1 SV=3,metabolic process,cytosol,DNA binding;structural molecule activity,5037,PEBP1,Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway,Signaling by BRAF and RAF1 fusions; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants,ENSG00000089220
B4E0Y9,0,6,5586932.432291667,2.1626713797933456e-5,1.2623508448133929,0.3361129338760447,0.32366555462282487,0.8037523716522456,raw,6456925.03125,4924249.4375,3471581.4375,6216130.4375,4969933.5625,7482774.6875,Serine/threonine-protein kinase 26 OS=Homo sapiens OX=9606 GN=STK26 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,STK26,NA,NA,ENSG00000134602
Q9Y2V2,0,6,9265851.651041666,3.586761146294921e-5,1.2622065985258202,0.33594807060107873,0.05011328316287762,0.6429522395902524,raw,9028664.375,7533847.296875,7660031.078125,11396039.75,9159009.46875,10817517.9375,Calcium-regulated heat-stable protein 1 OS=Homo sapiens OX=9606 GN=CARHSP1 PE=1 SV=2,development;metabolic process,cytosol;mitochondrion;nucleus,RNA binding;structural molecule activity,23589,CARHSP1,NA,NA,ENSG00000153048
Q02127,0,6,4923331.223958333,1.905794934937164e-5,1.2620099572039776,0.3357232931668399,0.35412067432868427,0.8383308462007302,raw,3867420.78125,4657726.96875,4755396.90625,5878097.8125,3815045.625,6566299.25,"Dihydroorotate dehydrogenase (quinone), mitochondrial OS=Homo sapiens OX=9606 GN=DHODH PE=1 SV=3",cellular homeostasis,cytoskeleton;cytosol;endosome;membrane,structural molecule activity,1723,DHODH,Pyrimidine metabolism,Pyrimidine biosynthesis,ENSG00000102967
P78527,0,6,646507127.0091146,0.0025025941826927064,1.2614032466899956,0.33502955163826853,0.2018666694761878,0.6920162065862512,raw,622951614.625,553729807.085938,564863143.203125,783208554.375,568496453.546875,785793189.21875,DNA-dependent protein kinase catalytic subunit OS=Homo sapiens OX=9606 GN=PRKDC PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,5591,PRKDC,"miRNA regulation of DNA damage response; Cell cycle; Retinoblastoma gene in cancer; Fas ligand pathway and stress induction of heat shock proteins; Pathways affected in adenoid cystic carcinoma; ATM signaling in development and disease ; Non-homologous end joining; Osteoblast differentiation and related diseases; DNA repair pathways, full network; DNA damage response",E3 ubiquitin ligases ubiquitinate target proteins; Cytosolic sensors of pathogen-associated DNA ; Nonhomologous End-Joining (NHEJ); IRF3-mediated induction of type I IFN,ENSG00000253729
Q9P2R7,0,6,30922946.536458332,1.1970105646301276e-4,1.261328712042027,0.3349443021795157,0.2159173533215919,0.7052300591128846,raw,27687933.375,30757312.3125,25387068.3125,38795081.125,27358468.84375,35551815.25,"Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=SUCLA2 PE=1 SV=3",cellular homeostasis,endosome;nucleus,structural molecule activity,8803,SUCLA2,NA,Citric acid cycle (TCA cycle),ENSG00000136143
P46934,0,6,774437.96875,2.9978075638797745e-6,1.2613065970279176,0.3349190070279964,0.4755303139309619,0.9571357750889941,raw,502593.75,557567.625,931152.6875,633924.8125,659387.25,1362001.6875,E3 ubiquitin-protein ligase NEDD4 OS=Homo sapiens OX=9606 GN=NEDD4 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,4734,NEDD4,Proteasome degradation; Ebola virus infection in host; EGF/EGFR signaling pathway; LDLRAD4 and what we know about it,Antigen processing: Ubiquitination & Proteasome degradation; Regulation of PTEN stability and activity; ISG15 antiviral mechanism; Downregulation of ERBB4 signaling; Regulation of PTEN localization,ENSG00000069869
O94832,0,6,6373524.854166667,2.4671570593621632e-5,1.2612576911519913,0.33486306691577905,0.2290185434079865,0.7149229308598871,raw,6702611.109375,3635653.40625,6113138.9375,7658684.875,5677340.984375,8453719.8125,Unconventional myosin-Id OS=Homo sapiens OX=9606 GN=MYO1D PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,4642,MYO1D,NA,NA,ENSG00000176658
Q9UBQ0,0,6,460785.175,1.7836745338923124e-6,1.261121625574196,0.33470741932288156,0.5138730155611464,0.998450598949019,raw,466722.375,NA,285023.8125,836301.375,269548.90625,446329.40625,Vacuolar protein sorting-associated protein 29 OS=Homo sapiens OX=9606 GN=VPS29 PE=1 SV=1,conjugation,cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,51699,VPS29,NA,WNT ligand biogenesis and trafficking,ENSG00000111237
P17612,0,6,6851781.119791667,2.652287477603104e-5,1.2609893603657067,0.334556102936245,0.3718959836201026,0.8574268511241254,raw,6776196.25,6162824.40625,5962282.0625,8179230.25,5485442.375,8544711.375,cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens OX=9606 GN=PRKACA PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,signal transducer activity;structural molecule activity,5566,PRKACA,Nicotine effect on dopaminergic neurons; Sterol regulatory element-binding proteins (SREBP) signaling; Follicle stimulating hormone (FSH) signaling pathway; Microtubule cytoskeleton regulation; Dopamine metabolism; Common pathways underlying drug addiction; Complement system; Mesodermal commitment pathway; IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Mesodermal commitment pathway; G protein signaling pathways; MAPK signaling pathway; Cannabinoid receptor signaling; Lipid metabolism pathway; Ras signaling; Hedgehog signaling pathway; Thermogenesis; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Endochondral ossification; Endochondral ossification with skeletal dysplasias; GPR143 in melanocytes and retinal pigment epithelium cells; Neuroinflammation and glutamatergic signaling; GDNF signaling; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways; Estrogen signaling pathway,"FCGR3A-mediated IL10 synthesis; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; MAPK6/MAPK4 signaling; Triglyceride catabolism; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Ion homeostasis; Interleukin-3, Interleukin-5 and GM-CSF signaling; RET signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; Regulation of MECP2 expression and activity; PKA activation; PKA activation in glucagon signalling; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; CD209 (DC-SIGN) signaling; Rap1 signalling; HDL assembly; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase; Loss of phosphorylation of MECP2 at T308; ROBO receptors bind AKAP5; PKA-mediated phosphorylation of key metabolic factors",ENSG00000072062; ENSG00000288516
O43819,0,6,5222527.015625,2.0216120104851314e-5,1.2607735743272173,0.3343092014974945,0.3112221649280422,0.7920100626951777,raw,5084849.875,4033582.40625,5037389.25,6351007.25,4245504,6582829.3125,"Protein SCO2 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=SCO2 PE=1 SV=3",cell growth;cellular homeostasis;defense response;metabolic process,endoplasmic reticulum;endosome,structural molecule activity,9997,SCO2,p53 transcriptional gene network,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000284194
Q9H4L5,0,6,4074572.7916666665,1.5772451283803435e-5,1.2607091016801284,0.3342354239783123,0.4855658247156242,0.9679759517854559,raw,3173505,3930260.21875,4122956.84375,5147598.75,2875266.71875,5197849.21875,Oxysterol-binding protein-related protein 3 OS=Homo sapiens OX=9606 GN=OSBPL3 PE=1 SV=1,cellular homeostasis;conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,26031,OSBPL3,NA,Synthesis of bile acids and bile salts,ENSG00000070882
P61158,0,6,65204140.8828125,2.524017088809319e-4,1.2606969517806277,0.3342215201489524,0.26239247712087194,0.7434453518424705,raw,59458926.484375,62650890.21875,52882376.9375,74959687.375,55261420.3125,86011543.96875,Actin-related protein 3 OS=Homo sapiens OX=9606 GN=ACTR3 PE=1 SV=3,cell differentiation;cell growth;coagulation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,10096,ACTR3,Physico-chemical features and toxicity-associated pathways,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,ENSG00000115091
Q8TEM1,0,6,128131710.14322917,4.959909319273329e-4,1.2604438278102559,0.3339318253401827,0.3182509121297801,0.799878940176558,raw,110429907.171875,125824870.078125,115612985.78125,152147657.90625,106179659.046875,158595180.875,Nuclear pore membrane glycoprotein 210 OS=Homo sapiens OX=9606 GN=NUP210 PE=1 SV=3,conjugation,cytoskeleton;extracellular;membrane,NA,23225,NUP210,NA,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses,ENSG00000132182
Q9UJC3,0,6,6047632.098958333,2.3410057333684168e-5,1.260424890060648,0.33391014916383,0.2567267651187404,0.737462267065437,raw,7123094.21875,3783627.28125,4112069.125,8310001.1875,4768978,8188022.78125,Protein Hook homolog 1 OS=Homo sapiens OX=9606 GN=HOOK1 PE=1 SV=2,cell growth;conjugation;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,51361,HOOK1,NA,NA,ENSG00000134709
Q9UNL2,0,6,7471392.333333333,2.892135632984488e-5,1.26039520666749,0.3338761728525783,0.13208371904685276,0.6514609890946903,raw,6028415.5,6411108.5,6467776,7598186,7768640,10554228,Translocon-associated protein subunit gamma OS=Homo sapiens OX=9606 GN=SSR3 PE=1 SV=1,conjugation,cytoskeleton;extracellular,NA,6747,SSR3,VEGFA-VEGFR2 signaling pathway,SRP-dependent cotranslational protein targeting to membrane,ENSG00000114850
P22830,0,6,9653226.5625,3.736711883020993e-5,1.2603508974686621,0.33382545401079067,0.4067142375331228,0.8914071190930648,raw,10290727.25,8176765.3125,7913489.9375,13385944.625,7846838.75,10305593.5,"Ferrochelatase, mitochondrial OS=Homo sapiens OX=9606 GN=FECH PE=1 SV=2",cellular homeostasis;metabolic process,cytoskeleton;endosome,structural molecule activity,2235,FECH,Hemesynthesis defects and porphyrias; Heme biosynthesis,Heme biosynthesis,ENSG00000066926
P07954,0,6,84466450.88802083,3.2696507090799624e-4,1.2599544781972378,0.33337161049862346,0.27665388076123354,0.756515890988102,raw,83806709.5,75764633.234375,68962960.65625,102364334.125,70307428.875,105592638.9375,"Fumarate hydratase, mitochondrial OS=Homo sapiens OX=9606 GN=FH PE=1 SV=3",cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,2271,FH,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Krebs cycle disorders; Type 2 papillary renal cell carcinoma; Metabolic reprogramming in colon cancer; TCA cycle in senescence; TCA cycle (aka Krebs or citric acid cycle),Citric acid cycle (TCA cycle),ENSG00000091483
J3KR72,0.16666666666666666,6,425007.0703125,1.6451794223644146e-6,1.2598231631438885,0.3332212420110836,0.5888170869509164,1,raw,282916.875,489443.96875,NA,418577.46875,NA,509089.96875,Transcription initiation factor TFIID subunit 6 OS=Homo sapiens OX=9606 GN=TAF6 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,NA,TAF6,NA,NA,ENSG00000106290
Q86W50,0,6,3569462.4583333335,1.3817196455189376e-5,1.259786236078375,0.3331789541117677,0.30670751750290076,0.787259868285476,raw,2973420.375,4145765.53125,2673768.59375,4203719.25,3674226.9375,3745874.0625,RNA N6-adenosine-methyltransferase METTL16 OS=Homo sapiens OX=9606 GN=METTL16 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,79066,METTL16,NA,NA,ENSG00000127804
H3BNC9,0,6,122674893.14583333,4.7486788795273957e-4,1.2592582131951133,0.3325741406424906,0.24882800991130732,0.7316541032247736,raw,114751124.5,123849996.875,84429633.25,165041659.5,103475648.75,144501296,40S ribosomal protein S17 OS=Homo sapiens OX=9606 PE=3 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,Golgi;nucleus,RNA binding;structural molecule activity,NA,NA,NA,NA,NA
Q96CB8,0,6,3031616.015625,1.1735221914659888e-5,1.2592473297644726,0.33256167176271606,0.18072235860143443,0.6742444420587625,raw,2546019.4375,2529979.46875,3107959.6875,3217695.375,2874352.1875,3913689.9375,Integrator complex subunit 12 OS=Homo sapiens OX=9606 GN=INTS12 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,57117,INTS12,NA,RNA polymerase II transcribes snRNA genes,ENSG00000138785
P61088,0,6,161642277.640625,6.257085294203173e-4,1.2592038810348711,0.33251189254407054,0.1472983867681662,0.6635952226369173,raw,150469713.5,143877501.375,141493215.25,181171108.125,151578814.28125,201263313.3125,Ubiquitin-conjugating enzyme E2 N OS=Homo sapiens OX=9606 GN=UBE2N PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7334,UBE2N,IL-1 signaling pathway; Interleukin-1 induced activation of NF-kB; MYD88 distinct input-output pathway; Prader-Willi and Angelman syndrome; 3q29 copy number variation syndrome,"FCERI mediated NF-kB activation; Downstream TCR signaling; E3 ubiquitin ligases ubiquitinate target proteins; Antigen processing: Ubiquitination & Proteasome degradation; CLEC7A (Dectin-1) signaling; Aggrephagy; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; IKK complex recruitment mediated by RIP1; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; TAK1-dependent IKK and NF-kappa-B activation  ; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; activated TAK1 mediates p38 MAPK activation; Nonhomologous End-Joining (NHEJ); Formation of Incision Complex in GG-NER; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling",ENSG00000177889
P57678,0,6,13623184.236979166,5.273461064371898e-5,1.2591613278984428,0.3324631377417984,0.15483064164493945,0.6638855679885327,raw,11912621.28125,12701862.203125,11402379.71875,14999912.03125,12793672.09375,17928658.09375,Gem-associated protein 4 OS=Homo sapiens OX=9606 GN=GEMIN4 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,50628,GEMIN4,NA,snRNP Assembly; SARS-CoV-2 modulates host translation machinery,ENSG00000179409
Q16658,0,6,242325866.14322916,9.380303442771898e-4,1.2591251891089903,0.33242173081532017,0.20986151097490455,0.6997404039201699,raw,224272027.0625,217602669.28125,205819404.015625,316659831.703125,215612262.6875,273989002.109375,Fascin OS=Homo sapiens OX=9606 GN=FSCN1 PE=1 SV=3,cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,6624,FSCN1,VEGFA-VEGFR2 signaling pathway,Interleukin-4 and Interleukin-13 signaling,ENSG00000075618
Q08J23,0,6,26794528.427083332,1.0372017286155567e-4,1.258978179856187,0.33225327901716206,0.37639848175280655,0.8615698665976935,raw,22783639.5625,27824997.0625,22877148.5,30809269.0625,21441052.21875,35031064.15625,RNA cytosine C(5)-methyltransferase NSUN2 OS=Homo sapiens OX=9606 GN=NSUN2 PE=1 SV=2,cell differentiation;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cell surface;endoplasmic reticulum;endosome;membrane;nucleus,RNA binding;structural molecule activity,54888,NSUN2,NA,tRNA modification in the nucleus and cytosol,ENSG00000037474
Q6GMV3,0,6,4962260.408854167,1.920864212225411e-5,1.2588756278493085,0.3321357572838622,0.07520939010728174,0.6429522395902524,raw,4950742.25,4325006.515625,3824900.1875,5994353.75,4815073.625,5863486.125,Putative peptidyl-tRNA hydrolase PTRHD1 OS=Homo sapiens OX=9606 GN=PTRHD1 PE=1 SV=1,NA,NA,structural molecule activity,391356,PTRHD1,NA,NA,ENSG00000184924
Q8N5M9,0,6,3062601.0833333335,1.1855163438825207e-5,1.2586202735678105,0.33184308681187213,0.11851606511758066,0.6429522395902524,raw,3176063,2372263.75,2740090.5,3561907,2985779.25,3539503,Protein jagunal homolog 1 OS=Homo sapiens OX=9606 GN=JAGN1 PE=1 SV=1,cell growth;coagulation;conjugation;development;metabolic process,cytoskeleton;extracellular,NA,84522,JAGN1,NA,NA,ENSG00000171135
Q15287,0,6,30635281.901041668,1.1858752219079117e-4,1.2585029460450703,0.33170859372546246,0.3079185957006638,0.7888038099739227,raw,27504851.1875,30214907.5625,21441045.65625,45840342.5,24195608.25,34614936.25,RNA-binding protein with serine-rich domain 1 OS=Homo sapiens OX=9606 GN=RNPS1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding,10921,RNPS1,mRNA processing,Regulation of expression of SLITs and ROBOs; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSG00000205937
Q9BVJ7,0,6,4370558.768229167,1.6918197018317957e-5,1.25840740731759,0.33159906797439165,0.24282359166618378,0.7289874209382666,raw,4014059.359375,4896830.53125,2447358.65625,5051322.03125,4276338.40625,5537443.625,Dual specificity protein phosphatase 23 OS=Homo sapiens OX=9606 GN=DUSP23 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,54935,DUSP23,NA,NA,ENSG00000158716
P42766,0,6,91810519.66666667,3.553935646320493e-4,1.258153119426444,0.33130751140194736,0.2274469119895001,0.7148463313429879,raw,69234298,103633328,74377308,107607080,87107348,108903756,60S ribosomal protein L35 OS=Homo sapiens OX=9606 GN=RPL35 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,11224,RPL35,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000136942
Q92665,0,6,91170434.75,3.5291583047884675e-4,1.258065559012643,0.3312071044095805,0.15523130441711663,0.6638855679885327,raw,81832462.40625,96941158.78125,66816559.59375,104147423.5,94334401.65625,102950602.5625,"28S ribosomal protein S31, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS31 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,structural molecule activity,10240,MRPS31,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000102738
Q9BV81,0.16666666666666666,6,1678670.2916666667,6.498042064932784e-6,1.2577734038173904,0.33087203459034104,0.03495175740549736,0.6429522395902524,raw,1362817.25,1587805.875,1581625.875,1801599.125,1741073.625,1997100,ER membrane protein complex subunit 6 OS=Homo sapiens OX=9606 GN=EMC6 PE=1 SV=1,cell growth;cellular homeostasis,cytoskeleton;extracellular,NA,83460,EMC6,NA,NA,ENSG00000127774
Q32P28,0,6,2770579.0833333335,1.072476204356265e-5,1.2577245641266888,0.3308160132534283,0.13670972138177634,0.654928512316515,raw,1889392.9375,2558102.46875,2849047.28125,3217388.3125,2688012.3125,3421531.1875,Prolyl 3-hydroxylase 1 OS=Homo sapiens OX=9606 GN=P3H1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,extracellular;membrane;nucleus,structural molecule activity,64175,P3H1,Type I collagen synthesis in the context of osteogenesis imperfecta,Collagen biosynthesis and modifying enzymes,ENSG00000117385
Q96DG6,0,6,33029834.989583332,1.278567079107635e-4,1.2576075332440133,0.3306817646789637,0.15779004176102407,0.6638855679885327,raw,33455892.25,25853704.3125,26718036,42074382.125,29211535.75,40865459.5,Carboxymethylenebutenolidase homolog OS=Homo sapiens OX=9606 GN=CMBL PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,134147,CMBL,NA,Phase I - Functionalization of compounds,ENSG00000164237
P29373,0,6,85041719.59375,3.291919050081912e-4,1.2575318620568625,0.33059495402610084,0.2283540114077763,0.7148463313429879,raw,76914544.359375,83236901.046875,67106140.15625,112107863.9375,74162377.875,96722490.1875,Cellular retinoic acid-binding protein 2 OS=Homo sapiens OX=9606 GN=CRABP2 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;defense response;development;metabolic process,cytosol;extracellular;membrane;nucleus,structural molecule activity,1382,CRABP2,Non-small cell lung cancer; Vitamin A and carotenoid metabolism,Signaling by Retinoic Acid,ENSG00000143320
Q8N9Z2,0,6,977774.6145833334,3.784912741428069e-6,1.2575263654249937,0.3305886480380708,0.22872304437271013,0.7149130481267827,raw,802003.90625,914876.34375,899351.96875,846696,1130958.8125,1272760.65625,Coiled-coil domain-containing protein 71L OS=Homo sapiens OX=9606 GN=CCDC71L PE=1 SV=2,cellular homeostasis;metabolic process,NA,NA,168455,CCDC71L,NA,NA,ENSG00000253276
G3V5Z7,0,6,141605599.39583334,5.481476297472126e-4,1.2574492850116743,0.3305002149512048,0.18523811018772512,0.6778506319470519,raw,123488621.375,140550800.125,116388423,176735503.125,126219082.875,166251165.875,Proteasome subunit alpha type OS=Homo sapiens OX=9606 GN=PSMA6 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,membrane;nucleus,NA,NA,PSMA6,NA,NA,ENSG00000100902
E7EPT4,0,6,15323882.567708334,5.931792205853345e-5,1.2574480550736225,0.3304988038196252,0.17219301509678228,0.6689341104244626,raw,13695169.875,11534842.875,13436573.03125,16895792.625,14103002.4375,22277914.5625,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFV2 PE=1 SV=1",NA,NA,structural molecule activity,NA,NDUFV2,NA,NA,ENSG00000178127
Q92466,0,6,5826958.723958333,2.2555842613569596e-5,1.2572702733970291,0.3302948169629617,0.23112109347318674,0.7181805368495511,raw,5826192.40625,4290130.34375,4786224.96875,8702334.3125,5339291.9375,6017578.375,DNA damage-binding protein 2 OS=Homo sapiens OX=9606 GN=DDB2 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,1643,DDB2,"miRNA regulation of DNA damage response; miRNA regulation of p53 pathway in prostate cancer; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Small cell lung cancer; Hepatitis B infection; Melanoma; Nucleotide excision repair; DNA repair pathways, full network; p53 transcriptional gene network; Nucleotide excision repair in xeroderma pigmentosum ; DNA damage response",Ub-specific processing proteases; Neddylation; TP53 Regulates Transcription of DNA Repair Genes; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER; Dual Incision in GG-NER,ENSG00000134574
P09622,0,6,82378142.58333333,3.1888134221167493e-4,1.2568018879908534,0.3297572529893328,0.45634590674163966,0.9399855109820654,raw,88559899.5,65090569.0625,72557899.1875,113814166.46875,63055416.59375,91190904.6875,"Dihydrolipoyl dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=DLD PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,endoplasmic reticulum;endosome;membrane;mitochondrion;nucleus,structural molecule activity,1738,DLD,Fatty acid beta-oxidation; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Tryptophan metabolism; 7q11.23 copy number variation syndrome; Neuroinflammation and glutamatergic signaling; Glycolysis and gluconeogenesis; TCA cycle (aka Krebs or citric acid cycle),Lysine catabolism; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid; Citric acid cycle (TCA cycle); Branched-chain amino acid catabolism; Glycine degradation,ENSG00000091140
H3BP13,0,6,387140.84375,1.4986013037994501e-6,1.256778904775025,0.3297308700923951,0.35844844180624463,0.8420882601494262,raw,411371.53125,340573.5625,295384.59375,517003.0625,306946.0625,451566.25,Trafficking protein particle complex subunit 2-like protein OS=Homo sapiens OX=9606 GN=TRAPPC2L PE=1 SV=1,conjugation,cytosol;nucleus,NA,NA,TRAPPC2L,NA,NA,ENSG00000167515
Q8NCW5,0,6,33960389.255208336,1.3145883323087645e-4,1.2565018623874429,0.32941280958318186,0.39295975010845074,0.8769264261349782,raw,32781475.125,31150221.4375,30793565.96875,42202068.25,27694693.5,39140311.25,NAD(P)H-hydrate epimerase OS=Homo sapiens OX=9606 GN=NAXE PE=1 SV=2,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cell surface;endosome;nucleus,structural molecule activity,128240,NAXE,NA,Nicotinamide salvaging,ENSG00000163382
Q9NYU2,0,6,62179583.798177086,2.4069381170700965e-4,1.2563024466426544,0.3291838254910649,0.46983169564942,0.9503046481670465,raw,65768013.90625,53321219.453125,53618989.71875,82624516.78125,47820723.5234375,69924039.40625,UDP-glucose:glycoprotein glucosyltransferase 1 OS=Homo sapiens OX=9606 GN=UGGT1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,extracellular;nucleus,structural molecule activity,56886,UGGT1,IL-18 signaling pathway,ER Quality Control Compartment (ERQC),ENSG00000136731
P49411,0,6,369730485.1770833,0.0014312067457769504,1.256243169928682,0.3291157525209743,0.13552028008998926,0.653793677153943,raw,371139860.875,310362439.90625,300882109.71875,427907352.6875,341849232.5625,466241915.3125,"Elongation factor Tu, mitochondrial OS=Homo sapiens OX=9606 GN=TUFM PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome;nucleus,RNA binding;structural molecule activity,7284,TUFM,16p11.2 distal deletion syndrome,Mitochondrial translation elongation; SARS-CoV-2 modulates autophagy,ENSG00000178952
Q13033,0,6,12394356.606770834,4.7977885233562626e-5,1.2560966763018522,0.32894750646978355,0.3199533024169711,0.802295473638468,raw,11843584.640625,10129302.4375,10042410.6875,19213358.5,10414100.25,12723383.125,Striatin-3 OS=Homo sapiens OX=9606 GN=STRN3 PE=1 SV=3,metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,29966,STRN3,NA,NA,ENSG00000196792
Q06323,0,6,137886217.953125,5.337501049978746e-4,1.2559521633925612,0.32878151602046257,0.23962009639521506,0.7258564963796661,raw,135712879.6875,120659675.6875,118105363.5,170448884.84375,119178290.875,163212213.125,Proteasome activator complex subunit 1 OS=Homo sapiens OX=9606 GN=PSME1 PE=1 SV=1,metabolic process,cytosol;membrane;nucleus,DNA binding,5720,PSME1,Proteasome degradation,Antigen processing: Ubiquitination & Proteasome degradation; FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000092010; ENSG00000284916
P48556,0,6,57348412.239583336,2.2199260744641577e-4,1.2557911743789292,0.3285965782934027,0.13966664939392864,0.6572502130392559,raw,53641242.6875,55812296.125,42641707.25,73347691.5,53549079.625,65098456.25,26S proteasome non-ATPase regulatory subunit 8 OS=Homo sapiens OX=9606 GN=PSMD8 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,NA,5714,PSMD8,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Ciliary landscape; Alzheimer's disease,Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000099341
Q9BWH6,0,6,357241.9453125,1.3828642822375012e-6,1.2555710314435362,0.32834364853181336,1,1,raw,298156.46875,NA,NA,374356.625,266142.1875,490312.5,RNA polymerase II-associated protein 1 OS=Homo sapiens OX=9606 GN=RPAP1 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,26015,RPAP1,NA,NA,ENSG00000103932
A0A0G2JKF9,0.6666666666666666,6,2403820.725,9.305060240327949e-6,1.2555667658779548,0.3283387472394052,0.6041725060233749,1,raw,2006412.375,2842684.75,1562486.375,3739123.75,NA,1868396.375,GABBR1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1,development,cytoplasm;cytoskeleton,structural molecule activity,NA,GABBR1,NA,NA,ENSG00000237051
Q15388,0,6,1391153.5208333333,5.3850801685298254e-6,1.2554068994477336,0.32815504279870855,0.23477309749402872,0.7192904383575112,raw,1404876.03125,1234058.421875,1145070.234375,1763691.0625,1229632.71875,1569592.65625,Mitochondrial import receptor subunit TOM20 homolog OS=Homo sapiens OX=9606 GN=TOMM20 PE=1 SV=1,cell growth;conjugation,cytoskeleton;endoplasmic reticulum;endosome;nucleus,catalytic activity;structural molecule activity,9804,TOMM20,NA,Ub-specific processing proteases; Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy,ENSG00000173726
P49915,0,6,101201816.69791667,3.9174676838878717e-4,1.255371831020005,0.3281147421173581,0.2975028471354431,0.7790952437047332,raw,101730530.375,91520283.625,79419489.96875,127709642.1875,82095205.40625,124735748.625,GMP synthase [glutamine-hydrolyzing] OS=Homo sapiens OX=9606 GN=GMPS PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,8833,GMPS,NA,Purine ribonucleoside monophosphate biosynthesis; Azathioprine ADME,ENSG00000163655
P29401,0,6,719850006.9772136,0.0027865005111491693,1.2551320538424025,0.32783915971481065,0.0787381221980869,0.6429522395902524,raw,711762857.671875,599488074.242188,580073531.410156,841959118.613281,692460082.527344,893356377.398438,Transketolase OS=Homo sapiens OX=9606 GN=TKT PE=1 SV=3,cellular homeostasis;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion,structural molecule activity,7086,TKT,Pentose phosphate metabolism; VEGFA-VEGFR2 signaling pathway; Metabolic reprogramming in colon cancer; Thiamine metabolic pathways,Nuclear events mediated by NFE2L2; Pentose phosphate pathway; Insulin effects increased synthesis of Xylulose-5-Phosphate,ENSG00000163931
P26639,0,6,223564421.46875,8.654058049028533e-4,1.2548442526541361,0.32750831248902706,0.14224854427072672,0.6572502130392559,raw,217682344.15625,188807260.625,191484691.65625,265663247.125,204591546.78125,273157438.46875,"Threonine--tRNA ligase 1, cytoplasmic OS=Homo sapiens OX=9606 GN=TARS1 PE=1 SV=3",cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol,RNA binding;structural molecule activity,6897,TARS1,NA,Cytosolic tRNA aminoacylation,ENSG00000113407
Q99747,0,6,5249867.270833333,2.0321952756618423e-5,1.2548427091027954,0.3275065378662167,0.13544319462094426,0.653793677153943,raw,3928288.25,4856443.625,5029041.25,6750973.9375,4840383.6875,6094072.875,Gamma-soluble NSF attachment protein OS=Homo sapiens OX=9606 GN=NAPG PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endosome;extracellular,structural molecule activity,8774,NAPG,NA,Retrograde transport at the Trans-Golgi-Network; COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; COPII-mediated vesicle transport; Intra-Golgi traffic,ENSG00000134265
Q12981,0,6,7613755.005208333,2.9472434546283385e-5,1.2548191157677335,0.32747941230917516,0.41877910863836837,0.9054509995230429,raw,6194197.8125,8675306.15625,5216937.4375,10885940,5221408.625,9488740,Vesicle transport protein SEC20 OS=Homo sapiens OX=9606 GN=BNIP1 PE=1 SV=3,cell growth;conjugation;metabolic process,cytoskeleton;endosome;extracellular;membrane;nucleus,structural molecule activity,662,BNIP1,NA,COPI-dependent Golgi-to-ER retrograde traffic,ENSG00000113734
Q5VWZ2,0,6,10084787.359375,3.9037667374251544e-5,1.2546364408689068,0.32726937139380546,0.4972933806097288,0.9805491336505413,raw,12508048.6875,7294825.78125,6969663.75,15693053.6875,7022021.4375,11021110.8125,Lysophospholipase-like protein 1 OS=Homo sapiens OX=9606 GN=LYPLAL1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,structural molecule activity,127018,LYPLAL1,NA,NA,ENSG00000143353
O14776,0,6,28186478.542643234,1.0910833660526261e-4,1.2545660322743812,0.3271884069190197,0.15763950678714506,0.6638855679885327,raw,25328174.390625,27014512.7363281,21527417.1875,37593532.9140625,25879366.7773438,31775867.25,Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,10915,TCERG1,NA,NA,ENSG00000113649
P13807,0,6,18412424.010416668,7.127349922793756e-5,1.2545626841208755,0.32718455668652474,0.18946207595634784,0.6806579357154494,raw,15222426.40625,19759856.0625,13157838.875,24186028.4375,16507333.65625,21641060.625,"Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",cellular homeostasis;defense response,cytosol;nucleus,structural molecule activity,2997,GYS1,AMP-activated protein kinase signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Insulin signaling; Glycogen synthesis and degradation; Disorders of galactose metabolism ; 2q37 copy number variation syndrome,Glycogen synthesis; Myoclonic epilepsy of Lafora; Glycogen storage disease type XV (GYG1); Glycogen storage disease type 0 (muscle GYS1),ENSG00000104812
Q5T8D3,0,6,1484005.3020833333,5.7445044005315704e-6,1.254469739351533,0.3270776700982017,0.4733181021112743,0.9543467306073279,raw,1780686.1875,1147034.25,1015941.375,1023127.8125,1703425.25,2233816.9375,Acyl-CoA-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=ACBD5 PE=1 SV=1,cellular homeostasis,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,91452,ACBD5,NA,RHOC GTPase cycle; RHOA GTPase cycle; Peroxisomal lipid metabolism; Class I peroxisomal membrane protein import,ENSG00000107897
O43353,0.5,6,221117.909375,8.559354886790698e-7,1.254288310098878,0.32686900343655123,0.5907628599679615,1,raw,163667.53125,296104.28125,129964.75,NA,177532.390625,338320.59375,Receptor-interacting serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=RIPK2 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;endoplasmic reticulum;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,8767,RIPK2,Nucleotide-binding oligomerization domain (NOD) pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Fas ligand pathway and stress induction of heat shock proteins; T-cell receptor signaling pathway,Downstream TCR signaling; SARS-CoV-2 activates/modulates innate and adaptive immune responses; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; p75NTR recruits signalling complexes; TAK1-dependent IKK and NF-kappa-B activation  ; activated TAK1 mediates p38 MAPK activation; Ovarian tumor domain proteases,ENSG00000104312
O95202,0,6,59396116.458333336,2.299191599183529e-4,1.254012888684003,0.3265521761662182,0.16701307534531898,0.6670444762382309,raw,53185099.21875,58737177.390625,48384058.578125,66694799.90625,54652741.6875,74722821.96875,Mitochondrial proton/calcium exchanger protein OS=Homo sapiens OX=9606 GN=LETM1 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;protein binding;structural molecule activity,3954,LETM1,NA,RHOG GTPase cycle; Mitochondrial calcium ion transport,ENSG00000168924
Q14139,0,6,4489528.752929688,1.737872340571286e-5,1.2540080417652344,0.32654659995623836,0.1718923922284578,0.6688917965646828,raw,4115808.25,3558941.40234375,3676011.9375,4609748.53125,4403938.9375,6572723.45898438,Ubiquitin conjugation factor E4 A OS=Homo sapiens OX=9606 GN=UBE4A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation,membrane;nucleus,structural molecule activity,9354,UBE4A,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000110344
Q8TE77,0,6,3129086.2864583335,1.2112524070479035e-5,1.2537698887143018,0.3262725866774628,0.5095302702085626,0.9930210100335384,raw,4109819,1380168.4375,2927007.40625,3669793.75,2833447.15625,3854281.96875,Protein phosphatase Slingshot homolog 3 OS=Homo sapiens OX=9606 GN=SSH3 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis,endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,54961,SSH3,Regulation of actin cytoskeleton,NA,ENSG00000172830
P29218,0,6,33876621.854166664,1.3113457414418086e-4,1.2533733808707967,0.3258162586237714,0.2509897513620758,0.7326612824296702,raw,33822096.25,31579766.375,26239702,40228835.25,28997616.125,42391715.125,Inositol monophosphatase 1 OS=Homo sapiens OX=9606 GN=IMPA1 PE=1 SV=1,cellular homeostasis;development,cytosol;nucleus,structural molecule activity,3612,IMPA1,NA,"Synthesis of IP2, IP, and Ins in the cytosol",ENSG00000133731
P15924,0,6,189996004.1484375,7.354642738687635e-4,1.2530871254463187,0.3254867267743154,0.26459829773255156,0.7454335379461359,raw,171898881.78125,186374666.84375,164685272.140625,218097050.625,165376457.96875,233543695.53125,Desmoplakin OS=Homo sapiens OX=9606 GN=DSP PE=1 SV=3,cell communication;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,1832,DSP,Arrhythmogenic right ventricular cardiomyopathy; Lung fibrosis; Epithelial to mesenchymal transition in colorectal cancer,Formation of the cornified envelope; Neutrophil degranulation; RND3 GTPase cycle; RND1 GTPase cycle; Apoptotic cleavage of cell adhesion  proteins,ENSG00000096696
Q9GZP4,0,6,7035866.239583333,2.7235458335692895e-5,1.253031474797852,0.32542265405679066,0.08918403845378145,0.6429522395902524,raw,6738193.59375,6330922.0625,5689543.875,8314687.3125,6698681.9375,8443168.65625,PITH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PITHD1 PE=1 SV=1,metabolic process,nucleus,NA,57095,PITHD1,NA,NA,ENSG00000057757
P19367,0,6,69244075.8359375,2.6804007896189316e-4,1.253017286996604,0.32540631864399766,0.16450828932539355,0.6638855679885327,raw,64072954.75,51305217.640625,63956244.125,93882275.875,62109483.125,80138279.5,Hexokinase-1 OS=Homo sapiens OX=9606 GN=HK1 PE=1 SV=3,cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;endosome,signal transducer activity;structural molecule activity,3098,HK1,Cori cycle; Photodynamic therapy-induced HIF-1 survival signaling; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; Disorders of fructose metabolism; Glucose metabolism in triple-negative breast cancer cells; Glycolysis and gluconeogenesis; Glucuronidation,Glycolysis; Defective HK1 causes hexokinase deficiency (HK deficiency),ENSG00000156515
Q9H9B4,0,6,86279226.70833333,3.3398222823374384e-4,1.252944677082465,0.3253227148506611,0.30009657630942316,0.7806964943416801,raw,82956359.71875,79775969.375,74143815.96875,99954876.1875,72880014.375,107964324.625,Sideroflexin-1 OS=Homo sapiens OX=9606 GN=SFXN1 PE=1 SV=4,cellular homeostasis;conjugation;metabolic process,endosome,catalytic activity,94081,SFXN1,NA,NA,ENSG00000164466
O43677,0,6,1855681.1145833333,7.1832414033441805e-6,1.2528630048268483,0.32522867079528617,0.03275983315553591,0.6429522395902524,raw,1671788.4375,1671964.125,1557771.125,1951673.8125,2009368,2271521.1875,"NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFC1 PE=1 SV=1",cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,4717,NDUFC1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; IL-18 signaling pathway; Oxidative phosphorylation,Complex I biogenesis,ENSG00000109390
O43676,0,6,9805098.708333334,3.7955007706909355e-5,1.2527983302196115,0.32515419486045205,0.4470512801004419,0.9281773929101287,raw,9469508.75,9385999.5,8615948.25,11863384.75,7700529.75,11795221.25,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 OS=Homo sapiens OX=9606 GN=NDUFB3 PE=1 SV=3,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,4709,NDUFB3,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease,Complex I biogenesis,ENSG00000119013
Q8WUZ0,0.16666666666666666,6,1093840.3072916667,4.234196771328608e-6,1.2526036336937356,0.3249299691936962,0.3972696875591386,0.8802567982819481,raw,996461.9375,1190524.5,693731.5625,1248171.84375,811164.125,1622987.875,B-cell CLL/lymphoma 7 protein family member C OS=Homo sapiens OX=9606 GN=BCL7C PE=1 SV=3,cell growth;metabolic process,membrane;nucleus,NA,9274,BCL7C,NA,NA,ENSG00000099385
Q9UBB5,0,6,912637.4583333334,3.5327703264441464e-6,1.252268389450007,0.3245437975998321,0.7088285389539146,1,raw,520998.1875,1379348.5625,551471.9375,690590.875,568964.25,1764450.9375,Methyl-CpG-binding domain protein 2 OS=Homo sapiens OX=9606 GN=MBD2 PE=1 SV=1,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,8932,MBD2,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,NoRC negatively regulates rRNA expression; RNA Polymerase I Promoter Opening,ENSG00000134046
Q969L4,0.8333333333333334,6,127573320,4.938294338312747e-4,1.2520656124521323,0.3243101663272803,0.08194955251796952,0.6429522395902524,raw,100332856,130387024,114298304,143108976,130570744,146742016,U7 snRNA-associated Sm-like protein LSm10 OS=Homo sapiens OX=9606 GN=LSM10 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding,84967,LSM10,NA,RNA Polymerase II Transcription Termination; SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,ENSG00000181817
Q8N9E0,0,6,474932.6666666667,1.8384387102881505e-6,1.2520298961640153,0.3242690115777337,0.30250630657341704,0.7825518083423609,raw,406397.21875,433742.9375,456169.65625,611123.6875,399103.375,543059.125,Protein FAM133A OS=Homo sapiens OX=9606 GN=FAM133A PE=1 SV=1,NA,NA,NA,286499,FAM133A,NA,NA,ENSG00000179083
Q15365,0,6,266925736.47395834,0.0010332551141408789,1.2520042386239707,0.3242394464809399,0.15596074039623659,0.6638855679885327,raw,224835042.796875,284001485.0625,201741209.15625,302353081.140625,252580848.96875,336042751.71875,Poly(rC)-binding protein 1 OS=Homo sapiens OX=9606 GN=PCBP1 PE=1 SV=2,cellular component movement;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5093,PCBP1,Ferroptosis,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000169564
P63241,0,6,411529565.0787762,0.0015930087272768535,1.2519967139922135,0.32423077575826353,0.19383787556730855,0.6848190557739395,raw,353091197.90625,444476152.1875,304100299.597656,474216292.375,380732575.820313,512560872.585938,Eukaryotic translation initiation factor 5A-1 OS=Homo sapiens OX=9606 GN=EIF5A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,protein binding;RNA binding;structural molecule activity,1984,EIF5A,Translation factors; eIF5A regulation in response to inhibition of the nuclear export system,Hypusine synthesis from eIF5A-lysine,ENSG00000132507; ENSG00000288145
H0YC42,0,6,44280117.666666664,1.7140594473289732e-4,1.251983117913196,0.3242151087025434,0.26272864975582605,0.743800410925904,raw,39441703.75,47093417.125,32321152.375,40465537.125,46727387.375,59631508.25,Uncharacterized protein OS=Homo sapiens OX=9606 PE=1 SV=2,NA,nucleus,NA,NA,NA,NA,NA,NA
Q9Y365,0.16666666666666666,6,446652.4010416667,1.7289673289508001e-6,1.251700703095889,0.32388963752706085,0.36346481043510526,0.8458062414401234,raw,307368.28125,372391.21875,529449.9375,551772.75,384733.09375,534199.125,START domain-containing protein 10 OS=Homo sapiens OX=9606 GN=STARD10 PE=1 SV=2,conjugation,cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,10809,STARD10,NA,Synthesis of PC,ENSG00000214530
P25490,0,6,7923539.979166667,3.0671595454687116e-5,1.2515660204493437,0.3237343955908943,0.19298794259715168,0.6839501208924997,raw,8706026.25,6072354.03125,6778961.40625,8202144,8484317.75,9297436.4375,Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,7528,YY1,Sterol regulatory element-binding proteins (SREBP) signaling; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Malignant pleural mesothelioma,UCH proteinases; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; DNA Damage Recognition in GG-NER; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,ENSG00000100811
P28838,0,6,79746177.109375,3.086931459660312e-4,1.2514481356252631,0.3235985019517711,0.08220633497902634,0.6429522395902524,raw,77398946.5625,65423262.90625,69647117.8125,92575406.4375,76571561.5625,96860767.375,Cytosol aminopeptidase OS=Homo sapiens OX=9606 GN=LAP3 PE=1 SV=3,cell organization and biogenesis,cytosol;extracellular;membrane;nucleus,structural molecule activity,51056,LAP3,NA,NA,ENSG00000002549
P12236,0,6,48451561.38346355,1.8755337813766275e-4,1.2514168579514113,0.323562443958172,0.19042417623762842,0.6816045476187055,raw,46440575.890625,43231968.0234375,42897398.5,56152906.796875,43869999.5273438,58116519.5625,ADP/ATP translocase 3 OS=Homo sapiens OX=9606 GN=SLC25A6 PE=1 SV=4,cell growth;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity,293,SLC25A6,Electron transport chain: OXPHOS system in mitochondria; Alzheimer's disease and miRNA effects; Alzheimer's disease,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane; Mitochondrial protein import; Influenza Virus Induced Apoptosis; Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,ENSG00000169100
O43395,0,6,17664650.419270832,6.837890803011087e-5,1.2513547088670731,0.32349079365098643,0.1988471519846336,0.688581468393609,raw,14732245.96875,17744126.125,15095877.125,20537392.65625,15674064.859375,22204195.78125,U4/U6 small nuclear ribonucleoprotein Prp3 OS=Homo sapiens OX=9606 GN=PRPF3 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane,structural molecule activity,9129,PRPF3,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000117360
P53992,0,6,28481846.713541668,1.1025169084740786e-4,1.2512189406282828,0.3233342570671023,0.17454250448372766,0.6697819849820321,raw,24403808.6875,29065242.28125,20697187.140625,35469907.71875,24887952.796875,36366981.65625,Protein transport protein Sec24C OS=Homo sapiens OX=9606 GN=SEC24C PE=1 SV=3,cell growth;conjugation;defense response,cytoskeleton;cytosol;extracellular,structural molecule activity,9632,SEC24C,Sterol regulatory element-binding proteins (SREBP) signaling,"MHC class II antigen presentation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; COPII-mediated vesicle transport; Cargo concentration in the ER; Regulation of cholesterol biosynthesis by SREBP (SREBF); Antigen Presentation: Folding, assembly and peptide loading of class I MHC",ENSG00000176986
Q9NVU7,0,6,431130240.7161458,0.0016688818843971095,1.2511900110353684,0.32330089994519257,0.18553007185713197,0.6778506319470519,raw,328125866.96875,435294949.015625,409593201.125,416543276.75,452587458.375,544636692.0625,Protein SDA1 homolog OS=Homo sapiens OX=9606 GN=SDAD1 PE=1 SV=3,conjugation;metabolic process,membrane,NA,55153,SDAD1,NA,NA,ENSG00000198301
O43175,0,6,132677012.51041667,5.135855519825306e-4,1.2511118012373958,0.32321071666900475,0.14307953729971237,0.6572502130392559,raw,136347831.25,92538818.21875,121819987.6875,143057978.1875,131711078.96875,170586380.75,D-3-phosphoglycerate dehydrogenase OS=Homo sapiens OX=9606 GN=PHGDH PE=1 SV=4,cell differentiation;cell growth;cellular homeostasis;defense response;metabolic process,cytosol,structural molecule activity,26227,PHGDH,"Trans-sulfuration, one-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Neuroinflammation and glutamatergic signaling; Amino acid metabolism in triple-negative breast cancer cells",Serine biosynthesis,ENSG00000092621
Q12874,0,6,51711858.3125,2.0017381152128807e-4,1.2509388000559207,0.3230112099549113,0.2487513770213824,0.7316541032247736,raw,49760706.25,48427544.25,42111999.375,60579894.09375,44462630.34375,64928375.5625,Splicing factor 3A subunit 3 OS=Homo sapiens OX=9606 GN=SF3A3 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane,structural molecule activity,10946,SF3A3,Exercise-induced circadian regulation; mRNA processing,mRNA Splicing - Major Pathway,ENSG00000183431
P46783,0,6,67254404.57291667,2.6033816892829105e-4,1.2509098047245877,0.3229777695455715,0.2446186184658068,0.7301988479077035,raw,62612158.75,62060218.15625,60722497.25,77631735.375,59446338.78125,81053479.125,40S ribosomal protein S10 OS=Homo sapiens OX=9606 GN=RPS10 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;membrane;nucleus,structural molecule activity,6204,RPS10,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000124614
P40222,0,6,9451888.1484375,3.658774869995878e-5,1.2507022247861648,0.32273834429105136,0.5243162580063541,1,raw,7782020.875,10336511.65625,7843276.59375,11528876.78125,6292744.859375,12927898.125,Alpha-taxilin OS=Homo sapiens OX=9606 GN=TXLNA PE=1 SV=3,conjugation;metabolic process,cell surface;cytosol;nucleus,structural molecule activity,200081,TXLNA,NA,Other interleukin signaling,ENSG00000084652
Q96BR5,0,6,2479979.1354166665,9.5998653351358e-6,1.2506488317348268,0.3226767536637029,0.17946959125766165,0.6742444420587625,raw,2521731.90625,2035956.6875,2066906.875,3153801.0625,2225558.96875,2875919.3125,Cytochrome c oxidase assembly factor 7 OS=Homo sapiens OX=9606 GN=COA7 PE=1 SV=2,NA,endosome;membrane,NA,65260,COA7,NA,NA,ENSG00000162377
P20674,0,6,42106214.083333336,1.629908813343648e-4,1.2505511763075001,0.3225640981380843,0.2708921634496953,0.7524189815502363,raw,42499559,34263922.375,36364636.375,51559289.25,34802004,53147873.5,"Cytochrome c oxidase subunit 5A, mitochondrial OS=Homo sapiens OX=9606 GN=COX5A PE=1 SV=2",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity;structural molecule activity,9377,COX5A,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly; Arachidonate epoxygenase / epoxide hydrolase,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000178741
P49589,0,6,83189092.28125,3.2202048470783193e-4,1.250423497174755,0.3224167939260508,0.2316989515940023,0.7184011161541765,raw,82136925.25,60878981.375,80356535.1875,103310761.625,71971650.5,100479699.75,"Cysteine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=CARS1 PE=1 SV=3",cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;nucleus,RNA binding;structural molecule activity,833,CARS1,NA,Signaling by ALK fusions and activated point mutants; Cytosolic tRNA aminoacylation,ENSG00000110619; ENSG00000278191
O60942,0,6,3717293.546875,1.4389442617295938e-5,1.2503313646340626,0.322310490696053,0.145057007092203,0.6572502130392559,raw,2929340.03125,3237695.375,3242897.21875,5304144.625,3927038.3125,3662645.71875,mRNA-capping enzyme OS=Homo sapiens OX=9606 GN=RNGTT PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,membrane,structural molecule activity,8732,RNGTT,mRNA processing; Ciliary landscape,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE,ENSG00000111880
Q567U6,0.16666666666666666,6,2012827.6041666667,7.791546979929551e-6,1.2501002742695444,0.3220438223987481,0.09930191422322343,0.6429522395902524,raw,1625786.875,1842758.375,1873882.875,2303632.75,1919449,2511455.75,Coiled-coil domain-containing protein 93 OS=Homo sapiens OX=9606 GN=CCDC93 PE=1 SV=2,conjugation,mitochondrion;nucleus,NA,54520,CCDC93,NA,NA,ENSG00000125633
O14828,0,6,5948310.416666667,2.3025588464070496e-5,1.2497301901258204,0.3216166585807474,0.9334991594745821,1,raw,4387232.875,8842116.75,4400433.375,5665969.25,5482857.375,6911252.875,Secretory carrier-associated membrane protein 3 OS=Homo sapiens OX=9606 GN=SCAMP3 PE=1 SV=3,conjugation,cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,10067,SCAMP3,NA,NA,ENSG00000116521; ENSG00000263290
P61289,0,6,53449014.5390625,2.0689824948245294e-4,1.249563736007396,0.3214244902815084,0.22767195306853538,0.7148463313429879,raw,55674163.40625,45866377.765625,41380746.34375,61441580.125,46762803.96875,69568415.625,Proteasome activator complex subunit 3 OS=Homo sapiens OX=9606 GN=PSME3 PE=1 SV=1,cell differentiation;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,10197,PSME3,Proteasome degradation,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000131467
P13489,0,6,102870938.72005208,3.982078496178909e-4,1.2495471214751477,0.32140530769646236,0.31547335801405,0.7958588159583763,raw,102840525.8125,92523797.6328125,85109221.875,124139644,84108360,128504083,Ribonuclease inhibitor OS=Homo sapiens OX=9606 GN=RNH1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cell surface;cytosol;membrane,DNA binding,6050,RNH1,NA,NA,ENSG00000023191; ENSG00000276230
Q29RF7,0,6,29665435.221354168,1.1483329805730292e-4,1.2494283001536552,0.3212681131247075,0.06283165082407319,0.6429522395902524,raw,25782845.75,28621054.296875,23564385.953125,35759955.21875,28802678.75,35461691.359375,Sister chromatid cohesion protein PDS5 homolog A OS=Homo sapiens OX=9606 GN=PDS5A PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,NA,23244,PDS5A,Cohesin complex - Cornelia de Lange syndrome,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,ENSG00000121892
Q9H0L4,0,6,834870.1223958334,3.2317371678136257e-6,1.2493118067356135,0.32113359375139333,0.3350598936349364,0.818506769250165,raw,869109.578125,623167.0625,590810.53125,729374.5625,778529.96875,1418229.03125,Cleavage stimulation factor subunit 2 tau variant OS=Homo sapiens OX=9606 GN=CSTF2T PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,23283,CSTF2T,mRNA processing,mRNA Splicing - Major Pathway; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,ENSG00000177613
O00767,0,6,37217259.876302086,1.4406600356144746e-4,1.2492652560233923,0.32107983636869736,0.24261877863284687,0.7289874209382666,raw,29242937.234375,40860427.6875,26764500.890625,43685278.8515625,31704901.9375,51045512.65625,Acyl-CoA desaturase OS=Homo sapiens OX=9606 GN=SCD PE=1 SV=2,cellular homeostasis;metabolic process,cytoskeleton;extracellular;membrane,structural molecule activity,6319,SCD,Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Adipogenesis; Liver X receptor pathway; Nuclear receptors meta-pathway; Fatty acid biosynthesis; Angiopoietin-like protein 8 regulatory pathway; PPAR signaling pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways,Activation of gene expression by SREBF (SREBP); Fatty acyl-CoA biosynthesis; NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,ENSG00000099194
P50502,0,6,147368214.48958334,5.704544016422618e-4,1.2492464216588477,0.3210580856243882,0.1620680315564541,0.6638855679885327,raw,141504999.25,134676229.875,111858351.875,158001803.375,139738645.8125,198429256.75,Hsc70-interacting protein OS=Homo sapiens OX=9606 GN=ST13 PE=1 SV=2,metabolic process,cytosol;nucleus,structural molecule activity,6767,ST13,NA,Regulation of HSF1-mediated heat shock response,ENSG00000100380
Q9UK99,0,6,40552857.057291664,1.569779201548016e-4,1.249221957356558,0.32102983269320057,0.27864620813810137,0.7591598077731446,raw,30944630.59375,46999188.0625,31145986,52026524,38656712,43544101.6875,F-box only protein 3 OS=Homo sapiens OX=9606 GN=FBXO3 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,26273,FBXO3,NA,NA,ENSG00000110429
H0Y9X1,0,6,8713962.997395834,3.373128028204222e-5,1.2489813666419665,0.3207519537643209,0.24050299573573455,0.7263138257852598,raw,9371824.5625,6257488.296875,6598586,11427245.875,6923399,11705234.25,Translation machinery-associated protein 16 (Fragment) OS=Homo sapiens OX=9606 GN=TMA16 PE=1 SV=1,NA,membrane,NA,NA,TMA16,NA,NA,ENSG00000198498
Q9BRK5,0,6,15851356.515625,6.135974523175206e-5,1.248946332247949,0.3207114850617758,0.30873022203776773,0.790022385374121,raw,14148405.625,15008579.4375,13824479.875,17670599.3125,13324197.21875,21131877.625,45 kDa calcium-binding protein OS=Homo sapiens OX=9606 GN=SDF4 PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,51150,SDF4,NA,NA,ENSG00000078808
Q12769,0,6,19509912.575520832,7.552181820828304e-5,1.2489276450399918,0.320689898750782,0.1733074234994758,0.6689341104244626,raw,19051360.296875,16918696.078125,16633939.96875,21130227.25,18258233.671875,25067018.1875,Nuclear pore complex protein Nup160 OS=Homo sapiens OX=9606 GN=NUP160 PE=1 SV=3,cellular homeostasis;conjugation;defense response,cytosol;membrane,structural molecule activity,23279,NUP160,NA,Rev-mediated nuclear export of HIV RNA; Nuclear import of Rev protein; Postmitotic nuclear pore complex (NPC) reformation; SUMOylation of DNA damage response and repair proteins; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000030066
P58546,0,6,52886609.427083336,2.047212096591381e-4,1.248640432036296,0.32035808735253396,0.2531565556458306,0.7343965948630279,raw,46769866.75,48364426.875,40571593.625,58398746.625,44858077.625,78356945.0625,Myotrophin OS=Homo sapiens OX=9606 GN=MTPN PE=1 SV=2,cell growth;cellular homeostasis;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding,136319,MTPN,NA,NA,ENSG00000105887
O15042,0,6,46105953.389322914,1.7847365623549244e-4,1.2486353924307831,0.3203522645164577,0.1093002480985013,0.6429522395902524,raw,36621924.84375,46599855.5625,35125829.4140625,57617729.71875,42484151.859375,58186228.9375,U2 snRNP-associated SURP motif-containing protein OS=Homo sapiens OX=9606 GN=U2SURP PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,NA,23350,U2SURP,NA,mRNA Splicing - Major Pathway,ENSG00000163714
O75182,0.6666666666666666,6,786864.6041666666,3.045910398643659e-6,1.2484127746930365,0.32009502517975574,0.18121436367739088,0.674297118008435,raw,782930.75,754982.25,628489.3125,788947.5,788417.0625,977420.75,Paired amphipathic helix protein Sin3b OS=Homo sapiens OX=9606 GN=SIN3B PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,23309,SIN3B,NA,NoRC negatively regulates rRNA expression; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,ENSG00000127511
F5GZG1,0,6,647529.4270833334,2.506551451084382e-6,1.2482036677633765,0.31985335607431276,0.17750462997967614,0.6729927735741504,raw,499066.625,618200.0625,540537.1875,674700.5,620647.1875,932025,Ras-related protein Rap-1b (Fragment) OS=Homo sapiens OX=9606 GN=RAP1B PE=1 SV=8,development,cytoskeleton,structural molecule activity,NA,RAP1B,Common pathways underlying drug addiction; Chemokine signaling pathway; Ras signaling,NA,ENSG00000127314
O15066,0,6,380556.30625,1.47311291464672e-6,1.2481869414896805,0.31983402343299866,0.24910462876625178,0.7316541032247736,raw,NA,326593.03125,328341.125,408737.21875,324443.15625,514667,Kinesin-like protein KIF3B OS=Homo sapiens OX=9606 GN=KIF3B PE=1 SV=1,cell differentiation;cell growth;conjugation;defense response;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,9371,KIF3B,NA,Intraflagellar transport; COPI-dependent Golgi-to-ER retrograde traffic; Translocation of SLC2A4 (GLUT4) to the plasma membrane; MHC class II antigen presentation; Kinesins,ENSG00000101350
Q9P035,0,6,24125424.4375,9.338821542709575e-5,1.248128095598349,0.319766005835576,0.06983136097240954,0.6429522395902524,raw,23362746.5625,20943035.625,19354759.625,29159700.375,23292524.25,28639780.1875,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 OS=Homo sapiens OX=9606 GN=HACD3 PE=1 SV=2,cellular homeostasis;coagulation;development;metabolic process,cytoskeleton;extracellular;membrane,DNA binding;structural molecule activity,51495,HACD3,NA,Synthesis of very long-chain fatty acyl-CoAs,ENSG00000074696
P49189,0,6,52361095.5234375,2.0268697371146594e-4,1.248112328061493,0.3197477802295696,0.16264830900287305,0.6638855679885327,raw,45099177.40625,47790273.65625,47026842,58694781.25,48544364.671875,67011134.15625,4-trimethylaminobutyraldehyde dehydrogenase OS=Homo sapiens OX=9606 GN=ALDH9A1 PE=1 SV=3,cell growth;cellular homeostasis,cytosol;nucleus,structural molecule activity,223,ALDH9A1,GABA receptor signaling; Fluoroacetic acid toxicity,Carnitine synthesis,ENSG00000143149
Q9BUL5,0.16666666666666666,6,681436.7057291666,2.6378046960138944e-6,1.2479195778833732,0.3195249627840118,0.17043431214923455,0.668039680404208,raw,544991.5625,649939.53125,617292.40625,680105.640625,684277.625,912013.46875,PHD finger protein 23 OS=Homo sapiens OX=9606 GN=PHF23 PE=1 SV=1,cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,79142,PHF23,NA,NA,ENSG00000040633
P07814,0,6,259723586.16666666,0.0010053759791570313,1.2478064351783238,0.31939415481972006,0.13549332348554305,0.653793677153943,raw,255758675.9375,221711112.296875,213901774.546875,309812474.5,238020158.03125,319137321.6875,Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens OX=9606 GN=EPRS1 PE=1 SV=5,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,RNA binding;structural molecule activity,2058,EPRS1,Parkinson's disease pathway; VEGFA-VEGFR2 signaling pathway; Amino acid metabolism,tRNA modification in the nucleus and cytosol; Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,ENSG00000136628
P62906,0,6,224379259.85416666,8.685600002983662e-4,1.247571816336617,0.3191228665368944,0.2537558891957165,0.734567694017451,raw,202618940,207969237.25,196348865.625,252781679,195222968.5,291333868.75,60S ribosomal protein L10a OS=Homo sapiens OX=9606 GN=RPL10A PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,structural molecule activity,4736,RPL10A,VEGFA-VEGFR2 signaling pathway; Cytoplasmic ribosomal proteins,SRP-dependent cotranslational protein targeting to membrane; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000198755
Q9BT40,0,6,592726.3958333334,2.2944118760194296e-6,1.2472166006636074,0.31871203579079355,0.045183256147310245,0.6429522395902524,raw,577351.5,525969.9375,444125.1875,655259.625,697653.6875,655998.4375,Inositol polyphosphate 5-phosphatase K OS=Homo sapiens OX=9606 GN=INPP5K PE=1 SV=3,cell growth;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,51763,INPP5K,Notch signaling; VEGFA-VEGFR2 signaling pathway; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,Synthesis of PIPs at the plasma membrane,ENSG00000132376
P60228,0,6,133690322.10546884,5.175080187147628e-4,1.247106963785667,0.31858520975871074,0.2057260576200148,0.6981228169837443,raw,112439382.03125,136637734.46875,107365610.726563,158687914.78125,116609420.453125,170401870.171875,Eukaryotic translation initiation factor 3 subunit E OS=Homo sapiens OX=9606 GN=EIF3E PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,3646,EIF3E,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000104408
O60353,0,6,528392.1458333334,2.0453774677790573e-6,1.2470351687293098,0.31850215244578106,0.3837197327810399,0.8693457658221697,raw,357695.8125,679963.75,273215.90625,746918.71875,340709.84375,771848.84375,Frizzled-6 OS=Homo sapiens OX=9606 GN=FZD6 PE=1 SV=2,cell death;cell differentiation;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,8323,FZD6,Alzheimer's disease and miRNA effects; Physico-chemical features and toxicity-associated pathways; Embryonic stem cell pluripotency pathways; Wnt signaling pathway and pluripotency; Wnt signaling in kidney disease; Epithelial to mesenchymal transition in colorectal cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Osteoblast differentiation and related diseases; Malignant pleural mesothelioma; Alzheimer's disease,Class B/2 (Secretin family receptors); Ca2+ pathway; PCP/CE pathway; Regulation of FZD by ubiquitination; Signaling by RNF43 mutants,ENSG00000164930
F8W727,0,6,93213138.5859375,3.608230267388954e-4,1.2469477569621297,0.31840102222409544,0.10405103265304817,0.6429522395902524,raw,75963628.765625,98261983.625,77195081.09375,105723916.84375,94722676.5,107411544.6875,60S ribosomal protein L32 OS=Homo sapiens OX=9606 GN=RPL32 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,structural molecule activity,NA,RPL32,NA,NA,ENSG00000144713
Q9Y232,0,6,2469538.5885416665,9.559450541884592e-6,1.246847168052663,0.3182846380583574,0.2264275870294529,0.7148463313429879,raw,1112902.53125,2762671.5625,2279557.75,2842260.125,2481369.25,3338470.3125,Chromodomain Y-like protein OS=Homo sapiens OX=9606 GN=CDYL PE=1 SV=2,cell growth;cellular component movement;metabolic process,membrane;nucleus,structural molecule activity,9425,CDYL,NA,NA,ENSG00000153046
P37198,0,6,15136761.864583334,5.859358791968428e-5,1.246737064436233,0.3181572343481149,0.5483396372560929,1,raw,13681855.875,15511961.625,13101721.875,19339337.5,10446561.0625,18739133.25,Nuclear pore glycoprotein p62 OS=Homo sapiens OX=9606 GN=NUP62 PE=1 SV=3,cell differentiation;cell growth;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;endoplasmic reticulum;membrane;nucleus,structural molecule activity,23636,NUP62,7q11.23 copy number variation syndrome,HCMV Early Events; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000213024
Q14435,0.3333333333333333,6,434437.078125,1.681682473465314e-6,1.2466513405409578,0.3180580332461919,1,1,raw,340880.34375,NA,NA,424958.9375,312592.46875,659316.5625,Polypeptide N-acetylgalactosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=GALNT3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,2591,GALNT3,FGF23 signaling in hypophosphatemic rickets and related disorders,O-linked glycosylation of mucins; FGFR3c ligand binding and activation; Defective GALNT3 causes HFTC,ENSG00000115339
Q15742,0,6,3253390.609375,1.2593699393099136e-5,1.2466018751653527,0.3180007879959774,0.19931555564944825,0.6896376876443636,raw,3412380.28125,2300243.8125,2846181.625,4209617.8125,2867488.25,3884431.875,NGFI-A-binding protein 2 OS=Homo sapiens OX=9606 GN=NAB2 PE=1 SV=1,cellular component movement;defense response;metabolic process,membrane,structural molecule activity,4665,NAB2,NA,NGF-stimulated transcription; EGR2 and SOX10-mediated initiation of Schwann cell myelination,ENSG00000166886
Q15555,0.16666666666666666,6,7953270.109375,3.0786679183546026e-5,1.2463122151462163,0.3176655248782818,0.3270819643596755,0.8096702428564433,raw,6997120.5,7339660.875,6531732.46875,8720596.75,6383413.125,11747096.9375,Microtubule-associated protein RP/EB family member 2 OS=Homo sapiens OX=9606 GN=MAPRE2 PE=1 SV=1,cell differentiation;cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,10982,MAPRE2,Ciliary landscape,NA,ENSG00000166974
P24390,0,6,8599147.96875,3.3286837505202246e-5,1.2461187848806607,0.3174415982095539,0.05053604230848318,0.6429522395902524,raw,7898148.9375,7594438.21875,7497335.28125,10386131.875,9463572.125,8755261.375,ER lumen protein-retaining receptor 1 OS=Homo sapiens OX=9606 GN=KDELR1 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;extracellular,structural molecule activity,10945,KDELR1,NA,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000105438
P30041,0,6,345170324.0052083,0.0013361356879232245,1.2460660201851086,0.31738050854681005,0.27211436239988507,0.7524601054912853,raw,336111157.15625,307240916.171875,305522124.234375,406516858.1875,296814196.34375,418816691.9375,Peroxiredoxin-6 OS=Homo sapiens OX=9606 GN=PRDX6 PE=1 SV=3,cellular homeostasis;coagulation;metabolic process,cell surface;cytosol;endosome;membrane;mitochondrion;nucleus,structural molecule activity,9588,PRDX6,Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling pathway,Neutrophil degranulation; Detoxification of Reactive Oxygen Species,ENSG00000117592
O75691,0,6,5265953.434895833,2.038422142918649e-5,1.245673265790154,0.3169257058908739,0.5044592745076393,0.9887033786631393,raw,5172543,5854745.953125,3233179.234375,6443298.53125,3561200.765625,7330753.125,Small subunit processome component 20 homolog OS=Homo sapiens OX=9606 GN=UTP20 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,NA,27340,UTP20,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000120800
O43715,0,6,2395464.0364583335,9.272711950174211e-6,1.2455998228291236,0.31684064432441505,0.09643276473053665,0.6429522395902524,raw,2238356.28125,2129944.96875,1900848.53125,2606281.78125,2367696.59375,3129656.0625,TP53-regulated inhibitor of apoptosis 1 OS=Homo sapiens OX=9606 GN=TRIAP1 PE=1 SV=1,cell differentiation;cell growth;coagulation;conjugation;development;metabolic process,endosome;membrane;nucleus,structural molecule activity,51499,TRIAP1,NA,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,ENSG00000170855
Q16762,0,6,16207184.375,6.273713566367428e-5,1.245406713002042,0.31661696077607576,0.3115540725123377,0.7920633653972666,raw,18077025.5,9931335.53125,15037129.53125,18727342.0625,14047621.25,21422652.375,Thiosulfate sulfurtransferase OS=Homo sapiens OX=9606 GN=TST PE=1 SV=4,cellular homeostasis;conjugation;metabolic process,endosome,RNA binding;structural molecule activity,7263,TST,NA,Sulfide oxidation to sulfate,ENSG00000128311
P11216,0,6,101691791.72526042,3.9364343526509507e-4,1.2453818219604793,0.31658812638750977,0.25202878846451987,0.7332218979864691,raw,104050804.5625,75581744.7421875,93463038.90625,120711484.234375,86760697.34375,129582980.5625,"Glycogen phosphorylase, brain form OS=Homo sapiens OX=9606 GN=PYGB PE=1 SV=5",cellular homeostasis,cell surface;mitochondrion;nucleus,structural molecule activity,5834,PYGB,IL-18 signaling pathway; Glycogen synthesis and degradation,Neutrophil degranulation; Glycogen breakdown (glycogenolysis),ENSG00000100994
C9JJ19,0,6,7666622.09375,2.9677080191649037e-5,1.2453161856171469,0.316512088885764,0.4285123584206959,0.9133397850930544,raw,5414814.6875,8121625.75,7750326.9375,10113992,7784655.0625,6814318.125,"28S ribosomal protein S34, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS34 PE=1 SV=2",NA,endosome,structural molecule activity,65993,MRPS34,NA,NA,ENSG00000074071
A0A3B3IUD7,0,6,67733766.90364583,2.6219375462900043e-4,1.2451727055198845,0.31634585804992094,0.3919195493179728,0.8763519738235003,raw,66656347.90625,59606661.515625,62521379.5,79687914.15625,54931633.28125,82998665.0625,"Programmed cell death 11, isoform CRA_a OS=Homo sapiens OX=9606 GN=PDCD11 PE=1 SV=1",cellular component movement;cellular homeostasis,membrane,RNA binding,22984,PDCD11,NA,NA,ENSG00000148843
Q8IXK0,0,6,7313276.223958333,2.83092974073973e-5,1.2449589157919028,0.3160981334891224,0.2723447222753202,0.7525679181563993,raw,7131875.0625,6670237.03125,6229010.15625,9222105,6322259.03125,8304171.0625,Polyhomeotic-like protein 2 OS=Homo sapiens OX=9606 GN=PHC2 PE=1 SV=1,metabolic process,membrane;nucleus,RNA binding;structural molecule activity,1912,PHC2,NA,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription,ENSG00000134686
Q96AE4,0,6,90283129.57291667,3.494811200453908e-4,1.2446048447504263,0.3156877671854345,0.17710198643188402,0.6724728279208513,raw,75921501.3125,90140249.5625,78380160.296875,112188991.3125,82070595.328125,102997279.625,Far upstream element-binding protein 1 OS=Homo sapiens OX=9606 GN=FUBP1 PE=1 SV=3,metabolic process,membrane;nucleus,RNA binding,8880,FUBP1,NA,NA,ENSG00000162613
P51580,0,6,6897885.463541667,2.670134220143962e-5,1.2445319390661045,0.31560325542220985,0.1171419285907684,0.6429522395902524,raw,7180490.3125,4343420.3125,6119582.5,8785172.375,7342631.40625,7616015.875,Thiopurine S-methyltransferase OS=Homo sapiens OX=9606 GN=TPMT PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,7172,TPMT,Metapathway biotransformation Phase I and II; Methylation pathways,Azathioprine ADME; Methylation; Defective TPMT causes TPMT deficiency,ENSG00000137364
Q9BV68,0,6,5566804.229166667,2.154879861039064e-5,1.2441263512656,0.31513301045857894,0.5178153042902303,1,raw,4802043.3125,6338161.125,3850323.625,5974348.625,3826922.5625,8609026.125,E3 ubiquitin-protein ligase RNF126 OS=Homo sapiens OX=9606 GN=RNF126 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,55658,RNF126,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000070423
P09651,0,6,465318342.4739583,0.0018012221804310025,1.2441218632428437,0.3151278061159123,0.22001216132939336,0.7087130179153194,raw,480489504.125,399635179.265625,383903349,597787497.140625,425298611.9375,504795913.375,Heterogeneous nuclear ribonucleoprotein A1 OS=Homo sapiens OX=9606 GN=HNRNPA1 PE=1 SV=5,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,3178,HNRNPA1,mRNA processing,mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA; SARS-CoV-1-host interactions; SARS-CoV-1 modulates host translation machinery,ENSG00000135486
P60891,0,6,43038790.807291664,1.6660083548149026e-4,1.2440412933643126,0.31503437352574326,0.24951570932218092,0.7322518008602272,raw,44981906.4375,36718527.59375,34340359.84375,55959349.0625,37572187.8125,48660414.09375,Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens OX=9606 GN=PRPS1 PE=1 SV=2,cellular homeostasis;defense response,cytosol;nucleus,signal transducer activity;structural molecule activity,5631,PRPS1,NA,5-Phosphoribose 1-diphosphate biosynthesis,ENSG00000147224
J3KTL2,0,6,149583472.77864584,5.790295468738649e-4,1.2437781471201195,0.31472917470241724,0.11062303201517815,0.6429522395902524,raw,130587567.0625,147060379.6875,128542453,164388150.28125,144011800.078125,182910486.5625,Serine/arginine-rich splicing factor 1 OS=Homo sapiens OX=9606 GN=SRSF1 PE=1 SV=1,NA,membrane,RNA binding,NA,SRSF1,NA,NA,ENSG00000136450
P33176,0,6,144225953.50292966,5.582908790186498e-4,1.2437034273060277,0.314642502377776,0.20238149447091508,0.6923632419251884,raw,108666065.185547,156610642.84375,125598975.785156,168502344.8125,135148357.703125,170829334.6875,Kinesin-1 heavy chain OS=Homo sapiens OX=9606 GN=KIF5B PE=1 SV=1,cell growth;coagulation;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,3799,KIF5B,Alzheimer's disease and miRNA effects; Envelope proteins and their potential roles in EDMD physiopathology; Insulin signaling; CCL18 signaling pathway; Alzheimer's disease,COPI-dependent Golgi-to-ER retrograde traffic; MHC class II antigen presentation; Kinesins; Insulin processing; Nuclear events stimulated by ALK signaling in cancer; RHO GTPases activate KTN1,ENSG00000170759
Q9NY27,0,6,10020068.171875,3.8787142893732064e-5,1.2431567427280443,0.31400820926246925,0.35458245854896936,0.8383308462007302,raw,7885153.53125,10676559.203125,7821406.875,13272636.5625,7221311.046875,13243341.8125,Serine/threonine-protein phosphatase 4 regulatory subunit 2 OS=Homo sapiens OX=9606 GN=PPP4R2 PE=1 SV=3,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,151987,PPP4R2,16p11.2 proximal deletion syndrome,Processing of DNA double-strand break ends,ENSG00000163605
P21127,0,6,27015014.427083332,1.0457366226316192e-4,1.2430331573446045,0.3138647801382848,0.32028280840014867,0.802295473638468,raw,21795408.625,26907785.21875,24679705.5,35683776.375,22345718.59375,30677692.25,Cyclin-dependent kinase 11B OS=Homo sapiens OX=9606 GN=CDK11B PE=1 SV=4,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,signal transducer activity;structural molecule activity,984,CDK11B,NA,Recruitment of mitotic centrosome proteins and complexes,ENSG00000248333
A6NMQ1,0,6,3262924.6145833335,1.2630605012504322e-5,1.2430173766829502,0.3138464645956204,0.2580290046540109,0.7381027251958325,raw,2924038.71875,3679044.125,2168095.125,3926877.5,3244861.28125,3634630.9375,DNA polymerase OS=Homo sapiens OX=9606 GN=POLA1 PE=1 SV=1,cell differentiation;cell proliferation;cellular component movement;cellular homeostasis;coagulation,cytosol;membrane,RNA binding;structural molecule activity,5422,POLA1,Retinoblastoma gene in cancer; Pyrimidine metabolism; DNA replication,NA,ENSG00000101868
P52788,0,6,57563882.85351563,2.228266825593427e-4,1.2429076134428936,0.313719063420739,0.2419943619777991,0.7280470037327816,raw,51579583.375,57455771.4375,45756755.5,64108656.875,50540186.8085938,75942343.125,Spermine synthase OS=Homo sapiens OX=9606 GN=SMS PE=1 SV=2,cellular homeostasis,cytosol,structural molecule activity,6611,SMS,Methionine de novo and salvage pathway; Amino acid metabolism,Metabolism of polyamines,ENSG00000102172
P52948,0,6,33911320.518229164,1.312688907993301e-4,1.242689230177917,0.31346555452607333,0.17183103755554188,0.6688917965646828,raw,31950043.53125,32844855.1875,24773923.375,39703975,30420363.515625,43774762.5,Nuclear pore complex protein Nup98-Nup96 OS=Homo sapiens OX=9606 GN=NUP98 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular component movement;conjugation;metabolic process,cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,4928,NUP98,SARS-CoV-2 innate immunity evasion and cell-specific immune response,NA,ENSG00000110713
Q9NZZ3,0,6,3654831.28125,1.4147654559499744e-5,1.2426826768777914,0.31345794647870956,0.9601862022305894,1,raw,2873728.5,6607703.9375,1621294.125,2219789.25,3571132.625,5035339.25,Charged multivesicular body protein 5 OS=Homo sapiens OX=9606 GN=CHMP5 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,NA,51510,CHMP5,Ferroptosis,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT),ENSG00000086065
Q02818,0,6,21908722.328125,8.480748124501717e-5,1.2426166086119181,0.3133812423488572,0.22648548672829671,0.7148463313429879,raw,20667416.5,16360901.3125,20900721.625,25681675,18728798.125,29112821.40625,Nucleobindin-1 OS=Homo sapiens OX=9606 GN=NUCB1 PE=1 SV=4,development,extracellular,DNA binding;RNA binding;structural molecule activity,4924,NUCB1,NA,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,ENSG00000104805
O94992,0,6,14046229.947916666,5.437219774983972e-5,1.2424768115290066,0.31321892687465785,0.2129089341074692,0.7022549232366887,raw,10802258.3125,15803369.59375,10570069.5,15925541.4375,13133066.25,18043074.59375,Protein HEXIM1 OS=Homo sapiens OX=9606 GN=HEXIM1 PE=1 SV=1,coagulation;defense response;metabolic process,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,10614,HEXIM1,Initiation of transcription and translation elongation at the HIV-1 LTR,NA,ENSG00000186834
Q8IXM3,0,6,5988864.34375,2.318257052623833e-5,1.2423711789608498,0.3130962669913079,0.22234524318666665,0.7106930585959085,raw,5987714.71875,4619676.34375,5117478.5625,6357807.875,5455191.125,8395317.4375,"39S ribosomal protein L41, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL41 PE=1 SV=1",cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome;Golgi;nucleus,structural molecule activity,64975,MRPL41,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000182154
Q9UJK0,0,6,655645.7786458334,2.5379694097679446e-6,1.2423236679758696,0.31304109412972964,0.32268476044805233,0.8037523716522456,raw,341624.71875,786303.625,587774.109375,730205.6875,666508.28125,821458.25,18S rRNA aminocarboxypropyltransferase OS=Homo sapiens OX=9606 GN=TSR3 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol,structural molecule activity,115939,TSR3,NA,rRNA modification in the nucleus and cytosol,ENSG00000007520
P38606,0,6,51821906.649739586,2.0059980269305578e-4,1.242226540224787,0.3129282964696715,0.12930316819887092,0.6498046150645307,raw,52749720.25,43661326.5,38057076.875,64348342.6875,47275510.9375,64839462.6484375,V-type proton ATPase catalytic subunit A OS=Homo sapiens OX=9606 GN=ATP6V1A PE=1 SV=2,cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,catalytic activity;structural molecule activity,523,ATP6V1A,Proximal tubule transport,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000114573
P52655,0,6,1421266.9,5.501647433414219e-6,1.242109345752727,0.31279218292339933,0.35619556187497364,0.8403332772639565,raw,1404711.625,1073873,NA,1576808.5,1138139,1912802.375,Transcription initiation factor IIA subunit 1 OS=Homo sapiens OX=9606 GN=GTF2A1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,2957,GTF2A1,NA,RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Estrogen-dependent gene expression,ENSG00000165417
Q9NPH2,0,6,68357025.04166667,2.646063532305698e-4,1.2420486350698745,0.31272166647333943,0.09901601381044119,0.6429522395902524,raw,66962294.5625,57468968.0625,59565198.625,77667322.0625,65307940.375,83170426.5625,Inositol-3-phosphate synthase 1 OS=Homo sapiens OX=9606 GN=ISYNA1 PE=1 SV=1,cellular homeostasis,cytosol;nucleus,structural molecule activity,51477,ISYNA1,NA,"Synthesis of IP2, IP, and Ins in the cytosol",ENSG00000105655
F5GY05,0,6,1996346.328125,7.727748850222858e-6,1.2419899443528277,0.3126534929697982,0.29141759455718325,0.7730231021500684,raw,1496572,2332605.703125,1566724.015625,2401541.625,1858727.375,2321907.25,Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens OX=9606 GN=FAM120B PE=1 SV=1,NA,NA,NA,84498,FAM120B,NA,NA,ENSG00000112584; ENSG00000275333
Q12789,0,6,3931490.2916666665,1.521858665155773e-5,1.2419873682556437,0.3126505005731984,0.49611954334640296,0.9797947585234871,raw,3760017.578125,4006018.375,3137560.765625,4889503.84375,2820416.96875,4975424.21875,General transcription factor 3C polypeptide 1 OS=Homo sapiens OX=9606 GN=GTF3C1 PE=1 SV=4,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,2975,GTF3C1,NA,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter,ENSG00000077235
Q9BYD1,0,6,7221678.041666667,2.795472578927944e-5,1.2419608434112293,0.3126196889312174,0.10521236133641235,0.6429522395902524,raw,6051398.5625,5974403.8125,7035285.75,7515600.0625,7326686.875,9426693.1875,"39S ribosomal protein L13, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL13 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome;Golgi,RNA binding;structural molecule activity,28998,MRPL13,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000172172
Q96JQ2,0,6,740674.1796875,2.867109759380111e-6,1.2418652640574457,0.31250865711673703,0.40620284249967936,0.8914071190930648,raw,777964.03125,668827.890625,538759.625,560030.3125,1067869.09375,830594.125,Calmin OS=Homo sapiens OX=9606 GN=CLMN PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,cytoskeleton;membrane;nucleus,motor activity,79789,CLMN,Vitamin D receptor pathway,NA,ENSG00000165959
Q9Y277,0,6,65214971.658854164,2.524436342302182e-4,1.2417873795071963,0.31241817453276166,0.5207365869008962,1,raw,53337225.34375,80129840.90625,50870371.40625,66439905.90625,63170185.203125,77342301.1875,Voltage-dependent anion-selective channel protein 3 OS=Homo sapiens OX=9606 GN=VDAC3 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,7419,VDAC3,Alzheimer's disease and miRNA effects; Ferroptosis; Hepatitis B infection; Alzheimer's disease,Ub-specific processing proteases; Mitochondrial calcium ion transport,ENSG00000078668
Q9Y2T2,0,6,12831772.30078125,4.967109776830012e-5,1.2416890440934847,0.31230392499736725,0.23003474062659826,0.7171432148124838,raw,11886943.96875,12135325.71875,9840768.375,14759888.09375,11010421.9296875,17357285.71875,AP-3 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP3M1 PE=1 SV=1,cell growth;conjugation,cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,26985,AP3M1,NA,Association of TriC/CCT with target proteins during biosynthesis,ENSG00000185009
O15431,0.16666666666666666,6,431659.5859375,1.6709309511687716e-6,1.2416600439950296,0.31227022993739445,1,1,raw,427036.875,428984,340382.84375,530234.625,NA,NA,High affinity copper uptake protein 1 OS=Homo sapiens OX=9606 GN=SLC31A1 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;mitochondrion;nucleus,catalytic activity;structural molecule activity,1317,SLC31A1,Copper homeostasis; Copper metabolism,Metal ion SLC transporters,ENSG00000136868
Q13347,0,6,105339134.29166667,4.077621014137624e-4,1.2415185246681502,0.31210578809347994,0.166759218456227,0.6670444762382309,raw,93266544.875,103773530.6875,87887808.0625,122537572.3125,95732589.09375,128836760.71875,Eukaryotic translation initiation factor 3 subunit I OS=Homo sapiens OX=9606 GN=EIF3I PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,RNA binding,8668,EIF3I,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000084623
A0A0A0MRR7,0,6,34269384.614583336,1.3265493758386068e-4,1.2414857853713372,0.31206774319684727,0.03954215306548914,0.6429522395902524,raw,30280129,30200678.0625,29100720.625,37481522,36128131,42425127,U1 small nuclear ribonucleoprotein C OS=Homo sapiens OX=9606 GN=SNRPC PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,NA,SNRPC,NA,NA,ENSG00000124562
O95249,0,6,2022189.75,7.827787340973073e-6,1.2411610100241806,0.31169028170189134,0.5280888199322942,1,raw,2011762.9375,1887130.5625,1516152,2342232.875,1208804.75,3167055.375,Golgi SNAP receptor complex member 1 OS=Homo sapiens OX=9606 GN=GOSR1 PE=1 SV=1,cell growth;conjugation,cytoskeleton;cytosol;extracellular,structural molecule activity,9527,GOSR1,NA,COPI-mediated anterograde transport; Intra-Golgi traffic,ENSG00000108587
Q15637,0,6,41947273.864583336,1.6237563232902156e-4,1.241130028366142,0.3116542689348774,0.23313554168624825,0.718951462768674,raw,42123568.6875,37443176,34008506.4375,49449329.8125,36378236.25,52280826,Splicing factor 1 OS=Homo sapiens OX=9606 GN=SF1 PE=1 SV=4,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,Golgi;membrane,RNA binding;structural molecule activity,7536,SF1,NA,mRNA Splicing - Major Pathway,ENSG00000168066
O96028,0.3333333333333333,6,352131.8515625,1.3630833852334316e-6,1.24092817998915,0.3114196204063624,1,1,raw,248044.03125,318319.1875,447152.9375,395011.25,NA,NA,Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens OX=9606 GN=NSD2 PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,7468,NSD2,NA,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; PKMTs methylate histone lysines; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ),ENSG00000109685
P60763,0,6,762520.0833333334,2.9516740728976593e-6,1.2408923185329679,0.31137792750792154,0.12144666661306101,0.6445597830897484,raw,625318.125,727318.75,713685.875,892069,714204.5,902524.25,Ras-related C3 botulinum toxin substrate 3 OS=Homo sapiens OX=9606 GN=RAC3 PE=1 SV=1,cell death;cell growth;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,5881,RAC3,Integrin-mediated cell adhesion; RalA downstream regulated genes; Focal adhesion; MAPK signaling pathway; Microglia pathogen phagocytosis pathway; Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Regulation of actin cytoskeleton,RAC3 GTPase cycle; PCP/CE pathway,ENSG00000169750
Q5T1Z8,0,6,13284770.317708334,5.142462863373337e-5,1.2408197085916852,0.3112935067523361,0.10029608752574601,0.6429522395902524,raw,13583101.65625,10149362.9375,11070122.625,16007591.3125,12593529.5625,16304913.8125,Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=1,NA,cytosol;membrane,RNA binding,NA,PUM1,NA,NA,ENSG00000134644
Q86W42,0,6,3525397.3177083335,1.3646622674977814e-5,1.240806721436469,0.3112784065711009,0.23436632964900533,0.7192904383575112,raw,3548545.1875,2758952.65625,2890770.125,5092306.25,3438482.6875,3423327,THO complex subunit 6 homolog OS=Homo sapiens OX=9606 GN=THOC6 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,membrane,RNA binding,79228,THOC6,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000131652
R4GMX3,0,6,5254839.942708333,2.0341201700963993e-5,1.2407931542964261,0.31126263187200404,0.5279894119515436,1,raw,4768853.0625,5606089.21875,4180363.28125,6955997.125,3616537.40625,6401199.5625,COMMD3-BMI1 readthrough OS=Homo sapiens OX=9606 GN=COMMD3-BMI1 PE=4 SV=1,NA,cytosol;membrane,structural molecule activity,100532731,COMMD3-BMI1,NA,NA,ENSG00000269897
Q9NYL9,0,6,33384409.9921875,1.2922924860176956e-4,1.2405616665242944,0.3109934512944846,0.18444031970416877,0.6768541777950948,raw,27781582.640625,34063264.4375,26477341.28125,33729376.375,32846774.625,45408120.59375,Tropomodulin-3 OS=Homo sapiens OX=9606 GN=TMOD3 PE=1 SV=1,cell differentiation;cell growth;metabolic process,endoplasmic reticulum,motor activity,29766,TMOD3,VEGFA-VEGFR2 signaling pathway,RND3 GTPase cycle; Striated Muscle Contraction; RHOBTB2 GTPase cycle,ENSG00000138594
Q86XN6,0.8333333333333334,6,836183.34375,3.2368205767726717e-6,1.2403837822159924,0.31078656822092937,0.1915184648417454,0.6827502624853531,raw,861606.25,680625.125,706149.1875,875896,795804.375,1097019.125,Zinc finger protein 761 OS=Homo sapiens OX=9606 GN=ZNF761 PE=1 SV=3,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,388561,ZNF761,NA,Generic Transcription Pathway,ENSG00000160336
Q12765,0,6,29921106.963541668,1.1582298956718216e-4,1.2403191003549556,0.31071133454354705,0.4554176071597964,0.9388814790284128,raw,31431929.9375,25637560.1875,26286798.625,38985623.0625,23502037.84375,33682692.125,Secernin-1 OS=Homo sapiens OX=9606 GN=SCRN1 PE=1 SV=2,cell organization and biogenesis;conjugation,cytoskeleton;membrane;nucleus,structural molecule activity,9805,SCRN1,NA,NA,ENSG00000136193
Q6PI77,0.5,6,4916756.375,1.9032498464040602e-5,1.2395788125912526,0.3098500010897192,0.18772072365477707,0.6796724904026823,raw,3786366.75,5252575,4343217.5,5408781,4693500,6016098,Protein BHLHb9 OS=Homo sapiens OX=9606 GN=BHLHB9 PE=1 SV=1,metabolic process,cytosol;membrane,structural molecule activity,80823,BHLHB9,NA,NA,ENSG00000198908
P57735,0,6,6180509.916666667,2.392442019174604e-5,1.2395606055422939,0.3098288104950715,0.34529808969046644,0.8277692477090556,raw,5612622,6258277.375,4299552.6875,9179360.875,4776061.4375,6957185.125,Ras-related protein Rab-25 OS=Homo sapiens OX=9606 GN=RAB25 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,57111,RAB25,Intracellular trafficking proteins involved in CMT neuropathy,RAB geranylgeranylation,ENSG00000132698
Q5SXM2,0.8333333333333334,6,142401461.33333334,5.51228368337409e-4,1.2393399558847529,0.3095719787588556,0.2395035670780559,0.7258167404748,raw,103130248,151965600,118925024,172113008,119937848,188337040,snRNA-activating protein complex subunit 4 OS=Homo sapiens OX=9606 GN=SNAPC4 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,6621,SNAPC4,NA,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 3 Promoter; RNA polymerase II transcribes snRNA genes,ENSG00000165684
M0R2B7,0,6,2622516.6614583335,1.0151620402612814e-5,1.2388478266158407,0.3089989854852365,0.29182487068704815,0.7730231021500684,raw,1930802.375,2974885.375,1861190.625,3685430.28125,2075156.09375,3207635.21875,DNA polymerase OS=Homo sapiens OX=9606 GN=POLD1 PE=1 SV=1,cell proliferation;cellular homeostasis;coagulation,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5424,POLD1,"Homologous recombination; Pyrimidine metabolism; DNA replication; Base excision repair; Nucleotide excision repair; DNA repair pathways, full network; Progeria-associated lipodystrophy; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",NA,ENSG00000062822
Q9HCE1,0,6,24492103.755208332,9.48076112683386e-5,1.238784183643818,0.30892486842526595,0.18338927299586577,0.6759724770040925,raw,21684868.25,22730101.875,19711078.75,33471459,22492242.84375,26862871.8125,Helicase MOV-10 OS=Homo sapiens OX=9606 GN=MOV10 PE=1 SV=2,coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,4343,MOV10,VEGFA-VEGFR2 signaling pathway,MAPK6/MAPK4 signaling; Oxidative Stress Induced Senescence; Estrogen-dependent gene expression; TP53 Regulates Metabolic Genes; Pre-NOTCH Transcription and Translation; Oncogene Induced Senescence; Transcriptional Regulation by VENTX; Ca2+ pathway; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; Regulation of RUNX1 Expression and Activity; Regulation of NPAS4 mRNA translation; Competing endogenous RNAs (ceRNAs) regulate PTEN translation,ENSG00000155363
Q96HC4,0,6,58452280.075520836,2.2626562023973e-4,1.238752664320838,0.3088881603771129,0.20677457406135533,0.6986564272044358,raw,55156117.8125,42906609.078125,51705855.71875,85164324.71875,53150676.3125,62630096.8125,PDZ and LIM domain protein 5 OS=Homo sapiens OX=9606 GN=PDLIM5 PE=1 SV=5,cell growth;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,10611,PDLIM5,Extracellular vesicles in the crosstalk of cardiac cells,Neurexins and neuroligins,ENSG00000163110
P37088,0.5,6,527204.1328125,2.0407787335181447e-6,1.2384166863133954,0.3084968154672195,1,1,raw,566858.9375,563335.9375,280977.03125,NA,NA,697644.625,Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens OX=9606 GN=SCNN1A PE=1 SV=1,conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,catalytic activity;structural molecule activity,6337,SCNN1A,Glucocorticoid receptor pathway; Nuclear receptors meta-pathway,Stimuli-sensing channels; Sensory perception of salty taste,ENSG00000111319
P16220,0.16666666666666666,6,2967023.9166666665,1.1485189387023485e-5,1.2382810553580823,0.3083388033662477,0.3482478324535877,0.8312036283838062,raw,2165769,2191291.75,3351507,4150107.625,2145886,3797582.125,Cyclic AMP-responsive element-binding protein 1 OS=Homo sapiens OX=9606 GN=CREB1 PE=1 SV=3,cell death;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,1385,CREB1,Androgen receptor signaling pathway; miRNA regulation of DNA damage response; Energy metabolism; miRNAs involved in DNA damage response; Folate-alcohol and cancer pathway hypotheses; Sterol regulatory element-binding proteins (SREBP) signaling; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; ATM signaling pathway; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; MFAP5-mediated ovarian cancer cell motility and invasiveness; Ovarian infertility; MECP2 and associated Rett syndrome; Transcription factor regulation in adipogenesis; BDNF-TrkB signaling; ERK pathway in Huntington's disease; VEGFA-VEGFR2 signaling pathway; Mitochondrial gene expression; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; p38 MAPK signaling pathway; NO/cGMP/PKG mediated neuroprotection; White fat cell differentiation; PI3K-Akt signaling pathway; Phosphodiesterases in neuronal function; Acute viral myocarditis; Thermogenesis; EGF/EGFR signaling pathway; G1 to S cell cycle control; Fragile X syndrome; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; Hepatitis B infection; Melanoma; mBDNF and proBDNF regulation of GABA neurotransmission; CAMKK2 pathway; GPR143 in melanocytes and retinal pigment epithelium cells; Galanin receptor pathway; Neuroinflammation and glutamatergic signaling; Malignant pleural mesothelioma; CCL18 signaling pathway; GDNF signaling; DYRK1A; Interferon type I signaling pathways; T-cell receptor signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response; Estrogen signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 4/6/7 and NR3C signaling,FCGR3A-mediated IL10 synthesis; HCMV Early Events; ADORA2B mediated anti-inflammatory cytokines production; AKT phosphorylates targets in the nucleus; Constitutive Signaling by AKT1 E17K in Cancer; NGF-stimulated transcription; Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; MECP2 regulates transcription of neuronal ligands; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; NCAM signaling for neurite out-growth; Regulation of MECP2 expression and activity; Transcriptional regulation of granulopoiesis; CREB phosphorylation; Gastrin-CREB signalling pathway via PKC and MAPK; NOTCH2 intracellular domain regulates transcription; MECP2 regulates neuronal receptors and channels; CaMK IV-mediated phosphorylation of CREB; CREB1 phosphorylation through the activation of Adenylate Cyclase; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde; PKA-mediated phosphorylation of CREB; CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling; MECP2 regulates transcription factors,ENSG00000118260
Q96KP1,0,6,1118000.3229166667,4.327718887374882e-6,1.2380805760058782,0.30810521020748266,0.5826897079109467,1,raw,947123.3125,1403707,822699.9375,1287210.75,1018568.8125,1228692.125,Exocyst complex component 2 OS=Homo sapiens OX=9606 GN=EXOC2 PE=1 SV=1,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,55770,EXOC2,RalA downstream regulated genes; Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Ciliary landscape,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing; VxPx cargo-targeting to cilium,ENSG00000112685
Q9NZL9,0,6,29991105.755208332,1.1609395111037648e-4,1.237965869382025,0.3079715401159408,0.1328618127362034,0.6514609890946903,raw,28659978.09375,28644074.84375,23142371.40625,37975710.1875,28649465.9375,32875034.0625,Methionine adenosyltransferase 2 subunit beta OS=Homo sapiens OX=9606 GN=MAT2B PE=1 SV=1,cellular homeostasis,cytosol;membrane;nucleus,DNA binding;structural molecule activity,27430,MAT2B,"Trans-sulfuration pathway; One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Methionine de novo and salvage pathway; Methylation pathways",Ub-specific processing proteases; Methylation,ENSG00000038274
M0QYN0,0,6,16503840.791666666,6.388547663563389e-5,1.237822238290546,0.307804146256196,0.08786531424079526,0.6429522395902524,raw,13190615.5,16530798.5,13369451.5,19793616.25,15676373,20462190,Myeloid-derived growth factor OS=Homo sapiens OX=9606 GN=MYDGF PE=1 SV=1,NA,NA,NA,NA,MYDGF,NA,NA,ENSG00000074842
V9GZ56,0,6,21109421.122395832,8.17134294331972e-5,1.237570859523905,0.3075111318645953,0.20127940474076125,0.691648270213144,raw,20689239.875,18948149.34375,17363065.21875,25450185.9375,18601485.984375,25604400.375,U6 snRNA-associated Sm-like protein LSm4 (Fragment) OS=Homo sapiens OX=9606 GN=LSM4 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding,NA,LSM4,Ciliary landscape,NA,ENSG00000130520
P43304,0,6,75807623.70800781,2.9344721839817147e-4,1.2374753643513627,0.3073998043179863,0.27665641371357946,0.756515890988102,raw,73003617.53125,70741135.5585938,63359788.0546875,87540412.5,64723591.1875,95477197.4160156,"Glycerol-3-phosphate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=GPD2 PE=1 SV=3",cellular homeostasis,cytoskeleton;endosome;nucleus,structural molecule activity,2820,GPD2,Fatty acid beta-oxidation,Triglyceride catabolism; Synthesis of PA,ENSG00000115159
Q13825,0,6,2927742.6145833335,1.1333133587519581e-5,1.2372253686725476,0.3071083205660448,0.4532045859075036,0.9359885112583651,raw,3108385.9375,2310119,2520870.5625,3845773.9375,2019482.25,3761824,"Methylglutaconyl-CoA hydratase, mitochondrial OS=Homo sapiens OX=9606 GN=AUH PE=1 SV=1",cellular homeostasis,endosome,RNA binding;structural molecule activity,549,AUH,Amino acid metabolism,Branched-chain amino acid catabolism,ENSG00000148090
Q9UQ80,0,6,339516880.1093752,0.001314251511840983,1.23720600743898,0.3070857437785664,0.19413722346532658,0.6848190557739395,raw,295845479.375,326213960.992188,305749069.804688,403593872.25,305551863.09375,400147035.140625,Proliferation-associated protein 2G4 OS=Homo sapiens OX=9606 GN=PA2G4 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cell surface;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,5036,PA2G4,NA,Neutrophil degranulation,ENSG00000170515
Q99536,0,6,49095983.423177086,1.900479010600115e-4,1.2371607658565114,0.30703298700266635,0.14112296712061104,0.6572502130392559,raw,46486098.34375,45544229.875,41417013.5546875,56345534.3125,45672719.359375,59110305.09375,Synaptic vesicle membrane protein VAT-1 homolog OS=Homo sapiens OX=9606 GN=VAT1 PE=1 SV=2,metabolic process,cell surface;cytoskeleton;endosome;mitochondrion,structural molecule activity,10493,VAT1,NA,Neutrophil degranulation,ENSG00000108828
Q8NBF6,0,6,1476903.2890625,5.71701289157703e-6,1.2371069335905807,0.30697021000959673,0.12461793680147651,0.6445597830897484,raw,1407648.6875,1468463.09375,1100492.90625,1620681.171875,1447488,1816645.875,Late secretory pathway protein AVL9 homolog OS=Homo sapiens OX=9606 GN=AVL9 PE=1 SV=1,metabolic process,cytoskeleton;mitochondrion;nucleus,NA,23080,AVL9,NA,NA,ENSG00000105778
Q969U7,0,6,9617370.208333334,3.7228320819172996e-5,1.2367939127274636,0.3066051237127908,0.053073942302342775,0.6429522395902524,raw,8442461.84375,9539676.1875,7891079.25,10453690.125,9759638.78125,11617675.0625,Proteasome assembly chaperone 2 OS=Homo sapiens OX=9606 GN=PSMG2 PE=1 SV=1,cell differentiation;cell growth;development;metabolic process,cytosol;nucleus,structural molecule activity,56984,PSMG2,NA,NA,ENSG00000128789
P27348,0,6,178571582.7421875,6.912409554280555e-4,1.2362474437633701,0.30596753787116304,0.482517765402401,0.9640789676901554,raw,184439656.625,154041886.546875,159304143.375,211946830.71875,133683925.15625,228013054.03125,14-3-3 protein theta OS=Homo sapiens OX=9606 GN=YWHAQ PE=1 SV=1,conjugation;development;metabolic process,cytosol;nucleus,structural molecule activity,10971,YWHAQ,Cell cycle; Pathogenic Escherichia coli infection; Primary focal segmental glomerulosclerosis (FSGS); IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Yap signaling pathway; Leukocyte-intrinsic Hippo pathway functions; Hepatitis B infection; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; TP53 Regulates Metabolic Genes; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Activation of BAD and translocation to mitochondria,ENSG00000134308
Q8TBZ6,0.5,6,292632.121875,1.1327631440992194e-6,1.2361468059937766,0.30585008927961,0.2858979356392391,0.7655844406429082,raw,304545.1875,315816,156097.203125,303400.03125,383302.1875,NA,tRNA methyltransferase 10 homolog A OS=Homo sapiens OX=9606 GN=TRMT10A PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;endoplasmic reticulum;membrane,RNA binding;structural molecule activity,93587,TRMT10A,NA,tRNA modification in the nucleus and cytosol,ENSG00000145331
P55084,0,6,78817643.92447917,3.050988441402995e-4,1.2355041987293274,0.3050999135203483,0.13337541043931198,0.6514609890946903,raw,72963952.625,64425406.671875,72768507.28125,99323378.5625,73518822.125,89905796.28125,"Trifunctional enzyme subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=HADHB PE=1 SV=3",cellular homeostasis;metabolic process,cytoskeleton;endosome;extracellular,RNA binding;structural molecule activity,3032,HADHB,Fatty acid beta-oxidation; Valproic acid pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,Acyl chain remodeling of CL; mitochondrial fatty acid beta-oxidation of unsaturated fatty acids; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA; Beta oxidation of octanoyl-CoA to hexanoyl-CoA; Beta oxidation of hexanoyl-CoA to butanoyl-CoA; Beta oxidation of myristoyl-CoA to lauroyl-CoA; Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA; Beta oxidation of palmitoyl-CoA to myristoyl-CoA,ENSG00000138029
Q96ER9,0,6,8902244.395833334,3.446010740977826e-5,1.2350080878036418,0.30452048974193613,0.22567964121427272,0.7148463313429879,raw,7308027.6875,8148728.0625,8236672.1875,10063745.0625,7793984.375,11862309,Mitochondrial potassium channel OS=Homo sapiens OX=9606 GN=CCDC51 PE=1 SV=2,cell growth;conjugation,cytoskeleton;endosome,catalytic activity,79714,CCDC51,NA,NA,ENSG00000164051
Q7L3T8,0.16666666666666666,6,844218.078125,3.2679225997300653e-6,1.234993867441314,0.3045038778958064,0.3330540390646859,0.8158667519449163,raw,788858.84375,NA,699960.765625,681494.625,916063.78125,1134712.375,"Probable proline--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=PARS2 PE=1 SV=1",cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome,structural molecule activity,25973,PARS2,NA,Mitochondrial tRNA aminoacylation,ENSG00000162396
P40121,0,6,48175748.325520836,1.864857206819571e-4,1.2349673214446644,0.30447286706219856,0.150209785860518,0.6638855679885327,raw,47755281.03125,37375634,43145070.171875,58976211.5,43686800.25,58115493,Macrophage-capping protein OS=Homo sapiens OX=9606 GN=CAPG PE=1 SV=2,cell growth;defense response;metabolic process,cell surface;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,822,CAPG,TYROBP causal network in microglia,NA,ENSG00000042493
Q9ULE4,0.3333333333333333,6,1000237.015625,3.871863483079202e-6,1.2348749434234005,0.30436494655640567,1,1,raw,848131.125,1504141.375,601339.6875,NA,1047335.875,NA,Protein FAM184B OS=Homo sapiens OX=9606 GN=FAM184B PE=2 SV=3,NA,NA,NA,27146,FAM184B,NA,NA,ENSG00000047662
Q12792,0,6,47156600.307291664,1.8254065372883262e-4,1.2346802927307794,0.3041375197020309,0.12751969440821231,0.64823440900854,raw,39161310.1875,48145701.59375,38335937.6875,53378590.5,44473512.9375,59444548.9375,Twinfilin-1 OS=Homo sapiens OX=9606 GN=TWF1 PE=1 SV=3,cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,5756,TWF1,NA,Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; RHOBTB2 GTPase cycle,ENSG00000151239
P31942,0,6,42588530.694986984,1.6485790289702648e-4,1.2345085613417723,0.30393684163459483,0.09911411553657676,0.6429522395902524,raw,40749408.4375,38409420,34456953.40625,47416757.8261719,41109922.25,53388722.25,Heterogeneous nuclear ribonucleoprotein H3 OS=Homo sapiens OX=9606 GN=HNRNPH3 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,3189,HNRNPH3,NA,NA,ENSG00000096746
Q9Y3B4,0,6,16487657.942708334,6.382283370105422e-5,1.2342832576696248,0.3036735189122003,0.43136468775218123,0.9162373203757352,raw,20015834.375,13647856.1875,11820630.0625,18763861.25,14590005.78125,20087760,Splicing factor 3B subunit 6 OS=Homo sapiens OX=9606 GN=SF3B6 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;defense response,membrane,RNA binding,51639,SF3B6,NA,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000115128
O14548,0.16666666666666666,6,5079395.677083333,1.9662066421247692e-5,1.234104039312379,0.30346402388197935,0.3889477857026522,0.8736156090837985,raw,4499974.1875,4376698.625,5238922.3125,6465375.1875,4172124.625,5723279.125,"Cytochrome c oxidase subunit 7A-related protein, mitochondrial OS=Homo sapiens OX=9606 GN=COX7A2L PE=1 SV=2",cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome;membrane,catalytic activity,9167,COX7A2L,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000115944
R4GMX5,0,6,720849.1666666666,2.7903682043608033e-6,1.2340498160864308,0.3034006343335378,1,1,raw,NA,757408.1875,588084.625,NA,NA,817054.6875,Basigin (Fragment) OS=Homo sapiens OX=9606 GN=BSG PE=1 SV=1,cell communication;cell growth;defense response,cytoplasm;cytoskeleton,NA,NA,BSG,NA,NA,ENSG00000172270
Q9P2J5,0,6,122967843.4609375,4.7600188280564915e-4,1.233871568152963,0.3031922343320207,0.09804123286715179,0.6429522395902524,raw,124069912.3125,96626043.640625,104218604.53125,142469637.96875,117336525.046875,153086337.265625,"Leucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=LARS1 PE=1 SV=2",cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;extracellular;membrane;mitochondrion;nucleus,DNA binding;structural molecule activity,51520,LARS1,NA,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,ENSG00000133706
P43487,0,6,87178301.71875,3.3746249905656096e-4,1.2337848724735816,0.3030908625002678,0.13878207298166667,0.6572502130392559,raw,79329107.5,77724066.875,68508959.125,95894777.9375,82912118.75,118700780.125,Ran-specific GTPase-activating protein OS=Homo sapiens OX=9606 GN=RANBP1 PE=1 SV=1,conjugation;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,5902,RANBP1,22q11.2 copy number variation syndrome,Rev-mediated nuclear export of HIV RNA,ENSG00000099901
Q9NX58,0,6,51795512.005208336,2.0049763044916464e-4,1.2337786123749594,0.3030835423941849,0.13778974027006313,0.6555000793022896,raw,49797022.453125,45780202.25,43566122.765625,56482634.40625,49374516.96875,65772573.1875,Cell growth-regulating nucleolar protein OS=Homo sapiens OX=9606 GN=LYAR PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
P00505,0,6,169879956.7526042,6.575961404972447e-4,1.2336768971118781,0.3029645987251711,0.23388275930283578,0.7192863412735425,raw,170339002.488281,146668444.75,148255950.269531,210143292.046875,150338264.867188,193534786.09375,"Aspartate aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=GOT2 PE=1 SV=3",cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;endosome,structural molecule activity,2806,GOT2,Alanine and aspartate metabolism; Amino acid metabolism; Metabolic reprogramming in colon cancer; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis and gluconeogenesis,Glyoxylate metabolism and glycine degradation; Gluconeogenesis; Aspartate and asparagine metabolism; Glutamate and glutamine metabolism; Degradation of cysteine and homocysteine,ENSG00000125166
Q9BW91,0,6,2925440.71875,1.1324223073031804e-5,1.2335761914892438,0.3028468260466275,0.413838004994782,0.8999719806515282,raw,3361478.625,2627446.4375,1901831.375,2478685.375,3036562.5,4146640,"ADP-ribose pyrophosphatase, mitochondrial OS=Homo sapiens OX=9606 GN=NUDT9 PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,53343,NUDT9,NA,NA,ENSG00000170502
Q9HCD5,0,6,66623394.145833336,2.578955616343193e-4,1.2335270912511955,0.3027894010734262,0.050346776562218414,0.6429522395902524,raw,54314475.78125,66420786.21875,58715947.265625,72427711.640625,75692048.28125,72169395.6875,Nuclear receptor coactivator 5 OS=Homo sapiens OX=9606 GN=NCOA5 PE=1 SV=2,cellular component movement;development;metabolic process,endoplasmic reticulum;membrane,structural molecule activity,57727,NCOA5,NA,NA,ENSG00000124160
Q13895,0,6,16912180.190104168,6.54661364000846e-5,1.2334997090172437,0.3027573753061114,0.32752060988793646,0.8099046276759172,raw,15660818.03125,16673829.53125,14462806.421875,19959164.875,14149298.40625,20567163.875,Bystin OS=Homo sapiens OX=9606 GN=BYSL PE=1 SV=3,cell differentiation;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding,705,BYSL,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000112578
Q9H089,0,6,9647053.78125,3.734322432726957e-5,1.2333802000598202,0.30261759146035777,0.1556715665010831,0.6638855679885327,raw,8277505.4375,9081126.0625,7637746.5625,9313068,10209311.3125,13363565.3125,Large subunit GTPase 1 homolog OS=Homo sapiens OX=9606 GN=LSG1 PE=1 SV=2,conjugation,cytosol;extracellular;membrane,structural molecule activity,55341,LSG1,NA,NA,ENSG00000041802
P0C7P3,0,6,405510.25,1.5697082835994129e-6,1.2333794192346883,0.3026166781224413,0.06561918124700404,0.6429522395902524,raw,339040.78125,NA,348292.125,416601.96875,419729.875,503886.5,Protein SLFN14 OS=Homo sapiens OX=9606 GN=SLFN14 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,protein binding;structural molecule activity,342618,SLFN14,NA,NA,ENSG00000236320
O75648,0.3333333333333333,6,304313.5885416667,1.1779814708647132e-6,1.2333421813086392,0.3025731199266268,1,1,raw,315342.6875,252054.140625,NA,NA,345543.9375,NA,Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens OX=9606 GN=TRMU PE=1 SV=2,cellular component movement;cellular homeostasis,endosome,RNA binding;structural molecule activity,55687,TRMU,NA,tRNA modification in the mitochondrion,ENSG00000100416
P48047,0,6,87251300.02604167,3.3774507156279104e-4,1.2333326191408176,0.3025619345915402,0.09875289758259538,0.6429522395902524,raw,84314334.5,78546766.65625,75273233.875,97357170,84028676.125,103987619,"ATP synthase subunit O, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PO PE=1 SV=1",cellular homeostasis;conjugation,cytoplasm;cytoskeleton;endosome,catalytic activity,539,ATP5PO,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000241837
P52298,0,6,7367436.994791667,2.8518950827066008e-5,1.2327100321948352,0.30183347750821454,0.2651445200467432,0.7454335379461359,raw,5477868.15625,6743306.875,6598699.75,11327150.5625,7304973.59375,6752623.03125,Nuclear cap-binding protein subunit 2 OS=Homo sapiens OX=9606 GN=NCBP2 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding,22916,NCBP2,mRNA processing; 3q29 copy number variation syndrome,Regulation of expression of SLITs and ROBOs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Abortive elongation of HIV-1 transcript in the absence of Tat; RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; mRNA Capping; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Signaling by FGFR2 IIIa TM; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; snRNP Assembly; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Processing of Intronless Pre-mRNAs; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,ENSG00000114503
Q9H490,0,6,1017577.6458333334,3.938988126367146e-6,1.232676034714833,0.3017936882058708,0.1839067342916455,0.676113606267618,raw,1100120,766977.625,816543.5,945434.9375,1335651.9375,1140737.875,Phosphatidylinositol glycan anchor biosynthesis class U protein OS=Homo sapiens OX=9606 GN=PIGU PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;extracellular,NA,128869,PIGU,NA,Attachment of GPI anchor to uPAR,ENSG00000101464
O14979,0,6,53768618.12109375,2.0813541769258448e-4,1.2323522048060136,0.301414635504776,0.216176635369904,0.7052519353827845,raw,50979306.109375,49711855.71875,46798927.5546875,61262515,48218133.671875,65640970.671875,Heterogeneous nuclear ribonucleoprotein D-like OS=Homo sapiens OX=9606 GN=HNRNPDL PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane,RNA binding,9987,HNRNPDL,NA,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,ENSG00000152795
Q13427,0,6,5828720.572916667,2.256266263576225e-5,1.2323131902276903,0.3013689610381424,0.40436787369485766,0.8902077371640484,raw,6294712.8125,5149534.875,4018990.125,6345839.75,4451274,8711971.875,Peptidyl-prolyl cis-trans isomerase G OS=Homo sapiens OX=9606 GN=PPIG PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9360,PPIG,NA,SARS-CoV-1 activates/modulates innate immune responses,ENSG00000138398
B7Z4C8,0,6,103583874.5,4.009675855295199e-4,1.232280440855846,0.3013306201483838,0.18935722613470396,0.6806579357154494,raw,81637570,102724258.5,97123586.25,106195639.75,100600380.75,133221811.75,60S ribosomal protein L31 OS=Homo sapiens OX=9606 GN=RPL31 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,structural molecule activity,NA,RPL31,NA,NA,ENSG00000071082
P15170,0,6,66100203.8125,2.558703201018735e-4,1.232243335371716,0.30128717816704464,0.32332879059840464,0.8037523716522456,raw,62218212.375,61982554.75,56653729.5,84734552.6875,54634583.5625,76377590,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens OX=9606 GN=GSPT1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;nucleus,RNA binding;structural molecule activity,2935,GSPT1,NA,Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000103342
Q9NSD9,0,6,77224206.67447917,2.989307345777894e-4,1.2320883546417347,0.30110571726080537,0.3845974621349269,0.8695425300008842,raw,80015598.0625,65590102.125,69118978.09375,98586286.5625,64184475.140625,85849800.0625,Phenylalanine--tRNA ligase beta subunit OS=Homo sapiens OX=9606 GN=FARSB PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;nucleus,RNA binding;structural molecule activity,10056,FARSB,VEGFA-VEGFR2 signaling pathway; Amino acid metabolism,Cytosolic tRNA aminoacylation,ENSG00000116120
Q13564,0,6,19856567.453125,7.68637005230344e-5,1.2320877442123905,0.30110500248771094,0.14275101372447757,0.6572502130392559,raw,20511911.28125,15090498.625,16631549.5,23376675.4375,18256295.375,25272474.5,NEDD8-activating enzyme E1 regulatory subunit OS=Homo sapiens OX=9606 GN=NAE1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,8883,NAE1,Alzheimer's disease and miRNA effects; Hijack of ubiquitination by SARS-CoV-2; Alzheimer's disease,Neddylation,ENSG00000159593
P35270,0,6,27770612.239583332,1.0749854059940828e-4,1.2319576635089862,0.3009526783582099,0.32135185367356645,0.8027885809803746,raw,26966405.875,24953603.75,24968067.375,33221470.375,23340287.6875,33173838.375,Sepiapterin reductase OS=Homo sapiens OX=9606 GN=SPR PE=1 SV=1,cellular homeostasis,cytosol;membrane,structural molecule activity,6697,SPR,NA,"eNOS activation; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",ENSG00000116096
Q9UJ83,0,6,1072287.4166666667,4.150766695394462e-6,1.2319405840875592,0.30093267721033917,0.15729202644100101,0.6638855679885327,raw,778080,1067609.625,1054797,1315231.625,1063144,1154862.25,2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2,cell growth;cellular homeostasis;conjugation,cytosol;membrane;mitochondrion;nucleus,structural molecule activity,26061,HACL1,NA,Peroxisomal protein import; Alpha-oxidation of phytanate,ENSG00000131373
Q86VH2,0.6666666666666666,6,4023574.5833333335,1.5575039972820392e-5,1.2317275325741475,0.30068315629431924,0.16391677310296449,0.6638855679885327,raw,3372652,4145273.5,3133166.25,4755683,3628825.25,5105847.5,Kinesin-like protein KIF27 OS=Homo sapiens OX=9606 GN=KIF27 PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,cell surface;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,55582,KIF27,NA,COPI-dependent Golgi-to-ER retrograde traffic; Kinesins,ENSG00000165115
Q86YJ6,0.8333333333333334,6,4023574.5833333335,1.5575039972820392e-5,1.2317275325741475,0.30068315629431924,0.16391677310296449,0.6638855679885327,raw,3372652,4145273.5,3133166.25,4755683,3628825.25,5105847.5,Threonine synthase-like 2 OS=Homo sapiens OX=9606 GN=THNSL2 PE=2 SV=3,cellular homeostasis;development,cell surface,antioxidant activity;structural molecule activity,55258,THNSL2,NA,NA,ENSG00000144115
Q8TD43,0.3333333333333333,6,1702424.5625,6.5899935647973294e-6,1.2315530644875137,0.30047879123408117,0.6062063920962325,1,raw,2058060.625,1283006.125,1259270.125,1580090.125,1142282.125,2891838.25,Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens OX=9606 GN=TRPM4 PE=1 SV=1,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,54795,TRPM4,Neuroinflammation and glutamatergic signaling,"Sensory perception of sweet, bitter, and umami (glutamate) taste; TRP channels",ENSG00000130529
P62829,0,6,218832474.47395834,8.470886935714436e-4,1.2310659858173356,0.29990809314655925,0.14318159760294166,0.6572502130392559,raw,171400380.328125,225929991.125,183977345.328125,249421089.6875,204131313.125,278134727.25,60S ribosomal protein L23 OS=Homo sapiens OX=9606 GN=RPL23 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;Golgi;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,9349,RPL23,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000125691
Q96QR8,0,6,1013373.953125,3.922715858857318e-6,1.23098233215928,0.2998100554949062,0.26115157263074934,0.7423144016558971,raw,1119938.75,729956.75,929135.1875,1143749,994015.53125,1163448.5,Transcriptional activator protein Pur-beta OS=Homo sapiens OX=9606 GN=PURB PE=1 SV=3,cell differentiation;cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,5814,PURB,NA,NA,ENSG00000146676
P06396,0,6,79835619.98958333,3.090393745261527e-4,1.2309265459307228,0.2997446732900492,0.1749032024562682,0.6697819849820321,raw,83883174.75,57847054.6875,67686330.4375,97482591.5,71205475.21875,100909093.34375,Gelsolin OS=Homo sapiens OX=9606 GN=GSN PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,2934,GSN,Ebola virus infection in host; Regulation of actin cytoskeleton,Neutrophil degranulation; Amyloid fiber formation; Sensory processing of sound by outer hair cells of the cochlea; Caspase-mediated cleavage of cytoskeletal proteins,ENSG00000148180
Q9H0D6,0,6,46124522.546875,1.785455364417979e-4,1.2308379242705432,0.2996408014280093,0.2456634144956294,0.7315699559274061,raw,47217369.625,38598905.59375,40755242.9375,50679131.46875,41379556.4375,58116929.21875,5'-3' exoribonuclease 2 OS=Homo sapiens OX=9606 GN=XRN2 PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,22803,XRN2,mRNA processing,Major pathway of rRNA processing in the nucleolus and cytosol; Association of TriC/CCT with target proteins during biosynthesis,ENSG00000088930
Q13043,0.3333333333333333,6,478298.425,1.851467379073778e-6,1.2307849470952341,0.29957870425707417,0.26502232068152026,0.7454335379461359,raw,421872,NA,377454.28125,490380.4375,405834.71875,695950.6875,Serine/threonine-protein kinase 4 OS=Homo sapiens OX=9606 GN=STK4 PE=1 SV=2,cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,6789,STK4,MAPK signaling pathway; Ras signaling; Non-small cell lung cancer,Signaling by Hippo,ENSG00000101109
A8MXP9,0,6,186808933.9453125,7.231272971875127e-4,1.2306673676294981,0.2994408739922001,0.20175069302205595,0.6920162065862512,raw,176159512.703125,180313961.71875,153831329.46875,216793763.78125,167332787.9375,226422248.0625,Matrin-3 OS=Homo sapiens OX=9606 GN=MATR3 PE=1 SV=1,NA,membrane,RNA binding;structural molecule activity,NA,MATR3,NA,NA,ENSG00000280987
Q9H6E4,0,6,611171.5260416666,2.365811979173642e-6,1.2306401644626008,0.2994089837278028,0.36837205445428656,0.852141615295751,raw,618114,642000.0625,429923.84375,612693.0625,574227.125,790071.0625,Coiled-coil domain-containing protein 134 OS=Homo sapiens OX=9606 GN=CCDC134 PE=1 SV=1,defense response;metabolic process,cell surface;extracellular;membrane,NA,79879,CCDC134,NA,NA,ENSG00000100147
Q9UN37,0,6,6708451.166666667,2.5968052266098855e-5,1.2304561319799106,0.29919322398608245,0.38861025377255287,0.8734136159176045,raw,6339790.625,6766558.375,5083665.0625,9096670.5,5163188.1875,7800834.25,Vacuolar protein sorting-associated protein 4A OS=Homo sapiens OX=9606 GN=VPS4A PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,27183,VPS4A,Ebola virus infection in host; Ciliary landscape,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Sealing of the nuclear envelope (NE) by ESCRT-III,ENSG00000132612
P43378,0.5,6,1370898.9270833333,5.306675729701668e-6,1.2303821901663823,0.2991065254925133,0.9859904341416681,1,raw,1166246.15625,2078479.21875,878972.9375,1163548.25,1434928.5,1503218.5,Tyrosine-protein phosphatase non-receptor type 9 OS=Homo sapiens OX=9606 GN=PTPN9 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,5780,PTPN9,VEGFA-VEGFR2 signaling pathway,Interleukin-37 signaling,ENSG00000169410
Q9NR50,0,6,5397461.856770833,2.089328342991341e-5,1.2303557577181878,0.29907553156895234,0.2535776194310894,0.7343965948630279,raw,4737305.203125,4093778.453125,5699577.609375,5564049.34375,5036803.890625,7253256.640625,Translation initiation factor eIF-2B subunit gamma OS=Homo sapiens OX=9606 GN=EIF2B3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,8891,EIF2B3,Translation factors,Recycling of eIF2:GDP,ENSG00000070785
A0A087X279,0,6,77430.6103515625,2.9972971206771246e-7,1.229772601214589,0.2983915696866327,0.5318438770618469,1,raw,80868.2421875,NA,57502.83984375,103555.6875,67795.671875,NA,Interferon-induced protein with tetratricopeptide repeats 2 OS=Homo sapiens OX=9606 GN=IFIT2 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q14764,0,6,87571325.86458333,3.3898387430507604e-4,1.2293620537116248,0.297909859707155,0.4779518208484513,0.9598491591476868,raw,82062500.625,84396738.28125,81977103.09375,103754147.5,70353932.375,102883533.3125,Major vault protein OS=Homo sapiens OX=9606 GN=MVP PE=1 SV=4,conjugation;development;metabolic process,cell surface;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,9961,MVP,16p11.2 proximal deletion syndrome,Neutrophil degranulation,ENSG00000013364
Q15836,0,6,15868679.46875,6.142680144800485e-5,1.2288319093509827,0.297287584440513,0.24530692916994548,0.7314625466162152,raw,12135748,17330336.8125,12780460.75,17390013.5,14279446.875,21296070.875,Vesicle-associated membrane protein 3 OS=Homo sapiens OX=9606 GN=VAMP3 PE=1 SV=3,cell communication;cell growth;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,9341,VAMP3,NA,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; ER-Phagosome pathway; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; Cargo recognition for clathrin-mediated endocytosis; Retrograde transport at the Trans-Golgi-Network; RHOH GTPase cycle,ENSG00000049245
Q86SX6,0,6,4217504.890625,1.632573372173724e-5,1.2287996542652895,0.2972497152555101,0.21123265479771217,0.7016553543929079,raw,3945531.1875,3951734.5,3183076.40625,4427733.1875,3911363.1875,5885590.875,"Glutaredoxin-related protein 5, mitochondrial OS=Homo sapiens OX=9606 GN=GLRX5 PE=1 SV=2",cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,51218,GLRX5,NA,Mitochondrial iron-sulfur cluster biogenesis,ENSG00000182512
P62851,0,6,145454356.91666666,5.630459623097498e-4,1.2286722558412733,0.2971001330169876,0.15872257496503872,0.6638855679885327,raw,120691837.5,146361623,128942762.5,160907050,135992403,179830465.5,40S ribosomal protein S25 OS=Homo sapiens OX=9606 GN=RPS25 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,structural molecule activity,6230,RPS25,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000118181; ENSG00000280831
Q9Y490,0,6,171223548.09635434,6.627971100462439e-4,1.228574054602712,0.2969848214673438,0.2947440843090954,0.7760918587221847,raw,167734025.306641,167520580.765625,133553853.242188,205811439.140625,144473340.279297,208248049.84375,Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3,cell communication;cell growth;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,antioxidant activity;motor activity;structural molecule activity,7094,TLN1,Integrin-mediated cell adhesion; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion,Platelet degranulation ; Signaling by BRAF and RAF1 fusions; XBP1(S) activates chaperone genes; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion; Smooth Muscle Contraction; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins,ENSG00000137076
P19971,0,6,19764553.794270832,7.650752061757534e-5,1.228143086535394,0.29647865371244214,0.15872042224023772,0.6638855679885327,raw,19339926.03125,18208499.296875,15331223.734375,18828936.4375,21172698.28125,25706038.984375,Thymidine phosphorylase OS=Homo sapiens OX=9606 GN=TYMP PE=1 SV=2,cell growth;cellular homeostasis;defense response;development;metabolic process,cytosol,antioxidant activity;structural molecule activity,1890,TYMP,Fluoropyrimidine activity; Bladder cancer; Pyrimidine metabolism,Pyrimidine salvage; Pyrimidine catabolism,ENSG00000025708
A0A075B6T4,0.6666666666666666,6,2725125.6041666665,1.0548814079814927e-5,1.2279881489570643,0.2962966376434554,0.16063182776951343,0.6638855679885327,raw,2368861,2839223.5,2066780.125,3447327.25,2537981.5,3090580.25,Kelch repeat and BTB domain-containing protein 4 OS=Homo sapiens OX=9606 GN=KBTBD4 PE=1 SV=1,NA,NA,NA,55709,KBTBD4,NA,NA,ENSG00000123444
O43657,0,6,3104898.09375,1.2018892882464504e-5,1.2279093770396954,0.2962040899264717,0.257597998795955,0.7380182509946936,raw,2719473.4375,2955350.875,2926965.1875,2733473.6875,3700077.375,3594048,Tetraspanin-6 OS=Homo sapiens OX=9606 GN=TSPAN6 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton,NA,7105,TSPAN6,NA,NA,ENSG00000000003
P62701,0,6,250370337.71354166,9.691700593919114e-4,1.2274111398458507,0.2956185823858724,0.303204793996808,0.7831794684063365,raw,223221190.25,246229403.71875,221277244.5625,273984175.5625,217860360.5625,319649651.625,"40S ribosomal protein S4, X isoform OS=Homo sapiens OX=9606 GN=RPS4X PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6191,RPS4X,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000198034
A0A0D9SEJ8,0.3333333333333333,6,1875770.7291666667,7.261007216725663e-6,1.2273850472122232,0.29558791286362207,0.2168073103581252,0.7052519353827845,raw,1514365.75,2095203.5,1487684.125,2095549.75,1825961.25,2235860,"Suppressor of hairy wing homolog 2 (Drosophila), isoform CRA_b OS=Homo sapiens OX=9606 GN=ZNF280B PE=1 SV=1",NA,membrane,NA,140883,ZNF280B,NA,NA,ENSG00000275004; ENSG00000277421
Q03701,0,6,10345775.815104166,4.0047939595192664e-5,1.2273559130587814,0.2955536675404917,0.39887068885379023,0.8828783020957324,raw,11487999.96875,7491377.625,8953965.234375,14963802.0625,9194586.625,9982923.375,CCAAT/enhancer-binding protein zeta OS=Homo sapiens OX=9606 GN=CEBPZ PE=1 SV=3,cellular component movement;metabolic process,membrane,structural molecule activity,10153,CEBPZ,Gastric cancer network 2,NA,ENSG00000115816
P36954,0,6,5684328.572916667,2.2003728999718555e-5,1.2273532238530878,0.29555050651121956,0.268838621471041,0.7488389926768765,raw,5067303.0625,4332421.3125,5609628,8000988.875,4876259.4375,6219370.75,DNA-directed RNA polymerase II subunit RPB9 OS=Homo sapiens OX=9606 GN=POLR2I PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis;coagulation,membrane,RNA binding;structural molecule activity,5438,POLR2I,Pyrimidine metabolism; Eukaryotic transcription initiation,mRNA Splicing - Major Pathway; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,ENSG00000105258
P61163,0,6,50787611.4811198,1.965961019385882e-4,1.2272116757020455,0.29538411383134455,0.36526874275415677,0.8485251827891261,raw,52017481.2734375,46054158.015625,42713981.7929688,63836460.359375,41950163.4609375,58153423.984375,Alpha-centractin OS=Homo sapiens OX=9606 GN=ACTR1A PE=1 SV=1,conjugation,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,10121,ACTR1A,NA,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,ENSG00000138107
Q6ZR64,0,6,1299415.7,5.029968017156482e-6,1.2270620013111033,0.29520814771652165,0.05285816295094699,0.6429522395902524,raw,1105418.375,1302578,1179354.625,1509416.375,1400311.125,NA,HBV PreS1-transactivated protein 1 OS=Homo sapiens OX=9606 GN=MXRA7 PE=1 SV=1,NA,NA,NA,439921,MXRA7,NA,NA,ENSG00000182534
P54920,0,6,11735806.244791666,4.542867233853447e-5,1.2270364852349174,0.295178147358525,0.16754114980781645,0.6670444762382309,raw,9504757.5625,10224706.40625,10081207.4375,11662684.3125,11999410.125,16942071.625,Alpha-soluble NSF attachment protein OS=Homo sapiens OX=9606 GN=NAPA PE=1 SV=3,cell death;cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,8775,NAPA,Synaptic vesicle pathway; VEGFA-VEGFR2 signaling pathway,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Golgi Associated Vesicle Biogenesis; Intra-Golgi traffic; COPII-mediated vesicle transport; Retrograde transport at the Trans-Golgi-Network,ENSG00000105402
P78356,0,6,479980.625,1.8579790844490945e-6,1.2270311244503778,0.2951718443722176,0.15103381553591488,0.6638855679885327,raw,419985.84375,440194.71875,NA,442079.4375,527442.875,570200.25,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta OS=Homo sapiens OX=9606 GN=PIP4K2B PE=1 SV=1,cell growth;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion,signal transducer activity;structural molecule activity,8396,PIP4K2B,Regulation of actin cytoskeleton,"Synthesis of PIPs at the plasma membrane; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; PI5P Regulates TP53 Acetylation; Synthesis of PIPs in the nucleus",ENSG00000276293; ENSG00000277292
Q9P2N5,0,6,2183271.7552083335,8.451327086057999e-6,1.2268961487885588,0.29501313655698047,0.467022923215386,0.9485672170384823,raw,2601203.6875,1651457.625,1369384.15625,3779036.4375,2026167,1672381.625,RNA-binding protein 27 OS=Homo sapiens OX=9606 GN=RBM27 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,structural molecule activity,54439,RBM27,NA,NA,ENSG00000091009
Q8TBA6,0,6,45836121.255208336,1.7742915061300582e-4,1.22676612010333,0.29486022900983605,0.3689506865824422,0.8528660202618379,raw,41229256.5,53675934.0625,29346121.0625,50578655.03125,41441205.1875,58745555.6875,Golgin subfamily A member 5 OS=Homo sapiens OX=9606 GN=GOLGA5 PE=1 SV=3,cell growth;conjugation,cytoskeleton;extracellular,structural molecule activity,9950,GOLGA5,NA,Intra-Golgi traffic,ENSG00000066455
P42704,0,6,483849156.8678387,0.0018729539624412408,1.2266612910600536,0.29473694324211386,0.3067464598254449,0.787259868285476,raw,476519709.1875,421114768.75,434183653.964844,584528281.6875,405945422.617188,580803105,"Leucine-rich PPR motif-containing protein, mitochondrial OS=Homo sapiens OX=9606 GN=LRPPRC PE=1 SV=3",cellular component movement;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;endosome;membrane;nucleus,motor activity;RNA binding;structural molecule activity,10128,LRPPRC,Ciliary landscape,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000138095
Q9P0J0,0,6,11755589.041666666,4.550525047713257e-5,1.2266100514471614,0.29467667829371896,0.3412836640329857,0.8242917664336578,raw,11345698.4375,11088324.34375,8604994.375,13601050.09375,9045754.1875,16847712.8125,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 OS=Homo sapiens OX=9606 GN=NDUFA13 PE=1 SV=3,cell growth;cellular homeostasis;conjugation;development;metabolic process,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,51079,NDUFA13,Nucleotide-binding oligomerization domain (NOD) pathway; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease,Complex I biogenesis,ENSG00000186010
Q9BXP5,0,6,69743921.34895833,2.6997495395533365e-4,1.2265860323876978,0.2946484276551301,0.2391715187056749,0.7257441137499081,raw,65898426.21875,68170521.59375,54845210.375,88117330.0625,60601950.6875,80830089.15625,Serrate RNA effector molecule homolog OS=Homo sapiens OX=9606 GN=SRRT PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,51593,SRRT,NA,RNA polymerase II transcribes snRNA genes; mRNA Splicing - Major Pathway,ENSG00000087087
Q9UBP9,0,6,1495219.0885416667,5.787912362461413e-6,1.2265314154089113,0.29458418642238565,0.8409896442430466,1,raw,1513306.9375,1254037.875,1557712.21875,2155035.75,635103.25,1856118.5,PTB domain-containing engulfment adapter protein 1 OS=Homo sapiens OX=9606 GN=GULP1 PE=1 SV=1,cell growth;conjugation;metabolic process,nucleus,NA,51454,GULP1,NA,NA,ENSG00000144366
P09960,0,6,192060569.08333334,7.43456093262564e-4,1.2264830229641328,0.2945272641809057,0.3742913162277733,0.8601385133507949,raw,197894103.265625,173494187.03125,155649416.90625,230521358.65625,152090590.640625,242713758,Leukotriene A-4 hydrolase OS=Homo sapiens OX=9606 GN=LTA4H PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cell surface;cytosol;membrane;nucleus,structural molecule activity,4048,LTA4H,Eicosanoid synthesis; Eicosanoid metabolism via lipooxygenases (LOX); Prostaglandin and leukotriene metabolism in senescence ; Leukotriene metabolic pathway,Neutrophil degranulation; Biosynthesis of protectins; Synthesis of Leukotrienes (LT) and Eoxins (EX); Biosynthesis of D-series resolvins; Biosynthesis of E-series 18(S)-resolvins; Biosynthesis of aspirin-triggered D-series resolvins; Biosynthesis of E-series 18(R)-resolvins,ENSG00000111144
Q8TEW0,0,6,1496206.1536458333,5.7917332381864095e-6,1.226454198102562,0.29449335749590194,0.5473813350410126,1,raw,1428837.84375,1115626.65625,1539450,1752404.171875,942421.6875,2198496.5625,Partitioning defective 3 homolog OS=Homo sapiens OX=9606 GN=PARD3 PE=1 SV=2,cell communication;cell differentiation;cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,56288,PARD3,Chemokine signaling pathway; Complement system in neuronal development and plasticity,Tight junction interactions; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),ENSG00000148498
Q96J01,0,6,9210341.770833334,3.565273571373047e-5,1.2263018205981315,0.2943141025935866,0.4220327563867389,0.9086347256931654,raw,10853122.75,7196475.75,5887477.5625,12041624.5,5974145.875,13309204.1875,THO complex subunit 3 OS=Homo sapiens OX=9606 GN=THOC3 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;metabolic process,membrane,RNA binding,84321,THOC3,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000051596
Q5U5X0,0,6,3790861.1666666665,1.4674218901475367e-5,1.2261795481719175,0.29417024680301557,0.078343314822045207,0.6429522395902524,raw,3777295.25,3442235.6875,3004087.75,4557310.75,3743438.5625,4220799,Complex III assembly factor LYRM7 OS=Homo sapiens OX=9606 GN=LYRM7 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytoskeleton;endosome,structural molecule activity,90624,LYRM7,Mitochondrial complex III assembly,NA,ENSG00000186687
Q8IY95,0,6,1805289.0677083333,6.988176510638713e-6,1.2261082136701136,0.294086313804917,0.5073278573091783,0.9908542223742782,raw,1806706.8125,1322624.8125,1815039.875,1216078.28125,2215218.0625,2456066.5625,Transmembrane protein 192 OS=Homo sapiens OX=9606 GN=TMEM192 PE=1 SV=1,NA,cytoskeleton;membrane;mitochondrion;nucleus,structural molecule activity,201931,TMEM192,NA,NA,ENSG00000170088
A0A0C4DGG9,0,6,91537996.30208333,3.54338641401722e-4,1.2260027777056968,0.2939622476891301,0.22851964984017775,0.7149130481267827,raw,83346167.25,87300707.2578125,82817532.171875,106711922.46875,82020739.0703125,107030909.59375,DNA helicase OS=Homo sapiens OX=9606 GN=CHD4 PE=1 SV=1,cell growth,membrane,RNA binding;structural molecule activity,NA,CHD4,Rett syndrome causing genes; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,NA,ENSG00000111642
P42677,0,6,83279531.25,3.223705690729178e-4,1.2257157023935967,0.2936243931316979,0.4736363731693593,0.9545409773602596,raw,65611750,102594937,64251863.5,87057180,78754518,101406939,40S ribosomal protein S27 OS=Homo sapiens OX=9606 GN=RPS27 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6232,RPS27,Cytoplasmic ribosomal proteins,"Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000177954
Q969E2,0.3333333333333333,6,2433559.4791666665,9.420177352063948e-6,1.2256403039362744,0.2935356447163531,0.01315337261312081,0.6429522395902524,raw,1986532.625,2184997.5,2318966.25,2678021,2601695.5,2831144,Secretory carrier-associated membrane protein 4 OS=Homo sapiens OX=9606 GN=SCAMP4 PE=1 SV=1,conjugation,cytoskeleton;extracellular;mitochondrion,NA,113178,SCAMP4,NA,NA,ENSG00000227500
Q9H4Z3,0,6,3480321.5989583335,1.3472137001407115e-5,1.2254375711510745,0.29329698923545366,0.3749180666379993,0.8612982611954039,raw,3937086.375,2896236.125,2580767.1875,3549156.5625,3049886.40625,4868796.9375,mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase OS=Homo sapiens OX=9606 GN=PCIF1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,63935,PCIF1,NA,NA,ENSG00000100982
P12956,0,6,613973348.1927085,0.0023766576814454408,1.225249500006931,0.2930755580207416,0.3231376346946622,0.8037523716522456,raw,607703244.328125,543806870.242188,540994793.132813,736440345.546875,510306739.640625,744588096.265625,X-ray repair cross-complementing protein 6 OS=Homo sapiens OX=9606 GN=XRCC6 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cell surface;cytosol;membrane;nucleus,RNA binding;structural molecule activity,2547,XRCC6,"Non-homologous end joining; DNA repair pathways, full network",Neutrophil degranulation; Cytosolic sensors of pathogen-associated DNA ; Nonhomologous End-Joining (NHEJ); 2-LTR circle formation; IRF3-mediated induction of type I IFN,ENSG00000196419
Q0IIM8,0,6,525959.5572916666,2.035961048873633e-6,1.2250778528959942,0.29287343446705144,0.49438459081274466,0.9787246705846804,raw,483145.53125,618534.3125,327286.40625,561615.1875,407423.21875,757752.6875,TBC1 domain family member 8B OS=Homo sapiens OX=9606 GN=TBC1D8B PE=1 SV=2,conjugation;metabolic process,cytosol,DNA binding;structural molecule activity,54885,TBC1D8B,NA,Golgi Associated Vesicle Biogenesis,ENSG00000133138
Q9P2E9,0,6,146794734.28125,5.682344907189222e-4,1.2248585478253267,0.29261514993472987,0.16391819020594792,0.6638855679885327,raw,136649421.3125,137012615.5625,119575589.875,186046140.75,134108426.4375,167376211.75,Ribosome-binding protein 1 OS=Homo sapiens OX=9606 GN=RRBP1 PE=1 SV=5,cell organization and biogenesis;cellular homeostasis;conjugation,extracellular;Golgi,structural molecule activity,6238,RRBP1,Ectoderm differentiation,Signaling by ALK fusions and activated point mutants,ENSG00000125844
Q8N5N7,0,6,5372169.515625,2.0795378142912067e-5,1.2248523699003273,0.2926078732706181,0.35663658626998485,0.8406066251623018,raw,5247645.28125,3658081.71875,5446773.84375,5692374.1875,4480610.0625,7707532,"39S ribosomal protein L50, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL50 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;cytosol;endosome;Golgi,NA,54534,MRPL50,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000136897
P56962,0.5,6,368053.5625,1.4247154686337133e-6,1.2247877789480317,0.29253179267026663,0.33000744820826433,0.812352598433114,raw,267303.09375,342260.46875,357844.46875,358871.96875,327389.5625,554651.8125,Syntaxin-17 OS=Homo sapiens OX=9606 GN=STX17 PE=1 SV=2,cell growth;cellular homeostasis;conjugation,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,55014,STX17,NA,COPII-mediated vesicle transport,ENSG00000136874
Q14CX7,0,6,11325177.348958334,4.383915005327815e-5,1.224744438611493,0.29248074056476403,0.13717000723667103,0.654928512316515,raw,11783152.25,10356545.5625,6894395.3125,12222181.5625,12263439.21875,14431350.1875,"N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;nucleus,NA,80018,NAA25,NA,NA,ENSG00000111300
P54105,0,6,4218826.296875,1.633084881398614e-5,1.2246193778366778,0.2923334169547877,0.5185336538350482,1,raw,3872613.1875,4854741.640625,2978926.328125,3915674.1875,3745791.75,5945210.6875,Methylosome subunit pICln OS=Homo sapiens OX=9606 GN=CLNS1A PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,NA,1207,CLNS1A,NA,snRNP Assembly,ENSG00000074201
O75152,0,6,6892546.424479167,2.6680675069491988e-5,1.2246032675261105,0.29231443765520704,0.2851651138313615,0.7655402884628064,raw,5913445.34375,7774260.96875,5367324.171875,7936985.4375,6572842.71875,7790419.90625,Zinc finger CCCH domain-containing protein 11A OS=Homo sapiens OX=9606 GN=ZC3H11A PE=1 SV=3,cellular homeostasis;conjugation,membrane,RNA binding;structural molecule activity,9877,ZC3H11A,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000058673
P12955,0,6,23002064.651041668,8.903975034571715e-5,1.2244937208708662,0.29218537586866195,0.36705614809184584,0.8512758464128771,raw,21392108.625,18750406.4375,21861382.71875,31856217.75,17957769.6875,26194502.6875,Xaa-Pro dipeptidase OS=Homo sapiens OX=9606 GN=PEPD PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,5184,PEPD,NA,NA,ENSG00000124299
Q7L5Y1,0,6,1384886.2109375,5.3608197503051956e-6,1.2241658984512558,0.2917990847090759,0.6554671420102005,1,raw,1112189.40625,1648386.046875,1111878,1361504.34375,962512.375,2112847.09375,Mitochondrial enolase superfamily member 1 OS=Homo sapiens OX=9606 GN=ENOSF1 PE=1 SV=1,cellular homeostasis,endosome,structural molecule activity,55556,ENOSF1,NA,NA,ENSG00000132199
Q9BTE6,0,6,10227937.606770834,3.959179425300873e-5,1.224037442924027,0.2916476902973898,0.18404415608484165,0.6762664172804989,raw,9544859.84375,9532415.25,8786646.234375,11668033.1875,9307571.8125,12528099.3125,Alanyl-tRNA editing protein Aarsd1 OS=Homo sapiens OX=9606 GN=AARSD1 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,nucleus,RNA binding;structural molecule activity,100885850; 80755,AARSD1,NA,NA,ENSG00000108825; ENSG00000266967
Q9BVC5,0,6,5873871.96875,2.2737441251236602e-5,1.2239664513016195,0.29156401456316217,0.10441924950997425,0.6429522395902524,raw,5394672.78125,4909388.5,5650085.03125,7068967.5,5617219.5,6602898.5,Ashwin OS=Homo sapiens OX=9606 GN=C2orf49 PE=1 SV=1,cellular component movement;cellular homeostasis;defense response,membrane;nucleus,NA,79074,C2orf49,NA,tRNA processing in the nucleus,ENSG00000135974
Q92616,0,6,220961012.3033855,8.553281485859754e-4,1.2239587823673963,0.2915549751258292,0.34970511618082956,0.8335032414377542,raw,212070307,217718404.023438,184986506.328125,259991079.0625,184521424.71875,266478352.6875,eIF-2-alpha kinase activator GCN1 OS=Homo sapiens OX=9606 GN=GCN1 PE=1 SV=6,NA,NA,NA,NA,NA,NA,NA,NA
A0A1W2PRS1,0,6,14299436.864583334,5.5352348053207716e-5,1.2238963665799187,0.29148140300525227,0.2828859164618605,0.7642736213388397,raw,16144028.75,12066435.5,10206582,17348139.8125,12491798.625,17539636.5,Lysosome membrane protein 2 (Fragment) OS=Homo sapiens OX=9606 GN=SCARB2 PE=1 SV=1,conjugation,cytoskeleton;mitochondrion,structural molecule activity,NA,SCARB2,Primary focal segmental glomerulosclerosis (FSGS),NA,ENSG00000138760
P51991,0,6,227080817.22395834,8.790175830154025e-4,1.2236981017918747,0.2912476750484229,0.10838802402162379,0.6429522395902524,raw,199673892.1875,233046015.65625,183489051.96875,245107380.0625,224535204.59375,276633358.875,Heterogeneous nuclear ribonucleoprotein A3 OS=Homo sapiens OX=9606 GN=HNRNPA3 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,220988,HNRNPA3,NA,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000170144
O76054,0.5,6,5512210.25,2.1337468264653214e-5,1.2234625898536666,0.2909699884154757,0.46673567275510797,0.9485672170384823,raw,6171801.8125,3089539,4727843.375,9775558.875,3524178.9375,5784339.5,SEC14-like protein 2 OS=Homo sapiens OX=9606 GN=SEC14L2 PE=1 SV=1,metabolic process,cytosol;membrane;nucleus,structural molecule activity,23541,SEC14L2,NA,NA,ENSG00000100003
P23528,0,6,522273630.5690105,0.002021693025539343,1.2233394954562804,0.2908248294114955,0.2803528416788816,0.7618988051018912,raw,459997909.101563,495296157.734375,442151619.671875,562733610.03125,453300979.015625,720161507.859375,Cofilin-1 OS=Homo sapiens OX=9606 GN=CFL1 PE=1 SV=3,cell differentiation;cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity,1072,CFL1,Brain-derived neurotrophic factor (BDNF) signaling pathway; VEGFA-VEGFR2 signaling pathway; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; 7q11.23 copy number variation syndrome; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Regulation of actin cytoskeleton; G13 signaling pathway,Platelet degranulation ; Regulation of actin dynamics for phagocytic cup formation; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; EPHB-mediated forward signaling; Sema3A PAK dependent Axon repulsion; RHO GTPases Activate ROCKs,ENSG00000172757
Q9Y2H6,0,6,2564336.7265625,9.926409015859301e-6,1.2233350225004946,0.2908195544057006,0.29694858984973216,0.7790952437047332,raw,1693049.578125,3112632.96875,1699261.1875,3184233.40625,2071166.84375,3625676.375,Fibronectin type-III domain-containing protein 3A OS=Homo sapiens OX=9606 GN=FNDC3A PE=1 SV=4,cell communication;defense response;metabolic process,cytoskeleton;cytosol;extracellular;nucleus,NA,22862,FNDC3A,NA,NA,ENSG00000102531
Q9NVI7,0,6,21994208.864583332,8.513839501209179e-5,1.2230672198546773,0.29050369665842435,0.16090036346042055,0.6638855679885327,raw,21036229.4375,19866467.5625,16898052.75,24298025.25,20413664.8125,29452813.375,ATPase family AAA domain-containing protein 3A OS=Homo sapiens OX=9606 GN=ATAD3A PE=1 SV=2,cell growth;coagulation;metabolic process,cytoskeleton;endosome,structural molecule activity,55210,ATAD3A,NA,NA,ENSG00000197785
P57088,0,6,9343275.713541666,3.6167315828637055e-5,1.2230093752082802,0.2904354631577376,0.1958304680741862,0.6857975396967068,raw,8316808.5625,10128303.96875,6940134.09375,10150217.3125,10352655.5,10171534.84375,Transmembrane protein 33 OS=Homo sapiens OX=9606 GN=TMEM33 PE=1 SV=2,cell growth;coagulation;metabolic process,cytoskeleton;extracellular;membrane;nucleus,NA,55161,TMEM33,NA,NA,ENSG00000109133
P31150,0,6,74058040.64583333,2.8667467682729744e-4,1.2227243563118961,0.29009920795142874,0.20871045613114575,0.6988382857167694,raw,73416520.125,68063027.375,59140252.1875,88687928.125,65272348.75,89768167.3125,Rab GDP dissociation inhibitor alpha OS=Homo sapiens OX=9606 GN=GDI1 PE=1 SV=2,cell growth;conjugation;development;metabolic process,cytosol;extracellular;nucleus,DNA binding;structural molecule activity,2664,GDI1,Ciliary landscape; Airway smooth muscle cell contraction,RAB GEFs exchange GTP for GDP on RABs,ENSG00000203879
O60341,0,6,12581707.083333334,4.8703108812982514e-5,1.222631886824137,0.2899900988824645,0.3767460011982827,0.8615698665976935,raw,12698612.75,11892147,9460402.75,14539718.125,9798600.375,17100761.5,Lysine-specific histone demethylase 1A OS=Homo sapiens OX=9606 GN=KDM1A PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,23028,KDM1A,Androgen receptor signaling pathway; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome; Thermogenesis; Vitamin D-sensitive calcium signaling in depression; Thyroid hormones production and peripheral downstream signaling effects; Neurogenesis regulation in the olfactory epithelium,Estrogen-dependent gene expression; Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; Factors involved in megakaryocyte development and platelet production; HDMs demethylate histones; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,ENSG00000004487
A0A1W2PPZ5,0,6,42774449.703125,1.6557758533946248e-4,1.2225984822312947,0.2899506812136433,0.14082717829470986,0.6572502130392559,raw,42743242.78125,35076402.625,36518985.75,50875147.5,39175095.8125,52257823.75,Transcription elongation factor A protein 1 OS=Homo sapiens OX=9606 GN=TCEA1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,NA,TCEA1,NA,NA,ENSG00000187735
P36543,0,6,13031648.921875,5.0444809376893795e-5,1.2224901960186125,0.28982289526990634,0.3160590087488634,0.7963816411712802,raw,11861778.5625,14942459.5,8486329.375,14500908,12438933.21875,15959484.875,V-type proton ATPase subunit E 1 OS=Homo sapiens OX=9606 GN=ATP6V1E1 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,catalytic activity;structural molecule activity,529,ATP6V1E1,VEGFA-VEGFR2 signaling pathway; Proximal tubule transport,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000131100
C9JNZ1,0,6,1404298.9895833333,5.435965568316075e-6,1.2223988051463748,0.289715038301219,0.5003805675727181,0.9847098756556558,raw,1282953.25,1494576.375,1097484.375,1738824.375,984987.1875,1826968.375,UTP--glucose-1-phosphate uridylyltransferase (Fragment) OS=Homo sapiens OX=9606 GN=UGP2 PE=1 SV=8,cellular homeostasis,NA,structural molecule activity,NA,UGP2,Glucuronidation,NA,ENSG00000169764
Q96A29,0.16666666666666666,6,447042.4166666667,1.7304770583776043e-6,1.2223067914803196,0.2896064381818773,1,1,raw,410304.21875,NA,422161.8125,508661.21875,NA,NA,GDP-fucose transporter 1 OS=Homo sapiens OX=9606 GN=SLC35C1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;extracellular,catalytic activity,55343,SLC35C1,NA,GDP-fucose biosynthesis; Transport of nucleotide sugars; Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C),ENSG00000181830
P24752,0,6,91363399.21875,3.53662785518916e-4,1.2220152875787784,0.28926233358228304,0.3229462590568095,0.8037523716522456,raw,99732822.9375,64717695.9375,83788312.0625,118460763.8125,79086013.8125,102394786.75,"Acetyl-CoA acetyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=ACAT1 PE=1 SV=1",cellular homeostasis;coagulation;defense response;metabolic process,endosome,structural molecule activity,38,ACAT1,Fatty acid beta-oxidation; Tryptophan metabolism; SARS-CoV-2 and COVID-19 pathway,Branched-chain amino acid catabolism; Utilization of Ketone Bodies; Synthesis of Ketone Bodies,ENSG00000075239
Q8WW22,0,6,734237.6979166666,2.842194485961218e-6,1.2217234248529645,0.2889177231646372,0.22297026108769932,0.7114915236088185,raw,664963.125,730562.75,595352.875,881474.25,640527.5625,892545.625,DnaJ homolog subfamily A member 4 OS=Homo sapiens OX=9606 GN=DNAJA4 PE=1 SV=1,coagulation;metabolic process,cytoskeleton;cytosol;nucleus,structural molecule activity,55466,DNAJA4,NA,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,ENSG00000140403
Q00796,0,6,76223596.921875,2.950574282499885e-4,1.2217024681071225,0.28889297578564993,0.23679562100925833,0.7210473708268809,raw,77561976.09375,62461133.328125,68707872.890625,86112255.34375,67740686.25,94757657.625,Sorbitol dehydrogenase OS=Homo sapiens OX=9606 GN=SORD PE=1 SV=4,cellular homeostasis;coagulation;metabolic process,cell surface;cytoskeleton;cytosol;endoplasmic reticulum;endosome,structural molecule activity,6652,SORD,Disorders of fructose metabolism; Polyol pathway,Formation of xylulose-5-phosphate; Fructose biosynthesis,ENSG00000140263
Q8N9N5,0.16666666666666666,6,198613.60546875,7.688225433015381e-7,1.2215583484996575,0.2887227764832975,0.376414190608093,0.8615698665976935,raw,153212.984375,206095.21875,NA,NA,237065.8125,198080.40625,Protein BANP OS=Homo sapiens OX=9606 GN=BANP PE=1 SV=3,cell differentiation;cell growth;metabolic process,membrane,RNA binding;structural molecule activity,54971,BANP,NA,Regulation of TP53 Activity through Association with Co-factors,ENSG00000172530
P04406,0,6,3507996352.136638,0.0135792644767559,1.221484158512864,0.28863515334472645,0.22411924408311312,0.7125799511687476,raw,3285262206.89063,3538281405.96436,2756854199.21094,4014003498.9375,3131622116.07031,4321954685.74609,Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens OX=9606 GN=GAPDH PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;motor activity;structural molecule activity,2597,GAPDH,Cori cycle; Alzheimer's disease and miRNA effects; HIF1A and PPARG regulation of glycolysis; VEGFA-VEGFR2 signaling pathway; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; 7q11.23 copy number variation syndrome; Glycolysis in senescence; Alzheimer's disease; Glycolysis and gluconeogenesis; Sudden infant death syndrome (SIDS) susceptibility pathways,Glycolysis; Gluconeogenesis,ENSG00000111640
Q96T76,0,6,13012118.109375,5.036920665620627e-5,1.2212631652000967,0.28837411451015377,0.27414594032073564,0.7551026273759062,raw,15561683.4375,8493440.9375,8432885.5,18563045.0625,10298772.4375,16722881.28125,MMS19 nucleotide excision repair protein homolog OS=Homo sapiens OX=9606 GN=MMS19 PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,64210,MMS19,2q11.2 copy number variation syndrome,Cytosolic iron-sulfur cluster assembly,ENSG00000155229
Q14697,0,6,318526492.4010417,0.0012329988543268156,1.2212050280540527,0.28830543466200953,0.279708410272471,0.7610269319214358,raw,325328328.140625,286676414.890625,250388120.953125,385480302.375,265993197.953125,397292590.09375,Neutral alpha-glucosidase AB OS=Homo sapiens OX=9606 GN=GANAB PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,extracellular;nucleus,structural molecule activity,23193,GANAB,NA,Maturation of spike protein; Calnexin/calreticulin cycle; Maturation of spike protein,ENSG00000089597
Q04446,0,6,12446444.513020834,4.817951470634654e-5,1.2210413394044828,0.2881120448332972,0.48134689234065664,0.9622845920836873,raw,11296947.78125,11662679.859375,10043573.25,19763856.3125,8117569.625,13794040.25,"1,4-alpha-glucan-branching enzyme OS=Homo sapiens OX=9606 GN=GBE1 PE=1 SV=3",cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,2632,GBE1,Glycogen synthesis and degradation; Disorders of galactose metabolism,Glycogen synthesis; Glycogen storage disease type IV (GBE1),ENSG00000114480
A0A0G2JJL1,0.16666666666666666,6,1311473.25,5.076642142199966e-6,1.220877814952292,0.2879188231075318,1,1,raw,NA,1306508.625,1140816.5,1487094.625,NA,NA,WD repeat-containing protein 46 (Fragment) OS=Homo sapiens OX=9606 GN=WDR46 PE=1 SV=1,NA,NA,NA,NA,WDR46,NA,NA,ENSG00000204221; ENSG00000226916; ENSG00000236222
Q9H936,0,6,20169481.213541668,7.807497279489013e-5,1.220725656983412,0.28773900885845943,0.25071412416294553,0.7326612824296702,raw,18188517.9375,20020072.125,15723520.5625,20021710.75,19194104.96875,27868960.9375,Mitochondrial glutamate carrier 1 OS=Homo sapiens OX=9606 GN=SLC25A22 PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity,79751,SLC25A22,NA,Organic anion transporters,ENSG00000177542
P83876,0,6,4867930.041666667,1.8843494363919537e-5,1.2204539609611957,0.2874178735330473,0.5659891054366516,1,raw,3948431.625,5181255,4357986.9375,6292449.375,3103974.125,6323483.1875,Thioredoxin-like protein 4A OS=Homo sapiens OX=9606 GN=TXNL4A PE=1 SV=1,cell differentiation;cell growth;cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;cytosol;membrane,NA,10907,TXNL4A,mRNA processing,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000141759
P46926,0,6,37602526.361979164,1.455573493263462e-4,1.2204138244849667,0.28737042754226905,0.4607718241867594,0.9425587783849652,raw,39141751.125,32550316.5625,31618917.140625,47769134.1875,27001460.90625,47533578.25,Glucosamine-6-phosphate isomerase 1 OS=Homo sapiens OX=9606 GN=GNPDA1 PE=1 SV=1,cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,10007,GNPDA1,NA,Glycolysis,ENSG00000113552
A0A024R161,0,6,824936.25,3.193283684115102e-6,1.2203044697062229,0.28724114953630475,0.3017986446230483,0.7822150763466589,raw,NA,808710.1875,676376.4375,NA,813115.75,1001542.625,Guanine nucleotide-binding protein subunit gamma OS=Homo sapiens OX=9606 GN=DNAJC25-GNG10 PE=3 SV=1,development,cytoplasm;cytoskeleton,structural molecule activity,552891,DNAJC25-GNG10,NA,NA,ENSG00000244115
O95479,0,6,4517134.5234375,1.7485583852868653e-5,1.2203032177459137,0.28723966941564566,0.42228074648412944,0.9086347256931654,raw,4001724.0625,3857347.515625,4003559,7119003.296875,3237856.515625,4883316.75,GDH/6PGL endoplasmic bifunctional protein OS=Homo sapiens OX=9606 GN=H6PD PE=1 SV=2,cellular homeostasis;metabolic process,endosome;extracellular,structural molecule activity,9563,H6PD,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism,NA,ENSG00000049239
Q9NQT4,0,6,8436703.703125,3.265802452359504e-5,1.2202946033089377,0.2872294850211517,0.4463112403861346,0.9277715124769401,raw,8113561.875,8510501.40625,6989545.25,9964594.25,6656700.5,10385318.9375,Exosome complex component RRP46 OS=Homo sapiens OX=9606 GN=EXOSC5 PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis;coagulation,cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,56915,EXOSC5,NA,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000077348
P62753,0,6,154394564.05989584,5.976530214650276e-4,1.2197179434082897,0.2865475668928594,0.2740408601101719,0.7551026273759062,raw,121183358.25,172864769.609375,125174960.75,158676738.25,147809516.5,200658041,40S ribosomal protein S6 OS=Homo sapiens OX=9606 GN=RPS6 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,6194,RPS6,IL-5 signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Kit receptor signaling pathway; MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Thermogenesis; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Cytoplasmic ribosomal proteins; EGFR tyrosine kinase inhibitor resistance; IL-2 signaling pathway; Malignant pleural mesothelioma; 2q37 copy number variation syndrome; Interferon type I signaling pathways,"SARS-CoV-2 modulates host translation machinery; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Nuclear events stimulated by ALK signaling in cancer; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000137154
P17174,0,6,208297318.25,8.063076726385292e-4,1.219680094619936,0.28650279825861874,0.22173488587921933,0.7104176293723399,raw,212592407.75,169447503.25,181843278.125,259294728,182713729.375,243892263,"Aspartate aminotransferase, cytoplasmic OS=Homo sapiens OX=9606 GN=GOT1 PE=1 SV=3",cellular homeostasis;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,2805,GOT1,Alanine and aspartate metabolism; Trans-sulfuration pathway; Amino acid metabolism; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; TCA cycle in senescence; Neuroinflammation and glutamatergic signaling; Glycolysis and gluconeogenesis,Gluconeogenesis; Aspartate and asparagine metabolism; Methionine salvage pathway,ENSG00000120053
Q15020,0.5,6,2192825.125,8.48830766471974e-6,1.2196749771475812,0.2864967450586779,0.19314544304005596,0.6839501208924997,raw,1930081.75,1758110.625,1847862.375,2107160,2253791.5,3259944.5,Squamous cell carcinoma antigen recognized by T-cells 3 OS=Homo sapiens OX=9606 GN=SART3 PE=1 SV=1,cell differentiation;cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,9733,SART3,NA,NA,ENSG00000075856
P57740,0,6,20595187.015625,7.972285697021378e-5,1.2196721310288579,0.28649337851739787,0.3027862728898629,0.7825518083423609,raw,20184220.21875,19855881.6875,16411632.96875,24217665.53125,17306546.875,25595174.8125,Nuclear pore complex protein Nup107 OS=Homo sapiens OX=9606 GN=NUP107 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,57122,NUP107,Gastric cancer network 1,SUMOylation of ubiquitinylation proteins; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000111581
Q16643,0,6,83252609.53157552,3.222663565544435e-4,1.2193205930159243,0.28607750015379696,0.43620356584707987,0.9194550812820881,raw,80190078.828125,79593586.046875,75802531.65625,97777414.4707031,68426660.1875,97725386,Drebrin OS=Homo sapiens OX=9606 GN=DBN1 PE=1 SV=4,cell differentiation;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,1627,DBN1,NA,RHOD GTPase cycle; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle; RHOH GTPase cycle,ENSG00000113758
Q15257,0,6,14961701.330729166,5.791593804493457e-5,1.219181021868143,0.28591235070157084,0.3001105078273562,0.7806964943416801,raw,16937418.125,12289773.375,10012182.78125,18053170.21875,12206663.234375,20271000.25,Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens OX=9606 GN=PTPA PE=1 SV=3,cell differentiation;cell growth;metabolic process,cytoskeleton;membrane;nucleus,antioxidant activity;DNA binding;structural molecule activity,5524,PTPA,Interleukin-11 signaling pathway; Constitutive androstane receptor pathway; Nuclear receptors meta-pathway; ATM signaling in development and disease ; Wnt signaling pathway and pluripotency; Netrin-UNC5B signaling pathway; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome,NA,ENSG00000119383
P27816,0,6,199970334.59863284,7.740743685113267e-4,1.2191621416682683,0.28589000899746786,0.18313572448430335,0.6755855526242318,raw,178828067.4375,183271804.8125,171831601.390625,218020409.6875,185702484.982422,262167639.28125,Microtubule-associated protein 4 OS=Homo sapiens OX=9606 GN=MAP4 PE=1 SV=3,cell differentiation;cell growth;defense response;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,4134,MAP4,Splicing factor NOVA regulated synaptic proteins; 2q37 copy number variation syndrome,NA,ENSG00000047849
Q8IWR0,0,6,279847.6770833333,1.0832752485634134e-6,1.2189457312825855,0.28563389712111886,0.18890809216176302,0.6799727501026726,raw,225732.328125,303929.46875,216218.890625,309001.09375,263559.09375,360645.1875,Zinc finger CCCH domain-containing protein 7A OS=Homo sapiens OX=9606 GN=ZC3H7A PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,29066,ZC3H7A,NA,NA,ENSG00000122299
Q9NRX4,0,6,20275881.760416668,7.84868435671066e-5,1.2187614709780015,0.28541579756599933,0.6291382365964305,1,raw,21367302.3125,17989522.9375,17750143.625,28794514.75,13828869.5,21924937.4375,14 kDa phosphohistidine phosphatase OS=Homo sapiens OX=9606 GN=PHPT1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane,structural molecule activity,29085,PHPT1,NA,NA,ENSG00000054148
A0A0C4DG89,0,6,1587271.5,6.144242277158877e-6,1.2185676102066823,0.28518629882809476,0.3287151842116807,0.8108690995151774,raw,1834988.875,1256134.5,1141335.625,1706502.875,1390794.625,2193872.5,RNA helicase OS=Homo sapiens OX=9606 GN=DDX46 PE=1 SV=1,NA,membrane,RNA binding;structural molecule activity,9879,DDX46,NA,NA,ENSG00000145833
O43264,0,6,10792065.341145834,4.1775502254610676e-5,1.2184429520910172,0.285038705175268,0.3921535338569511,0.8763519738235003,raw,10794706.8125,11668543.09375,6816436.296875,14217454.09375,8915814.34375,12339437.40625,Centromere/kinetochore protein zw10 homolog OS=Homo sapiens OX=9606 GN=ZW10 PE=1 SV=3,cell differentiation;cell growth;conjugation;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,RNA binding,9183,ZW10,NA,COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000086827
Q9Y446,0,6,29179492.244791668,1.1295223903187234e-4,1.218367289589336,0.28494911435352527,0.23496733021370664,0.7192904383575112,raw,30121017.4375,22813737.875,26266537.84375,36698462.375,25762554.125,33414643.8125,Plakophilin-3 OS=Homo sapiens OX=9606 GN=PKP3 PE=1 SV=1,cell communication;cell growth;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,11187,PKP3,NA,Formation of the cornified envelope,ENSG00000184363
Q96I25,0,6,18995475.260416668,7.353045913681283e-5,1.218028061610604,0.2845473712410465,0.49013890607134397,0.9737904765793668,raw,17645387.75,19642372.5625,15961701,24538604.6875,14692208.125,21492577.4375,Splicing factor 45 OS=Homo sapiens OX=9606 GN=RBM17 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding,84991,RBM17,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000134453
P0DPB6,0,6,7758255.942708333,3.0031789873507866e-5,1.2179254411444516,0.2844258171657884,0.4398868749538815,0.9233600879723239,raw,5604937.125,7764208.5,8006950.875,9776549.125,5940662.96875,9456227.0625,DNA-directed RNA polymerases I and III subunit RPAC2 OS=Homo sapiens OX=9606 GN=POLR1D PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,51082,POLR1D,Pyrimidine metabolism; Eukaryotic transcription initiation; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,NA,ENSG00000186184
P14621,0,6,1916230.19375,7.417623619656181e-6,1.2177542012188398,0.28422296044555934,0.6810862465132819,1,raw,386383.625,3080365.4375,1779766.25,2662893.53125,1671742.125,NA,Acylphosphatase-2 OS=Homo sapiens OX=9606 GN=ACYP2 PE=1 SV=2,cellular homeostasis,NA,structural molecule activity,98,ACYP2,NA,NA,ENSG00000170634
H0YF29,0,6,2649569.9505208335,1.0256342223923165e-5,1.2173423332624713,0.28373493062382027,0.34012792652553625,0.8240393274854595,raw,2912131,1906876.125,2200392.546875,3881610.875,2321321.03125,2675088.125,UPF0598 protein C8orf82 (Fragment) OS=Homo sapiens OX=9606 GN=C8orf82 PE=1 SV=1,NA,NA,NA,NA,C8orf82,NA,NA,ENSG00000213563
E7ERS3,0,6,2658216.1197916665,1.0289811078349976e-5,1.2172521859631964,0.283628091426865,0.3969325009015799,0.8797859861327824,raw,1622025.25,2662893.25,2748738.125,3832435.6875,1974413.78125,3108790.625,Zinc finger CCCH domain-containing protein 18 OS=Homo sapiens OX=9606 GN=ZC3H18 PE=1 SV=1,NA,membrane,NA,124245,ZC3H18,NA,NA,ENSG00000158545
P53999,0,6,79504586.984375,3.077579636359956e-4,1.2170666919724116,0.28340822601517757,0.25086693175822483,0.7326612824296702,raw,64086238.59375,89544556.375,64351959.21875,85728519.6875,77997226.40625,95319021.625,Activated RNA polymerase II transcriptional coactivator p15 OS=Homo sapiens OX=9606 GN=SUB1 PE=1 SV=3,cellular component movement;cellular homeostasis;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,10923,SUB1,NA,NA,ENSG00000113387
Q7L0Y3,0,6,46008288.328125,1.7809560005668907e-4,1.2169978009539655,0.2833265611858443,0.5519580220611487,1,raw,44294363.875,44514870.75,42879481.3125,54174499.8125,36213884.34375,53972629.875,tRNA methyltransferase 10 homolog C OS=Homo sapiens OX=9606 GN=TRMT10C PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,endosome;membrane;nucleus,RNA binding;structural molecule activity,54931,TRMT10C,NA,tRNA processing in the mitochondrion; tRNA modification in the mitochondrion; rRNA processing in the mitochondrion,ENSG00000174173
Q9NNW5,0,6,256581.54947916666,9.932133247833328e-7,1.2168546581942061,0.2831568620332881,0.30961472934584816,0.7910829974230433,raw,178148.265625,209790.9375,218370.84375,244287.609375,216780.546875,472111.09375,WD repeat-containing protein 6 OS=Homo sapiens OX=9606 GN=WDR6 PE=1 SV=1,cell differentiation;cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,NA,11180,WDR6,NA,RND2 GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle,ENSG00000178252
P30740,0,6,53535608.12890625,2.072334485934109e-4,1.2165797955731206,0.28283094987120927,0.23950409239196804,0.7258167404748,raw,56033287,42832074.7109375,44246821.875,68168964.84375,45606055.40625,64326444.9375,Leukocyte elastase inhibitor OS=Homo sapiens OX=9606 GN=SERPINB1 PE=1 SV=1,cell differentiation;metabolic process,cell surface;mitochondrion;nucleus,DNA binding,1992,SERPINB1,Vitamin D receptor pathway,Neutrophil degranulation,ENSG00000021355
P61224,0,6,44265708.276041664,1.713501667597741e-4,1.2165759762482191,0.2828264206740582,0.43596083965022564,0.919218088383844,raw,39770655.5,38118450,39558381.21875,68324173.75,31696812.9375,48125776.25,Ras-related protein Rap-1b OS=Homo sapiens OX=9606 GN=RAP1B PE=1 SV=1,cell differentiation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,5908,RAP1B,Integrin-mediated cell adhesion; Thyroid stimulating hormone (TSH) signaling pathway; Corticotropin-releasing hormone signaling pathway; Common pathways underlying drug addiction; Focal adhesion; Hepatocyte growth factor receptor signaling; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Ras signaling,Neutrophil degranulation; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Signaling by BRAF and RAF1 fusions; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Rap1 signalling; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins; MET activates RAP1 and RAC1,ENSG00000127314
Q13045,0,6,31664641.138020832,1.2257211622037677e-4,1.2165248566991647,0.2827657985091849,0.11119287159281037,0.6429522395902524,raw,29494465.96875,31300386,24744921.84375,36995586.203125,30102812.5,37349674.3125,Protein flightless-1 homolog OS=Homo sapiens OX=9606 GN=FLII PE=1 SV=2,cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,2314,FLII,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000177731; ENSG00000284571
Q9BR76,0,6,62181938.721354164,2.4070292748748205e-4,1.2164747908347153,0.28270642342917424,0.12993564432367927,0.6498046150645307,raw,53102664.703125,55298874.8125,52083302.0625,84922441.875,63086295.9375,64598052.9375,Coronin-1B OS=Homo sapiens OX=9606 GN=CORO1B PE=1 SV=1,cell growth;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,57175,CORO1B,NA,NA,ENSG00000172725
Q9Y2V7,0,6,2399893.755859375,9.289859154807968e-6,1.2159667983863653,0.282103836958078,0.8559590909304164,1,raw,2790035.53125,1394766.546875,2808221.80078125,2213894.125,1695989.8125,3496454.71875,Conserved oligomeric Golgi complex subunit 6 OS=Homo sapiens OX=9606 GN=COG6 PE=1 SV=2,cell growth;cellular homeostasis;conjugation,cytoskeleton;extracellular,NA,57511,COG6,NA,COPI-mediated anterograde transport; Intra-Golgi traffic; Retrograde transport at the Trans-Golgi-Network,ENSG00000133103
Q15181,0,6,177425439.08854166,6.868042952269317e-4,1.2158381077316094,0.28195114266164706,0.31166093583881105,0.7920633653972666,raw,168920670.34375,174022673.28125,149693104.78125,205380188.1875,151642977.375,214893020.5625,Inorganic pyrophosphatase OS=Homo sapiens OX=9606 GN=PPA1 PE=1 SV=2,cellular homeostasis,cytosol;nucleus,structural molecule activity,5464,PPA1,NA,Cytosolic tRNA aminoacylation; Pyrophosphate hydrolysis,ENSG00000180817
H3BMU8,0.3333333333333333,6,525445.64375,2.0339717173008603e-6,1.2158089904306326,0.2819165921006245,0.3872743017784674,0.872635004486454,raw,364729.78125,455799.1875,NA,492658.75,370215.5625,943824.9375,Phospholipase A2 group XV (Fragment) OS=Homo sapiens OX=9606 GN=PLA2G15 PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,NA,PLA2G15,NA,NA,ENSG00000103066
A0A5F9ZHY7,0,6,7877965.1875,3.049517789680175e-5,1.2157565161064465,0.2818543240292231,0.5089884893590564,0.9922392352661351,raw,7258066.75,9160819.5,5273485.5,7999568,6438525.375,11137326,BRI3-binding protein OS=Homo sapiens OX=9606 GN=BRI3BP PE=1 SV=1,NA,cytoskeleton;endosome,NA,NA,BRI3BP,NA,NA,ENSG00000184992
E9PG82,0.6666666666666666,6,2319259.6041666665,8.977728707173029e-6,1.2157543120331182,0.2818517085313823,0.02910787222710236,0.6429522395902524,raw,1991404,2298026,2055430.625,2555645.75,2593993.25,2421058,Sorcin OS=Homo sapiens OX=9606 GN=SRI PE=1 SV=1,NA,NA,NA,NA,SRI,NA,NA,ENSG00000075142
P33240,0,6,26589532.7578125,1.0292664569385416e-4,1.2157133729755245,0.2818031267009604,0.5612031695556432,1,raw,23292630.25,27946014.5625,24055386.953125,33974343.625,19891811.59375,30377009.5625,Cleavage stimulation factor subunit 2 OS=Homo sapiens OX=9606 GN=CSTF2 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,1478,CSTF2,mRNA processing,tRNA processing in the nucleus; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs,ENSG00000101811
Q9UKY7,0,6,30787620.354166668,1.1917721611783995e-4,1.2155120304494127,0.2815641724154413,0.16874902916980808,0.668039680404208,raw,24239088.25,33020033.78125,26232255.28125,34470861,29462903.375,37300580.4375,Protein CDV3 homolog OS=Homo sapiens OX=9606 GN=CDV3 PE=1 SV=1,NA,cytoplasm;cytoskeleton;cytosol;nucleus,NA,55573,CDV3,NA,NA,ENSG00000091527
Q8N8N7,0,6,7298563.98828125,2.8252347137428577e-5,1.2154777898439013,0.28152353156095544,0.44820398151189805,0.9287898029210243,raw,6206368.1875,6100063.6484375,7974551,9847839.9375,6118858.46875,7543702.6875,Prostaglandin reductase 2 OS=Homo sapiens OX=9606 GN=PTGR2 PE=1 SV=1,cellular homeostasis,nucleus,structural molecule activity,145482,PTGR2,Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX),Synthesis of Prostaglandins (PG) and Thromboxanes (TX),ENSG00000140043
Q15035,0,6,389245.9947916667,1.5067502298212515e-6,1.215435655500394,0.28147351990089275,0.20218473330794254,0.6923632419251884,raw,395051.25,393901.5,216235.90625,460026.125,390101.8125,480159.375,Translocating chain-associated membrane protein 2 OS=Homo sapiens OX=9606 GN=TRAM2 PE=1 SV=1,cell growth;cellular homeostasis;conjugation,NA,NA,9697,TRAM2,NA,NA,ENSG00000065308
A1L0T0,0,6,6400487.86328125,2.4775942946127958e-5,1.2153481076030987,0.281369598754767,0.3913229219209071,0.8763288281216618,raw,7095416.78125,5856551.5625,4361757.8046875,6916361.75,5301054.09375,8871785.1875,2-hydroxyacyl-CoA lyase 2 OS=Homo sapiens OX=9606 GN=ILVBL PE=1 SV=2,cellular homeostasis,cytoskeleton;extracellular;nucleus,structural molecule activity,10994,ILVBL,NA,NA,ENSG00000105135
P62495,0,6,67194889.8359375,2.60107790594741e-4,1.2150488262313213,0.2810142890956201,0.41305995681195695,0.8994253071939371,raw,58838391.375,78764832.703125,49010777.5625,77263410,59550487.75,79741439.625,Eukaryotic peptide chain release factor subunit 1 OS=Homo sapiens OX=9606 GN=ETF1 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;nucleus,protein binding;RNA binding,2107,ETF1,Translation factors,Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000120705
P12277,0,6,378789837.0598958,0.0014662750077863392,1.2149621769555339,0.28091140192320474,0.24704740625048055,0.7316541032247736,raw,392965074.03125,303479005.40625,324144876.078125,450781197.5625,323931167.46875,477437701.8125,Creatine kinase B-type OS=Homo sapiens OX=9606 GN=CKB PE=1 SV=1,cellular homeostasis;defense response;metabolic process,cell surface;cytosol;endosome;membrane;nucleus,signal transducer activity;structural molecule activity,1152,CKB,NA,RND3 GTPase cycle; Creatine metabolism,ENSG00000166165
O14545,0,6,871716.5859375,3.37436783878359e-6,1.2149146634865522,0.28085498141254905,0.5689495528285149,1,raw,1033086.5,978653.5625,353989.3125,843722.96875,765735.234375,1255111.9375,TRAF-type zinc finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TRAFD1 PE=1 SV=1,metabolic process,NA,structural molecule activity,10906,TRAFD1,NA,NA,ENSG00000135148
P08727,0,6,2578936316.91797,0.009982923241869961,1.2147475578352922,0.2806565320209902,0.2713962426347561,0.7524601054912853,raw,2109324308.57813,2599814240.22656,2295524158.15625,3158117999.14063,2171723231.1875,3139113964.21875,"CRAP Keratin, type I cytoskeletal 19 OS=Homo sapiens OX=9606 GN=KRT19 PE=1 SV=4",cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,3880,KRT19,Galanin receptor pathway,Formation of the cornified envelope,ENSG00000171345
G5E9Q6,0,6,19262910.895833332,7.456568804223067e-5,1.214650061187169,0.2805407354714876,0.3964857817710581,0.8796249026398788,raw,17810801.9375,14980344.6875,16987719.578125,31143347,14021117.546875,20634134.625,Profilin OS=Homo sapiens OX=9606 GN=PFN2 PE=1 SV=1,cell growth,cytoskeleton,motor activity,NA,PFN2,Physico-chemical features and toxicity-associated pathways,NA,ENSG00000070087
O75607,0,6,54110184.354166664,2.0945760213909946e-4,1.214405335834507,0.2802500347700606,0.5086002277645056,0.992236492858638,raw,61178209.25,42376486.5625,45890824.75,74295143.75,39868060.4375,61052381.375,Nucleoplasmin-3 OS=Homo sapiens OX=9606 GN=NPM3 PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,10360,NPM3,NA,NA,ENSG00000107833
Q9P003,0,6,4125645.0416666665,1.5970149206080516e-5,1.214320387745641,0.2801491142046792,0.2539971192848905,0.7347067144546545,raw,4629461,2958920,3617423,4392710.5,4092246.75,5063109,Protein cornichon homolog 4 OS=Homo sapiens OX=9606 GN=CNIH4 PE=1 SV=1,conjugation,cytoskeleton;extracellular;nucleus,antioxidant activity,29097,CNIH4,NA,NA,ENSG00000143771
Q8N392,0,6,52760933.75,2.0423472589858044e-4,1.2139593215431228,0.27972007926142123,0.31448001117886576,0.7952173759379562,raw,53146108.5,37369250.75,54003944.4375,65558591.75,45991840,60495867.0625,Rho GTPase-activating protein 18 OS=Homo sapiens OX=9606 GN=ARHGAP18 PE=1 SV=3,cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding,93663,ARHGAP18,NA,RHOC GTPase cycle; RHOA GTPase cycle,ENSG00000146376
Q6P597,0,6,9563330.916666666,3.7019137638799595e-5,1.2138556442494546,0.2795968617019068,0.35767959627303897,0.841423658454915,raw,10981579.9375,8331319.0625,6772661.4375,11113892.875,8221033.3125,11959498.875,Kinesin light chain 3 OS=Homo sapiens OX=9606 GN=KLC3 PE=1 SV=2,cell growth;conjugation;metabolic process,endoplasmic reticulum;endosome;nucleus,motor activity,147700,KLC3,Alzheimer's disease and miRNA effects; Alzheimer's disease,COPI-dependent Golgi-to-ER retrograde traffic; MHC class II antigen presentation; Kinesins; RHO GTPases activate KTN1,ENSG00000104892
P45954,0,6,18721145.901041668,7.246854499815553e-5,1.2137965940518591,0.2795266774919057,0.14378622727078733,0.6572502130392559,raw,17576212.96875,17230248.03125,15170876.53125,23928747.75,17506773.75,20914016.375,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADSB PE=1 SV=1",cellular homeostasis,endosome,structural molecule activity,36,ACADSB,Valproic acid pathway,Branched-chain amino acid catabolism,ENSG00000196177
Q9Y3C1,0,6,17848369.638020832,6.909007520659603e-5,1.2137722587334467,0.27949775271545463,0.2405457975814411,0.7263138257852598,raw,16460167.875,16367968.4375,14205132.671875,17469462.625,17241795.96875,25345690.25,Nucleolar protein 16 OS=Homo sapiens OX=9606 GN=NOP16 PE=1 SV=2,metabolic process,membrane;nucleus,NA,51491,NOP16,NA,NA,ENSG00000048162
P34897,0,6,203054194.31770834,7.86011822981322e-4,1.2137517576325079,0.27947338481099016,0.24695905254917877,0.7316541032247736,raw,216046233.28125,169717564.03125,160102375.15625,233492264.0625,176740234,262226495.375,"Serine hydroxymethyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=SHMT2 PE=1 SV=3",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,RNA binding;structural molecule activity,6472,SHMT2,"Glycine metabolism; Vitamin B12 metabolism; Folate metabolism; One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Neuroinflammation and glutamatergic signaling",RHOG GTPase cycle; Metabolism of folate and pterines,ENSG00000182199
Q9NRV9,0,6,9109627.78125,3.526287729776366e-5,1.213705430905286,0.27941831867845657,0.7217851386030677,1,raw,8502838,9546136.375,8070561,11586197.5625,5626795.25,11325238.5,Heme-binding protein 1 OS=Homo sapiens OX=9606 GN=HEBP1 PE=1 SV=1,metabolic process,cell surface;nucleus,structural molecule activity,50865,HEBP1,NA,G alpha (i) signalling events; Formyl peptide receptors bind formyl peptides and many other ligands,ENSG00000013583
Q7Z4W1,0,6,35716655.6875,1.382572457666282e-4,1.213517291307237,0.2791946654774876,0.20476932840136863,0.6969949879362929,raw,26906310.625,37610075.75,31313493,40420359.75,32409217.75,45640477.25,L-xylulose reductase OS=Homo sapiens OX=9606 GN=DCXR PE=1 SV=2,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,51181,DCXR,NA,Formation of xylulose-5-phosphate; Essential pentosuria,ENSG00000169738
A0A0C4DG17,0,6,457288043.359375,0.0017701373261272148,1.213470979059272,0.2791396059196847,0.5403919161355758,1,raw,465841973.875,434226746.78125,391859110.4375,565285716.125,340977621.9375,545537091,40S ribosomal protein SA OS=Homo sapiens OX=9606 GN=RPSA PE=1 SV=1,cell communication;cell growth;cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;Golgi;membrane,structural molecule activity,3921,RPSA,Cytoplasmic ribosomal proteins,NA,ENSG00000168028
Q8IWV7,0,6,5643353.518229167,2.1845116775332346e-5,1.2133352722402655,0.27897825512796437,0.39314052858573156,0.8769264261349782,raw,5151313.09375,5227216.734375,4887877.78125,7950096.46875,4393347.15625,6250269.875,E3 ubiquitin-protein ligase UBR1 OS=Homo sapiens OX=9606 GN=UBR1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,197131,UBR1,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000159459
Q13586,0,6,3346381.8541666665,1.2953663480940811e-5,1.2133246863409084,0.2789656680949506,0.2568988708874842,0.7376563020395609,raw,3274579.3125,3249441.875,2343059.375,4509531.5625,2842891.78125,3858787.21875,Stromal interaction molecule 1 OS=Homo sapiens OX=9606 GN=STIM1 PE=1 SV=3,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular,motor activity;structural molecule activity,6786,STIM1,CAMKK2 pathway,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Ion homeostasis; Elevation of cytosolic Ca2+ levels,ENSG00000167323
Q9Y6F9,0.3333333333333333,6,934027.15625,3.615568692215371e-6,1.213298029834121,0.2789339720180163,0.1910871706243289,0.6823711621042031,raw,752309.75,842455.5625,879287,912775.9375,943746.1875,1273588.5,Protein Wnt-6 OS=Homo sapiens OX=9606 GN=WNT6 PE=1 SV=2,cell death;defense response;development;metabolic process,cell surface;chromosome;cytoplasm;cytoskeleton;extracellular;nucleus,antioxidant activity,7475,WNT6,Alzheimer's disease and miRNA effects; lncRNA-mediated mechanisms of therapeutic resistance; Embryonic stem cell pluripotency pathways; Wnt signaling pathway and pluripotency; Wnt signaling in kidney disease; Epithelial to mesenchymal transition in colorectal cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Osteoblast differentiation and related diseases; Malignant pleural mesothelioma; Alzheimer's disease; DNA damage response (only ATM dependent),Class B/2 (Secretin family receptors); WNT ligand biogenesis and trafficking,ENSG00000115596
P05386,0,6,161441629.328125,6.249318306359549e-4,1.213168736440694,0.27878022506356726,0.27644939517916417,0.756515890988102,raw,187134498.125,102577295.9375,116470642.15625,212617429,124443568.5,225406342.25,60S acidic ribosomal protein P1 OS=Homo sapiens OX=9606 GN=RPLP1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,DNA binding;structural molecule activity,6176,RPLP1,Cytoplasmic ribosomal proteins,L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000137818
P62877,0,6,10225798.770833334,3.958351493457386e-5,1.2130011521238644,0.2785809207491044,0.4264021574534347,0.911043979658989,raw,9138462.75,9772068,9336018.75,11324601.5,8070149.125,13713492.5,E3 ubiquitin-protein ligase RBX1 OS=Homo sapiens OX=9606 GN=RBX1 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9978,RBX1,"Cell cycle; Dual hijack model of Vif in HIV infection; TGF-beta signaling pathway; Type 2 papillary renal cell carcinoma; NRF2-ARE regulation; Hippo-Merlin signaling dysregulation; 22q11.2 copy number variation syndrome; Nucleotide excision repair; Hijack of ubiquitination by SARS-CoV-2; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Potential therapeutics for SARS; Antigen processing: Ubiquitination & Proteasome degradation; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Degradation of DVL; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; Orc1 removal from chromatin; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Regulation of BACH1 activity; NOTCH1 Intracellular Domain Regulates Transcription; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Prolactin receptor signaling; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; DNA Damage Recognition in GG-NER; Nuclear events stimulated by ALK signaling in cancer; Dual Incision in GG-NER; Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,ENSG00000100387
P49773,0,6,62824115.255208336,2.4318875817788766e-4,1.2129707170922013,0.2785447220859549,0.41984364456388645,0.9064994547673523,raw,68003641.875,51292518.375,52820956.90625,82486426.25,48029578,74311570.125,Histidine triad nucleotide-binding protein 1 OS=Homo sapiens OX=9606 GN=HINT1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,3094,HINT1,NA,NA,ENSG00000169567
Q15125,0,6,7485232.270833333,2.897492998066689e-5,1.212647220535412,0.2781599072527927,0.8834012817367867,1,raw,5920115,13516118.25,3756600.25,7179011,7407206.625,7132342.5,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase OS=Homo sapiens OX=9606 GN=EBP PE=1 SV=3",cellular homeostasis;defense response;metabolic process,cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,10682,EBP,Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders,Cholesterol biosynthesis via desmosterol; Cholesterol biosynthesis via lathosterol,ENSG00000147155
P30050,0,6,244889147.625,9.47952668497435e-4,1.2125180300425573,0.2780062002148882,0.32641635558025256,0.8083072617124191,raw,217819647.75,237237718.75,225832107,273825501.5,209969057.5,304650853.25,60S ribosomal protein L12 OS=Homo sapiens OX=9606 GN=RPL12 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6136,RPL12,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000197958
O75348,0,6,10948427.604166666,4.2380772132514255e-5,1.2123423746295214,0.2777971843117482,0.4133190052098081,0.8996323316459364,raw,10428752.625,10163923.375,8646797.875,16111852.5,8017084.25,12322155,V-type proton ATPase subunit G 1 OS=Homo sapiens OX=9606 GN=ATP6V1G1 PE=1 SV=3,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion,catalytic activity;structural molecule activity,9550,ATP6V1G1,Osteoclast signaling; Proximal tubule transport,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000136888
Q14126,0,6,28939872.09375,1.1202468236466738e-4,1.2122693410400658,0.27771027126362846,0.4748919286677258,0.9561536977028555,raw,24315102.5,30576988,26409575.3125,32114930.03125,23155091.625,37067545.09375,Desmoglein-2 OS=Homo sapiens OX=9606 GN=DSG2 PE=1 SV=2,cell communication;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,1829,DSG2,Arrhythmogenic right ventricular cardiomyopathy; GDNF signaling,Formation of the cornified envelope; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; Apoptotic cleavage of cell adhesion  proteins,ENSG00000046604
Q00534,0,6,927491.5572916666,3.5902697415151616e-6,1.2122178644725894,0.27764900883381444,0.35109174479051913,0.8351153943011169,raw,714295.3125,1056347.65625,727844.625,982173.125,803765.125,1280523.5,Cyclin-dependent kinase 6 OS=Homo sapiens OX=9606 GN=CDK6 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,signal transducer activity;structural molecule activity,1021,CDK6,miRNA regulation of DNA damage response; miRNAs involved in DNA damage response; Cell cycle; Metastatic brain tumor; Glioblastoma signaling pathways; Retinoblastoma gene in cancer; Wnt signaling pathway; PI3K-Akt signaling pathway; Tumor suppressor activity of SMARCB1; Non-small cell lung cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; G1 to S cell cycle control; Measles virus infection; Small cell lung cancer; Head and neck squamous cell carcinoma; Melanoma; Influence of laminopathies on Wnt signaling; DYRK1A; DNA damage response,"Oxidative Stress Induced Senescence; Oncogene Induced Senescence; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3); Senescence-Associated Secretory Phenotype (SASP); Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6; Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6; Drug-mediated inhibition of CDK4/CDK6 activity; Regulation of RUNX1 Expression and Activity",ENSG00000105810
P00390,0,6,150214337.48046884,5.814715900732218e-4,1.212172758326605,0.2775953257247307,0.20536307526753686,0.6975621068909352,raw,147230990.25,130106650.773438,133290253.125,178469395.5625,134013601.453125,178175133.71875,"Glutathione reductase, mitochondrial OS=Homo sapiens OX=9606 GN=GSR PE=1 SV=2",cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome,structural molecule activity,2936,GSR,"Glutathione metabolism; Selenium micronutrient network; Trans-sulfuration, one-carbon metabolism and related pathways; Nuclear receptors meta-pathway; NRF2 pathway; Amino acid metabolism; Oxidative stress response; Vitamin D-sensitive calcium signaling in depression; Sulfation biotransformation reaction; Metapathway biotransformation Phase I and II",NA,ENSG00000104687
Q9HA92,0,6,2083864.2994791667,8.066526192098808e-6,1.211997174956689,0.2773863360379883,0.23584332973471697,0.7196640448521243,raw,1775067.1328125,1536513.8671875,2182477.6015625,2619872.234375,1744098.2734375,2645156.6875,"Radical S-adenosyl methionine domain-containing protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=RSAD1 PE=1 SV=2",cellular homeostasis,endosome;nucleus,structural molecule activity,55316,RSAD1,NA,NA,ENSG00000136444
O75694,0,6,39718099.72265625,1.5374661958231898e-4,1.2118781871368736,0.27724469250268424,0.1820493926378954,0.6743269455727479,raw,36025946.15625,39999737.609375,30282617.4296875,48474809.5,35412823.734375,48112663.90625,Nuclear pore complex protein Nup155 OS=Homo sapiens OX=9606 GN=NUP155 PE=1 SV=1,cell death;cell growth;cellular component movement;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;membrane,structural molecule activity,9631,NUP155,NA,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000113569
A0A5K1VW95,0,6,214887387.19921884,8.318174737325339e-4,1.2117515868265107,0.2770939717597195,0.1946354741611515,0.6851169040350013,raw,211153908.6875,187684759.8125,196855357.953125,238539792.375,197914383.585938,257176120.78125,Malate dehydrogenase OS=Homo sapiens OX=9606 GN=MDH1 PE=1 SV=1,cellular homeostasis,cytosol;endoplasmic reticulum,structural molecule activity,4190,MDH1,Sterol regulatory element-binding proteins (SREBP) signaling; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Clear cell renal cell carcinoma pathways; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; TCA cycle in senescence; Glycolysis and gluconeogenesis,NA,ENSG00000014641
Q3ZCW2,0,6,917134.85,3.5501794867644034e-6,1.2117377714996955,0.27707752332480784,0.5142411666822544,0.9988615467241881,raw,777701.875,1116380.125,630344.625,1225684,835563.625,NA,Galectin-related protein OS=Homo sapiens OX=9606 GN=LGALSL PE=1 SV=2,NA,NA,structural molecule activity,29094,LGALSL,NA,NA,ENSG00000119862
Q7Z417,0,6,24052293.776041668,9.310513058503258e-5,1.211620665130855,0.27693808973944917,0.08984268448010163,0.6429522395902524,raw,22019884.15625,22658897.15625,21061293.5625,28465105.3125,23428835.78125,26679746.6875,Nuclear fragile X mental retardation-interacting protein 2 OS=Homo sapiens OX=9606 GN=NUFIP2 PE=1 SV=1,NA,cytosol;Golgi;membrane;nucleus,RNA binding,57532,NUFIP2,NA,NA,ENSG00000108256
Q9Y3C8,0,6,3988333.5520833335,1.5438623843571596e-5,1.2114745671031986,0.276764118120476,0.532877871717835,1,raw,2965744.5625,5209464.5,2793896.25,5360608.75,3384734.25,4215553,Ubiquitin-fold modifier-conjugating enzyme 1 OS=Homo sapiens OX=9606 GN=UFC1 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response,NA,structural molecule activity,51506,UFC1,NA,NA,ENSG00000143222
Q3ZCQ8,0,6,15619543.645833334,6.04624101287382e-5,1.2114307315937225,0.27671191527773437,0.17398929163142016,0.669219086937761,raw,13786273.8125,15816581.6875,12446819.4375,18418614.75,14088279.0625,19160693.125,Mitochondrial import inner membrane translocase subunit TIM50 OS=Homo sapiens OX=9606 GN=TIMM50 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;development,cytoskeleton;endosome;membrane,antioxidant activity;RNA binding;structural molecule activity,92609,TIMM50,NA,Mitochondrial protein import,ENSG00000105197
P36578,0,6,381843786.6666667,0.0014780966818264982,1.2114098244160052,0.2766870166672685,0.12036968486719622,0.6445597830897484,raw,334478311.90625,387202121.40625,310456658.609375,424580950.8125,365284223.359375,469060453.90625,60S ribosomal protein L4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,6124,RPL4,Cytoplasmic ribosomal proteins,L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000174444
O75832,0,6,8251400.703125,3.194072661540203e-5,1.2112091594047751,0.2764480204246262,0.2773645040866765,0.7570746865029274,raw,8951668.625,7733242.6875,5627756.3125,9366574.375,7460581.765625,10368580.453125,26S proteasome non-ATPase regulatory subunit 10 OS=Homo sapiens OX=9606 GN=PSMD10 PE=1 SV=1,cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,5716,PSMD10,Proteasome degradation; Parkin-ubiquitin proteasomal system pathway,Degradation of DVL; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000101843
Q92905,0,6,14560297.169270834,5.6362124208385636e-5,1.2111977939526049,0.2764344827475972,0.26543452316990074,0.7454335379461359,raw,15258466.375,12159789.140625,11749169.21875,17478789.625,12234547.84375,18481020.8125,COP9 signalosome complex subunit 5 OS=Homo sapiens OX=9606 GN=COPS5 PE=1 SV=4,cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;extracellular;membrane;nucleus,RNA binding;structural molecule activity,10987,COPS5,TGF-beta signaling pathway,Cargo recognition for clathrin-mediated endocytosis; Neddylation; Formation of TC-NER Pre-Incision Complex; DNA Damage Recognition in GG-NER,ENSG00000121022
B8ZZ54,0.8333333333333334,6,110598996,4.281227420983276e-4,1.2111740134484148,0.2764061567776853,0.18274066003656636,0.6753459175264409,raw,86367296,118743512,87021656,126470360,101172096,143819056,"10 kDa heat shock protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPE1 PE=1 SV=1",metabolic process,NA,structural molecule activity,NA,HSPE1,NA,NA,ENSG00000115541
A0A087X1Z3,0,6,79643745.87760417,3.082966401982733e-4,1.2111467430801286,0.276373673197643,0.31025680277132395,0.791258249420452,raw,78624952.46875,76237766.5625,63547180.5,92335122.671875,66883242.625,100234210.4375,Proteasome activator complex subunit 2 OS=Homo sapiens OX=9606 GN=PSME2 PE=1 SV=1,NA,nucleus,NA,NA,PSME2,NA,NA,ENSG00000100911
B8ZZ87,0,6,2304268.7708333335,8.9197000007189e-6,1.2108450116004237,0.2760142116009129,0.5210321174895567,1,raw,2239122.03125,2271185.90625,2036603.46875,2729474.1875,1799172.90625,2750054.125,Mitotic-spindle organizing protein 2B OS=Homo sapiens OX=9606 GN=MZT2B PE=1 SV=1,NA,cytosol;endoplasmic reticulum;membrane,NA,80097,MZT2B,NA,NA,ENSG00000152082
H3BP20,0,6,4400265.145833333,1.7033188802128582e-5,1.2104152719122714,0.2755020953879619,0.17309384942398523,0.6689341104244626,raw,4548151.78125,3339179.1875,3672433.296875,5450765.6875,3885908.546875,5505152.375,Beta-hexosaminidase OS=Homo sapiens OX=9606 GN=HEXA PE=1 SV=1,cellular homeostasis,cytosol;mitochondrion;nucleus,structural molecule activity,3073,HEXA,"Degradation pathway of sphingolipids, including diseases; Glycosaminoglycan degradation",NA,ENSG00000213614
P52209,0,6,192219031.85677084,7.440694941028806e-4,1.2101001276991588,0.27512642581274294,0.6492435226271756,1,raw,201066442.96875,176503895.328125,175191431.9375,243310528.3125,143654165.96875,213587726.625,"6-phosphogluconate dehydrogenase, decarboxylating OS=Homo sapiens OX=9606 GN=PGD PE=1 SV=3",cellular homeostasis,cytosol,structural molecule activity,5226,PGD,Pentose phosphate metabolism; Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling pathway; Metabolic reprogramming in colon cancer,Nuclear events mediated by NFE2L2; Pentose phosphate pathway,ENSG00000142657
A0A2R8Y5Q8,0,6,4600945.989583333,1.7810013513203317e-5,1.2099330391438778,0.2749272071955943,0.3456888366242144,0.8277692477090556,raw,4260002.84375,4388712.375,3986453.5,5154318.1875,3814090.03125,6002099,Tubulin-folding cofactor E OS=Homo sapiens OX=9606 GN=TBCE PE=1 SV=1,metabolic process,endoplasmic reticulum;nucleus,motor activity,NA,TBCE,NA,NA,ENSG00000284770
O14757,0.16666666666666666,6,584355.7526041666,2.2620095680238157e-6,1.2098545458886685,0.27483361069086476,0.3164133611040561,0.796388541585002,raw,400347.625,564094.359375,567845.328125,833658.3125,457716.765625,682472.125,Serine/threonine-protein kinase Chk1 OS=Homo sapiens OX=9606 GN=CHEK1 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,signal transducer activity;structural molecule activity,1111,CHEK1,"miRNA regulation of DNA damage response; Cell cycle; Retinoblastoma gene in cancer; ATR signaling; ATM signaling in development and disease ; DNA repair pathways, full network; DNA damage response",Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; TP53 Regulates Transcription of DNA Repair Genes; Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Transcriptional Regulation by E2F6; Signaling by SCF-KIT; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,ENSG00000149554
Q9BZE9,0,6,562256.6614583334,2.1764651793637687e-6,1.2098206748568745,0.2747932205019806,0.3153602371396871,0.7958588159583763,raw,421646.8125,482051.125,629243.125,732674.6875,597807.1875,510117.03125,Tether containing UBX domain for GLUT4 OS=Homo sapiens OX=9606 GN=ASPSCR1 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,NA,79058,ASPSCR1,NA,Translocation of SLC2A4 (GLUT4) to the plasma membrane,ENSG00000169696
P29558,0.3333333333333333,6,1044244.703125,4.042214865345875e-6,1.2097436550765355,0.27470137251611937,1,1,raw,1176054.375,871822.0625,963506.5,NA,1165595.875,NA,"RNA-binding motif, single-stranded-interacting protein 1 OS=Homo sapiens OX=9606 GN=RBMS1 PE=1 SV=3",cell proliferation;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,5937,RBMS1,NA,NA,ENSG00000153250
O60508,0,6,5054691.255208333,1.9566436938001035e-5,1.2096709291281198,0.2746146396627756,0.4919565855240032,0.9768515932653652,raw,5423918.28125,5218850.5625,3339854.25,4040124.59375,5495963.84375,6809436,Pre-mRNA-processing factor 17 OS=Homo sapiens OX=9606 GN=CDC40 PE=1 SV=1,cellular component movement;cellular homeostasis;defense response,membrane,RNA binding,51362,CDC40,mRNA processing,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,ENSG00000168438
Q9NQR4,0,6,25400426.463541668,9.832367943049305e-5,1.209646930497397,0.2745860177887251,0.408907758311896,0.8935675900241862,raw,26174935.9375,20950645.75,23446693.75,32800535.8125,20667526.40625,28362221.125,Omega-amidase NIT2 OS=Homo sapiens OX=9606 GN=NIT2 PE=1 SV=1,cellular homeostasis,cell surface;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,56954,NIT2,NA,Neutrophil degranulation,ENSG00000114021
Q9Y2A7,0,6,43218171.080729164,1.6729520683493736e-4,1.2093998676015716,0.27429132616381374,0.15075092682332275,0.6638855679885327,raw,39820626.484375,38859907.046875,34993942.453125,46997166.4375,41010724.78125,57626659.28125,Nck-associated protein 1 OS=Homo sapiens OX=9606 GN=NCKAP1 PE=1 SV=1,cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,NA,10787,NCKAP1,Exercise-induced circadian regulation; Regulation of actin cytoskeleton,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway,ENSG00000061676
Q99590,0,6,2308634.88671875,8.936600999577726e-6,1.20930448060648,0.27417753437693654,0.26442913123207895,0.7453246187943735,raw,2055675.5,2356411.0859375,1899582.96875,1987846.796875,2849618.484375,2702674.484375,Protein SCAF11 OS=Homo sapiens OX=9606 GN=SCAF11 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,membrane,structural molecule activity,9169,SCAF11,Apoptosis,NA,ENSG00000139218
O75319,0.8333333333333334,6,844185.7916666666,3.267797620593055e-6,1.2091145407574122,0.27395091915727426,0.3603160706940137,0.8422895555819307,raw,734524.9375,972909.6875,560682.125,806126.5,814512.25,1176359.25,RNA/RNP complex-1-interacting phosphatase OS=Homo sapiens OX=9606 GN=DUSP11 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,8446,DUSP11,NA,NA,ENSG00000144048
Q01085,0,6,34352116.927083336,1.3297518989869756e-4,1.2085510133197772,0.27327837100185787,0.4210631668709091,0.9081628377481699,raw,34144297.125,33705429.3125,28128880.6875,41855379.625,27543984.0625,40734730.75,Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1,cell differentiation;coagulation;metabolic process,membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,7073,TIAL1,NA,FGFR2 alternative splicing,ENSG00000151923
Q9UMY1,0,6,4160242.8958333335,1.6104075631565894e-5,1.2079669251762741,0.2725809533902937,0.026798407115798586,0.6429522395902524,raw,3575611.75,4005267,3826517,4838230.0625,4347324.1875,4368507.375,Nucleolar protein 7 OS=Homo sapiens OX=9606 GN=NOL7 PE=1 SV=2,NA,endosome;membrane;nucleus,NA,51406,NOL7,NA,NA,ENSG00000225921
O15235,0,6,1404831.7916666667,5.438028016413818e-6,1.2079098636938361,0.2725128023006904,0.5654428984356131,1,raw,997329.875,1091036.5,1632126.5625,1317873.75,920709.375,2469914.6875,"28S ribosomal protein S12, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS12 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,6183,MRPS12,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000128626; ENSG00000283018
P78330,0,6,6538973.552083333,2.5312013570415754e-5,1.2078746435412315,0.2724707356847705,0.21068717069214413,0.7014620053011217,raw,6810351.125,5011569.125,5692044.375,8226050.4375,5754543,7739283.25,Phosphoserine phosphatase OS=Homo sapiens OX=9606 GN=PSPH PE=1 SV=2,cellular homeostasis;defense response;metabolic process,cytosol;nucleus,structural molecule activity,5723,PSPH,"Trans-sulfuration, one-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Neuroinflammation and glutamatergic signaling; Amino acid metabolism in triple-negative breast cancer cells",Serine biosynthesis,ENSG00000146733
Q00765,0,6,32608920.541666668,1.262273708087261e-4,1.2078742452082956,0.2724702599126784,0.32402773540990465,0.804368639449992,raw,29804621.75,36394773.5,24160676.75,36000235,30258532.75,39034683.5,Receptor expression-enhancing protein 5 OS=Homo sapiens OX=9606 GN=REEP5 PE=1 SV=3,cell growth;metabolic process,cytoskeleton;cytosol;extracellular,NA,7905,REEP5,NA,NA,ENSG00000129625
Q9NPA8,0,6,3277321.6041666665,1.268633498186478e-5,1.2077816673777293,0.2723596799443777,0.5181690366354861,1,raw,4103650.875,1899152.75,2849996.375,4463125.5,2293761.875,4054242.25,Transcription and mRNA export factor ENY2 OS=Homo sapiens OX=9606 GN=ENY2 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;metabolic process,endosome;membrane;nucleus,structural molecule activity,56943,ENY2,NA,HATs acetylate histones,ENSG00000120533
A0A0G2JL56,0,6,19817501.192708332,7.67124771382117e-5,1.2076576448001624,0.2722115273852393,0.35897573790510523,0.8420882601494262,raw,14822460.5,20342754.40625,19396018.9375,23439029.0625,16337661.375,24567082.875,"HLA class I histocompatibility antigen, A alpha chain OS=Homo sapiens OX=9606 GN=HLA-A PE=1 SV=1",metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,NA,NA,HLA-A,NA,NA,ENSG00000224320; ENSG00000229215
P21281,0,6,37331404.639322914,1.4450785177624173e-4,1.2076368282516494,0.2721866592528903,0.33838743361622176,0.8216110565431962,raw,37579331.4375,35644721.1640625,29873848.21875,44505243,31003099.390625,45382184.625,"V-type proton ATPase subunit B, brain isoform OS=Homo sapiens OX=9606 GN=ATP6V1B2 PE=1 SV=3",cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,catalytic activity;structural molecule activity,526,ATP6V1B2,NA,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000147416
S6AU73,0,6,21482009.7890625,8.315570004520251e-5,1.2073345058357847,0.2718254466403515,0.38180536090554873,0.8666785138959608,raw,21180614.921875,15962549.796875,21891292.546875,27053727.1875,17231787.03125,25572087.25,HLA class I histocompatibility antigen OS=Homo sapiens OX=9606 GN=HLA-B PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,NA,NA,HLA-B,NA,NA,ENSG00000206450
P42167,0,6,62877174.723958336,2.4339414851665285e-4,1.2073030380461955,0.2717878439582383,0.20956789844334048,0.6996099840186926,raw,59961360.90625,57588787.03125,58414314.09375,71097966.875,57809086.25,72391533.1875,"Lamina-associated polypeptide 2, isoforms beta/gamma OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2",NA,cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,7112,TMPO,Envelope proteins and their potential roles in EDMD physiopathology; Overlap between signal transduction pathways contributing to LMNA laminopathies,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOG GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle,ENSG00000120802
O75874,0,6,93446904.47135417,3.617279218599472e-4,1.2072753830797862,0.27175479662993673,0.20614060665289421,0.6985216041960465,raw,85826604.84375,85591898.484375,82513583.71875,118268914,85147433.75,103332992.03125,Isocitrate dehydrogenase [NADP] cytoplasmic OS=Homo sapiens OX=9606 GN=IDH1 PE=1 SV=2,cellular homeostasis;coagulation;defense response;metabolic process,cell surface;cytosol;endosome;mitochondrion;nucleus,structural molecule activity,3417,IDH1,Glutathione metabolism; TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism,Peroxisomal protein import; Neutrophil degranulation; Nuclear events mediated by NFE2L2; Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate; NADPH regeneration,ENSG00000138413
Q04760,0,6,128062235.33333333,4.957219986892828e-4,1.2072327317662979,0.2717038273761288,0.21725618654749723,0.7060075523227053,raw,129334179.875,109610104.828125,110147885.03125,156136455.28125,113224758.859375,149920028.125,Lactoylglutathione lyase OS=Homo sapiens OX=9606 GN=GLO1 PE=1 SV=4,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,2739,GLO1,NA,Pyruvate metabolism,ENSG00000124767
Q9BTY2,0,6,5916470.411458333,2.2902337523002123e-5,1.206913030615087,0.27132172015186606,0.337649080656551,0.8211705919010127,raw,5252922.875,7074881.875,2925484.21875,6258709.625,5448056.75,8538767.125,Plasma alpha-L-fucosidase OS=Homo sapiens OX=9606 GN=FUCA2 PE=1 SV=2,cellular homeostasis;metabolic process,cell surface;extracellular;mitochondrion,structural molecule activity,2519,FUCA2,NA,Neutrophil degranulation; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,ENSG00000001036
Q96E29,0,6,1135652.0364583333,4.396047717450269e-6,1.20631718307561,0.27060929221778734,0.3707654126260462,0.8556591383960601,raw,1061703.71875,773742.8125,1250724.625,1325475.875,933379.25,1468885.9375,"Transcription termination factor 3, mitochondrial OS=Homo sapiens OX=9606 GN=MTERF3 PE=1 SV=2",cell growth;metabolic process,cytoskeleton;cytosol;endosome,RNA binding,51001,MTERF3,Mitochondrial gene expression,PINK1-PRKN Mediated Mitophagy,ENSG00000156469
F5H0C4,0.16666666666666666,6,847876.5338541666,3.282084284331761e-6,1.2060685634952368,0.2703119249849954,0.8538885234226983,1,raw,776969.53125,869612.71875,843745.0625,1019911.53125,528207.796875,1048812.5625,Proteasomal ATPase-associated factor 1 OS=Homo sapiens OX=9606 GN=PAAF1 PE=1 SV=1,NA,NA,NA,NA,PAAF1,NA,NA,ENSG00000175575
A0A5F9ZHM4,0,6,1126316501.4518237,0.00435991036548062,1.2060604183515602,0.2703021817594232,0.23143751928327772,0.7183421463015945,raw,1149108744.8125,916974960.929688,1015522851.01563,1291427247.46875,998970630.984375,1385894573.5,L-lactate dehydrogenase OS=Homo sapiens OX=9606 GN=LDHB PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,3945,LDHB,Clear cell renal cell carcinoma pathways; Glycolysis and gluconeogenesis,NA,ENSG00000111716
Q8N5C6,0,6,3143331.8359375,1.2167667823372763e-5,1.2057259797009234,0.26990206922355564,0.41013235396104986,0.895261063488616,raw,2602024.15625,3399607.9375,2339749.921875,4828697.78125,2552583.09375,3137328.125,S1 RNA-binding domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SRBD1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,NA,RNA binding;structural molecule activity,55133,SRBD1,NA,NA,ENSG00000068784
Q9H6L5,0.5,6,752851.765625,2.9142485370567234e-6,1.205655136657156,0.2698173004516175,1,1,raw,822928.75,756551.125,519787.4375,912139.75,NA,NA,Reticulophagy regulator 1 OS=Homo sapiens OX=9606 GN=RETREG1 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,extracellular;membrane,structural molecule activity,54463,RETREG1,NA,NA,ENSG00000154153
P53701,0,6,17769292.877604168,6.878397333650458e-5,1.2055744289030068,0.26972072177791606,0.15045829597719054,0.6638855679885327,raw,17646973.65625,14385669.6875,15905104.421875,21274740.1875,16264998.125,21138271.1875,Cytochrome c-type heme lyase OS=Homo sapiens OX=9606 GN=HCCS PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;endosome,structural molecule activity,3052,HCCS,NA,NA,ENSG00000004961
Q9Y224,0,6,37639561.28125,1.4570070949926876e-4,1.2053257888700764,0.2694231468379807,0.2768988154187573,0.7566344694307385,raw,36528377.25,38093743.71875,26866322.65625,44028595.125,32101173.3125,48219155.625,"RNA transcription, translation and transport factor protein OS=Homo sapiens OX=9606 GN=RTRAF PE=1 SV=1",cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,51637,RTRAF,NA,tRNA processing in the nucleus,ENSG00000087302
P82921,0,6,4463256.510416667,1.7277024973425584e-5,1.2052938302891105,0.26938489402869503,0.41378291388369814,0.8999719806515282,raw,4691064.625,3396337.6875,4101557.625,5582393.25,3354074.625,5654111.25,"28S ribosomal protein S21, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS21 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,54460,MRPS21,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000266472
P28799,0,6,6296649.026041667,2.437398841359936e-5,1.2051560089827655,0.2692199172578285,0.5882047579596043,1,raw,8356933.65625,3873544.5,4733756.75,6461542.25,4282708.1875,10071408.8125,Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2,cell growth;coagulation;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;mitochondrion,antioxidant activity;structural molecule activity,2896,GRN,IL-18 signaling pathway,Neutrophil degranulation,ENSG00000030582
Q13206,0,6,13812371.518229166,5.346694439491214e-5,1.2050164045842042,0.2690527868296631,0.25818186786379455,0.7381027251958325,raw,12235861.40625,15497755.171875,9285962.84375,14744413.71875,13414783.59375,17695452.375,Probable ATP-dependent RNA helicase DDX10 OS=Homo sapiens OX=9606 GN=DDX10 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,1662,DDX10,NA,NA,ENSG00000178105
Q96GY0,0,6,974726.21875,3.7731125657450295e-6,1.2048632600597349,0.2688694242746525,0.1716914535122925,0.6688917965646828,raw,830295.34375,835012.34375,976838.3125,1176956.59375,882778.75,1146475.96875,Zinc finger C2HC domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ZC2HC1A PE=1 SV=2,NA,NA,structural molecule activity,51101,ZC2HC1A,NA,NA,ENSG00000104427
Q9Y624,0,6,11828885.666666666,4.5788977755104904e-5,1.2047441915626063,0.2687268454240121,0.35858127204033907,0.8420882601494262,raw,8278989.03125,13057247.96875,11029036.625,15151647.75,10169224.8125,13287167.8125,Junctional adhesion molecule A OS=Homo sapiens OX=9606 GN=F11R PE=1 SV=1,cell communication;cell growth;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;structural molecule activity,50848,F11R,1q21.1 copy number variation syndrome,Cell surface interactions at the vascular wall; Integrin cell surface interactions; Tight junction interactions; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),ENSG00000158769
Q9NVP1,0,6,56253954.5703125,2.1775602090019815e-4,1.204672434728395,0.2686409132296648,0.2788009775460177,0.7591598077731446,raw,57276396.6875,48475408.71875,48662784.15625,65961124.40625,48148717.203125,68999296.25,ATP-dependent RNA helicase DDX18 OS=Homo sapiens OX=9606 GN=DDX18 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,structural molecule activity,8886,DDX18,NA,NA,ENSG00000088205
Q6IQ49,0,6,785752.75,3.041606471195287e-6,1.204586244114859,0.26853768913682274,1,1,raw,714962.75,NA,756659.25,885636.25,NA,NA,Replication stress response regulator SDE2 OS=Homo sapiens OX=9606 GN=SDE2 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane,RNA binding,163859,SDE2,NA,NA,ENSG00000143751
P48637,0,6,73516780.921875,2.8457948965933774e-4,1.2044898280054954,0.2684222099748946,0.37623794610737377,0.8615698665976935,raw,74120573.125,65036713.09375,66952423.3125,84080835.875,61632663.75,89277476.375,Glutathione synthetase OS=Homo sapiens OX=9606 GN=GSS PE=1 SV=1,cellular homeostasis;coagulation;defense response;metabolic process,cytosol,structural molecule activity,2937,GSS,"Glutathione metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Amino acid metabolism; Ferroptosis; Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases; Metapathway biotransformation Phase I and II",Glutathione synthesis and recycling; Defective GSS causes GSS deficiency,ENSG00000100983
Q9GZZ9,0,6,9652258.010416666,3.7363369617389024e-5,1.2043972285541074,0.26831129338458903,0.4980292603473976,0.9817257423165381,raw,8167476.625,9231661.375,9751585.0625,12208397.75,7435839.875,11118587.375,Ubiquitin-like modifier-activating enzyme 5 OS=Homo sapiens OX=9606 GN=UBA5 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,79876,UBA5,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000081307
P54578,0,6,55066712.072916664,2.131602692939108e-4,1.2042530745905995,0.26813860728876676,0.0798027353796075,0.6429522395902524,raw,50131820.09375,54408714.1875,44399224.25,63078434.21875,53467902.3125,64914177.375,Ubiquitin carboxyl-terminal hydrolase 14 OS=Homo sapiens OX=9606 GN=USP14 PE=1 SV=3,cell death;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,DNA binding;structural molecule activity,9097,USP14,NA,Ub-specific processing proteases; Regulation of NF-kappa B signaling,ENSG00000101557
P30048,0,6,220285073.09375,8.527116244005213e-4,1.204215320689175,0.26809337741033407,0.21957589364050384,0.7087130179153194,raw,230069470.75,172064194.125,186583196.4375,277053181.5,190942759.5,264997636.25,"Thioredoxin-dependent peroxide reductase, mitochondrial OS=Homo sapiens OX=9606 GN=PRDX3 PE=1 SV=3",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;endosome;mitochondrion;nucleus,DNA binding;structural molecule activity,10935,PRDX3,Selenium micronutrient network,Detoxification of Reactive Oxygen Species,ENSG00000165672
Q9BZK7,0,6,30584183.059895832,1.1838972133562426e-4,1.2041620729011058,0.26802958315615877,0.30778256448528407,0.7887417335429273,raw,29003342.640625,31118067.171875,21421072.5625,33656730.0625,25794443.140625,42511442.78125,F-box-like/WD repeat-containing protein TBL1XR1 OS=Homo sapiens OX=9606 GN=TBL1XR1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,79718,TBL1XR1,Rett syndrome causing genes,"PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; HCMV Early Events; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Heme signaling; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Transcriptional activation of mitochondrial biogenesis; HDACs deacetylate histones; Cytoprotection by HMOX1; Activation of gene expression by SREBF (SREBP); NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Loss of MECP2 binding ability to the NCoR/SMRT complex; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; RORA activates gene expression",ENSG00000177565
Q9BXJ9,0,6,93666977.07063802,3.6257981100970137e-4,1.2037257040485154,0.2675066790635769,0.13694877991465182,0.654928512316515,raw,78020828.7265625,97140674.1953125,73008228,109958423.890625,86942981.1738281,116930726.4375,"N-alpha-acetyltransferase 15, NatA auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA15 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,protein binding,80155,NAA15,NA,NA,ENSG00000164134
Q9UKD2,0,6,41858760.0625,1.620330001801595e-4,1.2035637088492137,0.2673125107431572,0.27528849616658135,0.7559778268201988,raw,40550762.875,41453258.625,32838590.9375,51381722.5625,36122798.8125,48805426.5625,mRNA turnover protein 4 homolog OS=Homo sapiens OX=9606 GN=MRTO4 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,51154,MRTO4,NA,NA,ENSG00000053372
O15347,0,6,41603669.333333336,1.610455577403141e-4,1.203461908279676,0.2671904786585179,0.10871268117081927,0.6429522395902524,raw,41350756.125,35382709.625,37006327,46217988.875,39900174.5,49764059.875,High mobility group protein B3 OS=Homo sapiens OX=9606 GN=HMGB3 PE=1 SV=4,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding,3149,HMGB3,NA,NA,ENSG00000029993
H7BY55,0,6,10854712.53125,4.2018006145081355e-5,1.2033868187530437,0.2671004594674373,0.19257285883272987,0.6839501208924997,raw,11142222.4375,8597941.4375,9782993.25,11772725.125,10129105.8125,13703287.125,Complement decay-accelerating factor OS=Homo sapiens OX=9606 GN=CD55 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
P67870,0,6,36283922.682291664,1.4045310567580932e-4,1.2033817807731255,0.26709441961080516,0.2982622139350494,0.7796368726609018,raw,31741548.375,38425439.5,27482281.3125,46240473.8125,29764598.625,44049194.46875,Casein kinase II subunit beta OS=Homo sapiens OX=9606 GN=CSNK2B PE=1 SV=1,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cell surface;cytosol;membrane;nucleus,antioxidant activity;DNA binding;signal transducer activity;structural molecule activity,1460,CSNK2B,Alzheimer's disease and miRNA effects; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Measles virus infection; Malignant pleural mesothelioma; Alzheimer's disease,Regulation of PTEN stability and activity; KEAP1-NFE2L2 pathway; Neutrophil degranulation; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of TP53 Activity through Phosphorylation; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; WNT mediated activation of DVL; Signal transduction by L1; Receptor Mediated Mitophagy; Condensation of Prometaphase Chromosomes; Synthesis of PC,ENSG00000204435; ENSG00000206406; ENSG00000224398; ENSG00000224774; ENSG00000228875; ENSG00000230700; ENSG00000232960
Q13618,0,6,17809409.6328125,6.893926312994791e-5,1.2032733266521909,0.2669643916545271,0.2515431485882892,0.7326612824296702,raw,18744274.4375,17365620.984375,11863225.21875,20895588.53125,16288224,21699524.625,Cullin-3 OS=Homo sapiens OX=9606 GN=CUL3 PE=1 SV=2,cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,8452,CUL3,Hedgehog signaling pathway; NRF2-ARE regulation; 22q11.2 copy number variation syndrome; Head and neck squamous cell carcinoma,Potential therapeutics for SARS; Antigen processing: Ubiquitination & Proteasome degradation; Degradation of DVL; Hedgehog 'on' state; Regulation of RAS by GAPs; Neddylation; KEAP1-NFE2L2 pathway; RHOBTB3 ATPase cycle; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,ENSG00000036257
Q12931,0,6,210917742.54166666,8.164511935906489e-4,1.2032356383320932,0.2669192035805994,0.15226346411198977,0.6638855679885327,raw,213260496.59375,174659331.4375,180103461.03125,247838874.53125,193041661.90625,256602629.75,"Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens OX=9606 GN=TRAP1 PE=1 SV=3",metabolic process,cytoskeleton;endosome;membrane;nucleus,antioxidant activity;structural molecule activity,10131,TRAP1,TNF-alpha signaling pathway; TGF-beta signaling pathway; Clock-controlled autophagy in bone metabolism,Respiratory electron transport,ENSG00000126602
Q8IXU6,0,6,581366.8125,2.2504395422582703e-6,1.2030983915049576,0.2667546334796525,0.35452622678948703,0.8383308462007302,raw,498275.53125,669739.75,476380.71875,676430.25,586007.8125,NA,Solute carrier family 35 member F2 OS=Homo sapiens OX=9606 GN=SLC35F2 PE=1 SV=1,conjugation,cytoskeleton,catalytic activity,54733,SLC35F2,NA,NA,ENSG00000110660
Q8NI27,0,6,5214759.21875,2.0186051382544035e-5,1.202988297825372,0.26662260863916243,0.14928255988104763,0.6638855679885327,raw,5301287.0625,4946185.375,4098565.125,5950203.125,4991566.40625,6000748.21875,THO complex subunit 2 OS=Homo sapiens OX=9606 GN=THOC2 PE=1 SV=2,cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,membrane,RNA binding,57187,THOC2,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000125676
Q96GJ1,0.16666666666666666,6,9698481.75,3.754229921762207e-5,1.2026626064741641,0.2662319673376509,0.21168315442237085,0.7020295967770634,raw,7973958.5,7962348.25,7913206.25,9576018.5,9458495,15306864,tRNA (uracil(54)-C(5))-methyltransferase homolog OS=Homo sapiens OX=9606 GN=TRMT2B PE=1 SV=1,cellular component movement;cellular homeostasis,endosome,structural molecule activity,79979,TRMT2B,NA,NA,ENSG00000188917
P04899,0,6,92295312.59244792,3.5727017187299877e-4,1.202629285228115,0.2661919951441719,0.3226926510786626,0.8037523716522456,raw,94307194.15625,79526564.3984375,82989879.9375,113416593.5,79311830.1875,104219813.375,Guanine nucleotide-binding protein G(i) subunit alpha-2 OS=Homo sapiens OX=9606 GN=GNAI2 PE=1 SV=3,cell death;cell differentiation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;structural molecule activity,2771,GNAI2,Thyroid stimulating hormone (TSH) signaling pathway; Corticotropin-releasing hormone signaling pathway; S1P receptor signal transduction; Complement system; G protein signaling pathways; Chemokine signaling pathway; Hippo signaling regulation pathways; Purinergic signaling; Calcium regulation in cardiac cells; Serotonin HTR1 group and FOS pathway,"G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Adrenaline,noradrenaline inhibits insulin secretion",ENSG00000114353
Q02750,0,6,12518524.9375,4.845853413776735e-5,1.2025333151466606,0.2660768631687787,0.39374731138730035,0.87714149171028,raw,11185846.75,13555386.25,9239578.25,17445622.625,10233362.375,13451353.375,Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens OX=9606 GN=MAP2K1 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;mitochondrion;nucleus,DNA binding;signal transducer activity;structural molecule activity,5604,MAP2K1,"IL-5 signaling pathway; Osteopontin signaling; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; Thyroxine (thyroid hormone) production; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; Endothelin pathways; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; AGE/RAGE pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Aryl hydrocarbon receptor pathway; Common pathways underlying drug addiction; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Bladder cancer; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; IL6 signaling pathway; TGF-beta signaling pathway; BDNF-TrkB signaling; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Ethanol metabolism production of ROS by CYP2E1; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Hepatitis B infection; Melanoma; Netrin-UNC5B signaling pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Host-pathogen interaction of human coronaviruses - MAPK signaling; IL-2 signaling pathway; MAPK pathway in congenital thyroid cancer; Malignant pleural mesothelioma; Regulation of actin cytoskeleton; Alzheimer's disease; GDNF signaling; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; Estrogen signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling; Serotonin receptor 4/6/7 and NR3C signaling; Toll-like receptor signaling pathway",Signaling by BRAF and RAF1 fusions; Uptake and function of anthrax toxins; Signal transduction by L1; RAF activation; MAP3K8 (TPL2)-dependent MAPK1/3 activation; MAPK3 (ERK1) activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; Negative feedback regulation of MAPK pathway; Signaling by MAP2K mutants,ENSG00000169032
Q8IWX8,0,6,21194136.596354168,8.204135845896522e-5,1.2022830529957895,0.2657765891270096,0.5084299897038814,0.992236492858638,raw,19784122.4375,22111727.5625,17750093.359375,23786115.125,16437089.28125,27295671.8125,Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3,cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,10523,CHERP,NA,mRNA Splicing - Major Pathway,ENSG00000085872
O15226,0,6,12685612.515625,4.9105321131362155e-5,1.202075837709137,0.265527917043698,0.3545215926180002,0.8383308462007302,raw,11780241.125,9483570.5,12359021.6875,18426002.5625,9904096,14160743.21875,NF-kappa-B-repressing factor OS=Homo sapiens OX=9606 GN=NKRF PE=1 SV=2,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,55922,NKRF,Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; Network map of SARS-CoV-2 signaling pathway,NA,ENSG00000186416
Q9H0A0,0,6,64724576.63671875,2.505453415767479e-4,1.201860871161614,0.26526989762767056,0.24570216399093986,0.7315699559274061,raw,61562213.03125,61984951.71875,50930552.4375,83896764.796875,55983762.8515625,73989214.984375,RNA cytidine acetyltransferase OS=Homo sapiens OX=9606 GN=NAT10 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,55226,NAT10,Metapathway biotransformation Phase I and II,rRNA modification in the nucleus and cytosol,ENSG00000135372
P34896,0,6,12786128.015625,4.949441120486865e-5,1.2015574044019302,0.2649055748661698,0.5202179423134377,1,raw,14974743.375,8853095.125,11559484.28125,10762536.125,12573895.40625,17993013.78125,"Serine hydroxymethyltransferase, cytosolic OS=Homo sapiens OX=9606 GN=SHMT1 PE=1 SV=1",cell growth;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,6470,SHMT1,"Glycine metabolism; Folate metabolism; One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Male infertility; Neuroinflammation and glutamatergic signaling",Metabolism of folate and pterines; Carnitine synthesis,ENSG00000176974; ENSG00000284320
Q9NZE8,0,6,2136646.0729166665,8.270841587302531e-6,1.2015226614405243,0.26486385882113084,0.4029561539022263,0.888947988048845,raw,2126402.1875,1657213.4375,2178911.875,2813692.1875,2052477.25,1991179.5,"39S ribosomal protein L35, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL35 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,51318,MRPL35,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000132313
Q9P258,0,6,84961032.71875,3.2887957047148035e-4,1.2014005343497833,0.26471721064808007,0.18471421449102404,0.6769656016800908,raw,74887662.53125,86256914.078125,70303104.9375,107828014.140625,80520422.84375,89970077.78125,Protein RCC2 OS=Homo sapiens OX=9606 GN=RCC2 PE=1 SV=2,cell communication;cell differentiation;cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,DNA binding;motor activity;structural molecule activity,55920,RCC2,NA,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000179051; ENSG00000281540
Q9NT62,0,6,6986692.083333333,2.7045107831840926e-5,1.2013911026749033,0.2647058846301541,0.4984115827278408,0.9822049486438316,raw,7055466.5625,7548382.4375,4608175.0625,8570244.875,5069324.0625,9068559.5,Ubiquitin-like-conjugating enzyme ATG3 OS=Homo sapiens OX=9606 GN=ATG3 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;nucleus,structural molecule activity,64422,ATG3,Nanoparticle triggered autophagic cell death; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Autophagy; Clock-controlled autophagy in bone metabolism,Macroautophagy,ENSG00000144848
Q9BXW7,0,6,18375810.651041668,7.113177089061109e-5,1.2013679503166674,0.2646780817654671,0.37774103108209023,0.8617583924772685,raw,21439594.4375,12540995.625,14795828.96875,25756841.625,14399077.0625,21322526.1875,Haloacid dehalogenase-like hydrolase domain-containing 5 OS=Homo sapiens OX=9606 GN=HDHD5 PE=1 SV=1,cellular homeostasis,endosome,NA,27440,HDHD5,NA,NA,ENSG00000069998
Q53H12,0,6,22894815.489583332,8.862459463226664e-5,1.201155904794398,0.26442341871721947,0.22764834537561868,0.7148463313429879,raw,23998905.5625,15666979.859375,22154904.59375,24408895.9375,22312779.859375,28826427.125,"Acylglycerol kinase, mitochondrial OS=Homo sapiens OX=9606 GN=AGK PE=1 SV=2",cell growth;cellular homeostasis;conjugation,cytoskeleton;cytosol;endosome;nucleus,signal transducer activity;structural molecule activity,55750,AGK,NA,Signaling by BRAF and RAF1 fusions; Glycerophospholipid biosynthesis,ENSG00000006530; ENSG00000262327
Q14320,0,6,9015652.260416666,3.4899103130507334e-5,1.2011465895783577,0.2644122302711202,0.05434984002998864,0.6429522395902524,raw,8028311.375,8895685.25,7671017.0625,9741405.875,9072472,10685022,Protein FAM50A OS=Homo sapiens OX=9606 GN=FAM50A PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,NA,9130,FAM50A,NA,NA,ENSG00000071859
Q9C0B0,0,6,1041393.3802083334,4.031177548282969e-6,1.2010195566845983,0.2642596432185447,0.27625076036588014,0.756515890988102,raw,1174908.46875,866725.3125,831948.59375,1235522.5625,999186.53125,1140068.8125,RING finger protein unkempt homolog OS=Homo sapiens OX=9606 GN=UNK PE=1 SV=2,defense response;metabolic process,nucleus,RNA binding;structural molecule activity,85451,UNK,NA,NA,ENSG00000132478
Q15404,0,6,4414580.78125,1.708860385390232e-5,1.2009981365684006,0.26423391260423557,0.29464988599283504,0.7760918587221847,raw,5151638.03125,3301301.75,3410702.71875,5459801.9375,3964857.25,5199183,Ras suppressor protein 1 OS=Homo sapiens OX=9606 GN=RSU1 PE=1 SV=3,development;metabolic process,cytosol;nucleus,NA,6251,RSU1,NA,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,ENSG00000148484
Q9ULV0,0,6,640966.128125,2.4811452751797403e-6,1.2008436695407572,0.2640483476644444,0.7803456515547271,1,raw,588685.578125,609229.59375,568999.28125,NA,357305.78125,1080610.40625,Unconventional myosin-Vb OS=Homo sapiens OX=9606 GN=MYO5B PE=1 SV=3,cell growth;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,4645,MYO5B,Alstrom syndrome,Vasopressin regulates renal water homeostasis via Aquaporins,ENSG00000167306
P78537,0.16666666666666666,6,1307433.7447916667,5.061005435637891e-6,1.2008277420997242,0.26402921229056997,0.11432981276997344,0.6429522395902524,raw,922049.625,1246356.21875,1307706.53125,1451696.5625,1570330.28125,1346463.25,Biogenesis of lysosome-related organelles complex 1 subunit 1 OS=Homo sapiens OX=9606 GN=BLOC1S1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endosome;mitochondrion;nucleus,NA,2647,BLOC1S1,Alstrom syndrome,Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis,ENSG00000135441
Q9NYF8,0.5,6,56694570.86914063,2.1946162280337924e-4,1.2008241513394533,0.264024898283157,0.22704208461180267,0.7148463313429879,raw,49823798.171875,57777109.9746094,49199401.2832031,59829620.15625,52866387.0039063,70671108.625,Bcl-2-associated transcription factor 1 OS=Homo sapiens OX=9606 GN=BCLAF1 PE=1 SV=2,cellular component movement;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,9774,BCLAF1,Interactome of polycomb repressive complex 2 (PRC2),NA,ENSG00000029363
Q9UKV3,0,6,55904986.838541664,2.1640518565184234e-4,1.2007883385497462,0.2639818714132251,0.13502165050481388,0.653345503642978,raw,47968366.75,54597244.4375,49951399.5625,65219414.28125,52133761.5625,65559734.4375,Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens OX=9606 GN=ACIN1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,22985,ACIN1,NA,Apoptotic cleavage of cellular proteins,ENSG00000100813
Q14683,0,6,46082297.614583336,1.7838208600868887e-4,1.2007650812688446,0.2639539285296353,0.2881637405918955,0.7683277361586631,raw,42547497.9375,45699483.40625,39707944.8125,54874343.90625,39911341.75,53753173.875,Structural maintenance of chromosomes protein 1A OS=Homo sapiens OX=9606 GN=SMC1A PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,8243,SMC1A,miRNA regulation of DNA damage response; Cell cycle; Retinoblastoma gene in cancer; Constitutive androstane receptor pathway; Nuclear receptors meta-pathway; Pathways affected in adenoid cystic carcinoma; ATM signaling in development and disease ; mRNA processing; Regulation of sister chromatid separation at the metaphase-anaphase transition; Rett syndrome causing genes; CAMKK2 pathway; Cohesin complex - Cornelia de Lange syndrome; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; DNA damage response,Meiotic synapsis; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,ENSG00000072501
P10809,0,6,2165084480.511395,0.008380925127666361,1.2006383964703515,0.2638017112680166,0.3763758943354651,0.8615698665976935,raw,2219043314.48438,2025340630.37109,1717260800.57227,2664268606.80078,1727930313.72266,2636663217.11719,"60 kDa heat shock protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPD1 PE=1 SV=2",cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;mitochondrion;nucleus,RNA binding;structural molecule activity,3329,HSPD1,Apoptosis-related network due to altered Notch3 in ovarian cancer; Sudden infant death syndrome (SIDS) susceptibility pathways,Mitochondrial protein import; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,ENSG00000144381
Q96FJ2,0,6,13960710,5.4041154648813835e-5,1.2006350497513223,0.26379768982268365,0.345644950447519,0.8277692477090556,raw,13196586.5,11403516,10806492.5,13691461,11588466,23077738,"Dynein light chain 2, cytoplasmic OS=Homo sapiens OX=9606 GN=DYNLL2 PE=1 SV=1",metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,140735,DYNLL2,Ciliary landscape; Intraflagellar transport proteins binding to dynein; 3q29 copy number variation syndrome,Separation of Sister Chromatids; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Intraflagellar transport; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; HCMV Early Events; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Macroautophagy; Activation of BMF and translocation to mitochondria,ENSG00000264364
Q15056,0,6,79320015.59375,3.070434977481925e-4,1.2004535044174338,0.263579526645868,0.12449421169520843,0.6445597830897484,raw,71049845.5,77753046.375,70981554.8125,86826356,75970373.875,93338917,Eukaryotic translation initiation factor 4H OS=Homo sapiens OX=9606 GN=EIF4H PE=1 SV=5,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,protein binding;RNA binding,7458,EIF4H,Translation factors; 7q11.23 copy number variation syndrome,L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit,ENSG00000106682
O00203,0,6,45288991.427083336,1.7531124058875334e-4,1.2002767118430713,0.2633670431531104,0.22062826993904094,0.7095995211052282,raw,41832923.0625,45849162.46875,36738866.3125,55031681.96875,40689828.09375,51591486.65625,AP-3 complex subunit beta-1 OS=Homo sapiens OX=9606 GN=AP3B1 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,8546,AP3B1,NA,Golgi Associated Vesicle Biogenesis; Signaling by BRAF and RAF1 fusions,ENSG00000132842
Q9UP83,0,6,1609489.0911458333,6.230245372920919e-6,1.2000545009849906,0.26309992792985515,0.4092298913349604,0.8935675900241862,raw,1530021.40625,1390685.875,1302501.859375,2545237.75,1668898.84375,1219588.8125,Conserved oligomeric Golgi complex subunit 5 OS=Homo sapiens OX=9606 GN=COG5 PE=1 SV=3,cell growth;cellular homeostasis;conjugation,cytoskeleton;cytosol;extracellular;membrane,NA,10466,COG5,NA,COPI-mediated anterograde transport; Intra-Golgi traffic; Retrograde transport at the Trans-Golgi-Network,ENSG00000164597
Q8WV22,0,6,1076926.2291666667,4.168723288125014e-6,1.199713194433838,0.2626895538148682,0.9706460914476064,1,raw,1009436.90625,1170348.625,1033785.28125,1305630.8125,538273.0625,1404082.6875,Non-structural maintenance of chromosomes element 1 homolog OS=Homo sapiens OX=9606 GN=NSMCE1 PE=1 SV=5,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,197370,NSMCE1,NA,SUMOylation of DNA damage response and repair proteins,ENSG00000169189
Q16706,0,6,1190426.375,4.608076224590429e-6,1.1995454953702298,0.26248787601426143,0.3623743075502396,0.8454202181768983,raw,893328.1875,1270367.53125,997542.09375,1196597.125,1014659.875,1770063.4375,Alpha-mannosidase 2 OS=Homo sapiens OX=9606 GN=MAN2A1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytoskeleton;extracellular,structural molecule activity,4124,MAN2A1,NA,Intra-Golgi traffic; Reactions specific to the complex N-glycan synthesis pathway; Maturation of spike protein,ENSG00000112893
Q9BUB7,0,6,5230085.885416667,2.024538008169932e-5,1.1994726003274454,0.2624002023806599,0.6574359047587301,1,raw,5099477,5517449.875,3616884.6875,8685138.75,2344882.0625,6116682.9375,"Transmembrane protein 70, mitochondrial OS=Homo sapiens OX=9606 GN=TMEM70 PE=1 SV=2",cell growth,cytoskeleton;endosome;membrane,structural molecule activity,54968,TMEM70,NA,NA,ENSG00000175606
Q15393,0,6,131099585.984375,5.074794190680185e-4,1.199471179985809,0.26239849402896626,0.19567154521993702,0.6857975396967068,raw,130675108.0625,111892118.0625,116067967.890625,153331402.3125,117889893.515625,156741026.0625,Splicing factor 3B subunit 3 OS=Homo sapiens OX=9606 GN=SF3B3 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,23450,SF3B3,mRNA processing,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000189091
Q9UNS2,0,6,29395351.828125,1.1378781982434959e-4,1.1993278706966939,0.26222611477034763,0.2229777120764136,0.7114915236088185,raw,27764858.5,28053743.78125,23289234.125,33299168.625,25911307.8125,38053798.125,COP9 signalosome complex subunit 3 OS=Homo sapiens OX=9606 GN=COPS3 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytosol;membrane;nucleus,NA,8533,COPS3,Ciliary landscape,Formation of TC-NER Pre-Incision Complex; Neddylation; Cargo recognition for clathrin-mediated endocytosis; DNA Damage Recognition in GG-NER,ENSG00000141030
Q92930,0,6,8510123.578125,3.2942228895662906e-5,1.19924680382119,0.26212859453838927,0.11723097985901586,0.6429522395902524,raw,7825003.1875,8698770.25,6328540.78125,9670428.875,9384110.0625,9153888.3125,Ras-related protein Rab-8B OS=Homo sapiens OX=9606 GN=RAB8B PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,51762,RAB8B,Ectoderm differentiation; Ectoderm differentiation,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; TBC/RABGAPs,ENSG00000166128
O75817,0,6,1393530.4375,5.394281084612939e-6,1.19921967598549,0.2620959593572303,0.17015528393061063,0.668039680404208,raw,1122642.625,1485915.375,1217515.875,1539837.875,1346295.125,1648975.75,Ribonuclease P protein subunit p20 OS=Homo sapiens OX=9606 GN=POP7 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,10248,POP7,NA,tRNA processing in the nucleus,ENSG00000172336
Q13155,0,6,29882257.59375,1.1567260575425858e-4,1.1991860800408312,0.262055541923579,0.16275699461067802,0.6638855679885327,raw,29405878.28125,26564797.875,26189687.359375,35263119.90625,27594347.765625,34275714.375,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 OS=Homo sapiens OX=9606 GN=AIMP2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7965,AIMP2,Osteoclast signaling; Transcriptional activation by NRF2 in response to phytochemicals; NRF2-ARE regulation,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,ENSG00000106305
P62241,0,6,219718423.3203125,8.505181537218774e-4,1.1991037683345827,0.26195651245010737,0.27880695420839374,0.7591598077731446,raw,193869675.671875,220572441.796875,198355246.734375,237848523.828125,197347283.859375,270317368.03125,40S ribosomal protein S8 OS=Homo sapiens OX=9606 GN=RPS8 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,6202,RPS8,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000142937
Q05209,0,6,2925736.40625,1.1325367663379661e-5,1.1987161904630441,0.26149012490833634,0.30665886095235645,0.787259868285476,raw,2100895.75,2488635.59375,2415426.96875,5249999.0625,2518377.75,2781083.3125,Tyrosine-protein phosphatase non-receptor type 12 OS=Homo sapiens OX=9606 GN=PTPN12 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,5782,PTPN12,EGF/EGFR signaling pathway,Signaling by PDGF; SHC1 events in ERBB2 signaling; Downregulation of ERBB2 signaling; EGFR downregulation; Interleukin-37 signaling; Constitutive Signaling by Overexpressed ERBB2,ENSG00000127947
A0A087WYP4,0.6666666666666666,6,833711.3,3.22725142888604e-6,1.1980129940811453,0.2606435562024609,0.6512170509325247,1,raw,603671.4375,1076058,716518.25,987284.5625,NA,785024.25,Secretory carrier-associated membrane protein 4 OS=Homo sapiens OX=9606 GN=SCAMP4 PE=4 SV=1,NA,NA,NA,NA,SCAMP4,NA,NA,ENSG00000227500
P27695,0,6,109741041.11979167,4.24801645079405e-4,1.1978850079586654,0.26048942197452396,0.27452593144896814,0.7551026273759062,raw,114564710.0625,94426611.875,86803319.84375,133894652.125,91521604.1875,137235348.625,DNA-(apurinic or apyrimidinic site) endonuclease OS=Homo sapiens OX=9606 GN=APEX1 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,endoplasmic reticulum;endosome;extracellular;Golgi;membrane;nucleus,RNA binding;structural molecule activity,328,APEX1,"Thyroid stimulating hormone (TSH) signaling pathway; Spinal cord injury; Base excision repair; DNA repair pathways, full network",Displacement of DNA glycosylase by APEX1; POLB-Dependent Long Patch Base Excision Repair; PCNA-Dependent Long Patch Base Excision Repair; Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,ENSG00000100823
Q96I99,0,6,40359326.052083336,1.5622877208269038e-4,1.1977721294876313,0.2603534682873632,0.2622332153140482,0.7434453518424705,raw,41372181.1875,32309767.3125,36500292.75,49554445.5625,34766421.5625,47652847.9375,"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=SUCLG2 PE=1 SV=2",cellular homeostasis,cytoplasm;cytoskeleton;endosome;nucleus,structural molecule activity,8801,SUCLG2,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Metabolic reprogramming in colon cancer; TCA cycle (aka Krebs or citric acid cycle),Citric acid cycle (TCA cycle),ENSG00000172340
Q9Y2W1,0,6,99174218.24479167,3.838980442500418e-4,1.197741543232266,0.2603166272211319,0.5059976946615147,0.989873157379785,raw,93649722.6875,95077714.03125,89275875.21875,129880429.25,74993404.90625,112168163.375,Thyroid hormone receptor-associated protein 3 OS=Homo sapiens OX=9606 GN=THRAP3 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,9967,THRAP3,Interactome of polycomb repressive complex 2 (PRC2),PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation,ENSG00000054118
Q9H9A6,0,6,1700453.625,6.582364172148915e-6,1.197685788032367,0.26024946780505387,0.13971125736827028,0.6572502130392559,raw,1510770.75,1789198.8125,1267825,1719789.90625,1809428.65625,2105708.625,Leucine-rich repeat-containing protein 40 OS=Homo sapiens OX=9606 GN=LRRC40 PE=1 SV=1,development,nucleus,structural molecule activity,55631,LRRC40,NA,NA,ENSG00000066557
O75340,0,6,13888387.677083334,5.376119884160195e-5,1.197626996241296,0.26017864730428497,0.2988567452244408,0.7805333494403178,raw,14301389.0625,10993825.25,12814006.875,16303321.75,11790053.5,17127729.625,Programmed cell death protein 6 OS=Homo sapiens OX=9606 GN=PDCD6 PE=1 SV=1,cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,10016,PDCD6,Epithelial to mesenchymal transition in colorectal cancer,NA,ENSG00000249915
P55039,0,6,3979028.0208333335,1.5402602634523446e-5,1.1976090239299446,0.2601569971919436,0.19771617909840802,0.6875760999904456,raw,4136955.875,3186927.6875,3233850.8125,4954455.6875,3468965.625,4893012.4375,Developmentally-regulated GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=DRG2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development,cytosol;membrane;nucleus,RNA binding;structural molecule activity,1819,DRG2,NA,NA,ENSG00000108591
P05198,0,6,144625889.02083334,5.598390078152931e-4,1.1975182669555355,0.2600476630137836,0.33382122049563945,0.8171785949329411,raw,138077886.8125,143703621.0625,120081556.9375,171995228.375,121809329.6875,172087711.25,Eukaryotic translation initiation factor 2 subunit 1 OS=Homo sapiens OX=9606 GN=EIF2S1 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;Golgi;membrane;nucleus,protein binding;RNA binding,1965,EIF2S1,Translation factors; Alzheimer's disease and miRNA effects; Brain-derived neurotrophic factor (BDNF) signaling pathway; Ebola virus infection in host; Nonalcoholic fatty liver disease; Measles virus infection; Unfolded protein response; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell; Alzheimer's disease,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; ABC-family proteins mediated transport; Response of EIF2AK1 (HRI) to heme deficiency; PERK regulates gene expression; Recycling of eIF2:GDP; Response of EIF2AK4 (GCN2) to amino acid deficiency",ENSG00000134001
A0A2R8YGD3,0.8333333333333334,6,22099047.333333332,8.554421906422549e-5,1.1970365347755663,0.25946718547703906,0.26327583578319536,0.7438355132238149,raw,16382968,24298986,17480090,27006952,18338514,29086774,Cyclic nucleotide ras GEF OS=Homo sapiens OX=9606 GN=RAPGEF2 PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,DNA binding,NA,RAPGEF2,MAPK signaling pathway,NA,ENSG00000109756
Q96EV2,0,6,790863.9505208334,3.0613916524494965e-6,1.1970299125103843,0.25945920415375673,0.7198123117227648,1,raw,1243367.203125,101720.71875,765558.765625,1488347.734375,479345.71875,666843.5625,RNA-binding protein 33 OS=Homo sapiens OX=9606 GN=RBM33 PE=1 SV=3,NA,NA,NA,155435,RBM33,NA,NA,ENSG00000184863
O95271,0.16666666666666666,6,201011.6484375,7.781052381593726e-7,1.1964684732244513,0.2587823825663606,1,1,raw,NA,183031.671875,NA,218991.625,NA,NA,Poly [ADP-ribose] polymerase tankyrase-1 OS=Homo sapiens OX=9606 GN=TNKS PE=1 SV=2,cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,structural molecule activity,8658,TNKS,NAD+ biosynthetic pathways; Regulation of Wnt / B-catenin signaling by small molecule compounds,Degradation of AXIN; Ub-specific processing proteases; Regulation of PTEN stability and activity; XAV939 stabilizes AXIN,ENSG00000173273
Q9Y5T5,0,6,1225894.3854166667,4.74537097793842e-6,1.1964316764806482,0.2587380125747283,0.4341882946696736,0.9176747809749992,raw,815293.578125,1316922.125,1207829.859375,1691241.5625,975443.0625,1348636.125,Ubiquitin carboxyl-terminal hydrolase 16 OS=Homo sapiens OX=9606 GN=USP16 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,10600,USP16,NA,Ub-specific processing proteases,ENSG00000156256
O00170,0,6,19432565.713541668,7.522241268164316e-5,1.196342786790311,0.258630822601362,0.3313226698266601,0.8138862937420218,raw,16878150.0625,20207411.5625,16511588.53125,22578484.5,16244768.5625,24174991.0625,AH receptor-interacting protein OS=Homo sapiens OX=9606 GN=AIP PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
Q9UBW8,0,6,7536975,2.9175223291597893e-5,1.1962550242555692,0.25852498402446455,0.5885806297923006,1,raw,7199299.875,7630670.25,6630645.25,9088413.75,5544593.25,9128227.625,COP9 signalosome complex subunit 7a OS=Homo sapiens OX=9606 GN=COPS7A PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,NA,50813,COPS7A,Ciliary landscape,Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; DNA Damage Recognition in GG-NER,ENSG00000111652
Q96RS6,0,6,42490637.385416664,1.64478963181097e-4,1.1962208200564082,0.2584837328422402,0.3772068493408587,0.8616098076180547,raw,39995661.03125,42234204.8125,35087430.5625,55082305.1875,34700580.28125,47843642.4375,NudC domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NUDCD1 PE=1 SV=2,metabolic process,cytosol;membrane,NA,84955,NUDCD1,NA,NA,ENSG00000120526
P83731,0,6,157240442.83333334,6.086692645434321e-4,1.1960340967493448,0.2582585187249876,0.16531717033960883,0.6649444907331472,raw,137291440.5,160431422.5,133333800.5,173184958,147319584,191881451.5,60S ribosomal protein L24 OS=Homo sapiens OX=9606 GN=RPL24 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;defense response,cytosol;extracellular;Golgi;nucleus,RNA binding;structural molecule activity,6152,RPL24,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000114391
P42696,0,6,5022952.455729167,1.9443577758846014e-5,1.1957737933793031,0.25794449820175214,0.1782301149029956,0.6741527184744509,raw,4920734.4375,4606369.375,4481020.296875,5921446.78125,5508175.78125,4699968.0625,RNA-binding protein 34 OS=Homo sapiens OX=9606 GN=RBM34 PE=1 SV=2,NA,membrane;nucleus,NA,23029,RBM34,NA,NA,ENSG00000188739
Q5TCS8,0.3333333333333333,6,429227.9947916667,1.6615183931287677e-6,1.1954976255887755,0.25761126467547113,0.3967976808989418,0.8797635571156612,raw,265421.0625,498659.71875,372744.5625,571974.5625,317310.25,549257.8125,Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2,cellular homeostasis,cytoskeleton;cytosol;endosome;membrane;nucleus,signal transducer activity;structural molecule activity,221264,AK9,NA,Interconversion of nucleotide di- and triphosphates,ENSG00000155085
B5MDF5,0,6,538688469.5416666,0.0020852339809389383,1.1954895579974267,0.2576015288859105,0.3987708013136907,0.8828783020957324,raw,533341643.375,533845443,442015205.5,637604365.5,444046639,641277520.875,GTP-binding nuclear protein Ran OS=Homo sapiens OX=9606 GN=RAN PE=1 SV=1,conjugation,membrane,structural molecule activity,NA,RAN,22q11.2 copy number variation syndrome,NA,ENSG00000132341
Q10713,0,6,69695298.34505208,2.697867369324467e-4,1.1954006961348693,0.2574942880217402,0.23496709117169062,0.7192904383575112,raw,59498061.125,68293276.9921875,58093265.6875,71124023.6875,65318251.828125,95844910.75,Mitochondrial-processing peptidase subunit alpha OS=Homo sapiens OX=9606 GN=PMPCA PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;endosome,structural molecule activity,23203,PMPCA,NA,Mitochondrial protein import; Processing of SMDT1,ENSG00000165688
Q6ZRY4,0.3333333333333333,6,230242.98046875,8.912581462057117e-7,1.1950750269141697,0.2571011935694099,0.7109249364370245,1,raw,159189.21875,273386.5,NA,230061.15625,258335.046875,NA,RNA-binding protein with multiple splicing 2 OS=Homo sapiens OX=9606 GN=RBPMS2 PE=1 SV=1,defense response;metabolic process,nucleus,RNA binding;structural molecule activity,348093,RBPMS2,NA,NA,ENSG00000166831
Q5JWT2,0,6,1765093.46875,6.83258151729604e-6,1.1950102175475155,0.2570229535550717,0.46676558577391436,0.9485672170384823,raw,1816228.0625,1567997.96875,1279403.953125,1873773.59375,1225202.140625,2827955.09375,Mediator complex subunit 23 OS=Homo sapiens OX=9606 GN=MED23 PE=1 SV=1,NA,membrane,NA,NA,MED23,NA,NA,ENSG00000112282
P46087,0,6,67445058.82291667,2.6107618123631145e-4,1.1948748379047147,0.2568595050753473,0.32952252763625123,0.8114420357674528,raw,63307285.5,64985845.8125,54682174.9375,90460597.125,55590167.0625,75644282.5,Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase OS=Homo sapiens OX=9606 GN=NOP2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,4839,NOP2,Imatinib and chronic myeloid leukemia,rRNA modification in the nucleus and cytosol; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,ENSG00000111641
Q86WC4,0.6666666666666666,6,417702.30625,1.6169030750744374e-6,1.1947379647851382,0.25669423464254937,0.41742762705342534,0.9038582714714452,raw,415461.75,NA,313365.5625,393492.59375,355286.875,610904.75,Osteopetrosis-associated transmembrane protein 1 OS=Homo sapiens OX=9606 GN=OSTM1 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;cytosol;mitochondrion,NA,28962,OSTM1,Autosomal recessive osteopetrosis pathways,Stimuli-sensing channels,ENSG00000081087
A0A3B3IU42,0,6,2543646.9270833335,9.846319919150997e-6,1.1945352026303182,0.2564493702545586,0.3517597378432123,0.8364222954108064,raw,2503986.4375,2005037.6875,2475346.8125,3245181.75,2075439.96875,2956888.90625,Gem-associated protein 2 OS=Homo sapiens OX=9606 GN=GEMIN2 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,NA,NA,GEMIN2,NA,NA,ENSG00000092208
Q8WYQ5,0,6,165286.185546875,6.398139001849626e-7,1.194379154639451,0.2562608916159672,0.7004148785430298,1,raw,196439.953125,NA,109762.7109375,210192.65625,144749.421875,NA,Microprocessor complex subunit DGCR8 OS=Homo sapiens OX=9606 GN=DGCR8 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,54487,DGCR8,miRNA biogenesis; exRNA mechanism of action and biogenesis; DDX1 as a regulatory component of the Drosha microprocessor; 22q11.2 copy number variation syndrome,Transcriptional Regulation by MECP2; MicroRNA (miRNA) biogenesis,ENSG00000128191
P14324,0,6,83567044.86458333,3.234835187516474e-4,1.1943707793952987,0.2562507750918113,0.4495180026566689,0.9302873302266939,raw,68550596.46875,81501912.375,71848061.375,131827592.65625,61860881.25,85813225.0625,Farnesyl pyrophosphate synthase OS=Homo sapiens OX=9606 GN=FDPS PE=1 SV=4,cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,2224,FDPS,Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,ENSG00000160752
Q8N4B4,0.5,6,4050352.75,1.567869681019077e-5,1.1943328301760483,0.2562049350384842,0.5087511316760304,0.992236492858638,raw,3872636,3146508,3405827,7349598,2459856.5,4067691,F-box only protein 39 OS=Homo sapiens OX=9606 GN=FBXO39 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,nucleus,NA,162517,FBXO39,NA,NA,ENSG00000177294
Q9BPW8,0,6,51547921.3125,1.9953922024551038e-4,1.1941694836979042,0.25600760707027276,0.36381892406166044,0.8458062414401234,raw,55189898,36581505,49350456.5,59292732,42966844.375,65906092,Protein NipSnap homolog 1 OS=Homo sapiens OX=9606 GN=NIPSNAP1 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;endosome,structural molecule activity,8508,NIPSNAP1,NA,NA,ENSG00000184117
O95573,0,6,50428447.510416664,1.9520579759983682e-4,1.1941414869997553,0.2559737834199373,0.18668949473915616,0.6790811483756987,raw,41692346.375,53245187.8125,37892368.375,61652093.75,44506401,63582287.75,Long-chain-fatty-acid--CoA ligase 3 OS=Homo sapiens OX=9606 GN=ACSL3 PE=1 SV=3,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,2181,ACSL3,Fatty acid beta-oxidation; Fatty acid biosynthesis; Mitochondrial long chain fatty acid beta-oxidation; PPAR signaling pathway; Ferroptosis; Thermogenesis; Ciliary landscape; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-3 / omega-6 fatty acid synthesis; Omega-9 fatty acid synthesis; Fatty acid transporters,Synthesis of very long-chain fatty acyl-CoAs; Intracellular metabolism of fatty acids regulates insulin secretion,ENSG00000123983
Q9BQ52,0,6,28990816.17578125,1.1222188415565743e-4,1.19413716824894,0.25596856573700866,0.23518257044941873,0.7192904383575112,raw,26728232.6875,28870389.1328125,24804927.1875,31917176.09375,26274070.953125,35350101,Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens OX=9606 GN=ELAC2 PE=1 SV=2,cellular component movement;cellular homeostasis,cytosol;endosome;membrane,structural molecule activity,60528,ELAC2,NA,"tRNA processing in the nucleus; tRNA processing in the mitochondrion; rRNA processing in the mitochondrion; tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis",ENSG00000006744
A6NE01,0.8333333333333334,6,2118522.4583333335,8.20068605377355e-6,1.1940858566103738,0.2559065723253884,0.17551848549760588,0.6697819849820321,raw,1859280.25,1882993.875,1707772.375,2036066,2220140.25,3004882,Protein FAM186A OS=Homo sapiens OX=9606 GN=FAM186A PE=2 SV=3,NA,NA,NA,121006,FAM186A,NA,NA,ENSG00000185958
P61604,0,6,539656285.2838541,0.0020889803434230177,1.1940431359365338,0.25585495626571036,0.42794867797061675,0.9124139991183745,raw,538122001.9375,520956172.0625,437105812.703125,696482495.75,423227087.875,622044141.375,"10 kDa heat shock protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPE1 PE=1 SV=2",coagulation;metabolic process,endosome,structural molecule activity,3336,HSPE1,NA,RHOG GTPase cycle,ENSG00000115541
Q99436,0,6,75226882.546875,2.911992007185756e-4,1.1940152054101152,0.2558212089897266,0.28488732590866045,0.7650856811136656,raw,73976526.03125,69046164.625,64361659.96875,95435577.625,66099196.59375,82442170.4375,Proteasome subunit beta type-7 OS=Homo sapiens OX=9606 GN=PSMB7 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cell surface;cytosol;membrane;nucleus,structural molecule activity,5695,PSMB7,Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease,Neutrophil degranulation; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000136930
P61011,0,6,28922807.140625,1.1195862485248476e-4,1.193979107568128,0.255777592321678,0.24069762220920446,0.7263138257852598,raw,26283821.34375,25762432.9375,25728551.75,30759806.6875,26284508.6875,38717721.4375,Signal recognition particle 54 kDa protein OS=Homo sapiens OX=9606 GN=SRP54 PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,cytosol;extracellular;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6729,SRP54,VEGFA-VEGFR2 signaling pathway; mRNA processing,SRP-dependent cotranslational protein targeting to membrane,ENSG00000100883
P54727,0,6,102972869.8046875,3.986024193430914e-4,1.1937813795876442,0.25553865614773963,0.1705371317374881,0.668039680404208,raw,87327219.625,104909252.453125,88477616.1875,117281787.5,94602630.9375,125238712.125,UV excision repair protein RAD23 homolog B OS=Homo sapiens OX=9606 GN=RAD23B PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5887,RAD23B,"Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Josephin domain DUBs; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER; N-glycan trimming in the ER and Calnexin/Calreticulin cycle,ENSG00000119318
Q9Y285,0,6,47675347.93164062,1.8454869777466886e-4,1.1937691605842273,0.25552388930168746,0.17914978924526487,0.6741527184744509,raw,48888306.5625,40758047.5625,39238297.6269531,55710071.4375,43096011.7128906,58361352.6875,Phenylalanine--tRNA ligase alpha subunit OS=Homo sapiens OX=9606 GN=FARSA PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;nucleus,RNA binding;structural molecule activity,2193,FARSA,NA,Cytosolic tRNA aminoacylation,ENSG00000179115
P51970,0,6,15168994.770833334,5.8718359759471585e-5,1.1936836341053925,0.25542052505741253,0.5554730449847891,1,raw,16047532.375,12820906.5625,13060631.125,22492394.5,11002242.4375,15590261.625,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 OS=Homo sapiens OX=9606 GN=NDUFA8 PE=1 SV=3,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity;structural molecule activity,4702,NDUFA8,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000119421
Q86X27,0.6666666666666666,6,959726.0416666666,3.715047690139132e-6,1.193670491203666,0.25540464035983634,0.23788478288645018,0.7230836463868617,raw,782779.9375,955966.9375,891752.0625,934381.3125,950397,1243079,Ras-specific guanine nucleotide-releasing factor RalGPS2 OS=Homo sapiens OX=9606 GN=RALGPS2 PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton;nucleus,DNA binding,55103,RALGPS2,NA,NA,ENSG00000116191
P23246,0,6,224761023.52864584,8.700377868702405e-4,1.1933298630708322,0.2549928913456544,0.2164225267174215,0.7052519353827845,raw,219780763.3125,218052278.640625,180436900.6875,260208295.8125,201911915.15625,268175987.5625,"Splicing factor, proline- and glutamine-rich OS=Homo sapiens OX=9606 GN=SFPQ PE=1 SV=2",cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,6421,SFPQ,mRNA processing; Type 2 papillary renal cell carcinoma,Suppression of apoptosis; PTK6 Regulates Proteins Involved in RNA Processing,ENSG00000116560
Q14166,0,6,55857479.380208336,2.1622128684563812e-4,1.1933039200296829,0.25496152675417144,0.2699590223102275,0.7504180072492731,raw,61229337.0625,42432002.90625,43560772.21875,69005513.15625,45852043,73065207.9375,Tubulin--tyrosine ligase-like protein 12 OS=Homo sapiens OX=9606 GN=TTLL12 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,23170,TTLL12,NA,Carboxyterminal post-translational modifications of tubulin,ENSG00000100304
Q16543,0,6,113801809.125,4.405206587801708e-4,1.1932970862839534,0.25495326478574976,0.3038176977868075,0.7839919012018752,raw,93780462,122884761,95122937.5,124397984.5,99986682.5,146638027.25,Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1,coagulation;conjugation;metabolic process,cytosol;nucleus,DNA binding;structural molecule activity,11140,CDC37,TNF-alpha signaling pathway; Aryl hydrocarbon receptor pathway; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Interactions between LOXL4 and oxidative stress pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway,Regulation of necroptotic cell death; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; RHOBTB2 GTPase cycle; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; Constitutive Signaling by Overexpressed ERBB2; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants,ENSG00000105401
P26640,0,6,271296648.3828125,0.0010501746781474896,1.192934586843467,0.2545149367264694,0.421779002748979,0.9086347256931654,raw,279435754.5,248195841.203125,232758347.03125,333348576.34375,220142958.46875,313898412.75,Valine--tRNA ligase OS=Homo sapiens OX=9606 GN=VARS1 PE=1 SV=4,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol,structural molecule activity,7407,VARS1,Amino acid metabolism,Cytosolic tRNA aminoacylation,ENSG00000096171; ENSG00000204394; ENSG00000224264; ENSG00000226589; ENSG00000231116
P55263,0,6,29448009.5,1.1399165482910531e-4,1.1929315467114667,0.2545112600882047,0.33821612883733976,0.8216110565431962,raw,31774205.078125,25350180.25,24128848.28125,37904451.609375,25623080.96875,31907290.8125,Adenosine kinase OS=Homo sapiens OX=9606 GN=ADK PE=1 SV=2,cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane,signal transducer activity;structural molecule activity,132,ADK,Methionine metabolism leading to sulfur amino acids and related disorders,Ribavirin ADME; Purine salvage,ENSG00000156110
P36507,0,6,12905193.46875,4.9955307145380214e-5,1.192905562261809,0.2544798349447849,0.7074474327574252,1,raw,14541672.125,12017787.09375,9927508.21875,17346841.5625,7080234.375,16517117.4375,Dual specificity mitogen-activated protein kinase kinase 2 OS=Homo sapiens OX=9606 GN=MAP2K2 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;mitochondrion;nucleus,DNA binding;signal transducer activity;structural molecule activity,5605,MAP2K2,"IL-5 signaling pathway; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; Thyroxine (thyroid hormone) production; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Amyotrophic lateral sclerosis (ALS); Common pathways underlying drug addiction; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Bladder cancer; Kit receptor signaling pathway; Hepatocyte growth factor receptor signaling; IL6 signaling pathway; Pathways affected in adenoid cystic carcinoma; TGF-beta signaling pathway; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Ethanol metabolism production of ROS by CYP2E1; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Hepatitis B infection; Melanoma; Netrin-UNC5B signaling pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Host-pathogen interaction of human coronaviruses - MAPK signaling; IL-2 signaling pathway; MAPK pathway in congenital thyroid cancer; Kallmann syndrome; Malignant pleural mesothelioma; Regulation of actin cytoskeleton; Alzheimer's disease; GDNF signaling; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling; Serotonin receptor 4/6/7 and NR3C signaling; Toll-like receptor signaling pathway",Signaling by BRAF and RAF1 fusions; Uptake and function of anthrax toxins; Signal transduction by L1; RAF activation; MAPK1 (ERK2) activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; Negative feedback regulation of MAPK pathway; Signaling by MAP2K mutants,ENSG00000126934
O14618,0,6,3349065.0833333335,1.2964050116173122e-5,1.1929050230257365,0.2544791827947672,0.2118626144623787,0.7020623508840215,raw,2756453.625,2958099.5625,2763438.3125,3295828.125,3288187.375,5032383.5,Copper chaperone for superoxide dismutase OS=Homo sapiens OX=9606 GN=CCS PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9973,CCS,Amyotrophic lateral sclerosis (ALS); Copper homeostasis,Detoxification of Reactive Oxygen Species,ENSG00000173992
P30405,0,6,10613882.375,4.108576561304507e-5,1.1926812989303923,0.25420858630378634,0.49000336742304623,0.9737904765793668,raw,9121384,9905781,10511171.25,11814439.75,8034545,14295973.25,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial OS=Homo sapiens OX=9606 GN=PPIF PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endosome;nucleus,structural molecule activity,10105,PPIF,Alzheimer's disease and miRNA effects; Alzheimer's disease,NA,ENSG00000108179
O00268,0,6,620758.5403645834,2.4029227939993306e-6,1.1925380247023887,0.2540352680546604,0.34762842364860935,0.8305176189776291,raw,557161.453125,702889.765625,475797.203125,728613.6875,595652.9140625,664436.21875,Transcription initiation factor TFIID subunit 4 OS=Homo sapiens OX=9606 GN=TAF4 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,6874,TAF4,NA,RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,ENSG00000130699
Q4G0S7,0.8333333333333334,6,20545159,7.952920122282243e-5,1.192486527619982,0.25397296715687934,0.26756775262903615,0.7473260925206285,raw,16424192,18402836,19488544,21945134,17971590,29038658,Coiled-coil domain-containing protein 152 OS=Homo sapiens OX=9606 GN=CCDC152 PE=1 SV=3,NA,NA,NA,100129792,CCDC152,NA,NA,ENSG00000198865
Q9BVV7,0,6,1837823.3229166667,7.114114855973407e-6,1.192200397709071,0.25362675969365395,0.8816558837253242,1,raw,2387612.125,1282310.25,1670613.125,2846512.125,694595.1875,2145297.125,Mitochondrial import inner membrane translocase subunit Tim21 OS=Homo sapiens OX=9606 GN=TIMM21 PE=1 SV=1,cell growth;conjugation,cytoskeleton;endosome,NA,29090,TIMM21,NA,Mitochondrial protein import,ENSG00000075336
Q3LXA3,0,6,22832757.760416668,8.838437251325909e-5,1.1920588426208225,0.25345545212724996,0.705128657024304,1,raw,30711375.125,14218069.96875,19881845.40625,27323713.53125,16948776.03125,27912766.5,Triokinase/FMN cyclase OS=Homo sapiens OX=9606 GN=TKFC PE=1 SV=2,cellular homeostasis;metabolic process,cytosol,signal transducer activity;structural molecule activity,26007,TKFC,Novel intracellular components of RIG-I-like receptor pathway,SARS-CoV-2 activates/modulates innate and adaptive immune responses; DDX58/IFIH1-mediated induction of interferon-alpha/beta; SARS-CoV-1 activates/modulates innate immune responses; Fructose catabolism,ENSG00000149476
O94903,0,6,17324903.604166668,6.706376645231963e-5,1.1920118329412313,0.25339855731089733,0.5113733879916328,0.9944212432021446,raw,18464520.625,15025850,13905539.25,25797427.875,12845092.875,17910991,Pyridoxal phosphate homeostasis protein OS=Homo sapiens OX=9606 GN=PLPBP PE=1 SV=1,NA,cytosol;nucleus,structural molecule activity,11212,PLPBP,NA,NA,ENSG00000147471
P05556,0,6,134593187.58333334,5.21002962232417e-4,1.1917825055115505,0.25312097502015696,0.26339377241931944,0.7438355132238149,raw,136266726.625,118034730.90625,115113658.96875,159567503.875,116176204.25,162400300.875,Integrin beta-1 OS=Homo sapiens OX=9606 GN=ITGB1 PE=1 SV=2,cell communication;cell differentiation;cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;mitochondrion;nucleus,antioxidant activity;motor activity;structural molecule activity,3688,ITGB1,Integrin-mediated cell adhesion; Prolactin signaling pathway; Neural crest differentiation; Arrhythmogenic right ventricular cardiomyopathy; Pathogenic Escherichia coli infection; Primary focal segmental glomerulosclerosis (FSGS); Mammary gland development pathway - Embryonic development (Stage 1 of 4); Focal adhesion; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; TGF-beta signaling pathway; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; VEGFA-VEGFR2 signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Cells and molecules involved in local acute inflammatory response ; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Small cell lung cancer; Gastrin signaling pathway; Genes controlling nephrogenesis; Development of ureteric collection system; Malignant pleural mesothelioma; CCL18 signaling pathway; GDNF signaling,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Potential therapeutics for SARS; RAC1 GTPase cycle; RHOG GTPase cycle; RHO GTPases Activate Formins; HCMV Early Events; RAC2 GTPase cycle; RAC3 GTPase cycle; Integrin cell surface interactions; ECM proteoglycans; GPER1 signaling; CHL1 interactions; Interleukin-4 and Interleukin-13 signaling; Signal transduction by L1; Syndecan interactions; Other semaphorin interactions; Laminin interactions; MET activates PTK2 signaling; Basigin interactions; Platelet Adhesion to exposed collagen; Molecules associated with elastic fibres; TGF-beta receptor signaling activates SMADs; Fibronectin matrix formation; Localization of the PINCH-ILK-PARVIN complex to focal adhesions; MET interacts with TNS proteins,ENSG00000150093
Q16630,0,6,23844300.708333332,9.230000064981386e-5,1.1916627501160986,0.2529759995776745,0.3494193785480269,0.8331036551728049,raw,20842341.25,23887408,21817668,25999302.25,20539516.125,29979568.625,Cleavage and polyadenylation specificity factor subunit 6 OS=Homo sapiens OX=9606 GN=CPSF6 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,protein binding;RNA binding;structural molecule activity,11052,CPSF6,NA,Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease,ENSG00000111605
O00217,0,6,11398206.588541666,4.412184229673913e-5,1.1916551678029461,0.2529668199667621,0.25273737558085074,0.7343565802499625,raw,10871805.640625,11053144.421875,8835782.6875,12955443.375,9859773.46875,14813289.9375,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS8 PE=1 SV=1",cell growth;cellular homeostasis;coagulation;conjugation,cytoskeleton;endosome,catalytic activity;structural molecule activity,4728,NDUFS8,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000110717
P07741,0,6,62653579.192708336,2.4252862228746645e-4,1.1915940120822133,0.2528927789845708,0.2907317688359866,0.7730231021500684,raw,68110679.625,48357571.96875,51689733,74389637.75,52213574.8125,81160278,Adenine phosphoribosyltransferase OS=Homo sapiens OX=9606 GN=APRT PE=1 SV=2,cellular homeostasis;conjugation;metabolic process,cell surface;cytosol;membrane;nucleus,structural molecule activity,353,APRT,NA,Neutrophil degranulation; Purine salvage; Defective APRT disrupts adenine salvage,ENSG00000198931
P00338,0,6,1160553223.2145185,0.00449243886692834,1.1914938915358442,0.25277155524321954,0.35906384187596924,0.8420882601494262,raw,1117915262.5,1174665482.30664,924964241.082031,1331989206.52344,967135216.21875,1446649930.65625,L-lactate dehydrogenase A chain OS=Homo sapiens OX=9606 GN=LDHA PE=1 SV=2,cellular homeostasis,cytosol;nucleus,structural molecule activity,3939,LDHA,Cori cycle; HIF1A and PPARG regulation of glycolysis; Photodynamic therapy-induced HIF-1 survival signaling; VEGFA-VEGFR2 signaling pathway; Amino acid metabolism; Clear cell renal cell carcinoma pathways; PI3K/AKT/mTOR - vitamin D3 signaling; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Glycolysis in senescence; CCL18 signaling pathway; Glucose metabolism in triple-negative breast cancer cells; Glycolysis and gluconeogenesis,Pyruvate metabolism,ENSG00000134333; ENSG00000288299
Q96A26,0,6,17931547.75,6.941205318714733e-5,1.1914708298750354,0.2527436312514075,0.5699056443379715,1,raw,19485741,14763124.25,16580008.25,23216692,13723417,19820304,Protein FAM162A OS=Homo sapiens OX=9606 GN=FAM162A PE=1 SV=2,coagulation;metabolic process,cytoskeleton;cytosol;endosome,NA,26355,FAM162A,NA,NA,ENSG00000114023
Q8IXK2,0,6,731653.265625,2.8321902880978324e-6,1.1914545456530568,0.2527239133311277,1,1,raw,889204.5,686931,532030.5,818447.0625,NA,NA,Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens OX=9606 GN=GALNT12 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,79695,GALNT12,NA,O-linked glycosylation of mucins; Defective GALNT12 causes CRCS1,ENSG00000119514
P49821,0,6,30193589.53125,1.1687775487500904e-4,1.1913543269129676,0.25260255648956087,0.39014622611640537,0.874922600545966,raw,32594437.375,22547686.90625,27805566.09375,38831524,24407891.625,34974431.1875,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFV1 PE=1 SV=4",cellular homeostasis;conjugation,cytoskeleton;cytosol;endosome,catalytic activity;structural molecule activity,4723,NDUFV1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000167792
J3QRU1,0,6,12625899.895833334,4.8874176804128995e-5,1.1913532718604363,0.25260127885141875,0.15489947326743359,0.6638855679885327,raw,10176317.84375,13115944.484375,11232114.609375,12810179.5,12795119.5625,15625723.375,Tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=YES1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol,signal transducer activity;structural molecule activity,NA,YES1,NRF2-ARE regulation,NA,ENSG00000176105
P62857,0,6,80830325.41666667,3.1288982552864653e-4,1.1911717999607183,0.25238150478617466,0.6075095457764275,1,raw,84546472.6875,77909845.375,66031838,107116164,56573621.6875,92804010.75,40S ribosomal protein S28 OS=Homo sapiens OX=9606 GN=RPS28 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,6234,RPS28,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000233927
A0A0C4DGB5,0,6,33788831.510416664,1.3079474246346646e-4,1.1910752675241791,0.2522645841951435,0.45153455924385905,0.9336390139113204,raw,33630082.28125,31768867.34375,30558858.875,40055959.25,27888567.75,38830653.5625,Calpain inhibitor OS=Homo sapiens OX=9606 GN=CAST PE=1 SV=1,NA,NA,DNA binding,NA,CAST,NA,NA,ENSG00000153113
O75608,0,6,18941838.6875,7.332283485897725e-5,1.1910535822732604,0.25223831760258336,0.4606924096701516,0.9425587783849652,raw,19010049.3125,17585035.6875,15913167.875,25530395.25,14667664.25,20944719.75,Acyl-protein thioesterase 1 OS=Homo sapiens OX=9606 GN=LYPLA1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,10434,LYPLA1,NA,RAS processing; eNOS activation,ENSG00000120992
C9JU00,0.6666666666666666,6,1797406.3333333333,6.957662871474594e-6,1.1909819153217545,0.252151506507057,0.15796757019800603,0.6638855679885327,raw,1693084.875,1688639,1488387,2299051.5,1772642,1842633.625,Fibrinogen gamma chain (Fragment) OS=Homo sapiens OX=9606 GN=FGG PE=1 SV=1,cell growth;coagulation,cell surface,antioxidant activity;structural molecule activity,NA,FGG,Selenium micronutrient network; Folate metabolism; Blood clotting cascade; Complement system; Fibrin complement receptor 3 signaling pathway; Network map of SARS-CoV-2 signaling pathway,NA,ENSG00000171557
Q5VW36,0,6,462186.8625,1.78910039052545e-6,1.1900017207253217,0.2509636596509445,0.6782224273997575,1,raw,403204.6875,528235.8125,327223.375,NA,333604.9375,718665.5,Focadhesin OS=Homo sapiens OX=9606 GN=FOCAD PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q9HBD4,0,6,19337914.3125,7.485602221859224e-5,1.188979344202664,0.24972365177386782,0.4194129789238127,0.9059885383672683,raw,18513436.8125,17808947,16525887.28125,21174470.125,15097021.40625,26907723.25,SMARCA4 isoform 2 OS=Homo sapiens OX=9606 GN=SMARCA4 PE=1 SV=1,cell growth;metabolic process,membrane,structural molecule activity,6597,SMARCA4,Pre-implantation embryo; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; Tumor suppressor activity of SMARCB1; Rett syndrome causing genes; Thermogenesis,NA,ENSG00000127616
Q8TCC3,0,6,769892.171875,2.9802110296115336e-6,1.1889481380286782,0.2496857860333914,0.5973234049733562,1,raw,648300.375,NA,749666.5625,1035467,646134.75,NA,"39S ribosomal protein L30, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL30 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,51263,MRPL30,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000185414
G3V5R9,0,6,43124577.307291664,1.6693291039123915e-4,1.1888926925135994,0.24961850569348748,0.6118244733240916,1,raw,38090820.734375,47875476.96875,36728528.765625,56918804.71875,32610145.3125,46523687.34375,Kinesin light chain OS=Homo sapiens OX=9606 GN=KLC1 PE=1 SV=1,NA,endoplasmic reticulum;nucleus,NA,NA,KLC1,Alzheimer's disease and miRNA effects; Alzheimer's disease,NA,ENSG00000126214
H0Y8C2,0,6,58593161.135416664,2.2681096321619174e-4,1.1888785716779944,0.2496013702693972,0.6561424626265614,1,raw,70219236,49494743.8125,44798972,83482145,37984067.5,65579802.5,60S ribosomal protein L22-like 1 (Fragment) OS=Homo sapiens OX=9606 GN=RPL22L1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,structural molecule activity,NA,RPL22L1,NA,NA,ENSG00000163584
O95400,0,6,7330757.947916667,2.8376968216973617e-5,1.1887481953612364,0.24944315093200403,0.23608619778366713,0.7196640448521243,raw,5509369.5625,7071951.375,6745135.25,10231355.875,6549253.125,7877482.5,CD2 antigen cytoplasmic tail-binding protein 2 OS=Homo sapiens OX=9606 GN=CD2BP2 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,10421,CD2BP2,mRNA processing; Ciliary landscape,mRNA Splicing - Major Pathway,ENSG00000169217
P13984,0,6,21054341.510416668,8.15002192290627e-5,1.1886372976784305,0.24930855640569383,0.22696748728056776,0.7148463313429879,raw,19406491.125,19312825.53125,17974580.71875,27704187.5625,18972019.375,22955944.75,General transcription factor IIF subunit 2 OS=Homo sapiens OX=9606 GN=GTF2F2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,2963,GTF2F2,Eukaryotic transcription initiation,Viral Messenger RNA Synthesis; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Estrogen-dependent gene expression; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM,ENSG00000188342
O60506,0,6,326448023.46875,0.0012636626733937117,1.1885209329049866,0.24916731306769813,0.263520740545382,0.7438355132238149,raw,305792902.375,328949578.9375,263151843.0625,386019158.6875,283811197.3125,390963460.4375,Heterogeneous nuclear ribonucleoprotein Q OS=Homo sapiens OX=9606 GN=SYNCRIP PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;extracellular;membrane;nucleus,RNA binding,10492,SYNCRIP,NA,NA,ENSG00000135316
Q7RTV0,0,6,18254166.854166668,7.06608943206522e-5,1.1884804987585584,0.24911823094114735,0.6640885511290662,1,raw,15670091.25,20323742.75,16171672.375,24718808.75,13420968.75,19219717.25,PHD finger-like domain-containing protein 5A OS=Homo sapiens OX=9606 GN=PHF5A PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,84844,PHF5A,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000100410
Q96GW9,0,6,413180.9375,1.5994011007591578e-6,1.1884686953356622,0.24910390270921012,0.17884493307262886,0.6741527184744509,raw,431504.1875,329365.09375,355051.0625,471110.65625,379225.40625,512829.21875,"Methionine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=MARS2 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome,structural molecule activity,92935,MARS2,Amino acid metabolism,Mitochondrial tRNA aminoacylation,ENSG00000247626
Q9BQG2,0,6,8650836.125,3.3486919567319315e-5,1.1883351636772748,0.24894179807375233,0.18872962663505113,0.6797963848944265,raw,7164853.5,8789730.0625,7528113,10445145.3125,7766182.25,10210992.625,Peroxisomal NADH pyrophosphatase NUDT12 OS=Homo sapiens OX=9606 GN=NUDT12 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;mitochondrion;nucleus,structural molecule activity,83594,NUDT12,NA,Nicotinamide salvaging,ENSG00000112874
P36957,0,6,52510414.578125,2.0326497971018533e-4,1.188334660023891,0.24894118661461595,0.1666320815424645,0.6670444762382309,raw,44105943.6875,56567564.28125,42672480.59375,61177270.375,50709187.71875,59830040.8125,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial OS=Homo sapiens OX=9606 GN=DLST PE=1 SV=4",cell organization and biogenesis;cellular homeostasis,cytosol;endosome;membrane;nucleus,structural molecule activity,1743,DLST,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Metabolic reprogramming in colon cancer; 7q11.23 copy number variation syndrome; TCA cycle (aka Krebs or citric acid cycle),Lysine catabolism; Glyoxylate metabolism and glycine degradation; Citric acid cycle (TCA cycle),ENSG00000119689
O00264,0,6,19432667.354166668,7.52228061270148e-5,1.1882954706526738,0.24889360806144853,0.29326582235479165,0.774322745775844,raw,17866567.125,19932126.75,16028882.75,22215256.4375,16867915.125,23685255.9375,Membrane-associated progesterone receptor component 1 OS=Homo sapiens OX=9606 GN=PGRMC1 PE=1 SV=3,cellular homeostasis,cytoplasm;cytoskeleton;endosome;extracellular;nucleus,structural molecule activity,10857,PGRMC1,NA,Neutrophil degranulation,ENSG00000101856
P82933,0,6,17768021.833333332,6.877905319275791e-5,1.1881198179324095,0.24868033447233914,0.3111730350803765,0.7920100626951777,raw,18260787.0625,15570314.5625,15731866.25,19847769.125,15501391,21696003,"28S ribosomal protein S9, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS9 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,structural molecule activity,64965,MRPS9,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000135972
O15446,0,6,6639276.947916667,2.570028260014493e-5,1.1880100837517726,0.24854708169165474,0.48031529456987293,0.962082357312919,raw,5409051.28125,8133746.0625,4930444.15625,7182207.6875,5857417.375,8322795.125,DNA-directed RNA polymerase I subunit RPA34 OS=Homo sapiens OX=9606 GN=POLR1G PE=1 SV=1,cellular component movement;cellular homeostasis;development,cytosol;endosome;membrane;nucleus,NA,10849,POLR1G,2q13 copy number variation syndrome,B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination,ENSG00000117877
Q9NVD7,0,6,6511109.518229167,2.5204153399790278e-5,1.1879973005638327,0.2485315579673013,0.46231683865295553,0.944583057253577,raw,5058590.9375,7750070.53125,5397215.046875,6147907.375,6411876.90625,8300996.3125,Alpha-parvin OS=Homo sapiens OX=9606 GN=PARVA PE=1 SV=1,cell communication;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;motor activity,55742,PARVA,Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion,Localization of the PINCH-ILK-PARVIN complex to focal adhesions; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,ENSG00000197702
Q9NQ29,0,6,3872513.4427083335,1.4990290453494952e-5,1.187622234161201,0.24807600821645343,0.33842689302828183,0.8216110565431962,raw,3111411.5625,4124096.4375,3447270.3125,4366405.96875,3288027.75,4897868.625,Putative RNA-binding protein Luc7-like 1 OS=Homo sapiens OX=9606 GN=LUC7L PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,55692,LUC7L,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000007392
Q96JG6,0,6,1626615.2864583333,6.296539950304777e-6,1.1874967549415638,0.24792357101317708,0.660397904333843,1,raw,1510813.28125,1544415.5625,1648450.5,1985079,1236944.90625,1833988.46875,Syndetin OS=Homo sapiens OX=9606 GN=VPS50 PE=1 SV=3,conjugation,mitochondrion;nucleus,structural molecule activity,55610,VPS50,NA,NA,ENSG00000004766
Q68EM7,0,6,2775531.6484375,1.0743933155683925e-5,1.1873840968975,0.24778669576616572,0.5418988867008538,1,raw,2858445.78125,3004856.609375,1668380.125,3394073.0625,1763399.9375,3964034.375,Rho GTPase-activating protein 17 OS=Homo sapiens OX=9606 GN=ARHGAP17 PE=1 SV=1,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,DNA binding;structural molecule activity,55114,ARHGAP17,NA,CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle,ENSG00000140750; ENSG00000288353
A0A087WYF7,0,6,424860.5677083333,1.6446123186935966e-6,1.1870432647182179,0.24737251851555625,0.30070820788380553,0.7806964943416801,raw,397233.5,447802.8125,295534,531561.3125,350729.46875,526302.3125,MICOS complex subunit OS=Homo sapiens OX=9606 GN=APOOL PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P14927,0,6,20066373.375,7.767584791885337e-5,1.1869089901222272,0.24720931616507533,0.49873845437219194,0.9825746427243267,raw,22171901,15898596.4375,18161306.625,26316028.625,16049697.4375,21800710.125,Cytochrome b-c1 complex subunit 7 OS=Homo sapiens OX=9606 GN=UQCRB PE=1 SV=2,cellular homeostasis,cytoskeleton;endosome,NA,7381,UQCRB,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex III assembly,Respiratory electron transport,ENSG00000156467
Q9NTX5,0,6,18235215.389322918,7.058753422346212e-5,1.1868443340422616,0.24713072416901316,0.4761011948047002,0.9576932071680475,raw,16629502.125,19266854.5703125,14951774.28125,19736630.375,14458664.859375,24367866.125,Ethylmalonyl-CoA decarboxylase OS=Homo sapiens OX=9606 GN=ECHDC1 PE=1 SV=2,cellular homeostasis,cytosol,structural molecule activity,55862,ECHDC1,Fatty acid biosynthesis,NA,ENSG00000093144
O15427,0,6,38224585.484375,1.4796530660316802e-4,1.1868417570480387,0.24712759164293926,0.420040824508962,0.9065120883789316,raw,30513909.9375,42162773.78125,33696275.625,39992146.96875,32891439.28125,50090967.3125,Monocarboxylate transporter 4 OS=Homo sapiens OX=9606 GN=SLC16A3 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;membrane;nucleus,catalytic activity,9123,SLC16A3,Metabolic reprogramming in colon cancer,Pyruvate metabolism; Basigin interactions; Proton-coupled monocarboxylate transport,ENSG00000141526
K7EL20,0,6,4320893.333333333,1.6725944801352893e-5,1.1868120192677516,0.24709144269099217,0.5006575231988404,0.984977940523979,raw,4066308.75,4988159,3145982,4835255.5,3733689.25,5155965.5,Eukaryotic translation initiation factor 3 subunit G (Fragment) OS=Homo sapiens OX=9606 GN=EIF3G PE=1 SV=8,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,RNA binding,NA,EIF3G,NA,NA,ENSG00000130811
O75323,0,6,65264911.776041664,2.526369497275037e-4,1.186643703941204,0.2468868231693822,0.05653450943078409,0.6429522395902524,raw,59662661.75,55709714.296875,62335943.515625,69676855.4375,66107581.71875,78096713.9375,Protein NipSnap homolog 2 OS=Homo sapiens OX=9606 GN=NIPSNAP2 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytoskeleton;endosome,NA,2631,NIPSNAP2,NA,RHOJ GTPase cycle; RHOH GTPase cycle,ENSG00000146729
Q13416,0,6,7415663.119791667,2.8705631553134957e-5,1.186478134580993,0.24668551357675197,0.5334001039454279,1,raw,5618252.84375,9109706.015625,5665233.171875,10808467,6439232.625,6853087.0625,Origin recognition complex subunit 2 OS=Homo sapiens OX=9606 GN=ORC2 PE=1 SV=2,cell proliferation;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding,4999,ORC2,Cell cycle; G1 to S cell cycle control; DNA replication,Orc1 removal from chromatin; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; E2F-enabled inhibition of pre-replication complex formation; Assembly of the ORC complex at the origin of replication; CDC6 association with the ORC:origin complex,ENSG00000115942
Q9Y5K6,0,6,35380929.395833336,1.3695766741798895e-4,1.1863268007263323,0.2465014878284195,0.3347175896186071,0.8182372123213004,raw,34509888.875,35976575.375,27718909.4375,42969849.8125,30170346.8125,40940006.0625,CD2-associated protein OS=Homo sapiens OX=9606 GN=CD2AP PE=1 SV=1,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,23607,CD2AP,Primary focal segmental glomerulosclerosis (FSGS); Nephrotic syndrome; Genes controlling nephrogenesis; GDNF signaling,Nephrin family interactions,ENSG00000198087
Q6UN15,0,6,13495399.979166666,5.223996468100439e-5,1.1861582247803817,0.2462964676246831,0.504641272006822,0.9887033786631393,raw,13033328.25,13601369.03125,10911520.4375,15459589.5,9941535.03125,18025057.625,Pre-mRNA 3'-end-processing factor FIP1 OS=Homo sapiens OX=9606 GN=FIP1L1 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane,NA,81608,FIP1L1,NA,Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs; Signaling by cytosolic PDGFRA and PDGFRB fusion proteins,ENSG00000145216
Q07864,0.16666666666666666,6,8659140.520833334,3.351906543522246e-5,1.186141372145179,0.24627597003385204,0.13374328262007715,0.6514609890946903,raw,8737676,8234376.125,6575853,9591630,8451189,10364119,DNA polymerase epsilon catalytic subunit A OS=Homo sapiens OX=9606 GN=POLE PE=1 SV=5,cell differentiation;cell proliferation;cellular homeostasis;coagulation;defense response,cytoplasm;cytoskeleton;membrane,RNA binding;structural molecule activity,5426,POLE,"Retinoblastoma gene in cancer; Pyrimidine metabolism; G1 to S cell cycle control; DNA replication; Base excision repair; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Activation of the pre-replicative complex; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; DNA replication initiation; Gap-filling DNA repair synthesis and ligation in GG-NER,ENSG00000177084
Q9UHI6,0,6,4319397.309895833,1.6720153775399043e-5,1.1861326657826756,0.24626538051020758,0.5147408121902741,0.9988615467241881,raw,3752324.46875,4823752.703125,3273526.703125,3276933.671875,4450754.625,6339091.6875,Probable ATP-dependent RNA helicase DDX20 OS=Homo sapiens OX=9606 GN=DDX20 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,11218,DDX20,mRNA processing; Male infertility,snRNP Assembly; SARS-CoV-2 modulates host translation machinery,ENSG00000064703
A0A1B0GW77,0,6,76855777.71875,2.9750456598223366e-4,1.1861310435957018,0.24626340744027161,0.26976190239467646,0.7501656371282784,raw,76751151.5625,68065208.375,68478464.5625,91036923.5,67271950.5625,89530967.75,Alpha-aminoadipic semialdehyde dehydrogenase OS=Homo sapiens OX=9606 GN=ALDH7A1 PE=1 SV=1,NA,cytosol;endosome,structural molecule activity,NA,ALDH7A1,"Amino acid metabolism; Vitamin B6-dependent and responsive disorders; Cerebral organic acidurias, including diseases",NA,ENSG00000164904
P61086,0,6,53847878.09375,2.0844222876736343e-4,1.1858378902222666,0.245906799970251,0.3457740571224078,0.8277692477090556,raw,53267679.375,50504486,44074568.4375,70476227,44874174.625,59890133.125,Ubiquitin-conjugating enzyme E2 K OS=Homo sapiens OX=9606 GN=UBE2K PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,3093,UBE2K,NA,Antigen processing: Ubiquitination & Proteasome degradation; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Negative regulators of DDX58/IFIH1 signaling,ENSG00000078140
Q9Y2D5,0,6,3163039.9296875,1.2243956790207333e-5,1.1857890053176545,0.24584732517714522,0.2750491587722444,0.7556354420320032,raw,3149083.671875,2915823.78125,2434920.65625,4276342.28125,3457551.78125,2744517.40625,A-kinase anchor protein 2 OS=Homo sapiens OX=9606 GN=AKAP2 PE=1 SV=3,NA,NA,NA,445815,AKAP2,NA,NA,NA
P32322,0,6,103119710.65234384,3.9917083233619553e-4,1.1855832371171158,0.2455969547309346,0.20413558804152915,0.6957374751850184,raw,107892183.617188,82209318.40625,87808017.703125,127915164.3125,91835677.0625,121057902.8125,"Pyrroline-5-carboxylate reductase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PYCR1 PE=1 SV=2",cellular homeostasis;coagulation;metabolic process,endosome,structural molecule activity,5831,PYCR1,Amino acid metabolism; Metabolic reprogramming in colon cancer,Glutamate and glutamine metabolism,ENSG00000183010
P30536,0,6,13456466.135416666,5.208925387394898e-5,1.1855653532274664,0.24557519228296779,0.30246275371442544,0.7825518083423609,raw,12910417.5,11490825,10295676.1875,13623124,11668576.875,20750177.25,Translocator protein OS=Homo sapiens OX=9606 GN=TSPO PE=1 SV=3,cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endosome;extracellular;nucleus,catalytic activity;structural molecule activity,706,TSPO,NO/cGMP/PKG mediated neuroprotection,Pregnenolone biosynthesis,ENSG00000100300
O60825,0,6,1923655.75,7.446367546982207e-6,1.1853751021105496,0.24534366024016974,0.4798072489515122,0.962082357312919,raw,1797301.4375,1752038.3125,1814591.625,2130476.375,1481786.75,2565740,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 OS=Homo sapiens OX=9606 GN=PFKFB2 PE=1 SV=2",cellular homeostasis;metabolic process,cytosol;membrane,signal transducer activity;structural molecule activity,5208,PFKFB2,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Thyroid hormones production and peripheral downstream signaling effects,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",ENSG00000123836
Q9Y3Z3,0,6,25460983.53125,9.855809257001853e-5,1.185332113904214,0.24529133925199784,0.481246439705038,0.9622845920836873,raw,24722139.1875,22275793.125,24299434.078125,32997665.71875,19667969.515625,28802899.5625,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Homo sapiens OX=9606 GN=SAMHD1 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,25939,SAMHD1,NA,Interferon alpha/beta signaling; Nucleotide catabolism,ENSG00000101347
Q14739,0,6,21962893.479166668,8.501717484591191e-5,1.1853236174227324,0.24528099795145686,0.4118539710505228,0.8978780271505381,raw,21170824,22576734.75,15344387.25,31076586.4375,16514550.75,25094277.6875,Delta(14)-sterol reductase LBR OS=Homo sapiens OX=9606 GN=LBR PE=1 SV=2,cellular homeostasis;metabolic process,cytoskeleton;extracellular;membrane;nucleus,RNA binding;structural molecule activity,3930,LBR,Gastric cancer network 2; ATM signaling in development and disease ; Envelope proteins and their potential roles in EDMD physiopathology; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Regulation of MECP2 expression and activity; Initiation of Nuclear Envelope (NE) Reformation; Cholesterol biosynthesis,ENSG00000143815
P21579,0,6,11083304.169270834,4.2902872033829814e-5,1.1845297442469558,0.24431442596421613,0.336606334511929,0.820646994147619,raw,10195087.59375,6572558.171875,12991319.828125,12076384.5,11455517.734375,13208957.1875,Synaptotagmin-1 OS=Homo sapiens OX=9606 GN=SYT1 PE=1 SV=1,cell death;cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,antioxidant activity;structural molecule activity,6857,SYT1,Synaptic vesicle pathway,"Cargo recognition for clathrin-mediated endocytosis; Glutamate Neurotransmitter Release Cycle; Neurexins and neuroligins; Serotonin Neurotransmitter Release Cycle; Norepinephrine Neurotransmitter Release Cycle; Dopamine Neurotransmitter Release Cycle; Acetylcholine Neurotransmitter Release Cycle; GABA synthesis, release, reuptake and degradation; Toxicity of botulinum toxin type B (botB); Toxicity of botulinum toxin type G (botG)",ENSG00000067715
Q96JM3,0,6,3164774.6536458335,1.2250671812989506e-5,1.184463463855449,0.2442336976684718,0.22147553730031308,0.7102829728901873,raw,2502374.09375,2832497.3125,3442637.09375,3676393.71875,3354989.578125,3179756.125,Chromosome alignment-maintaining phosphoprotein 1 OS=Homo sapiens OX=9606 GN=CHAMP1 PE=1 SV=2,cell differentiation;cell growth;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,283489,CHAMP1,NA,NA,ENSG00000198824
Q7Z4G1,0.16666666666666666,6,646852.7083333334,2.5039319093402653e-6,1.1844214238880564,0.2441824914213497,1,1,raw,NA,576031.0625,NA,625410.375,NA,739116.6875,COMM domain-containing protein 6 OS=Homo sapiens OX=9606 GN=COMMD6 PE=1 SV=1,metabolic process,membrane;nucleus,structural molecule activity,170622,COMMD6,NA,Neddylation,ENSG00000188243
Q9P2D8,0.8333333333333334,6,2773652.9166666665,1.0736660686434778e-5,1.1843818117468834,0.24413424069391496,0.1541429883126971,0.6638855679885327,raw,2323554.5,2267452.5,2952816.25,3048967,2685529.5,3363597.75,Protein unc-79 homolog OS=Homo sapiens OX=9606 GN=UNC79 PE=2 SV=4,NA,cytoplasm;cytoskeleton,NA,57578,UNC79,NA,Stimuli-sensing channels,ENSG00000133958; ENSG00000276416
Q9Y694,0.5,6,301607.0703125,1.1675046849288812e-6,1.1843605264036556,0.24410831279232384,1,1,raw,275164.3125,339158.0625,266212.15625,325893.75,NA,NA,Solute carrier family 22 member 7 OS=Homo sapiens OX=9606 GN=SLC22A7 PE=1 SV=1,cellular homeostasis;conjugation,cytoplasm;cytoskeleton,catalytic activity,10864,SLC22A7,Fluoropyrimidine activity; Proximal tubule transport,Aspirin ADME; Organic anion transport,ENSG00000137204
P12004,0,6,309435268.813151,0.001197807218667874,1.1842880437825767,0.24402001745013582,0.23612868884978627,0.7196640448521243,raw,236693709.859375,348971594.5,239395452.019531,363122959.625,280313530.625,388114366.25,Proliferating cell nuclear antigen OS=Homo sapiens OX=9606 GN=PCNA PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,endoplasmic reticulum;membrane;nucleus,antioxidant activity;DNA binding;RNA binding;structural molecule activity,5111,PCNA,"Cell cycle; Retinoblastoma gene in cancer; Primary focal segmental glomerulosclerosis (FSGS); Oxidative damage response; EGF/EGFR signaling pathway; G1 to S cell cycle control; DNA replication; Hepatitis B infection; Base excision repair; Nucleotide excision repair; 7q11.23 copy number variation syndrome; DNA repair pathways, full network; 16p11.2 proximal deletion syndrome; p53 transcriptional gene network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",E3 ubiquitin ligases ubiquitinate target proteins; SUMOylation of DNA replication proteins; Termination of translesion DNA synthesis; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; G1/S-Specific Transcription; Recognition of DNA damage by PCNA-containing replication complex; Transcription of E2F targets under negative control by DREAM complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Removal of the Flap Intermediate; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER; Removal of the Flap Intermediate from the C-strand; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),ENSG00000132646
Q13011,0,6,21881484.61002605,8.470204550886435e-5,1.1841238612229197,0.2438199970360377,0.42184444008934496,0.9086347256931654,raw,23696335.484375,15859143.6640625,20575994.7695313,29168934.28125,17623973.0859375,24364526.375,"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial OS=Homo sapiens OX=9606 GN=ECH1 PE=1 SV=2",cellular homeostasis,cytosol;endosome;mitochondrion,structural molecule activity,1891,ECH1,Fatty acid biosynthesis; IL-18 signaling pathway,Peroxisomal protein import,ENSG00000104823; ENSG00000282853
Q13546,0,6,595846.9921875,2.3064915360203924e-6,1.1836542292068495,0.2432477003396113,0.3735252827566091,0.8594431551104292,raw,480778.65625,613695.0625,NA,696094.875,592819.375,NA,Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=RIPK1 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;mitochondrion;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,8737,RIPK1,Apoptosis modulation and signaling; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; TNF-alpha signaling pathway; Nanoparticle triggered regulated necrosis; Apoptosis; Apoptosis modulation by HSP70; Novel intracellular components of RIG-I-like receptor pathway; p38 MAPK signaling pathway; Cytosolic DNA-sensing pathway; Host-pathogen interaction of human coronaviruses - interferon induction; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Toll-like receptor signaling pathway,"Potential therapeutics for SARS; Ub-specific processing proteases; TRIF-mediated programmed cell death; IKK complex recruitment mediated by RIP1; Regulation by c-FLIP; CASP8 activity is inhibited; Dimerization of procaspase-8; TICAM1, RIP1-mediated IKK complex recruitment; RIP-mediated NFkB activation via ZBP1; Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; TLR3-mediated TICAM1-dependent programmed cell death; Ovarian tumor domain proteases; TNFR1-induced proapoptotic signaling; TRP channels; Microbial modulation of RIPK1-mediated regulated necrosis; SARS-CoV-1-mediated effects on programmed cell death; Defective RIPK1-mediated regulated necrosis",ENSG00000137275
Q86YP4,0,6,6698764.5546875,2.5930555914123258e-5,1.1835072836597789,0.24306858487904007,0.6793301624006917,1,raw,4595001.71875,7727707.484375,6590936.796875,9145798.09375,4205190.515625,7927952.71875,Transcriptional repressor p66-alpha OS=Homo sapiens OX=9606 GN=GATAD2A PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,54815,GATAD2A,NA,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,ENSG00000167491
Q709C8,0,6,2350789.65625,9.09977983642939e-6,1.1832481226360123,0.24275263307068717,0.34043056277708955,0.8242917664336578,raw,2481465.71875,1376721,2491028.078125,2449013.6875,2947504.296875,2359005.15625,Vacuolar protein sorting-associated protein 13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,NA,54832,VPS13C,NA,NA,ENSG00000129003
Q13541,0,6,19982831.197916668,7.735246066194029e-5,1.1830703215539353,0.2425358298416123,0.24275352309054876,0.7289874209382666,raw,20248209.4375,17487239.875,17605916.9375,20829037.8125,18644970.1875,25081612.9375,Eukaryotic translation initiation factor 4E-binding protein 1 OS=Homo sapiens OX=9606 GN=EIF4EBP1 PE=1 SV=3,cell differentiation;development;metabolic process,cytosol;nucleus,structural molecule activity,1978,EIF4EBP1,"Translation factors; AMP-activated protein kinase signaling; Target of rapamycin signaling; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; RAC1/PAK1/p38/MMP2 pathway; BDNF-TrkB signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; EGF/EGFR signaling pathway; Synaptic signaling pathways associated with autism spectrum disorder; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Malignant pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway; Hypertrophy model; Interferon type I signaling pathways; ErbB signaling pathway","mTORC1-mediated signalling; Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",ENSG00000187840
P04075,0,6,1477231560.0664084,0.00571828361090928,1.1829980635416113,0.24244771212131863,0.43076679574865656,0.9159312067530959,raw,1370922046.92188,1569164129.46094,1169346415.07813,1856318126.53125,1175733645.0625,1721904997.34375,Fructose-bisphosphate aldolase A OS=Homo sapiens OX=9606 GN=ALDOA PE=1 SV=2,cell growth;cellular homeostasis;metabolic process,cell surface;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,226,ALDOA,VEGFA-VEGFR2 signaling pathway; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; 16p11.2 proximal deletion syndrome; Glycolysis and gluconeogenesis; Sudden infant death syndrome (SIDS) susceptibility pathways,Glycolysis; Neutrophil degranulation; Platelet degranulation ; Gluconeogenesis,ENSG00000149925
O43719,0,6,30427944.096354168,1.177849287433474e-4,1.1827848669223018,0.24218769020444358,0.14183804709394204,0.6572502130392559,raw,25089510.0625,31745135.296875,23685958.890625,36904791.9375,28015393.734375,37126874.65625,HIV Tat-specific factor 1 OS=Homo sapiens OX=9606 GN=HTATSF1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,NA,27336,HTATSF1,NA,NA,ENSG00000102241
O96000,0,6,26078655.1484375,1.0094906605106731e-4,1.1827833977606896,0.2421858982019013,0.3532043271122818,0.8383308462007302,raw,27191682.796875,18303899.8125,24654398.625,28309453.25,21649548.8125,36362947.59375,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 OS=Homo sapiens OX=9606 GN=NDUFB10 PE=1 SV=3,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,4716,NDUFB10,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Modulators of TCR signaling and T cell activation; Oxidative phosphorylation,Complex I biogenesis,ENSG00000140990
P33947,0,6,468708.1119791667,1.8143437951665566e-6,1.1827807613520973,0.24218268245010083,0.7377464497981526,1,raw,757003.5625,108054.359375,396749.46875,895369.25,279832.46875,375239.5625,ER lumen protein-retaining receptor 2 OS=Homo sapiens OX=9606 GN=KDELR2 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;extracellular,structural molecule activity,11014,KDELR2,NA,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport,ENSG00000136240
Q8TBX8,0,6,14066408.260416666,5.445030690806767e-5,1.182675839139589,0.2420546980637185,0.1580284550163243,0.6638855679885327,raw,11364581.109375,15030073.5625,11871607.359375,16498111.1875,13440615.5,16193460.84375,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma OS=Homo sapiens OX=9606 GN=PIP4K2C PE=1 SV=3,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,signal transducer activity;structural molecule activity,79837,PIP4K2C,Regulation of actin cytoskeleton,"Synthesis of PIPs at the plasma membrane; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; PI5P Regulates TP53 Acetylation; Synthesis of PIPs in the nucleus",ENSG00000166908
P23368,0,6,40275445.458333336,1.5590407483313232e-4,1.1826277828896976,0.24199607513449625,0.4972308802731496,0.9805491336505413,raw,42708511.328125,35808183.4375,35596826.765625,50508272.0625,32624371.53125,44406507.625,"NAD-dependent malic enzyme, mitochondrial OS=Homo sapiens OX=9606 GN=ME2 PE=1 SV=1",cellular homeostasis;metabolic process,endosome;nucleus,structural molecule activity,4200,ME2,TCA cycle in senescence,Citric acid cycle (TCA cycle),ENSG00000082212
Q8IWS0,0,6,26077510.052083332,1.0094463344490593e-4,1.1826111740403658,0.24197581375287464,0.355844411566499,0.8403332772639565,raw,23049693,30076363.375,19522608.15625,30230265.0625,26327306.21875,27258824.5,PHD finger protein 6 OS=Homo sapiens OX=9606 GN=PHF6 PE=1 SV=1,defense response;metabolic process,membrane;nucleus,motor activity;RNA binding;structural molecule activity,84295,PHF6,Mesodermal commitment pathway,NA,ENSG00000156531
Q9UKV8,0,6,4119122.4114583335,1.5944900456711353e-5,1.1815484379257613,0.2406787742316649,0.3411142848463756,0.8242917664336578,raw,4363318.53125,4235978.25,2512417.96875,5018725.375,3579280.859375,5005013.484375,Protein argonaute-2 OS=Homo sapiens OX=9606 GN=AGO2 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cell surface;cytosol;membrane;nucleus,RNA binding;structural molecule activity,27161,AGO2,exRNA mechanism of action and biogenesis; Fragile X syndrome; Male infertility; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies,MAPK6/MAPK4 signaling; Transcriptional regulation by small RNAs; Estrogen-dependent gene expression; TP53 Regulates Metabolic Genes; Pre-NOTCH Transcription and Translation; Ca2+ pathway; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; MicroRNA (miRNA) biogenesis; Small interfering RNA (siRNA) biogenesis; Regulation of RUNX1 Expression and Activity; Regulation of NPAS4 mRNA translation; Post-transcriptional silencing by small RNAs; Competing endogenous RNAs (ceRNAs) regulate PTEN translation,ENSG00000123908
P22102,0,6,218621743.33333334,8.462729647037974e-4,1.181264257275505,0.2403317420545898,0.18650491449610787,0.6790811483756987,raw,226764143.40625,181024923.96875,175604194.78125,266734896.5,193733923.90625,267868377.4375,Trifunctional purine biosynthetic protein adenosine-3 OS=Homo sapiens OX=9606 GN=GART PE=1 SV=1,cellular homeostasis;defense response;metabolic process,cytosol,structural molecule activity,2618,GART,Folate metabolism; One-carbon metabolism; Metabolic reprogramming in colon cancer,Purine ribonucleoside monophosphate biosynthesis,ENSG00000159131; ENSG00000262473
P46778,0,6,99572652.64583333,3.8544036230435993e-4,1.1812440162715494,0.2403070212133068,0.9276965557940497,1,raw,72465037.5,161286143,69687555.125,102359205.25,82318007.5,109319967.5,60S ribosomal protein L21 OS=Homo sapiens OX=9606 GN=RPL21 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;Golgi;nucleus,structural molecule activity,6144,RPL21,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000122026
G3V0J0,0,6,405812.375,1.5708777931621982e-6,1.1812245846390383,0.24028328847895436,0.693018501720172,1,raw,NA,309617.875,422750.84375,595730.4375,295150.34375,NA,Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding,NA,FMR1,Ovarian infertility; Serotonin and anxiety; Fragile X syndrome; Disruption of postsynaptic signaling by CNV; 15q11.2 copy number variation syndrome,NA,ENSG00000102081
Q14008,0,6,49471783.6875,1.9150260359314484e-4,1.1811319794461586,0.2401701801915537,0.24543281913175652,0.7315287448139173,raw,40956167.96875,54315498.71875,36255832.21875,63078744.03125,42822922.875,59401536.3125,Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,9793,CKAP5,NA,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000175216
Q6NUM9,0,6,35026949.421875,1.3558743005074434e-4,1.18092799549544,0.23992100223843119,0.11418236379120862,0.6429522395902524,raw,24825805.75,34155682.015625,34176034.359375,40359435.75,37041702.09375,39603036.5625,"All-trans-retinol 13,14-reductase OS=Homo sapiens OX=9606 GN=RETSAT PE=1 SV=2",cellular homeostasis,cytoskeleton;extracellular;membrane,structural molecule activity,54884,RETSAT,Vitamin A and carotenoid metabolism,Retinoid metabolism and transport,ENSG00000042445
P08648,0,6,2656972.53125,1.028499721424853e-5,1.1807693540167956,0.23972718292884782,0.37593756250109894,0.8615698665976935,raw,2395513.125,2921730.375,1946951.4375,3449889.6875,2179543.9375,3048206.625,Integrin alpha-5 OS=Homo sapiens OX=9606 GN=ITGA5 PE=1 SV=2,cell communication;cell growth;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,antioxidant activity;structural molecule activity,3678,ITGA5,Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Epithelial to mesenchymal transition in colorectal cancer; CCL18 signaling pathway; GDNF signaling,Cell surface interactions at the vascular wall; Integrin cell surface interactions; GPER1 signaling; Signal transduction by L1; RUNX2 regulates genes involved in cell migration; Fibronectin matrix formation; Elastic fibre formation,ENSG00000161638
Q9NXV6,0,6,645266.6302083334,2.4977922865532995e-6,1.180726630475799,0.23967498123878658,0.48887240655201747,0.9723695596911428,raw,658372.8125,770192.03125,318103.8125,818251.5625,777358.3125,529321.25,CDKN2A-interacting protein OS=Homo sapiens OX=9606 GN=CDKN2AIP PE=1 SV=3,coagulation;metabolic process,membrane,RNA binding;structural molecule activity,55602,CDKN2AIP,NA,NA,ENSG00000168564
Q5SYU9,0.8333333333333334,6,2307017.9375,8.930341876453634e-6,1.1805520477687759,0.23946164800673156,0.34110310130800425,0.8242917664336578,raw,1770314.75,2386103.25,1917361.25,2263544.75,2021978.375,3482805.25,"Sarcosine dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=SARDH PE=1 SV=1",NA,NA,structural molecule activity,NA,SARDH,"Trans-sulfuration, one-carbon metabolism and related pathways",NA,ENSG00000123453
Q96R05,0,6,5561103.78125,2.1526732484281573e-5,1.180472800030738,0.23936479996312177,0.6303506449601257,1,raw,6948888.6875,4400940.3125,4570880.625,5395800.25,5245557.6875,6804555.125,Retinoid-binding protein 7 OS=Homo sapiens OX=9606 GN=RBP7 PE=1 SV=1,conjugation,cytosol;membrane,structural molecule activity,116362,RBP7,Vitamin A and carotenoid metabolism,NA,ENSG00000162444
Q92922,0,6,38157662.53027345,1.4770625146111885e-4,1.1804585352484704,0.2393473663933016,0.354232850143497,0.8383308462007302,raw,35592681.515625,37419499.8691406,32944602.8125,42015684.6875,32317721.6992188,48655784.5976563,SWI/SNF complex subunit SMARCC1 OS=Homo sapiens OX=9606 GN=SMARCC1 PE=1 SV=3,cell growth;cellular component movement;defense response;development;metabolic process,membrane;nucleus,structural molecule activity,6599,SMARCC1,Tumor suppressor activity of SMARCB1; Thermogenesis,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,ENSG00000173473
P15880,0,6,230035420.16666666,8.904546914828616e-4,1.1802837868656324,0.23913378219698955,0.5067187474560184,0.9902772197513048,raw,208120791,230611231.9375,216713830.6875,282492707.75,186490138.875,255783820.75,40S ribosomal protein S2 OS=Homo sapiens OX=9606 GN=RPS2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6187,RPS2,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; RMTs methylate histone arginines; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Protein methylation; SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000140988
Q6RFH5,0,6,11848070.330729166,4.5863240553879975e-5,1.1800920474332681,0.2388993944992309,0.12386915240078808,0.6445597830897484,raw,10704019.5,11042612.453125,9852868.4375,12620508.53125,11627291.6875,15241121.375,WD repeat-containing protein 74 OS=Homo sapiens OX=9606 GN=WDR74 PE=1 SV=1,cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,NA,54663,WDR74,NA,NA,ENSG00000133316
P62314,0,6,54797768.75,2.1211920421158293e-4,1.1798739649719587,0.23863275804372464,0.7056810222688827,1,raw,67195764,42586045.5,45772846.25,79282532.5,37494405,56455019.25,Small nuclear ribonucleoprotein Sm D1 OS=Homo sapiens OX=9606 GN=SNRPD1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,6632,SNRPD1,mRNA processing,snRNP Assembly; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000167088
E9PAU2,0,6,16107805.5625,6.23524456461087e-5,1.1798624174410353,0.23861863819057313,0.5323182463711615,1,raw,15671164.390625,17193658.25,12387813.890625,20286151.1875,12069692,19038353.65625,Ribonucleoprotein PTB-binding 1 OS=Homo sapiens OX=9606 GN=RAVER1 PE=1 SV=1,NA,NA,RNA binding,125950,RAVER1,NA,NA,ENSG00000161847
Q00839,0,6,503983951.7526045,0.00195089466633021,1.179821709963029,0.2385688616327954,0.2965172421769964,0.7788269335661613,raw,455365385.023438,508340101.382813,444216378.929688,575808240.40625,440422917.117188,599750687.65625,Heterogeneous nuclear ribonucleoprotein U OS=Homo sapiens OX=9606 GN=HNRNPU PE=1 SV=6,cell differentiation;cell growth;cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,3192,HNRNPU,mRNA processing; lncRNA in canonical Wnt signaling and colorectal cancer,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000153187
Q14677,0,6,29873162.328125,1.1563739847209223e-4,1.1796854560650387,0.23840223969921437,0.1568380854917225,0.6638855679885327,raw,23969819.96875,30353474.3125,26348863.0625,35400927.1875,27358337.25,35807552.1875,Clathrin interactor 1 OS=Homo sapiens OX=9606 GN=CLINT1 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,9685,CLINT1,NA,Golgi Associated Vesicle Biogenesis,ENSG00000113282
Q9H2J4,0,6,7726811.6640625,2.991007076859702e-5,1.1795694592167971,0.23826037450544682,0.28794756623216705,0.7680960150654869,raw,6839770.15625,8855603.1875,5068445.375,7724628.875,8067983.984375,9804438.40625,Phosducin-like protein 3 OS=Homo sapiens OX=9606 GN=PDCL3 PE=1 SV=1,cell growth;defense response;metabolic process,cytosol;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,79031,PDCL3,NA,NA,ENSG00000115539
Q8IVS2,0,6,5964271.903645833,2.3087374518380492e-5,1.179216014835037,0.2378280228005368,0.43780275871718094,0.9212994104748925,raw,6773828.75,5120766.046875,4394482.3125,6921465.03125,4587281.9375,7987807.34375,"Malonyl-CoA-acyl carrier protein transacylase, mitochondrial OS=Homo sapiens OX=9606 GN=MCAT PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,27349,MCAT,Mitochondrial fatty acid synthesis pathway,Mitochondrial Fatty Acid Beta-Oxidation,ENSG00000100294
Q9HD42,0,6,15885958.208333334,6.149368651602499e-5,1.1792090860873505,0.23781954589794363,0.33954389397319196,0.8234727301412407,raw,14651590.5,17357205,11261965.25,19312476.75,13280211.75,19452300,Charged multivesicular body protein 1a OS=Homo sapiens OX=9606 GN=CHMP1A PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,5119,CHMP1A,NA,HCMV Late Events,ENSG00000131165
P63000,0,6,71317681.1953125,2.760668933507454e-4,1.1791539878826227,0.237752134813014,0.45847547210963696,0.9412524313762942,raw,71209005.125,66785945.75,56744876.0625,101270271.46875,53145074.5,78750914.265625,Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens OX=9606 GN=RAC1 PE=1 SV=1,cell communication;cell death;cell growth;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,5879,RAC1,Androgen receptor signaling pathway; Nucleotide-binding oligomerization domain (NOD) pathway; Target of rapamycin signaling; Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; RANKL/RANK signaling pathway; Leptin signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Microtubule cytoskeleton regulation; RalA downstream regulated genes; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Alpha 6 beta 4 signaling pathway; Amyotrophic lateral sclerosis (ALS); Cardiac hypertrophic response; Focal adhesion; RAC1/PAK1/p38/MMP2 pathway; Wnt signaling pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Microglia pathogen phagocytosis pathway; Robo4 and VEGF signaling pathways crosstalk; p38 MAPK signaling pathway; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Ebola virus infection in host; Ras signaling; Pancreatic adenocarcinoma pathway; Wnt signaling; Ciliary landscape; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Hippo signaling regulation pathways; Leukocyte-intrinsic Hippo pathway functions; Neural crest cell migration during development; Neural crest cell migration in cancer; Gastrin signaling pathway; Melanoma; Netrin-UNC5B signaling pathway; Insulin signaling; CAMKK2 pathway; Regulation of actin cytoskeleton; GDNF signaling; 2q13 copy number variation syndrome; 2q21.1 copy number variation syndrome; 2q37 copy number variation syndrome; G13 signaling pathway; Genetic causes of porto-sinusoidal vascular disease; Interferon type I signaling pathways; DNA damage response (only ATM dependent); Toll-like receptor signaling pathway,"Regulation of actin dynamics for phagocytic cup formation; FCERI mediated MAPK activation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; NRAGE signals death through JNK; MAPK6/MAPK4 signaling; RHO GTPases Activate WASPs and WAVEs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; Neutrophil degranulation; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; EPHB-mediated forward signaling; DCC mediated attractive signaling; GPVI-mediated activation cascade; Signaling by SCF-KIT; DAP12 signaling; Ephrin signaling; Factors involved in megakaryocyte development and platelet production; RHO GTPases activate CIT; PCP/CE pathway; WNT5:FZD7-mediated leishmania damping; EPH-ephrin mediated repulsion of cells; Sema3A PAK dependent Axon repulsion; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion; Signal transduction by L1; RHO GTPases activate PKNs; RHO GTPases activate PAKs; DSCAM interactions; Azathioprine ADME; VEGFR2 mediated vascular permeability; Sema4D mediated inhibition of cell attachment and migration; Inactivation of CDC42 and RAC1; Activation of RAC1; CD28 dependent Vav1 pathway; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases; Nef and signal transduction; RHO GTPases Activate NADPH Oxidases; NTRK2 activates RAC1; MET activates RAP1 and RAC1; Activation of RAC1 downstream of NMDARs; Activated NTRK2 signals through CDK5; RHO GTPases activate KTN1",ENSG00000136238
O75438,0.16666666666666666,6,3858414.375,1.4935713723627335e-5,1.1790962456026244,0.23768148539690284,0.683716330330181,1,raw,3049617.25,4920174.5,3134793.75,3743486.5,3595792.25,4706622,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 OS=Homo sapiens OX=9606 GN=NDUFB1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome;membrane,catalytic activity,4707,NDUFB1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000183648
P61313,0,6,184867755.48958334,7.15613100192732e-4,1.1790217445605053,0.2375903260193905,0.1556349329597352,0.6638855679885327,raw,151916717.25,196840672.4375,159093722.25,209274304.5,179113113,212968003.5,60S ribosomal protein L15 OS=Homo sapiens OX=9606 GN=RPL15 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;Golgi;membrane;nucleus,structural molecule activity,6138,RPL15,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000174748
Q9BZL1,0.5,6,2659604.7083333335,1.029518622962264e-5,1.1788450825737258,0.2373741396175256,0.712460470430115,1,raw,2747353.25,1356557.5,3269835.5,3854629.5,3522663.25,1206589.25,Ubiquitin-like protein 5 OS=Homo sapiens OX=9606 GN=UBL5 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,membrane;nucleus,structural molecule activity,59286,UBL5,NA,NA,ENSG00000198258
Q6UWP7,0,6,2195191.5807291665,8.497468087078592e-6,1.1786717265244553,0.23716196729105374,0.7502791073094718,1,raw,2569696.53125,2302403.3125,1334369.25,3155560.3125,1095342.390625,2713777.6875,Lysocardiolipin acyltransferase 1 OS=Homo sapiens OX=9606 GN=LCLAT1 PE=1 SV=1,cellular homeostasis,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,253558,LCLAT1,NA,Synthesis of PA; Acyl chain remodeling of CL,ENSG00000172954
Q5VTR2,0,6,36557587.8984375,1.4151244895188467e-4,1.178167100148283,0.23654417198550165,0.19173316546997896,0.6828255842456847,raw,33291348.375,35585191.921875,29715199.671875,39222771.375,34026543.015625,47504473.03125,E3 ubiquitin-protein ligase BRE1A OS=Homo sapiens OX=9606 GN=RNF20 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,56254,RNF20,ATM signaling in development and disease,E3 ubiquitin ligases ubiquitinate target proteins; RHOBTB1 GTPase cycle,ENSG00000155827
Q10567,0,6,27580963.84375,1.0676442189855935e-4,1.178126759317199,0.23649477278453,0.38073915877080833,0.8650933221024324,raw,30589925.9375,24591498.421875,20420046.875,30841455.5,23004046.015625,36038810.3125,AP-1 complex subunit beta-1 OS=Homo sapiens OX=9606 GN=AP1B1 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
B4DLN1,0,6,65730543.567708336,2.544393852528361e-4,1.1781220715814174,0.23648903232700585,0.3136936407329073,0.7937979323424178,raw,62650869.5,58654535.21875,61528449.4375,72488024.3125,57194729.0625,81866653.875,"cDNA FLJ60124, highly similar to Mitochondrial dicarboxylate carrier OS=Homo sapiens OX=9606 PE=2 SV=1",cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;endosome;Golgi;membrane;nucleus,structural molecule activity,NA,NA,NA,NA,NA
P21675,0.8333333333333334,6,2670351.0833333335,1.033678486703357e-5,1.1779941424888034,0.2363323654643284,0.22356192035352776,0.7125799511687476,raw,2425945,2888633,2101036.75,3100210.75,2648532,2857749,Transcription initiation factor TFIID subunit 1 OS=Homo sapiens OX=9606 GN=TAF1 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,6872,TAF1,MECP2 and associated Rett syndrome,RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,ENSG00000147133
Q92900,0,6,40972775.3203125,1.5860340107889286e-4,1.1777536140755505,0.23603775909212082,0.24133998500465428,0.727008366442287,raw,38980557.46875,41426958.5,33232842.75,45909492.4375,37021433.578125,49265367.1875,Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5976,UPF1,NA,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000005007
Q6PKG0,0,6,14336988.5,5.549770840643244e-5,1.1775582018226698,0.23579836803833015,0.4929014312855417,0.9773523321302688,raw,16292179.3125,11204999.9375,11543100.375,18088864,9707798,19184989.375,La-related protein 1 OS=Homo sapiens OX=9606 GN=LARP1 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;nucleus,protein binding;RNA binding;structural molecule activity,23367,LARP1,SARS-CoV-2 innate immunity evasion and cell-specific immune response; Network map of SARS-CoV-2 signaling pathway,SARS-CoV-2 activates/modulates innate and adaptive immune responses,ENSG00000155506
Q12906,0,6,280199161.7864583,0.0010846358268719858,1.1775257285035667,0.23575858253783832,0.15860790553383264,0.6638855679885327,raw,272739148.5625,259662125.796875,238928823.3125,305758833.84375,264036761.453125,340069277.75,Interleukin enhancer-binding factor 3 OS=Homo sapiens OX=9606 GN=ILF3 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,endosome;membrane;nucleus,RNA binding,3609,ILF3,NA,NA,ENSG00000129351
Q8N1G0,0,6,628308.74375,2.4321492236566546e-6,1.1773890521383985,0.2355911180367216,0.5594113214101406,1,raw,372024.40625,708293.1875,NA,421811.5,774623.625,864791,Zinc finger protein 687 OS=Homo sapiens OX=9606 GN=ZNF687 PE=1 SV=1,NA,cytosol;membrane,RNA binding;structural molecule activity,57592,ZNF687,NA,NA,ENSG00000143373
Q969X5,0,6,8170538.510416667,3.1627713433307915e-5,1.1773781274243433,0.2355777315491508,0.3163559260325658,0.796388541585002,raw,8071906.09375,5648809.34375,7890305.03125,11521487.6875,6600850.34375,9289872.5625,Endoplasmic reticulum-Golgi intermediate compartment protein 1 OS=Homo sapiens OX=9606 GN=ERGIC1 PE=1 SV=1,conjugation,cytoskeleton;extracellular;membrane;nucleus,NA,57222,ERGIC1,NA,NA,ENSG00000113719
Q9H944,0,6,3690484.91796875,1.4285667862240835e-5,1.1769709288189865,0.2350786862500647,0.19011437256278946,0.6816045476187055,raw,2933783.03125,3392645.1015625,3339460.5625,5101636.0625,3444936.75,3930448,Mediator of RNA polymerase II transcription subunit 20 OS=Homo sapiens OX=9606 GN=MED20 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,9477,MED20,NA,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Generic Transcription Pathway,ENSG00000124641
B5MCA4,0,6,92406853.88541667,3.5770194219578703e-4,1.1768033015465167,0.2348731992224655,0.23346815041857297,0.718951462768674,raw,87358242.125,81176257.4375,89524893.25,102803467.75,83925829.375,109652433.375,Epithelial cell adhesion molecule OS=Homo sapiens OX=9606 GN=EPCAM PE=1 SV=1,NA,cytoplasm;cytoskeleton;nucleus,NA,NA,EPCAM,NA,NA,ENSG00000119888
A0A2R8Y891,0,6,53800871.416666664,2.0826026845833994e-4,1.1767761621378492,0.23483992744141613,0.24625104252126168,0.7316541032247736,raw,50856620.125,51286438.09375,41827295.03125,59846858.25,46937639.5,72050377.5,ATP-dependent 6-phosphofructokinase OS=Homo sapiens OX=9606 GN=PFKM PE=1 SV=1,cellular homeostasis,nucleus,signal transducer activity;structural molecule activity,5213,PFKM,Clear cell renal cell carcinoma pathways; Aerobic glycolysis; Insulin signaling; Glycolysis and gluconeogenesis,NA,ENSG00000152556
Q9Y3B7,0,6,15375850.65625,5.9519087723437554e-5,1.1767128615760274,0.2347623206153569,0.25517007866939745,0.735366952583477,raw,13634275.75,15049633.5625,14444131.75,17605315.25,13812650.25,17709097.375,"39S ribosomal protein L11, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL11 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,RNA binding;structural molecule activity,65003,MRPL11,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000174547
O15067,0,6,11558122.653645834,4.474086875063181e-5,1.176632265812088,0.23466350373750566,0.41917144503491427,0.9057644843679232,raw,11679933.015625,11310671.65625,9444207.78125,13308501.21875,9482715.75,14122706.5,Phosphoribosylformylglycinamidine synthase OS=Homo sapiens OX=9606 GN=PFAS PE=1 SV=4,cellular homeostasis;metabolic process,cytosol,structural molecule activity,5198,PFAS,NA,Purine ribonucleoside monophosphate biosynthesis,ENSG00000178921
P02769,0,6,5745709.0859375,2.2241329651589584e-5,1.1765074310999821,0.2345104329950493,0.2134018866667564,0.702871293386539,raw,5698112.234375,5170951.96875,4613591.875,5941746.71875,5427925.125,7621926.59375,CRAP Albumin OS=Bos taurus OX=9913 GN=ALB PE=1 SV=4,coagulation;metabolic process,cell surface;nucleus,RNA binding;structural molecule activity,280717,ALB,NA,NA,NA
Q9NUU7,0,6,52527441.734375,2.0333089091270553e-4,1.1764058826174075,0.23438590355194827,0.39581065765363727,0.8784033311564677,raw,47577779.6875,54081871.59375,45575689.0625,66938200.375,45020329.78125,55970779.90625,ATP-dependent RNA helicase DDX19A OS=Homo sapiens OX=9606 GN=DDX19A PE=1 SV=1,cellular homeostasis;conjugation,membrane;nucleus,RNA binding;structural molecule activity,55308,DDX19A,NA,NA,ENSG00000168872
P55060,0,6,191711157.44010416,7.421035396569204e-4,1.1763240493116855,0.234285543112962,0.394415136270814,0.877277789871942,raw,196538338.3125,188200091.75,150229143.609375,225699330.03125,158407266.96875,231192773.96875,Exportin-2 OS=Homo sapiens OX=9606 GN=CSE1L PE=1 SV=3,conjugation,cytosol;membrane;nucleus,structural molecule activity,1434,CSE1L,NA,NA,ENSG00000124207
A0A087WXI5,0,6,9627663.354166666,3.726816503095033e-5,1.1762486337142184,0.23419304717496714,0.09926771961259202,0.6429522395902524,raw,8366549.5,8396130.5625,9719581.90625,10436637.9375,9414435.28125,11432644.9375,Cadherin-1 OS=Homo sapiens OX=9606 GN=CDH1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
O43583,0,6,12897950.776041666,4.992727107295088e-5,1.1762232792191065,0.23416194898912912,0.24880353250117498,0.7316541032247736,raw,10491352.1875,13586737.53125,11313052.375,13306675.5625,12159546.5,16530340.5,Density-regulated protein OS=Homo sapiens OX=9606 GN=DENR PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,NA,RNA binding,8562,DENR,NA,NA,ENSG00000139726
Q6P996,0,6,13810002.584635416,5.345777438087327e-5,1.176089738135365,0.23399814505822839,0.47767082544760436,0.9595579936027474,raw,12396942.0625,11666413.890625,14533889.9921875,16655130.4375,10514480.25,17093158.875,Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PDXDC1 PE=1 SV=2,cellular homeostasis,extracellular;nucleus,structural molecule activity,23042,PDXDC1,NA,NA,ENSG00000179889; ENSG00000275498
Q9Y673,0,6,2933565.0833333335,1.1355672049686377e-5,1.1758137520120135,0.2336595564936815,0.18874704747605986,0.6797963848944265,raw,2482443.09375,2550936.953125,3018184.265625,2999426.75,2862578.375,3687821.0625,Dolichyl-phosphate beta-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG5 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;defense response,cytoskeleton;extracellular,structural molecule activity,29880,ALG5,NA,Synthesis of dolichyl-phosphate-glucose,ENSG00000120697
O94925,0,6,12476371.768229166,4.8295361495437355e-5,1.1755376726472968,0.23332077401478718,0.3176878944571255,0.7987484302904563,raw,12191425.375,12114849.9375,10238270.078125,15441525.5,10630697.21875,14241462.5,"Glutaminase kidney isoform, mitochondrial OS=Homo sapiens OX=9606 GN=GLS PE=1 SV=1",cell death;cell growth;cellular homeostasis;metabolic process,cytosol;endosome;nucleus,structural molecule activity,2744,GLS,Amino acid metabolism; Metabolic reprogramming in colon cancer; Neuroinflammation and glutamatergic signaling; Amino acid metabolism in triple-negative breast cancer cells,Glutamate Neurotransmitter Release Cycle; TP53 Regulates Metabolic Genes; Glutamate and glutamine metabolism,ENSG00000115419
P24386,0.16666666666666666,6,14427713.328125,5.584889931772493e-5,1.1754684654873726,0.23323583606007411,0.365571500443461,0.8489489584030998,raw,11882590.59375,12812407.640625,10022289.59375,26967223.53125,10914158.078125,13967610.53125,Rab proteins geranylgeranyltransferase component A 1 OS=Homo sapiens OX=9606 GN=CHM PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,1121,CHM,NA,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,ENSG00000188419
P41208,0,6,3140869.1197916665,1.2158134782138246e-5,1.1746978847744731,0.23228976429556256,0.3136111999279062,0.7937979323424178,raw,2550821.8125,2450332.6875,2409544.59375,2736162.125,2878400.625,5819952.875,Centrin-2 OS=Homo sapiens OX=9606 GN=CETN2 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,1069,CETN2,"Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Recruitment of NuMA to mitotic centrosomes; SUMOylation of DNA damage response and repair proteins; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER,ENSG00000147400
Q9Y657,0,6,2071369.8723958333,8.018160939453438e-6,1.174526667250242,0.23207946964889192,0.3613788805557852,0.8442145703049884,raw,2021527.90625,2160175.96875,1507994.515625,2496227.5,1705109.0625,2537184.28125,Spindlin-1 OS=Homo sapiens OX=9606 GN=SPIN1 PE=1 SV=3,cell death;cell differentiation;cell growth;cellular component movement;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane,structural molecule activity,10927,SPIN1,NA,NA,ENSG00000106723
O75475,0,6,56980415.416666664,2.2056811161364566e-4,1.174515026460177,0.2320651709583715,0.48089015173663857,0.9622845920836873,raw,54734800.71875,56623528.96875,51818071.5,64555423.125,47645482.5625,66505185.625,PC4 and SFRS1-interacting protein OS=Homo sapiens OX=9606 GN=PSIP1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,11168,PSIP1,MECP2 and associated Rett syndrome,Vpr-mediated nuclear import of PICs; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection,ENSG00000164985
P54852,0,6,2115278.8541666665,8.188130237171787e-6,1.1744323027738082,0.23196355518295395,0.8154204283636836,1,raw,2030104.25,2388079.75,1739748.625,2422140.25,1306962.25,2804638,Epithelial membrane protein 3 OS=Homo sapiens OX=9606 GN=EMP3 PE=1 SV=1,cell growth;metabolic process,cytoplasm;cytoskeleton,NA,2014,EMP3,NA,NA,ENSG00000142227
F8W930,0,6,48096826.84375,1.8618021988711994e-4,1.1743935171223805,0.23191590936221793,0.39208480390197664,0.8763519738235003,raw,47106990.3125,44572983.9375,42688462.375,61468789.9375,40397511.125,52346223.375,Insulin-like growth factor 2 mRNA-binding protein 2 OS=Homo sapiens OX=9606 GN=IGF2BP2 PE=1 SV=1,conjugation;metabolic process,NA,RNA binding,10644,IGF2BP2,NA,NA,ENSG00000073792
O00148,0,6,20367462.854166668,7.88413490364023e-5,1.1743288381926742,0.23183645171925754,0.3435180372477924,0.8250635218999488,raw,19575958.125,18188427.875,17395187,21359195.375,17326240.1875,28359768.5625,ATP-dependent RNA helicase DDX39A OS=Homo sapiens OX=9606 GN=DDX39A PE=1 SV=2,cellular component movement;cellular homeostasis;conjugation,membrane;nucleus,structural molecule activity,10212,DDX39A,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000123136
O00425,0,6,51862611.130208336,2.0075736753924996e-4,1.1743226836639054,0.23182889069281218,0.36391679454554937,0.8458062414401234,raw,53011571.125,45713844.15625,46484252.75,60069960.3125,43643347.96875,62252690.46875,Insulin-like growth factor 2 mRNA-binding protein 3 OS=Homo sapiens OX=9606 GN=IGF2BP3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,10643,IGF2BP3,NA,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,ENSG00000136231
P62888,0,6,155436067.36458334,6.016846245250345e-4,1.1743086006574095,0.23181158914039884,0.4467899471893685,0.9279078826673519,raw,125958772.5,184215372.8125,128353727.75,178674446.5,147914469.875,167499614.75,60S ribosomal protein L30 OS=Homo sapiens OX=9606 GN=RPL30 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;Golgi;membrane;nucleus,structural molecule activity,6156,RPL30,Cytoplasmic ribosomal proteins,L13a-mediated translational silencing of Ceruloplasmin expression; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Formation of a pool of free 40S subunits; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000156482
Q96CP2,0,6,1723998.21875,6.673504023344682e-6,1.1738995412492679,0.23130895227870632,0.03486211336076875,0.6429522395902524,raw,1499752.375,1665159.5625,1609360.125,1828093.3125,1760558.625,1981065.3125,FLYWCH family member 2 OS=Homo sapiens OX=9606 GN=FLYWCH2 PE=1 SV=1,NA,NA,NA,114984,FLYWCH2,NA,NA,ENSG00000162076
Q9NZ01,0,6,28781918.0625,1.1141325083789082e-4,1.173758443447003,0.2311355359623775,0.31204558357737944,0.7920821775382559,raw,25557446.375,26755401.25,27316411.0625,36617820.75,25040050.8125,31404378.125,Very-long-chain enoyl-CoA reductase OS=Homo sapiens OX=9606 GN=TECR PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,9524,TECR,Fragile X syndrome,Synthesis of very long-chain fatty acyl-CoAs,ENSG00000099797
Q96I51,0,6,297531.69921875,1.1517291434608148e-6,1.1737464847057324,0.23112083710784512,1,1,raw,258991.03125,380306.875,246839.078125,303989.8125,NA,NA,RCC1-like G exchanging factor-like protein OS=Homo sapiens OX=9606 GN=RCC1L PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
Q9HDC9,0,6,70511796.05533855,2.7294735548494107e-4,1.1735913829821205,0.23093018326896314,0.504272831367275,0.9887033786631393,raw,69286397.0195313,70324562.28125,60569126.53125,85540733.5625,56036038.4375,81313918.5,Adipocyte plasma membrane-associated protein OS=Homo sapiens OX=9606 GN=APMAP PE=1 SV=2,cellular homeostasis,cytoskeleton;nucleus,structural molecule activity,57136,APMAP,Ciliary landscape,NA,ENSG00000101474
O75879,0,6,3523072.5260416665,1.3637623531955388e-5,1.1735679764993183,0.23090140940959303,0.6499903284980344,1,raw,2836232.71875,3665176,3486622.25,4091788.21875,2339051.84375,4719564.125,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial OS=Homo sapiens OX=9606 GN=GATB PE=1 SV=1",cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome;nucleus,structural molecule activity,5188,GATB,NA,NA,ENSG00000059691
P49441,0,6,400630.203125,1.5508178856278674e-6,1.173415914422465,0.2307144637681345,1,1,raw,359112.9375,NA,NA,NA,182577.546875,660200.125,Inositol polyphosphate 1-phosphatase OS=Homo sapiens OX=9606 GN=INPP1 PE=1 SV=1,cellular homeostasis;development,cytosol,structural molecule activity,3628,INPP1,NA,"Synthesis of IP2, IP, and Ins in the cytosol",ENSG00000151689
Q8WWM7,0,6,36492637.90397135,1.4126103103006087e-4,1.1733703499024788,0.23065844187297338,0.45701865576706274,0.94030502550882,raw,32776034.1425781,38984501.625,31671691.3125,45743258.3125,31289238.46875,38491103.5625,Ataxin-2-like protein OS=Homo sapiens OX=9606 GN=ATXN2L PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,cytoskeleton;cytosol;membrane;nucleus,NA,11273,ATXN2L,16p11.2 distal deletion syndrome,NA,ENSG00000168488
E7ETB3,0,6,19271569.265625,7.459920412421491e-5,1.1733699249588383,0.23065791939156427,0.27105069645654606,0.7524466736516254,raw,19309456.5,18338531.21875,14802109.28125,21517881,16820129.65625,24841307.9375,Aspartyl aminopeptidase OS=Homo sapiens OX=9606 GN=DNPEP PE=1 SV=2,cell organization and biogenesis,cytosol,structural molecule activity,23549,DNPEP,Ciliary landscape,NA,ENSG00000123992
A0A1W2PP53,0.6666666666666666,6,719749.6770833334,2.7861121395469313e-6,1.1732922754912785,0.2305624437821684,0.6516298580207891,1,raw,486660.59375,982295.0625,523752.96875,1101016.875,610257.25,614515.3125,GPI transamidase component PIG-T OS=Homo sapiens OX=9606 GN=PIGT PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,NA,NA,PIGT,NA,NA,ENSG00000124155
Q14676,0,6,26494409.591145832,1.0255842905154024e-4,1.1732712193323238,0.23053655263013106,0.5497122777690341,1,raw,27427653.171875,23865411.71875,24301753.90625,33582290.15625,21276800.15625,28512548.4375,Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens OX=9606 GN=MDC1 PE=1 SV=3,cell differentiation;cell proliferation;cellular homeostasis;coagulation;development,membrane;nucleus,structural molecule activity,9656,MDC1,ATM signaling in development and disease ; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; NIPBL role in DNA damage - Cornelia de Lange syndrome,SUMOylation of DNA damage response and repair proteins; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; TP53 Regulates Transcription of DNA Repair Genes; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ),ENSG00000137337; ENSG00000206481; ENSG00000224587; ENSG00000225589; ENSG00000228575; ENSG00000231135; ENSG00000234012; ENSG00000237095
Q9NTG7,0.16666666666666666,6,357051.6302083333,1.3821275827446906e-6,1.1732663497145979,0.23053056476661937,0.575686654359848,1,raw,317516.25,298244.8125,395538.25,464071.71875,271204.78125,395733.96875,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial OS=Homo sapiens OX=9606 GN=SIRT3 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,endosome;membrane;nucleus,RNA binding;structural molecule activity,23410,SIRT3,"Energy metabolism; NAD metabolism, sirtuins and aging; NAD+ metabolism; NAD+ biosynthetic pathways; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Transcriptional activation of mitochondrial biogenesis; Regulation of FOXO transcriptional activity by acetylation",ENSG00000142082
Q9UBQ7,0,6,41746153.536458336,1.6159710639765968e-4,1.172803541482441,0.22996136505728262,0.3280178047026216,0.8102820770927855,raw,44845146.8125,32377273.046875,35936523.703125,52594547,33844667.21875,50878763.4375,Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1,cellular homeostasis,cytosol;mitochondrion;nucleus,structural molecule activity,9380,GRHPR,NA,Glyoxylate metabolism and glycine degradation,ENSG00000137106
Q5T0R9,0,6,677718.4557291666,2.623411551018192e-6,1.1727547490600558,0.22990134302661988,0.9579730975455389,1,raw,1621817.125,284718.0859375,172591.71875,1139949.53125,202407.7578125,644826.515625,Adenylyl cyclase-associated protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=CAP1 PE=1 SV=8,cell growth,cytoplasm;cytoskeleton,motor activity,NA,CAP1,NA,NA,ENSG00000131236
U3KQS2,0,6,3318669.9583333335,1.2846392228379806e-5,1.1727227628160033,0.22986199377220115,0.4066301221427601,0.8914071190930648,raw,2735893.375,3681949.875,2701871.4375,3002879.25,3208444.4375,4580981.375,Glucose-6-phosphate exchanger SLC37A4 OS=Homo sapiens OX=9606 GN=SLC37A4 PE=1 SV=2,conjugation,cytoskeleton,catalytic activity,NA,SLC37A4,NA,NA,ENSG00000137700
P19387,0,6,8260057.518229167,3.1974236679274895e-5,1.1725320189411004,0.229627319701691,0.38849992446441656,0.8734136159176045,raw,8115295,6693073.3125,7359317.046875,8629034.875,6663878.3125,12099746.5625,DNA-directed RNA polymerase II subunit RPB3 OS=Homo sapiens OX=9606 GN=POLR2C PE=1 SV=2,cellular component movement;cellular homeostasis,cytosol;membrane,RNA binding;structural molecule activity,5432,POLR2C,Pyrimidine metabolism; Eukaryotic transcription initiation,Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; mRNA Splicing - Major Pathway; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,ENSG00000102978
Q9UNX4,0,6,28250629.580729168,1.0935666181007553e-4,1.1722040816757113,0.22922376599732328,0.1755137252974914,0.6697819849820321,raw,24888126.875,29015672.484375,24705859.21875,34012289.71875,27224834.375,29656994.8125,WD repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=WDR3 PE=1 SV=1,cellular component movement;cellular homeostasis,cytoskeleton;membrane;nucleus,RNA binding,10885,WDR3,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000065183
Q86VP6,0,6,140008653.6796875,5.419659391016796e-4,1.172183962553333,0.22919900409141405,0.24001240465925444,0.7263138257852598,raw,136985793.59375,134900857.8125,115833923.484375,158128622.0625,125335974.40625,168866750.71875,Cullin-associated NEDD8-dissociated protein 1 OS=Homo sapiens OX=9606 GN=CAND1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytosol;extracellular;membrane;nucleus,structural molecule activity,55832,CAND1,Endoderm differentiation,Neutrophil degranulation; Neddylation; Iron uptake and transport,ENSG00000111530
Q8N2K0,0,6,1312532.8177083333,5.0807436715911596e-6,1.1719118060027565,0.22886400164578585,0.14450437247706305,0.6572502130392559,raw,1199672.625,1123500.5,1244085.78125,1316643.5,1335280.1875,1656014.3125,Lysophosphatidylserine lipase ABHD12 OS=Homo sapiens OX=9606 GN=ABHD12 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,26090,ABHD12,NA,Arachidonate production from DAG,ENSG00000100997
Q6YHK3,0,6,243634.2625,9.430950759318262e-7,1.1717979831273775,0.22872387192602306,0.9093573052093387,1,raw,242591.15625,351212.5,120607.671875,167016.796875,NA,336743.1875,CD109 antigen OS=Homo sapiens OX=9606 GN=CD109 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol,DNA binding;structural molecule activity,135228,CD109,NA,Platelet degranulation ; Post-translational modification: synthesis of GPI-anchored proteins,ENSG00000156535
H0Y993,0,6,27736216.3359375,1.0736539591348541e-4,1.1716532642545947,0.22854568584207066,0.20746462676998245,0.6988382857167694,raw,27478537.609375,26053433.6875,22000884.40625,30525590.625,25319432.1875,35039419.5,"DEK oncogene (DNA binding), isoform CRA_b OS=Homo sapiens OX=9606 GN=DEK PE=1 SV=2",cell growth,membrane,RNA binding,7913,DEK,IL-18 signaling pathway,NA,ENSG00000124795
H0Y5B0,0,6,610528.4583333334,2.363322698794944e-6,1.171417321187692,0.22825513215937906,1,1,raw,594018.6875,NA,561379.8125,676186.875,NA,NA,Band 4.1-like protein 2 (Fragment) OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1,cell growth,endoplasmic reticulum,motor activity,NA,EPB41L2,Splicing factor NOVA regulated synaptic proteins,NA,ENSG00000079819
Q9Y2X3,0,6,91544327.8125,3.543631503366965e-4,1.1713707751189548,0.22819780577748852,0.35053349630071945,0.8343501404863615,raw,98584967.78125,76975044.765625,72808666.578125,112898633.71875,72519103.90625,115479550.125,Nucleolar protein 58 OS=Homo sapiens OX=9606 GN=NOP58 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,51602,NOP58,NA,SUMOylation of RNA binding proteins; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000055044
Q9NWW5,0.16666666666666666,6,610311.75625,2.3624838567304542e-6,1.1713341044207026,0.22815264034928565,0.8566142066764248,1,raw,686152.25,484728.625,NA,714724.5625,273250.84375,892702.5,Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens OX=9606 GN=CLN6 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,54982,CLN6,NA,NA,ENSG00000128973
Q9NX14,0,6,10235983.114583334,3.9622937979361006e-5,1.1713097154211616,0.2281226008798679,0.3128027504807524,0.7926808206327974,raw,9058190.625,10136967.125,9464363.25,11085700.625,9067887.8125,12602789.25,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFB11 PE=1 SV=1",cell growth;cellular homeostasis,cytoskeleton;endosome,NA,54539,NDUFB11,Nonalcoholic fatty liver disease,Complex I biogenesis,ENSG00000147123
Q5TDH0,0,6,2564216.0546875,9.925941901546444e-6,1.171300042403359,0.22811068663357265,0.6051803860004058,1,raw,2824719.5625,1986694.890625,2433622.0625,2850501.625,1858709.46875,3431048.71875,Protein DDI1 homolog 2 OS=Homo sapiens OX=9606 GN=DDI2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,84301,DDI2,NA,NA,ENSG00000197312
Q68CQ4,0,6,9528545.947916666,3.688448690286475e-5,1.17102419672741,0.22777088637540702,0.1714432067838101,0.6688917965646828,raw,9820868.375,7514197.84375,8871862.34375,11500474.5,9150755.9375,10313116.6875,Digestive organ expansion factor homolog OS=Homo sapiens OX=9606 GN=DIEXF PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding,27042,UTP25,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000117597
E7EQL5,0.16666666666666666,6,686392.4166666666,2.656987985486153e-6,1.1710073603599445,0.22775014391890508,0.7102743854558189,1,raw,706655.125,604365.1875,663435.625,776888,464293.9375,902716.625,Cytoplasmic dynein 1 intermediate chain 2 (Fragment) OS=Homo sapiens OX=9606 GN=DYNC1I2 PE=1 SV=1,metabolic process,endoplasmic reticulum,NA,NA,DYNC1I2,Ciliary landscape; Intraflagellar transport proteins binding to dynein,NA,ENSG00000077380
Q9Y613,0.16666666666666666,6,2941869.9270833335,1.1387819651450758e-5,1.1709537438798714,0.22768408626339165,0.505226234335686,0.9892786797774812,raw,4079947.9375,1515612.28125,2006895.40625,3998730.125,1774711.875,4275321.9375,FH1/FH2 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHOD1 PE=1 SV=3,cell growth;conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,29109,FHOD1,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000135723
P36915,0,6,9356189.411458334,3.621730405604116e-5,1.1709534991236517,0.22768378470696965,0.14123591639566216,0.6572502130392559,raw,8091948.90625,8924511.65625,8769753.40625,10268973.4375,8877959.84375,11203989.21875,Guanine nucleotide-binding protein-like 1 OS=Homo sapiens OX=9606 GN=GNL1 PE=1 SV=2,coagulation;development;metabolic process,cell surface,structural molecule activity,2794,GNL1,NA,NA,ENSG00000204590; ENSG00000206492; ENSG00000226882; ENSG00000228581; ENSG00000229470; ENSG00000232143; ENSG00000235986
Q12905,0,6,155565879.27864584,6.021871194356164e-4,1.1709514275466384,0.22768123237971688,0.3104468936067769,0.791258249420452,raw,163129108.84375,139269768.53125,124552020.015625,191016262.875,130977694.28125,184450421.125,Interleukin enhancer-binding factor 2 OS=Homo sapiens OX=9606 GN=ILF2 PE=1 SV=2,metabolic process,membrane;nucleus,RNA binding,3608,ILF2,B cell receptor signaling pathway,Neutrophil degranulation,ENSG00000143621
A0A590UJG2,0,6,22445825.401041668,8.688657824121886e-5,1.1708897250576429,0.22760520854282604,0.4143010351692688,0.9004601981266763,raw,20847873.34375,23117819.46875,19357522.09375,27872691.84375,19068484.96875,24410560.6875,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 OS=Homo sapiens OX=9606 GN=MACF1 PE=1 SV=1",cell growth,cytoskeleton;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,NA,MACF1,Mesodermal commitment pathway; Mesodermal commitment pathway,NA,ENSG00000127603
A6NEM2,0.16666666666666666,6,26878895.9609375,1.0404675502996631e-4,1.170881320157061,0.2275948525275242,0.27754671689880916,0.7571895157467512,raw,24582926.796875,24505392.34375,26488393.71875,31014765.40625,23967389.53125,30714507.96875,Host cell factor 1 OS=Homo sapiens OX=9606 GN=HCFC1 PE=1 SV=2,metabolic process,membrane;nucleus,NA,3054,HCFC1,Mitochondrial gene expression; Malignant pleural mesothelioma,NA,ENSG00000172534
O14773,0,6,2183271.3541666665,8.451325533647359e-6,1.170820486758549,0.22751989503967146,0.5490168063516512,1,raw,2100024.75,2280476.25,1713548,2458752,1568838.375,2977988.75,Tripeptidyl-peptidase 1 OS=Homo sapiens OX=9606 GN=TPP1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,1200,TPP1,VEGFA-VEGFR2 signaling pathway,XBP1(S) activates chaperone genes,ENSG00000166340
P17029,0.16666666666666666,6,1992376.9791666667,7.712383714716685e-6,1.170812097959148,0.2275095582521039,0.2835418926437902,0.7643821370278715,raw,1631825.875,2061124.5,1815176.375,2298480.25,1734465.375,2413189.5,Zinc finger protein with KRAB and SCAN domains 1 OS=Homo sapiens OX=9606 GN=ZKSCAN1 PE=1 SV=3,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,7586,ZKSCAN1,NA,Generic Transcription Pathway,ENSG00000106261
A0A494C1L5,0,6,513079012.6601563,0.0019861011560463773,1.1706095867958608,0.2272599988894056,0.19539019166592952,0.6857975396967068,raw,405889698.828125,524207371.828125,491297439.875,575117493.085938,481338276.1875,600623796.15625,Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens OX=9606 GN=LRBA PE=1 SV=1,NA,NA,NA,NA,LRBA,NA,NA,ENSG00000198589
P11586,0,6,232508216.1953125,9.00026751399515e-4,1.1705508487567386,0.22718760651809777,0.44476289618998865,0.9271939562980955,raw,225820493.5625,222004756.0625,221157013.78125,259926570.3125,201806093.046875,264334370.40625,"C-1-tetrahydrofolate synthase, cytoplasmic OS=Homo sapiens OX=9606 GN=MTHFD1 PE=1 SV=3",NA,NA,NA,NA,NA,NA,NA,NA
Q96CQ1,0,6,564995.6875,2.187067801286639e-6,1.1703982069473662,0.22699946437874666,0.7858369974275384,1,raw,408365.40625,984154.3125,394606.375,502954.1875,461846.59375,638047.25,Solute carrier family 25 member 36 OS=Homo sapiens OX=9606 GN=SLC25A36 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity,55186,SLC25A36,NA,NA,ENSG00000114120
J3QS41,0,6,18302218.41015625,7.084689929950709e-5,1.1703852846445857,0.2269835355735364,0.36115337447456175,0.8439672265379375,raw,16307720.796875,18934554.5625,16319284.921875,20220393.234375,15870632.9140625,22160724.03125,Probable helicase with zinc finger domain OS=Homo sapiens OX=9606 GN=HELZ PE=1 SV=1,NA,NA,structural molecule activity,NA,HELZ,NA,NA,ENSG00000198265
A8MXV4,0,6,984973.8541666666,3.8127806091566283e-6,1.1701456608083824,0.22668812899320584,0.43395504352341574,0.9176747809749992,raw,1038006.5625,744134.25,1001111.625,1020216.15625,891755.65625,1214618.875,Nucleoside diphosphate-linked moiety X motif 19 OS=Homo sapiens OX=9606 GN=NUDT19 PE=1 SV=1,cellular homeostasis,cytosol;mitochondrion,structural molecule activity,390916,NUDT19,NA,Peroxisomal lipid metabolism; Peroxisomal protein import,ENSG00000213965
E7EX44,0,6,26015783.273763016,1.0070569241875602e-4,1.1699217431488655,0.2264120301958873,0.36368215162057504,0.8458062414401234,raw,23668732.125,26014560.875,23927305.2675781,31605893.625,22885133.0625,27993074.6875,Caldesmon OS=Homo sapiens OX=9606 GN=CALD1 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum,motor activity;structural molecule activity,NA,CALD1,NA,NA,ENSG00000122786
P61160,0,6,61523428.763020836,2.3815387099278547e-4,1.1696298521825428,0.22605203843283367,0.18693594610670486,0.6791107619890848,raw,51054508.0625,65036707.859375,48630946.3125,72990789.40625,55358745.9375,76068875,Actin-related protein 2 OS=Homo sapiens OX=9606 GN=ACTR2 PE=1 SV=1,cell differentiation;cell growth;coagulation;conjugation;metabolic process,cell surface;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,motor activity;structural molecule activity,10097,ACTR2,Physico-chemical features and toxicity-associated pathways; Embryonic stem cell pluripotency pathways,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Neutrophil degranulation; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,ENSG00000138071
Q92520,0,6,50797951.3359375,1.9663612695832214e-4,1.1694931481072819,0.22588340917165475,0.31910174203143093,0.801731762831818,raw,49672827.375,46937835.84375,45972412.03125,54893477.40625,45043793.796875,62267361.5625,Protein FAM3C OS=Homo sapiens OX=9606 GN=FAM3C PE=1 SV=1,development;metabolic process,cell surface;extracellular;nucleus,antioxidant activity,10447,FAM3C,NA,Platelet degranulation,ENSG00000196937
Q92673,0,6,681491.0625,2.638015108138981e-6,1.1694662098608606,0.22585017757710688,1,1,raw,NA,NA,612313.4375,748278.4375,NA,683881.3125,Sortilin-related receptor OS=Homo sapiens OX=9606 GN=SORL1 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,6653,SORL1,NA,Amyloid fiber formation,ENSG00000137642
P98170,0,6,852010.1627604166,3.2980853386465815e-6,1.1694495130332878,0.2258295796307145,0.2535482812547683,0.7343965948630279,raw,937342.09375,826188.2421875,428787.890625,966185.4375,863592.75,1089964.5625,E3 ubiquitin-protein ligase XIAP OS=Homo sapiens OX=9606 GN=XIAP PE=1 SV=2,cell death;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,331,XIAP,Nucleotide-binding oligomerization domain (NOD) pathway; Apoptosis modulation and signaling; Apoptosis; Focal adhesion; Copper homeostasis; NO/cGMP/PKG mediated neuroprotection; Complement system in neuronal development and plasticity,Regulation of PTEN stability and activity; Deactivation of the beta-catenin transactivating complex; Regulation of necroptotic cell death; Activation of caspases through apoptosome-mediated cleavage; SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Regulation of the apoptosome activity; Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway; Regulation of PTEN localization,ENSG00000101966
Q08170,0,6,2051858.109375,7.942631958271259e-6,1.1693944895041812,0.2257616980853846,0.33439084505093997,0.8181662188074962,raw,1983985.28125,1978583.5,1652836.75,2799935.90625,1932818.1875,1962989.03125,Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,6429,SRSF4,mRNA processing,mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000116350
Q9BYD2,0,6,5837688.4140625,2.25973766646496e-5,1.169336140701477,0.22568971071990235,0.49432907804549736,0.9787246705846804,raw,5574640.96875,5386972.21875,5531871.5625,7429057.78125,4634970.609375,6468617.34375,"39S ribosomal protein L9, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL9 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,65005,MRPL9,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000143436
P45973,0,6,24009668.958333332,9.294013221706607e-5,1.169223208945724,0.22555037187084973,0.2524017251158227,0.7337017596588913,raw,23723285.875,22446243.625,20331355,29693216.625,21619243.625,26244669,Chromobox protein homolog 5 OS=Homo sapiens OX=9606 GN=CBX5 PE=1 SV=1,cell growth;coagulation;metabolic process,membrane;nucleus,structural molecule activity,23468,CBX5,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome; 22q11.2 copy number variation syndrome,SUMOylation of chromatin organization proteins; Transcriptional Regulation by E2F6; Factors involved in megakaryocyte development and platelet production,ENSG00000094916
Q6PD62,0,6,12515951.765625,4.8448573528368915e-5,1.1692156562350018,0.22554105261220547,0.28639947918250824,0.7655844406429082,raw,11137701.6875,11850439,10925115.71875,13022375.1875,11220318.875,16939760.125,RNA polymerase-associated protein CTR9 homolog OS=Homo sapiens OX=9606 GN=CTR9 PE=1 SV=1,cell death;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,membrane;nucleus,structural molecule activity,9646,CTR9,Endoderm differentiation,E3 ubiquitin ligases ubiquitinate target proteins; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,ENSG00000198730
Q6N069,0.16666666666666666,6,554402.940625,2.1460638500529544e-6,1.1691667557940435,0.22548071310288043,0.8042615247027177,1,raw,741453.765625,NA,273377.59375,338358.84375,602754,816070.5,"N-alpha-acetyltransferase 16, NatA auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA16 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,protein binding,79612,NAA16,NA,NA,ENSG00000172766
Q5T653,0,6,7014852.005208333,2.715411336901958e-5,1.1691054704677877,0.22540508800217934,0.30085340052579035,0.7806964943416801,raw,7316881.125,6451665.40625,5517793.1875,8259132.6875,5989433.875,8554205.75,"39S ribosomal protein L2, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL2 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,structural molecule activity,51069,MRPL2,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000112651
O43824,0,6,275314.76953125,1.065728608168268e-6,1.1689341756321967,0.22519369192025973,0.6831684080580525,1,raw,NA,246314.15625,259620.828125,NA,215374.6875,379949.40625,Putative GTP-binding protein 6 OS=Homo sapiens OX=9606 GN=GTPBP6 PE=2 SV=4,NA,nucleus,protein binding;structural molecule activity,8225,GTPBP6,NA,NA,ENSG00000178605
Q9GZN1,0,6,1887197.0520833333,7.305237895810527e-6,1.1689263825346565,0.2251840736706724,0.2295665041534619,0.7159998615396436,raw,1636525.75,1998094.125,1547861.75,2335624.9375,1729128.125,2075947.625,Actin-related protein 6 OS=Homo sapiens OX=9606 GN=ACTR6 PE=1 SV=1,cell growth;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,64431,ACTR6,NA,NA,ENSG00000075089
Q99497,0,6,215165776.97916666,8.3289510554e-4,1.1689057816804262,0.2251586477648338,0.26251181393112916,0.7434848844978388,raw,212776588.4375,202900186.625,188796676.125,237171201.25,194564150.1875,254785859.25,Parkinson disease protein 7 OS=Homo sapiens OX=9606 GN=PARK7 PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,antioxidant activity;DNA binding;RNA binding;structural molecule activity,11315,PARK7,Androgen receptor signaling pathway; Synaptic vesicle pathway; Parkinson's disease pathway,Late endosomal microautophagy; Aggrephagy; SUMOylation of transcription cofactors; Chaperone Mediated Autophagy,ENSG00000116288
P60866,0,6,119375192,4.620949229733906e-4,1.168885161461745,0.2251331975103348,0.3156167345748086,0.7958588159583763,raw,91603049,133493927.5,101682976.5,118504880,114927248,156039071,40S ribosomal protein S20 OS=Homo sapiens OX=9606 GN=RPS20 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,DNA binding;structural molecule activity,6224,RPS20,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Translation initiation complex formation; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; SARS-CoV-2 modulates host translation machinery; SARS-CoV-1 modulates host translation machinery",ENSG00000008988
Q92643,0,6,2610845.0130208335,1.0106440081682323e-5,1.1687193628379313,0.22492854625279585,0.7953513336205934,1,raw,2603312.96875,2150606.0625,2583473.390625,3019355.375,740655.59375,4567666.6875,GPI-anchor transamidase OS=Homo sapiens OX=9606 GN=PIGK PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,10026,PIGK,NA,Attachment of GPI anchor to uPAR,ENSG00000142892
Q86U86,0,6,867239.9505208334,3.357039024786419e-6,1.1684847076660942,0.2246388532318584,0.367975228938129,0.8520069708429603,raw,635180.640625,823519.28125,762854.65625,891384,675580.53125,1414920.59375,Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1,cell differentiation;cell growth;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,55193,PBRM1,Clear cell renal cell carcinoma pathways,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,ENSG00000163939
A0A0C4DGQ5,0,6,108974032.64583333,4.2183259668873333e-4,1.1682027786782234,0.22429072147950835,0.7910116368721538,1,raw,125602175.25,89696953.125,99220547.625,156876112.125,66538688.3125,115909719.4375,Calcium-activated neutral proteinase small subunit OS=Homo sapiens OX=9606 GN=CAPNS1 PE=1 SV=1,NA,cytoplasm;cytoskeleton;nucleus,structural molecule activity,826,CAPNS1,Integrin-mediated cell adhesion,NA,ENSG00000126247
O15371,0,6,112362253.49479167,4.349482166595581e-4,1.168099165380481,0.22416275652078274,0.19489899330556693,0.6851169040350013,raw,96645297.75,119006113.25,89399747.1875,126516406.59375,103595014.625,139010941.5625,Eukaryotic translation initiation factor 3 subunit D OS=Homo sapiens OX=9606 GN=EIF3D PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,RNA binding,8664,EIF3D,Translation factors; VEGFA-VEGFR2 signaling pathway; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000100353
Q9NPE2,0,6,175115.989453125,6.77864540379134e-7,1.168006180192073,0.22404790787278175,0.6512649719972772,1,raw,135751.65625,192615.056640625,NA,161083.6875,164736.515625,221393.03125,Neugrin OS=Homo sapiens OX=9606 GN=NGRN PE=1 SV=2,cell growth;defense response;metabolic process,cytoskeleton;endoplasmic reticulum;endosome;membrane;nucleus,RNA binding,51335,NGRN,NA,NA,ENSG00000182768
P63218,0.16666666666666666,6,10017471.5,3.877709131710243e-5,1.1677122675482026,0.22368482788219934,0.9956918013468525,1,raw,7726817,14029630,8276986,9800248,9022699,11248449,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 OS=Homo sapiens OX=9606 GN=GNG5 PE=1 SV=3,development;metabolic process,cytoplasm;cytoskeleton,structural molecule activity,2787,GNG5,Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells,"G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation",ENSG00000174021
Q9HD45,0,6,12637488.598958334,4.891903604823315e-5,1.1674649627161098,0.2233792532546653,0.29803943546784756,0.7796322644514885,raw,13517332.75,9807854.96875,11587807.5,13763831.125,11367092.875,15781012.375,Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2,metabolic process,cytoskeleton,NA,56889,TM9SF3,NA,NA,ENSG00000077147
Q96CN7,0,6,20315328.8046875,7.863954094566962e-5,1.167319725759907,0.2231997654948115,0.45704543014194315,0.94030502550882,raw,20813148.09375,18896209.046875,17542009.875,22057917.5625,16726118.09375,25856570.15625,Isochorismatase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ISOC1 PE=1 SV=3,NA,mitochondrion;nucleus,NA,51015,ISOC1,NA,NA,ENSG00000066583
Q08379,0,6,5352975.255208333,2.072107819716814e-5,1.1672699955829453,0.22313830246424968,0.3107139937464129,0.7916530248757468,raw,4667066.28125,5276628.84375,4105554.09375,4655309.4375,7965566.4375,5447726.4375,Golgin subfamily A member 2 OS=Homo sapiens OX=9606 GN=GOLGA2 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;extracellular;nucleus,motor activity;structural molecule activity,2801,GOLGA2,NA,COPI-mediated anterograde transport; COPII-mediated vesicle transport; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; Golgi Cisternae Pericentriolar Stack Reorganization,ENSG00000167110
P51570,0,6,20857973.861979168,8.074009066416628e-5,1.1671508376657624,0.22299102093394185,0.25355743963003635,0.7343965948630279,raw,19237908.75,17115136.4375,20042589.0625,22453541.3125,18614119.359375,27684548.25,Galactokinase OS=Homo sapiens OX=9606 GN=GALK1 PE=1 SV=1,cellular homeostasis,cytosol;nucleus,signal transducer activity;structural molecule activity,2584,GALK1,Disorders of galactose metabolism,Galactose catabolism; Defective GALK1 causes GALCT2,ENSG00000108479
Q8N715,0.8333333333333334,6,6579862.5,2.547029248014111e-5,1.1668834802186343,0.22266050714342217,0.2930943083931167,0.774322745775844,raw,6022840,5704800,6674073.5,7027952.5,5935536.5,8113972.5,Coiled-coil domain-containing protein 185 OS=Homo sapiens OX=9606 GN=CCDC185 PE=1 SV=2,NA,NA,NA,164127,CCDC185,NA,NA,ENSG00000178395
O75907,0,6,2539321.75,9.82957739218468e-6,1.1668043610399406,0.2225626835658499,0.7926987677733706,1,raw,3295608.5625,1355898.9375,NA,2574119.25,1551603.5,3919378.5,Diacylglycerol O-acyltransferase 1 OS=Homo sapiens OX=9606 GN=DGAT1 PE=1 SV=2,cell growth;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;extracellular,structural molecule activity,8694,DGAT1,Triacylglyceride synthesis; Statin inhibition of cholesterol production; Glycerolipids and glycerophospholipids; Congenital generalized lipodystrophy; Synthesis of ceramides and 1-deoxyceramides; Vitamin A and carotenoid metabolism,Neutrophil degranulation; Acyl chain remodeling of DAG and TAG; Triglyceride biosynthesis,ENSG00000185000; ENSG00000285482
Q7Z4Q2,0,6,639854.2875,2.4768414001504284e-6,1.1666558975091423,0.22237910418056597,0.8640794970039346,1,raw,NA,1077464.96875,303696.53125,526549.75,479819.875,811740.3125,HEAT repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=HEATR3 PE=1 SV=2,conjugation;metabolic process,NA,structural molecule activity,55027,HEATR3,NA,NA,ENSG00000155393
Q8NC56,0,6,4562301.434895833,1.7660422528489665e-5,1.1664921458864503,0.2221765935383014,0.40322712578962133,0.8892677000455701,raw,3961294.03125,4306993.140625,3655827.765625,7292910.671875,3535964.625,4620818.375,LEM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=LEMD2 PE=1 SV=1,cell growth;defense response;metabolic process,cytoskeleton;endoplasmic reticulum;membrane;nucleus,RNA binding,221496,LEMD2,NA,Sealing of the nuclear envelope (NE) by ESCRT-III; Initiation of Nuclear Envelope (NE) Reformation; Depolymerisation of the Nuclear Lamina,ENSG00000161904
Q9UHD9,0,6,2948578.8020833335,1.1413789344352806e-5,1.1664035190027457,0.22206697734963432,0.5030119478732167,0.9876579753339259,raw,3219923.875,1944428.71875,2722826.53125,2267988.5,2794627.5,4741677.6875,Ubiquilin-2 OS=Homo sapiens OX=9606 GN=UBQLN2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,29978,UBQLN2,NA,Cargo recognition for clathrin-mediated endocytosis,ENSG00000188021
O60343,0,6,4215573.134114583,1.6318255996584057e-5,1.166374291414357,0.2220308260311164,0.4349704217613105,0.9187171423798299,raw,3963418.65625,4439174.15625,3267530.4921875,3993007.84375,3811163.5625,5819144.09375,TBC1 domain family member 4 OS=Homo sapiens OX=9606 GN=TBC1D4 PE=1 SV=2,conjugation;metabolic process,cytosol;nucleus,DNA binding,9882,TBC1D4,Ciliary landscape; Thyroid hormones production and peripheral downstream signaling effects; Insulin signaling,Translocation of SLC2A4 (GLUT4) to the plasma membrane,ENSG00000136111
O95139,0.5,6,3596879.0833333335,1.3923324730296698e-5,1.1663285952205877,0.22197430304010507,0.37381788253928117,0.8596105480165022,raw,2836185.5,3898855,3174362.25,3307924.25,3515468.5,4848479,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 OS=Homo sapiens OX=9606 GN=NDUFB6 PE=1 SV=3,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome;membrane,catalytic activity,4712,NDUFB6,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000165264
P61081,0,6,24186843.875,9.362596675352403e-5,1.1661568278101864,0.221761818975533,0.30067940892448974,0.7806964943416801,raw,22666802.5,24914283.5,19454671.25,26433046.5,21403529,30248730.5,NEDD8-conjugating enzyme Ubc12 OS=Homo sapiens OX=9606 GN=UBE2M PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,9040,UBE2M,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation; Dectin-1 mediated noncanonical NF-kB signaling; NIK-->noncanonical NF-kB signaling; TGF-beta receptor signaling activates SMADs,ENSG00000130725
M0R226,0,6,2687949.6979166665,1.0404908153908146e-5,1.1660577091218436,0.22163919042832758,0.15267784218367833,0.6638855679885327,raw,2288079.6875,2356057.375,2707769.5,3131894.25,2486481.875,3157415.5,"39S ribosomal protein L34, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL34 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,structural molecule activity,NA,MRPL34,NA,NA,ENSG00000130312
P52888,0,6,29836993.00390625,1.1549738897088143e-4,1.1660444090863535,0.22162273497803187,0.44210938628009366,0.9249261346766603,raw,32732567.96875,25201505.4375,24365229.71875,35785373.3125,22769653.7109375,38167627.875,Thimet oligopeptidase OS=Homo sapiens OX=9606 GN=THOP1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;endosome,structural molecule activity,7064,THOP1,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000172009
A0A0A0MSI8,0,6,2397418.3229166665,9.28027688753935e-6,1.1660327328567628,0.2216082884245933,0.5958043549167629,1,raw,2523183.375,2170159.8125,2176078.625,2728059.125,1844914.59375,2942114.40625,Exocyst complex component 5 OS=Homo sapiens OX=9606 GN=EXOC5 PE=1 SV=1,conjugation,nucleus,NA,NA,EXOC5,Ciliary landscape,NA,ENSG00000070367
P06733,0,6,3011906378.4030766,0.011658926973128834,1.1660252369904731,0.22159901399894594,0.22472756034537755,0.7132042007362297,raw,3184407711.76172,2546574911.21924,2504768496.76367,3402431157.9375,2720156235.95508,3713099756.78125,Alpha-enolase OS=Homo sapiens OX=9606 GN=ENO1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,2023,ENO1,Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; IL-18 signaling pathway; Glycolysis and gluconeogenesis,Glycolysis; Gluconeogenesis; Manipulation of host energy metabolism,ENSG00000074800
Q8IX12,0,6,14307439.489583334,5.538332578250812e-5,1.1659550754273156,0.22151220216891468,0.08135423513818268,0.6429522395902524,raw,12816280.78125,13772545.109375,12490090.171875,17310281.0625,14943207.625,14512232.1875,Cell division cycle and apoptosis regulator protein 1 OS=Homo sapiens OX=9606 GN=CCAR1 PE=1 SV=2,cell differentiation;cellular component movement;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,55749,CCAR1,NA,mRNA Splicing - Major Pathway,ENSG00000060339
O75533,0,6,160275080.45052084,6.204161829145993e-4,1.165912778190828,0.22145986471485538,0.46804126852829653,0.9488154073830735,raw,167997231.875,149161242.46875,135340193.75,195870119.34375,129286956.109375,183994739.15625,Splicing factor 3B subunit 1 OS=Homo sapiens OX=9606 GN=SF3B1 PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,23451,SF3B1,mRNA processing,B-WICH complex positively regulates rRNA expression; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000115524
Q9H0Z9,0.3333333333333333,6,467400.3697916667,1.809281595765848e-6,1.165840208025951,0.22137006393609585,0.36361835536401216,0.8458062414401234,raw,414181.8125,490822.5,346867.78125,467322.53125,404392.40625,680815.1875,RNA-binding protein 38 OS=Homo sapiens OX=9606 GN=RBM38 PE=1 SV=2,cell differentiation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane,RNA binding,55544,RBM38,NA,NA,ENSG00000132819
P06400,0,6,1496221.9947916667,5.791794558406642e-6,1.1655352504163408,0.22099263795609592,0.4811413994511368,0.9622845920836873,raw,1301189.84375,1690566.46875,1157286.6875,1970414.8125,1701259.59375,1156614.5625,Retinoblastoma-associated protein OS=Homo sapiens OX=9606 GN=RB1 PE=1 SV=2,cell differentiation;cell growth;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,5925,RB1,Androgen receptor signaling pathway; miRNA regulation of DNA damage response; Cell cycle; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; Adipogenesis; Spinal cord injury; Retinoblastoma gene in cancer; Aryl hydrocarbon receptor pathway; Bladder cancer; Fas ligand pathway and stress induction of heat shock proteins; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; Tumor suppressor activity of SMARCB1; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome; Ciliary landscape; G1 to S cell cycle control; Small cell lung cancer; Head and neck squamous cell carcinoma; Melanoma; Overlap between signal transduction pathways contributing to LMNA laminopathies; 7q11.23 copy number variation syndrome; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis in senescence; Sphingolipid metabolism in senescence; Prostaglandin and leukotriene metabolism in senescence ; ID signaling pathway; DNA damage response,"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Oncogene Induced Senescence; Cyclin D associated events in G1; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3); Aberrant regulation of mitotic exit in cancer due to RB1 defects; RUNX2 regulates osteoblast differentiation; Condensation of Prophase Chromosomes; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes; Cyclin A:Cdk2-associated events at S phase entry; Formation of Senescence-Associated Heterochromatin Foci (SAHF); Inhibition of replication initiation of damaged DNA by RB1/E2F1; Defective translocation of RB1 mutants to the nucleus; Replication of the SARS-CoV-1 genome; Replication of the SARS-CoV-2 genome",ENSG00000139687
Q9BYN8,0,6,10669539.125,4.130120988729762e-5,1.1654625886911867,0.22090269474909896,0.33296453884146837,0.8158667519449163,raw,10044675.8125,10080046.65625,8733082.9375,11706693.875,8848511.84375,14604223.625,"28S ribosomal protein S26, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS26 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,NA,64949,MRPS26,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000125901
P40937,0,6,14287444.083333334,5.5305924644498514e-5,1.1654519989807801,0.22088958596959332,0.6997152996398402,1,raw,18310419.03125,11322284.125,11481942.71875,17992248.15625,13381653.09375,13236117.375,Replication factor C subunit 5 OS=Homo sapiens OX=9606 GN=RFC5 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,5985,RFC5,"Retinoblastoma gene in cancer; DNA replication; Nucleotide excision repair; 7q11.23 copy number variation syndrome; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",HDR through Homologous Recombination (HRR); Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,ENSG00000111445
P05388,0,6,437019834.6354167,0.001691680184469959,1.165429164612662,0.22086131938083586,0.3774098484978255,0.861691417848595,raw,406216370,453000872.6875,363360130.5,505840672,365760534,527940428.625,60S acidic ribosomal protein P0 OS=Homo sapiens OX=9606 GN=RPLP0 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;extracellular;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6175,RPLP0,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000089157
Q6P087,0,6,252675.525,9.780933149170225e-7,1.1651709049986803,0.2205415820988057,0.3735204545461755,0.8594431551104292,raw,266405.9375,166839,267872.5,311260.5,250999.6875,NA,Mitochondrial mRNA pseudouridine synthase RPUSD3 OS=Homo sapiens OX=9606 GN=RPUSD3 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,endosome;nucleus,structural molecule activity,285367,RPUSD3,NA,NA,ENSG00000156990
Q9UNN5,0,6,7383534.878255208,2.858126486480276e-5,1.1648853228969607,0.2201879357970144,0.8238537029167318,1,raw,7171648.78125,7440065.21875,6960450.36328125,8354148.40625,4641340.25,9733556.25,FAS-associated factor 1 OS=Homo sapiens OX=9606 GN=FAF1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,DNA binding;structural molecule activity,11124,FAF1,Retinoblastoma gene in cancer; Fas ligand pathway and stress induction of heat shock proteins; VEGFA-VEGFR2 signaling pathway,NA,ENSG00000185104
Q70IA6,0,6,372445.76875,1.4417174618851838e-6,1.1648702886651665,0.22016931597994374,0.6398568998063081,1,raw,379780.53125,NA,321804.65625,405837.5,484234.34375,270571.8125,MOB kinase activator 2 OS=Homo sapiens OX=9606 GN=MOB2 PE=1 SV=1,development;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,81532,MOB2,NA,NA,ENSG00000182208
Q9BU76,0,6,3325387.6145833335,1.287239591302649e-5,1.164795931868092,0.22007722194390833,0.83960355231424,1,raw,2490365.96875,4053064.25,3102524.65625,3853946.75,1731431.3125,4720992.75,Multiple myeloma tumor-associated protein 2 OS=Homo sapiens OX=9606 GN=MMTAG2 PE=1 SV=1,NA,cell surface;nucleus,NA,79169,MMTAG2,NA,Neutrophil degranulation,ENSG00000143793
Q8WWZ4,0.8333333333333334,6,979364.0520833334,3.7910653681742823e-6,1.1647664153082744,0.22004066280692974,0.41491335148711544,0.9013279742103876,raw,774406.9375,1105741.875,837396.75,861784.125,1008923.625,1287931,ATP-binding cassette sub-family A member 10 OS=Homo sapiens OX=9606 GN=ABCA10 PE=2 SV=3,conjugation,cytoskeleton;nucleus,catalytic activity;structural molecule activity,10349,ABCA10,NA,ABC transporters in lipid homeostasis,ENSG00000154263
Q14257,0,6,36764556.130208336,1.423136118025219e-4,1.1643162103040265,0.21948292515695658,0.5638493034479021,1,raw,39059417.75,29815394.25,35087594.34375,40853054.875,27828784.4375,47943091.125,Reticulocalbin-2 OS=Homo sapiens OX=9606 GN=RCN2 PE=1 SV=1,NA,extracellular;membrane,structural molecule activity,5955,RCN2,NA,NA,ENSG00000117906
P48723,0,6,915151.2578125,3.5425011085039234e-6,1.1640882630158655,0.2192004498164109,0.463001957565442,0.9448882877131018,raw,676590.5,NA,955820.4296875,1115623.9375,718026.671875,1109694.75,Heat shock 70 kDa protein 13 OS=Homo sapiens OX=9606 GN=HSPA13 PE=1 SV=1,coagulation;metabolic process,endosome;extracellular;nucleus,structural molecule activity,6782,HSPA13,NA,Regulation of HSF1-mediated heat shock response,ENSG00000155304
Q9NX46,0,6,4728965.515625,1.8305570186530503e-5,1.1639545014354895,0.2190346649160396,0.33295413101515714,0.8158667519449163,raw,4176862.90625,5291333.75,3838052.40625,5369558.46875,4467318.375,5230667.1875,ADP-ribose glycohydrolase ARH3 OS=Homo sapiens OX=9606 GN=ADPRS PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,endosome;membrane;nucleus,structural molecule activity,54936,ADPRS,NA,POLB-Dependent Long Patch Base Excision Repair,ENSG00000116863
Q8IUF8,0,6,3450820.3645833335,1.3357939315960582e-5,1.1637940105191216,0.21883572637235285,0.44530289132389,0.9272762391647119,raw,3542072.46875,3814321.59375,2169139.40625,4439084.625,3051912.40625,3688391.6875,Ribosomal oxygenase 2 OS=Homo sapiens OX=9606 GN=RIOX2 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,84864,RIOX2,NA,HDMs demethylate histones,ENSG00000170854
Q8TC12,0,6,15064332.53125,5.831321788092714e-5,1.1634540491376324,0.21841423232437485,0.3842907226996175,0.8695425300008842,raw,12399702,14621879.25,12214347,24149945.5625,12573637.875,14426483.5,Retinol dehydrogenase 11 OS=Homo sapiens OX=9606 GN=RDH11 PE=1 SV=2,cellular homeostasis;development;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,51109,RDH11,NA,Retinoid metabolism and transport; The canonical retinoid cycle in rods (twilight vision); RA biosynthesis pathway,ENSG00000072042
P09525,0,6,72875816.97916667,2.82098352843788e-4,1.1633088979358748,0.2182342321060545,0.3249059934292778,0.8056423142874679,raw,80430575.875,55532859.75,64653654.5,80373360.125,64601869.875,91662581.75,Annexin A4 OS=Homo sapiens OX=9606 GN=ANXA4 PE=1 SV=4,development;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,DNA binding;structural molecule activity,307,ANXA4,Prostaglandin synthesis and regulation,NA,ENSG00000196975
P10909,0,6,878884.575,3.402114737433269e-6,1.1629213437590096,0.21775352088135227,0.8787767447292454,1,raw,NA,1156203.125,527251.25,1135700.5,708401.8125,866866.1875,Clusterin OS=Homo sapiens OX=9606 GN=CLU PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cell surface;cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,1191,CLU,Male infertility; Complement system in neuronal development and plasticity; Complement and coagulation cascades,Regulation of Complement cascade; Platelet degranulation ; Antimicrobial peptides; Terminal pathway of complement,ENSG00000120885
O60832,0,6,34254845.885416664,1.3259865894822587e-4,1.1628938381048373,0.21771939755875805,0.5041046574531395,0.9887033786631393,raw,35861188.0625,32177811.125,29160727.375,41702754.625,27348734.5625,39277859.5625,H/ACA ribonucleoprotein complex subunit DKC1 OS=Homo sapiens OX=9606 GN=DKC1 PE=1 SV=3,cell growth;cell proliferation;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,1736,DKC1,NA,rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase,ENSG00000130826
Q9NX62,0,6,4052901.765625,1.568856391204969e-5,1.162730036992511,0.2175161703255272,0.7275530470282359,1,raw,4442841.8125,3483277.28125,3697637.75,5025679.9375,2502148.1875,5165825.625,"Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase OS=Homo sapiens OX=9606 GN=BPNT2 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;defense response,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,54928,BPNT2,Proteoglycan biosynthesis,Cytosolic sulfonation of small molecules,ENSG00000104331
Q9NS69,0,6,33314270.174479168,1.289577411543822e-4,1.162526934002653,0.21726414168468597,0.2507377141004841,0.7326612824296702,raw,31348763,32367021.25,25253307.6875,36316577.25,29357650.359375,45242301.5,Mitochondrial import receptor subunit TOM22 homolog OS=Homo sapiens OX=9606 GN=TOMM22 PE=1 SV=3,cell growth;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity,56993,TOMM22,NA,Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy,ENSG00000100216
Q9NQZ2,0,6,8490339.404947916,3.286564542947374e-5,1.1624922782511,0.217221133282309,0.4564692219170172,0.9399855109820654,raw,9287838.84375,7242038.0390625,7261733.703125,9448249.3125,6905135.59375,10797040.9375,Something about silencing protein 10 OS=Homo sapiens OX=9606 GN=UTP3 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;defense response,membrane;nucleus,NA,57050,UTP3,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000132467
Q13451,0,6,29394190.552083332,1.1378332458749145e-4,1.1623336051149915,0.21702420073043113,0.2514595905464077,0.7326612824296702,raw,27301225.3125,26165458.375,25967003.6875,30412991.5625,27129490.1875,39388974.1875,Peptidyl-prolyl cis-trans isomerase FKBP5 OS=Homo sapiens OX=9606 GN=FKBP5 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,2289,FKBP5,Farnesoid X receptor pathway; Nuclear receptors meta-pathway; MECP2 and associated Rett syndrome,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; ESR-mediated signaling; MECP2 regulates neuronal receptors and channels,ENSG00000096060
P36871,0,6,61808211.169270836,2.3925624831151908e-4,1.1622343073507408,0.21690094651929392,0.3006958401597201,0.7806964943416801,raw,66389539,48515808.65625,51926093.21875,75977163.8125,50880462.453125,77160199.875,Phosphoglucomutase-1 OS=Homo sapiens OX=9606 GN=PGM1 PE=1 SV=3,cellular homeostasis,cell surface;cytosol;nucleus,structural molecule activity,5236,PGM1,Ectoderm differentiation; Clear cell renal cell carcinoma pathways; Glycogen synthesis and degradation; Disorders of galactose metabolism ; Disorders of fructose metabolism; Glucuronidation,Neutrophil degranulation; Glycogen synthesis; Glycogen breakdown (glycogenolysis); Galactose catabolism; Defective PGM1 causes PGM1-CDG,ENSG00000079739
Q99575,0,6,8634577.5625,3.342398354970775e-5,1.1621521857008297,0.21679900435306645,0.37946468369833775,0.8633096883236933,raw,5919677.375,9603577.0625,7888575.1875,10667523.90625,6879566,10848545.84375,Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens OX=9606 GN=POP1 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,10940,POP1,NA,tRNA processing in the nucleus,ENSG00000104356
Q13177,0,6,51436957.346354164,1.9910968472368283e-4,1.1619817006064592,0.21658734873194757,0.37525785904698217,0.8615698665976935,raw,53725755.625,51997594.09375,37379950.4375,60745053.09375,44353138.015625,60420252.8125,Serine/threonine-protein kinase PAK 2 OS=Homo sapiens OX=9606 GN=PAK2 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,5062,PAK2,Integrin-mediated cell adhesion; Apoptosis-related network due to altered Notch3 in ovarian cancer; Focal adhesion; Fas ligand pathway and stress induction of heat shock proteins; TGF-beta signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Ras signaling; Pancreatic adenocarcinoma pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Merlin signaling dysregulation; Neural crest cell migration during development; Neural crest cell migration in cancer; 3q29 copy number variation syndrome; Malignant pleural mesothelioma; Regulation of actin cytoskeleton; ErbB signaling pathway,FCERI mediated MAPK activation; Generation of second messenger molecules; Regulation of PAK-2p34 activity by PS-GAP/RHG10; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; Regulation of activated PAK-2p34 by proteasome mediated degradation; MAPK6/MAPK4 signaling; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; RHOU GTPase cycle; Ephrin signaling; Sema3A PAK dependent Axon repulsion; Smooth Muscle Contraction; RHO GTPases activate PAKs; VEGFR2 mediated vascular permeability; Activation of RAC1; RHOH GTPase cycle; CD209 (DC-SIGN) signaling; CD28 dependent Vav1 pathway; Nef and signal transduction; Stimulation of the cell death response by PAK-2p34,ENSG00000180370
P42285,0,6,30305740.776041668,1.1731188628837151e-4,1.1618048333944648,0.21636773695057318,0.20033788601126884,0.6907968838306926,raw,28204409.15625,31261633.7890625,24088141.671875,34452873.46875,27985719.421875,35841667.1484375,Exosome RNA helicase MTR4 OS=Homo sapiens OX=9606 GN=MTREX PE=1 SV=3,cellular component movement;cellular homeostasis;coagulation,membrane,structural molecule activity,23517,MTREX,NA,Major pathway of rRNA processing in the nucleolus and cytosol; mRNA Splicing - Major Pathway,ENSG00000039123
A0A0A6YYJ8,0,6,72087019.11458333,2.790449588984512e-4,1.161526352979704,0.21602188671825118,0.43667385027970257,0.9198966896755155,raw,69305804.21875,72721507.3125,63320987.421875,84467947.171875,60967489.3125,81738379.25,Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=3 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane,RNA binding,100996928,LUC7L2,NA,NA,ENSG00000269955
P46782,0,6,189541186.91015634,7.337037008956914e-4,1.1615006731990272,0.21598999032460828,0.28277378515205204,0.7642736213388397,raw,198529420.125,166109751.914063,152399509.890625,228907618.75,160708765.65625,230592055.125,40S ribosomal protein S5 OS=Homo sapiens OX=9606 GN=RPS5 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6193,RPS5,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000083845
Q13952,0,6,2671027.1302083335,1.0339401807985837e-5,1.1614536345475395,0.21593156263275537,0.5296580012250255,1,raw,2351352.6875,2810187.5859375,2281299.0234375,3775414.375,2076921.984375,2730987.125,Nuclear transcription factor Y subunit gamma OS=Homo sapiens OX=9606 GN=NFYC PE=1 SV=3,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4802,NFYC,NA,PPARA activates gene expression; Activation of gene expression by SREBF (SREBP); FOXO-mediated transcription of cell death genes; ATF4 activates genes in response to endoplasmic reticulum  stress; ATF6 (ATF6-alpha) activates chaperone genes,ENSG00000066136
P49368,0,6,513046282.9921875,0.001985974461268797,1.1613903748118937,0.21585298266220293,0.4652099361912915,0.9472023376131491,raw,485994023.1875,522423825.0625,449348235.40625,606738002,421312647.984375,592460964.3125,T-complex protein 1 subunit gamma OS=Homo sapiens OX=9606 GN=CCT3 PE=1 SV=4,cell growth;conjugation;metabolic process,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,7203,CCT3,16p11.2 proximal deletion syndrome,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,ENSG00000163468
Q96LJ7,0,6,1762643.953125,6.823099574564953e-6,1.1612709361315097,0.21570460666677016,0.4456959801531724,0.9273649839411913,raw,1812144.5625,2177959.46875,545774.125,1446539.1875,2104390.8125,2489055.5625,Dehydrogenase/reductase SDR family member 1 OS=Homo sapiens OX=9606 GN=DHRS1 PE=1 SV=1,NA,extracellular,structural molecule activity,115817,DHRS1,NA,NA,ENSG00000157379; ENSG00000284868
Q9H7N4,0,6,310206.1458333333,1.2007912419921095e-6,1.161129558420962,0.21552895658175703,0.684257613128922,1,raw,182228.84375,682330.09375,184799.109375,259943.84375,211591.296875,340343.6875,"Splicing factor, arginine/serine-rich 19 OS=Homo sapiens OX=9606 GN=SCAF1 PE=1 SV=3",cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,58506,SCAF1,NA,NA,ENSG00000126461
P47895,0,6,168400518.7890625,6.518693160176099e-4,1.1610729120299297,0.21545857213554043,0.2498853194319713,0.7326612824296702,raw,173574719.25,145081529.9375,152553241.1875,201532904.734375,153974907.25,183685810.375,Aldehyde dehydrogenase family 1 member A3 OS=Homo sapiens OX=9606 GN=ALDH1A3 PE=1 SV=2,cell growth;cellular homeostasis;defense response;metabolic process,cytosol;nucleus,structural molecule activity,220,ALDH1A3,Ethanol effects on histone modifications; Vitamin A and carotenoid metabolism,RA biosynthesis pathway,ENSG00000184254
Q9BQL6,0,6,2118024.8229166665,8.198759733943769e-6,1.1609914945928153,0.2153574030788338,0.3830895710044349,0.8681968915632151,raw,1478342.65625,2180253.625,1786587.40625,2063129.1875,1716343.25,3483492.8125,Fermitin family homolog 1 OS=Homo sapiens OX=9606 GN=FERMT1 PE=1 SV=1,cell communication;cell differentiation;cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,antioxidant activity;motor activity,55612,FERMT1,NA,NA,ENSG00000101311
P61326,0,6,42346540.020833336,1.639211700628434e-4,1.1608825144541495,0.21522197358945466,0.560428678164511,1,raw,38252375.5,43305485,38466678.75,56280816.125,33118590,44655294.75,Protein mago nashi homolog OS=Homo sapiens OX=9606 GN=MAGOH PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;membrane,NA,4116,MAGOH,NA,Regulation of expression of SLITs and ROBOs; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSG00000162385
Q10570,0,6,6692100.872395833,2.590476115975514e-5,1.1608483211114653,0.21517947894264222,0.6622038854809256,1,raw,5868214.96875,7273708.671875,5901170.5625,8443672.5,4402084.5625,8263753.96875,Cleavage and polyadenylation specificity factor subunit 1 OS=Homo sapiens OX=9606 GN=CPSF1 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,29894,CPSF1,mRNA processing,Transport of Mature mRNA Derived from an Intronless Transcript; tRNA processing in the nucleus; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs,ENSG00000071894; ENSG00000285049
C9JYN0,0,6,10222071.71875,3.9569087717188805e-5,1.1606342284193394,0.21491338134379645,0.3598932741819618,0.8422895555819307,raw,10154878.4375,11230456.3125,6653598.9375,12247829.25,9259567.875,11786099.5,Synaptophysin-like protein 1 OS=Homo sapiens OX=9606 GN=SYPL1 PE=1 SV=1,NA,cytoskeleton;extracellular,NA,NA,SYPL1,NA,NA,ENSG00000008282
Q8NBU5,0,6,16473727.9375,6.376891140299615e-5,1.1606164439056312,0.2148912746148354,0.40293530800377275,0.888947988048845,raw,16069289.0625,13748832.1875,16731522.375,19418880,13941642,18932202,ATPase family AAA domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ATAD1 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;mitochondrion;nucleus,catalytic activity;structural molecule activity,84896,ATAD1,NA,Class I peroxisomal membrane protein import,ENSG00000138138; ENSG00000283024
Q9UNS1,0.16666666666666666,6,272558.359375,1.0550586932764417e-6,1.1604220351544556,0.21464959612099505,1,1,raw,222669.546875,298864.5625,NA,NA,NA,296140.96875,Protein timeless homolog OS=Homo sapiens OX=9606 GN=TIMELESS PE=1 SV=2,cell differentiation;cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8914,TIMELESS,NA,Processing of DNA double-strand break ends,ENSG00000111602
Q9H3N1,0,6,35022311.354166664,1.3556947634106212e-4,1.1603336789557843,0.21453974306843854,0.5848208566632362,1,raw,39299549.375,26729244.0625,32922244,46335725.125,26646317.0625,38200788.5,Thioredoxin-related transmembrane protein 1 OS=Homo sapiens OX=9606 GN=TMX1 PE=1 SV=1,coagulation,cytoskeleton;extracellular;nucleus,structural molecule activity,81542,TMX1,NA,NA,ENSG00000139921
Q9HCY8,0,6,38015290.083333336,1.4715513540593104e-4,1.1598387025832446,0.21392418538441854,0.671862268808882,1,raw,38339213.5,35950668.75,35051920.125,49373465.75,27679495.375,41696977,Protein S100-A14 OS=Homo sapiens OX=9606 GN=S100A14 PE=1 SV=1,coagulation;development;metabolic process,cell surface;nucleus,antioxidant activity;structural molecule activity,57402,S100A14,NA,NA,ENSG00000189334
Q9BV79,0,6,2563861.4348958335,9.924569187479396e-6,1.15969380203615,0.2137439358724405,0.368516522787716,0.852141615295751,raw,2629598.40625,1844043.5625,2680894.296875,2786466.75,2333149.09375,3109016.5,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial OS=Homo sapiens OX=9606 GN=MECR PE=1 SV=2",cellular homeostasis,endosome;membrane,structural molecule activity,51102,MECR,Fatty acid biosynthesis; Mitochondrial fatty acid synthesis pathway,Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,ENSG00000116353
Q08211,0,6,315281307.7161458,0.001220436919624324,1.1596803518723529,0.21372720335468193,0.3881622613596443,0.872979446768193,raw,321814854.296875,294620431.65625,268870609.640625,373202363.46875,262993919.90625,370185667.328125,ATP-dependent RNA helicase A OS=Homo sapiens OX=9606 GN=DHX9 PE=1 SV=4,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;endoplasmic reticulum;Golgi;membrane;nucleus,RNA binding;structural molecule activity,1660,DHX9,MECP2 and associated Rett syndrome; mRNA processing,mRNA Splicing - Major Pathway; RIP-mediated NFkB activation via ZBP1; DEx/H-box helicases activate type I IFN and inflammatory cytokines production,ENSG00000135829
Q16740,0,6,20694884.84375,8.010878188003957e-5,1.1596308844316146,0.21366566229858533,0.4450743075594088,0.9271939562980955,raw,19301407.5,20323919.5625,18648210.375,26395763.625,17117499.75,22382508.25,"ATP-dependent Clp protease proteolytic subunit, mitochondrial OS=Homo sapiens OX=9606 GN=CLPP PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,endosome;nucleus,structural molecule activity,8192,CLPP,NA,NA,ENSG00000125656
Q9H3K6,0,6,40311096.166666664,1.5604207680025155e-4,1.1596169353921792,0.2136483082152082,0.6167042655792888,1,raw,38616658.125,42499664.5,33461020.625,53204400.25,29304302.75,44780530.75,BolA-like protein 2 OS=Homo sapiens OX=9606 GN=BOLA2 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,552900; 654483,BOLA2; BOLA2B,NA,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,ENSG00000169627; ENSG00000183336
P51668,0.5,6,1767685.25,6.842614162580352e-6,1.159262582792407,0.21320738600395248,0.9349333905513955,1,raw,1286667.25,2627584.25,1447728.625,1678297.625,1890355.75,1675478,Ubiquitin-conjugating enzyme E2 D1 OS=Homo sapiens OX=9606 GN=UBE2D1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7321,UBE2D1,Proteasome degradation,"Senescence-Associated Secretory Phenotype (SASP); FCERI mediated NF-kB activation; Downstream TCR signaling; E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CLEC7A (Dectin-1) signaling; CDK-mediated phosphorylation and removal of Cdc6; Neddylation; Peroxisomal protein import; IKK complex recruitment mediated by RIP1; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Signaling by BMP; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects; Inactivation of CSF3 (G-CSF) signaling; TICAM1, RIP1-mediated IKK complex recruitment; Negative regulators of DDX58/IFIH1 signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity; Ovarian tumor domain proteases",ENSG00000072401
P08651,0,6,4144222.609375,1.6042061967646715e-5,1.1592569794093552,0.2132004126119028,0.015010563118979286,0.6429522395902524,raw,3720346.28125,4042406.75,3751820.65625,4333892.25,4349324.28125,4667545.4375,Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4782,NFIC,NA,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination,ENSG00000141905
Q9UK59,0,6,4237092.3984375,1.6401555906918376e-5,1.1587786892299783,0.21260505776985206,0.2972099634781175,0.7790952437047332,raw,3702201.40625,4689886.875,3271982.015625,4852872.625,3791503.03125,5114108.4375,Lariat debranching enzyme OS=Homo sapiens OX=9606 GN=DBR1 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,structural molecule activity,51163,DBR1,NA,NA,ENSG00000138231
P61026,0,6,40153000.583333336,1.5543009733300303e-4,1.1586557953328165,0.21245204510231985,0.18553218572498328,0.6778506319470519,raw,33389244,43178711.75,32240830.625,48541467.5,37356025.25,46211724.375,Ras-related protein Rab-10 OS=Homo sapiens OX=9606 GN=RAB10 PE=1 SV=1,cell differentiation;cell growth;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,10890,RAB10,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,Neutrophil degranulation; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Translocation of SLC2A4 (GLUT4) to the plasma membrane,ENSG00000084733
Q15717,0,6,81523943.21744792,3.1557478258593014e-4,1.15855836766139,0.21233072837576092,0.5060910671394592,0.989873157379785,raw,74989484.875,84286909.2265625,73063601.4375,97651303.96875,65855060.796875,93297299,ELAV-like protein 1 OS=Homo sapiens OX=9606 GN=ELAVL1 PE=1 SV=2,cell growth;conjugation;metabolic process,cytosol;extracellular;membrane;nucleus,RNA binding;structural molecule activity,1994,ELAVL1,AMP-activated protein kinase signaling; Endoderm differentiation; Pre-implantation embryo; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Gastrin signaling pathway; IL-18 signaling pathway; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence,HuR (ELAVL1) binds and stabilizes mRNA; mRNA Splicing - Major Pathway,ENSG00000066044
O95070,0.5,6,654739.1770833334,2.5344600040683837e-6,1.1582208843163209,0.21191041595165577,0.9538339071456701,1,raw,471999.1875,940119.8125,566390.9375,712337.6875,581581.625,656005.8125,Protein YIF1A OS=Homo sapiens OX=9606 GN=YIF1A PE=1 SV=2,conjugation,cytoskeleton;extracellular;nucleus,NA,10897,YIF1A,NA,XBP1(S) activates chaperone genes,ENSG00000174851
Q13409,0,6,22904453.578125,8.866190315263553e-5,1.157964802110775,0.21159140134788595,0.4235992176602861,0.9086347256931654,raw,23902737.625,23225921.6875,15823004.9375,26301650.6875,18322482.78125,29850923.75,Cytoplasmic dynein 1 intermediate chain 2 OS=Homo sapiens OX=9606 GN=DYNC1I2 PE=1 SV=3,conjugation;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,1781,DYNC1I2,Ciliary landscape; Intraflagellar transport proteins binding to dynein,Separation of Sister Chromatids; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; HCMV Early Events; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000077380
A0A087WWU8,0,6,196495764.48958334,7.606244952168246e-4,1.1579637437112034,0.2115900826994191,0.43865934168130644,0.9224267229691854,raw,189832646.375,195562383.5625,168476718.5,243788716.125,161494800.5,219819321.875,Tropomyosin alpha-3 chain OS=Homo sapiens OX=9606 GN=TPM3 PE=1 SV=1,NA,endoplasmic reticulum,motor activity,7170,TPM3,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Striated muscle contraction pathway; VEGFA-VEGFR2 signaling pathway,NA,ENSG00000143549
Q9NRY5,0,6,4581823.553385417,1.773599159513227e-5,1.1578895815897168,0.21149768192104668,0.4213229630525278,0.9084454475353251,raw,3744461.8359375,4611620.890625,4218998.09375,4885133.9375,3684190.1875,6346536.375,Protein FAM114A2 OS=Homo sapiens OX=9606 GN=FAM114A2 PE=1 SV=4,NA,NA,structural molecule activity,10827,FAM114A2,NA,Signaling by BRAF and RAF1 fusions,ENSG00000055147
Q9H9J2,0,6,11778951.833333334,4.559568658227955e-5,1.157790588404291,0.21137433416375856,0.5310628498422845,1,raw,12987535.9375,11614564.84375,8410553.625,13550478.5625,9073731.15625,15036846.875,"39S ribosomal protein L44, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL44 PE=1 SV=1",cell organization and biogenesis;cellular component movement;cellular homeostasis,cytoplasm;cytoskeleton;endosome;Golgi;membrane,RNA binding;structural molecule activity,65080,MRPL44,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000135900
Q14240,0,6,43464359.1875,1.6824818770415543e-4,1.157629677388783,0.2111738128779247,0.24586142671918923,0.7315699559274061,raw,46794862.625,38033809.9375,34537881.9375,53769235.25,39982077.125,47668288.25,Eukaryotic initiation factor 4A-II OS=Homo sapiens OX=9606 GN=EIF4A2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,1974,EIF4A2,Translation factors; Translation inhibitors in chronically activated PDGFRA cells,L13a-mediated translational silencing of Ceruloplasmin expression; GTP hydrolysis and joining of the 60S ribosomal subunit; Deadenylation of mRNA; ISG15 antiviral mechanism; Translation initiation complex formation; Ribosomal scanning and start codon recognition,ENSG00000156976
P21283,0,6,32407299.864583332,1.2544690805356114e-4,1.1574560914208507,0.21095746528601492,0.26742144167646786,0.7473260925206285,raw,30037524,32539257.125,27077430.1875,40756176.25,29266296.5,34767115.125,V-type proton ATPase subunit C 1 OS=Homo sapiens OX=9606 GN=ATP6V1C1 PE=1 SV=4,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,catalytic activity,528,ATP6V1C1,Proximal tubule transport,Amino acids regulate mTORC1; ROS and RNS production in phagocytes; Insulin receptor recycling; Transferrin endocytosis and recycling; Ion channel transport,ENSG00000155097
Q5T1J5,0,6,4340929.333333333,1.6803503075577027e-5,1.15744285658734,0.21094096881761445,0.6102451587056977,1,raw,3722399.75,3555907.75,4840891.5,6459618.5,3158293.5,4308465,"Putative coiled-coil-helix-coiled-coil-helix domain-containing protein CHCHD2P9, mitochondrial OS=Homo sapiens OX=9606 GN=CHCHD2P9 PE=5 SV=1",cell growth;metabolic process,endosome;membrane,RNA binding,NA,CHCHD2P9,NA,NA,NA
Q13131,0,6,5594673.286458333,2.1656678226471455e-5,1.1573727173263657,0.21085354106297985,0.4481526092910041,0.9287898029210243,raw,6735611.9375,3994522.59375,4586009.96875,6190417,4623151.46875,7438326.75,5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Homo sapiens OX=9606 GN=PRKAA1 PE=1 SV=4,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,motor activity;signal transducer activity;structural molecule activity,5562,PRKAA1,AMP-activated protein kinase signaling; Target of rapamycin signaling; Energy metabolism; Thyroxine (thyroid hormone) production; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Leptin signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; mir-124 predicted interactions with cell cycle and differentiation ; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin and adiponectin; Lipid metabolism pathway; PI3K-Akt signaling pathway; Thermogenesis; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Hippo signaling regulation pathways; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; IL-18 signaling pathway; Insulin signaling; 1q21.1 copy number variation syndrome; Autophagy; p53 transcriptional gene network; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Malignant pleural mesothelioma,Activation of AMPK downstream of NMDARs; Regulation of TP53 Activity through Phosphorylation; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK,ENSG00000132356
Q7L2J0,0,6,3045472.7942708335,1.1788860756648144e-5,1.1572493033525186,0.21069969414834444,0.4250115983235372,0.9105262532056899,raw,2391692.75,3406629.53125,2877262.25,3329709.734375,3394354.5,2873188,7SK snRNA methylphosphate capping enzyme OS=Homo sapiens OX=9606 GN=MEPCE PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,56257,MEPCE,IL-18 signaling pathway,NA,ENSG00000146834
P30566,0,6,31037266.686197918,1.2014358359032594e-4,1.1571566545908272,0.21058418812948945,0.3087104169493352,0.790022385374121,raw,33640958.53125,25424786.3984375,27018950.78125,33021510.78125,28189534.59375,38927859.03125,Adenylosuccinate lyase OS=Homo sapiens OX=9606 GN=ADSL PE=1 SV=2,cellular homeostasis;coagulation;metabolic process,cytosol;nucleus,structural molecule activity,158,ADSL,NA,Purine ribonucleoside monophosphate biosynthesis,ENSG00000239900
P31939,0,6,140970606.40364584,5.456896061587477e-4,1.1570851870493093,0.2104950826039476,0.5413037370733236,1,raw,145559622.625,133828702.296875,125395471.453125,157266293.5,115348665.375,168424883.171875,Bifunctional purine biosynthesis protein ATIC OS=Homo sapiens OX=9606 GN=ATIC PE=1 SV=3,cellular homeostasis;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol,structural molecule activity,471,ATIC,One-carbon metabolism,Signaling by ALK fusions and activated point mutants; Purine ribonucleoside monophosphate biosynthesis,ENSG00000138363
Q7Z2W9,0,6,2832477.65625,1.0964368077319563e-5,1.156926115285307,0.21029673262596646,0.6851003165470334,1,raw,2715132.875,3402683.6875,1905315.4375,2204309.1875,2654274.25,4113150.5,"39S ribosomal protein L21, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL21 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,219927,MRPL21,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000197345
O15162,0,6,3566681.1302083335,1.380643008418588e-5,1.1568172354238953,0.21016095228007875,0.3376634850609267,0.8211705919010127,raw,3732910.0625,2844565.953125,3133131.15625,3476601.1875,3290642.921875,4922235.5,Phospholipid scramblase 1 OS=Homo sapiens OX=9606 GN=PLSCR1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,chromosome;cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,antioxidant activity;catalytic activity;RNA binding;structural molecule activity,5359,PLSCR1,EGF/EGFR signaling pathway; Complement system in neuronal development and plasticity,NA,ENSG00000188313
Q9H6Z4,0,6,15824965.916666666,6.125758864805524e-5,1.1568085499823875,0.21015012041308426,0.565437786420335,1,raw,16154863.6875,14738053.1875,14528204.5625,18688084.4375,12550288.5,18290301.125,Ran-binding protein 3 OS=Homo sapiens OX=9606 GN=RANBP3 PE=1 SV=1,conjugation;metabolic process,membrane;nucleus,structural molecule activity,8498,RANBP3,NA,NA,ENSG00000031823
O94906,0,6,47285821.973958336,1.830408638236137e-4,1.156386893426549,0.20962416240937365,0.3893646625709778,0.8741900145359902,raw,46819190.40625,43971178.0625,42502974,58814871.1875,40759024.1875,50847694,Pre-mRNA-processing factor 6 OS=Homo sapiens OX=9606 GN=PRPF6 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,24148,PRPF6,mRNA processing,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000101161
Q8NBZ7,0.3333333333333333,6,620832.953125,2.4032108417772387e-6,1.156366171708729,0.20959830999997534,0.16875991001686275,0.668039680404208,raw,598888.625,436337.46875,638518.0625,738360.6875,687177.6875,625715.1875,UDP-glucuronic acid decarboxylase 1 OS=Homo sapiens OX=9606 GN=UXS1 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular;nucleus,structural molecule activity,80146,UXS1,NA,NA,ENSG00000115652
Q9BRQ5,0.8333333333333334,6,1962553.375,7.596938153211873e-6,1.155953415023589,0.20908325833282115,0.5556285023592963,1,raw,1511300.375,2365585.5,1521091.25,1758310.625,1665070.25,2953962.25,Protein orai-3 OS=Homo sapiens OX=9606 GN=ORAI3 PE=1 SV=2,conjugation,cytoplasm;cytoskeleton,catalytic activity,93129,ORAI3,NA,NA,ENSG00000175938
P61513,0,6,39768338.25,1.5394109020920772e-4,1.1556830728525516,0.20874581659981287,0.4473309707837405,0.9282117643762616,raw,27953084.3125,43151488,40199130.75,49869444.25,42450986.75,34985895.4375,60S ribosomal protein L37a OS=Homo sapiens OX=9606 GN=RPL37A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,structural molecule activity,6168,RPL37A,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000197756
Q7L592,0.16666666666666666,6,449146.3828125,1.738621397731609e-6,1.155287666696086,0.2082521275219946,0.32885339528332247,0.8109264955343726,raw,NA,455802.03125,380370.5625,492701.9375,467711,NA,"Protein arginine methyltransferase NDUFAF7, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFAF7 PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis,endosome,structural molecule activity,55471,NDUFAF7,NA,Complex I biogenesis,ENSG00000003509
Q13123,0,6,16712906.1015625,6.469475716246834e-5,1.1552601886679859,0.20821781322308627,0.6352559712755801,1,raw,12676862.59375,20671306.4375,13456427.296875,17742509.21875,11849593.6875,23880737.375,Protein Red OS=Homo sapiens OX=9606 GN=IK PE=1 SV=3,cell differentiation;cellular component movement;cellular homeostasis;development;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,3550,IK,NA,NA,ENSG00000113141
O95433,0,6,104781821.21875,4.0560477259873114e-4,1.155012961325425,0.20790904136860036,0.44789042570539894,0.9287898029210243,raw,95301871.1875,115258925.1875,83448406.5625,113274035.5,88282136.375,133125552.5,Activator of 90 kDa heat shock protein ATPase homolog 1 OS=Homo sapiens OX=9606 GN=AHSA1 PE=1 SV=1,metabolic process,cytosol;extracellular,structural molecule activity,10598,AHSA1,T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection,NA,ENSG00000100591
O75390,0,6,156341838.99479166,6.051908176015037e-4,1.1549308526610833,0.20780647804026972,0.5821028159916999,1,raw,152449603.125,166026307.34375,128385368.625,192967996.875,122153007.875,176068750.125,"Citrate synthase, mitochondrial OS=Homo sapiens OX=9606 GN=CS PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,1431,CS,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Fluoroacetic acid toxicity; TCA cycle (aka Krebs or citric acid cycle),Citric acid cycle (TCA cycle); Mitochondrial protein import,ENSG00000062485
P35573,0,6,32860124.07421875,1.2719976612035247e-4,1.1548886857816651,0.2077538038405579,0.18100287857055417,0.674297118008435,raw,29518896.5,33740706.6640625,28396365.40625,33003423.4375,32794641.125,39706711.3125,Glycogen debranching enzyme OS=Homo sapiens OX=9606 GN=AGL PE=1 SV=3,cellular homeostasis;metabolic process,cell surface;cytosol;extracellular;membrane;nucleus,structural molecule activity,178,AGL,Glycogen synthesis and degradation,Neutrophil degranulation; Glycogen breakdown (glycogenolysis),ENSG00000162688
P29034,0,6,986419.1979166666,3.818375456776445e-6,1.1547869465040876,0.20762670482347698,0.08132621082103571,0.6429522395902524,raw,856885.3125,940011.625,976048.875,996516.625,1021924.25,1127128.5,Protein S100-A2 OS=Homo sapiens OX=9606 GN=S100A2 PE=1 SV=3,metabolic process,NA,structural molecule activity,6273,S100A2,Vitamin D receptor pathway,NA,ENSG00000196754
Q9Y4E5,0,6,1019835.53125,3.947728278908198e-6,1.1546922829289212,0.20750843515576892,0.1976098456775047,0.6875760999904456,raw,1042122.828125,995008.2890625,760581.625,969258.671875,1148710.5859375,1203331.1875,E3 SUMO-protein ligase ZNF451 OS=Homo sapiens OX=9606 GN=ZNF451 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,26036,ZNF451,NA,NA,ENSG00000112200
P32969,0,6,138419169.50390634,5.358131316760378e-4,1.1546344469616256,0.20743617196135833,0.5343820465189046,1,raw,152117300.125,120234411.625,116790925.167969,175639874.703125,103506583.277344,162225922.125,60S ribosomal protein L9 OS=Homo sapiens OX=9606 GN=RPL9 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,6133,RPL9; RPL9P7; RPL9P8; RPL9P9,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000163682
Q96AY3,0,6,11443647.59765625,4.429774198958852e-5,1.1545501717867739,0.207330867798239,0.23330846441107103,0.718951462768674,raw,10613927.78125,8964365.1875,10832496.03125,12186528.0625,10349809.3671875,15714759.15625,Peptidyl-prolyl cis-trans isomerase FKBP10 OS=Homo sapiens OX=9606 GN=FKBP10 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytoskeleton;endosome;extracellular,structural molecule activity,60681,FKBP10,Type I collagen synthesis in the context of osteogenesis imperfecta,NA,ENSG00000141756
Q15047,0.3333333333333333,6,208085.59765625,8.054881136512584e-7,1.154389519607011,0.20713010715967428,0.6928629630788727,1,raw,112308.0546875,298915.9140625,145299.875,345065.3984375,289166.7890625,57757.5546875,Histone-lysine N-methyltransferase SETDB1 OS=Homo sapiens OX=9606 GN=SETDB1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,9869,SETDB1,Histone modifications; Malignant pleural mesothelioma,PKMTs methylate histone lysines,ENSG00000143379
Q96P11,0,6,9332417.592447916,3.6125284628130564e-5,1.1542463397607112,0.2069511574533889,0.3771575765080522,0.8616098076180547,raw,8197463.96875,7285318.21875,9883796.0625,13118323.859375,8047710.6640625,9461892.78125,28S rRNA (cytosine-C(5))-methyltransferase OS=Homo sapiens OX=9606 GN=NSUN5 PE=1 SV=2,cellular component movement;cellular homeostasis;defense response;metabolic process,membrane,structural molecule activity,55695,NSUN5,NA,NA,ENSG00000130305
Q9Y3P9,0,6,240592.459375,9.31320420266794e-7,1.1538826889571037,0.2064965578978239,0.8181498812773004,1,raw,174215.296875,329605.53125,200139.125,284057.53125,214944.8125,NA,Rab GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RABGAP1 PE=1 SV=3,cell differentiation;metabolic process,cytosol;endoplasmic reticulum,DNA binding;motor activity;structural molecule activity,23637,RABGAP1,NA,TBC/RABGAPs,ENSG00000011454
P34949,0,6,8662749.03515625,3.353303379933698e-5,1.1538577587904997,0.20646538747069498,0.47655851443834063,0.9581420117875444,raw,10185065.25,5307303.71875,8306541.8359375,8515386.9375,7910079.90625,11752116.5625,Mannose-6-phosphate isomerase OS=Homo sapiens OX=9606 GN=MPI PE=1 SV=2,cellular homeostasis,cytosol,structural molecule activity,4351,MPI,NA,Synthesis of GDP-mannose; Defective MPI causes MPI-CDG,ENSG00000178802
O15143,0,6,31900795.453125,1.2348625682379372e-4,1.1538525437448208,0.20645886696373997,0.385746385778317,0.8705215576950358,raw,30569583.125,33180950.25,25015108.78125,35272791.25,26886525,40479814.3125,Actin-related protein 2/3 complex subunit 1B OS=Homo sapiens OX=9606 GN=ARPC1B PE=1 SV=3,cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,10095,ARPC1B,Pathogenic Escherichia coli infection; Microglia pathogen phagocytosis pathway,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; EPHB-mediated forward signaling,ENSG00000130429
Q9NQT5,0,6,10429684.611979166,4.0372746017524895e-5,1.153775403358702,0.2063624128948013,0.25513754520076704,0.735366952583477,raw,9019984.0625,9177213.65625,8677015.515625,15611663.53125,9685195.15625,10407035.75,Exosome complex component RRP40 OS=Homo sapiens OX=9606 GN=EXOSC3 PE=1 SV=3,cell proliferation;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,51010,EXOSC3,NA,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000107371
Q53FT3,0,6,3335549.640625,1.2911732567169651e-5,1.153134345460614,0.20556060339638166,1,1,raw,NA,NA,2663935.375,5421522.375,2184865.4375,3071875.375,Protein Hikeshi OS=Homo sapiens OX=9606 GN=HIKESHI PE=1 SV=2,cell growth;coagulation;conjugation;defense response,cytosol;membrane,structural molecule activity,51501,HIKESHI,NA,Regulation of HSF1-mediated heat shock response,ENSG00000149196
Q9HCF6,0.8333333333333334,6,1257984.8125,4.869591288564233e-6,1.1529238974960923,0.2052972863387567,0.8813781724727687,1,raw,1834784.75,651335.3125,1196115.375,1493551.625,993091.8125,1379030,Transient receptor potential cation channel subfamily M member 3 OS=Homo sapiens OX=9606 GN=TRPM3 PE=2 SV=4,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton,catalytic activity,80036,TRPM3,NA,TRP channels,ENSG00000083067
Q01581,0,6,4459343.630208333,1.7261878425401818e-5,1.1529165876381227,0.2052881392221974,0.8595048608474347,1,raw,2839987.84375,6505429.375,3642677.0625,4466095.75,3274269.09375,6027602.65625,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic OS=Homo sapiens OX=9606 GN=HMGCS1 PE=1 SV=2",cellular homeostasis,cytosol;nucleus,structural molecule activity,3157,HMGCS1,Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Endochondral ossification; Endochondral ossification with skeletal dysplasias; Cholesterol synthesis disorders,PPARA activates gene expression; Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,ENSG00000112972
P16144,0,6,69633902.72265625,2.6954907779300083e-4,1.152814912613032,0.20516090319791652,0.3366339335312841,0.820646994147619,raw,63821291.890625,71230156.2421875,60965719.78125,82115186.34375,60513865.515625,79157196.5625,Integrin beta-4 OS=Homo sapiens OX=9606 GN=ITGB4 PE=1 SV=5,cell communication;cell growth;cellular homeostasis;coagulation;defense response;development;metabolic process,chromosome;cytoplasm;cytoskeleton;membrane;nucleus,antioxidant activity,3691,ITGB4,Integrin-mediated cell adhesion; Focal adhesion; Arrhythmogenic right ventricular cardiomyopathy; Alpha 6 beta 4 signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; TGF-beta signaling pathway; Regulation of apoptosis by parathyroid hormone-related protein; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Netrin-UNC5B signaling pathway; Nephrotic syndrome; Malignant pleural mesothelioma; Congenital generalized lipodystrophy,Assembly of collagen fibrils and other multimeric structures; Syndecan interactions; Laminin interactions; Type I hemidesmosome assembly,ENSG00000132470
Q9Y5X3,0,6,18598396.005208332,7.199338677884899e-5,1.1523143658452946,0.20453435582146667,0.2328467908203691,0.718951462768674,raw,17638572.5,16766371.34375,16521421.5625,19320130.5625,17415129.9375,23928750.125,Sorting nexin-5 OS=Homo sapiens OX=9606 GN=SNX5 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,motor activity;structural molecule activity,27131,SNX5,NA,Golgi Associated Vesicle Biogenesis,ENSG00000089006
Q86V85,0,6,523008.21875,2.024536576726356e-6,1.1521631244469233,0.20434498949730875,0.4472253264870624,0.9282117643762616,raw,NA,505692.3125,464705.9375,626780,494854.625,NA,Integral membrane protein GPR180 OS=Homo sapiens OX=9606 GN=GPR180 PE=2 SV=1,development;metabolic process,cytoskeleton,NA,160897,GPR180,NA,NA,ENSG00000152749
Q9UJX3,0,6,4666128.640625,1.8062332036069447e-5,1.1521305937365205,0.20430425519837156,0.32602809931596693,0.8079129752982602,raw,5127793.78125,4586344.625,2968735.1875,5907888.09375,4672197.6875,4733812.46875,Anaphase-promoting complex subunit 7 OS=Homo sapiens OX=9606 GN=ANAPC7 PE=1 SV=4,NA,NA,NA,51434,ANAPC7,NA,NA,NA
P03897,0,6,3263533,1.263296003960453e-5,1.1520254540235242,0.20417259350575923,0.11307546291253769,0.6429522395902524,raw,3011558,2741570.5,3305197,3737001,3158359,3627512.5,NADH-ubiquinone oxidoreductase chain 3 OS=Homo sapiens OX=9606 GN=MT-ND3 PE=1 SV=1,cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity,4537,MT-ND3,Electron transport chain: OXPHOS system in mitochondria; Oxidative phosphorylation,Complex I biogenesis,ENSG00000198840
Q15773,0,6,2518803.71875,9.750153201017436e-6,1.1515110613966753,0.20352826970260504,0.9531734668366187,1,raw,3578595.125,1382674.625,2498031.875,4171423.75,1889931.8125,1592165.125,Myeloid leukemia factor 2 OS=Homo sapiens OX=9606 GN=MLF2 PE=1 SV=1,metabolic process,membrane;nucleus,NA,8079,MLF2,NA,NA,ENSG00000089693
Q9UK41,0,6,9973094.328125,3.860530968076919e-5,1.1513983562989796,0.2033870578213136,0.29817099479335446,0.7796368726609018,raw,9362362.625,9713261.796875,8599700.65625,12559945,8823486.953125,10779808.9375,Vacuolar protein sorting-associated protein 28 homolog OS=Homo sapiens OX=9606 GN=VPS28 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,51160,VPS28,7q11.23 copy number variation syndrome,Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy,ENSG00000160948; ENSG00000285339
O00411,0,6,7773416.905598958,3.0090477142292702e-5,1.1513511923883166,0.20332796052167834,0.4533341946094733,0.9359885112583651,raw,6853416.40625,8531857.75,6312061.046875,9823164.59375,6203450.74609375,8916550.890625,"DNA-directed RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=POLRMT PE=1 SV=2",cellular component movement;cellular homeostasis,endosome;nucleus,RNA binding;structural molecule activity,5442,POLRMT,Mitochondrial gene expression,Mitochondrial transcription initiation; Transcriptional activation of mitochondrial biogenesis,ENSG00000099821
Q9NZJ9,0,6,4293881.005208333,1.662138153762006e-5,1.1513411647878458,0.20331539543070876,0.22664149951849896,0.7148463313429879,raw,4135813.78125,4152285.5,3598247.28125,5223931.3125,4761732.65625,3891275.5,Diphosphoinositol polyphosphate phosphohydrolase 2 OS=Homo sapiens OX=9606 GN=NUDT4 PE=1 SV=2,cellular homeostasis;development,cytosol;membrane;nucleus,RNA binding;structural molecule activity,11163,NUDT4,NA,Synthesis of pyrophosphates in the cytosol,ENSG00000173598
E5RG17,0,6,7001819.59375,2.7103665607905226e-5,1.1510397161208696,0.2029376138889836,0.5438728176587926,1,raw,7242983.4375,6615068.875,5270398.71875,10559790.78125,4708468.75,7614207,Putative deoxyribonuclease TATDN1 (Fragment) OS=Homo sapiens OX=9606 GN=TATDN1 PE=1 SV=1,NA,membrane,structural molecule activity,NA,TATDN1,NA,NA,ENSG00000147687
J3KNI1,0,6,3066464.2630208335,1.1870117598816235e-5,1.1510367131131987,0.2029338499615834,0.7297423730985262,1,raw,2513541.125,3761716.359375,2691111.84375,3091365.46875,3097568.53125,3243482.25,Component of oligomeric Golgi complex 4 OS=Homo sapiens OX=9606 GN=COG4 PE=1 SV=1,conjugation,cytoskeleton;extracellular,NA,25839,COG4,NA,NA,ENSG00000103051
Q06830,0,6,1564807111.0078135,0.0060572838402586145,1.1505318118866859,0.20230087423272589,0.40441046032753725,0.8902077371640484,raw,1498148190.3125,1557683955.90625,1311982979.73438,2001420939,1295939449.21875,1723667151.875,Peroxiredoxin-1 OS=Homo sapiens OX=9606 GN=PRDX1 PE=1 SV=1,cell differentiation;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5052,PRDX1,Androgen receptor signaling pathway; Selenium micronutrient network; Nuclear receptors meta-pathway; NRF2 pathway,Detoxification of Reactive Oxygen Species; TP53 Regulates Metabolic Genes; Nuclear events mediated by NFE2L2; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,ENSG00000117450
Q8WY36,0.3333333333333333,6,264599.9869791667,1.0242522634174962e-6,1.1503765068465615,0.20210611826637243,0.41575196223115607,0.9013279742103876,raw,268944.3125,166725.765625,293590.9375,309387.21875,234504.84375,314446.84375,HMG box transcription factor BBX OS=Homo sapiens OX=9606 GN=BBX PE=1 SV=1,cellular component movement;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,56987,BBX,NA,NA,ENSG00000114439
B7WPE2,0,6,3532193.4739583335,1.3672930228886157e-5,1.1502842670989484,0.2019904351304381,0.6792061741606005,1,raw,4740614.96875,2377654.90625,2762873.375,5303079,2734979.03125,3273959.5625,"Echinoderm microtubule associated protein like 3, isoform CRA_e OS=Homo sapiens OX=9606 GN=EML3 PE=1 SV=1",NA,endoplasmic reticulum,NA,256364,EML3,NA,NA,ENSG00000149499
Q86X29,0,6,18095718.0546875,7.004754757277387e-5,1.1501219475961,0.20178683844330375,0.6422681867665739,1,raw,14746590.03125,20402673.5625,16692025.171875,23495278.9375,14039876.125,19197864.5,Lipolysis-stimulated lipoprotein receptor OS=Homo sapiens OX=9606 GN=LSR PE=1 SV=4,cell growth;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;nucleus,NA,51599,LSR,NA,LDL clearance; VLDL clearance,ENSG00000105699
Q92817,0,6,7775537.653645833,3.0098686443479558e-5,1.1499504843425874,0.20157174157716984,0.51660833396906,1,raw,8231960.53125,6079908.125,7615355.78125,9236430.84375,6023223.640625,9466347,Envoplakin OS=Homo sapiens OX=9606 GN=EVPL PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,2125,EVPL,NA,Formation of the cornified envelope,ENSG00000167880
Q9Y6G5,0,6,797076.7708333334,3.085441144439023e-6,1.149686531889458,0.20124055635607224,0.45515284441752923,0.9388814790284128,raw,597587.375,884898.625,737116.21875,1017356.03125,899566.6875,645935.6875,COMM domain-containing protein 10 OS=Homo sapiens OX=9606 GN=COMMD10 PE=1 SV=1,NA,membrane;nucleus,NA,51397,COMMD10,NA,Neddylation,ENSG00000145781
O00154,0,6,63836368.385416664,2.4710713539174956e-4,1.149569098095599,0.2010931859202051,0.2483043496795451,0.7316541032247736,raw,55042971.25,66061392.15625,55558139.90625,73690406,56723166,75942135,Cytosolic acyl coenzyme A thioester hydrolase OS=Homo sapiens OX=9606 GN=ACOT7 PE=1 SV=3,cellular homeostasis,cytosol;endosome;membrane,structural molecule activity,11332,ACOT7,NA,Mitochondrial Fatty Acid Beta-Oxidation,ENSG00000097021
P22234,0,6,229936131.64583334,8.900703509794628e-4,1.149305804292332,0.20076271759803901,0.28597997174162865,0.7655844406429082,raw,216558657.6875,226086232.4375,185972095.78125,248892122.25,202024221.765625,300083459.953125,Multifunctional protein ADE2 OS=Homo sapiens OX=9606 GN=PAICS PE=1 SV=3,cellular homeostasis,cytosol;nucleus,structural molecule activity,10606,PAICS,Metabolic reprogramming in colon cancer,Purine ribonucleoside monophosphate biosynthesis,ENSG00000128050
Q66K64,0.8333333333333334,6,839806.4375,3.2508453770622633e-6,1.1491873408864515,0.20061400576159033,0.20728662065351364,0.6988382857167694,raw,639893.3125,899279.6875,776936.3125,944428.1875,892845.375,885455.75,DDB1- and CUL4-associated factor 15 OS=Homo sapiens OX=9606 GN=DCAF15 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,nucleus,structural molecule activity,90379,DCAF15,NA,NA,ENSG00000132017; ENSG00000288453
Q15847,0,6,56593262.33154298,2.1906946292414963e-4,1.1491495554724804,0.20056656900029984,0.5914255634489238,1,raw,68359696.0908203,41637793.5625,45101753.3242188,78555514.375,33331222.0117188,72573594.625,Adipogenesis regulatory factor OS=Homo sapiens OX=9606 GN=ADIRF PE=1 SV=1,metabolic process,cytosol;membrane,NA,10974,ADIRF,NA,Transcriptional regulation of white adipocyte differentiation,ENSG00000148671
Q9H307,0,6,41536546.130208336,1.607857274451069e-4,1.1488052662489587,0.20013426776058205,0.32022783900969576,0.802295473638468,raw,33217204.4375,43290110.625,38306699.46875,49423560,35249795.1875,49731907.0625,Pinin OS=Homo sapiens OX=9606 GN=PNN PE=1 SV=5,cell communication;cellular component movement;cellular homeostasis,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,5411,PNN,NA,NA,ENSG00000100941
Q66PJ3,0,6,5260417.697916667,2.036279289022348e-5,1.1487668206242432,0.20008598608755593,0.3371499207474308,0.8207704247319269,raw,4848601.9375,5663870.875,3783261.625,6506466.9375,4322305.6875,6437999.125,ADP-ribosylation factor-like protein 6-interacting protein 4 OS=Homo sapiens OX=9606 GN=ARL6IP4 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
Q9H7L9,0,6,575208.84375,2.226602377705657e-6,1.1486750678915352,0.1999707525199972,0.11165331691897075,0.6429522395902524,raw,577178.0625,446326.78125,570812.3125,622413.375,NA,659313.6875,Sin3 histone deacetylase corepressor complex component SDS3 OS=Homo sapiens OX=9606 GN=SUDS3 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,64426,SUDS3,NA,Ub-specific processing proteases; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Potential therapeutics for SARS,ENSG00000111707
O00418,0,6,777403.5416666666,3.0092871365241394e-6,1.1486154605276877,0.19989588584799498,0.5945764303634595,1,raw,682977.0625,292214.71875,1052204.59375,1203419.4375,335642.34375,1097963.09375,Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;nucleus,RNA binding;signal transducer activity;structural molecule activity,29904,EEF2K,Translation factors; AMP-activated protein kinase signaling; BDNF-TrkB signaling,mTORC1-mediated signalling,ENSG00000103319
Q8IUE6,0,6,91695089.93229167,3.549467423625207e-4,1.1481796124748396,0.19934834389323905,0.5995857139311578,1,raw,106456539.375,77891408.09375,73112184.6875,106471347.75,64007831.5625,122231228.125,Histone H2A type 2-B OS=Homo sapiens OX=9606 GN=H2AC21 PE=1 SV=3,NA,nucleus,RNA binding;structural molecule activity,317772,H2AC21,NA,HATs acetylate histones; HCMV Late Events; UCH proteinases; Ub-specific processing proteases; HCMV Early Events; HDACs deacetylate histones; Metalloprotease DUBs; RMTs methylate histone arginines,ENSG00000184270
Q8NAV1,0,6,10528287.854166666,4.075443384428508e-5,1.1481018488821362,0.1992506301316765,0.22830250535115693,0.7148463313429879,raw,8197554.75,11534260.125,7976785.125,13183951.25,9034670.5,13242505.375,Pre-mRNA-splicing factor 38A OS=Homo sapiens OX=9606 GN=PRPF38A PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,NA,84950,PRPF38A,MECP2 and associated Rett syndrome,mRNA Splicing - Major Pathway,ENSG00000134748
Q9BUR5,0,6,2533533.5755208335,9.807171681288675e-6,1.1480979519332524,0.19924573325046668,0.2321674331074813,0.718627966119277,raw,2417734.3125,1981245.140625,2662503.6875,2417883.6875,2775795.8125,2946038.8125,MICOS complex subunit MIC26 OS=Homo sapiens OX=9606 GN=APOO PE=1 SV=1,cell growth;conjugation,cell surface;cytoskeleton;cytosol;endosome;extracellular,NA,79135,APOO,NA,Cristae formation,ENSG00000184831
Q96T37,0,6,5588250.158854167,2.1631814646310716e-5,1.148000944825732,0.19912382937844147,0.41341006650547496,0.8996323316459364,raw,5849344.53125,4523372.71875,4276913.046875,4909900.21875,4958646.8125,9011323.625,RNA-binding protein 15 OS=Homo sapiens OX=9606 GN=RBM15 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytoskeleton;membrane;nucleus,RNA binding,64783,RBM15,NA,NA,ENSG00000162775
H0YG38,0.8333333333333334,6,2360402.1041666665,9.136989103323284e-6,1.1477492065359651,0.19880743468410703,0.42098579859461294,0.9081628377481699,raw,1933250.25,2551286,2146048.75,2463125.75,2059413.875,3009288,Pre-mRNA-processing factor 40 homolog A (Fragment) OS=Homo sapiens OX=9606 GN=PRPF40A PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q8NBM4,0,6,1980042.859375,7.664639002942107e-6,1.1476392670748696,0.19866923662546446,0.9961605608460546,1,raw,2178717.4375,2715964.65625,1051258.59375,1271111.09375,1546257.6875,3116947.6875,Ubiquitin-associated domain-containing protein 2 OS=Homo sapiens OX=9606 GN=UBAC2 PE=1 SV=1,cell death;development;metabolic process,cytoskeleton;extracellular,NA,337867,UBAC2,NA,NA,ENSG00000134882
A6NJ78,0,6,3013053.0377604165,1.1663365629591114e-5,1.1476052648816308,0.1986264919027253,0.6519780118918863,1,raw,3521963.625,2957924.765625,1819601.6875,2755808.625,2088184.4765625,4934835.046875,12S rRNA N4-methylcytidine (m4C) methyltransferase OS=Homo sapiens OX=9606 GN=METTL15 PE=1 SV=1,cellular component movement;cellular homeostasis,endosome,structural molecule activity,196074,METTL15,NA,NA,ENSG00000169519
E7ESW6,0.8333333333333334,6,11824780.333333334,4.577308623142513e-5,1.1475893140267701,0.19860643938132483,0.12124711418166101,0.6445597830897484,raw,10312210,11809148,11102375,13774569,11834182,12116198,WD repeat-containing protein 87 OS=Homo sapiens OX=9606 GN=WDR87 PE=1 SV=2,NA,NA,NA,83889,WDR87,NA,NA,ENSG00000171804
Q07065,0,6,90371558.79166667,3.498234247767363e-4,1.147554098518047,0.19856216742905947,0.431773543728465,0.9162373203757352,raw,85910337.75,93887310.75,76080409.8125,107740768.25,75730439.5625,102880086.625,Cytoskeleton-associated protein 4 OS=Homo sapiens OX=9606 GN=CKAP4 PE=1 SV=2,NA,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;mitochondrion;nucleus,NA,10970,CKAP4,NA,Neutrophil degranulation; RND2 GTPase cycle; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; RND3 GTPase cycle; Surfactant metabolism,ENSG00000136026
Q9Y5J1,0,6,10312686.227864584,3.991985158954828e-5,1.1474724320301724,0.19845949337667265,0.2585948216286356,0.7381027251958325,raw,9187119.75,9213820.59375,9301564.8671875,14084498.46875,9516508.5625,10572605.125,U3 small nucleolar RNA-associated protein 18 homolog OS=Homo sapiens OX=9606 GN=UTP18 PE=1 SV=3,cellular component movement;cellular homeostasis,cytoskeleton;membrane;nucleus,NA,51096,UTP18,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000011260
Q9UQ35,0,6,85615900.85546875,3.314145296713347e-4,1.147263028869208,0.19819619078005019,0.21145783573151528,0.7020295967770634,raw,78705488.25,88972696.2890625,69406435.5,95278787.140625,79256912.921875,102075085.03125,Serine/arginine repetitive matrix protein 2 OS=Homo sapiens OX=9606 GN=SRRM2 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,23524,SRRM2,NA,mRNA Splicing - Major Pathway,ENSG00000167978
Q7Z3B4,0,6,14097191.921875,5.456946879951349e-5,1.1472077503067721,0.19812667574535633,0.34716522015402423,0.8299731034180416,raw,14481394.6875,12453107.0625,12034418.5,14286300.9375,12653264.46875,18674665.875,Nucleoporin p54 OS=Homo sapiens OX=9606 GN=NUP54 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;membrane,structural molecule activity,53371,NUP54,NA,SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; HCMV Late Events; HCMV Early Events; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000138750
O75223,0,6,9574685.364583334,3.706309009364011e-5,1.14718704996376,0.19810064336225852,0.9490335939415734,1,raw,6267333.8125,11760606.875,10422677.65625,7971214.15625,7189804.1875,13836475.5,Gamma-glutamylcyclotransferase OS=Homo sapiens OX=9606 GN=GGCT PE=1 SV=1,cell growth;development,cytosol,structural molecule activity,79017,GGCT,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases",Glutathione synthesis and recycling,ENSG00000006625
Q9Y6N7,0.6666666666666666,6,3197953.3,1.2379104561658005e-5,1.1470520301365488,0.19793083330448924,0.5876871220965605,1,raw,2518843.75,3918144,2702256,2990741.25,3859781.5,NA,Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,cell communication;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,6091,ROBO1,Development of ureteric collection system,Regulation of expression of SLITs and ROBOs; Netrin-1 signaling; Inactivation of CDC42 and RAC1; Activation of RAC1; Regulation of cortical dendrite branching; Regulation of commissural axon pathfinding by SLIT and ROBO; Role of ABL in ROBO-SLIT signaling; SLIT2:ROBO1 increases RHOA activity,ENSG00000169855
Q8IV08,0,6,4567479.643229167,1.7680467093368206e-5,1.1469683674656665,0.19782560344640343,0.6009428422148755,1,raw,5176592.625,3412695.359375,4400220.65625,3914253.625,4408669.09375,6092446.5,5'-3' exonuclease PLD3 OS=Homo sapiens OX=9606 GN=PLD3 PE=1 SV=1,cell proliferation;cellular homeostasis;coagulation;metabolic process,cytoskeleton;extracellular;mitochondrion,structural molecule activity,23646,PLD3,NA,Role of phospholipids in phagocytosis; Synthesis of PG,ENSG00000105223
Q96BW5,0,6,8350086.796875,3.2322735156087366e-5,1.146899212809043,0.19773861579196914,0.5900346325481419,1,raw,9959810.75,5883296.0625,7825455.90625,10530008.625,6926940.21875,8975009.21875,Phosphotriesterase-related protein OS=Homo sapiens OX=9606 GN=PTER PE=1 SV=1,cellular homeostasis;metabolic process,NA,structural molecule activity,9317,PTER,NA,NA,ENSG00000165983
K7EM18,0,6,31074560.984375,1.2028794780499029e-4,1.1466751898656962,0.19745678775093187,0.4068612203214287,0.8914071190930648,raw,23114365,38127141.84375,23206283.1875,38749652.625,26504668.875,36745254.375,Eukaryotic translation initiation factor 1 OS=Homo sapiens OX=9606 GN=EIF1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,RNA binding,NA,EIF1,NA,NA,ENSG00000173812
Q9H4L7,0,6,1631469.8,6.315331510121575e-6,1.14655666963888,0.19730766323662144,0.555484563877638,1,raw,1466054.96875,1942252.046875,1279426.203125,1566652.03125,NA,1902963.75,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens OX=9606 GN=SMARCAD1 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,56916,SMARCAD1,NA,NA,ENSG00000163104
O00193,0,6,9441696.520833334,3.654829745976542e-5,1.146384947748826,0.1970915719783202,0.2651576365297198,0.7454335379461359,raw,8560658.5,8965301.875,7945284.96875,9108355.09375,9174401.875,12896176.8125,Small acidic protein OS=Homo sapiens OX=9606 GN=SMAP PE=1 SV=1,NA,NA,NA,10944,SMAP,NA,NA,ENSG00000110696
P61353,0,6,161023290.83333334,6.233124649093845e-4,1.1458356449314036,0.1964001232858672,0.6867694561462787,1,raw,150292852,175200844,139062340,208285109,121087693,172210907,60S ribosomal protein L27 OS=Homo sapiens OX=9606 GN=RPL27 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,6155,RPL27,VEGFA-VEGFR2 signaling pathway; Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000131469
P53384,0,6,8858833.135416666,3.429206476454911e-5,1.145781544022651,0.1963320044803743,0.5235531655564909,1,raw,7286670.65625,9435075.71875,8470919.640625,10039742.78125,7110054.390625,10810535.625,Cytosolic Fe-S cluster assembly factor NUBP1 OS=Homo sapiens OX=9606 GN=NUBP1 PE=1 SV=2,cell growth;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,4682,NUBP1,NA,Cytosolic iron-sulfur cluster assembly,ENSG00000103274
P00533,0,6,67629677.265625,2.6179082926018876e-4,1.1454735779555074,0.19594418112867157,0.14311689832335348,0.6572502130392559,raw,58597273.9375,70195622.0625,60083168.09375,68823681.53125,68537633.8125,79540684.15625,Epidermal growth factor receptor OS=Homo sapiens OX=9606 GN=EGFR PE=1 SV=2,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,DNA binding;motor activity;RNA binding;signal transducer activity;structural molecule activity,1956,EGFR,"Androgen receptor signaling pathway; Glioblastoma signaling pathways; AGE/RAGE pathway; Gastric cancer network 2; Spinal cord injury; Aryl hydrocarbon receptor pathway; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Bladder cancer; TCA cycle nutrient use and invasiveness of ovarian cancer; Extracellular vesicle-mediated signaling in recipient cells; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Focal adhesion; RAC1/PAK1/p38/MMP2 pathway; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; ERK pathway in Huntington's disease; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; Endometrial cancer; PI3K-Akt signaling pathway; Ebola virus infection in host; Ras signaling; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Extracellular vesicles in the crosstalk of cardiac cells; EGF/EGFR signaling pathway; Relationship between inflammation, COX-2 and EGFR; Regulatory circuits of the STAT3 signaling pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; 22q11.2 copy number variation syndrome; Gastrin signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; Malignant pleural mesothelioma; Regulation of actin cytoskeleton; 2q37 copy number variation syndrome; ErbB signaling pathway","HCMV Early Events; NOTCH3 Activation and Transmission of Signal to the Nucleus; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RAF/MAP kinase cascade; Signaling by ERBB4; SHC1 events in ERBB2 signaling; GRB2 events in ERBB2 signaling; PI3K events in ERBB2 signaling; ERBB2 Regulates Cell Motility; ERBB2 Activates PTK6 Signaling; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Cargo recognition for clathrin-mediated endocytosis; Signal transduction by L1; GRB2 events in EGFR signaling; GAB1 signalosome; SHC1 events in EGFR signaling; EGFR downregulation; EGFR interacts with phospholipase C-gamma; Inhibition of Signaling by Overexpressed EGFR; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; PLCG1 events in ERBB2 signaling; EGFR Transactivation by Gastrin; Constitutive Signaling by EGFRvIII; PTK6 promotes HIF1A stabilization; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors; Signaling by ERBB2 ECD mutants",ENSG00000146648
Q12904,0,6,41864056.822916664,1.620535036537518e-4,1.1451241054024275,0.19550396211786034,0.272439186813812,0.7525679181563993,raw,35834782.75,42470335.875,39813377.5,46452437,37979602.4375,48633805.375,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens OX=9606 GN=AIMP1 PE=1 SV=2,cell death;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cell surface;cytosol;extracellular;membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,9255,AIMP1,Ciliary landscape,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,ENSG00000164022
Q9UHA3,0,6,2301615.6822916665,8.909430038218623e-6,1.1451098279464662,0.1954859744227064,0.021122018864736903,0.6429522395902524,raw,2157718.6875,2218634.875,2040973.15625,2470824.875,2478465.9375,2443076.5625,Probable ribosome biogenesis protein RLP24 OS=Homo sapiens OX=9606 GN=RSL24D1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,Golgi;membrane,structural molecule activity,51187,RSL24D1,NA,NA,ENSG00000137876
Q14974,0,6,258886705.1875,0.0010021364580712273,1.1450841485743537,0.1954536212655667,0.5108086146046452,0.9944212432021446,raw,279635816.6875,243162534.5625,206924842.6875,320206541.0625,201746999.6875,301643496.4375,Importin subunit beta-1 OS=Homo sapiens OX=9606 GN=KPNB1 PE=1 SV=2,cell differentiation;cell growth;conjugation;development;metabolic process,cell surface;cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,3837,KPNB1,Sterol regulatory element-binding proteins (SREBP) signaling; 22q11.2 copy number variation syndrome,Neutrophil degranulation; ISG15 antiviral mechanism; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Nuclear import of Rev protein; Apoptosis induced DNA fragmentation; Interferon alpha/beta signaling; Regulation of cholesterol biosynthesis by SREBP (SREBF); SARS-CoV-1 activates/modulates innate immune responses; Assembly of the ORC complex at the origin of replication; Initiation of Nuclear Envelope (NE) Reformation; Postmitotic nuclear pore complex (NPC) reformation; Inhibition of nitric oxide production,ENSG00000108424
Q9UH65,0,6,6821218.713541667,2.640456935155076e-5,1.1450625753425407,0.19542644082841096,0.7084993287177506,1,raw,7301548.125,5734409.3125,6672330.4375,8360729.5,4841826.40625,8016468.5,Switch-associated protein 70 OS=Homo sapiens OX=9606 GN=SWAP70 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,23075,SWAP70,NA,RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle,ENSG00000133789
P11940,0,6,266740318.90625,0.0010325373727472725,1.1450181587700718,0.19537047811243533,0.2858151272558632,0.7655844406429082,raw,238683483.1875,276964535.1875,226176007,317129422.125,233789406,307699059.9375,Polyadenylate-binding protein 1 OS=Homo sapiens OX=9606 GN=PABPC1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,26986,PABPC1,Translation factors; Endoderm differentiation; VEGFA-VEGFR2 signaling pathway; Acute viral myocarditis,AUF1 (hnRNP D0) binds and destabilizes mRNA; Regulation of expression of SLITs and ROBOs; Deadenylation of mRNA; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000070756
O94766,0,6,893888.4114583334,3.4601937782822166e-6,1.1449750426292904,0.19531615180049955,0.38945134169902446,0.8741900145359902,raw,862403.65625,885797.9375,807942.78125,1009928.46875,783041.09375,1014216.53125,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Homo sapiens OX=9606 GN=B3GAT3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;extracellular,DNA binding;structural molecule activity,26229,B3GAT3,Proteoglycan biosynthesis,A tetrasaccharide linker sequence is required for GAG synthesis; Defective B3GAT3 causes JDSSDHD,ENSG00000149541
Q13232,0,6,6780668.552083333,2.624760186591398e-5,1.1447747822080783,0.19506379696752016,0.33871325760010773,0.8220234029476299,raw,7444960.90625,5417288.90625,5828166.375,8522803.5,7643079.75,5827711.875,Nucleoside diphosphate kinase 3 OS=Homo sapiens OX=9606 GN=NME3 PE=1 SV=2,cellular homeostasis;metabolic process,cytosol,signal transducer activity;structural molecule activity,4832,NME3,Pyrimidine metabolism,Interconversion of nucleotide di- and triphosphates,ENSG00000103024
B9ZVM9,0.5,6,458684986.6666667,0.001775544818246525,1.1447324761636681,0.19501048006253643,0.21626414707208377,0.7052519353827845,raw,357802304,470532128,445867328,505778752,433496000,538633408,T-complex protein 10A homolog 2 OS=Homo sapiens OX=9606 GN=TCP10L2 PE=3 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
Q9H501,0,6,16264111.734375,6.295749839821521e-5,1.1447069267811185,0.19497828006854992,0.8311094895874802,1,raw,12096120.8125,22316157,13134210,18193559.0625,13846513.28125,17998110.25,ESF1 homolog OS=Homo sapiens OX=9606 GN=ESF1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,NA,51575,ESF1,NA,NA,ENSG00000089048
A0A5H1ZRP4,0,6,7026983.984375,2.7201075605348682e-5,1.144687045870503,0.1949532235763107,0.9781717885603176,1,raw,6846503.5625,6680778.6875,7495556.0625,7837103.9375,4613927.15625,8688034.5,Negative elongation factor B OS=Homo sapiens OX=9606 GN=NELFB PE=1 SV=1,cell differentiation;metabolic process,membrane,NA,NA,NELFB,Initiation of transcription and translation elongation at the HIV-1 LTR,NA,ENSG00000188986
P38159,0,6,144674156.91666666,5.600258502340026e-4,1.1446602731781639,0.1949194804826794,0.258623662180595,0.7381027251958325,raw,124096838.9375,153166401.1875,124949057.199219,158846761.53125,131662388.019531,175323494.625,"RNA-binding motif protein, X chromosome OS=Homo sapiens OX=9606 GN=RBMX PE=1 SV=3",cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cell surface;membrane;nucleus,RNA binding;structural molecule activity,27316,RBMX,mRNA processing,RND2 GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,ENSG00000147274
Q96EX1,0.16666666666666666,6,907473.5520833334,3.5127811241580002e-6,1.144606377727448,0.1948515506943711,0.7320696547040678,1,raw,602969,1189214.25,757668,867231.625,578340.3125,1449418.125,Small integral membrane protein 12 OS=Homo sapiens OX=9606 GN=SMIM12 PE=1 SV=3,NA,cytoskeleton,NA,113444,SMIM12,NA,NA,ENSG00000163866
Q6DD87,0,6,969724.75,3.7537521502511214e-6,1.1444926545752323,0.19470820361715377,0.5448312385939871,1,raw,998270.875,NA,806250.875,1189902.5,884474.75,NA,Zinc finger protein 787 OS=Homo sapiens OX=9606 GN=ZNF787 PE=1 SV=4,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,126208,ZNF787,NA,NA,ENSG00000142409
P48735,0,6,23245398.8125,8.998168374671961e-5,1.1442204089784522,0.1943649824589531,0.49473742300524015,0.9790666253301457,raw,25287799.25,17020470.0625,22989031.875,26460268.125,18780007.5625,28934816,"Isocitrate dehydrogenase [NADP], mitochondrial OS=Homo sapiens OX=9606 GN=IDH2 PE=1 SV=2",cellular homeostasis,cytosol;endosome;mitochondrion,structural molecule activity,3418,IDH2,"VEGFA-VEGFR2 signaling pathway; Metabolic reprogramming in colon cancer; Cerebral organic acidurias, including diseases; TCA cycle (aka Krebs or citric acid cycle)",Transcriptional activation of mitochondrial biogenesis; Citric acid cycle (TCA cycle),ENSG00000182054
P41236,0,6,9615407.744791666,3.722072422875976e-5,1.1441061550081337,0.1942209176745718,0.4600421564226668,0.9425587783849652,raw,10012419.75,8603702.75,8683896.625,11005998.59375,7931157.6875,11455271.0625,Protein phosphatase inhibitor 2 OS=Homo sapiens OX=9606 GN=PPP1R2 PE=1 SV=2,cellular homeostasis;metabolic process,NA,DNA binding;structural molecule activity,5504,PPP1R2,NA,NA,ENSG00000184203
Q96IZ7,0.16666666666666666,6,365938,1.4165262404188351e-6,1.1438851958689904,0.1939422656987678,0.25094981903142444,0.7326612824296702,raw,324890.3125,391369.21875,311742.65625,358512.53125,371637.21875,437476.0625,Serine/Arginine-related protein 53 OS=Homo sapiens OX=9606 GN=RSRC1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;metabolic process,membrane;nucleus,NA,51319,RSRC1,NA,NA,ENSG00000174891
H0Y886,0,6,9642212.875,3.732448544054413e-5,1.1438097931059594,0.19384716281760772,0.20123556014821745,0.691648270213144,raw,8122134.625,8750870.125,8609606.75,9845656.125,9290177.125,13234832.5,Complex I-SGDH (Fragment) OS=Homo sapiens OX=9606 GN=NDUFB5 PE=1 SV=1,NA,cytoskeleton;endosome;membrane,NA,NA,NDUFB5,NA,NA,ENSG00000136521
P38117,0,6,69048152.546875,2.672816704881457e-4,1.1437840008733038,0.19381463053303405,0.537787271208149,1,raw,71144208.9375,66253539.5625,60739579.8125,81373607.9375,56278869.71875,78499109.3125,Electron transfer flavoprotein subunit beta OS=Homo sapiens OX=9606 GN=ETFB PE=1 SV=3,cellular homeostasis,endosome;nucleus,structural molecule activity,2109,ETFB,NA,Respiratory electron transport; Protein methylation,ENSG00000105379
Q07666,0,6,74075017.72395833,2.8674039418009954e-4,1.1436910261797615,0.19369735351117445,0.3858427938926119,0.8705215576950358,raw,71996518.9375,74742024.6875,55902153.3125,82341772.625,59934464.34375,99533172.4375,"KH domain-containing, RNA-binding, signal transduction-associated protein 1 OS=Homo sapiens OX=9606 GN=KHDRBS1 PE=1 SV=1",cell differentiation;cellular component movement;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,10657,KHDRBS1,Leptin signaling pathway,PTK6 Regulates Proteins Involved in RNA Processing,ENSG00000121774
Q9HB40,0,6,9824970.71875,3.803193118631046e-5,1.143439373956931,0.1933798749665759,0.6292594028842796,1,raw,9567077.40625,10227215.9375,8281894.375,12690755,7243508.59375,10939373,Retinoid-inducible serine carboxypeptidase OS=Homo sapiens OX=9606 GN=SCPEP1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol,structural molecule activity,59342,SCPEP1,NA,NA,ENSG00000121064
Q10589,0.3333333333333333,6,418902.96875,1.6215507747862378e-6,1.143072544925766,0.19291696687999563,1,1,raw,372061.6875,361022.09375,517234.59375,NA,425293.5,NA,Bone marrow stromal antigen 2 OS=Homo sapiens OX=9606 GN=BST2 PE=1 SV=1,coagulation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,DNA binding;structural molecule activity,684,BST2,Ebola virus infection in host; Host-pathogen interaction of human coronaviruses - MAPK signaling,Neutrophil degranulation; Interferon alpha/beta signaling; SARS-CoV-1 activates/modulates innate immune responses,ENSG00000130303
J3KQY1,0,6,17374189.838541668,6.725455080454218e-5,1.1430064959262924,0.1928336026897644,0.7458265261117207,1,raw,19096829.53125,14908610.5,16411554.75,22540989.4375,12528641.125,18758513.6875,"39S ribosomal protein L22, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL22 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,Golgi,structural molecule activity,NA,MRPL22,NA,NA,ENSG00000082515
O75569,0,6,14324311.903645834,5.544863798637529e-5,1.1427531380379348,0.19251378063571345,0.5385130469618977,1,raw,17070380,9980303.921875,12638740.921875,19507230.3125,10868371.015625,15880845.25,Interferon-inducible double-stranded RNA-dependent protein kinase activator A OS=Homo sapiens OX=9606 GN=PRKRA PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,8575,PRKRA,VEGFA-VEGFR2 signaling pathway; Ebola virus infection in host,MicroRNA (miRNA) biogenesis; Small interfering RNA (siRNA) biogenesis,ENSG00000180228
P17655,0,6,96516190.0078125,3.736089604559149e-4,1.142753070385041,0.19251369522575573,0.21924740440161455,0.7087130179153194,raw,98966149.046875,90354069.46875,77694885.53125,111128740.53125,87859424.78125,113093870.6875,Calpain-2 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN2 PE=1 SV=6,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;mitochondrion;nucleus,motor activity;structural molecule activity,824,CAPN2,Integrin-mediated cell adhesion; Alzheimer's disease and miRNA effects; Focal adhesion; VEGFA-VEGFR2 signaling pathway; Alzheimer's disease,Degradation of the extracellular matrix; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,ENSG00000162909
P12110,0.3333333333333333,6,660300.29375,2.555986786431417e-6,1.1427048970376759,0.19245287638738925,0.7203375803561268,1,raw,568822.75,674180.625,609813.625,951469.9375,497214.53125,NA,Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4,cell communication;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,1292,COL6A2,miRNA targets in ECM and membrane receptors; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway,Collagen degradation; Signaling by PDGF; Assembly of collagen fibrils and other multimeric structures; Integrin cell surface interactions; ECM proteoglycans; NCAM1 interactions; Collagen chain trimerization,ENSG00000142173
P46777,0,6,314321718.5039063,0.00121672240159351,1.1426264126155439,0.19235378433350359,0.32499759411227974,0.8056423142874679,raw,284667889.8125,326271379.015625,265555021.0625,372806295.34375,269812112.601563,366817613.1875,60S ribosomal protein L5 OS=Homo sapiens OX=9606 GN=RPL5 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;extracellular;Golgi;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,6125,RPL5,VEGFA-VEGFR2 signaling pathway; Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000122406
A0A0D9SGH0,0.5,6,777378.7604166666,3.009191209643369e-6,1.1425976529823696,0.19231747158782134,0.4890431612816414,0.9724350346228805,raw,737435.875,905017.125,564070.75,842592.5,853557.625,761598.6875,Sodium/hydrogen exchanger OS=Homo sapiens OX=9606 GN=SLC9A6 PE=1 SV=5,cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;mitochondrion;nucleus,catalytic activity,NA,SLC9A6,NA,NA,ENSG00000198689
Q06124,0,6,41664140.627604164,1.6127963885549402e-4,1.1425487547787172,0.19225572920169776,0.3820121307491966,0.866868955431194,raw,44072628.5,36412132.375,35293227.984375,49789368.15625,34062359.9375,50355126.8125,Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens OX=9606 GN=PTPN11 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,5781,PTPN11,IL-5 signaling pathway; Heart development; IL-1 signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Pilocytic astrocytoma; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; VEGFA-VEGFR2 signaling pathway; Embryonic stem cell pluripotency pathways; IL-4 signaling pathway; Ras signaling; EGF/EGFR signaling pathway; Fragile X syndrome; Cancer immunotherapy by CTLA4 blockade; Cancer immunotherapy by PD-1 blockade; Gastrin signaling pathway; Netrin-UNC5B signaling pathway; Insulin signaling; IL-2 signaling pathway; Angiotensin II receptor type 1 pathway; Kallmann syndrome; GDNF signaling; Interferon type I signaling pathways; Type II interferon signaling; T-cell receptor signaling pathway,"PD-1 signaling; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon; Signal regulatory protein family interactions; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; Interleukin-3, Interleukin-5 and GM-CSF signaling; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RET signaling; PI3K Cascade; GPVI-mediated activation cascade; Signaling by SCF-KIT; Downstream signal transduction; Tie2 Signaling; Interleukin-6 signaling; Signaling by Leptin; Regulation of IFNG signaling; Regulation of IFNA/IFNB signaling; Signaling by CSF3 (G-CSF); GAB1 signalosome; PI-3K cascade:FGFR1; FRS-mediated FGFR1 signaling; PI-3K cascade:FGFR2; FRS-mediated FGFR2 signaling; FRS-mediated FGFR3 signaling; PI-3K cascade:FGFR3; FRS-mediated FGFR4 signaling; PI-3K cascade:FGFR4; Activated NTRK2 signals through FRS2 and FRS3; Spry regulation of FGF signaling; MAPK3 (ERK1) activation; MAPK1 (ERK2) activation; Prolactin receptor signaling; Interleukin-20 family signaling; Netrin mediated repulsion signals; Interleukin-37 signaling; Platelet sensitization by LDL; PECAM1 interactions; CTLA4 inhibitory signaling; MET activates PTPN11; STAT5 activation downstream of FLT3 ITD mutants; Regulation of RUNX1 Expression and Activity; STAT5 Activation",ENSG00000179295
P07686,0,6,59555715.729166664,2.305369600787274e-4,1.1423019409547615,0.1919440439945254,0.5259450798239321,1,raw,61498155.375,53224749.3125,56365756.375,66694047.8125,49302123.25,70249462.25,Beta-hexosaminidase subunit beta OS=Homo sapiens OX=9606 GN=HEXB PE=1 SV=3,cellular homeostasis,mitochondrion,structural molecule activity,3074,HEXB,NA,NA,NA
C9JXA7,0,6,2796835.2083333335,1.0826398085827234e-5,1.141860921451373,0.1913869412862625,0.4151759654855496,0.9013279742103876,raw,2740839.25,2830947,2370294.5,3225508.75,2380874,3232547.75,Late endosomal/lysosomal adaptor and MAPK and MTOR activator 4 OS=Homo sapiens OX=9606 GN=LAMTOR4 PE=1 SV=1,metabolic process,cytoskeleton;mitochondrion,NA,NA,LAMTOR4,NA,NA,ENSG00000188186
Q8N1F7,0,6,64875672.958333336,2.511302272797846e-4,1.1418607708263326,0.19138675097761007,0.3784163713528813,0.8617583924772685,raw,55872180.46875,68542536.28125,57576871.3125,78266033.3125,54892697.875,74103718.5,Nuclear pore complex protein Nup93 OS=Homo sapiens OX=9606 GN=NUP93 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane,structural molecule activity,9688,NUP93,NA,HCMV Early Events; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000102900
P47813,0,6,30692647.119791668,1.18809579855332e-4,1.1417040090272277,0.19118867516866428,0.45094709250535503,0.9329711840543342,raw,24020097.625,37443942.09375,23208897,39062445.5,26497690.75,33922809.75,"Eukaryotic translation initiation factor 1A, X-chromosomal OS=Homo sapiens OX=9606 GN=EIF1AX PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,RNA binding,1964,EIF1AX,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000173674
Q02952,0,6,394558351.8880208,0.0015273140773185347,1.141568314376005,0.19101719671765505,0.43170229248719494,0.9162373203757352,raw,380086043.96875,386170445.734375,352474083.65625,433894184.53125,332462533.59375,482262819.84375,A-kinase anchor protein 12 OS=Homo sapiens OX=9606 GN=AKAP12 PE=1 SV=4,development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,9590,AKAP12,G protein signaling pathways,RHOD GTPase cycle; RHOF GTPase cycle,ENSG00000131016
A0A2R8Y5A3,0,6,99167055.18001302,3.83870316413029e-4,1.1414722841992881,0.19089583027336743,0.4529008530263532,0.9356414401466827,raw,94141843.78125,104027496.703125,84501040.0625,118744504.28125,84742241.1269531,108845205.125,Catenin beta-1 OS=Homo sapiens OX=9606 GN=CTNNB1 PE=1 SV=1,cell communication,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,structural molecule activity,NA,CTNNB1,Neural crest differentiation; Primary focal segmental glomerulosclerosis (FSGS); Endoderm differentiation; Ectoderm differentiation; Ectoderm differentiation; RAC1/PAK1/p38/MMP2 pathway; Regulation of Wnt / B-catenin signaling by small molecule compounds; Physico-chemical features and toxicity-associated pathways; Embryonic stem cell pluripotency pathways; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; OSX and miRNAs in tooth development; PTF1A related regulatory pathway; Wnt signaling in kidney disease; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; Ciliary landscape; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Osteoblast differentiation and related diseases; Genes controlling nephrogenesis; GDNF/RET signaling axis; Mammalian disorder of sexual development; 1q21.1 copy number variation syndrome; 7q11.23 copy number variation syndrome; Development of ureteric collection system; Malignant pleural mesothelioma; Sudden infant death syndrome (SIDS) susceptibility pathways,NA,ENSG00000168036
O43488,0,6,28315826.135416668,1.09609034153204e-4,1.1414140404241926,0.19082221468891636,0.35276896862828283,0.8381547534932687,raw,31090577.75,21200442.03125,24271128.875,35399227.375,22446358.8125,35487221.96875,Aflatoxin B1 aldehyde reductase member 2 OS=Homo sapiens OX=9606 GN=AKR7A2 PE=1 SV=3,cellular homeostasis,cytosol;extracellular;nucleus,structural molecule activity,8574,AKR7A2,Aflatoxin B1 metabolism; Metapathway biotransformation Phase I and II,Aflatoxin activation and detoxification,ENSG00000053371
Q9HA65,0.16666666666666666,6,202252.63802083334,7.829090418334325e-7,1.1414125595916167,0.19082034298318662,0.19891269065714742,0.688581468393609,raw,195439.4375,171315.78125,194770.328125,207117.96875,195541.984375,249330.328125,TBC1 domain family member 17 OS=Homo sapiens OX=9606 GN=TBC1D17 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
O15018,0.6666666666666666,6,3909481.5416666665,1.513339196859554e-5,1.1408081370203376,0.19005617721440923,0.4341253928273589,0.9176747809749992,raw,2933320.75,4512118.5,3240952.5,4583676,3039360,5147461.5,PDZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PDZD2 PE=1 SV=4,cell communication,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,NA,23037,PDZD2,NA,NA,ENSG00000133401
Q9H4G4,0,6,4138691.0208333335,1.6020649487061286e-5,1.1407095254309225,0.1899314650954077,0.3586984952588531,0.8420882601494262,raw,4459884.1875,3163738.0625,3976487.375,4305063,3839541.125,5087432.375,Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,metabolic process,cell surface;cytoskeleton;extracellular,structural molecule activity,152007,GLIPR2,NA,NA,ENSG00000122694
P49711,0,6,3409825.390625,1.319924998515245e-5,1.1406953751615294,0.1899135686461841,0.5202663928246882,1,raw,3696959.96875,2502861.25,2743294.796875,3129263.6875,2411152.34375,5975420.296875,Transcriptional repressor CTCF OS=Homo sapiens OX=9606 GN=CTCF PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,10664,CTCF,MECP2 and associated Rett syndrome; Prion disease pathway; Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors; Sudden infant death syndrome (SIDS) susceptibility pathways,Activation of anterior HOX genes in hindbrain development during early embryogenesis,ENSG00000102974
Q8WVM0,0,6,3450513.0052083335,1.3356749544414783e-5,1.1406337656344863,0.1898356458619889,0.5147454210358221,0.9988615467241881,raw,3261929.53125,2682873.65625,3790667.125,4582403.8125,3060176.28125,3325027.625,"Dimethyladenosine transferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=TFB1M PE=1 SV=1",cellular component movement;cellular homeostasis,endosome,RNA binding;structural molecule activity,51106,TFB1M,Energy metabolism; Mitochondrial gene expression,Transcriptional activation of mitochondrial biogenesis; rRNA modification in the mitochondrion,ENSG00000029639
Q96N67,0,6,12228612.174479166,4.733629748497005e-5,1.1406294256905072,0.18983015660877148,0.5741237378946227,1,raw,10456161.4375,13227985.25,11384190.203125,15088229.21875,9922413.25,13292693.6875,Dedicator of cytokinesis protein 7 OS=Homo sapiens OX=9606 GN=DOCK7 PE=1 SV=4,cell differentiation;cell growth;conjugation;defense response;development;metabolic process,nucleus,DNA binding;structural molecule activity,85440,DOCK7,NA,CDC42 GTPase cycle; RAC1 GTPase cycle; Factors involved in megakaryocyte development and platelet production; MET activates RAP1 and RAC1,ENSG00000116641
E9PB61,0,6,100538708.86458333,3.891799137682122e-4,1.1405146112254332,0.18968492925193312,0.5356040263601983,1,raw,111485626.75,88914685.765625,86410590.34375,127150986.25,85816009.078125,103454355,THO complex subunit 4 OS=Homo sapiens OX=9606 GN=ALYREF PE=1 SV=1,NA,membrane,RNA binding,10189,ALYREF,NA,NA,ENSG00000183684
A0A286YFF7,0,6,4519492.1484375,1.7494710091951685e-5,1.140387421677464,0.18952403174064056,0.1803698375799579,0.6742444420587625,raw,4679258.6875,4296028.9375,3553978.265625,5336167.75,4457221.875,4794297.375,Palmitoyl-protein hydrolase 1 OS=Homo sapiens OX=9606 GN=PPT1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,extracellular;nucleus,structural molecule activity,NA,PPT1,NA,NA,ENSG00000131238
A0A024R571,0,6,73937205.765625,2.862069315300805e-4,1.1402691219473904,0.18937436393156515,0.8222590082729891,1,raw,65657665.3125,87860395.125,61627955.15625,104797566.125,48812244.5,74867408.375,EH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=EHD1 PE=1 SV=1,cell growth;conjugation,cytoplasm;cytoskeleton;mitochondrion,structural molecule activity,10938,EHD1,Insulin signaling,NA,ENSG00000110047
P47712,0,6,3222002.7298177085,1.247219860601496e-5,1.1402100934073909,0.1892996777152876,0.13623503880105226,0.654928512316515,raw,2933801.25,2740886.14453125,3328902.34375,3656880.34375,3125186.046875,3546360.25,Cytosolic phospholipase A2 OS=Homo sapiens OX=9606 GN=PLA2G4A PE=1 SV=2,cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,structural molecule activity,5321,PLA2G4A,Eicosanoid synthesis; AGE/RAGE pathway; Nanoparticle triggered regulated necrosis; PDGF pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; p38 MAPK signaling pathway; Ras signaling; Eicosanoid metabolism via cyclooxygenases (COX); Omega-3 / omega-6 fatty acid synthesis; Lipid metabolism in senescent cells; Prostaglandin synthesis and regulation,COPI-independent Golgi-to-ER retrograde traffic; Arachidonic acid metabolism; ADP signalling through P2Y purinoceptor 1; Synthesis of PA; Acyl chain remodelling of PC; Acyl chain remodelling of PS; Acyl chain remodelling of PE; Acyl chain remodelling of PI; Acyl chain remodelling of PG; Acyl chain remodeling of CL; Platelet sensitization by LDL; Hydrolysis of LPC; phospho-PLA2 pathway,ENSG00000116711
O60493,0,6,8886511.408854166,3.439920586663117e-5,1.1402051730035343,0.18929345197004932,0.3639784194205832,0.8458062414401234,raw,7178275.953125,9991655.65625,7512691.65625,9120626.0625,8184707.375,11331111.75,Sorting nexin-3 OS=Homo sapiens OX=9606 GN=SNX3 PE=1 SV=3,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,8724,SNX3,NA,Ub-specific processing proteases; WNT ligand biogenesis and trafficking,ENSG00000112335
P04424,0,6,14516303.6875,5.619182781572957e-5,1.1400934596230916,0.18915209474798328,0.7252142009617815,1,raw,14201713.5,14064571,14180448.53125,17187884.0625,11296168.40625,16167036.625,Argininosuccinate lyase OS=Homo sapiens OX=9606 GN=ASL PE=1 SV=4,cellular homeostasis;defense response;metabolic process,cytosol;nucleus,structural molecule activity,435,ASL,Alanine and aspartate metabolism,Urea cycle,ENSG00000126522
A0A3B3IUB1,0,6,5072926.825520833,1.9637025846112955e-5,1.1399836559384313,0.18901314047282125,0.24028399250382976,0.7263138257852598,raw,4573775.140625,4287500.6875,4978872.71875,6630383.03125,4753000.46875,5214028.90625,eIF-2B GDP-GTP exchange factor subunit epsilon OS=Homo sapiens OX=9606 GN=EIF2B5 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol,DNA binding;RNA binding;structural molecule activity,NA,EIF2B5,DYRK1A,NA,ENSG00000145191
Q5LJA5,0,6,24840085.145833332,9.615462844337304e-5,1.1398196471123379,0.18880556579288407,0.2760578844140172,0.756515890988102,raw,22951829.625,23638746.71875,21311881.5625,26160946.34375,22361736.59375,32615370.03125,Ubiquitin carboxyl-terminal hydrolase OS=Homo sapiens OX=9606 GN=UCHL5 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,NA,UCHL5,NA,NA,ENSG00000116750
P20839,0,6,7417295.119791667,2.8711948937020654e-05,1.1396565943836434,0.18859917157020273,0.5170302110110031,1,raw,6476605.28125,7779852.375,6943111.09375,8380636.03125,6057205.875,8866360.0625,Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens OX=9606 GN=IMPDH1 PE=1 SV=2,cellular homeostasis,cell surface;cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,3614,IMPDH1,NA,Potential therapeutics for SARS; Neutrophil degranulation; Purine ribonucleoside monophosphate biosynthesis; Azathioprine ADME,ENSG00000106348
Q9HB71,0,6,93991747.33333333,3.638369791617261e-4,1.1395889349610366,0.18851351874146077,0.41537706942209884,0.9013279742103876,raw,90432815.3125,98996135.9375,76379884.8125,103056235.6875,81113407.5,113972004.75,Calcyclin-binding protein OS=Homo sapiens OX=9606 GN=CACYBP PE=1 SV=2,defense response;metabolic process,cytosol;membrane;nucleus,motor activity;structural molecule activity,27101,CACYBP,Gastric cancer network 2,NA,ENSG00000116161
Q86YQ8,0.16666666666666666,6,18003697.666666668,6.969134161907397e-5,1.1394262841894596,0.1883075916726307,0.6093539358561814,1,raw,17465208,18257820,16385691,20803440,14469473,20640554,Copine-8 OS=Homo sapiens OX=9606 GN=CPNE8 PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton,structural molecule activity,144402,CPNE8,NA,RHOD GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle; RHOJ GTPase cycle,ENSG00000139117
Q9Y289,0.3333333333333333,6,402941.9270833333,1.559766444256881e-6,1.139091056630402,0.1878830777733095,0.35899373694673664,0.8420882601494262,raw,334702.84375,437094.0625,334075.46875,486166.4375,327722.8125,497889.9375,Sodium-dependent multivitamin transporter OS=Homo sapiens OX=9606 GN=SLC5A6 PE=2 SV=2,conjugation,cytoplasm;cytoskeleton,catalytic activity,8884,SLC5A6,Nuclear receptors meta-pathway; NRF2 pathway,"Transport of vitamins, nucleosides, and related molecules; Biotin transport and metabolism; Vitamin B5 (pantothenate) metabolism",ENSG00000138074
Q9UNX3,0,6,144808906.33333334,5.605474579505816e-4,1.1389665129060424,0.18772533056262514,0.23364319610590836,0.7191765918530469,raw,120529362.75,158750260.4375,119936278.8125,160361509.5,136603405.25,172672621.25,60S ribosomal protein L26-like 1 OS=Homo sapiens OX=9606 GN=RPL26L1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi,RNA binding;structural molecule activity,51121,RPL26L1,NA,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000037241
P55789,0,6,796544.5104166666,3.083380793103702e-6,1.1384873296598066,0.1871182356654183,0.760589509684227,1,raw,1515830.375,538288.5,510907.75,837039.3125,581662,795539.125,FAD-linked sulfhydryl oxidase ALR OS=Homo sapiens OX=9606 GN=GFER PE=1 SV=2,defense response;development;metabolic process,cell surface;cytosol;endosome,antioxidant activity;structural molecule activity,2671,GFER,NA,Mitochondrial protein import,ENSG00000127554
Q01167,0,6,1419169.9270833333,5.493530164472742e-6,1.1384136157156541,0.18702482207891488,0.6965102900658305,1,raw,1346467.96875,1464312.46875,1314247.53125,1532837.46875,1098766.84375,1758387.28125,Forkhead box protein K2 OS=Homo sapiens OX=9606 GN=FOXK2 PE=1 SV=3,cellular component movement;cellular homeostasis;coagulation;metabolic process,endosome;membrane;nucleus,RNA binding;structural molecule activity,3607,FOXK2,NA,UCH proteinases,ENSG00000141568
H0YKD8,0,6,139523736.16666666,5.400888495902524e-4,1.138401695481655,0.1870097156604079,0.30494945449040856,0.7849075999456834,raw,111962125,159310034,109813279,169454114,125011623,161591242,60S ribosomal protein L28 OS=Homo sapiens OX=9606 GN=RPL28 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,structural molecule activity,NA,RPL28,NA,NA,ENSG00000108107
M0QZR4,0,6,12640499.401041666,4.893069070053968e-5,1.1383978474221068,0.18700483901112672,0.5218749825400568,1,raw,11080646.9375,14303477.75,10220401.53125,16283048.28125,10127040.71875,13828381.1875,Rho guanine nucleotide exchange factor 1 OS=Homo sapiens OX=9606 GN=ARHGEF1 PE=1 SV=1,development,cytoplasm;cytoskeleton;cytosol,antioxidant activity;DNA binding,NA,ARHGEF1,NA,NA,ENSG00000076928
Q69YN4,0,6,3545727.9583333335,1.3725321487153203e-5,1.138136594170614,0.1866737139772919,0.3917823713388729,0.8763519738235003,raw,3969149.296875,3096572.515625,2852288.828125,3376311.625,3462611.421875,4517434.0625,Protein virilizer homolog OS=Homo sapiens OX=9606 GN=VIRMA PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,NA,25962,VIRMA,NA,NA,ENSG00000164944
Q9UBR2,0,6,16496970.395833334,6.385888170430679e-5,1.1381335792171856,0.18666989223555788,0.4936325584542373,0.978252162891754,raw,13342071.75,19562688,13656637.5,16668098.375,15185059.875,20567266.875,Cathepsin Z OS=Homo sapiens OX=9606 GN=CTSZ PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,1522,CTSZ,NA,Neutrophil degranulation; Metabolism of Angiotensinogen to Angiotensins; Lysosome Vesicle Biogenesis; COPII-mediated vesicle transport; Cargo concentration in the ER,ENSG00000101160
Q9Y294,0,6,4003785.421875,1.5498437197263835e-5,1.1380580119505224,0.18657410019297965,0.708895983704724,1,raw,3729042,5142087.4375,2651089.46875,4243866.125,3587771.8125,4668855.6875,Histone chaperone ASF1A OS=Homo sapiens OX=9606 GN=ASF1A PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,25842,ASF1A,22q11.2 copy number variation syndrome,Formation of Senescence-Associated Heterochromatin Foci (SAHF),ENSG00000111875
I3L0U5,0,6,2533937.1666666665,9.80873396082366e-6,1.1380195283764647,0.18652531445482243,0.9081979813771723,1,raw,1810067.90625,3589610.59375,2086920.375,2875532.78125,2059892.625,2781598.71875,Coiled-coil domain-containing protein 137 (Fragment) OS=Homo sapiens OX=9606 GN=CCDC137 PE=1 SV=1,NA,membrane;nucleus,NA,NA,CCDC137,NA,NA,ENSG00000185298
P43490,0,6,62986713.6015625,2.438181675976784e-4,1.1379366680751586,0.18642026661073818,0.3925704102512378,0.8766453461629867,raw,62699918.7421875,65795902.3203125,46931706.421875,74771960.265625,52849224,74871569.859375,Nicotinamide phosphoribosyltransferase OS=Homo sapiens OX=9606 GN=NAMPT PE=1 SV=1,cell death;cellular homeostasis;development;metabolic process,cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,10135,NAMPT,"Adipogenesis; NAD metabolism, sirtuins and aging; NAD+ metabolism; NAD+ biosynthetic pathways; Caloric restriction and aging; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence","NPAS4 regulates expression of target genes; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Nicotinamide salvaging",ENSG00000105835
Q9BWS9,0,6,2692990.5885416665,1.042442116935173e-5,1.1378380240952854,0.18629519871086633,0.4261758666423103,0.911043979658989,raw,2818325.96875,1851005.25,2597908.5,2892685.46875,2106144.15625,3891874.1875,Chitinase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CHID1 PE=1 SV=1,cellular homeostasis;coagulation;metabolic process,cell surface;extracellular;mitochondrion,structural molecule activity,66005,CHID1,NA,Platelet degranulation,ENSG00000177830
P62310,0,6,16714430.875,6.470065947811993e-5,1.137601921564153,0.18599580697989299,0.3783241371871298,0.8617583924772685,raw,16409340.25,16655770.75,13947770.75,18667297,14264208.25,20342198.25,U6 snRNA-associated Sm-like protein LSm3 OS=Homo sapiens OX=9606 GN=LSM3 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,27258,LSM3,NA,mRNA Splicing - Major Pathway; mRNA decay by 5' to 3' exoribonuclease,ENSG00000170860
Q9Y4P3,0,6,16890497.8359375,6.53822051777706e-5,1.1375077927032944,0.18587642878903807,0.9118359656692641,1,raw,15005713.28125,18769850.875,16300079.046875,21506905.75,11218971.125,18541466.9375,Transducin beta-like protein 2 OS=Homo sapiens OX=9606 GN=TBL2 PE=1 SV=1,coagulation;development,extracellular,structural molecule activity,26608,TBL2,7q11.23 copy number variation syndrome,NA,ENSG00000106638
P61758,0,6,44049372.93147787,1.7051274432126085e-4,1.1372896315023566,0.18559970956971494,0.5695781919840971,1,raw,37269075.5048828,54962150.1582031,27906085,53151790.1289063,28499253.296875,62507883.5,Prefoldin subunit 3 OS=Homo sapiens OX=9606 GN=VBP1 PE=1 SV=4,cell growth;metabolic process,cytosol;membrane;nucleus,motor activity;structural molecule activity,7411,VBP1,Cellular proteostasis,Prefoldin mediated transfer of substrate  to CCT/TriC,ENSG00000155959
A0A087X1N7,0.5,6,16814952.333333332,6.508977261601305e-5,1.1370670372443012,0.18531731267246032,0.16337249950067817,0.6638855679885327,raw,15692978,15266686,16676462,17843968,19272672,16136948,Nebulin OS=Homo sapiens OX=9606 GN=NEB PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P05067,0,6,2351040.1197916665,9.100749367276252e-6,1.137012980727712,0.18524872487624441,0.9328533155397281,1,raw,2318085.5625,2546227.28125,2105865.90625,2635693.375,1282843.96875,3217524.625,Amyloid-beta precursor protein OS=Homo sapiens OX=9606 GN=APP PE=1 SV=3,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;DNA binding;RNA binding;structural molecule activity,351,APP,Alzheimer's disease and miRNA effects; Endoderm differentiation; Apoptosis-related network due to altered Notch3 in ovarian cancer; Copper homeostasis; TGF-beta signaling pathway; Fragile X syndrome; Inclusion body myositis; Alzheimer's disease; GDNF signaling; DYRK1A; Neurogenesis regulation in the olfactory epithelium,Amyloid fiber formation; G alpha (q) signalling events; G alpha (i) signalling events; ECM proteoglycans; Lysosome Vesicle Biogenesis; Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; TAK1-dependent IKK and NF-kappa-B activation  ; TRAF6 mediated NF-kB activation; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; Formyl peptide receptors bind formyl peptides and many other ligands; Advanced glycosylation endproduct receptor signaling,ENSG00000142192
Q96IU4,0,6,22698757.411458332,8.786566439733573e-5,1.1369943765259565,0.18522511880520207,0.44273218381333546,0.9249261346766603,raw,25527806.1875,16787077.28125,21837124,24828687.1875,20780424.125,26431425.6875,Protein ABHD14B OS=Homo sapiens OX=9606 GN=ABHD14B PE=1 SV=1,cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,84836,ABHD14B,NA,Cytosolic sulfonation of small molecules,ENSG00000114779
P50995,0,6,77874016.95833333,3.014461151022865e-4,1.1369749439345327,0.18520046121371467,0.31977321449295815,0.802275970216152,raw,85090145.25,66505679.4375,62442046.0625,89628896.9375,66831970.9375,96745363.125,Annexin A11 OS=Homo sapiens OX=9606 GN=ANXA11 PE=1 SV=1,cell differentiation;conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,311,ANXA11,NA,NA,ENSG00000122359
Q9NRX2,0,6,9651693.742513016,3.7361185366799726e-5,1.1367101625638272,0.1848644439076491,0.3599671921169518,0.8422895555819307,raw,8723201.125,9159371.4375,9572854.875,11471588.8125,8571595.609375,10411550.5957031,"39S ribosomal protein L17, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL17 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,63875,MRPL17,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000158042
Q5VZU9,0,6,15855589.361979166,6.137613035145086e-5,1.136221809536645,0.1842445005833365,0.5410092495309745,1,raw,13254972.0625,18426020.1875,12732609.703125,20936046,12222270.46875,17561617.75,Tripeptidyl-peptidase 2 OS=Homo sapiens OX=9606 GN=TPP2 PE=1 SV=1,cell organization and biogenesis,cytosol;membrane,structural molecule activity,7174,TPP2,NA,NA,ENSG00000134900
Q9UGV2,0,6,6618731.671875,2.5620752945860133e-5,1.1358224577168732,0.1837373424225632,0.5382139080881406,1,raw,5337007.875,8112290,5277897.65625,7998599.875,5994754.6875,6991839.9375,Protein NDRG3 OS=Homo sapiens OX=9606 GN=NDRG3 PE=1 SV=2,development;metabolic process,nucleus,NA,57446,NDRG3,NA,NA,ENSG00000101079
Q9Y383,0,6,6889781.5,2.6669972196115853e-5,1.1358069974428153,0.1837177050114848,0.19526041257964194,0.6857975396967068,raw,6684201.5,6368690,5740297,7230877,6519869.5,8794754,Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,51631,LUC7L2,NA,NA,ENSG00000146963
P41440,0.16666666666666666,6,328110.965625,1.270099832695634e-6,1.1357995720680343,0.18370827331541806,0.7936675867353047,1,raw,340526.15625,359243.75,242932.484375,246888.5625,NA,450963.875,Reduced folate transporter OS=Homo sapiens OX=9606 GN=SLC19A1 PE=1 SV=3,cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton,catalytic activity;structural molecule activity,6573,SLC19A1,Folate metabolism; Ethanol effects on histone modifications,Metabolism of folate and pterines,ENSG00000173638
Q9UBQ5,0,6,35376599.346354164,1.3694090603024142e-4,1.135760523918046,0.18365867341933856,0.11856567876781267,0.6429522395902524,raw,34894923.25,34725599.140625,29568914.75,38771471.375,34666411.25,39632276.3125,Eukaryotic translation initiation factor 3 subunit K OS=Homo sapiens OX=9606 GN=EIF3K PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,protein binding;RNA binding,27335,EIF3K,NA,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000178982; ENSG00000282986
Q92889,0.3333333333333333,6,313246.828125,1.212561558971824e-6,1.1355665188523514,0.18341221824877524,0.778158679079844,1,raw,328304.1875,354352.3125,226489.9375,NA,261618.015625,395469.6875,DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,2072,ERCC4,"Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Fanconi Anemia Pathway; Dual incision in TC-NER; HDR through Single Strand Annealing (SSA); Formation of Incision Complex in GG-NER; Dual Incision in GG-NER,ENSG00000175595
Q96C01,0,6,13321283.96875,5.156597100548491e-5,1.1353848838076104,0.18318143922060992,0.6458507530022313,1,raw,12952361.9375,13501938.5,12305353.25,15329896.875,10762891.75,15075261.5,Protein FAM136A OS=Homo sapiens OX=9606 GN=FAM136A PE=1 SV=1,NA,nucleus,NA,84908,FAM136A,NA,NA,ENSG00000035141
Q96RE7,0,6,3515827.7239583335,1.3609579294249322e-5,1.1352103667435607,0.18295966926553786,0.8220134854139126,1,raw,2744632.375,5368965.9375,1992920.90625,4947578.75,3115735.125,2925133.25,Nucleus accumbens-associated protein 1 OS=Homo sapiens OX=9606 GN=NACC1 PE=1 SV=1,cellular component movement;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,112939,NACC1,NA,NA,ENSG00000160877
P09211,0,6,342613772.640625,0.0013262394156232425,1.135012274297355,0.18270789925378886,0.44122793219197615,0.9242467522608051,raw,365932415.96875,323575752.25,276820067.125,429446426.375,292645523.65625,367262450.46875,Glutathione S-transferase P OS=Homo sapiens OX=9606 GN=GSTP1 PE=1 SV=2,cell differentiation;cellular homeostasis;coagulation;defense response;metabolic process,cell surface;cytosol;endosome;membrane;nucleus,DNA binding;structural molecule activity,2950,GSTP1,Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Exercise-induced circadian regulation; Arachidonate epoxygenase / epoxide hydrolase; Metapathway biotransformation Phase I and II,Paracetamol ADME; Neutrophil degranulation; Detoxification of Reactive Oxygen Species; Glutathione conjugation,ENSG00000084207
B4DUC8,0,6,156114916.64583334,6.043124134405887e-4,1.1343821813630441,0.1819067763174737,0.5386824355035532,1,raw,164051975.875,141300667.875,140209945.125,181378735.5,123650537.25,186097638.25,S-methyl-5'-thioadenosine phosphorylase OS=Homo sapiens OX=9606 GN=MTAP PE=1 SV=1,cellular homeostasis,cytosol;membrane,structural molecule activity,NA,MTAP,Methionine de novo and salvage pathway,NA,ENSG00000099810
P62266,0,6,113864223.73177092,4.40762262353116e-4,1.1340438099408643,0.18147637499228217,0.9264370210174773,1,raw,85968038.5859375,151268105.671875,101256046.773438,114828793.0625,110380834.296875,119483524,40S ribosomal protein S23 OS=Homo sapiens OX=9606 GN=RPS23 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,6228,RPS23,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000186468
Q99614,0,6,13106332.932291666,5.0733907148906865e-5,1.1340113075379774,0.18143502586006424,0.5032148530003309,0.9876579753339259,raw,11293283.53125,14288234.125,11783348.1875,16203019.0625,11109290.5625,13960822.125,Tetratricopeptide repeat protein 1 OS=Homo sapiens OX=9606 GN=TTC1 PE=1 SV=1,metabolic process,cytosol,structural molecule activity,7265,TTC1,NA,NA,ENSG00000113312
E7ETU7,0,6,2628590.53125,1.0175132024638357e-5,1.1340047345735966,0.18142666367660518,0.7289068181667568,1,raw,2587139,1383881.75,3501078.625,2933827.875,2000002.9375,3365613,"39S ribosomal protein L3, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL3 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,structural molecule activity,NA,MRPL3,NA,NA,ENSG00000114686
P08236,0.16666666666666666,6,2458491.4947916665,9.5166878384287e-6,1.13387848194745,0.18126603456087084,0.4433443996468578,0.9253830590262077,raw,2472628.5,2511057.25,1860738.46875,3137044.25,2803660.25,1965820.25,Beta-glucuronidase OS=Homo sapiens OX=9606 GN=GUSB PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cell surface;mitochondrion;nucleus,antioxidant activity;structural molecule activity,2990,GUSB,Glycosaminoglycan degradation,Neutrophil degranulation; HS-GAG degradation; Hyaluronan uptake and degradation; MPS VII - Sly syndrome,ENSG00000169919
Q15043,0,6,1421641.5052083333,5.50309750995014e-6,1.133707400363904,0.1810483417673474,0.4833016332058742,0.9651683200517861,raw,1506049.4375,1288372.03125,980899.71875,1460636.90625,1011600.1875,2282290.75,Metal cation symporter ZIP14 OS=Homo sapiens OX=9606 GN=SLC39A14 PE=1 SV=3,cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;mitochondrion,catalytic activity,23516,SLC39A14,Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis; Ferroptosis,Zinc influx into cells by the SLC39 gene family,ENSG00000104635
Q92804,0,6,13999088.895833334,5.4189717282446355e-5,1.1337003671018853,0.18103939158875015,0.34070664869935124,0.8242917664336578,raw,12897772.5,11255186,13827671.5,19614401.125,13639493.75,12760008.5,TATA-binding protein-associated factor 2N OS=Homo sapiens OX=9606 GN=TAF15 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8148,TAF15,NA,RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,ENSG00000270647; ENSG00000276833
J3QQX3,0,6,370481.84375,1.4341152142456532e-6,1.133290487885941,0.18051770380395044,1,1,raw,353158.875,NA,NA,400231.59375,207206.90625,521330,"NADPH:adrenodoxin oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=FDXR PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,NA,FDXR,NA,NA,ENSG00000161513
P17858,0,6,39626864.657552086,1.5339345357122866e-4,1.1332331191315645,0.1804446707085067,0.3937264612816591,0.87714149171028,raw,48184310.765625,27735974.46875,29743465.59375,47278480.5,31431324.859375,53387631.7578125,"ATP-dependent 6-phosphofructokinase, liver type OS=Homo sapiens OX=9606 GN=PFKL PE=1 SV=6",cellular homeostasis;metabolic process,cell surface;cytosol;nucleus,signal transducer activity;structural molecule activity,5211,PFKL,Photodynamic therapy-induced HIF-1 survival signaling; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Insulin signaling; Disorders of fructose metabolism; Glycolysis and gluconeogenesis,Glycolysis; Neutrophil degranulation,ENSG00000141959
J3QRS3,0,6,147702155.95833334,5.71747071037756e-4,1.1331399167921508,0.18032601190802153,0.5292167937723742,1,raw,139821762.40625,146429707.84375,126569866.125,203479908.46875,111474070.6875,158437620.21875,Myosin regulatory light chain 12A OS=Homo sapiens OX=9606 GN=MYL12A PE=1 SV=1,NA,NA,structural molecule activity,10627,MYL12A,Focal adhesion,NA,ENSG00000101608
P20290,0,6,62721326.119791664,2.4279086698444046e-4,1.1329619026126525,0.18009934938800662,0.5345177574556175,1,raw,61942361.125,69410400.9375,45179223.875,70178335.3125,49811652.28125,79805983.1875,Transcription factor BTF3 OS=Homo sapiens OX=9606 GN=BTF3 PE=1 SV=1,conjugation;metabolic process,cytosol;Golgi;membrane;nucleus,NA,689,BTF3,NA,NA,ENSG00000145741
P68366,0,6,156762157.90104166,6.068178493939037e-4,1.1328278450419829,0.17992863258356828,0.3409168048010086,0.8242917664336578,raw,182853848.96875,121589534.75,120532811.625,177978276.3125,136542925.25,201075550.5,Tubulin alpha-4A chain OS=Homo sapiens OX=9606 GN=TUBA4A PE=1 SV=1,cell differentiation;cell growth,cell surface;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,7277,TUBA4A,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Platelet degranulation ; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,ENSG00000127824
P17301,0,6,51189853.739583336,1.9815316000339412e-4,1.1326707520996626,0.17972855547074792,0.596590119367427,1,raw,50597487.71875,51757343.40625,44164602.28125,64016775.75,39292618.8125,57310294.46875,Integrin alpha-2 OS=Homo sapiens OX=9606 GN=ITGA2 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q86XP3,0,6,55244899.408854164,2.13850022850704e-4,1.132568695522178,0.17959855904279307,0.5145322658352643,0.9988615467241881,raw,54323674.921875,53829285.828125,48507638.3125,69942468.203125,43900965.15625,60965364.03125,ATP-dependent RNA helicase DDX42 OS=Homo sapiens OX=9606 GN=DDX42 PE=1 SV=1,metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,11325,DDX42,NA,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000198231
Q14103,0,6,224086202.21354166,8.674255899941603e-4,1.1323160116398725,0.1792766479236314,0.15930018863152356,0.6638855679885327,raw,198988928.9375,201115223.125,206381640.46875,226524208.125,225318350.375,286188862.25,Heterogeneous nuclear ribonucleoprotein D0 OS=Homo sapiens OX=9606 GN=HNRNPD PE=1 SV=1,cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,3184,HNRNPD,mRNA processing,mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000138668
P30049,0,6,34455393.333333336,1.3337496729123204e-4,1.132289923418388,0.1792434082794353,0.5263455358781027,1,raw,35459426,27930522.8125,35082556.875,40150350.75,28244332.5625,39865171,"ATP synthase subunit delta, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1D PE=1 SV=2",cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity,513,ATP5F1D,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000099624
P26641,0,6,621990940.7552085,0.0024076933493721612,1.1322252453939492,0.17916099711573638,0.4352023656744708,0.9187171423798299,raw,608860254.125,604194807.914063,495236454.421875,855177097.25,484392416.164063,684084614.65625,Elongation factor 1-gamma OS=Homo sapiens OX=9606 GN=EEF1G PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,RNA binding,1937,EEF1G,Translation factors,Signaling by ALK fusions and activated point mutants; Eukaryotic Translation Elongation,ENSG00000254772
O95567,0.8333333333333334,6,41870560.666666664,1.6207867968175507e-4,1.132172476067222,0.17909375623727006,0.2562383984325232,0.7369596008729927,raw,44581536,35403768,35203772,48441228,37119072,50473988,Uncharacterized protein C22orf31 OS=Homo sapiens OX=9606 GN=C22orf31 PE=2 SV=1,NA,NA,NA,25770,C22orf31,NA,NA,ENSG00000100249
P19022,0.8333333333333334,6,41870560.666666664,1.6207867968175507e-4,1.132172476067222,0.17909375623727006,0.2562383984325232,0.7369596008729927,raw,44581536,35403768,35203772,48441228,37119072,50473988,Cadherin-2 OS=Homo sapiens OX=9606 GN=CDH2 PE=1 SV=4,cell communication;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,RNA binding;structural molecule activity,1000,CDH2,Neural crest differentiation; Arrhythmogenic right ventricular cardiomyopathy; Brain-derived neurotrophic factor (BDNF) signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); Splicing factor NOVA regulated synaptic proteins; Epithelial to mesenchymal transition in colorectal cancer; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Malignant pleural mesothelioma; CCL18 signaling pathway; GDNF signaling,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Myogenesis; Adherens junctions interactions,ENSG00000170558
Q6NVY1,0,6,15820944.30240885,6.124202119639666e-5,1.1319671266504723,0.17883206160885487,0.39462645981233185,0.8773167604394403,raw,16292917.5488281,14200536.671875,14671749.578125,17450272.3125,13867142.640625,18443047.0625,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial OS=Homo sapiens OX=9606 GN=HIBCH PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,26275,HIBCH,Amino acid metabolism,Branched-chain amino acid catabolism,ENSG00000198130
Q7KZN9,0,6,4153852.3697916665,1.607933825029338e-5,1.1317482514640342,0.1785530776428628,0.4370209943195873,0.9203531686342353,raw,4797862.0625,3439129.59375,3115008.3125,4942107.8125,3199034.4375,5429972,Cytochrome c oxidase assembly protein COX15 homolog OS=Homo sapiens OX=9606 GN=COX15 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome;membrane;nucleus,catalytic activity;structural molecule activity,1355,COX15,Electron transport chain: OXPHOS system in mitochondria; Mitochondrial complex IV assembly,Heme biosynthesis,ENSG00000014919
Q06203,0,6,43831861.645833336,1.6967076987831498e-4,1.1316814917484668,0.17846797324684865,0.5262250749533992,1,raw,41222196.25,41288220.75,42825193.3125,54774360.875,36156083.4375,46725115.25,Amidophosphoribosyltransferase OS=Homo sapiens OX=9606 GN=PPAT PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,5471,PPAT,Fluoropyrimidine activity; Metabolic reprogramming in colon cancer,Purine ribonucleoside monophosphate biosynthesis,ENSG00000128059
Q8WWH5,0,6,5717257.682291667,2.2131195804213604e-5,1.131536632755377,0.17828329166535958,0.7744136378945312,1,raw,6808647,4755655.78125,4848194.78125,7024600.5,3162214.53125,7704233.5,Probable tRNA pseudouridine synthase 1 OS=Homo sapiens OX=9606 GN=TRUB1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;endosome;membrane,RNA binding;structural molecule activity,142940,TRUB1,NA,NA,ENSG00000165832
Q01469,0,6,399582093.9375,0.0015467607115521556,1.1312992712840806,0.1779806270150575,0.5401089244366202,1,raw,395951449.25,387454003,371043709,438326431.25,336045685,468671286.125,Fatty acid-binding protein 5 OS=Homo sapiens OX=9606 GN=FABP5 PE=1 SV=3,cellular homeostasis;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,catalytic activity;structural molecule activity,2171,FABP5,PPAR signaling pathway; Fatty acid transporters,Triglyceride catabolism; Neutrophil degranulation; Signaling by Retinoic Acid,ENSG00000164687
G3XAI2,0,6,3331811.6458333335,1.2897262991151462e-5,1.1312022747908788,0.17785692645003082,0.42292058692478157,0.9086347256931654,raw,2902589.5,3112483.90625,3345591.46875,2827536,3520848.875,4281820.125,Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
E7ETY2,0,6,34476966.817708336,1.3345847708446054e-4,1.131166446336834,0.17781123139378768,0.11356339861830171,0.6429522395902524,raw,32423973.9375,34176065.46875,30455319.75,36676911.375,33636912.0625,39492618.3125,Treacle protein OS=Homo sapiens OX=9606 GN=TCOF1 PE=1 SV=1,NA,cytosol;membrane,NA,6949,TCOF1,NA,NA,ENSG00000070814
O60264,0,6,63056735.032552086,2.440892167764694e-4,1.1311469823251639,0.1777864066875756,0.3887577815547582,0.8734669263913436,raw,49167940.9375,72418988.796875,51085927.2265625,81916520.640625,52566449.46875,71184583.125,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Homo sapiens OX=9606 GN=SMARCA5 PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8467,SMARCA5,NA,Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; NoRC negatively regulates rRNA expression,ENSG00000153147
P50583,0,6,11108312.4453125,4.299967772015006e-5,1.131088831750765,0.17771223798703029,0.3462799028056414,0.8284180109507631,raw,11977250.78125,8554985.734375,10044247.46875,13547334.59375,9277917.0625,13248139.03125,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] OS=Homo sapiens OX=9606 GN=NUDT2 PE=1 SV=3,cellular homeostasis;coagulation;metabolic process,endosome,structural molecule activity,318,NUDT2,NA,Detoxification of Reactive Oxygen Species,ENSG00000164978
P20338,0,6,1227464.5364583333,4.751448947845731e-6,1.130824965688173,0.17737563960550204,0.4799783760463454,0.962082357312919,raw,1373454.1875,910419.875,1110950.75,1256290.84375,1011281.25,1702390.3125,Ras-related protein Rab-4A OS=Homo sapiens OX=9606 GN=RAB4A PE=1 SV=3,conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;mitochondrion;nucleus,structural molecule activity,5867,RAB4A,VEGFA-VEGFR2 signaling pathway; Insulin signaling; Intracellular trafficking proteins involved in CMT neuropathy; 16p11.2 distal deletion syndrome,RAB geranylgeranylation; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Synthesis of PIPs at the plasma membrane; TBC/RABGAPs; MET receptor recycling,ENSG00000168118
Q9NVH2,0,6,7064588.572916667,2.7346640937261258e-5,1.1307592124194514,0.17729174981209803,0.41583958337696275,0.9013279742103876,raw,6273454.6875,7636683.96875,5929330.625,8635250.75,5908123.71875,8004687.6875,Integrator complex subunit 7 OS=Homo sapiens OX=9606 GN=INTS7 PE=1 SV=1,cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,NA,25896,INTS7,NA,RNA polymerase II transcribes snRNA genes,ENSG00000143493
P00918,0,6,25178618.302083332,9.746507201326722e-5,1.1306972913502422,0.17721274478206706,0.45815297961739637,0.9412524313762942,raw,21810056.6875,28190593.3125,21182621.4375,25265907.8125,22747503.0625,31875027.5,Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,760,CA2,Proximal tubule transport,Reversible hydration of carbon dioxide; Erythrocytes take up carbon dioxide and release oxygen; Erythrocytes take up oxygen and release carbon dioxide,ENSG00000104267
X5CMH5,0,6,2226686.1640625,8.61938191871872e-6,1.130683193014994,0.17719475612559094,0.5563586828307373,1,raw,2393627.1875,2626905.46875,1076584.640625,1706461.90625,2850103.75,2706434.03125,Antigen peptide transporter 2 OS=Homo sapiens OX=9606 GN=TAP2 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;extracellular,antioxidant activity;catalytic activity;structural molecule activity,6891,TAP2,NA,NA,ENSG00000223481; ENSG00000225967; ENSG00000232326
P52597,0,6,134635613.15136734,5.21167189315652e-4,1.130583162478664,0.17706711653245372,0.5313332112638776,1,raw,138587210.742188,125014959.070313,124100003.207031,151481454.791016,111945684.097656,156684367,Heterogeneous nuclear ribonucleoprotein F OS=Homo sapiens OX=9606 GN=HNRNPF PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,3185,HNRNPF,MECP2 and associated Rett syndrome,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000169813
Q96I24,0,6,34922746.494791664,1.351840661460884e-4,1.1305060076531652,0.1769686587753327,0.5051078301810802,0.9892786797774812,raw,35248048.4375,28400028.0625,34968636.125,43877830.71875,27509682.40625,39532253.21875,Far upstream element-binding protein 3 OS=Homo sapiens OX=9606 GN=FUBP3 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,Golgi;membrane;nucleus,RNA binding,8939,FUBP3,NA,NA,ENSG00000107164
Q3YEC7,0,6,2266989.8697916665,8.77539538753443e-6,1.130496089675924,0.17695600189491795,0.7017034962202667,1,raw,1907833.28125,2693287,1852113.609375,2656877.96875,1447076.9375,3044750.421875,Rab-like protein 6 OS=Homo sapiens OX=9606 GN=RABL6 PE=1 SV=2,NA,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,55684,RABL6,NA,NA,ENSG00000196642
Q9Y3D9,0,6,14023548.61002605,5.428439951546705e-5,1.1303812111461362,0.17680939094410536,0.28578787279190254,0.7655844406429082,raw,14077095.6875,12744011.25,13045218.4375,15642556.625,12719925.1875,15912484.4726563,"28S ribosomal protein S23, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS23 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,structural molecule activity,51649,MRPS23,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000181610
Q96PK6,0,6,58107890.997395836,2.2493250871242834e-4,1.1303283516141074,0.17674192523688512,0.5447570010594033,1,raw,57375042.6875,54650053.984375,56806556.0625,64210060.875,49890245.84375,65715386.53125,RNA-binding protein 14 OS=Homo sapiens OX=9606 GN=RBM14 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,100526737; 10432,RBM14,Ciliary landscape,RUNX2 regulates bone development,ENSG00000239306
Q99961,0,6,17598637.61328125,6.812337602226276e-5,1.1292103757721432,0.17531429019341074,0.6425604421245877,1,raw,17144114.4375,17689394.8984375,15931517.625,19359311.90625,13544442.75,21923044.0625,Endophilin-A2 OS=Homo sapiens OX=9606 GN=SH3GL1 PE=1 SV=1,cell growth;conjugation;defense response;development,cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,structural molecule activity,6455,SH3GL1,Fragile X syndrome,Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell,ENSG00000141985
P60468,0,6,37757199.916666664,1.4615608230546755e-4,1.1291557210786498,0.17524446089922358,0.377223316029789,0.8616098076180547,raw,28297360.5,36361554,35545145,57193740.5,31952126.5,37193273,Protein transport protein Sec61 subunit beta OS=Homo sapiens OX=9606 GN=SEC61B PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation,cytoskeleton;cytosol;extracellular,protein binding;structural molecule activity,10952,SEC61B,NA,ER-Phagosome pathway; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; SRP-dependent cotranslational protein targeting to membrane,ENSG00000106803
G5E975,0,6,7741969.895833333,2.9968747465364602e-5,1.129122205162261,0.17520163778537493,0.689766141634789,1,raw,7660887.5,6951125.75,7879898.75,8650078.1875,5943098.9375,9366730.25,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 OS=Homo sapiens OX=9606 GN=SMARCB1 PE=1 SV=1,cell growth,membrane;nucleus,RNA binding,6598,SMARCB1,Tumor suppressor activity of SMARCB1; Thermogenesis; Modulators of TCR signaling and T cell activation; DYRK1A,NA,ENSG00000099956; ENSG00000275837
P06703,0,6,730300064.875,0.0028269521210560673,1.1289651600169524,0.17500096507785134,0.32742666575962004,0.8099046276759172,raw,581729825.25,733365141.5,739133933.75,800391284.5,656752705.25,870427499,Protein S100-A6 OS=Homo sapiens OX=9606 GN=S100A6 PE=1 SV=1,cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,catalytic activity;motor activity;structural molecule activity,6277,S100A6,Gastric cancer network 2; Vitamin D receptor pathway; Prostaglandin synthesis and regulation,NA,ENSG00000197956
O75528,0.16666666666666666,6,2121043.6375,8.2104454022052e-6,1.1289085563780041,0.17492862995243577,0.6637195596464767,1,raw,1716186.21875,2588555,1556886.75,NA,1661354.40625,3082235.8125,Transcriptional adapter 3 OS=Homo sapiens OX=9606 GN=TADA3 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;development;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,10474,TADA3,NA,Ub-specific processing proteases; HATs acetylate histones,ENSG00000171148
Q9BUH6,0,6,4167632.97265625,1.613268221994527e-5,1.1288983623589286,0.17491560238958703,0.2682051945455347,0.7479002559362639,raw,4277530.34375,2462368.96875,4363256.1953125,4902848.625,4170896.703125,4828897,Protein PAXX OS=Homo sapiens OX=9606 GN=PAXX PE=1 SV=2,cell proliferation;cellular homeostasis;coagulation,membrane;nucleus,structural molecule activity,286257,PAXX,NA,NA,ENSG00000148362
P20700,0,6,264270364.93945315,0.0010229763142985892,1.1286687737715138,0.1746221658734817,0.5329526116609009,1,raw,232551098.75,279502307.375,246618247.824219,292412613.71875,219072395.4375,315465526.53125,Lamin-B1 OS=Homo sapiens OX=9606 GN=LMNB1 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;membrane,motor activity;RNA binding;structural molecule activity,4001,LMNB1,Fas ligand pathway and stress induction of heat shock proteins; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome,Meiotic synapsis; RHOD GTPase cycle; RHOF GTPase cycle; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; Initiation of Nuclear Envelope (NE) Reformation; Depolymerisation of the Nuclear Lamina; Breakdown of the nuclear lamina; Formation of Senescence-Associated Heterochromatin Foci (SAHF),ENSG00000113368
P62805,0,6,3665606435.5338564,0.014189364599964642,1.1286387645686944,0.17458380678651128,0.29058139724973225,0.7730231021500684,raw,3466078891.98438,3332012652.3125,3663838481.79688,3911950998.54688,3378494126.875,4241263461.6875,Histone H4 OS=Homo sapiens OX=9606 GN=H4C1 PE=1 SV=2,cell growth;metabolic process,cell surface;membrane;nucleus,RNA binding;structural molecule activity,121504; 554313; 8294; 8359; 8360; 8361; 8362; 8363; 8364; 8365; 8366; 8367; 8368; 8370,H4C1; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9,Gastric cancer network 1; Histone modifications; 22q11.2 copy number variation syndrome; Male infertility; Type II interferon signaling,Amyloid fiber formation; Meiotic synapsis; HCMV Late Events; RUNX1 regulates transcription of genes involved in differentiation of HSCs; HCMV Early Events; SUMOylation of chromatin organization proteins; Transcriptional regulation by small RNAs; Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RMTs methylate histone arginines; HDMs demethylate histones; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; HATs acetylate histones; RNA Polymerase I Promoter Escape; Meiotic recombination; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Packaging Of Telomere Ends; Condensation of Prophase Chromosomes; DNA Damage/Telomere Stress Induced Senescence; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; Nonhomologous End-Joining (NHEJ); RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis,ENSG00000158406; ENSG00000197061; ENSG00000197238; ENSG00000197837; ENSG00000270276; ENSG00000270882; ENSG00000273542; ENSG00000274618; ENSG00000275126; ENSG00000276180; ENSG00000276966; ENSG00000277157; ENSG00000278637; ENSG00000278705
P98179,0,6,15652854.375,6.059135416284252e-5,1.1285825951037805,0.17451200575720577,0.4314546687192865,0.9162373203757352,raw,17168931.75,15042718.25,11978364,16976950,13835695,18914467.25,RNA-binding protein 3 OS=Homo sapiens OX=9606 GN=RBM3 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,protein binding,5935,RBM3,NA,NA,ENSG00000102317
Q9H6T3,0,6,11912879.268229166,4.611411245180371e-5,1.1285079820815076,0.17441662293265628,0.4457398526640084,0.9273649839411913,raw,9178155.359375,13766071.6875,9501476.75,15535121.78125,8844023.71875,14652426.3125,RNA polymerase II-associated protein 3 OS=Homo sapiens OX=9606 GN=RPAP3 PE=1 SV=2,metabolic process,cytosol;nucleus,NA,79657,RPAP3,NA,NA,ENSG00000005175
P78371,0,6,535716026.8997397,0.002073727815958998,1.1284475795778055,0.1743394017466928,0.6168468556470076,1,raw,526019817.3125,539076935.921875,481391014.789063,650318732.46875,423903871.25,593585789.65625,T-complex protein 1 subunit beta OS=Homo sapiens OX=9606 GN=CCT2 PE=1 SV=4,cell growth;conjugation;metabolic process,cell surface;cytosol;endoplasmic reticulum;mitochondrion;nucleus,structural molecule activity,10576,CCT2,16p11.2 proximal deletion syndrome,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Neutrophil degranulation; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle; Folding of actin by CCT/TriC,ENSG00000166226
Q9Y262,0,6,139199189.55729166,5.388325471881552e-4,1.128114618618055,0.17391365577850124,0.271396217494185,0.7524601054912853,raw,111816921.4375,153217743.3125,111954060.09375,172847176.0625,120991323,164367913.4375,Eukaryotic translation initiation factor 3 subunit L OS=Homo sapiens OX=9606 GN=EIF3L PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding,51386,EIF3L,NA,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000100129
P06132,0,6,19992502.58203125,7.738989806767425e-5,1.128092853866096,0.17388582154773874,0.5502686767036262,1,raw,23901019.0625,14660832.59375,18203609.96875,24437725.03125,18216466.515625,20535362.3203125,Uroporphyrinogen decarboxylase OS=Homo sapiens OX=9606 GN=UROD PE=1 SV=2,cellular homeostasis,cytosol;membrane,structural molecule activity,7389,UROD,Hemesynthesis defects and porphyrias; Heme biosynthesis,Heme biosynthesis,ENSG00000126088
Q12797,0,6,68514992.80729167,2.652178379223705e-4,1.1280041502756533,0.17377237586710384,0.4597330037171072,0.942396941601306,raw,76100257.21875,52958651.03125,65247572.5625,77952868.5,59737578.15625,79093029.375,Aspartyl/asparaginyl beta-hydroxylase OS=Homo sapiens OX=9606 GN=ASPH PE=1 SV=3,cell differentiation;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular,structural molecule activity,444,ASPH,NA,Stimuli-sensing channels; Ion homeostasis,ENSG00000198363
P30038,0,6,6240250.434895833,2.415567251232448e-5,1.1279782116439274,0.17373920048772887,0.6873604680133308,1,raw,6880679.25,3505955.1875,7056585.359375,6629961.125,3954641.0625,9413680.625,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH4A1 PE=1 SV=3",cellular homeostasis,cytosol;endosome,structural molecule activity,8659,ALDH4A1,22q11.2 copy number variation syndrome; p53 transcriptional gene network,Glyoxylate metabolism and glycine degradation; Proline catabolism,ENSG00000159423
P52272,0,6,469856554.3958333,0.00181878935375522,1.1279232870640974,0.17366894970860156,0.2835306148420157,0.7643821370278715,raw,430003183.09375,483201873.828125,409672125.09375,530125694.34375,421121804.171875,545014645.84375,Heterogeneous nuclear ribonucleoprotein M OS=Homo sapiens OX=9606 GN=HNRNPM PE=1 SV=3,cellular component movement;cellular homeostasis;coagulation,membrane;nucleus,RNA binding;structural molecule activity,4670,HNRNPM,mRNA processing,mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000099783
A0A024R1R8,0.16666666666666666,6,9335802.416666666,3.6138387099929244e-5,1.1274219295008947,0.17302753474760443,0.475651031532532,0.9571357750889941,raw,5871192.5,11193730,8897503,10031240,10902468,9118681,Coiled-coil domain-containing protein 72 OS=Homo sapiens OX=9606 GN=hCG_2014768 PE=3 SV=1,NA,NA,NA,NA,NA,NA,NA,ENSG00000225528
O14737,0,6,37196278.08203125,1.4398478416866587e-4,1.1271211128262895,0.1726425461099095,0.2864138994964035,0.7655844406429082,raw,32202612.25,39030116.75,32862218.875,41926165.3671875,33164886.625,43991668.625,Programmed cell death protein 5 OS=Homo sapiens OX=9606 GN=PDCD5 PE=1 SV=3,metabolic process,cytosol;membrane,DNA binding;motor activity;RNA binding;structural molecule activity,9141,PDCD5,NA,NA,ENSG00000105185
Q9NSA3,0,6,827435.84375,3.2029594765642654e-6,1.1270800432807528,0.17258997686202027,0.48993197496691887,0.9737904765793668,raw,871698.375,809020.125,678233.4375,997941.6875,695891,911830.4375,Beta-catenin-interacting protein 1 OS=Homo sapiens OX=9606 GN=CTNNBIP1 PE=1 SV=1,cell death;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,56998,CTNNBIP1,lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma,Deactivation of the beta-catenin transactivating complex,ENSG00000178585
Q8TC07,0,6,8040022.677083333,3.112249368923433e-5,1.1264062975118032,0.17172730492915741,0.4336065156365092,0.9176747809749992,raw,8268009.375,7436665.03125,6025435.3125,7724402.8125,6787088.28125,11998535.25,TBC1 domain family member 15 OS=Homo sapiens OX=9606 GN=TBC1D15 PE=1 SV=2,metabolic process,cell surface;nucleus,DNA binding,64786,TBC1D15,NA,TBC/RABGAPs,ENSG00000121749
A0A1W2PP11,0,6,414278.59765625,1.6036500839595643e-6,1.126404488163128,0.17172498752338378,0.9968187072503927,1,raw,270136.5,NA,557701.453125,401232.03125,NA,428044.40625,"Presenilins-associated rhomboid-like protein, mitochondrial OS=Homo sapiens OX=9606 GN=PARL PE=4 SV=1",NA,cytoskeleton,structural molecule activity,NA,NA,NA,NA,NA
Q9BVG4,0,6,8148215.278645833,3.15413014083902e-5,1.1260859384728428,0.17131693246034718,0.1692394752768799,0.668039680404208,raw,7114725.640625,8576253.90625,7195885.3125,8622928.25,8011792.5,9367706.0625,Protein PBDC1 OS=Homo sapiens OX=9606 GN=PBDC1 PE=1 SV=1,NA,NA,NA,51260,PBDC1,NA,NA,ENSG00000102390
P15121,0,6,10713203.557291666,4.147023254718574e-5,1.126064481997956,0.17128944304433505,0.2241268478587457,0.7125799511687476,raw,10537560.375,9969201.71875,9362388.25,10542652.875,10622845.6875,13244572.4375,Aldo-keto reductase family 1 member B1 OS=Homo sapiens OX=9606 GN=AKR1B1 PE=1 SV=3,cellular homeostasis;coagulation;defense response;metabolic process,cell surface;cytosol;membrane,structural molecule activity,231,AKR1B1,Eicosanoid metabolism via cyclooxygenases (COX); Disorders of galactose metabolism ; Polyol pathway; Metapathway biotransformation Phase I and II,Pregnenolone biosynthesis; Fructose biosynthesis,ENSG00000085662
P55081,0,6,5999960.71875,2.3225523994752196e-5,1.1260040491171377,0.1712120153672644,0.9322646899646707,1,raw,4743410.5625,7963247.75,5136113.875,7025866.625,5341099.5,5790026,Microfibrillar-associated protein 1 OS=Homo sapiens OX=9606 GN=MFAP1 PE=1 SV=2,cellular component movement;cellular homeostasis,cell surface;chromosome;endoplasmic reticulum;membrane,NA,4236,MFAP1,Canonical and non-canonical Notch signaling; Ciliary landscape,NA,ENSG00000140259
Q96P70,0,6,37614135.770833336,1.4560228872121007e-4,1.1259626608540703,0.1711589855941148,0.4636007447419057,0.9452899578480187,raw,37404984.6875,38292411.40625,32242419.9375,42232722.625,32396450.53125,43115825.4375,Importin-9 OS=Homo sapiens OX=9606 GN=IPO9 PE=1 SV=3,conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,55705,IPO9,NA,NA,ENSG00000198700
Q8IUI8,0,6,4231272.729166667,1.6379028281384288e-5,1.125958652045377,0.17115384910165526,0.9334011355612563,1,raw,3875330.75,5805766.625,2885595.25,4815383.8125,3642097.75,4363462.1875,Cytokine receptor-like factor 3 OS=Homo sapiens OX=9606 GN=CRLF3 PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,51379,CRLF3,NA,NA,ENSG00000176390
E9PSI1,0,6,4778769.270833333,1.8498357833957118e-5,1.1259010599263595,0.1710800542164079,0.9636962877967428,1,raw,2865928.125,7058981,4315594.625,5209794.25,4363385.0625,4858932.5625,Transmembrane 9 superfamily member OS=Homo sapiens OX=9606 PE=3 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endoplasmic reticulum;membrane;mitochondrion;nucleus,NA,NA,NA,NA,NA,NA
H7C561,0.3333333333333333,6,417556.8125,1.6163398766236288e-6,1.1257350209187162,0.1708672812417758,0.7600487446660036,1,raw,299397.5625,NA,489929.03125,431686.375,371300.78125,495470.3125,Splicing factor 1 (Fragment) OS=Homo sapiens OX=9606 GN=SF1 PE=1 SV=8,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,NA,SF1,NA,NA,ENSG00000168066
Q16629,0,6,71229606.05208333,2.757259592266239e-4,1.1256862264921077,0.17080474698490747,0.45669162096986066,0.9401690650546738,raw,54221402.375,78893504,67847644.25,88809330.8125,63104286.125,74501468.75,Serine/arginine-rich splicing factor 7 OS=Homo sapiens OX=9606 GN=SRSF7 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;metabolic process,membrane;nucleus,structural molecule activity,6432,SRSF7,mRNA processing,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA Splicing - Minor Pathway,ENSG00000115875
Q9H0U6,0,6,2976844.5625,1.1523204576811857e-5,1.1256476075346957,0.17075525154579851,0.30750723984211953,0.7885345351708948,raw,1457352.375,3133576.0625,3187308.5,3587786.1875,3299118.125,3195926.125,"39S ribosomal protein L18, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL18 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;endosome;Golgi,RNA binding;structural molecule activity,29074,MRPL18,NA,Mitochondrial translation elongation; Mitochondrial translation initiation; Mitochondrial translation termination,ENSG00000112110
Q13443,0,6,9408854.854166666,3.6421169141273154e-5,1.1255526254853314,0.17063351192471748,0.50088639334416,0.984977940523979,raw,7752636.28125,10297392.5625,8902461.546875,8930115.4375,8980266.0625,11590257.234375,Disintegrin and metalloproteinase domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ADAM9 PE=1 SV=1,cell communication;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cell surface;cytoskeleton;nucleus,antioxidant activity;structural molecule activity,8754,ADAM9,Copper homeostasis; VEGFA-VEGFR2 signaling pathway,Collagen degradation,ENSG00000168615
Q5HY81,0,6,23990193.963541668,9.286474556371383e-5,1.1254360192387058,0.17048404226454114,0.8544719251915474,1,raw,20967477.46875,30267766.8125,19660560.9375,25292178.25,22126703.4375,25626476.875,Ubiquitin-like protein 4A OS=Homo sapiens OX=9606 GN=UBL4A PE=1 SV=2,NA,cytosol;membrane,NA,NA,UBL4A,NA,NA,ENSG00000102178
Q9NWY4,0,6,1338287.171875,5.180437386051324e-6,1.1254063757301729,0.17044604178716155,0.6161192695890773,1,raw,1249094.1875,1771305,653282.75,1405738.5625,1017889.9375,1932412.59375,Histone PARylation factor 1 OS=Homo sapiens OX=9606 GN=HPF1 PE=1 SV=2,cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,54969,HPF1,NA,NA,ENSG00000056050
P25398,0,6,181401059.8725585,7.021937086317008e-4,1.1253429368916317,0.17036471518426166,0.6099575652205651,1,raw,151971865.015625,225431753.494141,139849571.280273,195292896.099609,157378727.267578,218481546.078125,40S ribosomal protein S12 OS=Homo sapiens OX=9606 GN=RPS12 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,6206,RPS12,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000112306
Q9BUK6,0,6,3290709.3489583335,1.273815821912745e-5,1.1251243030522056,0.1700843983226745,0.8112894970486236,1,raw,1945373.6875,4673310.53125,2874464.3125,3234129.65625,2530593.34375,4486384.5625,Protein misato homolog 1 OS=Homo sapiens OX=9606 GN=MSTO1 PE=1 SV=1,cell growth,cytoskeleton;cytosol;endosome;nucleus,NA,55154,MSTO1,NA,NA,ENSG00000125459
A0A5H1ZRQ2,0,6,236383947.24739584,9.150294970451768e-4,1.1242420725863032,0.16895271110877444,0.37818429638994966,0.8617583924772685,raw,252906008.984375,227200967.59375,187075838.25,261013354.59375,210318528.125,279788985.9375,RNA helicase OS=Homo sapiens OX=9606 GN=DDX17 PE=1 SV=1,NA,NA,RNA binding;structural molecule activity,NA,DDX17,NA,NA,ENSGGOG00000008309; ENSPPAG00000042301; ENSPTRG00000014369
H0YNJ9,0.5,6,1241353.2604166667,4.805211448413896e-6,1.1239454769839683,0.16857205157954414,0.9973829602222419,1,raw,849414.0625,1780799.375,1095519,1231303.625,998506.25,1492577.25,Deoxyuridine 5'-triphosphate nucleotidohydrolase OS=Homo sapiens OX=9606 GN=DUT PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,NA,DUT,NA,NA,ENSG00000128951
P16885,0,6,4230797.559895833,1.637718892679204e-5,1.1238759489329861,0.16848280269773344,0.3165235252451234,0.796388541585002,raw,4009437.5,3518026.203125,4352846.96875,5176969.46875,3821394.84375,4506110.375,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 OS=Homo sapiens OX=9606 GN=PLCG2 PE=1 SV=4",cell death;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,5336,PLCG2,"Leptin signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; Corticotropin-releasing hormone signaling pathway; Myometrial relaxation and contraction pathways; Microglia pathogen phagocytosis pathway; GPR40 pathway; Ras signaling; Non-small cell lung cancer; Non-genomic actions of 1,25 dihydroxyvitamin D3; Resistin as a regulator of inflammation; EGFR tyrosine kinase inhibitor resistance; GDNF signaling; 2q13 copy number variation syndrome; ErbB signaling pathway",Role of phospholipids in phagocytosis; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Generation of second messenger molecules; CLEC7A (Dectin-1) signaling; Toll Like Receptor 4 (TLR4) Cascade; GPVI-mediated activation cascade; DAP12 signaling; Synthesis of IP3 and IP4 in the cytosol; Erythropoietin activates Phospholipase C gamma (PLCG); Dectin-2 family,ENSG00000197943
K7ELL7,0,6,176617069.92447916,6.836751418379971e-4,1.1237719901074512,0.16834934684856973,0.5973036203332786,1,raw,168399903.5,192943533.921875,146846248.71875,189739848.09375,144948346.21875,216824539.09375,Glucosidase 2 subunit beta OS=Homo sapiens OX=9606 GN=PRKCSH PE=1 SV=1,cellular homeostasis;defense response;metabolic process,extracellular,RNA binding;structural molecule activity,5589,PRKCSH,NA,NA,ENSG00000130175
Q96C86,0,6,6728008.875,2.6043759099105058e-5,1.1237277139747457,0.16829250416514135,0.818577977828584,1,raw,6079086.5,7310337.53125,6344460.75,4832601.1875,7129446.375,8672120.90625,m7GpppX diphosphatase OS=Homo sapiens OX=9606 GN=DCPS PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,28960,DCPS,NA,mRNA decay by 3' to 5' exoribonuclease,ENSG00000110063
Q5GLZ8,0,6,9000644.213541666,3.48410077913628e-5,1.123685641053194,0.1682384879378641,0.3504296559107725,0.8343501404863615,raw,8612051.875,9492270,7122673.34375,10666327.5,7865675.90625,10244866.65625,Probable E3 ubiquitin-protein ligase HERC4 OS=Homo sapiens OX=9606 GN=HERC4 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,26091,HERC4,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000148634
Q15046,0,6,92908197.96354167,3.596426180538358e-4,1.1235430671903057,0.16805542637010235,0.45715751063008536,0.94030502550882,raw,94059749.21875,95254532.125,75742506.625,107022569.1875,79576801.5625,105793029.0625,Lysine--tRNA ligase OS=Homo sapiens OX=9606 GN=KARS1 PE=1 SV=3,cell organization and biogenesis;cellular component movement;cellular homeostasis;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,3735,KARS1,NA,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation; Mitochondrial tRNA aminoacylation,ENSG00000065427
Q9Y230,0,6,181548355.828125,7.027638833229531e-4,1.1235001457965037,0.16800031173622626,0.3202144586398757,0.802295473638468,raw,176848376.75,166060415.21875,177808890.4375,204512223.0625,165371052.4375,198689177.0625,RuvB-like 2 OS=Homo sapiens OX=9606 GN=RUVBL2 PE=1 SV=3,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,10856,RUVBL2,NA,HATs acetylate histones; Telomere Extension By Telomerase,ENSG00000183207
Q8IZ81,0,6,13059441.416666666,5.055239262367084e-5,1.1233579188155973,0.16781766543244764,0.7071079136476239,1,raw,14122189.25,11986609.71875,12029088.5,13703469.3125,10651018.59375,15864273.125,ELMO domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ELMOD2 PE=1 SV=1,coagulation;metabolic process,NA,DNA binding,255520,ELMOD2,Lung fibrosis,NA,ENSG00000179387
P12081,0,6,99964547.62630208,3.869573666147142e-4,1.1233144998187365,0.16776190263326102,0.26358451921467574,0.7438355132238149,raw,87366491.328125,106175947.125,81847976.9921875,116891474.125,88236415.25,119268980.9375,"Histidine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=HARS1 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;endosome;nucleus,structural molecule activity,3035,HARS1,Allograft rejection,Cytosolic tRNA aminoacylation,ENSG00000170445
Q9H444,0,6,15882395.609375,6.147989588780773e-5,1.1232469532944211,0.16767514868708835,0.5073704207788633,0.9908542223742782,raw,13705977.25,16875787.09375,14682737.625,18955676.4375,12925924.0625,18148271.1875,Charged multivesicular body protein 4b OS=Homo sapiens OX=9606 GN=CHMP4B PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,128866,CHMP4B,NA,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex,ENSG00000101421
P62424,0,6,326619228.515625,0.001264325398886529,1.1231556461430263,0.16755786928701952,0.630497428058063,1,raw,279893871.75,400966053.125,258172139.5,355897905.9375,289967496.15625,374817904.625,60S ribosomal protein L7a OS=Homo sapiens OX=9606 GN=RPL7A PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytoskeleton;cytosol;Golgi;membrane,structural molecule activity,6130,RPL7A,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000148303; ENSG00000280858
Q00325,0.6666666666666666,6,221083602.66666666,8.558026892633859e-4,1.1230788503298137,0.1674592215820715,0.34920815320771487,0.8328815148344924,raw,192849615.375,234520737.5,198208116.875,263385280.25,197547409,239990457,"Phosphate carrier protein, mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A3 PE=1 SV=2",conjugation,cytoplasm;cytoskeleton;endosome,catalytic activity;structural molecule activity,5250,SLC25A3,NA,NA,ENSG00000075415
P43034,0,6,65336635.276041664,2.5291458752353663e-4,1.1230574917998437,0.16743178438274273,0.515849725167596,1,raw,46669727.375,77646278.40625,57365557.3125,86508850.8125,52412786.96875,71416610.78125,Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens OX=9606 GN=PAFAH1B1 PE=1 SV=2,cell death;cell differentiation;cell growth;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,5048,PAFAH1B1,Wnt signaling pathway and pluripotency; Ciliary landscape; Neurogenesis regulation in the olfactory epithelium,AURKA Activation by TPX2; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; COPI-independent Golgi-to-ER retrograde traffic; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000007168
Q9NYB0,0,6,10059302.095052084,3.893901529204794e-5,1.1230418158413737,0.16741164669117295,0.43922755682881015,0.9230713176727005,raw,9852448.28125,10705838.78125,7881665.3046875,11315783.4375,8576972.140625,12023104.625,Telomeric repeat-binding factor 2-interacting protein 1 OS=Homo sapiens OX=9606 GN=TERF2IP PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,54386,TERF2IP,Splicing factor NOVA regulated synaptic proteins; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,Polymerase switching on the C-strand of the telomere; Meiotic synapsis; Telomere Extension By Telomerase; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; Packaging Of Telomere Ends; DNA Damage/Telomere Stress Induced Senescence; Telomere C-strand synthesis initiation; Removal of the Flap Intermediate from the C-strand,ENSG00000166848
O14647,0,6,376169.8671875,1.4561332458666821e-6,1.122856342134898,0.16717336162361032,1,1,raw,NA,NA,348234.71875,330442.8125,434984.375,391017.5625,Chromodomain-helicase-DNA-binding protein 2 OS=Homo sapiens OX=9606 GN=CHD2 PE=1 SV=2,cell growth;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,1106,CHD2,Prion disease pathway; Male infertility; Dravet syndrome,NA,ENSG00000173575
Q4G176,0,6,10434824.278645834,4.03926413896927e-5,1.1227186858489882,0.16699648395191974,0.4528021531203678,0.9356414401466827,raw,10139314.1875,9196104.984375,10161344.46875,11383597.5,8640072.21875,13088512.3125,"Malonate--CoA ligase ACSF3, mitochondrial OS=Homo sapiens OX=9606 GN=ACSF3 PE=1 SV=3",cellular homeostasis,endosome;membrane,structural molecule activity,197322,ACSF3,NA,Synthesis of very long-chain fatty acyl-CoAs,ENSG00000176715
P11908,0,6,10864832.1875,4.205717878804859e-5,1.1226493794719066,0.1669074224139976,0.721000436424555,1,raw,10360076.875,11021551,10335416.875,13337533.25,8503681.25,11630733.875,Ribose-phosphate pyrophosphokinase 2 OS=Homo sapiens OX=9606 GN=PRPS2 PE=1 SV=2,cellular homeostasis;metabolic process,cytosol;nucleus,signal transducer activity;structural molecule activity,5634,PRPS2,NA,5-Phosphoribose 1-diphosphate biosynthesis,ENSG00000101911
Q92844,0.3333333333333333,6,291015.0520833333,1.1265035542438764e-6,1.1226235329121863,0.16687420711680284,0.4221449514567368,0.9086347256931654,raw,299229.34375,251072.703125,242790,249810.671875,281860.125,421327.46875,TRAF family member-associated NF-kappa-B activator OS=Homo sapiens OX=9606 GN=TANK PE=1 SV=2,coagulation;development;metabolic process,cytosol;nucleus,DNA binding;structural molecule activity,10010,TANK,TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; Novel intracellular components of RIG-I-like receptor pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon; TICAM1-dependent activation of IRF3/IRF7; TRAF6 mediated IRF7 activation,ENSG00000136560
Q8TEQ6,0,6,53475086.958333336,2.069991744097585e-4,1.122221846480994,0.16635790338044923,0.5042278835167251,0.9887033786631393,raw,52931900.296875,58959386.3125,39672724.765625,66165511.375,46419232.125,56701766.875,Gem-associated protein 5 OS=Homo sapiens OX=9606 GN=GEMIN5 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,protein binding;RNA binding,25929,GEMIN5,NA,snRNP Assembly; SARS-CoV-2 modulates host translation machinery,ENSG00000082516
A0A494C1J1,0,6,2941403.4166666665,1.1386013814815486e-5,1.122053961277213,0.1661420590082484,0.4865999679078732,0.969215915751001,raw,2237681.75,3613581.25,2228829.75,3015212.5,2500867.25,4052248,Cytospin-A OS=Homo sapiens OX=9606 GN=SPECC1L PE=1 SV=1,cell differentiation;metabolic process,endoplasmic reticulum;nucleus,NA,NA,SPECC1L,NA,NA,ENSG00000100014
P62879,0,6,29743999.78125,1.1513741722683273e-4,1.1219621636432653,0.16602402421352058,0.6890463352614788,1,raw,30578883.625,26909926.0625,28873087.46875,36750006.375,22957583.46875,32394511.6875,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 OS=Homo sapiens OX=9606 GN=GNB2 PE=1 SV=3,development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,2783,GNB2,Corticotropin-releasing hormone signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells,"Extra-nuclear estrogen signaling; G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation",ENSG00000172354
Q96HR9,0,6,6393440.03125,2.4748661168858775e-5,1.1216238867507966,0.1655889792560746,0.617288097083672,1,raw,7541240.5,5461027.375,5036129.8125,6125218.75,5176707.875,9020315.875,Receptor expression-enhancing protein 6 OS=Homo sapiens OX=9606 GN=REEP6 PE=1 SV=2,cell growth;metabolic process,cytoskeleton;extracellular;nucleus,NA,92840,REEP6,NA,NA,ENSG00000115255
M0QZ12,0.6666666666666666,6,1759659.7083333333,6.811547724100587e-6,1.121287960804931,0.16515682789858097,0.4658418391307054,0.9482152842086344,raw,1502772.875,1645768.25,1818980.5,1845380.125,1480184.5,2264872,Protein Aster-A OS=Homo sapiens OX=9606 GN=GRAMD1A PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,NA,57655,GRAMD1A,NA,NA,ENSG00000089351
Q96GA3,0,6,2673817.171875,1.0350201908638666e-5,1.1210739802606804,0.16488148548813356,0.39836110458091256,0.8823979883260089,raw,2667008.9375,2724560.375,1931471.71875,2165322.6875,2978761.8125,3575777.5,Protein LTV1 homolog OS=Homo sapiens OX=9606 GN=LTV1 PE=1 SV=1,conjugation;metabolic process,cytosol;membrane;nucleus,NA,84946,LTV1,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000135521
Q8NBK3,0,6,1188045.2369791667,4.598858967873255e-6,1.121070689417979,0.16487725054066568,0.773525242336557,1,raw,895728.671875,909522.625,1540733.75,1019639.15625,702368.59375,2060278.625,Formylglycine-generating enzyme OS=Homo sapiens OX=9606 GN=SUMF1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,extracellular,structural molecule activity,285362,SUMF1,NA,Glycosphingolipid metabolism; The activation of arylsulfatases,ENSG00000144455
Q86TV6,0.16666666666666666,6,317398.9166666667,1.2286340695386774e-6,1.1207658544376238,0.16448490800493207,1,1,raw,NA,280295.5625,331474.8125,NA,NA,340426.375,Tetratricopeptide repeat protein 7B OS=Homo sapiens OX=9606 GN=TTC7B PE=1 SV=3,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol,NA,145567,TTC7B,NA,NA,ENSG00000165914
P0CG29,0,6,3847697.640625,1.4894229823475434e-5,1.1206921639978649,0.16439004757822318,0.3067579557642485,0.787259868285476,raw,4428227.5,2955468.796875,2860913.390625,4851068.8125,3206203.21875,4784304.125,Glutathione S-transferase theta-2 OS=Homo sapiens OX=9606 GN=GSTT2 PE=1 SV=1,cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,2953,GSTT2,Glutathione metabolism; Oxidative stress response,Glutathione conjugation,ENSG00000277897
Q9NQB0,0,6,2162585.578125,8.371252011448387e-6,1.1202305704964424,0.1637957043154444,0.709866147261666,1,raw,2073373.46875,2102553.40625,1985245.09375,3123314.875,1368370.28125,2322656.34375,Transcription factor 7-like 2 OS=Homo sapiens OX=9606 GN=TCF7L2 PE=1 SV=2,cell death;cell growth;cell proliferation;cellular component movement;cellular homeostasis;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6934,TCF7L2,Arrhythmogenic right ventricular cardiomyopathy; Wnt signaling pathway; Amplification and expansion of oncogenic pathways as metastatic traits; Wnt signaling pathway and pluripotency; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Hippo signaling regulation pathways; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Malignant pleural mesothelioma; DNA damage response (only ATM dependent),"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); Deactivation of the beta-catenin transactivating complex; Transcriptional Regulation by VENTX; Ca2+ pathway; Binding of TCF/LEF:CTNNB1 to target gene promoters; RUNX3 regulates WNT signaling; Repression of WNT target genes; Signaling by TCF7L2 mutants",ENSG00000148737
Q96KP4,0,6,59119316.846354164,2.2884768356523774e-4,1.1200346411089015,0.16354335351784596,0.7717524553256534,1,raw,65275191,53240996.5,54304876.046875,73110475.125,44040476.46875,64743885.9375,Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2,cell organization and biogenesis,cytosol;membrane,structural molecule activity,55748,CNDP2,NA,Glutathione synthesis and recycling; Paracetamol ADME,ENSG00000133313
Q96EE3,0,6,11936084.416666666,4.620393832852198e-5,1.1197667662772393,0.1631982678403513,0.1733644660817346,0.6689341104244626,raw,10502039.9375,12508376.53125,10124918.78125,13159520.6875,11337547.5625,13984103,Nucleoporin SEH1 OS=Homo sapiens OX=9606 GN=SEH1L PE=1 SV=3,cell differentiation;cell growth;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,81929,SEH1L,NA,Amino acids regulate mTORC1,ENSG00000085415
Q7Z434,0,6,9151912.434244791,3.5426558906490075e-5,1.1197424961259896,0.16316699810868407,0.35915571577457456,0.8420882601494262,raw,9005362.08984375,7553813.890625,9352687.75,10809610.53125,8106313.71875,10083686.625,Mitochondrial antiviral-signaling protein OS=Homo sapiens OX=9606 GN=MAVS PE=1 SV=2,coagulation;development;metabolic process,cytoskeleton;endosome;mitochondrion;nucleus,structural molecule activity,57506,MAVS,Novel intracellular components of RIG-I-like receptor pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Hepatitis B infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Network map of SARS-CoV-2 signaling pathway; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses; Ovarian tumor domain proteases; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation,ENSG00000088888
Q86X55,0,6,20661036.526041668,7.997775686971573e-5,1.1196580509396272,0.16305819340931094,0.6286015569581882,1,raw,22792108.25,17907036.375,18783588.96875,22676226.25,16287891.8125,25519367.5,Histone-arginine methyltransferase CARM1 OS=Homo sapiens OX=9606 GN=CARM1 PE=1 SV=3,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,10498,CARM1,Androgen receptor signaling pathway; Nitric oxide metabolism in cystic fibrosis,"Heme signaling; Transcriptional activation of mitochondrial biogenesis; Cytoprotection by HMOX1; RMTs methylate histone arginines; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Estrogen-dependent gene expression; Activation of gene expression by SREBF (SREBP); TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest; RORA activates gene expression",ENSG00000142453
Q969H6,0.3333333333333333,6,1009118.6770833334,3.906243915049224e-6,1.119597732622491,0.16298047032142884,0.4187373459267192,0.9054509995230429,raw,1172030.375,836498.9375,782346.5625,1310751,1077171.75,875913.4375,Ribonuclease P/MRP protein subunit POP5 OS=Homo sapiens OX=9606 GN=POP5 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,51367,POP5,NA,tRNA processing in the nucleus,ENSG00000167272
Q92879,0,6,25929500.05078125,1.0037169472116359e-4,1.11958724481317,0.16296695584124987,0.8231084965150247,1,raw,26333572.7734375,22338999.953125,26618192.453125,36363312.90625,14440190.03125,29482732.1875,CUGBP Elav-like family member 1 OS=Homo sapiens OX=9606 GN=CELF1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding,10658,CELF1,Adipogenesis; mRNA processing,NA,ENSG00000149187
O95218,0,6,22545933.34375,8.727409068245398e-5,1.1190843381588533,0.16231876701897116,0.2574460442053335,0.7380182509946936,raw,19768766.25,21720138,19930097.75,29939280.375,22303460.25,21613857.4375,Zinc finger Ran-binding domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ZRANB2 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,structural molecule activity,9406,ZRANB2,NA,NA,ENSG00000132485
P60174,0,6,1130546405.3020833,0.0043762840949056634,1.1187704304566901,0.16191402843224137,0.7264220168285694,1,raw,1201437362.5,1113314899.46875,981597792.46875,1371451030.71875,869933557.34375,1245543789.3125,Triosephosphate isomerase OS=Homo sapiens OX=9606 GN=TPI1 PE=1 SV=4,cellular homeostasis,cytosol,structural molecule activity,7167,TPI1,Fatty acid beta-oxidation; Cori cycle; HIF1A and PPARG regulation of glycolysis; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; Disorders of fructose metabolism; Glycolysis and gluconeogenesis,Glycolysis; Gluconeogenesis,ENSG00000111669
Q09161,0,6,25098905.201822918,9.715650690599764e-5,1.118763427970424,0.1619049984440049,0.291842890854246,0.7730231021500684,raw,26918261.34375,22718850.3125,20222267.640625,28045004.78125,22573880.796875,30115166.3359375,Nuclear cap-binding protein subunit 1 OS=Homo sapiens OX=9606 GN=NCBP1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,4686,NCBP1,mRNA processing; 3q29 copy number variation syndrome,Regulation of expression of SLITs and ROBOs; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; snRNP Assembly; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Abortive elongation of HIV-1 transcript in the absence of Tat; RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; mRNA Capping; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Signaling by FGFR2 IIIa TM; Processing of Intronless Pre-mRNAs; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,ENSG00000136937
P05023,0,6,328735676.7109375,0.0012725180555801419,1.1186366368378846,0.16174148639158645,0.6199030505863454,1,raw,327211674.96875,304714131.421875,319674687.28125,398328479.625,264885269.90625,357599817.0625,Sodium/potassium-transporting ATPase subunit alpha-1 OS=Homo sapiens OX=9606 GN=ATP1A1 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;nucleus,catalytic activity;structural molecule activity,476,ATP1A1,Pre-implantation embryo; Proximal tubule transport; Arsenic metabolism and reactive oxygen species generation,Potential therapeutics for SARS; Ion homeostasis; Ion transport by P-type ATPases,ENSG00000163399
Q99735,0.16666666666666666,6,1451432.7708333333,5.618417890706169e-6,1.11859031416453,0.1616817432429451,0.6487608267722934,1,raw,1033946.6875,3071735,823742.1875,1084071.25,1156562.75,1538538.75,Microsomal glutathione S-transferase 2 OS=Homo sapiens OX=9606 GN=MGST2 PE=1 SV=1,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,DNA binding;structural molecule activity,4258,MGST2,Nuclear receptors meta-pathway; NRF2 pathway; Metapathway biotransformation Phase I and II,Aflatoxin activation and detoxification; Glutathione conjugation,ENSG00000085871
B4DUT8,0,6,35119353.260416664,1.3594512032070728e-4,1.1182942307456698,0.16129982090945183,0.46727655231575455,0.9485672170384823,raw,34830495.4375,25955486,35443521.5625,50956875.8125,29025870.25,34503870.5,Calponin OS=Homo sapiens OX=9606 GN=CNN2 PE=1 SV=1,cell growth,endoplasmic reticulum,motor activity;structural molecule activity,1265,CNN2,Myometrial relaxation and contraction pathways; Burn wound healing,NA,ENSG00000064666
Q01780,0,6,23002306.651041668,8.904068711465118e-5,1.1182356191498943,0.16122420496487844,0.5199902652515453,1,raw,22734028.578125,22269622.9375,21784544.1875,24902685.59375,20016331.234375,26306627.375,Exosome component 10 OS=Homo sapiens OX=9606 GN=EXOSC10 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,5394,EXOSC10,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000171824
Q9Y2X7,0,6,11892737,4.6036142819002065e-5,1.1179130419439682,0.16080797097595043,0.6859461360623592,1,raw,14471416.21875,9323711.34375,10605369.46875,14560584.75,10539459.375,11855880.84375,ARF GTPase-activating protein GIT1 OS=Homo sapiens OX=9606 GN=GIT1 PE=1 SV=2,conjugation;defense response;development;metabolic process,cytosol;endoplasmic reticulum;endosome;nucleus,DNA binding;motor activity;structural molecule activity,28964,GIT1,CAMKK2 pathway; Regulation of actin cytoskeleton,CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; Ephrin signaling; Activation of RAC1 downstream of NMDARs,ENSG00000108262
O00445,0.6666666666666666,6,391801.525,1.5166425492805236e-6,1.117639978342448,0.16045553244987223,0.643641394199927,1,raw,421495.875,NA,323280.5625,381585.9375,360477.4375,472167.8125,Synaptotagmin-5 OS=Homo sapiens OX=9606 GN=SYT5 PE=1 SV=2,cell death;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,6861,SYT5,NA,Regulation of insulin secretion,ENSG00000129990
Q9GZZ1,0,6,26591269.177083332,1.0293336727909948e-4,1.1174167782488962,0.1601673879379139,0.5685025726811778,1,raw,26048778.03125,26907641.3125,23804625.71875,31711524,21967704.375,29107341.625,N-alpha-acetyltransferase 50 OS=Homo sapiens OX=9606 GN=NAA50 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,80218,NAA50,Metapathway biotransformation Phase I and II,NA,ENSG00000121579
P18583,0,6,30096047.1171875,1.1650017345664493e-4,1.1173386766699536,0.16006654758831415,0.3846693460145655,0.8695425300008842,raw,25200504.359375,33294489.8125,26016553.1875,31993281,26870233.15625,37201221.1875,Protein SON OS=Homo sapiens OX=9606 GN=SON PE=1 SV=4,cell differentiation;cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,6651,SON,NA,NA,ENSG00000159140
Q96GC5,0,6,4193789.90625,1.6233934297631762e-5,1.1172728430043612,0.15998154140082713,0.7467835654026818,1,raw,3903034.375,3732151.125,4252439.5,6612733.25,2301626.875,4360754.3125,"39S ribosomal protein L48, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL48 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,NA,51642,MRPL48,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000175581
Q32MZ4,0,6,36735578.2513021,1.4220143999783813e-4,1.1170084977186832,0.15964016126435226,0.6283613624099733,1,raw,33724253.8007813,38953207.6875,33996417.9570313,37974287.75,30978279.9375,44787022.375,Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens OX=9606 GN=LRRFIP1 PE=1 SV=2,cellular component movement;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,9208,LRRFIP1,IL-18 signaling pathway; 2q37 copy number variation syndrome,Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,ENSG00000124831
Q13948,0,6,353180.5833333333,1.3671429692956123e-6,1.1168992505063102,0.15949905390504232,1,1,raw,327646.1875,NA,NA,NA,321265.03125,410630.53125,Protein CASP OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=2,conjugation,cytoskeleton;extracellular;membrane,NA,1523,CUX1,NA,Intra-Golgi traffic,ENSG00000257923
A0A0A0MRM9,0,6,55085832.0670573,2.1323428175890993e-4,1.1168979836892388,0.15949741756072355,0.4191808705118738,0.9057644843679232,raw,43925101.703125,55334993.9375,57978882.4804688,61803543.15625,49587640.21875,61884830.90625,Nucleolar and coiled-body phosphoprotein 1 (Fragment) OS=Homo sapiens OX=9606 GN=NOLC1 PE=1 SV=1,NA,membrane,NA,NA,NOLC1,NA,NA,ENSG00000166197
Q6P1S2,0.6666666666666666,6,2090037.6770833333,8.0904230034939508e-06,1.116886795092802,0.1594829651992005,0.2948159009745506,0.7760918587221847,raw,2051426.0625,2081201.375,1661681.5,2284235.25,1855910.125,2605771.75,Protein C3orf33 OS=Homo sapiens OX=9606 GN=C3orf33 PE=1 SV=2,metabolic process,cell surface;cytoskeleton,NA,285315,C3orf33,NA,NA,ENSG00000174928
A8MUS3,0,6,234272298.26822916,9.068554178581471e-4,1.116848894505098,0.1594340077597082,0.4011628004377127,0.8863775625080058,raw,198312726.125,245675263.015625,218740252.96875,268765436.6875,199757964.90625,274382145.90625,60S ribosomal protein L23a OS=Homo sapiens OX=9606 GN=RPL23A PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi,RNA binding;structural molecule activity,NA,RPL23A,NA,NA,ENSG00000198242
Q9H9G7,0,6,610623.4453125,2.363690388262798e-6,1.1167850026520607,0.15935147278414874,0.7386487754041804,1,raw,649674.375,NA,492448.09375,472075.6875,NA,828295.625,Protein argonaute-3 OS=Homo sapiens OX=9606 GN=AGO3 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,192669,AGO3,NA,MAPK6/MAPK4 signaling; Oxidative Stress Induced Senescence; Estrogen-dependent gene expression; TP53 Regulates Metabolic Genes; Pre-NOTCH Transcription and Translation; Oncogene Induced Senescence; Transcriptional Regulation by VENTX; Ca2+ pathway; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; MicroRNA (miRNA) biogenesis; Small interfering RNA (siRNA) biogenesis; Regulation of RUNX1 Expression and Activity; Regulation of NPAS4 mRNA translation; Post-transcriptional silencing by small RNAs; Competing endogenous RNAs (ceRNAs) regulate PTEN translation,ENSG00000126070
Q8N983,0,6,5647460.9375,2.186101637356357e-5,1.1166781884763366,0.15921348055544904,0.9854863740043569,1,raw,4358333,8738503,3794253.5,6138489.25,4236960.125,6618226.75,"39S ribosomal protein L43, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL43 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,84545,MRPL43,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000055950
Q86WX3,0,6,5150765.427083333,1.9938334870130104e-5,1.1163877288770179,0.15883817177246817,0.36937506358516337,0.8535673349470447,raw,4352053.8125,5642942.5625,4599420.125,4937441.25,5134736.1875,6237998.625,Active regulator of SIRT1 OS=Homo sapiens OX=9606 GN=RPS19BP1 PE=1 SV=1,NA,cytosol;membrane,structural molecule activity,91582,RPS19BP1,NA,Regulation of HSF1-mediated heat shock response,ENSG00000187051
Q02790,0,6,275004582.0286458,0.0010645278890932092,1.1160539771930225,0.1584068038208065,0.37927587356592357,0.8631584800024487,raw,251042735.96875,289992035.265625,238355453.515625,307224704.359375,239765798.75,323646764.3125,Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Homo sapiens OX=9606 GN=FKBP4 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytosol;endoplasmic reticulum;endosome;membrane;nucleus,motor activity;structural molecule activity,2288,FKBP4,Androgen receptor signaling pathway,Potential therapeutics for SARS; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Estrogen-dependent gene expression; Attenuation phase,ENSG00000004478
Q9H832,0,6,30705483.052083332,1.188592670562004e-4,1.115933849741297,0.15825150971305643,0.5844194354037618,1,raw,31662227.6875,30260184,25138833.90625,40362294.09375,23040995,33768363.625,Ubiquitin-conjugating enzyme E2 Z OS=Homo sapiens OX=9606 GN=UBE2Z PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,DNA binding;structural molecule activity,65264,UBE2Z,NA,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000159202
Q8TCT8,0.16666666666666666,6,674662.0833333334,2.6115804984923827e-6,1.115632346951421,0.15786166998250356,1,1,raw,626375.875,NA,NA,640907,NA,756703.375,Signal peptide peptidase-like 2A OS=Homo sapiens OX=9606 GN=SPPL2A PE=1 SV=2,cell organization and biogenesis;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,84888,SPPL2A,NA,Regulation of TNFR1 signaling,ENSG00000138600
O43347,0,6,748044.4869791666,2.895639820971408e-6,1.1156246146149875,0.1578516707725341,0.49442590020748417,0.9787246705846804,raw,774112.53125,620371.609375,502490.59375,560590.875,615597.3125,1415104,RNA-binding protein Musashi homolog 1 OS=Homo sapiens OX=9606 GN=MSI1 PE=1 SV=1,defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4440,MSI1,NA,Regulation of expression of SLITs and ROBOs,ENSG00000135097
B4DJL6,0,6,475735.9921875,1.8415483400064594e-6,1.1155279030382137,0.15772660060257343,0.29592129536618195,0.7781307263542354,raw,459169,439985.21875,NA,NA,473427.875,530361.875,Integrator complex subunit 14 OS=Homo sapiens OX=9606 GN=INTS14 PE=1 SV=1,NA,cytoskeleton;membrane;nucleus,NA,NA,INTS14,NA,NA,ENSG00000138614
P15927,0,6,27148402.208333332,1.0508999916255983e-4,1.1153546654697575,0.15750253772724515,0.49506803861929705,0.9791715762431008,raw,29879146.4375,26443185.171875,21200297.84375,31003670.375,23645851.109375,30718262.3125,Replication protein A 32 kDa subunit OS=Homo sapiens OX=9606 GN=RPA2 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6118,RPA2,"miRNA regulation of DNA damage response; Retinoblastoma gene in cancer; G1 to S cell cycle control; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair; DNA damage response",Presynaptic phase of homologous DNA pairing and strand exchange; HDR through Homologous Recombination (HRR); Meiotic recombination; Fanconi Anemia Pathway; Regulation of HSF1-mediated heat shock response; Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; HSF1 activation; Formation of Incision Complex in GG-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Removal of the Flap Intermediate; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER; Removal of the Flap Intermediate from the C-strand; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),ENSG00000117748
P13995,0,6,38067808.575520836,1.47358431653631e-4,1.1151767078739423,0.15727233379953176,0.6346465837904292,1,raw,42964555.8125,31734818.25,34983967.390625,47913071.90625,31418208.34375,39392229.75,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial OS=Homo sapiens OX=9606 GN=MTHFD2 PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,10797,MTHFD2,"Folate metabolism; One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways",Metabolism of folate and pterines,ENSG00000065911
Q8NFH4,0,6,10530362.661458334,4.0762465311288944e-5,1.1151038106965971,0.1571780242313744,0.48494430940442323,0.96704014350865,raw,7890566.03125,12509756.75,9016681.0625,11915187.3125,8798800.25,13051184.5625,Nucleoporin Nup37 OS=Homo sapiens OX=9606 GN=NUP37 PE=1 SV=1,cell differentiation;conjugation;metabolic process,cytosol;membrane;nucleus,NA,79023,NUP37,NA,Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; ISG15 antiviral mechanism; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Vpr-mediated nuclear import of PICs; tRNA processing in the nucleus; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000075188
Q9H9F9,0,6,329328.25,1.2748118747881177e-6,1.1149524506744501,0.15698218490888,1,1,raw,290917.625,345083.375,NA,351983.75,NA,NA,Actin-related protein 5 OS=Homo sapiens OX=9606 GN=ACTR5 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,NA,79913,ACTR5,NA,UCH proteinases; DNA Damage Recognition in GG-NER,ENSG00000101442
Q8N999,0,6,8275975.828125,3.203585559742651e-5,1.1148138775043355,0.15680286672378088,0.2844725327489306,0.7650076250313386,raw,7504494.5625,8825981.75,6978549.5,8770820.9375,7736681.28125,9839326.9375,Uncharacterized protein C12orf29 OS=Homo sapiens OX=9606 GN=C12orf29 PE=1 SV=2,metabolic process,NA,NA,91298,C12orf29,NA,NA,ENSG00000133641
Q9BY32,0,6,12675258.697916666,4.906524206203246e-5,1.114808144436173,0.1567954474671305,0.916536101401777,1,raw,14343143.75,11048078.875,12170133.4375,16751076.75,8171755.5,13567363.875,Inosine triphosphate pyrophosphatase OS=Homo sapiens OX=9606 GN=ITPA PE=1 SV=2,cell growth;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,3704,ITPA,NA,Purine catabolism; Ribavirin ADME,ENSG00000125877
Q99613,0,6,394395239.6770833,0.0015266826787566862,1.1147932660163262,0.15677619288428987,0.20126105236045158,0.691648270213144,raw,328585315.5,423220240.6875,330092826.0625,466280630.5,366304697.03125,451887728.28125,Eukaryotic translation initiation factor 3 subunit C OS=Homo sapiens OX=9606 GN=EIF3C PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,protein binding;RNA binding;structural molecule activity,8663,EIF3C,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000184110
Q7Z4V5,0,6,18183944.161458332,7.038906606861436e-5,1.1147495425830594,0.15671960766860393,0.8083511816085567,1,raw,16597326.78125,16441297.3125,20029313.34375,24781515.1875,12752349.90625,18501862.4375,Hepatoma-derived growth factor-related protein 2 OS=Homo sapiens OX=9606 GN=HDGFL2 PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,84717,HDGFL2,NA,NA,ENSG00000167674
Q9HCC0,0,6,7153281.854166667,2.7689967840287106e-5,1.1147420594518425,0.15670992306042947,0.4228864050649744,0.9086347256931654,raw,7969172.96875,6161076.9375,6229790.34375,7034307.25,6868011.59375,8657332.03125,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Homo sapiens OX=9606 GN=MCCC2 PE=1 SV=1",cellular homeostasis,cytosol;endosome;nucleus,structural molecule activity,64087,MCCC2,NA,Biotin transport and metabolism; Branched-chain amino acid catabolism; Defective HLCS causes multiple carboxylase deficiency,ENSG00000131844
Q9NP79,0,6,31473393.479166668,1.21831806858721e-4,1.1147295496221241,0.15669373279433793,0.7165540921479152,1,raw,31767758.3125,31286289.25,27953259.3125,40587119.125,22370183.75,34875751.125,Vacuolar protein sorting-associated protein VTA1 homolog OS=Homo sapiens OX=9606 GN=VTA1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,51534,VTA1,NA,Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT),ENSG00000009844
O14929,0,6,25040756.041666668,9.693141464659947e-5,1.114576120604645,0.15649514963371408,0.4232823824878124,0.9086347256931654,raw,26263738.625,26626105.5,17594298.59375,25741401.75,24342170.40625,29676821.375,Histone acetyltransferase type B catalytic subunit OS=Homo sapiens OX=9606 GN=HAT1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis,membrane;nucleus,structural molecule activity,100598934; 100970485; 102127119; 103217315; 104673520; 105548069; 105579802; 695933,HAT1,NA,NA,ENSCATG00000044185; ENSCSAG00000014790; ENSMFAG00000044656; ENSMLEG00000030988; ENSMMUG00000007313; ENSNLEG00000031960; ENSPPAG00000043422; ENSPPYG00000012932; ENSPTEG00000037699; ENSPTRG00000012637; ENSRROG00000043073; ENSTGEG00000018560
P06899,0,6,147106874.66666666,5.694427692979087e-4,1.1143701556934642,0.1562285262879986,0.5298043422159543,1,raw,172023952,107879664,140426704,156487328,148671680,157151920,Histone H2B type 1-J OS=Homo sapiens OX=9606 GN=H2BC11 PE=1 SV=3,cell growth;coagulation;metabolic process,cell surface;cytosol;membrane;nucleus,RNA binding;structural molecule activity,8970,H2BC11,NA,Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; E3 ubiquitin ligases ubiquitinate target proteins; Amyloid fiber formation; Meiotic synapsis; HCMV Late Events; Ub-specific processing proteases; RUNX1 regulates transcription of genes involved in differentiation of HSCs; HCMV Early Events; Transcriptional regulation by small RNAs; Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; HATs acetylate histones; RNA Polymerase I Promoter Escape; Meiotic recombination; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Packaging Of Telomere Ends; Condensation of Prophase Chromosomes; DNA Damage/Telomere Stress Induced Senescence; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; Nonhomologous End-Joining (NHEJ); RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis,ENSG00000124635
Q96G46,0,6,954505.0989583334,3.6948377028022676e-6,1.1139212854261293,0.1556472891073536,0.39542974317398194,0.8782783839678473,raw,830650.21875,974634.8125,848730.21875,945418.65625,851386.3125,1276210.375,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Homo sapiens OX=9606 GN=DUS3L PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,NA,structural molecule activity,56931,DUS3L,NA,NA,ENSG00000141994
P49789,0,6,1259835.2708333333,4.876754312863344e-6,1.1136229659732844,0.15526086895204327,0.7330433759990029,1,raw,1274539.8125,1145388,1225090.6875,1665288.5,884415.5,1364289.125,Bis(5'-adenosyl)-triphosphatase OS=Homo sapiens OX=9606 GN=FHIT PE=1 SV=3,cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;membrane;nucleus,structural molecule activity,2272,FHIT,Non-small cell lung cancer; Small cell lung cancer,NA,ENSG00000189283
O95477,0.5,6,692698.234375,2.6813974653738717e-6,1.1135631365025958,0.15518335797926353,0.7897786911010638,1,raw,701050.0625,657259.9375,641792.875,731900.4375,416963.59375,1007222.5,Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,antioxidant activity;catalytic activity;structural molecule activity,19,ABCA1,"Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; SREBF and miR33 in cholesterol and lipid homeostasis; Nuclear receptors in lipid metabolism and toxicity; Statin inhibition of cholesterol production; Metabolic pathway of LDL, HDL and TG, including diseases; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; 2q37 copy number variation syndrome",PPARA activates gene expression; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; Defective ABCA1 causes TGD; HDL assembly,ENSG00000165029
Q9H6R0,0,6,1822416.15625,7.0544745456644485e-6,1.1133406856334394,0.1548951293062057,0.731983413843103,1,raw,1823163.359375,1616480.5625,1761806.9375,2661239.296875,1110315.4375,1961491.34375,ATP-dependent RNA helicase DHX33 OS=Homo sapiens OX=9606 GN=DHX33 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,protein binding;RNA binding;structural molecule activity,56919,DHX33,NA,NA,ENSG00000005100
Q8IV48,0,6,6981411.057291667,2.7024665265164728e-5,1.113268360757583,0.15480140585714613,0.8118459125189341,1,raw,6450339,6968228.4375,7173304.28125,7757508.25,5407452.375,8131634,3'-5' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=ERI1 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,protein binding;RNA binding;structural molecule activity,90459,ERI1,exRNA mechanism of action and biogenesis,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000104626
P47897,0,6,100730174.83333333,3.8992106819568786e-4,1.1132135549561577,0.15473038075032966,0.4860143618816231,0.9683228814105764,raw,110819826.34375,91785862.6875,83142023.1875,123366132.84375,84258584.875,111008619.0625,Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;endosome;nucleus,DNA binding;structural molecule activity,5859,QARS1,NA,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation; Mitochondrial tRNA aminoacylation,ENSG00000172053
Q9HD26,0,6,8085897.614583333,3.130007309543517e-5,1.1131990514392758,0.15471158445729646,0.35427443158541494,0.8383308462007302,raw,6739649.1875,8485671.8125,7466136.25,9426753.5625,6950933.0625,9446241.8125,Golgi-associated PDZ and coiled-coil motif-containing protein OS=Homo sapiens OX=9606 GN=GOPC PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,57120,GOPC,NA,RHOQ GTPase cycle; RHO GTPases regulate CFTR trafficking,ENSG00000047932
Q9Y6D5,0,6,2078329.8098958333,8.045102481737718e-6,1.1131561358957531,0.15465596526214104,0.54447032357288,1,raw,2542945.140625,1987842.65625,1255525.15625,2212779.25,1812148.09375,2658738.5625,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 OS=Homo sapiens OX=9606 GN=ARFGEF2 PE=1 SV=3,cell growth;cellular homeostasis;conjugation;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,antioxidant activity;DNA binding;motor activity;structural molecule activity,10564,ARFGEF2,NA,Association of TriC/CCT with target proteins during biosynthesis,ENSG00000124198
Q9NRF9,0,6,5987445.276041667,2.317707739175712e-5,1.1126305381674655,0.15397460863526066,0.5426681497453185,1,raw,5311390.3125,6776942.890625,4624473.625,5571688,5145330.578125,8494846.25,DNA polymerase epsilon subunit 3 OS=Homo sapiens OX=9606 GN=POLE3 PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,54107,POLE3,"Pyrimidine metabolism; Base excision repair; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Activation of the pre-replicative complex; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; DNA replication initiation; Gap-filling DNA repair synthesis and ligation in GG-NER,ENSG00000148229
P54619,0,6,3774755.4557291665,1.461187456400954e-5,1.1125467100739612,0.1538659086429894,0.6649621296870855,1,raw,4482883.90625,3720990.3125,2557615.4375,4770603.84375,2845466.640625,4270972.59375,5'-AMP-activated protein kinase subunit gamma-1 OS=Homo sapiens OX=9606 GN=PRKAG1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,5571,PRKAG1,AMP-activated protein kinase signaling; Target of rapamycin signaling; Energy metabolism; Sterol regulatory element-binding proteins (SREBP) signaling; Angiopoietin-like protein 8 regulatory pathway; Leptin and adiponectin; Lipid metabolism pathway; Thermogenesis; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Hippo signaling regulation pathways; 1q21.1 copy number variation syndrome; Autophagy; p53 transcriptional gene network; Malignant pleural mesothelioma,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Activation of AMPK downstream of NMDARs; Regulation of TP53 Activity through Phosphorylation; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; Activation of PPARGC1A (PGC-1alpha) by phosphorylation; Lipophagy,ENSG00000181929
P78344,0,6,46117965.4453125,1.785201542556779e-4,1.1125373318914997,0.15385374743282867,0.40286819656380063,0.888947988048845,raw,36791266.125,53250031.921875,36691154.0625,59242648.4375,38263054.3125,52469637.8125,Eukaryotic translation initiation factor 4 gamma 2 OS=Homo sapiens OX=9606 GN=EIF4G2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi,RNA binding,1982,EIF4G2,VEGFA-VEGFR2 signaling pathway; Exercise-induced circadian regulation; Acute viral myocarditis,ISG15 antiviral mechanism,ENSG00000110321
Q9NP72,0,6,15308777.4375,5.925945091504726e-5,1.1125058881823757,0.15381297188041324,0.34312326398812354,0.8250629268698745,raw,15014050.5625,14985004.25,12514141.40625,15439100.65625,13922056,19978311.75,Ras-related protein Rab-18 OS=Homo sapiens OX=9606 GN=RAB18 PE=1 SV=1,cell growth;conjugation;defense response;development,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,22931,RAB18,NA,Neutrophil degranulation; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; COPI-independent Golgi-to-ER retrograde traffic,ENSG00000099246
Q6P161,0.16666666666666666,6,5411642.270833333,2.0948175047125985e-5,1.1122779764264958,0.15351738616860638,0.448707231954943,0.9292156027898348,raw,5200063.625,4289088.625,4851983.375,8630412.25,4101551.5,5396754.25,"39S ribosomal protein L54, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL54 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,116541,MRPL54,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000183617
Q53F19,0,6,4058933.7708333335,1.571191347853349e-5,1.112215697507993,0.1534366042019484,0.6100899579136059,1,raw,3710673.25,4254448.78125,3783190.5,4594481.4375,3278943.9375,4731864.71875,Nuclear cap-binding protein subunit 3 OS=Homo sapiens OX=9606 GN=NCBP3 PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;conjugation,membrane;nucleus,RNA binding,55421,NCBP3,NA,NA,ENSG00000074356
Q13442,0,6,52917737.509114586,2.0484170478402588e-4,1.1121021092185248,0.15328925721622016,0.40652009616217005,0.8914071190930648,raw,55068249.25,53202984.75,42128088.4296875,59473692,46850736,60782674.625,28 kDa heat- and acid-stable phosphoprotein OS=Homo sapiens OX=9606 GN=PDAP1 PE=1 SV=1,development,cell surface;cytoplasm;cytoskeleton;cytosol;nucleus,NA,11333,PDAP1,NA,Neutrophil degranulation,ENSG00000106244
K7EJ20,0,6,3506719.53125,1.3574321972041336e-5,1.1120320686297969,0.1531983929050122,0.4690732686885149,0.9493149485362801,raw,2996597.0625,3867970.0625,3106242.4375,3723428.1875,3044772.6875,4301306.75,Glutathione peroxidase OS=Homo sapiens OX=9606 GN=GPX4 PE=1 SV=3,coagulation;metabolic process,NA,structural molecule activity,NA,GPX4,"Trans-sulfuration, one-carbon metabolism and related pathways; Ferroptosis; Metapathway biotransformation Phase I and II",NA,ENSG00000167468
Q8IYU8,0,6,9869508.078125,3.820433289980743e-5,1.112031905643885,0.15319818145518924,0.4685127001502789,0.9488697854576846,raw,8065878.6875,10809686.25,8989514.34375,11202749.6875,8128503.5,12020716,"Calcium uptake protein 2, mitochondrial OS=Homo sapiens OX=9606 GN=MICU2 PE=1 SV=2",conjugation;metabolic process,cytoskeleton;endosome,structural molecule activity,221154,MICU2,NA,Processing of SMDT1,ENSG00000165487
Q6FI81,0,6,12519025.578125,4.846047209059633e-5,1.1115921617438551,0.1526275666993865,0.7651445893417497,1,raw,8294288.90625,15567186.0625,12370016.296875,15578324.8125,9553924.234375,13750413.15625,Anamorsin OS=Homo sapiens OX=9606 GN=CIAPIN1 PE=1 SV=2,cell growth;cellular homeostasis;metabolic process,endosome;membrane;nucleus,structural molecule activity,57019,CIAPIN1,NA,Cytosolic iron-sulfur cluster assembly,ENSG00000005194
Q2TAY7,0,6,27768542.645833332,1.0749052931374271e-4,1.1115067053723695,0.15251665171918566,0.5666391651627272,1,raw,26691979.71875,31349934.46875,20624250.875,31171146,21928282.4375,34845662.375,WD40 repeat-containing protein SMU1 OS=Homo sapiens OX=9606 GN=SMU1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,55234,SMU1,NA,NA,ENSG00000122692
Q15061,0,6,20911920.369791668,8.094891468324975e-5,1.1114286957613755,0.1524153945446303,0.3678958277129334,0.8520069708429603,raw,17736710.21875,23728078.8125,15589803.21875,26372067.6875,17241049.40625,24803812.875,WD repeat-containing protein 43 OS=Homo sapiens OX=9606 GN=WDR43 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,23160,WDR43,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000163811
A0A087WZT2,0,6,6484353.135416667,2.5100580886543233e-5,1.1114026861400823,0.15238163224312393,0.9476738666780021,1,raw,5698351.9375,6754336.40625,6831297.59375,7506787.625,3605567.8125,8509777.4375,Methyltransferase-like protein 7B OS=Homo sapiens OX=9606 GN=METTL7B PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P19623,0,6,26210125.817708332,1.0145798191350183e-4,1.1112580339447768,0.1521938491926298,0.48824917024509285,0.9714038060008826,raw,30839529.875,22239738.75,21265296.625,28495553.75,23631231.71875,30789404.1875,Spermidine synthase OS=Homo sapiens OX=9606 GN=SRM PE=1 SV=1,cellular homeostasis;metabolic process,cytosol,structural molecule activity,6723,SRM,Methionine de novo and salvage pathway; Amino acid metabolism,Metabolism of polyamines,ENSG00000116649
Q9NUP9,0,6,14233467.28125,5.5096983357928285e-5,1.1112455704030006,0.15217766826056972,0.4423761961690652,0.9249261346766603,raw,15404600.4375,11505630.6875,13543169.625,17118294,12501753.5625,15327355.375,Protein lin-7 homolog C OS=Homo sapiens OX=9606 GN=LIN7C PE=1 SV=1,cell death;conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,motor activity;structural molecule activity,55327,LIN7C,NA,Assembly and cell surface presentation of NMDA receptors; Neurexins and neuroligins; Dopamine Neurotransmitter Release Cycle,ENSG00000148943
P60981,0,6,97442551.40364583,3.7719485540344406e-4,1.1110595637177778,0.15193616144060187,0.7451582772502787,1,raw,102617539.40625,95575358.125,87623181.40625,114014198.5625,77559363.1875,107265667.734375,Destrin OS=Homo sapiens OX=9606 GN=DSTN PE=1 SV=3,cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity,11034,DSTN,Androgen receptor signaling pathway,NA,ENSG00000125868
A0A2R8Y611,0,6,1546238.9375,5.98540744313542e-6,1.1106876090762738,0.15145310276649362,1,1,raw,NA,1418660.375,NA,1575688.5,1159212.75,2031394.125,AP-3 complex subunit delta (Fragment) OS=Homo sapiens OX=9606 GN=AP3D1 PE=1 SV=1,conjugation,cytoskeleton,NA,NA,AP3D1,NA,NA,ENSG00000065000
Q8NFZ8,0,6,305819.896875,1.1838123090950367e-6,1.1106233590739785,0.1513696446995741,0.6202489254264578,1,raw,233635.296875,370504.28125,259443.25,396724.375,268792.28125,NA,Cell adhesion molecule 4 OS=Homo sapiens OX=9606 GN=CADM4 PE=1 SV=1,cell communication;metabolic process,cytoskeleton;nucleus,antioxidant activity;structural molecule activity,199731,CADM4,NA,NA,ENSG00000105767
Q9H098,0,6,4418659.083333333,1.7104390741072813e-5,1.1106180585056096,0.15136275926727558,0.6657850866011545,1,raw,5862725.21875,3400698,2992871.84375,6511248.5,2699110.4375,5045300.5,Protein FAM107B OS=Homo sapiens OX=9606 GN=FAM107B PE=1 SV=1,NA,NA,NA,83641,FAM107B,NA,NA,ENSG00000065809
P32119,0,6,196522669.015625,7.607286411845132e-4,1.1105083777124154,0.15122027666568172,0.7929517445561678,1,raw,191253800.125,181289982.8125,204867744.53125,226873452.875,147343687.125,227507346.625,Peroxiredoxin-2 OS=Homo sapiens OX=9606 GN=PRDX2 PE=1 SV=5,cell differentiation;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;nucleus,structural molecule activity,7001,PRDX2,Selenium micronutrient network; VEGFA-VEGFR2 signaling pathway,Detoxification of Reactive Oxygen Species; TP53 Regulates Metabolic Genes; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,ENSG00000167815
Q9UKE5,0,6,75219300.59114583,2.9116985137731e-4,1.110466534071996,0.15116591530192855,0.29270793180845583,0.774322745775844,raw,58668412.40625,81143289.03125,71931207.671875,79877198.875,74570603.84375,85125091.71875,TRAF2 and NCK-interacting protein kinase OS=Homo sapiens OX=9606 GN=TNIK PE=1 SV=1,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,signal transducer activity;structural molecule activity,23043,TNIK,Hippo-Yap signaling pathway; Malignant pleural mesothelioma,Oxidative Stress Induced Senescence,ENSG00000154310
Q15311,0,6,547047.1328125,2.117589915162661e-6,1.1103459444981683,0.1510092393268124,1,1,raw,NA,460398.09375,NA,334509.65625,511201.15625,882079.625,RalA-binding protein 1 OS=Homo sapiens OX=9606 GN=RALBP1 PE=1 SV=3,conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane,catalytic activity;DNA binding;structural molecule activity,10928,RALBP1,RalA downstream regulated genes; Ras signaling; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway,CDC42 GTPase cycle; RAC1 GTPase cycle,ENSG00000017797
O95298,0,6,11002449.229166666,4.258988692617484e-5,1.1097995299526362,0.150299097059022,0.4728817432274096,0.9537394792651158,raw,11910578,8079357,9997157.4375,16177545.25,8755217.0625,11094840.625,NADH dehydrogenase [ubiquinone] 1 subunit C2 OS=Homo sapiens OX=9606 GN=NDUFC2 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;endosome;mitochondrion;nucleus,catalytic activity,4718,NDUFC2,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Neutrophil degranulation; Complex I biogenesis,ENSG00000151366
Q96RP9,0,6,29184178.401041668,1.1297037888970298e-4,1.1097035737993968,0.15017435250131128,0.3195060742273659,0.802275970216152,raw,25574730.28125,26809388.96875,26951835.28125,29750474.75,26026799.4375,39991841.6875,"Elongation factor G, mitochondrial OS=Homo sapiens OX=9606 GN=GFM1 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,endosome,RNA binding;structural molecule activity,85476,GFM1,NA,Mitochondrial translation elongation,ENSG00000168827
P51610,0,6,1283151.0625,4.96700848354792e-6,1.1095638778483543,0.14999272621204382,1,1,raw,NA,1216508.375,NA,NA,NA,1349793.75,Host cell factor 1 OS=Homo sapiens OX=9606 GN=HCFC1 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,3054,HCFC1,Mitochondrial gene expression; Malignant pleural mesothelioma,UCH proteinases; Transcriptional activation of mitochondrial biogenesis; HATs acetylate histones,ENSG00000172534
P46781,0,6,285087431.5416667,0.0011035580551688514,1.1094148033118851,0.14979888109164094,0.4274947869736824,0.9117218023274877,raw,254211931.375,308348340.25,243141869,321559739.75,241176495.625,342086213.25,40S ribosomal protein S9 OS=Homo sapiens OX=9606 GN=RPS9 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6203,RPS9,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000170889; ENSG00000274005; ENSG00000274626; ENSG00000274646; ENSG00000274950; ENSG00000275323; ENSG00000277079; ENSG00000277359; ENSG00000278081; ENSG00000278270
Q15233,0,6,200928501.88899735,7.777833823593347e-4,1.1093755121417581,0.14974778552311957,0.4025131599724523,0.888947988048845,raw,164857995.8125,231328418.001953,167743460.40625,217674954.828125,182889423.535156,241076758.75,Non-POU domain-containing octamer-binding protein OS=Homo sapiens OX=9606 GN=NONO PE=1 SV=4,cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4841,NONO,mRNA processing,NA,ENSG00000147140
Q7Z3E2,0,6,590475.25,2.28569781204158e-6,1.1092285570042006,0.14955666404142232,0.4076299663659531,0.8921091312456526,raw,454862.5,405277.3125,NA,1209978.125,406797.84375,475460.46875,Coiled-coil domain-containing protein 186 OS=Homo sapiens OX=9606 GN=CCDC186 PE=1 SV=2,cell death;conjugation;metabolic process,extracellular,structural molecule activity,55088,CCDC186,NA,NA,ENSG00000165813
P48643,0,6,418205635.3671877,0.001618851434911522,1.1090215736250195,0.14928743029592673,0.4783414905982357,0.9603583426780172,raw,399410582.789063,451026953.078125,336380361.945313,473445239.359375,348772053.78125,500198621.25,T-complex protein 1 subunit epsilon OS=Homo sapiens OX=9606 GN=CCT5 PE=1 SV=1,conjugation;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;RNA binding;structural molecule activity,22948,CCT5,16p11.2 proximal deletion syndrome,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,ENSG00000150753
Q15819,0,6,6346382.916666667,2.4566505618995994e-5,1.1089436183789136,0.14918601693973882,0.0629624529214622,0.6429522395902524,raw,5777999.75,6413918.25,5722356.75,6907162,6345771,6911089.75,Ubiquitin-conjugating enzyme E2 variant 2 OS=Homo sapiens OX=9606 GN=UBE2V2 PE=1 SV=4,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,NA,7336,UBE2V2,NA,Antigen processing: Ubiquitination & Proteasome degradation; E3 ubiquitin ligases ubiquitinate target proteins; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ); Formation of Incision Complex in GG-NER,ENSG00000169139
Q5VT25,0,6,8772895.4375,3.395940457582822e-5,1.10883299445189,0.14904209208262767,0.24836201971589345,0.7316541032247736,raw,8101407.5,9089857.875,7675696.375,8983107.9375,8437390.125,10349912.8125,Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens OX=9606 GN=CDC42BPA PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;nucleus,signal transducer activity;structural molecule activity,8476,CDC42BPA,Male infertility,CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOJ GTPase cycle,ENSG00000143776
O43765,0,6,36646455.739583336,1.4185645156684253e-4,1.108662550895856,0.14882031208939003,0.260980294779439,0.7423144016558971,raw,35640687.125,34507813.125,32194508.25,38257520.125,33980249.5,45297956.3125,Small glutamine-rich tetratricopeptide repeat-containing protein alpha OS=Homo sapiens OX=9606 GN=SGTA PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,6449,SGTA,NA,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,ENSG00000104969
Q9Y3A3,0,6,5936523.911458333,2.2979963538781407e-5,1.1081313116288898,0.14812884836458856,0.47680712813206183,0.9582435981037789,raw,5914026.0625,5902711.21875,4319450.0625,8631122.375,4310854.625,6540979.125,MOB-like protein phocein OS=Homo sapiens OX=9606 GN=MOB4 PE=1 SV=1,NA,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,25843,MOB4,NA,NA,ENSG00000115540
P84098,0,6,95321811.84375,3.68985587069227e-4,1.1078590216520952,0.14777430584219337,0.5376027294774117,1,raw,79031185.75,100804400,95277568.1875,93811010.75,87555412.125,115451294.25,60S ribosomal protein L19 OS=Homo sapiens OX=9606 GN=RPL19 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;membrane;nucleus,structural molecule activity,6143,RPL19,Cytoplasmic ribosomal proteins,Major pathway of rRNA processing in the nucleolus and cytosol; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000108298
Q96DV4,0,6,19332463.53125,7.483492253866994e-5,1.1071479900253436,0.14684807686715504,0.6583560796594881,1,raw,20921379.3125,16104175.25,17763619.5,27743366.5625,13795284.9375,19666955.625,"39S ribosomal protein L38, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL38 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,NA,64978,MRPL38,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000204316
O75718,0,6,2339354.8151041665,9.055516183739334e-6,1.1071343570605763,0.14683031200470328,0.621620057374272,1,raw,1793566.90625,3041937.828125,1772566.875,1962469.6875,2938643.0625,2526944.53125,Cartilage-associated protein OS=Homo sapiens OX=9606 GN=CRTAP PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;extracellular;nucleus,NA,10491,CRTAP,Type I collagen synthesis in the context of osteogenesis imperfecta,Collagen biosynthesis and modifying enzymes,ENSG00000170275
O95630,0,6,6508701.401041667,2.5194831708175587e-5,1.1065806148951958,0.14610855594964803,0.6352151364048608,1,raw,6981715.40625,5667871.65625,6046369.8125,6690795.625,5170326.234375,8495129.671875,STAM-binding protein OS=Homo sapiens OX=9606 GN=STAMBP PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion,structural molecule activity,10617,STAMBP,EGF/EGFR signaling pathway,Metalloprotease DUBs,ENSG00000124356
Q03001,0,6,22235762.161458332,8.607343478244392e-5,1.106557606736056,0.14607855894650779,0.485831033115242,0.9682310561096137,raw,19633510.4375,23308419.015625,20684789.125,22888910.75,19430883.140625,27468060.5,Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4,cell communication;cell growth;coagulation;conjugation;development;metabolic process,chromosome;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,667,DST,NA,RND2 GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; Type I hemidesmosome assembly,ENSG00000151914
D3YTA9,0,6,10798176.692708334,4.1799158966547415e-5,1.106528693399628,0.1460408621544032,0.33782641438845595,0.8212837193351332,raw,10499306.5,10359340.71875,8549966.1875,11462907.75,9232601,14684938,Calcineurin subunit B type 1 OS=Homo sapiens OX=9606 GN=PPP3R1 PE=1 SV=1,NA,NA,DNA binding;structural molecule activity,NA,PPP3R1,Alzheimer's disease and miRNA effects; Initiation of transcription and translation elongation at the HIV-1 LTR; Wnt signaling; Regucalcin in proximal tubule epithelial kidney cells; Alzheimer's disease,NA,ENSG00000221823
Q9H0P0,0.16666666666666666,6,295879.609375,1.1453339928746461e-6,1.1065117788035905,0.14601880869073752,0.7284611763874518,1,raw,192550.59375,360262.03125,281326.40625,213059.5,254345.75,473733.375,Cytosolic 5'-nucleotidase 3A OS=Homo sapiens OX=9606 GN=NT5C3A PE=1 SV=3,cellular homeostasis;coagulation,cytosol;extracellular;membrane;nucleus,structural molecule activity,51251,NT5C3A,NA,NA,ENSG00000122643
Q5JPH6,0,6,84531986.90625,3.272187572961663e-4,1.1061710724194673,0.1455745196102787,0.5088464395694617,0.992236492858638,raw,84979817.21875,85388294.328125,72392467.171875,94002215.546875,71154169.921875,99274957.25,"Probable glutamate--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=EARS2 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome,RNA binding;structural molecule activity,124454,EARS2,NA,Mitochondrial tRNA aminoacylation,ENSG00000103356
D6RBZ0,0,6,81727582.0234375,3.1636305740912916e-4,1.1058526928903472,0.14515922156677896,0.08174668091229965,0.6429522395902524,raw,74219758.6875,82111028.515625,72739970.90625,90485620.3125,80006411.71875,90802702,Heterogeneous nuclear ribonucleoprotein A/B OS=Homo sapiens OX=9606 GN=HNRNPAB PE=1 SV=1,metabolic process,membrane;nucleus,RNA binding,NA,HNRNPAB,Pre-implantation embryo,NA,ENSG00000197451
P37837,0,6,210409446.125,8.144836056054733e-4,1.1058104503968678,0.14510411097179535,0.5415812337178607,1,raw,210042794.25,192639984.25,199587369.875,265318372.5,174162356.5,220705799.375,Transaldolase OS=Homo sapiens OX=9606 GN=TALDO1 PE=1 SV=2,cellular homeostasis,cytosol;nucleus,structural molecule activity,6888,TALDO1,Pentose phosphate metabolism; Cori cycle; Metabolic reprogramming in colon cancer,"Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Nuclear events mediated by NFE2L2; Pentose phosphate pathway; Insulin effects increased synthesis of Xylulose-5-Phosphate; TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P; TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P",ENSG00000177156
A0A087WT53,0.3333333333333333,6,4754582.208333333,1.8404731020918022e-5,1.1057273141763861,0.14499564326666736,0.43288904527981265,0.9168514603569733,raw,4842341,4781137.5,3576126.5,5063522,3954220.75,6310145.5,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MAGI1 PE=1 SV=1",NA,membrane;nucleus,structural molecule activity,NA,MAGI1,Pathways affected in adenoid cystic carcinoma,NA,ENSG00000151276; ENSG00000282956
P34059,0,6,823053.7125,3.1859964830938298e-6,1.1054506505324824,0.1446346218785136,0.7581979448516821,1,raw,921779.40625,NA,644428.8125,712264.1875,712504.3125,1124291.84375,N-acetylgalactosamine-6-sulfatase OS=Homo sapiens OX=9606 GN=GALNS PE=1 SV=1,NA,cell surface;mitochondrion,structural molecule activity,2588,GALNS,Glycosaminoglycan degradation,Keratan sulfate degradation; Neutrophil degranulation; MPS IV - Morquio syndrome A,ENSG00000141012
A0A2Y9D025,0,6,6841846.09375,2.648441682663178e-5,1.1053063941064747,0.14444634426454628,0.49904423680161636,0.9829025937005593,raw,7100331.71875,5429818.96875,6325770.96875,10059480.96875,6134060.3125,6001613.625,Complex I-B14 OS=Homo sapiens OX=9606 GN=NDUFA6 PE=1 SV=1,NA,cytoskeleton;endosome,NA,4700,NDUFA6,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,NA,ENSG00000184983; ENSG00000273397; ENSG00000277365; ENSG00000281013
P51148,0,6,67913186.20833333,2.628882770703089e-4,1.105034574651712,0.14409150979608837,0.3370138835164059,0.8207563950745482,raw,55871287.6875,64706186.5,62143662,97207962.25,61739704.625,65810314.1875,Ras-related protein Rab-5C OS=Homo sapiens OX=9606 GN=RAB5C PE=1 SV=2,conjugation;metabolic process,cytoplasm;cytoskeleton;mitochondrion;nucleus,structural molecule activity,5878,RAB5C,Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis; TBC/RABGAPs,ENSG00000108774
Q9H147,0.5,6,2500148.5729166665,9.677940138717929e-6,1.1050029673138608,0.14405024375538913,0.7858036298236108,1,raw,3721553.21875,1686763.34375,1751285.625,2874885.25,1863878.5,3102525.5,Deoxynucleotidyltransferase terminal-interacting protein 1 OS=Homo sapiens OX=9606 GN=DNTTIP1 PE=1 SV=2,NA,membrane;nucleus,RNA binding;structural molecule activity,116092,DNTTIP1,NA,NA,ENSG00000101457
P0CG13,0,6,490999.359375,1.900632010295529e-6,1.1046138248754638,0.14354208879036207,0.5318418812081276,1,raw,417372.65625,519173.625,NA,490025.15625,NA,537426,Chromosome transmission fidelity protein 8 homolog OS=Homo sapiens OX=9606 GN=CHTF8 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;metabolic process,membrane,RNA binding,54921,CHTF8,Gastric cancer network 2,Polymerase switching on the C-strand of the telomere,ENSG00000168802
Q8WUD4,0,6,2797742.09375,1.0829908590310949e-5,1.1045937936172046,0.14351592647160827,0.6943962148851301,1,raw,1534394.25,3608360.5,2821510.625,3116623.125,2457162.9375,3248401.125,Coiled-coil domain-containing protein 12 OS=Homo sapiens OX=9606 GN=CCDC12 PE=1 SV=1,NA,membrane,NA,151903,CCDC12,NA,NA,ENSG00000160799
O15212,0,6,33336544.203125,1.2904396271665956e-4,1.1045717894332199,0.14348718681772438,0.3596610651036719,0.8422895555819307,raw,30519401,36709322.703125,27599108.3125,32643589.828125,33710869.375,38836974,Prefoldin subunit 6 OS=Homo sapiens OX=9606 GN=PFDN6 PE=1 SV=1,cell growth;metabolic process,nucleus,structural molecule activity,10471,PFDN6,Cellular proteostasis,Prefoldin mediated transfer of substrate  to CCT/TriC,ENSG00000204220; ENSG00000206283; ENSG00000224782; ENSG00000235692; ENSG00000237335
P35232,0,6,273847789.1757813,0.0010600500064168773,1.104467560251047,0.14335104535481213,0.29398479008678974,0.7750607974821754,raw,268390386.5,263937406.40625,226463661.882813,291510303.3125,245238521.1875,347546455.765625,Prohibitin OS=Homo sapiens OX=9606 GN=PHB PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;endosome;membrane;mitochondrion;nucleus,antioxidant activity;structural molecule activity,5245,PHB1,NA,RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Processing of SMDT1,ENSG00000167085
Q8WXK1,0.8333333333333334,6,2228091.5625,8.62482214019056e-6,1.1044401917650564,0.14331529521632738,0.7613960224667895,1,raw,2284180,2094940.375,2180063.5,2407749.75,1808441.5,2593174.25,Ankyrin repeat and SOCS box protein 15 OS=Homo sapiens OX=9606 GN=ASB15 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;development,cytosol,NA,142685,ASB15,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation,ENSG00000146809
Q9NRK6,0,6,3891640.5729166665,1.5064330541826888e-5,1.1043693613993055,0.14322276879882642,0.3658939421538258,0.8494181513311093,raw,3996809.1875,3556159.59375,3213036.75,5209197.15625,3548379.34375,3826261.40625,"ATP-binding cassette sub-family B member 10, mitochondrial OS=Homo sapiens OX=9606 GN=ABCB10 PE=1 SV=2",cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,23456,ABCB10,NA,Mitochondrial ABC transporters,ENSG00000135776
P56192,0,6,78542987.96354167,3.0403566574462753e-4,1.1041356238969986,0.14291739304558873,0.37578269858937885,0.8615698665976935,raw,82769961.625,70574982.75,68639060.625,90125208.1875,67759451.375,91389263.21875,"Methionine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=MARS1 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,4141,MARS1,NA,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,ENSG00000166986
Q5JTJ3,0,6,5313425.447916667,2.0567983028499806e-5,1.1040505874264586,0.1428062776932925,0.44873671987313496,0.9292156027898348,raw,6314404.875,3732582.75,4658657.625,5066728,5143393.6875,6964785.75,Cytochrome c oxidase assembly factor 6 homolog OS=Homo sapiens OX=9606 GN=COA6 PE=1 SV=1,cell growth;cellular homeostasis,cytoplasm;cytoskeleton;endosome;membrane,structural molecule activity,388753,COA6,Mitochondrial complex IV assembly,Mitochondrial protein import,ENSG00000168275
X6R4W8,0,6,9894383.791666666,3.830062544384743e-5,1.1039642295950698,0.14269342698759108,0.44045959401018636,0.9233600879723239,raw,9191648.8125,11426895.5,7067863.4375,10147251.5,9281866.25,12250777.25,BUB3-interacting and GLEBS motif-containing protein ZNF207 OS=Homo sapiens OX=9606 GN=ZNF207 PE=1 SV=1,NA,membrane,NA,NA,ZNF207,NA,NA,ENSG00000010244
Q9ULW3,0,6,1423893.75,5.511815827936363e-6,1.1038476581256094,0.1425410796956942,0.7687652375504833,1,raw,1306290.0625,1393971.6875,1806704.5,474491.09375,1567578.625,1994326.53125,Activator of basal transcription 1 OS=Homo sapiens OX=9606 GN=ABT1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,29777,ABT1,NA,NA,ENSG00000146109
P31946,0,6,173381444.88541666,6.711502120083859e-4,1.1037907345864182,0.14246668045713207,0.9005652865212392,1,raw,182163042.84375,163687526.09375,169207911.5625,201069878.875,127878791.875,196281518.0625,14-3-3 protein beta/alpha OS=Homo sapiens OX=9606 GN=YWHAB PE=1 SV=3,conjugation;development;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,DNA binding;structural molecule activity,7529,YWHAB,Cell cycle; IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Hepatitis B infection; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,"TP53 Regulates Metabolic Genes; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; Signaling by BRAF and RAF1 fusions; mTORC1-mediated signalling; Signaling by Hippo; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; Rap1 signalling; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; ARMS-mediated activation; Activation of BAD and translocation to mitochondria ; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA",ENSG00000166913
Q99504,0,6,1755577.8541666667,6.795747087007292e-6,1.103761672203733,0.14242869435519404,0.4079297033874522,0.8921091312456526,raw,1661482.65625,1391052.6875,1717396.21875,1833880.875,1422459.5625,2507195.125,Eyes absent homolog 3 OS=Homo sapiens OX=9606 GN=EYA3 PE=1 SV=3,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,2140,EYA3,NA,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,ENSG00000158161
P24539,0,6,109404074.2890625,4.2349726467103346e-4,1.1037509083211705,0.142414625126207,0.6454214242752072,1,raw,105297711.5625,108218525.140625,95806673.890625,155894521.09375,74984569.265625,116222444.78125,"ATP synthase F(0) complex subunit B1, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PB PE=1 SV=2",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,515,ATP5PB,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000116459
Q12996,0,6,14167650.708333334,5.4842210957710496e-5,1.1030873635337697,0.14154705561261982,0.5305512126676234,1,raw,13316691.875,14738708.125,12698209.25,16258082.6875,11741726.90625,16252485.40625,Cleavage stimulation factor subunit 3 OS=Homo sapiens OX=9606 GN=CSTF3 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding,1479,CSTF3,mRNA processing,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs,ENSG00000176102
P62917,0,6,157168407.51041666,6.083904196977246e-4,1.102906615614621,0.1413106414341088,0.3498785934113563,0.8336350815660651,raw,122111560.125,173582956.3125,145214137,157448846.25,153207154.5,191445790.875,60S ribosomal protein L8 OS=Homo sapiens OX=9606 GN=RPL8 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,6132,RPL8,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000161016
Q9BSJ2,0,6,1913967.0260416667,7.408863019649287e-6,1.1027912134690747,0.1411596777789388,0.5682051594150441,1,raw,1562394.3125,2013649.09375,1821472.5625,2606974.5,1470607.75,2008703.9375,Gamma-tubulin complex component 2 OS=Homo sapiens OX=9606 GN=TUBGCP2 PE=1 SV=2,cell differentiation;cell growth;defense response,cytosol;endoplasmic reticulum;membrane,motor activity,10844,TUBGCP2,15q11.2 copy number variation syndrome,Recruitment of NuMA to mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes,ENSG00000130640
Q7L014,0.16666666666666666,6,87915114.58333333,3.4031466187365146e-4,1.1026230009069204,0.14093960172417877,0.682907083541791,1,raw,86955847.03125,92117563.5,77292384.46875,104111628.5625,71133746.9375,95879517,Probable ATP-dependent RNA helicase DDX46 OS=Homo sapiens OX=9606 GN=DDX46 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,cytoskeleton;membrane,structural molecule activity,9879,DDX46,NA,mRNA Splicing - Major Pathway,ENSG00000145833
Q9H6U6,0,6,298387.546875,1.155042083529567e-6,1.1023320813191515,0.1405589062148776,0.5859217465679079,1,raw,239884.296875,351992.75,249484.546875,412920.125,264432.15625,271611.40625,Breast carcinoma-amplified sequence 3 OS=Homo sapiens OX=9606 GN=BCAS3 PE=1 SV=3,cell growth;cellular homeostasis;coagulation;defense response;metabolic process,endoplasmic reticulum;membrane;nucleus,DNA binding;motor activity;structural molecule activity,54828,BCAS3,Ectoderm differentiation,NA,ENSG00000141376
Q99471,0,6,42005801.479166664,1.626021895650736e-4,1.1017435266097373,0.13978841995960484,0.6874374532406886,1,raw,38180752.1875,47922601.6875,34881812.6875,52798416.1875,30993362.125,47257864,Prefoldin subunit 5 OS=Homo sapiens OX=9606 GN=PFDN5 PE=1 SV=2,cellular component movement;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,5204,PFDN5,Cellular proteostasis,Prefoldin mediated transfer of substrate  to CCT/TriC,ENSG00000123349
O00459,0,6,587683.625,2.2748915823909038e-6,1.101689543338273,0.13971772900092738,1,1,raw,NA,NA,559248.75,NA,616118.5,NA,Phosphatidylinositol 3-kinase regulatory subunit beta OS=Homo sapiens OX=9606 GN=PIK3R2 PE=1 SV=2,cell growth;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;DNA binding;structural molecule activity,5296,PIK3R2,IL-5 signaling pathway; Androgen receptor signaling pathway; AMP-activated protein kinase signaling; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; IL-9 signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; Bladder cancer; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; IL6 signaling pathway; TGF-beta signaling pathway; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Microglia pathogen phagocytosis pathway; IL-4 signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; Ebola virus infection in host; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Translation inhibitors in chronically activated PDGFRA cells; Cancer immunotherapy by CTLA4 blockade; Measles virus infection; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; Head and neck squamous cell carcinoma; Melanoma; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; mBDNF and proBDNF regulation of GABA neurotransmission; Modulators of TCR signaling and T cell activation; Regulation of actin cytoskeleton; Alzheimer's disease; G13 signaling pathway; Interferon type I signaling pathways; Notch signaling pathway; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response (only ATM dependent); Toll-like receptor signaling pathway,"Role of phospholipids in phagocytosis; Role of LAT2/NTAL/LAB on calcium mobilization; Downstream TCR signaling; RND2 GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; G alpha (q) signalling events; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; Extra-nuclear estrogen signaling; RHOU GTPase cycle; PIP3 activates AKT signaling; Synthesis of PIPs at the plasma membrane; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RET signaling; Interleukin receptor SHC signaling; Regulation of signaling by CBL; Nephrin family interactions; RAF/MAP kinase cascade; PI3K Cascade; GPVI-mediated activation cascade; Interleukin-7 signaling; Signaling by SCF-KIT; Downstream signal transduction; PI3K/AKT activation; Signaling by ALK; Tie2 Signaling; DAP12 signaling; Costimulation by the CD28 family; CD28 dependent PI3K/Akt signaling; VEGFA-VEGFR2 Pathway; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants; Signaling by PDGFRA extracellular domain mutants; RND3 GTPase cycle; RND1 GTPase cycle",ENSG00000105647
Q9H3U5,0.5,6,1079209.7604166667,4.177562714302239e-6,1.1015183677087477,0.13949355203506242,0.6979397780694225,1,raw,1294220.625,1026587.625,770703.1875,1433731.25,819210.75,1130805.125,Major facilitator superfamily domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MFSD1 PE=2 SV=2,conjugation;metabolic process,cytoskeleton;mitochondrion,catalytic activity;structural molecule activity,64747,MFSD1,NA,NA,ENSG00000118855
A6NDU8,0,6,2841470.0442708335,1.0999177125834718e-5,1.1014244357437717,0.13937052098775468,0.4715063413529261,0.9525429676692956,raw,2614846.0625,2750219.5,2117588.5,4753323.78125,2332363.71875,2480478.703125,UPF0600 protein C5orf51 OS=Homo sapiens OX=9606 GN=C5orf51 PE=1 SV=1,cell growth;cellular homeostasis,cytosol;membrane,NA,285636,RIMOC1,NA,NA,ENSG00000205765
Q9NZM1,0,6,104727924.85546875,4.053961426864207e-4,1.1013369674141438,0.13925594650385964,0.5654887822734379,1,raw,96768894.375,112573239.65625,92556662.1015625,115555337.125,86932345.5,123981070.375,Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,cell growth;coagulation;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,26509,MYOF,Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Hepatitis C and hepatocellular carcinoma,NA,ENSG00000138119
Q8TDH9,0.16666666666666666,6,374939.95,1.4513723028390767e-6,1.1006353778303528,0.1383366072126901,0.258149015116037,0.7381027251958325,raw,403869.0625,379774.03125,255071.1875,426067,409918.46875,NA,Biogenesis of lysosome-related organelles complex 1 subunit 5 OS=Homo sapiens OX=9606 GN=BLOC1S5 PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,extracellular;nucleus,NA,63915,BLOC1S5,NA,NA,ENSG00000188428
Q5T9A4,0,6,55211778.721354164,2.1372181445763067e-4,1.1003506602320976,0.13796335571336715,0.6114370131344053,1,raw,49982294.171875,60193969.3125,49253554.15625,66234473.875,44783320.0625,60823060.75,ATPase family AAA domain-containing protein 3B OS=Homo sapiens OX=9606 GN=ATAD3B PE=1 SV=1,cell growth,cytoplasm;cytoskeleton;endosome,structural molecule activity,83858,ATAD3B,NA,Neutrophil degranulation,ENSG00000160072
Q9Y324,0,6,4591757.5,1.7774445366127566e-5,1.100291248211494,0.13788545714460315,0.60447122748209,1,raw,4213974.375,4654834.875,3894757.0625,6961881.75,3188497.8125,4636599.125,rRNA-processing protein FCF1 homolog OS=Homo sapiens OX=9606 GN=FCF1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,NA,51077,FCF1,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000119616
Q06546,0,6,2108049.0416666665,8.160144023333493e-6,1.100127463143166,0.1376706871964423,0.6978966414606931,1,raw,1779842.6875,2748646.6875,1304053.4375,1830042.9375,1434625,3551083.5,GA-binding protein alpha chain OS=Homo sapiens OX=9606 GN=GABPA PE=1 SV=1,cellular component movement;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,2551,GABPA,Energy metabolism; Allograft rejection; Myometrial relaxation and contraction pathways; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; Mitochondrial gene expression; Malignant pleural mesothelioma,Transcriptional activation of mitochondrial biogenesis,ENSG00000154727
Q9BUJ2,0,6,54326165.325520836,2.1029365281805145e-4,1.0999992250866757,0.13750250741902229,0.4997085300905763,0.9839362768040791,raw,52159679.96875,58103272.4375,45041924.84375,61055198.3125,45683361.734375,63913554.65625,Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Homo sapiens OX=9606 GN=HNRNPUL1 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,11100,HNRNPUL1,NA,mRNA Splicing - Major Pathway,ENSG00000105323
Q99832,0,6,395488621.1764323,0.0015309150995072404,1.099925884115902,0.13740631445824772,0.8292775268898847,1,raw,388085085.25,438258613.582031,338439792.523438,482051993.015625,298576895.359375,427519347.328125,T-complex protein 1 subunit eta OS=Homo sapiens OX=9606 GN=CCT7 PE=1 SV=2,conjugation;metabolic process,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,10574,CCT7,VEGFA-VEGFR2 signaling pathway; 16p11.2 proximal deletion syndrome,Formation of tubulin folding intermediates by CCT/TriC; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle; Folding of actin by CCT/TriC,ENSG00000135624
Q14118,0,6,3013978.8489583335,1.1666949394752216e-5,1.0997153949122866,0.13713020422696698,0.9318349485607957,1,raw,2691472.9375,3365390.625,2909832.46875,3805464.25,2111725.25,3199987.5625,Dystroglycan OS=Homo sapiens OX=9606 GN=DAG1 PE=1 SV=2,cell communication;cell death;cell growth;cell organization and biogenesis;coagulation;defense response;metabolic process,cell surface;chromosome;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity;structural molecule activity,1605,DAG1,Arrhythmogenic right ventricular cardiomyopathy; Primary focal segmental glomerulosclerosis (FSGS); T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Acute viral myocarditis; Fragile X syndrome,"Regulation of expression of SLITs and ROBOs; ECM proteoglycans; Non-integrin membrane-ECM interactions; O-linked glycosylation; EGR2 and SOX10-mediated initiation of Schwann cell myelination; Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3; Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2; Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",ENSG00000173402
A0A087X2D5,0,6,13342099.114583334,5.1646545311162545e-5,1.099532157113959,0.1368897981268724,0.5574012788855043,1,raw,12592488.6875,13295218.6875,12204861.25,17238260.75,10875919.0625,13845846.25,"39S ribosomal protein L45, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL45 PE=1 SV=1",NA,endosome,NA,84311,MRPL45,NA,NA,ENSG00000278845
Q9Y2Q3,0,6,19968034.455729168,7.729518327183239e-5,1.0992839468811963,0.13656408496443484,0.506656464017125,0.9902772197513048,raw,19421900.28125,18915105.5,19359167.390625,21281221.9375,17279202.375,23551609.25,Glutathione S-transferase kappa 1 OS=Homo sapiens OX=9606 GN=GSTK1 PE=1 SV=3,cellular homeostasis;metabolic process,cytosol;endosome;mitochondrion,structural molecule activity,373156,GSTK1,Metapathway biotransformation Phase I and II,Peroxisomal protein import; Glutathione conjugation,ENSG00000197448
Q99757,0,6,2310270.1822916665,8.94293114044825e-6,1.099251065125137,0.13652093045823235,0.6192199396105316,1,raw,2005126.78125,2614137.8125,2143010.34375,2443451.46875,2451756.9375,2204137.75,"Thioredoxin, mitochondrial OS=Homo sapiens OX=9606 GN=TXN2 PE=1 SV=2",coagulation;metabolic process,endosome;membrane;nucleus,structural molecule activity,25828,TXN2,Oxidative stress response,Detoxification of Reactive Oxygen Species; Degradation of cysteine and homocysteine,ENSG00000100348
Q96B23,0,6,1761517.59375,6.818739498238283e-6,1.0992299509192338,0.1364932191794653,0.8375042297083788,1,raw,1585053.1875,1959317.25,1561323.8125,2729091.125,991982.25,1742337.9375,Uncharacterized protein C18orf25 OS=Homo sapiens OX=9606 GN=C18orf25 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,147339,C18orf25,NA,NA,ENSG00000152242
Q9BYC8,0,6,1570675.953125,6.080001811226019e-6,1.099152619110152,0.1363917207241624,0.552392977856761,1,raw,1675273.75,1595113.5625,1206312.9375,1753273.25,1917271.84375,1276810.375,"39S ribosomal protein L32, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL32 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,64983,MRPL32,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000106591
Q15018,0,6,2645345.2760416665,1.023998873711128e-5,1.0991251290581676,0.13635563814842175,0.35890052786764043,0.8420882601494262,raw,2641391.09375,2060223.515625,2619673.875,3415304.84375,2264443.4375,2871034.890625,BRISC complex subunit Abraxas 2 OS=Homo sapiens OX=9606 GN=ABRAXAS2 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,23172,ABRAXAS2,NA,Metalloprotease DUBs,ENSG00000165660
Q9BUQ8,0,6,44847286.291666664,1.7360142385792606e-4,1.0987874104670998,0.13591228571139607,0.40710329379416793,0.8914071190930648,raw,41349709.25,46330908.75,41350983.75,50907819.25,39922105.875,49222190.875,Probable ATP-dependent RNA helicase DDX23 OS=Homo sapiens OX=9606 GN=DDX23 PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,structural molecule activity,9416,DDX23,NA,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000174243
Q9UNW1,0,6,3714214.046875,1.4377522039063095e-5,1.098689236458105,0.13578337862497622,0.9033674634915074,1,raw,3118172.8125,4953258,2846006.28125,3753541.5625,2172214.375,5442091.25,Multiple inositol polyphosphate phosphatase 1 OS=Homo sapiens OX=9606 GN=MINPP1 PE=1 SV=1,cellular homeostasis;metabolic process,extracellular,structural molecule activity,9562,MINPP1,NA,Synthesis of IPs in the ER lumen,ENSG00000107789
P07384,0,6,238056891.98274732,9.215053757907454e-4,1.0985694150528456,0.13562603188092087,0.6542410614801306,1,raw,230742202.849609,244128764.65625,218012677.953125,286760679.1875,195210700.4375,253486326.8125,Calpain-1 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endosome;mitochondrion;nucleus,structural molecule activity,823,CAPN1,Integrin-mediated cell adhesion; Alzheimer's disease and miRNA effects; Alzheimer's disease,Formation of the cornified envelope; Degradation of the extracellular matrix; Neutrophil degranulation; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,ENSG00000014216
Q969X1,0,6,763304.7760416666,2.954711576004796e-6,1.0984343831253065,0.13544869045563146,0.5420282564517139,1,raw,523840.09375,893980.6875,733986.6875,733994.6875,712047.375,981979.125,Protein lifeguard 3 OS=Homo sapiens OX=9606 GN=TMBIM1 PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,antioxidant activity,64114,TMBIM1,NA,Neutrophil degranulation,ENSG00000135926
Q9NV31,0,6,5129110.84375,1.9854511147212552e-5,1.0980714571984473,0.13497194103840493,0.7273139946918104,1,raw,5334049.125,5425924.3125,4322995.1875,4746957.625,6046742.1875,4897996.625,U3 small nucleolar ribonucleoprotein protein IMP3 OS=Homo sapiens OX=9606 GN=IMP3 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,55272,IMP3,IL-18 signaling pathway,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000177971
Q01433,0,6,13393689.541666666,5.184624906895199e-5,1.0979001239286261,0.13474681821683812,0.4459407918274739,0.9275095183793717,raw,13272306.875,13123909.90625,11599488.09375,16608019.625,11349670.4375,14408742.3125,AMP deaminase 2 OS=Homo sapiens OX=9606 GN=AMPD2 PE=1 SV=2,cellular homeostasis;metabolic process,cytosol,structural molecule activity,271,AMPD2,NA,Purine salvage,ENSG00000116337
P04264,0,6,820860.4947916666,3.177506655760223e-6,1.0973783459009467,0.13406101311511762,0.8460719936697438,1,raw,701422.625,1563736.3125,327889.875,769726,456891.15625,1105497,"CRAP Keratin, type II cytoskeletal 1 OS=Homo sapiens OX=9606 GN=KRT1 PE=1 SV=6",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,metal ion binding;structural molecule activity,3848,KRT1,Corticotropin-releasing hormone signaling pathway,Formation of the cornified envelope; Neutrophil degranulation,ENSG00000167768
Q12972,0,6,12633476.096354166,4.890350386729388e-5,1.096918584867182,0.1334564504747456,0.8437536736235883,1,raw,14065621.4375,11142124.9375,11955801,14473974.953125,8734492.6875,15428841.5625,Nuclear inhibitor of protein phosphatase 1 OS=Homo sapiens OX=9606 GN=PPP1R8 PE=1 SV=2,cell differentiation;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,5511,PPP1R8,NA,NA,ENSG00000117751
A0A669KAV7,0,6,322182.890625,1.2471525744369375e-6,1.0963161241142632,0.13266386119201357,1,1,raw,307380.0625,NA,NA,NA,NA,336985.71875,Protein Wiz OS=Homo sapiens OX=9606 GN=WIZ PE=1 SV=1,NA,membrane;nucleus,NA,NA,WIZ,NA,NA,ENSG00000011451
O15118,0,6,15752863.510416666,6.0978484126386364e-5,1.0962910381366169,0.13263084897152025,0.49249965357274317,0.9773523321302688,raw,13146253.8125,14476266.0625,15448149.25,23458899.75,12117411.4375,15870200.75,NPC intracellular cholesterol transporter 1 OS=Homo sapiens OX=9606 GN=NPC1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,catalytic activity;structural molecule activity,4864,NPC1,"Irinotecan pathway; Degradation pathway of sphingolipids, including diseases; Ebola virus infection in host",LDL clearance,ENSG00000141458
O60524,0,6,13448795.203125,5.205956010921391e-5,1.0959807346713015,0.13222243859181865,0.8283126826990969,1,raw,11689496.359375,13356662.84375,14466154.859375,16947899.5,9593912.5,14638645.15625,Nuclear export mediator factor NEMF OS=Homo sapiens OX=9606 GN=NEMF PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation,cytosol;membrane;nucleus,protein binding;RNA binding,9147,NEMF,NA,NA,ENSG00000165525
P27708,0,6,116382745.35677083,4.505113235844575e-4,1.0958873241922256,0.13209947239915337,0.680017266473706,1,raw,125481525.53125,109784531.765625,102365912.09375,133404816,89746073.5,137513613.25,CAD protein OS=Homo sapiens OX=9606 GN=CAD PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,790,CAD,Endothelin pathways; Amino acid metabolism; Pyrimidine metabolism,Pyrimidine biosynthesis,ENSG00000084774
G8JLA2,0,6,645036.01875,2.4968996020491747e-6,1.0957599302705874,0.13193175327481022,0.6540432677707881,1,raw,695752.0625,NA,485914.03125,518633.5625,546256.6875,978623.75,Myosin light polypeptide 6 OS=Homo sapiens OX=9606 GN=MYL6 PE=1 SV=1,NA,NA,structural molecule activity,NA,MYL6,Ciliary landscape,NA,ENSG00000092841
Q9Y697,0,6,4168694.3541666665,1.6136790770466397e-5,1.0956346571921367,0.13176680730819285,0.674472424333407,1,raw,4255893.8125,4474575.5625,3354127.625,4902500.0625,3293721,4731348.0625,"Cysteine desulfurase, mitochondrial OS=Homo sapiens OX=9606 GN=NFS1 PE=1 SV=3",cell growth;cell organization and biogenesis;cellular homeostasis,cytosol;endosome;membrane,structural molecule activity,9054,NFS1,NA,NA,ENSG00000244005
Q01130,0,6,93648121.36979167,3.625068216097748e-4,1.0956209406449406,0.13174874570493883,0.8374064655430373,1,raw,91069197.75,104582160.671875,79896885.875,114582405.25,67285447.265625,104472631.40625,Serine/arginine-rich splicing factor 2 OS=Homo sapiens OX=9606 GN=SRSF2 PE=1 SV=4,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,6427,SRSF2,mRNA processing,mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Minor Pathway,ENSG00000161547
F6TLX2,0,6,48322748.033854164,1.8705474861616475e-4,1.0954765944277416,0.13155866053648602,0.77760091931747,1,raw,49077373,51291269.90625,41433974.90625,57085416.875,37285340.078125,53763113.4375,Glyoxalase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=GLOD4 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P31948,0,6,584782753.9095054,0.002263662467022295,1.0950167737941754,0.13095296962948563,0.2787945746360863,0.7591598077731446,raw,517577439.033203,623572478.40625,489891069.117188,670454518.554688,524378694.814453,682822323.53125,Stress-induced-phosphoprotein 1 OS=Homo sapiens OX=9606 GN=STIP1 PE=1 SV=1,metabolic process,cytosol;extracellular;membrane;nucleus,structural molecule activity,10963,STIP1,VEGFA-VEGFR2 signaling pathway,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; RND1 GTPase cycle,ENSG00000168439
D6RER5,0,6,61098962.588541664,2.3651078534898804e-4,1.09498402026719,0.1309098158999665,0.7001849823699681,1,raw,59576833.125,60073135,59305264.46875,72235175.34375,50167687.34375,65235680.25,Septin-11 OS=Homo sapiens OX=9606 GN=SEPTIN11 PE=1 SV=1,NA,endoplasmic reticulum;nucleus,structural molecule activity,NA,SEPTIN11,22q11.2 copy number variation syndrome,NA,ENSG00000138758
O75976,0,6,5785093.192708333,2.2393783402488212e-5,1.0947969022413926,0.13066325767511283,0.6587343675252639,1,raw,5108707.15625,7302979.8125,4029530.40625,6979825.53125,4411517.40625,6877998.84375,Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cell surface;cytoplasm;cytoskeleton,structural molecule activity,1362,CPD,NA,Golgi Associated Vesicle Biogenesis; RND3 GTPase cycle; RND1 GTPase cycle,ENSG00000108582
Q5T2T1,0,6,18552214.481770832,7.181462059503715e-5,1.0946491434329413,0.1304685317982682,0.6315528036060845,1,raw,15076646,20046953.4375,18264267.078125,23200084.375,14732371.6875,19992964.3125,MAGUK p55 subfamily member 7 OS=Homo sapiens OX=9606 GN=MPP7 PE=1 SV=1,cell growth;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,143098,MPP7,NA,RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle,ENSG00000150054
H7C1N3,0.6666666666666666,6,2365840.2708333335,9.158039952874587e-6,1.0943896497958334,0.13012649109409305,0.4390798389393829,0.923035835434251,raw,2315654.25,1687715.5,2137365,3988266.25,1847018.375,2219022.25,BET1 homolog (Fragment) OS=Homo sapiens OX=9606 GN=BET1 PE=1 SV=1,conjugation,NA,NA,NA,BET1,NA,NA,ENSG00000105829
P50238,0,6,11283075.833333334,4.3676177359422315e-5,1.0942959563604442,0.13000297307551398,0.42512735337484664,0.9105262532056899,raw,8698409,12757369,10635122,11637971,11455111,12514473,Cysteine-rich protein 1 OS=Homo sapiens OX=9606 GN=CRIP1 PE=1 SV=3,coagulation;defense response;development;metabolic process,nucleus,structural molecule activity,1396,CRIP1,NA,NA,ENSG00000213145
Q86W92,0,6,18006204.3359375,6.970104480048226e-5,1.0942529064590305,0.12994621594265449,0.46746113221414076,0.9485672170384823,raw,18530925.21875,15937639.984375,15474094.4375,17439808.875,15378469.9375,25276287.5625,Liprin-beta-1 OS=Homo sapiens OX=9606 GN=PPFIBP1 PE=1 SV=2,cell communication;cell growth,cytoplasm;cytoskeleton;cytosol;nucleus,NA,8496,PPFIBP1,NA,Signaling by ALK fusions and activated point mutants; Receptor-type tyrosine-protein phosphatases,ENSG00000110841
Q9Y5P6,0,6,12040518.90625,4.660819859911301e-5,1.0941690267782502,0.12983562227905204,0.34370824817348683,0.8250635218999488,raw,10224622.5,11573164.375,11125036.5625,16571205.625,11187465.25,11561619.125,Mannose-1-phosphate guanyltransferase beta OS=Homo sapiens OX=9606 GN=GMPPB PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,nucleus,structural molecule activity,29925,GMPPB,NA,Synthesis of GDP-mannose,ENSG00000173540
B7ZLQ5,0,6,4417753.15625,1.710088394624569e-5,1.0941585268647132,0.129821777758231,0.9979047261303755,1,raw,3114204.8125,5541585.53125,4602650.9375,6424669.96875,3407433.75,3415973.9375,Probable global transcription activator SNF2L1 OS=Homo sapiens OX=9606 GN=SMARCA1 PE=1 SV=1,cell growth;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6594,SMARCA1,Nuclear receptors meta-pathway; Rett syndrome causing genes,NA,ENSG00000102038
Q8N205,0,6,536775.265625,2.077828071874478e-6,1.093412487349031,0.12883775708478515,1,1,raw,NA,519630.40625,NA,591617.8125,467682.46875,568170.375,Nesprin-4 OS=Homo sapiens OX=9606 GN=SYNE4 PE=1 SV=2,metabolic process,cytoskeleton;membrane,NA,163183,SYNE4,Envelope proteins and their potential roles in EDMD physiopathology,NA,ENSG00000181392
H7C2Q8,0,6,46093634.677083336,1.7842597116552014e-4,1.0933332552445951,0.1287332110811302,0.5301517104060709,1,raw,44522292.625,47990274.75,41448349.25,52469363.3125,40507206.75,49624321.375,"EBNA1 binding protein 2, isoform CRA_d OS=Homo sapiens OX=9606 GN=EBNA1BP2 PE=1 SV=1",metabolic process,membrane;nucleus,NA,10969,EBNA1BP2,NA,NA,ENSG00000117395
Q9HD23,0,6,404215.09375,1.564694803683232e-6,1.0929172120499258,0.12818412169730184,0.8341469370340382,1,raw,267373.75,538252.125,381516.875,367035.0625,466897.65625,NA,"Magnesium transporter MRS2 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=MRS2 PE=1 SV=1",conjugation,cytoskeleton;endosome,catalytic activity,57380,MRS2,NA,Miscellaneous transport and binding events,ENSG00000124532
P49458,0,6,54846611.619791664,2.1230827232344136e-4,1.092872965381363,0.12812571311812596,0.30478154783951833,0.7849075999456834,raw,48399818,58147694.4375,47962511,61821113.03125,49200490,63548043.25,Signal recognition particle 9 kDa protein OS=Homo sapiens OX=9606 GN=SRP9 PE=1 SV=2,conjugation;metabolic process,cytoskeleton;cytosol;extracellular;Golgi,RNA binding;structural molecule activity,6726,SRP9,NA,SRP-dependent cotranslational protein targeting to membrane,ENSG00000143742
Q9BVS5,0.5,6,32829407,1.2708086198451592e-4,1.0927328611872444,0.12794075055636644,0.6093589549273852,1,raw,23911862,35318772,33011534,23183278,36072788,45478208,"tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=TRMT61B PE=1 SV=2",cell growth;cellular component movement;cellular homeostasis,endosome;nucleus,structural molecule activity,55006,TRMT61B,NA,tRNA modification in the mitochondrion,ENSG00000171103
P13639,0,6,2006642024.8098967,0.007767602936208871,1.092709912385301,0.12791045177832502,0.4709832936747758,0.9518152783945985,raw,1924159383.35938,2147817212.32422,1627577021.49609,2346941157.89844,1677376981.15625,2315980392.625,Elongation factor 2 OS=Homo sapiens OX=9606 GN=EEF2 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;nucleus,protein binding;RNA binding;structural molecule activity,1938,EEF2,Translation factors; AMP-activated protein kinase signaling; Brain-derived neurotrophic factor (BDNF) signaling pathway; IL-18 signaling pathway,Neutrophil degranulation; Protein methylation; Uptake and function of diphtheria toxin; Peptide chain elongation; Synthesis of diphthamide-EEF2,ENSG00000167658
Q9Y3C4,0.16666666666666666,6,707224.90625,2.737629427883619e-6,1.0926262943534597,0.12780004742081405,0.5985610401047496,1,raw,668484.75,837513.9375,503148.75,704430.125,614682.125,915089.75,EKC/KEOPS complex subunit TPRKB OS=Homo sapiens OX=9606 GN=TPRKB PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,51002,TPRKB,NA,tRNA modification in the nucleus and cytosol,ENSG00000144034
Q96DI7,0,6,24732933.986979168,9.573985209271197e-5,1.0924412169694235,0.12755565202031993,0.28464139131215643,0.7650076250313386,raw,24470850.15625,22250664.65625,22820724.859375,24930300.4375,23411806.90625,30513256.90625,U5 small nuclear ribonucleoprotein 40 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP40 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,NA,9410,SNRNP40,mRNA processing,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000060688
Q8NFF5,0,6,1124152.1692708333,4.351532352463782e-6,1.0924289104639842,0.12753939976427478,0.6721808982507333,1,raw,1323555.375,970951.71875,892887.859375,1384946.53125,726681.375,1445890.15625,FAD synthase OS=Homo sapiens OX=9606 GN=FLAD1 PE=1 SV=1,cellular homeostasis,cytoplasm;cytoskeleton;cytosol;endosome,structural molecule activity,80308,FLAD1,Selenium micronutrient network; Folate metabolism,Vitamin B2 (riboflavin) metabolism,ENSG00000160688
Q9NR28,0,6,18955689.979166668,7.337645246116541e-5,1.0920912387067832,0.12709339117641438,0.4310962582716442,0.9162373203757352,raw,20479719.5,18176461.90625,15715503.875,21053091.3125,17162764.09375,21146599.1875,"Diablo homolog, mitochondrial OS=Homo sapiens OX=9606 GN=DIABLO PE=1 SV=1",coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome,NA,56616,DIABLO,Apoptosis modulation and signaling; TNF-alpha signaling pathway; Nanomaterial induced apoptosis; Apoptosis; Complement system in neuronal development and plasticity,SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Regulation of the apoptosome activity; Release of apoptotic factors from the mitochondria,ENSG00000184047
Q7Z5K2,0,6,2731218.2838541665,1.0572398513931664e-5,1.0920787027653085,0.12707683061466032,0.8584173272446873,1,raw,2550496.46875,3635303.515625,1756833.34375,4020159.53125,1639173.96875,2785342.875,Wings apart-like protein homolog OS=Homo sapiens OX=9606 GN=WAPL PE=1 SV=1,cell differentiation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,NA,23063,WAPL,Cohesin complex - Cornelia de Lange syndrome,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,ENSG00000062650
O75531,0,6,47847209.5625,1.8521396486863967e-4,1.091940351888319,0.1268940500441548,0.4616478581599185,0.9440364171936885,raw,50596706.5,40552267.875,45514509.5,55248585.5,40753949,54417239,Barrier-to-autointegration factor OS=Homo sapiens OX=9606 GN=BANF1 PE=1 SV=1,cell differentiation;cell growth;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,8815,BANF1,Envelope proteins and their potential roles in EDMD physiopathology; Familial partial lipodystrophy; Progeria-associated lipodystrophy,Vpr-mediated nuclear import of PICs; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection; Nuclear Envelope Breakdown; Initiation of Nuclear Envelope (NE) Reformation,ENSG00000175334
P14618,0,6,2633423260.65625,0.010193839259243118,1.0918226446614705,0.12673852434573057,0.710543569513012,1,raw,2628072509.78906,2634139268.38281,2468749010.29297,2869389078,2175072386.56641,3025117310.90625,Pyruvate kinase PKM OS=Homo sapiens OX=9606 GN=PKM PE=1 SV=4,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cell surface;cytosol;extracellular;membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,5315,PKM,Photodynamic therapy-induced HIF-1 survival signaling; Amino acid metabolism; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Glycolysis in senescence; Glucose metabolism in triple-negative breast cancer cells; Glycolysis and gluconeogenesis,Neutrophil degranulation,ENSG00000067225
Q9Y4Y9,0,6,4998571.458333333,1.9349200234296002e-5,1.0914505782692177,0.12624680545453248,0.6485604524551147,1,raw,6741280.5,3653627.25,3417328.75,5581004,3240413.75,7357774.5,U6 snRNA-associated Sm-like protein LSm5 OS=Homo sapiens OX=9606 GN=LSM5 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,23658,LSM5,NA,mRNA Splicing - Major Pathway; mRNA decay by 5' to 3' exoribonuclease,ENSG00000106355
Q5VTL8,0,6,4738101.744791667,1.8340936036354967e-5,1.0913989004001141,0.12617849528819086,0.4384771375247247,0.9223184869519775,raw,4512578.90625,4771025.25,3870995.625,4925023.65625,3928968.96875,6420018.0625,Pre-mRNA-splicing factor 38B OS=Homo sapiens OX=9606 GN=PRPF38B PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,NA,55119,PRPF38B,NA,NA,ENSG00000134186
A0A0G2JMG9,0.8333333333333334,6,661183.984375,2.559407505128914e-6,1.091204290942635,0.12592122259558877,0.8641765225184135,1,raw,629022.625,743711.5625,546517.125,686392.1875,305000.40625,1056460,Putative zinc finger protein 66 OS=Homo sapiens OX=9606 GN=ZNF66 PE=1 SV=1,metabolic process,NA,structural molecule activity,NA,ZNF66,NA,NA,ENSG00000275050
P63096,0,6,15174129.729166666,5.873823690593526e-5,1.090443676616108,0.12491525410049914,0.4318198568744607,0.9162373203757352,raw,13443067.96875,16827698.6875,13305337.65625,15347653.59375,14508721.3125,17612299.15625,Guanine nucleotide-binding protein G(i) subunit alpha-1 OS=Homo sapiens OX=9606 GN=GNAI1 PE=1 SV=2,cell differentiation;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,antioxidant activity;structural molecule activity,2770,GNAI1,Nicotine effect on dopaminergic neurons; Thyroid stimulating hormone (TSH) signaling pathway; Endothelin pathways; Corticotropin-releasing hormone signaling pathway; S1P receptor signal transduction; Common pathways underlying drug addiction; G protein signaling pathways; Cell-type dependent selectivity of CCK2R signaling; Chemokine signaling pathway; Purinergic signaling; Prostaglandin and leukotriene metabolism in senescence ; Calcium regulation in cardiac cells; Serotonin HTR1 group and FOS pathway,"G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Adrenaline,noradrenaline inhibits insulin secretion",ENSG00000127955
Q9H9Y6,0,6,3555142.671875,1.3761765334957468e-5,1.09029088176573,0.12471308701654357,0.5828427461588026,1,raw,2872048.875,4117234.40625,3095796.0625,3099581.75,3375318.21875,4770876.71875,DNA-directed RNA polymerase I subunit RPA2 OS=Homo sapiens OX=9606 GN=POLR1B PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;defense response,cytosol;membrane;nucleus,RNA binding;structural molecule activity,84172,POLR1B,Pyrimidine metabolism; Eukaryotic transcription initiation; 2q13 copy number variation syndrome,B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination,ENSG00000125630
O43324,0,6,21092984.1328125,8.164980273397962e-5,1.0900038874513736,0.12433328032038261,0.49287703168239294,0.9773523321302688,raw,18081007.9375,22948639.140625,18689833.90625,24868464.25,16955853.6875,25014105.875,Eukaryotic translation elongation factor 1 epsilon-1 OS=Homo sapiens OX=9606 GN=EEF1E1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,NA,9521,EEF1E1,NA,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,ENSG00000124802
Q9HCS7,0,6,6748932.5703125,2.6124753593955785e-5,1.0898987068061055,0.12419405979204957,0.8177574076190018,1,raw,6561538.34375,7518914.296875,5732665.625,8194854.96875,4868734.8125,7616887.375,Pre-mRNA-splicing factor SYF1 OS=Homo sapiens OX=9606 GN=XAB2 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response,membrane;nucleus,NA,56949,XAB2,Rett syndrome causing genes; Nucleotide excision repair in xeroderma pigmentosum,mRNA Splicing - Major Pathway; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER,ENSG00000076924
O43172,0,6,21893716.354166668,8.474939393002114e-5,1.0898580753262037,0.12414027504409465,0.8167464126005252,1,raw,21800153.59375,24496636.25,17959884.09375,27201921.5625,16144629.1875,23759073.4375,U4/U6 small nuclear ribonucleoprotein Prp4 OS=Homo sapiens OX=9606 GN=PRPF4 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,RNA binding,9128,PRPF4,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000136875
Q04917,0,6,106832021.66666667,4.13540987838997e-4,1.089811506619432,0.12407862859741593,0.661602244625351,1,raw,100174620.75,115574018.75,92856939.625,125953895.5,81171346.375,125261309,14-3-3 protein eta OS=Homo sapiens OX=9606 GN=YWHAH PE=1 SV=4,cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,antioxidant activity;motor activity;structural molecule activity,7533,YWHAH,Cell cycle; Myometrial relaxation and contraction pathways; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,Translocation of SLC2A4 (GLUT4) to the plasma membrane; TP53 Regulates Metabolic Genes; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Activation of BAD and translocation to mitochondria,ENSG00000128245
F8W7C6,0,6,16490901.833333334,6.383539062652073e-5,1.089519262334922,0.12369170304345752,0.43268406321845043,0.9168514603569733,raw,15807113,17129524,13640662,16381206,14861764,21125142,60S ribosomal protein L10 OS=Homo sapiens OX=9606 GN=RPL10 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;Golgi;nucleus,structural molecule activity,NA,RPL10,NA,NA,ENSG00000147403
A8MUH2,0,6,29755687.796875,1.1518266090426234e-4,1.089454362935756,0.12360576346137622,0.20235810243076957,0.6923632419251884,raw,26849664.0625,28340888.5625,27631652.5,29927758.4375,29251483.65625,36532679.5625,"ATP synthase-coupling factor 6, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PF PE=1 SV=1",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,NA,ATP5PF,NA,NA,ENSG00000154723
Q6UVK1,0,6,205053.9765625,7.937528720794508e-7,1.0893676203459135,0.1234908911999193,0.6018122235667533,1,raw,175267.046875,219104.515625,NA,NA,219836.15625,206008.1875,Chondroitin sulfate proteoglycan 4 OS=Homo sapiens OX=9606 GN=CSPG4 PE=1 SV=2,cell growth;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,1464,CSPG4,Spinal cord injury,"A tetrasaccharide linker sequence is required for GAG synthesis; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective B3GALT6 causes EDSP2 and SEMDJL1; Chondroitin sulfate biosynthesis; Dermatan sulfate biosynthesis; CS/DS degradation; Defective CHST3 causes SEDCJD; Defective CHST14 causes EDS, musculocontractural type; Defective CHSY1 causes TPBS",ENSG00000173546
O75822,0,6,29630408.940104168,1.1469771321370942e-4,1.0892272719220053,0.12330500994575161,0.7653328132030781,1,raw,26395554.8125,34238345.9375,25948326.9375,37293340.140625,23633374.875,30273510.9375,Eukaryotic translation initiation factor 3 subunit J OS=Homo sapiens OX=9606 GN=EIF3J PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,8669,EIF3J,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit",ENSG00000104131
A0A0B4J2C3,0,6,113476440.79166667,4.392611755289971e-4,1.0890976441207538,0.12313330609673413,0.40527405048645343,0.8912744470641923,raw,99897384.09375,128055733.546875,85534897.171875,135701400.6875,93155855,138513374.25,Translationally-controlled tumor protein OS=Homo sapiens OX=9606 GN=TPT1 PE=1 SV=1,NA,cytosol,NA,7178,TPT1,NA,NA,ENSG00000133112
E7EUU4,0,6,189266497.18196616,7.326403917888073e-4,1.088678699655707,0.12257823614080035,0.3207421920874588,0.8027088205665207,raw,166025554.53125,206932934.34375,156951789.390625,225200953.4375,170870069.982422,209617681.40625,Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,RNA binding;structural molecule activity,NA,EIF4G1,Acute viral myocarditis; Fragile X syndrome; Malignant pleural mesothelioma,NA,ENSG00000114867
O95602,0,6,8527751.815104166,3.3010466849232386e-5,1.0884801810629832,0.12231513931991415,0.5637947774994877,1,raw,8013703.15625,9390385.6875,7628867.328125,8722757.0625,8638061.71875,8772735.9375,DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens OX=9606 GN=POLR1A PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,25885,POLR1A,Pyrimidine metabolism; Eukaryotic transcription initiation; 2q13 copy number variation syndrome,B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination,ENSG00000068654
P49207,0,6,143721297.50520834,5.563373828986596e-4,1.0884683041763838,0.12229939735310659,0.6635557114970438,1,raw,106746195,178758756,123265598,194573240,115199867.03125,143784129,60S ribosomal protein L34 OS=Homo sapiens OX=9606 GN=RPL34 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;Golgi;nucleus,RNA binding;structural molecule activity,6164,RPL34,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000109475
Q8WXX5,0,6,22947714.518229168,8.882936391605103e-5,1.08814622959219,0.12187244494458839,0.4848758177649309,0.96704014350865,raw,21786183.40625,24567588.859375,19656239.53125,26733129.1875,20098428.1875,24844717.9375,DnaJ homolog subfamily C member 9 OS=Homo sapiens OX=9606 GN=DNAJC9 PE=1 SV=1,cell growth;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,23234,DNAJC9,NA,NA,ENSG00000213551
P50991,0,6,394853113.1458333,0.0015284550822328925,1.0878898351022823,0.12153246982486099,0.5409386518959794,1,raw,379061469.828125,428612876.953125,326564536.65625,435372386.78125,333223816.625,466283592.03125,T-complex protein 1 subunit delta OS=Homo sapiens OX=9606 GN=CCT4 PE=1 SV=4,conjugation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,10575,CCT4,16p11.2 proximal deletion syndrome,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,ENSG00000115484
A0A0J9YVP6,0.16666666666666666,6,84832432.75,3.2838176693576824e-4,1.0875066762756027,0.1210242577890794,0.38816959950557356,0.872979446768193,raw,84816188.5,89905190.1875,66770923.625,92238171.25,78534873.0625,96729249.875,60 kDa poly(U)-binding-splicing factor (Fragment) OS=Homo sapiens OX=9606 GN=PUF60 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding,NA,PUF60,NA,NA,ENSG00000274081
A0A1B0GW23,0,6,1701990.90625,6.588314904867379e-6,1.087432551897404,0.12092592044567917,0.47619954227434597,0.9576932071680475,raw,2327746.03125,503124.875,1555959.03125,1692000.5,1681077.875,2452037.125,N-acyl-L-amino-acid amidohydrolase (Fragment) OS=Homo sapiens OX=9606 GN=ABHD14A-ACY1 PE=3 SV=1,cellular homeostasis,nucleus,structural molecule activity,NA,ABHD14A-ACY1,NA,NA,ENSG00000114786
P11413,0,6,153836260.56510416,5.954918587803926e-4,1.0870580838369208,0.12042902870442006,0.3920505333005441,0.8763519738235003,raw,165839185.1875,131582848.765625,135971523.625,180276826.875,131356952.75,177990226.1875,Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens OX=9606 GN=G6PD PE=1 SV=4,cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,2539,G6PD,Glutathione metabolism; Pentose phosphate metabolism; Cori cycle; Vitamin D receptor pathway; Nuclear receptors meta-pathway; NRF2 pathway; ATM signaling in development and disease ; Metabolic reprogramming in colon cancer; Vitamin D-sensitive calcium signaling in depression; Pentose phosphate pathway in senescent cells; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Glycolysis in senescence; Sulfation biotransformation reaction,TP53 Regulates Metabolic Genes; Nuclear events mediated by NFE2L2; Pentose phosphate pathway,ENSG00000160211
Q8TEX9,0,6,16514793.545572916,6.392787415464819e-5,1.086968102255401,0.12030960421695562,0.7217898457854698,1,raw,17087088.9375,16202984.5859375,14453905.1640625,21834260.8125,11898394.3671875,17612127.40625,Importin-4 OS=Homo sapiens OX=9606 GN=IPO4 PE=1 SV=2,cell growth;conjugation,membrane;nucleus,structural molecule activity,79711,IPO4,NA,NA,ENSG00000196497; ENSG00000285248
O00541,0,6,27230228.729166668,1.054067452067602e-4,1.0868661257975798,0.12017424805391856,0.5286869083620072,1,raw,25327557.75,29650655.40625,23214415.28125,32226292.96875,23046116.40625,29916334.5625,Pescadillo homolog OS=Homo sapiens OX=9606 GN=PES1 PE=1 SV=1,cell differentiation;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,23481,PES1,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000100029
Q15599,0,6,1999367.5052083333,7.739443663594232e-6,1.0866916947750875,0.11994269150705779,0.4063265109016387,0.8914071190930648,raw,1987115.8125,2086977.1875,1694113.59375,2159382.25,1847052.9375,2221563.25,Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens OX=9606 GN=SLC9A3R2 PE=1 SV=2,cell growth;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,antioxidant activity;structural molecule activity,9351,SLC9A3R2,NA,NA,ENSG00000065054
A0A087WYN9,0,6,5003161.670572917,1.936696869804249e-5,1.0865630087731981,0.11977183748182867,0.31044613319582715,0.791258249420452,raw,5540137.3125,4033340.734375,4212841.1015625,5835245.625,4382478.84375,6014926.40625,ATP-dependent RNA helicase DHX29 OS=Homo sapiens OX=9606 GN=DHX29 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q96DB5,0,6,19221764.794270832,7.440641370462643e-5,1.0864902648952046,0.1196752478276797,0.8008437645418435,1,raw,20387030.5,18546144.890625,17676754.5625,23367331.4375,15203121.5,20150205.875,Regulator of microtubule dynamics protein 1 OS=Homo sapiens OX=9606 GN=RMDN1 PE=1 SV=1,cell differentiation;cell growth,endoplasmic reticulum;nucleus,motor activity,51115,RMDN1,NA,NA,ENSG00000176623
A0A0U1RRH7,0,6,1904423917.34375,0.007371922161127439,1.0864724113424862,0.11965154081029611,0.28320190850030297,0.7643417997205958,raw,1999098576.6875,1767445641.9375,1612288390.25,2137245788.75,1738499655.3125,2171965451.125,Histone H2A OS=Homo sapiens OX=9606 PE=3 SV=1,NA,membrane;nucleus,RNA binding;structural molecule activity,NA,NA,NA,NA,NA
Q9H4A4,0,6,75333505.37239583,2.9161193191942894e-4,1.0862457622663502,0.11935054871355635,0.7719106266819948,1,raw,84992664.84375,68308033,64916418.53125,105477461.15625,54107143.328125,74199311.375,Aminopeptidase B OS=Homo sapiens OX=9606 GN=RNPEP PE=1 SV=2,cell organization and biogenesis,cell surface;cytoplasm;cytoskeleton,structural molecule activity,6051,RNPEP,NA,NA,ENSG00000176393
A0A2R8YE63,0,6,5741406.4453125,2.2224674362036694e-5,1.0860854514874376,0.11913761657439295,0.9155038885827789,1,raw,6270091.234375,6373365.140625,4808906.359375,6818407.90625,3255648.875,6922019.15625,Epidermal growth factor receptor kinase substrate 8 OS=Homo sapiens OX=9606 GN=EPS8 PE=1 SV=1,cell growth,nucleus,motor activity;structural molecule activity,NA,EPS8,NA,NA,ENSG00000151491
Q3BDU5,0,6,25612044.21875,9.914284033532156e-5,1.0860575959809495,0.11910061440630751,0.9693989896470641,1,raw,50631118.0625,8749795.1875,18439031.8125,44263420.5,11563049.1875,20025850.5625,Prelamin-A/C OS=Homo sapiens OX=9606 GN=LMNA PE=1 SV=1,NA,endoplasmic reticulum;membrane,NA,NA,LMNA,Lamin A-processing pathway; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome,NA,ENSG00000160789
Q58FF6,0.16666666666666666,6,2763179.9166666665,1.0696120268888892e-5,1.0858887475403751,0.11887630241158821,0.2805173800089163,0.7620524127696975,raw,2720816.25,2915079.5,2149983,2956144.25,2882552.75,2954503.75,Putative heat shock protein HSP 90-beta 4 OS=Homo sapiens OX=9606 GN=HSP90AB4P PE=5 SV=1,coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,NA,HSP90AB4P,NA,NA,NA
Q96KG9,0,6,7002718.958333333,2.710714699964917e-5,1.0857536522286626,0.11869680569838428,0.8192445554342918,1,raw,5177214.59375,9045305.34375,6051579.875,7645273,4275967.625,9820973.3125,N-terminal kinase-like protein OS=Homo sapiens OX=9606 GN=SCYL1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,57410,SCYL1,NA,NA,ENSG00000142186
Q08623,0,6,3167273.3196614585,1.2260344014228994e-5,1.0857185661218902,0.11865018428474494,0.6569847823022692,1,raw,4332951.84375,2262410.75,2297435.5625,4127294.15625,2456341.35546875,3527206.25,Pseudouridine-5'-phosphatase OS=Homo sapiens OX=9606 GN=PUDP PE=1 SV=3,cellular homeostasis,cytosol,structural molecule activity,8226,PUDP,NA,Pyrimidine salvage,ENSG00000130021
Q8N4T8,0,6,1235463.828125,4.782413773992775e-6,1.085119853032645,0.1178543991917149,0.553585563051163,1,raw,1457520.84375,844142.15625,1207070.78125,1309816.46875,1151633.3125,1442599.40625,Carbonyl reductase family member 4 OS=Homo sapiens OX=9606 GN=CBR4 PE=1 SV=3,cell growth;cellular homeostasis,endosome;nucleus,structural molecule activity,84869,CBR4,NA,Fatty acyl-CoA biosynthesis,ENSG00000145439
Q8IY85,0.6666666666666666,6,5300708.583333333,2.051875673230169e-5,1.0850502724311801,0.11776188700796318,0.6255341381557353,1,raw,3521164.5,5733699,5642473.5,3820640.5,5702605.5,7383668.5,EF-hand calcium-binding domain-containing protein 13 OS=Homo sapiens OX=9606 GN=EFCAB13 PE=2 SV=2,NA,NA,NA,124989,EFCAB13,NA,NA,ENSG00000178852
O60313,0,6,15680455.635416666,6.069819715167899e-5,1.0850433133723827,0.1177526341354769,0.44815555490903425,0.9287898029210243,raw,16242872.875,15369001.21875,13092708.875,15740581.125,14206156.21875,19431413.5,"Dynamin-like 120 kDa protein, mitochondrial OS=Homo sapiens OX=9606 GN=OPA1 PE=1 SV=3",cell growth;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,motor activity;structural molecule activity,4976,OPA1,NA,Regulation of Apoptosis,ENSG00000198836
O43290,0,6,15139609.177083334,5.8604609712640805e-5,1.0850274004357956,0.1177314758252389,0.5969098647446873,1,raw,13719767.53125,17378629.84375,12479425.625,14075751.5625,14327790.9375,18856289.5625,U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens OX=9606 GN=SART1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;extracellular;membrane;nucleus,NA,9092,SART1,NA,mRNA Splicing - Major Pathway,ENSG00000175467
P07093,0,6,2481500.3697916665,9.605753951267533e-6,1.0849117620419586,0.11757771028160731,0.8111302762395427,1,raw,2482599.03125,1669916.25,3080043.625,2843316.71875,1811711.78125,3001414.8125,Glia-derived nexin OS=Homo sapiens OX=9606 GN=SERPINE2 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cell surface;chromosome;cytoplasm;cytoskeleton;cytosol;nucleus,antioxidant activity;DNA binding;structural molecule activity,5270,SERPINE2,NA,Intrinsic Pathway of Fibrin Clot Formation; Common Pathway of Fibrin Clot Formation; Dissolution of Fibrin Clot,ENSG00000135919
P15531,0,6,1282140.2,4.963095489388512e-6,1.0847950122680576,0.11742245029718111,0.8098995239050026,1,raw,1734245.25,NA,588341.125,1358074.125,530147.25,2199893.25,Nucleoside diphosphate kinase A OS=Homo sapiens OX=9606 GN=NME1 PE=1 SV=1,cell proliferation;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,protein binding;signal transducer activity;structural molecule activity,4830,NME1,Pyrimidine metabolism,Interconversion of nucleotide di- and triphosphates; Azathioprine ADME; Ribavirin ADME,ENSG00000239672
P18124,0,6,371806505.3333333,0.001439242907714127,1.0846043517293602,0.11716886396453524,0.4592115440709628,0.9417841405292566,raw,319950768.625,414397922.53125,322589278.15625,399004302.5,325438970.0625,449457790.125,60S ribosomal protein L7 OS=Homo sapiens OX=9606 GN=RPL7 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,6129,RPL7,VEGFA-VEGFR2 signaling pathway; Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000147604
Q6PJT7,0,6,6329405.005208333,2.4500785040405528e-5,1.0842995775131736,0.11676340916568592,0.4916914189721637,0.9765999326713443,raw,5746378.21875,6668390.875,4887815.125,5878885.6875,5299855.875,9495104.25,Zinc finger CCCH domain-containing protein 14 OS=Homo sapiens OX=9606 GN=ZC3H14 PE=1 SV=1,metabolic process,membrane;nucleus,RNA binding;structural molecule activity,79882,ZC3H14,NA,NA,ENSG00000100722
C9JIF9,0,6,72682712.01302083,2.813508539458851e-4,1.0840840094375581,0.1164765604765881,0.5027540198008457,0.98745256394626,raw,75944763.59375,63909334.421875,69999768.8125,82330503.8125,62767205.65625,81144695.78125,Acyl-peptide hydrolase OS=Homo sapiens OX=9606 GN=APEH PE=1 SV=1,cell organization and biogenesis,cytoskeleton;cytosol;membrane,structural molecule activity,NA,APEH,NA,NA,ENSG00000164062
Q9P013,0,6,3227332.4166666665,1.2492829536048912e-5,1.0840056024287175,0.11637221294200692,0.9726686721036991,1,raw,3029577.6875,3416270.375,3197140.1875,3465717.875,1988360.25,4266928.125,Spliceosome-associated protein CWC15 homolog OS=Homo sapiens OX=9606 GN=CWC15 PE=1 SV=2,cellular component movement;cellular homeostasis,endosome;membrane;nucleus,RNA binding,51503,CWC15,NA,mRNA Splicing - Major Pathway,ENSG00000150316
F8W8D3,0.16666666666666666,6,781398.734375,3.0247523117912183e-6,1.0839976012375443,0.11636156417653713,0.7330175694736771,1,raw,998390.3125,471428.34375,1015054.65625,517072.9375,586129.34375,1100316.8125,Histone RNA hairpin-binding protein OS=Homo sapiens OX=9606 GN=SLBP PE=1 SV=1,NA,cytosol;membrane,RNA binding,NA,SLBP,NA,NA,ENSG00000163950
Q9NY93,0,6,12866555.614583334,4.9805742098020934e-5,1.0836079358455646,0.11584286432543099,0.6754858323856022,1,raw,11052962.4375,14477042.6875,11806100.40625,13733804.625,10441985.1875,15687438.34375,Probable ATP-dependent RNA helicase DDX56 OS=Homo sapiens OX=9606 GN=DDX56 PE=1 SV=1,cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,54606,DDX56,NA,NA,ENSG00000136271
Q9UKR5,0,6,5007353.791666667,1.9383196172457036e-5,1.0835047240899487,0.11570544360812918,0.5380341286026985,1,raw,4760959.125,4845166,4878602.125,5994728.75,4314906.5,5249760.25,Ergosterol biosynthetic protein 28 homolog OS=Homo sapiens OX=9606 GN=ERG28 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,11161,ERG28,NA,NA,ENSG00000133935
Q96B26,0,6,10558531.583333334,4.087150568698167e-5,1.083123083474582,0.11519719661991694,0.6164440926081016,1,raw,10408647.5,11094189.1875,8931332.21875,13117630.6875,8525543.53125,11273846.375,Exosome complex component RRP43 OS=Homo sapiens OX=9606 GN=EXOSC8 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,11340,EXOSC8,NA,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000120699
Q9H583,0,6,93149535.89583333,3.605768241595137e-4,1.082621948291343,0.11452954161346623,0.6628968946697467,1,raw,92083494.09375,99163788.625,76105554.875,122057597.21875,69795168.78125,99691611.78125,HEAT repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=HEATR1 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,endosome;membrane;nucleus,RNA binding,55127,HEATR1,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000119285
O15144,0,6,67066262.151041664,2.5960987977132486e-4,1.0824477962420749,0.11429744904553293,0.7760431010854935,1,raw,70058322,65833909.234375,61611322.265625,79309914.0625,54322335.375,71261769.96875,Actin-related protein 2/3 complex subunit 2 OS=Homo sapiens OX=9606 GN=ARPC2 PE=1 SV=1,cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,motor activity,10109,ARPC2,Pathogenic Escherichia coli infection,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,ENSG00000163466
Q9NPD8,0,6,7143018.822916667,2.765024020043592e-5,1.0824317101739425,0.11427600924654764,0.9429414615693921,1,raw,6205197.75,10018570.5625,5390574.125,8415064.9375,6716702.8125,6112002.75,Ubiquitin-conjugating enzyme E2 T OS=Homo sapiens OX=9606 GN=UBE2T PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation,membrane,structural molecule activity,29089,UBE2T,Gastric cancer network 2,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Fanconi Anemia Pathway,ENSG00000077152
P23921,0,6,60927006.6953125,2.3584515337047318e-4,1.0820727936703958,0.11379755603604498,0.8448188662381737,1,raw,53580221.15625,81624487.421875,43187099.6875,70678987.84375,46731585.609375,69759658.453125,Ribonucleoside-diphosphate reductase large subunit OS=Homo sapiens OX=9606 GN=RRM1 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endosome,structural molecule activity,6240,RRM1,Fluoropyrimidine activity; Retinoblastoma gene in cancer; Pyrimidine metabolism,Interconversion of nucleotide di- and triphosphates,ENSG00000167325
Q9H3K2,0,6,9581096.328125,3.708790658737167e-5,1.0818195848116208,0.11345992079118365,0.14494709401518663,0.6572502130392559,raw,8725256.25,9588418.25,9204642.375,9860614.125,9439153.09375,10668493.875,Growth hormone-inducible transmembrane protein OS=Homo sapiens OX=9606 GN=GHITM PE=1 SV=2,cell growth;metabolic process,cytoskeleton;endosome,NA,27069,GHITM,NA,NA,ENSG00000165678
Q641Q2,0,6,4719711.903645833,1.8269749954176543e-5,1.0817769681010372,0.1134030867969317,0.7255025193039075,1,raw,5191767.984375,4248706.578125,4255230.4375,6250304.5,3769051.640625,4603210.28125,WASH complex subunit 2A OS=Homo sapiens OX=9606 GN=WASHC2A PE=1 SV=3,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,387680,WASHC2A,NA,NA,ENSG00000099290
P0C0S5,0,6,171969577.41666666,6.656849492658501e-4,1.0816371031379777,0.11321654600331874,0.6509390998575963,1,raw,172948175,137192453.5,186064200,212031712,136513761,187067163,Histone H2A.Z OS=Homo sapiens OX=9606 GN=H2AZ1 PE=1 SV=2,metabolic process,membrane;nucleus,RNA binding;structural molecule activity,3015,H2AZ1,Proteasome degradation; Retinoblastoma gene in cancer; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,Amyloid fiber formation; Meiotic synapsis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Transcriptional regulation by small RNAs; Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RMTs methylate histone arginines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; RNA Polymerase I Promoter Escape; Meiotic recombination; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Packaging Of Telomere Ends; Condensation of Prophase Chromosomes; DNA Damage/Telomere Stress Induced Senescence; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis,ENSG00000164032
J3KPD3,0,6,371775.1145833333,1.439121395815714e-6,1.0816170190795091,0.11318975749867036,0.764108637345743,1,raw,486963.3125,263889.125,324042.71875,424626.9375,285426.96875,445701.625,"RNA binding motif protein 7, isoform CRA_c OS=Homo sapiens OX=9606 GN=RBM7 PE=1 SV=1",NA,membrane,RNA binding,10179,RBM7,NA,NA,ENSG00000076053
Q5SRE5,0,6,7219088.975260417,2.7944703653008706e-5,1.0814121576143736,0.11291648090685319,0.8825626894404593,1,raw,5758677.078125,8930870.125,6554453.9453125,7729517.046875,4683064.125,9657951.53125,Nucleoporin NUP188 homolog OS=Homo sapiens OX=9606 GN=NUP188 PE=1 SV=1,conjugation,cytosol;membrane,structural molecule activity,23511,NUP188,NA,HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000095319
Q14181,0.3333333333333333,6,365213.75,1.4137227077722575e-6,1.0811735480813962,0.11259812053812832,0.969057672165963,1,raw,282258.09375,462421.5625,347430.375,375632.53125,338384.8125,385155.125,DNA polymerase alpha subunit B OS=Homo sapiens OX=9606 GN=POLA2 PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis;conjugation,cytosol;membrane,RNA binding,23649,POLA2,Pyrimidine metabolism; G1 to S cell cycle control; DNA replication,Activation of the pre-replicative complex; Defective pyroptosis; Inhibition of replication initiation of damaged DNA by RB1/E2F1; Polymerase switching on the C-strand of the telomere; Telomere C-strand synthesis initiation; DNA replication initiation; Polymerase switching; Removal of the Flap Intermediate,ENSG00000014138
Q9NR19,0,6,1518022.1458333333,5.876181766063716e-6,1.0811078717451066,0.11251048076670066,0.6811413278829335,1,raw,1772340.5625,1968717.28125,445544.34375,2128395.75,1512553.375,1280581.5625,"Acetyl-coenzyme A synthetase, cytoplasmic OS=Homo sapiens OX=9606 GN=ACSS2 PE=1 SV=1",cellular homeostasis,cytosol;endosome;nucleus,structural molecule activity,55902,ACSS2,Fatty acid beta-oxidation; Fatty acid biosynthesis; Lipid metabolism pathway; Ethanol effects on histone modifications; Fluoroacetic acid toxicity; Amino acid conjugation of benzoic acid,Transcriptional activation of mitochondrial biogenesis; Ethanol oxidation,ENSG00000131069
Q9NTZ6,0,6,23115621.375,8.947932229304969e-5,1.0810857446331454,0.1124809527221677,0.33058002557890426,0.8133261464868501,raw,22288237.875,24084102.375,19472817.875,25913526.625,21051785.8125,25883257.6875,RNA-binding protein 12 OS=Homo sapiens OX=9606 GN=RBM12 PE=1 SV=1,metabolic process,membrane;nucleus,NA,10137,RBM12,NA,NA,ENSG00000244462
O95182,0,6,3420087.03125,1.3238972241969344e-5,1.0810484923834667,0.11243123921691098,0.7098326484186929,1,raw,2736579.75,3219176.9375,4049675.0625,3755803.9375,3480086.375,3279200.125,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 OS=Homo sapiens OX=9606 GN=NDUFA7 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;endosome;Golgi,catalytic activity;structural molecule activity,4701,NDUFA7,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000267855
P60903,0,6,16291912.854166666,6.306511503190159e-5,1.080823630856787,0.1121311228435972,0.6783608880738107,1,raw,13874727.25,21588603.5,10293173.125,18742766,11125104.75,22127102.5,Protein S100-A10 OS=Homo sapiens OX=9606 GN=S100A10 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,6281,S100A10,Prostaglandin synthesis and regulation,Dissolution of Fibrin Clot,ENSG00000197747
Q9ULF5,0.16666666666666666,6,1039078904.1796883,0.004022218336538367,1.0805227125240267,0.11172939788126486,0.28923011028993495,0.7705885302475419,raw,1001655548.01563,919501141.0625,1077740544,1164523136,1008678784,1062374272,Zinc transporter ZIP10 OS=Homo sapiens OX=9606 GN=SLC39A10 PE=1 SV=2,conjugation;metabolic process,cytoplasm;cytoskeleton,catalytic activity,57181,SLC39A10,Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis,Zinc influx into cells by the SLC39 gene family,ENSG00000196950
A6NDG6,0,6,16726816.739583334,6.474860449118927e-5,1.0802155310687505,0.11131919626014786,0.6425587580059824,1,raw,16506503.25,16200181.8125,15834637.75,17499688,13675004.0625,20644885.5625,Glycerol-3-phosphate phosphatase OS=Homo sapiens OX=9606 GN=PGP PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,nucleus,structural molecule activity,283871,PGP,NA,Glycolysis,ENSG00000184207
P63244,0,6,407097480.2421875,0.0015758523661698071,1.080082542305543,0.11114157055952759,0.5074353374115191,0.9908542223742782,raw,408735705.625,411024041.140625,349410187.6875,441468300.0625,345719633.625,486227013.3125,Receptor of activated protein C kinase 1 OS=Homo sapiens OX=9606 GN=RACK1 PE=1 SV=3,cell differentiation;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytoplasm;cytosol;endosome;Golgi;membrane;nucleus,antioxidant activity;DNA binding;protein binding;structural molecule activity,10399,RACK1,Androgen receptor signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; VEGFA-VEGFR2 signaling pathway; Measles virus infection; Angiotensin II receptor type 1 pathway; Interferon type I signaling pathways,Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway; TNFR1-mediated ceramide production,ENSG00000204628
P51659,0,6,77655966.375,3.006020530671049e-4,1.080080722646053,0.11113913998979714,0.6601349409086075,1,raw,82402062.1875,74004656.03125,69918991.3125,89000878.875,63405396.40625,87203813.4375,Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens OX=9606 GN=HSD17B4 PE=1 SV=3,cellular homeostasis;defense response,cytosol;mitochondrion,structural molecule activity,3295,HSD17B4,Steroid biosynthesis; Disorders of bile acid synthesis and biliary transport,TYSND1 cleaves peroxisomal proteins; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol; alpha-linolenic acid (ALA) metabolism; Beta-oxidation of pristanoyl-CoA; Beta-oxidation of very long chain fatty acids,ENSG00000133835
O14936,0,6,6266311.484375,2.425655342778036e-5,1.0800010991149385,0.11103278061732183,0.3279876061850061,0.8102820770927855,raw,5419132.96875,6178789.46875,6014552.0625,6265062.53125,5852669.5625,7867662.3125,Peripheral plasma membrane protein CASK OS=Homo sapiens OX=9606 GN=CASK PE=1 SV=3,cell communication;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,chromosome;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,8573,CASK,Parkin-ubiquitin proteasomal system pathway; Splicing factor NOVA regulated synaptic proteins,Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Assembly and cell surface presentation of NMDA receptors; Nephrin family interactions; Neurexins and neuroligins; Dopamine Neurotransmitter Release Cycle; Syndecan interactions,ENSG00000147044
P13051,0,6,1723949.9895833333,6.673317330844485e-6,1.079860954183741,0.11084555903322173,0.7318789436873996,1,raw,2612038.3125,854628.375,1311842.5625,2114210,922879.8125,2528100.875,Uracil-DNA glycosylase OS=Homo sapiens OX=9606 GN=UNG PE=1 SV=2,cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,endosome;membrane,protein binding;RNA binding;structural molecule activity,7374,UNG,"Base excision repair; DNA repair pathways, full network",NA,ENSG00000076248
P52434,0,6,21306625.135416668,8.247679552023903e-5,1.0798516096920396,0.11083307473131722,0.7634236512421333,1,raw,16023743.25,26210313.5,19734442.5,26966302.5,17594679.5625,21310269.5,"DNA-directed RNA polymerases I, II, and III subunit RPABC3 OS=Homo sapiens OX=9606 GN=POLR2H PE=1 SV=4",cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,5437,POLR2H,Pyrimidine metabolism; Eukaryotic transcription initiation; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation; mRNA Splicing - Major Pathway; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,ENSG00000163882
Q6UWU4,0.16666666666666666,6,870068.1979166666,3.3679870177540643e-6,1.079582043858558,0.11047288650090988,0.7625394467698687,1,raw,602655.75,772258.0625,1354010.125,891633.1875,833715.9375,766136.125,Bombesin receptor-activated protein C6orf89 OS=Homo sapiens OX=9606 GN=C6orf89 PE=1 SV=1,cell differentiation;coagulation;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,NA,221477,C6orf89,NA,NA,ENSG00000198663
Q99584,0,6,60713095.416666664,2.3501711436024912e-4,1.0795361343179881,0.11041153416995457,0.6058965614629114,1,raw,59521790,57166571.875,58950168.25,74839295.5,50161910.125,63638836.75,Protein S100-A13 OS=Homo sapiens OX=9606 GN=S100A13 PE=1 SV=1,conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,6284,S100A13,NA,NA,ENSG00000189171
Q96HV5,0.16666666666666666,6,6973002.666666667,2.6992116839037887e-5,1.0793108388962136,0.11011041733032502,0.3376185835375767,0.8211705919010127,raw,5911506,7447558,6494198.5,7756056,6380352.5,7848345,Transmembrane protein 41A OS=Homo sapiens OX=9606 GN=TMEM41A PE=1 SV=1,NA,cytoskeleton,NA,90407,TMEM41A,NA,NA,ENSG00000163900
Q13616,0,6,31641409.791666668,1.2248218893293756e-4,1.0791995454015137,0.10996164568280645,0.34366225585895904,0.8250635218999488,raw,27041825.8125,34527501.6875,26604091.375,37068799.8125,27344175.9375,37262064.125,Cullin-1 OS=Homo sapiens OX=9606 GN=CUL1 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,8454,CUL1,Cell cycle; TNF-alpha signaling pathway; Parkin-ubiquitin proteasomal system pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; TGF-beta signaling pathway; Malignant pleural mesothelioma; Notch signaling pathway,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; SCF-beta-TrCP mediated degradation of Emi1; Degradation of beta-catenin by the destruction complex; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; NIK-->noncanonical NF-kB signaling; Orc1 removal from chromatin; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Neddylation; Regulation of PLK1 Activity at G2/M Transition; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; SCF(Skp2)-mediated degradation of p27/p21; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Circadian Clock; Cyclin D associated events in G1; Regulation of BACH1 activity; MAP3K8 (TPL2)-dependent MAPK1/3 activation; NOTCH1 Intracellular Domain Regulates Transcription; Prolactin receptor signaling; Iron uptake and transport; Nuclear events stimulated by ALK signaling in cancer; Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,ENSG00000055130
P82650,0,6,21065126.540364582,8.154196749768995e-5,1.0789403265843587,0.10961507527866575,0.5714172144804698,1,raw,22040250.40625,21803224.3203125,16505383.265625,23524377.96875,17189726.40625,25327796.875,"28S ribosomal protein S22, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS22 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,56945,MRPS22,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000175110
Q92598,0,6,178632391.670573,6.91476343506664e-4,1.0789172772456022,0.109584254740126,0.5855328010126,1,raw,156647610.25,214727464.367188,136447578.015625,198783745.5,147215649.359375,217972302.53125,Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,coagulation;metabolic process,cell surface;cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,10808,HSPH1,NA,Regulation of HSF1-mediated heat shock response; Scavenging by Class F Receptors,ENSG00000120694
Q13523,0,6,16231982.098958334,6.283312631424799e-5,1.078871627756874,0.10952321235468741,0.44299664562456004,0.9249308478488519,raw,12547599.0625,19548700.625,12558509.875,18377050.59375,13537248.625,20822783.8125,Serine/threonine-protein kinase PRP4 homolog OS=Homo sapiens OX=9606 GN=PRPF4B PE=1 SV=3,cell organization and biogenesis;cellular component movement;cellular homeostasis,membrane;nucleus,signal transducer activity;structural molecule activity,8899,PRPF4B,mRNA processing,NA,ENSG00000112739
P11766,0,6,74154624.75,2.870485486797955e-4,1.0788561762720859,0.10950255008168253,0.8970672556517603,1,raw,77150351.375,70969696.21875,72626821.09375,85872252.9375,59954732.375,78353894.5,Alcohol dehydrogenase class-3 OS=Homo sapiens OX=9606 GN=ADH5 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;endosome,structural molecule activity,128,ADH5,Folate-alcohol and cancer pathway hypotheses; Amino acid metabolism,Ethanol oxidation,ENSG00000197894
Q00059,0,6,23669250.25,9.162238977686131e-5,1.078517039509089,0.10904896984196341,0.6171488344083178,1,raw,23949963.75,20034859.625,24186679.125,29248172.5,18765382.5,25830444,"Transcription factor A, mitochondrial OS=Homo sapiens OX=9606 GN=TFAM PE=1 SV=1",cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;endosome;nucleus,RNA binding;structural molecule activity,7019,TFAM,"Energy metabolism; NAD metabolism, sirtuins and aging; VEGFA-VEGFR2 signaling pathway; Mitochondrial gene expression",Mitochondrial transcription initiation; Transcriptional activation of mitochondrial biogenesis,ENSG00000108064
A0A2R8YD14,0,6,81360815.41666667,3.1494332367663826e-4,1.0781792987569654,0.10859711493449895,0.5925214827116757,1,raw,87015284,85241280.75,59201958.8125,91164742.625,63830326.4375,101711299.875,40S ribosomal protein S24 OS=Homo sapiens OX=9606 GN=RPS24 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi,structural molecule activity,NA,RPS24,NA,NA,ENSG00000138326
Q15291,0,6,6737291.5,2.6079691639296205e-5,1.0781711837767405,0.10858625636412993,0.6916149686000863,1,raw,5861063.21875,7245597.8125,6682133.875,6396361.125,6319229.46875,7919363.5,Retinoblastoma-binding protein 5 OS=Homo sapiens OX=9606 GN=RBBP5 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,membrane,RNA binding;structural molecule activity,5929,RBBP5,NA,Neddylation; Formation of the beta-catenin:TCF transactivating complex; Deactivation of the beta-catenin transactivating complex; Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,ENSG00000117222
P54136,0,6,131643035.10416667,5.0958308126904e-4,1.0779213191115764,0.10825187505678209,0.4425341614019114,0.9249261346766603,raw,132634934.8125,136152597.34375,109022843.53125,142523411.5625,117518047.3125,152006376.0625,"Arginine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=RARS1 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5917,RARS1,Amino acid metabolism,Selenoamino acid metabolism; Cytosolic tRNA aminoacylation,ENSG00000113643
Q9Y3L5,0,6,4587938.1015625,1.775966068099147e-5,1.077587843215015,0.10780548027036956,0.797283949663814,1,raw,4889106.171875,4567305.21875,4054646.890625,5268441.375,3584927.703125,5163201.25,Ras-related protein Rap-2c OS=Homo sapiens OX=9606 GN=RAP2C PE=1 SV=1,cellular component movement;development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,57826,RAP2C,NA,Neutrophil degranulation,ENSG00000123728
Q13243,0,6,14474887.580729166,5.603150830254189e-5,1.077269665356417,0.10737943481703453,0.6475727045078716,1,raw,12408741.34375,17517833.203125,11483833.25,14398090.375,12169397,18871430.3125,Serine/arginine-rich splicing factor 5 OS=Homo sapiens OX=9606 GN=SRSF5 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,6430,SRSF5,mRNA processing,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,ENSG00000100650
Q9Y6N1,0.16666666666666666,6,927856.53125,3.591682536002339e-6,1.0772268469532384,0.10732209065557516,0.9884682218257044,1,raw,880348.0625,996724.8125,910180.5625,980470.9375,647190.8125,1152224,"Cytochrome c oxidase assembly protein COX11, mitochondrial OS=Homo sapiens OX=9606 GN=COX11 PE=1 SV=3",cellular homeostasis;metabolic process,endosome;nucleus,structural molecule activity,1353,COX11,Electron transport chain: OXPHOS system in mitochondria; Copper homeostasis; Mitochondrial complex IV assembly; 2q11.2 copy number variation syndrome,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000166260
P41091,0,6,135215259.89583334,5.234109705674199e-4,1.0772266879775585,0.10732187774457813,0.5777713773720067,1,raw,128494415.25,146199418.5,117396624.75,157489915.375,116451220.5,145259965,Eukaryotic translation initiation factor 2 subunit 3 OS=Homo sapiens OX=9606 GN=EIF2S3 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,RNA binding;structural molecule activity,1968,EIF2S3,Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; ABC-family proteins mediated transport; Formation of the ternary complex, and subsequently, the 43S complex; Response of EIF2AK1 (HRI) to heme deficiency; PERK regulates gene expression; Recycling of eIF2:GDP; Response of EIF2AK4 (GCN2) to amino acid deficiency",ENSG00000130741
Q96KR1,0,6,15235592.638020834,5.897615650762844e-5,1.0772010838144606,0.10728758650528676,0.6732958433802949,1,raw,13809757.359375,15685018.625,15227960.328125,16895919.0625,13008907.953125,16785992.5,Zinc finger RNA-binding protein OS=Homo sapiens OX=9606 GN=ZFR PE=1 SV=2,NA,membrane;nucleus,RNA binding;structural molecule activity,51663,ZFR,Exercise-induced circadian regulation,NA,ENSG00000056097
O14519,0,6,1982171.0989583333,7.672877303462113e-6,1.0770544527023098,0.10709119013997102,0.6518084737808085,1,raw,1370779,2458123.875,1868063.28125,2012005.875,1998422.65625,2185631.90625,Cyclin-dependent kinase 2-associated protein 1 OS=Homo sapiens OX=9606 GN=CDK2AP1 PE=1 SV=1,cell differentiation;cell proliferation;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,8099,CDK2AP1,NA,NA,ENSG00000111328
O60262,0.16666666666666666,6,904210.425,3.500149735399896e-6,1.0768769899433313,0.10685346238519561,0.7029617138685627,1,raw,754791.4375,NA,971992.875,796625.0625,829010,1168632.75,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 OS=Homo sapiens OX=9606 GN=GNG7 PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton,structural molecule activity,2788,GNG7,Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells,"G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation",ENSG00000176533
B4DDD6,0,6,564385.1770833334,2.1847045484261618e-6,1.0767418815918501,0.1066724460024953,0.6546508531842358,1,raw,711189.4375,509755.875,379061.0625,548875.5,477499.5,759929.6875,Drebrin-like protein OS=Homo sapiens OX=9606 GN=DBNL PE=1 SV=1,cell growth;conjugation;defense response,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;mitochondrion;nucleus,motor activity,NA,DBNL,NA,NA,ENSG00000136279
Q13885,0,6,17079330.447916668,6.611316602336554e-5,1.0764819768089746,0.1063241651289429,0.4105348603666381,0.8958624930054537,raw,16479720.8125,16619372.6875,15942189.5,20302651.8125,15391925.4375,17740122.4375,Tubulin beta-2A chain OS=Homo sapiens OX=9606 GN=TUBB2A PE=1 SV=1,cell differentiation;cell growth;defense response,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,7280,TUBB2A,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,ENSG00000137267
Q99541,0.16666666666666666,6,547099.3541666666,2.117792061205125e-6,1.076471107330466,0.10630959784193877,1,1,raw,520560.78125,NA,NA,NA,511384.46875,609352.8125,Perilipin-2 OS=Homo sapiens OX=9606 GN=PLIN2 PE=1 SV=2,cell growth;coagulation;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,NA,123,PLIN2,Adipogenesis,PPARA activates gene expression; Late endosomal microautophagy; Lipophagy; Chaperone Mediated Autophagy,ENSG00000147872
O60925,0,6,13552874.989583334,5.246244734315906e-5,1.0764017512326787,0.10621664325990682,0.6374694925701422,1,raw,14611072.25,13022997.4375,11112258.375,11961254.375,12016158.5,18593509,Prefoldin subunit 1 OS=Homo sapiens OX=9606 GN=PFDN1 PE=1 SV=2,metabolic process,nucleus,structural molecule activity,5201,PFDN1,Cellular proteostasis,Prefoldin mediated transfer of substrate  to CCT/TriC,ENSG00000113068
Q9Y244,0,6,8324106.229166667,3.2222165781221044e-5,1.0763893677560123,0.10620004566228755,0.681550698954589,1,raw,9063637,7826632.625,7377480.3125,9756002.5,6769707.0625,9151177.875,Proteasome maturation protein OS=Homo sapiens OX=9606 GN=POMP PE=1 SV=1,cell growth,cytoskeleton;cytosol;extracellular;membrane;nucleus,NA,51371,POMP,NA,NA,ENSG00000132963
Q6F5E8,0,6,302835.59375,1.1722602328254873e-6,1.0758370324434583,0.10545955531819586,1,1,raw,291772.03125,NA,NA,NA,313899.15625,NA,"Capping protein, Arp2/3 and myosin-I linker protein 2 OS=Homo sapiens OX=9606 GN=CARMIL2 PE=1 SV=2",cell growth;coagulation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,structural molecule activity,146206,CARMIL2,NA,NA,ENSG00000159753
Q9Y676,0,6,9253775.544270834,3.582086550564775e-5,1.075821775583197,0.10543909575782608,0.4607916692628979,0.9425587783849652,raw,9711421.875,7608795.890625,9227327.3125,10385567.625,8141781.4375,10447759.125,"28S ribosomal protein S18b, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS18B PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane;nucleus,structural molecule activity,28973,MRPS18B,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000203624; ENSG00000204568; ENSG00000223775; ENSG00000226111; ENSG00000227420; ENSG00000229861; ENSG00000233813
P20962,0,6,44375390.640625015,1.7177474127114898e-4,1.0756717788871348,0.10523793364933687,0.6823964852053326,1,raw,43433388.3359375,48447557.25,37263217,52113670.0898438,35853608.1679688,49140903,Parathymosin OS=Homo sapiens OX=9606 GN=PTMS PE=1 SV=2,cell proliferation;cellular homeostasis;metabolic process,membrane,structural molecule activity,5763,PTMS,IL-18 signaling pathway,NA,ENSG00000159335
P18074,0,6,36271641.143229164,1.404055645011984e-4,1.0756250887309704,0.10517531127696117,0.7550929157997772,1,raw,44813565.0625,33378305.671875,27068389.125,35902543,29980716.625,46486327.375,General transcription and DNA repair factor IIH helicase subunit XPD OS=Homo sapiens OX=9606 GN=ERCC2 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,2068,ERCC2,"Fluoropyrimidine activity; Eukaryotic transcription initiation; Male infertility; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Cytosolic iron-sulfur cluster assembly; Formation of Incision Complex in GG-NER; Dual Incision in GG-NER,ENSG00000104884
F5H5D3,0,6,1515289027.187175,0.00586560201134991,1.0756228838002517,0.10517235388417898,0.7819092361472841,1,raw,1589764159.67188,1560145944.03906,1292054185.95508,1678128679.47656,1145265095.40234,1826376098.57813,Tubulin alpha chain OS=Homo sapiens OX=9606 GN=TUBA1C PE=1 SV=1,cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,84790,TUBA1C,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; VEGFA-VEGFR2 signaling pathway; Alzheimer's disease,NA,ENSG00000167553
O75934,0,6,15239052.71875,5.898955029331572e-5,1.0755252480929351,0.10504139260934378,0.4671883755298367,0.9485672170384823,raw,17276401.375,12906111,12318144,18581205.875,12042805.3125,18309648.75,Pre-mRNA-splicing factor SPF27 OS=Homo sapiens OX=9606 GN=BCAS2 PE=1 SV=1,cellular component movement;cellular homeostasis,endoplasmic reticulum;membrane;nucleus,NA,10286,BCAS2,NA,mRNA Splicing - Major Pathway,ENSG00000116752
Q7L2E3,0,6,56359570.794270836,2.1816485560075108e-4,1.0753965031485473,0.10486868554278266,0.5545379062890725,1,raw,55477733.71875,61041771.53125,43707034.78125,72081057.78125,46189266.109375,59660560.84375,ATP-dependent RNA helicase DHX30 OS=Homo sapiens OX=9606 GN=DHX30 PE=1 SV=1,cell growth;defense response,cytosol;endosome;nucleus,RNA binding;structural molecule activity,22907,DHX30,NA,NA,ENSG00000132153
Q9BV57,0,6,9025080.450520834,3.493559914535742e-5,1.075211338574773,0.10462025716099226,0.5065223376405568,0.9902772197513048,raw,10335403.90625,8030865.796875,7239536.53125,9673559.40625,7758373.59375,11112743.46875,"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase OS=Homo sapiens OX=9606 GN=ADI1 PE=1 SV=1",cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,55256,ADI1,Methionine de novo and salvage pathway,Methionine salvage pathway,ENSG00000182551
Q13098,0,6,2216378.4375,8.579481265726017e-6,1.075123954429512,0.10450300226265147,0.4176372760291303,0.9038582714714452,raw,1858399.25,2281839.5,2098704.75,2256367.75,1955759.625,2847199.75,COP9 signalosome complex subunit 1 OS=Homo sapiens OX=9606 GN=GPS1 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,DNA binding,2873,GPS1,NA,Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; RHOBTB1 GTPase cycle; DNA Damage Recognition in GG-NER,ENSG00000169727
J3KTC1,0,6,380119.8359375,1.4714233616327666e-6,1.0750655083829397,0.10442457213076922,0.7913676009875201,1,raw,399495.5,327861.8125,NA,491751.6875,NA,301370.34375,RNA-binding protein Musashi homolog 2 (Fragment) OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=8,NA,NA,RNA binding,NA,MSI2,NA,NA,ENSG00000153944
O75746,0,6,6749690.260416667,2.6127686571440108e-5,1.0749398576802323,0.10425594404383702,0.558031944499495,1,raw,6931942.875,7104509.0625,4803539.75,7451421.6875,4966549.125,9240179.0625,Calcium-binding mitochondrial carrier protein Aralar1 OS=Homo sapiens OX=9606 GN=SLC25A12 PE=1 SV=2,cellular homeostasis;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,8604,SLC25A12,NA,Gluconeogenesis; Mitochondrial protein import; Aspartate and asparagine metabolism,ENSG00000115840
P50914,0,6,163862007.79166666,6.343009849881987e-4,1.0748535475617342,0.1041401011170712,0.7877091135867942,1,raw,190115610.75,117445445.625,168498564.875,223186430,126236653.875,157689341.625,60S ribosomal protein L14 OS=Homo sapiens OX=9606 GN=RPL14 PE=1 SV=4,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,structural molecule activity,9045,RPL14,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000188846
Q15293,0,6,88698847.49739583,3.433484496689869e-4,1.0745716852627571,0.10376172894848516,0.4708434034412476,0.9518052181312325,raw,100424395.1875,67917447.65625,80421156.6875,102790839.875,72726034,107913211.578125,Reticulocalbin-1 OS=Homo sapiens OX=9606 GN=RCN1 PE=1 SV=1,defense response,extracellular,structural molecule activity,5954,RCN1,VEGFA-VEGFR2 signaling pathway,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,ENSG00000049449
Q13444,0,6,1092981.7135416667,4.230873201279215e-6,1.0745505773114679,0.10373338962393422,0.5581607904034732,1,raw,920359.40625,1248215.9375,935315.03125,862912.25,1249816.5,1341271.15625,Disintegrin and metalloproteinase domain-containing protein 15 OS=Homo sapiens OX=9606 GN=ADAM15 PE=1 SV=4,cell communication;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,antioxidant activity;structural molecule activity,8751,ADAM15,NA,Degradation of the extracellular matrix; Invadopodia formation,ENSG00000143537
O75940,0,6,8259743.75,3.197302209940064e-5,1.0745413092296172,0.10372094621394483,0.5891457963516715,1,raw,7393818.0625,7786846.0625,8892183.5,9555018.5,8634217,7296379.375,Survival of motor neuron-related-splicing factor 30 OS=Homo sapiens OX=9606 GN=SMNDC1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,10285,SMNDC1,NA,mRNA Splicing - Major Pathway,ENSG00000119953
H0YIC4,0,6,2549023.375,9.867131858753343e-6,1.074482544378967,0.10364204549956654,0.3759277808025346,0.8615698665976935,raw,2477060.25,2525587.25,2464964.75,2661558,2404807,2760163,Citrate synthase (Fragment) OS=Homo sapiens OX=9606 GN=CS PE=1 SV=1,NA,cytoskeleton;endosome,structural molecule activity,NA,CS,TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism,NA,ENSG00000062485
Q9HAV4,0,6,20518973.536458332,7.942783870724792e-5,1.0740436497539385,0.10305262647406158,0.6000341313382633,1,raw,24282702.75,16616994.921875,16916427.953125,26080682.6875,14725070.28125,24491962.625,Exportin-5 OS=Homo sapiens OX=9606 GN=XPO5 PE=1 SV=1,cellular component movement;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,57510,XPO5,miRNA biogenesis; exRNA mechanism of action and biogenesis,MicroRNA (miRNA) biogenesis,ENSG00000124571
P29992,0,6,15769185.307291666,6.104166492084943e-5,1.0736579405974276,0.10253443465839572,0.5619827418293375,1,raw,16437044.875,16200011.28125,13419616.25,16354208.375,14556467.3125,17647763.75,Guanine nucleotide-binding protein subunit alpha-11 OS=Homo sapiens OX=9606 GN=GNA11 PE=1 SV=2,cell death;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;structural molecule activity,2767,GNA11,Corticotropin-releasing hormone signaling pathway; G protein signaling pathways; GPR40 pathway; Hippo signaling regulation pathways; PKC-gamma calcium signaling pathway in ataxia; Calcium regulation in cardiac cells,G alpha (q) signalling events; Thrombin signalling through proteinase activated receptors (PARs); G-protein activation; ADP signalling through P2Y purinoceptor 1; Thromboxane signalling through TP receptor; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion; PLC beta mediated events; Acetylcholine regulates insulin secretion,ENSG00000088256
Q9BY44,0,6,23178464.166666668,8.972258334660796e-5,1.0733886683487102,0.10217256292418021,0.46015753066950726,0.9425587783849652,raw,18960144,27312411.8125,18780701.6875,27853955.1875,20158992.375,26004579.9375,Eukaryotic translation initiation factor 2A OS=Homo sapiens OX=9606 GN=EIF2A PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;Golgi;nucleus,protein binding;RNA binding,83939,EIF2A,Photodynamic therapy-induced unfolded protein response; VEGFA-VEGFR2 signaling pathway; 7q11.23 copy number variation syndrome,NA,ENSG00000144895
Q00688,0,6,34025622.84375,1.3171134893005487e-4,1.0733661997067743,0.10214236348335913,0.5451262648487682,1,raw,35724534,32810283.8125,24866968.8125,31990624.625,26691363.8125,52069962,Peptidyl-prolyl cis-trans isomerase FKBP3 OS=Homo sapiens OX=9606 GN=FKBP3 PE=1 SV=1,NA,membrane,structural molecule activity,2287,FKBP3,NA,NA,ENSG00000100442
Q96MW1,0,6,3157226.2916666665,1.2221452511316353e-5,1.0732928755853341,0.10204380629033495,0.3247384710312236,0.8055660735320965,raw,2931840,2833480.0625,2776538.625,4425428.625,2996031.3125,2980039.125,Coiled-coil domain-containing protein 43 OS=Homo sapiens OX=9606 GN=CCDC43 PE=1 SV=2,NA,cytosol,NA,124808,CCDC43,NA,NA,ENSG00000180329
P20020,0,6,26682826.911458332,1.0328778232551577e-4,1.0731978153488564,0.10191602289726356,0.525290926579267,1,raw,27524446.25,26445515.1875,22558310.25,32607954.4375,22579466.21875,28381269.125,Plasma membrane calcium-transporting ATPase 1 OS=Homo sapiens OX=9606 GN=ATP2B1 PE=1 SV=4,coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,catalytic activity;structural molecule activity,490,ATP2B1,Vitamin D receptor pathway; Splicing factor NOVA regulated synaptic proteins; Vitamin D-sensitive calcium signaling in depression; Calcium regulation in cardiac cells,Sensory processing of sound by inner hair cells of the cochlea; Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels,ENSG00000070961
P06730,0,6,43259716.020833336,1.6745602505500247e-4,1.0730358223189345,0.10169823995204358,0.5292268267112739,1,raw,41412732.875,46605881.5,35655794.25,54162185.875,37284355.75,44437345.875,Eukaryotic translation initiation factor 4E OS=Homo sapiens OX=9606 GN=EIF4E PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,1977,EIF4E,"Translation factors; Leptin signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Interleukin-1 (IL-1) structural pathway; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; Hypertrophy model; Interferon type I signaling pathways",Deadenylation of mRNA; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling,ENSG00000151247
Q9Y2R0,0,6,1632175.5104166667,6.318063277042052e-6,1.0728282442914374,0.10141912460968673,0.6379242893667074,1,raw,1913466.6875,1226259,1556541.96875,2009133.25,1417749.96875,1669902.1875,"Cytochrome c oxidase assembly factor 3 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=COA3 PE=1 SV=1",cell growth;metabolic process,endosome,NA,28958,COA3,Mitochondrial complex IV assembly; Arsenic metabolism and reactive oxygen species generation,NA,ENSG00000183978
Q9UBS8,0,6,371056,1.4363377420897838e-6,1.0728183683959966,0.10140584385292783,1,1,raw,NA,353876.84375,NA,NA,285825.75,473465.40625,E3 ubiquitin-protein ligase RNF14 OS=Homo sapiens OX=9606 GN=RNF14 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9604,RNF14,Androgen receptor signaling pathway,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000013561
P17812,0,6,44269080.848958336,1.713632218074439e-4,1.0726239192131555,0.10114433052844626,0.45534719611656144,0.9388814790284128,raw,43246682.3125,45021977.46875,37359952.5,46387425.875,38078944.125,55519502.8125,CTP synthase 1 OS=Homo sapiens OX=9606 GN=CTPS1 PE=1 SV=2,cell differentiation;cellular homeostasis;metabolic process,cytosol;nucleus,structural molecule activity,1503,CTPS1,Pyrimidine metabolism,Interconversion of nucleotide di- and triphosphates,ENSG00000171793
Q9UER7,0,6,431166.2890625,1.6690214255995383e-6,1.0725529811404695,0.10104891461594531,0.8094856704825065,1,raw,NA,345523.09375,492718.09375,486175.03125,400248.9375,NA,Death domain-associated protein 6 OS=Homo sapiens OX=9606 GN=DAXX PE=1 SV=2,cell growth;cellular component movement;coagulation;development;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,1616,DAXX,Androgen receptor signaling pathway; Amyotrophic lateral sclerosis (ALS); Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; p38 MAPK signaling pathway,SUMOylation of transcription cofactors; HCMV Early Events; Regulation of TP53 Degradation; Inhibition of DNA recombination at telomere; Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations; Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations,ENSG00000204209; ENSG00000206206; ENSG00000206279; ENSG00000227046; ENSG00000231617
Q9UKA4,0.3333333333333333,6,167952.65234375,6.501356491888348e-7,1.0725366554292441,0.1010269546733651,1,1,raw,192490.578125,144528.515625,161537.078125,NA,173254.4375,NA,A-kinase anchor protein 11 OS=Homo sapiens OX=9606 GN=AKAP11 PE=1 SV=1,cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,11215,AKAP11,G protein signaling pathways,NA,ENSG00000023516
Q92947,0,6,2408430.8977864585,9.322905970273685e-6,1.0722760530197268,0.10067636946448093,0.7890612257347518,1,raw,3105377.1875,1831068.57421875,1988740.8125,3329821.59375,1421054.15625,2774523.0625,"Glutaryl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=GCDH PE=1 SV=1",cellular homeostasis,endosome,structural molecule activity,2639,GCDH,Fatty acid beta-oxidation; Tryptophan metabolism,Lysine catabolism,ENSG00000105607
P46013,0,6,88215120.5390625,3.41475968730475e-4,1.0722391905275883,0.10062677192977623,0.9408207658673461,1,raw,65665471.40625,129342532.890625,72321509.03125,91957804.03125,70409091.90625,99594313.96875,Proliferation marker protein Ki-67 OS=Homo sapiens OX=9606 GN=MKI67 PE=1 SV=2,cell differentiation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4288,MKI67,Primary focal segmental glomerulosclerosis (FSGS),NA,ENSG00000148773
Q9BTE1,0,6,24450872.026041668,9.464800547090183e-5,1.0720025123950088,0.10030828696692838,0.45868545132128985,0.9412524313762942,raw,21455722.453125,25787295,21157296.8125,23000588.375,22163710.921875,33140618.59375,Dynactin subunit 5 OS=Homo sapiens OX=9606 GN=DCTN5 PE=1 SV=1,defense response,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,NA,84516,DCTN5,NA,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic,ENSG00000166847
P82970,0,6,5799156.578125,2.2448222008131333e-5,1.0719637727979061,0.1002561504897663,0.3480219090950712,0.831176225005324,raw,6246797.625,5161409.5,5111245.21875,6262001,5317145.375,6696340.75,High mobility group nucleosome-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=HMGN5 PE=1 SV=1,cell growth;metabolic process,endosome;membrane;nucleus,RNA binding;structural molecule activity,79366,HMGN5,NA,NA,ENSG00000198157
O95398,0.6666666666666666,6,2173155.625,8.41216809220768e-6,1.071432972029114,0.09954159901502024,0.4726447616320299,0.9535792290076607,raw,2054443.25,2178066.5,2055320.125,2202137.75,1974537.125,2574429,Rap guanine nucleotide exchange factor 3 OS=Homo sapiens OX=9606 GN=RAPGEF3 PE=1 SV=6,defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,DNA binding;structural molecule activity,10411,RAPGEF3,Corticotropin-releasing hormone signaling pathway,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Integrin signaling; Rap1 signalling,ENSG00000079337
P61916,0,6,25934651.763020832,1.0039163672109377e-4,1.0713221278190406,0.0993923384743843,0.740095945878237,1,raw,28345575.375,21911474.328125,25490918.265625,30367242.125,20051795.859375,29440904.625,NPC intracellular cholesterol transporter 2 OS=Homo sapiens OX=9606 GN=NPC2 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cell surface;extracellular;mitochondrion,catalytic activity;structural molecule activity,10577,NPC2,"TYROBP causal network in microglia; Degradation pathway of sphingolipids, including diseases; Ebola virus infection in host",Neutrophil degranulation; LDL clearance,ENSG00000119655
P39019,0,6,259264209.109375,0.0010035977553707613,1.071090384530455,0.09908022781168177,0.6699167378256153,1,raw,220646675.59375,299142158.25,232848237.625,249401508.375,232500828.8125,321045846,40S ribosomal protein S19 OS=Homo sapiens OX=9606 GN=RPS19 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;Golgi;membrane;nucleus,structural molecule activity,6223,RPS19,Complement system; Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000105372
Q6IN84,0,6,516277.1041666667,1.9984807955979747e-6,1.0707242893411266,0.09858703507589182,1,1,raw,NA,404620.25,619929.5625,524281.5,NA,NA,"rRNA methyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=MRM1 PE=1 SV=1",cellular component movement;cellular homeostasis,endosome,structural molecule activity,79922,MRM1,NA,rRNA modification in the mitochondrion,ENSG00000274853; ENSG00000278619
P28065,0,6,1533582.6458333333,5.936415621427295e-6,1.0706723615677811,0.0985170658424265,0.57346258956335,1,raw,1786027.5,1215631.0625,1338346.8125,1766769.875,1182470.34375,1912250.28125,Proteasome subunit beta type-9 OS=Homo sapiens OX=9606 GN=PSMB9 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5698,PSMB9,Proteasome degradation; Type II interferon signaling,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000239836; ENSG00000240065; ENSG00000240118; ENSG00000240508; ENSG00000242711; ENSG00000243067; ENSG00000243594; ENSG00000243958
Q4U2R6,0.5,6,882638.0729166666,3.416644325211297e-6,1.0706166557418713,0.09844200216054401,0.8118158695072268,1,raw,873490.8125,1128279.75,560559.8125,1163077.125,635247.125,935173.8125,"39S ribosomal protein L51, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL51 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,51258,MRPL51,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000111639
Q96TA2,0,6,5240478.864583333,2.0285610742919823e-5,1.0706094364817855,0.09843227391114294,0.9965951772222909,1,raw,5229678.71875,5815087.65625,4670661.125,5823010.84375,3678747.125,6225687.71875,ATP-dependent zinc metalloprotease YME1L1 OS=Homo sapiens OX=9606 GN=YME1L1 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome;membrane,structural molecule activity,10730,YME1L1,NA,Processing of SMDT1,ENSG00000136758
P05387,0,6,413673295.0182292,0.0016013069901290487,1.0703507087329287,0.09808358433570415,0.5234614163928176,1,raw,405551920,412895989.03125,384942583.765625,434082785,366592842.8125,477973649.5,60S acidic ribosomal protein P2 OS=Homo sapiens OX=9606 GN=RPLP2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;nucleus,structural molecule activity,6181,RPLP2,VEGFA-VEGFR2 signaling pathway; Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000177600
A0A2R8Y5P7,0,6,8689445.9140625,3.363637597617564e-5,1.0702147642315343,0.09790033700154069,0.7497308588177982,1,raw,8758928.6875,9637977.421875,7202625.125,9447330.1875,7708355.75,9381458.3125,Histidine--tRNA ligase OS=Homo sapiens OX=9606 GN=HARS2 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome,structural molecule activity,NA,HARS2,NA,NA,ENSG00000112855
Q9ULE6,0,6,11663309.734375,4.514804226091475e-5,1.0701465152128162,0.0978083314865568,0.7663332438724071,1,raw,11199692.90625,11478895.46875,11834227.734375,12284099.984375,10036874.4375,13146067.875,Paladin OS=Homo sapiens OX=9606 GN=PALD1 PE=1 SV=3,NA,cytosol;nucleus,structural molecule activity,27143,PALD1,NA,NA,ENSG00000107719
O75179,0,6,20766521.588541668,8.038608385134506e-5,1.0697492887451037,0.09727271974265676,0.5501447570813206,1,raw,19021716.59375,20914185.484375,17911018.4375,30175581.0625,16228160.15625,20348467.796875,Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3,coagulation;defense response;metabolic process,cytoskeleton;membrane;nucleus,structural molecule activity,26057,ANKRD17,NA,NA,ENSG00000132466
Q93084,0,6,2282101.5885416665,8.83389203490968e-6,1.0696984862555756,0.09720420439904602,0.7862241316928762,1,raw,1740945.71875,2950952.3125,1945535.9375,2893171.5625,1862287,2299717,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens OX=9606 GN=ATP2A3 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
Q969Q0,0.3333333333333333,6,17230448.166666668,6.66981345535581e-5,1.0695481870120909,0.09700148259394406,0.6032299417200238,1,raw,15142723,20125672,14146389,17676086,14766443,21525376,60S ribosomal protein L36a-like OS=Homo sapiens OX=9606 GN=RPL36AL PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;extracellular;Golgi;membrane,structural molecule activity,6166,RPL36AL,NA,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000165502
Q96E11,0,6,11410697.313476583,4.417019321856786e-5,1.069400393258744,0.09680211238249153,0.4294208148877967,0.9141713485315045,raw,8452249.125,12091998.1621094,11907465.2382813,11723278.515625,11358005.25,12931187.5898438,"Ribosome-recycling factor, mitochondrial OS=Homo sapiens OX=9606 GN=MRRF PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis,endosome,protein binding,92399,MRRF,NA,Mitochondrial translation termination,ENSG00000148187
E9PHY5,0,6,48781930.203125,1.8883221800142832e-4,1.0690991925310358,0.09639571454922788,0.672985740559608,1,raw,46812759.4375,51229058.75,44972971.375,53661811.1875,41246035.125,54768945.34375,Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1,NA,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,NA,EPB41L2,Splicing factor NOVA regulated synaptic proteins,NA,ENSG00000079819
Q13573,0,6,21413949.927083332,8.289224399414256e-5,1.0688138665202822,0.0960106302059221,0.6226820810413235,1,raw,18951692.1875,23539842.25,19251255.4375,25159709.8125,16898740.4375,24682459.4375,SNW domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SNW1 PE=1 SV=1,cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane,antioxidant activity;structural molecule activity,22938,SNW1,TGF-beta signaling pathway; Novel intracellular components of RIG-I-like receptor pathway; Splicing factor NOVA regulated synaptic proteins; Notch signaling pathway,mRNA Splicing - Major Pathway; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Pre-NOTCH Transcription and Translation; Downregulation of SMAD2/3:SMAD4 transcriptional activity; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; NOTCH3 Intracellular Domain Regulates Transcription; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells; NOTCH4 Intracellular Domain Regulates Transcription; RUNX3 regulates NOTCH signaling,ENSG00000100603
A0A494C0R8,0,6,25328347.340820316,9.804466503810646e-5,1.068646855098698,0.09578517899856694,0.9100223885278611,1,raw,19441606.5996094,32709598.46875,22995701.9140625,24574284.53125,22287423.84375,29961468.6875,Clustered mitochondria protein homolog OS=Homo sapiens OX=9606 GN=CLUH PE=1 SV=1,cell growth,nucleus,RNA binding,NA,CLUH,NA,NA,ENSG00000132361
M0QWZ7,0,6,977512332.3177084,0.003783897460938876,1.0685676073801913,0.09567818899587788,0.46729153884516594,0.9485672170384823,raw,921070450.78125,1034858383.1875,890757862.65625,999500666.625,913070484.15625,1105816146.5,Seryl-tRNA synthetase OS=Homo sapiens OX=9606 GN=SARS2 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,NA,structural molecule activity,NA,SARS2,NA,NA,ENSG00000104835
M0QXF9,0,6,5060812.380208333,1.959013148238665e-5,1.0685198392751796,0.09561369485612481,0.6204284561290081,1,raw,5464177,3975273.53125,4851490.875,7133177.625,3756841,5183914.25,Branched-chain-amino-acid aminotransferase (Fragment) OS=Homo sapiens OX=9606 GN=BCAT2 PE=1 SV=1,cellular homeostasis,endosome;membrane,structural molecule activity,NA,BCAT2,"Trans-sulfuration, one-carbon metabolism and related pathways",NA,ENSG00000105552
Q9NY26,0.16666666666666666,6,249987.15104166666,9.676867644739479e-7,1.0683175433717766,0.09534053293947775,1,1,raw,NA,281563.90625,210817.453125,257580.09375,NA,NA,Zinc transporter ZIP1 OS=Homo sapiens OX=9606 GN=SLC39A1 PE=1 SV=1,conjugation;defense response,cytoplasm;cytoskeleton;extracellular,antioxidant activity;catalytic activity,27173,SLC39A1,Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis,Zinc influx into cells by the SLC39 gene family,ENSG00000143570
Q96PZ0,0,6,10855112.005208334,4.2019552487205825e-5,1.0680874815424264,0.09502981558231578,0.5454599729416222,1,raw,8155527.5,12039984.625,10607555.953125,12824435.0625,8710816.828125,12792352.0625,Pseudouridylate synthase 7 homolog OS=Homo sapiens OX=9606 GN=PUS7 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,54517,PUS7,NA,tRNA modification in the nucleus and cytosol,ENSG00000091127
O75380,0,6,9414067.463541666,3.644134687072661e-5,1.0676776583038263,0.09447614987235989,0.6324471561084763,1,raw,7702303.65625,8938679.8125,10705067.15625,10226421.5,8223577.53125,10688355.125,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS6 PE=1 SV=1",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity;structural molecule activity,4726,NDUFS6,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000145494
Q96F44,0.16666666666666666,6,464796.1666666667,1.799200866074088e-6,1.067532495068244,0.09427998531208391,0.4449811856178605,0.9271939562980955,raw,456203.53125,433320.5625,423266.625,410369.25,462583.78125,603033.25,E3 ubiquitin-protein ligase TRIM11 OS=Homo sapiens OX=9606 GN=TRIM11 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,81559,TRIM11,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000154370
Q13630,0,6,25705403.125,9.950422762081781e-5,1.0672143606532345,0.0938499849632949,0.626750820371276,1,raw,27422332.5625,26044295.75,21111197.46875,27794846.4375,21628345.53125,30231401,GDP-L-fucose synthase OS=Homo sapiens OX=9606 GN=GFUS PE=1 SV=1,cell communication;cellular homeostasis;metabolic process,cytosol,structural molecule activity,7264,GFUS,NA,GDP-fucose biosynthesis,ENSG00000104522; ENSG00000278243
Q9BX40,0,6,857819.9739583334,3.320574804112667e-6,1.0672075791426288,0.0938408174678356,0.9809474606840396,1,raw,527632.8125,1201891.1875,857155,334047.875,914762.3125,1311430.65625,Protein LSM14 homolog B OS=Homo sapiens OX=9606 GN=LSM14B PE=1 SV=1,metabolic process,nucleus,RNA binding,149986,LSM14B,NA,NA,ENSG00000149657
A0A140TA86,0,6,4382582.497395833,1.6964740224741646e-5,1.0669150483306094,0.09344530809174084,0.7919747404852309,1,raw,4963364.71875,3082856.390625,4717593.625,5670079.84375,3289145.875,4572454.53125,MICOS complex subunit MIC13 OS=Homo sapiens OX=9606 GN=MICOS13 PE=1 SV=1,NA,cytoskeleton;endosome;membrane,NA,125988,MICOS13,NA,NA,ENSG00000174917
Q12899,0,6,643105.1510416666,2.489425317400869e-6,1.0669097118818738,0.09343809206512953,0.547572881485119,1,raw,511770.34375,734726.3125,430879.78125,1177820.125,457421.59375,546012.75,Tripartite motif-containing protein 26 OS=Homo sapiens OX=9606 GN=TRIM26 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,7726,TRIM26,NA,Interferon gamma signaling,ENSG00000137313; ENSG00000226060; ENSG00000228881; ENSG00000230230; ENSG00000231002; ENSG00000231641; ENSG00000234046; ENSG00000234127
Q9H6Q4,0.5,6,436932.2786458334,1.6913412599615707e-6,1.0668734620037919,0.09338907347693678,0.598187596988554,1,raw,184486.953125,1231285.1875,218058.296875,196824.234375,318102.84375,472836.15625,Cytosolic iron-sulfur assembly component 3 OS=Homo sapiens OX=9606 GN=CIAO3 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;metabolic process,nucleus,structural molecule activity,64428,CIAO3,NA,Cytosolic iron-sulfur cluster assembly,ENSG00000103245
A0A0A6YYL6,0,6,150764873.90104166,5.836026868329124e-4,1.066442643461342,0.09280637522460333,0.8819771008712806,1,raw,124474667.75,156907666.25,164515060,184237833.5,107120989.53125,167333026.375,60S ribosomal protein L17 OS=Homo sapiens OX=9606 GN=RPL17-C18orf32 PE=3 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi,structural molecule activity,100526842,RPL17-C18orf32,NA,NA,ENSG00000215472
O15400,0,6,5232389.427083333,2.0254296967119064e-5,1.0662067979408147,0.09248728559115278,0.4397932703598048,0.9233600879723239,raw,5012734.875,5011442.0625,5180004.25,5344612,4830366,6015177.375,Syntaxin-7 OS=Homo sapiens OX=9606 GN=STX7 PE=1 SV=4,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,8417,STX7,NA,NA,ENSG00000079950
P62249,0,6,163892491.10416666,6.344189842450431e-4,1.0661727116784707,0.09244116239269912,0.5656301580352825,1,raw,142268455.375,180938483.875,146872292.125,187368471.25,132995570,192911674,40S ribosomal protein S16 OS=Homo sapiens OX=9606 GN=RPS16 PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6217,RPS16,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000105193
P40227,0,6,377904066.3398438,0.0014628462371532036,1.0661074006772941,0.09235278389402402,0.9303451569255294,1,raw,341349793.0625,432262361.90625,351995424.078125,460838103.0625,290296292.898438,390682423.03125,T-complex protein 1 subunit zeta OS=Homo sapiens OX=9606 GN=CCT6A PE=1 SV=3,metabolic process,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,908,CCT6A,16p11.2 proximal deletion syndrome,Formation of tubulin folding intermediates by CCT/TriC; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; RHOBTB2 GTPase cycle; Folding of actin by CCT/TriC,ENSG00000146731
P08754,0,6,9628430.212239584,3.727113349714669e-5,1.0660229502546477,0.09223849800529912,0.5342396303495638,1,raw,8898587.265625,9746843.328125,8420736.375,9486098.25,7888744.8046875,13329571.25,Guanine nucleotide-binding protein G(i) subunit alpha OS=Homo sapiens OX=9606 GN=GNAI3 PE=1 SV=3,cell differentiation;cell growth;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;nucleus,antioxidant activity;structural molecule activity,2773,GNAI3,Thyroid stimulating hormone (TSH) signaling pathway; S1P receptor signal transduction; Complement system; G protein signaling pathways; Chemokine signaling pathway; Hippo signaling regulation pathways; Purinergic signaling; Calcium regulation in cardiac cells; Serotonin HTR1 group and FOS pathway,G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production,ENSG00000065135
Q14653,0,6,2740914.75,1.0609933010854383e-5,1.065936726011716,0.09212180228245367,0.8425327675609802,1,raw,2673071.1875,4025901.625,1766677,2849324.75,1955953.625,3174560.3125,Interferon regulatory factor 3 OS=Homo sapiens OX=9606 GN=IRF3 PE=1 SV=1,cellular component movement;coagulation;development;metabolic process,cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,3661,IRF3,Apoptosis; TLR4 signaling and tolerance; Toll-like receptor signaling related to MyD88; Novel intracellular components of RIG-I-like receptor pathway; Fibrin complement receptor 3 signaling pathway; White fat cell differentiation; Ebola virus infection in host; Measles virus infection; Cytosolic DNA-sensing pathway; Hepatitis B infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; STING pathway in Kawasaki-like disease and COVID-19; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; Toll-like receptor signaling pathway,ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon; Interferon gamma signaling; Interferon alpha/beta signaling; Negative regulators of DDX58/IFIH1 signaling; TICAM1-dependent activation of IRF3/IRF7; SARS-CoV-1 activates/modulates innate immune responses; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Regulation of innate immune responses to cytosolic DNA; IRF3-mediated induction of type I IFN; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production; IRF3 mediated activation of type 1 IFN,ENSG00000126456
Q02878,0,6,322975819.40625,0.001250221958937656,1.0655202625878002,0.09155802855654256,0.8986024099573809,1,raw,314600430.4375,334989998.8125,311876861.625,335213133.25,262178249.828125,378996242.484375,60S ribosomal protein L6 OS=Homo sapiens OX=9606 GN=RPL6 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;extracellular;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6128,RPL6,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000089009
O43447,0,6,22155603.0859375,8.576314332902019e-5,1.0654098241868404,0.09140848922203325,0.8892883402275273,1,raw,22554168.84375,24882566.9375,19959427.28125,27016765.5625,14491256.828125,24029433.0625,Peptidyl-prolyl cis-trans isomerase H OS=Homo sapiens OX=9606 GN=PPIH PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,10465,PPIH,NA,mRNA Splicing - Major Pathway; SARS-CoV-1 activates/modulates innate immune responses,ENSG00000171960
Q86TM6,0,6,9423888.645833334,3.647936413711623e-5,1.065152286829787,0.09105971002638988,0.4689908917208762,0.9493149485362801,raw,8834185.6875,6185480.3125,8782645.25,17474535.375,6588478.5,8678006.75,E3 ubiquitin-protein ligase synoviolin OS=Homo sapiens OX=9606 GN=SYVN1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,84447,SYVN1,NA,Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; ER Quality Control Compartment (ERQC); XBP1(S) activates chaperone genes,ENSG00000162298
Q9UPT5,0,6,2830118.0052083335,1.0955233995538626e-5,1.065024567707254,0.09088671054558793,0.793572083828532,1,raw,2486686.5625,3484854.875,2210946.875,2648382.28125,2042119.4375,4107718,Exocyst complex component 7 OS=Homo sapiens OX=9606 GN=EXOC7 PE=1 SV=3,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,23265,EXOC7,Angiopoietin-like protein 8 regulatory pathway; Ciliary landscape,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing; VxPx cargo-targeting to cilium,ENSG00000182473
Q9NVS9,0,6,14397955.302083334,5.573370760560133e-5,1.0649138192503358,0.09073668155817265,0.6059931489015705,1,raw,11973753.75,16781024.25,12587847.1875,14874015.125,12300746.875,17870344.625,Pyridoxine-5'-phosphate oxidase OS=Homo sapiens OX=9606 GN=PNPO PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,55163,PNPO,Selenium micronutrient network; Vitamin B6-dependent and responsive disorders,Vitamins B6 activation to pyridoxal phosphate,ENSG00000108439
Q9Y6A4,0,6,6101155.036458333,2.361724173495719e-5,1.0648807050845428,0.0906918193498885,0.789278126963531,1,raw,4806715.375,7842549.28125,4912049.25,9134730.625,4680139.21875,5230746.46875,Cilia- and flagella-associated protein 20 OS=Homo sapiens OX=9606 GN=CFAP20 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,NA,29105,CFAP20,NA,NA,ENSG00000070761
P18887,0,6,4844189.140625,1.8751594617796676e-5,1.0640513557054543,0.08956778320149456,0.6690344184461716,1,raw,4294691.5,5509105.875,4380964.0625,4661570.75,4630788.8125,5588013.84375,DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
Q96K17,0,6,25759575.770833332,9.971392700797036e-5,1.0637944079452424,0.08921935826622947,0.46965898616914215,0.9502277451744474,raw,23672113.375,27314333.75,23336247.875,29056835.5,22639034.75,28538889.375,Transcription factor BTF3 homolog 4 OS=Homo sapiens OX=9606 GN=BTF3L4 PE=1 SV=1,NA,NA,NA,91408,BTF3L4,NA,NA,ENSG00000134717
Q6Y7W6,0,6,10863882.327799484,4.205350193243234e-5,1.0636528826464202,0.08902741193883965,0.5960526470949723,1,raw,9885588.75,11302403.6875,10573687.4980469,11246733.1875,9638645.96875,12536234.875,GRB10-interacting GYF protein 2 OS=Homo sapiens OX=9606 GN=GIGYF2 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,26058,GIGYF2,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000204120
Q9NX20,0,6,2069463.8385416667,8.010782785313792e-6,1.063625416670252,0.08899015773695534,0.4585299452243829,0.9412524313762942,raw,2458383.4375,1547180.4375,1700761.96875,2521674.375,1645620.4375,2543162.375,"39S ribosomal protein L16, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL16 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,RNA binding;structural molecule activity,54948,MRPL16,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000166902
A6NHN6,0.6666666666666666,6,1730257.0625,6.697731669575892e-6,1.0635466713913906,0.08888334416602132,0.9643096158809641,1,raw,1383039.125,2334890,1445587.125,1537449.375,1497137,2183439.75,Nuclear pore complex-interacting protein family member B15 OS=Homo sapiens OX=9606 GN=NPIPB15 PE=3 SV=3,NA,cell surface;membrane,NA,440348,NPIPB15,NA,NA,ENSG00000196436
Q9Y316,0,6,10363159.9765625,4.0115232745599043e-5,1.0633558313280629,0.08862444747155351,0.5958470725577898,1,raw,8589606.90625,12651062.6875,8073040.046875,13452581.28125,8389336.1875,11023332.75,Protein MEMO1 OS=Homo sapiens OX=9606 GN=MEMO1 PE=1 SV=1,metabolic process,NA,NA,51072,MEMO1,NA,ERBB2 Regulates Cell Motility,ENSG00000162959
Q9BRT2,0,6,2707081.296875,1.0478965540530059e-5,1.0633417029652221,0.08860527886042958,0.6296338809105895,1,raw,3079393.9375,2647007.59375,2118265.625,2417787.25,2814673.5625,3165359.8125,Ubiquinol-cytochrome-c reductase complex assembly factor 2 OS=Homo sapiens OX=9606 GN=UQCC2 PE=1 SV=1,cell growth;metabolic process,cytoskeleton;endosome;membrane,NA,84300,UQCC2,Mitochondrial complex III assembly,NA,ENSG00000137288
Q5VIR6,0,6,2349089.8645833335,9.09320003466221e-6,1.06311377694,0.08829600575253335,0.6770122757868147,1,raw,2345690.0625,2553768.828125,1916674.65625,1905244.625,2493735.421875,2879425.59375,Vacuolar protein sorting-associated protein 53 homolog OS=Homo sapiens OX=9606 GN=VPS53 PE=1 SV=2,conjugation,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,NA,55275,VPS53,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000141252; ENSG00000283883
Q9UIV1,0,6,2298102.1145833335,8.895829207322838e-6,1.0630124471808606,0.08815848998375428,0.8613001531855815,1,raw,2550471.4375,2351930.65625,1804106.71875,3338225.9375,1243746.375,2500131.5625,CCR4-NOT transcription complex subunit 7 OS=Homo sapiens OX=9606 GN=CNOT7 PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,29883,CNOT7,NA,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,ENSG00000198791
P35237,0,6,46727161.075520836,1.8087831764876253e-4,1.0629095836986593,0.08801887937375005,0.5802542834585867,1,raw,51731004.75,37717417.71875,43871088.5,61207923.53125,40090204.765625,45745327.1875,Serpin B6 OS=Homo sapiens OX=9606 GN=SERPINB6 PE=1 SV=3,coagulation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;nucleus,DNA binding;structural molecule activity,5269,SERPINB6,Ectoderm differentiation,Neutrophil degranulation; Dissolution of Fibrin Clot,ENSG00000124570
Q96AE7,0,6,1036514.40625,4.012291303513911e-6,1.0626237231608069,0.08763082656695466,0.7247584426592046,1,raw,888797.5625,1186603.75,973351.5,1140461.625,944457.375,1085414.625,Tetratricopeptide repeat protein 17 OS=Homo sapiens OX=9606 GN=TTC17 PE=1 SV=1,cell growth,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,NA,55761,TTC17,NA,NA,ENSG00000052841
P52565,0,6,188355961.46875,7.291157572042352e-4,1.0624806914399205,0.08743662325787825,0.8013628123586909,1,raw,176771290.1875,194513837.625,184859314.875,223875125.75,153706747.6875,196409452.6875,Rho GDP-dissociation inhibitor 1 OS=Homo sapiens OX=9606 GN=ARHGDIA PE=1 SV=3,development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane,DNA binding,396,ARHGDIA,Ciliary landscape; Nephrotic syndrome,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RHOH GTPase cycle; Axonal growth stimulation; Axonal growth inhibition (RHOA activation),ENSG00000141522
O95985,0,6,507463.5390625,1.9643639609383007e-6,1.0621838447205867,0.08703349204785904,1,1,raw,NA,452019.03125,NA,398904.96875,698802.84375,480127.3125,DNA topoisomerase 3-beta-1 OS=Homo sapiens OX=9606 GN=TOP3B PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8940,TOP3B,NA,NA,ENSG00000100038
Q9UPQ9,0,6,541493.6110026041,2.096092532080128e-6,1.0618320097961238,0.08655553845415372,0.9944033990868077,1,raw,482668.111328125,902250.9921875,236361.578125,381992.515625,287649.484375,958038.984375,Trinucleotide repeat-containing gene 6B protein OS=Homo sapiens OX=9606 GN=TNRC6B PE=1 SV=4,metabolic process,cytosol;membrane;nucleus,NA,23112,TNRC6B,NA,MAPK6/MAPK4 signaling; Oxidative Stress Induced Senescence; Estrogen-dependent gene expression; TP53 Regulates Metabolic Genes; Pre-NOTCH Transcription and Translation; Oncogene Induced Senescence; Transcriptional Regulation by VENTX; Ca2+ pathway; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; Regulation of RUNX1 Expression and Activity; Regulation of NPAS4 mRNA translation; Post-transcriptional silencing by small RNAs; Competing endogenous RNAs (ceRNAs) regulate PTEN translation,ENSG00000100354
J3KR97,0,6,23649841.15625,9.154725822288324e-5,1.0617807463880617,0.08648588595805791,0.8340975531613991,1,raw,24284408.375,25095224.40625,19458601.609375,33550973.40625,13725121.890625,25784717.25,Tubulin-specific chaperone D OS=Homo sapiens OX=9606 GN=TBCD PE=1 SV=1,cell growth;metabolic process,NA,DNA binding;motor activity,NA,TBCD,NA,NA,ENSG00000141556
A0A0A0MTN0,0,6,20635938.59375,7.988060412889241e-5,1.0612902749227306,0.08581930367586738,0.844506525473214,1,raw,23425940.15625,20148225.9375,17141292.84375,23695176.5625,14543273.59375,24861722.46875,Cullin-2 OS=Homo sapiens OX=9606 GN=CUL2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,membrane;nucleus,structural molecule activity,8453,CUL2,Type 2 papillary renal cell carcinoma; Hijack of ubiquitination by SARS-CoV-2,NA,ENSG00000108094
Q8IZP0,0,6,14582854.8359375,5.64494437181276e-5,1.0611761939107478,0.08566421608054135,0.7094418490898978,1,raw,11699110.78125,17085628.875,13451103.953125,18793873.65625,12193420.453125,14273991.296875,Abl interactor 1 OS=Homo sapiens OX=9606 GN=ABI1 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,DNA binding;motor activity;structural molecule activity,10006,ABI1,EGF/EGFR signaling pathway,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RAC2 GTPase cycle; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway,ENSG00000136754
X6R8A1,0,6,9011736.0859375,3.488394383053904e-5,1.060874984068813,0.08525465579033337,0.8598889639007916,1,raw,10141026.78125,10834265.203125,5285653.5625,10758361.625,5109640.53125,11941468.8125,Carboxypeptidase OS=Homo sapiens OX=9606 GN=CTSA PE=1 SV=1,cell organization and biogenesis,nucleus,structural molecule activity,5476,CTSA,Ciliary landscape,NA,ENSG00000064601
Q13363,0,6,25470094.588541668,9.859336098087393e-5,1.06075943696043,0.08509751350534252,0.4287871074517392,0.9136493636581154,raw,27945642.4375,23302246.46875,20856577.4375,29160424.125,21912073.125,29643603.9375,C-terminal-binding protein 1 OS=Homo sapiens OX=9606 GN=CTBP1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,1487,CTBP1,Notch signaling; Ectoderm differentiation; Ectoderm differentiation; Wnt signaling pathway; Pathways affected in adenoid cystic carcinoma; Wnt signaling pathway and pluripotency; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Malignant pleural mesothelioma,Deactivation of the beta-catenin transactivating complex; SUMOylation of transcription cofactors; Repression of WNT target genes; Signaling by TCF7L2 mutants,ENSG00000159692
Q9BVC6,0.3333333333333333,6,5402288.25,2.0911966137518783e-5,1.0607141115837704,0.08503586701798643,0.713594652060499,1,raw,6380119,5035221.5,4124778,5340930.5,4212467.5,7320213,Transmembrane protein 109 OS=Homo sapiens OX=9606 GN=TMEM109 PE=1 SV=1,coagulation;conjugation;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane,catalytic activity,79073,TMEM109,NA,NA,ENSG00000110108
Q9NUJ1,0,6,145033919.75520834,5.614184727578232e-4,1.0603811457344812,0.08458292349096347,0.4685843136122712,0.9488697854576846,raw,165301636.75,114822382.375,126231719.5625,175282738.96875,118024193.625,170540847.25,"Mycophenolic acid acyl-glucuronide esterase, mitochondrial OS=Homo sapiens OX=9606 GN=ABHD10 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytosol;endosome,structural molecule activity,55347,ABHD10,NA,Glucuronidation,ENSG00000144827
Q96B97,0,6,19021949.309895832,7.363293875297018e-5,1.060362302144797,0.08455728573320656,0.7490971715083674,1,raw,17095040.703125,22327841.875,15767551.59375,23675601.8125,13768470,21497189.875,SH3 domain-containing kinase-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3KBP1 PE=1 SV=2,cell death;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,30011,SH3KBP1,EGF/EGFR signaling pathway,Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Reelin signalling pathway,ENSG00000147010
P42166,0,6,96396410.04947917,3.7314529870431917e-4,1.0603456455968678,0.08453462318872769,0.6741127305595218,1,raw,91113798.09375,105175061,84718208.09375,96612119.0625,82875500.265625,117883773.78125,"Lamina-associated polypeptide 2, isoform alpha OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2",NA,membrane;nucleus,RNA binding;structural molecule activity,7112,TMPO,Envelope proteins and their potential roles in EDMD physiopathology; Overlap between signal transduction pathways contributing to LMNA laminopathies,NA,ENSG00000120802
Q9UHG3,0,6,21382977.247395832,8.277235042333705e-5,1.0603342471072386,0.08451911444125616,0.49498374560730063,0.9791715762431008,raw,20328537.9375,17275121.296875,22030506.15625,29584965.71875,17523687.40625,21555044.96875,Prenylcysteine oxidase 1 OS=Homo sapiens OX=9606 GN=PCYOX1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;conjugation,cell surface;cytoplasm;cytoskeleton;mitochondrion,structural molecule activity,51449,PCYOX1,NA,NA,ENSG00000116005
O14744,0,6,49889454.479166664,1.931193846769687e-4,1.0603224536885896,0.08450306817917724,0.941398098871561,1,raw,50524335.5625,54924325.1875,43365390.5625,58237495.25,37755180.5,54529999.8125,Protein arginine N-methyltransferase 5 OS=Homo sapiens OX=9606 GN=PRMT5 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;extracellular;membrane;nucleus,RNA binding;structural molecule activity,10419,PRMT5,Transcription co-factors SKI and SKIL protein partners; Nitric oxide metabolism in cystic fibrosis,snRNP Assembly; RMTs methylate histone arginines; Regulation of TP53 Activity through Methylation,ENSG00000100462
A0A2R8Y4Z8,0,6,1240626.9114583333,4.802399790812935e-6,1.0596133719262995,0.08353795520940681,0.48100549322167246,0.9622845920836873,raw,1162755.0625,856580.625,1169496.59375,2204208.375,818650,1232070.8125,Coiled-coil domain-containing protein 9 OS=Homo sapiens OX=9606 GN=CCDC9 PE=1 SV=1,NA,NA,NA,NA,CCDC9,NA,NA,ENSG00000105321
O75208,0,6,11130868.489583334,4.308699094968535e-5,1.059579578559707,0.08349194380455506,0.8405130116031037,1,raw,10581755.46875,11925061.890625,10457257.546875,11212212,9231010.90625,13377913.125,"Ubiquinone biosynthesis protein COQ9, mitochondrial OS=Homo sapiens OX=9606 GN=COQ9 PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome;nucleus,structural molecule activity,57017,COQ9,NA,Ubiquinol biosynthesis,ENSG00000088682
J3KR44,0,6,45427453.822916664,1.758472210472167e-4,1.0593798365860048,0.08321995487101391,0.6869737718491069,1,raw,51217465.28125,37158213.46875,43083032.28125,51943662.84375,34903599.0625,54258750,Ubiquitin thioesterase OS=Homo sapiens OX=9606 GN=OTUB1 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
O95149,0.3333333333333333,6,250352.68229166666,9.691017162070778e-7,1.0592331752758386,0.08302021330044831,0.5523347900374773,1,raw,194776.828125,503388.09375,167787.640625,206314.078125,182153.125,247696.328125,Snurportin-1 OS=Homo sapiens OX=9606 GN=SNUPN PE=1 SV=1,conjugation,cytosol;membrane;nucleus,RNA binding;structural molecule activity,10073,SNUPN,NA,snRNP Assembly,ENSG00000169371
Q14738,0,6,11663009.552083334,4.5146880271471036e-5,1.058955358428886,0.08264177202074675,0.7601257933448281,1,raw,11624543.96875,12191864.1875,9938973.15625,15938230.21875,7974572.65625,12309873.125,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform OS=Homo sapiens OX=9606 GN=PPP2R5D PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,5528,PPP2R5D,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; 16p11.2 proximal deletion syndrome; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome,"Separation of Sister Chromatids; DARPP-32 events; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling; PP2A-mediated dephosphorylation of key metabolic factors; ERKs are inactivated",ENSG00000112640
A0A096LP25,0.3333333333333333,6,1471949.2135416667,5.6978359327143895e-6,1.0589318635694338,0.0826097628402131,0.5671533792491266,1,raw,845611.9375,1761652.5625,1515090.28125,1604377.375,1779128,1325835.125,AP2-associated protein kinase 1 (Fragment) OS=Homo sapiens OX=9606 GN=AAK1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
O60220,0,6,4638467.916666667,1.7955258867073712e-5,1.0589078478018115,0.08257704324517731,0.8362422026544558,1,raw,4186829.25,4675380.875,5368958.5,4950797.5,2884245.625,5764595.75,Mitochondrial import inner membrane translocase subunit Tim8 A OS=Homo sapiens OX=9606 GN=TIMM8A PE=1 SV=1,cell growth;conjugation;defense response,cytoskeleton;endosome,structural molecule activity,1678,TIMM8A,NA,Mitochondrial protein import,ENSG00000126953
Q9BV20,0,6,1758653.484375,6.807652685485529e-6,1.0587853437051404,0.08241012949802846,0.7014741989137643,1,raw,1904693.125,1268376.375,1779423.125,2665105,1050296.15625,1884027.125,Methylthioribose-1-phosphate isomerase OS=Homo sapiens OX=9606 GN=MRI1 PE=1 SV=1,cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,84245,MRI1,Methionine de novo and salvage pathway,Methionine salvage pathway,ENSG00000037757
P10109,0,6,3619192.9635416665,1.4009700555820874e-5,1.0587325075865366,0.0823381334992614,0.9764733288818376,1,raw,2712988.625,5161748.25,2940713.34375,4217736.5625,2872329.25,3809641.75,"Adrenodoxin, mitochondrial OS=Homo sapiens OX=9606 GN=FDX1 PE=1 SV=1",cellular homeostasis;metabolic process,endosome,structural molecule activity,2230,FDX1,NA,Endogenous sterols; Pregnenolone biosynthesis; Defective CYP11A1 causes AICSR; Electron transport from NADPH to Ferredoxin,ENSG00000137714
Q6P6B1,0,6,1994443.4166666667,7.720382782708902e-6,1.0582230044403287,0.08164368557877529,0.8572338157367225,1,raw,1670605.28125,2222128.5625,1916735.9375,2028334.0625,1102551.03125,3026305.625,Glutamate-rich protein 5 OS=Homo sapiens OX=9606 GN=ERICH5 PE=1 SV=1,NA,NA,NA,203111,ERICH5,NA,NA,ENSG00000177459
Q96EH3,0,6,4077635.3411458335,1.5784306247485318e-5,1.0580771274003478,0.0814447949967383,0.8547416901119588,1,raw,5011997.578125,4240928,2715890.75,5303080,3280728.96875,3913186.75,Mitochondrial assembly of ribosomal large subunit protein 1 OS=Homo sapiens OX=9606 GN=MALSU1 PE=1 SV=1,metabolic process,cytosol;endosome,protein binding,115416,MALSU1,NA,NA,ENSG00000156928
Q6DD88,0,6,7833704.643229167,3.0323847719627325e-5,1.0580684761836594,0.081432998958325,0.6485871645069106,1,raw,8890191.796875,6876275.125,6738076.625,9188483.03125,5902769.59375,9406431.6875,Atlastin-3 OS=Homo sapiens OX=9606 GN=ATL3 PE=1 SV=1,cell growth;metabolic process,cytoskeleton;extracellular,structural molecule activity,25923,ATL3,NA,NA,ENSG00000184743
Q9NZB2,0,6,28573995.764322918,1.1060839484770661e-4,1.057988477414404,0.08132391510068986,0.46815399476973474,0.9488154073830735,raw,25920280.9375,31811474.46875,23329577.1328125,32450826.03125,24275642.578125,33656173.4375,Constitutive coactivator of PPAR-gamma-like protein 1 OS=Homo sapiens OX=9606 GN=FAM120A PE=1 SV=2,NA,cytoplasm;cytoskeleton;cytosol;membrane,NA,23196,FAM120A,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000048828
Q8WVJ2,0,6,4903404.760416667,1.8980815084863666e-5,1.057554513120986,0.08073203098808195,0.6674469391535953,1,raw,4071790.0625,5674444.65625,4594719.5,5427574.125,4859166.34375,4792733.875,NudC domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NUDCD2 PE=1 SV=1,metabolic process,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,134492,NUDCD2,NA,NA,ENSG00000170584
Q6L8Q7,0,6,20803406.497395832,8.052886334204397e-5,1.057052892867661,0.08004756817630299,0.9454385776435986,1,raw,22006056.5625,19349454.5625,20830084.875,23261565.75,17254092.8125,22119184.421875,"2',5'-phosphodiesterase 12 OS=Homo sapiens OX=9606 GN=PDE12 PE=1 SV=2",cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;endosome,structural molecule activity,201626,PDE12,Phosphodiesterases in neuronal function,OAS antiviral response,ENSG00000174840
P52758,0,6,3912599.7708333335,1.51454624653415e-5,1.0569690848008542,0.07993318007276451,0.7275548552505195,1,raw,4330851.125,3424826.5625,3659776.5,4447413.625,3035155.0625,4577575.75,2-iminobutanoate/2-iminopropanoate deaminase OS=Homo sapiens OX=9606 GN=RIDA PE=1 SV=1,cell differentiation;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;endosome;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,10247,RIDA,NA,Threonine catabolism,ENSG00000132541
P30626,0,6,40605406.84375,1.5718133754093433e-4,1.0565956610471592,0.07942339052951074,0.6564230428563108,1,raw,40418562.75,38557834.375,37602934.25,54724071.375,31588997.8125,40740040.5,Sorcin OS=Homo sapiens OX=9606 GN=SRI PE=1 SV=1,conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,6717,SRI,NA,Stimuli-sensing channels; Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels; Sodium/Calcium exchangers,ENSG00000075142
P31949,0,6,67420975.45833333,2.609829558323089e-4,1.0565333508135306,0.07933830848806976,0.5891708463763479,1,raw,80609311.75,58021866.25,52517812,74556533,53653903.5,85166426.25,Protein S100-A11 OS=Homo sapiens OX=9606 GN=S100A11 PE=1 SV=2,development;metabolic process,membrane;nucleus,structural molecule activity,6282,S100A11,NA,Neutrophil degranulation,ENSG00000163191
Q14558,0,6,56450140.247395836,2.1851544506380752e-4,1.056520009736081,0.0793200911475744,0.5794019508175612,1,raw,53349590.84375,48729287.796875,50873395.5625,93969847.5,38029959.40625,53748760.375,Phosphoribosyl pyrophosphate synthase-associated protein 1 OS=Homo sapiens OX=9606 GN=PRPSAP1 PE=1 SV=2,cellular homeostasis,nucleus,DNA binding;structural molecule activity,5635,PRPSAP1,NA,NA,ENSG00000161542
Q96BJ3,0,6,1744607.90625,6.7532830109070065e-6,1.0563813960188861,0.07913079947297157,0.6541158965254783,1,raw,1639501.90625,2071681.5,1313629.1875,1731939.3125,1541430.375,2169465.15625,"Axin interactor, dorsalization-associated protein OS=Homo sapiens OX=9606 GN=AIDA PE=1 SV=1",defense response;metabolic process,cytoskeleton;nucleus,structural molecule activity,64853,AIDA,NA,NA,ENSG00000186063
Q8NC96,0,6,2577252.7057291665,9.976406073858979e-6,1.056359277452451,0.07910059193589963,0.6740794646129651,1,raw,2541358.453125,2503791.96875,1767168.25,5151253.5,2644903.875,855040.1875,Adaptin ear-binding coat-associated protein 1 OS=Homo sapiens OX=9606 GN=NECAP1 PE=1 SV=2,conjugation,cytoplasm;cytoskeleton;cytosol,NA,25977,NECAP1,NA,Golgi Associated Vesicle Biogenesis; Cargo recognition for clathrin-mediated endocytosis,ENSG00000089818
O75937,0,6,28749421.90625,1.1128745997156681e-4,1.056136715916302,0.0787966023172771,0.5372121367853604,1,raw,24578572.9375,28387301.96875,29589839.25,29980871.875,24468657.25,35491288.15625,DnaJ homolog subfamily C member 8 OS=Homo sapiens OX=9606 GN=DNAJC8 PE=1 SV=2,NA,cytosol;membrane;nucleus,structural molecule activity,22826,DNAJC8,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000126698; ENSG00000285317
Q96EV8,0.16666666666666666,6,2440521.6119791665,9.447127392284387e-6,1.0559696900345448,0.07856842497627324,0.3998390902558158,0.884006512615099,raw,2143743.4375,2618412.75,2258436.21875,2621116.4375,2236456.328125,2764964.5,Dysbindin OS=Homo sapiens OX=9606 GN=DTNBP1 PE=1 SV=1,cell growth;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,NA,84062,DTNBP1,Alstrom syndrome,Golgi Associated Vesicle Biogenesis,ENSG00000047579
B4DL54,0,6,1361903.75,5.271855884876162e-6,1.0559254242881169,0.07850794661972131,0.7256409637351242,1,raw,1089335.4375,1430281,1405350.3125,1483945.125,947586.125,1814924.5,Protein farnesyltransferase subunit beta OS=Homo sapiens OX=9606 GN=CHURC1-FNTB PE=2 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,nucleus,structural molecule activity,100529261,CHURC1-FNTB,NA,NA,ENSG00000125954
P21291,0,6,12648239.680664066,4.896065290504784e-5,1.055809482824777,0.07834952884313541,0.330788404488297,0.8133261464868501,raw,12225962.8125,11832683.2089844,11516108.6230469,15923090.15625,12232776.59375,12158816.6894531,Cysteine and glycine-rich protein 1 OS=Homo sapiens OX=9606 GN=CSRP1 PE=1 SV=3,cell growth;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,1465,CSRP1,MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling pathway,MTF1 activates gene expression,ENSG00000159176
Q68CP9,0,6,4613198.083333333,1.7857440706599322e-5,1.0553523530846136,0.07772475549959922,0.729132542202664,1,raw,3977970,5340212,3876994.5,6822347,3463505,4198160,AT-rich interactive domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ARID2 PE=1 SV=2,cell differentiation;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,196528,ARID2,NA,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,ENSG00000189079
P05141,0,6,497363928.578125,0.0019252689140474984,1.0553136484756092,0.07767184428822303,0.51808621155234,1,raw,443217157.46875,530668377,469620862.40625,560021581.0625,440204866,540450727.53125,ADP/ATP translocase 2 OS=Homo sapiens OX=9606 GN=SLC25A5 PE=1 SV=7,cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;endosome,catalytic activity;structural molecule activity,292,SLC25A5,Electron transport chain: OXPHOS system in mitochondria; Alzheimer's disease and miRNA effects; Alzheimer's disease,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane; Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,ENSG00000005022
Q8N9M5,0.16666666666666666,6,157062.9296875,6.079821207401314e-7,1.0553017162192653,0.07765553188252176,1,1,raw,NA,152836.859375,NA,161289,NA,NA,Transmembrane protein 102 OS=Homo sapiens OX=9606 GN=TMEM102 PE=1 SV=1,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;endosome;nucleus,NA,284114,TMEM102,NA,NA,ENSG00000181284; ENSG00000284228
Q9BW27,0,6,18867812.5078125,7.303628351419945e-5,1.0551384644912034,0.07743233440825657,0.6001785087318641,1,raw,18454923.78125,19886482.96875,16132984.34375,17825780.5625,17022532.328125,23884171.0625,Nuclear pore complex protein Nup85 OS=Homo sapiens OX=9606 GN=NUP85 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,79902,NUP85,NA,SARS-CoV-2 activates/modulates innate and adaptive immune responses; SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000125450
Q96CU9,0,6,5221148.223958333,2.0210782876752827e-5,1.0544487681678305,0.07648900152730569,0.6920751229017688,1,raw,5885841.375,3667252.90625,5540596.09375,6206318.1875,4326233.53125,5700647.25,FAD-dependent oxidoreductase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FOXRED1 PE=1 SV=2,cell growth,cytoskeleton;endosome;nucleus,structural molecule activity,55572,FOXRED1,NA,NA,ENSG00000110074
P23634,0,6,3601697.6875,1.3941977286861675e-5,1.0543781165223187,0.07639233282548988,0.7149074408928693,1,raw,3677463.9375,3713754.5,3231125.4375,3971361.5,3139043.25,3877437.5,Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens OX=9606 GN=ATP2B4 PE=1 SV=2,coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,catalytic activity;DNA binding;structural molecule activity,493,ATP2B4,Vitamin D-sensitive calcium signaling in depression,Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels,ENSG00000058668
P78417,0,6,142757232.0221355,5.526055374651305e-4,1.0540248623838961,0.07590889772931209,0.7220813788487291,1,raw,132403893.71875,145136801.25,136816496.125,187908593.21875,110069619.320313,144207988.5,Glutathione S-transferase omega-1 OS=Homo sapiens OX=9606 GN=GSTO1 PE=1 SV=2,cellular homeostasis;development;metabolic process,cytosol;nucleus,structural molecule activity,9446,GSTO1,Myometrial relaxation and contraction pathways; Arsenic metabolism and reactive oxygen species generation; Metapathway biotransformation Phase I and II,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Glutathione conjugation; Vitamin C (ascorbate) metabolism; Methylation,ENSG00000148834
Q9Y5S9,0,6,58032059.962239586,2.2463897086957805e-4,1.0539213457560155,0.07576720253307193,0.7239455469361331,1,raw,62215757.5625,52216816.7734375,55995827.375,65570514.9375,48105323.9375,64088119.1875,RNA-binding protein 8A OS=Homo sapiens OX=9606 GN=RBM8A PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding,9939,RBM8A,NA,Regulation of expression of SLITs and ROBOs; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSG00000265241
P13010,0,6,477138766.75,0.0018469784045998421,1.0538676662868751,0.07569371974755533,0.4965900996978221,0.9799840988442335,raw,560267324.84375,411515209.984375,358871921.484375,565417237.546875,378203514.390625,588557392.25,X-ray repair cross-complementing protein 5 OS=Homo sapiens OX=9606 GN=XRCC5 PE=1 SV=3,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,7520,XRCC5,"Non-homologous end joining; Male infertility; DNA repair pathways, full network; p53 transcriptional gene network",Neutrophil degranulation; Cytosolic sensors of pathogen-associated DNA ; Nonhomologous End-Joining (NHEJ); 2-LTR circle formation; IRF3-mediated induction of type I IFN,ENSG00000079246
O94818,0.16666666666666666,6,316759.578125,1.2261592245628018e-6,1.0535159116334156,0.07521210386691028,1,1,raw,NA,308504.625,NA,325014.53125,NA,NA,Nucleolar protein 4 OS=Homo sapiens OX=9606 GN=NOL4 PE=1 SV=2,NA,membrane,RNA binding,8715,NOL4,NA,NA,ENSG00000101746
P62263,0,6,195441381,7.565430336565078e-4,1.0533223215486498,0.07494697534242824,0.9310904132722864,1,raw,210872531.625,190649160,180426701.0625,245182288.125,144702589.375,200815015.8125,40S ribosomal protein S14 OS=Homo sapiens OX=9606 GN=RPS14 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6208,RPS14,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000164587
Q92896,0,6,86536574.11458333,0.00033497840614873724,1.053313371158915,0.074934716286029393,0.9411632404537104,1,raw,98133806.75,73317174.625,86608717.625,91372616.4375,66421478.4375,103365650.8125,Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,chromosome;cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular,antioxidant activity;structural molecule activity,2734,GLG1,NA,Cell surface interactions at the vascular wall,ENSG00000090863
Q9Y6I4,0,6,1081187.8828125,4.1852199192945e-6,1.0532886462460607,0.07490085083933522,0.9385063277835051,1,raw,1135415.203125,750465.96875,1320310.5625,597580.5625,1292686.875,1390668.125,Ubiquitin carboxyl-terminal hydrolase 3 OS=Homo sapiens OX=9606 GN=USP3 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,9960,USP3,NA,Ub-specific processing proteases,ENSG00000140455
P06454,0,6,482070462.3463542,0.001866068731983152,1.052882303351963,0.07434417343800595,0.987769408465319,1,raw,448790153.0625,555785222.75,443816184.625,472523210.078125,349368194.75,622139808.8125,Prothymosin alpha OS=Homo sapiens OX=9606 GN=PTMA PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,5757,PTMA,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000187514
O75165,0,6,1351666.7005208333,5.232228819057074e-6,1.052864888731442,0.07432031113700459,0.9958518738710683,1,raw,1081337,1838274.109375,1138687.65625,1249531.34375,866715.828125,1935454.265625,DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,NA,23317,DNAJC13,NA,Neutrophil degranulation,ENSG00000138246
Q9Y2B0,0,6,31426244.4375,1.2164929546408191e-4,1.052568394930275,0.07391398133995541,0.96778155724959,1,raw,33736955.625,27858706,32295184.25,39639600.375,21034130.125,33992890.25,Protein canopy homolog 2 OS=Homo sapiens OX=9606 GN=CNPY2 PE=1 SV=1,metabolic process,extracellular,NA,10330,CNPY2,NA,NA,ENSG00000257727
O15294,0,6,5904409.848958333,2.2855651736733792e-5,1.0515225651058173,0.07247980985757209,0.7880014376186155,1,raw,4304186.375,9255575.78125,4901138.9375,4959751.90625,5153658.1875,6852147.90625,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Homo sapiens OX=9606 GN=OGT PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,8473,OGT,Ectoderm differentiation; Ectoderm differentiation; Malignant pleural mesothelioma,UCH proteinases; Regulation of necroptotic cell death; HATs acetylate histones,ENSG00000147162
Q7Z4R8,0,6,738204.625,2.857550246520028e-6,1.0514546953141126,0.07238668910558356,1,1,raw,719688.9375,NA,NA,756720.3125,NA,NA,UPF0669 protein C6orf120 OS=Homo sapiens OX=9606 GN=C6orf120 PE=1 SV=1,metabolic process,cell surface;mitochondrion,NA,387263,C6orf120,NA,Neutrophil degranulation,ENSG00000185127
U3KQK0,0,6,3671483458.5507817,0.014212114238753234,1.0513984699511036,0.07230954054024916,0.42605730985085,0.911043979658989,raw,4070037305.6875,3262794992.03906,3104176171.02344,4279230995.84375,3244736326.61719,4067924960.09375,Histone H2B OS=Homo sapiens OX=9606 GN=H2BC15 PE=1 SV=1,NA,cytosol;membrane;nucleus,RNA binding;structural molecule activity,NA,H2BC15,NA,NA,ENSG00000233822
O95716,0,6,9459472.485677084,3.661710725992265e-5,1.0508900560893688,0.071611742723957,0.6678504017812823,1,raw,7795523.8984375,10417558.5,9414905,10281292.28125,8192238.546875,10655316.6875,Ras-related protein Rab-3D OS=Homo sapiens OX=9606 GN=RAB3D PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,9545,RAB3D,NA,RAB geranylgeranylation; Neutrophil degranulation,ENSG00000105514
Q9P016,0,6,5529803.364583333,2.1405570261324743e-5,1.0504778524172398,0.07104574550011349,0.8575114068077,1,raw,6859270,4189572,5136919.375,6381337.34375,3406210.25,7205511.21875,Thymocyte nuclear protein 1 OS=Homo sapiens OX=9606 GN=THYN1 PE=1 SV=1,NA,NA,NA,29087,THYN1,NA,NA,ENSG00000151500
A0A087WUB9,0,6,9432122.364583334,3.6511236417845766e-5,1.050346115486433,0.07086481057179055,0.5164027078192717,1,raw,9671425.59375,9153231,7725161.1875,9614060.625,7732106.59375,12696749.1875,Beta-catenin-like protein 1 OS=Homo sapiens OX=9606 GN=CTNNBL1 PE=1 SV=1,NA,cytosol;endoplasmic reticulum;membrane,NA,NA,CTNNBL1,NA,NA,ENSG00000132792
Q8WYP5,0,6,15143321.107421882,5.861897839456824e-5,1.050231671085267,0.07070760775717583,0.7477396177656159,1,raw,14608163.671875,14786049.5507813,14614857.265625,20194640.234375,11307229.953125,15348985.96875,Protein ELYS OS=Homo sapiens OX=9606 GN=AHCTF1 PE=1 SV=3,cell differentiation;cell growth;conjugation;metabolic process,cytoskeleton;cytosol;membrane;nucleus,RNA binding,25909,AHCTF1,Gastric cancer network 2,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000153207
O00429,0,6,29059968.752604168,1.124895700468801e-4,1.0502282992940861,0.07070297594653983,0.9766496358696686,1,raw,33750473.9375,27972575.203125,25219904.625,31101168.75,20869987.15625,35445702.84375,Dynamin-1-like protein OS=Homo sapiens OX=9606 GN=DNM1L PE=1 SV=2,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;mitochondrion;nucleus,DNA binding;motor activity;structural molecule activity,10059,DNM1L,Synaptic vesicle pathway; CAMKK2 pathway,Apoptotic execution phase,ENSG00000087470
Q9NW64,0,6,6942816.9375,2.6875269511209783e-5,1.050033597723806,0.07043549026668255,0.6957689133542257,1,raw,5791983.3125,7844069.71875,6034635,10538663.5,5110980.59375,6336569.5,Pre-mRNA-splicing factor RBM22 OS=Homo sapiens OX=9606 GN=RBM22 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,55696,RBM22,NA,mRNA Splicing - Major Pathway,ENSG00000086589
P38919,0,6,211531157.41927084,8.188256894625989e-4,1.049649236219168,0.06990729959533018,0.8004085304779468,1,raw,218904990.71875,227565326.046875,176949526.09375,244797180.9375,171196464.40625,229773456.3125,Eukaryotic initiation factor 4A-III OS=Homo sapiens OX=9606 GN=EIF4A3 PE=1 SV=4,cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,9775,EIF4A3,NA,Regulation of expression of SLITs and ROBOs; Deadenylation of mRNA; ISG15 antiviral mechanism; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSG00000141543
P55769,0,6,42757895.5625,1.6551350515488778e-4,1.0495346359105662,0.06974977809446156,0.49675769359682403,0.9800406958404904,raw,47482270.875,36149887.9375,38526604.6875,49834287.875,36444526,48109796,NHP2-like protein 1 OS=Homo sapiens OX=9606 GN=SNU13 PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4809,SNU13,mRNA processing,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; mRNA Splicing - Major Pathway,ENSG00000100138
C9JZG2,0.5,6,1229090.6,4.757743352021737e-6,1.0491918313400732,0.06927848041373957,0.8980587162872526,1,raw,1002844,1244673,1345186,1761920.625,790829.375,NA,Trifunctional purine biosynthetic protein adenosine-3 (Fragment) OS=Homo sapiens OX=9606 GN=GART PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,NA,GART,Metabolic reprogramming in colon cancer,NA,ENSG00000159131
A0A590UK80,0,6,72493956.625,2.8062019203006343e-4,1.048739972372111,0.06865701626396374,0.9991282870673406,1,raw,61258072.875,91384967.9375,64866237.0625,95839068.75,53358834.25,68256558.875,Uncharacterized protein (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1,metabolic process,membrane,RNA binding;structural molecule activity,NA,NA,NA,NA,NA
Q5TGZ0,0.6666666666666666,6,2231783.65,8.639114011561317e-6,1.0484236111487244,0.06822174953021173,0.5874310097435542,1,raw,2435972,2095207.375,1993903.375,2495793.5,2138042,NA,MICOS complex subunit MIC10 OS=Homo sapiens OX=9606 GN=MICOS10 PE=1 SV=1,cell growth,cytoskeleton;endosome,NA,440574,MICOS10,NA,Cristae formation,ENSG00000173436
P82914,0,6,2948891.4166666665,1.1414999458526325e-5,1.0480314147568388,0.06768196232825711,0.46737445535667016,0.9485672170384823,raw,2886557.4375,2980369.625,2594003.9375,3588827.0625,2618387.5625,3025202.875,"28S ribosomal protein S15, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS15 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane,structural molecule activity,64960,MRPS15,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000116898
Q16342,0.3333333333333333,6,644434.5875,2.494571494152665e-6,1.047632154634426,0.06713224565234424,0.7379896569299728,1,raw,584876.125,693591.875,594539.6875,NA,560006.625,789158.625,Programmed cell death protein 2 OS=Homo sapiens OX=9606 GN=PDCD2 PE=1 SV=2,metabolic process,membrane;nucleus,RNA binding;structural molecule activity,5134,PDCD2,NA,NA,ENSG00000071994
A0A5F9ZHQ7,0.5,6,566357.8177083334,2.1923405337794966e-6,1.0471752487942696,0.06650290302244795,0.858994580485364,1,raw,648549.1875,503164.5625,521364.5,721746,457362.65625,545960,HAUS augmin-like complex subunit 3 OS=Homo sapiens OX=9606 GN=HAUS3 PE=1 SV=1,cell differentiation;cell growth;metabolic process,endoplasmic reticulum;nucleus,NA,NA,HAUS3,NA,NA,ENSG00000214367
P62258,0,6,1078956098.71875,0.004176580803565207,1.0471509698171722,0.06646945344850227,0.7587630985921505,1,raw,1069069678.3125,1190564331.15625,904583439.03125,1198491355.40625,864327194.40625,1246700594,14-3-3 protein epsilon OS=Homo sapiens OX=9606 GN=YWHAE PE=1 SV=1,coagulation;conjugation;defense response;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7531,YWHAE,Cell cycle; Myometrial relaxation and contraction pathways; VEGFA-VEGFR2 signaling pathway; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,RAB GEFs exchange GTP for GDP on RABs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Recruitment of NuMA to mitotic centrosomes; Regulation of HSF1-mediated heat shock response; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; TP53 Regulates Metabolic Genes; Signaling by Hippo; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; HSF1 activation; NADE modulates death signalling; Activation of BAD and translocation to mitochondria,ENSG00000108953; ENSG00000274474
Q8NBN3,0,6,2160108.96875,8.361665190273884e-6,1.0465867834286393,0.06569194545036637,0.9385664146765558,1,raw,2381852.40625,2756048.5625,1272420.40625,2884444,1804697.5,1861190.9375,Transmembrane protein 87A OS=Homo sapiens OX=9606 GN=TMEM87A PE=1 SV=3,conjugation,cytoskeleton;cytosol;extracellular,NA,25963,TMEM87A,NA,RHOA GTPase cycle,ENSG00000103978
Q9UL54,0,6,4211745.78125,1.630344052029019e-5,1.0465187867674262,0.06559821062173607,0.7653002247521223,1,raw,3743070.375,5233415.0625,3901745.203125,4250039.1875,4058955.203125,4083249.65625,Serine/threonine-protein kinase TAO2 OS=Homo sapiens OX=9606 GN=TAOK2 PE=1 SV=2,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;DNA binding;motor activity;signal transducer activity;structural molecule activity,9344,TAOK2,MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; 16p11.2 proximal deletion syndrome,NA,ENSG00000149930
Q9NZL4,0,6,11816274.9921875,4.574016251506665e-5,1.046466805645204,0.06552654944304757,0.8918277208771362,1,raw,11942525.25,11365337.59375,11824465.171875,12373910.296875,9364018.625,14027393.015625,Hsp70-binding protein 1 OS=Homo sapiens OX=9606 GN=HSPBP1 PE=1 SV=2,metabolic process,NA,DNA binding;structural molecule activity,23640,HSPBP1,NA,NA,ENSG00000133265
Q8N684,0,6,239374099.234375,9.266042139436582e-4,1.0463719631408943,0.06539579038719721,0.8963247984933861,1,raw,270514242.125,209346473.90625,226471819.6875,335418038.8125,157520258.3125,236973762.5625,Cleavage and polyadenylation specificity factor subunit 7 OS=Homo sapiens OX=9606 GN=CPSF7 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding,79869,CPSF7,NA,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; RHOBTB1 GTPase cycle; Processing of Intronless Pre-mRNAs,ENSG00000149532
Q9GZT8,0,6,8082384.8203125,3.128647525847419e-5,1.0462862580219416,0.06527761882061216,0.6661779955415714,1,raw,8054588.25,8186329.359375,7645743.015625,8873827.375,7306415.921875,8427405,NIF3-like protein 1 OS=Homo sapiens OX=9606 GN=NIF3L1 PE=1 SV=2,defense response;metabolic process,endosome;membrane;nucleus,structural molecule activity,60491,NIF3L1,NA,NA,ENSG00000196290
Q92934,0,6,850600.5794270834,3.29262891766892e-6,1.045810075237526,0.06462087415491465,0.7082681540519651,1,raw,686725.65625,1121119.1953125,583086.765625,1172477.75,493531.421875,1046662.6875,Bcl2-associated agonist of cell death OS=Homo sapiens OX=9606 GN=BAD PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endosome,DNA binding;structural molecule activity,572,BAD,Leptin signaling pathway; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Amyotrophic lateral sclerosis (ALS); Apoptosis; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; RAC1/PAK1/p38/MMP2 pathway; IL6 signaling pathway; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Oxidative damage response; IL-4 signaling pathway; NO/cGMP/PKG mediated neuroprotection; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Ras signaling; Non-small cell lung cancer; Pancreatic adenocarcinoma pathway; Measles virus infection; Gastrin signaling pathway; Hepatitis B infection; Melanoma; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; EGFR tyrosine kinase inhibitor resistance; Host-pathogen interaction of human coronaviruses - apoptosis; Alzheimer's disease; ErbB signaling pathway; DNA damage response (only ATM dependent),NRAGE signals death through JNK; Constitutive Signaling by AKT1 E17K in Cancer; AKT phosphorylates targets in the cytosol; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members; Activation of BAD and translocation to mitochondria,ENSG00000002330
Q9UKM9,0,6,44136574.192708336,1.7085029569534763e-4,1.0458032819698078,0.06461150281138728,0.711943077167917,1,raw,43816671.75,48321908.75,37593686.40625,45190762.5,39315600.625,50580815.125,RNA-binding protein Raly OS=Homo sapiens OX=9606 GN=RALY PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,22913,RALY,NA,NA,ENSG00000125970
P61106,0,6,32283778.651041668,1.2496876410505032e-4,1.0457915708231955,0.0645953470887642,0.6207459638522248,1,raw,30471774.5,37247650.15625,24961286.09375,37395305.375,26104302.59375,37522353.1875,Ras-related protein Rab-14 OS=Homo sapiens OX=9606 GN=RAB14 PE=1 SV=4,cell growth;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,51552,RAB14,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Ciliary landscape,RAB geranylgeranylation; RAB GEFs exchange GTP for GDP on RABs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Neutrophil degranulation; Synthesis of PIPs at the plasma membrane,ENSG00000119396
P82979,0,6,28864509.291666668,1.1173295702676169e-4,1.0456812601365546,0.064443162773132,0.7575256512506289,1,raw,25239763,32346573.75,27396340,29086540,25293633,33824206,SAP domain-containing ribonucleoprotein OS=Homo sapiens OX=9606 GN=SARNP PE=1 SV=3,cellular homeostasis;conjugation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,84324,SARNP,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000205323
Q9UMX5,0,6,9922832.197916666,3.841074768846598e-5,1.045118453185887,0.06366646588423966,0.5933802542282982,1,raw,8294817,10374989.125,10063325.5,12054307.375,8669066.3125,10080487.875,Neudesin OS=Homo sapiens OX=9606 GN=NENF PE=1 SV=1,development;metabolic process,cell surface;cytoskeleton;endosome;extracellular;nucleus,antioxidant activity;structural molecule activity,29937,NENF,NA,NA,ENSG00000117691
Q9BQ61,0,6,7387670.328125,2.859727296796913e-5,1.0450841502584645,0.06361911290209007,0.7390127661790967,1,raw,6529215.4375,8906790.28125,6139434.5,7610103.75,6416225.6875,8724252.3125,Telomerase RNA component interacting RNase OS=Homo sapiens OX=9606 GN=TRIR PE=1 SV=1,cellular component movement;cellular homeostasis,NA,RNA binding;structural molecule activity,79002,TRIR,NA,NA,ENSG00000123144
E9PR30,0,6,35187578.333333336,1.362092158943863e-4,1.0448662687835983,0.0633183052642,0.5228309633407555,1,raw,31388484,39129084,31063050,37166252,31493940,40884660,40S ribosomal protein S30 OS=Homo sapiens OX=9606 GN=FAU PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,structural molecule activity,NA,FAU,NA,NA,ENSG00000149806
Q8IXT5,0,6,5931513.708333333,2.2960569312993457e-5,1.0443853179199039,0.06265408134532308,0.7949524512051417,1,raw,7443649.71875,5593501.53125,4341377.8125,6734005.5625,5841770.875,5634776.75,RNA-binding protein 12B OS=Homo sapiens OX=9606 GN=RBM12B PE=1 SV=2,metabolic process,membrane;nucleus,NA,389677,RBM12B,NA,NA,ENSG00000183808
Q4G0J3,0,6,7085872.395833333,2.742902946662384e-5,1.044242270744253,0.06245646502313377,0.8325956057714502,1,raw,7198064.65625,8347992.0625,5311195.9375,8717326.1875,6071805.71875,6868849.8125,La-related protein 7 OS=Homo sapiens OX=9606 GN=LARP7 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding,51574,LARP7,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000174720
Q7Z7A3,0,6,2417723.828125,9.358878401873924e-6,1.0439795503679092,0.06209345245209435,0.6023732362647338,1,raw,2430065.03125,2463247.59375,2091871.375,3064626.65625,2272661.375,2183870.9375,Cytoplasmic tRNA 2-thiolation protein 1 OS=Homo sapiens OX=9606 GN=CTU1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol,RNA binding;structural molecule activity,90353,CTU1,NA,tRNA modification in the nucleus and cytosol,ENSG00000142544
Q15907,0,6,138379186.57291666,5.356583599089196e-4,1.0439038250964114,0.06198880247500121,0.5806043164439297,1,raw,116721894.25,145202664.3125,136310799.5,172887156.625,116857239.75,142295365,Ras-related protein Rab-11B OS=Homo sapiens OX=9606 GN=RAB11B PE=1 SV=4,cell death;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,9230,RAB11B,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Intracellular trafficking proteins involved in CMT neuropathy,RAB geranylgeranylation; TBC/RABGAPs,ENSG00000185236
Q9P2K8,0.16666666666666666,6,718058.0375,2.7795638940541895e-6,1.0436520339358055,0.06164078030454221,0.6131714393745542,1,raw,726652.0625,519964.4375,NA,1279365.875,431673.125,632634.6875,eIF-2-alpha kinase GCN2 OS=Homo sapiens OX=9606 GN=EIF2AK4 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;Golgi;nucleus,RNA binding;signal transducer activity;structural molecule activity,440275,EIF2AK4,Measles virus infection,Response of EIF2AK4 (GCN2) to amino acid deficiency,ENSG00000128829
P07437,0,6,512870577.8229167,0.0019852943160451548,1.043521889973305,0.061460864249254524,0.8730625971671813,1,raw,547176757.609375,537148534.890625,472245577.25,570087104.9375,379574568,570990924.25,Tubulin beta chain OS=Homo sapiens OX=9606 GN=TUBB PE=1 SV=2,cell differentiation;cell growth;coagulation;conjugation;metabolic process,cell surface;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,antioxidant activity;motor activity;structural molecule activity,203068,TUBB,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,Potential therapeutics for SARS; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Neutrophil degranulation,ENSG00000183311; ENSG00000196230; ENSG00000224156; ENSG00000227739; ENSG00000229684; ENSG00000232421; ENSG00000232575; ENSG00000235067
J3QR07,0,6,1552762.8541666667,6.0106611723153335e-6,1.042868284952713,0.06055695589684089,0.7615849293746912,1,raw,1151843.125,2314246,1381023.875,1440226,1348842.375,1680395.75,YTH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=YTHDC1 PE=1 SV=1,NA,cytoplasm;cytoskeleton;membrane,RNA binding,91746,YTHDC1,NA,NA,ENSG00000083896; ENSG00000275272
D3YTI2,0.3333333333333333,6,601421.8125,2.3280713644565652e-06,1.0425991608020344,0.06018460380809142,0.7032708612084728,1,raw,501379,680687.0625,517979.6875,540045.1875,433303.75,935136.1875,Acid phosphatase OS=Homo sapiens OX=9606 GN=ACP1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,NA,ACP1,NA,NA,ENSG00000143727
P52306,0,6,10879985.369791666,4.211583593855494e-5,1.0423610681203044,0.059855105788961784,0.6630512930383581,1,raw,11453211.125,11265725.96875,8404776.5625,14971895.3125,8760811.875,10423491.375,Rap1 GTPase-GDP dissociation stimulator 1 OS=Homo sapiens OX=9606 GN=RAP1GDS1 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;endosome;extracellular;membrane,DNA binding,5910,RAP1GDS1,NA,RHOT2 GTPase cycle; RHOT1 GTPase cycle,ENSG00000138698
Q9BYD6,0,6,17651150.828125,6.832665184164999e-5,1.0422248203950768,0.059666517811962555,0.912490411650846,1,raw,19810811.875,18049516.53125,15681083.4375,21865172.75,11688666.25,18811654.125,"39S ribosomal protein L1, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL1 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis,cytoskeleton;cytosol;endosome;Golgi,structural molecule activity,65008,MRPL1,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000169288
Q96G03,0,6,42689090.104166664,1.652471629405968e-4,1.0420754163772095,0.05945969114444843,0.7527243403566023,1,raw,44659803.8125,43585852.09375,43088500.78125,49589699.8125,29790939.15625,45419744.96875,Phosphoglucomutase-2 OS=Homo sapiens OX=9606 GN=PGM2 PE=1 SV=4,cellular homeostasis,cell surface;cytosol;nucleus,structural molecule activity,55276,PGM2,Clear cell renal cell carcinoma pathways; Glucuronidation,Neutrophil degranulation; Pentose phosphate pathway,ENSG00000169299
P54709,0,6,53417799.4375,2.0677741750965803e-4,1.0418994963752348,0.059216119195965006,0.7279562187406787,1,raw,62510640.125,48381145.875,45741725.21875,60567106.9375,47658280.46875,55647898,Sodium/potassium-transporting ATPase subunit beta-3 OS=Homo sapiens OX=9606 GN=ATP1B3 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,structural molecule activity,483,ATP1B3,Calcium regulation in cardiac cells,Potential therapeutics for SARS; Ion homeostasis; Ion transport by P-type ATPases; Basigin interactions,ENSG00000069849
Q9HAB8,0,6,9960398.78125,3.855616590426906e-5,1.0418265609625368,0.05911512361847335,0.9362442715380284,1,raw,10711453.15625,11359107.59375,7609963.0625,11834220,8156008.6875,10091640.1875,Phosphopantothenate--cysteine ligase OS=Homo sapiens OX=9606 GN=PPCS PE=1 SV=2,cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,79717,PPCS,NA,Coenzyme A biosynthesis,ENSG00000127125
O95989,0,6,2610452.421875,1.0104920382553429e-5,1.041757749207367,0.05901983169532943,0.5615813835782157,1,raw,2502438.125,2416077.75,2786281.71875,2705546.59375,2516967.71875,2735402.625,Diphosphoinositol polyphosphate phosphohydrolase 1 OS=Homo sapiens OX=9606 GN=NUDT3 PE=1 SV=1,cell death;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,11165,NUDT3,NA,Synthesis of pyrophosphates in the cytosol,ENSG00000272325
Q9P0P0,0.5,6,440664.4635416667,1.7057883461866764e-6,1.0414304285739098,0.058566465202957566,0.9203704495042578,1,raw,331057.25,561823.375,446570.09375,352599.46875,344773.09375,607163.5,E3 ubiquitin-protein ligase RNF181 OS=Homo sapiens OX=9606 GN=RNF181 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,nucleus,structural molecule activity,51255,RNF181,NA,E3 ubiquitin ligases ubiquitinate target proteins,ENSG00000168894
P98175,0,6,10450576.3046875,4.045361663202277e-5,1.0413478391653253,0.058452049441949434,0.838587738750064,1,raw,11373356.21875,11933452.234375,7352156.421875,12848220.4375,7656152.203125,11540120.3125,RNA-binding protein 10 OS=Homo sapiens OX=9606 GN=RBM10 PE=1 SV=3,cell differentiation;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8241,RBM10,NA,NA,ENSG00000182872
Q8TD30,0,6,665477.1015625,2.576025929969425e-6,1.0410567390119565,0.05804869962721718,0.9599090604807097,1,raw,526963.25,296723.53125,1143578.25,1190529.84375,491800.609375,343267.125,Alanine aminotransferase 2 OS=Homo sapiens OX=9606 GN=GPT2 PE=1 SV=1,cellular homeostasis,endosome,structural molecule activity,84706,GPT2,Amino acid metabolism; Amino acid metabolism pathway excerpt: histidine catabolism extension,NA,ENSG00000166123
Q9Y281,0,6,164766681.84114584,6.378029293889257e-4,1.0409080532104278,0.057842636326164154,0.8951565114562066,1,raw,147611452.953125,193581340.875,149359793.09375,160718525.875,153649950.125,183679028.125,Cofilin-2 OS=Homo sapiens OX=9606 GN=CFL2 PE=1 SV=1,cell growth;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity,1073,CFL2,Leptin signaling pathway; Microtubule cytoskeleton regulation; Regulation of actin cytoskeleton; G13 signaling pathway,NA,ENSG00000165410
Q9UL15,0,6,1438570.4166666667,5.568628412186192e-6,1.0405870680593536,0.05739768338383687,0.7016129009978422,1,raw,1660262.40625,1108383.28125,1197825.34375,1246441.5625,862953.28125,2555556.625,BAG family molecular chaperone regulator 5 OS=Homo sapiens OX=9606 GN=BAG5 PE=1 SV=1,cell growth;metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,9529,BAG5,NA,Regulation of HSF1-mediated heat shock response,ENSG00000166170
Q86UY8,0,6,3128273.28125,1.2109376971213036e-5,1.040229585161721,0.056901975308939465,0.8161044823149614,1,raw,4326216,1875364.96875,2827678.875,4500257.875,2467064.96875,2773057,5'-nucleotidase domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NT5DC3 PE=1 SV=1,NA,cytosol;nucleus,structural molecule activity,51559,NT5DC3,NA,NA,ENSG00000111696
O75439,0,6,20127806.84375,7.791365355949283e-5,1.0401685685592945,0.056817348864140645,0.7616327036979103,1,raw,20861341.3125,19133227.0625,21947086.625,23310567.09375,13815307.4375,21699311.53125,Mitochondrial-processing peptidase subunit beta OS=Homo sapiens OX=9606 GN=PMPCB PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;endosome,structural molecule activity,9512,PMPCB,NA,Mitochondrial protein import; Processing of SMDT1,ENSG00000105819
Q96FK6,0,6,492767.2604166667,1.9074754597760003e-6,1.0400565584227153,0.05666198445994004,0.9710879618311015,1,raw,565959.75,450392.0625,456607.5,363657.5625,474897.625,645089.0625,WD repeat-containing protein 89 OS=Homo sapiens OX=9606 GN=WDR89 PE=2 SV=1,NA,NA,NA,112840,WDR89,NA,NA,ENSG00000140006
Q0VDG4,0,6,79347.85677083333,3.0715126944149215e-7,1.0398988472532333,0.056443201766888516,0.5046521426741268,0.9887033786631393,raw,69597.2890625,89791.1171875,68433.015625,84773.375,71163.4140625,92328.9296875,Secernin-3 OS=Homo sapiens OX=9606 GN=SCRN3 PE=1 SV=1,cell organization and biogenesis,NA,structural molecule activity,79634,SCRN3,NA,NA,ENSG00000144306
H0YKT2,0.5,6,1699599.5208333333,6.579057981034206e-6,1.0397763027960825,0.05627318071257104,0.980213330030039,1,raw,1413294.375,2138216,1536837.5,1469510,1709729.875,1930009.375,POU domain protein (Fragment) OS=Homo sapiens OX=9606 GN=POU2F2 PE=1 SV=2,cellular component movement,membrane;nucleus,RNA binding;structural molecule activity,NA,POU2F2,Ectoderm differentiation; Prion disease pathway; Sudden infant death syndrome (SIDS) susceptibility pathways,NA,ENSG00000028277
Q8N7H5,0,6,11824839.924479166,4.577331690553322e-5,1.0397144019437057,0.05618729040051184,0.523140984192847,1,raw,8972236.53125,14521925.6875,8957166.453125,15098655.28125,8432695.46875,14966360.125,RNA polymerase II-associated factor 1 homolog OS=Homo sapiens OX=9606 GN=PAF1 PE=1 SV=2,cell death;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytoskeleton;membrane;nucleus,structural molecule activity,54623,PAF1,Endoderm differentiation,E3 ubiquitin ligases ubiquitinate target proteins; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,ENSG00000006712
Q9ULJ3,0.16666666666666666,6,312109.51875,1.2081590957863611e-6,1.039690937293794,0.05615473077067291,0.961499824525224,1,raw,519608.796875,227600.5625,197643.625,395730.40625,219964.203125,NA,Zinc finger and BTB domain-containing protein 21 OS=Homo sapiens OX=9606 GN=ZBTB21 PE=1 SV=2,cellular component movement;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,49854,ZBTB21,NA,NA,ENSG00000173276
A0A0J9YXF2,0,6,5633304.59375,2.1806217931231086e-5,1.0395709916822133,0.0559882823431957,0.6770799993087268,1,raw,6877366.65625,4601949.875,4576388.40625,7149510.875,3958603.6875,6636008.0625,"Paraoxonase 2, isoform CRA_a OS=Homo sapiens OX=9606 GN=PON2 PE=1 SV=1",NA,cell surface;cytoskeleton,structural molecule activity,NA,PON2,"Phase I biotransformations, non P450; Male infertility",NA,ENSG00000105854
Q9NTI5,0,6,2042929.4127604167,7.908069455750897e-6,1.0394706808135321,0.05584906628531625,0.9715668294000533,1,raw,3605237.875,1043962.48828125,1419438.10546875,1705829.34375,1085168.3984375,3397940.265625,Sister chromatid cohesion protein PDS5 homolog B OS=Homo sapiens OX=9606 GN=PDS5B PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding,23047,PDS5B,Cohesin complex - Cornelia de Lange syndrome,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,ENSG00000083642
Q9NPI6,0,6,3242484.28125,1.2551481585777457e-5,1.0391326381356925,0.0553798160971907,0.6373159251083451,1,raw,2414853.5625,3360633.3125,3276256.5625,3404465.125,2129851.4375,4868845.6875,mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,DNA binding;motor activity;RNA binding;structural molecule activity,55802,DCP1A,TGF-beta signaling pathway,"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); mRNA decay by 5' to 3' exoribonuclease; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA",ENSG00000272886
E5RHU8,0.16666666666666666,6,1005842.2916666666,3.893561203998625e-6,1.0388632818236785,0.055005802833720266,0.6698242108722897,1,raw,1037387.6875,1111333.25,709426.0625,1038506.6875,736996.6875,1401403.375,Leptin receptor overlapping transcript-like 1 (Fragment) OS=Homo sapiens OX=9606 GN=LEPROTL1 PE=1 SV=1,NA,cytoskeleton,NA,NA,LEPROTL1,NA,NA,ENSG00000104660
Q96P48,0,6,547323.6158854166,2.1186601662101555e-6,1.038599976333198,0.05464009766334216,0.8694650322649574,1,raw,578605.84375,626755.4609375,409586.234375,664837.84375,403216.296875,600940.015625,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ARAP1 PE=1 SV=3",cell differentiation;cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,DNA binding;structural molecule activity,116985,ARAP1,NA,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,ENSG00000186635
Q9H9Y2,0,6,5643156.859375,2.1844355519525795e-5,1.0382456002020617,0.05414775803276229,0.5362348358824592,1,raw,5801483.1875,4568903,5727559.03125,7150255.375,4743643.4375,5867097.125,Ribosome production factor 1 OS=Homo sapiens OX=9606 GN=RPF1 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,80135,RPF1,NA,NA,ENSG00000117133
P50990,0,6,675819087.1067709,0.002616059197630865,1.0382454762879467,0.054147585847790065,0.6415366997969375,1,raw,602742094.28125,794107435.09375,560392557.390625,758555878.5625,581825037.65625,757291519.65625,T-complex protein 1 subunit theta OS=Homo sapiens OX=9606 GN=CCT8 PE=1 SV=4,cell growth;conjugation;metabolic process,cell surface;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,10694,CCT8,16p11.2 proximal deletion syndrome,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Neutrophil degranulation; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,ENSG00000156261
Q9UHV9,0,6,39256295.666666664,1.51959001015127e-4,1.0381944793073612,0.05407672120197395,0.9014355567738305,1,raw,36651488,44016139,35712020.5,51346330,29760424,38051372.5,Prefoldin subunit 2 OS=Homo sapiens OX=9606 GN=PFDN2 PE=1 SV=1,metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,5202,PFDN2,Cellular proteostasis,Prefoldin mediated transfer of substrate  to CCT/TriC,ENSG00000143256
Q15942,0,6,18201612.860677082,7.045746064932865e-5,1.038174788147867,0.054049357728050605,0.6727593107667822,1,raw,18672247.53125,18769374.375,15169204.4375,23039716.4375,14174077.7578125,19385056.625,Zyxin OS=Homo sapiens OX=9606 GN=ZYX PE=1 SV=1,cell communication;cell death;cell growth;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,7791,ZYX,Integrin-mediated cell adhesion; Focal adhesion,NA,ENSG00000159840; ENSG00000285443
Q9Y4R8,0,6,2471137.6041666665,9.56564024503554e-6,1.0381189463722447,0.053971755362407794,0.9873245937321697,1,raw,2843325.84375,2944383.09375,1639996.5625,2576566.75,1765933.5,3056619.875,Telomere length regulation protein TEL2 homolog OS=Homo sapiens OX=9606 GN=TELO2 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;metabolic process,cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,9894,TELO2,Fragile X syndrome; Malignant pleural mesothelioma,NA,ENSG00000100726
Q9UK45,0,6,13139177.166666666,5.086104540685945e-5,1.0379925534275933,0.053796093819475546,0.9436571418975154,1,raw,15995719.5,12134039,10991998.5,17188349.25,9929914.625,12595042.125,U6 snRNA-associated Sm-like protein LSm7 OS=Homo sapiens OX=9606 GN=LSM7 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,51690,LSM7,mRNA processing,mRNA Splicing - Major Pathway; mRNA decay by 5' to 3' exoribonuclease,ENSG00000130332
Q9Y333,0,6,23358376.770833332,9.041901532356626e-5,1.037988967231717,0.0537911093945615,0.9309953681753094,1,raw,24382842.375,26337012.125,19898020.75,27631420.5,16591843.5,25309121.375,U6 snRNA-associated Sm-like protein LSm2 OS=Homo sapiens OX=9606 GN=LSM2 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,57819,LSM2,mRNA processing,mRNA Splicing - Major Pathway; mRNA decay by 5' to 3' exoribonuclease,ENSG00000172850; ENSG00000204392; ENSG00000224979; ENSG00000225998; ENSG00000231502; ENSG00000236826
F6VRR5,0,6,4368885.739583333,1.691172081475944e-5,1.0379628576339088,0.05375481935465946,0.9296030064104314,1,raw,2760039.5625,6235112.875,4276171.4375,4438507.125,3303095.1875,5200388.25,Polymerase delta-interacting protein 3 OS=Homo sapiens OX=9606 GN=POLDIP3 PE=1 SV=1,NA,membrane;nucleus,RNA binding,84271,POLDIP3,NA,NA,ENSG00000100227
P17931,0,6,66162873.75,2.5611291204628525e-4,1.0378971057692135,0.053663426013269094,0.8327873430550692,1,raw,77304254.5,47763187.5,68376501.25,86866413,45699113.5,70967772.75,Galectin-3 OS=Homo sapiens OX=9606 GN=LGALS3 PE=1 SV=5,cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;membrane;nucleus,antioxidant activity;DNA binding;structural molecule activity,3958,LGALS3,AGE/RAGE pathway; Spinal cord injury; 2q13 copy number variation syndrome,Neutrophil degranulation; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells; Advanced glycosylation endproduct receptor signaling; RUNX2 regulates genes involved in differentiation of myeloid cells,ENSG00000131981
Q9H2M9,0,6,5140439.833333333,1.9898365054219267e-5,1.0372757641591994,0.05279949173652243,0.6657502279009153,1,raw,2769938.09375,6167921.84375,5598208.90625,6397835.84375,4120438.46875,5788295.84375,Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP2 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,DNA binding;structural molecule activity,25782,RAB3GAP2,NA,RAB GEFs exchange GTP for GDP on RABs; COPI-independent Golgi-to-ER retrograde traffic,ENSG00000118873
Q9H5V8,0,6,27642831.541666668,1.0700390841685826e-4,1.0371607945853132,0.05263957743731725,0.8110748076844903,1,raw,30116118.90625,28107516.75,26072463.046875,29152014.40625,20868593.265625,31540282.875,CUB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CDCP1 PE=1 SV=3,NA,cell surface;cytoplasm;cytoskeleton,NA,64866,CDCP1,NA,NA,ENSG00000163814
O94808,0,6,826360.3,3.1987961047783526e-6,1.037032958173706,0.05246174548978702,0.6623734515695725,1,raw,815413.5,NA,688305.75,1334693.9375,774132.125,519256.1875,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 OS=Homo sapiens OX=9606 GN=GFPT2 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol,structural molecule activity,9945,GFPT2,NA,Synthesis of UDP-N-acetyl-glucosamine,ENSG00000131459
P84077,0,6,98122525.28645833,3.798269975909277e-4,1.0368490476153878,0.052205870902507834,0.9821550485535138,1,raw,83447081.3125,110488626.53125,100952341.125,114679545.4375,74495218.5625,104672338.75,ADP-ribosylation factor 1 OS=Homo sapiens OX=9606 GN=ARF1 PE=1 SV=2,cell differentiation;cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,375,ARF1,Neural crest cell migration during development; Neural crest cell migration in cancer; Insulin signaling; 2q37 copy number variation syndrome,COPI-dependent Golgi-to-ER retrograde traffic; MHC class II antigen presentation; COPI-mediated anterograde transport; Lysosome Vesicle Biogenesis; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Golgi Associated Vesicle Biogenesis; Synthesis of PIPs at the plasma membrane; Synthesis of PIPs at the Golgi membrane; Intra-Golgi traffic; Nef Mediated CD4 Down-regulation,ENSG00000143761
Q9BYJ9,0,6,5615040.510416667,2.1735518650754988e-5,1.036825051286102,0.05217248148487455,0.9003969676312882,1,raw,6257299.5,5121569.5,5622645.625,6487724.875,4215614.75,5985388.8125,YTH domain-containing family protein 1 OS=Homo sapiens OX=9606 GN=YTHDF1 PE=1 SV=1,cell growth;metabolic process,nucleus,protein binding;RNA binding,54915,YTHDF1,NA,NA,ENSG00000149658
Q969L2,0,6,2568666.9583333335,9.94317110924802e-6,1.0367344070643991,0.05204634864726285,0.7335416207245009,1,raw,2422070.5,2881773.75,2233317.5,2714643,2172563,2987634,Protein MAL2 OS=Homo sapiens OX=9606 GN=MAL2 PE=1 SV=1,conjugation;defense response,cytoplasm;cytoskeleton;nucleus,structural molecule activity,114569,MAL2,NA,NA,ENSG00000147676
O43660,0,6,10743078.934895834,4.158587852087179e-5,1.036562907384132,0.051807674013311,0.6986776118228692,1,raw,9106624.75,13494946.21875,8025292.515625,13988360.6875,7512363.03125,12330886.40625,Pleiotropic regulator 1 OS=Homo sapiens OX=9606 GN=PLRG1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;membrane;nucleus,NA,5356,PLRG1,NA,mRNA Splicing - Major Pathway,ENSG00000171566
Q9H2D6,0,6,18296940.5234375,7.082646888498039e-5,1.0365521087304626,0.051792644298146825,0.7164068974732887,1,raw,21313309.5,16202646.6875,15810354.640625,22092355.90625,15194596.03125,19168380.375,TRIO and F-actin-binding protein OS=Homo sapiens OX=9606 GN=TRIOBP PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,11078,TRIOBP,NA,NA,ENSG00000100106
Q9UBE0,0,6,30028914.15625,1.162403053894724e-4,1.0365188617770227,0.05174636974649003,0.567239750363156,1,raw,29759155.875,29909046.0625,26324280.8125,30845926.375,24832688.125,38502387.6875,SUMO-activating enzyme subunit 1 OS=Homo sapiens OX=9606 GN=SAE1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,DNA binding;structural molecule activity,10055,SAE1,NA,"SUMO is conjugated to E1 (UBA2:SAE1); SUMO is transferred from E1 to E2 (UBE2I, UBC9)",ENSG00000142230
O43292,0,6,1703264.75,6.593245885246755e-6,1.0355221032977693,0.050358348322062985,0.990914150092356,1,raw,1382201.875,2017605.6875,1704028.8125,2137940.625,1213252,1764559.5,Glycosylphosphatidylinositol anchor attachment 1 protein OS=Homo sapiens OX=9606 GN=GPAA1 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular,motor activity,8733,GPAA1,NA,Attachment of GPI anchor to uPAR,ENSG00000197858
P62854,0,6,57931553.479166664,2.2424991570010942e-4,1.035008672723537,0.049642856654857515,0.9721519866947459,1,raw,49499657.8125,69697240.75,54962405.75,56886566.625,55427974.75,61115475.1875,40S ribosomal protein S26 OS=Homo sapiens OX=9606 GN=RPS26 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;extracellular;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6231,RPS26,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000197728
A0A0D9SF53,0,6,109426846.3515625,4.235854140954707e-4,1.0347635739670498,0.049301173880117004,0.7910122999858684,1,raw,118944972.78125,115007128.78125,86810011.703125,119005187.609375,84302306.046875,132491471.1875,RNA helicase OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=1,NA,cytosol;membrane,RNA binding;structural molecule activity,NA,DDX3X,Novel intracellular components of RIG-I-like receptor pathway; Hepatitis B infection,NA,ENSG00000215301
P62875,0,6,3730515.2916666665,1.4440623277521212e-5,1.0345941209886167,0.049064898660234425,0.9264686122025252,1,raw,3441893.53125,5393336.0625,2491353.25,3560962.8125,3477059.53125,4018486.5625,"DNA-directed RNA polymerases I, II, and III subunit RPABC5 OS=Homo sapiens OX=9606 GN=POLR2L PE=1 SV=1",cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,5441,POLR2L,Pyrimidine metabolism; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation; mRNA Splicing - Major Pathway; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,ENSG00000177700
Q9NSC5,0,6,853271.4010416666,3.302967523937017e-6,1.0345254773606172,0.04896917502800082,0.6277846341350571,1,raw,838747.1875,647822.8125,727190.34375,752296.9375,400225.375,1753345.75,Homer protein homolog 3 OS=Homo sapiens OX=9606 GN=HOMER3 PE=1 SV=2,conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,antioxidant activity;structural molecule activity,9454,HOMER3,PKC-gamma calcium signaling pathway in ataxia,Neurexins and neuroligins,ENSG00000051128
P11142,0,6,2117631125.8092449,0.008197235753697279,1.0344970382104197,0.048929514733682344,0.5968622986561452,1,raw,1883755521.78125,2480119254.42578,1715222124.71875,2444068386.32813,1774392207.89453,2408229259.70703,Heat shock cognate 71 kDa protein OS=Homo sapiens OX=9606 GN=HSPA8 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,antioxidant activity;structural molecule activity,3312,HSPA8,Parkin-ubiquitin proteasomal system pathway; MAPK signaling pathway; Exercise-induced circadian regulation; Measles virus infection; Extrafollicular B cell activation by SARS-CoV-2,"Late endosomal microautophagy; AUF1 (hnRNP D0) binds and destabilizes mRNA; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Regulation of HSF1-mediated heat shock response; Neutrophil degranulation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis; CHL1 interactions; Interleukin-4 and Interleukin-13 signaling; GABA synthesis, release, reuptake and degradation; mRNA Splicing - Major Pathway; Lipophagy; Chaperone Mediated Autophagy; Protein methylation; Attenuation phase",ENSG00000109971
I3L0A0,0,6,59028751.76953125,2.2849711104261041e-4,1.0343672473573473,0.04874849887717382,0.6847301003056598,1,raw,56731199.125,65637935.109375,48711014.2734375,75785500.546875,50385077.75,56921783.8125,HCG2044781 OS=Homo sapiens OX=9606 GN=PEDS1-UBE2V1 PE=3 SV=1,cellular homeostasis,cytoskeleton;membrane,NA,NA,PEDS1-UBE2V1,NA,NA,ENSG00000124208
Q9UKX7,0,6,15517704.4765625,6.0068196202951335e-5,1.034000673130015,0.04823712484145353,0.8468986407076382,1,raw,14710243.234375,17455981.0625,13831705.578125,18368467.5625,13529428.015625,15210401.40625,Nuclear pore complex protein Nup50 OS=Homo sapiens OX=9606 GN=NUP50 PE=1 SV=2,conjugation,cytoskeleton;membrane,NA,10762,NUP50,NA,HCMV Early Events; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses,ENSG00000093000
Q9UKZ1,0,6,1348387.4583333333,5.219535049600821e-6,1.033985669701641,0.04821619107485774,0.5917643842297672,1,raw,1220881.40625,1332655.5,1304888.21875,1106373.5,1349235.71875,1776290.40625,CCR4-NOT transcription complex subunit 11 OS=Homo sapiens OX=9606 GN=CNOT11 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,NA,55571,CNOT11,NA,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,ENSG00000158435
P32019,0.3333333333333333,6,348391.3020833333,1.3486039201578595e-6,1.03378958939896,0.04794257905643665,0.6910686458764801,1,raw,318671.5625,474220.1875,190915.3125,329439.34375,317055.28125,460046.125,"Type II inositol 1,4,5-trisphosphate 5-phosphatase OS=Homo sapiens OX=9606 GN=INPP5B PE=1 SV=4",cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion,structural molecule activity,3633,INPP5B,NA,"Synthesis of IP2, IP, and Ins in the cytosol; Synthesis of IP3 and IP4 in the cytosol",ENSG00000204084
O43513,0,6,199572.46875,7.725342512926862e-7,1.0337228951470752,0.04784950153724145,1,1,raw,184875,208621.84375,199040.40625,205752.625,NA,NA,Mediator of RNA polymerase II transcription subunit 7 OS=Homo sapiens OX=9606 GN=MED7 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,9443,MED7,NA,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Generic Transcription Pathway,ENSG00000155868
Q9NRG0,0,6,651193.54375,2.520735048869496e-6,1.0331047570822338,0.046986551260416606,0.9932155034158738,1,raw,493159.46875,811278.3125,NA,650657.4375,581956.4375,718916.0625,Chromatin accessibility complex protein 1 OS=Homo sapiens OX=9606 GN=CHRAC1 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,54108,CHRAC1,Acute viral myocarditis,NA,ENSG00000104472
C9JNU6,0,6,1288203.3958333333,4.986565793097651e-6,1.0330711393541228,0.04693960450266988,0.5164211878220178,1,raw,1304967.5,1278172.625,916579.875,1320443.25,937920.5,1971136.625,"HIG1 domain family member 1A, mitochondrial OS=Homo sapiens OX=9606 GN=HIGD1A PE=4 SV=1",NA,cytoskeleton;endosome;membrane,NA,NA,HIGD1A,Mitochondrial complex IV assembly,NA,ENSG00000181061
Q9UNH6,0,6,316826.15625,1.2264169448900168e-6,1.0327721763218516,0.04652203896533714,1,1,raw,NA,311718.3125,NA,NA,321934,NA,Sorting nexin-7 OS=Homo sapiens OX=9606 GN=SNX7 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;mitochondrion;nucleus,structural molecule activity,51375,SNX7,NA,NA,ENSG00000162627
Q9Y6Y0,0.5,6,349552.2083333333,1.353097725572414e-6,1.0327683975058868,0.04651676027062454,0.7822358777136348,1,raw,321281.15625,439369.59375,327395.03125,366046.65625,453767.03125,189453.78125,Influenza virus NS1A-binding protein OS=Homo sapiens OX=9606 GN=IVNS1ABP PE=1 SV=3,cellular component movement;cellular homeostasis;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,NA,10625,IVNS1ABP,NA,NA,ENSG00000116679
P13073,0,6,100981669.3125,3.908945897459506e-4,1.0326593015169594,0.046364353829646474,0.531533212704924,1,raw,85844338.90625,113937376.25,88494277.6875,117658491.375,83743688.78125,116211842.875,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial OS=Homo sapiens OX=9606 GN=COX4I1 PE=1 SV=1",cellular homeostasis;conjugation,cytoskeleton;cytosol;endosome;membrane,catalytic activity,1327,COX4I1,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000131143
Q8N0V3,0.16666666666666666,6,385672.1,1.4929158760430375e-6,1.0326352853957754,0.04633080129030936,0.4681198424845695,0.9488154073830735,raw,NA,377276.46875,357391.46875,379044.125,350734.8125,463913.625,"Putative ribosome-binding factor A, mitochondrial OS=Homo sapiens OX=9606 GN=RBFA PE=1 SV=3",cellular component movement;cellular homeostasis,endosome,NA,79863,RBFA,NA,NA,ENSG00000101546
Q9H074,0,6,20432612.555989582,7.909354001462163e-5,1.0324469442968918,0.04606764589029524,0.5650838167544687,1,raw,17605305.75,22208648.78125,19643984.6171875,22498681.6875,18176544.125,22462510.375,Polyadenylate-binding protein-interacting protein 1 OS=Homo sapiens OX=9606 GN=PAIP1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,RNA binding,10605,PAIP1,Translation factors,Deadenylation of mRNA,ENSG00000172239
Q8N543,0,6,9005852.6875,3.486116951284162e-5,1.0322839697853743,0.04583989464344536,0.5482584676717474,1,raw,8914682.4375,9391110.03125,8128533.875,9694292.34375,8276182.5625,9630314.875,Prolyl 3-hydroxylase OGFOD1 OS=Homo sapiens OX=9606 GN=OGFOD1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,55239,OGFOD1,NA,NA,ENSG00000087263
P61201,0,6,34999198.125,1.3548000627887837e-4,1.0317279688579661,0.04506263189114651,0.8005837927448106,1,raw,27386559.375,42128540.625,33607615.40625,37751520.3125,34673916.78125,34447036.25,COP9 signalosome complex subunit 2 OS=Homo sapiens OX=9606 GN=COPS2 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9318,COPS2,Ciliary landscape,Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; RHOBTB1 GTPase cycle; DNA Damage Recognition in GG-NER,ENSG00000166200
Q9UEW8,0,6,22159698.036458332,8.577899466139336e-5,1.0315732600057357,0.04484628180983947,0.9516582866675858,1,raw,25285977.75,21088098.875,19747587.875,26084338.5,15891255.5625,24860929.65625,STE20/SPS1-related proline-alanine-rich protein kinase OS=Homo sapiens OX=9606 GN=STK39 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,signal transducer activity;structural molecule activity,27347,STK39,NA,NA,ENSG00000198648
G8JLH6,0,6,16540044.875,6.402562068750054e-5,1.0315536365507305,0.044818837389169884,0.9224239306353261,1,raw,19464347.75,12914724.3125,16860431.8125,17392439.75,13734660.625,18873665,Tetraspanin OS=Homo sapiens OX=9606 GN=CD9 PE=1 SV=2,metabolic process,cell surface;cytoplasm;cytoskeleton,NA,NA,CD9,NA,NA,ENSG00000010278
Q14061,0,6,13810284.303710934,5.345886490020413e-5,1.0314239428833514,0.0446374409330238,0.9669592503027383,1,raw,13346529.3535156,9644232.5,18692833.46875,19280236,10990268.5,10907606,Cytochrome c oxidase copper chaperone OS=Homo sapiens OX=9606 GN=COX17 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;metabolic process,endosome;nucleus,DNA binding;structural molecule activity,10063,COX17,Electron transport chain: OXPHOS system in mitochondria; Copper homeostasis; IL-18 signaling pathway; Mitochondrial complex IV assembly,Mitochondrial protein import,ENSG00000138495
P62244,0,6,28649710.768229168,1.1090148353985288e-4,1.0307404042105937,0.04368103036279084,0.654267711381078,1,raw,22753191.1875,41445638.15625,26236797.671875,27043327.4375,26921514.0625,27497796.09375,40S ribosomal protein S15a OS=Homo sapiens OX=9606 GN=RPS15A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,structural molecule activity,6210,RPS15A,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000134419
Q14197,0,6,10657447.609375,4.125440428315363e-5,1.030343077453669,0.043124797338725714,0.8650287544852581,1,raw,12798833.625,8556900.65625,10130007.625,13187189.625,8734945.5625,10536808.5625,"Peptidyl-tRNA hydrolase ICT1, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL58 PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;endosome;Golgi;membrane,RNA binding;structural molecule activity,3396,MRPL58,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000167862
Q14157,0,6,51457702.15625,1.9918998676274395e-4,1.029812186310574,0.04238124752010718,0.6919511182917724,1,raw,49011342.875,57701945.71875,43093101.71875,59422166.875,41622326.625,57895329.125,Ubiquitin-associated protein 2-like OS=Homo sapiens OX=9606 GN=UBAP2L PE=1 SV=2,cell growth;metabolic process,membrane;nucleus,NA,9898,UBAP2L,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000143569
Q8WUM0,0,6,29104406.744791668,1.1266158711535924e-4,1.029594725833926,0.04207656839082443,0.6360675357573163,1,raw,29497512.9375,30527674.46875,29791224.84375,31134409.75,22244485.84375,31431132.625,Nuclear pore complex protein Nup133 OS=Homo sapiens OX=9606 GN=NUP133 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,55746,NUP133,Ciliary landscape,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; SUMOylation of DNA replication proteins; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation,ENSG00000069248
G3V180,0,6,34527707.424479164,1.3365489123370346e-4,1.0291495767210581,0.04145267893859671,0.8966794535265636,1,raw,41517567.53125,27781845.84375,33039559.125,43544825.5,28591674.890625,32690771.65625,Dipeptidyl peptidase 3 OS=Homo sapiens OX=9606 GN=DPP3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol,structural molecule activity,NA,DPP3,NA,NA,ENSG00000254986
Q5F1R6,0,6,555510.5,2.150351152594667e-6,1.028764060275647,0.0409121483152672,1,1,raw,NA,545058.4375,NA,312780.125,808692.9375,NA,DnaJ homolog subfamily C member 21 OS=Homo sapiens OX=9606 GN=DNAJC21 PE=1 SV=2,metabolic process,cytosol;Golgi;membrane;nucleus,structural molecule activity,134218,DNAJC21,NA,NA,ENSG00000168724
Q9H0R6,0,6,1612604.5026041667,6.242304962470052e-6,1.0282433005017033,0.040181672018741274,0.8425228452697615,1,raw,1909239.28125,1532237.75,1506152.546875,1798819.75,966015.1875,1963162.5,"Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial OS=Homo sapiens OX=9606 GN=QRSL1 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,endosome;nucleus,structural molecule activity,55278,QRSL1,NA,NA,ENSG00000130348
P61457,0,6,19030440.466145832,7.366580756036275e-5,1.0277772920079442,0.0395276823097661,0.6944802515866633,1,raw,20620241.625,19330677,15031981.875,18734093.5,15449529.625,25016119.171875,Pterin-4-alpha-carbinolamine dehydratase OS=Homo sapiens OX=9606 GN=PCBD1 PE=1 SV=2,cellular component movement;cellular homeostasis,cytosol;membrane,structural molecule activity,5092,PCBD1,NA,Phenylalanine metabolism,ENSG00000166228
Q14696,0,6,21194365.755208332,8.204224552051704e-5,1.0274299888715812,0.03904008913904602,0.8360621924619567,1,raw,19825362,25134631.65625,17480471,26614145.3125,17959960.125,20151624.4375,LRP chaperone MESD OS=Homo sapiens OX=9606 GN=MESD PE=1 SV=2,cell death;conjugation;development;metabolic process,cytoplasm;cytoskeleton;extracellular,antioxidant activity;structural molecule activity,23184,MESD,NA,NA,ENSG00000117899
E7EW49,0,6,1742057.2369791667,6.743409507874348e-6,1.0272148869252828,0.038738016001250264,0.8857698747391278,1,raw,1176752.75,2743711.3125,1160340.34375,1801796.34375,1191918.875,2377823.796875,CLIP-associating protein 2 OS=Homo sapiens OX=9606 GN=CLASP2 PE=1 SV=1,metabolic process,cytosol;extracellular;nucleus,NA,NA,CLASP2,7q11.23 copy number variation syndrome,NA,ENSG00000163539
Q96EL3,0,6,9951723.677083334,3.852258504442272e-5,1.0272133317853431,0.0387358318483473,0.7356327529112636,1,raw,11363983.5,9599948.296875,8318272.875,9861194.875,9359480.578125,11207461.9375,"39S ribosomal protein L53, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL53 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,NA,116540,MRPL53,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000204822
A0A0A0MQS2,0,6,356411.703125,1.3796504595557998e-6,1.0270730331212687,0.03853877247953105,0.936469403993369,1,raw,296539.6875,545903,208330.65625,318717.28125,208297.34375,560682.25,CLK4-associating serine/arginine-rich protein OS=Homo sapiens OX=9606 GN=CLASRP PE=1 SV=1,NA,membrane,NA,11129,CLASRP,mRNA processing,NA,ENSG00000104859
A0A0G2JPQ2,0,6,7129485.169270833,2.7597852157876622e-5,1.0268896211740455,0.03828111686262024,0.5382151282693858,1,raw,6134526.46875,10002032.984375,6600148.765625,6832238.4375,6777624.265625,6430340.09375,"NACHT, LRR and PYD domains-containing protein 2 OS=Homo sapiens OX=9606 GN=NLRP2 PE=1 SV=1",NA,NA,NA,NA,NLRP2,NA,NA,ENSG00000277060
Q9BWJ5,0,6,16984286.911458332,6.574525762528871e-5,1.026829977347005,0.038197319781872754,0.98193140032611,1,raw,19047888.25,15425400.40625,16387982.0625,20962780,13253999.5,16827671.25,Splicing factor 3B subunit 5 OS=Homo sapiens OX=9606 GN=SF3B5 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,83443,SF3B5,mRNA processing,mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway,ENSG00000169976
B8ZZN6,0,6,17525049,6.783851847341863e-5,1.0268098241298589,0.03816900425505561,0.5809781293836702,1,raw,15850454.75,12511561,18890314.75,29822019,12846993.75,15228950.75,Small ubiquitin-related modifier 1 OS=Homo sapiens OX=9606 GN=SUMO1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;membrane,NA,NA,SUMO1,NA,NA,ENSG00000116030
J3QQ67,0,6,214758776.65625,8.313196292645916e-4,1.0265055320614689,0.03774140246467485,0.7715155392571746,1,raw,191168477.875,234018312.125,208597822.5,233061919,181485036.4375,240221092,60S ribosomal protein L18 (Fragment) OS=Homo sapiens OX=9606 GN=RPL18 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,NA,RPL18,NA,NA,ENSG00000063177
A0A087WVA1,0,6,2726266.7578125,1.0553231423965227e-5,1.0265019264369035,0.037736334955876256,0.9523032051909835,1,raw,2819867.53125,3410365.1875,1864891.25,2894599.453125,1409827.125,3958050,Selenoprotein T OS=Homo sapiens OX=9606 GN=SELENOT PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q92759,0,6,665390.7864583334,2.5756918088614872e-6,1.0264898276087278,0.037719330582258535,0.9546939647006042,1,raw,522904.125,981654.75,474416.78125,732594.125,486984,793790.9375,General transcription factor IIH subunit 4 OS=Homo sapiens OX=9606 GN=GTF2H4 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation,membrane,RNA binding;structural molecule activity,2968,GTF2H4,"Eukaryotic transcription initiation; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Dual Incision in GG-NER,ENSG00000213780; ENSG00000221974; ENSG00000226384; ENSG00000233149; ENSG00000234370; ENSG00000236895
G3V1V0,0,6,241775933.265625,9.359015837997447e-4,1.0260395343352722,0.03708632050695615,0.7859391155595014,1,raw,242497924.5,253319832.3125,215255022.75,296371739.875,194398622.625,248812457.53125,Myosin light polypeptide 6 OS=Homo sapiens OX=9606 GN=MYL6 PE=1 SV=1,NA,NA,structural molecule activity,NA,MYL6,Ciliary landscape,NA,ENSG00000092841
P46100,0,6,3331816.6106770835,1.2897282209793558e-5,1.0258058691417413,0.036757730821961994,0.9317513614326357,1,raw,3103153.78125,2957564.8359375,3868563.390625,3968395.03125,2632373.74609375,3460848.87890625,Transcriptional regulator ATRX OS=Homo sapiens OX=9606 GN=ATRX PE=1 SV=5,NA,NA,NA,NA,NA,NA,NA,NA
Q8N5M1,0,6,3839517.3020833335,1.4862564174650278e-5,1.0253379161174816,0.03609945076959972,0.589818233117521,1,raw,3959149.78125,4519432.4375,2391518.21875,4056292.875,3476765.0625,4633945.4375,ATP synthase mitochondrial F1 complex assembly factor 2 OS=Homo sapiens OX=9606 GN=ATPAF2 PE=1 SV=1,cell growth,cytosol;endosome;membrane,NA,91647,ATPAF2,7q11.23 copy number variation syndrome,NA,ENSG00000171953
Q8TDD1,0,6,36831605.411458336,1.425731559501421e-4,1.0249694645951344,0.035580930283529315,0.702776260471509,1,raw,35157681.25,41434724.75,31380990.5,41792997.375,32164557.03125,39058681.5625,ATP-dependent RNA helicase DDX54 OS=Homo sapiens OX=9606 GN=DDX54 PE=1 SV=2,cellular component movement;cellular homeostasis;development,extracellular;membrane,antioxidant activity;structural molecule activity,79039,DDX54,NA,NA,ENSG00000123064
Q8TAD8,0,6,7553876.75,2.9240649053295228e-5,1.0249366132670004,0.03553468967894605,0.7089498046923263,1,raw,7669586,7888791,6775444.5,6851375.5,7860839.5,8277224,Smad nuclear-interacting protein 1 OS=Homo sapiens OX=9606 GN=SNIP1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;development;metabolic process,cytosol;membrane,RNA binding,79753,SNIP1,TGF-beta signaling pathway,NA,ENSG00000163877
Q9UNK0,0,6,755646.6614583334,2.9250674279266357e-6,1.0248972135441954,0.03547922978364462,0.9571526323220333,1,raw,450988.15625,724187.59375,1115464.9375,532982.1875,1143236.90625,567020.1875,Syntaxin-8 OS=Homo sapiens OX=9606 GN=STX8 PE=1 SV=2,cell growth;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,9482,STX8,NA,NA,ENSG00000170310
Q9H009,0,6,437478.89375,1.693457177517171e-6,1.024333019056741,0.034684823575142985,0.42315005423255997,0.9086347256931654,raw,393786.25,NA,375664.3125,393835.34375,375775.375,648333.1875,Nascent polypeptide-associated complex subunit alpha-2 OS=Homo sapiens OX=9606 GN=NACA2 PE=1 SV=1,conjugation,Golgi;membrane;nucleus,structural molecule activity,342538,NACA2,NA,NA,ENSG00000253506
Q8WUA4,0,6,2696879.4192708335,1.0439474623140109e-5,1.024011137764558,0.03423140704719936,0.7291570969677893,1,raw,2567608.796875,3101856.734375,2676726.734375,3176335.84375,2846683.75,1812064.65625,General transcription factor 3C polypeptide 2 OS=Homo sapiens OX=9606 GN=GTF3C2 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,structural molecule activity,2976,GTF3C2,NA,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter,ENSG00000115207
P63173,0,6,54688251.583333336,2.1169526917242423e-4,1.023978325801389,0.03418517862914167,0.6306454616922406,1,raw,59738532.4375,55041956.0625,39065389,78570594.5625,40002111.625,55710925.8125,60S ribosomal protein L38 OS=Homo sapiens OX=9606 GN=RPL38 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,6169,RPL38,Mesodermal commitment pathway; Mesodermal commitment pathway; Cytoplasmic ribosomal proteins,L13a-mediated translational silencing of Ceruloplasmin expression; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Response of EIF2AK4 (GCN2) to amino acid deficiency; Formation of a pool of free 40S subunits; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000172809
Q9Y5J7,0,6,4204380.765625,1.6274930942454855e-5,1.0238957552252155,0.03406883928783434,0.552350664061213,1,raw,3914703.71875,3999464.25,4253638.8125,5165203.25,3798240.09375,4095034.46875,Mitochondrial import inner membrane translocase subunit Tim9 OS=Homo sapiens OX=9606 GN=TIMM9 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endosome,structural molecule activity,26520,TIMM9,NA,Mitochondrial protein import,ENSG00000100575
Q8TF42,0.16666666666666666,6,414205.6796875,1.6033678224394914e-6,1.0233902949393325,0.03335645709525512,0.9197487838500266,1,raw,416357.71875,NA,401006.0625,332628.28125,506830.65625,NA,Ubiquitin-associated and SH3 domain-containing protein B OS=Homo sapiens OX=9606 GN=UBASH3B PE=1 SV=2,cell communication;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,structural molecule activity,84959,UBASH3B,NA,NA,ENSG00000154127
O43709,0,6,4266290.307291667,1.65145794356508e-5,1.0230248146393999,0.032841139729395695,0.7905833515271793,1,raw,3823503.3125,5268986.5,3268477.65625,5083510.0625,2762960.375,5390303.9375,Probable 18S rRNA (guanine-N(7))-methyltransferase OS=Homo sapiens OX=9606 GN=BUD23 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,114049,BUD23,7q11.23 copy number variation syndrome,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000071462
Q5VV41,0,6,4019977.96875,1.5561117671955312e-5,1.0229611915882635,0.0327514141299919,0.7430983186593688,1,raw,4371228.75,4118824.40625,3240643.28125,5082489.09375,3315052.3125,3991629.96875,Rho guanine nucleotide exchange factor 16 OS=Homo sapiens OX=9606 GN=ARHGEF16 PE=1 SV=1,metabolic process,cytosol,antioxidant activity;DNA binding;structural molecule activity,27237,ARHGEF16,NA,CDC42 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOG GTPase cycle,ENSG00000130762
Q0JRZ9,0.16666666666666666,6,269811.825,1.044427007000625e-6,1.0218753571145598,0.031219234789131852,0.8460452716076423,1,raw,200952.6875,318390.34375,NA,361598.0625,182473.875,285644.15625,F-BAR domain only protein 2 OS=Homo sapiens OX=9606 GN=FCHO2 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,115548,FCHO2,NA,Cargo recognition for clathrin-mediated endocytosis,ENSG00000157107
P37802,0,6,82185301.75260417,3.1813486576770896e-4,1.0215755330214007,0.03079587767540655,0.8581081314626575,1,raw,90157829.09375,77698888.96875,81735445.375,92103032.3125,62080060.984375,89336553.78125,Transgelin-2 OS=Homo sapiens OX=9606 GN=TAGLN2 PE=1 SV=3,metabolic process,cell surface;cytosol;endoplasmic reticulum,NA,8407,TAGLN2,NA,Platelet degranulation,ENSG00000158710
A0A0U1RRB6,0,6,784350.3697916666,3.0361779331255914e-6,1.0215548833708905,0.030766715417188346,0.986929913204154,1,raw,1024509.71875,785090.71875,538442.28125,648740.125,662726.46875,1046592.90625,Exocyst complex component OS=Homo sapiens OX=9606 GN=EXOC6B PE=1 SV=1,cell growth;conjugation,nucleus,NA,23233,EXOC6B,Ciliary landscape,NA,ENSG00000144036
P53041,0,6,30850594.669270832,1.1942098629152362e-4,1.0215193212929499,0.030716491853720378,0.9025538597984719,1,raw,26021388.75,36585165.640625,29087798.75,29870179.125,26581351.375,36957684.375,Serine/threonine-protein phosphatase 5 OS=Homo sapiens OX=9606 GN=PPP5C PE=1 SV=1,cell differentiation;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,motor activity;RNA binding;structural molecule activity,5536,PPP5C,MAPK signaling pathway; ATM signaling in development and disease,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Negative regulation of MAPK pathway; ESR-mediated signaling,ENSG00000011485
Q9Y5P4,0,6,4284176.208333333,1.6583814792894525e-5,1.0215133414668616,0.030708046501279132,0.7762699796658541,1,raw,2167163.8125,5507733.0625,4668791.8125,4769233.125,3679701.8125,4912433.625,Ceramide transfer protein OS=Homo sapiens OX=9606 GN=CERT1 PE=1 SV=1,cell differentiation;cell growth;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;endosome;extracellular;membrane,catalytic activity;signal transducer activity;structural molecule activity,10087,CERT1,Sphingolipid pathway,NA,ENSG00000113163
P09382,0,6,524706582.2721355,0.0020311108502231645,1.0212496952649441,0.030335647879091442,0.9755572035713655,1,raw,586851729.9375,483769625.414063,507154210.882813,640432627.84375,412100216.238281,517931083.316406,Galectin-1 OS=Homo sapiens OX=9606 GN=LGALS1 PE=1 SV=2,cell communication;metabolic process,extracellular;nucleus,structural molecule activity,3956,LGALS1,NA,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,ENSG00000100097
Q9NSE4,0,6,37826267.34375,1.4642343858664567e-4,1.0209230419819844,0.029874118776445028,0.7381364608746527,1,raw,45318582,30445212.59375,33506790.5,46266784.59375,26633526.1875,44786708.1875,"Isoleucine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=IARS2 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome,RNA binding;structural molecule activity,55699,IARS2,NA,Mitochondrial tRNA aminoacylation,ENSG00000067704
Q96PU4,0.16666666666666666,6,319039.28125,1.2349838322748385e-6,1.0202140874812429,0.028871927234483185,0.8237036154414216,1,raw,256943.03125,NA,360968.09375,358571.9375,240755.8125,377957.53125,E3 ubiquitin-protein ligase UHRF2 OS=Homo sapiens OX=9606 GN=UHRF2 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cell proliferation;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,115426,UHRF2,NA,SUMOylation of transcription cofactors,ENSG00000147854
A6NEL0,0.16666666666666666,6,20343860.353515632,7.874998503071912e-5,1.0201690498704161,0.02880823768852063,0.9726667138164153,1,raw,23119636,18081611.390625,19927244,20883964.6875,18446300.3125,21604405.7304688,Non-histone chromosomal protein HMG-14 OS=Homo sapiens OX=9606 GN=HMGN1 PE=1 SV=1,NA,membrane;nucleus,RNA binding,NA,HMGN1,ATM signaling in development and disease ; Malignant pleural mesothelioma; Nucleotide excision repair in xeroderma pigmentosum,NA,ENSG00000205581
Q9BRP1,0,6,1603179.0833333333,6.205819673366202e-6,1.0200944406113819,0.02870272346590847,0.843826410280165,1,raw,1560701.5625,1678589.3125,1631772.84375,1664562.40625,1235081.75,1848366.625,Programmed cell death protein 2-like OS=Homo sapiens OX=9606 GN=PDCD2L PE=1 SV=1,cell differentiation;metabolic process,nucleus,NA,84306,PDCD2L,NA,NA,ENSG00000126249
Q9BQA1,0,6,26213177.21875,1.0146979372218407e-4,1.0196797611338266,0.02811613301530133,0.8681485592816046,1,raw,23416503.3125,30776333.4375,23480877.171875,31382004.328125,22072763.53125,26150581.53125,Methylosome protein 50 OS=Homo sapiens OX=9606 GN=WDR77 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;extracellular;membrane;nucleus,RNA binding;structural molecule activity,79084,WDR77,NA,RMTs methylate histone arginines; snRNP Assembly,ENSG00000116455
P10644,0,6,57687446.25,2.2330498979574717e-4,1.0193127250062486,0.027596738058818952,0.7223495475041268,1,raw,56919724.34375,63601462.875,48506074.84375,64244558.65625,48023076.34375,64829780.4375,cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR1A PE=1 SV=1,cell differentiation;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,DNA binding;structural molecule activity,5573,PRKAR1A,Mesodermal commitment pathway; Myometrial relaxation and contraction pathways; Mesodermal commitment pathway; G protein signaling pathways; Cannabinoid receptor signaling; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Fragile X syndrome; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; FCGR3A-mediated IL10 synthesis; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase,ENSG00000108946
Q12849,0,6,37160904.125,1.4384785349089472e-4,1.0191698769989563,0.027394542453268025,0.9162046365068717,1,raw,38247663.25,40329995.75,32046989.0625,38980866.25,29233267.5,44126642.9375,G-rich sequence factor 1 OS=Homo sapiens OX=9606 GN=GRSF1 PE=1 SV=3,cellular component movement;cellular homeostasis;defense response;metabolic process,endosome;membrane;nucleus,RNA binding,2926,GRSF1,VEGFA-VEGFR2 signaling pathway,Viral mRNA Translation,ENSG00000132463
Q9UNI6,0,6,2703072.3958333335,1.0463447301044782e-5,1.018845358710314,0.02693509453408091,0.801232692456818,1,raw,2342694.625,3547667.28125,2497458.0625,2572964.59375,1643125.46875,3614524.34375,Dual specificity protein phosphatase 12 OS=Homo sapiens OX=9606 GN=DUSP12 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,11266,DUSP12,NA,NA,ENSG00000081721
Q9BSH4,0,6,6692931.622395833,2.5907976948151613e-5,1.018421135898784,0.026334265769762177,0.6592798275383086,1,raw,7632372.375,6255781.40625,7168479.359375,7772969.34375,3892358.1875,7435629.0625,Translational activator of cytochrome c oxidase 1 OS=Homo sapiens OX=9606 GN=TACO1 PE=1 SV=1,cell growth;metabolic process,endosome,protein binding;RNA binding,51204,TACO1,Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000136463
Q9Y5Q8,0,6,3193682.46875,1.2362572404478305e-5,1.0182781978600466,0.02613176558079331,0.749765286345889,1,raw,1942184.53125,5073473.9375,3069748.40625,3125857.875,3177910.4375,2772919.625,General transcription factor 3C polypeptide 5 OS=Homo sapiens OX=9606 GN=GTF3C5 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,9328,GTF3C5,NA,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter,ENSG00000148308
P24844,0,6,505218.015625,1.95567166095116e-6,1.0182480877049727,0.02608910492699609,1,1,raw,500650.0625,NA,NA,NA,509785.96875,NA,Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4,cell growth;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,10398,MYL9,Focal adhesion; Striated muscle contraction pathway,RHO GTPases activate CIT; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; Smooth Muscle Contraction; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs,ENSG00000101335
Q9ULX3,0,6,12846310.145833334,4.97273729815751e-5,1.0180657305914855,0.02583071086058241,0.8619321161528158,1,raw,11678021.03125,15000330.9375,11345752.5,15271322.875,10362944.46875,13419489.0625,RNA-binding protein NOB1 OS=Homo sapiens OX=9606 GN=NOB1 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,28987,NOB1,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000141101
Q12907,0,6,37939938.088541664,1.4686345190246787e-4,1.0178639940148906,0.02554480279995104,0.646485872377338,1,raw,41264451.03125,41707129.75,26560907.875,42026467.4375,34079073.5,42001598.9375,Vesicular integral-membrane protein VIP36 OS=Homo sapiens OX=9606 GN=LMAN2 PE=1 SV=1,cell growth;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,10960,LMAN2,NA,COPII-mediated vesicle transport; Cargo concentration in the ER,ENSG00000169223
H7C1E4,0,6,4990190.447916667,1.9316757795477318e-5,1.0175977278087884,0.025167354348651368,0.9848748150468779,1,raw,4378244.875,6048962.75,4516215,6155410.75,3692885.0625,5149424.25,AP-1 complex subunit sigma-1A (Fragment) OS=Homo sapiens OX=9606 GN=AP1S1 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;extracellular,structural molecule activity,NA,AP1S1,NA,NA,ENSG00000106367
P10588,0.3333333333333333,6,517323.3541666667,2.0025307728592545e-6,1.017260459015715,0.02468911363112148,0.9690443398389028,1,raw,588910.5,595649.9375,356405.28125,369081.21875,362557,831336.1875,Nuclear receptor subfamily 2 group F member 6 OS=Homo sapiens OX=9606 GN=NR2F6 PE=1 SV=2,cellular component movement;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,2063,NR2F6,Nuclear receptors; IL6 signaling pathway,Nuclear Receptor transcription pathway,ENSG00000160113
Q9H857,0,6,2536005.4322916665,9.816740105389047e-6,1.0171190426448642,0.024488540732024607,0.8355055669022555,1,raw,2840789.6875,2661958.875,1951007.890625,2707529.0625,1889971.765625,3164775.3125,5'-nucleotidase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NT5DC2 PE=1 SV=1,NA,NA,structural molecule activity,64943,NT5DC2,NA,NA,ENSG00000168268
Q9UNA1,0,6,363366.8333333333,1.406573393073592e-6,1.0164529000559588,0.023543365767978983,1,1,raw,430935.0625,NA,299768.75,NA,359396.6875,NA,Rho GTPase-activating protein 26 OS=Homo sapiens OX=9606 GN=ARHGAP26 PE=1 SV=1,cell growth;defense response;development;metabolic process,cytosol;endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,23092,ARHGAP26,NA,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle,ENSG00000145819
B7ZM99,0,6,40011354.458333336,1.5488179283083015e-4,1.0163960022325165,0.02346260599518266,0.9787907065313564,1,raw,41930543.28125,43172175.1875,34735629.8125,44918048.28125,32693693.625,42618036.5625,Formyltetrahydrofolate synthetase OS=Homo sapiens OX=9606 GN=MTHFD1L PE=1 SV=1,cellular homeostasis,endosome,structural molecule activity,25902,MTHFD1L,"One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways",NA,ENSG00000120254
Q9BT22,0,6,563010.61875,2.1793837073324436e-6,1.0161555104807403,0.02312120627457418,0.8152457374154766,1,raw,246264.265625,383658.46875,896617.203125,202089.09375,1086424.0625,NA,Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,56052,ALG1,Nephrotic syndrome,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein; Defective ALG1 causes CDG-1k",ENSG00000033011
Q9NRR3,0,6,728694.5520833334,2.8207372677237436e-6,1.0161249196928297,0.023077774101175726,0.9970073558344716,1,raw,723588.875,683782.0625,778015.9375,735256.6875,539149.3125,912374.4375,CDC42 small effector protein 2 OS=Homo sapiens OX=9606 GN=CDC42SE2 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,structural molecule activity,56990,CDC42SE2,NA,CDC42 GTPase cycle,ENSG00000158985
O95292,0,6,18923292.947916668,7.325104530236449e-5,1.016093486527817,0.023033144575975103,0.7253065452409564,1,raw,18549824.125,20206826,16855246.8125,18012715.375,17126506.5,22788638.875,Vesicle-associated membrane protein-associated protein B/C OS=Homo sapiens OX=9606 GN=VAPB PE=1 SV=3,cell growth;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,motor activity;structural molecule activity,9217,VAPB,Ciliary landscape,RHOC GTPase cycle; RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RHOD GTPase cycle; Sphingolipid de novo biosynthesis,ENSG00000124164
Q01804,0,6,1446437.5234375,5.59908155773834e-6,1.0159395530631206,0.02281456639122865,0.8163116678498978,1,raw,1252991.53125,1702585.46875,1314857.75,1686569.34375,1448657.390625,1272963.65625,OTU domain-containing protein 4 OS=Homo sapiens OX=9606 GN=OTUD4 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;membrane,structural molecule activity,54726,OTUD4,NA,NA,ENSG00000164164
Q8IYS1,0,6,13652734.380208334,5.284899765269933e-5,1.015820600242152,0.022645636367841688,0.8564914991484815,1,raw,14825948,14750816.5625,10527944.8125,18921577.9375,10694503.21875,12195615.75,Peptidase M20 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PM20D2 PE=1 SV=2,cell organization and biogenesis;metabolic process,membrane,structural molecule activity,135293,PM20D2,NA,NA,ENSG00000146281
O43684,0,6,62274354.447916664,2.4106066377533176e-4,1.015808759563271,0.022628819827344247,0.9227599660543686,1,raw,64137361.375,67706003.9375,53447074.25,76494747.625,46709646,65151293.5,Mitotic checkpoint protein BUB3 OS=Homo sapiens OX=9606 GN=BUB3 PE=1 SV=1,cell differentiation;cell growth;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9184,BUB3,Cell cycle; Regulation of sister chromatid separation at the metaphase-anaphase transition,Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of mitotic proteins; APC-Cdc20 mediated degradation of Nek2A,ENSG00000154473
Q9Y2Q9,0,6,2899774.0286458335,1.1224868701424456e-5,1.015697078340267,0.0224701966585161,0.7724696134207607,1,raw,3194339.4375,2848468.890625,2494837.28125,2839854,2533998.9375,3487145.625,"28S ribosomal protein S28, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS28 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,NA,28957,MRPS28,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000147586
Q96FZ7,0,6,2034099.0260416667,7.873887505529397e-6,1.0153932217458506,0.02203853450626434,0.6436073703902032,1,raw,1463181.9375,1592573.6875,2653448.75,2335168.75,1465927.15625,2694293.875,Charged multivesicular body protein 6 OS=Homo sapiens OX=9606 GN=CHMP6 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,79643,CHMP6,Ferroptosis,Late endosomal microautophagy; Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Sealing of the nuclear envelope (NE) by ESCRT-III; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex,ENSG00000176108
A0A140T913,0,6,20795606.208333332,8.049866884423319e-5,1.0151861394990744,0.021744277076864868,0.8304891086226971,1,raw,21255556.25,20873089,20899201.375,23253633.375,17275577.6875,21216579.5625,"HLA class I histocompatibility antigen, A alpha chain OS=Homo sapiens OX=9606 GN=HLA-A PE=1 SV=1",metabolic process,cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,NA,NA,HLA-A,NA,NA,ENSG00000235657
P30153,0,6,170290580.96614584,6.591856446576028e-4,1.0151712885801527,0.02172317207654808,0.9416289462752486,1,raw,193104979.8125,167699153.9375,146983548.265625,191212152.25,126709020.34375,196034631.1875,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform OS=Homo sapiens OX=9606 GN=PPP2R1A PE=1 SV=4,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,DNA binding;structural molecule activity,5518,PPP2R1A,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; 16p11.2 proximal deletion syndrome; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome,"Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Regulation of TP53 Degradation; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Cyclin D associated events in G1; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Cyclin A/B1/B2 associated events during G2/M transition; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Spry regulation of FGF signaling; MASTL Facilitates Mitotic Progression; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; Initiation of Nuclear Envelope (NE) Reformation; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling; Inhibition of replication initiation of damaged DNA by RB1/E2F1; DARPP-32 events; PP2A-mediated dephosphorylation of key metabolic factors; ERKs are inactivated",ENSG00000105568
P33908,0.3333333333333333,6,17863104.963541668,6.914711485610326e-5,1.0149000908895915,0.02133771216655928,0.49380971495398945,0.9783284299355225,raw,14926167,16916477.9375,16200975,16442371,14185496.84375,28507142,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA OS=Homo sapiens OX=9606 GN=MAN1A1 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis;coagulation;conjugation,cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,4121,MAN1A1,NA,"Intra-Golgi traffic; Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",ENSG00000111885
Q9Y5Y5,0,6,862164.0234375,3.337390385104303e-6,1.0147740005150216,0.021158461754781147,0.7872124010128014,1,raw,813978.890625,1038670.09375,662924.765625,954676.8125,648718.171875,1054015.40625,Peroxisomal membrane protein PEX16 OS=Homo sapiens OX=9606 GN=PEX16 PE=1 SV=2,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion,structural molecule activity,9409,PEX16,NA,Class I peroxisomal membrane protein import,ENSG00000121680
Q99567,0,6,6568710.25,2.5427122722519025e-5,1.0141304699054832,0.020243269872944347,0.8678831251300406,1,raw,6392542.1875,8554030.59375,5235965.125,8941604.875,3805246.90625,6482871.8125,Nuclear pore complex protein Nup88 OS=Homo sapiens OX=9606 GN=NUP88 PE=1 SV=2,cell differentiation;cellular homeostasis;conjugation,cytosol;membrane,structural molecule activity,4927,NUP88,Ciliary landscape,Viral Messenger RNA Synthesis; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses,ENSG00000108559
P31323,0,6,637194,2.4665435708711292e-6,1.0140693827632092,0.020156365106501963,0.8071741234841158,1,raw,873048.25,722934.5625,223478.546875,451872.03125,666499.109375,885331.5,cAMP-dependent protein kinase type II-beta regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR2B PE=1 SV=3,cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,5577,PRKAR2B,Myometrial relaxation and contraction pathways; G protein signaling pathways; Cannabinoid receptor signaling; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways,FCGR3A-mediated IL10 synthesis; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase,ENSG00000005249; ENSG00000284096
Q6RW13,0,6,2650327.1666666665,1.0259273366740368e-5,1.013933321482596,0.019962780616026504,0.799965811021233,1,raw,2256254.5625,3503016.3125,2376434.4375,2409546.0625,2369644.75,2987066.875,Type-1 angiotensin II receptor-associated protein OS=Homo sapiens OX=9606 GN=AGTRAP PE=1 SV=1,coagulation;development;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,57085,AGTRAP,NA,Signaling by BRAF and RAF1 fusions,ENSG00000177674
Q86X83,0,6,2407850.9583333335,9.320661055962502e-6,1.0135979984247674,0.019485580671161556,0.8394121898643288,1,raw,2746421.1875,2153249.90625,2154165.84375,3377205.34375,1832605.28125,2183458.1875,COMM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=COMMD2 PE=1 SV=2,NA,nucleus,NA,51122,COMMD2,NA,Neddylation,ENSG00000114744
P07311,0,6,8100747.395833333,3.135755579689035e-5,1.013580239756244,0.01946030381831286,0.8680650681510991,1,raw,7891410.75,7872912.0625,8101792.0625,11035133.375,5704658.125,7998578,Acylphosphatase-1 OS=Homo sapiens OX=9606 GN=ACYP1 PE=1 SV=2,cellular homeostasis,NA,structural molecule activity,97,ACYP1,NA,NA,ENSG00000119640
M0QZM1,0.16666666666666666,6,1601794.4375,6.200459784104624e-6,1.0134861971252451,0.019326440581269536,0.8677962290214445,1,raw,1426054.5,1806864.75,1648166.625,1670394.125,1098413.125,1960873.5,Heterogeneous nuclear ribonucleoprotein M (Fragment) OS=Homo sapiens OX=9606 GN=HNRNPM PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding,NA,HNRNPM,NA,NA,ENSG00000099783
Q15102,0,6,52187794.053385414,2.020161330777194e-4,1.0134427469955942,0.01926458810561689,0.9569683003328735,1,raw,56683731.40625,44968357.3046875,55734188.40625,63817695.9375,35439382.265625,56483409,Platelet-activating factor acetylhydrolase IB subunit gamma OS=Homo sapiens OX=9606 GN=PAFAH1B3 PE=1 SV=1,cellular homeostasis;defense response;metabolic process,cytosol;nucleus,structural molecule activity,5050,PAFAH1B3,NA,COPI-independent Golgi-to-ER retrograde traffic,ENSG00000079462
P56182,0,6,15370023.364583334,5.949653059202074e-5,1.0133129867491883,0.019079854976574075,0.6860494236720958,1,raw,15489536.9375,19013376.75,9622847.6875,15695748.9375,14499731.5625,17898898.3125,Ribosomal RNA processing protein 1 homolog A OS=Homo sapiens OX=9606 GN=RRP1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,NA,8568,RRP1,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000160214
Q92785,0,6,5045917.466145833,1.953247407425108e-5,1.0131558437728545,0.018856106760260883,0.7938584697337698,1,raw,4183611.546875,5461916.3125,5075838.4375,6739648.015625,3671875.109375,5142615.375,Zinc finger protein ubi-d4 OS=Homo sapiens OX=9606 GN=DPF2 PE=1 SV=2,cell growth;cellular component movement;defense response;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,5977,DPF2,Tumor suppressor activity of SMARCB1,NA,ENSG00000133884
B4DYU2,0,6,1165369.825,4.511083672383863e-6,1.0131259484724757,0.018813536371709263,0.910912084220449,1,raw,1006830.9375,1102666.75,1283771.375,1824028.6875,NA,609551.375,Conserved oligomeric Golgi complex subunit 8 OS=Homo sapiens OX=9606 GN=COG8 PE=1 SV=1,conjugation,cytoskeleton;extracellular,NA,NA,COG8,NA,NA,ENSG00000213380
Q13596,0,6,19788853.841145832,7.660158478702986e-5,1.0127299003644068,0.01824945216100722,0.8880897992278023,1,raw,19804962.796875,19884700.3125,19488294.21875,20057078,18402077.6875,21096010.03125,Sorting nexin-1 OS=Homo sapiens OX=9606 GN=SNX1 PE=1 SV=3,cell growth;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,6642,SNX1,NA,NA,ENSG00000028528
Q15369,0,6,47224399,1.8280309880774613e-4,1.0125494534076358,0.01799237164529365,0.6132165432841764,1,raw,43846354.75,52461627.5,40791352.5,53119992.25,40121998.25,53005068.75,Elongin-C OS=Homo sapiens OX=9606 GN=ELOC PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,6921,ELOC,Dual hijack model of Vif in HIV infection; VEGFA-VEGFR2 signaling pathway; Type 2 papillary renal cell carcinoma; Hijack of ubiquitination by SARS-CoV-2,Antigen processing: Ubiquitination & Proteasome degradation; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Vif-mediated degradation of APOBEC3G; Neddylation; Regulation of expression of SLITs and ROBOs; Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Inactivation of CSF3 (G-CSF) signaling,ENSG00000154582
Q9BT67,0.5,6,163385.7890625,6.324575679994096e-7,1.0120493339410992,0.01727961819171199,0.7435923828896143,1,raw,83804.625,297773.4375,NA,115164.1171875,126663.5,193523.265625,NEDD4 family-interacting protein 1 OS=Homo sapiens OX=9606 GN=NDFIP1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cell surface;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,80762,NDFIP1,NA,NA,ENSG00000131507
H0YE88,0,6,2307105.0494791665,8.930679082221673e-6,1.0119943374065385,0.01720121748443533,0.9433744614525639,1,raw,2326126.171875,3088043.4375,1570835,1589676.125,2676221.75,2591727.8125,Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=1,cellular component movement;development,membrane,RNA binding;structural molecule activity,NA,TEAD1,Mesodermal commitment pathway; Mesodermal commitment pathway; miR-509-3p alteration of YAP1/ECM axis; Hippo-Yap signaling pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Malignant pleural mesothelioma,NA,ENSG00000187079
Q9Y4F3,0.6666666666666666,6,2377354.7708333335,9.202611960688213e-6,1.0118045095133639,0.01693057422230929,0.7203512718731758,1,raw,1778695.25,3671158.5,2069798,2160273.5,1799691.875,2784511.5,Meiosis regulator and mRNA stability factor 1 OS=Homo sapiens OX=9606 GN=MARF1 PE=1 SV=6,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,extracellular;mitochondrion;nucleus,RNA binding;structural molecule activity,9665,MARF1,NA,NA,ENSG00000166783; ENSG00000277140
O94830,0.3333333333333333,6,109340.10807291667,4.2324965490197187e-7,1.0116362691855192,0.016690666546459787,0.9894530842637295,1,raw,83528.0078125,119581.84375,125245.5234375,98795.7734375,102186.5859375,126702.9140625,Phospholipase DDHD2 OS=Homo sapiens OX=9606 GN=DDHD2 PE=1 SV=2,cell growth;cellular homeostasis;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,23259,DDHD2,NA,Synthesis of PA,ENSG00000085788
P17096,0,6,110623179.9296875,4.282163567844186e-4,1.0113948130467771,0.01634628471400166,0.8671645016201113,1,raw,102261772.65625,126603436.734375,96514329.1875,154120602.1875,80811912.375,103427026.4375,High mobility group protein HMG-I/HMG-Y OS=Homo sapiens OX=9606 GN=HMGA1 PE=1 SV=3,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,3159,HMGA1,Adipogenesis; Pre-implantation embryo; Male infertility; 7q11.23 copy number variation syndrome; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence,Vpr-mediated nuclear import of PICs; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection; Formation of Senescence-Associated Heterochromatin Foci (SAHF),ENSG00000137309
J3QLS3,0,6,14569103.447916666,5.6396212837558504e-5,1.0113136264769587,0.016230472212863944,0.9473109845069322,1,raw,15994017.84375,14829138.59375,13049568.09375,15407338.3125,11959589.65625,16174968.1875,"28S ribosomal protein S7, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS7 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,Golgi;nucleus,NA,NA,MRPS7,NA,NA,ENSG00000125445
X6R8W7,0.6666666666666666,6,203927.67578125,7.893930225660227e-7,1.0107340734863086,0.015403470704982731,0.534562607504479,1,raw,197161.109375,144709.671875,181064.765625,183008.328125,128815.6484375,388806.53125,Rap1 GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RAP1GAP PE=1 SV=1,metabolic process,NA,DNA binding,5909,RAP1GAP,Thyroid stimulating hormone (TSH) signaling pathway; Splicing factor NOVA regulated synaptic proteins; Fragile X syndrome; GDNF signaling,NA,ENSG00000076864
Q9BZZ5,0,6,60200670.481770836,2.3303354510391375e-4,1.0103848236018484,0.014904874524339692,0.7832828188271357,1,raw,60364368.1875,68539849.8125,55257008.734375,69251624.0625,45846623.75,61944548.34375,Apoptosis inhibitor 5 OS=Homo sapiens OX=9606 GN=API5 PE=1 SV=3,metabolic process,membrane;nucleus,structural molecule activity,8539,API5,NA,NA,ENSG00000166181
Q13310,0,6,44285356.765625,1.7142622500209765e-4,1.0102651072648883,0.014733925402268028,0.7972976691000637,1,raw,43236908.375,49060224.9375,38823547.0625,49432946.75,39222074.9375,45936438.53125,Polyadenylate-binding protein 4 OS=Homo sapiens OX=9606 GN=PABPC4 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding,8761,PABPC4,NA,NA,ENSG00000090621
Q32P41,0,6,4248432.5703125,1.6445453099972383e-5,1.0101984190519433,0.014638689083588435,0.6668222142419217,1,raw,4596248.0625,4379471.71875,3035530.234375,6180153.21875,3066487.84375,4232704.34375,tRNA (guanine(37)-N1)-methyltransferase OS=Homo sapiens OX=9606 GN=TRMT5 PE=1 SV=2,cellular component movement;cellular homeostasis,endosome;membrane;nucleus,structural molecule activity,57570,TRMT5,NA,Synthesis of wybutosine at G37 of tRNA(Phe),ENSG00000126814
E5RI98,0.5,6,2370228.4166666665,9.175026228472368e-6,1.0100395136649052,0.014411733623926405,0.9486676735949118,1,raw,1690603.5,3053061.5,2413911.75,2438146.25,1948247.75,2677399.75,Nucleophosmin (Fragment) OS=Homo sapiens OX=9606 GN=NPM1 PE=1 SV=1,NA,membrane,NA,NA,NA,NA,NA,NA
Q969G5,0,6,5043685.708333333,1.9523835060255088e-5,1.0100076026085787,0.014366152585400412,0.8652997517427659,1,raw,6291321.71875,3929998.5,4481521,7823586.8125,3209315.9375,4526370.28125,Caveolae-associated protein 3 OS=Homo sapiens OX=9606 GN=CAVIN3 PE=1 SV=3,cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,112464,CAVIN3,NA,NA,ENSG00000170955
Q6ZMI0,0,6,396508.0677083333,1.5348613219906714e-6,1.0099028584784644,0.014216528292517398,0.7029585044013794,1,raw,347238.9375,392143.71875,475196.59375,370610.6875,397831.40625,396027.0625,Protein phosphatase 1 regulatory subunit 21 OS=Homo sapiens OX=9606 GN=PPP1R21 PE=1 SV=1,NA,mitochondrion,NA,129285,PPP1R21,NA,NA,ENSG00000162869
P17987,0,6,449098924.4635417,0.001738437689025144,1.0099002155911225,0.014212752795281369,0.7643974973570768,1,raw,420786309.875,500006093.75,401782507.0625,491863961.96875,375198412.25,504956261.875,T-complex protein 1 subunit alpha OS=Homo sapiens OX=9606 GN=TCP1 PE=1 SV=1,cell growth;conjugation;metabolic process,cytosol;endoplasmic reticulum;extracellular;nucleus,structural molecule activity,6950,TCP1,16p11.2 proximal deletion syndrome,Formation of tubulin folding intermediates by CCT/TriC; BBSome-mediated cargo-targeting to cilium; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Association of TriC/CCT with target proteins during biosynthesis; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Prefoldin mediated transfer of substrate  to CCT/TriC; Folding of actin by CCT/TriC,ENSG00000120438
P15559,0,6,39371785.466145836,1.5240605579343083e-4,1.0092683664847242,0.013309840962919086,0.7590366720294546,1,raw,42584840.3125,28162121.546875,44486324.875,39388897.3125,36709888.3125,44898640.4375,NAD(P)H dehydrogenase [quinone] 1 OS=Homo sapiens OX=9606 GN=NQO1 PE=1 SV=1,cell death;cellular homeostasis;coagulation;metabolic process,cytosol;nucleus,structural molecule activity,1728,NQO1,Dopamine metabolism; Aryl hydrocarbon receptor pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; NRF2 pathway; Transcriptional activation by NRF2 in response to phytochemicals; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Interactions between LOXL4 and oxidative stress pathway; Benzene metabolism; Oxidative stress response; NRF2-ARE regulation; Male infertility; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Estrogen metabolism,Regulation of ornithine decarboxylase (ODC); Nuclear events mediated by NFE2L2,ENSG00000181019
Q8N335,0,6,4408736.421875,1.7065980654308057e-5,1.0090906632120626,0.013055801292960585,0.9219882289808723,1,raw,4740705.03125,3595636.3125,4800100.46875,5029977.25,3628323.03125,4657676.4375,Glycerol-3-phosphate dehydrogenase 1-like protein OS=Homo sapiens OX=9606 GN=GPD1L PE=1 SV=1,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,23171,GPD1L,Sudden infant death syndrome (SIDS) susceptibility pathways,Synthesis of PA,ENSG00000152642
Q86WV6,0,6,1038194.58125,4.018795170223561e-6,1.0090443210872415,0.012989544522035356,0.8612474872974887,1,raw,442837.0625,1608334.875,1186300.78125,1377800.5,NA,575699.6875,Stimulator of interferon genes protein OS=Homo sapiens OX=9606 GN=STING1 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endosome;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,340061,STING1,Novel intracellular components of RIG-I-like receptor pathway; Cytosolic DNA-sensing pathway; Pathways of nucleic acid metabolism and innate immune sensing; STING pathway in Kawasaki-like disease and COVID-19,Neutrophil degranulation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; SARS-CoV-1 activates/modulates innate immune responses; Regulation of innate immune responses to cytosolic DNA; IRF3-mediated induction of type I IFN; STAT6-mediated induction of chemokines,ENSG00000184584; ENSG00000288243
O95793,0,6,16573792.096354166,6.415625435929577e-5,1.0081372572119869,0.011692074173427042,0.7322525553100958,1,raw,18018497.9375,16475627.890625,13323915,22777611.125,12237406.3125,16609694.3125,Double-stranded RNA-binding protein Staufen homolog 1 OS=Homo sapiens OX=9606 GN=STAU1 PE=1 SV=2,cell growth;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,RNA binding;structural molecule activity,6780,STAU1,NA,NA,ENSG00000124214
Q5VUJ9,0.16666666666666666,6,4541339.963541667,1.757928180462124e-5,1.0080629994761592,0.011585803710540899,0.9925252337748429,1,raw,4596816,4828692.375,4211917.21875,5931333.625,3045400.4375,4633880.125,Dynein regulatory complex protein 8 OS=Homo sapiens OX=9606 GN=EFCAB2 PE=1 SV=1,NA,endoplasmic reticulum;nucleus,structural molecule activity,84288,EFCAB2,NA,NA,ENSG00000203666
Q96A72,0,6,2485503.7708333335,9.621250900549765e-6,1.0080302271878898,0.011538900703136627,0.6156945802088181,1,raw,2077904.25,2985656.5,2042293.875,2779293,2018243,3009632,Protein mago nashi homolog 2 OS=Homo sapiens OX=9606 GN=MAGOHB PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation,cytosol;membrane;nucleus,NA,55110,MAGOHB,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),ENSG00000111196
Q9GZT3,0,6,42392071.125,1.64097418508775e-4,1.007919305579476,0.01138014072234691,0.694265321278672,1,raw,42890855,41564693.125,44924543.4375,45280314.625,35357123.8125,44334896.75,"SRA stem-loop-interacting RNA-binding protein, mitochondrial OS=Homo sapiens OX=9606 GN=SLIRP PE=1 SV=1",cell growth;metabolic process,endoplasmic reticulum;endosome;membrane;nucleus,RNA binding,81892,SLIRP,NA,NA,ENSG00000119705
O43166,0.16666666666666666,6,2173396.3111979165,8.41309977548478e-6,1.0077780248751198,0.011177903046281006,0.6394134392377773,1,raw,2015294.5078125,3352293,1601581.484375,2273517.25,1614038.625,2183653,Signal-induced proliferation-associated 1-like protein 1 OS=Homo sapiens OX=9606 GN=SIPA1L1 PE=1 SV=4,cell growth;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,antioxidant activity;DNA binding,26037,SIPA1L1,NA,Neurexins and neuroligins,ENSG00000197555
Q8NA72,0.3333333333333333,6,79554.30208333333,3.079504080998652e-7,1.0075637141093823,0.010871071629927898,1,1,raw,NA,79155.1640625,NA,93392.65625,66115.0859375,NA,Centrosomal protein POC5 OS=Homo sapiens OX=9606 GN=POC5 PE=1 SV=2,cell differentiation,cytosol;endoplasmic reticulum;membrane,NA,134359,POC5,NA,NA,ENSG00000152359
Q66K14,0,6,3569091.515625,1.381576055599321e-5,1.0075298872674465,0.01082263535175115,0.938475517710111,1,raw,4488504.4375,3676608.71875,2438378.96875,4452095.5,2456739.6875,3902221.78125,TBC1 domain family member 9B OS=Homo sapiens OX=9606 GN=TBC1D9B PE=1 SV=3,metabolic process,cytoskeleton,DNA binding;structural molecule activity,23061,TBC1D9B,NA,NA,ENSG00000197226; ENSG00000284400
A0A0A0MS54,0,6,17411387.098958332,6.739853939127517e-5,1.0071510579430103,0.010280082750111651,0.9250436360872839,1,raw,17502375.3125,18102400.3125,16871021.96875,17627535.8125,14611747.375,19753241.8125,cAMP-dependent protein kinase catalytic subunit beta OS=Homo sapiens OX=9606 GN=PRKACB PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q9H9A5,0,6,3573458.4973958335,1.3832664906647738e-5,1.0070272702112035,0.010102751930363408,0.6492799709455614,1,raw,3310690.546875,3864018.03125,3078733.71875,3100368.8125,3232041.375,4854898.5,CCR4-NOT transcription complex subunit 10 OS=Homo sapiens OX=9606 GN=CNOT10 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,NA,25904,CNOT10,Ciliary landscape,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,ENSG00000182973
Q9BT09,0,6,11593716.559895834,4.4878650839953315e-5,1.0062513150377042,0.008990668640556166,0.520230313451844,1,raw,11336022.5,11616923.65625,9712174,11362907.765625,9772887.859375,15761383.578125,Protein canopy homolog 3 OS=Homo sapiens OX=9606 GN=CNPY3 PE=1 SV=1,coagulation,extracellular,antioxidant activity,10695,CNPY3,NA,Trafficking and processing of endosomal TLR,ENSG00000137161
Q9NXH8,0.16666666666666666,6,591070.5875,2.2880023313608513e-6,1.0061386331843365,0.008829103978234906,0.8880707725281329,1,raw,406330.28125,820092.375,NA,589207.875,501360.90625,638361.5,Torsin-4A OS=Homo sapiens OX=9606 GN=TOR4A PE=1 SV=2,NA,cell surface;cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,54863,TOR4A,NA,Platelet degranulation,ENSG00000198113
Q9Y6X5,0,6,975885.0208333334,3.7775982260440247e-6,1.006069059059123,0.008729338684774818,0.8491163565581467,1,raw,1161184.875,800791.875,928037.1875,922061.6875,933669.5,1109565,Bis(5'-adenosyl)-triphosphatase ENPP4 OS=Homo sapiens OX=9606 GN=ENPP4 PE=1 SV=3,cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton,structural molecule activity,22875,ENPP4,NA,Neutrophil degranulation,ENSG00000001561
Q9NVJ2,0,6,20992158.307291668,8.125951140713696e-5,1.0058272718191124,0.008382576032605053,0.7762379345174251,1,raw,21907609.625,21343719.6875,17986980.375,27600441,15646103.8125,21468095.34375,ADP-ribosylation factor-like protein 8B OS=Homo sapiens OX=9606 GN=ARL8B PE=1 SV=1,cell differentiation;cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,55207,ARL8B,Ciliary landscape,NA,ENSG00000134108
Q86YS6,0,6,697115.33125,2.6984958088908327e-6,1.004897251883874,0.007047997149858595,0.8543468827941498,1,raw,593653.3125,820334.1875,605509,478270.34375,NA,987809.8125,Ras-related protein Rab-43 OS=Homo sapiens OX=9606 GN=RAB43 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,339122,RAB43,NA,RAB geranylgeranylation; Retrograde transport at the Trans-Golgi-Network,ENSG00000172780
P62277,0,6,187059943.14583334,7.240989402503385e-4,1.003928767231028,0.00565690792580696,0.8184421274280254,1,raw,189700122.5,191798564.75,167251688.5,245628940.5,137534932.5,190445410.125,40S ribosomal protein S13 OS=Homo sapiens OX=9606 GN=RPS13 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6207,RPS13,Cytoplasmic ribosomal proteins,"Major pathway of rRNA processing in the nucleolus and cytosol; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000110700
Q5M775,0,6,775708.6484375,3.0027262963440467e-6,1.0038220116175083,0.005503486698451843,0.6263414110262061,1,raw,661006.625,627930.0625,795460.015625,1412449.34375,493872.84375,663533,Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,cell growth;defense response;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,NA,92521,SPECC1,NA,NA,ENSG00000128487
O76031,0,6,17330648.592447918,6.708600499177518e-5,1.0030944635794334,0.00445747406614515,0.7777066401309145,1,raw,17079881.90625,19032105.71875,15130795.40625,19035930.828125,15177617.1015625,18527560.59375,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial OS=Homo sapiens OX=9606 GN=CLPX PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;endosome;membrane;nucleus,DNA binding;structural molecule activity,10845,CLPX,NA,NA,ENSG00000166855
P39748,0,6,68366901.15625,2.646445831368946e-4,1.002454311563621,0.003536485076559466,0.8673765784767388,1,raw,69935522.875,73694514,59441959.1875,70107166.4375,57787093.3125,79235151.125,Flap endonuclease 1 OS=Homo sapiens OX=9606 GN=FEN1 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,endosome;membrane;nucleus,RNA binding;structural molecule activity,2237,FEN1,"Base excision repair; DNA repair pathways, full network",HDR through MMEJ (alt-NHEJ); Early Phase of HIV Life Cycle; POLB-Dependent Long Patch Base Excision Repair; PCNA-Dependent Long Patch Base Excision Repair; Removal of the Flap Intermediate; Removal of the Flap Intermediate from the C-strand,ENSG00000168496
Q9C0J8,0,6,5953375.455729167,2.3045194956811827e-5,1.0024191529762163,0.0034858852550785965,0.9833638967479896,1,raw,5865453.9375,6986413.546875,4982305.625,5460832.0625,5421932.8125,7003314.75,pre-mRNA 3' end processing protein WDR33 OS=Homo sapiens OX=9606 GN=WDR33 PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,NA,55339,WDR33,NA,mRNA Splicing - Major Pathway; Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs,ENSG00000136709
Q9Y266,0,6,219814191.0690105,8.508888655064326e-4,1.0023345480698795,0.0033641156044569693,0.9444214028575915,1,raw,199947477.609375,244656908.0625,212037754.3125,245228071.375,178939407.796875,238075527.257813,Nuclear migration protein nudC OS=Homo sapiens OX=9606 GN=NUDC PE=1 SV=1,cell differentiation;cell growth;conjugation;metabolic process,cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,structural molecule activity,10726,NUDC,Ciliary landscape,RND2 GTPase cycle; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000090273
A0A0U1RQV1,0.16666666666666666,6,207853.59635416666,8.045900491370172e-7,1.0022394322185566,0.003227205549287272,0.6191224753800479,1,raw,203511.40625,303553.1875,156224.25,203967.15625,157673.53125,222192.046875,Endogenous retrovirus group K3 member 1 (Fragment) OS=Homo sapiens OX=9606 GN=ERVK3-1 PE=1 SV=1,NA,NA,NA,NA,ERVK3-1,NA,NA,ENSG00000142396
B4E2Q0,0,6,2099758.9427083335,8.12805349786156e-6,1.001888789693938,0.002722377334183176,0.9245071460062595,1,raw,1612507.8125,3368857.0625,1456783.96875,1685704.0625,1099480.625,3375220.125,Calcium-transporting ATPase OS=Homo sapiens OX=9606 GN=ATP2C1 PE=1 SV=1,conjugation,cytoskeleton;extracellular,catalytic activity;structural molecule activity,27032,ATP2C1,NA,NA,ENSG00000017260
Q8NBJ5,0,6,18624524.635416668,7.209452929565868e-5,1.001759784368036,0.0025366008995393206,0.9489371961649335,1,raw,20226927.125,20620165.25,14731350.3125,19182661.1875,14757274.3125,22228769.625,Procollagen galactosyltransferase 1 OS=Homo sapiens OX=9606 GN=COLGALT1 PE=1 SV=1,cell growth;metabolic process,extracellular,structural molecule activity,79709,COLGALT1,Type I collagen synthesis in the context of osteogenesis imperfecta,Collagen biosynthesis and modifying enzymes,ENSG00000130309
O15228,0,6,2902093.4453125,1.1233847038112084e-5,1.0016631652277157,0.002397447103052033,0.7205520274825816,1,raw,3125757.46875,2463008.546875,2850137.75,2854878,2362237.53125,3756541.375,Dihydroxyacetone phosphate acyltransferase OS=Homo sapiens OX=9606 GN=GNPAT PE=1 SV=1,cell growth;cellular homeostasis;coagulation;defense response;metabolic process,cytoskeleton;cytosol;endosome;mitochondrion,structural molecule activity,8443,GNPAT,Triacylglyceride synthesis,Peroxisomal protein import; Plasmalogen biosynthesis; Synthesis of PA,ENSG00000116906
P49761,0,6,1381545.71875,5.347888885405929e-6,1.0015162481239446,0.002185826939626156,0.8508680073577408,1,raw,1160430.125,2142985.40625,972231.875,1053827.625,1162189.625,1797609.65625,Dual specificity protein kinase CLK3 OS=Homo sapiens OX=9606 GN=CLK3 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,signal transducer activity;structural molecule activity,1198,CLK3,mRNA processing,NA,ENSG00000179335
Q96C90,0,6,5404921.114583333,2.0922157814168272e-5,1.0010679500955315,0.0015399041826099377,0.7720218072088034,1,raw,7235825,4319808.6875,3977877.3125,5959614.875,3692848.3125,7243552.5,Protein phosphatase 1 regulatory subunit 14B OS=Homo sapiens OX=9606 GN=PPP1R14B PE=1 SV=3,coagulation;metabolic process,nucleus,DNA binding,26472,PPP1R14B,NA,NA,ENSG00000173457
O00186,0,6,6640130.317708333,2.570358594853366e-5,1.0010599890310663,0.0015284310015012128,0.7201486426214301,1,raw,6134793.9375,6369792.625,6190836.46875,10824038.375,4123921.8125,6197398.6875,Syntaxin-binding protein 3 OS=Homo sapiens OX=9606 GN=STXBP3 PE=1 SV=2,cell communication;cell death;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,6814,STXBP3,Insulin signaling,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Disinhibition of SNARE formation,ENSG00000116266
O60613,0,6,3281890.4479166665,1.2704020729341807e-5,1.0004599408525685,6.634018359920961e-4,0.7680134050271579,1,raw,3872658.375,2961793.875,2502211.375,2963156.125,2089278.3125,5302244.625,Selenoprotein F OS=Homo sapiens OX=9606 GN=SELENOF PE=1 SV=4,cell growth;metabolic process,extracellular,structural molecule activity,9403,SELENOF,Selenium metabolism / selenoproteins; Selenium micronutrient network,NA,ENSG00000183291
Q9H9B1,0,6,1986363.1536458333,7.68910452082165e-6,1.0002628773859787,3.792020614734762e-4,0.9639466164822412,1,raw,1073477.546875,2640232.828125,2206649.015625,2274609.125,1515981.3125,2207229.09375,Histone-lysine N-methyltransferase EHMT1 OS=Homo sapiens OX=9606 GN=EHMT1 PE=1 SV=4,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,79813,EHMT1,Histone modifications; MTHFR deficiency,Senescence-Associated Secretory Phenotype (SASP); Regulation of TP53 Activity through Methylation; Transcriptional Regulation by E2F6; Transcriptional Regulation by VENTX; PKMTs methylate histone lysines,ENSG00000181090
Q9Y3D2,0,6,630254.81875,2.4396823749099352e-6,0.999852823076793,-2.123470439196299e-4,0.8686798618692141,1,raw,947211.9375,NA,384420.59375,478252.5625,625657.75,715731.25,"Methionine-R-sulfoxide reductase B2, mitochondrial OS=Homo sapiens OX=9606 GN=MSRB2 PE=1 SV=2",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation,cytosol;endosome;nucleus,motor activity;structural molecule activity,22921,MSRB2,Sulindac metabolic pathway; Methionine de novo and salvage pathway,Protein repair,ENSG00000148450
Q969T9,0,6,3699892.4739583335,1.4322084003547434e-5,0.9997470280810223,-3.650075032643038e-4,0.6899650141340814,1,raw,4123882.40625,3757581.09375,2972094.3125,3544793.875,3756630.53125,4044372.625,WW domain-binding protein 2 OS=Homo sapiens OX=9606 GN=WBP2 PE=1 SV=1,cell growth;cellular component movement;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,23558,WBP2,NA,NA,ENSG00000132471
Q53GA4,0,6,4755011.947916667,1.8406394519642778e-5,0.9992564212343477,-0.0010731564353506592,0.6790256384859059,1,raw,4930116.625,4725131.375,4310656.3125,4637445.625,4307451,5619270.75,Pleckstrin homology-like domain family A member 2 OS=Homo sapiens OX=9606 GN=PHLDA2 PE=1 SV=2,metabolic process,cytoskeleton;nucleus,structural molecule activity,7262,PHLDA2,NA,NA,ENSG00000181649; ENSG00000274538
Q9BVI4,0,6,26590938.450520832,1.029320870544325e-4,0.9990144058327312,-0.0014226129921983616,0.8649569141774662,1,raw,25968932.21875,27709589.28125,24755367.4375,35473916.75,19694487.625,25943337.390625,Nucleolar complex protein 4 homolog OS=Homo sapiens OX=9606 GN=NOC4L PE=1 SV=1,cellular component movement;cellular homeostasis,cytoskeleton;membrane;nucleus,NA,79050,NOC4L,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000184967; ENSG00000288146
Q9Y3F4,0,6,88832336.19270833,3.438651772012722e-4,0.9987351062356598,-0.0018260110596821331,0.8840458040460462,1,raw,74411296.9375,114543284.21875,73695764.125,105653702.375,73602546.8125,91087422.6875,Serine-threonine kinase receptor-associated protein OS=Homo sapiens OX=9606 GN=STRAP PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,11171,STRAP,TGF-beta signaling pathway; Epithelial to mesenchymal transition in colorectal cancer,Downregulation of TGF-beta receptor signaling,ENSG00000023734
Q9BYC9,0,6,4064304.8854166665,1.5732704773090458e-5,0.9987187940719687,-0.0018495745348242703,0.9482762296900472,1,raw,4484087.125,3576779.25,4089945.5625,4084705.5,3539114,4611197.875,"39S ribosomal protein L20, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL20 PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,RNA binding;structural molecule activity,55052,MRPL20,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000242485
P27338,0,6,24308459.15625,9.409673294103816e-5,0.998659694887797,-0.0019349485392217635,0.9532294755437509,1,raw,23480054.8125,29819211.875,19159797.6875,23448584.375,18303316.25,31639789.9375,Amine oxidase [flavin-containing] B OS=Homo sapiens OX=9606 GN=MAOB PE=1 SV=3,cellular homeostasis;metabolic process,cytoskeleton;endosome,structural molecule activity,4129,MAOB,Dopamine metabolism; GABA metabolism (aka GHB); Overlap between signal transduction pathways contributing to LMNA laminopathies,Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,ENSG00000069535
H0Y742,0,6,1553904.25,6.0150794539603695e-6,0.9986412078295057,-0.0019616557692460424,0.7459408579412884,1,raw,1404188.25,1792086.4375,1224369.5,1061425,2439076.0625,1402280.25,SUN domain-containing protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=SUN1 PE=1 SV=1,NA,cytoskeleton;membrane;nucleus,NA,NA,SUN1,NA,NA,ENSG00000164828
A0A0A0MT33,0,6,2854509.2545572915,1.1049651204845661e-5,0.9984538769290822,-0.002232310245241261,0.7296974611078191,1,raw,2676919.92578125,2812448.28125,2632314.78125,2672781.078125,1914921.8359375,4417669.625,SR-related and CTD-associated factor 8 OS=Homo sapiens OX=9606 GN=SCAF8 PE=1 SV=1,NA,membrane,RNA binding,22828,SCAF8,NA,NA,ENSG00000213079
Q9Y606,0,6,6035091.62109375,2.3361513820950935e-5,0.9981924270270409,-0.0026101362813542015,0.9651972199799583,1,raw,7741582.9921875,4782362.25,5659035.96875,6123998.1875,4773717.78125,7129852.546875,tRNA pseudouridine synthase A OS=Homo sapiens OX=9606 GN=PUS1 PE=1 SV=3,cellular component movement;cellular homeostasis,endosome;membrane;nucleus,RNA binding;structural molecule activity,80324,PUS1,NA,NA,ENSG00000177192
Q8TCD5,0,6,6736044.65625,2.6074865174459054e-5,0.9981898055373167,-0.0026139251451931357,0.8445927253282897,1,raw,8580435.96875,5348120.21875,6643070.8125,7758728.75,5454866.625,6631045.5625,"5'(3')-deoxyribonucleotidase, cytosolic type OS=Homo sapiens OX=9606 GN=NT5C PE=1 SV=2",cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,30833,NT5C,Pyrimidine metabolism,Purine catabolism; Pyrimidine catabolism,ENSG00000125458
Q8ND56,0,6,6950668.203125,2.69056613365417e-5,0.998130201566535,-0.0027000740118915422,0.9183548883421009,1,raw,7534089.8125,7418341.875,5701065.71875,6300975.5625,5690405.875,9059130.375,Protein LSM14 homolog A OS=Homo sapiens OX=9606 GN=LSM14A PE=1 SV=3,cell differentiation;cell growth;development;metabolic process,cytosol;endoplasmic reticulum;nucleus,RNA binding,26065,LSM14A,NA,NA,ENSG00000257103; ENSG00000262860
Q9UIG0,0,6,16277108.364583334,6.300780765204271e-5,0.9981090741118208,-0.0027306119083403656,0.9014603997218396,1,raw,18208545.609375,16514993.3125,14434975.4375,15532967.515625,14407679.96875,18563488.34375,Tyrosine-protein kinase BAZ1B OS=Homo sapiens OX=9606 GN=BAZ1B PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,signal transducer activity;structural molecule activity,9031,BAZ1B,IL-18 signaling pathway; 7q11.23 copy number variation syndrome,B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,ENSG00000009954
A0A0B4J2F0,0,6,887475.25,3.43536877653391e-6,0.9978660011785662,-0.003081999179109181,0.8661519618265484,1,raw,711457.75,1064810.125,825593.875,716734.875,709939.5,1296315.375,Protein PIGBOS1 OS=Homo sapiens OX=9606 GN=PIGBOS1 PE=1 SV=1,coagulation;metabolic process,NA,NA,101928527,PIGBOS1,NA,NA,ENSG00000225973
P33897,0.16666666666666666,6,962959,3.7275622972948454e-6,0.9977373750327669,-0.00326797631779541,0.7847285615360052,1,raw,1116285,908618.4375,752472.25,750769.6875,802047.75,1447560.875,ATP-binding cassette sub-family D member 1 OS=Homo sapiens OX=9606 GN=ABCD1 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,catalytic activity;structural molecule activity,215,ABCD1,Vitamin D receptor pathway,Class I peroxisomal membrane protein import; alpha-linolenic acid (ALA) metabolism; Beta-oxidation of very long chain fatty acids; Linoleic acid (LA) metabolism; ABC transporters in lipid homeostasis; Defective ABCD1 causes ALD,ENSG00000101986
Q9NS86,0,6,3345087.2565104165,1.2948652163310878e-5,0.9977182274745098,-0.0032956633155004707,0.7006725181174207,1,raw,2483239.1875,3893774.8515625,3064421.375,3057429.0625,2396775.5625,5174883.5,LanC-like protein 2 OS=Homo sapiens OX=9606 GN=LANCL2 PE=1 SV=1,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane,structural molecule activity,55915,LANCL2,NA,NA,ENSG00000132434
A0A5F9ZHR7,0,6,2504184.7890625,9.69356411349665e-6,0.9970694780420182,-0.004234056528417392,0.8996678822604703,1,raw,2796275.28125,1876968.859375,2930493.3125,2921905.4375,1882299.0625,2617166.78125,Lysosomal acid phosphatase OS=Homo sapiens OX=9606 GN=ACP2 PE=1 SV=1,NA,cytoskeleton,NA,NA,ACP2,NA,NA,ENSG00000134575
Q99797,0,6,4838412.475260417,1.8729233458061825e-5,0.9968480173802426,-0.004554531373081596,0.8328284833576381,1,raw,5466865.03125,4578996.25,4735794.078125,4720866.9375,3533302.3671875,5994650.1875,Mitochondrial intermediate peptidase OS=Homo sapiens OX=9606 GN=MIPEP PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation,endosome,structural molecule activity,4285,MIPEP,NA,NA,ENSG00000027001
P62081,0,6,165657740.55208334,6.412521695492718e-4,0.996039713888005,-0.005724828611037843,0.6167933208341752,1,raw,197884503.25,129782042.9375,144142060.375,197100824,128090830,196946182.75,40S ribosomal protein S7 OS=Homo sapiens OX=9606 GN=RPS7 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;endoplasmic reticulum;Golgi;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,6201,RPS7,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000171863
P78310,0,6,2584097.7291666665,1.0002902790011717e-5,0.9957659733624545,-0.006121377434767392,0.9214386590744142,1,raw,2286046.15625,3165625.75,2365645.90625,2151102.4375,2383943.71875,3152222.40625,Coxsackievirus and adenovirus receptor OS=Homo sapiens OX=9606 GN=CXADR PE=1 SV=1,cell communication;cell differentiation;cell growth;coagulation;conjugation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;membrane;nucleus,antioxidant activity;structural molecule activity,1525,CXADR,Acute viral myocarditis,Cell surface interactions at the vascular wall; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,ENSG00000154639
P49756,0,6,50278179.140625,1.9462411685360425e-4,0.9957470983373101,-0.006148724385746806,0.996276061317913,1,raw,47483713.125,57807001.875,45480189.375,64441718.5,39174682.40625,47281769.5625,RNA-binding protein 25 OS=Homo sapiens OX=9606 GN=RBM25 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding,58517,RBM25,NA,NA,ENSG00000119707
Q8TCF1,0,6,3328193.46484375,1.2883257207892194e-5,0.9953096258330072,-0.006782698712020683,0.8412638370828318,1,raw,2832141.5,3599087.8359375,3657454.078125,3025467.5,3214710.625,3640299.25,AN1-type zinc finger protein 1 OS=Homo sapiens OX=9606 GN=ZFAND1 PE=1 SV=1,cell growth;metabolic process,nucleus,structural molecule activity,79752,ZFAND1,NA,NA,ENSG00000104231
P46063,0,6,66596762.572916664,2.577924722534403e-4,0.9952640529432552,-0.006848757841362893,0.8088950140281915,1,raw,61785962.546875,73868257.40625,61906482.953125,68993450.84375,59508000.4375,73518421.25,ATP-dependent DNA helicase Q1 OS=Homo sapiens OX=9606 GN=RECQL PE=1 SV=3,cell growth;cell proliferation;cellular homeostasis;coagulation,membrane;nucleus,RNA binding;structural molecule activity,5965,RECQL,Progeria-associated lipodystrophy,NA,ENSG00000004700
O95336,0,6,22044612.375,8.533350427954812e-5,0.9950851526943133,-0.007108107810630822,0.6799417207028133,1,raw,22231872.875,20274195.375,22085604.75,26464612.375,19234331.5,21977057.375,6-phosphogluconolactonase OS=Homo sapiens OX=9606 GN=PGLS PE=1 SV=2,cellular homeostasis,cytosol;nucleus,structural molecule activity,25796,PGLS,Pentose phosphate metabolism,Pentose phosphate pathway,ENSG00000130313
O60568,0,6,11008593.0625,4.261366937329273e-5,0.9946662747667004,-0.007715533551848457,0.6940878323221991,1,raw,12526708.625,11283916.9375,10518693.6875,13434984.375,7063523.125,11223731.625,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 OS=Homo sapiens OX=9606 GN=PLOD3 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cell surface;chromosome;cytoskeleton;extracellular,structural molecule activity,8985,PLOD3,VEGFA-VEGFR2 signaling pathway; IL-18 signaling pathway,Collagen biosynthesis and modifying enzymes,ENSG00000106397
Q96PN6,0.3333333333333333,6,682389.1015625,2.641491368863345e-6,0.9946564543093721,-0.007729777520290466,0.8366568263966927,1,raw,964224,574737.5625,414193.65625,959071.625,252026.015625,930081.75,Adenylate cyclase type 10 OS=Homo sapiens OX=9606 GN=ADCY10 PE=1 SV=3,cellular homeostasis;conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,structural molecule activity,55811,ADCY10,Endothelin pathways; Phosphodiesterases in neuronal function; Thermogenesis; Envelope proteins and their potential roles in EDMD physiopathology,Hedgehog 'off' state,ENSG00000143199
P68371,0,6,1915951006.770835,0.007416542901933587,0.9942156058282681,-0.008369345987901575,0.9147637268294153,1,raw,2219475990.60938,1843425314.90625,1632901418.76563,2156575328.6875,1436690321.03125,2206637666.625,Tubulin beta-4B chain OS=Homo sapiens OX=9606 GN=TUBB4B PE=1 SV=1,cell differentiation;cell growth;coagulation,cell surface;cytosol;endoplasmic reticulum;mitochondrion;nucleus,antioxidant activity;motor activity;RNA binding;structural molecule activity,10383,TUBB4B,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Neutrophil degranulation; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,ENSG00000188229
Q9H159,0.6666666666666666,6,2781611.6875,1.0767468658623774e-5,0.9937914837340037,-0.008984916077789309,0.8126164432050351,1,raw,4059409.5,1889695.375,2655747.25,2639259,2498489.25,2947069.75,Cadherin-19 OS=Homo sapiens OX=9606 GN=CDH19 PE=2 SV=1,cell communication;cell growth;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,28513,CDH19,Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Malignant pleural mesothelioma,NA,ENSG00000071991
Q9NTM9,0,6,4411229.78125,1.7075632313828198e-5,0.9932188721735321,-0.009816420432117702,0.9999593020590221,1,raw,5354640.25,4518808.5,3360180.5625,3937736.125,3977683.5,5318329.75,Copper homeostasis protein cutC homolog OS=Homo sapiens OX=9606 GN=CUTC PE=1 SV=1,cell growth;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,51076,CUTC,NA,Ion transport by P-type ATPases,ENSG00000119929
Q8N122,0,6,38563865.638020836,1.4927864175964987e-4,0.9931937432097847,-0.009852921842854053,0.9310604458365948,1,raw,34129682.96875,42635915.828125,38547755.390625,38285389.46875,37175783.484375,40608666.6875,Regulatory-associated protein of mTOR OS=Homo sapiens OX=9606 GN=RPTOR PE=1 SV=1,cell growth;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;mitochondrion;nucleus,DNA binding;RNA binding;structural molecule activity,57521,RPTOR,AMP-activated protein kinase signaling; Target of rapamycin signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; PI3K-Akt signaling pathway; Thermogenesis; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; CAMKK2 pathway; Autophagy; p53 transcriptional gene network; Malignant pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway; GDNF signaling; DYRK1A; Interferon type I signaling pathways,Regulation of PTEN gene transcription; Amino acids regulate mTORC1; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; HSF1-dependent transactivation,ENSG00000141564
Q99598,0,6,15026258.947916666,5.816583709549781e-5,0.9931876031439042,-0.00986184081766504,0.8840330845868376,1,raw,16690493.625,16450469.25,12469700.375,16338402.125,11242215.5625,16966272.75,Translin-associated protein X OS=Homo sapiens OX=9606 GN=TSNAX PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;extracellular;membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,7257,TSNAX,NA,Small interfering RNA (siRNA) biogenesis,ENSG00000116918
A1X283,0,6,6430365.34375,2.4891597059889267e-5,0.9931547396455109,-0.009909578818452933,0.9877394590080577,1,raw,5257468.9375,6770597.25,7245181.875,5829495.65625,6283861.625,7195586.71875,SH3 and PX domain-containing protein 2B OS=Homo sapiens OX=9606 GN=SH3PXD2B PE=1 SV=3,cell growth;cellular homeostasis;defense response;metabolic process,endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,285590,SH3PXD2B,NA,NA,ENSG00000174705
Q12933,0,6,1503379.26953125,5.819499982490794e-6,0.9924125047837548,-0.010988181023553508,0.5301295227357206,1,raw,1196677.03125,2499590.03125,1290076.2421875,1429194.4375,1187597.25,1417140.625,TNF receptor-associated factor 2 OS=Homo sapiens OX=9606 GN=TRAF2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,7186,TRAF2,RANKL/RANK signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Apoptosis; MAPK signaling pathway; Novel intracellular components of RIG-I-like receptor pathway; Oxidative damage response; p38 MAPK signaling pathway; Nonalcoholic fatty liver disease; Small cell lung cancer; 16p11.2 proximal deletion syndrome; 16p11.2 distal deletion syndrome; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Malignant pleural mesothelioma; Alzheimer's disease,Ub-specific processing proteases; Regulation by c-FLIP; CASP8 activity is inhibited; Dimerization of procaspase-8; TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway; Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway; TRAF6 mediated NF-kB activation; Regulation of NF-kappa B signaling; TNFR1-induced proapoptotic signaling; TRAF6 mediated IRF7 activation; Defective RIPK1-mediated regulated necrosis,ENSG00000127191
Q12974,0,6,1153300.203125,4.464362817764034e-6,0.9921703707613213,-0.01134022029531496,0.6518955957393718,1,raw,1321460.34375,1283669.5,1157621.53125,1577102.09375,1273618.84375,306328.90625,Protein tyrosine phosphatase type IVA 2 OS=Homo sapiens OX=9606 GN=PTP4A2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,8073,PTP4A2,NA,RAB geranylgeranylation,ENSG00000184007
Q9H0E2,0,6,1141262.28125,4.4177646721326725e-6,0.9920862628581002,-0.011462525094899274,0.9882879636307471,1,raw,1180506.375,NA,1092355.03125,1670854.78125,621332.9375,NA,Toll-interacting protein OS=Homo sapiens OX=9606 GN=TOLLIP PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cell surface;cytosol;membrane;mitochondrion;nucleus,antioxidant activity;structural molecule activity,54472,TOLLIP,IL-1 signaling pathway; Interleukin-1 (IL-1) structural pathway; Toll-like receptor signaling related to MyD88; Signal transduction through IL1R; Toll-like receptor signaling pathway,Interleukin-1 signaling; Neutrophil degranulation,ENSG00000078902
P29966,0,6,23855117.09375,9.234187029376773e-5,0.9914041596429923,-0.01245478293838488,0.9495784099045609,1,raw,22023958.0625,26297208.125,22883655.5625,22686951.3125,19176180.75,30062748.75,Myristoylated alanine-rich C-kinase substrate OS=Homo sapiens OX=9606 GN=MARCKS PE=1 SV=4,cell growth;coagulation;defense response;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,4082,MARCKS,Brain-derived neurotrophic factor (BDNF) signaling pathway,Acetylcholine regulates insulin secretion,ENSG00000277443
P53609,0,6,1655166.6822916667,6.40706086203983e-6,0.9913827532186994,-0.012485933983382661,0.7890579284265518,1,raw,1177372.59375,2141871.03125,1812440.21875,2123414,1399650.25,1276252,Geranylgeranyl transferase type-1 subunit beta OS=Homo sapiens OX=9606 GN=PGGT1B PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,nucleus,structural molecule activity,5229,PGGT1B,NA,NA,ENSG00000164219
Q8WUM4,0,6,109542523.55729167,4.2403319431324994e-4,0.9912141956309788,-0.01273124576663314,0.6766676845177915,1,raw,117647307.875,117189045.875,101295427.78125,116159445.84375,88025517.5625,116938396.40625,Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cell surface;cytoplasm;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,antioxidant activity;structural molecule activity,10015,PDCD6IP,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells,Budding and maturation of HIV virion; Regulation of necroptotic cell death; Uptake and function of anthrax toxins,ENSG00000170248
Q9H3G5,0,6,2190477.5625,8.479220377030916e-6,0.9911465041540475,-0.01282977289958911,0.9848909019701491,1,raw,1922384.90625,2401976,2260378.3125,2850522.3125,1467237.78125,2240366.0625,Probable serine carboxypeptidase CPVL OS=Homo sapiens OX=9606 GN=CPVL PE=1 SV=2,cell organization and biogenesis,NA,structural molecule activity,54504,CPVL,NA,NA,ENSG00000106066
Q92692,0,6,3619383.4479166665,1.4010437910551941e-5,0.9911040649238133,-0.01289154800306235,0.7230855327311905,1,raw,3679728.40625,3603771,4035207,4660954.875,3646993.78125,2089645.625,Nectin-2 OS=Homo sapiens OX=9606 GN=NECTIN2 PE=1 SV=1,cell communication;cell growth;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,5819,NECTIN2,Monoamine transport,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Nectin/Necl  trans heterodimerization,ENSG00000130202
Q9BU89,0,6,2057614.8333333333,7.964915925899182e-6,0.9908722506788452,-0.013229026569799135,0.8983333472806737,1,raw,2234771.40625,2229484.1875,1619570.25,1828126.1875,1604787.21875,2828949.75,Deoxyhypusine hydroxylase OS=Homo sapiens OX=9606 GN=DOHH PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol,structural molecule activity,83475,DOHH,NA,Hypusine synthesis from eIF5A-lysine,ENSG00000129932
Q9H910,0,6,23162140.440104168,8.965939508242877e-5,0.9907635542244831,-0.013387295647739307,0.7073225153445645,1,raw,19994714.328125,33637332.875,19052285.96875,21791404.25,18876310.5625,25620794.65625,Jupiter microtubule associated homolog 2 OS=Homo sapiens OX=9606 GN=JPT2 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,NA,90861,JPT2,NA,NA,ENSG00000206053
A0A024R4E5,0,6,69829759.2890625,2.7030722798694845e-4,0.9906713178393842,-0.013521611417935932,0.9130261060439577,1,raw,65570940.15625,79490947.21875,62741508.53125,78749401.4375,54312974.953125,78112783.4375,"High density lipoprotein binding protein (Vigilin), isoform CRA_a OS=Homo sapiens OX=9606 GN=HDLBP PE=1 SV=1",NA,cytosol,RNA binding,3069,HDLBP,2q37 copy number variation syndrome,NA,ENSG00000115677
Q96JM7,0.16666666666666666,6,511331.56875,1.979336895017469e-6,0.9905300103250083,-0.013727409433188675,0.9466497779273366,1,raw,659138.71875,344734.4375,NA,771164.53125,279614.84375,502005.3125,Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens OX=9606 GN=L3MBTL3 PE=1 SV=2,cell growth;metabolic process,membrane,structural molecule activity,84456,L3MBTL3,NA,NA,ENSG00000198945
Q08380,0,6,59793860.614583336,2.3145880607234993e-4,0.9904365240007342,-0.013863577565445578,0.8523916428591267,1,raw,66613031.1875,56708925.5,54399320.875,65975979.0625,52300220.625,62765686.4375,Galectin-3-binding protein OS=Homo sapiens OX=9606 GN=LGALS3BP PE=1 SV=1,cell communication;coagulation;conjugation;development,cell surface;cytoskeleton;nucleus,structural molecule activity,3959,LGALS3BP,Network map of SARS-CoV-2 signaling pathway,Platelet degranulation,ENSG00000108679
Q9Y3T6,0,6,381470.609375,1.4766521326788986e-6,0.9901874471254591,-0.014226434907265459,1,1,raw,383351.4375,NA,NA,379589.78125,NA,NA,R3H and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=R3HCC1 PE=1 SV=3,NA,NA,RNA binding,203069,R3HCC1,NA,NA,ENSG00000104679
P02795,0,6,21958272.223958332,8.499928621650944e-5,0.9901718330432885,-0.014249184677109429,0.8919592152628728,1,raw,26831470.0625,14679663,22907050.0625,32007229.65625,12642304.8125,22681915.75,Metallothionein-2 OS=Homo sapiens OX=9606 GN=MT2A PE=1 SV=1,coagulation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,4502,MT2A,Copper homeostasis; Zinc homeostasis; Lung fibrosis,Interferon gamma signaling; Metallothioneins bind metals,ENSG00000125148
O60361,0,6,6481161.270833333,2.5088225351075048e-5,0.990104524665478,-0.014347257314836768,0.9402015423575285,1,raw,6252197.75,7755059.5,5544110.375,5965965.625,5691314.875,7678319.5,Putative nucleoside diphosphate kinase OS=Homo sapiens OX=9606 GN=NME2P1 PE=5 SV=1,cellular homeostasis;metabolic process,NA,signal transducer activity;structural molecule activity,NA,NME2P1,NA,Interconversion of nucleotide di- and triphosphates,NA
Q9H9Q2,0,6,6564135.8125,2.5409415321937764e-5,0.990062027091547,-0.014409182448472765,0.6213591147104554,1,raw,6320453.9375,5073118.5625,6757845.875,10425024.5,4550730.5625,6257641.4375,COP9 signalosome complex subunit 7b OS=Homo sapiens OX=9606 GN=COPS7B PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,NA,64708,COPS7B,Ciliary landscape,Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; DNA Damage Recognition in GG-NER,ENSG00000144524
P35249,0,6,23692127.916666668,9.171094798932597e-5,0.9900335137008235,-0.014450732087418096,0.9490414355057067,1,raw,23912153.75,27545821.40625,19918570.125,25174606.125,19720051.96875,25881564.125,Replication factor C subunit 4 OS=Homo sapiens OX=9606 GN=RFC4 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,5984,RFC4,"Gastric cancer network 2; Retinoblastoma gene in cancer; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,ENSG00000163918
Q96QC0,0,6,3632000.3255208335,1.4059277162552158e-5,0.9898964222514893,-0.014650518100879844,0.9487816525367461,1,raw,2854755.34375,4829421.6875,3326004.359375,4234625.40625,1766567.90625,4780627.25,Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Homo sapiens OX=9606 GN=PPP1R10 PE=1 SV=1,conjugation;metabolic process,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,5514,PPP1R10,NA,NA,ENSG00000204569; ENSG00000206489; ENSG00000227804; ENSG00000230995; ENSG00000231737; ENSG00000235291; ENSG00000238104
Q5VZK9,0,6,1753380.39453125,6.787240839402974e-6,0.9896117083250605,-0.01506552561332053,0.905558804531273,1,raw,1544379.8515625,1784284.890625,1855804.921875,2424569.8125,1145493.671875,1765749.21875,F-actin-uncapping protein LRRC16A OS=Homo sapiens OX=9606 GN=CARMIL1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,structural molecule activity,55604,CARMIL1,NA,Factors involved in megakaryocyte development and platelet production,ENSG00000079691
Q7Z2T5,0,6,16836580.5625,6.517349432337434e-5,0.9895014341665825,-0.015226296595356174,0.987065805102483,1,raw,16029407.625,17176319.28125,17244442.59375,20510078.75,13063242.5625,16995992.5625,TRMT1-like protein OS=Homo sapiens OX=9606 GN=TRMT1L PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,81627,TRMT1L,NA,NA,ENSG00000121486
P62306,0,6,46416149.838541664,1.7967440994241305e-4,0.9892878584524119,-0.015537724018209317,0.9388119925850291,1,raw,47581026.1875,49063192.875,41937983.8125,54776214.96875,38067149.6875,47071331.5,Small nuclear ribonucleoprotein F OS=Homo sapiens OX=9606 GN=SNRPF PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,6636,SNRPF,mRNA processing,snRNP Assembly; RNA Polymerase II Transcription Termination; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway; SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,ENSG00000139343
P41227,0,6,35377193.09375,1.3694320439435332e-4,0.9892871091507242,-0.01553881673781476,0.8461153499814102,1,raw,34997626.25,41980424.0625,31219131.875,44633286.875,24809989,34622700.5,N-alpha-acetyltransferase 10 OS=Homo sapiens OX=9606 GN=NAA10 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,8260,NAA10,NA,NA,ENSG00000102030
O75175,0,6,3106039.296875,1.2023310418145986e-5,0.9887448215196945,-0.016329861294267094,0.8800956023075936,1,raw,3354398.8125,2776122.125,3104585.15625,2744876.375,3711237.3125,2945016,CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1,cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,NA,4849,CNOT3,NA,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,ENSG00000088038; ENSG00000273943; ENSG00000274176; ENSG00000274616; ENSG00000274941; ENSG00000275979; ENSG00000276082; ENSG00000277114; ENSG00000277600; ENSG00000277615
Q8NC60,0,6,896877.9791666666,3.471766233469606e-6,0.9884900712723248,-0.016701619775688716,0.8749783274359564,1,raw,874533,1047365.46875,817672.53125,585593.5625,864467.1875,1191636.125,Nitric oxide-associated protein 1 OS=Homo sapiens OX=9606 GN=NOA1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome,structural molecule activity,84273,NOA1,NA,NA,ENSG00000084092
P61006,0,6,8971477.473958334,3.47281049171949e-5,0.9879906504599469,-0.017430705505436926,0.8377830013933585,1,raw,8526221.5625,9962376.5,8003807.0625,11298216.875,8423827.1875,7614415.65625,Ras-related protein Rab-8A OS=Homo sapiens OX=9606 GN=RAB8A PE=1 SV=1,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,4218,RAB8A,Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Ciliary landscape; Joubert syndrome,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of PLK1 Activity at G2/M Transition; Anchoring of the basal body to the plasma membrane; VxPx cargo-targeting to cilium; TBC/RABGAPs,ENSG00000167461
Q15435,0,6,17281227.015625,6.689469673624408e-5,0.9879719334544519,-0.017458036924795396,0.6785739431681463,1,raw,21544074.5625,14209001.8125,13582276.09375,20405450.0625,12661618.5625,21284941,Protein phosphatase 1 regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PPP1R7 PE=1 SV=1,metabolic process,nucleus,DNA binding,5510,PPP1R7,2q37 copy number variation syndrome,NA,ENSG00000115685
Q99470,0,6,4054414.9166666665,1.5694421238034524e-5,0.9879692478481293,-0.017461958611290913,0.8598952224689258,1,raw,3803111.0625,5187913.375,3456179.6875,5125498.875,2325075.375,4428711.125,Stromal cell-derived factor 2 OS=Homo sapiens OX=9606 GN=SDF2 PE=1 SV=2,metabolic process,extracellular;nucleus,structural molecule activity,6388,SDF2,NA,NA,ENSG00000132581
Q05048,0,6,9768368.447916666,3.781282685196226e-5,0.9877386784528881,-0.017798689886371857,0.9888411711866414,1,raw,9927623.28125,10967575.75,8372365.75,12306659.375,7230089.03125,9805897.5,Cleavage stimulation factor subunit 1 OS=Homo sapiens OX=9606 GN=CSTF1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,NA,1477,CSTF1,mRNA processing,mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Processing of Intronless Pre-mRNAs,ENSG00000101138
Q8N8R5,0,6,754637.0729166666,2.921159365191153e-6,0.9876680578426859,-0.017901842318015167,0.5855932468074576,1,raw,619559.75,1346489.25,550347.875,611919.375,550982.625,848523.5625,UPF0565 protein C2orf69 OS=Homo sapiens OX=9606 GN=C2orf69 PE=1 SV=1,cellular homeostasis,cytoskeleton;endosome,NA,205327,C2orf69,NA,NA,ENSG00000178074
A0A087WT20,0,6,12774096.434895834,4.944783760547044e-5,0.9874760127207555,-0.018182391519501972,0.8301755562410985,1,raw,12527587.28125,13184993.96875,11943349.21875,16386165,10231791.203125,12370691.9375,DDB1- and CUL4-associated factor 13 OS=Homo sapiens OX=9606 GN=DCAF13 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;endoplasmic reticulum;membrane;nucleus,NA,25879,DCAF13,NA,NA,ENSG00000164934
Q15691,0,6,62106747.614583336,2.4041186677286095e-4,0.9872595741212123,-0.018498641348136044,0.7234232147502357,1,raw,62966865.875,66144302.40625,50072846.4375,84764325.375,46527504.40625,62164641.1875,Microtubule-associated protein RP/EB family member 1 OS=Homo sapiens OX=9606 GN=MAPRE1 PE=1 SV=3,cell differentiation;cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,motor activity;structural molecule activity,22919,MAPRE1,Microtubule cytoskeleton regulation,Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Resolution of Sister Chromatid Cohesion; Recruitment of NuMA to mitotic centrosomes; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000101367
P36639,0,6,3750151.4270833335,1.4516633697532597e-5,0.9866899800465141,-0.019331236657331653,0.845585544769941,1,raw,4113822.96875,4212155.59375,3061943.09375,3583841.96875,3373053.21875,4156091.71875,"7,8-dihydro-8-oxoguanine triphosphatase OS=Homo sapiens OX=9606 GN=NUDT1 PE=1 SV=3",NA,NA,NA,NA,NA,NA,NA,NA
P09669,0,6,28678891.166666668,1.1101443928670779e-4,0.985848273818817,-0.020562468013080717,0.9966272498535875,1,raw,30470195.5,25869325,29722734.5,34210176,22498809.5,29302106.5,Cytochrome c oxidase subunit 6C OS=Homo sapiens OX=9606 GN=COX6C PE=1 SV=2,cellular homeostasis,cytoskeleton;endosome,NA,1345,COX6C,Electron transport chain: OXPHOS system in mitochondria; Ciliary landscape; Nonalcoholic fatty liver disease; Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000164919
A0A494C1T9,0,6,1018858.2786458334,3.943945386840909e-6,0.9854258191369953,-0.021180822696452998,0.9101308154195147,1,raw,1129883.84375,1316457.4375,668997.71875,826409.703125,659247.625,1512153.34375,Protein FAM83H OS=Homo sapiens OX=9606 GN=FAM83H PE=1 SV=1,NA,NA,NA,NA,FAM83H,NA,NA,ENSG00000180921
O14925,0,6,2169988.8020833335,8.399909491679126e-6,0.9851451869506935,-0.021591735741431063,0.7762772845389163,1,raw,2157557.4375,2311947.875,1888659.75,1990521.8125,1860604.0625,2810641.875,Mitochondrial import inner membrane translocase subunit Tim23 OS=Homo sapiens OX=9606 GN=TIMM23 PE=1 SV=1,cell growth;conjugation,cytoskeleton;endosome,catalytic activity,100287932,TIMM23,NA,Mitochondrial protein import,ENSG00000265354
Q9UGP4,0,6,528819.484375,2.0470316722011536e-6,0.9850129721610983,-0.021785370572914416,0.7035258191237859,1,raw,414372.9375,659434.375,448368.1875,633696.5,408162.71875,608882.1875,LIM domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LIMD1 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,8994,LIMD1,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Malignant pleural mesothelioma,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,ENSG00000144791
Q14353,0,6,15511858.583333334,6.004556706589041e-5,0.9847929259837928,-0.02210769627047149,0.9305841880937823,1,raw,17409678.875,12748507.6875,16060905.875,15528678.5,12554640.1875,18768740.375,Guanidinoacetate N-methyltransferase OS=Homo sapiens OX=9606 GN=GAMT PE=1 SV=1,cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,2593,GAMT,MECP2 and associated Rett syndrome; Creatine pathway,Transcriptional Regulation by MECP2; Creatine metabolism,ENSG00000130005
Q96DH6,0,6,18582949.608072918,7.193359460951362e-5,0.9845003095656178,-0.02253643512039981,0.7224183958409863,1,raw,19019162.9453125,17045249.78125,18718290.171875,18428162.46875,16560909.5,21725922.78125,RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1,defense response;metabolic process,cytosol;nucleus,RNA binding;structural molecule activity,124540,MSI2,NA,RHOBTB2 GTPase cycle,ENSG00000153944
Q9NQH7,0,6,3641706.5572916665,1.4096849461681989e-5,0.984378349751935,-0.022715167128876248,0.8398963350346903,1,raw,4365411.875,3730562.6875,3086758.65625,4190709.5625,2179579.625,4297216.9375,Xaa-Pro aminopeptidase 3 OS=Homo sapiens OX=9606 GN=XPNPEP3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endosome;nucleus,structural molecule activity,63929,XPNPEP3,Ciliary landscape; Ciliopathies,NA,ENSG00000196236
Q92552,0,6,15461383.390625,5.9850180320153284e-5,0.9843666735582436,-0.022732279742785848,0.729101584243278,1,raw,15048714.65625,15742911.5625,14782909.28125,14813453.1875,14006965.625,18373346.03125,"28S ribosomal protein S27, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS27 PE=1 SV=3",cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome;Golgi;membrane;nucleus,protein binding;RNA binding,23107,MRPS27,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000113048
P50548,0,6,665238.134375,2.5751009008888353e-6,0.9835873406605706,-0.023874928155630686,0.9250214749115097,1,raw,NA,903130.46875,385588.375,1033227.28125,686857.609375,317386.9375,ETS domain-containing transcription factor ERF OS=Homo sapiens OX=9606 GN=ERF PE=1 SV=2,cellular component movement;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,2077,ERF,Ciliary landscape,Oncogene Induced Senescence,ENSG00000105722
S4R347,0,6,1186471.5885416667,4.5927674597355025e-6,0.9835070758590352,-0.02399266285125579,0.608764584902832,1,raw,1177838.4375,1194608.03125,833961.21875,2029830.71875,1158412.4375,724178.6875,Formin-binding protein 1-like OS=Homo sapiens OX=9606 GN=FNBP1L PE=1 SV=1,cellular homeostasis;conjugation;development,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,NA,100984941; 469385,FNBP1L,NA,NA,ENSPPAG00000029809; ENSPTRG00000000970
Q9UBC2,0,6,9413105.026041666,3.6437621327127664e-5,0.9834288332600388,-0.02410744057135792,0.7254319913199703,1,raw,9085039.3125,12012176.25,7965865.625,9024732.4375,7833861.9375,10556954.59375,Epidermal growth factor receptor substrate 15-like 1 OS=Homo sapiens OX=9606 GN=EPS15L1 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton;cytosol;membrane,structural molecule activity,58513,EPS15L1,EGF/EGFR signaling pathway,Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation,ENSG00000127527
Q9NRR5,0,6,18460101.856770832,7.145805759697093e-5,0.9833597354108207,-0.02420881102472751,0.899558334084243,1,raw,14952616.34375,18316622.0625,22636861.640625,16210988.71875,18011828.625,20631693.75,Ubiquilin-4 OS=Homo sapiens OX=9606 GN=UBQLN4 PE=1 SV=2,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,56893,UBQLN4,NA,NA,ENSG00000160803
P62072,0,6,4595668.989583333,1.7789586531117036e-5,0.9831245887478823,-0.024553837854539417,0.7906249848001812,1,raw,4090974.375,4923150.5625,4536046.6875,4375264.3125,4021937.5,5626640.5,Mitochondrial import inner membrane translocase subunit Tim10 OS=Homo sapiens OX=9606 GN=TIMM10 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endosome,structural molecule activity,26519,TIMM10,NA,Mitochondrial protein import,ENSG00000134809
P35268,0,6,60156047.125,2.3286081049914064e-4,0.9830324689004977,-0.024689026288819946,0.9984379088949928,1,raw,50611208,81893993.25,48004254.875,60780459.0625,47189741.1875,72456626.375,60S ribosomal protein L22 OS=Homo sapiens OX=9606 GN=RPL22 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;Golgi;membrane;nucleus,structural molecule activity,6146,RPL22,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000116251
P40818,0,6,9188582.1875,3.556850554148203e-5,0.9828157148614719,-0.025007168840259435,0.7138864629068391,1,raw,10054531.03125,6680079.5,10087717.78125,9824214.25,9914367.5625,8570583,Ubiquitin carboxyl-terminal hydrolase 8 OS=Homo sapiens OX=9606 GN=USP8 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,9101,USP8,EGF/EGFR signaling pathway; Male infertility,Negative regulation of MET activity; Ub-specific processing proteases; Downregulation of ERBB2:ERBB3 signaling; Regulation of FZD by ubiquitination,ENSG00000138592
Q15696,0.5,6,1489571.025,5.766049013439655e-6,0.982033409995795,-0.02615598723606915,0.8439777415441151,1,raw,NA,1775049,1318833.625,2095295.25,772561,1486116.25,U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 OS=Homo sapiens OX=9606 GN=ZRSR2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,8233,ZRSR2,NA,mRNA Splicing - Minor Pathway,ENSG00000169249
Q8TDB6,0,6,1030326.5625,3.988338494449297e-6,0.9819136937609356,-0.026331871829120668,0.6504761253114043,1,raw,1090194.875,746681.96875,967058.8125,733177.25,1837501.46875,807345,E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,DNA binding;structural molecule activity,151636,DTX3L,Notch signaling,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000163840
Q9NX74,0,6,3445408.5833333335,1.3336990602932606e-5,0.9816736222445511,-0.026684644517199468,0.7657248102391165,1,raw,2352875,3565007.5,4130917.25,3191997.75,3376441.5,4055212.5,tRNA-dihydrouridine(20) synthase [NAD(P)+]-like OS=Homo sapiens OX=9606 GN=DUS2 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,cytosol;extracellular;nucleus,DNA binding;RNA binding;structural molecule activity,54920,DUS2,NA,tRNA modification in the nucleus and cytosol,ENSG00000167264
P49006,0,6,19368761.489583332,7.497542997559311e-5,0.9816356749481198,-0.026740414004423688,0.8265922191802251,1,raw,16682753.0625,23689037.625,15487977.375,16376385.5625,12701887.5625,31274527.75,MARCKS-related protein OS=Homo sapiens OX=9606 GN=MARCKSL1 PE=1 SV=2,cell differentiation;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,65108,MARCKSL1,NA,NA,ENSG00000175130
O15160,0,6,16899988.953125,6.541894477996274e-5,0.9815296786546763,-0.026896203558035573,0.7619316630452606,1,raw,19379750.46875,18295692.0625,14081386.625,16617852.25,14003452.0625,19021800.25,DNA-directed RNA polymerases I and III subunit RPAC1 OS=Homo sapiens OX=9606 GN=POLR1C PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane,RNA binding;structural molecule activity,9533,POLR1C,Pyrimidine metabolism; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination,ENSG00000171453
P16070,0,6,47896871.0625,1.8540620185383542e-4,0.9810994986670051,-0.02752863942723892,0.8188175761589246,1,raw,47256464.75,45453000.5,52723627,46363293.875,40721656.625,54863183.625,CD44 antigen OS=Homo sapiens OX=9606 GN=CD44 PE=1 SV=3,cell communication;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,960,CD44,Hepatitis C and hepatocellular carcinoma; Wnt signaling pathway and pluripotency; Hippo-Merlin signaling dysregulation; Gastrin signaling pathway; Malignant pleural mesothelioma; CCL18 signaling pathway,Neutrophil degranulation; Cell surface interactions at the vascular wall; Degradation of the extracellular matrix; Integrin cell surface interactions; Interferon gamma signaling; Hyaluronan uptake and degradation,ENSG00000026508
Q5HYK3,0,6,630867.6875,2.4420547567514157e-6,0.9810907187839661,-0.027541550197670128,0.8053210996878355,1,raw,917862.9375,NA,422536.25,655938.8125,NA,527132.75,"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial OS=Homo sapiens OX=9606 GN=COQ5 PE=1 SV=2",cellular homeostasis,cytoskeleton;endosome;nucleus,structural molecule activity,84274,COQ5,NA,Ubiquinol biosynthesis,ENSG00000110871
P55036,0,6,46526740.614583336,1.801025008654965e-4,0.9807210387511405,-0.02808526755927478,0.7876220281046775,1,raw,41795525.0625,55502403.5625,45125548.46875,54432374.875,36762297.75,45542293.96875,26S proteasome non-ATPase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMD4 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,5710,PSMD4,Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; VEGFA-VEGFR2 signaling pathway; Alzheimer's disease,FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000159352
Q9NPQ8,0,6,882431.2395833334,3.415843684545228e-6,0.9806223340656678,-0.02823047493329991,0.9645262044836013,1,raw,467369.5625,1324335.8125,827491.34375,1484720.25,458313.03125,732357.4375,Synembryn-A OS=Homo sapiens OX=9606 GN=RIC8A PE=1 SV=3,cell communication;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,DNA binding;structural molecule activity,60626,RIC8A,NA,NA,ENSG00000177963
Q01518,0,6,289997542.1757813,0.001122564828328739,0.9799939570858263,-0.029155241689302166,0.7072193347197879,1,raw,302422324.4375,334945416.820313,258107684.15625,328244484.4375,212790651.390625,303474691.8125,Adenylyl cyclase-associated protein 1 OS=Homo sapiens OX=9606 GN=CAP1 PE=1 SV=5,cell growth;conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,10487,CAP1,Angiopoietin-like protein 8 regulatory pathway; Insulin signaling; Complement system in neuronal development and plasticity,Neutrophil degranulation; Platelet degranulation ; Role of ABL in ROBO-SLIT signaling,ENSG00000131236
P48449,0,6,8755897.484375,3.3893606417028174e-5,0.9794710212607243,-0.029925285500062775,0.6620348904636428,1,raw,7746887.4375,8849759.0625,8833042.34375,8392414,7587851.75,11125430.3125,Lanosterol synthase OS=Homo sapiens OX=9606 GN=LSS PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,4047,LSS,Cholesterol biosynthesis pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,ENSG00000160285
J3KTA4,0,6,121095768.0625,4.687551800146593e-4,0.9793909442379559,-0.030043238398976713,0.9052282960669773,1,raw,121318497.4375,147366565.75,98180271.375,126227948.5625,96156868.6875,137324456.5625,DEAD box protein 5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,1655,DDX5,Ciliary landscape,NA,ENSG00000108654
Q9BZD4,0.6666666666666666,6,6442871.5234375,2.4940007806230822e-5,0.9789532550121575,-0.03068812205759594,0.424497544163848,0.9100061300747335,raw,310585.4375,37079760,249928.140625,304048.625,275770.6875,437136.25,Kinetochore protein Nuf2 OS=Homo sapiens OX=9606 GN=NUF2 PE=1 SV=2,cell differentiation;cell growth;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,83540,NUF2,NA,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000143228
Q15554,0,6,4182169.7760416665,1.6188953400984823e-5,0.9781216595897158,-0.031914174933995836,0.8004461111690719,1,raw,3951512.03125,4175008.171875,4670272.53125,4083665.921875,3142093.375,5070466.625,Telomeric repeat-binding factor 2 OS=Homo sapiens OX=9606 GN=TERF2 PE=1 SV=3,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,7014,TERF2,"Hematopoietic stem cell gene regulation by GABP alpha/beta complex; DNA repair pathways, full network; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",Meiotic synapsis; Telomere Extension By Telomerase; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; Packaging Of Telomere Ends; DNA Damage/Telomere Stress Induced Senescence; Polymerase switching on the C-strand of the telomere; Telomere C-strand synthesis initiation; Removal of the Flap Intermediate from the C-strand,ENSG00000132604
Q9H773,0,6,27065957.64908855,1.0477086072503763e-4,0.977958702896784,-0.032154550347833474,0.5693298361362312,1,raw,31607948.671875,26929381.703125,26387898.0625,30911268.484375,19103648.2539063,27455600.71875,dCTP pyrophosphatase 1 OS=Homo sapiens OX=9606 GN=DCTPP1 PE=1 SV=1,cell proliferation;cellular homeostasis;coagulation,cytosol;endosome;membrane,structural molecule activity,79077,DCTPP1,Pyrimidine metabolism,Interconversion of nucleotide di- and triphosphates,ENSG00000179958
Q9NWV4,0,6,8140239.041666667,3.151042582569371e-5,0.9766449081020298,-0.03409397735995447,0.9745703955962979,1,raw,8631246.8125,8990601.125,6925554.4375,11900478.75,3963889.875,8429663.25,CXXC motif containing zinc binding protein OS=Homo sapiens OX=9606 GN=CZIB PE=1 SV=1,NA,NA,structural molecule activity,54987,CZIB,NA,NA,ENSG00000162384
P51153,0,6,10246935.2578125,3.9665333134477287e-05,0.9765758210648836,-0.03419603600026445,0.9167974562018857,1,raw,8767512.875,13133970.609375,8414737.3125,14439883.625,8507878.125,8217629,Ras-related protein Rab-13 OS=Homo sapiens OX=9606 GN=RAB13 PE=1 SV=1,cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,5872,RAB13,Leukocyte-intrinsic Hippo pathway functions,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Translocation of SLC2A4 (GLUT4) to the plasma membrane,ENSG00000143545
Q8NDC0,0,6,5572245.416666667,2.156986115342468e-5,0.9763957327562736,-0.03446210491456262,0.9527716769289272,1,raw,4616466,6207098,5946632,5333844,5268848.5,6060584,MAPK-interacting and spindle-stabilizing protein-like OS=Homo sapiens OX=9606 GN=MAPK1IP1L PE=1 SV=4,NA,NA,NA,93487,MAPK1IP1L,NA,NA,ENSG00000168175
P62269,0,6,306821340.6666667,0.0011876888439430178,0.976285845004507,-0.03462448112223619,0.9220918972620136,1,raw,273346320.75,374719866.75,280139790.5,365833701.75,237365750.75,309522613.5,40S ribosomal protein S18 OS=Homo sapiens OX=9606 GN=RPS18 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6222,RPS18,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000096150; ENSG00000223367; ENSG00000226225; ENSG00000231500; ENSG00000235650
Q9NRW7,0,6,1609580.2057291667,6.23059807255358e-6,0.9752972691414774,-0.03608607771710652,0.8401341291790967,1,raw,989194.34375,3143683.859375,975867.5625,2441677.6875,951760.96875,1155296.8125,Vacuolar protein sorting-associated protein 45 OS=Homo sapiens OX=9606 GN=VPS45 PE=1 SV=1,conjugation,cytoskeleton;extracellular;mitochondrion,NA,11311,VPS45,NA,Intra-Golgi traffic; Factors involved in megakaryocyte development and platelet production; SARS-CoV-2 modulates autophagy,ENSG00000136631
P50613,0,6,1083784.015625,4.195269409242302e-6,0.9752701172797681,-0.03612624229333614,0.9848277029738807,1,raw,485499.09375,1205479.25,1572644.4375,1533753.125,691129.8125,1014198.375,Cyclin-dependent kinase 7 OS=Homo sapiens OX=9606 GN=CDK7 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,1022,CDK7,"MicroRNAs in cardiomyocyte hypertrophy; Cell cycle; Cardiac hypertrophic response; Eukaryotic transcription initiation; G1 to S cell cycle control; Nucleotide excision repair; DNA repair pathways, full network; Malignant pleural mesothelioma; Nucleotide excision repair in xeroderma pigmentosum",RUNX1 regulates transcription of genes involved in differentiation of HSCs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; Cyclin D associated events in G1; Cyclin A/B1/B2 associated events during G2/M transition; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Cyclin E associated events during G1/S transition ; Cyclin A:Cdk2-associated events at S phase entry,ENSG00000134058; ENSG00000277273
A0A494BZY7,0,6,434176.1125,1.6806722896208925e-6,0.9751894386274886,-0.036245593336799754,0.7939910872281268,1,raw,379644.375,453588.5625,NA,625831.75,308735.53125,403080.34375,EEF1A lysine methyltransferase 2 OS=Homo sapiens OX=9606 GN=EEF1AKMT2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,NA,EEF1AKMT2,NA,NA,ENSG00000203791
P23526,0,6,360877480.4023438,0.0013969372422819,0.9750035672618277,-0.03652059760302826,0.8282796567583655,1,raw,373647684.203125,369762279.992188,358725723.421875,442336918.6875,260272734.078125,360519542.03125,Adenosylhomocysteinase OS=Homo sapiens OX=9606 GN=AHCY PE=1 SV=4,cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,191,AHCY,"Folate metabolism; Trans-sulfuration pathway; One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Methionine de novo and salvage pathway; Ethanol effects on histone modifications","Methylation; Sulfur amino acid metabolism; Metabolism of ingested SeMet, Sec, MeSec into H2Se; Defective AHCY causes HMAHCHD",ENSG00000101444
E9PK91,0,6,2548766.1,9.866135961119033e-6,0.9749466622161834,-0.03660480142108962,0.9711671170569847,1,raw,3199175.25,2442669,1956850.25,3423630,NA,1721506,Bcl-2-associated transcription factor 1 OS=Homo sapiens OX=9606 GN=BCLAF1 PE=1 SV=1,metabolic process,membrane,NA,NA,BCLAF1,Interactome of polycomb repressive complex 2 (PRC2),NA,ENSG00000029363
Q9UBG0,0.8333333333333334,6,1085406.1979166667,4.201548789309113e-6,0.9749329221958744,-0.03662513360910822,0.8088880127413156,1,raw,861601.75,1101659.125,1210068.5,1074043.75,816964.5625,1448099.5,C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2,cellular homeostasis;conjugation,cytoskeleton,structural molecule activity,9902,MRC2,NA,Cross-presentation of soluble exogenous antigens (endosomes),ENSG00000011028
Q8NFU3,0,6,8390756.208333334,3.248016425203564e-5,0.9748939852137356,-0.03668275327866222,0.9024591670119313,1,raw,9352546.125,7167866.75,8842074.375,6972775.25,8620085.125,9389189.625,Thiosulfate:glutathione sulfurtransferase OS=Homo sapiens OX=9606 GN=TSTD1 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,100131187,TSTD1,NA,Sulfide oxidation to sulfate,ENSG00000215845
Q9NRC6,0.3333333333333333,6,577110.3125,2.233962860573551e-6,0.9747456207855312,-0.036902326808630925,0.803239137962325,1,raw,619533.625,NA,551133.375,558373.625,516056.0625,640454.875,"Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2",cell growth;conjugation,cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,51332,SPTBN5,NA,COPI-mediated anterograde transport; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins,ENSG00000137877
A0A2C9F2R7,0.8333333333333334,6,324445.1380208333,1.255909611963833e-6,0.9745485942625063,-0.037193969995652436,0.9879820609374509,1,raw,262563.46875,375983.84375,333119.09375,275198.375,255880.859375,443925.1875,Protein furry homolog-like (Fragment) OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=1,metabolic process,NA,NA,NA,FRYL,NA,NA,ENSG00000075539
Q8NDA8,0,6,324445.1380208333,1.255909611963833e-6,0.9745485942625063,-0.037193969995652436,0.9879820609374509,1,raw,262563.46875,375983.84375,333119.09375,275198.375,255880.859375,443925.1875,Maestro heat-like repeat-containing protein family member 1 OS=Homo sapiens OX=9606 GN=MROH1 PE=2 SV=3,NA,nucleus,NA,727957,MROH1,NA,NA,ENSG00000179832
Q08AM6,0,6,877870.32421875,3.3981886274200816e-6,0.9745170652855617,-0.03724064538440949,0.5430051509271462,1,raw,648949,1911088.421875,554404.3046875,920893,599475.34375,632411.875,Protein VAC14 homolog OS=Homo sapiens OX=9606 GN=VAC14 PE=1 SV=1,cellular homeostasis;development;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,55697,VAC14,NA,Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the early endosome membrane; Synthesis of PIPs at the late endosome membrane,ENSG00000103043
A0A2R8YDB8,0,6,438282.375,1.6965674100546761e-6,0.974066371880948,-0.03790801547387068,0.9241696229899321,1,raw,NA,526517.734375,368859.9375,212992,422558.4375,660483.765625,Histone deacetylase complex subunit SAP130 OS=Homo sapiens OX=9606 GN=SAP130 PE=1 SV=1,metabolic process,membrane,NA,79595,SAP130,NA,NA,ENSG00000136715
P22681,0,6,3663405.265625,1.4180843990092161e-5,0.9740201466393956,-0.0379764815570041,0.6067737515900933,1,raw,3009329.4375,4879723.75,3632189.71875,2931147.5,3832296.90625,3695744.28125,E3 ubiquitin-protein ligase CBL OS=Homo sapiens OX=9606 GN=CBL PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,antioxidant activity;structural molecule activity,867,CBL,RANKL/RANK signaling pathway; Prolactin signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Physico-chemical features and toxicity-associated pathways; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; IL-4 signaling pathway; EGF/EGFR signaling pathway; Insulin signaling; IL-2 signaling pathway; Interferon type I signaling pathways; ErbB signaling pathway; T-cell receptor signaling pathway,Regulation of signaling by CBL; Regulation of KIT signaling; Negative regulation of FLT3; Cargo recognition for clathrin-mediated endocytosis; Interleukin-6 signaling; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Spry regulation of FGF signaling; TGF-beta receptor signaling activates SMADs; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1; FLT3 signaling by CBL mutants,ENSG00000110395
A0A0A0MSV9,0,6,1570457.8541666667,6.079157561933824e-6,0.9737777881266569,-0.038335501781852785,0.7666272258339377,1,raw,1202492,1536301.125,1729350.75,2579679,1203964.25,1170960,Tapasin OS=Homo sapiens OX=9606 GN=TAPBP PE=1 SV=1,metabolic process,cytoskeleton,NA,6892,TAPBP,NA,NA,ENSG00000206208; ENSG00000231925
H3BSW6,0,6,8120580.21875,3.143432758359476e-5,0.9734768551745591,-0.03878141622101622,0.7440946529540908,1,raw,6410278.6875,11023532.78125,7805495.40625,9490615.1875,6240257.9375,7753301.3125,Cytoplasmic tRNA 2-thiolation protein 2 OS=Homo sapiens OX=9606 GN=CTU2 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,nucleus,RNA binding;structural molecule activity,348180,CTU2,NA,NA,ENSG00000174177
P58107,0,6,21682404.87890625,8.393141861833448e-5,0.9732691264029283,-0.03908930361121005,0.8669588352011338,1,raw,22774819.4375,22444293.125,20562509.703125,21844337.5625,16871652.8828125,25596816.5625,Epiplakin OS=Homo sapiens OX=9606 GN=EPPK1 PE=1 SV=3,cell growth;coagulation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,structural molecule activity,83481,EPPK1,NA,NA,ENSG00000261150
Q15631,0,6,29470155.25,1.1407737983167066e-4,0.973056085073154,-0.039405133329065,0.725209827517975,1,raw,32593219.4375,30025265.0625,28356054.625,35461968.5,21168157,29216266.875,Translin OS=Homo sapiens OX=9606 GN=TSN PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis,cytosol;extracellular;membrane;nucleus,RNA binding;structural molecule activity,7247,TSN,NA,Small interfering RNA (siRNA) biogenesis,ENSG00000211460
O95456,0,6,11600103,4.490337240478237e-5,0.9728354691998148,-0.03973226505135721,0.9811399775749043,1,raw,11451490.8125,14627733.78125,8631157.5,13692655.3125,8396696.15625,12800884.4375,Proteasome assembly chaperone 1 OS=Homo sapiens OX=9606 GN=PSMG1 PE=1 SV=1,cell differentiation;cell growth;defense response,cytosol;extracellular;membrane;nucleus,structural molecule activity,8624,PSMG1,NA,NA,ENSG00000183527
A0A2R8YG42,0,6,9992094.895833334,3.867885985249694e-5,0.9727161222150328,-0.03990926503847223,0.8448285156292278,1,raw,10991359.09375,9521066.875,8868788.125,13524810.1875,7785249.84375,9261295.25,Rho guanine nucleotide exchange factor 7 OS=Homo sapiens OX=9606 GN=ARHGEF7 PE=1 SV=1,cell growth;development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,DNA binding;structural molecule activity,NA,ARHGEF7,NA,NA,ENSG00000102606
P60602,0,6,3663805.9166666665,1.4182394888642658e-5,0.9724691654074731,-0.04027558835559937,0.4736850406432699,0.9545409773602596,raw,2871627.875,6216197.75,3288149.5,3197624,2939036,3470200.375,Reactive oxygen species modulator 1 OS=Homo sapiens OX=9606 GN=ROMO1 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;endosome,NA,140823,ROMO1,NA,NA,ENSG00000125995
Q96CM8,0.16666666666666666,6,2821343.859375,1.0921269750748037e-5,0.9716733432743411,-0.04145670414716273,0.9332420140396327,1,raw,2610433.90625,3121002.65625,2642442.53125,4043594.75,1942998.34375,2567590.96875,"Medium-chain acyl-CoA ligase ACSF2, mitochondrial OS=Homo sapiens OX=9606 GN=ACSF2 PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,80221,ACSF2,Mitochondrial long chain fatty acid beta-oxidation,Mitochondrial Fatty Acid Beta-Oxidation,ENSG00000167107
Q86TW2,0.8333333333333334,6,1152764.9791666667,4.462290994718928e-6,0.9711940521956628,-0.04216850864600884,0.9939575156808103,1,raw,1079476.5,1407712.75,968899.1875,929798.1875,1163541,1367162.25,AarF domain-containing protein kinase 1 OS=Homo sapiens OX=9606 GN=ADCK1 PE=1 SV=2,cell growth;cellular homeostasis;metabolic process,cell surface;cytoskeleton;endosome,signal transducer activity;structural molecule activity,57143,ADCK1,NA,NA,ENSG00000063761
P61247,0,6,385535316.0631512,0.0014923863928086804,0.9707036504623804,-0.04289717747621732,0.8564006516065279,1,raw,355208101.513672,465309747.453125,318601592.435547,424696376.59375,309267728.820313,440128349.5625,40S ribosomal protein S3a OS=Homo sapiens OX=9606 GN=RPS3A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;extracellular;Golgi;membrane;nucleus,RNA binding;structural molecule activity,6189,RPS3A,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000145425
Q99807,0,6,1762927.8541666667,6.824198540168971e-6,0.9705823830214293,-0.043077420812738965,0.9777798635002976,1,raw,1822208.75,1968462.015625,1487165.2265625,1768603.7109375,1420855.546875,2110271.875,"5-demethoxyubiquinone hydroxylase, mitochondrial OS=Homo sapiens OX=9606 GN=COQ7 PE=1 SV=3",cellular homeostasis;metabolic process,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,10229,COQ7,NA,Ubiquinol biosynthesis,ENSG00000167186
Q9Y2W2,0,6,4315636.708333333,1.670559668979153e-5,0.9704627187149599,-0.04325530344058625,0.7177802520892165,1,raw,4307921.9375,4724604.71875,4090206.96875,4725968.9375,4075724.3125,3969393.375,WW domain-binding protein 11 OS=Homo sapiens OX=9606 GN=WBP11 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,51729,WBP11,NA,mRNA Splicing - Major Pathway,ENSG00000084463
Q96AA3,0.16666666666666666,6,2069777.4791666667,8.011996871239205e-6,0.9701093814605248,-0.04378067212987331,0.8787160894880304,1,raw,1443662.21875,2284374.1875,2585413,1647662.65625,2508133.40625,1949419.40625,Protein RFT1 homolog OS=Homo sapiens OX=9606 GN=RFT1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;extracellular,catalytic activity,91869,RFT1,NA,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein; Defective RFT1 causes CDG-1n",ENSG00000163933
P30040,0,6,80465608.47916667,3.114780259552381e-4,0.9695843345308344,-0.04456170535584495,0.9456441737055518,1,raw,77749639.1875,94084989.375,68327679.5,87333021.875,64074989.125,91223331.8125,Endoplasmic reticulum resident protein 29 OS=Homo sapiens OX=9606 GN=ERP29 PE=1 SV=4,conjugation;metabolic process,extracellular;nucleus,structural molecule activity,10961,ERP29,NA,NA,ENSG00000089248
Q9Y5Z4,0,6,6311636.052083333,2.443200238223301e-5,0.9689217981653212,-0.04554786469785601,0.8275057278703649,1,raw,6237631.625,7344146.75,5628118.4375,7115903.875,5067004.25,6477011.375,Heme-binding protein 2 OS=Homo sapiens OX=9606 GN=HEBP2 PE=1 SV=1,cell growth;conjugation;metabolic process,cell surface;endosome;mitochondrion;nucleus,structural molecule activity,23593,HEBP2,NA,Neutrophil degranulation,ENSG00000051620
B1AK88,0,6,143153449.27083334,5.541392730424334e-4,0.9687316406166527,-0.04583103128259346,0.9419703186429025,1,raw,136702185.875,170235241.75,119993202.53125,164912265.03125,112612301.75,154465498.6875,F-actin-capping protein subunit beta OS=Homo sapiens OX=9606 GN=CAPZB PE=1 SV=1,cell growth,endoplasmic reticulum,motor activity,832,CAPZB,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000077549
A0A1C7CYX9,0,6,44978280.96940105,1.7410849718282252e-4,0.9687281334845514,-0.04583625432996498,0.7224558887121826,1,raw,46335750.8671875,46137683.1484375,45084471.3828125,44694871.6796875,36426686.1875,51190222.5507813,Dihydropyrimidinase-related protein 2 OS=Homo sapiens OX=9606 GN=DPYSL2 PE=1 SV=1,cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,motor activity;structural molecule activity,1808,DPYSL2,Microtubule cytoskeleton regulation; Brain-derived neurotrophic factor (BDNF) signaling pathway,NA,ENSG00000092964
Q9UBB9,0,6,22645245.210611984,8.765852155706931e-5,0.9687208898467816,-0.04584704208248154,0.7110123958617112,1,raw,34902916.078125,17798906.875,18938410.5292969,21640056.6875,17242172.90625,25349008.1875,Tuftelin-interacting protein 11 OS=Homo sapiens OX=9606 GN=TFIP11 PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,chromosome;membrane;nucleus,RNA binding,24144,TFIP11,NA,mRNA Splicing - Major Pathway,ENSG00000100109
P04062,0,6,7826022.651041667,3.0294111142632625e-5,0.9686391760177065,-0.04596874185128105,0.6065370807544811,1,raw,7877216.5,9011170.578125,7369420.578125,8728572.84375,6089192.71875,7880562.6875,Lysosomal acid glucosylceramidase OS=Homo sapiens OX=9606 GN=GBA PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cytoskeleton;extracellular;mitochondrion,antioxidant activity;structural molecule activity,2629,GBA1,Sphingolipid pathway,Glycosphingolipid metabolism; Association of TriC/CCT with target proteins during biosynthesis,ENSG00000177628
P62995,0,6,25093121.716145832,9.713411934520133e-5,0.9682620600559247,-0.046530529230673114,0.8590653719123952,1,raw,26327079.0625,21837976.375,25769179.515625,33308737.6875,18364438.8125,24951318.84375,Transformer-2 protein homolog beta OS=Homo sapiens OX=9606 GN=TRA2B PE=1 SV=1,cellular component movement;cellular homeostasis;defense response;metabolic process,cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,6434,TRA2B,mRNA processing,mRNA Splicing - Major Pathway; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle,ENSG00000136527
Q13464,0,6,16044359.614583334,6.210684980727206e-5,0.9680846847183522,-0.046794839867493,0.8519012559162773,1,raw,14820773.0625,18000307.84375,14833819.6875,17425822.34375,13803865.8125,17381568.9375,Rho-associated protein kinase 1 OS=Homo sapiens OX=9606 GN=ROCK1 PE=1 SV=1,cell communication;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,DNA binding;motor activity;signal transducer activity;structural molecule activity,6093,ROCK1,Androgen receptor signaling pathway; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; Leptin signaling pathway; Microtubule cytoskeleton regulation; Pathogenic Escherichia coli infection; AGE/RAGE pathway; Focal adhesion; TGF-beta signaling pathway; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; EGF/EGFR signaling pathway; Gastrin signaling pathway; mBDNF and proBDNF regulation of GABA neurotransmission; MAP3K1 role in promoting and blocking gonadal determination; Airway smooth muscle cell contraction; RAS and bradykinin pathways in COVID-19; Regulation of actin cytoskeleton; GDNF signaling; G13 signaling pathway,Neutrophil degranulation; Potential therapeutics for SARS; RHOC GTPase cycle; RHOA GTPase cycle; G alpha (12/13) signalling events; RHOB GTPase cycle; EPHB-mediated forward signaling; VEGFA-VEGFR2 Pathway; RND3 GTPase cycle; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases Activate ROCKs; RHOBTB1 GTPase cycle; RHOH GTPase cycle; Apoptotic cleavage of cellular proteins,ENSG00000067900
Q13769,0,6,645146.075,2.4973256238508104e-6,0.967803470028429,-0.047213982926389404,0.6363424723003877,1,raw,607300.5,1005853.5,437081.3125,645116.875,NA,530378.1875,THO complex subunit 5 homolog OS=Homo sapiens OX=9606 GN=THOC5 PE=1 SV=2,cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,membrane;nucleus,RNA binding,8563,THOC5,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000100296
Q96ST3,0,6,11126836.002604166,4.307138141030945e-5,0.9675924053749375,-0.04752864922693926,0.6430493266442692,1,raw,9708291.96875,14689004.875,10310151.5625,11104562.75,9393669.578125,11555335.28125,Paired amphipathic helix protein Sin3a OS=Homo sapiens OX=9606 GN=SIN3A PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,25942,SIN3A,Androgen receptor signaling pathway; Retinoblastoma gene in cancer; MECP2 and associated Rett syndrome; TGF-beta signaling pathway; Transcription co-factors SKI and SKIL protein partners; Hedgehog signaling pathway,"Cytoprotection by HMOX1; Factors involved in megakaryocyte development and platelet production; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; SUMOylation of transcription cofactors; NoRC negatively regulates rRNA expression; MECP2 regulates transcription of neuronal ligands; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Regulation of lipid metabolism by PPARalpha; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; MECP2 regulates neuronal receptors and channels; Loss of MECP2 binding ability to 5mC-DNA",ENSG00000169375
Q16763,0,6,4525908.315104167,1.7519546726699198e-5,0.9673946332713724,-0.04782356059154736,0.4849593235625235,0.96704014350865,raw,3809098.296875,7530482.453125,3820142,4025962.4375,3684901.25,4284863.453125,Ubiquitin-conjugating enzyme E2 S OS=Homo sapiens OX=9606 GN=UBE2S PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,27338,UBE2S,NA,APC-Cdc20 mediated degradation of Nek2A; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,ENSG00000108106
Q8WXF1,0,6,22839907.15625,8.8412047438522545e-05,0.967333273250782,-0.04791507092449487,0.7684702755067886,1,raw,25875510.125,23791357.8125,19894930.28125,21849861.875,20597540.9375,25030241.90625,Paraspeckle component 1 OS=Homo sapiens OX=9606 GN=PSPC1 PE=1 SV=1,coagulation;metabolic process,membrane;nucleus,NA,55269,PSPC1,NA,NA,ENSG00000121390
P09417,0,6,10151302.619791666,3.929514435605857e-5,0.9670701400411776,-0.048307565040584984,0.8314783890605568,1,raw,10480335.25,12073852.78125,8392414.3125,11676262.5,8293532.5625,9991418.3125,Dihydropteridine reductase OS=Homo sapiens OX=9606 GN=QDPR PE=1 SV=2,cellular homeostasis,cytosol;nucleus,structural molecule activity,5860,QDPR,NA,Phenylalanine metabolism,ENSG00000151552
Q15526,0,6,3630036.1197916665,1.405167382822518e-5,0.9668685836878944,-0.048608282275134695,0.7274042355389301,1,raw,3780657.1875,2902457.03125,3559506.75,3441575.25,2243576.5,5852444,Surfeit locus protein 1 OS=Homo sapiens OX=9606 GN=SURF1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,6834,SURF1,Electron transport chain: OXPHOS system in mitochondria; Type II diabetes mellitus; Mitochondrial complex IV assembly,Respiratory electron transport; TP53 Regulates Metabolic Genes; Cytoprotection by HMOX1,ENSG00000148290; ENSG00000280627
Q969M7,0.16666666666666666,6,373611.4088541667,1.4462295917936291e-6,0.9667573661357578,-0.048774243029973414,0.6040647067455014,1,raw,256533.453125,578989.25,372360.6875,359982.4375,303861.09375,369941.53125,NEDD8-conjugating enzyme UBE2F OS=Homo sapiens OX=9606 GN=UBE2F PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,140739,UBE2F,2q37 copy number variation syndrome,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation,ENSG00000184182
P16298,0,6,710217.75,2.7492145644514213e-6,0.9661352260349303,-0.04970296351121836,1,1,raw,NA,NA,722450.5625,NA,NA,697984.9375,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform OS=Homo sapiens OX=9606 GN=PPP3CB PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,5532,PPP3CB,Physiological and pathological hypertrophy of the heart; Energy metabolism; MicroRNAs in cardiomyocyte hypertrophy; Alzheimer's disease and miRNA effects; Amyotrophic lateral sclerosis (ALS); Initiation of transcription and translation elongation at the HIV-1 LTR; MAPK signaling pathway; Wnt signaling; Alzheimer's disease,FCERI mediated Ca+2 mobilization; Ca2+ pathway; CLEC7A (Dectin-1) induces NFAT activation; Calcineurin activates NFAT; DARPP-32 events; ROBO receptors bind AKAP5,ENSG00000107758
Q08209,0,6,44970454.395833336,1.740782009391112e-4,0.9659191585611825,-0.05002564539497708,0.8666197339934708,1,raw,48072859.4375,49509126.9375,39702748.78125,56724332.125,29379163.15625,46434495.9375,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform OS=Homo sapiens OX=9606 GN=PPP3CA PE=1 SV=1,cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,structural molecule activity,5530,PPP3CA,Physiological and pathological hypertrophy of the heart; Energy metabolism; MicroRNAs in cardiomyocyte hypertrophy; Alzheimer's disease and miRNA effects; Spinal cord injury; Amyotrophic lateral sclerosis (ALS); T cell receptor and co-stimulatory signaling; Cardiac hypertrophic response; Initiation of transcription and translation elongation at the HIV-1 LTR; G protein signaling pathways; MAPK signaling pathway; VEGFA-VEGFR2 signaling pathway; Mitochondrial gene expression; Serotonin and anxiety-related events; Serotonin and anxiety; Wnt signaling; Vitamin D in inflammatory diseases; Fragile X syndrome; Alzheimer's disease; Th17 cell differentiation pathway,FCERI mediated Ca+2 mobilization; Ca2+ pathway; CLEC7A (Dectin-1) induces NFAT activation; Calcineurin activates NFAT; DARPP-32 events,ENSG00000138814
A6NMH8,0,6,10488077.802083334,4.059878290367588e-5,0.965740793670354,-0.050292075460891095,0.9732323097462154,1,raw,12805266,9701493.6875,9046440.625,10736156.25,8272542.5,12366567.75,Tetraspanin OS=Homo sapiens OX=9606 GN=CD81 PE=1 SV=1,NA,cytoskeleton,NA,NA,CD81,Extracellular vesicles in the crosstalk of cardiac cells; 16p11.2 distal deletion syndrome,NA,ENSG00000110651
Q9H1E5,0.16666666666666666,6,697996.6458333334,2.701907330059324e-6,0.9655391480120413,-0.0505933401155307,0.994628770579462,1,raw,618363.125,710991.5625,765156.5,686490.1875,670040.8125,736937.6875,Thioredoxin-related transmembrane protein 4 OS=Homo sapiens OX=9606 GN=TMX4 PE=1 SV=1,NA,cytoskeleton;membrane;nucleus,structural molecule activity,56255,TMX4,NA,NA,ENSG00000125827
Q9H4L4,0,6,3099362.46484375,1.1997464761845917e-5,0.9653833668821439,-0.050826124872372216,0.8375679684294619,1,raw,2517150.21875,3467312.1796875,3107254.5,4241586.4375,2430014.953125,2832856.5,Sentrin-specific protease 3 OS=Homo sapiens OX=9606 GN=SENP3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,membrane;nucleus,structural molecule activity,26168,SENP3,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000161956
Q8TD19,0,6,3884848.390625,1.5038038370896691e-5,0.9652416169683793,-0.051037975335007604,0.9790462951676481,1,raw,3470928.15625,3671898.71875,4489680.40625,4290817.96875,3052138.71875,4333626.375,Serine/threonine-protein kinase Nek9 OS=Homo sapiens OX=9606 GN=NEK9 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,signal transducer activity;structural molecule activity,91754,NEK9,Ciliopathies,"EML4 and NUDC in mitotic spindle formation; Nuclear Pore Complex (NPC) Disassembly; Activation of NIMA Kinases NEK9, NEK6, NEK7",ENSG00000119638
Q8IUX1,0,6,559861.28125,2.16719279190774e-6,0.9650985564667887,-0.05125181606568304,0.9507676727394612,1,raw,507438.9375,694085.375,463005.84375,724134.5625,NA,410641.6875,"Complex I assembly factor TMEM126B, mitochondrial OS=Homo sapiens OX=9606 GN=TMEM126B PE=1 SV=2",cell growth,cytoskeleton;endosome,NA,55863,TMEM126B,NA,Complex I biogenesis,ENSG00000171204
Q9NVT9,0,6,3540587.28125,1.3705422203717044e-5,0.9649826683642668,-0.05142506389469276,0.9362246980541344,1,raw,3110416.875,4129947.75,3448601.5,3905303.3125,2663926.25,3985328,Armadillo repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=ARMC1 PE=1 SV=1,cell growth,cytoskeleton;cytosol;endosome,structural molecule activity,55156,ARMC1,NA,NA,ENSG00000104442
A6NGJ0,0.16666666666666666,6,1574979.375,6.096660124955475e-6,0.9648676158037066,-0.05159708320636699,0.9579918549867906,1,raw,NA,1776035.75,1402269.875,1974831.25,NA,1146780.625,Dynein light chain Tctex-type 3 OS=Homo sapiens OX=9606 GN=DYNLT3 PE=1 SV=1,NA,NA,NA,NA,DYNLT3,Ciliary landscape; Intraflagellar transport proteins binding to dynein; 3q29 copy number variation syndrome,NA,ENSG00000165169
Q92820,0,6,12829975.985677084,4.966414432951784e-5,0.9647585783263827,-0.05176012807842796,0.9606807007567942,1,raw,14315061.75,10761250.4140625,13267938.0625,12800357.0625,10310181.5625,15525067.0625,Gamma-glutamyl hydrolase OS=Homo sapiens OX=9606 GN=GGH PE=1 SV=2,cellular homeostasis,cell surface;mitochondrion;nucleus,structural molecule activity,8836,GGH,Fluoropyrimidine activity,Neutrophil degranulation,ENSG00000137563
P11717,0,6,4371961.6953125,1.6923627673311252e-5,0.9646477684895791,-0.051925842058251646,0.9698960904181364,1,raw,5314756.4375,3484337.984375,4362155.78125,5126867.9375,3324366.65625,4619285.375,Cation-independent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=IGF2R PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,signal transducer activity;structural molecule activity,3482,IGF2R,NA,Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Cargo recognition for clathrin-mediated endocytosis; Retrograde transport at the Trans-Golgi-Network,ENSG00000197081
Q6P6C2,0,6,2036853.9375,7.884551619042505e-6,0.9644033641763518,-0.052291411313084575,0.8337198572468711,1,raw,1349789,3145721,1834646.6875,1769339.4375,1454808.5,2666819,RNA demethylase ALKBH5 OS=Homo sapiens OX=9606 GN=ALKBH5 PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;extracellular;membrane,structural molecule activity,54890,ALKBH5,NA,Reversal of alkylation damage by DNA dioxygenases,ENSG00000091542
S4R2Z7,0,6,2469747.9036458335,9.560260789351563e-6,0.9641757389332422,-0.052631966502561384,0.9304636175192769,1,raw,2020212.203125,3119310.6875,2206616,2544983.71875,1947839.59375,2979525.21875,"39S ribosomal protein L42, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL42 PE=1 SV=1",NA,cytoplasm;cytoskeleton;endosome;Golgi,NA,NA,MRPL42,NA,NA,ENSG00000198015
Q9UKX2,0.5,6,1271839.21875,4.9232209471363075e-6,0.9636606680468096,-0.053402872403656855,0.6479098932460565,1,raw,1443165.125,1067099.625,1436234.5,1194311.625,1028321.9375,1461902.5,Myosin-2 OS=Homo sapiens OX=9606 GN=MYH2 PE=1 SV=1,metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,4620,MYH2,NA,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis,ENSG00000125414
Q9GZS1,0,6,3456392.7447916665,1.337950969888527e-5,0.9633303714599388,-0.053897443725264726,0.8708232652492512,1,raw,2880163.21875,3405821.25,4263665.53125,3789545.875,2291842.09375,4107318.5,DNA-directed RNA polymerase I subunit RPA49 OS=Homo sapiens OX=9606 GN=POLR1E PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,64425,POLR1E,Pyrimidine metabolism; Eukaryotic transcription initiation; 2q13 copy number variation syndrome,B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Initiation; RNA Polymerase I Transcription Termination,ENSG00000137054
E9PRY8,0,6,274509181.1276042,0.0010626102189527685,0.963276897978998,-0.05397752847010713,0.9684855043580369,1,raw,218875720.71875,372337101.40625,228478573.09375,327925462.0625,210837925.296875,288600304.1875,Elongation factor 1-delta OS=Homo sapiens OX=9606 GN=EEF1D PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,NA,EEF1D,NA,NA,ENSG00000104529
O95562,0.16666666666666666,6,874818.515625,3.3863752411257295e-6,0.9630714536889062,-0.054285254182708804,0.8227331976182483,1,raw,731131,1068059.875,NA,NA,775016.5625,925066.625,Vesicle transport protein SFT2B OS=Homo sapiens OX=9606 GN=SFT2D2 PE=1 SV=1,conjugation,cytoskeleton,NA,375035,SFT2D2,TYROBP causal network in microglia,NA,ENSG00000213064
Q2TAL8,0,6,7883567.927083333,3.0516865799227912e-5,0.9628893750419564,-0.05455803643027094,0.6469118686287587,1,raw,9118470.125,8353987.4375,6843908.8125,7468772.25,6736190.9375,8780078,Glutamine-rich protein 1 OS=Homo sapiens OX=9606 GN=QRICH1 PE=1 SV=1,coagulation;development;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,RNA binding,54870,QRICH1,NA,NA,ENSG00000198218
O96033,0.5,6,3952809.5,1.530111215595772e-5,0.9628143526771915,-0.05467044665423097,0.43550955892844895,0.9190906186778963,raw,3344442.25,5842364,3792148.25,3796694,3220077,3721131.5,Molybdopterin synthase sulfur carrier subunit OS=Homo sapiens OX=9606 GN=MOCS2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,structural molecule activity,4338,MOCS2,NA,Molybdenum cofactor biosynthesis,ENSG00000164172
Q92945,0,6,191789603.84895834,7.424072014701471e-4,0.9621749833573615,-0.05562880519021658,0.4631383431019615,0.9448932939804333,raw,197902300.5,204148595.125,200194790.46875,211338654.0625,144530863.75,192622419.1875,Far upstream element-binding protein 2 OS=Homo sapiens OX=9606 GN=KHSRP PE=1 SV=4,cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,8570,KHSRP,Pre-implantation embryo,ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA,ENSG00000088247
Q9Y3E2,0,6,1748100.8541666667,6.766804023702548e-6,0.962049142012376,-0.05581750533404554,0.9701068021038834,1,raw,1998097.34375,2251381.90625,1021304.734375,1407714.1875,1644166.921875,2165940.03125,BolA-like protein 1 OS=Homo sapiens OX=9606 GN=BOLA1 PE=1 SV=1,cell growth;cellular homeostasis;metabolic process,cytosol;endosome,NA,51027,BOLA1,NA,NA,ENSG00000178096
Q9Y2Z0,0,6,53406367.729166664,2.0673316598391603e-4,0.9617944173093973,-0.05619954270516767,0.8094152424039527,1,raw,49739175.8125,63531409,43578013.53125,61104154.5,41691593.78125,60793859.75,Protein SGT1 homolog OS=Homo sapiens OX=9606 GN=SUGT1 PE=1 SV=3,cell differentiation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,10910,SUGT1,Nucleotide-binding oligomerization domain (NOD) pathway,The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection,ENSG00000165416
Q9UFW8,0,6,2243141.3645833335,8.683079111492124e-6,0.9617773742585263,-0.056225107568492944,0.6790011032773178,1,raw,2481776.125,2217235.59375,2160239.6875,1873908.71875,2338771.9375,2386916.125,CGG triplet repeat-binding protein 1 OS=Homo sapiens OX=9606 GN=CGGBP1 PE=1 SV=2,cell growth;metabolic process,membrane,RNA binding;structural molecule activity,8545,CGGBP1,NA,NA,ENSG00000163320
P82675,0,6,12378228.770833334,4.791545525141636e-5,0.9614782517163585,-0.05667387018314996,0.7064311184311409,1,raw,11720388.40625,14847047.703125,11768816.109375,14275113.46875,8762800.46875,12895206.46875,"28S ribosomal protein S5, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS5 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,64969,MRPS5,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000289685
P17152,0,6,2674885.8333333335,1.0354338639445124e-5,0.9614657375032507,-0.056692647842086136,0.8292091431607649,1,raw,2564125.5625,2623303.875,2563037.9375,4181506.875,1652021.875,2465318.875,"Transmembrane protein 11, mitochondrial OS=Homo sapiens OX=9606 GN=TMEM11 PE=1 SV=1",cell growth,cytoplasm;cytoskeleton;endosome,NA,8834,TMEM11,NA,Cristae formation,ENSG00000178307
A0A5F9ZI63,0,6,2461028.875,9.526509900217921e-6,0.9613379794502163,-0.05688436362481792,0.9088195200594446,1,raw,2666025.625,3276604.0625,1321011.28125,2929557.03125,2010023.5625,2562951.6875,Polycomb protein EED OS=Homo sapiens OX=9606 GN=EED PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,membrane,NA,NA,EED,NA,NA,ENSCJAG00000014209; ENSPANG00000023331
Q71U36,0,6,102901427.34895842,3.983258694542572e-4,0.9613363065913957,-0.05688687411257144,0.8648646585527562,1,raw,102078890.695313,115668022.078125,93392971.7578125,107465727.75,89782054.53125,109020897.28125,Tubulin alpha-1A chain OS=Homo sapiens OX=9606 GN=TUBA1A PE=1 SV=1,cell differentiation;cell growth;conjugation;metabolic process,cytosol;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,7846,TUBA1A,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recycling pathway of L1; Intraflagellar transport; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,ENSG00000167552
Q9H0G5,0,6,317812.68359375,1.230235738973475e-6,0.9612291055370862,-0.05704776167313506,0.7842335571470793,1,raw,NA,476784.65625,206837.53125,NA,335566.78125,252061.765625,Nuclear speckle splicing regulatory protein 1 OS=Homo sapiens OX=9606 GN=NSRP1 PE=1 SV=1,cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding,84081,NSRP1,NA,NA,ENSG00000126653
Q5TCU3,0,6,30047765.135416668,1.1631327651203188e-4,0.9609986018931195,-0.057393762788784504,0.7958541390419545,1,raw,26234746.25,36131804.875,25643010.8125,34722613.96875,23055954.03125,34498460.875,Tropomyosin beta chain OS=Homo sapiens OX=9606 GN=TPM2 PE=1 SV=1,NA,endoplasmic reticulum,motor activity,7169,TPM2,Striated muscle contraction pathway,NA,ENSG00000198467
Q9Y3Y2,0,6,5421378.255208333,2.0985862516980157e-5,0.9608218110674558,-0.05765919367551987,0.966819842058849,1,raw,4189390.09375,6212401.125,5910706.15625,5969010.5,5447513.5,4799248.15625,Chromatin target of PRMT1 protein OS=Homo sapiens OX=9606 GN=CHTOP PE=1 SV=2,cellular homeostasis;conjugation;defense response;metabolic process,membrane;nucleus,RNA binding,26097,CHTOP,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000160679
P31749,0,6,8671060.385416666,3.356520658745188e-5,0.9601824649965768,-0.05861950537437328,0.7841049124308415,1,raw,8634221.6875,8178952.28125,8143400.90625,13371233.3125,5845267.5625,7853286.5625,RAC-alpha serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=AKT1 PE=1 SV=2,cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,207,AKT1,"IL-5 signaling pathway; Androgen receptor signaling pathway; AMP-activated protein kinase signaling; Target of rapamycin signaling; Angiogenesis; MicroRNAs in cardiomyocyte hypertrophy; Transcription factors regulate miRNAs related to cardiac hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; Sterol regulatory element-binding proteins (SREBP) signaling; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Microtubule cytoskeleton regulation; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; IL-17 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; Apoptosis; Primary focal segmental glomerulosclerosis (FSGS); T cell receptor and co-stimulatory signaling; S1P receptor signal transduction; Cardiac hypertrophic response; Mammary gland development pathway - Embryonic development (Stage 1 of 4); IL-3 signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Extracellular vesicle-mediated signaling in recipient cells; Kit receptor signaling pathway; Focal adhesion; Copper homeostasis; RAC1/PAK1/p38/MMP2 pathway; Ovarian infertility; MECP2 and associated Rett syndrome; Wnt signaling pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; Pathways affected in adenoid cystic carcinoma; Wnt/beta-catenin signaling pathway in leukemia; TGF-beta signaling pathway; BDNF-TrkB signaling; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Regulation of apoptosis by parathyroid hormone-related protein; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin-insulin signaling overlap; IL-4 signaling pathway; Lipid metabolism pathway; Clear cell renal cell carcinoma pathways; Fibrin complement receptor 3 signaling pathway; PI3K/AKT/mTOR - vitamin D3 signaling; Endometrial cancer; PI3K-Akt signaling pathway; Somatroph axis (GH) and its relationship to dietary restriction and aging; Caloric restriction and aging; Chromosomal and microsatellite instability in colorectal cancer ; Ebola virus infection in host; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Neovascularisation processes; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Resistin as a regulator of inflammation; Relationship between inflammation, COX-2 and EGFR; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Neural crest cell migration during development; Neural crest cell migration in cancer; Translation inhibitors in chronically activated PDGFRA cells; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; Head and neck squamous cell carcinoma; Melanoma; Endochondral ossification; Netrin-UNC5B signaling pathway; EGFR tyrosine kinase inhibitor resistance; Endochondral ossification with skeletal dysplasias; Insulin signaling; Regucalcin in proximal tubule epithelial kidney cells; Host-pathogen interaction of human coronaviruses - apoptosis; Kisspeptin/kisspeptin receptor system in the ovary; IL-2 signaling pathway; 3q29 copy number variation syndrome; Modulators of TCR signaling and T cell activation; Kallmann syndrome; Neuroinflammation and glutamatergic signaling; Malignant pleural mesothelioma; CCL18 signaling pathway; Alzheimer's disease; GDNF signaling; Roles of ceramides in the development of insulin resistance; Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution; Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; Dravet syndrome; Clock-controlled autophagy in bone metabolism; LDL- influence on CD14 and TLR4; EPO receptor signaling; Notch signaling pathway; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response; Estrogen signaling pathway; Toll-like receptor signaling pathway","RAB GEFs exchange GTP for GDP on RABs; Regulation of PTEN stability and activity; KEAP1-NFE2L2 pathway; Translocation of SLC2A4 (GLUT4) to the plasma membrane; AKT phosphorylates targets in the nucleus; Constitutive Signaling by AKT1 E17K in Cancer; Regulation of localization of FOXO transcription factors; Regulation of TP53 Degradation; Negative regulation of NOTCH4 signaling; Deactivation of the beta-catenin transactivating complex; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; CD28 dependent PI3K/Akt signaling; TP53 Regulates Metabolic Genes; Interleukin-4 and Interleukin-13 signaling; Downregulation of ERBB2:ERBB3 signaling; G beta:gamma signalling through PI3Kgamma; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; AKT phosphorylates targets in the cytosol; Regulation of TP53 Activity through Association with Co-factors; Integrin signaling; VEGFR2 mediated vascular permeability; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; MTOR signalling; FLT3 Signaling; eNOS activation; Regulation of TP53 Activity through Acetylation; KSRP (KHSRP) binds and destabilizes mRNA; RUNX2 regulates genes involved in cell migration; Cyclin E associated events during G1/S transition ; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation; Cyclin A:Cdk2-associated events at S phase entry; CTLA4 inhibitory signaling; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1; Activation of BAD and translocation to mitochondria ; AKT-mediated inactivation of FOXO1A; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA",ENSG00000142208
O15127,0,6,5078377.098958333,1.9658123560320487e-5,0.9599924441169927,-0.05890504413465504,0.8716146106590166,1,raw,4876332.78125,5399508.0625,4694069.375,7005644.96875,3813464.78125,4681242.625,Secretory carrier-associated membrane protein 2 OS=Homo sapiens OX=9606 GN=SCAMP2 PE=1 SV=2,conjugation,cytoskeleton;extracellular;mitochondrion;nucleus,NA,10066,SCAMP2,Serotonin transporter activity; Monoamine transport,NA,ENSG00000140497
Q96MX6,0,6,3478870.5520833335,1.3466520077298345e-5,0.9597540091377706,-0.05926341329666984,0.8632064876672704,1,raw,3522905.25,3534952.5625,3217585.6875,3381122.4375,2673797.875,4542859.5,WD repeat-containing protein 92 OS=Homo sapiens OX=9606 GN=WDR92 PE=1 SV=1,cell growth;metabolic process,nucleus,structural molecule activity,116143,DNAAF10,NA,NA,ENSG00000243667
Q9NW82,0,6,4311187.5234375,1.668837413527841e-5,0.9593046155494861,-0.059939096576728204,0.8025119139463015,1,raw,4881287.59375,3494318.90625,4149521.171875,6194838.1875,3166504.46875,3980654.8125,WD repeat-containing protein 70 OS=Homo sapiens OX=9606 GN=WDR70 PE=1 SV=1,metabolic process,membrane;nucleus,structural molecule activity,55100,WDR70,NA,NA,ENSG00000082068
O14497,0,6,8393645.940104166,3.249135024769926e-5,0.9592336557727587,-0.06004581669752453,0.5378868604882354,1,raw,7683936.34375,9773713.65625,8404020.375,8386242.09375,8052543.984375,8061419.1875,AT-rich interactive domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ARID1A PE=1 SV=3,cell growth;cellular component movement;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8289,ARID1A,Pathways affected in adenoid cystic carcinoma; Tumor suppressor activity of SMARCB1; Thermogenesis,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,ENSG00000117713
P35637,0,6,143700844.88541666,5.562582119117158e-4,0.9590701941495842,-0.06029168522738212,0.8749506195741128,1,raw,122650227.25,155976814.875,157108760.6875,162637116,114239436.375,149592714.125,RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,2521,FUS,MECP2 and associated Rett syndrome; mRNA processing,mRNA Splicing - Major Pathway,ENSG00000089280
P54725,0,6,13024569.265625,5.041740440979207e-5,0.959027453968662,-0.060355979187737954,0.9061416680530128,1,raw,14739490.3125,10666996.96875,13422581.25,12713686.90625,12872623.921875,13732036.234375,UV excision repair protein RAD23 homolog A OS=Homo sapiens OX=9606 GN=RAD23A PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;extracellular;membrane;nucleus,RNA binding;structural molecule activity,5886,RAD23A,"Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Josephin domain DUBs; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER,ENSG00000179262
Q8WUF5,0,6,7510626.317708333,2.9073228965054586e-5,0.9587693051755353,-0.06074437277963337,0.7340407428835803,1,raw,7927742.875,8711524,6393122.71875,7438238.65625,6240787.84375,8352341.8125,RelA-associated inhibitor OS=Homo sapiens OX=9606 GN=PPP1R13L PE=1 SV=4,cellular component movement;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,10848,PPP1R13L,IL-18 signaling pathway,Regulation of TP53 Activity through Association with Co-factors,ENSG00000104881
P23396,0,6,450454129.3723958,0.0017436836140576257,0.9581268325397877,-0.06171144877500978,0.7577325278548233,1,raw,445586554.359375,590920357.5,357106438.9375,452377897.3125,342153261.21875,514580266.90625,40S ribosomal protein S3 OS=Homo sapiens OX=9606 GN=RPS3 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;Golgi;membrane;nucleus,motor activity;RNA binding;structural molecule activity,6188,RPS3,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000149273
Q96B49,0,6,6016460.5,2.3289393757121222e-5,0.9577422180188814,-0.062290696578253736,0.9300997272451716,1,raw,5607863.25,6453864.625,5839270.625,5592516,4655715.5,7949533,Mitochondrial import receptor subunit TOM6 homolog OS=Homo sapiens OX=9606 GN=TOMM6 PE=1 SV=1,cell growth;conjugation,cytoskeleton;endosome,NA,100188893,TOMM6,NA,Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy,ENSG00000214736
Q9BV40,0,6,7875937.567708333,3.048732909006266e-5,0.9574058277902645,-0.06279750702633574,0.7172949807373773,1,raw,6367063.8125,11266514.3125,7084854.8125,9562878.125,6878450.34375,6095864,Vesicle-associated membrane protein 8 OS=Homo sapiens OX=9606 GN=VAMP8 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,8673,VAMP8,NA,Neutrophil degranulation; Cargo recognition for clathrin-mediated endocytosis; ER-Phagosome pathway; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis,ENSG00000118640
O75157,0.3333333333333333,6,2225035.7760416665,8.612993355797177e-6,0.9567886941051252,-0.06372775285849056,0.919667508674696,1,raw,1510295.625,2814565,2282800.28125,2520766.375,2037629.875,2184157.5,TSC22 domain family protein 2 OS=Homo sapiens OX=9606 GN=TSC22D2 PE=1 SV=3,metabolic process,NA,NA,9819,TSC22D2,NA,NA,ENSG00000196428
Q99733,0,6,87065750.6796875,3.3702682006116165e-4,0.9564158543144612,-0.06429004937225397,0.6725770114804157,1,raw,86290776.609375,94505447.15625,62707047.5,137410783.78125,59974014.40625,81506434.625,Nucleosome assembly protein 1-like 4 OS=Homo sapiens OX=9606 GN=NAP1L4 PE=1 SV=1,cell growth,membrane;nucleus,structural molecule activity,4676,NAP1L4,NA,NA,ENSG00000205531; ENSG00000273562
Q9UKU7,0,6,592843.6197916666,2.2948656436330278e-6,0.9560254134854896,-0.06487912582132253,0.6997962123820407,1,raw,663309.25,516300.34375,632502.625,634140.5,533718.125,577090.875,"Isobutyryl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACAD8 PE=1 SV=1",cellular homeostasis,endosome,structural molecule activity,27034,ACAD8,NA,Branched-chain amino acid catabolism,ENSG00000151498
Q7Z3D6,0,6,4188430.2864583335,1.6213187498792712e-5,0.9558370434633493,-0.06516341457513497,0.9989550127502871,1,raw,5671128.75,2725549.90625,4171665.4375,5307577.25,1833985.4375,5420674.9375,"D-glutamate cyclase, mitochondrial OS=Homo sapiens OX=9606 GN=DGLUCY PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,80017,DGLUCY,NA,NA,ENSG00000133943
P07199,0,6,832989.78125,3.2244584687607473e-6,0.9557750035448584,-0.06525705772089294,0.6790505456854672,1,raw,736343.75,1354977.75,589762.625,751410.25,563680.375,1001763.9375,Major centromere autoantigen B OS=Homo sapiens OX=9606 GN=CENPB PE=1 SV=2,NA,membrane;nucleus,RNA binding;structural molecule activity,1059,CENPB,IL-18 signaling pathway,NA,ENSG00000125817
Q9UPT8,0,6,1900001.1979166667,7.354802053014935e-6,0.9550126997564158,-0.06640817665648503,0.9058722449540362,1,raw,1823816.96875,2055599.3984375,1769162.671875,1604227.59375,1741768.3671875,2405432.1875,Zinc finger CCCH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=ZC3H4 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,23211,ZC3H4,NA,NA,ENSG00000130749
P19474,0,6,1709852.0078125,6.618744804582299e-6,0.9541583571222007,-0.0676993715543281,0.8163822589508137,1,raw,1909522.28125,1653642.46875,1437653.453125,2350612.15625,1577836.78125,1329844.90625,E3 ubiquitin-protein ligase TRIM21 OS=Homo sapiens OX=9606 GN=TRIM21 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,6737,TRIM21,NA,Antigen processing: Ubiquitination & Proteasome degradation; KEAP1-NFE2L2 pathway; Interferon gamma signaling; Regulation of innate immune responses to cytosolic DNA; STING mediated induction of host immune responses,ENSG00000132109
Q9HC36,0,6,8138189.305989583,3.1502491409556247e-5,0.9534734762295464,-0.06873528875030922,0.9051798756748172,1,raw,8944899.625,10217335.8046875,5576872.15625,7986052.0625,6362017.5,9741958.6875,"rRNA methyltransferase 3, mitochondrial OS=Homo sapiens OX=9606 GN=MRM3 PE=1 SV=2",cellular component movement;cellular homeostasis,endosome,structural molecule activity,55178,MRM3,NA,rRNA modification in the mitochondrion,ENSG00000171861
Q9BPZ3,0,6,1929816.3020833333,7.470214711478674e-6,0.9530664866958963,-0.06935123365807666,0.8340735278788841,1,raw,2829500.625,1763804.9375,1450827.9375,851751.625,1681023.375,3001989.3125,Polyadenylate-binding protein-interacting protein 2 OS=Homo sapiens OX=9606 GN=PAIP2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,nucleus,RNA binding;structural molecule activity,51247,PAIP2,NA,NA,ENSG00000120727
Q9BPX3,0,6,3280655.6875,1.2699241038435593e-5,0.9530405287371718,-0.06939052779846075,0.9205305086814913,1,raw,2555863.5,4525878.125,2919316.5,3676727.875,1692802.84375,4313345.28125,Condensin complex subunit 3 OS=Homo sapiens OX=9606 GN=NCAPG PE=1 SV=1,cell differentiation;cell growth;metabolic process,cytosol;membrane;nucleus,NA,64151,NCAPG,NA,Condensation of Prometaphase Chromosomes,ENSG00000109805
Q9H845,0,6,22911741.634114582,8.869011482387734e-5,0.9526224273422214,-0.07002358079121371,0.5701346482017866,1,raw,26343739.28125,21554540.25,23151744.5234375,25095636.859375,18247998.703125,23076790.1875,"Complex I assembly factor ACAD9, mitochondrial OS=Homo sapiens OX=9606 GN=ACAD9 PE=1 SV=1",cell growth;cellular homeostasis,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,28976,ACAD9,Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction,Complex I biogenesis,ENSG00000177646
Q03393,0.16666666666666666,6,1134531.9375,4.3917118748585055e-6,0.9525890924106513,-0.07007406562186988,0.9028233537677642,1,raw,933537.15625,1323453.5,1183919.9375,1383216.96875,855274.84375,1127789.21875,6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens OX=9606 GN=PTS PE=1 SV=1,cellular homeostasis;defense response,cytosol;endosome;nucleus,structural molecule activity,5805,PTS,NA,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",ENSG00000150787
P22307,0,6,37620368.208333336,1.4562641415027323e-4,0.9525873259549044,-0.07007674091946588,0.750212519541838,1,raw,42702784.1875,34787190.4375,37279898.625,38996183.5625,31278021.4375,40678131,Non-specific lipid-transfer protein OS=Homo sapiens OX=9606 GN=SCP2 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;metabolic process,cytosol;endosome;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;catalytic activity;structural molecule activity,6342,SCP2,PPAR-alpha pathway; Nuclear receptors meta-pathway; Mitochondrial long chain fatty acid beta-oxidation; PPAR signaling pathway; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Disorders of bile acid synthesis and biliary transport; DNA damage response (only ATM dependent),TYSND1 cleaves peroxisomal proteins; alpha-linolenic acid (ALA) metabolism,ENSG00000116171
F8W809,0.3333333333333333,6,1005314.1510416666,3.8915168001544114e-6,0.9521929207827361,-0.07067419188011559,0.8848752816549672,1,raw,1574330.125,1194081.625,354005.03125,880784.3125,529617.8125,1499066,Thioredoxin-disulfide reductase OS=Homo sapiens OX=9606 GN=TXNRD1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q5SY16,0,6,1690256.9322916667,6.542893325210796e-6,0.9520828320690113,-0.0708410001181427,0.7156553897711151,1,raw,1754654.09375,1827479.0625,1224248.0625,1652743.1875,1165585.5625,2516831.625,Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Homo sapiens OX=9606 GN=NOL9 PE=1 SV=1,cellular component movement;cellular homeostasis,endoplasmic reticulum;membrane,RNA binding;signal transducer activity;structural molecule activity,79707,NOL9,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000162408
P27448,0,6,1694125.1171875,6.557866860093043e-6,0.9512101699368961,-0.07216395503603511,0.9139068961851957,1,raw,715618.4375,2501011.09375,1756311.453125,2378987.1875,1665382.0625,1147440.46875,MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens OX=9606 GN=MARK3 PE=1 SV=5,cell growth;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,motor activity;signal transducer activity;structural molecule activity,4140,MARK3,Complement system in neuronal development and plasticity,Signaling by BRAF and RAF1 fusions; RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants,ENSG00000075413
Q15007,0,6,9172941,3.55079593491624e-5,0.9511276245354588,-0.07228915660825062,0.769785434960879,1,raw,11589476.5625,8444546.8125,8212512.125,11023071.3125,7287634.5,8480404.6875,Pre-mRNA-splicing regulator WTAP OS=Homo sapiens OX=9606 GN=WTAP PE=1 SV=2,cell differentiation;cellular component movement;cellular homeostasis;metabolic process,cytoskeleton;membrane;nucleus,structural molecule activity,9589,WTAP,NA,Processing of Capped Intron-Containing Pre-mRNA,ENSG00000146457
G3V582,0.3333333333333333,6,587024.9791666666,2.272341999931418e-6,0.9510385126269006,-0.07242433019392586,1,1,raw,667053.9375,531421.75,NA,562599.25,NA,NA,Gephyrin OS=Homo sapiens OX=9606 GN=GPHN PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,NA,GPHN,Splicing factor NOVA regulated synaptic proteins; GABA receptor signaling; Fragile X syndrome,NA,ENSG00000171723
O43818,0,6,24103139.752604168,9.330195261504997e-5,0.9509564753247591,-0.07254878352823073,0.8100525008015429,1,raw,29691656.421875,22744230.9375,21302796.546875,28235472.9375,19026359.390625,23618322.28125,U3 small nucleolar RNA-interacting protein 2 OS=Homo sapiens OX=9606 GN=RRP9 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,9136,RRP9,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000114767
Q96HQ2,0,6,6104700.53125,2.3630966153868764e-5,0.9503609630826793,-0.07345251750676206,0.7660735478634434,1,raw,7281150.5625,6284922.5,5409339.375,7967299.1875,3712546.5625,5972945,CDKN2AIP N-terminal-like protein OS=Homo sapiens OX=9606 GN=CDKN2AIPNL PE=1 SV=1,NA,membrane,NA,91368,CDKN2AIPNL,NA,NA,ENSG00000237190
Q9GZN8,0,6,3313673.015625,1.282704933294882e-5,0.9503387901481406,-0.07348617751292341,0.6474120540010412,1,raw,3120700.25,4970962.71875,2471907.875,2662649.9375,3690094.8125,2965722.5,UPF0687 protein C20orf27 OS=Homo sapiens OX=9606 GN=C20orf27 PE=1 SV=3,metabolic process,NA,structural molecule activity,54976,C20orf27,NA,NA,ENSG00000101220
P04004,0.3333333333333333,6,1794234.4895833333,6.94538483557129e-6,0.9502890135690859,-0.07356174456885156,0.974439535696677,1,raw,2658263.5,840583.4375,1915567.5,1820342.75,1231888.75,2298761,Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,cell communication;cell growth;conjugation;defense response;metabolic process,cell surface;chromosome;cytoplasm;cytoskeleton;extracellular;nucleus,antioxidant activity;enzyme regulator activity;structural molecule activity,7448,VTN,Primary focal segmental glomerulosclerosis (FSGS); Complement system; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Epithelial to mesenchymal transition in colorectal cancer; Inflammatory response pathway; Complement system in neuronal development and plasticity,Regulation of Complement cascade; Integrin cell surface interactions; ECM proteoglycans; Syndecan interactions; Molecules associated with elastic fibres,ENSG00000109072
A0A669KB89,0,6,7628211.830729167,2.952839613732727e-5,0.9501715311659009,-0.07374011320812919,0.9139663953455108,1,raw,9809790.109375,6589131.140625,6780614.546875,10205682.875,5941305.40625,6442746.90625,Protein scribble homolog OS=Homo sapiens OX=9606 GN=SCRIB PE=1 SV=1,NA,cytoplasm;cytoskeleton;membrane;nucleus,NA,NA,SCRIB,NA,NA,ENSG00000180900
Q6DKK2,0,6,5269671.5,2.0398613858460405e-5,0.9499679081662743,-0.0740493177715585,0.5201124881327365,1,raw,5985557,4733496,5593493.78125,4908047.8125,4711347.34375,5686087.0625,"Tetratricopeptide repeat protein 19, mitochondrial OS=Homo sapiens OX=9606 GN=TTC19 PE=1 SV=4",cell differentiation;cell growth,cytoskeleton;endoplasmic reticulum;endosome;nucleus,NA,54902,TTC19,Mitochondrial complex III assembly,NA,ENSG00000011295
E7EX17,0,6,71358602.55729167,2.762252977335566e-4,0.9496305737085841,-0.07456171105781353,0.36844683527188493,0.852141615295751,raw,72049009.65625,94072762.796875,63650971,68618963.203125,61339966.3125,68419942.375,Eukaryotic translation initiation factor 4B OS=Homo sapiens OX=9606 GN=EIF4B PE=1 SV=1,cell growth,cytosol,RNA binding,1975,EIF4B,Translation factors; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Malignant pleural mesothelioma; Interferon type I signaling pathways,NA,ENSG00000063046
Q93096,0,6,3427910.2109375,1.3269255348153603e-5,0.9495542113050817,-0.07467772679443059,0.3955206671802295,0.8782783839678473,raw,3832417.59375,3526626.125,3344856.1875,3415411.03125,2809062.0625,3639088.265625,Protein tyrosine phosphatase type IVA 1 OS=Homo sapiens OX=9606 GN=PTP4A1 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,7803,PTP4A1,NA,NA,ENSG00000112245
A0A1P0AYU5,0,6,1862731.8125,7.210534274301077e-6,0.9494032762329171,-0.0749070666106146,0.7842683159763153,1,raw,2111035.6875,1548146.1875,1721122.1875,1544319.5625,1469815.0625,2781952.1875,Sidoreflexin OS=Homo sapiens OX=9606 GN=SFXN3 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P84101,0.6666666666666666,6,3789267.75,1.4668050871589828e-5,0.9487501235664415,-0.07589992646078063,0.8737340691342939,1,raw,3403266.25,4506887,3328169,4200084,3157600.75,4139599.5,Small EDRK-rich factor 2 OS=Homo sapiens OX=9606 GN=SERF2 PE=1 SV=1,metabolic process,cytosol;membrane,NA,10169,SERF2,NA,NA,ENSG00000140264
Q9H0B6,0,6,19490423.98763022,7.544637893677868e-5,0.9486578106747321,-0.07604030676464779,0.9518874847285884,1,raw,20304007.3125,21156867.9375,17308067.3632813,24244571.3125,14667474.875,19261555.125,Kinesin light chain 2 OS=Homo sapiens OX=9606 GN=KLC2 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;endosome;membrane;mitochondrion;nucleus,motor activity,64837,KLC2,Alzheimer's disease and miRNA effects; Alzheimer's disease,MHC class II antigen presentation; COPI-dependent Golgi-to-ER retrograde traffic; Kinesins; RHO GTPases activate KTN1,ENSG00000174996
Q6P3X3,0,6,2565748.8880208335,9.93187541661964e-6,0.94773624963264,-0.0774424748876003,0.8188883454444462,1,raw,2691850.5,3151711.25,2009431.234375,2986991,2079232.90625,2475276.4375,Tetratricopeptide repeat protein 27 OS=Homo sapiens OX=9606 GN=TTC27 PE=1 SV=1,NA,NA,NA,55622,TTC27,NA,NA,ENSG00000018699
Q9H2D1,0.16666666666666666,6,493553.05625,1.9105172330204528e-6,0.9473256885065111,-0.0780675885031443,0.7756224110423035,1,raw,446083.90625,568536,NA,435332.09375,495468.53125,522344.75,Mitochondrial folate transporter/carrier OS=Homo sapiens OX=9606 GN=SLC25A32 PE=1 SV=2,cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity,81034,SLC25A32,NA,Metabolism of folate and pterines,ENSG00000164933
Q14684,0,6,22114445.768229168,8.560382557432101e-5,0.9471160979102422,-0.07838681215757998,0.5915939096955984,1,raw,23637680.765625,25654689.90625,19343404.671875,24705942.40625,18320449.953125,21024506.90625,Ribosomal RNA processing protein 1 homolog B OS=Homo sapiens OX=9606 GN=RRP1B PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,23076,RRP1B,NA,NA,ENSG00000160208
O96017,0,6,1077733.546875,4.17184837138559e-6,0.9469130115197308,-0.07869619676854175,0.945849042981806,1,raw,1397823.03125,707055.90625,1172469.9375,1752832.75,669520.4375,766699.21875,Serine/threonine-protein kinase Chk2 OS=Homo sapiens OX=9606 GN=CHEK2 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,extracellular;membrane;nucleus,signal transducer activity;structural molecule activity,11200,CHEK2,miRNA regulation of DNA damage response; Cell cycle; ATM signaling in development and disease ; miRNA regulation of p53 pathway in prostate cancer; DNA damage response,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Regulation of TP53 Degradation; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Regulation of TP53 Activity through Phosphorylation; Regulation of TP53 Activity through Methylation; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; Stabilization of p53,ENSG00000183765
Q96HS1,0,6,29842894.776041668,1.1552023441217146e-4,0.9463188943793237,-0.07960166416282956,0.7953368721713469,1,raw,31797069.34375,31783372.9375,27065277.125,29732740.75,25612383.125,33066525.375,"Serine/threonine-protein phosphatase PGAM5, mitochondrial OS=Homo sapiens OX=9606 GN=PGAM5 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;endosome,DNA binding;structural molecule activity,192111,PGAM5,NRF2-ARE regulation,NA,ENSG00000247077
Q99986,0,6,10802495.265625,4.181587592914113e-5,0.9459376013001176,-0.08018307544950978,0.7988348603085026,1,raw,12882076.78125,10679995.15625,9362701.59375,9723382.0625,10102609,12064207,Serine/threonine-protein kinase VRK1 OS=Homo sapiens OX=9606 GN=VRK1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;extracellular;membrane;nucleus,signal transducer activity;structural molecule activity,7443,VRK1,NA,Nuclear Envelope Breakdown; Initiation of Nuclear Envelope (NE) Reformation,ENSG00000100749
Q9BVM2,0,6,3584252.25,1.3874446940206403e-5,0.9457353363747716,-0.08049159242413353,0.6453457466141765,1,raw,2919646.75,4457594.25,3931637.75,4221702.375,2256643.625,3718288.75,Protein DPCD OS=Homo sapiens OX=9606 GN=DPCD PE=1 SV=2,conjugation;defense response;metabolic process,cell surface,NA,25911,DPCD,NA,NA,ENSG00000166171
Q96RN5,0,6,1297708.7125,5.023360360706983e-6,0.9455099081840956,-0.08083551834832624,0.9632744716846664,1,raw,986934.375,1635178,NA,780142.1875,1286694.4375,1799594.5625,Mediator of RNA polymerase II transcription subunit 15 OS=Homo sapiens OX=9606 GN=MED15 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,51586,MED15,Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; 22q11.2 copy number variation syndrome,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Generic Transcription Pathway,ENSG00000099917
P09668,0.16666666666666666,6,567362.6015625,2.1962299978290794e-6,0.9446845073799393,-0.08209549638316371,0.8147409308110668,1,raw,586757.125,NA,579599.5625,NA,445942.59375,657151.125,Pro-cathepsin H OS=Homo sapiens OX=9606 GN=CTSH PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cell surface;cytosol;mitochondrion;nucleus,DNA binding;structural molecule activity,1512,CTSH,NA,MHC class II antigen presentation; Neutrophil degranulation; Surfactant metabolism,ENSG00000103811
Q14444,0,6,98030635.25,3.794712962210884e-4,0.944644969042427,-0.08215587945998974,0.50570154552864,0.989873157379785,raw,84617562.875,136323968.5,92948322.1875,94180167.8125,79933555.0625,100180235.0625,Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2,metabolic process,cytosol;nucleus,NA,4076,CAPRIN1,NA,NA,ENSG00000135387
P11279,0,6,38493822.3125,1.4900750782831054e-4,0.9444916283683531,-0.08239008574326438,0.6589902535044697,1,raw,41200453.25,40329914.375,38592848.25,46739579,26008872.5,38091266.5,Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,3916,LAMP1,NA,Neutrophil degranulation,ENSG00000185896
P49321,0,6,109232932.05224624,4.2283478231256236e-4,0.9443331626387409,-0.08263215978198649,0.7137452986890165,1,raw,103197568.643555,138824238.890625,97730706.1230469,131096332.5625,76742638.9140625,107806107.179688,Nuclear autoantigenic sperm protein OS=Homo sapiens OX=9606 GN=NASP PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;conjugation;defense response;metabolic process,membrane;nucleus,structural molecule activity,4678,NASP,NA,NA,ENSG00000132780
P62328,0,6,106767622.04166667,4.132917003676613e-4,0.9436374380101269,-0.08369543747986394,0.9832696032502564,1,raw,128639116.5,64943117.75,128089782.75,173964078.25,61282757.25,83686879.75,Thymosin beta-4 OS=Homo sapiens OX=9606 GN=TMSB4X PE=1 SV=2,cell growth;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,7114,TMSB4X,Genes targeted by miRNAs in adipocytes; VEGFA-VEGFR2 signaling pathway; IL-18 signaling pathway; Regulation of actin cytoskeleton,Platelet degranulation,ENSG00000205542
P22626,0,6,1009949061.5406909,0.003909458288449862,0.943196306430194,-0.08437002617239651,0.9775477765542475,1,raw,961590260,1031623755.11719,1032934961.19727,1157911773.03906,906968381.53125,968665238.359375,Heterogeneous nuclear ribonucleoproteins A2/B1 OS=Homo sapiens OX=9606 GN=HNRNPA2B1 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;conjugation;metabolic process,cell surface;membrane;nucleus,RNA binding;structural molecule activity,3181,HNRNPA2B1,mRNA processing,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA,ENSG00000122566
P26373,0,6,267805769.01692718,0.0010366616726003388,0.9431235147646705,-0.08448137120916178,0.8132189499859983,1,raw,243308778.453125,322389882.75,250712109.742188,304053479.34375,223443198.75,262927165.0625,60S ribosomal protein L13 OS=Homo sapiens OX=9606 GN=RPL13 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;defense response,cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,6137,RPL13,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000167526
P07099,0,6,23800591.239583332,9.213080365622712e-5,0.9429920440114374,-0.08468249589967812,0.7185445582333856,1,raw,29661452,23772525.0625,20269606.3125,22417302,18404402.8125,28278259.25,Epoxide hydrolase 1 OS=Homo sapiens OX=9606 GN=EPHX1 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,2052,EPHX1,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Benzene metabolism; Benzo(a)pyrene metabolism; Aflatoxin B1 metabolism; Metapathway biotransformation Phase I and II,Phase I - Functionalization of compounds,ENSG00000143819
E9PN30,0.16666666666666666,6,1139470.88125,4.41083025945324e-6,0.9429279136124336,-0.08478061311645052,0.7473316507041565,1,raw,NA,953757.125,1109629.25,2143339.25,523367.90625,967260.875,Selenoprotein S (Fragment) OS=Homo sapiens OX=9606 GN=SELENOS PE=1 SV=1,conjugation,extracellular,NA,NA,SELENOS,NA,NA,ENSG00000131871
A0A2U3TZH3,0,6,2612185107.9062533,0.010111627516629905,0.942723669061665,-0.08509314444979132,0.9711857591198747,1,raw,2249042865.82813,2988018335.26563,2625326306.625,3326149759.84375,2009616131.60938,2474957248.26563,Elongation factor 1-alpha OS=Homo sapiens OX=9606 GN=EEF1A2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,RNA binding;structural molecule activity,NA,EEF1A2,NA,NA,ENSG00000101210
Q9UK76,0,6,32882323.625,1.2728569938283725e-4,0.9425744482068338,-0.08532152232355035,0.5689367901973528,1,raw,27300928.625,44857088.75,32064638.5625,30223309,27219603.1875,35628373.625,Jupiter microtubule associated homolog 1 OS=Homo sapiens OX=9606 GN=JPT1 PE=1 SV=3,NA,cytoskeleton;membrane;nucleus,NA,51155,JPT1,NA,NA,ENSG00000189159
Q92609,0,6,9885166.869791666,3.8264947236905746e-5,0.9425144813038553,-0.08541330998642328,0.6721723025917724,1,raw,12252479.25,9110036.125,9366099.03125,11548139.125,7399090.4375,9635157.25,TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1,cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,DNA binding;structural molecule activity,9779,TBC1D5,NA,NA,ENSG00000131374
Q9Y6Q5,0,6,16617425.322916666,6.432515622349111e-5,0.9423173771998384,-0.08571504630646436,0.46749372269919254,0.9485672170384823,raw,15950329.3125,18662654.21875,17222515.875,17586143.375,13172402.25,17110506.90625,AP-1 complex subunit mu-2 OS=Homo sapiens OX=9606 GN=AP1M2 PE=1 SV=4,conjugation,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,10053,AP1M2,NA,MHC class II antigen presentation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Nef mediated downregulation of MHC class I complex cell surface expression,ENSG00000129354
Q03405,0,6,1276696.6510416667,4.942023805276767e-6,0.942216105223964,-0.0858701028006878,0.8907568668214317,1,raw,1854248.59375,1359046.6875,718762.125,1236081.25,677229.25,1814812,Urokinase plasminogen activator surface receptor OS=Homo sapiens OX=9606 GN=PLAUR PE=1 SV=1,coagulation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;nucleus,antioxidant activity;structural molecule activity,5329,PLAUR,Primary focal segmental glomerulosclerosis (FSGS); Complement system; VEGFA-VEGFR2 signaling pathway; Complement and coagulation cascades,Neutrophil degranulation; Attachment of GPI anchor to uPAR; Dissolution of Fibrin Clot,ENSG00000011422
Q8N128,0.3333333333333333,6,549614.68125,2.127528756538154e-6,0.9416617138259589,-0.08671922128981095,0.8955857819342881,1,raw,570800.375,773977.75,328293.5625,591794.5625,483207.15625,NA,Protein FAM177A1 OS=Homo sapiens OX=9606 GN=FAM177A1 PE=1 SV=1,NA,NA,NA,283635,FAM177A1,NA,NA,ENSG00000151327
H3BN98,0,6,140040234.97916666,5.420881886068383e-4,0.9414337884653277,-0.08706846198278818,0.602237764196325,1,raw,146197062.0625,162161612.28125,128556154.21875,161838066.25,103853661.0625,137634854,40S ribosomal protein S15a (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=2,cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;extracellular;Golgi;nucleus,structural molecule activity,NA,NA,NA,NA,NA
P19174,0,6,723097.5885416666,2.799071724043015e-6,0.9413182176362928,-0.08724557873697476,0.5435146147192771,1,raw,646381.28125,637929.5625,586843.90625,500028.5625,600494.71875,1366907.5,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Homo sapiens OX=9606 GN=PLCG1 PE=1 SV=1",cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,5335,PLCG1,Angiogenesis; IL-1 signaling pathway; RANKL/RANK signaling pathway; Leptin signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; Corticotropin-releasing hormone signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; PDGF pathway; Primary focal segmental glomerulosclerosis (FSGS); T cell receptor and co-stimulatory signaling; Myometrial relaxation and contraction pathways; Kit receptor signaling pathway; MFAP5-mediated ovarian cancer cell motility and invasiveness; BDNF-TrkB signaling; Physico-chemical features and toxicity-associated pathways; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling pathway; GPR40 pathway; Ras signaling; Non-small cell lung cancer; EGF/EGFR signaling pathway; Resistin as a regulator of inflammation; Fragile X syndrome; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; IL-18 signaling pathway; EGFR tyrosine kinase inhibitor resistance; mBDNF and proBDNF regulation of GABA neurotransmission; Modulators of TCR signaling and T cell activation; CCL18 signaling pathway; Th17 cell differentiation pathway; GDNF signaling; ErbB signaling pathway; T-cell receptor signaling pathway,ISG15 antiviral mechanism; Role of phospholipids in phagocytosis; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; Generation of second messenger molecules; Signaling by ALK fusions and activated point mutants; RET signaling; Downstream signal transduction; Signaling by ALK; DAP12 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; EGFR interacts with phospholipase C-gamma; Signaling by FGFR1 in disease; Synthesis of IP3 and IP4 in the cytosol; Phospholipase C-mediated cascade: FGFR1; Phospholipase C-mediated cascade; FGFR2; Signaling by FGFR2 in disease; VEGFR2 mediated cell proliferation; Phospholipase C-mediated cascade; FGFR3; Phospholipase C-mediated cascade; FGFR4; Signaling by FGFR3 in disease; DAG and IP3 signaling; Erythropoietin activates Phospholipase C gamma (PLCG); Role of second messengers in netrin-1 signaling; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; PLCG1 events in ERBB2 signaling; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; Signaling by FGFR4 in disease; PLC-gamma1 signalling; PECAM1 interactions; Activated NTRK2 signals through PLCG1; Activated NTRK3 signals through PLCG1,ENSG00000124181
A0A087WZV0,0,6,824686.59375,3.1923172782506948e-6,0.9411630942844283,-0.08748334544366154,0.7454826682954306,1,raw,1072497.15625,880430.5625,641259.03125,1009394.7421875,405817.59375,938720.4765625,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase OS=Homo sapiens OX=9606 GN=PPIP5K2 PE=1 SV=1,cellular homeostasis,cytosol,signal transducer activity;structural molecule activity,23262,PPIP5K2,NA,NA,ENSG00000145725
J3KNA0,0,6,3708409.96875,1.4355054766012733e-5,0.9409224365921318,-0.08785229324696198,0.6549433524143737,1,raw,3024577.8125,4070707.25,4459823.625,2845893.125,3576787.75,4272670.25,Mitochondrial inner membrane protein OXA1L OS=Homo sapiens OX=9606 GN=OXA1L PE=1 SV=1,metabolic process,cytoskeleton;endosome,structural molecule activity,5018,OXA1L,NA,NA,ENSG00000155463
O75506,0,6,7200119.640625,2.7871274382819892e-5,0.9408724981178397,-0.08792886480946205,0.9123286827180767,1,raw,9632548,7889493,4414177.25,7015605.125,5185894.96875,9062999.5,Heat shock factor-binding protein 1 OS=Homo sapiens OX=9606 GN=HSBP1 PE=1 SV=1,cellular component movement;coagulation;conjugation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,3281,HSBP1,NA,HSF1 activation; Attenuation phase,ENSG00000230989
Q9UN36,0,6,203794.015625,7.888756313177057e-7,0.9408238941585906,-0.08800339403881027,0.6668174499292772,1,raw,189188.109375,228599.171875,207834.84375,176630.84375,NA,216717.109375,Protein NDRG2 OS=Homo sapiens OX=9606 GN=NDRG2 PE=1 SV=2,cell death;cell differentiation;development;metabolic process,cytosol;extracellular;membrane;nucleus,NA,57447,NDRG2,NA,NA,ENSG00000165795
Q96EK6,0,6,2856930.3802083335,1.1059023251520377e-5,0.9403570504331004,-0.08871944758315167,0.8048129051631182,1,raw,2366325.375,3889650.65625,2540537.5,2225190.75,3200662.625,2919215.375,Glucosamine 6-phosphate N-acetyltransferase OS=Homo sapiens OX=9606 GN=GNPNAT1 PE=1 SV=1,cellular homeostasis,cytoskeleton;cytosol;extracellular;mitochondrion,structural molecule activity,64841,GNPNAT1,NA,Synthesis of UDP-N-acetyl-glucosamine,ENSG00000100522
Q6NS38,0,6,404572.234375,1.56607727576001e-6,0.9403274407767076,-0.0887648754097153,0.9713435860534121,1,raw,517626.875,393870.84375,297936.71875,480130.625,367500.78125,370367.5625,DNA oxidative demethylase ALKBH2 OS=Homo sapiens OX=9606 GN=ALKBH2 PE=1 SV=1,cell proliferation;cellular homeostasis;coagulation,membrane,RNA binding;structural molecule activity,121642,ALKBH2,Direct reversal repair,ALKBH2 mediated reversal of alkylation damage,ENSG00000189046
P31146,0,6,331055.66796875,1.2814986164790746e-6,0.940286626026086,-0.0888274966985438,0.8046317280188866,1,raw,206289.5625,504922.421875,NA,380540.53125,232470.15625,NA,Coronin-1A OS=Homo sapiens OX=9606 GN=CORO1A PE=1 SV=4,cell communication;cell differentiation;cell growth;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,11151,CORO1A,16p11.2 proximal deletion syndrome,Prevention of phagosomal-lysosomal fusion,ENSG00000102879
Q9BZH6,0,6,1578505.2005208333,6.110308405181631e-6,0.9401821487585631,-0.08898780655097761,0.9825334529774106,1,raw,1018625.109375,1409854.5,2326203.0625,1675635.4375,853658.5,2187054.59375,WD repeat-containing protein 11 OS=Homo sapiens OX=9606 GN=WDR11 PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,NA,55717,WDR11,NA,RHOH GTPase cycle,ENSG00000120008
P52738,0.5,6,21100009.166666668,8.167699626073623e-5,0.940073938497922,-0.08915386308724485,0.7835394850648786,1,raw,9560787,39171392,18752342,17628588,17348630,24138316,Zinc finger protein 140 OS=Homo sapiens OX=9606 GN=ZNF140 PE=1 SV=2,cellular component movement;metabolic process,membrane,RNA binding;structural molecule activity,7699,ZNF140,NA,Generic Transcription Pathway,ENSG00000196387
Q9UJU6,0,6,15117691.630208334,5.8519768072051286e-5,0.9393467673930403,-0.09027025623535903,0.38445962819558444,0.8695425300008842,raw,17392668.40625,16096531.375,15110528.34375,16337746.84375,10169620.09375,15599054.71875,Drebrin-like protein OS=Homo sapiens OX=9606 GN=DBNL PE=1 SV=1,cell growth;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;mitochondrion;nucleus,DNA binding;motor activity;structural molecule activity,28988,DBNL,T-cell receptor signaling pathway,Neutrophil degranulation; Neurexins and neuroligins; Caspase-mediated cleavage of cytoskeletal proteins,ENSG00000136279
P51398,0,6,19276768.192708332,7.461932889025605e-5,0.9389975529317378,-0.09080669672912907,0.9593689318862713,1,raw,19383449.875,18411908.9375,19793875.5,24641353.59375,15229009.25,18201012,"28S ribosomal protein S29, mitochondrial OS=Homo sapiens OX=9606 GN=DAP3 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis;development,cytoskeleton;endosome;Golgi;membrane,structural molecule activity,7818,DAP3,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000132676
Q9NUQ3,0,6,4840081.955729167,1.8735695926818423e-5,0.9386851869950159,-0.09128670198499683,0.8844596180821067,1,raw,4748691.90625,5317413.4375,4251414.953125,6437730.25,4457526.75,3827714.4375,Gamma-taxilin OS=Homo sapiens OX=9606 GN=TXLNG PE=1 SV=2,cell differentiation;metabolic process,cytoskeleton;cytosol;membrane,structural molecule activity,55787,TXLNG,NA,NA,ENSG00000086712
P56377,0.16666666666666666,6,402320.9,1.557362481947549e-6,0.9386270987533156,-0.09137598240882178,0.7289042365172298,1,raw,249398.6875,669639.5,NA,363027.8125,313080.125,416458.375,AP-1 complex subunit sigma-2 OS=Homo sapiens OX=9606 GN=AP1S2 PE=1 SV=1,cell growth;conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,8905,AP1S2,NA,MHC class II antigen presentation; Lysosome Vesicle Biogenesis; Golgi Associated Vesicle Biogenesis; Nef mediated downregulation of MHC class I complex cell surface expression,ENSG00000182287
O60216,0,6,7815268.822916667,3.0252483654577228e-5,0.938263939641326,-0.09193427572019852,0.35996464684940616,0.8422895555819307,raw,8071235.25,8826204.5,7993166.0625,5712250.5625,8281309.40625,8007447.15625,Double-strand-break repair protein rad21 homolog OS=Homo sapiens OX=9606 GN=RAD21 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,5885,RAD21,Cell cycle; Prion disease pathway; Regulation of sister chromatid separation at the metaphase-anaphase transition; Cohesin complex - Cornelia de Lange syndrome; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome,Meiotic synapsis; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,ENSG00000164754
Q8WUD1,0.16666666666666666,6,604636.00625,2.3405133349233254e-6,0.9380962362345393,-0.09219216317386152,0.9764528424589789,1,raw,500836.3125,888121.8125,414350.6875,829444.5625,NA,390426.65625,Ras-related protein Rab-2B OS=Homo sapiens OX=9606 GN=RAB2B PE=1 SV=1,cell growth;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,84932,RAB2B,NA,RAB geranylgeranylation,ENSG00000129472
Q14011,0,6,18220553.78125,7.053077993021564e-5,0.9380788445580921,-0.09221891002240537,0.5260760770996924,1,raw,19369895.125,18098271.375,18824745.625,17659095.625,15236945.6875,20134369.25,Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1,cell growth;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,1153,CIRBP,NA,NA,ENSG00000099622
Q96C36,0,6,42711915.135416664,1.6533551740420538e-4,0.9378121854365512,-0.09262907008894952,0.8018999423162942,1,raw,42676009.25,45284958.1875,42932390.875,53571622.75,31543990.4375,40262519.3125,Pyrroline-5-carboxylate reductase 2 OS=Homo sapiens OX=9606 GN=PYCR2 PE=1 SV=1,cellular homeostasis;coagulation,endosome,structural molecule activity,29920,PYCR2,Metabolic reprogramming in colon cancer,Glutamate and glutamine metabolism,ENSG00000143811
Q9P275,0,6,2061521.6510416667,7.980039006312769e-6,0.9376123319258388,-0.09293654998721376,0.8516478582448379,1,raw,1325013.5625,2719842.25,2290635.734375,2419307.890625,1466602.15625,2147728.3125,Ubiquitin carboxyl-terminal hydrolase 36 OS=Homo sapiens OX=9606 GN=USP36 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,57602,USP36,NA,NA,ENSG00000055483
Q92696,0,6,15889974.989583334,6.150923525937125e-5,0.9374994869599843,-0.093110193896003,0.5310153283902959,1,raw,16084423.96875,18997991.78125,15266238.53125,18861691.375,11050365.0625,15079139.21875,Geranylgeranyl transferase type-2 subunit alpha OS=Homo sapiens OX=9606 GN=RABGGTA PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,5875,RABGGTA,NA,RAB geranylgeranylation; TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,ENSG00000100949; ENSG00000285193
P11172,0,6,25520889.075520832,9.878998369749424e-5,0.9372681236296395,-0.09346627720909322,0.7752827781397124,1,raw,30593939.8125,26071707.03125,21789592.265625,27546127.4375,18449243.34375,28674724.5625,Uridine 5'-monophosphate synthase OS=Homo sapiens OX=9606 GN=UMPS PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7372,UMPS,Fluoropyrimidine activity; Pyrimidine metabolism,Pyrimidine biosynthesis,ENSG00000114491
Q3B7T1,0,6,232366.30924479166,8.994774372558334e-7,0.9369767819795113,-0.09391479613633895,0.8362295567839853,1,raw,209503.890625,376137.234375,152438.359375,406561.6796875,196300.28125,53256.41015625,Erythroid differentiation-related factor 1 OS=Homo sapiens OX=9606 GN=EDRF1 PE=1 SV=1,metabolic process,membrane,NA,26098,EDRF1,NA,NA,ENSG00000107938
Q9Y5L4,0,6,8048101.104166667,3.115376484430665e-5,0.9363794723875142,-0.09483478731627892,0.6268904573102031,1,raw,6982836.375,11630280.125,6903779,8075716.6875,6464556.9375,8231437.5,Mitochondrial import inner membrane translocase subunit Tim13 OS=Homo sapiens OX=9606 GN=TIMM13 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endosome;membrane,structural molecule activity,26517,TIMM13,NA,Mitochondrial protein import,ENSG00000099800
P48634,0,6,10642582.8828125,4.119686372920068e-5,0.9363098697948907,-0.09494202914544433,0.44295504268926195,0.9249308478488519,raw,11919253.015625,10416045.625,10387403.203125,10485327.140625,9725828.140625,10921640.171875,Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,metabolic process,cytoplasm;cytoskeleton;cytosol;membrane,NA,7916,PRRC2A,NA,NA,ENSG00000204469; ENSG00000206427; ENSG00000225164; ENSG00000225748; ENSG00000226618; ENSG00000231370; ENSG00000231825
Q8WVV9,0,6,7634051.239583333,2.9551000173722672e-5,0.9359707283911999,-0.09546468331073363,0.7163206711780152,1,raw,9139839.0625,8317470.75,6538524.546875,9825864.453125,4197699.46875,7784909.15625,Heterogeneous nuclear ribonucleoprotein L-like OS=Homo sapiens OX=9606 GN=HNRNPLL PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding,92906,HNRNPLL,NA,NA,ENSG00000143889
O75818,0,6,4887670.61328125,1.8919909050814377e-5,0.9359049053941201,-0.09556614572606577,0.6478790268541121,1,raw,6188833.8125,4724930.4765625,4263413.484375,3990149.59375,5022635.34375,5136060.96875,Ribonuclease P protein subunit p40 OS=Homo sapiens OX=9606 GN=RPP40 PE=1 SV=3,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,10799,RPP40,NA,tRNA processing in the nucleus; Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000124787
Q92522,0,6,9164397.697916666,3.5474888688064435e-5,0.9355273257429058,-0.09614830124169242,0.7827599890323508,1,raw,11930717.75,7180603.125,9399371.625,12012950.125,5669374.5625,8793369,Histone H1.10 OS=Homo sapiens OX=9606 GN=H1-10 PE=1 SV=1,cell growth;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,8971,H1-10,NA,NA,ENSG00000184897
A0A3B3ITJ4,0.16666666666666666,6,1809102.2291666667,7.0029370527652016e-6,0.934730289653036,-0.0973779501140306,0.934621648811081,1,raw,1420320,1808644.5,2140136.25,2582483.25,1327616.125,1575413.25,Heterogeneous nuclear ribonucleoprotein L (Fragment) OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,NA,HNRNPL,Hippocampal synaptogenesis and neurogenesis,NA,ENSG00000104824
P68431,0,6,520403543.9505208,0.0020144540212081534,0.9347011447509366,-0.09742293406471801,0.575919337392504,1,raw,615404854.9375,487027500.625,503179674.4375,520426932.9375,455225162.359375,541157138.40625,Histone H3.1 OS=Homo sapiens OX=9606 GN=H3C1 PE=1 SV=2,cell growth,cell surface;membrane;nucleus,RNA binding;structural molecule activity,8350; 8351; 8352; 8353; 8354; 8355; 8356; 8357; 8358; 8968,H3C1; H3C10; H3C11; H3C12; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8,Histone modifications; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma,Estrogen-dependent gene expression; HATs acetylate histones; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Transcriptional regulation of granulopoiesis; B-WICH complex positively regulates rRNA expression; NoRC negatively regulates rRNA expression; RNA Polymerase I Promoter Escape; SIRT1 negatively regulates rRNA expression; Amyloid fiber formation; HCMV Late Events; RUNX1 regulates transcription of genes involved in differentiation of HSCs; HCMV Early Events; Transcriptional regulation by small RNAs; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; HDACs deacetylate histones; Interleukin-7 signaling; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); Factors involved in megakaryocyte development and platelet production; RMTs methylate histone arginines; HDMs demethylate histones; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Meiotic recombination; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Condensation of Prophase Chromosomes; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; RNA Polymerase I Promoter Opening,ENSG00000197153; ENSG00000197409; ENSG00000273983; ENSG00000274750; ENSG00000275379; ENSG00000275714; ENSG00000277775; ENSG00000278828; ENSG00000286522; ENSG00000287080
P35250,0,6,30202167.734375,1.1691096063615494e-4,0.9342827939624608,-0.09806879581394363,0.5976735397987025,1,raw,28695496.5,35750615.3125,30604213.53125,36640595.8125,20929095.125,28592990.125,Replication factor C subunit 2 OS=Homo sapiens OX=9606 GN=RFC2 PE=1 SV=3,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,5982,RFC2,"DNA replication; Nucleotide excision repair; 7q11.23 copy number variation syndrome; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,ENSG00000049541
P02765,0,6,344328.15625,1.3328757020128047e-6,0.9340209940825555,-0.09847311698840547,0.9767260148574897,1,raw,219552.890625,547853.9375,271510.40625,226764.359375,NA,455959.1875,Alpha-2-HS-glycoprotein OS=Homo sapiens OX=9606 GN=AHSG PE=1 SV=2,coagulation;conjugation;defense response;metabolic process,chromosome;extracellular;nucleus,DNA binding,197,AHSG,NA,Neutrophil degranulation; Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,ENSG00000145192
Q9BQP7,0,6,7499228.703125,2.9029109414378046e-5,0.9338052688390724,-0.09880636612032903,0.9321882618372686,1,raw,8400627.1875,6473448.09375,7424697.8125,10171000.125,6480659.0625,6044939.9375,Mitochondrial genome maintenance exonuclease 1 OS=Homo sapiens OX=9606 GN=MGME1 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation,endosome,structural molecule activity,92667,MGME1,NA,NA,ENSG00000125871
Q9BRT6,0.3333333333333333,6,8287560,3.2080697301306565e-5,0.9329301344725413,-0.10015905070643583,0.4963552752605163,0.9797947585234871,raw,9751805,8523590.25,8041708.25,9097752.75,5543351.5,8767152.25,Protein LLP homolog OS=Homo sapiens OX=9606 GN=LLPH PE=1 SV=1,cell growth;defense response;metabolic process,membrane;nucleus,structural molecule activity,84298,LLPH,NA,NA,ENSG00000139233
Q96MG7,0,6,269564.484375,1.043469564795568e-6,0.932467065549712,-0.10087532416526859,0.938483734722956,1,raw,127670.015625,284314.75,405609.375,230737.4375,299490.84375,NA,Non-structural maintenance of chromosomes element 3 homolog OS=Homo sapiens OX=9606 GN=NSMCE3 PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,structural molecule activity,56160,NSMCE3,NA,SUMOylation of DNA damage response and repair proteins,ENSG00000185115; ENSG00000282130
Q6P2C8,0,6,510299.1041666667,1.9753402803598094e-6,0.9319823357090863,-0.10162548381296481,0.8551064877568508,1,raw,468780.09375,895825.65625,242424.4375,268463.875,834893.6875,351406.875,Mediator of RNA polymerase II transcription subunit 27 OS=Homo sapiens OX=9606 GN=MED27 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9442,MED27,NA,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Generic Transcription Pathway,ENSG00000160563
Q9HD15,0,6,3284465.1770833335,1.2713987366932208e-5,0.9318266318367662,-0.10186653126887635,0.6966065120869112,1,raw,2858948.8125,4393287.8125,3190888.625,4519144.5,1771166.3125,2973355,Steroid receptor RNA activator 1 OS=Homo sapiens OX=9606 GN=SRA1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q9NPJ6,0.16666666666666666,6,423930.225,1.6410110123003373e-6,0.9298265085824595,-0.10496653840529627,0.6123756129573001,1,raw,211841.875,809569.875,384046.375,437842.25,NA,276350.75,Mediator of RNA polymerase II transcription subunit 4 OS=Homo sapiens OX=9606 GN=MED4 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,29079,MED4,NA,Generic Transcription Pathway; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation,ENSG00000136146
E9PSH4,0,6,360534.075,1.3956079385104371e-6,0.9297637438730131,-0.10506392581090998,0.9231585175724064,1,raw,346169.59375,380150.84375,NA,335124.8125,308587.0625,432638.0625,Repressor of RNA polymerase III transcription MAF1 OS=Homo sapiens OX=9606 GN=MAF1 PE=1 SV=1,metabolic process,membrane;nucleus,NA,NA,MAF1,NA,NA,ENSG00000179632
Q86VN1,0,6,4847265.661458333,1.87635036638362e-5,0.929455109262014,-0.10554290721331375,0.9549566017072953,1,raw,5148937.84375,4669858.71875,4773591.1875,4436838.71875,4198726.6875,5855640.8125,Vacuolar protein-sorting-associated protein 36 OS=Homo sapiens OX=9606 GN=VPS36 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;cytosol;membrane;mitochondrion,structural molecule activity,51028,VPS36,Network map of SARS-CoV-2 signaling pathway,Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events,ENSG00000136100
Q14657,0,6,511909.2291666667,1.981572987301571e-6,0.9293995616722125,-0.10562913044917713,0.7814798287013316,1,raw,603285.6875,561908.25,400867.15625,522237.28125,525102.6875,458054.3125,EKC/KEOPS complex subunit LAGE3 OS=Homo sapiens OX=9606 GN=LAGE3 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,NA,8270,LAGE3,NA,tRNA modification in the nucleus and cytosol,ENSG00000196976
P13284,0,6,1624773.8958333333,6.289412026615043e-6,0.9293111669921827,-0.10576635090489339,0.9003058632051602,1,raw,1353648.5,1915573.25,1672152.375,1131809.875,1553949.875,2121509.5,Gamma-interferon-inducible lysosomal thiol reductase OS=Homo sapiens OX=9606 GN=IFI30 PE=1 SV=3,metabolic process,cell surface;cytosol;mitochondrion;nucleus,structural molecule activity,10437,IFI30,NA,MHC class II antigen presentation; Interferon gamma signaling,ENSG00000216490
Q7Z7H8,0,6,7612851.333333333,2.9468936481245957e-5,0.9292092936260893,-0.10592451133769273,0.8604840247003721,1,raw,10176207.6875,5595087.375,7728137,11220557.25,5758111.5,5199007.1875,"39S ribosomal protein L10, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL10 PE=1 SV=3",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi;membrane;nucleus,structural molecule activity,124995,MRPL10,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000159111
Q16512,0,6,4802786.802083333,1.8591328400680726e-5,0.9291853822257289,-0.1059616367762993,0.3901289217596607,0.874922600545966,raw,5502076,5689325.4375,4132866.21875,4032399.1875,4173615.9375,5286438.03125,Serine/threonine-protein kinase N1 OS=Homo sapiens OX=9606 GN=PKN1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,signal transducer activity;structural molecule activity,5585,PKN1,Apoptosis-related network due to altered Notch3 in ovarian cancer; PI3K-Akt signaling pathway; IL-18 signaling pathway; G13 signaling pathway,RHOC GTPase cycle; RHOA GTPase cycle; RAC1 GTPase cycle; RHOB GTPase cycle; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,ENSG00000123143
P42025,0,6,1228059,4.75375008411948e-6,0.9289703802190785,-0.1062954971947088,0.8152938621878404,1,raw,2243072.15625,206124.78125,1486174.0625,NA,1660824.4375,544099.5625,Beta-centractin OS=Homo sapiens OX=9606 GN=ACTR1B PE=1 SV=1,NA,cell surface;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,10120,ACTR1B,NA,Neutrophil degranulation; MHC class II antigen presentation,ENSG00000115073
A0A2R8YEC9,0.3333333333333333,6,1859653.3333333333,7.198617647658952e-6,0.9281922182263728,-0.10750449258856855,0.895766006496912,1,raw,1854111.375,2025766.625,1630342.875,2457004.25,1469723.125,1720971.75,Beta-mannosidase OS=Homo sapiens OX=9606 GN=MANBA PE=1 SV=1,cellular homeostasis,mitochondrion,structural molecule activity,NA,MANBA,NA,NA,ENSG00000109323
Q14195,0,6,7753458.2265625,3.0013218173343756e-5,0.9280530487297423,-0.10772082083633,0.5606073049678785,1,raw,8656361.84375,8789776.4375,6909706.46875,8033563,5502319.359375,8629022.25,Dihydropyrimidinase-related protein 3 OS=Homo sapiens OX=9606 GN=DPYSL3 PE=1 SV=1,cell growth;coagulation;defense response;metabolic process,cell surface;cytosol;endoplasmic reticulum;extracellular;nucleus,motor activity;structural molecule activity,1809,DPYSL3,NA,CRMPs in Sema3A signaling,ENSG00000113657
Q9NWB6,0,6,4542620.104166667,1.7584237159863765e-5,0.9280206226563398,-0.10777122932605668,0.7198634481825188,1,raw,5821447.25,4828185,3606242.125,2757200.25,4480655.25,5761990.75,Arginine and glutamate-rich protein 1 OS=Homo sapiens OX=9606 GN=ARGLU1 PE=1 SV=1,NA,cytosol;endosome;membrane,NA,55082,ARGLU1,NA,NA,ENSG00000134884
P62280,0,6,169203913.25,6.549792125993399e-4,0.9275753955144534,-0.10846354273447628,0.4126155045496585,0.8987349134294045,raw,183370922,192232486.25,156794690,180023324.5,132711701.25,170090355.5,40S ribosomal protein S11 OS=Homo sapiens OX=9606 GN=RPS11 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;Golgi;membrane,RNA binding;structural molecule activity,6205,RPS11,VEGFA-VEGFR2 signaling pathway; IL-18 signaling pathway; Cytoplasmic ribosomal proteins,"L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000142534
H0YDN1,0,6,266468.1927083333,1.0314839869276683e-6,0.9271015066590834,-0.10920078933052947,1,1,raw,239911.296875,NA,309056.125,NA,250437.15625,NA,Plectin OS=Homo sapiens OX=9606 GN=PLEC PE=1 SV=9,cell growth,cytosol;endoplasmic reticulum;nucleus,motor activity,NA,PLEC,NA,NA,ENSG00000178209
O95155,0,6,2033746.9856770833,7.87252477628532e-6,0.9268410472241488,-0.10960615630030744,0.7101636038157877,1,raw,1413210.46875,3227056.625,1856789.6875,2595328.296875,1720948.8984375,1389147.9375,Ubiquitin conjugation factor E4 B OS=Homo sapiens OX=9606 GN=UBE4B PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,structural molecule activity,10277,UBE4B,NA,NA,ENSG00000130939
Q13308,0,6,33514485.697916668,1.2973276463565064e-4,0.9264885038940928,-0.11015501985217611,0.4624818562799885,0.9446381420181073,raw,39448966.75,30388876.3125,36495760.25,33812902.3125,24064183.78125,36876224.78125,Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,cell communication;cell death;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,signal transducer activity;structural molecule activity,5754,PTK7,NA,NA,ENSG00000112655
Q92620,0,6,6438830.203125,2.492436407349852e-5,0.926127766106844,-0.1107168573268111,0.6201153631735203,1,raw,6063076.0625,8222602.71875,5978858.28125,7615180.6875,4456976.71875,6296286.75,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Homo sapiens OX=9606 GN=DHX38 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,structural molecule activity,9785,DHX38,mRNA processing,mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000140829
P55061,0,6,1103579.84375,4.271897991105578e-6,0.9248588377373569,-0.11269491265026563,0.8457976627460755,1,raw,1150811.875,976048.75,1118889.875,965148.375,902707.3125,1507872.875,Bax inhibitor 1 OS=Homo sapiens OX=9606 GN=TMBIM6 PE=1 SV=2,cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;endosome;extracellular;membrane;nucleus,DNA binding;structural molecule activity,7009,TMBIM6,NA,NA,ENSG00000139644
Q9H2P0,0,6,14576550.666666666,5.642504061925244e-5,0.924668359014785,-0.11299207260541907,0.7122287056077199,1,raw,14154618.3125,14794180.9375,13147807.9375,20170663.9375,13088327.6875,12103705.1875,Activity-dependent neuroprotector homeobox protein OS=Homo sapiens OX=9606 GN=ADNP PE=1 SV=1,cell growth;cellular component movement;development;metabolic process,cell surface;membrane;nucleus,motor activity;RNA binding;structural molecule activity,23394,ADNP,NA,NA,ENSG00000101126
A0A0B4J2A0,0,6,9031977.552083334,3.4962297453120256e-5,0.9246186259045795,-0.11306966976807009,0.824777478594252,1,raw,9458151.09375,8912971.8125,8217378.34375,11806269.8125,7555994.5,8241099.75,FGGY_N domain-containing protein OS=Homo sapiens OX=9606 PE=1 SV=1,cellular homeostasis,NA,signal transducer activity,NA,NA,NA,NA,NA
Q5T5H1,0,6,16576760.8125,6.416774609921053e-5,0.9243333662693767,-0.11351483293734677,0.92988057631391,1,raw,13165667.625,20079854.5,16977322.5,21829490.125,12169465.875,15238764.25,Alpha-endosulfine OS=Homo sapiens OX=9606 GN=ENSA PE=1 SV=1,cell differentiation;metabolic process,NA,DNA binding,NA,ENSA,NA,NA,ENSG00000143420
A0A087WU03,0,6,3333155.2083333335,1.2902463849047862e-5,0.9241572695291793,-0.11378971006103665,0.9420457134799591,1,raw,3486168,3588944,2998708.25,3221767.5,2336806,4366537.5,Heterogeneous nuclear ribonucleoprotein D-like OS=Homo sapiens OX=9606 GN=HNRNPDL PE=1 SV=1,NA,NA,NA,NA,HNRNPDL,NA,NA,ENSG00000152795
Q96BN8,0,6,1683340.89375,6.516121713424048e-6,0.9241522459997107,-0.11379755227684658,0.8451831423040562,1,raw,1112523.375,2431574.5625,1673637.78125,2106459.6875,1092509.0625,NA,Ubiquitin thioesterase otulin OS=Homo sapiens OX=9606 GN=OTULIN PE=1 SV=3,cell death;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;nucleus,structural molecule activity,90268,OTULIN,NA,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Regulation of TNFR1 signaling,ENSG00000154124
A0A6I8PU73,0,6,40883659.578125,1.582584388523873e-4,0.9239783997764861,-0.11406896932783953,0.7819561466021379,1,raw,36668073.0625,52502673.625,36295833.90625,42192035.59375,33536566.53125,44106774.75,DnaJ homolog subfamily C member 7 OS=Homo sapiens OX=9606 GN=DNAJC7 PE=1 SV=1,NA,cytosol;membrane,NA,NA,DNAJC7,Pregnane X receptor pathway; Nuclear receptors meta-pathway,NA,ENSG00000168259
Q5ZPR3,0,6,2478830.7552083335,9.595420017352237e-6,0.9238785839349458,-0.11422482967958943,0.8379359892748299,1,raw,2262553.96875,3192340.40625,2123542.09375,2907239.1875,1961895.0625,2425413.8125,CD276 antigen OS=Homo sapiens OX=9606 GN=CD276 PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton,antioxidant activity,80381,CD276,NA,NA,ENSG00000103855
P02549,0.8333333333333334,6,615610.4635416666,2.3829948665707673e-6,0.9238607829981815,-0.11425262723984429,0.9276347975702623,1,raw,548961.8125,925118.6875,401772.21875,467383.0625,495746.125,854680.875,"Spectrin alpha chain, erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTA1 PE=1 SV=5",cell growth;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,6708,SPTA1,NA,RAF/MAP kinase cascade; COPI-mediated anterograde transport; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins,ENSG00000163554
Q9NZN8,0,6,4331195.013020833,1.676582204721895e-5,0.9237459157159578,-0.11443201439919316,0.7163153185290196,1,raw,4131203.703125,4764442.21875,4334775.1875,4941724.28125,3810793.8125,4004230.875,CCR4-NOT transcription complex subunit 2 OS=Homo sapiens OX=9606 GN=CNOT2 PE=1 SV=1,cellular component movement;cellular homeostasis;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,4848,CNOT2,NA,Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,ENSG00000111596
J3QTA6,0,6,4017227.6614583335,1.5550471380922785e-5,0.9235449241071496,-0.11474595478387002,0.9865141104154632,1,raw,5330101.0625,2846504.96875,3847031.1875,4617368.59375,2539772.375,4922587.78125,MICOS complex subunit MIC25 OS=Homo sapiens OX=9606 GN=CHCHD6 PE=1 SV=1,NA,cytoskeleton;cytosol;endosome,NA,NA,CHCHD6,NA,NA,ENSG00000159685
Q99871,0,6,324472.14375,1.2560141496833543e-6,0.923403114595588,-0.11496749634886885,0.2912697241276181,0.7730231021500684,raw,300361.65625,432936.40625,312301.78125,287525.6875,289235.1875,NA,HAUS augmin-like complex subunit 7 OS=Homo sapiens OX=9606 GN=HAUS7 PE=1 SV=3,NA,NA,NA,NA,NA,NA,NA,NA
Q9UJA5,0,6,1305873.65625,5.054966417124789e-6,0.9231494098028008,-0.11536393094130074,0.6498913854776045,1,raw,1006653.53125,1300442.84375,1273840.65625,1175945.25,842342.65625,2236017,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Homo sapiens OX=9606 GN=TRMT6 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,NA,51605,TRMT6,NA,tRNA modification in the nucleus and cytosol,ENSG00000089195
Q8NB16,0.16666666666666666,6,634173.0416666666,2.454849604269195e-6,0.9222498757646385,-0.11677040531126623,1,1,raw,NA,668841.375,NA,734015.40625,NA,499662.34375,Mixed lineage kinase domain-like protein OS=Homo sapiens OX=9606 GN=MLKL PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,197259,MLKL,DNA damage response (only ATM dependent),Regulation of necroptotic cell death; TRP channels; Microbial modulation of RIPK1-mediated regulated necrosis,ENSG00000168404
Q99595,0.16666666666666666,6,637920.5,2.4693558131462256e-6,0.9216929060953423,-0.11764194797751527,1,1,raw,694641.875,NA,616849.8125,NA,602269.8125,NA,Mitochondrial import inner membrane translocase subunit Tim17-A OS=Homo sapiens OX=9606 GN=TIMM17A PE=1 SV=1,cell growth;conjugation,cytoskeleton;endosome;membrane,catalytic activity,10440,TIMM17A,NA,Mitochondrial protein import,ENSG00000134375
Q9UJX2,0,6,1836983.3802083333,7.110863483099307e-6,0.9216317736096367,-0.11773763978370445,0.5291095374455925,1,raw,2394553.78125,1940506.625,1595394.875,1087425.375,1788432.5625,2215587.0625,Cell division cycle protein 23 homolog OS=Homo sapiens OX=9606 GN=CDC23 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,8697,CDC23,Cell cycle,Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,ENSG00000094880
Q9NSY1,0,6,264849.2890625,1.025217298321859e-6,0.9213372794546464,-0.1181987058660513,1,1,raw,NA,275692.65625,NA,NA,254005.921875,NA,BMP-2-inducible protein kinase OS=Homo sapiens OX=9606 GN=BMP2K PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,55589,BMP2K,NA,NA,ENSG00000138756
Q7L8W6,0,6,752692.9583333334,2.9136338026049433e-6,0.9212669388558428,-0.11830885435275074,1,1,raw,NA,827615.5625,720672.5625,709790.75,NA,NA,Diphthine--ammonia ligase OS=Homo sapiens OX=9606 GN=DPH6 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,89978,DPH6,NA,Synthesis of diphthamide-EEF2,ENSG00000134146
Q96T51,0,6,984802.675,3.8121179838447006e-6,0.9210632273486226,-0.1186278998613436,0.8044205858190716,1,raw,NA,1011505.5625,1097399.15625,1633142.09375,969606.1875,212360.375,RUN and FYVE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RUFY1 PE=1 SV=2,conjugation;development;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,80230,RUFY1,NA,Synthesis of PIPs at the plasma membrane,ENSG00000176783; ENSG00000284260
H7BY36,0.3333333333333333,6,305941.66875,1.1842836814485027e-6,0.9209336116914603,-0.11883093589501639,0.7881672314767995,1,raw,NA,209873.0625,453181.5,279934.53125,372815.8125,213903.4375,RNA-binding protein EWS (Fragment) OS=Homo sapiens OX=9606 GN=EWSR1 PE=1 SV=1,metabolic process,membrane,RNA binding;structural molecule activity,NA,EWSR1,NA,NA,ENSG00000182944
Q9BW60,0,6,1536666.5520833333,5.948353256015987e-6,0.9208409008839136,-0.11897617997509692,0.628310224604497,1,raw,1124318,1636674,1341725.1875,1035318,1201202.875,2880761.25,Elongation of very long chain fatty acids protein 1 OS=Homo sapiens OX=9606 GN=ELOVL1 PE=1 SV=1,cellular homeostasis;metabolic process,cytoskeleton;extracellular,structural molecule activity,64834,ELOVL1,Omega-9 fatty acid synthesis,Synthesis of very long-chain fatty acyl-CoAs; alpha-linolenic acid (ALA) metabolism; Linoleic acid (LA) metabolism,ENSG00000066322
Q96H20,0,6,2451590.3333333335,9.489973815028299e-6,0.9206530617610234,-0.11927050032315747,0.38217812866167983,0.8669667838289875,raw,3081002.625,3053370.5,1941987.8125,1916902.9375,1879743.625,2836534.5,Vacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,structural molecule activity,11267,SNF8,NA,Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events,ENSG00000159210
Q92608,0.6666666666666666,6,831841.8333333334,3.2200148243548853e-6,0.9205973766945442,-0.11935776337831568,0.9206647265515837,1,raw,723547.0625,1035050.125,714770.9375,916955.25,658016.25,942711.375,Dedicator of cytokinesis protein 2 OS=Homo sapiens OX=9606 GN=DOCK2 PE=1 SV=2,cell differentiation;cell growth;conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,antioxidant activity;DNA binding;structural molecule activity,1794,DOCK2,Chemokine signaling pathway,Neutrophil degranulation; RHOA GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; Factors involved in megakaryocyte development and platelet production; Nef and signal transduction,ENSG00000134516
O60504,0.5,6,307711.9661458333,1.1911364070865697e-6,0.9205627920817044,-0.11941196295343906,0.7085187205411498,1,raw,388471.9375,247575.828125,318888.859375,293557.21875,356713.265625,241064.6875,Vinexin OS=Homo sapiens OX=9606 GN=SORBS3 PE=1 SV=2,cell communication;cell growth;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity,10174,SORBS3,NA,Smooth Muscle Contraction,ENSG00000120896
A0A499FIJ6,0.3333333333333333,6,255097.4375,9.874684074415715e-7,0.9205452232247359,-0.11943949691952112,0.8269968810302142,1,raw,369491.5625,117212.3125,217488.15625,582344.9375,107899.234375,136148.421875,Myocardin-related transcription factor A OS=Homo sapiens OX=9606 GN=MRTFA PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P82912,0,6,2566638.140625,9.935317665438192e-6,0.9199394670875863,-0.12038916133260721,0.8448285452574725,1,raw,3541627.125,1908796.3125,2441086.46875,2928800.75,1755977.0625,2823541.125,"28S ribosomal protein S11, mitochondrial OS=Homo sapiens OX=9606 GN=MRPS11 PE=1 SV=2",cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis,cytoskeleton;cytosol;endosome;Golgi,RNA binding;structural molecule activity,64963,MRPS11,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000181991
G3V4T6,0,6,3134301.0208333335,1.2132710025692765e-5,0.9193851023306888,-0.12125880590011254,0.6233816835161228,1,raw,2838100.75,3285310.875,3608020.75,3020465.875,2437260.125,3616647.75,Maleylacetoacetate isomerase OS=Homo sapiens OX=9606 GN=GSTZ1 PE=1 SV=1,cellular homeostasis,cytosol,structural molecule activity,NA,GSTZ1,Metapathway biotransformation Phase I and II,NA,ENSG00000100577
O14980,0,6,158902525.97526067,6.151030986472908e-4,0.9193631371287538,-0.12129327400969403,0.7746258228234407,1,raw,181555130.328125,177559249.476563,105454362.976563,164451112.875,161153871.570313,163241428.625,Exportin-1 OS=Homo sapiens OX=9606 GN=XPO1 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,7514,XPO1,eIF5A regulation in response to inhibition of the nuclear export system; 22q11.2 copy number variation syndrome,Separation of Sister Chromatids; MAPK6/MAPK4 signaling; NPAS4 regulates expression of target genes; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Rev-mediated nuclear export of HIV RNA; NEP/NS2 Interacts with the Cellular Export Machinery; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Heme signaling; Deactivation of the beta-catenin transactivating complex; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; Downregulation of TGF-beta receptor signaling; HuR (ELAVL1) binds and stabilizes mRNA; Cyclin A/B1/B2 associated events during G2/M transition,ENSG00000082898
Q8TD16,0,6,2258853.5208333335,8.743900020011288e-6,0.9192148102862566,-0.12152605217486953,0.9685880417157461,1,raw,2762825.625,2881507.4375,1171002.8125,2648724.3125,1834461.28125,2254599.65625,Protein bicaudal D homolog 2 OS=Homo sapiens OX=9606 GN=BICD2 PE=1 SV=1,cell growth;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity;structural molecule activity,23299,BICD2,NA,COPI-independent Golgi-to-ER retrograde traffic,ENSG00000185963
Q7L266,0,6,1121082.765625,4.3396508566728006e-6,0.9183655734821177,-0.12285953377264905,0.6269279075810201,1,raw,1015975.5,1214767.0625,1342554.78125,1426030.875,611568.125,1115600.25,Isoaspartyl peptidase/L-asparaginase OS=Homo sapiens OX=9606 GN=ASRGL1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;nucleus,structural molecule activity,80150,ASRGL1,NA,Phenylalanine metabolism,ENSG00000162174
P62942,0,6,73027400.29296875,2.826851236672889e-4,0.9183069507823202,-0.12295162931738311,0.8361865310683179,1,raw,74062717.25,65823978.5390625,73350516.75,106559357.125,51009542.71875,67358289.375,Peptidyl-prolyl cis-trans isomerase FKBP1A OS=Homo sapiens OX=9606 GN=FKBP1A PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;nucleus,antioxidant activity;structural molecule activity,2280,FKBP1A,Target of rapamycin signaling; Spinal cord injury; Head and neck squamous cell carcinoma; TGF-beta receptor signaling in skeletal dysplasias; Calcium regulation in cardiac cells; TGF-beta receptor signaling,Potential therapeutics for SARS; mTORC1-mediated signalling; SARS-CoV-1 activates/modulates innate immune responses; TGF-beta receptor signaling activates SMADs; Calcineurin activates NFAT; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); TGFBR1 LBD Mutants in Cancer,ENSG00000088832
Q96NL6,0.6666666666666666,6,2370777.6041666665,9.177152103633352e-6,0.9173304823323011,-0.12448651447268866,0.7091373083832109,1,raw,2488015,3000387.25,1840612.375,2264397.75,2282332,2348921.25,Sodium channel and clathrin linker 1 OS=Homo sapiens OX=9606 GN=SCLT1 PE=1 SV=2,cell growth;defense response,cytoskeleton;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,132320,SCLT1,Genes related to primary cilium development (based on CRISPR); Ciliopathies; Bardet-Biedl syndrome,Anchoring of the basal body to the plasma membrane,ENSG00000151466
Q9Y5Q9,0,6,2813470.2122395835,1.0890791287797712e-5,0.9171284640044528,-0.12480426575462993,0.7936081034603071,1,raw,2214551.34375,3492642.4609375,3083767.28125,2828210.75,1378985.03125,3882664.40625,General transcription factor 3C polypeptide 3 OS=Homo sapiens OX=9606 GN=GTF3C3 PE=1 SV=1,cellular component movement;cellular homeostasis,cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,9330,GTF3C3,NA,RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter,ENSG00000119041
Q15119,0.3333333333333333,6,358673.375,1.3884052692726227e-6,0.9168696424616692,-0.12521146416711623,0.8109585729696336,1,raw,306340.40625,393448.53125,397758.96875,440172.5625,280874.21875,333445.5625,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Homo sapiens OX=9606 GN=PDK2 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytosol;endosome;membrane,signal transducer activity;structural molecule activity,5164,PDK2,NA,Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid,ENSG00000005882
Q9NUL3,0,6,579196.6171875,2.242038833375918e-6,0.91617428713953,-0.12630602137529465,1,1,raw,1012860.53125,488888.625,367130.125,NA,447907.1875,NA,Double-stranded RNA-binding protein Staufen homolog 2 OS=Homo sapiens OX=9606 GN=STAU2 PE=1 SV=2,coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity;protein binding;RNA binding;structural molecule activity,27067,STAU2,NA,NA,ENSG00000040341
Q9NVW2,0.16666666666666666,6,275257.859375,1.065508312026095e-6,0.9154216944235051,-0.1274916123585161,1,1,raw,NA,NA,287412.28125,NA,263103.4375,NA,E3 ubiquitin-protein ligase RLIM OS=Homo sapiens OX=9606 GN=RLIM PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,51132,RLIM,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000131263
Q9NP66,0.5,6,224847.0390625,8.703707483576728e-7,0.9146857832239078,-0.12865186716145496,1,1,raw,226535.734375,198232.375,267411.03125,207209.015625,NA,NA,High mobility group protein 20A OS=Homo sapiens OX=9606 GN=HMG20A PE=1 SV=1,cell growth;metabolic process,membrane,RNA binding;structural molecule activity,10363,HMG20A,NA,NA,ENSG00000140382
Q15031,0,6,16458437.994791666,6.37097248603008e-5,0.914304610440239,-0.1292532001094981,0.9742063294820026,1,raw,15219271.9375,17443706.84375,16841983.21875,14292831.59375,13915050.5,21037783.875,"Probable leucine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=LARS2 PE=1 SV=2",cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome,structural molecule activity,23395,LARS2,Amino acid metabolism; IL-18 signaling pathway,Mitochondrial tRNA aminoacylation,ENSG00000011376
Q8N6H7,0,6,7349262.671875,2.8448599004316515e-5,0.913799721414001,-0.13005009216886318,0.607044238508486,1,raw,7630687.1875,9196980.5,6294634.34375,7438626.0625,5130449.71875,8404198.21875,ADP-ribosylation factor GTPase-activating protein 2 OS=Homo sapiens OX=9606 GN=ARFGAP2 PE=1 SV=1,cell growth;conjugation,cytoplasm;cytoskeleton;cytosol;extracellular,DNA binding;structural molecule activity,84364,ARFGAP2,IL-18 signaling pathway,COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; CDC42 GTPase cycle,ENSG00000149182
Q13509,0,6,42703717.072916664,1.6530378314689447e-4,0.9128302388587732,-0.1315815110510752,0.6462703631451702,1,raw,45683404.5625,51918051.90625,35386621.5,46732943.9375,32301978.15625,44199302.375,Tubulin beta-3 chain OS=Homo sapiens OX=9606 GN=TUBB3 PE=1 SV=2,cell differentiation;cell growth;defense response;development,endoplasmic reticulum;nucleus,antioxidant activity;motor activity;structural molecule activity,10381,TUBB3,Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Exercise-induced circadian regulation; Alzheimer's disease,COPI-mediated anterograde transport; Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state,ENSG00000258947
Q8N5H7,0.6666666666666666,6,1360744.6354166667,5.26736901490654e-6,0.9125122376143542,-0.13208418803238092,0.7610077490110594,1,raw,1431524,1133416.375,1358600.5,1998856.5,1034256.3125,1207814.125,SH2 domain-containing protein 3C OS=Homo sapiens OX=9606 GN=SH2D3C PE=1 SV=1,coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,DNA binding;structural molecule activity,10044,SH2D3C,NA,NA,ENSG00000095370
P55011,0,6,3037286.28125,1.1757171206747502e-5,0.9121593383856178,-0.1326422347299632,0.3943729805993131,0.877277789871942,raw,3261099,3521632.875,3157478.125,2974641.90625,1786549.25,3522316.53125,Solute carrier family 12 member 2 OS=Homo sapiens OX=9606 GN=SLC12A2 PE=1 SV=1,cell death;cell growth;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,catalytic activity;structural molecule activity,6558,SLC12A2,NA,Cation-coupled Chloride cotransporters,ENSG00000064651
Q8WVK2,0,6,1208579.5546875,4.678346203041374e-6,0.9115023724310574,-0.133681683614651,0.9260547094942231,1,raw,1340400.515625,779278.5625,1542802.65625,1293527.90625,1073689.4375,1221778.25,U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP27 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding,11017,SNRNP27,NA,mRNA Splicing - Major Pathway,ENSG00000124380
Q9HD20,0,6,2349702.5208333335,9.095571593927665e-6,0.9110952698073226,-0.13432617577523695,0.9380471791295999,1,raw,3328543.71875,1438966.875,2177937.28125,2991335.625,1128811.1875,3032620.4375,Manganese-transporting ATPase 13A1 OS=Homo sapiens OX=9606 GN=ATP13A1 PE=1 SV=2,conjugation;metabolic process,cytoskeleton;extracellular,catalytic activity;structural molecule activity,57130,ATP13A1,NA,Ion transport by P-type ATPases,ENSG00000105726
Q4KMP7,0,6,920983.046875,3.5650756490971903e-6,0.9105245374673718,-0.1352301983821234,0.9019226507853877,1,raw,893065.375,1280723.0625,485345.9375,1817042.4375,236563.53125,813157.9375,TBC1 domain family member 10B OS=Homo sapiens OX=9606 GN=TBC1D10B PE=1 SV=3,conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol,DNA binding,26000,TBC1D10B,NA,TBC/RABGAPs,ENSG00000169221
Q9UMS0,0,6,6766060.9375,2.6191056578550503e-5,0.9104313518747182,-0.1353778553279153,0.2721442370947183,0.7524601054912853,raw,6426942.625,7708134.6875,7220961.125,6180755,5851290.0625,7208282.125,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial OS=Homo sapiens OX=9606 GN=NFU1 PE=1 SV=2",cell growth;cell organization and biogenesis;cellular homeostasis,cytosol;endosome;membrane,structural molecule activity,27247,NFU1,NA,NA,ENSG00000169599
Q9BRT3,0,6,4672139.369791667,1.808559924414468e-5,0.9103608876583528,-0.135489519221636,0.8739376999315059,1,raw,4402597.5625,6436920.34375,3452088.3125,4007952.625,3911878.59375,5821398.78125,Migration and invasion enhancer 1 OS=Homo sapiens OX=9606 GN=MIEN1 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane,NA,84299,MIEN1,NA,NA,ENSG00000141741
P18077,0,6,109512266.83333333,4.239160721684164e-4,0.9088703999086509,-0.13785350645165648,0.5290720682920499,1,raw,102499133,171456374,85094454,87386114,93158428,117479098,60S ribosomal protein L35a OS=Homo sapiens OX=9606 GN=RPL35A PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,6165,RPL35A,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000182899
A8MU27,0.3333333333333333,6,84517006.515625,3.271607690128723e-4,0.9087760249709703,-0.1380033202469411,0.774805494781144,1,raw,65484496.4375,118343882.15625,80757775,115329165.375,53795990.375,73390729.75,Small ubiquitin-related modifier 3 OS=Homo sapiens OX=9606 GN=SUMO3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,NA,NA,SUMO3,NA,NA,ENSG00000184900
Q9NZ43,0,6,783908.6640625,3.03446811409639e-6,0.9087733499598072,-0.13800756687197654,0.35664694697558424,0.8406066251623018,raw,945639.640625,903553.984375,784438.046875,872912.53125,821125.78125,375782,Vesicle transport protein USE1 OS=Homo sapiens OX=9606 GN=USE1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;extracellular,structural molecule activity,55850,USE1,NA,COPI-dependent Golgi-to-ER retrograde traffic,ENSG00000053501
P62760,0,6,6150390.463541667,2.380782941489688e-5,0.9086294128374929,-0.13823608789906824,0.7455661759191184,1,raw,8320822.5,5060355.90625,5845043.75,6332880.5625,3782696,7560544.0625,Visinin-like protein 1 OS=Homo sapiens OX=9606 GN=VSNL1 PE=1 SV=2,metabolic process,cytoskeleton;cytosol,structural molecule activity,7447,VSNL1,NA,NA,ENSG00000163032
Q9P0M9,0,6,3302818.78125,1.2785033177720766e-5,0.9086259014529633,-0.13824166318285766,0.9366433797054508,1,raw,4077137,4303937.125,1396478.1875,3420011.625,2708680,3910668.75,"39S ribosomal protein L27, mitochondrial OS=Homo sapiens OX=9606 GN=MRPL27 PE=1 SV=1",cell organization and biogenesis;cellular homeostasis,cytoskeleton;endosome;Golgi,structural molecule activity,51264,MRPL27,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000108826
P62318,0,6,96078421.83072917,3.7191438347823326e-4,0.9082099027128443,-0.1389023275406359,0.6803004641364605,1,raw,132043808.53125,81990216.796875,89580948.28125,119923494.5,60849500.03125,92082562.84375,Small nuclear ribonucleoprotein Sm D3 OS=Homo sapiens OX=9606 GN=SNRPD3 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding;structural molecule activity,6634,SNRPD3,mRNA processing,snRNP Assembly; RNA Polymerase II Transcription Termination; SARS-CoV-2 modulates host translation machinery; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway; SLBP independent Processing of Histone Pre-mRNAs; SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,ENSG00000100028
Q96EC8,0,6,2887253.9583333335,1.11764041852235e-5,0.9070402314549786,-0.1407615524760606,0.6457806933409916,1,raw,2817193.5,2464859.5,2631181.25,4984585.5,2039116.75,2386587.25,Protein YIPF6 OS=Homo sapiens OX=9606 GN=YIPF6 PE=1 SV=2,conjugation;defense response,cytoskeleton;extracellular;nucleus,structural molecule activity,286451,YIPF6,NA,Golgi Associated Vesicle Biogenesis,ENSG00000181704
Q32Q12,0,6,789043602.7239584,0.0030543451844112983,0.9064538954245447,-0.14169445223056107,0.46693080937253284,0.9485672170384823,raw,958665258.90625,825408333.4375,710009611.9375,868985858.34375,604407075.875,766785477.84375,Nucleoside diphosphate kinase OS=Homo sapiens OX=9606 GN=NME1-NME2 PE=1 SV=1,cellular homeostasis,cytosol,signal transducer activity;structural molecule activity,NA,NME1-NME2,NA,NA,ENSG00000011052
Q9NVV4,0,6,4933298.192708333,1.9096530947270218e-5,0.9061052075711479,-0.14224952405391617,0.9393696321930473,1,raw,4120399.125,5798788.125,5025809.875,6861713.75,3239165.78125,4553912.5,"Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1",cellular component movement;cellular homeostasis,endosome;membrane;nucleus,structural molecule activity,55149,MTPAP,NA,NA,ENSG00000107951
P30260,0,6,9326495.619791666,3.610236099171505e-5,0.906045752554225,-0.14234419106564833,0.49571027616473123,0.9797947585234871,raw,7823795.4375,8932403.875,13416310.34375,9363192.8125,7088716.625,9334554.625,Cell division cycle protein 27 homolog OS=Homo sapiens OX=9606 GN=CDC27 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,996,CDC27,Cell cycle; 2q21.1 copy number variation syndrome,Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,ENSG00000004897
Q13641,0,6,516262.65625,1.9984248684926244e-6,0.9052362756663023,-0.14363369579376256,0.4399885891685029,0.9233600879723239,raw,484562.65625,675901.4375,514719.59375,466979.5,343562.25,611850.5,Trophoblast glycoprotein OS=Homo sapiens OX=9606 GN=TPBG PE=1 SV=1,cell communication;cell death;cell growth;defense response;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,NA,7162,TPBG,NA,NA,ENSG00000146242; ENSG00000283085
Q9BRA2,0,6,26816150.869791668,1.0380387216984918e-4,0.9048605827928378,-0.14423257010338264,0.5909741034329472,1,raw,32183159.75,29363336.8125,22117095.3125,26086819.1875,22025221.46875,29121272.6875,Thioredoxin domain-containing protein 17 OS=Homo sapiens OX=9606 GN=TXNDC17 PE=1 SV=1,development;metabolic process,cytosol,structural molecule activity,84817,TXNDC17,NA,NA,ENSG00000129235
Q7Z4H8,0,6,2166792.53125,8.387536899855095e-6,0.9047896073478435,-0.14434573664035033,0.8727196410462039,1,raw,2773507.625,2010608.53125,1821779.53125,2509440.875,1557624.09375,2327794.53125,Protein O-glucosyltransferase 3 OS=Homo sapiens OX=9606 GN=POGLUT3 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,extracellular;nucleus,structural molecule activity,143888,POGLUT3,NA,NA,ENSG00000178202
Q96S82,0,6,471860.2395833333,1.8265455109338465e-6,0.9043830857501018,-0.1449940845898681,1,1,raw,477972.6875,NA,496931.375,NA,440676.65625,NA,Ubiquitin-like protein 7 OS=Homo sapiens OX=9606 GN=UBL7 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol,structural molecule activity,84993,UBL7,NA,NA,ENSG00000138629; ENSG00000288408
P55809,0,6,16857941.895833332,6.525618289137494e-5,0.9041937173773487,-0.14529620149504813,0.6298358975764108,1,raw,19009408.25,19165903.1875,13895287.4375,16338921.5,15408441.75,17329689.25,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=OXCT1 PE=1 SV=1",cellular homeostasis;coagulation;defense response;metabolic process,endosome,structural molecule activity,5019,OXCT1,NA,Utilization of Ketone Bodies,ENSG00000083720
Q9NRX1,0,6,3160522.2864583335,1.2234211129198837e-5,0.9040471517069287,-0.14553007472505597,0.4357682750377419,0.919218088383844,raw,3963859.6875,3347397.375,2702118.28125,3131898.125,2791655.1875,3026205.0625,RNA-binding protein PNO1 OS=Homo sapiens OX=9606 GN=PNO1 PE=1 SV=1,NA,cytosol;membrane,NA,56902,PNO1,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000115946
Q9Y6K5,0,6,12209377.140625,4.7261839707450986e-5,0.9039073398350993,-0.14575320633095804,0.4870903147028578,0.9696450818929633,raw,10797309.34375,15246133.5625,13207555.28125,13781092.03125,7690775.375,12533397.25,2'-5'-oligoadenylate synthase 3 OS=Homo sapiens OX=9606 GN=OAS3 PE=1 SV=3,cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,4940,OAS3,Measles virus infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction,OAS antiviral response; Interferon gamma signaling; Interferon alpha/beta signaling,ENSG00000111331
Q9Y478,0.16666666666666666,6,712805.234375,2.7592305767646032e-6,0.90309326268729,-0.14705311197776674,1,1,raw,392539.875,931990.625,802215.25,724475.1875,NA,NA,5'-AMP-activated protein kinase subunit beta-1 OS=Homo sapiens OX=9606 GN=PRKAB1 PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytosol;membrane;nucleus,signal transducer activity;structural molecule activity,5564,PRKAB1,AMP-activated protein kinase signaling; Target of rapamycin signaling; Energy metabolism; Sterol regulatory element-binding proteins (SREBP) signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; Angiopoietin-like protein 8 regulatory pathway; Leptin and adiponectin; Lipid metabolism pathway; Thermogenesis; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Hippo signaling regulation pathways; 1q21.1 copy number variation syndrome; Autophagy; p53 transcriptional gene network; Malignant pleural mesothelioma,Translocation of SLC2A4 (GLUT4) to the plasma membrane; Activation of AMPK downstream of NMDARs; Regulation of TP53 Activity through Phosphorylation; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; Activation of PPARGC1A (PGC-1alpha) by phosphorylation; Lipophagy,ENSG00000111725
O43414,0,6,1336007.3125,5.171612173503973e-6,0.9028122109619567,-0.14750216309318945,1,1,raw,NA,1428566.8125,NA,1607053.625,972401.5,NA,ERI1 exoribonuclease 3 OS=Homo sapiens OX=9606 GN=ERI3 PE=1 SV=2,cellular component movement;cellular homeostasis,NA,structural molecule activity,79033,ERI3,NA,NA,ENSG00000117419
Q8IYM0,0.5,6,1592523.5833333333,6.164572808173784e-6,0.9027436844090432,-0.14761167276648016,0.4350822888872953,0.9187171423798299,raw,1970883.25,1551693.875,1500933.375,1354958.125,1442716.25,1733956.625,Protein FAM186B OS=Homo sapiens OX=9606 GN=FAM186B PE=2 SV=2,NA,nucleus,NA,84070,FAM186B,IL-18 signaling pathway,NA,ENSG00000135436
Q96F24,0,6,256441.42708333334,9.926709185544957e-7,0.9026724437942524,-0.14772552849216727,1,1,raw,NA,NA,274235.1875,240415.90625,254673.1875,NA,Nuclear receptor-binding factor 2 OS=Homo sapiens OX=9606 GN=NRBF2 PE=1 SV=1,cellular homeostasis;coagulation;metabolic process,cytoskeleton;membrane;mitochondrion;nucleus,NA,29982,NRBF2,Alzheimer's disease and miRNA effects; Alzheimer's disease,NA,ENSG00000148572
O75449,0,6,480037.8385416667,1.8582005549798352e-6,0.9015385620745977,-0.14953889260972078,0.6476276281078156,1,raw,387824.578125,629007.375,490447.21875,545916.65625,477392.390625,349638.8125,Katanin p60 ATPase-containing subunit A1 OS=Homo sapiens OX=9606 GN=KATNA1 PE=1 SV=1,cell differentiation;cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity;structural molecule activity,11104,KATNA1,NA,NA,ENSG00000186625
P06493,0,6,52718907.885416664,2.040720460458224e-4,0.9015156696573065,-0.14957552686765999,0.3213688217960056,0.8027885809803746,raw,53108372.125,65413449.9375,53615933.375,58971250.125,35338947.65625,49865494.09375,Cyclin-dependent kinase 1 OS=Homo sapiens OX=9606 GN=CDK1 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;endosome;extracellular;membrane;nucleus,signal transducer activity;structural molecule activity,983,CDK1,miRNA regulation of DNA damage response; Cell cycle; Microtubule cytoskeleton regulation; Spinal cord injury; Retinoblastoma gene in cancer; ATM signaling pathway; PPAR-alpha pathway; Nuclear receptors meta-pathway; TGF-beta signaling pathway; ATM signaling in development and disease ; G1 to S cell cycle control; Cohesin complex - Cornelia de Lange syndrome; DNA damage response,"Cdc20:Phospho-APC/C mediated degradation of Cyclin A; MAPK6/MAPK4 signaling; The role of GTSE1 in G2/M progression after G2 checkpoint; Resolution of Sister Chromatid Cohesion; Recruitment of NuMA to mitotic centrosomes; Nuclear Pore Complex (NPC) Disassembly; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Regulation of TP53 Degradation; APC/C:Cdc20 mediated degradation of Cyclin B; Phosphorylation of the APC/C; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest; Transcriptional regulation by RUNX2; Ovarian tumor domain proteases; MASTL Facilitates Mitotic Progression; E2F-enabled inhibition of pre-replication complex formation; MAPK3 (ERK1) activation; Golgi Cisternae Pericentriolar Stack Reorganization; Condensation of Prophase Chromosomes; G1/S-Specific Transcription; Initiation of Nuclear Envelope (NE) Reformation; Condensation of Prometaphase Chromosomes; Activation of NIMA Kinases NEK9, NEK6, NEK7; G2/M DNA replication checkpoint; Depolymerisation of the Nuclear Lamina; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1; Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes; Phosphorylation of Emi1",ENSG00000170312
Q86WJ1,0,6,1109756.015625,4.29580561897225e-6,0.9011394582661814,-0.1501777034102217,0.7559813948488117,1,raw,710133.25,NA,1718495.625,1245013.375,NA,765381.8125,Chromodomain-helicase-DNA-binding protein 1-like OS=Homo sapiens OX=9606 GN=CHD1L PE=1 SV=3,cell growth;cell proliferation;cellular homeostasis;coagulation,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,9557,CHD1L,1q21.1 copy number variation syndrome; Nucleotide excision repair in xeroderma pigmentosum,Formation of Incision Complex in GG-NER; Dual Incision in GG-NER,ENSG00000131778
Q9NX40,0,6,21092215.588541668,8.164682774060217e-5,0.9009593577916059,-0.15046606724474804,0.8528252432421183,1,raw,21585322.03125,19231398.625,23809080.125,28364466.125,14115528.75,19447497.875,OCIA domain-containing protein 1 OS=Homo sapiens OX=9606 GN=OCIAD1 PE=1 SV=1,conjugation;metabolic process,extracellular;mitochondrion,NA,54940,OCIAD1,NA,NA,ENSG00000109180
A0A0U1RQK7,0,6,2936068.875,1.1365364092044305e-5,0.9007235289717765,-0.15084374643936005,0.4534880645838694,0.9360322690576942,raw,3075993.359375,3474071.3125,2684704.921875,3247673.09375,2363350.96875,2770619.59375,Eukaryotic translation initiation factor 4 gamma 3 OS=Homo sapiens OX=9606 GN=EIF4G3 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q9Y6K9,0,6,1784306.5260416667,6.906954224728218e-6,0.9005956271865192,-0.1510486221505752,0.7997656178658755,1,raw,1791892.6875,1973984.75,1680935.1875,2159488.875,1613770.71875,1485766.9375,NF-kappa-B essential modulator OS=Homo sapiens OX=9606 GN=IKBKG PE=1 SV=2,cell growth;coagulation;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;structural molecule activity,8517,IKBKG,Nucleotide-binding oligomerization domain (NOD) pathway; MicroRNAs in cardiomyocyte hypertrophy; IL-1 signaling pathway; RANKL/RANK signaling pathway; Leptin signaling pathway; IL-17 signaling pathway; B cell receptor signaling pathway; TNF-alpha signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis; Ebstein-Barr virus LMP1 signaling; Cardiac hypertrophic response; Nod-like receptor (NLR) signaling pathway; RAC1/PAK1/p38/MMP2 pathway; MAPK signaling pathway; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; Toll-like receptor signaling related to MyD88; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; ATM signaling in development and disease ; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Fibrin complement receptor 3 signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Pancreatic adenocarcinoma pathway; miRNAs involvement in the immune response in sepsis; Supression of HMGB1 mediated inflammation by THBD; Altered glycosylation of MUC1 in tumor microenvironment; Resistin as a regulator of inflammation; Vitamin D in inflammatory diseases; Canonical NF-kB pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Small cell lung cancer; Hepatitis B infection; Host-pathogen interaction of human coronaviruses - interferon induction; STING pathway in Kawasaki-like disease and COVID-19; Modulators of TCR signaling and T cell activation; CCL18 signaling pathway; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Network map of SARS-CoV-2 signaling pathway; T-cell receptor signaling pathway; Estrogen signaling pathway; Toll-like receptor signaling pathway,"ER-Phagosome pathway; FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; CLEC7A (Dectin-1) signaling; Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; IKK complex recruitment mediated by RIP1; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; TAK1-dependent IKK and NF-kappa-B activation  ; Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway; MAP3K8 (TPL2)-dependent MAPK1/3 activation; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; Regulation of NF-kappa B signaling; activated TAK1 mediates p38 MAPK activation; Ovarian tumor domain proteases; RIP-mediated NFkB activation via ZBP1; IKBKB deficiency causes SCID; IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR); IkBA variant leads to EDA-ID; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; SUMOylation of immune response proteins",ENSG00000269335
Q15126,0,6,3515171.4375,1.3607038844803075e-5,0.9005508961489744,-0.15112028011422984,0.9547648498875048,1,raw,3103108.625,5066721.75,2471820.8125,4562840.8125,2122348.8125,3764187.8125,Phosphomevalonate kinase OS=Homo sapiens OX=9606 GN=PMVK PE=1 SV=3,cellular homeostasis;metabolic process,cytosol;mitochondrion,signal transducer activity;structural molecule activity,10654,PMVK,Cholesterol biosynthesis pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,ENSG00000163344
Q6NW29,0,6,1050310.2734375,4.065694360535666e-6,0.9002857622697558,-0.15154509080841022,0.8601665881842644,1,raw,1106369.125,1103902.25,NA,1486637.875,504331.84375,NA,RWD domain-containing protein 4 OS=Homo sapiens OX=9606 GN=RWDD4 PE=1 SV=3,NA,NA,NA,201965,RWDD4,NA,NA,ENSG00000182552
Q13257,0,6,10427381.875,4.036383224700702e-5,0.9002665156406715,-0.15157593358556856,0.4233411803870476,0.9086347256931654,raw,8952101.25,15740158.25,9812933.5,9767367.5,8059277,10232453.75,Mitotic spindle assembly checkpoint protein MAD2A OS=Homo sapiens OX=9606 GN=MAD2L1 PE=1 SV=1,cell differentiation;cell growth;development;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,4085,MAD2L1,Regulation of sister chromatid separation at the metaphase-anaphase transition; Malignant pleural mesothelioma,Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of mitotic proteins; APC-Cdc20 mediated degradation of Nek2A,ENSG00000164109
Q8N5U6,0,6,600613.11328125,2.3249409334437556e-6,0.9001519567968185,-0.1517595280983665,1,1,raw,589767.046875,619584,635381.65625,NA,NA,557719.75,RING finger protein 10 OS=Homo sapiens OX=9606 GN=RNF10 PE=1 SV=2,cell death;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,9921,RNF10,NA,NA,ENSG00000022840
Q9H3Z4,0,6,4559732.6875,1.7650479046011198e-5,0.8998521931654837,-0.15224004644425207,0.505918914873666,0.989873157379785,raw,3825009.1875,5673586.09375,5014331,5278848.5625,4124678.375,3441942.90625,DnaJ homolog subfamily C member 5 OS=Homo sapiens OX=9606 GN=DNAJC5 PE=1 SV=1,cell death;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,80331,DNAJC5,NA,"Sensory processing of sound by inner hair cells of the cochlea; Neutrophil degranulation; GABA synthesis, release, reuptake and degradation",ENSG00000101152
Q96K37,0,6,1225258.3125,4.742908774020602e-6,0.8997941561187697,-0.1523330977924178,0.7905173261592771,1,raw,1071255.78125,1640290.4375,1077253.875,1248447.15625,1475923.75,838378.875,Solute carrier family 35 member E1 OS=Homo sapiens OX=9606 GN=SLC35E1 PE=1 SV=2,conjugation,cytoskeleton;extracellular,catalytic activity,79939,SLC35E1,NA,NA,ENSG00000127526
Q9NTJ3,0,6,14577755.536458334,5.642970460516313e-5,0.8996909587708223,-0.15249856990557717,0.43198967122747484,0.9163220476577977,raw,15012488.96875,18708278.125,12779069.59375,15450116,11497213.375,14019367.15625,Structural maintenance of chromosomes protein 4 OS=Homo sapiens OX=9606 GN=SMC4 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,10051,SMC4,Ciliary landscape,Condensation of Prophase Chromosomes; Condensation of Prometaphase Chromosomes,ENSG00000113810
Q8NEZ2,0,6,476733.1145833333,1.8454081469644883e-6,0.8996704902167976,-0.15253139252873996,0.918787114835059,1,raw,163997.71875,793386.09375,506747.09375,629864,455905.40625,310498.375,Vacuolar protein sorting-associated protein 37A OS=Homo sapiens OX=9606 GN=VPS37A PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,NA,137492,VPS37A,7q11.23 copy number variation syndrome,Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy,ENSG00000155975
Q15645,0,6,7182397.96875,2.7802674747813334e-5,0.8990759241004058,-0.15348514299852456,0.43728302314768186,0.9206301785457761,raw,7006051.65625,8851820.0625,6726615.34375,7005731.09375,6047737.90625,7456431.75,Pachytene checkpoint protein 2 homolog OS=Homo sapiens OX=9606 GN=TRIP13 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,structural molecule activity,9319,TRIP13,Male infertility,NA,ENSG00000071539
Q9UNE7,0,6,9314421.2734375,3.605562184889145e-5,0.8989461998308435,-0.1536933190361988,0.48450100799443846,0.9669461418389712,raw,7983449.734375,9943180.25,11634970.96875,7293873.0625,8571840.6875,10459212.9375,E3 ubiquitin-protein ligase CHIP OS=Homo sapiens OX=9606 GN=STUB1 PE=1 SV=2,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,10273,STUB1,Androgen receptor signaling pathway; Parkin-ubiquitin proteasomal system pathway,Antigen processing: Ubiquitination & Proteasome degradation; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Regulation of necroptotic cell death; Downregulation of ERBB2 signaling; Regulation of TNFR1 signaling; Downregulation of TGF-beta receptor signaling,ENSG00000103266
K7ELE3,0.16666666666666666,6,560229.4869791666,2.1686180964053246e-6,0.8982524261967358,-0.15480716790815904,0.9941402650378877,1,raw,552900.46875,296708.75,828170.03125,261962.578125,924990.90625,496644.1875,TLE family member 5 (Fragment) OS=Homo sapiens OX=9606 GN=TLE5 PE=1 SV=1,cell death;development;metabolic process,membrane,NA,NA,TLE5,Ectoderm differentiation,NA,ENSG00000104964
O14521,0,6,2865581.6354166665,1.1092511793336652e-5,0.8976318639321197,-0.15580420557063934,0.32856944405546423,0.810793084229206,raw,3166316.6875,2756035.125,3310161.5625,3095699.8125,2842186.75,2023089.875,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial OS=Homo sapiens OX=9606 GN=SDHD PE=1 SV=1",cellular homeostasis;coagulation;metabolic process,cytoskeleton;endosome,structural molecule activity,6392,SDHD,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Mitochondrial complex II assembly; TCA cycle (aka Krebs or citric acid cycle),Respiratory electron transport; Citric acid cycle (TCA cycle),ENSG00000204370
O95714,0,6,6616421.78125,2.5611811483965466e-05,0.8972046222328319,-0.15649104194511304,0.9322555476980112,1,raw,8862906.109375,4312608.640625,6333589.875,10820827.34375,3869292.40625,5499306.3125,E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;conjugation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;structural molecule activity,8924,HERC2,Prader-Willi and Angelman syndrome,Antigen processing: Ubiquitination & Proteasome degradation; SUMOylation of DNA damage response and repair proteins; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ),ENSG00000128731
H3BMD8,0,6,4400224.34375,1.703303085946697e-5,0.8938619199169533,-0.1618761078150504,0.9235711853384588,1,raw,5380102.5,5535119.5625,2606832,7161339.25,908884,4809068.75,cAMP-regulated phosphoprotein 19 OS=Homo sapiens OX=9606 GN=ARPP19 PE=1 SV=1,cell differentiation;metabolic process,nucleus,DNA binding,10776,ARPP19,NA,NA,ENSG00000128989
Q13162,0,6,57204286.174479164,2.2143470322999557e-4,0.893729725108555,-0.16208948629596456,0.44672803876570205,0.9279078826673519,raw,65452435.125,61384224.890625,55718257.4375,66072377.125,39737516.03125,54860906.4375,Peroxiredoxin-4 OS=Homo sapiens OX=9606 GN=PRDX4 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cell surface;cytosol;extracellular;nucleus,structural molecule activity,10549,PRDX4,Selenium micronutrient network,Neutrophil degranulation,ENSG00000123131
P40938,0,6,13383147.5,5.1805441394842114e-5,0.8934913820709175,-0.16247428067768618,0.6853311719895623,1,raw,13743693.03125,15032314.78125,12582325.25,12279871.28125,10555536.09375,16105144.5625,Replication factor C subunit 3 OS=Homo sapiens OX=9606 GN=RFC3 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,5983,RFC3,"Gastric cancer network 2; Retinoblastoma gene in cancer; DNA replication; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Regulation of TP53 Activity through Phosphorylation; Activation of ATR in response to replication stress; Processing of DNA double-strand break ends; Presynaptic phase of homologous DNA pairing and strand exchange; G2/M DNA damage checkpoint; Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; HDR through Single Strand Annealing (SSA); Impaired BRCA2 binding to RAD51; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER,ENSG00000133119
Q96JP5,0.16666666666666666,6,1649865.1067708333,6.386538749439273e-6,0.8929833895925926,-0.1632947548995065,0.6862520824935383,1,raw,1061250.96875,2505208.96875,1677682.171875,1485535.46875,1498142.3125,1671370.75,E3 ubiquitin-protein ligase ZFP91 OS=Homo sapiens OX=9606 GN=ZFP91 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development;metabolic process,membrane,structural molecule activity,80829,ZFP91,NA,NA,ENSG00000186660
P53803,0.16666666666666666,6,1831900.9583333333,7.091189702429313e-6,0.8929807433498245,-0.16329903014921412,0.8313484347727538,1,raw,1897715.375,1214418.125,2126769.5,3255308.25,1084452,1412742.5,"DNA-directed RNA polymerases I, II, and III subunit RPABC4 OS=Homo sapiens OX=9606 GN=POLR2K PE=1 SV=1",cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,5440,POLR2K,Pyrimidine metabolism; Eukaryotic transcription initiation; Cytosolic DNA-sensing pathway; 2q13 copy number variation syndrome,Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; B-WICH complex positively regulates rRNA expression; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; RNA Polymerase III Transcription Termination; Cytosolic sensors of pathogen-associated DNA ; RNA Polymerase III Chain Elongation; mRNA Splicing - Major Pathway; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,ENSG00000147669
Q9UL03,0,6,1085531.8072916667,4.202035016417885e-6,0.8906846724014438,-0.16701332765279078,0.5305422399685709,1,raw,1295631.65625,1087415.125,1019574.359375,1258774.5625,883251.15625,968543.984375,Integrator complex subunit 6 OS=Homo sapiens OX=9606 GN=INTS6 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane,structural molecule activity,26512,INTS6,NA,RNA polymerase II transcribes snRNA genes,ENSG00000102786
O75477,0,6,23763311.71875,9.198649664386259e-5,0.8904534193468989,-0.1673879506406462,0.4833365945773154,0.9651683200517861,raw,30375673.6875,23903951.96875,21315198.1875,27048122.5,18241717.65625,21695206.3125,Erlin-1 OS=Homo sapiens OX=9606 GN=ERLIN1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,10613,ERLIN1,NA,ABC-family proteins mediated transport; Defective CFTR causes cystic fibrosis,ENSG00000107566
P00761,0,6,265272680,0.001026856221781364,0.8901542933810376,-0.16787267004124648,0.9101539411234922,1,raw,249129936,310946336,250432000,405257056,152947632,222923120,CRAP Trypsin OS=Sus scrofa OX=9823 PE=1 SV=1,cell organization and biogenesis;metabolic process,cell surface,structural molecule activity,NA,NA,NA,NA,NA
Q06330,0,6,376786.171875,1.4585189280367133e-6,0.8901260670456128,-0.16791841788529216,0.6961127996548861,1,raw,NA,483528.6875,316980.5625,293417.375,NA,413218.0625,Recombining binding protein suppressor of hairless OS=Homo sapiens OX=9606 GN=RBPJ PE=1 SV=3,cell differentiation;cellular component movement;coagulation;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,3516,RBPJ,Neural crest differentiation; Notch signaling; Canonical and non-canonical Notch signaling; PTF1A related regulatory pathway; Epithelial to mesenchymal transition in colorectal cancer; Osteoblast differentiation and related diseases; Genetic causes of porto-sinusoidal vascular disease; Notch signaling pathway,Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH1 Intracellular Domain Regulates Transcription; Pre-NOTCH Transcription and Translation; Notch-HLH transcription pathway; NOTCH3 Intracellular Domain Regulates Transcription; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells; NOTCH2 intracellular domain regulates transcription; NOTCH4 Intracellular Domain Regulates Transcription; RUNX3 regulates NOTCH signaling,ENSG00000168214
Q08426,0,6,1579788.4479166667,6.115275786566311e-6,0.8896867728781965,-0.16863059111550643,0.4271828946692005,0.911332120317874,raw,1276705.84375,1702506.625,2129365.6875,1562399.96875,1514697.625,1293054.9375,Peroxisomal bifunctional enzyme OS=Homo sapiens OX=9606 GN=EHHADH PE=1 SV=3,cellular homeostasis,cytosol;mitochondrion,structural molecule activity,1962,EHHADH,Constitutive androstane receptor pathway; PPAR-alpha pathway; Nuclear receptors meta-pathway; Mitochondrial long chain fatty acid beta-oxidation; Valproic acid pathway; Amino acid metabolism; PPAR signaling pathway; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX),Peroxisomal protein import; Beta-oxidation of very long chain fatty acids,ENSG00000113790
Q9Y371,0,6,8095307.098958333,3.1336496701417605e-5,0.8893363570123887,-0.16919892913190857,0.5991924092009817,1,raw,9342975.125,9080907.5625,6925769.53125,9234013,5912196.125,8075981.25,Endophilin-B1 OS=Homo sapiens OX=9606 GN=SH3GLB1 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;metabolic process,cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,51100,SH3GLB1,Nanoparticle triggered autophagic cell death,NA,ENSG00000097033
P01034,0,6,529296.675,2.048878851346239e-6,0.8889718796411042,-0.16979031108987638,0.7431826334041356,1,raw,NA,623939.4375,482420.71875,414761.125,442955.78125,682406.3125,Cystatin-C OS=Homo sapiens OX=9606 GN=CST3 PE=1 SV=1,cell growth;coagulation;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;nucleus,DNA binding;structural molecule activity,1471,CST3,NA,Amyloid fiber formation; Neutrophil degranulation; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,ENSG00000101439
H3BR70,0,6,26997078.192708332,1.0450423206830243e-4,0.8887808492832555,-0.1701003638283752,0.6946103991664384,1,raw,28895396.3125,28931209.3125,25718400.625,25681674.875,20017359.5,32738428.53125,Pyruvate kinase OS=Homo sapiens OX=9606 GN=PKM PE=1 SV=1,cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,NA,NA,NA,NA
O15439,0,6,1772097.6796875,6.859694439666489e-6,0.8886545484368473,-0.17030539362052807,0.5446381060507723,1,raw,2193241.8125,1645381.46875,1784318.265625,1902467.46875,1158142.75,1949034.3125,Multidrug resistance-associated protein 4 OS=Homo sapiens OX=9606 GN=ABCC4 PE=1 SV=3,cell death;cell growth;cellular homeostasis;conjugation,cytoplasm;cytoskeleton;extracellular;membrane,catalytic activity;structural molecule activity,10257,ABCC4,Fluoropyrimidine activity; Drug induction of bile acid pathway; Ectoderm differentiation; Pregnane X receptor pathway; Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; TYROBP causal network in microglia; Aspirin and miRNAs; Proximal tubule transport; FOXA2 pathway; Prostaglandin synthesis and regulation,ABC-family proteins mediated transport; Paracetamol ADME; Platelet degranulation ; Azathioprine ADME,ENSG00000125257
P22492,0.16666666666666666,6,27433063.666666668,1.0619190829843821e-4,0.8879482502752591,-0.1714524962925873,0.5450362432113307,1,raw,35446604,34560104,18745162,24627052,19744710,31474750,Histone H1t OS=Homo sapiens OX=9606 GN=H1-6 PE=2 SV=4,cell growth;metabolic process,nucleus,RNA binding;structural molecule activity,3010,H1-6,NA,NA,ENSG00000187475
Q9Y5Y6,0,6,533557.4322916666,2.065372012777142e-6,0.8875276707178005,-0.17213599534320217,0.9201485604140138,1,raw,278734,867074.65625,489013.40625,769552.75,406177.59375,390792.1875,Suppressor of tumorigenicity 14 protein OS=Homo sapiens OX=9606 GN=ST14 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton,structural molecule activity,6768,ST14,NA,Formation of the cornified envelope,ENSG00000149418
O75955,0,6,2310712.125,8.94464187681101e-6,0.8871327422507778,-0.17277810280908282,0.16350865797056693,0.6638855679885327,raw,2375718.84375,2558633.53125,2620618.84375,2324836.78125,2280892.375,1703572.375,Flotillin-1 OS=Homo sapiens OX=9606 GN=FLOT1 PE=1 SV=3,cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,antioxidant activity;structural molecule activity,10211,FLOT1,Angiopoietin-like protein 8 regulatory pathway; Insulin signaling,RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; Regulation of necroptotic cell death; Synaptic adhesion-like molecules,ENSG00000137312; ENSG00000206379; ENSG00000206480; ENSG00000230143; ENSG00000232280
O14641,0,6,872217.65625,3.3763074549096853e-6,0.8869773508648876,-0.1730308293825506,0.7050304999440047,1,raw,445921.96875,1379085.8125,967572.125,NA,1008712.4375,559795.9375,Segment polarity protein dishevelled homolog DVL-2 OS=Homo sapiens OX=9606 GN=DVL2 PE=1 SV=1,cell death;cell differentiation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,1856,DVL2,Alzheimer's disease and miRNA effects; Neural crest differentiation; Notch signaling; Wnt signaling pathway; Regulation of Wnt / B-catenin signaling by small molecule compounds; Embryonic stem cell pluripotency pathways; Wnt signaling pathway and pluripotency; Wnt signaling in kidney disease; Type 2 papillary renal cell carcinoma; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Malignant pleural mesothelioma; Alzheimer's disease; DNA damage response (only ATM dependent),Asymmetric localization of PCP proteins; Degradation of DVL; RHO GTPases Activate Formins; Cargo recognition for clathrin-mediated endocytosis; WNT mediated activation of DVL; Disassembly of the destruction complex and recruitment of AXIN to the membrane; Negative regulation of TCF-dependent signaling by DVL-interacting proteins; WNT5:FZD7-mediated leishmania damping; Signaling by Hippo; WNT5A-dependent internalization of FZD4,ENSG00000004975
E9PLN8,0,6,2336468.25,9.044342446071398e-6,0.8866600006692241,-0.1735471012777029,0.6888945338660153,1,raw,2159216.75,2462500.25,1752839.625,4330346,1399415.75,1914491.125,VKc domain-containing protein (Fragment) OS=Homo sapiens OX=9606 PE=4 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation,extracellular,structural molecule activity,NA,NA,NA,NA,NA
E9PL57,0,6,11088286.25,4.2922157399341865e-5,0.8858227898207407,-0.17490998055144286,0.3673443196200794,0.8513844201444349,raw,11097643.21875,14308210.625,10169866.90625,10203900.125,9008699.875,11741396.75,NEDD8 (Fragment) OS=Homo sapiens OX=9606 GN=NEDD8-MDP1 PE=3 SV=1,NA,NA,structural molecule activity,NA,NEDD8-MDP1,NA,NA,ENSG00000255526
Q9UEE9,0,6,3530567.4895833335,1.3666636131160044e-5,0.8850964562320789,-0.1760934087935682,0.20053612494578837,0.6908116999475278,raw,3720920.75,4168420.71875,3700757.09375,3689454.40625,2488214.6875,3415637.28125,Craniofacial development protein 1 OS=Homo sapiens OX=9606 GN=CFDP1 PE=1 SV=1,cell communication;cell growth;metabolic process,membrane;nucleus,NA,10428,CFDP1,NA,NA,ENSG00000153774
Q9H0R4,0,6,568838.4375,2.201942879060386e-6,0.8848957973413709,-0.17642051710400333,0.8138087157400843,1,raw,418372.125,942412.375,433369.46875,480273.3125,304666.59375,833936.75,Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=HDHD2 PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,84064,HDHD2,NA,NA,ENSG00000167220
P07305,0,6,79551461.66666667,3.079394130003072e-4,0.884733069419399,-0.17668584592081282,0.19963288634281917,0.6903970652689163,raw,83698858,78902743,87938323,73149423,69807866,83811557,Histone H1.0 OS=Homo sapiens OX=9606 GN=H1-0 PE=1 SV=3,cell growth;metabolic process,endoplasmic reticulum;extracellular;membrane;nucleus,RNA binding;structural molecule activity,3005,H1-0,NA,Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF),ENSG00000189060
P17535,0,6,25304028.979166668,9.795052997313265e-5,0.883822431791207,-0.17817154711079036,0.8919611570889094,1,raw,28757482.1875,25011573.1875,23109423.3125,22105789.4375,19977281.5625,32862624.1875,Transcription factor jun-D OS=Homo sapiens OX=9606 GN=JUND PE=1 SV=3,cellular component movement;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,3727,JUND,Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; TGF-beta signaling pathway; MAPK signaling pathway; EGF/EGFR signaling pathway; Angiotensin II receptor type 1 pathway; Hypertrophy model,NGF-stimulated transcription; Estrogen-dependent gene expression,ENSG00000130522
P02786,0,6,92971567.734375,3.5988791901529575e-4,0.8837851576170411,-0.1782323923646267,0.7749627785260423,1,raw,74653923.25,144585360.65625,72243180.84375,102894835.3125,63847450.96875,99604655.375,Transferrin receptor protein 1 OS=Homo sapiens OX=9606 GN=TFRC PE=1 SV=2,coagulation;conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;endosome;membrane;mitochondrion;nucleus,RNA binding;structural molecule activity,7037,TFRC,Iron metabolism in placenta; Ferroptosis; 3q29 copy number variation syndrome,RHOC GTPase cycle; RND2 GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle; Golgi Associated Vesicle Biogenesis; RND1 GTPase cycle; Cargo recognition for clathrin-mediated endocytosis; Transferrin endocytosis and recycling; RHOH GTPase cycle,ENSG00000072274
C9JRZ6,0,6,39212363.486979164,1.5178894191952573e-4,0.8837759862194133,-0.1782473638748592,0.7771438879310755,1,raw,37022371.875,40896952.75,42166932.25,47819000.78125,31225178.515625,36143744.75,MICOS complex subunit MIC19 OS=Homo sapiens OX=9606 GN=CHCHD3 PE=1 SV=2,NA,cytoskeleton;endosome,NA,54927,CHCHD3,NA,NA,ENSG00000106554
F8VX04,0,6,6486912.635416667,2.511048857285171e-5,0.8833943885332027,-0.17887042671694048,0.2618306658231519,0.7434453518424705,raw,6775981.25,7432533.0625,6226572.75,6565858,5454167.875,6466362.875,Sodium-coupled neutral amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC38A1 PE=1 SV=1,NA,cytoskeleton,NA,81539,SLC38A1,Synaptic vesicle pathway; Ferroptosis; Neuroinflammation and glutamatergic signaling,NA,ENSG00000111371
P22087,0,6,123647509.107422,4.786328318269493e-4,0.8831393232423611,-0.1792870408243355,0.704951504142639,1,raw,112722973.292969,127823691.09375,144465942.0625,156891365.945313,87094954.203125,112886128.046875,rRNA 2'-O-methyltransferase fibrillarin OS=Homo sapiens OX=9606 GN=FBL PE=1 SV=2,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,2091,FBL,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000105202; ENSG00000280548
M0R2Z9,0,6,2419552.84375,9.365958422606804e-6,0.8824687607139893,-0.1803828868272991,0.5793043988941127,1,raw,3000585.59375,3244152.25,1603786.859375,1484654.5,2321274.84375,2862863.015625,SURP and G-patch domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUGP2 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding,10147,SUGP2,mRNA processing,NA,ENSG00000064607
Q5RKV6,0,6,7322519.828125,2.834507890004941e-5,0.88143925362311,-0.18206694850302194,0.39388717086095304,0.8771698202096033,raw,9627448.40625,7994337.8125,6590291.0625,8486010.9375,4167173.5625,7069857.1875,Exosome complex component MTR3 OS=Homo sapiens OX=9606 GN=EXOSC6 PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis;defense response;metabolic process,cytosol;membrane;mitochondrion;nucleus,NA,118460,EXOSC6,NA,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000223496
O14672,0,6,12412536.416666666,4.804825829611222e-5,0.88023598582577,-0.1840377416607667,0.8505242670258875,1,raw,14245529.8125,10818838.125,13065731.765625,17024465.1875,7819726.328125,11500927.28125,Disintegrin and metalloproteinase domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ADAM10 PE=1 SV=1,cell death;cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,antioxidant activity;structural molecule activity,102,ADAM10,Alzheimer's disease and miRNA effects; Copper homeostasis; Canonical and non-canonical Notch signaling; VEGFA-VEGFR2 signaling pathway; 3q29 copy number variation syndrome; Interactions of natural killer cells in pancreatic cancer; Alzheimer's disease; Hypertrophy model,Amyloid fiber formation; Collagen degradation; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; NOTCH3 Activation and Transmission of Signal to the Nucleus; Neutrophil degranulation; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant; Signaling by EGFR; EPH-ephrin mediated repulsion of cells; NOTCH4 Activation and Transmission of Signal to the Nucleus,ENSG00000137845
P78345,0,6,2690623.5416666665,1.0415258458699271e-5,0.8802270214863479,-0.1840524341683349,0.8076568180925818,1,raw,2345024.9375,3267681.4375,2800417.75,4008540.875,1257072.875,2465003.375,Ribonuclease P protein subunit p38 OS=Homo sapiens OX=9606 GN=RPP38 PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,10557,RPP38,Sphingolipid metabolism in senescence,tRNA processing in the nucleus; Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000152464
Q13426,0,6,7906228.5625,3.0604583895441675e-5,0.8799496747985038,-0.18450707794962745,0.5772229616230374,1,raw,8481723.09375,10559146.875,6181321.5,9074578,5439251.84375,7701350.0625,DNA repair protein XRCC4 OS=Homo sapiens OX=9606 GN=XRCC4 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,7518,XRCC4,"Non-homologous end joining; Male infertility; DNA repair pathways, full network",SUMOylation of DNA damage response and repair proteins; Nonhomologous End-Joining (NHEJ); 2-LTR circle formation,ENSG00000152422
Q9BZL4,0,6,539748.4453125,2.089337089918038e-6,0.8794484753506772,-0.18532903854720337,1,1,raw,148533.96875,1492855.0625,275402.46875,NA,242202.28125,NA,Protein phosphatase 1 regulatory subunit 12C OS=Homo sapiens OX=9606 GN=PPP1R12C PE=1 SV=1,development,endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,54776,PPP1R12C,Focal adhesion,NA,ENSG00000125503
Q9H7E2,0,6,334585.7125,1.295163228266762e-6,0.8789574142940362,-0.18613482676001458,0.9702073375385367,1,raw,320173.8125,NA,342849.0625,565722,153140.0625,291043.625,Tudor domain-containing protein 3 OS=Homo sapiens OX=9606 GN=TDRD3 PE=1 SV=1,cell growth;cell proliferation;cellular component movement;cellular homeostasis,cytosol;extracellular;membrane;nucleus,structural molecule activity,81550,TDRD3,NA,NA,ENSG00000083544
P61964,0,6,13323760.010416666,5.1575555629091104e-5,0.8788920135190247,-0.18624217767679963,0.7477285357639609,1,raw,13097617.25,14618952.25,13781097.75,17878109.375,8454686.6875,12112096.75,WD repeat-containing protein 5 OS=Homo sapiens OX=9606 GN=WDR5 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;defense response;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,11091,WDR5,Malignant pleural mesothelioma,Neddylation; Activation of anterior HOX genes in hindbrain development during early embryogenesis; RMTs methylate histone arginines; PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; HATs acetylate histones,ENSG00000196363
Q96GK7,0,6,9115251.015625,3.5284644534421816e-5,0.8785227054675153,-0.1868485216393937,0.8843380928036423,1,raw,11963166.1875,5452156.75,10439878.3125,10509913.125,7855915.53125,8470476.1875,Fumarylacetoacetate hydrolase domain-containing protein 2A OS=Homo sapiens OX=9606 GN=FAHD2A PE=1 SV=1,NA,NA,structural molecule activity,51011,FAHD2A,NA,NA,ENSG00000115042
O00469,0,6,961493.2604166666,3.7218884985053995e-6,0.8780092417894877,-0.18769196946193206,1,1,raw,433230.59375,1835745.375,NA,NA,NA,615503.8125,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 OS=Homo sapiens OX=9606 GN=PLOD2 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;coagulation,cytoskeleton;extracellular,structural molecule activity,5352,PLOD2,Clear cell renal cell carcinoma pathways; Type I collagen synthesis in the context of osteogenesis imperfecta,Collagen biosynthesis and modifying enzymes,ENSG00000152952
A0A494C0W0,0,6,13479769.354166666,5.217945937555197e-5,0.8777035691436573,-0.18819432088522228,0.4450548593140012,0.9271939562980955,raw,13670565,14564474,14629590.625,12783290.8125,9655832.125,15574863.5625,Poly(A)-specific ribonuclease PARN OS=Homo sapiens OX=9606 GN=PARN PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,NA,PARN,Lung fibrosis,NA,ENSG00000140694
P23229,0,6,32877299.208333332,1.272662501371969e-4,0.8770814425547228,-0.18921728264553164,0.39469927677317984,0.8773167604394403,raw,32344714.0625,39042216.3125,31603010.8125,33985608.125,27718414.3125,32569831.625,Integrin alpha-6 OS=Homo sapiens OX=9606 GN=ITGA6 PE=1 SV=5,cell communication;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;structural molecule activity,3655,ITGA6,Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; Alpha 6 beta 4 signaling pathway; Mammary gland development pathway - Embryonic development (Stage 1 of 4); Focal adhesion; Regulation of apoptosis by parathyroid hormone-related protein; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Small cell lung cancer; Malignant pleural mesothelioma; GDNF signaling,Assembly of collagen fibrils and other multimeric structures; Integrin cell surface interactions; Syndecan interactions; Laminin interactions; Basigin interactions; Type I hemidesmosome assembly,ENSG00000091409
Q9UHB7,0.16666666666666666,6,786350.0364583334,3.043918534827039e-6,0.8767507758579083,-0.189761292733071,0.5911630336111351,1,raw,657348.9375,1014592.59375,821879.34375,889544.84375,516708.3125,818026.1875,AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1,metabolic process,membrane;nucleus,NA,27125,AFF4,NA,Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,ENSG00000072364
Q96FN4,0,6,1846857,7.149083732220236e-6,0.8766195450528705,-0.1899772494305643,0.8034191744873653,1,raw,1831216.90625,1980566.15625,1446937.5625,1605280.53125,1016451.40625,3200689.4375,Copine-2 OS=Homo sapiens OX=9606 GN=CPNE2 PE=1 SV=3,metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,221184,CPNE2,NA,NA,ENSG00000140848
A0A2R8Y851,0,6,26524042.166666668,1.0267313515147099e-4,0.8765976280528526,-0.19001331974486851,0.5420969831133049,1,raw,21993182.53125,32292266.75,29599829.28125,27911747,28307324.4375,19039903,40S ribosomal protein S29 OS=Homo sapiens OX=9606 GN=RPS29 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,Golgi,RNA binding;structural molecule activity,NA,RPS29,NA,NA,ENSG00000213741
Q7LBC6,0,6,16194998.041666666,6.268996302530068e-5,0.87550108113552,-0.19181913467754094,0.6496769088581595,1,raw,13375375.6875,15210268.25,15808459.296875,12976873.546875,11710155.875,28088855.59375,Lysine-specific demethylase 3B OS=Homo sapiens OX=9606 GN=KDM3B PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,51780,KDM3B,Thermogenesis,HDMs demethylate histones,ENSG00000120733
A0A2R8Y7R9,0,6,2215939.3619791665,8.577781628091264e-6,0.8754932465957626,-0.19183204488687386,0.4677370384133492,0.9487880408298386,raw,2438798.390625,2832258.40625,1863513.875,1631493.8125,2611981.875,1917589.8125,Liprin-alpha-1 (Fragment) OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1,NA,cytosol;nucleus,NA,NA,PPFIA1,NA,NA,ENSG00000131626
Q96G21,0,6,8190787.205729167,3.1706095039602976e-5,0.875488650282532,-0.1918396190123585,0.6203193723127408,1,raw,7839114.65625,9668980.75,8279830.28125,10333548.15625,5774351.953125,7248897.4375,U3 small nucleolar ribonucleoprotein protein IMP4 OS=Homo sapiens OX=9606 GN=IMP4 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,92856,IMP4,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000136718
Q15286,0,6,16029870.4375,6.205076298507645e-5,0.87513991632954935,-0.19241440313368274,0.6569242129531697,1,raw,16008297.75,20739443.75,13838069.375,20754351.375,12728813.5,12110246.875,Ras-related protein Rab-35 OS=Homo sapiens OX=9606 GN=RAB35 PE=1 SV=1,cell differentiation;cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,11021,RAB35,NA,RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; TBC/RABGAPs,ENSG00000111737
P40429,0,6,155453844.07291666,6.017534372031995e-4,0.8747784460056478,-0.19301042116785264,0.3561125126524447,0.8403332772639565,raw,169449701,189989346.8125,137880610.5,162541357.125,120614986.1875,152247062.8125,60S ribosomal protein L13a OS=Homo sapiens OX=9606 GN=RPL13A PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;Golgi;nucleus,RNA binding;structural molecule activity,23521,RPL13A,VEGFA-VEGFR2 signaling pathway; Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000142541
Q8TB61,0,6,4535436.265625,1.7556428908735967e-5,0.8744253764362879,-0.19359282525042637,0.6736785227833073,1,raw,4713534.1875,5106767.25,4294191.125,3339938.375,4121633.90625,5636552.75,Adenosine 3'-phospho 5'-phosphosulfate transporter 1 OS=Homo sapiens OX=9606 GN=SLC35B2 PE=1 SV=1,cellular homeostasis;conjugation,cytoskeleton;extracellular,catalytic activity,347734,SLC35B2,Proteoglycan biosynthesis,Transport and synthesis of PAPS; Transport of nucleotide sugars,ENSG00000157593
Q9H8M5,0.16666666666666666,6,1235309.1770833333,4.781815128160342e-6,0.8744007454244299,-0.19363346398313716,0.5542711312654901,1,raw,1068384.625,2071944.25,967897.125,1506237.875,863194.875,934196.3125,Metal transporter CNNM2 OS=Homo sapiens OX=9606 GN=CNNM2 PE=1 SV=2,conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity;structural molecule activity,54805,CNNM2,NA,NA,ENSG00000148842
Q8ND24,0,6,1185676.4947916667,4.5896896947576426e-6,0.8736455118723339,-0.19488008061421064,0.950306038332067,1,raw,880506.71875,1855319.1875,867699.1875,518201.71875,1620891.28125,1371440.875,RING finger protein 214 OS=Homo sapiens OX=9606 GN=RNF214 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,257160,RNF214,NA,NA,ENSG00000167257
Q96AJ9,0,6,3088770.9192708335,1.1956465460787738e-5,0.8733145539414514,-0.19542671173724868,0.6469372667382647,1,raw,3689319.5625,4440905.25,1839919.8125,3878307.1875,2072063.078125,2612110.625,Vesicle transport through interaction with t-SNAREs homolog 1A OS=Homo sapiens OX=9606 GN=VTI1A PE=1 SV=2,cell growth;cellular homeostasis;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,143187,VTI1A,NA,Intra-Golgi traffic; Retrograde transport at the Trans-Golgi-Network,ENSG00000151532
O00115,0,6,9390910.15625,3.635170618450084e-5,0.8728444664948369,-0.19620349419115082,0.9213824649954439,1,raw,10375958.125,9338458.125,8798550.9375,13171687.75,6509784.5,8151021.5,Deoxyribonuclease-2-alpha OS=Homo sapiens OX=9606 GN=DNASE2 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;metabolic process,mitochondrion,RNA binding;structural molecule activity,1777,DNASE2,NA,Lysosome Vesicle Biogenesis,ENSG00000105612
P23919,0,6,15815548.677083334,6.122113502208007e-5,0.8725474831954145,-0.19669445135124827,0.3950529382651162,0.8778262927434315,raw,15361276.1875,19504421.3125,15529875.75,13550554,13022225.4375,17924939.375,Thymidylate kinase OS=Homo sapiens OX=9606 GN=DTYMK PE=1 SV=4,cellular homeostasis;metabolic process,cytosol;endosome;membrane;nucleus,signal transducer activity;structural molecule activity,1841,DTYMK,Pyrimidine metabolism; 2q37 copy number variation syndrome,Interconversion of nucleotide di- and triphosphates,ENSG00000168393
Q9BU23,0,6,697013.1875,2.698100415949488e-6,0.8724553208769783,-0.19684684322085227,1,1,raw,552290.4375,710741.625,904930.375,NA,620090.3125,NA,Lipase maturation factor 2 OS=Homo sapiens OX=9606 GN=LMF2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,NA,91289,LMF2,NA,Assembly of active LPL and LIPC lipase complexes,ENSG00000100258
J3KQR7,0,6,38924472.833333336,1.5067453274294213e-4,0.872061015069956,-0.19749901600977976,0.3661973105769416,0.8498427717501061,raw,35819211,49430914,40291292,29350957,35136465,43517998,Centrosomal protein of 170 kDa protein B OS=Homo sapiens OX=9606 GN=CEP170B PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q6UXH1,0,6,4356563.114583333,1.6864020598702783e-5,0.8720462404963053,-0.197523458548012,0.8785040396607477,1,raw,3902174.8125,5215239.59375,3616627.46875,3402876.875,3070793.5,6931666.4375,Protein disulfide isomerase CRELD2 OS=Homo sapiens OX=9606 GN=CRELD2 PE=1 SV=1,NA,cell surface;extracellular,structural molecule activity,79174,CRELD2,NA,NA,ENSG00000184164
P04040,0,6,44266841.497395836,1.7135455339845166e-4,0.8712024331634566,-0.1989201115534441,0.5938853914753852,1,raw,59112952.15625,37711237.359375,43493805.78125,51499347.75,31316508.375,42467197.5625,Catalase OS=Homo sapiens OX=9606 GN=CAT PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;coagulation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,847,CAT,Selenium micronutrient network; Folate metabolism; Amyotrophic lateral sclerosis (ALS); Oxidative stress response; Tryptophan metabolism; Male infertility; Arsenic metabolism and reactive oxygen species generation; DNA damage response (only ATM dependent),"Neutrophil degranulation; Peroxisomal protein import; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Detoxification of Reactive Oxygen Species",ENSG00000121691
Q8N4P3,0,6,573352.2875,2.2194157487003648e-6,0.8696326263019631,-0.20152202742799713,0.7453283663285208,1,raw,649079.25,340717.4375,NA,292138.875,300459.125,1284366.75,"Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 OS=Homo sapiens OX=9606 GN=HDDC3 PE=1 SV=3",NA,NA,structural molecule activity,374659,HDDC3,NA,NA,ENSG00000184508
P17480,0,6,17406710.858398434,6.738043791654556e-5,0.8681891750051348,-0.20391866039121312,0.5824067017262244,1,raw,20521471.1269531,19315382.71875,15069936.25,16769406.1875,12130055.2421875,20634013.625,Nucleolar transcription factor 1 OS=Homo sapiens OX=9606 GN=UBTF PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,7343,UBTF,Ectoderm differentiation,NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; RNA Polymerase I Promoter Opening,ENSG00000108312
Q9Y4W2,0,6,4578655.640625,1.77237287758774e-5,0.8676751780497289,-0.20477303692007415,0.4266807600987086,0.911332120317874,raw,3968066.6875,5750605.5,4840944.78125,4200367.625,3800098.6875,4911850.5625,Ribosomal biogenesis protein LAS1L OS=Homo sapiens OX=9606 GN=LAS1L PE=1 SV=2,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,81887,LAS1L,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000001497
Q5K651,0,6,943633.4765625,3.6527542394843746e-6,0.8675931345352446,-0.20490945821090678,0.8917042970740178,1,raw,1063728.1875,NA,918902.28125,1450148.75,341754.6875,NA,Sterile alpha motif domain-containing protein 9 OS=Homo sapiens OX=9606 GN=SAMD9 PE=1 SV=1,cell growth;conjugation,cytosol;nucleus,NA,54809,SAMD9,NA,NA,ENSG00000205413
Q9BWF3,0,6,29501886.458333332,1.1420020962591001e-4,0.8673592275959982,-0.2052984676046983,0.5602847361370098,1,raw,26746611.8125,38868251.75,27546175.8125,33116574.5,23198920.5625,27534784.3125,RNA-binding protein 4 OS=Homo sapiens OX=9606 GN=RBM4 PE=1 SV=1,cell death;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,5936,RBM4,NA,Circadian Clock,ENSG00000173933
Q9Y4P1,0,6,5412795.848958333,2.095264048576432e-5,0.8672282899097175,-0.20551627518040722,0.22864569349435954,0.7149130481267827,raw,5728558.375,6669399.15625,5271897.09375,5783891.625,3981250.34375,5041778.5,Cysteine protease ATG4B OS=Homo sapiens OX=9606 GN=ATG4B PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytosol;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,23192,ATG4B,2q37 copy number variation syndrome,Macroautophagy,ENSG00000168397
P52292,0,6,43374221.940104164,1.6789927128614112e-4,0.8671060790101252,-0.2057195959036032,0.34189852830546147,0.8247147020235626,raw,41009345.25,70860098.53125,37765553.6875,35559452.5625,32911332.171875,42139549.4375,Importin subunit alpha-1 OS=Homo sapiens OX=9606 GN=KPNA2 PE=1 SV=1,cell death;cell proliferation;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,3838,KPNA2,NA,ISG15 antiviral mechanism; NS1 Mediated Effects on Host Pathways; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Estrogen-dependent gene expression; SARS-CoV-1 activates/modulates innate immune responses; Sensing of DNA Double Strand Breaks; CaMK IV-mediated phosphorylation of CREB; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,ENSG00000182481
Q6P9B6,0,6,364254.9796875,1.4100113596581212e-6,0.8654729174964619,-0.20843941961071463,0.6408785547961057,1,raw,419045.46875,385462.5,NA,134038.640625,347533.2890625,535195,MTOR-associated protein MEAK7 OS=Homo sapiens OX=9606 GN=MEAK7 PE=1 SV=2,development;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,NA,57707,MEAK7,NA,NA,ENSG00000140950
Q96BK5,0,6,1170791.6171875,4.5320711372103945e-6,0.8652828837395584,-0.20875623005802574,0.4289535213160856,0.913727986982181,raw,1153535.03125,1800807.4375,948565.203125,820777.234375,1222871.3125,1078193.484375,PIN2/TERF1-interacting telomerase inhibitor 1 OS=Homo sapiens OX=9606 GN=PINX1 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular homeostasis;metabolic process,endoplasmic reticulum;endosome;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,54984,PINX1,NA,NA,ENSG00000254093
Q9H4B6,0.16666666666666666,6,291205.9375,1.1272424613855825e-6,0.8652777486680798,-0.2087647918408585,0.6079325717468047,1,raw,404063.03125,361839.28125,176487.078125,226492.765625,228726.71875,349626.75,Protein salvador homolog 1 OS=Homo sapiens OX=9606 GN=SAV1 PE=1 SV=2,cell differentiation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,60485,SAV1,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Yap signaling pathway; Hippo-Merlin signaling dysregulation; Leukocyte-intrinsic Hippo pathway functions; Malignant pleural mesothelioma,Signaling by Hippo,ENSG00000151748
P07858,0,6,76126953.72135417,2.946833276386942e-4,0.8647224331566534,-0.20969097782672846,0.42633862845811427,0.911043979658989,raw,85028370.25,82729310.59375,77126592.453125,89336659.875,51002898.40625,71537890.75,Cathepsin B OS=Homo sapiens OX=9606 GN=CTSB PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytoplasm;cytoskeleton;mitochondrion;nucleus,structural molecule activity,1508,CTSB,Ebola virus infection in host,MHC class II antigen presentation; Collagen degradation; Assembly of collagen fibrils and other multimeric structures; Neutrophil degranulation; Trafficking and processing of endosomal TLR,ENSG00000164733
Q9HBM6,0,6,689713.5625,2.6698439616929817e-6,0.8646715369620619,-0.2097758950738419,0.6594161019820808,1,raw,460158,1172025.375,NA,513879.3125,584525.0625,717980.0625,Transcription initiation factor TFIID subunit 9B OS=Homo sapiens OX=9606 GN=TAF9B PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,51616,TAF9B,NA,Ub-specific processing proteases; RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation,ENSG00000187325
P62312,0,6,26818256.208333332,1.0381202182167335e-4,0.864483689330649,-0.21008935085065986,0.5769567022304395,1,raw,26408649.5,33003927.5,26082975.5,34453028.5,18131109.5,22829846.75,U6 snRNA-associated Sm-like protein LSm6 OS=Homo sapiens OX=9606 GN=LSM6 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,11157,LSM6,NA,mRNA Splicing - Major Pathway; mRNA decay by 5' to 3' exoribonuclease,ENSG00000164167
O75391,0,6,3327505.421875,1.2880593830708709e-5,0.8641290262001154,-0.2106813524507748,0.4345478750357336,0.9181597060129082,raw,3665538.46875,4779838.34375,2515562.53125,3403995.96875,2432599.03125,3167498.1875,Sperm-associated antigen 7 OS=Homo sapiens OX=9606 GN=SPAG7 PE=1 SV=2,NA,membrane,RNA binding,9552,SPAG7,NA,NA,ENSG00000091640
P63313,0,6,262605367.53125,0.0010165311992273228,0.8640618858751664,-0.21079345003585012,0.40376579370009513,0.8896213849325956,raw,245388894.625,292988735.9375,294354259.375,230662773.6875,212031191.0625,300206350.5,Thymosin beta-10 OS=Homo sapiens OX=9606 GN=TMSB10 PE=1 SV=2,cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity,9168,TMSB10,VEGFA-VEGFR2 signaling pathway; Extrafollicular B cell activation by SARS-CoV-2,NA,ENSG00000034510
Q6I9Y2,0,6,429201.8645833333,1.6614172445031212e-6,0.8634247944276237,-0.2118575725256075,1,1,raw,472195.3125,NA,NA,NA,304567.28125,510843,THO complex subunit 7 homolog OS=Homo sapiens OX=9606 GN=THOC7 PE=1 SV=3,cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding,80145,THOC7,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination,ENSG00000163634
A0A087X0R6,0,6,6508539.666666667,2.519420564314226e-5,0.8625017413204016,-0.21340072542308083,0.40819300991426755,0.8924083312504362,raw,5816347.75,9206939.4375,6207719.25,5016610.0625,6405714.375,6397907.125,Sorting nexin-12 OS=Homo sapiens OX=9606 GN=SNX12 PE=1 SV=1,NA,NA,structural molecule activity,NA,SNX12,NA,NA,ENSG00000147164
Q8WVY7,0,6,6134304.359375,2.3745560974182346e-5,0.8624795462904336,-0.21343785122832754,0.172955047275208,0.6689341104244626,raw,6496815.84375,6975807.75,6406605.375,6509922.75,4813303.65625,5603370.78125,Ubiquitin-like domain-containing CTD phosphatase 1 OS=Homo sapiens OX=9606 GN=UBLCP1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,membrane,structural molecule activity,134510,UBLCP1,NA,NA,ENSG00000164332
O60885,0,6,1087774.9583333333,4.210718132988844e-6,0.8622995412762013,-0.21373898236353533,0.8047611110750641,1,raw,1246143.109375,1160447.75,688169.34375,1000653.5625,576349.359375,1854886.625,Bromodomain-containing protein 4 OS=Homo sapiens OX=9606 GN=BRD4 PE=1 SV=2,cell differentiation;cell growth;cellular component movement;coagulation;metabolic process,membrane;nucleus,RNA binding;signal transducer activity;structural molecule activity,23476,BRD4,VEGFA-VEGFR2 signaling pathway; 7q11.23 copy number variation syndrome,Potential therapeutics for SARS,ENSG00000141867
Q6PL18,0.16666666666666666,6,420750.9791666667,1.6287043233320999e-6,0.862233439054144,-0.21384958082594613,0.7857015499916163,1,raw,814537.28125,313921.96875,240983.484375,702321.28125,136380.921875,316360.9375,ATPase family AAA domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ATAD2 PE=1 SV=1,cell growth;metabolic process,membrane,structural molecule activity,29028,ATAD2,Gastric cancer network 2,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,ENSG00000156802
Q9GZY8,0.16666666666666666,6,92695.81640625,3.588205005123816e-7,0.8622154074768837,-0.21387975170303072,1,1,raw,NA,99554.34375,NA,NA,NA,85837.2890625,Mitochondrial fission factor OS=Homo sapiens OX=9606 GN=MFF PE=1 SV=1,cell growth;conjugation;development;metabolic process,cytoskeleton;endosome;extracellular;mitochondrion;nucleus,structural molecule activity,56947,MFF,NA,NA,ENSG00000168958
Q7Z7G8,0.5,6,97077.503125,3.757817732263498e-7,0.8621710629721866,-0.21395395269930123,0.6944484642729638,1,raw,107362.875,68671.84375,124222.46875,95580.1171875,89550.2109375,NA,Vacuolar protein sorting-associated protein 13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2,cell growth;conjugation;defense response;metabolic process,cytoskeleton;extracellular,structural molecule activity,157680,VPS13B,NA,NA,ENSG00000132549
F5H7W8,0,6,1043000.03125,4.037396807719586e-6,0.8621571435246871,-0.21397724468954327,0.8638695315058053,1,raw,1063797.28125,1717382.25,467892.46875,1480653.375,706929.625,821345.1875,Protein CUSTOS OS=Homo sapiens OX=9606 GN=C12orf43 PE=1 SV=2,cell death;development,membrane,NA,64897,C12orf43,NA,NA,ENSG00000157895
P46937,0,6,6764736.7734375,2.6185930810958314e-5,0.8617837658290629,-0.21460217348536867,0.2631381979836103,0.7438355132238149,raw,7585060.375,8234396.09375,7286969.5,7009755.625,3375970.171875,7096268.875,Transcriptional coactivator YAP1 OS=Homo sapiens OX=9606 GN=YAP1 PE=1 SV=2,cell death;cell differentiation;cell growth;cellular component movement;coagulation;defense response;development;metabolic process,cytoskeleton;cytosol;membrane;nucleus,RNA binding;structural molecule activity,10413,YAP1,Mesodermal commitment pathway; Mesodermal commitment pathway; RAC1/PAK1/p38/MMP2 pathway; TGF-beta signaling pathway; miR-509-3p alteration of YAP1/ECM axis; Ciliary landscape; Leukocyte-intrinsic Hippo pathway functions; Netrin-UNC5B signaling pathway; Galanin receptor pathway; Malignant pleural mesothelioma,RUNX1 regulates transcription of genes involved in differentiation of HSCs; Nuclear signaling by ERBB4; Signaling by Hippo; RUNX2 regulates osteoblast differentiation; YAP1- and WWTR1 (TAZ)-stimulated gene expression; EGR2 and SOX10-mediated initiation of Schwann cell myelination; RUNX3 regulates YAP1-mediated transcription,ENSG00000137693
P12109,0,6,1520121.2994791667,5.884307476490056e-6,0.8617203961611102,-0.21470826328515633,0.6661115926422118,1,raw,2409117.71875,1187115.5,1327333.875,1206512.625,914662.203125,2075985.875,Collagen alpha-1(VI) chain OS=Homo sapiens OX=9606 GN=COL6A1 PE=1 SV=3,cell communication;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;nucleus,enzyme regulator activity;structural molecule activity,1291,COL6A1,miRNA targets in ECM and membrane receptors; PI3K-Akt signaling pathway,Collagen degradation; Signaling by PDGF; Assembly of collagen fibrils and other multimeric structures; Integrin cell surface interactions; ECM proteoglycans; NCAM1 interactions; Collagen chain trimerization,ENSG00000142156
Q8IZV2,0,6,567169.1041666666,2.195480979857044e-6,0.8610630744834866,-0.21580917327965413,1,1,raw,NA,625065.5625,NA,552998,523443.75,NA,CKLF-like MARVEL transmembrane domain-containing protein 8 OS=Homo sapiens OX=9606 GN=CMTM8 PE=1 SV=2,defense response;development;metabolic process,cell surface;cytoskeleton;membrane;nucleus,antioxidant activity;structural molecule activity,152189,CMTM8,NA,NA,ENSG00000170293
A0A087WWS1,0,6,18012517.744791668,6.972548366528564e-5,0.8610076441524444,-0.2159020487497167,0.23510026203958403,0.7192904383575112,raw,21335348.34375,21745058.5,16081271.0625,15700196.78125,13846097.3125,19367134.46875,THO complex subunit 1 OS=Homo sapiens OX=9606 GN=THOC1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q9UKM7,0,6,668580.71875,2.5880398645329538e-6,0.8607416770160393,-0.21634776923534774,0.7186780677628157,1,raw,543699.3125,939143.875,609376.75,756043.3125,494640.34375,NA,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase OS=Homo sapiens OX=9606 GN=MAN1B1 PE=1 SV=2",cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,11253,MAN1B1,NA,ER Quality Control Compartment (ERQC); Maturation of spike protein; Defective MAN1B1 causes MRT15,ENSG00000177239
Q5JVF3,0,6,7980968.713541667,3.089389898478301e-5,0.8605202912184781,-0.2167188832202267,0.8569265057060188,1,raw,7865540.625,8116662.953125,7416789.84375,11697063.6875,6407457.015625,6382298.15625,PCI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PCID2 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,membrane;nucleus,RNA binding,55795,PCID2,NA,NA,ENSG00000126226
Q12872,0,6,1987862.8359375,7.694909710002433e-6,0.8604427002954275,-0.21684897322277866,0.42581761925878364,0.911043979658989,raw,1975771.171875,2723685.03125,1736360.9375,1894636.25,1494039.09375,2102684.53125,"Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3",cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding,6433,SFSWAP,mRNA processing,NA,ENSG00000061936
P53985,0,6,20265142.9921875,7.844527437509487e-5,0.860064905112405,-0.2174825574557867,0.43286201803756025,0.9168514603569733,raw,23928701,21987578.4375,18413380.484375,22881961.75,15468491.71875,18910744.5625,Monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC16A1 PE=1 SV=3,cell differentiation;cell growth;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,catalytic activity;structural molecule activity,6566,SLC16A1,Photodynamic therapy-induced HIF-1 survival signaling; Fragile X syndrome; Glucose metabolism in triple-negative breast cancer cells,Basigin interactions; Pyruvate metabolism; Aspirin ADME; Proton-coupled monocarboxylate transport; Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),ENSG00000155380; ENSG00000281917
Q9C004,0,6,1685857.265625,6.525862453089208e-6,0.8600318998810057,-0.2175379223440078,0.6503621203599763,1,raw,2226031.6875,1458346.9375,1636213,1407195.375,1251837.09375,2135519.5,Protein sprouty homolog 4 OS=Homo sapiens OX=9606 GN=SPRY4 PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,DNA binding,81848,SPRY4,NA,NA,ENSG00000187678
P20226,0.3333333333333333,6,772878.0625,2.9917692510078717e-6,0.8588181275613316,-0.21957545158677974,0.5999017021653712,1,raw,820192,817860.375,819099.5625,862445.8125,544792.5625,NA,TATA-box-binding protein OS=Homo sapiens OX=9606 GN=TBP PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,6908,TBP,Prion disease pathway; Eukaryotic transcription initiation,Estrogen-dependent gene expression; RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter; RNA Polymerase III Transcription Initiation From Type 3 Promoter; B-WICH complex positively regulates rRNA expression; RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; SIRT1 negatively regulates rRNA expression,ENSG00000112592
A0A087X0K4,0.8333333333333334,6,59246316.666666664,2.2933929301274287e-4,0.8584211062804621,-0.22024254634207702,0.4817427785244202,0.9628032018384659,raw,55840668,72354928,57490892,60353452,47934808,61503152,CUB and sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CSMD2 PE=1 SV=1,NA,cytoskeleton,NA,NA,CSMD2,NA,NA,ENSG00000121904
H7BZT1,0.3333333333333333,6,698972.1875,2.705683599179927e-6,0.8582426612856267,-0.22054247893797818,0.7703891885055978,1,raw,380027.6875,1021322.5625,770668.875,634144.75,688697.0625,NA,Splicing factor 1 (Fragment) OS=Homo sapiens OX=9606 GN=SF1 PE=1 SV=1,NA,NA,NA,NA,SF1,NA,NA,ENSG00000168066
Q6P4E1,0,6,2149855.640625,8.321975110695686e-6,0.8562876857937397,-0.22383251655595995,0.333454699158633,0.8165647006470518,raw,2633569.0625,2752925.734375,2111176.625,2357296.40625,697957.921875,2346208.09375,Protein GOLM2 OS=Homo sapiens OX=9606 GN=GOLM2 PE=1 SV=2,NA,cytoskeleton;extracellular,NA,113201,GOLM2,NA,NA,ENSG00000166734
P43246,0,6,8666764.2265625,3.354857638848393e-5,0.8559911276991173,-0.22433225163806653,0.20861120777114112,0.6988382857167694,raw,9153226.625,9555439.046875,10281324,8800722.125,5448379.125,8761494.4375,DNA mismatch repair protein Msh2 OS=Homo sapiens OX=9606 GN=MSH2 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,membrane,RNA binding;structural molecule activity,4436,MSH2,"RAC1/PAK1/p38/MMP2 pathway; Chromosomal and microsatellite instability in colorectal cancer ; Ciliary landscape; DNA repair pathways, full network; p53 transcriptional gene network; DNA mismatch repair",TP53 Regulates Transcription of DNA Repair Genes; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta); Defective Mismatch Repair Associated With MSH3; Defective Mismatch Repair Associated With MSH2; Defective Mismatch Repair Associated With MSH6,ENSG00000095002
Q53H82,0,6,16212677.583333334,6.275839957654546e-5,0.8558008860368844,-0.22465292225879793,0.7320074909295838,1,raw,16988909,15855598.375,17241184.6875,14539123.375,12235244.0625,20416006,Endoribonuclease LACTB2 OS=Homo sapiens OX=9606 GN=LACTB2 PE=1 SV=2,cellular component movement;cellular homeostasis,endosome,RNA binding;structural molecule activity,51110,LACTB2,NA,NA,ENSG00000147592
Q08722,0,6,1921527.8958333333,7.4381307383893085e-6,0.85562802911910385,-0.22494435103706026,0.8579341862305554,1,raw,1725207.625,1816343.25,2344679,1476136,1549302,2617499.5,Leukocyte surface antigen CD47 OS=Homo sapiens OX=9606 GN=CD47 PE=1 SV=1,cell communication;coagulation;conjugation;development;metabolic process,cell surface;cytoplasm;cytoskeleton;nucleus,structural molecule activity,961,CD47,Spinal cord injury; Malignant pleural mesothelioma,Cell surface interactions at the vascular wall; Integrin cell surface interactions; Neutrophil degranulation; Signal regulatory protein family interactions,ENSG00000196776
P62633,0,6,32798787.364583332,1.2696233502902137e-4,0.8551413274153532,-0.2257652239977019,0.5525937828009417,1,raw,36223757.6875,34440354.25,31755680.25,38636697.8125,26284863.9375,29451370.25,Cellular nucleic acid-binding protein OS=Homo sapiens OX=9606 GN=CNBP PE=1 SV=1,cell proliferation;cellular homeostasis;metabolic process,cytosol;extracellular;membrane;nucleus,RNA binding;structural molecule activity,7555,CNBP,NA,SARS-CoV-2 activates/modulates innate and adaptive immune responses,ENSG00000169714
A0A2R8YHD2,0,6,2133909.175,8.260247203236636e-6,0.8541854483932179,-0.22737877394987355,0.40517006018470797,0.8912744470641923,raw,1453185.375,1914676.875,4030705.375,1543033.375,NA,1727944.875,Tropomyosin alpha-4 chain (Fragment) OS=Homo sapiens OX=9606 GN=TPM4 PE=1 SV=2,NA,endoplasmic reticulum,motor activity,NA,TPM4,NA,NA,ENSG00000167460
Q02447,0,6,1270038.5208333333,4.916250542723467e-6,0.8538883659840191,-0.22788062500478778,0.9959285536602369,1,raw,1159006.890625,1554621.484375,1093245.65625,1981949.75,841744.84375,989662.5,Transcription factor Sp3 OS=Homo sapiens OX=9606 GN=SP3 PE=1 SV=3,cellular component movement;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,6670,SP3,"MECP2 and associated Rett syndrome; Non-genomic actions of 1,25 dihydroxyvitamin D3; Sudden infant death syndrome (SIDS) susceptibility pathways",SUMOylation of transcription factors,ENSG00000172845
Q6BCY4,0,6,1618658.5963541667,6.265740032506044e-6,0.8536500369082012,-0.2282833523196552,0.07321637938983175,0.6429522395902524,raw,1715086.09375,1639591.84375,1895158.0625,1348206.9375,1496106.890625,1617801.75,NADH-cytochrome b5 reductase 2 OS=Homo sapiens OX=9606 GN=CYB5R2 PE=1 SV=1,cellular homeostasis;conjugation,cytoskeleton;extracellular,structural molecule activity,51700,CYB5R2,Oxidation by cytochrome P450,Erythrocytes take up carbon dioxide and release oxygen,ENSG00000166394
Q8N3U4,0,6,2850363.0026041665,1.1033601287397927e-5,0.853615223996669,-0.22834218841968423,0.24795306730677044,0.7316541032247736,raw,2994714.59375,3764206.75,2607306.953125,2855042.4375,2324573.3125,2556333.96875,Cohesin subunit SA-2 OS=Homo sapiens OX=9606 GN=STAG2 PE=1 SV=3,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,10735,STAG2,Cell cycle; Cohesin complex - Cornelia de Lange syndrome,Meiotic synapsis; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin,ENSG00000101972
P40763,0,6,18594752.766927082,7.197928400016656e-5,0.8535748189135703,-0.2284104786645414,0.9728749605407306,1,raw,20637003.09375,16007523.6875,18909993.65625,26245627.84375,13663619.1328125,16104749.1875,Signal transducer and activator of transcription 3 OS=Homo sapiens OX=9606 GN=STAT3 PE=1 SV=2,cell differentiation;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,6774,STAT3,IL-5 signaling pathway; Androgen receptor signaling pathway; Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Transcription factors regulate miRNAs related to cardiac hypertrophy; Cell differentiation - expanded index; Cell differentiation - index; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; Microtubule cytoskeleton regulation; IL-7 signaling pathway; IL-17 signaling pathway; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; AGE/RAGE pathway; Interleukin-11 signaling pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Mammary gland development pathway - Involution (Stage 4 of 4); Dopaminergic neurogenesis; IL-3 signaling pathway; TCA cycle nutrient use and invasiveness of ovarian cancer; Estrogen receptor pathway; Nuclear receptors meta-pathway; Kit receptor signaling pathway; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; VEGFA-VEGFR2 signaling pathway; Development of pulmonary dendritic cells and macrophage subsets; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Leptin-insulin signaling overlap; IL-4 signaling pathway; Prion disease pathway; Clear cell renal cell carcinoma pathways; Non-small cell lung cancer; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Extracellular vesicles in the crosstalk of cardiac cells; ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; EGF/EGFR signaling pathway; IL-10 anti-inflammatory signaling pathway ; Regulatory circuits of the STAT3 signaling pathway; Interactions between immune cells and microRNAs in tumor microenvironment; Neural crest cell migration during development; Neural crest cell migration in cancer; Cancer immunotherapy by PD-1 blockade; Measles virus infection; Gastrin signaling pathway; Hepatitis B infection; EGFR tyrosine kinase inhibitor resistance; TGF-beta receptor signaling in skeletal dysplasias; mBDNF and proBDNF regulation of GABA neurotransmission; IL-2 signaling pathway; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Th17 cell differentiation pathway; Inflammatory bowel disease signaling; 2q11.2 copy number variation syndrome; 2q21.1 copy number variation syndrome; Neurogenesis regulation in the olfactory epithelium; TGF-beta receptor signaling; EPO receptor signaling; Interferon type I signaling pathways; Notch signaling pathway; Serotonin receptor 2 and STAT3 signaling,"Interleukin-4 and Interleukin-13 signaling; Interleukin-7 signaling; Signaling by SCF-KIT; Downstream signal transduction; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants; Signaling by PDGFRA extracellular domain mutants; Cytoprotection by HMOX1; Association of TriC/CCT with target proteins during biosynthesis; Interleukin-10 signaling; Senescence-Associated Secretory Phenotype (SASP); Growth hormone receptor signaling; Interleukin-6 signaling; Signaling by Leptin; PTK6 Activates STAT3; Inactivation of CSF3 (G-CSF) signaling; Signaling by cytosolic FGFR1 fusion mutants; STAT3 nuclear events downstream of ALK signaling; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation; Interleukin-20 family signaling; Interleukin-35 Signalling; Interleukin-23 signaling; Interleukin-27 signaling; Transcriptional regulation of granulopoiesis; Interleukin-37 signaling; Signalling to STAT3; Nuclear events stimulated by ALK signaling in cancer; MET activates STAT3; Interleukin-15 signaling; Interleukin-9 signaling; Interleukin-21 signaling",ENSG00000168610
Q96S55,0,6,10830189.625,4.192307929901875e-5,0.853085117991813,-0.2292383988558456,0.11219699407952415,0.6429522395902524,raw,11953380.4375,11442487.84375,11206386.625,9583532.375,9560001.65625,11235348.8125,ATPase WRNIP1 OS=Homo sapiens OX=9606 GN=WRNIP1 PE=1 SV=2,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,56897,WRNIP1,NA,NA,ENSG00000124535
Q5BKZ1,0,6,13122429.822916666,5.079621734341923e-5,0.8523644158937801,-0.23045772945933124,0.4260160599231221,0.911043979658989,raw,12926592.4375,16974152.625,12058735.375,12030283.9375,10276650.875,14468163.6875,DBIRD complex subunit ZNF326 OS=Homo sapiens OX=9606 GN=ZNF326 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,284695,ZNF326,NA,NA,ENSG00000162664
Q9Y5G0,0.8333333333333334,6,5311727,2.0561408428316323e-5,0.851581891049923,-0.23178282378462867,0.9407692263192453,1,raw,4787630,5524053,5753968,7234670.5,3865857,4704183.5,Protocadherin gamma-B5 OS=Homo sapiens OX=9606 GN=PCDHGB5 PE=2 SV=1,cell communication;defense response,cytoplasm;cytoskeleton,structural molecule activity,56101,PCDHGB5,NA,NA,ENSG00000276547
H0YJH6,0.3333333333333333,6,191198.421875,7.401187679678201e-7,0.8513591577918981,-0.23216021344100518,1,1,raw,NA,218277.40625,NA,185832.46875,151197.171875,209486.640625,Signal transducer and activator of transcription OS=Homo sapiens OX=9606 GN=STAT6 PE=1 SV=2,cellular component movement;development,cytosol;membrane,RNA binding;structural molecule activity,6778,STAT6,Thymic stromal lymphopoietin (TSLP) signaling pathway; Adipogenesis; VEGFA-VEGFR2 signaling pathway; IL-4 signaling pathway; Interactions between immune cells and microRNAs in tumor microenvironment; Neuroinflammation and glutamatergic signaling; Th17 cell differentiation pathway; Inflammatory bowel disease signaling,NA,ENSG00000166888
Q9P0R6,0,6,445928.03125,1.7261633325971485e-6,0.8512393710039206,-0.2323632158544826,0.6593134612449278,1,raw,NA,559073.75,398768.15625,512585.8125,313284.40625,NA,GSK3B-interacting protein OS=Homo sapiens OX=9606 GN=GSKIP PE=1 SV=2,coagulation;development;metabolic process,membrane;nucleus,DNA binding;structural molecule activity,51527,GSKIP,NA,NA,ENSG00000100744
P36551,0,6,161654695.5078125,6.257565983137395e-4,0.851036072187773,-0.23270781131515517,0.4259875142277722,0.911043979658989,raw,196599364.90625,160234156.1875,152295867.375,165264880.171875,129609276.78125,165924627.625,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial OS=Homo sapiens OX=9606 GN=CPOX PE=1 SV=3",cellular homeostasis;metabolic process,cytoskeleton;cytosol;endosome;nucleus,structural molecule activity,1371,CPOX,Hemesynthesis defects and porphyrias; Heme biosynthesis,Heme biosynthesis,ENSG00000080819
Q9UBN7,0,6,54280308.979166664,2.1011614537717234e-4,0.8507482746982148,-0.2331957744530039,0.7492590141059188,1,raw,53864405.125,59520696.53125,56253347,75124005.125,33061962.1875,47857437.90625,Histone deacetylase 6 OS=Homo sapiens OX=9606 GN=HDAC6 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;mitochondrion;nucleus,motor activity;RNA binding;structural molecule activity,10013,HDAC6,Neural crest differentiation; Ectoderm differentiation; Ectoderm differentiation; Ethanol effects on histone modifications; 7q11.23 copy number variation syndrome,Transcriptional regulation by RUNX2; Late endosomal microautophagy; Cilium Assembly; Aggrephagy; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; RUNX2 regulates osteoblast differentiation; Chaperone Mediated Autophagy; HSF1 activation,ENSG00000094631
E7EMK3,0,6,12916174.057291666,4.9997812410765365e-5,0.8503588208506061,-0.23385635972231106,0.4685738883195544,0.9488697854576846,raw,13650178.75,19485513.609375,9478650.8125,11607549.90625,11094591.703125,12180559.5625,Flotillin OS=Homo sapiens OX=9606 GN=FLOT2 PE=1 SV=1,NA,cytoplasm;cytoskeleton;mitochondrion;nucleus,NA,NA,FLOT2,NA,NA,ENSG00000132589
Q5T1M5,0,6,534489.9270833334,2.0689816497687902e-6,0.8500098242744086,-0.23444857910753794,1,1,raw,NA,593873.375,NA,610036.4375,399559.96875,NA,FK506-binding protein 15 OS=Homo sapiens OX=9606 GN=FKBP15 PE=1 SV=2,conjugation,cytoskeleton;endoplasmic reticulum;mitochondrion;nucleus,motor activity;structural molecule activity,23307,FKBP15,TYROBP causal network in microglia,NA,ENSG00000119321
Q8N6Y1,0.5,6,3672914.95,1.4217655464864634e-5,0.8496751365215727,-0.23501674600745254,0.44147983796094575,0.924499927816703,raw,3678771,4757689,3240442.5,3759927.25,NA,2927745,Protocadherin-20 OS=Homo sapiens OX=9606 GN=PCDH20 PE=2 SV=2,cell communication,cytoplasm;cytoskeleton,structural molecule activity,64881,PCDH20,NA,NA,ENSG00000280165
H3BM14,0,6,2314032.7421875,8.957495806658361e-6,0.8496368398913555,-0.23508177274683092,0.9512429451364233,1,raw,2061770.0625,2287795.15625,2664760.25,3610408.9375,1943795.046875,1315667,NEDD8 ultimate buster 1 OS=Homo sapiens OX=9606 GN=NUB1 PE=1 SV=1,NA,cytosol;membrane,NA,51667,NUB1,NA,NA,ENSG00000013374
Q86Y56,0,6,8978749.591145834,3.475625489019441e-5,0.8494595681718499,-0.23538281397125463,0.3570894982648575,0.8406066251623018,raw,10172164.984375,10921465.96875,8789875.6875,8640842.875,4884936.484375,10463211.546875,"Dynein assembly factor 5, axonemal OS=Homo sapiens OX=9606 GN=DNAAF5 PE=1 SV=4",cell growth;metabolic process,nucleus,structural molecule activity,54919,DNAAF5,Ciliopathies,NA,ENSG00000164818
Q8N490,0,6,793207.15,3.070462051120242e-6,0.8487241545510911,-0.23663235798206986,0.6257117861322358,1,raw,569211.6875,1022475.4375,880220.25,722794.25,771334.125,NA,Probable hydrolase PNKD OS=Homo sapiens OX=9606 GN=PNKD PE=1 SV=2,cellular homeostasis;metabolic process,cytoskeleton;endosome;membrane,structural molecule activity,25953,PNKD,Mitochondrial complex IV assembly,NA,ENSG00000127838
Q15643,0,6,267068.046875,1.0338059900197438e-6,0.8482237366456703,-0.23748323909067104,0.4117791891339997,0.8978780271505381,raw,446420.921875,190291.34375,259092,206721.453125,NA,232814.515625,Thyroid receptor-interacting protein 11 OS=Homo sapiens OX=9606 GN=TRIP11 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;conjugation;defense response,cytoskeleton;endoplasmic reticulum;extracellular;membrane,structural molecule activity,9321,TRIP11,NA,Intraflagellar transport; Intra-Golgi traffic; Signaling by FLT3 fusion proteins,ENSG00000100815
Q9NXN4,0.5,6,6203133.552083333,2.4011995062957492e-5,0.8472446788282386,-0.23914942408363324,0.27205765027408624,0.7524601054912853,raw,7591713.53125,7833472,5182623.96875,6636867.46875,4673226.59375,5300897.75,Ganglioside-induced differentiation-associated protein 2 OS=Homo sapiens OX=9606 GN=GDAP2 PE=1 SV=1,metabolic process,NA,NA,54834,GDAP2,NA,NA,ENSG00000196505
Q9ULH7,0,6,1230243.3723958333,4.7622056717259714e-6,0.8471567960026853,-0.2392990794263629,0.4405042740485165,0.9233600879723239,raw,879982.96875,2262693.421875,1159872.421875,982593.8046875,809849.2421875,1286468.375,Myocardin-related transcription factor B OS=Homo sapiens OX=9606 GN=MRTFB PE=1 SV=3,cellular component movement;metabolic process,membrane,structural molecule activity,57496,MRTFB,NA,NA,ENSG00000186260
O43815,0,6,1999891.875,7.741473470746206e-6,0.8464732009811338,-0.24046370121846836,0.6578468650926597,1,raw,1737856.0625,2465521.375,2149375.5625,1170456.5,2656752.9375,1819388.8125,Striatin OS=Homo sapiens OX=9606 GN=STRN PE=1 SV=4,cell death;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,6801,STRN,NA,"Extra-nuclear estrogen signaling; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Signaling by cytosolic PDGFRA and PDGFRB fusion proteins",ENSG00000115808
Q9BRR6,0,6,2194460.7708333335,8.494639161429425e-6,0.846375620826814,-0.24063002251434396,0.5639034438785702,1,raw,2218088,2761281.09375,1928108.75,2337081,1602253.4375,2319952.34375,ADP-dependent glucokinase OS=Homo sapiens OX=9606 GN=ADPGK PE=1 SV=1,cellular homeostasis,cell surface;cytoskeleton;extracellular,signal transducer activity;structural molecule activity,83440,ADPGK,NA,Glycolysis,ENSG00000159322
Q9BRT9,0,6,311760.546875,1.206808244499789e-6,0.8454841323054147,-0.24215041589858896,1,1,raw,337863.15625,NA,NA,NA,NA,285657.9375,DNA replication complex GINS protein SLD5 OS=Homo sapiens OX=9606 GN=GINS4 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,NA,84296,GINS4,NA,Unwinding of DNA,ENSG00000147536
Q5JTZ9,0,6,1428762.9088541667,5.530664078967125e-6,0.8449048332329413,-0.24313924385334432,0.999237737553047,1,raw,1414091.65625,1575337.4375,1296334.0625,2060347.8125,1031693.609375,1194772.875,"Alanine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=AARS2 PE=1 SV=1",cell organization and biogenesis;cellular component movement;cellular homeostasis,endosome,RNA binding;structural molecule activity,57505,AARS2,NA,Mitochondrial tRNA aminoacylation,ENSG00000124608
Q9HAT2,0,6,3517845.07421875,1.361738834818741e-5,0.8443329940892025,-0.24411600333034378,0.9429244091863842,1,raw,4907153.46875,1416318.6875,4100829.359375,3944041.53125,3276261.8671875,3462465.53125,Sialate O-acetylesterase OS=Homo sapiens OX=9606 GN=SIAE PE=1 SV=1,cellular homeostasis;metabolic process,mitochondrion,structural molecule activity,54414,SIAE,NA,NA,ENSG00000110013
P48960,0,6,7953889.484375,3.078907675072998e-5,0.8443163596637786,-0.24414442652313334,0.2994902589560511,0.7805333494403178,raw,7536683.40625,9395268.875,9033261.078125,8735873.03125,5395320.40625,7626930.109375,Adhesion G protein-coupled receptor E5 OS=Homo sapiens OX=9606 GN=ADGRE5 PE=1 SV=4,cell communication;cell death;coagulation;development;metabolic process,cytoplasm;cytoskeleton,structural molecule activity,976,ADGRE5,"Vitamin D receptor pathway; GPCRs, class B secretin-like",Neutrophil degranulation; Class B/2 (Secretin family receptors),ENSG00000123146
P21583,0.16666666666666666,6,1161728.8958333333,4.496989832159317e-6,0.8435650619940079,-0.24542875074174733,0.31514760587178847,0.7958588159583763,raw,1119441.5,1865322.75,1027730.375,1136514.75,866957.4375,954406.5625,Kit ligand OS=Homo sapiens OX=9606 GN=KITLG PE=1 SV=1,cell communication;cell differentiation;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,antioxidant activity,4254,KITLG,Pluripotent stem cell differentiation pathway; Kit receptor signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Neovascularisation processes; IL-18 signaling pathway; Malignant pleural mesothelioma; CCL18 signaling pathway,NA,ENSG00000049130
E9PN70,0,6,716416.8875,2.773211091012517e-6,0.8431354066546246,-0.246163749815203,0.8808955631409191,1,raw,536627.75,948634.3125,745258.59375,1028432.3125,323131.46875,NA,Trafficking protein particle complex subunit OS=Homo sapiens OX=9606 GN=TRAPPC4 PE=1 SV=1,conjugation,extracellular;nucleus,NA,NA,TRAPPC4,NA,NA,ENSG00000196655; ENSG00000280495
A0A5F9ZHP1,0,6,1826631.0598958333,7.0707902101080424e-06,0.8428550930487382,-0.2466434761872122,0.5369449695348882,1,raw,1982649.78125,2028538.453125,2025450.625,2476115.8125,1707161.375,739870.3125,Activating signal cointegrator 1 complex subunit 1 OS=Homo sapiens OX=9606 GN=ASCC1 PE=1 SV=1,NA,NA,RNA binding,NA,ASCC1,Neuroinflammation,NA,ENSG00000138303
Q9H7B4,0,6,328888688.0520833,0.0012731103542203887,0.8427914268296183,-0.24675245625813091,0.9101749219462676,1,raw,248818092.375,400563144.46875,314604026.875,563019869.75,209701755.09375,236625239.75,Histone-lysine N-methyltransferase SMYD3 OS=Homo sapiens OX=9606 GN=SMYD3 PE=1 SV=4,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,RNA binding;structural molecule activity,64754,SMYD3,Histone modifications,PKMTs methylate histone lysines,ENSG00000185420
P62891,0,6,1127925.5,4.366138711988192e-6,0.8417421796545921,-0.24854968236987107,1,1,raw,NA,1149224.875,1233130.75,NA,1001420.875,NA,60S ribosomal protein L39 OS=Homo sapiens OX=9606 GN=RPL39 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation,cell surface;cytosol;Golgi,RNA binding;structural molecule activity,6170,RPL39,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000198918
Q9UBI6,0,6,9456027.9375,3.660377359990585e-5,0.8411996500611427,-0.2494798449783441,0.9877661177277542,1,raw,10493717.5625,8565423.625,9252687.8125,13696458.875,6944522,7783357.75,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 OS=Homo sapiens OX=9606 GN=GNG12 PE=1 SV=3,development,cytoplasm;cytoskeleton,structural molecule activity,55970,GNG12,Myometrial relaxation and contraction pathways; G protein signaling pathways; MAPK signaling pathway; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Regulation of actin cytoskeleton; Calcium regulation in cardiac cells,"G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation",ENSG00000172380
A0A5F9ZHB6,0,6,1965712.7057291667,7.60916775188713e-6,0.8401488886339544,-0.2512830743060294,0.7737624797808635,1,raw,868220.4375,3579654.578125,1872213.09375,1572937.75,1247737.875,2653512.5,DNA primase OS=Homo sapiens OX=9606 GN=PRIM1 PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis,nucleus,structural molecule activity,NA,PRIM1,NA,NA,ENSG00000198056
H7BXH9,0.6666666666666666,6,252007.42447916666,9.755071338726982e-7,0.8390288291398373,-0.25320771218111854,0.9633371646999992,1,raw,245067.203125,259618.171875,245405.453125,205902.25,152908.71875,403142.75,Protein N-lysine methyltransferase METTL21A OS=Homo sapiens OX=9606 GN=METTL21A PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,151194,METTL21A,NA,NA,ENSG00000144401
P13987,0,6,11114326.265625,4.3022956893883916e-5,0.8389269570762133,-0.2533828900044955,0.29924018891330123,0.7805333494403178,raw,10707951.1875,13857769.75,11003778.375,10925958.75,8983188.90625,11207310.625,CD59 glycoprotein OS=Homo sapiens OX=9606 GN=CD59 PE=1 SV=1,coagulation;development;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,966,CD59,Complement system; Complement system in neuronal development and plasticity,Regulation of Complement cascade; COPI-mediated anterograde transport; Neutrophil degranulation; COPII-mediated vesicle transport; Cargo concentration in the ER,ENSG00000085063
P08582,0,6,2692589.6458333335,1.0422869141775314e-5,0.8383010899863733,-0.2544595896104423,0.615290888803932,1,raw,3481066.0625,3045746.21875,1952996.25,2522277.3125,2600199.65625,2553252.375,Melanotransferrin OS=Homo sapiens OX=9606 GN=MELTF PE=1 SV=2,conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,4241,MELTF,3q29 copy number variation syndrome,Post-translational modification: synthesis of GPI-anchored proteins; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,ENSG00000163975
A0A0A0MTC1,0,6,1831859.63671875,7.091029748690281e-6,0.8379558908253828,-0.25505379101323555,0.6884887567067643,1,raw,2265776.796875,1098936.421875,2444018.1875,1804293.703125,1330153.2734375,2047979.4375,E3 ubiquitin-protein ligase RNF213 OS=Homo sapiens OX=9606 GN=RNF213 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,57674,RNF213,NA,NA,ENSG00000173821
P01033,0.16666666666666666,6,2370708.7916666665,9.17688573416115e-6,0.8367274681358977,-0.2571702981494761,0.7215584871420442,1,raw,3290475.125,2199776.78125,1927720.34375,2536553.125,1612976.5625,2656750.8125,Metalloproteinase inhibitor 1 OS=Homo sapiens OX=9606 GN=TIMP1 PE=1 SV=1,coagulation;defense response;development;metabolic process,cell surface;chromosome;extracellular;nucleus,antioxidant activity;DNA binding;structural molecule activity,7076,TIMP1,Matrix metalloproteinases; Mammary gland development pathway - Puberty (Stage 2 of 4); IL1 and megakaryocytes in obesity; Lung fibrosis; IL6 signaling pathway; IL-18 signaling pathway; Burn wound healing; CCL18 signaling pathway,Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Interleukin-10 signaling; Interleukin-4 and Interleukin-13 signaling; Activation of Matrix Metalloproteinases,ENSG00000102265
O75427,0.16666666666666666,6,280664.7625,1.0864381420955743e-6,0.8366482108625135,-0.2573069609165838,0.3212271107438545,0.8027885809803746,raw,364533.03125,235892.265625,300340.25,236548.078125,266010.1875,NA,Leucine-rich repeat and calponin homology domain-containing protein 4 OS=Homo sapiens OX=9606 GN=LRCH4 PE=1 SV=2,defense response;metabolic process,membrane;nucleus,NA,4034,LRCH4,NA,NA,ENSG00000077454
J3KNE7,0,6,1647926,6.37903257182487e-6,0.836438483254364,-0.25766865524224375,0.6581695613751541,1,raw,1121371.125,2398122.9375,1740381.5,1297932.5,2005882.3125,1323865.625,Tumor protein D53 OS=Homo sapiens OX=9606 GN=TPD52L1 PE=1 SV=1,NA,nucleus,NA,7164,TPD52L1,NA,NA,ENSG00000111907
Q8IUH4,0,6,1780737.2447916667,6.893137729720703e-6,0.8349948804234066,-0.26016074282211604,0.6193327654368628,1,raw,1265462.875,2597077.5625,1861443.75,1271854.75,1520038.0625,2168546.46875,Palmitoyltransferase ZDHHC13 OS=Homo sapiens OX=9606 GN=ZDHHC13 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;conjugation,cytoskeleton;extracellular,catalytic activity;structural molecule activity,54503,ZDHHC13,NA,NA,ENSG00000177054
P18615,0,6,7837122.385416667,3.033707761510574e-5,0.8348684246569553,-0.2603792482613874,0.29021641783892765,0.7729244348258341,raw,8995187.9375,9581228.5,7021674.40625,8720117.84375,5862174.25,6842351.375,Negative elongation factor E OS=Homo sapiens OX=9606 GN=NELFE PE=1 SV=3,metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,RNA binding;structural molecule activity,7936,NELFE,Initiation of transcription and translation elongation at the HIV-1 LTR,Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes,ENSG00000204356; ENSG00000206268; ENSG00000206357; ENSG00000229363; ENSG00000231044; ENSG00000233801
Q8NBJ4,0,6,11884199.203125,4.600309346826832e-5,0.8343219026970029,-0.2613239752186604,0.31606925517782913,0.7963816411712802,raw,10250752.375,14857404,13810814.3125,11522664.875,8285902.96875,12577656.6875,Golgi membrane protein 1 OS=Homo sapiens OX=9606 GN=GOLM1 PE=1 SV=1,cell growth;metabolic process,cytoplasm;cytoskeleton;extracellular,NA,51280,GOLM1,NA,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation,ENSG00000135052
F8VW96,0,6,1876255.7552083333,7.262884726345618e-6,0.8339452171321377,-0.261975480483233,0.4954887328963257,0.9797289827868773,raw,2521067.78125,1700539.90625,2039773.1875,1701059.09375,803375.3125,2491719.25,Cysteine and glycine-rich protein 2 OS=Homo sapiens OX=9606 GN=CSRP2 PE=1 SV=1,NA,NA,structural molecule activity,NA,CSRP2,Mesodermal commitment pathway; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity,NA,ENSG00000175183
O14964,0,6,32902846.489583332,1.2736514228357685e-4,0.833833136758011,-0.2621693885044036,0.3093709196780202,0.7908013906987075,raw,36161446.0625,37946628.3125,32067267.9375,36856278.3125,24232846.3125,30152612,Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Homo sapiens OX=9606 GN=HGS PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,9146,HGS,TGF-beta signaling pathway; VEGFA-VEGFR2 signaling pathway; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; EGF/EGFR signaling pathway,Endosomal Sorting Complex Required For Transport (ESCRT); Ub-specific processing proteases; Lysosome Vesicle Biogenesis; RHOU GTPase cycle; Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Inhibition of membrane repair; Prevention of phagosomal-lysosomal fusion; RHOBTB3 ATPase cycle,ENSG00000185359
A0A3B3IT54,0,6,6284947.751302083,2.4328693410853074e-5,0.833407321459858,-0.2629063207559086,0.703651081649795,1,raw,5526724.46875,8663094.6875,5621176.1875,7047335.84375,3631468.78125,7219886.5390625,UPF0488 protein C8orf33 OS=Homo sapiens OX=9606 GN=C8orf33 PE=1 SV=1,NA,NA,NA,NA,C8orf33,NA,NA,ENSG00000182307
Q00535,0,6,1951015.53125,7.552275783002364e-6,0.833331071298849,-0.26303832195022836,0.20751044574727062,0.6988382857167694,raw,1728787.875,2440649.5,2283009.5,2033869.0625,1600076.8125,1619700.4375,Cyclin-dependent-like kinase 5 OS=Homo sapiens OX=9606 GN=CDK5 PE=1 SV=3,cell communication;cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,antioxidant activity;catalytic activity;motor activity;signal transducer activity;structural molecule activity,1020,CDK5,miRNA regulation of DNA damage response; Nicotine effect on dopaminergic neurons; Alzheimer's disease and miRNA effects; Brain-derived neurotrophic factor (BDNF) signaling pathway; ATM signaling in development and disease ; Alzheimer's disease; Neurogenesis regulation in the olfactory epithelium; DNA damage response,NPAS4 regulates expression of target genes; NGF-stimulated transcription; Regulation of TP53 Activity through Phosphorylation; Factors involved in megakaryocyte development and platelet production; CRMPs in Sema3A signaling; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; DARPP-32 events; Activated NTRK2 signals through CDK5,ENSG00000164885
Q02880,0,6,8021428.434895833,3.1050516381659555e-5,0.8331707142308848,-0.26331596503401755,0.37226136255422887,0.8579888640379237,raw,8813460.75,10498459.125,7708598.0625,8695212.875,3665831.109375,8747008.6875,DNA topoisomerase 2-beta OS=Homo sapiens OX=9606 GN=TOP2B PE=1 SV=3,cell differentiation;cell growth;cell proliferation;cellular homeostasis;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,7155,TOP2B,NA,SUMOylation of DNA replication proteins,ENSG00000077097
Q96JY0,0.6666666666666666,6,1437844.425,5.5658181376419825e-6,0.8331142072909472,-0.26341381418454657,0.4463297680151289,0.9277715124769401,raw,1360958.5,NA,1839136.875,1325410.125,1140460.5,1523256.125,Protein maelstrom homolog OS=Homo sapiens OX=9606 GN=MAEL PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,membrane;nucleus,RNA binding,84944,MAEL,NA,PIWI-interacting RNA (piRNA) biogenesis,ENSG00000143194
Q10472,0,6,1176320.9791666667,4.553474998892603e-6,0.832822087937962,-0.2639197628782941,0.7028654162165772,1,raw,986100.8125,1964721.75,865747.40625,1701764.40625,818577.9375,721013.5625,Polypeptide N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=GALNT1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytoskeleton;extracellular;nucleus,structural molecule activity,2589,GALNT1,Metabolism of spingolipids in ER and Golgi apparatus,COPI-independent Golgi-to-ER retrograde traffic; O-linked glycosylation of mucins; Maturation of protein 3a; Maturation of protein 3a,ENSG00000141429
Q14332,0.3333333333333333,6,229506.89583333334,8.884088023244072e-7,0.8327878022825802,-0.2639791570320996,0.1603860508944539,0.6638855679885327,raw,214509.3125,283705.8125,253064.765625,210749.25,221810.703125,193201.53125,Frizzled-2 OS=Homo sapiens OX=9606 GN=FZD2 PE=1 SV=1,cell death;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,2535,FZD2,MicroRNAs in cardiomyocyte hypertrophy; Alzheimer's disease and miRNA effects; Physico-chemical features and toxicity-associated pathways; Embryonic stem cell pluripotency pathways; Wnt signaling pathway and pluripotency; Wnt signaling in kidney disease; Epithelial to mesenchymal transition in colorectal cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Osteoblast differentiation and related diseases; Malignant pleural mesothelioma; Alzheimer's disease,"Asymmetric localization of PCP proteins; Class B/2 (Secretin family receptors); Ca2+ pathway; Disassembly of the destruction complex and recruitment of AXIN to the membrane; WNT5A-dependent internalization of FZD2, FZD5 and ROR2",ENSG00000180340
A6NIH7,0,6,2576740.8958333335,9.974424885385648e-6,0.8326785636551876,-0.26416841096056326,0.32629925029584,0.8083009869512469,raw,3182183.9375,3115599.375,2198832.5,2594292.8125,1666303.25,2703233.5,Protein unc-119 homolog B OS=Homo sapiens OX=9606 GN=UNC119B PE=1 SV=1,cell growth;conjugation;defense response,cytosol;nucleus,structural molecule activity,84747,UNC119B,NA,Trafficking of myristoylated proteins to the cilium,ENSG00000175970
Q7L7X3,0,6,2666926.2942708335,1.0323527693482502e-5,0.8323146019496873,-0.26479914719036823,0.5420017094255545,1,raw,2442159,2600096.21875,3686299.46875,2984004.90625,1220837.296875,3068160.875,Serine/threonine-protein kinase TAO1 OS=Homo sapiens OX=9606 GN=TAOK1 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;endoplasmic reticulum;nucleus,DNA binding;motor activity;signal transducer activity;structural molecule activity,57551,TAOK1,Microtubule cytoskeleton regulation; MAPK signaling pathway,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000160551
Q86YV9,0.16666666666666666,6,945218.1927083334,3.658888590123522e-6,0.8322952946607715,-0.2648326139263643,0.5251199920577229,1,raw,1110176.1875,912468.078125,957457.203125,796887.125,758587.5625,1135733,Hermansky-Pudlak syndrome 6 protein OS=Homo sapiens OX=9606 GN=HPS6 PE=1 SV=1,cell growth;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,79803,HPS6,NA,NA,ENSG00000166189
Q9HA72,0.3333333333333333,6,330322.8828125,1.27866204470348e-6,0.8318033089427245,-0.2656856708002271,0.5230160511794789,1,raw,452883.96875,257616.75,350852.25,257228.953125,291840.0625,371515.3125,Calcium homeostasis modulator protein 2 OS=Homo sapiens OX=9606 GN=CALHM2 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton,catalytic activity,51063,CALHM2,NA,NA,ENSG00000138172
Q8N1G2,0,6,2189941.375,8.47714482416804e-6,0.8315842946243303,-0.2660655833018946,0.6088760481457106,1,raw,3597508.125,2336232.71875,1255676.65625,2325783.4375,1942774.4375,1681672.875,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 OS=Homo sapiens OX=9606 GN=CMTR1 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,23070,CMTR1,NA,NA,ENSG00000137200
P49593,0,6,634919.3109375,2.4577383723243125e-6,0.8300594773897068,-0.26871337931833983,0.6375777993141412,1,raw,289203.90625,845019.5859375,951369.25,NA,346062.09375,742941.71875,Protein phosphatase 1F OS=Homo sapiens OX=9606 GN=PPM1F PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9647,PPM1F,NA,Negative regulation of NMDA receptor-mediated neuronal transmission,ENSG00000100034
Q9NRL3,0,6,1371891.9270833333,5.310519579088001e-6,0.8297475291544479,-0.2692556666752994,0.2632749089486658,0.7438355132238149,raw,1292513.6875,1468949.3125,1828795.9375,1218857.0625,892523.9375,1529711.625,Striatin-4 OS=Homo sapiens OX=9606 GN=STRN4 PE=1 SV=2,NA,cytoskeleton;nucleus,structural molecule activity,29888,STRN4,NA,NA,ENSG00000090372
Q86TJ2,0.16666666666666666,6,5253594.75,2.0336381627219995e-5,0.8287803495538131,-0.2709382978683831,0.7493416318180735,1,raw,4910446,6356826,5163811.5,7333860.5,3476959,4279665.5,Transcriptional adapter 2-beta OS=Homo sapiens OX=9606 GN=TADA2B PE=1 SV=2,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,structural molecule activity,93624,TADA2B,NA,Ub-specific processing proteases; HATs acetylate histones,ENSG00000173011
O95059,0,6,673612.0052083334,2.6075157027659147e-6,0.8285746110886685,-0.27129648048098864,0.6124329202768857,1,raw,175150.296875,1316203.171875,882003.78125,266994.96875,1090572.53125,310747.28125,Ribonuclease P protein subunit p14 OS=Homo sapiens OX=9606 GN=RPP14 PE=1 SV=3,cellular component movement;cellular homeostasis,endosome;membrane;nucleus,RNA binding;structural molecule activity,11102,RPP14,NA,tRNA processing in the nucleus; Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000163684
Q8NC51,0,6,177959270.14453134,6.888707264222705e-4,0.8276386073221544,-0.27292714991528294,0.4060021891531755,0.8914071190930648,raw,169835613.25,224667948.492188,171229483.5,175639402.125,140439305.5,185943868,Plasminogen activator inhibitor 1 RNA-binding protein OS=Homo sapiens OX=9606 GN=SERBP1 PE=1 SV=2,cell growth;metabolic process,cytosol;membrane;nucleus,protein binding;RNA binding;structural molecule activity,26135,SERBP1,Apoptosis-related network due to altered Notch3 in ovarian cancer,NA,ENSG00000142864
Q13572,0,6,743380.4583333334,2.8775856179017958e-6,0.8276164510527616,-0.27296577204764594,0.9759430280054682,1,raw,803759.8125,754705.5,661733.4375,624606.6875,492012.9375,1123464.375,Inositol-tetrakisphosphate 1-kinase OS=Homo sapiens OX=9606 GN=ITPK1 PE=1 SV=2,cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol,signal transducer activity;structural molecule activity,3705,ITPK1,2q37 copy number variation syndrome,Factors involved in megakaryocyte development and platelet production; Synthesis of IP3 and IP4 in the cytosol; Synthesis of pyrophosphates in the cytosol,ENSG00000100605; ENSG00000274958
Q9BSF4,0.5,6,1138427.9125,4.4067929837335495e-6,0.8274786236547366,-0.27320605178399177,0.09312226893370021,0.6429522395902524,raw,1123535.5,1292493.125,1277671.75,1063598.25,934840.9375,NA,Mitochondrial import inner membrane translocase subunit Tim29 OS=Homo sapiens OX=9606 GN=TIMM29 PE=1 SV=2,cell growth;conjugation,cytoskeleton;endosome,catalytic activity,90580,TIMM29,NA,NA,ENSG00000142444
Q96PD2,0,6,3214994.9557291665,1.2445071890879207e-5,0.8269469166414838,-0.2741333719672849,0.31506365564411354,0.7958588159583763,raw,2782736.5625,4180331.1875,3803118.09375,1870863.875,3507943.234375,3144976.78125,"Discoidin, CUB and LCCL domain-containing protein 2 OS=Homo sapiens OX=9606 GN=DCBLD2 PE=1 SV=1",coagulation;development;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,131566,DCBLD2,NA,NA,ENSG00000057019
Q16563,0,6,1932681.6666666667,7.481306383075116e-6,0.826922623644036,-0.27417575425451496,0.6215798590199798,1,raw,1144876.125,2999397.5,2131901.25,1444980.75,1762917.375,2112017,Synaptophysin-like protein 1 OS=Homo sapiens OX=9606 GN=SYPL1 PE=1 SV=1,cell death,cytoplasm;cytoskeleton;extracellular;nucleus,NA,6856,SYPL1,NA,NA,ENSG00000008282
Q8WXD5,0,6,2055447.2291666667,7.95652524720245e-6,0.8258297198174459,-0.2760837559788455,0.1353149590921167,0.653793677153943,raw,2142181.1875,2650656.25,2029576.3125,1676084.4375,1866690.6875,1967494.5,Gem-associated protein 6 OS=Homo sapiens OX=9606 GN=GEMIN6 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,NA,79833,GEMIN6,NA,SARS-CoV-2 modulates host translation machinery; snRNP Assembly,ENSG00000152147
E5RIM7,0,6,17614523.020833332,6.818486757721817e-5,0.8235040948548459,-0.28015227115055735,0.16767176601673037,0.6671879916796575,raw,21896607,20936284.75,16379426.75,13488525,13784867.625,19201427,Copper transport protein ATOX1 OS=Homo sapiens OX=9606 GN=ATOX1 PE=1 SV=1,conjugation,NA,structural molecule activity,NA,ATOX1,Copper homeostasis,NA,ENSG00000177556
Q9Y2Y0,0,6,3623580.7708333335,1.4026685520942145e-5,0.8233874236026527,-0.28035668174512113,0.39346674697451783,0.87714149171028,raw,2920296.8125,5030079.25,3906912.28125,3207143.28125,3460150.5625,3216902.4375,ADP-ribosylation factor-like protein 2-binding protein OS=Homo sapiens OX=9606 GN=ARL2BP PE=1 SV=1,cellular component movement;development;metabolic process,cytosol;endoplasmic reticulum;endosome;membrane;nucleus,DNA binding;structural molecule activity,23568,ARL2BP,Ciliopathies,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,ENSG00000102931
Q8NI60,0,6,1596205.1432291667,6.178823927757215e-6,0.823179168231221,-0.28072162172956544,0.7868285958206103,1,raw,1912833.609375,1213550.609375,1843076.8125,2146140.515625,944446.875,1517182.4375,"Atypical kinase COQ8A, mitochondrial OS=Homo sapiens OX=9606 GN=COQ8A PE=1 SV=1",cellular homeostasis,cytoskeleton;endosome,signal transducer activity;structural molecule activity,56997,COQ8A,NA,NA,ENSG00000163050
Q8IX18,0,6,7710704.1484375,2.984771944528332e-5,0.8228879707561122,-0.2812320616110149,0.27274625907290523,0.7531212750525818,raw,9559911.875,7369068.25,8173767.84375,5857774.34375,6726095.234375,8577607.34375,Probable ATP-dependent RNA helicase DHX40 OS=Homo sapiens OX=9606 GN=DHX40 PE=1 SV=2,NA,NA,RNA binding;structural molecule activity,79665,DHX40,NA,NA,ENSG00000108406
Q9Y5H0,0.3333333333333333,6,401578.890625,1.5544902037192034e-6,0.8226666800424793,-0.28162008277691475,1,1,raw,448570.875,NA,NA,307008.28125,369024.3125,481712.09375,Protocadherin gamma-A3 OS=Homo sapiens OX=9606 GN=PCDHGA3 PE=2 SV=2,cell communication;cell growth;conjugation;defense response,cytoplasm;cytoskeleton,structural molecule activity,56112,PCDHGA3,NA,NA,ENSG00000254245
Q9BVC3,0,6,1287848.03125,4.985190195982273e-6,0.8222515601466037,-0.28234825444312395,0.038012257897630054,0.6429522395902524,raw,1415125.09375,1528832.6875,1306202.71875,1257085.0625,1077121.75,1142720.875,Sister chromatid cohesion protein DCC1 OS=Homo sapiens OX=9606 GN=DSCC1 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding,79075,DSCC1,Gastric cancer network 2,Polymerase switching on the C-strand of the telomere,ENSG00000136982
F8VVT9,0.6666666666666666,6,38250868,1.480670448021171e-4,0.8220612086018626,-0.2826822775512207,0.665151187900776,1,raw,37944340,52895924,31679026,53038008,22755340,31192570,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens OX=9606 GN=AGAP2 PE=1 SV=1",cell differentiation;development;metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,116986,AGAP2,Prolactin signaling pathway; Fragile X syndrome; Netrin-UNC5B signaling pathway,NA,ENSG00000135439
O00291,0,6,1471746.4713541667,5.697051128652954e-6,0.8217496917361773,-0.2832290847813774,0.34231838553067395,0.8247147020235626,raw,1610151.84375,2008798.03125,1218398,1323141.78125,1395050.046875,1274939.125,Huntingtin-interacting protein 1 OS=Homo sapiens OX=9606 GN=HIP1 PE=1 SV=5,cell growth;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,3092,HIP1,DYRK1A,Clathrin-mediated endocytosis; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants,ENSG00000127946
A5D8V6,0.16666666666666666,6,253619.7640625,9.817484133469744e-7,0.8211274571311382,-0.2843219173434504,0.9155448092882055,1,raw,429726.25,NA,105533.3671875,429990.78125,67714.359375,235134.0625,Vacuolar protein sorting-associated protein 37C OS=Homo sapiens OX=9606 GN=VPS37C PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;mitochondrion,structural molecule activity,55048,VPS37C,7q11.23 copy number variation syndrome,Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy,ENSG00000167987
Q9BW71,0,6,1086732.9296875,4.206684496361626e-6,0.8207947976349637,-0.28490650800918904,0.31335920100644993,0.7937979323424178,raw,1089843.234375,1528131.90625,1030975.5625,700374.96875,1254282.71875,916789.1875,HIRA-interacting protein 3 OS=Homo sapiens OX=9606 GN=HIRIP3 PE=1 SV=3,cell growth,membrane,NA,8479,HIRIP3,22q11.2 copy number variation syndrome; 16p11.2 proximal deletion syndrome,NA,ENSG00000149929
P67809,0,6,209119704.15364584,8.094910840696048e-4,0.8206860185001775,-0.2850977196480888,0.1438722311105579,0.6572502130392559,raw,229007262.5,255126657.15625,211233655.578125,220703015.484375,150704575.734375,187943058.46875,Y-box-binding protein 1 OS=Homo sapiens OX=9606 GN=YBX1 PE=1 SV=3,cellular component movement;cellular homeostasis;conjugation;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,RNA binding;structural molecule activity,4904,YBX1,Brain-derived neurotrophic factor (BDNF) signaling pathway; MECP2 and associated Rett syndrome; mRNA processing; Sudden infant death syndrome (SIDS) susceptibility pathways,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway; Noncanonical activation of NOTCH3,ENSG00000065978
O15091,0,6,736118.125,2.849473517673519e-6,0.8204577524621703,-0.285499047415938,0.5466571631061772,1,raw,NA,1047306.625,611907.5,676324.4375,608933.9375,NA,Mitochondrial ribonuclease P catalytic subunit OS=Homo sapiens OX=9606 GN=PRORP PE=1 SV=2,cellular component movement;cellular homeostasis,endosome;membrane,structural molecule activity,9692,PRORP,NA,tRNA processing in the mitochondrion; tRNA modification in the mitochondrion; rRNA processing in the mitochondrion,ENSG00000100890
Q9Y546,0,6,318638.3203125,1.233431734134302e-6,0.8201577651630662,-0.2860266423203152,0.16739805985113462,0.6670444762382309,raw,NA,372848.46875,327460.21875,304816.90625,269427.6875,NA,Leucine-rich repeat-containing protein 42 OS=Homo sapiens OX=9606 GN=LRRC42 PE=1 SV=1,NA,NA,NA,115353,LRRC42,NA,NA,ENSG00000116212
Q92835,0.16666666666666666,6,383206.2890625,1.4833708550370733e-6,0.8199373125384832,-0.28641448070173137,0.6141092419027169,1,raw,NA,520877.53125,321729.53125,425342.6875,264875.40625,NA,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 OS=Homo sapiens OX=9606 GN=INPP5D PE=1 SV=2",cellular homeostasis;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum,structural molecule activity,3635,INPP5D,B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; IL-4 signaling pathway; EGF/EGFR signaling pathway; Netrin-UNC5B signaling pathway,Downstream TCR signaling; Synthesis of PIPs at the plasma membrane; Interleukin receptor SHC signaling; Synthesis of IP3 and IP4 in the cytosol; PECAM1 interactions,ENSG00000168918; ENSG00000281614
P50336,0,6,11744966.833333334,4.546413248218436e-5,0.8198158719705255,-0.2866281734783404,0.5714829126238521,1,raw,13206917,9584418,14800176,14736721,7857458,10284111,Protoporphyrinogen oxidase OS=Homo sapiens OX=9606 GN=PPOX PE=1 SV=1,cellular homeostasis,cytoskeleton;endosome,structural molecule activity,5498,PPOX,Hemesynthesis defects and porphyrias; Heme biosynthesis,Heme biosynthesis,ENSG00000143224
Q8WUM9,0.3333333333333333,6,34601463.333333336,1.339403963746778e-4,0.8193668481333211,-0.28741857282971744,0.12191859204549745,0.6445597830897484,raw,38876216,42313008,39083900,34669876,20448070,32217710,Sodium-dependent phosphate transporter 1 OS=Homo sapiens OX=9606 GN=SLC20A1 PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton,catalytic activity;structural molecule activity,6574,SLC20A1,2q13 copy number variation syndrome,Sodium-coupled phosphate cotransporters,ENSG00000144136
O43169,0,6,227807071.12565118,8.818288726572393e-4,0.8185911635260035,-0.2887850015317505,0.5115173198555043,0.9944212432021446,raw,353023924.96875,175269779.59375,223001030.054688,234133247.582031,143474292.808594,237940151.746094,Cytochrome b5 type B OS=Homo sapiens OX=9606 GN=CYB5B PE=1 SV=3,cellular homeostasis;coagulation,cytoskeleton;endosome;nucleus,DNA binding;structural molecule activity,80777,CYB5B,Oxidation by cytochrome P450,Phase I - Functionalization of compounds,ENSG00000103018
Q9Y4K4,0,6,674978.0625,2.612803636786326e-6,0.8173300164860748,-0.29100937635249524,1,1,raw,NA,NA,742823.875,NA,607132.25,NA,Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens OX=9606 GN=MAP4K5 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;development,nucleus,signal transducer activity;structural molecule activity,11183,MAP4K5,Angiopoietin-like protein 8 regulatory pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Insulin signaling,NA,ENSG00000012983
Q9Y5B0,0,6,2343341.9427083335,9.070950139423632e-6,0.8157821953154898,-0.2937440746536603,0.19041029418390837,0.6816045476187055,raw,2479176.09375,2684902.6875,3065816.75,2215802.5625,1113314.84375,2501038.71875,RNA polymerase II subunit A C-terminal domain phosphatase OS=Homo sapiens OX=9606 GN=CTDP1 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,9150,CTDP1,NA,Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes,ENSG00000060069
O75688,0,6,3277571.7682291665,1.2687303353443958e-5,0.8151418322382951,-0.29487698908462606,0.792244411047241,1,raw,4090195.09375,2835248.9375,3281211.4375,2674652.703125,2106095.3125,4678027.125,Protein phosphatase 1B OS=Homo sapiens OX=9606 GN=PPM1B PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;membrane,structural molecule activity,5495,PPM1B,MAPK signaling pathway,ISG15 antiviral mechanism; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants,ENSG00000138032
Q9C005,0,6,15745943.526041666,6.095169724049183e-5,0.8150713448972569,-0.29500174790617273,0.3791451364574566,0.8631393797055038,raw,17561636.125,18566139.75,14802516.375,18279450.15625,10951932.375,14313986.375,Protein dpy-30 homolog OS=Homo sapiens OX=9606 GN=DPY30 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation,extracellular;membrane,structural molecule activity,84661,DPY30,NA,PKMTs methylate histone lysines; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,ENSG00000162961
P51531,0,6,52929453,2.048870548167051e-4,0.8147680581229125,-0.29553867237806036,0.7286225661685745,1,raw,52646076,58491784,55106392,74170296,32263242,44898928,Probable global transcription activator SNF2L2 OS=Homo sapiens OX=9606 GN=SMARCA2 PE=1 SV=2,cell growth;cellular component movement;defense response;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,6595,SMARCA2,Retinoblastoma gene in cancer; Pathways affected in adenoid cystic carcinoma; VEGFA-VEGFR2 signaling pathway; Rett syndrome causing genes; Thermogenesis,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,ENSG00000080503
Q03426,0,6,1542270.3359375,5.970045200758163e-6,0.8141534539928449,-0.2966273514409125,0.5720007424745969,1,raw,1527528.265625,1642084.59375,1740426.03125,1977905.03125,1028769.25,1336908.84375,Mevalonate kinase OS=Homo sapiens OX=9606 GN=MVK PE=1 SV=1,cellular homeostasis;metabolic process,cytosol;mitochondrion;nucleus,signal transducer activity;structural molecule activity,4598,MVK,Cholesterol biosynthesis pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis,ENSG00000110921
O43251,0,6,2183201.5364583335,8.451055273067972e-6,0.8140819014789301,-0.29675414939638933,0.5113502499703868,0.9944212432021446,raw,2434848.75,2220991.5625,2336549.6875,2735100.75,1469575.65625,1902142.8125,RNA binding protein fox-1 homolog 2 OS=Homo sapiens OX=9606 GN=RBFOX2 PE=1 SV=3,cellular component movement;cellular homeostasis;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,23543,RBFOX2,Mammalian disorder of sexual development,FGFR2 alternative splicing,ENSG00000100320; ENSG00000277564
A0A3B3IS55,0,6,3286054.3854166665,1.2720139106586625e-5,0.8134861388775391,-0.29781033109528,0.651291081350108,1,raw,3863581.28125,2862233.6875,3837568,4509563.90625,1521571.0625,3121808.375,Actin-binding LIM protein 1 OS=Homo sapiens OX=9606 GN=ABLIM1 PE=1 SV=1,cell growth,nucleus,motor activity;structural molecule activity,NA,ABLIM1,Male infertility,NA,ENSG00000099204
P33316,0.16666666666666666,6,18143463.015625,7.02323657387357e-5,0.8132146182554056,-0.298291945746249,0.30172208550322926,0.7822150763466589,raw,18832257.5,25096658.6875,16036941.9375,15314667.09375,15230994.1875,18349258.6875,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial OS=Homo sapiens OX=9606 GN=DUT PE=1 SV=4",cell proliferation;cellular homeostasis,endosome;membrane,structural molecule activity,1854,DUT,Pyrimidine metabolism,NA,ENSG00000128951
O43678,0,6,10163665.822916666,3.9343001647846226e-5,0.8130366303924758,-0.29860774222410097,0.3736232681394311,0.8594431551104292,raw,11972244.25,10649577.0625,10218578.875,12018321,7464777.5,8658496.25,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 OS=Homo sapiens OX=9606 GN=NDUFA2 PE=1 SV=3,cell growth;cellular homeostasis;conjugation;defense response,cytoskeleton;endosome,catalytic activity,4695,NDUFA2,Electron transport chain: OXPHOS system in mitochondria; Nonalcoholic fatty liver disease; Oxidative phosphorylation,Complex I biogenesis,ENSG00000131495
Q93034,0,6,5717721.838541667,2.2132992527996813e-5,0.8127962378226837,-0.29903437054194715,0.2488839340369284,0.7316541032247736,raw,6813403.0625,6642523.171875,5920991.484375,6338942.5625,3191452.90625,5399017.84375,Cullin-5 OS=Homo sapiens OX=9606 GN=CUL5 PE=1 SV=4,cell differentiation;cell organization and biogenesis;cellular homeostasis;conjugation;development,cytosol;nucleus,catalytic activity;structural molecule activity,8065,CUL5,Apoptosis-related network due to altered Notch3 in ovarian cancer; Dual hijack model of Vif in HIV infection; Modulators of TCR signaling and T cell activation,Antigen processing: Ubiquitination & Proteasome degradation; Vif-mediated degradation of APOBEC3G; Neddylation; Downregulation of ERBB2 signaling; Inactivation of CSF3 (G-CSF) signaling,ENSG00000166266
Q9UBU9,0,6,9817223.147135416,3.800194075489426e-5,0.8113392457463601,-0.3016228193853645,0.3363814996158006,0.8205987136201499,raw,9952387.671875,13464524.453125,8822905.5078125,10216087.875,9289063.875,7158369.5,Nuclear RNA export factor 1 OS=Homo sapiens OX=9606 GN=NXF1 PE=1 SV=1,cellular homeostasis;conjugation,cytosol;membrane;nucleus,RNA binding,10482,NXF1,mRNA processing,Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript,ENSG00000162231
O94905,0,6,9535895.270833334,3.6912935735073406e-5,0.8112154620789129,-0.30184294396132394,0.23066059046127743,0.7174306065866879,raw,10815073.125,10590542.25,9491171.0625,8591211.625,7295512.625,10431860.9375,Erlin-2 OS=Homo sapiens OX=9606 GN=ERLIN2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,structural molecule activity,11160,ERLIN2,NA,ABC-family proteins mediated transport; Defective CFTR causes cystic fibrosis; Signaling by FGFR1 in disease; Signaling by plasma membrane FGFR1 fusions,ENSG00000147475
A0A087WTP2,0,6,735027.8333333334,2.845253057498453e-6,0.8110752320196085,-0.3020923557497067,1,1,raw,639885.1875,946019.375,NA,NA,NA,619178.9375,Farnesyl pyrophosphate synthase OS=Homo sapiens OX=9606 GN=FDPS PE=1 SV=1,NA,NA,NA,NA,FDPS,Sterol regulatory element-binding proteins (SREBP) signaling; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol synthesis disorders,NA,ENSG00000160752
P01008,0.3333333333333333,6,374253.1875,1.4487138822809885e-6,0.8107994289342694,-0.30258302220735034,0.5692508460112253,1,raw,NA,551301.5625,298004.46875,NA,289752.6875,357954.03125,Antithrombin-III OS=Homo sapiens OX=9606 GN=SERPINC1 PE=1 SV=1,coagulation;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular,DNA binding;structural molecule activity,462,SERPINC1,Complement and coagulation cascades,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Intrinsic Pathway of Fibrin Clot Formation; Common Pathway of Fibrin Clot Formation,ENSG00000117601
P08581,0,6,7392482.731770833,2.861590152265274e-5,0.8105991892480754,-0.3029393624687646,0.5576220978101165,1,raw,8242606.859375,8292142.90625,7202630.90625,9519403.875,4416661.40625,6681450.4375,Hepatocyte growth factor receptor OS=Homo sapiens OX=9606 GN=MET PE=1 SV=4,cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;nucleus,signal transducer activity;structural molecule activity,4233,MET,Glioblastoma signaling pathways; Extracellular vesicle-mediated signaling in recipient cells; Focal adhesion; Hepatocyte growth factor receptor signaling; TGF-beta signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; EGFR tyrosine kinase inhibitor resistance; Malignant pleural mesothelioma; GDNF signaling,"PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RAF/MAP kinase cascade; InlB-mediated entry of Listeria monocytogenes into host cell; MET activates PTK2 signaling; Sema4D mediated inhibition of cell attachment and migration; MET Receptor Activation; MET activates RAS signaling; MET interacts with TNS proteins; MET activates PI3K/AKT signaling; MET activates PTPN11; MET activates RAP1 and RAC1; MET receptor recycling; MET activates STAT3; MECP2 regulates neuronal receptors and channels; Drug-mediated inhibition of MET activation",ENSG00000105976
E9PN81,0.16666666666666666,6,354867.4791666667,1.3736728519882265e-6,0.8099473933446745,-0.3040998879091508,1,1,raw,NA,314431.59375,450261.15625,NA,299909.6875,NA,Ribonuclease H2 subunit C OS=Homo sapiens OX=9606 GN=RNASEH2C PE=1 SV=1,cellular component movement;cellular homeostasis,nucleus,NA,NA,RNASEH2C,NA,NA,ENSG00000172922
Q9NZ32,0,6,3661872.8268229165,1.4174912002228132e-5,0.8093788341219086,-0.3051129729699982,0.889915638814584,1,raw,3470632.8125,3943577.390625,3334699.53125,5736465.78125,2786826.2265625,2699035.21875,Actin-related protein 10 OS=Homo sapiens OX=9606 GN=ACTR10 PE=1 SV=1,conjugation;metabolic process,cell surface;cytosol;endoplasmic reticulum;mitochondrion;nucleus,NA,55860,ACTR10,NA,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Neutrophil degranulation,ENSG00000131966
P26358,0,6,29470136.1953125,1.1407730607200414e-4,0.809263941108394,-0.30531778107669755,0.2194195346822446,0.7087130179153194,raw,31226571.84375,38707341.40625,27973520.96875,26539153.4375,21049773.859375,31324455.65625,DNA (cytosine-5)-methyltransferase 1 OS=Homo sapiens OX=9606 GN=DNMT1 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,1786,DNMT1,Trans-sulfuration pathway; One-carbon metabolism; Retinoblastoma gene in cancer; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; MTHFR deficiency,SUMOylation of DNA methylation proteins; NoRC negatively regulates rRNA expression; PRC2 methylates histones and DNA; Defective pyroptosis; DNA methylation,ENSG00000130816
Q9NZM5,0,6,2312164.171875,8.950262671865789e-6,0.8084658016791676,-0.3067413462859602,0.37627421103375686,0.8615698665976935,raw,3426512.40625,2376951.5,2132605.15625,2927180.09375,1921684,1088051.875,Ribosome biogenesis protein NOP53 OS=Homo sapiens OX=9606 GN=NOP53 PE=1 SV=2,cell differentiation;cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,29997,NOP53,NA,NA,ENSG00000105373
P56381,0,6,15464139.916666666,5.9860850683631304e-5,0.8084592946263585,-0.3067529580703775,0.4482677929051861,0.9287898029210243,raw,13482019.5,22223626,16150481.5,6851375.5,16110440,17966897,"ATP synthase subunit epsilon, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1E PE=1 SV=2",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity;structural molecule activity,514,ATP5F1E,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000124172
P49750,0,6,2138179.9114583335,8.276778993482916e-6,0.8083683385725811,-0.3069152782152928,0.0931689121618495,0.6429522395902524,raw,2277008.4375,2263219.25,2733236.6875,1505465.09375,2209462,1840688,YLP motif-containing protein 1 OS=Homo sapiens OX=9606 GN=YLPM1 PE=1 SV=4,metabolic process,cytosol;membrane,NA,56252,YLPM1,NA,NA,ENSG00000119596
O43760,0,6,20001265.125,7.74238173984025e-5,0.8071294630656493,-0.3091279954330869,0.6731422347008231,1,raw,20216995.75,21222371.75,21099944.5,25903540.25,14534351.625,17030386.875,Synaptogyrin-2 OS=Homo sapiens OX=9606 GN=SYNGR2 PE=1 SV=1,cell growth;conjugation,cytoskeleton;extracellular;nucleus,NA,9144,SYNGR2,NA,NA,ENSG00000108639
Q9NWT6,0,6,2863246.875,1.1083474061821207e-5,0.8070165698573182,-0.30932979932040916,0.3033225811303491,0.7831794684063365,raw,2994667.8125,3619313,2664699.75,2886553.5625,2093401.5625,2920845.5625,Hypoxia-inducible factor 1-alpha inhibitor OS=Homo sapiens OX=9606 GN=HIF1AN PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,55662,HIF1AN,MicroRNA for targeting cancer growth and vascularization in glioblastoma; Photodynamic therapy-induced HIF-1 survival signaling,Cellular response to hypoxia,ENSG00000166135
Q9H5Q4,0,6,2415756.2291666665,9.351261932540049e-6,0.8068654334752463,-0.30960000954532046,0.6160460547225822,1,raw,3277937.140625,2074470.953125,2298371.71875,2575101.828125,2644854.171875,1623801.5625,"Dimethyladenosine transferase 2, mitochondrial OS=Homo sapiens OX=9606 GN=TFB2M PE=1 SV=1",cellular component movement;cellular homeostasis;metabolic process,endosome,structural molecule activity,64216,TFB2M,Energy metabolism; Mitochondrial gene expression,Mitochondrial transcription initiation; Transcriptional activation of mitochondrial biogenesis,ENSG00000162851
Q86WQ0,0,6,3620907.2291666665,1.4016336385499292e-5,0.8064181686000064,-0.3103999517664829,0.40710171638125653,0.8914071190930648,raw,3129300,4902536.5,3865315.5625,4320605.5,2984161.4375,2523524.375,Nuclear receptor 2C2-associated protein OS=Homo sapiens OX=9606 GN=NR2C2AP PE=1 SV=1,NA,membrane,NA,126382,NR2C2AP,NA,Nuclear Receptor transcription pathway,ENSG00000184162
A0A2R8YFB8,0.8333333333333334,6,2090216.2291666667,8.09111416896822e-6,0.8061538078877167,-0.31087297485953397,0.07685600104237648,0.6429522395902524,raw,2423744.75,2482613.25,2210270,2001368.125,1435272.125,1988029.125,Ras-related protein Rab-15 OS=Homo sapiens OX=9606 GN=RAB15 PE=1 SV=1,development,NA,structural molecule activity,NA,RAB15,NA,NA,ENSG00000139998
B7ZC38,0,6,3981968.65625,1.5413985675451727e-5,0.8054705184610209,-0.31209630998836707,0.025563567894708945,0.6429522395902524,raw,4522772.0625,4665570.125,4232561.3125,3649871.125,3757979.1875,3063058.125,Endophilin-B2 OS=Homo sapiens OX=9606 GN=SH3GLB2 PE=1 SV=1,NA,cytosol;membrane,NA,56904,SH3GLB2,NA,NA,ENSG00000148341
P07711,0,6,573346.2708333334,2.219392458508548e-6,0.8053821556106766,-0.3122545872140505,0.3425108542776808,0.8247147020235626,raw,447760.25,798438.1875,665379.3125,535884.625,422243.0625,570372.1875,Procathepsin L OS=Homo sapiens OX=9606 GN=CTSL PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,1514,CTSL,Primary focal segmental glomerulosclerosis (FSGS); Ebola virus infection in host; Mitochondrial immune response to SARS-CoV-2,MHC class II antigen presentation; Collagen degradation; Assembly of collagen fibrils and other multimeric structures; Attachment and Entry; RUNX1 regulates transcription of genes involved in differentiation of keratinocytes; Attachment and Entry; Trafficking and processing of endosomal TLR; Endosomal/Vacuolar pathway,ENSG00000135047
Q13042,0,6,1852914.546875,7.172532169116662e-6,0.8049003830756001,-0.31311785294690364,0.3424408961152971,0.8247147020235626,raw,2137216.84375,2563901.71875,1534275.78125,1720246.65625,2083929.4375,1077916.84375,Cell division cycle protein 16 homolog OS=Homo sapiens OX=9606 GN=CDC16 PE=1 SV=2,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,NA,8881,CDC16,Cell cycle,Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,ENSG00000130177
Q6QNY0,0,6,182130.12239583334,7.050158702960395e-7,0.8043892902531965,-0.31403422135133247,0.6412117233103375,1,raw,193552.078125,190818.109375,193997.515625,245889.234375,155691.21875,112832.578125,Biogenesis of lysosome-related organelles complex 1 subunit 3 OS=Homo sapiens OX=9606 GN=BLOC1S3 PE=1 SV=1,cell growth;coagulation;conjugation;defense response;metabolic process,cytosol;extracellular;nucleus,catalytic activity,388552,BLOC1S3,NA,Golgi Associated Vesicle Biogenesis,ENSG00000189114
O14975,0,6,3119281.6380208335,1.2074570805746211e-5,0.8039870244196182,-0.31475587701117896,0.6363221413783893,1,raw,3879849.5625,2781954.609375,3243563.96875,4134564.703125,2607783.34375,2067973.640625,Very long-chain acyl-CoA synthetase OS=Homo sapiens OX=9606 GN=SLC27A2 PE=1 SV=2,cellular homeostasis;conjugation,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion,catalytic activity;structural molecule activity,11001,SLC27A2,PPAR signaling pathway,Peroxisomal protein import; Neutrophil degranulation; Fatty acyl-CoA biosynthesis; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol; Alpha-oxidation of phytanate; Synthesis of bile acids and bile salts via 24-hydroxycholesterol,ENSG00000140284
Q92793,0,6,393770.9479166667,1.5242660790586296e-06,0.8033678879591302,-0.31586729943379005,1,1,raw,NA,494577.59375,354795.875,NA,NA,331939.375,CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,1387,CREBBP,Androgen receptor signaling pathway; Angiogenesis; TNF-alpha signaling pathway; Notch signaling; Initiation of transcription and translation elongation at the HIV-1 LTR; IL6 signaling pathway; Pathways affected in adenoid cystic carcinoma; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; TGF-beta signaling pathway; VEGFA-VEGFR2 signaling pathway; Wnt signaling pathway and pluripotency; Clear cell renal cell carcinoma pathways; Ebola virus infection in host; Type 2 papillary renal cell carcinoma; Ciliary landscape; Hepatitis B infection; Male infertility; TGF-beta receptor signaling in skeletal dysplasias; Overlap between signal transduction pathways contributing to LMNA laminopathies; 15q13.3 copy number variation syndrome; TGF-beta receptor signaling; Sudden infant death syndrome (SIDS) susceptibility pathways,"Transcriptional regulation of white adipocyte differentiation; PPARA activates gene expression; NPAS4 regulates expression of target genes; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Heme signaling; Formation of the beta-catenin:TCF transactivating complex; SUMOylation of transcription cofactors; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Transcriptional activation of mitochondrial biogenesis; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Cytoprotection by HMOX1; Pre-NOTCH Transcription and Translation; Activation of gene expression by SREBF (SREBP); Nuclear events mediated by NFE2L2; HATs acetylate histones; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; NOTCH3 Intracellular Domain Regulates Transcription; FOXO-mediated transcription of cell death genes; Regulation of FOXO transcriptional activity by acetylation; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells; RORA activates gene expression; Attenuation phase; CD209 (DC-SIGN) signaling; Activation of the TFAP2 (AP-2) family of transcription factors; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Regulation of gene expression by Hypoxia-inducible Factor; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production; NOTCH4 Intracellular Domain Regulates Transcription; RUNX3 regulates NOTCH signaling",ENSG00000005339
A4D1E9,0,6,2363827.3828125,9.150248172025003e-6,0.8032059009261919,-0.31615822648801817,0.3542778135741137,0.8383308462007302,raw,2702599.03125,2597549.859375,2382569.5625,2772920.875,1640957.59375,2086367.375,GTP-binding protein 10 OS=Homo sapiens OX=9606 GN=GTPBP10 PE=1 SV=1,metabolic process,endosome;membrane;nucleus,structural molecule activity,85865,GTPBP10,NA,NA,ENSG00000105793
Q9NZW5,0.16666666666666666,6,1397507.578125,5.409676381240095e-6,0.8028146886478109,-0.31686108176743655,0.39140647634304276,0.8763288281216618,raw,1629719.875,1624500.28125,1249052.96875,990523.53125,1304172.6875,1587076.125,MAGUK p55 subfamily member 6 OS=Homo sapiens OX=9606 GN=MPP6 PE=1 SV=2,cell growth,cytoplasm;cytoskeleton;nucleus,NA,51678,PALS2,NA,NA,ENSG00000105926
Q9BU61,0,6,3761175.4270833335,1.4559307006329109e-5,0.8004279723811613,-0.3211565092148907,0.49230342530216953,0.9772652407166027,raw,4194546.375,4743196.5,3714678,5155448.4375,1401751,3357432.25,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 OS=Homo sapiens OX=9606 GN=NDUFAF3 PE=1 SV=1,cell growth,cytoskeleton;endosome;membrane,NA,25915,NDUFAF3,NA,Complex I biogenesis,ENSG00000178057
P20336,0,6,412858.65625,1.5981535674408908e-6,0.7998911860504045,-0.322124339915864,1,1,raw,NA,NA,476415.25,NA,313610.40625,448550.3125,Ras-related protein Rab-3A OS=Homo sapiens OX=9606 GN=RAB3A PE=1 SV=1,cell death;cell growth;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,motor activity;structural molecule activity,5864,RAB3A,Synaptic vesicle pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Intracellular trafficking proteins involved in CMT neuropathy,"Neutrophil degranulation; RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation; Sensory processing of sound by inner hair cells of the cochlea; Glutamate Neurotransmitter Release Cycle; Serotonin Neurotransmitter Release Cycle; Norepinephrine Neurotransmitter Release Cycle; Dopamine Neurotransmitter Release Cycle; Acetylcholine Neurotransmitter Release Cycle; GABA synthesis, release, reuptake and degradation",ENSG00000105649
Q5W111,0,6,1986687.3333333335,7.690359402888981e-6,0.7997480011899668,-0.32238261326935935,0.519868523417654,1,raw,1761813.875,4742540,828899.25,1827907.25,1409007.125,1349956.5,SPRY domain-containing protein 7 OS=Homo sapiens OX=9606 GN=SPRYD7 PE=1 SV=2,NA,NA,NA,57213,SPRYD7,NA,NA,ENSG00000123178
O60784,0,6,2852737.2890625,1.1042792022086591e-5,0.7992965126813224,-0.32319730009527103,0.8179387831682943,1,raw,3033263,2604346.875,2485007.296875,2081645.375,1719160.21875,5193000.96875,Target of Myb protein 1 OS=Homo sapiens OX=9606 GN=TOM1 PE=1 SV=2,cell growth;cellular homeostasis;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,motor activity;structural molecule activity,10043,TOM1,NA,Neutrophil degranulation,ENSG00000100284
Q7Z5L9,0,6,504051.4869791667,1.9511560915458968e-6,0.7992172351637687,-0.3233403996234128,0.9473542309135752,1,raw,600792.5,460671.15625,471669.4375,376966.34375,254958.359375,859251.125,Interferon regulatory factor 2-binding protein 2 OS=Homo sapiens OX=9606 GN=IRF2BP2 PE=1 SV=2,cellular component movement;metabolic process,membrane;nucleus,structural molecule activity,359948,IRF2BP2,NA,NA,ENSG00000168264
Q9BVG9,0,6,893927.7291666666,3.4603459750083485e-6,0.7982503009891462,-0.32508690310769445,0.5123234286655028,0.9957139915248271,raw,1341117.75,994211,650719.0625,1182390,519436.6875,675691.875,Phosphatidylserine synthase 2 OS=Homo sapiens OX=9606 GN=PTDSS2 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,81490,PTDSS2,Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids,Synthesis of PS,ENSG00000174915
Q9NWX6,0,6,2710598.9427083335,1.0492582157627535e-5,0.7978439241637221,-0.32582154375008365,0.15193398375029593,0.6638855679885327,raw,3077261.75,3409846.125,3164615.03125,2786006,1300995.875,2524868.875,Probable tRNA(His) guanylyltransferase OS=Homo sapiens OX=9606 GN=THG1L PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;coagulation,cytoskeleton;cytosol;endosome;nucleus,DNA binding;RNA binding;structural molecule activity,54974,THG1L,NA,tRNA modification in the nucleus and cytosol,ENSG00000113272
D6RF23,0.6666666666666666,6,1162972.6354166667,4.501804280934901e-6,0.7977052523579584,-0.32607231775308393,0.44033368252215543,0.9233600879723239,raw,942135.1875,1480465.5625,1400956.3125,751546.1875,1426671.875,976060.6875,Receptor of-activated protein C kinase 1 OS=Homo sapiens OX=9606 GN=RACK1 PE=1 SV=1,defense response,Golgi,protein binding,NA,RACK1,Measles virus infection; Angiotensin II receptor type 1 pathway,NA,ENSG00000204628
Q9Y3L3,0,6,7703712.377604167,2.982065467788444e-5,0.7974865531671737,-0.32646790183128144,0.3024337967743668,0.7825518083423609,raw,8595042.0625,9225119.984375,7348336.25,6854430.46875,5425092.71875,8774252.78125,SH3 domain-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3BP1 PE=1 SV=3,cell growth;conjugation;development;metabolic process,cytoplasm;cytosol;membrane;nucleus,antioxidant activity;DNA binding;structural molecule activity,23616,SH3BP1,NA,RAC1 GTPase cycle,ENSG00000100092
P22223,0,6,7290615.036458333,2.8221577174098757e-5,0.7968132128128614,-0.32768652441215873,0.6126774577465899,1,raw,7829314.40625,10616774.125,5444911.75,10460011.375,5054100.9375,4338577.625,Cadherin-3 OS=Homo sapiens OX=9606 GN=CDH3 PE=1 SV=2,cell communication;cell death;coagulation;development;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,1001,CDH3,Overview of nanoparticle effects; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Malignant pleural mesothelioma,Adherens junctions interactions,ENSG00000062038
P09455,0,6,5440859.666666667,2.1061274008902628e-5,0.7961009031210036,-0.32897679576858474,0.09017868688073391,0.6429522395902524,raw,6207582,6563103.5,5353214,4649921,4261698.5,5609639,Retinol-binding protein 1 OS=Homo sapiens OX=9606 GN=RBP1 PE=1 SV=2,cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5947,RBP1,Retinoblastoma gene in cancer; Vitamin A and carotenoid metabolism,Retinoid metabolism and transport; The canonical retinoid cycle in rods (twilight vision); Retinoid cycle disease events,ENSG00000114115
O75503,0,6,1257910.625,4.869304112757235e-6,0.7947059165267014,-0.3315070096609394,0.6856116473141691,1,raw,541048.375,1730587.25,1808448.0625,1259669.0625,770526.625,1437184.375,Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens OX=9606 GN=CLN5 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,1203,CLN5,NA,NA,ENSG00000102805
P52594,0,6,6343174.802083333,2.4554087180655174e-5,0.794346741675023,-0.3321591967152558,0.6254662726929828,1,raw,6774032.53125,9820728.03125,4204818.375,7801063.3125,2746468.1875,6711938.375,Arf-GAP domain and FG repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=AGFG1 PE=1 SV=2,cell growth;cellular homeostasis;conjugation,cytosol;membrane;nucleus,DNA binding;RNA binding;structural molecule activity,3267,AGFG1,NA,Cargo recognition for clathrin-mediated endocytosis,ENSG00000173744
Q9P032,0,6,3685362.09375,1.4265837686279573e-5,0.7941848351408515,-0.3324532818416135,0.6324600863143439,1,raw,3579662.0625,4206241.1875,4069841.625,5142729.125,1881492.0625,3232206.5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 OS=Homo sapiens OX=9606 GN=NDUFAF4 PE=1 SV=1,cell growth;coagulation;metabolic process,cytoskeleton;endosome,structural molecule activity,29078,NDUFAF4,NA,Complex I biogenesis,ENSG00000123545
Q99622,0,6,1883434.5416666667,7.2906734211316e-6,0.7939842634575341,-0.33281768104149523,0.3118995286187562,0.7920821775382559,raw,1986440.3125,2622494.75,1754292.6875,2082219.5625,1031926.5625,1823233.375,Protein C10 OS=Homo sapiens OX=9606 GN=C12orf57 PE=1 SV=1,cell growth;defense response;metabolic process,membrane;nucleus,NA,113246,C12orf57,NA,NA,ENSG00000111678
P26583,0,6,120066595.52083333,4.6477130867254835e-4,0.7936972474640224,-0.3333392926520828,0.5232026941472915,1,raw,125749582.5,117954193,139818107.5,151305022.25,85765570.375,99807097.5,High mobility group protein B2 OS=Homo sapiens OX=9606 GN=HMGB2 PE=1 SV=2,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cell surface;membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,3148,HMGB2,Retinoblastoma gene in cancer; Ectoderm differentiation; Ectoderm differentiation,Apoptosis induced DNA fragmentation,ENSG00000164104
Q14643,0.5,6,744805.9166666666,2.8831034901473407e-6,0.7934506235240052,-0.3337876480253845,0.15080029667366207,0.6638855679885327,raw,701486.625,817623.875,1058917.25,679448,556595,654764.75,"Inositol 1,4,5-trisphosphate receptor type 1 OS=Homo sapiens OX=9606 GN=ITPR1 PE=1 SV=3",coagulation;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,catalytic activity;structural molecule activity,3708,ITPR1,Alzheimer's disease and miRNA effects; Myometrial relaxation and contraction pathways; G protein signaling pathways; Cell-type dependent selectivity of CCK2R signaling; Resistin as a regulator of inflammation; Fragile X syndrome; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Vitamin D-sensitive calcium signaling in depression; PKC-gamma calcium signaling pathway in ataxia; Type I collagen synthesis in the context of osteogenesis imperfecta; GPR143 in melanocytes and retinal pigment epithelium cells; STING pathway in Kawasaki-like disease and COVID-19; Alzheimer's disease; GDNF signaling; Calcium regulation in cardiac cells; T-cell receptor signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling,Ca2+ pathway; VEGFR2 mediated cell proliferation; Role of phospholipids in phagocytosis; FCERI mediated Ca+2 mobilization; FCGR3A-mediated IL10 synthesis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Ion homeostasis; cGMP effects; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Elevation of cytosolic Ca2+ levels; PLC beta mediated events; DAG and IP3 signaling; CLEC7A (Dectin-1) induces NFAT activation; Effects of PIP2 hydrolysis,ENSG00000150995
Q04206,0,6,8514187.796875,3.2957961267010445e-5,0.792435014297523,-0.335635466758195,0.17017433205336335,0.668039680404208,raw,10085165.03125,9541447.3125,8501835.34375,9167403.21875,6228298.9375,7560976.9375,Transcription factor p65 OS=Homo sapiens OX=9606 GN=RELA PE=1 SV=2,cell death;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;membrane;nucleus,motor activity;RNA binding;structural molecule activity,5970,RELA,Androgen receptor signaling pathway; Nucleotide-binding oligomerization domain (NOD) pathway; Osteopontin signaling; Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; IL-1 signaling pathway; RANKL/RANK signaling pathway; Leptin signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; IL-17 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; B cell receptor signaling pathway; AGE/RAGE pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis; Aryl hydrocarbon receptor pathway; Ebstein-Barr virus LMP1 signaling; Interleukin-1 (IL-1) structural pathway; Nod-like receptor (NLR) signaling pathway; RAC1/PAK1/p38/MMP2 pathway; Initiation of transcription and translation elongation at the HIV-1 LTR; Photodynamic therapy-induced NF-kB survival signaling; MAPK signaling pathway; Toll-like receptor signaling related to MyD88; Novel intracellular components of RIG-I-like receptor pathway; VEGFA-VEGFR2 signaling pathway; ApoE and miR-146 in inflammation and atherosclerosis; Chemokine signaling pathway; IL-4 signaling pathway; NO/cGMP/PKG mediated neuroprotection; Fibrin complement receptor 3 signaling pathway; PI3K/AKT/mTOR - vitamin D3 signaling; PI3K-Akt signaling pathway; Ebola virus infection in host; Ras signaling; Pancreatic adenocarcinoma pathway; miRNAs involvement in the immune response in sepsis; ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; Nonalcoholic fatty liver disease; Supression of HMGB1 mediated inflammation by THBD; Altered glycosylation of MUC1 in tumor microenvironment; Resistin as a regulator of inflammation; Vitamin D in inflammatory diseases; Signal transduction through IL1R; Canonical NF-kB pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; Head and neck squamous cell carcinoma; IL-18 signaling pathway; CAMKK2 pathway; Activation of NLRP3 inflammasome by SARS-CoV-2; Neuroinflammation; STING pathway in Kawasaki-like disease and COVID-19; Modulators of TCR signaling and T cell activation; CCL18 signaling pathway; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Alzheimer's disease; GDNF signaling; T-cell receptor signaling pathway; Toll-like receptor signaling pathway,FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; Dectin-1 mediated noncanonical NF-kB signaling; Transcriptional regulation of white adipocyte differentiation; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; PKMTs methylate histone lysines; RIP-mediated NFkB activation via ZBP1; NF-kB is activated and signals survival; TAK1-dependent IKK and NF-kappa-B activation  ; IkBA variant leads to EDA-ID; TRAF6 mediated NF-kB activation; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; SARS-CoV-1 activates/modulates innate immune responses; CD209 (DC-SIGN) signaling; Interleukin-1 processing; CLEC7A/inflammasome pathway; Regulated proteolysis of p75NTR; DEx/H-box helicases activate type I IFN and inflammatory cytokines production ; SUMOylation of immune response proteins,ENSG00000173039
Q6IA86,0,6,3934075.34375,1.5228593248601195e-5,0.7916046736060821,-0.33714796485613935,0.5105471228872117,0.9944212432021446,raw,4426182,6325535.78125,2698001.34375,1276421,3870988.25,5007323.6875,Elongator complex protein 2 OS=Homo sapiens OX=9606 GN=ELP2 PE=1 SV=2,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,55250,ELP2,NA,HATs acetylate histones,ENSG00000134759
Q330K2,0.16666666666666666,6,206126.1953125,7.97903372969886e-7,0.7912513791245337,-0.33779198577527236,1,1,raw,230147.703125,NA,NA,NA,NA,182104.6875,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 OS=Homo sapiens OX=9606 GN=NDUFAF6 PE=1 SV=2",cell growth;cellular homeostasis,cytoskeleton;endosome;membrane;nucleus,NA,137682,NDUFAF6,NA,Complex I biogenesis,ENSG00000156170
Q9UKJ3,0,6,364911.16796875,1.4125514290661792e-6,0.7900531054025587,-0.3399784639698665,0.5875806032012345,1,raw,217146.4375,691992.71875,NA,NA,248274.828125,302230.6875,G patch domain-containing protein 8 OS=Homo sapiens OX=9606 GN=GPATCH8 PE=1 SV=2,NA,membrane,structural molecule activity,23131,GPATCH8,NA,NA,ENSG00000186566
A0A0A0MQS1,0,6,1868336.1822916667,7.23222848717568e-6,0.7897924312917001,-0.3404545526022066,0.7907421430670553,1,raw,1767953.84375,2225008.75,1908742.96875,2996596.96875,804203.8125,1507510.75,Pyrroline-5-carboxylate reductase OS=Homo sapiens OX=9606 GN=PYCR3 PE=1 SV=1,cellular homeostasis,cytosol;endoplasmic reticulum;nucleus,structural molecule activity,65263,PYCR3,NA,NA,ENSG00000104524; ENSG00000276657
A0A0C4DFX9,0,6,9802013.875,3.7943066483631127e-5,0.7896438327995556,-0.34072601947074305,0.23340082207765098,0.718951462768674,raw,11115584.1875,11714994.4375,9484763.21875,11109254.34375,7489584.78125,7897902.28125,Negative elongation factor A OS=Homo sapiens OX=9606 GN=NELFA PE=1 SV=1,NA,cytosol;membrane,NA,7469,NELFA,Initiation of transcription and translation elongation at the HIV-1 LTR,NA,ENSG00000185049
Q13671,0,6,1909782.8880208333,7.3926664472789825e-6,0.7880671203016875,-0.34360958449181395,0.5410122847097658,1,raw,1938007.15625,2369862.59375,1925369.71875,2608382.46875,1089795.671875,1527279.71875,Ras and Rab interactor 1 OS=Homo sapiens OX=9606 GN=RIN1 PE=1 SV=4,conjugation;development,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,9610,RIN1,Ras signaling; EGF/EGFR signaling pathway,RAB GEFs exchange GTP for GDP on RABs,ENSG00000174791
O94842,0,6,1448894.3072916667,5.608591635392108e-6,0.7880132440035574,-0.3437082178736189,0.169825139052196,0.668039680404208,raw,1678881.03125,1748810.3125,1755448.09375,642288.5625,1489852.15625,1378085.6875,TOX high mobility group box family member 4 OS=Homo sapiens OX=9606 GN=TOX4 PE=1 SV=1,metabolic process,membrane;nucleus,RNA binding,9878,TOX4,NA,NA,ENSG00000092203
P0CG12,0.3333333333333333,6,1403244.1822916667,5.431882466240777e-6,0.7879827869179404,-0.3437639797988052,0.21106269631431598,0.7016553543929079,raw,1330310.15625,1813700.46875,1481109.65625,1429164.75,1037416.625,1327763.4375,Decreased expression in renal and prostate cancer protein OS=Homo sapiens OX=9606 GN=DERPC PE=1 SV=1,NA,membrane,NA,NA,DERPC,NA,NA,ENSG00000286140
P78337,0.6666666666666666,6,320785.0078125,1.2417414455436912e-6,0.7879146991335539,-0.3438886451527512,0.08505096073223264,0.6429522395902524,raw,355305.59375,397595.34375,338506.875,279950.5,328965.03125,224386.703125,Pituitary homeobox 1 OS=Homo sapiens OX=9606 GN=PITX1 PE=1 SV=2,cellular component movement;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,5307,PITX1,NA,NA,ENSG00000069011
Q8NBN7,0,6,3622246.9140625,1.402152223339932e-5,0.7878061995186179,-0.34408732482602067,0.3990785124568803,0.8828783020957324,raw,3957766.59375,5128741.453125,3083243.5625,3726432.125,1796843.4375,4040454.3125,Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2,cellular homeostasis;defense response;metabolic process,cytoskeleton;endosome,structural molecule activity,112724,RDH13,NA,RA biosynthesis pathway,ENSG00000160439; ENSG00000273944; ENSG00000274418; ENSG00000274504; ENSG00000275474; ENSG00000276341; ENSG00000276684; ENSG00000276826; ENSG00000278149; ENSG00000278284
P10412,0,6,620444895.7916666,0.0024017086927917448,0.7873388750574412,-0.3449433814690433,0.25508803023650084,0.735366952583477,raw,689659768.75,977105665.4375,511803515.09375,542995946.5,426431907.96875,574672571,Histone H1.4 OS=Homo sapiens OX=9606 GN=H1-4 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,3008,H1-4,Pathways affected in adenoid cystic carcinoma,Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF),ENSG00000168298
Q9UKK3,0,6,9987276.526041666,3.866020820318493e-5,0.7869676207099612,-0.34562381671768955,0.8300960765471117,1,raw,10008039.65625,11498986.90625,9292599.03125,14162732.40625,7876003.15625,7085298,Protein mono-ADP-ribosyltransferase PARP4 OS=Homo sapiens OX=9606 GN=PARP4 PE=1 SV=3,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,143,PARP4,NAD+ biosynthetic pathways; 16p11.2 proximal deletion syndrome,Maturation of nucleoprotein; Nicotinamide salvaging; Maturation of nucleoprotein,ENSG00000102699
P78549,0,6,845015,3.2710074412810967e-6,0.7868988518339939,-0.3457498916015751,1,1,raw,1000045.9375,NA,NA,755658.25,837420.8125,786935,Endonuclease III-like protein 1 OS=Homo sapiens OX=9606 GN=NTHL1 PE=1 SV=2,cell proliferation;cellular homeostasis;coagulation,endosome;membrane,RNA binding;structural molecule activity,4913,NTHL1,"Base excision repair; DNA repair pathways, full network",Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Displacement of DNA glycosylase by APEX1; Defective NTHL1 substrate processing; Defective NTHL1 substrate binding,ENSG00000065057
Q6AI12,0,6,979381.5989583334,3.791133291180023e-6,0.7859313406492312,-0.34752481145114483,0.6967894539151683,1,raw,1232222.625,1134834.5,758914.6875,1370804.625,487611.15625,891902,Ankyrin repeat domain-containing protein 40 OS=Homo sapiens OX=9606 GN=ANKRD40 PE=1 SV=2,NA,NA,NA,91369,ANKRD40,NA,NA,ENSG00000154945
E9PL71,0,6,57069756.708333336,2.2091394693000732e-4,0.7857470442740748,-0.347863154804672,0.7083116639480009,1,raw,50804987.375,78790895.5,52518443.5,83862958.125,35175044,41266211.75,Elongation factor 1-delta (Fragment) OS=Homo sapiens OX=9606 GN=EEF1D PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,nucleus,RNA binding,NA,EEF1D,NA,NA,ENSG00000104529; ENSG00000273594
P25942,0,6,1154443.6458333333,4.468789022751681e-6,0.7857425978694985,-0.3478713187857254,0.5002287965237808,0.9846858703893063,raw,984779.625,1821187.375,1060877,1507708.375,718533.25,833576.25,Tumor necrosis factor receptor superfamily member 5 OS=Homo sapiens OX=9606 GN=CD40 PE=1 SV=1,cell differentiation;cell growth;coagulation;development;metabolic process,cytoplasm;cytoskeleton;nucleus,structural molecule activity,958,CD40,"Allograft rejection; Complement system; Vitamin D receptor pathway; Nod-like receptor (NLR) signaling pathway; Non-genomic actions of 1,25 dihydroxyvitamin D3; Inflammatory response pathway; Genes associated with the development of rheumatoid arthritis; Extrafollicular B cell activation by SARS-CoV-2; Toll-like receptor signaling pathway",NA,ENSG00000101017
Q9Y508,0,6,2985845.1666666665,1.1558045429583928e-5,0.785578435046333,-0.3481727681862995,0.45730044524973296,0.9403248735753034,raw,2863727.8125,4283130,2797308.5625,3364734.5625,1400238.625,3205931.4375,E3 ubiquitin-protein ligase RNF114 OS=Homo sapiens OX=9606 GN=RNF114 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane,structural molecule activity,55905,RNF114,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000124226
Q2NKX8,0,6,1373649.0208333333,5.317321194125933e-6,0.7850613743467648,-0.34912264979453617,0.5854348059667166,1,raw,1092674.5625,2095994.5625,1351322.234375,1956794.890625,857816.59375,887291.28125,DNA excision repair protein ERCC-6-like OS=Homo sapiens OX=9606 GN=ERCC6L PE=1 SV=1,cell differentiation;cell growth;metabolic process,cytosol;nucleus,RNA binding;structural molecule activity,54821,ERCC6L,NA,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000186871
Q8NDH2,0.5,6,410822.53125,1.5902718374995543e-6,0.7833797927670363,-0.3522161803474672,1,1,raw,265258.90625,467432.875,544420.875,NA,366177.46875,NA,Coiled-coil domain-containing protein 168 OS=Homo sapiens OX=9606 GN=CCDC168 PE=2 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
Q96Q11,0,6,2037586.9479166667,7.88738906278901e-6,0.7833601661693124,-0.3522523257142153,0.8657993389080397,1,raw,2439680.3125,1315743.3125,2570234.5625,3148725.125,1911148.375,839990,"CCA tRNA nucleotidyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=TRNT1 PE=1 SV=2",cellular component movement;cellular homeostasis,endosome;membrane,RNA binding;structural molecule activity,51095,TRNT1,NA,tRNA processing in the nucleus; tRNA processing in the mitochondrion,ENSG00000072756
Q9Y5A9,0,6,4981216.510416667,1.928202016793214e-5,0.7830976330838142,-0.3527359074414017,0.41781340559856456,0.9039170734430766,raw,4700754.25,6932828.75,4573221.1875,3581278.6875,5252344.375,4846871.8125,YTH domain-containing family protein 2 OS=Homo sapiens OX=9606 GN=YTHDF2 PE=1 SV=2,cell differentiation;cell growth;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,RNA binding,51441,YTHDF2,NA,NA,ENSG00000198492
H3BPG6,0,6,121466.455078125,4.701900894381555e-7,0.7824384561652246,-0.3539508156562273,1,1,raw,NA,130219.3671875,NA,101888.640625,101138.0625,152619.75,RING-type E3 ubiquitin transferase OS=Homo sapiens OX=9606 GN=ZNF598 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,NA,ZNF598,NA,NA,ENSG00000167962
Q15542,0,6,283524.9140625,1.0975096343698289e-6,0.7823238069307091,-0.3541622265347666,1,1,raw,NA,318151.96875,NA,248897.859375,NA,NA,Transcription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;membrane;nucleus,structural molecule activity,6877,TAF5,Eukaryotic transcription initiation,RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Regulation of TP53 Activity through Phosphorylation,ENSG00000148835
Q96E52,0.16666666666666666,6,436502.6875,1.6896783358303665e-6,0.7822070510134689,-0.3543775539375524,0.3865346299337856,0.8718036490354405,raw,393315.0625,513226.78125,538437.25,453489.6875,NA,284044.65625,"Metalloendopeptidase OMA1, mitochondrial OS=Homo sapiens OX=9606 GN=OMA1 PE=1 SV=1",cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoskeleton;endosome,structural molecule activity,115209,OMA1,NA,Regulation of Apoptosis,ENSG00000162600
Q13888,0,6,711547.046875,2.75436020088367e-6,0.781908813532188,-0.3549277251239951,0.7737323037941151,1,raw,729467.375,939308.9375,577016.8125,1095052.625,451174.53125,477262,General transcription factor IIH subunit 2 OS=Homo sapiens OX=9606 GN=GTF2H2 PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,membrane,structural molecule activity,2966,GTF2H2,"Eukaryotic transcription initiation; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Dual Incision in GG-NER,ENSG00000145736; ENSG00000275045; ENSG00000276910
O95347,0,6,14495887.869791666,5.611279928766345e-5,0.7808830324368372,-0.35682162995290106,0.213124279277487,0.7026129861227434,raw,16290400.71875,20378120,12749575.53125,13511674.171875,9955927.203125,14089629.59375,Structural maintenance of chromosomes protein 2 OS=Homo sapiens OX=9606 GN=SMC2 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,10592,SMC2,Retinoblastoma gene in cancer,Condensation of Prophase Chromosomes; Condensation of Prometaphase Chromosomes,ENSG00000136824
O75494,0,6,21442893.458333332,8.300428284090351e-5,0.7806388087011685,-0.35727290814307056,0.5510954926678416,1,raw,23699916.75,23463699.25,20964781.75,27226326.5,16365922.25,16936714.25,Serine/arginine-rich splicing factor 10 OS=Homo sapiens OX=9606 GN=SRSF10 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;conjugation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,10772,SRSF10,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000188529
P63220,0,6,129418782.26822917,5.009731186321138e-4,0.7801912673610464,-0.3581002444426255,0.4176049733759117,0.9038582714714452,raw,141449247.9375,155259453.234375,125095133.890625,159063411.5,85287979.03125,110357468.015625,40S ribosomal protein S21 OS=Homo sapiens OX=9606 GN=RPS21 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis,cytosol;extracellular;Golgi;membrane;nucleus,structural molecule activity,6227,RPS21,Cytoplasmic ribosomal proteins,"Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery",ENSG00000171858
Q86W34,0.3333333333333333,6,608316.0875,2.35475873074857e-6,0.7801446150620261,-0.35818651438132365,0.6299550084962848,1,raw,582792.3125,735683.4375,NA,840215.3125,375504.21875,507385.15625,Archaemetzincin-2 OS=Homo sapiens OX=9606 GN=AMZ2 PE=1 SV=2,cell organization and biogenesis,NA,structural molecule activity,51321,AMZ2,NA,NA,ENSG00000196704
Q9NYY8,0,6,1905359.3125,7.375543025273794e-6,0.7791774569950003,-0.359976156625199,0.5494747686428836,1,raw,2507676.59375,2254249.15625,1336726.3125,1756460.125,1894764,1682279.6875,"FAST kinase domain-containing protein 2, mitochondrial OS=Homo sapiens OX=9606 GN=FASTKD2 PE=1 SV=1",cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,endosome;nucleus,RNA binding,22868,FASTKD2,NA,NA,ENSG00000118246
Q5JSZ5,0,6,411883.48828125,1.5943787448847466e-6,0.7786888844098944,-0.36088106258538544,0.5838280795475446,1,raw,351427.71875,569864.1875,NA,466814.9375,NA,259427.109375,Protein PRRC2B OS=Homo sapiens OX=9606 GN=PRRC2B PE=1 SV=2,metabolic process,NA,NA,84726,PRRC2B,NA,NA,ENSG00000288701
Q13057,0,6,16306853.588541666,6.312294980799293e-5,0.7783810507476879,-0.3614515059465246,0.5795386803204575,1,raw,15357033.625,17959819.4375,19327856.0625,21976164.53125,9240664.75,13979583.125,Bifunctional coenzyme A synthase OS=Homo sapiens OX=9606 GN=COASY PE=1 SV=4,cellular homeostasis,cytoskeleton;endosome,signal transducer activity;structural molecule activity,80347,COASY,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway,Coenzyme A biosynthesis,ENSG00000068120
Q5QPA5,0,6,2964933.6979166665,1.1477098263096507e-5,0.7770573035867419,-0.36390710172148005,0.5147924286164632,0.9988615467241881,raw,3373434.125,3395126.1875,2802319.75,2621351.625,1828851.5625,3768518.9375,"39S ribosomal protein S18a, mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPS18A PE=1 SV=9",cell organization and biogenesis;cellular homeostasis,endosome;Golgi;nucleus,structural molecule activity,NA,MRPS18A,NA,NA,ENSG00000096080
O95551,0,6,880160.4479166666,3.4070535726072554e-6,0.7762993508021071,-0.36531501381599424,0.2998277517007423,0.7806964943416801,raw,1267831.34375,703522,1066723.15625,1038434.09375,546143.671875,658308.421875,Tyrosyl-DNA phosphodiesterase 2 OS=Homo sapiens OX=9606 GN=TDP2 PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;development,membrane;nucleus,RNA binding;structural molecule activity,51567,TDP2,Oxidative damage response,Nonhomologous End-Joining (NHEJ),ENSG00000111802
P19838,0,6,3782787.1171875,1.4642964691872429e-5,0.7760813527141498,-0.3657202040657497,0.40086894864449524,0.8860057746512888,raw,4225630.375,4607791.453125,3918100.75,4860133.875,3279432.9375,1805633.3125,Nuclear factor NF-kappa-B p105 subunit OS=Homo sapiens OX=9606 GN=NFKB1 PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation;development;metabolic process,cell surface;cytosol;endosome;membrane;nucleus,motor activity;RNA binding;structural molecule activity,4790,NFKB1,"Osteopontin signaling; Selenium micronutrient network; Vitamin B12 metabolism; MicroRNAs in cardiomyocyte hypertrophy; Transcription factors regulate miRNAs related to cardiac hypertrophy; Folate metabolism; IL-1 signaling pathway; RANKL/RANK signaling pathway; Leptin signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; Neural crest differentiation; IL-17 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Quercetin and Nf-kB / AP-1 induced apoptosis; PDGF pathway; Apoptosis; T cell receptor and co-stimulatory signaling; Aryl hydrocarbon receptor pathway; Ebstein-Barr virus LMP1 signaling; Cardiac hypertrophic response; Apoptosis-related network due to altered Notch3 in ovarian cancer; IL1 and megakaryocytes in obesity; Myometrial relaxation and contraction pathways; Melatonin metabolism and effects; RAC1/PAK1/p38/MMP2 pathway; Initiation of transcription and translation elongation at the HIV-1 LTR; Photodynamic therapy-induced NF-kB survival signaling; NAD metabolism, sirtuins and aging; Hepatitis C and hepatocellular carcinoma; MAPK signaling pathway; Apoptosis modulation by HSP70; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; TLR4 signaling and tolerance; Toll-like receptor signaling related to MyD88; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; MYD88 distinct input-output pathway; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Oxidative damage response; IL-4 signaling pathway; Prion disease pathway; NO/cGMP/PKG mediated neuroprotection; Oxidative stress response; Fibrin complement receptor 3 signaling pathway; PI3K-Akt signaling pathway; Ebola virus infection in host; Ras signaling; Pancreatic adenocarcinoma pathway; miRNAs involvement in the immune response in sepsis; ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; Non-genomic actions of 1,25 dihydroxyvitamin D3; Ciliary landscape; Nonalcoholic fatty liver disease; Supression of HMGB1 mediated inflammation by THBD; Altered glycosylation of MUC1 in tumor microenvironment; Resistin as a regulator of inflammation; Vitamin D in inflammatory diseases; Signal transduction through IL1R; Interactions between immune cells and microRNAs in tumor microenvironment; Canonical NF-kB pathway; Cancer immunotherapy by PD-1 blockade; Measles virus infection; Cytosolic DNA-sensing pathway; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; Head and neck squamous cell carcinoma; Aspirin and miRNAs; IL-18 signaling pathway; Autosomal recessive osteopetrosis pathways; FGF23 signaling in hypophosphatemic rickets and related disorders; TGF-beta receptor signaling in skeletal dysplasias; Kisspeptin/kisspeptin receptor system in the ovary; Activation of NLRP3 inflammasome by SARS-CoV-2; Host-pathogen interaction of human coronaviruses - interferon induction; 16p11.2 proximal deletion syndrome; STING pathway in Kawasaki-like disease and COVID-19; RAS and bradykinin pathways in COVID-19; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Modulators of TCR signaling and T cell activation; Neuroinflammation and glutamatergic signaling; Malignant pleural mesothelioma; Prostaglandin signaling; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Inclusion body myositis; Alzheimer's disease; Th17 cell differentiation pathway; Ulcerative colitis signaling; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction; Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; Inflammatory bowel disease signaling; Dravet syndrome; Genetic causes of porto-sinusoidal vascular disease; TGF-beta receptor signaling; Notch signaling pathway; T-cell receptor signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways; Estrogen signaling pathway; Toll-like receptor signaling pathway",FCERI mediated NF-kB activation; Downstream TCR signaling; Transcriptional regulation of white adipocyte differentiation; Activation of NF-kappaB in B cells; HCMV Early Events; Neutrophil degranulation; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; PKMTs methylate histone lysines; RIP-mediated NFkB activation via ZBP1; NF-kB is activated and signals survival; TAK1-dependent IKK and NF-kappa-B activation  ; IkBA variant leads to EDA-ID; MAP3K8 (TPL2)-dependent MAPK1/3 activation; TRAF6 mediated NF-kB activation; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; SARS-CoV-1 activates/modulates innate immune responses; CD209 (DC-SIGN) signaling; Interleukin-1 processing; CLEC7A/inflammasome pathway; Regulated proteolysis of p75NTR; DEx/H-box helicases activate type I IFN and inflammatory cytokines production,ENSG00000109320
Q8N201,0,6,1713282.6953125,6.6320248106664635e-6,0.7749806974113724,-0.3677677175271852,0.4120096656761964,0.8978780271505381,raw,1535662.109375,2152875.046875,1905144.40625,1476450.140625,2068366.78125,1141197.6875,Integrator complex subunit 1 OS=Homo sapiens OX=9606 GN=INTS1 PE=1 SV=2,cell differentiation;cellular component movement;cellular homeostasis;defense response;metabolic process,cytoskeleton;membrane,NA,26173,INTS1,NA,RNA polymerase II transcribes snRNA genes,ENSG00000164880
P52943,0,6,2121780.4583333335,8.21329759586889e-6,0.7727277046303621,-0.3719679710167247,0.8951016352805008,1,raw,1754466.5,2210091.75,2535892.5,3209538.5,1312894.375,1707799.125,Cysteine-rich protein 2 OS=Homo sapiens OX=9606 GN=CRIP2 PE=1 SV=1,metabolic process,nucleus,structural molecule activity,1397,CRIP2,VEGFA-VEGFR2 signaling pathway,NA,ENSG00000182809
P28676,0,6,1583822.859375,6.130892775497156e-6,0.7700660427885677,-0.37694591464121574,0.45267597706261326,0.9356414401466827,raw,2119356.375,1176762.78125,1846568,1592985.6875,1421979.3125,1345285,Grancalcin OS=Homo sapiens OX=9606 GN=GCA PE=1 SV=2,cell growth,cell surface;cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,25801,GCA,NA,Neutrophil degranulation,ENSG00000115271
P78332,0,6,1009889.9622395834,3.909229518246141e-6,0.7696054324405918,-0.37780911214188057,0.313506082513956,0.7937979323424178,raw,747233.84375,1377134.25,1313606.484375,704756.421875,856758.7734375,1059850,RNA-binding protein 6 OS=Homo sapiens OX=9606 GN=RBM6 PE=1 SV=5,cellular component movement;cellular homeostasis,membrane,RNA binding,10180,RBM6,NA,NA,ENSG00000004534
Q9Y3B2,0,6,3163662.1979166665,1.2246365556925174e-5,0.7691752051096752,-0.37861583772419555,0.16231778031818347,0.6638855679885327,raw,4085476.1875,3901314.625,3937931.3125,854464,3028959.125,3173827.9375,Exosome complex component CSL4 OS=Homo sapiens OX=9606 GN=EXOSC1 PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;mitochondrion;nucleus,RNA binding,51013,EXOSC1,NA,"Major pathway of rRNA processing in the nucleolus and cytosol; ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA; mRNA decay by 3' to 5' exoribonuclease",ENSG00000171311
Q9Y2K3,0.8333333333333334,6,2388277,9.24489132008366e-6,0.7689094315587041,-0.37911441911388055,0.8312177711914165,1,raw,1892240.25,2958914,2602699.25,3805722,1454961.375,1615125.125,Myosin-15 OS=Homo sapiens OX=9606 GN=MYH15 PE=1 SV=5,NA,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,22989,MYH15,NA,NA,ENSG00000144821
Q969M3,0,6,1262398.0520833333,4.886674700713413e-6,0.7682750495887337,-0.3803051932666102,0.5965944420032768,1,raw,1188253.875,1600920.5,1288095,1747709.75,759797.9375,989611.25,Protein YIPF5 OS=Homo sapiens OX=9606 GN=YIPF5 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;extracellular;membrane;nucleus,NA,81555,YIPF5,NA,NA,ENSG00000145817
Q6P1M0,0,6,3878969.5833333335,1.501528182527691e-5,0.7674760785366314,-0.38180631106827134,0.2826443723570766,0.7642736213388397,raw,3806942.8125,5467091.03125,3671624.25,4090687.875,2817883.78125,3419587.75,Long-chain fatty acid transport protein 4 OS=Homo sapiens OX=9606 GN=SLC27A4 PE=1 SV=1,cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,catalytic activity;structural molecule activity,10999,SLC27A4,PPAR signaling pathway; Fatty acid transporters,Transport of fatty acids; Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),ENSG00000167114
Q7L4I2,0,6,2791016.3854166665,1.0803873736484424e-5,0.7653916437425913,-0.3857299445955246,0.24739430142748062,0.7316541032247736,raw,3341371.125,2797653.625,3188764.5625,2440653.75,1798732.5,3178922.75,Arginine/serine-rich coiled-coil protein 2 OS=Homo sapiens OX=9606 GN=RSRC2 PE=1 SV=1,NA,NA,NA,65117,RSRC2,NA,NA,ENSG00000111011
Q71RC2,0,6,3448109.8072916665,1.3347446895031886e-5,0.7644502309438087,-0.38750551600606253,0.5493350633640324,1,raw,1890185.046875,6472545.8125,3445376.109375,2486511.453125,3760221.859375,2633818.5625,La-related protein 4 OS=Homo sapiens OX=9606 GN=LARP4 PE=1 SV=3,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;nucleus,RNA binding,113251,LARP4,NA,NA,ENSG00000161813
O15111,0,6,9058683.703125,3.5065675521894496e-5,0.7637583210314797,-0.38881190192593845,0.8653628798050351,1,raw,9489677.625,10217594.90625,8128907.96875,13268296.96875,5999804.5,7247820.25,Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens OX=9606 GN=CHUK PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,1147,CHUK,Nucleotide-binding oligomerization domain (NOD) pathway; Osteopontin signaling; MicroRNAs in cardiomyocyte hypertrophy; IL-1 signaling pathway; RANKL/RANK signaling pathway; Leptin signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Alzheimer's disease and miRNA effects; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis; Ebstein-Barr virus LMP1 signaling; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Nod-like receptor (NLR) signaling pathway; RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced NF-kB survival signaling; MAPK signaling pathway; Canonical and non-canonical Notch signaling; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; Toll-like receptor signaling related to MyD88; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; Chemokine signaling pathway; IL-4 signaling pathway; Fibrin complement receptor 3 signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Pancreatic adenocarcinoma pathway; miRNAs involvement in the immune response in sepsis; Supression of HMGB1 mediated inflammation by THBD; Altered glycosylation of MUC1 in tumor microenvironment; Resistin as a regulator of inflammation; Vitamin D in inflammatory diseases; Signal transduction through IL1R; Canonical NF-kB pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; IL-18 signaling pathway; Host-pathogen interaction of human coronaviruses - interferon induction; Neuroinflammation; STING pathway in Kawasaki-like disease and COVID-19; Modulators of TCR signaling and T cell activation; CCL18 signaling pathway; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Alzheimer's disease; GDNF signaling; T-cell receptor signaling pathway; Estrogen signaling pathway; Toll-like receptor signaling pathway,"FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; ER-Phagosome pathway; Dectin-1 mediated noncanonical NF-kB signaling; NIK-->noncanonical NF-kB signaling; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Constitutive Signaling by AKT1 E17K in Cancer; IKK complex recruitment mediated by RIP1; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; RIP-mediated NFkB activation via ZBP1; TAK1-dependent IKK and NF-kappa-B activation  ; Regulation of TNFR1 signaling; TNFR1-induced NFkappaB signaling pathway; IKBKB deficiency causes SCID; IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR); IkBA variant leads to EDA-ID; MAP3K8 (TPL2)-dependent MAPK1/3 activation; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; Regulation of NF-kappa B signaling; AKT phosphorylates targets in the cytosol",ENSG00000213341
Q96EB6,0,6,602499.9114583334,2.3322446273159773e-6,0.7623478887052344,-0.3914785895902056,0.4717484236763315,0.9525429676692956,raw,256257.640625,885450.71875,989280.015625,754175.53125,310499.4375,419336.125,NAD-dependent protein deacetylase sirtuin-1 OS=Homo sapiens OX=9606 GN=SIRT1 PE=1 SV=2,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoskeleton;cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,23411,SIRT1,"Androgen receptor signaling pathway; Energy metabolism; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Melatonin metabolism and effects; NAD metabolism, sirtuins and aging; NAD+ metabolism; NAD+ biosynthetic pathways; Interactions between LOXL4 and oxidative stress pathway; Somatroph axis (GH) and its relationship to dietary restriction and aging; Caloric restriction and aging; CAMKK2 pathway; 3q29 copy number variation syndrome; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Inclusion body myositis; Prostaglandin and leukotriene metabolism in senescence ; DYRK1A",Regulation of HSF1-mediated heat shock response; Heme signaling; Circadian Clock; SIRT1 negatively regulates rRNA expression; Regulation of FOXO transcriptional activity by acetylation,ENSG00000096717
P16989,0,6,42293812.114583336,1.637170631846141e-4,0.7619522024675455,-0.39222759510295196,0.24089905124890246,0.7266108621466467,raw,44995902.8125,56172568.8125,42459031.78125,49233994.6875,26616647.34375,34284727.25,Y-box-binding protein 3 OS=Homo sapiens OX=9606 GN=YBX3 PE=1 SV=4,coagulation;defense response;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,8531,YBX3,RalA downstream regulated genes; Apoptosis-related network due to altered Notch3 in ovarian cancer,NA,ENSG00000060138
O60927,0,6,1236945.5875,4.788149584530828e-6,0.7618603563042248,-0.39240150888748554,0.580698353309774,1,raw,2185854.96875,293297.625,1882834,281451.71875,NA,1541289.625,E3 ubiquitin-protein ligase PPP1R11 OS=Homo sapiens OX=9606 GN=PPP1R11 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,DNA binding;structural molecule activity,6992,PPP1R11,NA,NA,ENSG00000204619; ENSG00000206501; ENSG00000227720; ENSG00000233314; ENSG00000234058; ENSG00000236560; ENSG00000237403; ENSG00000237829
Q8IU81,0,6,1778024.109375,6.882635329009331e-6,0.7618182010603962,-0.39248133827268034,0.2844290066762879,0.7650076250313386,raw,2049088.5,1975713.96875,1774625.65625,1468803.9375,2047970.46875,1351942.125,Interferon regulatory factor 2-binding protein 1 OS=Homo sapiens OX=9606 GN=IRF2BP1 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,26145,IRF2BP1,NA,NA,ENSG00000170604
Q9NXR7,0,6,2329871.6979166665,9.01880754911527e-6,0.761181014561307,-0.3936885166435737,0.5981339694864011,1,raw,2236964.375,3013369.5,2222904.1875,3136908.5625,1666348.75,1702734.8125,BRISC and BRCA1-A complex member 2 OS=Homo sapiens OX=9606 GN=BABAM2 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;development;metabolic process,cytosol;membrane;nucleus,antioxidant activity;structural molecule activity,9577,BABAM2,NA,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Metalloprotease DUBs; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ),ENSG00000158019
Q14807,0.3333333333333333,6,333476.40625,1.2908691636662404e-6,0.760621578733595,-0.3947492262707602,0.38808430014330186,0.872979446768193,raw,328133.75,237786.09375,573462.84375,318259.4375,209739.90625,NA,Kinesin-like protein KIF22 OS=Homo sapiens OX=9606 GN=KIF22 PE=1 SV=5,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,3835,KIF22,16p11.2 proximal deletion syndrome,COPI-dependent Golgi-to-ER retrograde traffic; MHC class II antigen presentation; Kinesins,ENSG00000079616
P16949,0,6,119323417.3834635,4.6189450622817263e-4,0.7603757450096666,-0.39521558224909975,0.36235927673184826,0.8454202181768983,raw,135786090.75,153249058.796875,107276376.5,91123876.78125,81570354.703125,146934746.769531,Stathmin OS=Homo sapiens OX=9606 GN=STMN1 PE=1 SV=3,cell differentiation;cell growth;defense response;development;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;nucleus,motor activity,3925,STMN1,Microtubule cytoskeleton regulation; Retinoblastoma gene in cancer; RAC1/PAK1/p38/MMP2 pathway; MAPK signaling pathway; EGF/EGFR signaling pathway; IL-18 signaling pathway,Nuclear signaling by ERBB4,ENSG00000117632
P31483,0,6,909326.709375,3.519954595979099e-6,0.7600793810266022,-0.39577799655092083,0.5249598302424511,1,raw,1473323.125,NA,744189.3125,723280.8125,646932.6875,958907.609375,Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,RNA binding,7072,TIA1,NA,FGFR2 alternative splicing,ENSG00000116001
Q9NUQ6,0,6,10152507.895833334,3.929980991454108e-5,0.7600650098288029,-0.3958052745594075,0.3486591877413544,0.8318534222236237,raw,8968314.9375,14813413.875,10311671.25,11259157.5625,6337032.0625,9225457.6875,SPATS2-like protein OS=Homo sapiens OX=9606 GN=SPATS2L PE=1 SV=2,NA,cytosol;membrane;nucleus,NA,26010,SPATS2L,NA,NA,ENSG00000196141
E2QRJ6,0,6,2160420.015625,8.362869235933088e-6,0.759016702413637,-0.3977964619156624,0.8340943270253509,1,raw,1954482.5,2648351.21875,2127467.59375,3416557.46875,1614783.4375,1200877.875,DNA-directed RNA polymerase II subunit RPB11-b2 OS=Homo sapiens OX=9606 GN=POLR2J3 PE=3 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,NA,POLR2J3,NA,NA,ENSG00000168255
P18084,0,6,1451647.6666666667,5.619249740874432e-6,0.7588838858436145,-0.3980489340589511,0.4794301930109715,0.9617230627501859,raw,1534350.21875,2125316.96875,1210210.65625,1929268.25,1164393.65625,746346.25,Integrin beta-5 OS=Homo sapiens OX=9606 GN=ITGB5 PE=1 SV=1,cell communication;cell growth;defense response;development;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity;structural molecule activity,3693,ITGB5,Integrin-mediated cell adhesion; Arrhythmogenic right ventricular cardiomyopathy; miRNA targets in ECM and membrane receptors; Focal adhesion; VEGFA-VEGFR2 signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms,Integrin cell surface interactions; ECM proteoglycans; Syndecan interactions; Smooth Muscle Contraction; Molecules associated with elastic fibres; TGF-beta receptor signaling activates SMADs; Cross-presentation of particulate exogenous antigens (phagosomes),ENSG00000082781
E9PPM1,0,6,3176137.6875,1.2294657503530511e-5,0.7585823452687118,-0.39862229917093267,0.7252852491758199,1,raw,3562203.75,2826556.4375,3617421.125,4473752.75,1874667.1875,2702224.875,Tumor protein p53-inducible protein 11 OS=Homo sapiens OX=9606 GN=TP53I11 PE=1 SV=1,NA,cytoskeleton,NA,NA,TP53I11,NA,NA,ENSG00000175274
Q969G3,0,6,14501627.026041666,5.613501525164092e-5,0.758417354135016,-0.3989361184701794,0.2963397909602702,0.7788269335661613,raw,14235945.25,15716761.4375,17665934.625,16913740.34375,10557515.875,11919864.625,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 OS=Homo sapiens OX=9606 GN=SMARCE1 PE=1 SV=2,cell growth;cellular component movement;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6605,SMARCE1,Androgen receptor signaling pathway; Pathways affected in adenoid cystic carcinoma; Tumor suppressor activity of SMARCB1; Thermogenesis,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines,ENSG00000073584
Q04323,0,6,14191406.6015625,5.4934168737781715e-5,0.756703903582122,-0.40219920735724374,0.08651267886850379,0.6429522395902524,raw,17817686.265625,16362047.5625,13783150.78125,13416305.875,10286536.375,13482712.75,UBX domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBXN1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoskeleton;cytosol;extracellular;membrane;nucleus,structural molecule activity,51035,UBXN1,NA,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; N-glycan trimming in the ER and Calnexin/Calreticulin cycle,ENSG00000162191
Q9UBL6,0,6,1153712.4088541667,4.465958443885988e-6,0.7566365874821361,-0.4023275546845757,0.26062946129488906,0.7417268452744826,raw,1194714.625,1188856.84375,1751532.21875,1423476.8125,459729.15625,903964.796875,Copine-7 OS=Homo sapiens OX=9606 GN=CPNE7 PE=1 SV=1,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;membrane;nucleus,structural molecule activity,27132,CPNE7,NA,Glycerophospholipid biosynthesis,ENSG00000178773
A0A087WVP1,0,6,20598762.62109375,7.973669794593062e-5,0.7561896565700202,-0.4031799791210542,0.3156361399080846,0.7958588159583763,raw,21766593.8125,34309206.71875,16373050.96875,19335513.40625,12381131.7890625,19427079.03125,Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q92530,0,6,8052228.052083333,3.1169740036871504e-5,0.756180462482001,-0.40319752015155186,0.10735176135373461,0.6429522395902524,raw,7872875.4375,10706697.75,8827023.09375,6575898.34375,6234678.03125,8096195.65625,Proteasome inhibitor PI31 subunit OS=Homo sapiens OX=9606 GN=PSMF1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;extracellular;membrane;nucleus,DNA binding;structural molecule activity,9491,PSMF1,NA,UCH proteinases; Ub-specific processing proteases; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,ENSG00000125818
Q6PJG6,0,6,752137.1354166666,2.911482242104299e-6,0.7546027548869231,-0.4062107277708172,1,1,raw,NA,1248302.09375,482733.875,NA,525375.4375,NA,BRCA1-associated ATM activator 1 OS=Homo sapiens OX=9606 GN=BRAT1 PE=1 SV=2,cell differentiation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,NA,221927,BRAT1,NA,NA,ENSG00000106009
Q9UIQ6,0,6,1808570.8515625,7.000880118749404e-6,0.7544362722627201,-0.40652905440516524,0.87860951755505,1,raw,1922426.25,776638.828125,2976586.40625,3225645.0625,1450348.09375,499780.46875,Leucyl-cystinyl aminopeptidase OS=Homo sapiens OX=9606 GN=LNPEP PE=1 SV=3,cell death;cell organization and biogenesis;cellular homeostasis;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,structural molecule activity,4012,LNPEP,NA,Antigen processing: Ubiquitination & Proteasome degradation; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Endosomal/Vacuolar pathway,ENSG00000113441
Q92747,0,6,2130715.4166666665,8.247884337164452e-6,0.7535691176803686,-0.40818825239195927,0.3759844270692932,0.8615698665976935,raw,1514857.0625,3660914.09375,2311294.375,1141549.5,1966628.84375,2189048.625,Actin-related protein 2/3 complex subunit 1A OS=Homo sapiens OX=9606 GN=ARPC1A PE=1 SV=2,cell growth,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity,10552,ARPC1A,Pathogenic Escherichia coli infection,Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Clathrin-mediated endocytosis; EPHB-mediated forward signaling,ENSG00000241685
Q13185,0,6,129676380.19075541,5.019702662820868e-4,0.7533428906690262,-0.4086214251160765,0.4300107961299081,0.9145993870052763,raw,154291142.21875,154181543.167969,116771248.542969,158987993.507813,77674784.2890625,116151569.417969,Chromobox protein homolog 3 OS=Homo sapiens OX=9606 GN=CBX3 PE=1 SV=4,cell growth;coagulation;metabolic process,cytoskeleton;endoplasmic reticulum;membrane;nucleus,structural molecule activity,11335,CBX3,Exercise-induced circadian regulation; Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome; NIPBL role in DNA damage - Cornelia de Lange syndrome,RNA Polymerase I Promoter Escape; Transcriptional Regulation by E2F6; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,ENSG00000122565
Q8WTW3,0,6,633263.8333333334,2.4513301079004818e-6,0.7531718828937365,-0.40894895203416975,1,1,raw,NA,NA,757993.1875,784035.9375,357762.375,NA,Conserved oligomeric Golgi complex subunit 1 OS=Homo sapiens OX=9606 GN=COG1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation,cytoskeleton;extracellular,NA,9382,COG1,NA,COPI-mediated anterograde transport; Intra-Golgi traffic; Retrograde transport at the Trans-Golgi-Network,ENSG00000166685
O15357,0,6,741614.7864583334,2.870750797405135e-6,0.7529365793659104,-0.4093997445819403,0.04673376287843643,0.6429522395902524,raw,869015.09375,903948.1875,742994.828125,724145.6875,559427.984375,650156.9375,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 OS=Homo sapiens OX=9606 GN=INPPL1 PE=1 SV=2",cell communication;cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;extracellular;membrane;nucleus,motor activity;structural molecule activity,3636,INPPL1,EGF/EGFR signaling pathway; Insulin signaling,Synthesis of PIPs at the plasma membrane; Interleukin receptor SHC signaling; Synthesis of IP3 and IP4 in the cytosol,ENSG00000165458
Q8IYS2,0,6,1610042.63671875,6.232388117946863e-6,0.7515417497429433,-0.4120748437409856,0.026504932925243162,0.6429522395902524,raw,1911901.15625,1948281.6875,1667220.96875,1301953.78125,1252986.1640625,1577912.0625,Uncharacterized protein KIAA2013 OS=Homo sapiens OX=9606 GN=KIAA2013 PE=1 SV=1,NA,cytoskeleton,NA,90231,KIAA2013,NA,NA,ENSG00000116685
A0A3B3ITQ6,0,6,2601307.5833333335,1.0069521206303178e-5,0.7501307257766984,-0.41478605795177037,0.9800722990678252,1,raw,2536320.75,2460582,2772801.5,4221605.5,1713963.625,1902572.125,Serine/threonine-protein kinase Nek5 OS=Homo sapiens OX=9606 GN=NEK5 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,NEK5,NA,NA,ENSG00000197168
Q9H4A3,0,6,1309571.4088541667,5.069280217807907e-6,0.7500142979259818,-0.41500999614512285,0.04922142485060895,0.6429522395902524,raw,1641146.171875,1326099.875,1513003.53125,1160644.71875,1134774.28125,1081759.875,Serine/threonine-protein kinase WNK1 OS=Homo sapiens OX=9606 GN=WNK1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;nucleus,DNA binding;signal transducer activity;structural molecule activity,65125,WNK1,Ciliary landscape,Stimuli-sensing channels,ENSG00000060237
O75616,0,6,7000884.510416667,2.710004595080855e-5,0.7482656338271324,-0.4183775780176467,0.12637230947468672,0.646524034332063,raw,7460597.9375,6936712.625,9592229,7177535.3125,5165034.5625,5673197.625,"GTPase Era, mitochondrial OS=Homo sapiens OX=9606 GN=ERAL1 PE=1 SV=2",cell growth,cytoskeleton;cytosol;endosome,protein binding;RNA binding;structural molecule activity,26284,ERAL1,NA,Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination,ENSG00000132591
Q96GX2,0.16666666666666666,6,1360871.25,5.267859133122498e-6,0.7474852016847052,-0.4198830770046069,0.36024877481504136,0.8422895555819307,raw,961433.9375,1929996,1627052.0625,1319777.5,966096.75,NA,Ataxin-7-like protein 3B OS=Homo sapiens OX=9606 GN=ATXN7L3B PE=1 SV=2,metabolic process,nucleus,NA,552889,ATXN7L3B,NA,NA,ENSG00000253719
O94763,0,6,1146555.2083333333,4.4382533070986095e-6,0.7470910466568923,-0.4206440224803313,0.16080623718150597,0.6638855679885327,raw,1659864.625,1253889.65625,1239035.125,478925.46875,1007546.375,1240070,Unconventional prefoldin RPB5 interactor 1 OS=Homo sapiens OX=9606 GN=URI1 PE=1 SV=3,cellular component movement;metabolic process,cytosol;endosome;membrane;nucleus,DNA binding;structural molecule activity,8725,URI1,NA,NA,ENSG00000105176
E9PDI4,0,6,18120094.953125,7.014190923047747e-5,0.7470135191641549,-0.4207937422950802,0.12593076496376965,0.6461789084539729,raw,20986615.5,21830767.5625,18428685.34375,19249645.9375,12547569.875,15677285.5,Ladinin-1 OS=Homo sapiens OX=9606 GN=LAD1 PE=1 SV=1,NA,cell surface;chromosome;endoplasmic reticulum,structural molecule activity,NA,LAD1,NA,NA,ENSG00000159166
Q86U38,0,6,1762761.140625,6.823553201050311e-6,0.7465221975467351,-0.42174293591471923,0.1589835168327036,0.6638855679885327,raw,2337558.9375,2235869.96875,2018549.4375,1793347.5,522114.4375,1669126.5625,Nucleolar protein 9 OS=Homo sapiens OX=9606 GN=NOP9 PE=1 SV=1,cellular component movement;cellular homeostasis;conjugation,membrane;nucleus,NA,161424,NOP9,NA,NA,ENSG00000196943; ENSG00000285326
P13726,0,6,455556.8125,1.7634358249425127e-6,0.7450080147096659,-0.4246721488834444,0.7067605987070695,1,raw,495343.8125,491136.1875,441512.40625,354891.8125,328930.28125,621526.375,Tissue factor OS=Homo sapiens OX=9606 GN=F3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cell surface;chromosome;cytoplasm;cytoskeleton;nucleus,structural molecule activity,2152,F3,Blood clotting cascade; VEGFA-VEGFR2 signaling pathway; Macrophage markers; STING pathway in Kawasaki-like disease and COVID-19; Complement and coagulation cascades,NGF-stimulated transcription; Extrinsic Pathway of Fibrin Clot Formation,ENSG00000117525
Q86YV6,0.3333333333333333,6,690208.9010416666,2.6717613904436487e-06,0.7440717536969416,-0.42648634222175785,0.22900901602472643,0.7149229308598871,raw,645698.4375,704197.9375,1003325.75,480445.96875,629921.0625,677664.25,Myosin light chain kinase family member 4 OS=Homo sapiens OX=9606 GN=MYLK4 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,340156,MYLK4,Focal adhesion,NA,ENSG00000145949
Q9BVJ6,0,6,32304171.796875,1.250477048715124e-4,0.7434213732280412,-0.42774792887379925,0.23422120366433047,0.7192904383575112,raw,31358160.4375,39371634,37722014.53125,36608494.4375,20721375.53125,28043351.84375,U3 small nucleolar RNA-associated protein 14 homolog A OS=Homo sapiens OX=9606 GN=UTP14A PE=1 SV=1,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,NA,10813,UTP14A,NA,Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol,ENSG00000156697
Q53TN4,0,6,760674.1375,2.94452851624241e-6,0.7424739459624858,-0.42958769347255416,0.5740926257165466,1,raw,922112.234375,751047.6875,848882.390625,895144.6875,386183.6875,NA,Cytochrome b reductase 1 OS=Homo sapiens OX=9606 GN=CYBRD1 PE=1 SV=1,conjugation;metabolic process,cytoplasm;cytoskeleton;mitochondrion,catalytic activity;structural molecule activity,79901,CYBRD1,NA,Iron uptake and transport,ENSG00000071967
O94776,0,6,18699334.1015625,7.238411270002582e-5,0.7420291908263957,-0.4304521524723956,0.15575958728885642,0.6638855679885327,raw,18920310.8125,25576732.28125,18807764.46875,18709754.953125,13955910.25,16225531.84375,Metastasis-associated protein MTA2 OS=Homo sapiens OX=9606 GN=MTA2 PE=1 SV=1,cell growth;cell organization and biogenesis;cell proliferation;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,9219,MTA2,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,ENSG00000149480
P05165,0,6,1113357.0494791667,4.309745026596121e-6,0.7404038800741385,-0.4336156392398554,0.8757155898376494,1,raw,1213732.8125,636806.453125,1632390.140625,2024426.546875,701292.375,471493.96875,"Propionyl-CoA carboxylase alpha chain, mitochondrial OS=Homo sapiens OX=9606 GN=PCCA PE=1 SV=4",cellular homeostasis,cytosol;endosome;nucleus,structural molecule activity,5095,PCCA,NA,Biotin transport and metabolism; Defective HLCS causes multiple carboxylase deficiency; Propionyl-CoA catabolism,ENSG00000175198
O94919,0,6,990609.5625,3.834596131834005e-6,0.7401916985523795,-0.4340291393687555,1,1,raw,NA,1138506.25,NA,NA,842712.875,NA,Endonuclease domain-containing 1 protein OS=Homo sapiens OX=9606 GN=ENDOD1 PE=1 SV=2,cellular homeostasis;coagulation,cell surface;cytosol,RNA binding;structural molecule activity,23052,ENDOD1,NA,Platelet degranulation,ENSG00000149218
Q14244,0,6,3168479.2604166665,1.2265012145781722e-5,0.7398029323743986,-0.43478707596963007,0.014976382476407306,0.6429522395902524,raw,3884119.5,3733214.03125,3356488.71875,2761842.6875,2338143.75,2937066.875,Ensconsin OS=Homo sapiens OX=9606 GN=MAP7 PE=1 SV=1,cell growth;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;nucleus,antioxidant activity;structural molecule activity,9053,MAP7,NA,NA,ENSG00000135525
Q15814,0,6,1205517.015625,4.666491279681846e-6,0.7384958334035415,-0.4373383135655516,0.5731080328013951,1,raw,879082.3125,2122820.9375,1087202.28125,1724544.34375,770253.59375,649198.625,Tubulin-specific chaperone C OS=Homo sapiens OX=9606 GN=TBCC PE=1 SV=2,cell growth;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,6903,TBCC,NA,Post-chaperonin tubulin folding pathway,ENSG00000124659
Q86U90,0,6,604318.140625,2.3392828942510265e-6,0.7384579817242674,-0.43741226094214625,0.1445634279473997,0.6572502130392559,raw,808165.8125,725600.1875,565133,535825.25,363796.53125,627388.0625,"YrdC domain-containing protein, mitochondrial OS=Homo sapiens OX=9606 GN=YRDC PE=1 SV=1",cellular component movement;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;endosome;nucleus,RNA binding;structural molecule activity,79693,YRDC,NA,NA,ENSG00000196449
Q9Y3D8,0,6,2349823.7317708335,9.096040794922354e-6,0.7374659417967635,-0.4393516716075576,0.29930086766588565,0.7805333494403178,raw,2469038.4375,3534740.609375,2133774.03125,2214241.125,1140397.375,2606750.8125,Adenylate kinase isoenzyme 6 OS=Homo sapiens OX=9606 GN=AK6 PE=1 SV=1,cellular homeostasis,cytosol;endoplasmic reticulum;membrane;nucleus,signal transducer activity;structural molecule activity,102157402,AK6,NA,Interconversion of nucleotide di- and triphosphates,ENSG00000085231; ENSG00000279247
Q8IZ83,0,6,1504480.90625,5.823764358749937e-6,0.7367590812554962,-0.4407351568417517,0.1107034132278704,0.6429522395902524,raw,1940501.625,1859322.6875,1512292.75,1369872.875,827753.25,1517142.25,Aldehyde dehydrogenase family 16 member A1 OS=Homo sapiens OX=9606 GN=ALDH16A1 PE=1 SV=2,NA,NA,structural molecule activity,126133,ALDH16A1,NA,NA,ENSG00000161618
Q8WUX1,0.6666666666666666,6,360473.915625,1.3953750648179136e-6,0.7366990039207,-0.44085280290701856,0.5263617372432841,1,raw,316336,528014.5,333201.1875,395936.5,228881.390625,NA,Sodium-coupled neutral amino acid transporter 5 OS=Homo sapiens OX=9606 GN=SLC38A5 PE=1 SV=1,conjugation,cytoplasm;cytoskeleton,catalytic activity,92745,SLC38A5,Neuroinflammation and glutamatergic signaling,Amino acid transport across the plasma membrane,ENSG00000017483
A0A0B4J1R6,0.3333333333333333,6,1438251.7916666667,5.567395032014268e-6,0.7364636938227067,-0.4413136898339726,0.14352468977902957,0.6572502130392559,raw,1934558.875,1685745.75,1306568.5,1234699.625,1043205.625,1424732.375,Transketolase OS=Homo sapiens OX=9606 GN=TKT PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
O43542,0.3333333333333333,6,544965.6484375,2.109532601529725e-6,0.7362970612128913,-0.4416401516031839,0.3050298934167469,0.7849075999456834,raw,597649.1875,NA,654204.0625,554257.5625,NA,373751.78125,DNA repair protein XRCC3 OS=Homo sapiens OX=9606 GN=XRCC3 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,7517,XRCC3,Fluoropyrimidine activity; Male infertility,Resolution of D-loop Structures through Holliday Junction Intermediates; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA); Homologous DNA Pairing and Strand Exchange,ENSG00000126215
A1L390,0,6,902859.2395833334,3.4949193696046532e-06,0.7356932202913767,-0.44282379848287806,0.5594789444562368,1,raw,1155975.65625,1301137.765625,618817.0625,197792.0625,1292989.4375,850443.453125,Pleckstrin homology domain-containing family G member 3 OS=Homo sapiens OX=9606 GN=PLEKHG3 PE=1 SV=1,metabolic process,cytosol;endoplasmic reticulum,DNA binding;motor activity,26030,PLEKHG3,NA,RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle,ENSG00000126822
P21589,0,6,8388297.182291667,3.247064549499512e-5,0.7350825818444605,-0.4440217582378343,0.21658648914519416,0.7052519353827845,raw,9482715.375,9891336.375,9674298.40625,9605773.6875,4564251,7111408.25,5'-nucleotidase OS=Homo sapiens OX=9606 GN=NT5E PE=1 SV=1,cell communication;cell proliferation;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane,structural molecule activity,4907,NT5E,Pluripotent stem cell differentiation pathway; NAD+ metabolism,Purinergic signaling in leishmaniasis infection; Purine catabolism; Pyrimidine catabolism; Nicotinate metabolism,ENSG00000135318
P04818,0,6,3465402.140625,1.3414384583724332e-5,0.7347358042804942,-0.4447025148344741,0.39265758949327256,0.8766453461629867,raw,3207810.0625,7927293.875,2143871.625,2966729.1875,2356892.90625,2189815.1875,Thymidylate synthase OS=Homo sapiens OX=9606 GN=TYMS PE=1 SV=3,cell proliferation;cellular homeostasis;defense response;metabolic process,cytoskeleton;cytosol;endosome;membrane;nucleus,RNA binding;structural molecule activity,7298,TYMS,"Fluoropyrimidine activity; One-carbon metabolism; Retinoblastoma gene in cancer; Trans-sulfuration, one-carbon metabolism and related pathways; Ethanol effects on histone modifications; Pyrimidine metabolism",Interconversion of nucleotide di- and triphosphates; G1/S-Specific Transcription,ENSG00000176890
O95239,0,6,1462621.7942708333,5.661729996319361e-6,0.7339608678505171,-0.4462249490708912,0.2432600416621002,0.7296766980978389,raw,1638088.84375,1895024.8125,1625735.625,656591.625,1202293.109375,1757996.75,Chromosome-associated kinesin KIF4A OS=Homo sapiens OX=9606 GN=KIF4A PE=1 SV=3,cell differentiation;cell growth;conjugation,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,24137,KIF4A,Retinoblastoma gene in cancer,Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; MHC class II antigen presentation; Kinesins,ENSG00000090889
Q99805,0,6,14129136.5,5.4693124536696215e-5,0.7334870208811295,-0.4471566573814689,0.287602477363912,0.7679922323249051,raw,12729353.25,20038966.25,14681536.71875,14698321.65625,9305727.96875,13320913.15625,Transmembrane 9 superfamily member 2 OS=Homo sapiens OX=9606 GN=TM9SF2 PE=1 SV=1,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;extracellular;mitochondrion,NA,9375,TM9SF2,NA,NA,ENSG00000125304
P13535,0.16666666666666666,6,1030811,3.990213725856238e-6,0.7334630032072046,-0.4472038984987521,0.29690524739216906,0.7790952437047332,raw,1081705.25,1726043.125,759525.0625,863706.5625,723075,NA,Myosin-8 OS=Homo sapiens OX=9606 GN=MYH8 PE=1 SV=3,cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,4626,MYH8,Striated muscle contraction pathway,Striated Muscle Contraction,ENSG00000133020
P09429,0,6,365473306.8385417,0.0014147274382803612,0.7326238416490841,-0.44885544370545594,0.25384493806017655,0.734567694017451,raw,431808149.21875,392820682.625,405404140.8125,428763458.3125,237034671,297008739.0625,High mobility group protein B1 OS=Homo sapiens OX=9606 GN=HMGB1 PE=1 SV=3,cell growth;cell proliferation;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;RNA binding;structural molecule activity,3146,HMGB1,"Retinoblastoma gene in cancer; VEGFA-VEGFR2 signaling pathway; Supression of HMGB1 mediated inflammation by THBD; Base excision repair; DNA repair pathways, full network; Malignant pleural mesothelioma; Clock-controlled autophagy in bone metabolism; DNA damage response (only ATM dependent)",ER-Phagosome pathway; Neutrophil degranulation; MyD88 deficiency (TLR2/4); IRAK4 deficiency (TLR2/4); Regulation of TLR by endogenous ligand; Apoptosis induced DNA fragmentation; TAK1-dependent IKK and NF-kappa-B activation  ; TRAF6 mediated NF-kB activation; Pyroptosis; Advanced glycosylation endproduct receptor signaling,ENSG00000189403
Q96BW9,0,6,1128994.40625,4.370276390369974e-6,0.7320540631310282,-0.4499778975653622,0.42994675278346306,0.9145993870052763,raw,1342984.875,1234561.3125,1192696.25,903765.625,607745.875,1492212.5,"Phosphatidate cytidylyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=TAMM41 PE=1 SV=2",cellular homeostasis,cytoskeleton;endosome,structural molecule activity,132001,TAMM41,NA,NA,ENSG00000144559
A7XZE4,0,6,15009136.791666666,5.809955815310681e-5,0.7305782227159264,-0.45288934481183624,0.2742685304919093,0.7551026273759062,raw,10458267.5,21730960.5,21305091.75,12508733.25,8175601.25,15876166.5,Beta tropomyosin isoform OS=Homo sapiens OX=9606 GN=TPM2 PE=1 SV=1,NA,endoplasmic reticulum,motor activity,7169,TPM2,Striated muscle contraction pathway,NA,ENSG00000198467
Q9HC07,0,6,3757969.09375,1.4546895463110867e-5,0.7302603066060721,-0.453517280060175,0.09704970992885888,0.6429522395902524,raw,4015524.96875,5251693.9375,3892598.0625,2510578.90625,3042315.0625,3835103.625,Transmembrane protein 165 OS=Homo sapiens OX=9606 GN=TMEM165 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoskeleton;extracellular;mitochondrion;nucleus,catalytic activity,55858,TMEM165,IL-18 signaling pathway,NA,ENSG00000134851
Q02487,0,6,2241635.0989583335,8.677248438583454e-6,0.7302326396543218,-0.4535719396519158,0.2512560463527664,0.7326612824296702,raw,2490987.625,3539613.34375,2030448.21875,934683.90625,1819000.46875,2635077.03125,Desmocollin-2 OS=Homo sapiens OX=9606 GN=DSC2 PE=1 SV=1,cell communication;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,1824,DSC2,Arrhythmogenic right ventricular cardiomyopathy,Formation of the cornified envelope,ENSG00000134755
Q8IXQ6,0,6,476296.4661458333,1.8437179044382773e-6,0.7298493800401186,-0.4543293310176406,0.6192782999298946,1,raw,708244.40625,213159.109375,647720.84375,498744.15625,317171.625,472738.65625,Protein mono-ADP-ribosyltransferase PARP9 OS=Homo sapiens OX=9606 GN=PARP9 PE=1 SV=2,cell proliferation;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;endosome;membrane;nucleus,DNA binding;structural molecule activity,83666,PARP9,NA,Maturation of nucleoprotein; Nicotinamide salvaging; Maturation of nucleoprotein,ENSG00000138496
O15530,0,6,370376.046875,1.4337056802546717e-6,0.7295685262613268,-0.4548846022077913,1,1,raw,NA,428287.21875,NA,312464.875,NA,NA,3-phosphoinositide-dependent protein kinase 1 OS=Homo sapiens OX=9606 GN=PDPK1 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,DNA binding;signal transducer activity;structural molecule activity,5170,PDPK1,MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Cardiac hypertrophic response; Focal adhesion; VEGFA-VEGFR2 signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin-insulin signaling overlap; PPAR signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; EGF/EGFR signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Modulators of TCR signaling and T cell activation; GDNF signaling; ErbB signaling pathway; T-cell receptor signaling pathway; Serotonin HTR1 group and FOS pathway,Role of LAT2/NTAL/LAB on calcium mobilization; FCERI mediated NF-kB activation; Downstream TCR signaling; CLEC7A (Dectin-1) signaling; Constitutive Signaling by AKT1 E17K in Cancer; Regulation of TP53 Degradation; PIP3 activates AKT signaling; GPVI-mediated activation cascade; CD28 dependent PI3K/Akt signaling; G beta:gamma signalling through PI3Kgamma; RHO GTPases activate PKNs; Activation of AKT2; Integrin signaling; RSK activation; VEGFR2 mediated vascular permeability; VEGFR2 mediated cell proliferation; Estrogen-stimulated signaling through PRKCZ; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways,ENSG00000140992
Q6WCQ1,0.5,6,1582484.90625,6.125713631188522e-6,0.7278793874261816,-0.45822868509274173,0.2861768842808286,0.7655844406429082,raw,1526713.25,2620663.75,1514023.875,1907527.125,780513.6875,1145467.75,Myosin phosphatase Rho-interacting protein OS=Homo sapiens OX=9606 GN=MPRIP PE=1 SV=3,cell growth,cytosol;endoplasmic reticulum,motor activity,23164,MPRIP,NA,Signaling by BRAF and RAF1 fusions,ENSG00000133030
Q9H2H8,0,6,5665687.291666667,2.193156960647256e-5,0.7273736265588925,-0.45923147803318437,0.14792384686688484,0.6638855679885327,raw,6967116,6569106.75,5853007.5,6176370,3650328.5,4778195,Peptidyl-prolyl cis-trans isomerase-like 3 OS=Homo sapiens OX=9606 GN=PPIL3 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,53938,PPIL3,NA,mRNA Splicing - Major Pathway,ENSG00000240344
Q5BJH7,0,6,2702739.7708333335,1.0462159727628741e-5,0.7266891863654553,-0.46058965669920615,0.29189702964249215,0.7730231021500684,raw,2822510.9375,4174696.75,2329284.78125,2887632.03125,1692666.0625,2309648.0625,Protein YIF1B OS=Homo sapiens OX=9606 GN=YIF1B PE=1 SV=1,conjugation,cytoskeleton;extracellular;nucleus,NA,90522,YIF1B,NA,NA,ENSG00000167645
Q5TEC6,0.16666666666666666,6,803161419.4427084,0.0031089944906859492,0.7263465610076489,-0.4612700307569608,0.45788547948224373,0.9412524313762942,raw,1043873144.8125,857815218.5,766140336,1070158109.875,457910573.53125,623071133.9375,Histone H3 OS=Homo sapiens OX=9606 GN=H3-2 PE=1 SV=1,NA,nucleus,RNA binding;structural molecule activity,NA,H3-7,NA,NA,ENSG00000273213
Q9UPU5,0,6,976401.4114583334,3.7795971462726394e-6,0.725451326217122,-0.46304927422850845,0.26762014505270243,0.7473260925206285,raw,956815.0859375,987197.734375,1582218.4765625,1147822.4921875,833607.4609375,350747.21875,Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,23358,USP24,NA,Ub-specific processing proteases,ENSG00000162402
P52701,0,6,11617192.4921875,4.496952490635101e-5,0.7249491826024932,-0.4640482260727447,0.14387665208344097,0.6572502130392559,raw,14066725.375,14945147.9375,11211813.203125,12330786.1875,6951021.1875,10197661.0625,DNA mismatch repair protein Msh6 OS=Homo sapiens OX=9606 GN=MSH6 PE=1 SV=2,cell differentiation;cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;extracellular;membrane;nucleus,RNA binding;structural molecule activity,2956,MSH6,"Glioblastoma signaling pathways; Retinoblastoma gene in cancer; Chromosomal and microsatellite instability in colorectal cancer ; DNA repair pathways, full network; DNA mismatch repair",Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Defective Mismatch Repair Associated With MSH2; Defective Mismatch Repair Associated With MSH6,ENSG00000116062
Q9ULC5,0,6,32984111.036458332,1.276797129569264e-4,0.7248235244383251,-0.4642983154969228,0.043039047475420276,0.6429522395902524,raw,41645397.625,39027907.375,33270638.6875,28288345.375,23769991.78125,31902385.375,Long-chain-fatty-acid--CoA ligase 5 OS=Homo sapiens OX=9606 GN=ACSL5 PE=1 SV=1,cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;endosome;extracellular;membrane,structural molecule activity,51703,ACSL5,Fatty acid beta-oxidation; Fatty acid biosynthesis; PPAR signaling pathway; Ferroptosis; Thermogenesis; Fatty acid transporters,Synthesis of very long-chain fatty acyl-CoAs,ENSG00000197142
O75381,0,6,10165185.71875,3.934888508255544e-5,0.7228457053329506,-0.4682403645945092,0.016585266072339795,0.6429522395902524,raw,11547766.4375,12334072.53125,12162605.03125,9063086.3125,7091897.1875,8791686.8125,Peroxisomal membrane protein PEX14 OS=Homo sapiens OX=9606 GN=PEX14 PE=1 SV=1,cell growth;cellular component movement;conjugation;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,antioxidant activity;motor activity;structural molecule activity,5195,PEX14,NA,E3 ubiquitin ligases ubiquitinate target proteins; Peroxisomal protein import; Class I peroxisomal membrane protein import,ENSG00000142655
Q96DT7,0.5,6,408565.6328125,1.5815355055015684e-6,0.7217277955471066,-0.47047327725027943,1,1,raw,NA,408367.90625,NA,294730.46875,260101.59375,671062.5625,Zinc finger and BTB domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ZBTB10 PE=1 SV=2,cellular component movement;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,65986,ZBTB10,NA,NA,ENSG00000205189
Q6NXE6,0,6,1387704.6796875,5.371729890662785e-6,0.716048817332271,-0.4818701468917478,0.7166386676660454,1,raw,884727.875,1836149.5625,1785087.046875,2119021.875,423032.25,1278209.46875,Armadillo repeat-containing protein 6 OS=Homo sapiens OX=9606 GN=ARMC6 PE=1 SV=2,metabolic process,cytosol,NA,93436,ARMC6,NA,NA,ENSG00000105676
L0R819,0,6,1272459.015625,4.925620147375602e-6,0.7157699852087669,-0.48243204721906735,0.4801880834104562,0.962082357312919,raw,1305460,1349448,1636560.25,572532.6875,1804858.78125,965894.375,ASNSD1 upstream open reading frame protein OS=Homo sapiens OX=9606 GN=ASDURF PE=1 SV=1,metabolic process,nucleus,NA,NA,ASDURF,NA,NA,ENSG00000286053
F8WES2,0,6,15589817.833333334,6.0347343113495125e-5,0.7152086650354726,-0.483563879439988,0.5304139274776035,1,raw,16875600,13666880,20542566,21233064,9774671,11446126,S-methyl-5'-thioadenosine phosphorylase OS=Homo sapiens OX=9606 GN=MTAP PE=4 SV=1,cellular homeostasis,NA,structural molecule activity,NA,MTAP,Methionine de novo and salvage pathway,NA,ENSG00000099810
Q7Z7K6,0,6,396495.0364583333,1.5348108787254996e-6,0.714168296099756,-0.48566400475347815,0.43649225811903114,0.9197887936170145,raw,315645.3125,736755.8125,338602.875,394689.3125,225423.875,367853.03125,Centromere protein V OS=Homo sapiens OX=9606 GN=CENPV PE=1 SV=1,cell differentiation;cell growth;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,201161,CENPV,NA,NA,ENSG00000166582
P16403,0,6,22566913.083333332,8.735530212165118e-5,0.7140384011168456,-0.4859264301412923,0.6627641190408602,1,raw,40204664,19821768,15048862,28707674,6126928.5,25491582,Histone H1.2 OS=Homo sapiens OX=9606 GN=H1-2 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,3006,H1-2,NA,Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF),ENSG00000187837
Q5T280,0,6,2448792.671875,9.479144218573333e-6,0.713846584695923,-0.4863140420339031,0.33825567321479755,0.8216110565431962,raw,2594480.09375,3683239.9375,2059383.09375,2319548.6875,1406835.96875,2629268.25,Putative methyltransferase C9orf114 OS=Homo sapiens OX=9606 GN=SPOUT1 PE=1 SV=3,cell differentiation;cellular component movement;cellular homeostasis;metabolic process,endoplasmic reticulum;nucleus,RNA binding;structural molecule activity,51490,SPOUT1,NA,NA,ENSG00000198917
Q7Z5G4,0,6,2623569.640625,1.0155696428114942e-5,0.7135433574053285,-0.48692699929537797,0.2711154421576799,0.7524466736516254,raw,2511446.9375,3736010.9375,2709402.71875,3096795.5625,1933276.3125,1754485.375,Golgin subfamily A member 7 OS=Homo sapiens OX=9606 GN=GOLGA7 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cell surface;cytoskeleton;extracellular;nucleus,NA,51125,GOLGA7,NA,Neutrophil degranulation; RAS processing; Maturation of spike protein,ENSG00000147533
P49247,0,6,4896150.6953125,1.8952734990504078e-5,0.7130622857917022,-0.4878999937047412,0.37725197671611216,0.8616098076180547,raw,3665803.25390625,8099748.8046875,5148727.46484375,5162847.0390625,3628414.234375,3671363.375,Ribose-5-phosphate isomerase OS=Homo sapiens OX=9606 GN=RPIA PE=1 SV=3,cellular homeostasis,cytosol;nucleus,structural molecule activity,22934,RPIA,Pentose phosphate metabolism; Metabolic reprogramming in colon cancer; Pentose phosphate pathway in senescent cells,Pentose phosphate pathway; RPIA deficiency: failed conversion of R5P to RU5P; RPIA deficiency: failed conversion of RU5P to R5P,ENSG00000153574
P51687,0,6,2475351.34375,9.581951403456048e-6,0.7128086282943417,-0.48841329461265864,0.6443474785452026,1,raw,2136171.53125,2772054.25,3095380.1875,3596910.96875,1275646.9375,1975944.1875,"Sulfite oxidase, mitochondrial OS=Homo sapiens OX=9606 GN=SUOX PE=1 SV=2",cellular homeostasis,endosome,structural molecule activity,6821,SUOX,NA,Sulfide oxidation to sulfate,ENSG00000139531
O15514,0,6,1173853.109375,4.54392200817332e-6,0.7119162361897867,-0.4902205906937917,0.6042102931575769,1,raw,1299457.1875,1999327.03125,609705.75,908604.5,802670.8125,1423353.375,DNA-directed RNA polymerase II subunit RPB4 OS=Homo sapiens OX=9606 GN=POLR2D PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis;coagulation;conjugation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5433,POLR2D,Pyrimidine metabolism,Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; mRNA Splicing - Major Pathway; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere,ENSG00000144231
Q8IZ73,0,6,1876549.5208333333,7.264021877219114e-6,0.7113165470503512,-0.4914363701627977,0.28412127785589847,0.7650076250313386,raw,1741399.375,3086809.78125,1837162.5,1031774.03125,1366452.5625,2195698.875,RNA pseudouridylate synthase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RPUSD2 PE=1 SV=2,cellular component movement;cellular homeostasis,NA,structural molecule activity,27079,RPUSD2,NA,NA,ENSG00000166133
P49336,0.16666666666666666,6,785475.2125,3.0405321385174828e-6,0.7110818750528725,-0.4919124113687057,0.27609304011763236,0.756515890988102,raw,713005.4375,1468041.40625,642830.15625,480763.6875,622735.375,NA,Cyclin-dependent kinase 8 OS=Homo sapiens OX=9606 GN=CDK8 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,signal transducer activity;structural molecule activity,1024,CDK8,Sterol regulatory element-binding proteins (SREBP) signaling; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; lncRNA in canonical Wnt signaling and colorectal cancer,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Generic Transcription Pathway; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; NOTCH1 Intracellular Domain Regulates Transcription,ENSG00000132964
Q9Y2Z9,0,6,8597009.5,3.3278559608130365e-5,0.7100994062176113,-0.4939070944692112,0.4605538250028725,0.9425587783849652,raw,4869502.5,12731095,11564432,6962089.5,6414595,9040343,"Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial OS=Homo sapiens OX=9606 GN=COQ6 PE=1 SV=2",cellular homeostasis,cytoskeleton;endosome;extracellular;nucleus,structural molecule activity,51004,COQ6,Nephrotic syndrome,Ubiquinol biosynthesis,ENSG00000119723
O95391,0,6,1762324.5390625,6.8218631399746944e-6,0.7099504184595563,-0.49420982173518807,0.2652805379250529,0.7454335379461359,raw,2301902.5625,2277523.046875,1390422.59375,1634236.6875,1586739.78125,1383122.5625,Pre-mRNA-splicing factor SLU7 OS=Homo sapiens OX=9606 GN=SLU7 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;coagulation;conjugation,cytosol;membrane;nucleus,RNA binding;structural molecule activity,10569,SLU7,NA,Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway,ENSG00000164609
Q9ULW0,0,6,1483982.2239583333,5.744415066355721e-6,0.7098030272490107,-0.4945093675048165,0.1501721712526405,0.6638855679885327,raw,1497802.34375,1516905.34375,2012840.28125,1414557.5,1428720.125,1033067.75,Targeting protein for Xklp2 OS=Homo sapiens OX=9606 GN=TPX2 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;motor activity;structural molecule activity,22974,TPX2,Gastric cancer network 1,AURKA Activation by TPX2; Regulation of TP53 Activity through Phosphorylation,ENSG00000088325
Q15003,0,6,4515749.567708333,1.7480222764017033e-5,0.7088723889217468,-0.49640215774688223,0.46030762395143765,0.9425587783849652,raw,4045648.96875,7504670.5625,3730714.5,2644600.5,4473479.6875,4695383.1875,Condensin complex subunit 2 OS=Homo sapiens OX=9606 GN=NCAPH PE=1 SV=3,cell differentiation;cell growth;metabolic process,cytosol;membrane;nucleus,structural molecule activity,23397,NCAPH,2q11.2 copy number variation syndrome,Condensation of Prometaphase Chromosomes,ENSG00000121152
Q9BTL3,0,6,3551929.2708333335,1.3749326433021869e-5,0.7066211414005795,-0.5009911810147335,0.7156353194683902,1,raw,3785709.15625,3136651.4375,4345797.46875,5203799.9375,2675062.125,2164555.5,RNA guanine-N7 methyltransferase activating subunit OS=Homo sapiens OX=9606 GN=RAMAC PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,DNA binding;RNA binding;structural molecule activity,83640,RAMAC,NA,NA,ENSG00000169612
E5RK97,0.8333333333333334,6,2635852.5416666665,1.020324287487365e-5,0.7060729931492846,-0.5021107592506187,0.08969308407667269,0.6429522395902524,raw,3403505.5,3173208.75,2590295.75,2696536.5,1711051.75,2240517,Cytoplasmic dynein 2 light intermediate chain 1 OS=Homo sapiens OX=9606 GN=DYNC2LI1 PE=4 SV=1,NA,NA,NA,NA,DYNC2LI1,Intraflagellar transport proteins binding to dynein; Genes related to primary cilium development (based on CRISPR); Ciliopathies; 3q29 copy number variation syndrome; Bardet-Biedl syndrome,NA,ENSG00000138036
Q68D91,0,6,366714.390625,1.4195316066096316e-6,0.7059130177538449,-0.5024376685951456,1,1,raw,NA,NA,429933.28125,NA,303495.5,NA,Metallo-beta-lactamase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MBLAC2 PE=1 SV=3,cellular homeostasis,cytoplasm;cytoskeleton;extracellular,structural molecule activity,153364,MBLAC2,NA,NA,ENSG00000176055
Q15386,0,6,4327758.134114583,1.6752518074535476e-5,0.7057200654714072,-0.5028320647113073,0.13841668649128047,0.65680569707651415,raw,4621335.78125,6127405.015625,4229876.0546875,3691782.234375,2985108.40625,4311041.3125,Ubiquitin-protein ligase E3C OS=Homo sapiens OX=9606 GN=UBE3C PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,nucleus,structural molecule activity,9690,UBE3C,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000009335
A0A5H1ZRS1,0,6,1300394.0416666667,5.03375512492591e-6,0.7054458589277769,-0.5033927307801426,0.19404600874048836,0.6848190557739395,raw,1159621.53125,1937851.234375,1441482.609375,979127.125,1267393.8125,1016887.9375,Pericentriolar material 1 protein OS=Homo sapiens OX=9606 GN=PCM1 PE=1 SV=1,cell growth;metabolic process,cytoskeleton;cytosol;endoplasmic reticulum;membrane,NA,NA,PCM1,Prader-Willi and Angelman syndrome; Joubert syndrome,NA,ENSG00000078674
J3QRB6,0.16666666666666666,6,420760.6875,1.6287419037662648e-6,0.7038717684051112,-0.5066154727529231,1,1,raw,NA,511960.5625,423882.25,NA,326439.25,NA,Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens OX=9606 GN=MAP3K3 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,MAP3K3,Ebstein-Barr virus LMP1 signaling; Malignant pleural mesothelioma,NA,ENSG00000198909
O43318,0,6,18450396.333333332,7.142048803976118e-5,0.7037735988010502,-0.5068167007105807,0.20734514256462358,0.6988382857167694,raw,16169487,28243384,21102932,19876948,10303821,15005806,Mitogen-activated protein kinase kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP3K7 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;mitochondrion;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,6885,MAP3K7,IL-1 signaling pathway; RANKL/RANK signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; IL-17 signaling pathway; B cell receptor signaling pathway; TNF-alpha signaling pathway; Ebstein-Barr virus LMP1 signaling; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Nod-like receptor (NLR) signaling pathway; Fas ligand pathway and stress induction of heat shock proteins; Wnt signaling pathway; IL6 signaling pathway; TGF-beta signaling pathway; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; Angiopoietin-like protein 8 regulatory pathway; Wnt signaling pathway and pluripotency; p38 MAPK signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; miRNAs involvement in the immune response in sepsis; Signal transduction through IL1R; Measles virus infection; Hepatitis B infection; IL-18 signaling pathway; Insulin signaling; Host-pathogen interaction of human coronaviruses - interferon induction; T-cell receptor signaling pathway; DNA damage response (only ATM dependent); Toll-like receptor signaling pathway,"FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; CLEC7A (Dectin-1) signaling; Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Ca2+ pathway; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TAK1-dependent IKK and NF-kappa-B activation  ; TNFR1-induced NFkappaB signaling pathway; TICAM1,TRAF6-dependent induction of TAK1 complex; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; Alpha-protein kinase 1 signaling pathway",ENSG00000135341
Q99549,0,6,621728.540625,2.406677612635529e-6,0.7035162997924135,-0.5073442451892173,0.6538497649900111,1,raw,990945.21875,464986.75,NA,398459.8125,255791.703125,998459.21875,M-phase phosphoprotein 8 OS=Homo sapiens OX=9606 GN=MPHOSPH8 PE=1 SV=2,cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,54737,MPHOSPH8,NA,NA,ENSG00000196199
O00488,0,6,11546296.802083334,4.469509151773012e-5,0.7031438867597379,-0.5081081517148912,0.6903854220695294,1,raw,10620039,16605082.4375,10275645.3125,18229055.5625,6080543,7467415.5,Zinc finger protein 593 OS=Homo sapiens OX=9606 GN=ZNF593 PE=1 SV=2,metabolic process,membrane,RNA binding;structural molecule activity,51042,ZNF593,NA,NA,ENSG00000142684
P33993,0,6,74283183.92708333,2.875461943131683e-4,0.7009851877009443,-0.5125441354676803,0.036821873362682604,0.6429522395902524,raw,81363562.8125,98059461.0625,79737267.234375,65764456.46875,52036126.265625,68738229.71875,DNA replication licensing factor MCM7 OS=Homo sapiens OX=9606 GN=MCM7 PE=1 SV=4,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,4176,MCM7,miRNA regulation of DNA damage response; Cell cycle; Retinoblastoma gene in cancer; Ciliary landscape; G1 to S cell cycle control; DNA replication,Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA,ENSG00000166508
Q9C037,0,6,715750.596875,2.770631915977245e-6,0.6991075231211727,-0.5164137349317461,0.40371010583080724,0.8896213849325956,raw,755844.375,737027.4375,911424.484375,422237.40625,752219.28125,NA,E3 ubiquitin-protein ligase TRIM4 OS=Homo sapiens OX=9606 GN=TRIM4 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;coagulation;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,structural molecule activity,89122,TRIM4,NA,Antigen processing: Ubiquitination & Proteasome degradation; SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Negative regulators of DDX58/IFIH1 signaling; Ovarian tumor domain proteases; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation,ENSG00000146833
Q8NHP6,0,6,322400.37109375,1.2479944295893483e-6,0.6985032737060128,-0.5176612176944817,1,1,raw,199777.59375,465790.65625,367401.84375,NA,256631.390625,NA,Motile sperm domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MOSPD2 PE=1 SV=1,metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,NA,158747,MOSPD2,NA,Neutrophil degranulation; RHOD GTPase cycle,ENSG00000130150
P53677,0,6,450843.871875,1.745192286242382e-6,0.6977931189906883,-0.5191287238482774,0.292404121685164,0.774075451590556,raw,335908.375,622312.59375,623099.96875,NA,230056.390625,442842.03125,AP-3 complex subunit mu-2 OS=Homo sapiens OX=9606 GN=AP3M2 PE=1 SV=1,cell growth;conjugation,cytoskeleton;extracellular;mitochondrion;nucleus,NA,10947,AP3M2,NA,NA,ENSG00000070718
A0A0U1RRL7,0,6,558708.6354166666,2.1627309621201088e-6,0.6943008881322148,-0.5263670779884478,1,1,raw,NA,NA,701718.4375,NA,313866.53125,660540.9375,Protein MMP24OS OS=Homo sapiens OX=9606 GN=MMP24OS PE=1 SV=1,NA,NA,NA,NA,MMP24OS,NA,NA,ENSG00000126005
O43688,0,6,4625008.770833333,1.7903159240233807e-5,0.6936708832123181,-0.527676766059712,0.12126983607651748,0.6445597830897484,raw,6189173.5,5414918.25,4684941.875,4989296.25,2715551.625,3756171.125,Phospholipid phosphatase 2 OS=Homo sapiens OX=9606 GN=PLPP2 PE=1 SV=1,cellular homeostasis;development,cytoplasm;cytoskeleton;extracellular;mitochondrion,structural molecule activity,8612,PLPP2,Triacylglyceride synthesis,Sphingolipid de novo biosynthesis,ENSG00000141934
Q9UJY4,0.16666666666666666,6,307437.165625,1.190072669107346e-6,0.6917479562733447,-0.5316816183993186,0.646039734446979,1,raw,414758.21875,256191.171875,359395.4375,NA,108209.625,398631.375,ADP-ribosylation factor-binding protein GGA2 OS=Homo sapiens OX=9606 GN=GGA2 PE=1 SV=3,conjugation;metabolic process,cytoskeleton;extracellular;mitochondrion;nucleus,structural molecule activity,23062,GGA2,NA,Amyloid fiber formation; TBC/RABGAPs,ENSG00000103365
Q9Y5J9,0,6,536825.0375,2.0780207361153397e-6,0.6900829264225687,-0.5351583556777699,0.2564559878218909,0.7372848386648087,raw,494275.75,827602.0625,512273.96875,NA,347190.34375,502783.0625,Mitochondrial import inner membrane translocase subunit Tim8 B OS=Homo sapiens OX=9606 GN=TIMM8B PE=1 SV=1,cell growth;conjugation;metabolic process,cytoskeleton;endosome,catalytic activity;structural molecule activity,26521,TIMM8B,NA,Mitochondrial protein import,ENSG00000150779
Q8IWJ2,0.16666666666666666,6,362212.509375,1.402105067354691e-6,0.688312621636315,-0.5388641298930963,0.6091448806495147,1,raw,275704,576593.96875,NA,165010.765625,381906.25,411847.5625,GRIP and coiled-coil domain-containing protein 2 OS=Homo sapiens OX=9606 GN=GCC2 PE=1 SV=4,cell growth;conjugation;metabolic process,cytosol;extracellular;membrane,structural molecule activity,9648,GCC2,Deregulation of Rab and Rab effector genes in bladder cancer,Signaling by ALK fusions and activated point mutants; Retrograde transport at the Trans-Golgi-Network,ENSG00000135968
Q9Y6K0,0,6,1943766.6875,7.524215900222846e-6,0.6878933645720388,-0.5397431554347127,0.5476463701696834,1,raw,1903947,2069227.875,2381785,2716724.25,1167507.875,1423408.125,Choline/ethanolaminephosphotransferase 1 OS=Homo sapiens OX=9606 GN=CEPT1 PE=1 SV=1,cellular homeostasis,cytoskeleton;extracellular;membrane,structural molecule activity,10390,CEPT1,"Trans-sulfuration, one-carbon metabolism and related pathways; Kennedy pathway from sphingolipids",Synthesis of PC; Synthesis of PE,ENSG00000134255
A0A0A0MQT0,0,6,43048115.2890625,1.666369300469814e-4,0.6878064064312994,-0.539925541273863,0.043402819775406845,0.6429522395902524,raw,51022675.0625,56787891.28125,43673387.859375,41681582.625,30029432.125,35093722.78125,"Retinol binding protein 1, cellular OS=Homo sapiens OX=9606 GN=RBP1 PE=1 SV=1",cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,5947,RBP1,Retinoblastoma gene in cancer; Vitamin A and carotenoid metabolism,NA,ENSG00000114115
P54259,0.3333333333333333,6,235870.09375,9.130403979005342e-7,0.6874711945479939,-0.5406288298767234,1,1,raw,NA,226557.265625,302854.875,NA,NA,178198.140625,Atrophin-1 OS=Homo sapiens OX=9606 GN=ATN1 PE=1 SV=3,cellular component movement;defense response;metabolic process,membrane;nucleus,structural molecule activity,1822,ATN1,NA,Regulation of PTEN gene transcription,ENSG00000111676
Q96FC9,0,6,224184.146875,8.678047284904758e-7,0.6870614144712088,-0.5414890316620695,0.6172548848666518,1,raw,358903.8125,NA,173164.09375,350904.09375,90608.046875,147340.6875,ATP-dependent DNA helicase DDX11 OS=Homo sapiens OX=9606 GN=DDX11 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,1663,DDX11,NA,XBP1(S) activates chaperone genes,ENSG00000013573
D6RFG8,0,6,5622422.875,2.1764095385471332e-5,0.6851710939120778,-0.5454638067890981,0.22392676503062742,0.7125799511687476,raw,7444257.875,8544738.9375,4229074.5,4119625.125,3542232.6875,5854608.125,Deoxycytidine kinase OS=Homo sapiens OX=9606 GN=DCK PE=1 SV=1,NA,membrane,NA,NA,DCK,NA,NA,ENSG00000156136
Q15021,0,6,7477273.712239583,2.8944122830045864e-5,0.6846569857911304,-0.546546718261546,0.12454459918132138,0.6445597830897484,raw,9638692.6875,10159328.828125,6603359.703125,6330161.75,5176443.8515625,6955655.453125,Condensin complex subunit 1 OS=Homo sapiens OX=9606 GN=NCAPD2 PE=1 SV=3,cell differentiation;cell growth;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9918,NCAPD2,NA,Condensation of Prometaphase Chromosomes,ENSG00000010292
P52756,0,6,1659777.1666666667,6.424907798127988e-6,0.683952930116691,-0.5480310531444351,0.14283172863450422,0.6572502130392559,raw,1617455.375,2419471.6875,1860613.09375,1654804.75,883529.6875,1522788.40625,RNA-binding protein 5 OS=Homo sapiens OX=9606 GN=RBM5 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,RNA binding;structural molecule activity,10181,RBM5,mRNA processing,mRNA Splicing - Major Pathway,ENSG00000003756
Q9NVQ4,0.6666666666666666,6,240953.1359375,9.327165797667238e-7,0.6803245261337312,-0.5557049947622347,0.6425264570790022,1,raw,NA,403752.84375,167409.65625,249417.234375,117002.4140625,267183.53125,Fas apoptotic inhibitory molecule 1 OS=Homo sapiens OX=9606 GN=FAIM PE=1 SV=1,development;metabolic process,nucleus,NA,55179,FAIM,Neurogenesis regulation in the olfactory epithelium,NA,ENSG00000158234
A0A3B3IT92,0,6,57769195.53125,2.2362143684969075e-4,0.6787565871506329,-0.5590338009339899,0.033294696987032385,0.6429522395902524,raw,66000408.1875,79313462.78125,62121112.28125,48089135.75,37256518.875,53834535.3125,DNA helicase OS=Homo sapiens OX=9606 GN=MCM4 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis,membrane;nucleus,RNA binding;structural molecule activity,NA,MCM4,Cell cycle; Ciliary landscape,NA,ENSG00000104738
Q9GZU8,0,6,2033985.4661458333,7.873447921303906e-6,0.6768459387830148,-0.5631006047314152,0.4800336197735671,0.962082357312919,raw,1882262.53125,2844181.53125,2091141.75,2836386.59375,1275938.640625,1274001.75,PSME3-interacting protein OS=Homo sapiens OX=9606 GN=PSME3IP1 PE=1 SV=1,metabolic process,membrane,NA,80011,PSME3IP1,NA,NA,ENSG00000172775
Q8N806,0,6,2476758.814453125,9.587399646556237e-6,0.6767860229212201,-0.5632283208598514,0.46199363288669726,0.9444697421082727,raw,2222532.21875,3953556.36328125,2143692.2734375,2675711.6875,2505900.625,1359159.71875,Putative E3 ubiquitin-protein ligase UBR7 OS=Homo sapiens OX=9606 GN=UBR7 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,NA,structural molecule activity,55148,UBR7,NA,NA,ENSG00000012963; ENSG00000278787
Q9NVI1,0,6,4112973.8372395835,1.5921099657881982e-5,0.6755093487794441,-0.5659523588753935,0.6090003491751801,1,raw,3002988.9375,5808203.328125,4761036.328125,6069798.25,2028547.1015625,3007269.078125,Fanconi anemia group I protein OS=Homo sapiens OX=9606 GN=FANCI PE=1 SV=4,cell differentiation;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,55215,FANCI,"Gastric cancer network 2; DNA repair pathways, full network",Fanconi Anemia Pathway; TP53 Regulates Transcription of DNA Repair Genes,ENSG00000140525
Q9ULJ7,0,6,99438.5078125,3.849210948972219e-7,0.6749131808759649,-0.5672261654283417,1,1,raw,NA,126952.15625,NA,90997.265625,80366.1015625,NA,Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,conjugation,mitochondrion,NA,57182,ANKRD50,NA,NA,ENSG00000151458
P52732,0.6666666666666666,6,702320.2,2.7186435748028475e-6,0.6746538132231172,-0.567780696522794,0.5161426847007796,1,raw,NA,1375623.03125,517270.625,468405.28125,539834.5625,610467.5,Kinesin-like protein KIF11 OS=Homo sapiens OX=9606 GN=KIF11 PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,3832,KIF11,NA,COPI-dependent Golgi-to-ER retrograde traffic; MHC class II antigen presentation; Kinesins,ENSG00000138160
Q8NDT2,0.3333333333333333,6,4895488.5,1.8950171668202382e-5,0.6730502475052753,-0.5712138796199406,0.6031364416594541,1,raw,5410582.5,NA,5344353,7171216.5,2932121.75,3619168.75,Putative RNA-binding protein 15B OS=Homo sapiens OX=9606 GN=RBM15B PE=1 SV=3,cell growth;cellular component movement;cellular homeostasis;conjugation;metabolic process,membrane;nucleus,RNA binding,29890,RBM15B,NA,NA,ENSG00000259956
Q8NC54,0.3333333333333333,6,1139452.7,4.410759880816124e-6,0.6709606040220957,-0.5757000349455358,0.3915221071919884,0.8763288281216618,raw,1398823,1731708.25,689622,854876.25,NA,1022234,CRAP Keratinocyte-associated transmembrane protein 2 OS=Homo sapiens OX=9606 GN=KCT2 PE=1 SV=2,NA,cytoskeleton,NA,56951,KCT2,NA,NA,ENSG00000113583
O75935,0,6,6720829.395833333,2.6015967722882518e-5,0.6698226760517914,-0.5781488772874894,0.208653268806714,0.6988382857167694,raw,7671825.78125,9944666.375,6266671.75,7802261.09375,3500788.5,5138762.875,Dynactin subunit 3 OS=Homo sapiens OX=9606 GN=DCTN3 PE=1 SV=1,cell differentiation;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,structural molecule activity,11258,DCTN3,NA,MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2,ENSG00000137100
Q92541,0,6,5220051.578125,2.0206537819941667e-5,0.6696210659923236,-0.5785831797162575,0.4962080857171474,0.9797947585234871,raw,5401034.4375,6769197.3125,5114582.03125,7223215.375,3616646.4375,3195633.875,RNA polymerase-associated protein RTF1 homolog OS=Homo sapiens OX=9606 GN=RTF1 PE=1 SV=4,cell death;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,membrane,RNA binding;structural molecule activity,23168,RTF1,Endoderm differentiation,E3 ubiquitin ligases ubiquitinate target proteins; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events,ENSG00000137815
Q9NUQ2,0,6,3555370.8385416665,1.376264855580505e-5,0.6679327115814067,-0.5822253238608869,0.1555899174686439,0.6638855679885327,raw,3046636.0625,4635784.7109375,5316408.9375,3551003.4375,3131050.8203125,1651341.0625,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon OS=Homo sapiens OX=9606 GN=AGPAT5 PE=1 SV=3,cellular homeostasis;metabolic process,cytoskeleton;endosome;extracellular;membrane;nucleus,structural molecule activity,55326,AGPAT5,Triacylglyceride synthesis,Synthesis of PA,ENSG00000155189; ENSG00000284980
O94915,0,6,5445494.666666667,2.1079215843651525e-5,0.6678320924591248,-0.5824426715684625,0.9876070741869658,1,raw,5142238.15625,5766625.875,5481186.96875,9482598.6875,3660512.5625,3139805.75,Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2,cell growth;defense response;metabolic process,nucleus,NA,285527,FRYL,NA,NA,ENSG00000075539
Q9Y5U2,0.16666666666666666,6,1232349.5390625,4.770358529177313e-6,0.6650454610202207,-0.5884751314965342,0.3937501210838351,0.87714149171028,raw,1304796.75,1361820.859375,1452631.65625,1606889.234375,905672.78125,762285.953125,Protein TSSC4 OS=Homo sapiens OX=9606 GN=TSSC4 PE=1 SV=3,NA,NA,NA,10078,TSSC4,NA,NA,ENSG00000184281
P61024,0,6,6453952.4375,2.498290142629039e-5,0.6629634236751483,-0.5929988172163085,0.17305522008491808,0.6689341104244626,raw,5548728,10066942.25,7755280.25,6674014.5,3723819,4954930.625,Cyclin-dependent kinases regulatory subunit 1 OS=Homo sapiens OX=9606 GN=CKS1B PE=1 SV=1,cell differentiation;metabolic process,membrane;nucleus,DNA binding;structural molecule activity,1163,CKS1B,Small cell lung cancer,SCF(Skp2)-mediated degradation of p27/p21; Cyclin D associated events in G1,ENSG00000173207
P25205,0,6,98788438.54427083,3.824047118581921e-4,0.6628985221341871,-0.5931400583638676,0.07574251605390878,0.6429522395902524,raw,102628019.53125,137628932.1875,106202519.71875,87231653.8125,67805490.265625,91234015.75,DNA replication licensing factor MCM3 OS=Homo sapiens OX=9606 GN=MCM3 PE=1 SV=3,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,endoplasmic reticulum;membrane;nucleus,RNA binding;structural molecule activity,4172,MCM3,Cell cycle; Retinoblastoma gene in cancer; Ciliary landscape; G1 to S cell cycle control; DNA replication,Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA,ENSG00000112118
P52735,0,6,2222124.4140625,8.601723630764938e-6,0.6625898773059395,-0.5938119320239384,0.4268290175540926,0.911332120317874,raw,2047666.875,3572643.90625,1927646.84375,2367197.6875,2272064.859375,1145526.3125,Guanine nucleotide exchange factor VAV2 OS=Homo sapiens OX=9606 GN=VAV2 PE=1 SV=2,cell growth;coagulation;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;nucleus,antioxidant activity;DNA binding;structural molecule activity,7410,VAV2,Integrin-mediated cell adhesion; Prolactin signaling pathway; B cell receptor signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Focal adhesion; Hepatitis C and hepatocellular carcinoma; VEGFA-VEGFR2 signaling pathway; Chemokine signaling pathway; Microglia pathogen phagocytosis pathway; Ebola virus infection in host; EGF/EGFR signaling pathway; 16p11.2 distal deletion syndrome; GDNF signaling,Regulation of actin dynamics for phagocytic cup formation; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; FCGR3A-mediated phagocytosis; RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; GPVI-mediated activation cascade; DAP12 signaling; EPH-ephrin mediated repulsion of cells; Signal transduction by L1; Azathioprine ADME; VEGFR2 mediated vascular permeability,ENSG00000160293
P07203,0,6,9045255.9296875,3.5013697335905015e-5,0.6621966283934847,-0.5946684296860995,0.02243810837285492,0.6429522395902524,raw,10638966.25,12630838.90625,10192318.625,7098108.984375,5347203.875,8364098.9375,Glutathione peroxidase 1 OS=Homo sapiens OX=9606 GN=GPX1 PE=1 SV=4,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytosol;endosome;membrane;nucleus,structural molecule activity,2876,GPX1,"Glutathione metabolism; Selenium micronutrient network; Folate metabolism; Amyotrophic lateral sclerosis (ALS); Trans-sulfuration, one-carbon metabolism and related pathways; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling pathway; TYROBP causal network in microglia; Oxidative stress response; Male infertility; p53 transcriptional gene network",Detoxification of Reactive Oxygen Species; Synthesis of 15-eicosatetraenoic acid derivatives; Synthesis of 12-eicosatetraenoic acid derivatives; Synthesis of 5-eicosatetraenoic acids,ENSG00000233276
Q9UNN8,0,6,1495543.5520833335,5.789168343312897e-6,0.6618029925366664,-0.5955262796526748,0.3359687695543309,0.8198753611919075,raw,1440324.875,3673908.375,950251.875,818086.125,953211.3125,1137478.75,Endothelial protein C receptor OS=Homo sapiens OX=9606 GN=PROCR PE=1 SV=1,coagulation;metabolic process,cell surface;cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,structural molecule activity,10544,PROCR,NA,Cell surface interactions at the vascular wall; Common Pathway of Fibrin Clot Formation,ENSG00000101000
Q96FZ5,0.16666666666666666,6,595752.9140625,2.306127364677947e-6,0.6604122432036177,-0.598561228655852,1,1,raw,794251.25,413790.4375,707637.5,NA,467332.46875,NA,CKLF-like MARVEL transmembrane domain-containing protein 7 OS=Homo sapiens OX=9606 GN=CMTM7 PE=1 SV=1,development;metabolic process,cell surface;cytoskeleton,antioxidant activity,112616,CMTM7,NA,NA,ENSG00000153551
P48201,0,6,836753.97890625,3.2390294746530055e-6,0.660136638021213,-0.5991634240631175,0.9431055822538614,1,raw,1116370,NA,603542.08984375,1667017.3125,501967.6796875,294872.8125,"ATP synthase F(0) complex subunit C3, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5MC3 PE=1 SV=1",cellular homeostasis;conjugation,cytoskeleton;endosome,catalytic activity;structural molecule activity,518,ATP5MC3,Electron transport chain: OXPHOS system in mitochondria; 7q11.23 copy number variation syndrome; Oxidative phosphorylation,Cristae formation; Formation of ATP by chemiosmotic coupling,ENSG00000154518
Q96B36,0,6,1253537.825,4.85237724005174e-6,0.6591282032454084,-0.6013689920248511,0.2847742891885886,0.7650733473821373,raw,1726741.0625,1900168.375,851638.8125,NA,1207778.125,581362.75,Proline-rich AKT1 substrate 1 OS=Homo sapiens OX=9606 GN=AKT1S1 PE=1 SV=1,cell growth;development;metabolic process,cytosol;membrane;nucleus,NA,84335,AKT1S1,Target of rapamycin signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; VEGFA-VEGFR2 signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; Thermogenesis; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Thyroid hormones production and peripheral downstream signaling effects; Autophagy; p53 transcriptional gene network; Malignant pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway; DYRK1A,Constitutive Signaling by AKT1 E17K in Cancer; mTORC1-mediated signalling; AKT phosphorylates targets in the cytosol; HSF1-dependent transactivation,ENSG00000204673
Q9BSL1,0.16666666666666666,6,403883.11875,1.563409746382096e-6,0.6587684356956578,-0.6021566636182898,0.4791042623034517,0.9613425968574663,raw,522433.8125,363748.15625,513967.71875,NA,158302.984375,460962.921875,Ubiquitin-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBAC1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,NA,10422,UBAC1,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000130560
O95297,0,6,5289094.875,2.047380069438615e-5,0.6586179408736978,-0.6024862831408947,0.6243635076521064,1,raw,4633351.5,5478289.5,7257152.5,8061689.5,2695986.5,3608099.75,Myelin protein zero-like protein 1 OS=Homo sapiens OX=9606 GN=MPZL1 PE=1 SV=1,cell death;development,cytoplasm;cytoskeleton,structural molecule activity,9019,MPZL1,NA,NA,ENSG00000197965
E9PN89,0,6,1351067.0390625,5.2299075619285526e-6,0.6563119850957265,-0.6075463160902674,0.6056441420975643,1,raw,628133.8125,2871132.5,NA,1383083.25,521918.59375,NA,Heat shock cognate 71 kDa protein (Fragment) OS=Homo sapiens OX=9606 GN=HSPA8 PE=1 SV=1,metabolic process,NA,structural molecule activity,NA,HSPA8,Measles virus infection; Extrafollicular B cell activation by SARS-CoV-2,NA,ENSG00000109971
P49736,0,6,75647819.86783855,2.928286263609426e-4,0.6554855493374055,-0.6093641193664416,0.12450056933041277,0.6445597830897484,raw,79004183.6796875,119487139.75,78495902.2773438,63918985.3125,51452929.625,61527778.5625,DNA replication licensing factor MCM2 OS=Homo sapiens OX=9606 GN=MCM2 PE=1 SV=4,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4171,MCM2,Cell cycle; Ciliary landscape; G1 to S cell cycle control; DNA replication,Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA,ENSG00000073111
Q6ZU45,0.8333333333333334,6,3197128.7916666665,1.2375912934416202e-5,0.6529964970906036,-0.6148528422329145,0.07322895369528441,0.6429522395902524,raw,3449708,4607313,3393346.5,2754281,1969565,3008559.25,Putative C-type lectin domain family 20 member A OS=Homo sapiens OX=9606 GN=CLEC20A PE=2 SV=2,NA,NA,structural molecule activity,NA,CLEC20A,NA,NA,ENSG00000188585
Q05086,0,6,6702662.247395833,2.5945643672154517e-5,0.6495909849492155,-0.6223964840072972,0.05326667265728783,0.6429522395902524,raw,10026667.5625,7737578.75,7341372.953125,5027663.375,4768889.6875,5313801.15625,Ubiquitin-protein ligase E3A OS=Homo sapiens OX=9606 GN=UBE3A PE=1 SV=4,cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;conjugation;defense response;development;metabolic process,cytosol;membrane;nucleus,structural molecule activity,7337,UBE3A,Androgen receptor signaling pathway; MECP2 and associated Rett syndrome; Prader-Willi and Angelman syndrome; Synaptic signaling pathways associated with autism spectrum disorder,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000114062
Q86SF2,0,6,708469.6015625,2.7424475762352045e-6,0.6466699306038067,-0.6288985665756982,0.4338962465315268,0.9176747809749992,raw,336399.8125,1461528.171875,814647.53125,313793.71875,797640.3125,526808.0625,N-acetylgalactosaminyltransferase 7 OS=Homo sapiens OX=9606 GN=GALNT7 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytoskeleton;extracellular,structural molecule activity,51809,GALNT7,NA,O-linked glycosylation of mucins,ENSG00000109586
Q15750,0,6,1688122.1041666667,6.534629520801725e-6,0.6463101245619289,-0.6297015030225895,0.5271091865096281,1,raw,1875302.125,2009059.1875,1743677.78125,2461788.4375,826878.34375,1212026.75,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 OS=Homo sapiens OX=9606 GN=TAB1 PE=1 SV=1,defense response;development;metabolic process,cytoskeleton;cytosol;membrane;mitochondrion;nucleus,DNA binding;structural molecule activity,10454,TAB1,MicroRNAs in cardiomyocyte hypertrophy; IL-1 signaling pathway; RANKL/RANK signaling pathway; TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; TGF-beta signaling pathway; MAPK signaling pathway; TLR4 signaling and tolerance; miRNAs involvement in the immune response in sepsis; Signal transduction through IL1R; Hepatitis B infection; Toll-like receptor signaling pathway,"Ub-specific processing proteases; FCERI mediated NF-kB activation; CLEC7A (Dectin-1) signaling; SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TAK1-dependent IKK and NF-kappa-B activation  ; TNFR1-induced NFkappaB signaling pathway; TICAM1,TRAF6-dependent induction of TAK1 complex; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; Alpha-protein kinase 1 signaling pathway",ENSG00000100324
Q6EEV4,0,6,1030014.8854166666,3.987132009287661e-6,0.6454057784810731,-0.6317216001913142,0.28197686671306715,0.7642515538458274,raw,1570996.625,935793.0625,1112238.875,1272847.75,603966.25,684246.75,"DNA-directed RNA polymerase II subunit GRINL1A, isoforms 4/5 OS=Homo sapiens OX=9606 GN=POLR2M PE=1 SV=1",NA,NA,NA,81488,POLR2M,NA,NA,ENSG00000255529
A0A0A6YYL4,0,6,915625.5208333334,3.5443369550513463e-6,0.6433604485715024,-0.636300847742929,0.12564973951689576,0.6456364983916238,raw,914661.125,1300196.25,1059229.125,1006793.25,681466.125,531407.25,Coronin OS=Homo sapiens OX=9606 GN=CORO7-PAM16 PE=1 SV=1,NA,cytoskeleton;cytosol;extracellular,NA,100529144,CORO7-PAM16,NA,NA,ENSG00000103426; ENSG00000278760
P33992,0,6,71312208.89322917,2.7604571036483926e-4,0.6425804673734967,-0.6380509672552516,0.06387014963642064,0.6429522395902524,raw,78984792.75,108789238.1875,78084323.09375,51367209.8125,50175460.828125,60472228.6875,DNA replication licensing factor MCM5 OS=Homo sapiens OX=9606 GN=MCM5 PE=1 SV=5,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,RNA binding;structural molecule activity,4174,MCM5,Cell cycle; Ciliary landscape; G1 to S cell cycle control; DNA replication,Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA,ENSG00000100297
Q05D32,0,6,974875.9010416666,3.7736919778144836e-6,0.6417856894311212,-0.6398364741939934,0.24947967529513912,0.7322518008602272,raw,1480617.0625,1331404.53125,777455.84375,854476.375,280906.375,1124395.21875,CTD small phosphatase-like protein 2 OS=Homo sapiens OX=9606 GN=CTDSPL2 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,membrane,structural molecule activity,51496,CTDSPL2,NA,NA,ENSG00000137770
Q7Z2E3,0.3333333333333333,6,742228.25,2.873125481653043e-6,0.641314464743049,-0.640896147593578,0.7370695891998882,1,raw,899022.5625,763424.8125,717987.5,1212905.75,489595.375,370433.5,Aprataxin OS=Homo sapiens OX=9606 GN=APTX PE=1 SV=2,cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,54840,APTX,NA,NA,ENSG00000137074
A0A0A0MR59,0,6,1330503.5911458333,5.150307565296761e-6,0.6408813199352003,-0.6418708753184829,0.8689003313439316,1,raw,1956415.078125,1246513.84375,983793.375,2564212.96875,798867.4375,433218.84375,Pumilio homolog 2 OS=Homo sapiens OX=9606 GN=PUM2 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P57081,0,6,674057.20625,2.609239051961086e-6,0.6408456858133211,-0.6419510939152732,0.38442830103260933,0.8695425300008842,raw,NA,633417.4375,1093441.40625,411788.75,541037.3125,690601.125,tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 OS=Homo sapiens OX=9606 GN=WDR4 PE=1 SV=2,cellular component movement;cellular homeostasis;coagulation,cytosol;membrane;nucleus,NA,10785,WDR4,NA,tRNA modification in the nucleus and cytosol,ENSG00000160193
Q68CZ2,0.3333333333333333,6,1201320.0625,4.65024510073522e-6,0.6390812521133843,-0.6459287293348365,0.2589936978001943,0.7382628436284326,raw,1414878.25,1738991.125,1053183.375,1447620.625,673069.75,880177.25,Tensin-3 OS=Homo sapiens OX=9606 GN=TNS3 PE=1 SV=2,cellular homeostasis,cytosol;nucleus,structural molecule activity,64759,TNS3,NA,MET interacts with TNS proteins,ENSG00000136205
O75674,0,6,1174753.265625,4.547406464416187e-6,0.6385970895292908,-0.6470221171926775,0.0932689399065134,0.6429522395902524,raw,1367770.59375,1676725.3125,1082361.78125,NA,912516.515625,834392.125,TOM1-like protein 1 OS=Homo sapiens OX=9606 GN=TOM1L1 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;conjugation;development;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,DNA binding;structural molecule activity,10040,TOM1L1,NA,NA,ENSG00000141198
Q6P4A7,0,6,1465326.0052083333,5.672197850853726e-6,0.6380373805169502,-0.6482871456516899,0.15731251220862622,0.6638855679885327,raw,2075999.65625,1944719.96875,1246986.5,795624,1212795.84375,1515830.0625,Sideroflexin-4 OS=Homo sapiens OX=9606 GN=SFXN4 PE=1 SV=1,conjugation,endosome;membrane;nucleus,catalytic activity,119559,SFXN4,NA,NA,ENSG00000183605
Q9Y3U8,0,6,143966267.11979166,5.572856470504081e-4,0.6375437110407537,-0.6494038359905785,0.17064701339008126,0.6680991561970162,raw,158698722.53125,204478529,146431382.8125,166716063.0625,86295532.8125,101177372.5,60S ribosomal protein L36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis,cytosol;extracellular;Golgi;membrane,structural molecule activity,25873,RPL36,Cytoplasmic ribosomal proteins,Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),ENSG00000130255
H0Y860,0,6,798454.8984375,3.090775801987426e-6,0.6374735331963093,-0.649562649886971,0.2305042071831967,0.7173388538497806,raw,851429.921875,941790.03125,1135439.125,600366.21875,263428.25,998275.84375,Stromal interaction molecule 2 OS=Homo sapiens OX=9606 GN=STIM2 PE=1 SV=1,conjugation;metabolic process,cytoskeleton;extracellular,structural molecule activity,NA,NA,NA,NA,NA
Q9NR77,0.3333333333333333,6,1403395.0104166667,5.432466313769198e-6,0.6369812122046602,-0.6506772741465946,0.08121467158016522,0.6429522395902524,raw,1388088.625,1879458,1819096.5,1496921,884186.375,952619.5625,Peroxisomal membrane protein 2 OS=Homo sapiens OX=9606 GN=PXMP2 PE=1 SV=3,NA,cytoskeleton;cytosol;endosome;mitochondrion;nucleus,NA,5827,PXMP2,NA,Glyoxylate metabolism and glycine degradation; Class I peroxisomal membrane protein import,ENSG00000176894
E5RFU2,0,6,658979.1458333334,2.550872694176902e-6,0.6363847692994271,-0.6520287870611553,0.5846645576301965,1,raw,633436.0625,763597.5625,755025.5,957897.6875,403109.0625,440809,Bifunctional epoxide hydrolase 2 OS=Homo sapiens OX=9606 GN=EPHX2 PE=1 SV=1,NA,cytosol,NA,NA,EPHX2,Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; Familial hyperlipidemia type 2; ALA oxylipin metabolism; Linoleic acid oxylipin metabolism; Metapathway biotransformation Phase I and II,NA,ENSG00000120915
P06746,0,6,2649214.0729166665,1.025496464093184e-5,0.635876822764453,-0.6531807702547867,0.6991233848686889,1,raw,3178540.40625,2454995.3125,3081850.90625,4542804.125,677416.125,1959677.5625,DNA polymerase beta OS=Homo sapiens OX=9606 GN=POLB PE=1 SV=3,cell proliferation;cellular homeostasis;coagulation;defense response;development;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,5423,POLB,"Male infertility; Base excision repair; DNA repair pathways, full network",Ub-specific processing proteases; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway; POLB-Dependent Long Patch Base Excision Repair; PCNA-Dependent Long Patch Base Excision Repair; Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,ENSG00000070501
Q9Y6I3,0,6,2572404.2838541665,9.957638094554949e-6,0.6347342742260035,-0.6557753478695669,0.014669748471547724,0.6429522395902524,raw,3433716.125,3316100.125,2866680.125,2179497.3125,1470051.703125,2168380.3125,Epsin-1 OS=Homo sapiens OX=9606 GN=EPN1 PE=1 SV=2,conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion,structural molecule activity,29924,EPN1,VEGFA-VEGFR2 signaling pathway; EGF/EGFR signaling pathway,Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation,ENSG00000063245
A0A087WTW0,0,6,8725759.604166666,3.3776944309934335e-5,0.6334961136820515,-0.6585923260166676,0.02250161423026043,0.6429522395902524,raw,12173372.46875,11037560.3125,9959578.84375,6992251.5625,4463002.125,7728792.3125,RING-type E3 ubiquitin transferase OS=Homo sapiens OX=9606 GN=UHRF1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis,membrane,RNA binding;structural molecule activity,NA,UHRF1,Pathways affected in adenoid cystic carcinoma; Malignant pleural mesothelioma,NA,ENSG00000276043
Q9UKG1,0,6,1067873.2526041667,4.133679704636341e-6,0.6332089536303955,-0.6592464394330471,0.22005640866129472,0.7087130179153194,raw,1054978.625,1544722.421875,1148859.40625,1276434.75,654776.25,727468.0625,DCC-interacting protein 13-alpha OS=Homo sapiens OX=9606 GN=APPL1 PE=1 SV=1,cell differentiation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,motor activity;structural molecule activity,26060,APPL1,Follicle stimulating hormone (FSH) signaling pathway; Chromosomal and microsatellite instability in colorectal cancer,Caspase activation via Dependence Receptors in the absence of ligand,ENSG00000157500
P00167,0,6,1637496.5260416667,6.338660641236235e-6,0.6328605056194199,-0.6600405573646694,0.11407842346231777,0.6429522395902524,raw,2698598.3125,1556938.75,1966973.5,1302175.875,1244819.84375,1055472.875,Cytochrome b5 OS=Homo sapiens OX=9606 GN=CYB5A PE=1 SV=2,cellular homeostasis;conjugation,cytoskeleton;cytosol;endosome;extracellular;nucleus,catalytic activity;structural molecule activity,1528,CYB5A,Oxidation by cytochrome P450,Vitamin C (ascorbate) metabolism,ENSG00000166347
Q01974,0.16666666666666666,6,1405908.5911458333,5.442196249059536e-6,0.6328370290085097,-0.6600940766126955,0.23529665908013622,0.7192904383575112,raw,1753613.65625,1398043.640625,1822484.3125,1702667.15625,648891.125,1109751.65625,Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens OX=9606 GN=ROR2 PE=1 SV=2,cell death;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,signal transducer activity;structural molecule activity,4920,ROR2,Cardiac progenitor differentiation; Ectoderm differentiation; Wnt signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Malignant pleural mesothelioma,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",ENSG00000169071
Q8IWV8,0,6,600113.01875,2.323005094514195e-6,0.6324262958356046,-0.6610307397101839,0.1429929811817947,0.6572502130392559,raw,685514.171875,753941.8125,NA,454146.3125,695548.703125,411414.09375,E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens OX=9606 GN=UBR2 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,23304,UBR2,Male infertility,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000024048
A0A0A0MQS9,0.8333333333333334,6,697374.8333333334,2.699500327444481e-6,0.631567639761468,-0.6629908425487411,0.2938849045091938,0.7750607974821754,raw,1267866.5,706612.5625,579052.4375,477369.96875,787636.75,365710.78125,Laminin subunit alpha-4 OS=Homo sapiens OX=9606 GN=LAMA4 PE=1 SV=1,cell communication;defense response;metabolic process,cell surface;chromosome;nucleus,antioxidant activity,3910,LAMA4,miRNA targets in ECM and membrane receptors; Focal adhesion; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Small cell lung cancer; Malignant pleural mesothelioma,NA,ENSG00000112769
Q9H1B7,0,6,5975594.166666667,2.313120238722695e-5,0.6315592029025661,-0.663010115062138,0.05515821412312464,0.6429522395902524,raw,6877885.5625,7839280.4375,7181559.3125,4535579.875,3434282.09375,5984977.71875,Probable E3 ubiquitin-protein ligase IRF2BPL OS=Homo sapiens OX=9606 GN=IRF2BPL PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane,structural molecule activity,64207,IRF2BPL,NA,NA,ENSG00000119669
P19256,0,6,1255699.078125,4.860743334209083e-6,0.6314910403421594,-0.6631658298304054,0.362862519845626,0.8458062414401234,raw,1222516.625,NA,1819818.125,1329731.25,650730.3125,NA,Lymphocyte function-associated antigen 3 OS=Homo sapiens OX=9606 GN=CD58 PE=1 SV=1,cell communication;coagulation;metabolic process,cytoplasm;cytoskeleton;nucleus,antioxidant activity,965,CD58,NA,Cell surface interactions at the vascular wall; Neutrophil degranulation,ENSG00000116815
O95210,0,6,794790.4947916666,3.0765910933214516e-6,0.6302069040729008,-0.6661025353634299,0.10204720148325735,0.6429522395902524,raw,807310.875,1142760.625,985722.5,844080.875,367658.96875,621209.125,Starch-binding domain-containing protein 1 OS=Homo sapiens OX=9606 GN=STBD1 PE=1 SV=1,cell growth;cellular homeostasis;conjugation,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,8987,STBD1,Exercise-induced circadian regulation,RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Neutrophil degranulation,ENSG00000118804
Q8NBT2,0.16666666666666666,6,341868.94375,1.3233562232021427e-6,0.6271093116395536,-0.6732111532717971,0.07687387035454793,0.6429522395902524,raw,421840.8125,464985.875,327155.53125,NA,208477.625,286884.875,Kinetochore protein Spc24 OS=Homo sapiens OX=9606 GN=SPC24 PE=1 SV=2,NA,NA,NA,NA,NA,NA,NA,NA
B8ZZA8,0,6,942076.9583333334,3.6467290414581935e-6,0.6270787928178908,-0.6732813649928603,0.18306396959678037,0.6755855526242318,raw,887782.375,1638620.375,985908.5,841738.4375,741702.5625,556709.5,Glutaminase OS=Homo sapiens OX=9606 GN=GLS PE=1 SV=1,cellular homeostasis,NA,structural molecule activity,NA,GLS,Amino acid metabolism; Metabolic reprogramming in colon cancer,NA,ENSG00000115419
F5H136,0.5,6,1535845.453125,5.945174826280732e-6,0.6263481487364871,-0.6749633085945833,0.4236002286045104,0.9086347256931654,raw,NA,2067987,1654204.625,1744090.875,NA,677099.3125,T-complex protein 1 subunit alpha (Fragment) OS=Homo sapiens OX=9606 GN=TCP1 PE=1 SV=1,metabolic process,NA,structural molecule activity,NA,TCP1,16p11.2 proximal deletion syndrome,NA,ENSG00000120438
Q9NVM9,0,6,1499861.546875,5.8058830680159545e-6,0.6258627474523635,-0.6760817880179024,0.24758774685899398,0.7316541032247736,raw,2099547.09375,2430947.3125,1040337.8125,545625.25,1314028.3125,1568683.5,Integrator complex subunit 13 OS=Homo sapiens OX=9606 GN=INTS13 PE=1 SV=2,cell differentiation;cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane;nucleus,NA,55726,INTS13,NA,RNA polymerase II transcribes snRNA genes,ENSG00000064102
Q05BV3,0.5,6,3921271.7916666665,1.517903138977098e-5,0.6252637525308326,-0.6774632103902185,0.5932413056601419,1,raw,4405171,3412973.25,5084379,5825115.5,2045598.25,2754393.75,Echinoderm microtubule-associated protein-like 5 OS=Homo sapiens OX=9606 GN=EML5 PE=2 SV=3,NA,endoplasmic reticulum;nucleus,motor activity,161436,EML5,NA,NA,ENSG00000165521
O75170,0.16666666666666666,6,1678518.0989583333,6.497452935175953e-6,0.6250751055123034,-0.6778985485682251,0.276323314263956,0.756515890988102,raw,3068547.65625,1681535.859375,1488172.859375,1918072.75,580035.875,1334743.59375,Serine/threonine-protein phosphatase 6 regulatory subunit 2 OS=Homo sapiens OX=9606 GN=PPP6R2 PE=1 SV=2,metabolic process,cytosol;membrane;nucleus,DNA binding;structural molecule activity,9701,PPP6R2,NA,NA,ENSG00000100239
Q9NSI2,0,6,2460333.140625,9.523816750016113e-6,0.6248285090495636,-0.6784678140609666,0.09887316141323202,0.6429522395902524,raw,3118595.625,3096737.75,2563716.625,2627819.9375,1934930.03125,1420198.875,Protein FAM207A OS=Homo sapiens OX=9606 GN=FAM207A PE=1 SV=2,cellular component movement;cellular homeostasis,membrane;nucleus,NA,85395,SLX9,NA,NA,ENSG00000160256
Q9H6S0,0,6,1663790.5625,6.440443436709126e-6,0.6237213742880635,-0.6810263954520192,0.012381448825325455,0.6429522395902524,raw,1853653.40625,2016704.6875,2166967.59375,1233058.0625,1156163.25,1556196.375,3'-5' RNA helicase YTHDC2 OS=Homo sapiens OX=9606 GN=YTHDC2 PE=1 SV=2,cell differentiation;metabolic process,extracellular;membrane;nucleus,RNA binding;structural molecule activity,64848,YTHDC2,NA,NA,ENSG00000047188
P46939,0,6,154553643.23958334,5.982688083806571e-4,0.6236917616620894,-0.6810948923876651,0.48703846702344106,0.9696450818929633,raw,158530138.78125,222749340.484375,141454229.203125,222085101.84375,88223837.40625,94279211.71875,Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,cell growth;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,antioxidant activity;motor activity;structural molecule activity,7402,UTRN,Primary focal segmental glomerulosclerosis (FSGS),EGR2 and SOX10-mediated initiation of Schwann cell myelination,ENSG00000152818
Q14566,0,6,67109876.90885417,2.5977871014398616e-4,0.623610195099398,-0.6812835807401961,0.06271678656047038,0.6429522395902524,raw,71594525.125,99603645.75,74502931.84375,55945209,44647075.78125,56365873.953125,DNA replication licensing factor MCM6 OS=Homo sapiens OX=9606 GN=MCM6 PE=1 SV=1,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,4175,MCM6,Cell cycle; Retinoblastoma gene in cancer; Ciliary landscape; G1 to S cell cycle control; DNA replication,Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA,ENSG00000076003
J3QS39,0.16666666666666666,6,2285502.675,8.84705745695976e-6,0.620213042996127,-0.6891642289368767,0.20405849004138016,0.6957374751850184,raw,2543043,NA,2931550,1505514.75,1648942.125,2798463.5,Polyubiquitin-B (Fragment) OS=Homo sapiens OX=9606 GN=UBB PE=1 SV=1,NA,NA,NA,NA,UBB,Proteasome degradation; Dual hijack model of Vif in HIV infection,NA,ENSG00000170315
Q96LD4,0,6,6477691.489583333,2.5074794015195367e-5,0.6197769271404555,-0.6901790471585179,0.059045286013213884,0.6429522395902524,raw,8050377.5625,7011058.53125,7918739.5625,6658824.65625,4345292.3125,4881856.3125,E3 ubiquitin-protein ligase TRIM47 OS=Homo sapiens OX=9606 GN=TRIM47 PE=1 SV=2,cell organization and biogenesis;cellular homeostasis,cytosol;membrane,structural molecule activity,91107,TRIM47,NA,NA,ENSG00000132481
H3BUX1,0,6,755713.89375,2.925327680497698e-6,0.61665898826786,-0.6974551937474286,0.3868592272710408,0.8719782263249817,raw,1140927.4375,368596.28125,1093337.9375,NA,688577.375,487130.4375,Mesothelin (Fragment) OS=Homo sapiens OX=9606 GN=MSLN PE=1 SV=1,NA,cytoskeleton,NA,NA,MSLN,NA,NA,ENSG00000102854
Q9H1A4,0,6,458526.71875,1.7749321716862477e-6,0.6127597677652646,-0.7066065181711095,1,1,raw,510264.96875,660707.375,350464.6875,NA,312669.84375,NA,Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1,cell differentiation;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane,structural molecule activity,64682,ANAPC1,Cell cycle; 2q13 copy number variation syndrome,Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,ENSG00000153107
I3L4Q0,0,6,1049074.0416666667,4.0609089740969125e-6,0.6102795708019992,-0.7124577980955044,0.5109676047098962,0.9944212432021446,raw,1517034.625,1223607.75,887544.4375,1619535.375,299979.25,746742.8125,"HCG1818442, isoform CRA_a OS=Homo sapiens OX=9606 GN=MCRIP1 PE=1 SV=1",NA,membrane;nucleus,NA,348262,MCRIP1,NA,NA,ENSG00000225663
Q7Z7F0,0,6,380733.328125,1.4737981567671491e-6,0.6081068952186159,-0.7176031467998004,1,1,raw,NA,473517.4375,NA,NA,NA,287949.21875,KH homology domain-containing protein 4 OS=Homo sapiens OX=9606 GN=KHDC4 PE=1 SV=1,cell growth;cellular component movement;cellular homeostasis,membrane;nucleus,RNA binding,22889,KHDC4,NA,NA,ENSG00000132680
Q9NVN8,0,6,507796.8984375,1.9656543770803166e-6,0.6071781716469862,-0.7198081687958857,0.47169662476138724,0.9525429676692956,raw,1034672.3125,353309.96875,NA,317994.25,325211.0625,NA,Guanine nucleotide-binding protein-like 3-like protein OS=Homo sapiens OX=9606 GN=GNL3L PE=1 SV=1,metabolic process,cytosol;membrane,structural molecule activity,54552,GNL3L,NA,NA,ENSG00000130119
Q6KC79,0,6,20497487.53125,7.934466754115045e-5,0.6058437563678275,-0.722982316002713,0.08519457329872829,0.6429522395902524,raw,20921286.828125,25648659.65625,26701928.203125,21874709.84375,12675031,15163309.65625,Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,cell differentiation;cell growth;cell proliferation;coagulation;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,25836,NIPBL,Cohesin complex - Cornelia de Lange syndrome; NIPBL role in DNA damage - Cornelia de Lange syndrome,Cohesin Loading onto Chromatin,ENSG00000164190
Q86Y79,0.3333333333333333,6,6912736.041666667,2.6758827987554896e-5,0.6034229000329805,-0.7287586467668274,0.09448799096170692,0.6429522395902524,raw,9324096,8606005,6898025,7443696.5,4162426.25,5042167.5,Probable peptidyl-tRNA hydrolase OS=Homo sapiens OX=9606 GN=PTRH1 PE=1 SV=1,NA,NA,structural molecule activity,138428,PTRH1,NA,NA,ENSG00000187024
Q9UBF6,0,6,1248106.5208333333,4.8313529548674204e-6,0.6014288036916904,-0.7335341316178339,0.10447927645740479,0.6429522395902524,raw,1236032.75,2052013.875,1421972.875,1234140.25,788444.25,756035.125,RING-box protein 2 OS=Homo sapiens OX=9606 GN=RNF7 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;membrane;nucleus,structural molecule activity,9616,RNF7,Apoptosis-related network due to altered Notch3 in ovarian cancer; Modulators of TCR signaling and T cell activation,Antigen processing: Ubiquitination & Proteasome degradation; Neddylation; Inactivation of CSF3 (G-CSF) signaling,ENSG00000114125
Q9BRF8,0.16666666666666666,6,829449.125,3.210752779582723e-6,0.6011459956079948,-0.7342126853803609,0.17973325696655046,0.6742444420587625,raw,758423.5,1445570,917916.3125,910467.625,455923.25,488394.0625,Serine/threonine-protein phosphatase CPPED1 OS=Homo sapiens OX=9606 GN=CPPED1 PE=1 SV=3,NA,cell surface;cytoplasm;cytoskeleton;cytosol;mitochondrion,structural molecule activity,55313,CPPED1,NA,Neutrophil degranulation,ENSG00000103381
Q9Y315,0,6,1087034.65625,4.207852463594361e-6,0.5965958348954767,-0.7451741892836572,0.010162063662805655,0.6429522395902524,raw,1418931,1383815.8125,1244112.3125,825578.75,677844.875,971925.1875,Deoxyribose-phosphate aldolase OS=Homo sapiens OX=9606 GN=DERA PE=1 SV=2,cellular homeostasis,cell surface;cytosol;membrane;nucleus,structural molecule activity,51071,DERA,Pentose phosphate pathway in senescent cells,Neutrophil degranulation; Pentose phosphate pathway,ENSG00000023697
P35499,0.6666666666666666,6,901871.8125,3.491097092677846e-6,0.5964510986326843,-0.7455242346736978,0.35404108406958495,0.8383308462007302,raw,1189831.25,507489.375,1392686.125,NA,690743.5625,728608.75,Sodium channel protein type 4 subunit alpha OS=Homo sapiens OX=9606 GN=SCN4A PE=1 SV=4,conjugation;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity,6329,SCN4A,NA,Interaction between L1 and Ankyrins; Phase 0 - rapid depolarisation,ENSG00000007314
Q8IVD9,0,6,3795678.533854167,1.4692866669760778e-5,0.5956935620806857,-0.7473577275541748,0.2931897917885407,0.774322745775844,raw,3719181.40625,8623871.15625,2838404.4375,3114054.109375,1690819.25,2787740.84375,NudC domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NUDCD3 PE=1 SV=3,cell growth;metabolic process,endoplasmic reticulum;nucleus,structural molecule activity,23386,NUDCD3,NA,NA,ENSG00000015676
Q96A49,0,6,9622937.046875,3.724986975060522e-5,0.5944571467284242,-0.7503552822767822,0.06337114709189115,0.6429522395902524,raw,10957476.25,14782860.3125,10183044,8076022,6053383.28125,7684836.4375,Synapse-associated protein 1 OS=Homo sapiens OX=9606 GN=SYAP1 PE=1 SV=1,development;metabolic process,cytoplasm;cytoskeleton;cytosol;extracellular;membrane;nucleus,NA,94056,SYAP1,NA,NA,ENSG00000169895
Q9BXS6,0.3333333333333333,6,226066.73958333334,8.75092143220226e-7,0.5943862999241982,-0.7505272314657665,1,1,raw,NA,309854.125,NA,183603.359375,NA,184742.734375,Nucleolar and spindle-associated protein 1 OS=Homo sapiens OX=9606 GN=NUSAP1 PE=1 SV=1,cell differentiation;cell growth;metabolic process,endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding,51203,NUSAP1,NA,NA,ENSG00000137804
Q8WYL5,0,6,11291150.166666666,4.3707432667809404e-5,0.5940526518640664,-0.7513372897589189,1,1,raw,NA,9397890,17247970,NA,7227590.5,NA,Protein phosphatase Slingshot homolog 1 OS=Homo sapiens OX=9606 GN=SSH1 PE=1 SV=2,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,motor activity;structural molecule activity,54434,SSH1,Regulation of actin cytoskeleton,NA,ENSG00000084112
Q5T6F2,0,6,2610381.625,1.0104646331672741e-5,0.5927474263307893,-0.7545106012507128,0.31254162302004024,0.7923036832218412,raw,2500686.75,4490427.5,2306399.78125,2661689.34375,2450360.125,1252726.25,Ubiquitin-associated protein 2 OS=Homo sapiens OX=9606 GN=UBAP2 PE=1 SV=1,metabolic process,membrane;nucleus,NA,55833,UBAP2,NA,NA,ENSG00000137073
Q63ZY3,0.16666666666666666,6,756098.4401041666,2.926816238672401e-6,0.5917230895333793,-0.7570059035253446,0.15893106748119923,0.6638855679885327,raw,822279.34375,898456.46875,954005.3125,458297.09375,531637.4375,871914.984375,KN motif and ankyrin repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=KANK2 PE=1 SV=1,defense response;metabolic process,endosome;nucleus,NA,25959,KANK2,NA,NA,ENSG00000197256
A0A0A0MR05,0,6,759319.5104166666,2.9392848279413214e-6,0.5898431426184747,-0.7615967462662588,1,1,raw,NA,NA,1045085.5,NA,514756.46875,718116.5625,G protein beta subunit-like OS=Homo sapiens OX=9606 GN=MLST8 PE=1 SV=1,development,nucleus,NA,NA,MLST8,Target of rapamycin signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; PI3K-Akt signaling pathway; Thermogenesis; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Autophagy; p53 transcriptional gene network; Malignant pleural mesothelioma; DYRK1A; Dravet syndrome,NA,ENSG00000167965
A0A5H1ZRP2,0,6,1550266.7916666667,6.0009990491442625e-6,0.5880307459069308,-0.7660365047784312,0.14485851108074022,0.6572502130392559,raw,2133649.4375,2026277.84375,1449664.609375,1191513.671875,773759.71875,1726735.46875,Trans-Golgi network integral membrane protein 2 OS=Homo sapiens OX=9606 GN=TGOLN2 PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
A0A286YF11,0,6,786368.3151041666,3.043989290478166e-6,0.5876439908027742,-0.7669856953555703,0.1408413279514478,0.6572502130392559,raw,1249697.3125,1025540.21875,666020.96875,390775.21875,602652.546875,783523.625,"Calcium uptake protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=MICU1 PE=1 SV=1",conjugation,endosome,structural molecule activity,NA,MICU1,NA,NA,ENSG00000107745
P04626,0,6,8748432.666666666,3.386471051071673e-5,0.5833622118137364,-0.7775361584191743,0.04535334045607742,0.6429522395902524,raw,9085709,11444508,12238129,8515559,4530397.5,6676293.5,Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens OX=9606 GN=ERBB2 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion;nucleus,antioxidant activity;signal transducer activity;structural molecule activity,2064,ERBB2,Leptin signaling pathway; Prolactin signaling pathway; Glioblastoma signaling pathways; Mammary gland development pathway - Puberty (Stage 2 of 4); Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Bladder cancer; Extracellular vesicle-mediated signaling in recipient cells; Focal adhesion; RAC1/PAK1/p38/MMP2 pathway; Pathways affected in adenoid cystic carcinoma; Physico-chemical features and toxicity-associated pathways; Endometrial cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; 2q11.2 copy number variation syndrome; ErbB signaling pathway; DNA damage response (only ATM dependent),"PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RAF/MAP kinase cascade; SHC1 events in ERBB2 signaling; GRB7 events in ERBB2 signaling; Downregulation of ERBB2:ERBB3 signaling; GRB2 events in ERBB2 signaling; PI3K events in ERBB2 signaling; ERBB2 Regulates Cell Motility; ERBB2 Activates PTK6 Signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Sema4D induced cell migration and growth-cone collapse; PLCG1 events in ERBB2 signaling; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors; Signaling by ERBB2 ECD mutants; Constitutive Signaling by Overexpressed ERBB2; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants",ENSG00000141736
P08962,0,6,9528883.916666666,3.6885795161648525e-5,0.5808389723109122,-0.7837898383970445,0.48817955095468873,0.9714038060008826,raw,10934163,12489788,8795277,13857265,4745822.5,6350988,CD63 antigen OS=Homo sapiens OX=9606 GN=CD63 PE=1 SV=2,cell communication;conjugation;metabolic process,cell surface;cytoplasm;cytoskeleton;membrane;mitochondrion;nucleus,NA,967,CD63,Extracellular vesicles in the crosstalk of cardiac cells,Neutrophil degranulation; Platelet degranulation,ENSG00000135404
Q13111,0,6,1452810.7760416667,5.6237520744669115e-6,0.5762158101089564,-0.79531884943146125,0.22735397727623838,0.7148463313429879,raw,1079540.15625,2502708.875,1817978.109375,1442100.421875,897304.90625,977232.1875,Chromatin assembly factor 1 subunit A OS=Homo sapiens OX=9606 GN=CHAF1A PE=1 SV=3,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation,membrane;nucleus,structural molecule activity,10036,CHAF1A,Nanoparticle triggered autophagic cell death,NA,ENSG00000167670
Q8TAA9,0,6,1608945.890625,6.2281426730330426e-6,0.5712744307613555,-0.8077441360127863,0.2174291352556986,0.7062442676008074,raw,1084486.59375,2372599.8125,2604314.6875,1487778.390625,1183275.859375,921220,Vang-like protein 1 OS=Homo sapiens OX=9606 GN=VANGL1 PE=1 SV=1,cell death;development;metabolic process,cytoplasm;cytoskeleton,NA,81839,VANGL1,Wnt signaling,RHOC GTPase cycle; RHOA GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle; RND2 GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; RHOH GTPase cycle,ENSG00000173218
Q12962,0,6,1001298.175,3.875971173726126e-6,0.5704743603727095,-0.809766047977928,0.12609187944660244,0.6461789084539729,raw,1234963.5,1202913.875,1184476,NA,583998,800139.5,Transcription initiation factor TFIID subunit 10 OS=Homo sapiens OX=9606 GN=TAF10 PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6881,TAF10,NA,Ub-specific processing proteases; RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; HATs acetylate histones,ENSG00000166337
E5RJF8,0,6,1313898.3125,5.086029428204441e-6,0.5693219082477476,-0.8126834773078998,0.29532140719858746,0.777132610140259,raw,800588,3294069.75,1157197.75,NA,573533.125,744102.9375,Centrin-3 OS=Homo sapiens OX=9606 GN=CETN3 PE=1 SV=1,NA,endoplasmic reticulum,structural molecule activity,1070,CETN3,Breast cancer pathway,NA,ENSG00000153140
Q9H9H4,0,6,1018908.3541666666,3.944139226478396e-6,0.5675131090003421,-0.8172743772479416,0.1204822293856947,0.6445597830897484,raw,1467145.625,1452375.9375,875558.25,681600.375,804145.5625,832624.375,Vacuolar protein sorting-associated protein 37B OS=Homo sapiens OX=9606 GN=VPS37B PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;mitochondrion;nucleus,structural molecule activity,79720,VPS37B,7q11.23 copy number variation syndrome,Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy,ENSG00000139722
P53634,0,6,1656299.66875,6.411446591448276e-6,0.5656971612811519,-0.8218981634599972,0.03599312275771307,0.6429522395902524,raw,2275367.46875,1996615.9375,1738110.5625,1291367,980037.375,NA,Dipeptidyl peptidase 1 OS=Homo sapiens OX=9606 GN=CTSC PE=1 SV=2,cell organization and biogenesis;cellular homeostasis;metabolic process,cell surface;cytoskeleton;endoplasmic reticulum;extracellular;membrane;mitochondrion;nucleus,DNA binding;structural molecule activity,1075,CTSC,NA,MHC class II antigen presentation; Neutrophil degranulation; COPII-mediated vesicle transport; Cargo concentration in the ER,ENSG00000109861
F6RH32,0.6666666666666666,6,59209.405078125,2.2919641024641413e-7,0.5639157731060619,-0.8264483982144172,0.35942546572842965,0.8421609633723253,raw,122630.5,37467.015625,56190.43359375,NA,25352.068359375,54407.0078125,Voltage-dependent N-type calcium channel subunit alpha OS=Homo sapiens OX=9606 GN=CACNA1B PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
Q9P2B2,0,6,5525996.71875,2.1390834940830843e-5,0.5596692385550109,-0.8373536407105945,0.3850970183698798,0.8701645811656724,raw,7308040.390625,4813117.84375,7259397.328125,4062861.375,2050392.3125,7662171.0625,Prostaglandin F2 receptor negative regulator OS=Homo sapiens OX=9606 GN=PTGFRN PE=1 SV=2,cell growth;metabolic process,cytoskeleton;extracellular,NA,5738,PTGFRN,Prostaglandin synthesis and regulation,NA,ENSG00000134247
O00635,0,6,548453.453125,2.123033705162853e-6,0.5594686598504102,-0.8378707778854614,0.9511554589525321,1,raw,559668.984375,NA,560895.796875,1107004.40625,201238.015625,313460.0625,E3 ubiquitin-protein ligase TRIM38 OS=Homo sapiens OX=9606 GN=TRIM38 PE=1 SV=1,cell organization and biogenesis;cellular component movement;cellular homeostasis;coagulation;metabolic process,cytosol;membrane;nucleus,structural molecule activity,10475,TRIM38,NA,Interferon gamma signaling,ENSG00000112343
Q9NYJ8,0.16666666666666666,6,489631.25,1.8953361327713295e-6,0.5566746220037854,-0.8450937805785941,0.06790920928021577,0.6429522395902524,raw,571780.0625,754519.25,469018.03125,NA,286868.90625,365970,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 OS=Homo sapiens OX=9606 GN=TAB2 PE=1 SV=1,defense response;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;mitochondrion,structural molecule activity,23118,TAB2,IL-1 signaling pathway; RANKL/RANK signaling pathway; TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; MAPK signaling pathway; TLR4 signaling and tolerance; Exercise-induced circadian regulation; miRNAs involvement in the immune response in sepsis; Measles virus infection; Hepatitis B infection; Toll-like receptor signaling pathway,"Downstream TCR signaling; SARS-CoV-2 activates/modulates innate and adaptive immune responses; FCERI mediated NF-kB activation; CLEC7A (Dectin-1) signaling; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Nuclear signaling by ERBB4; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TAK1-dependent IKK and NF-kappa-B activation  ; TNFR1-induced NFkappaB signaling pathway; TICAM1,TRAF6-dependent induction of TAK1 complex; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; Alpha-protein kinase 1 signaling pathway",ENSG00000055208
P04732,0,6,1927456.7875,7.461081157920579e-6,0.5521688964254403,-0.8568184714246012,0.31627324459518225,0.796388541585002,raw,3336627.75,NA,1909195.75,2072659.5,706696.3125,1612104.625,Metallothionein-1E OS=Homo sapiens OX=9606 GN=MT1E PE=1 SV=1,coagulation;metabolic process,membrane;nucleus,structural molecule activity,4493,MT1E,Copper homeostasis; Zinc homeostasis,Metallothioneins bind metals,ENSG00000169715
B5MBW9,0.16666666666666666,6,224490.41666666666,8.689902823180187e-7,0.5492712643990807,-0.8644092768946847,1,1,raw,NA,245875.296875,283051.4375,NA,144544.515625,NA,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial OS=Homo sapiens OX=9606 GN=CHCHD10 PE=1 SV=1",NA,endosome,NA,400916,CHCHD10,NA,NA,ENSG00000250479; ENSG00000273607
A0A1W2PS04,0.8333333333333334,6,3426348.7916666665,1.3263211178459744e-5,0.5490963705334623,-0.8648687196290066,0.3054097033236975,0.7849418786698309,raw,4018751.75,4067958.75,3803658.75,4460189.5,2206682,2000852,STE20-related kinase adapter protein alpha OS=Homo sapiens OX=9606 GN=STRADA PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,92335,STRADA,AMP-activated protein kinase signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway,NA,ENSG00000266173
Q7Z7E8,0,6,1878942.1640625,7.273283669976562e-6,0.548464597208555,-0.866529595644578,1,1,raw,NA,2081986.25,NA,1141895.75,570810.5,3721076.15625,Ubiquitin-conjugating enzyme E2 Q1 OS=Homo sapiens OX=9606 GN=UBE2Q1 PE=1 SV=1,cell death;cell organization and biogenesis;cellular homeostasis;conjugation;defense response;metabolic process,cytosol;membrane;nucleus,structural molecule activity,55585,UBE2Q1,NA,Antigen processing: Ubiquitination & Proteasome degradation,ENSG00000160714
P02042,0,6,9419983.692708334,3.6464248274404055e-5,0.5450457861248346,-0.875550667491932,0.3482690184978783,0.8312036283838062,raw,14265731.125,4064755.40625,17323152,9441911,3676677,7747675.625,Hemoglobin subunit delta OS=Homo sapiens OX=9606 GN=HBD PE=1 SV=2,cellular homeostasis;conjugation;metabolic process,cytosol;nucleus,structural molecule activity,3045,HBD,VEGFA-VEGFR2 signaling pathway,Factors involved in megakaryocyte development and platelet production,ENSG00000223609
P61599,0,6,3006103.0520833335,1.1636462610276031e-5,0.5435247808473993,-0.8795822815471241,0.07726813530500133,0.6429522395902524,raw,3539065.0625,3068968.5,4917664.75,2667588.625,1923569.5625,1919761.8125,N-alpha-acetyltransferase 20 OS=Homo sapiens OX=9606 GN=NAA20 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,cytosol;membrane;nucleus,structural molecule activity,51126,NAA20,Metapathway biotransformation Phase I and II,NA,ENSG00000173418
Q01432,0.5,6,548899.953125,2.1247620825555997e-6,0.5432287124061702,-0.8803683595034296,0.037660353630656354,0.6429522395902524,raw,870376.375,620559.6875,657335.375,472813.4375,229386.21875,442928.625,AMP deaminase 3 OS=Homo sapiens OX=9606 GN=AMPD3 PE=1 SV=1,cellular homeostasis,cell surface;cytosol;nucleus,structural molecule activity,272,AMPD3,NA,Neutrophil degranulation; Purine salvage,ENSG00000133805
P58557,0.16666666666666666,6,1242639.7375,4.8101913317445124e-6,0.5396476870937366,-0.8899102542108517,0.4069220424814773,0.8914071190930648,raw,NA,1533899.375,1481090,1892949,491993.875,813266.4375,Endoribonuclease YbeY OS=Homo sapiens OX=9606 GN=YBEY PE=1 SV=2,cellular component movement;cellular homeostasis,membrane,structural molecule activity,54059,YBEY,NA,NA,ENSG00000182362
Q8IWA5,0,6,2108493.3489583335,8.16186391287067e-6,0.5350893829066256,-0.902148191214241,0.060021174105614514,0.6429522395902524,raw,2153118.21875,3477433.625,2631163.90625,913341.25,1860737.8125,1615165.28125,Choline transporter-like protein 2 OS=Homo sapiens OX=9606 GN=SLC44A2 PE=1 SV=3,cellular homeostasis;conjugation,cytoplasm;cytoskeleton;endosome,catalytic activity,57153,SLC44A2,NA,"Neutrophil degranulation; Synthesis of PC; Transport of bile salts and organic acids, metal ions and amine compounds",ENSG00000129353
Q9NZ08,0,6,569431.9125,2.2042401887427163e-6,0.5346803867563893,-0.9032513383832321,0.3778613772331829,0.8617583924772685,raw,766613.0625,1032578.484375,228182.078125,403879.875,415906.0625,NA,Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens OX=9606 GN=ERAP1 PE=1 SV=3,cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;extracellular;nucleus,antioxidant activity;structural molecule activity,51752,ERAP1,NA,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",ENSG00000164307
A0A087X1C1,0,6,2734680.3125,1.0585799839899192e-5,0.5345477677049942,-0.9036092205582532,0.05520833989970954,0.6429522395902524,raw,4297616,2881938.25,3312667,2711824.75,1433257.125,1770778.75,Thymosin beta-15B OS=Homo sapiens OX=9606 GN=TMSB15B PE=3 SV=1,cell growth;metabolic process,endoplasmic reticulum;nucleus,motor activity,NA,TMSB15B,NA,NA,ENSG00000269226
Q96PV6,0,6,471889.7552083333,1.8266597643246256e-6,0.5331683761787405,-0.9073368825083247,0.14447309707433112,0.6572502130392559,raw,590217.375,882964.625,405610.375,337604.4375,216258.625,398683.09375,Leukocyte receptor cluster member 8 OS=Homo sapiens OX=9606 GN=LENG8 PE=1 SV=3,NA,membrane;nucleus,NA,114823,LENG8,NA,NA,ENSG00000167615; ENSG00000274305; ENSG00000276458; ENSG00000276681
J3QKY0,0.5,6,3096344.6,1.1985782769975138e-5,0.5302359485013768,-0.9152936107128379,0.4807639039506134,0.9622845920836873,raw,4151447.125,3347692.25,NA,5081996.375,935269.5,1965317.75,Testis-expressed protein 2 (Fragment) OS=Homo sapiens OX=9606 GN=TEX2 PE=1 SV=1,NA,NA,NA,NA,TEX2,NA,NA,ENSG00000136478
Q9ULP9,0,6,1020919.5755208334,3.9519245557513e-6,0.5259902059092326,-0.9268921585213638,0.3026792264583757,0.7825518083423609,raw,1133830.28125,883686.546875,1741511.34375,519348.375,464810.46875,1382330.4375,TBC1 domain family member 24 OS=Homo sapiens OX=9606 GN=TBC1D24 PE=1 SV=2,cell growth;coagulation;conjugation;defense response;metabolic process,cytoplasm;cytoskeleton;nucleus,DNA binding,57465,TBC1D24,NA,TBC/RABGAPs,ENSG00000162065
P04183,0,6,6802790.067708333,2.6333233058522148e-5,0.5246497173039338,-0.9305735669085575,0.005988907776913693,0.6429522395902524,raw,9229589.875,8883776.59375,9285586.375,4842301.71875,3577562.90625,4997922.9375,"Thymidine kinase, cytosolic OS=Homo sapiens OX=9606 GN=TK1 PE=1 SV=2",cell growth;cell proliferation;cellular homeostasis,cytosol,signal transducer activity;structural molecule activity,7083,TK1,Fluoropyrimidine activity; Pyrimidine metabolism,Pyrimidine salvage; G1/S-Specific Transcription,ENSG00000167900
Q99547,0,6,1240332.4739583333,4.801260039147589e-6,0.5242839449803532,-0.9315797276557757,0.3420249749758177,0.8247147020235626,raw,1898122.375,1462741.125,1118725,1752452.21875,766891.6875,443062.4375,M-phase phosphoprotein 6 OS=Homo sapiens OX=9606 GN=MPHOSPH6 PE=1 SV=2,cellular component movement;cellular homeostasis,cytosol;membrane;nucleus,RNA binding,10200,MPHOSPH6,NA,Major pathway of rRNA processing in the nucleolus and cytosol,ENSG00000135698
A0A0A0MTS7,0,6,681108.234375,2.636533201136612e-6,0.5176233221446227,-0.9500254737231294,1,1,raw,779152.1875,812155.5625,729817.84375,NA,403307.34375,NA,Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,nucleus,signal transducer activity;structural molecule activity,7273,TTN,Striated muscle contraction pathway,NA,ENSG00000155657
P14210,0.6666666666666666,6,895211.6927083334,3.465316128554884e-6,0.5161003866179048,-0.9542763835222778,0.05437550222828364,0.6429522395902524,raw,1170492.75,899935.6875,1485186,464457.15625,555025.8125,796172.75,Hepatocyte growth factor OS=Homo sapiens OX=9606 GN=HGF PE=1 SV=2,cell death;cell differentiation;defense response;development;metabolic process,cell surface;nucleus,antioxidant activity;structural molecule activity,3082,HGF,Pluripotent stem cell differentiation pathway; Extracellular vesicle-mediated signaling in recipient cells; Nuclear receptors meta-pathway; NRF2 pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; Lung fibrosis; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; EGFR tyrosine kinase inhibitor resistance; Malignant pleural mesothelioma,"Platelet degranulation ; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RAF/MAP kinase cascade; Interleukin-7 signaling; Interleukin-4 and Interleukin-13 signaling; MET activates PTK2 signaling; MET Receptor Activation; MET activates RAS signaling; MET interacts with TNS proteins; MET activates PI3K/AKT signaling; MET activates PTPN11; MET activates RAP1 and RAC1; MET receptor recycling; MET activates STAT3; Drug-mediated inhibition of MET activation",ENSG00000019991
Q9NYJ1,0,6,3804010.6145833335,1.4725119704400942e-5,0.5114802521842681,-0.9672495550649627,0.20354746109769375,0.6947398829435072,raw,4487700.75,6112816.5,3591520.625,4782339.6875,1836991.875,2012694.25,"Cytochrome c oxidase assembly factor 4 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=COA4 PE=1 SV=2",cell growth,endosome,NA,51287,COA4,NA,Mitochondrial protein import,ENSG00000181924
O95352,0,6,1249783.8333333333,4.837845740994121e-6,0.510722781538272,-0.969387680874743,0.7827414998828133,1,raw,1039166,1596206.90625,1407643.34375,2372791.5625,530725.75,552169.4375,Ubiquitin-like modifier-activating enzyme ATG7 OS=Homo sapiens OX=9606 GN=ATG7 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;coagulation;conjugation;metabolic process,cell surface;cytosol;endoplasmic reticulum;nucleus,structural molecule activity,10533,ATG7,Nanoparticle triggered autophagic cell death; Ferroptosis; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Autophagy; Clock-controlled autophagy in bone metabolism,Neutrophil degranulation; Antigen processing: Ubiquitination & Proteasome degradation; Signaling by BRAF and RAF1 fusions; Macroautophagy,ENSG00000197548
Q68D10,0.3333333333333333,6,4127619.3333333335,1.5977791582527e-5,0.507073252116843,-0.979733919982211,0.09206844696604781,0.6429522395902524,raw,4233389,7057680,4708286,3578760.75,2129133.25,3058467,Protein SPT2 homolog OS=Homo sapiens OX=9606 GN=SPTY2D1 PE=1 SV=3,cell growth;metabolic process,membrane,RNA binding;structural molecule activity,144108,SPTY2D1,NA,NA,ENSG00000179119
P43007,0.5,6,207438.3484375,8.029826468715034e-7,0.506248929230771,-0.9820811434498296,0.6296230920104832,1,raw,214871.8125,NA,255093.09375,111232.3046875,349669.5859375,106324.9453125,Neutral amino acid transporter A OS=Homo sapiens OX=9606 GN=SLC1A4 PE=1 SV=1,cell death;conjugation;metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;nucleus,catalytic activity,6509,SLC1A4,Neuroinflammation and glutamatergic signaling,Amino acid transport across the plasma membrane,ENSG00000115902
A0A087WV05,0,6,5597256.041666667,2.166667593243581e-5,0.5059492761166844,-0.9829353399343226,0.03754267736167438,0.6429522395902524,raw,6502572.625,9089603.75,6487872.375,4598878.4375,2351949.625,4552659.4375,Uncharacterized protein OS=Homo sapiens OX=9606 PE=3 SV=1,cellular component movement,endosome;membrane,structural molecule activity,NA,NA,NA,NA,NA
Q6NSW5,0,6,1113147.2395833333,4.308932863817323e-6,0.5054689748989645,-0.9843055509945423,0.18250949974871106,0.675199014539673,raw,1042891.84375,1664564,1485693.1875,750971.8125,375459.09375,1359303.5,Putative DENN domain-containing protein 10 B OS=Homo sapiens OX=9606 GN=DENND10P1 PE=5 SV=1,conjugation;metabolic process,mitochondrion,DNA binding;structural molecule activity,NA,DENND10P1,NA,NA,NA
Q8IYQ7,0,6,1133705.4739583333,4.388512679110809e-6,0.5050999914545423,-0.9853590775262641,0.21124251916804201,0.7016553543929079,raw,1498198.21875,1140602.75,1464959.5625,739951.0625,543021.75,1415499.5,Threonine synthase-like 1 OS=Homo sapiens OX=9606 GN=THNSL1 PE=1 SV=2,NA,nucleus,NA,79896,THNSL1,NA,NA,ENSG00000185875
Q8WXI9,0,6,7552607.924479167,2.9235737498210014e-5,0.5019527737071271,-0.9943764604794115,0.12841381347335076,0.6498046150645307,raw,8800846.9375,11020085.203125,8497432.09375,8855516.59375,4417609.53125,3724157.1875,Transcriptional repressor p66-beta OS=Homo sapiens OX=9606 GN=GATAD2B PE=1 SV=1,cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,57459,GATAD2B,NA,Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation,ENSG00000143614; ENSG00000261992
P48436,0.5,6,706000.1263020834,2.7328883708330727e-6,0.5008858560059839,-0.9974462214790644,0.10793563120902366,0.6429522395902524,raw,1168260.28125,577716.28125,1116631.28125,734599.40625,289369.9140625,349423.59375,Transcription factor SOX-9 OS=Homo sapiens OX=9606 GN=SOX9 PE=1 SV=1,cell communication;cell death;cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;development;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,6662,SOX9,Neural crest differentiation; Spinal cord injury; Endochondral ossification; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; Endochondral ossification with skeletal dysplasias; Somatic sex determination; Mammalian disorder of sexual development; MAP3K1 role in promoting and blocking gonadal determination; Prostaglandin synthesis and regulation,Deactivation of the beta-catenin transactivating complex; Transcriptional regulation by RUNX2; Transcriptional regulation of testis differentiation,ENSG00000125398
Q8N1Q1,0,6,2431812.4166666665,9.413414567453162e-6,0.499609790920394,-1.0011263449753403,0.5356960023227708,1,raw,2770469.875,2746993.5,2774333,3880172.75,1034751.5,1384153.875,Carbonic anhydrase 13 OS=Homo sapiens OX=9606 GN=CA13 PE=1 SV=1,cellular homeostasis,cytosol;nucleus,structural molecule activity,377677,CA13,NA,Reversible hydration of carbon dioxide,ENSG00000185015
P31327,0,6,871221.5052083334,3.372451408011191e-6,0.4989420139562358,-1.0030559367171472,0.21330564636875884,0.702871293386539,raw,1134260,849730.28125,1233028.96875,339348.8125,565929.96875,1105031,"Carbamoyl-phosphate synthase [ammonia], mitochondrial OS=Homo sapiens OX=9606 GN=CPS1 PE=1 SV=2",cellular homeostasis;coagulation;defense response;metabolic process,cytoskeleton;endosome;membrane;nucleus,structural molecule activity,1373,CPS1,Amino acid metabolism,Urea cycle,ENSG00000021826
Q8IV50,0.16666666666666666,6,1428373.875,5.529158149922209e-6,0.4950686196114649,-1.0142995892667575,0.5499250993275723,1,raw,1475254.46875,1829491.9375,1569670.15625,2322796.625,595935.625,777094.4375,LysM and putative peptidoglycan-binding domain-containing protein 2 OS=Homo sapiens OX=9606 GN=LYSMD2 PE=1 SV=1,NA,NA,NA,256586,LYSMD2,NA,NA,ENSG00000140280
Q8TDY2,0.3333333333333333,6,167090.5671875,6.467985640943552e-7,0.49199507211892296,-1.02328422945536,0.11127597929926011,0.6429522395902524,raw,175144.546875,275943.6796875,166972.28125,134445.796875,82946.53125,NA,RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,9821,RB1CC1,Alzheimer's disease and miRNA effects; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Autophagy; Malignant pleural mesothelioma; Alzheimer's disease; Clock-controlled autophagy in bone metabolism,Macroautophagy,ENSG00000023287
Q96EK9,0,6,309527.9010416667,1.1981657930230951e-6,0.49113523920656554,-1.025807754527555,1,1,raw,468444.5,NA,NA,NA,204982.15625,255157.046875,Protein KTI12 homolog OS=Homo sapiens OX=9606 GN=KTI12 PE=1 SV=1,cellular component movement;cellular homeostasis;metabolic process,NA,structural molecule activity,112970,KTI12,NA,NA,ENSG00000198841
Q9H467,0.16666666666666666,6,510962.1640625,1.97790694941691e-6,0.49027547814828015,-1.0283354899812538,1,1,raw,711733.0625,536771.25,532178.5625,263165.78125,NA,NA,CUE domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CUEDC2 PE=1 SV=1,metabolic process,cytoskeleton;cytosol;membrane,structural molecule activity,79004,CUEDC2,NA,NA,ENSG00000107874
Q99661,0,6,841477.59375,3.2573143326775997e-6,0.48909159877021446,-1.0318234114765255,0.013128142418050496,0.6429522395902524,raw,1214885.09375,967478.9375,1127747.46875,433340.0625,551571.8125,753842.1875,Kinesin-like protein KIF2C OS=Homo sapiens OX=9606 GN=KIF2C PE=1 SV=2,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;RNA binding;structural molecule activity,11004,KIF2C,Microtubule cytoskeleton regulation,COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Kinesins; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000142945
Q96FZ2,0,6,1706570.96875,6.606044079519938e-6,0.48672249623099506,-1.0388286376104854,0.056024363481535736,0.6429522395902524,raw,2370816.25,1540141.6875,2606975.53125,1208675,806246.375,NA,Abasic site processing protein HMCES OS=Homo sapiens OX=9606 GN=HMCES PE=1 SV=1,cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,nucleus,RNA binding;structural molecule activity,56941,HMCES,NA,NA,ENSG00000183624
Q8IZQ5,0.16666666666666666,6,526791.734375,2.039182361432637e-6,0.4864781881243723,-1.0395529735197042,0.06502718815437877,0.6429522395902524,raw,646655.5,809115.75,525552.25,NA,249464.015625,403171.15625,Selenoprotein H OS=Homo sapiens OX=9606 GN=SELENOH PE=1 SV=2,NA,extracellular,NA,280636,SELENOH,Selenium micronutrient network,NA,ENSG00000211450
P60520,0.16666666666666666,6,1208032.675,4.6762292612979756e-6,0.48619508267128536,-1.040392792721103,0.09968085541563938,0.6429522395902524,raw,1155657,1970149.75,1393731.125,NA,560635.1875,959990.3125,Gamma-aminobutyric acid receptor-associated protein-like 2 OS=Homo sapiens OX=9606 GN=GABARAPL2 PE=1 SV=1,cell growth;cellular homeostasis;coagulation;conjugation;metabolic process,cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,antioxidant activity;motor activity;structural molecule activity,11345,GABARAPL2,Network map of SARS-CoV-2 signaling pathway; 2q37 copy number variation syndrome,Macroautophagy; TBC/RABGAPs,ENSG00000034713
Q8WZA9,0,6,1402551.3489583333,5.429200545814628e-6,0.4853506928000902,-1.0429005436006515,0.06854192018478153,0.6429522395902524,raw,1962536.28125,2405166.859375,1318915.28125,952518.34375,538120.234375,1238051.09375,Immunity-related GTPase family Q protein OS=Homo sapiens OX=9606 GN=IRGQ PE=1 SV=1,NA,NA,structural molecule activity,126298,IRGQ,NA,NA,ENSG00000167378
Q8WW01,0,6,1055927.640625,4.08743888562779e-6,0.4805523467844371,-1.0572345019051392,0.21403928302265765,0.703661823235592,raw,1297024.15625,1308594,1308208.9375,628662.875,442967.8125,1350108.0625,tRNA-splicing endonuclease subunit Sen15 OS=Homo sapiens OX=9606 GN=TSEN15 PE=1 SV=1,cellular component movement;cellular homeostasis,membrane,RNA binding,116461,TSEN15,NA,tRNA processing in the nucleus,ENSG00000198860
Q9UEU0,0.16666666666666666,6,537093.83125,2.0790612222089832e-6,0.47395645505638895,-1.0771735778735685,5.646458002515173e-4,0.5858850014706761,raw,799115.75,768039.1875,NA,337198.65625,371235.5625,409880,Vesicle transport through interaction with t-SNAREs homolog 1B OS=Homo sapiens OX=9606 GN=VTI1B PE=1 SV=3,cell growth;cellular homeostasis;conjugation;metabolic process,cell surface;cytoskeleton;cytosol;extracellular;mitochondrion;nucleus,structural molecule activity,10490,VTI1B,NA,Platelet degranulation,ENSG00000100568
O95429,0,6,642917.9114583334,2.4887005230831523e-6,0.4725994183576116,-1.0813102411429019,0.06371992500132281,0.6429522395902524,raw,899818.90625,621752.3125,1012175.0625,293839.78125,650659.09375,379262.3125,BAG family molecular chaperone regulator 4 OS=Homo sapiens OX=9606 GN=BAG4 PE=1 SV=1,cell growth;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane,structural molecule activity,9530,BAG4,Oxidative damage response,Regulation of HSF1-mediated heat shock response; Signaling by FGFR1 in disease; Signaling by plasma membrane FGFR1 fusions; TNF signaling,ENSG00000156735
F8VWL3,0.3333333333333333,6,373118.265625,1.4443206609791208e-6,0.4700544953736835,-1.0891000707613328,1,1,raw,429600.6875,618431.875,242504.765625,201935.734375,NA,NA,"FYVE, RhoGEF and PH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FGD4 PE=1 SV=1",cell growth,endoplasmic reticulum;nucleus,DNA binding;structural molecule activity,NA,FGD4,Nuclear receptors meta-pathway; Intracellular trafficking proteins involved in CMT neuropathy,NA,ENSG00000139132
A0A0A0MT26,0,6,786675.2760416666,3.0451775196939135e-6,0.4696711618944084,-1.0902770809577755,0.5826089584627114,1,raw,1073157.6875,883395.25,720249.9375,338280.625,387359.0625,1317609.09375,Sodium/potassium-transporting ATPase subunit alpha-3 OS=Homo sapiens OX=9606 GN=ATP1A3 PE=1 SV=1,conjugation,cytoskeleton,catalytic activity;structural molecule activity,NA,ATP1A3,Sudden infant death syndrome (SIDS) susceptibility pathways,NA,ENSG00000105409
Q7Z7K0,0,6,1392134.703125,5.388878272205257e-6,0.4669530980886835,-1.098650445494133,0.20802700274296965,0.6988382857167694,raw,689517.6875,2306076.3125,3068346.4375,1432773.875,410493.15625,445600.75,COX assembly mitochondrial protein homolog OS=Homo sapiens OX=9606 GN=CMC1 PE=1 SV=1,NA,endosome,structural molecule activity,152100,CMC1,Mitochondrial complex IV assembly,NA,ENSG00000187118
M0QXZ5,0,6,3375976.6041666665,1.3068223160322662e-5,0.46564554703567373,-1.102695912782361,0.2447796279662252,0.7301988479077035,raw,4146298.375,3997919,4333756.875,4491568,1355612,1930705.375,Zinc finger protein 428 (Fragment) OS=Homo sapiens OX=9606 GN=ZNF428 PE=1 SV=1,NA,NA,NA,NA,ZNF428,NA,NA,ENSG00000131116
O00592,0,6,4247473.072916667,1.644173893735792e-5,0.4571832887873049,-1.1291554245464828,0.21383091453766503,0.703661823235592,raw,5543306.5625,5617011.625,4609441.375,5472953.1875,2534307.125,1707818.5625,Podocalyxin OS=Homo sapiens OX=9606 GN=PODXL PE=1 SV=2,cell communication;defense response;metabolic process,cell surface;cytoplasm;cytoskeleton;endoplasmic reticulum;membrane;nucleus,NA,5420,PODXL,Primary focal segmental glomerulosclerosis (FSGS); Ectoderm differentiation; Hepatitis C and hepatocellular carcinoma; Nephrotic syndrome; Malignant pleural mesothelioma,NA,ENSG00000128567
P54760,0,6,308931.140625,1.195855765670233e-6,0.4557104245226758,-1.1338107218352047,1,1,raw,164791.296875,470804.65625,412258.234375,NA,187870.375,NA,Ephrin type-B receptor 4 OS=Homo sapiens OX=9606 GN=EPHB4 PE=1 SV=2,cell communication;cell growth;cell organization and biogenesis;cellular homeostasis;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton;cytosol;nucleus,signal transducer activity;structural molecule activity,2050,EPHB4,Vitamin D receptor pathway; Neovascularisation processes; Neural crest cell migration during development; Neural crest cell migration in cancer,EPHB-mediated forward signaling; Ephrin signaling; EPH-ephrin mediated repulsion of cells,ENSG00000196411
Q6ICG6,0,6,592840.9921875,2.294855472319167e-6,0.4513537511218461,-1.147669497459735,1,1,raw,NA,797443.9375,NA,929839.65625,284151.0625,359929.3125,Uncharacterized protein KIAA0930 OS=Homo sapiens OX=9606 GN=KIAA0930 PE=1 SV=1,NA,NA,NA,23313,KIAA0930,NA,NA,ENSG00000100364
Q99808,0,6,1420704.78125,5.499471502082664e-6,0.45111459336419385,-1.1484341375075329,0.024139741220025875,0.6429522395902524,raw,1903581.875,2457779.75,1614338.8125,1108740.3125,864856.0625,574931.875,Equilibrative nucleoside transporter 1 OS=Homo sapiens OX=9606 GN=SLC29A1 PE=1 SV=3,cell death;cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;nucleus,catalytic activity,2030,SLC29A1,Fluoropyrimidine activity,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane; Azathioprine ADME; Ribavirin ADME,ENSG00000112759
Q8TF05,0,6,813129.2083333334,3.147579263304605e-6,0.45015139170897267,-1.1515178149200427,1,1,raw,1283683.65625,NA,NA,820914,NA,334789.96875,Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Homo sapiens OX=9606 GN=PPP4R1 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;development,nucleus,DNA binding,9989,PPP4R1,16p11.2 proximal deletion syndrome,NA,ENSG00000154845
P50895,0,6,921811.7916666666,3.5682836754404677e-6,0.44881314461719346,-1.1558131653837551,0.011315125667590582,0.6429522395902524,raw,1465862.25,1136196.0625,1204348.5,540527.4375,528528.625,655407.875,Basal cell adhesion molecule OS=Homo sapiens OX=9606 GN=BCAM PE=1 SV=2,cell communication;development,cytoplasm;cytoskeleton,structural molecule activity,4059,BCAM,NA,NA,ENSG00000187244
Q9ULD2,0,6,470658.90625,1.8218952144624322e-6,0.4482625058819406,-1.157584262106752,1,1,raw,NA,649963.53125,NA,291354.28125,NA,NA,Microtubule-associated tumor suppressor 1 OS=Homo sapiens OX=9606 GN=MTUS1 PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton;endoplasmic reticulum;endosome;extracellular;membrane,motor activity,57509,MTUS1,NA,NA,ENSG00000129422
Q9UBV8,0,6,1653679.1705729167,6.4013027844896985e-6,0.44740586682272293,-1.1603439203397863,0.13563852630827622,0.653793677153943,raw,1707640.25,2476887.7734375,2097748.53125,938545,728974.9375,1972278.53125,Peflin OS=Homo sapiens OX=9606 GN=PEF1 PE=1 SV=1,cell growth;conjugation;defense response;metabolic process,cytoskeleton;extracellular;nucleus,structural molecule activity,553115,PEF1,NA,NA,ENSG00000162517
A8MUM1,0,6,1371788.5911458333,5.310119571253211e-6,0.4462863161309107,-1.1639585230113023,0.2688602648406135,0.7488389926768765,raw,3193741.0625,1307916.8125,1109474.90625,1256811.609375,495143.46875,867643.6875,EARP and GARP complex-interacting protein 1 OS=Homo sapiens OX=9606 GN=EIPR1 PE=1 SV=2,NA,extracellular,NA,7260,EIPR1,Ciliary landscape,NA,ENSG00000032389
A0A096LNH6,0,6,579929.91875,2.2448774041322245e-6,0.44493336636793385,-1.168338801973694,0.08019091862073288,0.6429522395902524,raw,894763.453125,467638.875,899779.671875,399222.9375,NA,238244.65625,Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=1,development;metabolic process,cytosol;membrane,DNA binding,NA,DOCK1,NA,NA,ENSG00000150760
Q53HL2,0.5,6,132580.2001953125,5.132107967378149e-7,0.4420387068595788,-1.177755390996002,1,1,raw,118781.8203125,199924.9375,146746.4375,NA,64867.60546875,NA,Borealin OS=Homo sapiens OX=9606 GN=CDCA8 PE=1 SV=2,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,NA,55143,CDCA8,NA,Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; SUMOylation of DNA replication proteins; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,ENSG00000134690
P31350,0,6,12072128.984375,4.6730559504855933e-05,0.4411209858360025,-1.1807536982265787,0.0034243853464795662,0.6429522395902524,raw,17326573.1875,15942690.125,16295580.5625,7188322.5625,6359200.78125,9320406.6875,Ribonucleoside-diphosphate reductase subunit M2 OS=Homo sapiens OX=9606 GN=RRM2 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;defense response;metabolic process,cytosol;membrane,structural molecule activity,6241,RRM2,Fluoropyrimidine activity; Retinoblastoma gene in cancer; Hepatitis C and hepatocellular carcinoma; Pyrimidine metabolism,Transcriptional Regulation by E2F6; Interconversion of nucleotide di- and triphosphates; G1/S-Specific Transcription,ENSG00000171848
O14944,0.16666666666666666,6,930339.1666666666,3.6012926836587765e-6,0.4374049425026977,-1.1929585725264011,0.09924111043767773,0.6429522395902524,raw,1026352.5,1822035.125,1031645.25,517056.46875,736014,448931.65625,Proepiregulin OS=Homo sapiens OX=9606 GN=EREG PE=1 SV=1,cell death;cell differentiation;cell growth;cellular component movement;cellular homeostasis;coagulation;defense response;development;metabolic process,cell surface;cytoplasm;cytoskeleton,antioxidant activity;DNA binding,2069,EREG,ErbB signaling pathway,"PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RAF/MAP kinase cascade; SHC1 events in ERBB2 signaling; PI3K events in ERBB4 signaling; SHC1 events in ERBB4 signaling; Nuclear signaling by ERBB4; GRB2 events in ERBB2 signaling; PI3K events in ERBB2 signaling; ERBB2 Regulates Cell Motility; ERBB2 Activates PTK6 Signaling; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Cargo recognition for clathrin-mediated endocytosis; GRB2 events in EGFR signaling; GAB1 signalosome; SHC1 events in EGFR signaling; EGFR downregulation; EGFR interacts with phospholipase C-gamma; Inhibition of Signaling by Overexpressed EGFR; Estrogen-dependent nuclear events downstream of ESR-membrane signaling",ENSG00000124882
P00374,0,6,3953678.765625,1.5304477036259044e-5,0.43718237740281807,-1.1936928470019041,0.04663618024840282,0.6429522395902524,raw,5598102.90625,6480099,4195316.3125,2447391.9375,2408986.65625,2592175.78125,Dihydrofolate reductase OS=Homo sapiens OX=9606 GN=DHFR PE=1 SV=2,cell growth;cellular homeostasis;coagulation;defense response;metabolic process,cytosol;endosome,RNA binding;structural molecule activity,1719,DHFR,"Fluoropyrimidine activity; Folate metabolism; One-carbon metabolism; Retinoblastoma gene in cancer; Trans-sulfuration, one-carbon metabolism and related pathways; Ethanol effects on histone modifications","G1/S-Specific Transcription; Metabolism of folate and pterines; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",ENSG00000228716
Q15714,0.3333333333333333,6,4965026.5,1.921934951173392e-5,0.43456569003993983,-1.2023538199613621,0.099149856097635,0.6429522395902524,raw,6264420,7117383.5,5910922,5612637.5,2162494,2722302,TSC22 domain family protein 1 OS=Homo sapiens OX=9606 GN=TSC22D1 PE=1 SV=3,cellular component movement;cellular homeostasis;metabolic process,cytosol;membrane,NA,8848,TSC22D1,Ectoderm differentiation; Ectoderm differentiation,NA,ENSG00000102804
Q96KB5,0.3333333333333333,6,5062407.296875,1.9596305318691204e-5,0.43257209175205125,-1.208987504921993,0.2092595734809448,0.6993492614438964,raw,4243240.5625,11866606.125,5437755.8125,2352221.40625,2159051.5625,4315568.3125,Lymphokine-activated killer T-cell-originated protein kinase OS=Homo sapiens OX=9606 GN=PBK PE=1 SV=3,cell differentiation;cell organization and biogenesis;cellular homeostasis;coagulation;development;metabolic process,membrane,signal transducer activity;structural molecule activity,55872,PBK,"4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling pathway",NA,ENSG00000168078
Q7Z3C6,0,6,164928.6953125,6.384300747891697e-7,0.43143700296744764,-1.2127781777578357,1,1,raw,NA,230437.9375,NA,NA,99419.453125,NA,Autophagy-related protein 9A OS=Homo sapiens OX=9606 GN=ATG9A PE=1 SV=3,cell growth;cellular homeostasis;conjugation;defense response;metabolic process,cytoskeleton;endosome;extracellular;mitochondrion;nucleus,catalytic activity,79065,ATG9A,Autophagy,Macroautophagy,ENSG00000198925
Q9Y618,0.16666666666666666,6,199335.94791666666,7.716186919169929e-7,0.4304991506194623,-1.215917703718898,1,1,raw,NA,321337.125,NA,161214.71875,115456,NA,Nuclear receptor corepressor 2 OS=Homo sapiens OX=9606 GN=NCOR2 PE=1 SV=3,cellular component movement;conjugation;metabolic process,membrane;nucleus,antioxidant activity;RNA binding;structural molecule activity,9612,NCOR2,Androgen receptor signaling pathway; Adipogenesis; Aryl hydrocarbon receptor pathway; Notch signaling; Rett syndrome causing genes; Notch signaling pathway,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; HCMV Early Events; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; SUMOylation of transcription cofactors; HDACs deacetylate histones; Nuclear Receptor transcription pathway; Cytoprotection by HMOX1; Downregulation of SMAD2/3:SMAD4 transcriptional activity; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Loss of MECP2 binding ability to the NCoR/SMRT complex; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,ENSG00000196498
Q96SQ9,0,6,1317292.2395833333,5.0991671367004425e-6,0.4281144841257907,-1.2239314487406112,0.1153137340915631,0.6429522395902524,raw,2180962.375,1641825.875,1438726.75,1555862.34375,702889.4375,383486.65625,Cytochrome P450 2S1 OS=Homo sapiens OX=9606 GN=CYP2S1 PE=1 SV=2,cellular homeostasis,cytoskeleton;extracellular;nucleus,structural molecule activity,29785,CYP2S1,Vitamin D receptor pathway; Oxidation by cytochrome P450; Metapathway biotransformation Phase I and II,CYP2E1 reactions; Miscellaneous substrates,ENSG00000167600
Q9Y6I9,0,6,2311303.921875,8.94693269056207e-6,0.4279927356105329,-1.2243417851478575,0.03310454105775722,0.6429522395902524,raw,3027169.75,3990149.5,2545298.15625,1707755,906187.0625,1691264.0625,Testis-expressed protein 264 OS=Homo sapiens OX=9606 GN=TEX264 PE=1 SV=1,cell growth;cell proliferation;cellular homeostasis;coagulation,cell surface;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,structural molecule activity,51368,TEX264,NA,Platelet degranulation,ENSG00000164081
A0A0U1RQM3,0,6,846192.275,3.2755646092431263e-6,0.41848844341126923,-1.256740311689897,0.22222656646715394,0.7106930585959085,raw,468706.25,1396069.25,1288086.90625,523152.40625,NA,554946.5625,5-formyltetrahydrofolate cyclo-ligase OS=Homo sapiens OX=9606 GN=MTHFS PE=1 SV=1,NA,NA,structural molecule activity,NA,MTHFS,Disorders of folate metabolism and transport,NA,ENSG00000136371
Q6PCB7,0,6,1076187,4.165861771933018e-6,0.4155288107420038,-1.2669795849829129,1,1,raw,1472881.625,NA,NA,612024.75,400709.125,1819132.5,Long-chain fatty acid transport protein 1 OS=Homo sapiens OX=9606 GN=SLC27A1 PE=1 SV=1,cellular homeostasis;coagulation;conjugation;development;metabolic process,cytoplasm;cytoskeleton;extracellular,catalytic activity;structural molecule activity,376497,SLC27A1,PPAR-alpha pathway; Nuclear receptors meta-pathway; PPAR signaling pathway,PPARA activates gene expression; Transport of fatty acids,ENSG00000130304
E7EXA6,0,6,491103.7734375,1.9010361914939835e-6,0.41491784001533993,-1.2691024055053797,0.18727974649382034,0.6796563727916235,raw,1092101.90625,491507.34375,473437.96875,435161.5,196437.859375,257976.0625,Chromosome transmission fidelity protein 18 homolog OS=Homo sapiens OX=9606 GN=CHTF18 PE=1 SV=2,NA,cytosol;membrane,structural molecule activity,NA,CHTF18,7q11.23 copy number variation syndrome,NA,ENSG00000127586
O75153,0.5,6,921599.375,3.5674614219925183e-6,0.4144376961494632,-1.2707728621946957,0.08018964858829966,0.6429522395902524,raw,1070643.5,1634217.25,881425.6875,631981.9375,389728.5,NA,Clustered mitochondria protein homolog OS=Homo sapiens OX=9606 GN=CLUH PE=1 SV=2,cell growth,nucleus,RNA binding,23277,CLUH,Translation factors,NA,ENSG00000132361
Q9Y3C7,0,6,630006.8125,2.4387223561064414e-6,0.4143930334038698,-1.2709283456229636,1,1,raw,890851.125,NA,NA,NA,NA,369162.5,Mediator of RNA polymerase II transcription subunit 31 OS=Homo sapiens OX=9606 GN=MED31 PE=1 SV=1,cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;defense response;metabolic process,membrane;nucleus,structural molecule activity,51003,MED31,NA,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Generic Transcription Pathway,ENSG00000108590
P18858,0,6,1672393.9296875,6.473746606582307e-6,0.4090115214444522,-1.2897866118752006,0.17157097758920942,0.6688917965646828,raw,3212717.46875,2304273.125,1283940.03125,776375.84375,525146.265625,1931910.84375,DNA ligase 1 OS=Homo sapiens OX=9606 GN=LIG1 PE=1 SV=1,cell differentiation;cell proliferation;cellular homeostasis;coagulation;metabolic process,endosome;membrane;nucleus,RNA binding;structural molecule activity,3978,LIG1,"Base excision repair; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair",Gap-filling DNA repair synthesis and ligation in TC-NER; Early Phase of HIV Life Cycle; POLB-Dependent Long Patch Base Excision Repair; PCNA-Dependent Long Patch Base Excision Repair; Processive synthesis on the lagging strand; Gap-filling DNA repair synthesis and ligation in GG-NER; Processive synthesis on the C-strand of the telomere; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),ENSG00000105486
Q6PI78,0.3333333333333333,6,645681.3880208334,2.4993977916520454e-6,0.40188682707286355,-1.315138804945575,0.33120030535880907,0.8138690889259484,raw,742562.75,1176140.125,522933.125,942059,191967.140625,298426.1875,Transmembrane protein 65 OS=Homo sapiens OX=9606 GN=TMEM65 PE=1 SV=2,defense response;metabolic process,cytoplasm;cytoskeleton;endosome;nucleus,NA,157378,TMEM65,NA,NA,ENSG00000164983
Q8IVM0,0.16666666666666666,6,695789.5,2.693363587705844e-6,0.39809315679206553,-1.3288220231240273,0.10478139144694504,0.6429522395902524,raw,576973.9375,1260996.125,1107507.8125,460195.09375,328172.75,440891.28125,Coiled-coil domain-containing protein 50 OS=Homo sapiens OX=9606 GN=CCDC50 PE=1 SV=1,metabolic process,cytosol;nucleus,structural molecule activity,152137,CCDC50,NA,NA,ENSG00000152492
Q96EI5,0,6,787008.93125,3.046469080990791e-6,0.3934406104099127,-1.3457822165460191,0.04181901188041478,0.6429522395902524,raw,860636.84375,972895.40625,1335959.28125,393214.875,NA,372338.25,Transcription elongation factor A protein-like 4 OS=Homo sapiens OX=9606 GN=TCEAL4 PE=1 SV=2,NA,membrane,structural molecule activity,79921,TCEAL4,NA,NA,ENSG00000133142
O75717,0,6,2188308.5963541665,8.470824426186365e-6,0.38982041259344574,-1.3591184568921664,0.27616307036971793,0.756515890988102,raw,1962985.15625,5560664.03125,1764307.140625,1139045.96875,687762.9375,2015086.34375,WD repeat and HMG-box DNA-binding protein 1 OS=Homo sapiens OX=9606 GN=WDHD1 PE=1 SV=1,cell differentiation;cell proliferation;cellular homeostasis;coagulation,membrane;nucleus,RNA binding;structural molecule activity,11169,WDHD1,Mesodermal commitment pathway,NA,ENSG00000198554
Q9Y2X0,0,6,1363354.4817708333,5.277471589233717e-6,0.3895160675171043,-1.3602452542791303,0.26770791454422505,0.7473260925206285,raw,1777060.515625,1963509.25,1367516.4375,532669.625,616895.5,1922475.5625,Mediator of RNA polymerase II transcription subunit 16 OS=Homo sapiens OX=9606 GN=MED16 PE=1 SV=2,cell growth;cellular component movement;cellular homeostasis;metabolic process,membrane,structural molecule activity,10025,MED16,NA,PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Generic Transcription Pathway,ENSG00000175221
Q7Z6Z7,0,6,16038556.9029948,6.208438782401057e-5,0.3895059840240562,-1.3602826021446688,0.010855563527434895,0.6429522395902524,raw,25906467.03125,19467733.546875,24731117.3125,8007956.21875,8027343.375,10090723.9335938,E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens OX=9606 GN=HUWE1 PE=1 SV=3,cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;metabolic process,cell surface;cytoskeleton;cytosol;endosome;extracellular;membrane;nucleus,RNA binding;structural molecule activity,10075,HUWE1,NA,Antigen processing: Ubiquitination & Proteasome degradation; Neutrophil degranulation,ENSG00000086758
A0A0B4J1V9,0,6,1831645.734375,7.090201744266557e-6,0.3850700250210333,-1.3768072709906136,0.11751577031301065,0.6429522395902524,raw,2364073.21875,3653426.25,1642856.9375,1406824.9375,532771.375,1389921.6875,"Helicase, lymphoid-specific, isoform CRA_b OS=Homo sapiens OX=9606 GN=HELLS PE=1 SV=1",cell growth,NA,structural molecule activity,3070,HELLS,Apoptosis; Apoptosis-related network due to altered Notch3 in ovarian cancer,NA,ENSG00000119969
A0A5F9ZHU7,0,6,925466.4895833333,3.5824308137528654e-6,0.38439057891446526,-1.3793551175684684,0.35072472841916,0.834523763574089,raw,210805.078125,2535118.8125,1247680,479186.875,600411.734375,479596.4375,DNA primase large subunit OS=Homo sapiens OX=9606 GN=PRIM2 PE=1 SV=1,cell proliferation;cellular component movement;cellular homeostasis,membrane,RNA binding;structural molecule activity,NA,PRIM2,DNA replication,NA,ENSG00000146143
A0A6I8PRA0,0,6,3113626.6614583335,1.2052680696794054e-5,0.38087765612805924,-1.3926004390122475,0.0792422030676878,0.6429522395902524,raw,2872504.28125,5746858.375,4766177.625,1815330.5625,1422407.25,2058481.875,Treacle protein (Fragment) OS=Homo sapiens OX=9606 GN=TCOF1 PE=1 SV=1,NA,cytosol;membrane,NA,NA,TCOF1,NA,NA,ENSG00000070814
P69905,0,6,1726346.7083333333,6.6825948997230345e-6,0.380008923319303,-1.3958947987591468,1,1,raw,1649792.875,NA,2745971.25,NA,783276,NA,Hemoglobin subunit alpha OS=Homo sapiens OX=9606 GN=HBA1 PE=1 SV=2,cellular homeostasis;coagulation;conjugation;metabolic process,cell surface;cytosol;Golgi;nucleus,antioxidant activity;structural molecule activity,3039; 3040,HBA1; HBA2,Selenium micronutrient network; Vitamin B12 metabolism; Folate metabolism; Effects of nitric oxide,Scavenging of heme from plasma; Heme signaling; Cytoprotection by HMOX1; Erythrocytes take up carbon dioxide and release oxygen; Erythrocytes take up oxygen and release carbon dioxide,ENSG00000188536; ENSG00000206172
O76080,0,6,972870.075,3.7659275335049655e-6,0.37843847404673536,-1.4018693267840492,0.3223714827139542,0.8037523716522456,raw,NA,2204320.8125,1008441.125,736639.625,488683.6875,426265.125,AN1-type zinc finger protein 5 OS=Homo sapiens OX=9606 GN=ZFAND5 PE=1 SV=1,defense response;development;metabolic process,nucleus,RNA binding;structural molecule activity,7763,ZFAND5,NA,NA,ENSG00000107372
E9PBE1,0.16666666666666666,6,323994.6328125,1.2541657306258754e-6,0.3711637230727114,-1.4298723841542538,1,1,raw,NA,472583.4375,NA,175405.828125,NA,NA,Protein kinase C zeta type OS=Homo sapiens OX=9606 GN=PRKCZ PE=1 SV=1,cell organization and biogenesis;cellular homeostasis,NA,signal transducer activity;structural molecule activity,NA,PRKCZ,"Type II diabetes mellitus; Glioblastoma signaling pathways; Allograft rejection; Interleukin-1 induced activation of NF-kB; Chemokine signaling pathway; Prader-Willi and Angelman syndrome; Splicing factor NOVA regulated synaptic proteins; Non-genomic actions of 1,25 dihydroxyvitamin D3; Osteoblast differentiation and related diseases",NA,ENSG00000067606
G3V4K3,0,6,734303.121875,2.8424477385715815e-6,0.35878493815323875,-1.4788087679181752,0.13097408400024985,0.6498046150645307,raw,1458081.75,1012445.4375,513129.796875,428773.625,259085,NA,Spermatogenesis-defective protein 39 homolog OS=Homo sapiens OX=9606 GN=VIPAS39 PE=1 SV=1,conjugation,mitochondrion,NA,NA,VIPAS39,NA,NA,ENSG00000151445
A0A0U1RQM0,0.16666666666666666,6,627382.41015625,2.428563436329489e-6,0.35406520345066644,-1.4979130282720072,1,1,raw,1176177.5,395960.8125,692279.3125,NA,245112.015625,NA,PCNA-associated factor OS=Homo sapiens OX=9606 PE=1 SV=1,coagulation;metabolic process,membrane;nucleus,NA,NA,NA,NA,NA,NA
Q5W0Z9,0,6,1622791.715625,6.2817391140496824e-6,0.33610191934293454,-1.573029313566568,0.1012472154247658,0.6429522395902524,raw,1859171.40625,2505329.625,2209024.46875,1127087.078125,413346,NA,Palmitoyltransferase ZDHHC20 OS=Homo sapiens OX=9606 GN=ZDHHC20 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;conjugation;metabolic process,cytoplasm;cytoskeleton;extracellular;nucleus,structural molecule activity,253832,ZDHHC20,NA,Maturation of spike protein,ENSG00000180776
Q13356,0,6,442269.0716145834,1.7119996974015662e-6,0.3326143438157886,-1.5880777094681464,0.15741244308582206,0.6638855679885327,raw,420421.4921875,1071472.65625,490376.203125,139838.21875,150349.453125,381156.40625,RING-type E3 ubiquitin-protein ligase PPIL2 OS=Homo sapiens OX=9606 GN=PPIL2 PE=1 SV=1,cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;extracellular;membrane;nucleus,structural molecule activity,23759,PPIL2,NA,Basigin interactions,ENSG00000100023
Q9Y6A5,0.16666666666666666,6,769778.728125,2.9797718949802943e-6,0.32208360523679413,-1.6344928686452103,0.16753089367141552,0.6670444762382309,raw,926445.9375,1212458.75,973693.78125,144891.59375,NA,591403.578125,Transforming acidic coiled-coil-containing protein 3 OS=Homo sapiens OX=9606 GN=TACC3 PE=1 SV=1,cell differentiation;cell growth;defense response;metabolic process,cytosol;endoplasmic reticulum;nucleus,NA,10460,TACC3,NA,NOTCH3 Activation and Transmission of Signal to the Nucleus; Negative regulation of NOTCH4 signaling,ENSG00000013810
Q9NVV0,0.16666666666666666,6,873256.7421875,3.380329700471827e-6,0.3209117569910876,-1.639751449418384,0.10268924212741655,0.6429522395902524,raw,NA,1539796.75,1079442.90625,NA,268458.5,605328.8125,Trimeric intracellular cation channel type B OS=Homo sapiens OX=9606 GN=TMEM38B PE=1 SV=1,cell growth;cellular homeostasis;conjugation;defense response;development;metabolic process,cytoskeleton;cytosol;extracellular;membrane,catalytic activity;structural molecule activity,55151,TMEM38B,Type I collagen synthesis in the context of osteogenesis imperfecta,NA,ENSG00000095209
Q5TBB1,0,6,343520.240625,1.3297483042490936e-6,0.3055478802985022,-1.7105296223502027,0.2066093669340647,0.6986564272044358,raw,467772.96875,796031.15625,167943,143703.4375,142150.640625,NA,Ribonuclease H2 subunit B OS=Homo sapiens OX=9606 GN=RNASEH2B PE=1 SV=1,cell differentiation;cell proliferation;cellular component movement;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,NA,79621,RNASEH2B,NA,NA,ENSG00000136104
P11388,0,6,2004646.47249349,7.75987826093514e-6,0.2817733681437655,-1.8273928333554128,0.15155930302275966,0.6638855679885327,raw,2289223.99414063,5156767.15625,1964900.91894531,1161472.65625,553656.75,901857.359375,DNA topoisomerase 2-alpha OS=Homo sapiens OX=9606 GN=TOP2A PE=1 SV=3,cell differentiation;cell growth;cell proliferation;cellular homeostasis;coagulation;defense response;metabolic process,membrane;nucleus,RNA binding;structural molecule activity,7153,TOP2A,Gastric cancer network 1; Gastric cancer network 2; Retinoblastoma gene in cancer,SUMOylation of DNA replication proteins; Transcription of E2F targets under negative control by DREAM complex,ENSG00000131747
Q15648,0,6,1363245.9973958335,5.277051652075339e-6,0.2808771619498755,-1.831988770818681,0.24278842444715468,0.7289874209382666,raw,1163887.125,3538886.6875,1269219.390625,326909.3125,932912.90625,947660.5625,Mediator of RNA polymerase II transcription subunit 1 OS=Homo sapiens OX=9606 GN=MED1 PE=1 SV=4,cell differentiation;cell growth;cellular component movement;cellular homeostasis;conjugation;defense response;development;metabolic process,membrane,antioxidant activity;RNA binding;structural molecule activity,5469,MED1,"Energy metabolism; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; Non-genomic actions of 1,25 dihydroxyvitamin D3","Estrogen-dependent gene expression; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; Heme signaling; BMAL1:CLOCK,NPAS2 activates circadian gene expression; Transcriptional activation of mitochondrial biogenesis; Nuclear Receptor transcription pathway; Cytoprotection by HMOX1; Activation of gene expression by SREBF (SREBP); RORA activates gene expression",ENSG00000125686
Q02241,0,6,1477363.7109375,5.718795159796237e-6,0.2626149569526638,-1.9289790091708878,0.09754797797420658,0.6429522395902524,raw,1358916.640625,3097604.578125,2090398.65625,1554963.203125,548969.953125,213329.234375,Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3,cell differentiation;cell growth;metabolic process,cytosol;endoplasmic reticulum;membrane;nucleus,motor activity;structural molecule activity,9493,KIF23,Malignant pleural mesothelioma,COPI-dependent Golgi-to-ER retrograde traffic; MHC class II antigen presentation; Kinesins; Mitotic Telophase/Cytokinesis,ENSG00000137807
O00762,0,6,1650728.9375,6.389882591552267e-6,0.2499185459249903,-2.0004701301525,0.11047154299713026,0.6429522395902524,raw,2680049.1875,3720587.875,1257610.5,314300.1875,1510231.65625,421594.21875,Ubiquitin-conjugating enzyme E2 C OS=Homo sapiens OX=9606 GN=UBE2C PE=1 SV=1,cell differentiation;cell growth;cell organization and biogenesis;cellular homeostasis;metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,structural molecule activity,11065,UBE2C,Gastric cancer network 1; Gastric cancer network 2,Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Separation of Sister Chromatids; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects,ENSG00000175063
Q5T3I0,0,6,1089036.0984375,4.2155999382410905e-6,0.24966925801031734,-2.001909902962278,0.2738217405726052,0.7551026273759062,raw,1152864.75,2119037.71875,NA,1597608.25,253684.2734375,321985.5,G patch domain-containing protein 4 OS=Homo sapiens OX=9606 GN=GPATCH4 PE=1 SV=2,metabolic process,membrane,NA,NA,GPATCH4,NA,NA,NA
P55072,0,6,198262681.3333334,7.674641349202989e-4,0.23840397349151565,-2.068519813413076,0.001160077596945778,0.6429522395902524,raw,333867102.71875,335736410.59375,287087938.070313,79595243.90625,64112523.4609375,89176869.25,Transitional endoplasmic reticulum ATPase OS=Homo sapiens OX=9606 GN=VCP PE=1 SV=4,cell differentiation;cell growth;cell organization and biogenesis;cell proliferation;cellular homeostasis;coagulation;conjugation;development;metabolic process,cell surface;cytoskeleton;cytosol;extracellular;membrane;mitochondrion;nucleus,antioxidant activity;DNA binding;structural molecule activity,7415,VCP,Alstrom syndrome; Clock-controlled autophagy in bone metabolism,E3 ubiquitin ligases ubiquitinate target proteins; ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis; Neddylation; KEAP1-NFE2L2 pathway; Aggrephagy; Neutrophil degranulation; Attachment and Entry; Attachment and Entry; Ovarian tumor domain proteases; Josephin domain DUBs; Protein methylation; RHOH GTPase cycle; HSF1 activation; Translesion Synthesis by POLH; N-glycan trimming in the ER and Calnexin/Calreticulin cycle,ENSG00000165280
Q8TBC3,0,6,349682.8515625,1.3536034384588803e-6,0.23519116907154997,-2.0880942038281556,1,1,raw,566200.375,NA,NA,NA,133165.328125,NA,SH3KBP1-binding protein 1 OS=Homo sapiens OX=9606 GN=SHKBP1 PE=1 SV=2,cell growth;metabolic process,mitochondrion,structural molecule activity,92799,SHKBP1,NA,CDC42 GTPase cycle,ENSG00000160410
A0A590TQL1,0.16666666666666666,6,379703.9140625,1.4698133505109324e-6,0.2340811931414053,-2.0949190666807516,1,1,raw,NA,615362.9375,NA,NA,144044.890625,NA,"Adrenocortical dysplasia homolog (Mouse), isoform CRA_a OS=Homo sapiens OX=9606 GN=ACD PE=1 SV=1",NA,NA,NA,NA,NA,NA,NA,NA
Q8IVF2,0.16666666666666666,6,1507559.2578125,5.835680491443223e-6,0.21681598338135782,-2.2054569807460567,1,1,raw,1525196.25,2441995.75,1695445.375,NA,NA,367599.65625,Protein AHNAK2 OS=Homo sapiens OX=9606 GN=AHNAK2 PE=1 SV=2,metabolic process,cytoplasm;cytoskeleton;cytosol;membrane;nucleus,NA,113146,AHNAK2,NA,NA,ENSG00000185567
Q92805,0,6,1113590.9166666667,4.3106503138520674e-6,0.21139839540108532,-2.241963668761291,1,1,raw,NA,2348032.25,NA,143907.484375,848833.015625,NA,Golgin subfamily A member 1 OS=Homo sapiens OX=9606 GN=GOLGA1 PE=1 SV=3,NA,cytoskeleton;cytosol;extracellular;nucleus,NA,2800,GOLGA1,NA,Retrograde transport at the Trans-Golgi-Network,ENSG00000136935
A0A087X211,0.16666666666666666,6,180142.640625,6.973224356684809e-7,0.19639172464500146,-2.348193954772166,1,1,raw,368205.21875,133697.359375,NA,NA,38525.34375,NA,Protein CIP2A OS=Homo sapiens OX=9606 GN=CIP2A PE=1 SV=1,NA,NA,NA,NA,NA,NA,NA,NA
P33552,0,6,3154298.4635416665,1.2210119046722628e-5,0.14175787804741646,-2.8184991812075655,0.036243091091683236,0.6429522395902524,raw,3272321,6738718.125,5655769,2211538,463877.28125,583567.375,Cyclin-dependent kinases regulatory subunit 2 OS=Homo sapiens OX=9606 GN=CKS2 PE=1 SV=1,cell differentiation;cell growth;metabolic process,nucleus,DNA binding;structural molecule activity,1164,CKS2,Small cell lung cancer,NA,ENSG00000123975
Q9H0H5,0,6,1223335.521875,4.735465755325786e-6,0.1298711918774884,-2.9448466482796043,0.01777242416016255,0.6429522395902524,raw,1481127.375,2257273.21875,1887907.4375,225583.578125,NA,264786,Rac GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RACGAP1 PE=1 SV=1,cell differentiation;cell growth;conjugation;defense response;development;metabolic process,cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;membrane;nucleus,DNA binding;motor activity;structural molecule activity,29127,RACGAP1,S1P receptor signal transduction; Wnt signaling pathway and pluripotency,RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; COPI-dependent Golgi-to-ER retrograde traffic; MHC class II antigen presentation; Kinesins; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle,ENSG00000161800
